data_2l9y_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l9y _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.945 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 27.7 m-85 . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.782 0.325 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.15 -30.62 4.61 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.045 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -70.82 -66.77 2.08 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 119.796 -1.192 . . . . 0.0 113.383 -178.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 16.1 m120 68.37 11.99 8.56 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.515 0.326 . . . . 0.0 110.677 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.637 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.9 OUTLIER -58.47 -35.93 72.94 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 121.076 -0.25 . . . . 0.0 111.135 -179.221 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.6 p -62.81 -19.52 64.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.388 0.613 . . . . 0.0 110.788 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.78 -22.05 78.63 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.801 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.491 ' HB3' ' HB3' ' A' ' 26' ' ' ARG . 67.4 m -132.67 -16.88 2.58 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 117.584 0.692 . . . . 0.0 111.877 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.483 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 19.4 m -94.81 133.86 38.06 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -111.38 179.87 3.91 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 41.77 48.32 3.7 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 124.089 0.868 . . . . 0.0 111.984 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.751 HG21 ' HA3' ' A' ' 133' ' ' GLY . 7.4 mt -80.6 104.14 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 109.695 -0.484 . . . . 0.0 109.695 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.556 ' HA ' HD13 ' A' ' 129' ' ' LEU . 78.0 m -146.57 127.06 14.09 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.705 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -95.66 155.7 16.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.718 0.77 . . . . 0.0 113.068 -179.122 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.422 ' HB2' HH22 ' A' ' 22' ' ' ARG . 31.0 t70 -94.28 75.63 3.96 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.428 177.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.7 -53.82 4.74 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.747 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.602 ' CB ' ' HB3' ' A' ' 40' ' ' ASN . . . -149.62 -10.8 0.3 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 120.781 0.324 . . . . 0.0 110.455 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -92.55 96.27 10.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.138 0.494 . . . . 0.0 110.814 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.781 HD21 HD11 ' A' ' 153' ' ' LEU . 45.4 tp -59.65 129.01 39.8 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.329 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.599 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 26.7 ttm180 -133.34 120.02 20.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.195 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.685 ' HB3' HG12 ' A' ' 14' ' ' ILE . . . -142.15 149.43 39.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.648 0.737 . . . . 0.0 112.053 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 63.3 mm-40 -83.65 75.46 10.05 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.365 -1.288 . . . . 0.0 108.873 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.845 ' SG ' HD12 ' A' ' 164' ' ' LEU . 56.0 m -62.96 124.24 20.59 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.86 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.491 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 16.2 ttm180 -76.51 118.01 18.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.736 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.605 ' HG2' ' HA3' ' A' ' 162' ' ' GLY . 10.7 mtm180 -84.1 163.96 19.5 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.76 -16.22 11.33 Favored Glycine 0 C--N 1.338 0.648 0 O-C-N 124.374 1.046 . . . . 0.0 113.387 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -72.39 -10.34 59.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.346 0.593 . . . . 0.0 109.819 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.48 13.98 64.48 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -114.2 162.29 12.45 Favored Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.208 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.492 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 61.5 m-85 -100.99 138.78 37.58 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.959 0.409 . . . . 0.0 111.138 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.8 m -132.5 132.21 42.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.589 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 m -69.39 110.44 4.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.185 0.517 . . . . 0.0 111.635 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.425 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 40.4 t -114.51 142.31 46.57 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.784 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.599 ' HB ' ' HG3' ' A' ' 22' ' ' ARG . 1.9 p -139.52 135.44 40.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.098 0.475 . . . . 0.0 111.35 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.489 HG22 ' HB3' ' A' ' 21' ' ' LEU . 12.3 tt -134.42 150.5 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.087 -177.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.497 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 2.7 m-20 -84.87 97.98 10.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.546 HD22 ' HB3' ' A' ' 21' ' ' LEU . 3.9 mm? -79.58 -8.93 59.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.242 0.544 . . . . 0.0 110.545 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.602 ' HB3' ' CB ' ' A' ' 19' ' ' ALA . 12.9 p30 -65.22 -15.75 62.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.766 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.6 mtt85 -113.97 20.07 16.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.557 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -136.82 -31.7 0.84 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.346 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.586 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 48.3 mt -103.8 133.58 48.55 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.118 0.485 . . . . 0.0 110.044 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.704 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 6.1 m -122.31 146.78 46.98 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.306 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.419 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 8.1 p-10 -94.78 91.81 6.66 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.754 ' HB3' ' HD2' ' A' ' 51' ' ' ARG . 15.1 t70 -93.51 97.6 10.63 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.741 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.6 t30 53.2 46.96 25.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.396 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.536 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 75.44 29.37 60.04 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.957 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.575 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 70.5 m-70 -142.68 122.59 13.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.942 ' HB3' ' HB ' ' A' ' 151' ' ' ILE . 14.7 m-85 -62.5 126.12 26.27 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.754 ' HD2' ' HB3' ' A' ' 46' ' ' ASP . 54.3 mtt85 -143.98 137.71 27.92 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.344 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.446 ' CD1' HD13 ' A' ' 151' ' ' ILE . 86.6 m95 . . . . . 0 C--N 1.325 -0.474 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.6 m . . . . . 0 N--CA 1.45 -0.435 0 CA-C-O 121.151 0.501 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 106' ' ' GLN . . . -124.59 177.15 6.09 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.112 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 p -129.46 120.18 25.01 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.474 HG21 ' CE1' ' A' ' 80' ' ' PHE . 7.9 p -107.05 147.39 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.565 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 13.4 m -95.37 124.87 39.62 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.554 ' CG2' HD12 ' A' ' 99' ' ' ILE . 47.9 t -73.99 133.13 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.362 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -99.16 170.2 8.85 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 124.384 1.052 . . . . 0.0 111.17 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.811 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 41.5 tt0 -61.48 119.63 8.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.645 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.55 18.78 51.23 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.67 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -110.36 148.02 32.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.15 0.475 . . . . 0.0 111.014 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.637 ' HA ' HG12 ' A' ' 99' ' ' ILE . 74.3 p -126.57 173.17 9.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.367 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.56 HD13 HD13 ' A' ' 93' ' ' ILE . 1.5 mm? -52.75 -43.03 65.49 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.539 0.685 . . . . 0.0 109.701 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.457 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 65.1 mtp180 -61.8 -38.26 87.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.744 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -72.9 -41.01 65.07 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.537 HG12 ' O ' ' A' ' 72' ' ' THR . 42.8 mm -62.71 -47.98 90.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.731 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -55.49 -50.38 60.42 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.213 178.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.13 -36.74 84.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.754 0.312 . . . . 0.0 111.432 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -70.32 -42.82 71.45 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.65 ' HB2' ' HG ' ' A' ' 82' ' ' CYS . 97.5 m-85 -105.08 18.72 21.87 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.5 t70 52.94 39.08 28.65 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.681 0.753 . . . . 0.0 111.528 178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.731 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 3.4 p -116.86 170.88 8.28 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.218 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.65 ' O ' HG13 ' A' ' 87' ' ' ILE . 6.1 t70 -96.06 124.4 40.05 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.031 -0.667 . . . . 0.0 110.199 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.457 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 5.7 p90 -52.29 -29.49 23.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.512 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -68.86 -43.22 75.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.425 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.666 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 14.0 tp10 -65.31 -45.56 83.85 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.65 HG13 ' O ' ' A' ' 83' ' ' ASP . 4.8 mt -54.97 -46.42 76.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.18 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.585 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.01 -50.01 72.37 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.889 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.427 ' HA ' ' NE ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -55.61 -39.67 71.09 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.666 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 10.9 mmt180 -69.91 -30.98 68.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.688 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.705 HD21 HD11 ' A' ' 93' ' ' ILE . 66.1 t30 -95.39 -3.85 46.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.154 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 50.4 m-80 74.9 17.82 2.72 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.935 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.705 HD11 HD21 ' A' ' 91' ' ' ASN . 14.3 pt -105.55 -179.77 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.538 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 2.3 mp0 -104.69 161.52 14.07 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.496 ' O ' HD21 ' A' ' 73' ' ' LEU . 15.9 p-10 -60.33 -59.65 5.06 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 122.027 0.917 . . . . 0.0 109.284 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -75.78 12.28 1.12 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.602 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 3.8 t70 -63.62 -35.62 81.11 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 9.5 mp 72.17 117.16 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 O-C-N 124.193 0.933 . . . . 0.0 109.313 -176.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.637 HG12 ' HA ' ' A' ' 72' ' ' THR . 7.5 pt -95.72 178.97 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.918 -178.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.441 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 91.3 m-85 -124.35 157.6 64.16 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.751 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.811 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 53.6 Cg_endo -72.4 131.93 18.39 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 123.198 2.598 . . . . 0.0 113.044 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.42 18.96 24.54 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 66' ' ' THR . 33.9 tt0 -105.79 158.71 16.54 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 83.0 t -119.21 118.75 58.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 109.722 -0.474 . . . . 0.0 109.722 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.543 HD12 HG23 ' A' ' 99' ' ' ILE . 94.9 mt -112.52 150.55 31.12 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.035 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.599 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 40.8 mt-30 -90.56 111.74 23.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.781 0.8 . . . . 0.0 110.964 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.0 m -119.55 151.23 51.41 Favored Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.608 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.45 -16.13 53.49 Favored 'Trans proline' 0 N--CA 1.475 0.389 0 C-N-CA 123.542 2.828 . . . . 0.0 114.975 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.6 t . . . . . 0 C--N 1.322 -0.611 0 CA-C-O 121.01 0.433 . . . . 0.0 111.39 179.842 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.704 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.446 -0.699 0 N-CA-C 113.18 0.032 . . . . 0.0 113.18 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 15.5 m120 75.25 24.39 1.44 Allowed 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.457 0.703 . . . . 0.0 112.099 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.586 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 23.8 p90 -59.62 -40.19 86.74 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.069 0.461 . . . . 0.0 110.019 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.441 ' HA ' ' HB1' ' A' ' 124' ' ' ALA . 66.0 t-105 -56.69 -34.58 67.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.386 -178.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -57.03 -25.81 59.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.86 0.362 . . . . 0.0 111.028 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.757 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 9.7 m -132.01 25.45 4.61 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.477 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.441 ' HB1' ' HA ' ' A' ' 121' ' ' TRP . . . -115.89 139.87 49.79 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 120.98 0.419 . . . . 0.0 110.816 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.442 ' HA ' ' HD3' ' A' ' 125' ' ' ARG . 17.8 mmt180 -128.98 146.72 50.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.486 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.7 t70 51.35 59.31 4.69 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 124.014 0.821 . . . . 0.0 110.745 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.481 HG11 HD12 ' A' ' 136' ' ' LEU . 35.1 t -82.78 124.65 39.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.598 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -145.66 144.01 30.16 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.07 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.556 HD13 ' HA ' ' A' ' 15' ' ' CYS . 21.3 mt -86.25 138.85 31.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.29 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.631 HG21 ' HB ' ' A' ' 135' ' ' VAL . 34.4 m -132.6 157.56 43.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.92 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.441 ' O ' ' HG2' ' A' ' 134' ' ' LYS . 0.7 OUTLIER 65.37 18.08 11.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.387 178.578 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.727 ' O ' HD13 ' A' ' 14' ' ' ILE . . . 90.42 30.46 12.09 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.222 -0.99 . . . . 0.0 113.829 178.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.751 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 86.69 -9.87 69.73 Favored Glycine 0 C--O 1.261 1.832 0 CA-C-O 123.011 1.339 . . . . 0.0 113.213 176.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.708 ' HG3' HG21 ' A' ' 135' ' ' VAL . 8.4 ptpp? -74.18 -17.4 60.91 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.708 HG21 ' HG3' ' A' ' 134' ' ' LYS . 22.8 t -137.79 143.13 34.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.782 177.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.661 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 34.1 tp -126.24 119.15 26.7 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.489 ' OE2' ' HD3' ' A' ' 148' ' ' ARG . 16.2 tt0 -112.15 138.26 49.08 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.76 0.314 . . . . 0.0 111.357 -176.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . . . -162.86 167.04 23.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.988 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -94.36 106.17 18.14 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.536 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 67.0 mt -96.96 130.5 44.26 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.268 0.556 . . . . 0.0 111.567 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.757 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 74.4 ttt180 -73.28 141.32 47.19 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.128 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.51 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 2.0 p90 -159.06 -169.94 2.84 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 121.081 -0.247 . . . . 0.0 111.352 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.7 m -56.01 -29.65 60.67 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -101.14 27.16 21.87 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.243 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 93.68 -111.1 4.07 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.363 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -128.88 133.32 47.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.717 0.258 . . . . 0.0 110.339 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.51 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 54.0 t30 -133.01 141.42 48.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.712 0.291 . . . . 0.0 110.497 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.489 ' HD3' ' OE2' ' A' ' 137' ' ' GLU . 24.9 ttm180 -79.6 114.73 18.75 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.921 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.575 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 36.2 t -125.78 168.26 14.05 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.698 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.661 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -146.73 163.05 37.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.082 0.468 . . . . 0.0 111.978 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.942 ' HB ' ' HB3' ' A' ' 50' ' ' PHE . 9.0 tt -145.47 152.9 14.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.302 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.654 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 15.1 m-85 -93.32 105.84 17.87 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.781 HD11 HD21 ' A' ' 21' ' ' LEU . 22.2 mt -67.25 -34.09 76.7 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.243 178.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.455 ' HA ' ' CD1' ' A' ' 7' ' ' PHE . 1.9 p-10 -57.41 -11.93 2.22 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.908 178.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.945 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 36.5 mt-10 -62.3 -55.27 29.84 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.106 0.479 . . . . 0.0 111.938 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -118.34 -12.13 9.94 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.959 -0.697 . . . . 0.0 111.828 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.435 ' CG2' ' HG ' ' A' ' 164' ' ' LEU . 49.6 mm -87.2 108.84 18.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.298 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -115.25 154.86 16.7 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.562 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.536 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.0 t30 -94.47 113.68 25.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.107 0.479 . . . . 0.0 109.891 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 160' ' ' ARG . 15.2 tpt180 -110.97 86.72 2.37 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.92 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.0 t30 55.17 55.9 7.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.368 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.605 ' HA3' ' HG2' ' A' ' 27' ' ' ARG . . . 79.99 7.63 88.35 Favored Glycine 0 C--O 1.228 -0.231 0 CA-C-N 115.509 -0.769 . . . . 0.0 113.781 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -123.47 125.16 44.41 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.855 0.359 . . . . 0.0 111.397 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.845 HD12 ' SG ' ' A' ' 25' ' ' CYS . 0.2 OUTLIER -73.87 112.09 9.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.591 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 47.9 mm . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.166 -179.125 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.75 -26.66 12.18 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.22 -72.63 0.64 Allowed Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 119.66 -1.257 . . . . 0.0 112.61 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 64.53 14.43 8.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.615 0.245 . . . . 0.0 110.677 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.564 ' CE2' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -64.05 -32.5 74.07 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.994 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.5 t -70.7 -11.1 60.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.359 0.6 . . . . 0.0 109.728 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.58 -16.92 72.13 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.418 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.455 ' HB2' ' HB3' ' A' ' 26' ' ' ARG . 33.3 p -137.21 -11.27 1.68 Allowed 'General case' 0 C--O 1.221 -0.419 0 O-C-N 122.507 -0.408 . . . . 0.0 111.928 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 12.1 m -105.18 132.53 51.28 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.535 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 25.1 ptt180 -108.89 -176.77 3.13 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 44.28 42.3 5.08 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 123.913 0.758 . . . . 0.0 112.058 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.736 HG21 ' HA3' ' A' ' 133' ' ' GLY . 5.6 mt -80.2 100.97 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 121.108 0.48 . . . . 0.0 110.889 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.537 ' HA ' HD13 ' A' ' 129' ' ' LEU . 71.7 m -147.82 127.13 13.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.515 -0.766 . . . . 0.0 108.984 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.701 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -92.57 158.36 16.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.676 0.75 . . . . 0.0 112.782 -179.046 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -96.13 74.31 2.98 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.18 -55.41 5.03 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.226 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.448 ' HB1' ' HB2' ' A' ' 40' ' ' ASN . . . -148.67 -12.42 0.34 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -85.89 92.37 8.63 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.798 HD22 HD21 ' A' ' 153' ' ' LEU . 43.2 tp -58.87 125.2 22.57 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.548 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 2.3 ttt180 -133.08 122.64 24.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.14 0.495 . . . . 0.0 110.703 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.615 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -138.83 176.24 8.86 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.243 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.535 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 6.2 mt-10 -115.61 80.07 1.38 Allowed 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.587 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 55.6 m -64.77 126.69 28.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.691 -178.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 10' ' ' SER . 43.5 ttt-85 -74.73 114.68 13.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.676 178.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.6 ttm180 -82.57 154.9 24.76 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -48.75 -22.47 2.82 Favored Glycine 0 C--N 1.332 0.325 0 O-C-N 124.633 1.208 . . . . 0.0 115.115 -177.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -72.48 -14.41 61.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.509 0.671 . . . . 0.0 110.574 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.31 7.78 53.97 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -102.74 147.44 17.03 Favored Glycine 0 C--O 1.225 -0.445 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.511 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.437 ' HD1' ' O ' ' A' ' 24' ' ' GLU . 84.4 m-85 -96.57 124.63 40.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.02 0.41 . . . . 0.0 110.318 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.9 m -117.01 126.44 52.89 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.339 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.3 m -67.09 126.25 28.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.253 0.549 . . . . 0.0 110.245 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 46.8 t -129.86 152.69 49.06 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.763 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 5.3 p -144.12 133.77 19.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.044 0.45 . . . . 0.0 111.171 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.451 HG23 ' HB3' ' A' ' 21' ' ' LEU . 11.2 tt -135.07 153.53 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.226 -178.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -82.97 111.6 18.98 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 122.041 -0.412 . . . . 0.0 111.157 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.517 HD23 ' HB3' ' A' ' 21' ' ' LEU . 2.0 mm? -88.83 -2.0 58.37 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.448 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 66.9 t30 -74.78 -14.73 60.74 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 41' ' ' ARG . 50.9 mtm180 -107.18 17.25 23.17 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.296 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.433 ' HB2' HD11 ' A' ' 39' ' ' LEU . 39.8 m-85 -134.01 -33.86 1.02 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.339 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.577 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 35.8 mt -105.73 137.18 44.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.926 0.394 . . . . 0.0 111.624 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.657 ' HG ' ' HA2' ' A' ' 118' ' ' GLY . 5.9 m -129.94 140.76 50.88 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.677 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.804 ' CB ' ' HG ' ' A' ' 140' ' ' LEU . 21.2 p-10 -80.71 93.79 6.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.36 0.6 . . . . 0.0 110.542 178.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -92.78 91.24 7.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.981 0.42 . . . . 0.0 111.065 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.9 t30 51.86 45.23 28.58 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.361 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.35 34.4 29.26 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.728 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.653 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 32.8 t60 -155.35 122.0 5.33 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.724 ' HZ ' ' HB1' ' A' ' 138' ' ' ALA . 55.3 m-85 -58.44 143.98 43.65 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.93 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.647 ' HA ' ' NE ' ' A' ' 51' ' ' ARG . 4.4 mmp_? -146.14 134.26 21.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.449 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.8 ' HZ2' ' HA ' ' A' ' 153' ' ' LEU . 95.0 m95 . . . . . 0 C--N 1.322 -0.62 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.107 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.2 m . . . . . 0 N--CA 1.45 -0.462 0 CA-C-O 120.95 0.405 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.3 177.16 7.79 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.203 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.44 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 8.9 p -130.32 119.73 23.27 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.404 HG23 ' CE1' ' A' ' 80' ' ' PHE . 8.2 p -109.48 140.51 27.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.685 0.278 . . . . 0.0 110.623 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 7.1 m -88.27 131.1 34.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.246 0.546 . . . . 0.0 110.28 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.489 ' CG2' HD12 ' A' ' 99' ' ' ILE . 43.0 t -81.1 134.93 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.9 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.58 HE21 ' HA ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -108.8 170.61 7.93 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 124.1 0.875 . . . . 0.0 109.939 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.655 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 34.7 tt0 -65.12 120.13 12.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.834 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.67 -7.19 45.52 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.879 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -95.04 148.15 22.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.331 0.586 . . . . 0.0 112.029 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.605 ' HA ' HG12 ' A' ' 99' ' ' ILE . 74.5 p -133.38 170.75 15.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 99' ' ' ILE . 1.1 mm? -52.18 -45.9 65.32 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.899 0.772 . . . . 0.0 109.453 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -57.49 -38.64 74.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.367 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.66 -43.74 46.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.594 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 72' ' ' THR . 43.5 mm -59.83 -46.55 93.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.885 0.374 . . . . 0.0 110.059 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.642 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.86 -51.73 56.39 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.555 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -66.85 -30.81 71.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.025 0.44 . . . . 0.0 111.43 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -70.12 -46.82 63.99 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.404 ' CE1' HG23 ' A' ' 65' ' ' VAL . 89.7 m-85 -103.59 12.62 34.72 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.0 t0 60.21 57.88 2.8 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.96 0.886 . . . . 0.0 110.812 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.642 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -140.02 164.88 28.85 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.065 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.677 ' O ' HG13 ' A' ' 87' ' ' ILE . 6.8 m-20 -83.05 114.95 21.64 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.622 ' HD1' ' HB2' ' A' ' 95' ' ' ASN . 10.6 p90 -54.57 -31.53 56.86 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.724 0.64 . . . . 0.0 111.142 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.512 ' HA ' ' HB3' ' A' ' 95' ' ' ASN . 51.0 t-80 -71.86 -36.03 70.01 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.719 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.592 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 9.9 tp10 -68.77 -47.0 67.3 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.677 HG13 ' O ' ' A' ' 83' ' ' ASP . 7.1 mt -51.91 -47.94 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.017 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.589 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.83 -50.92 69.05 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.345 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -56.8 -39.79 74.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.934 0.397 . . . . 0.0 111.418 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.592 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 21.7 mmt180 -70.17 -31.07 68.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.108 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.508 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 17.5 t-20 -90.74 -6.04 54.93 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.985 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.508 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 93.0 m-20 79.5 17.75 0.8 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.524 0.73 . . . . 0.0 111.089 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.589 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 14.5 pt -110.68 -173.17 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.585 178.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.526 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 52.5 mt-30 -115.1 154.42 28.94 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.622 ' HB2' ' HD1' ' A' ' 84' ' ' PHE . 6.9 p-10 -56.6 -55.1 38.25 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 122.199 1.0 . . . . 0.0 109.329 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -78.52 12.92 1.78 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.091 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.526 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 0.7 OUTLIER -70.96 -29.96 66.1 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.093 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 9.6 mp 69.88 114.61 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 O-C-N 124.266 0.979 . . . . 0.0 110.433 -177.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.605 HG12 ' HA ' ' A' ' 72' ' ' THR . 9.5 pt -94.63 176.03 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 114.81 -1.087 . . . . 0.0 111.338 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.543 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 90.5 m-85 -130.71 160.03 68.28 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.941 -178.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.655 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 20.1 Cg_endo -66.05 135.28 40.03 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.299 2.666 . . . . 0.0 114.048 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.73 23.38 18.5 Favored Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.397 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.512 ' O ' ' HA ' ' A' ' 66' ' ' THR . 46.1 mt-30 -111.88 165.35 12.16 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 120.574 -0.45 . . . . 0.0 109.837 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.44 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 65.6 t -125.45 115.73 44.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.477 ' HB3' HG21 ' A' ' 87' ' ' ILE . 81.7 mt -108.19 150.87 26.69 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.711 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -90.62 115.41 27.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.394 0.616 . . . . 0.0 110.613 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.0 m -120.37 150.5 51.95 Favored Pre-proline 0 C--N 1.311 -1.08 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.388 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.93 -19.28 58.27 Favored 'Trans proline' 0 C--N 1.332 -0.304 0 C-N-CA 123.195 2.597 . . . . 0.0 113.96 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 C--N 1.32 -0.694 0 CA-C-O 121.356 0.598 . . . . 0.0 111.351 179.937 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.657 ' HA2' ' HG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.444 -0.809 0 N-CA-C 112.088 -0.405 . . . . 0.0 112.088 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 21.6 m120 75.24 27.16 1.12 Allowed 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.751 0.82 . . . . 0.0 112.476 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.577 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 18.8 p90 -63.46 -39.29 94.07 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.484 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 63.7 t-105 -61.94 -31.44 71.77 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.133 -178.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -58.75 -16.22 15.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 111.27 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.673 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 36.3 m -145.75 30.55 1.08 Allowed 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.164 177.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.484 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -110.38 136.47 49.49 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.595 177.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.4 tmm_? -125.03 137.04 54.23 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.61 57.99 3.52 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.625 0.578 . . . . 0.0 111.164 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.504 ' HA ' ' HB3' ' A' ' 138' ' ' ALA . 34.6 t -85.53 124.96 40.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.114 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.477 ' O ' HD11 ' A' ' 136' ' ' LEU . 38.7 ptt180 -148.98 142.97 25.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.956 0.408 . . . . 0.0 111.143 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.724 HD11 ' CD1' ' A' ' 21' ' ' LEU . 23.1 mt -85.09 131.97 34.38 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.726 HG23 ' HB ' ' A' ' 135' ' ' VAL . 28.9 m -125.28 158.98 33.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.712 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.667 ' HB3' ' CG ' ' A' ' 134' ' ' LYS . 0.2 OUTLIER 68.55 11.13 8.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.152 179.52 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.654 ' O ' HD13 ' A' ' 14' ' ' ILE . . . 91.28 31.33 9.77 Favored Glycine 0 N--CA 1.437 -1.251 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.092 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.736 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 93.25 -14.91 64.17 Favored Glycine 0 C--O 1.265 2.062 0 CA-C-O 123.005 1.336 . . . . 0.0 113.627 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.667 ' CG ' ' HB3' ' A' ' 131' ' ' ASP . 7.8 ptpp? -72.99 -15.63 61.53 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 121.241 -1.153 . . . . 0.0 109.024 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.726 ' HB ' HG23 ' A' ' 130' ' ' VAL . 12.0 t -139.27 147.37 24.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.718 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 47.9 tp -128.95 123.14 31.73 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -112.46 130.94 55.82 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 123.273 0.358 . . . . 0.0 110.772 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.724 ' HB1' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.72 161.6 26.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.188 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.633 ' HG2' ' HG3' ' A' ' 148' ' ' ARG . 39.3 mt-10 -98.0 106.17 18.43 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.628 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.804 ' HG ' ' CB ' ' A' ' 45' ' ' ASN . 0.5 OUTLIER -89.71 126.03 35.5 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.852 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.673 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 52.3 ttt-85 -69.97 140.38 52.97 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.647 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.647 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 2.9 p90 -151.6 -164.94 2.11 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.148 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.3 t -59.78 -25.61 65.05 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -107.65 28.88 11.29 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.591 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 96.46 -114.45 4.94 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.485 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -125.27 129.38 49.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.78 0.29 . . . . 0.0 110.666 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.647 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 22.9 t-20 -123.56 132.87 54.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.711 0.291 . . . . 0.0 111.114 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.633 ' HG3' ' HG2' ' A' ' 139' ' ' GLU . 38.2 mtp85 -74.86 113.18 11.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.533 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.653 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 33.7 t -128.9 165.53 20.88 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.047 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.56 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 19.4 ptt180 -147.74 148.69 31.25 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.138 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.724 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 11.6 tt -130.68 161.67 40.15 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.428 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.537 ' O ' ' HG3' ' A' ' 155' ' ' GLU . 14.6 m-85 -104.88 105.46 15.53 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 122.265 -0.272 . . . . 0.0 110.991 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.8 ' HA ' ' HZ2' ' A' ' 52' ' ' TRP . 9.9 mp -69.27 -31.62 70.25 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.502 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.556 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 11.1 t70 -58.99 -7.84 1.21 Allowed 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.932 178.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.537 ' HG3' ' O ' ' A' ' 152' ' ' TYR . 37.0 mt-10 -72.73 -51.78 17.81 Favored 'General case' 0 CA--C 1.508 -0.635 0 O-C-N 121.862 -0.523 . . . . 0.0 112.31 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -122.55 2.22 9.57 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.126 -177.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.423 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 46.2 mm -106.26 110.44 31.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.431 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.446 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -113.43 168.77 12.68 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.28 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.587 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 1.6 t30 -100.83 119.8 39.19 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.654 ' HD3' HD13 ' A' ' 165' ' ' ILE . 58.5 ttt180 -115.12 88.68 2.92 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.807 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 17.8 m120 59.55 34.7 22.49 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.937 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.58 -4.55 43.34 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.023 -1.084 . . . . 0.0 114.243 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' A' ' 160' ' ' ARG . 14.4 pt-20 -122.02 139.79 53.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.683 0.742 . . . . 0.0 110.9 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.401 ' CD2' ' HD2' ' A' ' 7' ' ' PHE . 76.0 mt -76.23 115.12 15.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.386 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.654 HD13 ' HD3' ' A' ' 160' ' ' ARG . 47.7 mt . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.953 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.678 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 33.9 m-85 . . . . . 0 N--CA 1.452 -0.37 0 CA-C-O 120.703 0.287 . . . . 0.0 111.488 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.39 -26.99 6.51 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -76.09 -67.85 1.63 Allowed Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 119.069 -1.539 . . . . 0.0 112.363 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 63.94 15.01 8.84 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 122.973 0.509 . . . . 0.0 110.71 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.674 ' CE2' HD13 ' A' ' 14' ' ' ILE . 2.1 p90 -56.4 -37.23 69.85 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.533 ' HA ' HD12 ' A' ' 14' ' ' ILE . 3.9 m -60.2 -23.05 63.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.841 0.353 . . . . 0.0 111.745 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.19 -21.66 77.2 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.974 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 33.2 p -125.19 -24.88 3.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.12 0.486 . . . . 0.0 111.321 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.2 m -94.64 131.63 40.22 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.815 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 12' ' ' ARG . 10.5 ptm180 -113.4 -179.54 3.67 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 47.53 44.65 17.12 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 123.832 0.708 . . . . 0.0 111.41 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.784 HG22 ' HA3' ' A' ' 133' ' ' GLY . 7.2 mt -80.22 103.25 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-O 121.039 0.447 . . . . 0.0 110.425 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.571 ' O ' ' HB3' ' A' ' 22' ' ' ARG . 72.0 m -146.95 127.5 14.15 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.792 HD21 HD12 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -91.91 157.99 16.53 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.086 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -97.24 76.08 2.6 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 113.958 -1.474 . . . . 0.0 107.815 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.44 -58.92 5.01 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.994 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.504 ' HB2' ' HB3' ' A' ' 40' ' ' ASN . . . -148.66 -6.45 0.4 Allowed 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -97.81 98.03 9.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.117 0.484 . . . . 0.0 110.382 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.875 ' HB2' HD21 ' A' ' 39' ' ' LEU . 42.9 tp -54.25 129.88 36.74 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 114.871 -1.058 . . . . 0.0 112.489 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.571 ' HB3' ' O ' ' A' ' 15' ' ' CYS . 16.2 ttp180 -132.62 124.1 27.67 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.601 -0.439 . . . . 0.0 110.089 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.633 ' HB3' HG12 ' A' ' 14' ' ' ILE . . . -147.23 144.43 28.89 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.663 0.744 . . . . 0.0 111.682 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.601 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 2.3 mm-40 -79.27 75.66 5.84 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.882 178.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.566 ' HB2' ' HA2' ' A' ' 162' ' ' GLY . 46.2 m -62.43 124.57 21.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.49 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' A' ' 10' ' ' SER . 58.6 ttp180 -68.92 119.92 14.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.336 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -90.27 153.5 20.42 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.93 -13.07 4.23 Favored Glycine 0 C--N 1.33 0.232 0 O-C-N 124.443 1.09 . . . . 0.0 115.005 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -83.52 -2.91 57.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.978 0.418 . . . . 0.0 110.554 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.59 10.99 66.79 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -112.4 145.29 18.02 Favored Glycine 0 C--O 1.226 -0.387 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.408 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.601 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 69.4 m-85 -89.35 133.36 34.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.878 0.339 . . . . 0.0 110.433 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.8 m -115.16 124.75 52.28 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.307 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.0 m -68.31 107.42 2.82 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.09 0.472 . . . . 0.0 109.938 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 48.0 t -113.18 152.58 29.53 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.062 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.639 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.2 p -145.13 130.61 13.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.097 0.475 . . . . 0.0 110.757 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.3 tt -130.11 143.23 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.676 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.15 101.37 3.92 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.71 0.29 . . . . 0.0 111.572 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.875 HD21 ' HB2' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -82.44 -9.78 59.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.079 0.466 . . . . 0.0 110.301 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 2.1 p-10 -62.59 -18.13 61.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.215 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -112.63 20.7 16.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.303 0.573 . . . . 0.0 110.179 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 27.4 m-85 -131.34 -33.35 1.48 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.001 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.586 HD22 HG22 ' A' ' 151' ' ' ILE . 50.3 mt -106.25 135.01 48.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.689 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.622 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 3.3 m -126.34 138.15 53.54 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.033 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.888 ' CB ' ' HG ' ' A' ' 140' ' ' LEU . 16.1 p-10 -86.75 102.14 13.96 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.524 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.452 ' CB ' ' HD3' ' A' ' 51' ' ' ARG . 17.1 t70 -107.05 93.2 4.42 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.083 0.468 . . . . 0.0 110.507 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.7 t30 55.99 43.15 27.69 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.096 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 149' ' ' SER . . . 83.06 27.36 41.03 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.697 -0.764 . . . . 0.0 113.649 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.45 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 69.9 m-70 -144.47 139.06 28.06 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.968 ' HZ ' ' HB3' ' A' ' 138' ' ' ALA . 49.8 m-85 -80.88 144.25 32.11 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.206 0.527 . . . . 0.0 111.892 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.452 ' HD3' ' CB ' ' A' ' 46' ' ' ASP . 26.6 mtp180 -146.6 132.82 19.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.711 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.64 ' HZ2' ' HA ' ' A' ' 153' ' ' LEU . 97.2 m95 . . . . . 0 C--N 1.32 -0.708 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.315 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 55.3 m . . . . . 0 N--CA 1.453 -0.321 0 CA-C-O 121.077 0.465 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -133.89 176.59 8.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.642 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.505 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 20.7 p -129.62 122.58 29.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.885 0.374 . . . . 0.0 111.124 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.472 HG23 ' CE2' ' A' ' 80' ' ' PHE . 10.8 p -108.22 139.79 29.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.838 0.352 . . . . 0.0 111.46 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.0 m -91.62 125.64 36.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.242 0.544 . . . . 0.0 109.648 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.826 HG21 HD13 ' A' ' 99' ' ' ILE . 86.6 t -84.06 131.14 34.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.341 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -106.1 169.46 8.49 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 124.059 0.849 . . . . 0.0 110.688 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.671 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 33.0 tt0 -55.65 117.67 3.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.295 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.36 4.89 40.52 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.34 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.418 ' HB2' HG11 ' A' ' 67' ' ' VAL . 95.3 m-20 -109.75 138.44 46.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.065 0.46 . . . . 0.0 111.939 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.677 ' HA ' HG12 ' A' ' 99' ' ' ILE . 68.6 p -122.84 173.99 7.42 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.652 HD21 HG21 ' A' ' 99' ' ' ILE . 0.7 OUTLIER -51.34 -43.06 61.66 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.525 0.602 . . . . 0.0 110.372 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -62.07 -35.89 79.99 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.883 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -73.89 -40.63 63.06 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 72' ' ' THR . 46.1 mm -63.14 -49.25 84.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.688 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -59.31 -52.57 52.46 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.652 -0.704 . . . . 0.0 113.539 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -64.5 -25.59 68.06 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -81.57 -49.5 10.47 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.561 ' HB2' ' HG ' ' A' ' 82' ' ' CYS . 96.2 m-85 -94.13 12.95 24.7 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.8 t70 60.59 44.32 11.74 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.998 0.904 . . . . 0.0 110.797 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.688 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.8 p -126.19 162.4 25.5 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.865 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.457 ' O ' HG13 ' A' ' 87' ' ' ILE . 4.1 p-10 -92.91 119.09 31.85 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.558 0.694 . . . . 0.0 109.437 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.666 ' HD2' ' HB2' ' A' ' 95' ' ' ASN . 7.7 p90 -47.86 -32.57 6.34 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 114.431 -1.258 . . . . 0.0 111.895 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.401 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 40.7 t-80 -60.48 -47.85 84.33 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.951 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.601 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 6.2 tp10 -63.54 -47.04 83.24 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.928 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.483 HD13 ' HA ' ' A' ' 84' ' ' PHE . 5.1 mt -49.7 -47.06 21.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.413 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.607 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.84 -50.3 71.48 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.907 178.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 85' ' ' HIS . 48.6 mtm180 -58.9 -34.48 71.73 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 11.5 mmt180 -74.98 -28.22 60.47 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.914 0.388 . . . . 0.0 111.538 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.459 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 5.4 t30 -96.43 -5.1 40.48 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.622 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 89.6 m-20 78.2 15.66 1.36 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.313 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.607 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 17.0 pt -103.57 -169.22 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.388 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.421 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 41.6 mt-30 -120.42 153.35 36.69 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.666 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 4.4 p30 -56.94 -57.5 12.27 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 121.826 0.822 . . . . 0.0 109.6 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.68 11.93 2.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.495 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.485 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 0.7 OUTLIER -71.48 -35.08 70.69 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.369 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 9.7 mp 72.65 119.46 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.367 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.826 HD13 HG21 ' A' ' 67' ' ' VAL . 7.1 pt -94.55 176.68 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.328 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.507 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 92.7 m-85 -124.44 160.39 53.25 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.977 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.671 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 28.9 Cg_endo -70.66 132.04 21.13 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.958 2.439 . . . . 0.0 113.143 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.47 9.29 41.55 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -100.46 148.03 25.2 Favored 'General case' 0 C--O 1.215 -0.757 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.505 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 61.1 t -114.6 111.15 34.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.589 HD12 HG23 ' A' ' 99' ' ' ILE . 64.3 mt -101.08 151.66 21.54 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.086 -177.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.43 ' HG2' HG23 ' A' ' 64' ' ' THR . 17.8 mt-30 -90.29 113.72 25.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.702 0.763 . . . . 0.0 110.786 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.8 m -120.19 151.1 52.69 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.607 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.99 -16.35 54.42 Favored 'Trans proline' 0 C--N 1.333 -0.262 0 C-N-CA 123.392 2.728 . . . . 0.0 114.201 -177.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.2 t . . . . . 0 C--N 1.321 -0.654 0 CA-C-O 120.939 0.399 . . . . 0.0 111.088 -179.969 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.622 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.442 -0.957 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 19.7 m120 74.35 25.77 1.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.465 0.706 . . . . 0.0 112.241 178.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.616 ' CD2' ' HE1' ' A' ' 50' ' ' PHE . 12.4 p90 -64.14 -40.43 96.14 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.501 ' HA ' ' HB1' ' A' ' 124' ' ' ALA . 62.7 t-105 -59.17 -31.01 68.6 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.081 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -53.77 -28.02 32.32 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.739 0.304 . . . . 0.0 110.834 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.696 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 16.2 m -137.63 31.18 2.55 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.281 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.501 ' HB1' ' HA ' ' A' ' 121' ' ' TRP . . . -111.65 146.69 37.01 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.15 0.5 . . . . 0.0 111.318 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -132.34 148.02 52.41 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.558 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 50.66 50.82 18.18 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 124.053 0.846 . . . . 0.0 112.116 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.425 HG22 ' HB1' ' A' ' 138' ' ' ALA . 31.6 t -74.22 125.24 33.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -149.59 153.51 37.22 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.126 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.691 HD21 HD13 ' A' ' 153' ' ' LEU . 25.8 mt -97.5 139.71 33.01 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.807 0.337 . . . . 0.0 110.799 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.538 HG23 ' HB ' ' A' ' 135' ' ' VAL . 33.7 m -133.44 156.04 41.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.789 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.586 ' HB3' ' HD2' ' A' ' 134' ' ' LYS . 1.4 m-20 70.13 5.74 5.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.663 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.721 ' O ' HD11 ' A' ' 14' ' ' ILE . . . 99.35 35.59 4.66 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.289 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.784 ' HA3' HG22 ' A' ' 14' ' ' ILE . . . 82.48 -9.58 58.08 Favored Glycine 0 C--O 1.256 1.523 0 CA-C-O 123.003 1.335 . . . . 0.0 113.198 176.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.642 ' O ' ' HA ' ' A' ' 152' ' ' TYR . 18.1 ptpt -74.47 -16.23 60.86 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.563 HG22 ' HG3' ' A' ' 134' ' ' LYS . 24.4 t -140.69 140.21 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.075 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.792 HD12 HD21 ' A' ' 16' ' ' LEU . 7.7 tt -119.01 125.15 48.7 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -110.35 124.45 51.71 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.968 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -157.46 155.67 30.82 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.939 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 31.1 mt-10 -95.0 108.33 20.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.272 0.558 . . . . 0.0 110.605 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.888 ' HG ' ' CB ' ' A' ' 45' ' ' ASN . 0.2 OUTLIER -90.24 128.7 36.46 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.752 -179.81 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.696 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 75.7 ttt180 -70.04 140.69 52.87 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.403 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.458 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.7 p90 -156.46 -171.95 3.89 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.383 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.8 m -55.87 -29.9 60.65 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.787 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -97.67 20.75 49.42 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.204 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 98.75 -110.12 3.94 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.251 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -129.44 133.1 47.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.636 0.255 . . . . 0.0 110.786 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.458 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 11.8 t30 -134.43 127.37 31.39 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.622 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 29.7 ttp180 -79.93 102.35 9.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.448 0.642 . . . . 0.0 110.759 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.45 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 11.4 t -105.27 174.62 5.8 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.124 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.647 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 34.7 ptt180 -147.43 148.24 31.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.918 0.389 . . . . 0.0 111.787 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.709 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 10.9 tt -131.6 159.59 42.96 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.512 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.643 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 44.0 m-85 -99.79 106.04 17.88 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.341 0.115 . . . . 0.0 110.775 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.691 HD13 HD21 ' A' ' 129' ' ' LEU . 16.5 mt -68.74 -35.86 77.66 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.312 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.425 ' HA ' ' HD1' ' A' ' 7' ' ' PHE . 8.3 p-10 -58.26 -8.05 1.02 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.976 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.678 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 41.8 mt-10 -69.41 -55.2 11.02 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.236 0.541 . . . . 0.0 111.912 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -122.23 6.02 9.7 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.306 -177.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.455 HG12 ' CH2' ' A' ' 52' ' ' TRP . 44.3 mm -107.15 113.2 42.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.88 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.422 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -112.71 173.04 14.95 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.965 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.528 ' CG ' ' HB3' ' A' ' 25' ' ' CYS . 0.9 OUTLIER -110.95 128.27 55.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.674 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.96 89.14 3.07 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.37 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 56.99 42.16 26.58 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.442 0.464 . . . . 0.0 111.794 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.566 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 92.51 7.93 62.93 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.928 -0.654 . . . . 0.0 113.406 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -123.59 127.01 47.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.147 0.473 . . . . 0.0 112.094 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.41 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 42.1 mt -70.82 110.39 5.56 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.481 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 63.3 mt . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.382 179.854 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.487 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 45.3 m-85 . . . . . 0 N--CA 1.456 -0.154 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -118.73 -27.75 5.78 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.54 -71.24 0.85 Allowed Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 119.988 -1.101 . . . . 0.0 112.784 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 65.78 10.47 6.85 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 122.455 0.302 . . . . 0.0 110.749 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.624 ' CE2' HD11 ' A' ' 14' ' ' ILE . 1.1 p90 -61.08 -34.08 74.36 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.3 t -68.02 -16.88 64.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.106 0.479 . . . . 0.0 110.279 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.24 -21.16 79.94 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.746 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 11.1 m -130.45 -19.17 3.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.978 0.389 . . . . 0.0 111.622 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 m -94.41 135.09 36.23 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.514 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 11.7 ptm180 -112.72 -178.91 3.51 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 40.75 47.98 2.57 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 123.909 0.755 . . . . 0.0 112.343 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.687 HG12 ' HB3' ' A' ' 23' ' ' ALA . 7.9 mt -80.66 103.83 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.511 ' HA ' HD11 ' A' ' 129' ' ' LEU . 45.4 t -147.95 126.19 12.23 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.738 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -92.34 154.93 18.26 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.559 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -95.09 74.66 3.45 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.4 -57.87 4.88 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.925 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.442 ' HA ' ' HZ ' ' A' ' 120' ' ' PHE . . . -145.28 -9.31 0.58 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.816 0.341 . . . . 0.0 110.257 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -94.98 95.59 8.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.823 0.344 . . . . 0.0 110.089 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.824 ' HB2' HD23 ' A' ' 39' ' ' LEU . 42.8 tp -59.28 128.12 35.53 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.369 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.545 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 51.1 ttt180 -131.1 129.83 42.38 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.05 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.687 ' HB3' HG12 ' A' ' 14' ' ' ILE . . . -150.61 147.34 27.3 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.383 0.611 . . . . 0.0 111.19 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.552 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 1.3 mm-40 -84.49 81.31 8.9 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.842 178.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.533 ' HB2' ' HA2' ' A' ' 162' ' ' GLY . 58.6 m -67.6 128.08 35.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.494 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 10' ' ' SER . 51.1 ttt-85 -74.37 116.19 14.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.793 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -89.5 159.02 17.45 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.092 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.48 -18.23 3.52 Favored Glycine 0 C--N 1.337 0.592 0 O-C-N 124.861 1.351 . . . . 0.0 114.442 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -71.64 -12.37 61.31 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.03 9.62 60.58 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.39 163.69 12.12 Favored Glycine 0 C--O 1.228 -0.238 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.032 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.552 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 70.2 m-85 -100.02 134.03 43.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.63 0.252 . . . . 0.0 110.499 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.6 m -123.79 128.68 49.9 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.271 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.4 114.72 6.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.02 0.438 . . . . 0.0 110.771 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 29.7 t -119.89 149.56 41.89 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.777 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 2.8 p -142.04 136.48 29.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.002 0.43 . . . . 0.0 111.204 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.421 HG22 HD11 ' A' ' 39' ' ' LEU . 13.4 tt -134.06 144.38 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.73 -177.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -77.84 98.81 5.71 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.798 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.824 HD23 ' HB2' ' A' ' 21' ' ' LEU . 1.3 mp -76.25 -6.4 51.25 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.272 0.558 . . . . 0.0 110.153 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.582 HD22 ' HA ' ' A' ' 119' ' ' ASN . 4.8 t-20 -63.61 -21.65 66.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.65 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 41' ' ' ARG . 16.8 ptt85 -111.32 19.35 18.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.039 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 38.6 m-85 -131.44 -32.66 1.52 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.638 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.584 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 51.7 mt -109.71 138.53 45.95 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.036 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 m -132.79 144.22 50.09 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.612 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.459 ' ND2' ' HB2' ' A' ' 123' ' ' SER . 21.6 p-10 -88.27 106.5 18.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.425 0.631 . . . . 0.0 110.205 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -103.24 92.43 4.51 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 122.133 -0.354 . . . . 0.0 110.906 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 49.51 44.29 24.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.78 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.575 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 85.82 30.0 24.8 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.486 178.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.672 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 21.9 t-160 -152.58 124.6 8.01 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.754 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 63.6 m-85 -62.26 143.3 57.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.791 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.4 mtm180 -144.8 134.32 23.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.409 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.559 ' HA ' ' O ' ' A' ' 42' ' ' TYR . 99.4 m95 . . . . . 0 C--N 1.323 -0.563 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.882 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.8 m . . . . . 0 N--CA 1.448 -0.554 0 CA-C-O 121.177 0.513 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.43 176.55 5.13 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.68 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.538 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 10.0 p -126.85 115.89 20.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.957 0.408 . . . . 0.0 112.074 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.554 HG21 ' CE2' ' A' ' 80' ' ' PHE . 7.4 p -106.29 148.04 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.062 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 10.3 m -93.04 130.27 38.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.172 0.51 . . . . 0.0 110.454 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.579 HG23 HD13 ' A' ' 99' ' ' ILE . 58.2 t -83.26 138.39 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.185 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.41 ' HG3' ' H ' ' A' ' 69' ' ' GLN . 21.1 tp60 -108.4 171.2 7.55 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 124.373 1.045 . . . . 0.0 109.61 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.69 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 63.7 tt0 -68.95 126.05 28.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.395 -178.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.44 8.55 59.71 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.988 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -119.84 123.18 43.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.902 0.382 . . . . 0.0 110.962 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.549 ' HA ' HG12 ' A' ' 99' ' ' ILE . 69.3 p -104.76 -176.91 3.21 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.551 HD13 ' HB ' ' A' ' 87' ' ' ILE . 1.3 mm? -51.53 -40.79 60.34 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.392 0.615 . . . . 0.0 109.55 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.421 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 38.8 ttm180 -60.06 -42.47 94.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.253 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -70.66 -43.39 69.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.355 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.503 HG12 ' O ' ' A' ' 72' ' ' THR . 38.3 mm -62.96 -45.33 99.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.729 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.95 -56.22 26.36 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.654 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -64.72 -26.73 68.49 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 45.6 ttm-85 -72.98 -38.86 66.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.565 ' HB2' ' HG ' ' A' ' 82' ' ' CYS . 96.8 m-85 -111.02 19.64 18.26 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.9 t70 55.27 36.17 26.48 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.679 0.752 . . . . 0.0 111.776 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.729 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.5 p -113.72 171.19 7.73 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.666 ' O ' HG13 ' A' ' 87' ' ' ILE . 6.9 t70 -97.77 127.34 43.65 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.91 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.47 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 11.1 p90 -52.92 -30.12 32.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.287 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -73.33 -38.01 65.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.975 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -68.16 -45.91 72.21 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.666 HG13 ' O ' ' A' ' 83' ' ' ASP . 6.0 mt -54.67 -47.03 73.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.603 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.93 -47.89 81.28 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.679 177.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -56.75 -42.41 79.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.981 0.42 . . . . 0.0 111.369 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -69.79 -36.24 75.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.759 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.496 HD21 HG21 ' A' ' 93' ' ' ILE . 7.2 t30 -89.4 -5.33 57.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.387 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 94.0 m-20 74.8 21.05 2.17 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.587 0.755 . . . . 0.0 111.425 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.603 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 17.6 pt -108.89 -173.48 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.495 ' H ' ' HB2' ' A' ' 97' ' ' ASP . 88.7 mt-30 -110.62 158.15 18.9 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.528 ' O ' HD21 ' A' ' 73' ' ' LEU . 3.2 p-10 -58.98 -55.34 36.46 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-O 122.221 1.01 . . . . 0.0 108.43 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -79.68 12.06 2.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.666 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.495 ' HB2' ' H ' ' A' ' 94' ' ' GLN . 4.4 t70 -63.73 -32.57 74.1 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.1 mt 70.68 112.44 0.05 Allowed 'General case' 0 C--O 1.234 0.249 0 O-C-N 124.465 1.103 . . . . 0.0 110.123 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.739 HG21 HD13 ' A' ' 105' ' ' LEU . 14.4 pt -95.33 175.14 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.155 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.524 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 97.5 m-85 -128.96 158.8 71.52 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.969 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.69 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 20.8 Cg_endo -66.97 138.81 49.19 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.508 2.806 . . . . 0.0 114.307 -178.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.07 11.3 57.72 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.702 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.473 ' O ' ' HA ' ' A' ' 66' ' ' THR . 74.1 mt-30 -102.64 166.04 10.73 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.352 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.538 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 80.9 t -122.39 114.78 43.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-O 120.931 0.396 . . . . 0.0 110.198 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.739 HD13 HG21 ' A' ' 99' ' ' ILE . 79.0 mt -107.26 152.01 24.68 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.823 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -89.9 116.22 27.81 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.795 0.807 . . . . 0.0 111.45 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.9 m -126.29 150.91 71.42 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 114.253 -1.339 . . . . 0.0 109.954 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.68 -17.41 59.82 Favored 'Trans proline' 0 N--CA 1.476 0.442 0 C-N-CA 123.735 2.957 . . . . 0.0 114.952 -177.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.6 t . . . . . 0 C--N 1.324 -0.542 0 CA-C-O 120.942 0.401 . . . . 0.0 111.268 -179.859 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.445 -0.718 0 N-CA-C 111.905 -0.478 . . . . 0.0 111.905 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.582 ' HA ' HD22 ' A' ' 40' ' ' ASN . 6.9 m-20 72.28 25.55 2.84 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 178.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.584 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 25.3 p90 -55.78 -39.14 70.84 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.537 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 62.2 t-105 -59.03 -32.96 70.21 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.67 -178.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -52.31 -38.6 58.91 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 121.7 0.762 . . . . 0.0 110.77 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.892 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 17.2 m -122.91 25.85 8.42 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.503 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.59 ' O ' ' HD2' ' A' ' 125' ' ' ARG . . . -114.72 134.61 54.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.857 0.36 . . . . 0.0 111.05 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.59 ' HD2' ' O ' ' A' ' 124' ' ' ALA . 7.1 mpt_? -131.33 158.61 40.23 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.631 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.9 t70 53.94 46.1 26.32 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.761 0.791 . . . . 0.0 110.214 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.477 ' CG1' HD11 ' A' ' 136' ' ' LEU . 22.5 t -79.85 122.09 34.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.614 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 128' ' ' ARG . 1.3 ptp85 -146.55 147.8 31.5 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.286 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.689 HD22 HD13 ' A' ' 153' ' ' LEU . 19.4 mt -86.97 127.84 35.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.204 0.526 . . . . 0.0 110.072 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.847 HG22 ' HB ' ' A' ' 135' ' ' VAL . 27.6 m -116.79 157.17 17.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.909 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.454 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 0.9 OUTLIER 68.42 3.23 3.67 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.584 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.635 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 97.91 29.24 7.78 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.32 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.657 ' HA3' HG23 ' A' ' 14' ' ' ILE . . . 98.34 -22.05 42.89 Favored Glycine 0 C--O 1.261 1.828 0 CA-C-O 123.014 1.341 . . . . 0.0 113.098 177.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.591 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 40.5 pttt -67.97 -14.79 63.24 Favored 'General case' 0 C--N 1.317 -0.814 0 O-C-N 121.279 -1.13 . . . . 0.0 109.271 177.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.847 ' HB ' HG22 ' A' ' 130' ' ' VAL . 3.1 t -140.85 146.91 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.895 177.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 26.5 tp -129.33 122.62 29.91 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -117.49 137.62 52.41 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.884 0.373 . . . . 0.0 110.988 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.606 ' HB2' ' HZ ' ' A' ' 50' ' ' PHE . . . -160.09 169.32 23.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.575 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 124' ' ' ALA . 8.5 mm-40 -95.33 106.45 18.5 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.575 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 58.8 mt -97.81 125.06 42.46 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.457 0.646 . . . . 0.0 111.468 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.892 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 65.4 ttt180 -70.28 141.34 52.41 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.933 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.401 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 4.8 p90 -152.35 -173.73 4.65 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.868 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.0 m -56.2 -24.66 43.3 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -108.56 27.98 12.5 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.502 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 102.43 -117.89 5.94 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.161 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.422 ' CH2' ' HD3' ' A' ' 125' ' ' ARG . 80.0 m95 -127.2 142.14 51.56 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.401 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 54.6 t30 -138.02 137.74 38.16 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.8 ttt85 -85.03 113.75 21.68 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.065 0.46 . . . . 0.0 110.72 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.672 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 47.5 t -122.75 166.61 14.67 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.943 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 10.2 ptt180 -147.37 145.25 29.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.205 0.526 . . . . 0.0 111.677 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.754 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 6.9 tt -124.79 150.56 29.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.676 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.326 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.567 ' CB ' ' HG3' ' A' ' 155' ' ' GLU . 18.1 m-85 -94.74 103.96 15.87 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 122.166 -0.334 . . . . 0.0 110.921 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.736 HD11 HD21 ' A' ' 21' ' ' LEU . 25.4 mt -65.07 -36.51 84.57 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.09 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.591 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 8.8 t70 -57.61 -7.97 0.77 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.943 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.567 ' HG3' ' CB ' ' A' ' 152' ' ' TYR . 42.0 mt-10 -70.63 -54.31 12.46 Favored 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 122.002 -0.436 . . . . 0.0 112.081 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -125.57 5.03 7.54 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.165 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.482 HG12 ' CH2' ' A' ' 52' ' ' TRP . 41.7 mm -101.87 106.47 19.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -110.89 161.88 12.68 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.978 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER -103.61 136.36 43.46 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.791 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -119.01 86.55 2.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.621 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 48.6 50.48 17.01 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.533 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 99.55 6.01 55.18 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.318 -0.944 . . . . 0.0 113.815 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' A' ' 159' ' ' ASN . 37.8 mt-10 -123.25 153.81 39.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 117.121 0.461 . . . . 0.0 111.288 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.46 HD22 ' HD2' ' A' ' 7' ' ' PHE . 30.8 mt -103.58 121.61 43.26 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.581 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 13.8 tt . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.956 -179.416 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.559 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 58.0 m-85 . . . . . 0 C--O 1.233 0.198 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -96.2 -32.45 12.45 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.91 -74.94 0.37 Allowed Glycine 0 N--CA 1.436 -1.345 0 C-N-CA 119.994 -1.098 . . . . 0.0 113.275 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 66.46 15.72 10.19 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 122.332 0.253 . . . . 0.0 110.83 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.597 ' CE2' HD11 ' A' ' 14' ' ' ILE . 1.4 p90 -61.43 -35.11 76.64 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.509 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.561 ' HA ' HD13 ' A' ' 14' ' ' ILE . 0.9 OUTLIER -64.48 -21.43 66.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.246 0.546 . . . . 0.0 110.419 -179.001 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.47 -25.3 75.89 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.265 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 18.4 p -125.72 -10.93 6.72 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 117.135 0.467 . . . . 0.0 111.173 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 6.8 m -107.98 132.33 53.63 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -111.81 -179.46 3.7 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 45.37 46.3 10.36 Favored 'General case' 0 C--N 1.315 -0.933 0 O-C-N 123.859 0.724 . . . . 0.0 111.762 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.714 HG12 ' HB1' ' A' ' 23' ' ' ALA . 8.0 mt -80.92 106.82 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.529 ' HA ' HD12 ' A' ' 129' ' ' LEU . 73.5 m -147.78 126.98 12.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.064 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.732 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -102.47 158.89 15.9 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 121.431 0.634 . . . . 0.0 111.991 179.447 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -103.47 77.63 1.52 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.77 -54.71 4.98 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.589 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -149.53 -13.44 0.29 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.146 0.498 . . . . 0.0 110.291 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.56 ' HG3' ' CG2' ' A' ' 36' ' ' VAL . 21.0 tpt180 -83.25 85.75 7.16 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.316 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.732 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 54.0 tp -62.78 128.4 35.75 Favored 'General case' 0 C--O 1.213 -0.838 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -133.66 121.88 22.64 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.797 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.714 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -143.22 147.31 34.65 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.452 0.644 . . . . 0.0 111.54 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.513 ' O ' ' HD2' ' A' ' 32' ' ' TYR . 4.7 mm-40 -82.21 76.76 9.08 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.561 -1.199 . . . . 0.0 109.376 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.565 ' HB3' ' CG ' ' A' ' 159' ' ' ASN . 69.5 m -65.04 124.81 23.05 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.194 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 10' ' ' SER . 72.0 ttt180 -64.67 134.59 54.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.89 178.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -115.05 151.87 33.48 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.65 -10.62 6.4 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 114.495 -1.23 . . . . 0.0 113.737 -178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -79.22 1.46 24.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.17 0.51 . . . . 0.0 110.155 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.95 12.15 74.93 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.963 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -130.21 160.56 23.01 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 119.984 -1.103 . . . . 0.0 112.953 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.513 ' HD2' ' O ' ' A' ' 24' ' ' GLU . 76.7 m-85 -95.85 125.15 40.21 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.9 m -108.4 137.34 46.52 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.733 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.1 m -71.93 112.74 8.28 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.151 0.5 . . . . 0.0 110.387 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.478 ' HG ' ' HG ' ' A' ' 164' ' ' LEU . 28.0 t -114.32 146.45 40.49 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.19 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.9 p -143.37 133.71 21.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.062 0.458 . . . . 0.0 110.981 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.461 HG22 ' HB3' ' A' ' 21' ' ' LEU . 9.3 tt -135.18 154.0 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.892 -177.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.541 ' OD1' ' HB3' ' A' ' 40' ' ' ASN . 35.2 t0 -89.46 112.4 23.54 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.079 -0.388 . . . . 0.0 110.664 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.511 HD22 ' CB ' ' A' ' 21' ' ' LEU . 3.6 mm? -86.46 -4.83 59.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.927 0.394 . . . . 0.0 110.149 178.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.541 ' HB3' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -71.68 -15.45 62.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.805 0.812 . . . . 0.0 108.892 179.058 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.8 mtt180 -105.87 13.22 29.77 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.527 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.409 ' HB2' HD11 ' A' ' 39' ' ' LEU . 48.2 m-85 -133.96 -29.51 1.29 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.712 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.625 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 31.9 mt -109.2 140.62 42.57 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.107 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.47 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 3.1 m -128.56 145.36 51.15 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.842 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.607 HD21 ' HA ' ' A' ' 120' ' ' PHE . 8.1 p30 -89.93 104.43 16.99 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -106.67 94.26 5.03 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.373 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 50.08 42.93 25.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.225 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.647 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 86.2 29.7 24.54 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.241 -0.98 . . . . 0.0 113.125 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.626 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 16.9 t-80 -153.71 127.33 8.72 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.806 ' HZ ' ' HB2' ' A' ' 138' ' ' ALA . 81.4 m-85 -64.08 149.53 47.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.929 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -144.63 129.5 18.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.82 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.468 ' HZ2' ' O ' ' A' ' 152' ' ' TYR . 94.2 m95 . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.971 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 49.2 m . . . . . 0 N--CA 1.451 -0.416 0 CA-C-O 121.127 0.489 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -124.28 176.72 6.26 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.873 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.452 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 17.4 p -128.06 113.67 16.09 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.355 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.422 HG21 ' CE2' ' A' ' 80' ' ' PHE . 9.7 p -102.63 139.78 22.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.918 0.389 . . . . 0.0 110.957 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 8.2 m -88.47 126.16 35.1 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.536 ' CG2' HD12 ' A' ' 99' ' ' ILE . 43.9 t -75.33 130.23 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.132 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -103.6 169.43 8.53 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 124.258 0.974 . . . . 0.0 110.344 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.585 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 6.1 tp-100 -62.0 121.29 12.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.265 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.03 16.04 39.84 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.908 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -121.04 129.54 53.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.862 0.331 . . . . 0.0 111.075 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.657 ' HA ' HG12 ' A' ' 99' ' ' ILE . 74.4 p -115.02 178.05 4.42 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.537 HD11 ' HB ' ' A' ' 87' ' ' ILE . 1.3 mm? -52.24 -42.71 63.84 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.641 0.734 . . . . 0.0 109.31 178.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.681 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 65.8 mtt180 -59.74 -41.12 90.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.4 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -71.61 -44.48 64.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.278 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.538 HG12 ' O ' ' A' ' 72' ' ' THR . 37.8 mm -58.83 -45.28 91.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.627 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.44 -49.96 68.88 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.693 -0.685 . . . . 0.0 113.321 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.681 ' HD3' ' O ' ' A' ' 74' ' ' ARG . 1.0 OUTLIER -73.84 -27.04 60.89 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 122.434 -0.451 . . . . 0.0 111.632 -179.011 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -76.54 -38.48 54.97 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.452 ' HB2' ' HG ' ' A' ' 82' ' ' CYS . 95.6 m-85 -112.47 19.94 17.11 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.2 t70 53.55 55.0 9.17 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 122.072 0.939 . . . . 0.0 111.701 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.627 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -136.32 172.87 12.38 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.235 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.666 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.9 t70 -98.73 122.66 42.24 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.905 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.423 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 14.1 p90 -53.16 -27.56 21.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.091 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.78 -34.61 58.0 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.923 0.392 . . . . 0.0 109.954 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.491 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 39.7 tt0 -69.42 -48.56 60.6 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.666 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.4 mt -53.36 -43.89 52.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.973 178.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.593 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.44 -52.0 65.29 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.322 178.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -61.25 -32.41 72.21 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.816 ' HB3' ' HB2' ' A' ' 106' ' ' GLN . 1.9 mmp_? -65.34 -37.11 86.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.08 0.467 . . . . 0.0 110.491 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.649 HD21 HG21 ' A' ' 93' ' ' ILE . 9.9 t30 -93.62 -4.35 50.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.928 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 17.3 m120 78.34 16.82 1.21 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.491 0.716 . . . . 0.0 111.178 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.649 HG21 HD21 ' A' ' 91' ' ' ASN . 11.1 pt -102.57 -175.88 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.548 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 26.2 mt-30 -112.29 160.89 17.21 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.738 -0.385 . . . . 0.0 109.969 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.433 ' O ' HD22 ' A' ' 73' ' ' LEU . 11.2 p-10 -55.82 -58.26 8.6 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 122.36 1.076 . . . . 0.0 109.277 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -76.39 12.0 1.38 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.859 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 1.9 t70 -66.17 -35.92 81.75 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.9 mp 68.71 115.88 0.04 OUTLIER 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.097 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.689 HG21 HD11 ' A' ' 105' ' ' LEU . 10.1 pt -94.54 176.6 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.665 -178.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.439 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 15.3 m-85 -129.25 157.22 76.78 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.624 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.585 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 17.9 Cg_endo -64.93 135.82 45.97 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 122.889 2.393 . . . . 0.0 112.863 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.68 20.95 22.94 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.53 ' O ' ' HA ' ' A' ' 66' ' ' THR . 92.6 mt-30 -109.77 165.81 11.4 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.452 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 88.5 t -125.52 115.21 42.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.689 HD11 HG21 ' A' ' 99' ' ' ILE . 87.1 mt -110.77 151.2 28.06 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.952 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.816 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 71.2 mt-30 -90.19 115.08 27.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.872 0.844 . . . . 0.0 110.581 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.1 151.25 68.92 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.36 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.22 -21.03 71.91 Favored 'Trans proline' 0 N--CA 1.474 0.346 0 C-N-CA 123.395 2.73 . . . . 0.0 114.673 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.9 t . . . . . 0 C--N 1.32 -0.688 0 CA-C-O 121.079 0.466 . . . . 0.0 111.184 179.735 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.444 -0.785 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 90.9 m-20 74.21 29.8 1.26 Allowed 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 122.94 0.496 . . . . 0.0 111.459 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.625 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 19.6 p90 -62.75 -39.36 93.89 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.076 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.539 ' HA ' ' HB2' ' A' ' 124' ' ' ALA . 42.8 t-105 -62.35 -32.39 73.16 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.848 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -52.58 -37.69 58.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.796 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.623 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 31.3 m -123.29 26.62 7.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.462 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.539 ' HB2' ' HA ' ' A' ' 121' ' ' TRP . . . -107.42 144.64 34.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.251 177.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.465 ' HB2' ' CZ3' ' A' ' 146' ' ' TRP . 1.8 tpt180 -129.75 137.85 50.77 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.7 t70 54.53 67.66 0.98 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.481 0.658 . . . . 0.0 110.659 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.467 ' CG1' HD12 ' A' ' 136' ' ' LEU . 39.2 t -91.79 124.51 44.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.866 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -148.0 148.11 30.36 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.972 0.415 . . . . 0.0 110.559 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.588 ' HG ' ' HG ' ' A' ' 16' ' ' LEU . 30.4 mt -86.68 134.83 33.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.674 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.593 HG22 ' HB ' ' A' ' 135' ' ' VAL . 35.6 m -127.82 157.31 39.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.18 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.498 ' HB3' ' HD3' ' A' ' 134' ' ' LYS . 6.4 m-20 72.38 1.88 4.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.931 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.618 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 99.09 28.03 7.93 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.628 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.623 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 98.07 -23.14 37.34 Favored Glycine 0 C--O 1.266 2.13 0 CA-C-O 123.282 1.49 . . . . 0.0 112.654 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.738 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 15.9 ptmt -64.72 -20.0 66.09 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 121.721 -0.87 . . . . 0.0 108.933 177.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.593 ' HB ' HG22 ' A' ' 130' ' ' VAL . 6.8 t -136.94 146.01 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.324 0.583 . . . . 0.0 110.378 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 30.5 tp -124.95 121.54 34.74 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.491 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 40.2 tt0 -112.02 134.46 53.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.951 0.405 . . . . 0.0 111.788 -177.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.806 ' HB2' ' HZ ' ' A' ' 50' ' ' PHE . . . -163.29 161.85 24.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.749 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -96.06 110.29 22.56 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.647 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 50.8 mt -96.19 137.04 35.85 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.175 0.512 . . . . 0.0 111.115 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.623 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 56.4 ttt180 -72.59 140.74 48.23 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.942 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.476 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 3.3 p90 -159.42 -170.34 2.92 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.563 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.4 m -54.66 -32.46 59.24 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 123.349 0.406 . . . . 0.0 111.789 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -97.51 16.52 60.43 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.404 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 141' ' ' ARG . . . 101.58 -110.23 3.8 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.266 -0.968 . . . . 0.0 112.395 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.465 ' CZ3' ' HB2' ' A' ' 125' ' ' ARG . 70.7 m95 -132.93 129.39 38.24 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.476 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 65.7 t30 -130.35 145.02 51.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.721 0.295 . . . . 0.0 110.617 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -73.88 109.28 7.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.272 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.626 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 35.8 t -122.6 165.32 16.64 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 27.7 mtt85 -145.98 158.82 43.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.09 0.471 . . . . 0.0 111.026 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.737 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 10.2 tt -140.21 146.87 24.06 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.063 178.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.66 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 69.4 m-85 -90.71 102.76 15.51 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.301 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.681 HD11 HD23 ' A' ' 21' ' ' LEU . 20.6 mt -63.21 -34.16 77.05 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.813 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.738 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 6.1 t70 -58.52 -9.09 1.45 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.156 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.66 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 43.6 mt-10 -74.2 -50.69 18.11 Favored 'General case' 0 CA--C 1.508 -0.663 0 O-C-N 121.92 -0.488 . . . . 0.0 112.156 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -120.53 1.25 10.62 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.39 -177.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.428 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 47.5 mm -105.93 110.79 32.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.029 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -114.98 160.14 13.36 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.174 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.565 ' CG ' ' HB3' ' A' ' 25' ' ' CYS . 2.8 t30 -102.53 128.31 49.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.925 0.393 . . . . 0.0 109.972 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -124.46 91.39 3.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.451 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 58.82 42.23 20.24 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.34 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.489 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 92.19 15.39 53.87 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.882 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 159' ' ' ASN . 10.5 tp10 -124.09 143.86 50.21 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.674 -0.309 . . . . 0.0 111.225 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.553 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 18.6 mt -103.31 110.49 22.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.927 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.45 HD11 ' H ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.818 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.465 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 22.7 m-85 . . . . . 0 CA--C 1.516 -0.345 0 CA-C-O 121.65 0.738 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.76 -25.92 2.04 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.642 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.06 -70.17 1.25 Allowed Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 119.576 -1.297 . . . . 0.0 112.718 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 66.08 10.85 7.37 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 122.535 0.334 . . . . 0.0 110.619 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.663 ' CE2' HD11 ' A' ' 14' ' ' ILE . 1.0 OUTLIER -58.5 -33.53 69.93 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.54 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.507 ' HG ' ' CG ' ' A' ' 154' ' ' ASP . 59.2 p -63.32 -22.35 66.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.507 0.594 . . . . 0.0 110.398 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.03 -21.73 79.02 Favored Glycine 0 CA--C 1.522 0.519 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.421 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.435 ' HB3' ' HB3' ' A' ' 26' ' ' ARG . 59.4 m -127.84 -18.18 4.31 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 117.15 0.475 . . . . 0.0 111.485 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.8 m -101.42 129.98 47.55 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.973 0.416 . . . . 0.0 109.97 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.437 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 2.8 ptm180 -110.08 -178.47 3.53 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 42.89 47.72 4.9 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 123.748 0.655 . . . . 0.0 112.358 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.723 HG21 ' HA3' ' A' ' 133' ' ' GLY . 6.3 mt -81.76 103.39 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-O 121.253 0.549 . . . . 0.0 109.833 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.603 ' CA ' HD11 ' A' ' 129' ' ' LEU . 82.6 m -145.67 125.1 13.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.858 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.734 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -93.39 153.42 18.52 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 122.021 0.915 . . . . 0.0 113.1 -178.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -94.05 73.92 4.08 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.956 -1.474 . . . . 0.0 107.835 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.03 -55.2 4.78 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.946 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.501 ' HB3' ' HB3' ' A' ' 40' ' ' ASN . . . -146.33 -12.4 0.47 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.083 0.468 . . . . 0.0 110.102 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -88.89 94.49 9.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.898 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.853 ' HB2' HD23 ' A' ' 39' ' ' LEU . 46.7 tp -60.15 122.86 15.46 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.473 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.461 ' HB3' ' O ' ' A' ' 15' ' ' CYS . 51.4 ttp180 -126.25 125.58 42.61 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.581 -178.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.67 ' HB2' HG12 ' A' ' 14' ' ' ILE . . . -148.25 145.91 28.41 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.63 0.728 . . . . 0.0 111.323 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.566 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 2.3 mm-40 -81.17 76.04 8.13 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.386 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.642 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 54.9 m -64.99 130.44 43.37 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.306 0.574 . . . . 0.0 111.336 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.435 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 3.8 tmm_? -72.18 118.88 15.61 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.394 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 14.0 ptm180 -87.17 156.44 19.69 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -50.92 -20.44 4.32 Favored Glycine 0 C--N 1.339 0.702 0 O-C-N 124.672 1.232 . . . . 0.0 114.768 -177.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -72.22 -9.96 59.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.236 0.541 . . . . 0.0 110.057 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.13 6.43 63.15 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.408 ' O ' ' HG2' ' A' ' 27' ' ' ARG . . . -106.36 164.9 13.53 Favored Glycine 0 C--O 1.224 -0.506 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.524 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.566 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 71.0 m-85 -101.61 130.34 47.92 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.878 0.37 . . . . 0.0 110.912 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.4 m -119.1 133.46 55.78 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.873 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.8 m -71.48 110.4 6.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.279 0.561 . . . . 0.0 111.079 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.4 t -113.61 150.88 32.46 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.665 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.611 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 5.1 p -144.88 137.02 21.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.937 0.399 . . . . 0.0 110.676 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.431 HG21 ' HB3' ' A' ' 21' ' ' LEU . 10.6 tt -133.98 144.77 34.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.267 -177.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.0 92.71 3.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.025 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.853 HD23 ' HB2' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -71.87 -11.13 60.65 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.139 0.495 . . . . 0.0 110.669 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 26.5 p30 -67.25 -8.64 33.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.909 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.431 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 30.5 ttm180 -108.25 -0.91 20.58 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.729 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.471 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 91.4 m-85 -125.64 -23.03 4.12 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.634 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.602 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 48.7 mt -111.02 137.66 48.39 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.19 0.519 . . . . 0.0 111.207 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.407 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 5.2 m -130.61 146.16 52.06 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.051 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.632 HD21 ' HA ' ' A' ' 120' ' ' PHE . 7.2 p30 -94.91 106.05 18.01 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -102.42 90.03 3.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.976 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.468 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 66.9 t30 52.5 43.23 31.26 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.138 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.555 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 84.75 38.64 9.33 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.644 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -150.9 137.61 18.9 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.702 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 15.0 m-85 -80.51 141.76 34.84 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.298 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -141.03 131.55 25.39 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.487 ' CZ2' ' HA ' ' A' ' 153' ' ' LEU . 86.1 m95 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.598 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 91.0 m . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 121.168 0.508 . . . . 0.0 110.467 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.89 177.9 7.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.743 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.422 HG21 ' HG2' ' A' ' 106' ' ' GLN . 11.5 p -128.8 115.78 18.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.72 0.295 . . . . 0.0 111.284 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.487 HG22 ' CE2' ' A' ' 80' ' ' PHE . 12.0 p -102.07 145.41 11.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.066 0.46 . . . . 0.0 111.447 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 3.8 m -92.96 131.33 38.06 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.938 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.534 HG22 HD13 ' A' ' 99' ' ' ILE . 49.2 t -83.31 135.62 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.808 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -102.63 169.42 8.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 124.349 1.03 . . . . 0.0 111.051 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.632 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 6.5 tp-100 -63.39 116.66 5.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.389 -178.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.68 -16.47 58.67 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.96 -0.564 . . . . 0.0 113.151 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -82.38 134.96 35.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.027 0.441 . . . . 0.0 110.979 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.587 ' HA ' HG12 ' A' ' 99' ' ' ILE . 68.6 p -113.37 178.64 4.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.692 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.552 HD23 ' O ' ' A' ' 95' ' ' ASN . 1.7 mm? -52.96 -41.18 64.29 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.216 0.532 . . . . 0.0 110.198 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.507 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 43.1 ttm105 -65.65 -36.88 84.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.282 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -68.47 -39.4 81.42 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 72' ' ' THR . 42.2 mm -66.41 -49.55 74.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.504 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.765 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -58.07 -45.84 93.38 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.67 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 78' ' ' ARG . 24.8 ttm180 -64.68 -37.24 86.9 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.899 0.381 . . . . 0.0 111.815 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -77.92 -33.87 51.56 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.647 ' HB2' ' HG ' ' A' ' 82' ' ' CYS . 96.4 m-85 -110.3 20.46 17.79 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.5 t0 53.87 46.32 25.95 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.9 0.857 . . . . 0.0 111.135 178.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.765 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.8 p -130.09 170.77 13.59 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.425 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.602 ' O ' HG13 ' A' ' 87' ' ' ILE . 6.2 t70 -100.16 122.55 43.17 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.507 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 8.8 p90 -51.09 -30.19 15.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.512 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -63.67 -48.1 78.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.62 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.696 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 16.5 mm-40 -67.7 -43.39 80.2 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.337 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.602 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.3 mt -53.68 -48.36 60.38 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.773 0.797 . . . . 0.0 109.01 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.623 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.17 -48.43 78.42 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.827 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -37.85 78.19 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.696 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 68.7 mmt-85 -67.92 -33.6 75.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.822 0.344 . . . . 0.0 110.994 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.523 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 11.4 t-20 -92.8 -5.33 51.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.535 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.523 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 5.6 m-20 78.2 15.3 1.4 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.359 0.664 . . . . 0.0 111.031 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.623 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 15.4 pt -100.83 -177.78 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.603 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . 16.7 mm100 -110.83 152.51 26.59 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.022 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.552 ' O ' HD23 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -53.87 -68.71 0.16 Allowed 'General case' 0 C--O 1.243 0.711 0 CA-C-O 122.194 0.997 . . . . 0.0 110.252 179.688 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -73.75 13.4 0.5 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.547 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.603 ' HB2' ' HB2' ' A' ' 94' ' ' GLN . 7.3 t70 -66.84 -31.79 72.64 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 8.5 mp 73.97 114.17 0.06 Allowed 'General case' 0 N--CA 1.463 0.206 0 O-C-N 124.361 1.038 . . . . 0.0 109.829 -177.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.587 HG12 ' HA ' ' A' ' 72' ' ' THR . 7.1 pt -94.61 176.36 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.651 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.514 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 92.3 m-85 -123.25 160.04 51.91 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.598 -178.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.632 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 42.1 Cg_endo -70.55 139.19 36.93 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 123.43 2.753 . . . . 0.0 113.716 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.6 9.56 61.28 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.475 ' O ' ' HA ' ' A' ' 66' ' ' THR . 27.1 tt0 -94.09 162.85 13.71 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 115.16 -0.52 . . . . 0.0 109.754 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 72.9 t -127.43 118.95 50.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.417 ' HB3' HG23 ' A' ' 87' ' ' ILE . 69.8 mt -115.38 151.66 34.26 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.124 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.422 ' HG2' HG21 ' A' ' 64' ' ' THR . 71.8 mt-30 -89.65 118.33 29.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.67 0.747 . . . . 0.0 110.987 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.403 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 29.6 m -125.19 151.88 70.08 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.43 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.403 ' HD2' ' HB ' ' A' ' 107' ' ' VAL . 29.9 Cg_endo -62.92 -16.89 56.96 Favored 'Trans proline' 0 N--CA 1.472 0.253 0 C-N-CA 123.196 2.597 . . . . 0.0 114.392 -177.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.4 t . . . . . 0 C--N 1.323 -0.568 0 CA-C-O 121.035 0.445 . . . . 0.0 111.056 179.829 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.441 -1.018 0 N-CA-C 111.396 -0.681 . . . . 0.0 111.396 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.6 m120 69.42 31.18 3.89 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 122.943 0.497 . . . . 0.0 111.96 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.632 ' HA ' HD21 ' A' ' 45' ' ' ASN . 24.0 p90 -59.38 -35.78 74.58 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.515 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 57.5 t-105 -64.97 -33.23 75.53 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.826 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.52 -22.69 45.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.293 0.568 . . . . 0.0 110.954 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.723 ' OG ' ' HB3' ' A' ' 141' ' ' ARG . 47.9 t -133.64 23.98 4.01 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.179 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.515 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -111.02 144.5 40.04 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.334 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.598 ' HB2' ' CZ3' ' A' ' 146' ' ' TRP . 0.1 OUTLIER -129.52 128.03 41.99 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.421 ' N ' ' HD3' ' A' ' 125' ' ' ARG . 24.6 t0 56.94 62.92 2.07 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 124.071 0.857 . . . . 0.0 111.626 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.54 ' CG1' HD11 ' A' ' 136' ' ' LEU . 60.5 t -76.06 131.05 35.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.525 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -140.88 138.42 33.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.449 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.661 HD23 HD13 ' A' ' 153' ' ' LEU . 13.7 mt -86.91 131.9 33.97 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 177.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.644 HG23 ' HB ' ' A' ' 135' ' ' VAL . 33.9 m -128.74 158.61 41.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.213 0.53 . . . . 0.0 111.189 -178.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 67.46 11.54 8.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.014 -0.993 . . . . 0.0 111.889 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.7 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 92.73 31.22 8.87 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.203 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.723 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 88.23 -16.62 51.7 Favored Glycine 0 C--O 1.263 1.944 0 CA-C-O 123.441 1.578 . . . . 0.0 112.687 177.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.861 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 14.8 ptpt -68.09 -16.42 64.01 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 121.381 -1.07 . . . . 0.0 109.1 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.644 ' HB ' HG23 ' A' ' 130' ' ' VAL . 14.3 t -140.55 141.76 31.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.981 177.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.54 HD11 ' CG1' ' A' ' 127' ' ' VAL . 42.6 tp -120.53 126.88 51.45 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -120.16 134.64 55.21 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.746 0.308 . . . . 0.0 110.455 -177.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.405 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . . . -160.63 158.98 29.85 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.675 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -95.05 108.68 20.77 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.555 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 56.0 mt -94.19 131.29 39.91 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.699 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.723 ' HB3' ' OG ' ' A' ' 123' ' ' SER . 65.2 ttt180 -73.46 141.23 46.85 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.443 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.621 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 0.8 OUTLIER -154.56 -170.68 3.6 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.583 -179.748 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.2 m -58.34 -26.55 63.24 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -95.0 6.25 69.19 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.389 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 141' ' ' ARG . . . 111.26 -112.49 3.19 Favored Glycine 0 C--O 1.224 -0.491 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.746 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.598 ' CZ3' ' HB2' ' A' ' 125' ' ' ARG . 93.4 m95 -124.85 126.04 44.94 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.621 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 60.6 t30 -118.27 140.27 50.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.445 -178.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -73.55 104.74 4.62 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.2 m -118.55 156.3 29.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.577 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 17.4 ptt180 -148.79 163.43 37.38 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.535 -0.466 . . . . 0.0 112.16 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.702 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 8.9 tt -148.42 144.77 18.71 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.612 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.608 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.603 ' CB ' ' HG3' ' A' ' 155' ' ' GLU . 38.0 m-85 -88.76 104.42 16.88 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 122.154 -0.341 . . . . 0.0 110.929 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.661 HD13 HD23 ' A' ' 129' ' ' LEU . 27.8 mt -66.69 -35.31 79.83 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.904 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.861 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 4.8 t0 -55.91 -10.24 0.74 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.947 178.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.603 ' HG3' ' CB ' ' A' ' 152' ' ' TYR . 45.4 mt-10 -71.74 -55.09 8.29 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -125.22 8.58 7.91 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.884 -0.726 . . . . 0.0 112.388 -176.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.447 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 41.1 mm -106.65 107.81 23.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -110.54 178.04 19.73 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.656 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.642 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -117.75 134.44 54.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.893 0.377 . . . . 0.0 110.808 179.364 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.447 ' HB2' HD13 ' A' ' 165' ' ' ILE . 43.9 ttm180 -125.2 92.68 3.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.363 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 66.9 t30 57.9 46.35 16.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.83 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.441 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 87.52 11.56 68.55 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.613 178.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -122.69 133.03 54.51 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 117.19 0.495 . . . . 0.0 110.956 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.478 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 29.7 mt -76.03 122.59 24.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.471 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.447 HD13 ' HB2' ' A' ' 160' ' ' ARG . 43.7 pt . . . . . 0 C--N 1.323 -0.565 0 CA-C-O 121.646 0.736 . . . . 0.0 111.765 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.555 ' CD1' ' HG2' ' A' ' 155' ' ' GLU . 64.7 m-85 . . . . . 0 N--CA 1.455 -0.221 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.72 -27.89 11.52 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -71.02 -73.87 0.76 Allowed Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 119.068 -1.539 . . . . 0.0 112.16 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 65.44 23.07 11.94 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 122.711 0.404 . . . . 0.0 110.145 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.777 ' HD2' HD12 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -64.62 -34.96 79.51 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.531 179.725 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.416 ' HA ' HD11 ' A' ' 14' ' ' ILE . 28.8 t -66.02 -15.47 63.06 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.487 0.66 . . . . 0.0 109.916 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.55 -28.42 72.34 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.113 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 28.6 m -136.33 -3.22 2.18 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 117.413 0.607 . . . . 0.0 111.494 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.422 ' OG ' ' HB3' ' A' ' 23' ' ' ALA . 6.0 t -105.92 133.72 50.19 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.471 ' CG ' ' HB2' ' A' ' 24' ' ' GLU . 14.9 ptm180 -112.02 -176.39 2.91 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 42.61 44.52 3.68 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 124.04 0.837 . . . . 0.0 112.177 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.63 HG22 ' HA3' ' A' ' 133' ' ' GLY . 6.4 mt -78.17 102.86 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-O 121.012 0.434 . . . . 0.0 109.886 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.537 ' HA ' HD11 ' A' ' 129' ' ' LEU . 80.0 m -147.35 126.1 12.63 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.685 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -89.12 153.57 20.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.007 0.908 . . . . 0.0 113.191 -178.322 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.651 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 21.3 t70 -92.96 72.07 4.72 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 113.726 -1.579 . . . . 0.0 107.166 177.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.56 -56.69 5.03 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.939 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -148.56 -12.1 0.34 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.651 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 56.3 mtp180 -84.4 89.51 7.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.017 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.859 HD21 HD13 ' A' ' 153' ' ' LEU . 42.6 tp -57.24 123.46 15.41 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.155 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.58 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 22.2 ttp180 -125.74 134.73 51.67 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.141 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.518 ' HB3' HG12 ' A' ' 14' ' ' ILE . . . -155.63 141.69 18.28 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.695 0.759 . . . . 0.0 111.363 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.471 ' HB2' ' CG ' ' A' ' 12' ' ' ARG . 78.2 mm-40 -78.93 79.58 5.32 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.367 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.736 ' SG ' HD13 ' A' ' 164' ' ' LEU . 25.6 m -67.09 122.49 17.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.183 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 10' ' ' SER . 58.1 ttt-85 -68.69 118.85 12.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.391 178.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.1 ttt180 -88.0 155.1 20.0 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -47.25 -25.05 2.59 Favored Glycine 0 N--CA 1.463 0.459 0 O-C-N 124.598 1.187 . . . . 0.0 115.533 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -75.24 -5.77 46.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.205 0.526 . . . . 0.0 110.89 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.85 5.98 65.86 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -101.63 135.22 12.08 Favored Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.585 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.432 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 94.8 m-85 -87.81 130.52 34.84 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.776 0.322 . . . . 0.0 110.366 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 41.7 m -118.08 137.05 53.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.525 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.5 m -71.18 111.25 6.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.286 0.565 . . . . 0.0 111.16 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 162' ' ' GLY . 32.3 t -117.46 149.75 40.06 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.474 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.7 p -144.77 137.02 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.969 0.414 . . . . 0.0 111.633 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.632 HG21 HD22 ' A' ' 164' ' ' LEU . 12.4 tt -135.36 148.14 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.32 -178.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.462 ' OD2' ' HB3' ' A' ' 40' ' ' ASN . 25.2 t70 -81.89 109.24 16.08 Favored 'General case' 0 CA--C 1.516 -0.363 0 O-C-N 121.938 -0.476 . . . . 0.0 111.3 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.608 HD23 ' HB3' ' A' ' 21' ' ' LEU . 3.4 mm? -88.3 0.93 55.59 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.119 0.485 . . . . 0.0 110.092 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.462 ' HB3' ' OD2' ' A' ' 38' ' ' ASP . 26.2 t-20 -73.86 -24.5 59.76 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.7 mtt85 -100.63 13.41 34.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.248 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -132.02 -31.24 1.5 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.295 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.57 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 49.3 mt -105.85 134.79 48.41 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.999 0.428 . . . . 0.0 110.8 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.54 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 1.9 m -126.79 146.36 50.28 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.288 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.721 HD21 ' HA ' ' A' ' 120' ' ' PHE . 8.0 p30 -91.98 100.93 13.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.743 0.782 . . . . 0.0 109.498 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -100.89 94.06 5.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.042 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.409 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 64.3 t30 52.18 43.87 30.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.486 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.717 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 80.29 41.09 12.19 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.644 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.45 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 34.3 t-80 -160.69 127.69 4.23 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.696 ' HB2' ' HB ' ' A' ' 151' ' ' ILE . 87.6 m-85 -67.52 151.44 47.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.892 0.377 . . . . 0.0 111.547 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -148.39 130.47 15.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.038 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 96.3 m95 . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.094 177.319 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.45 -0.443 0 CA-C-O 121.016 0.436 . . . . 0.0 110.005 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.35 176.14 6.04 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.966 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.4 p -130.93 125.49 33.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.599 0.238 . . . . 0.0 111.111 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.583 HG23 ' CE2' ' A' ' 80' ' ' PHE . 8.4 p -115.46 143.33 25.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.959 0.409 . . . . 0.0 111.285 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 16.3 m -88.53 127.11 35.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.087 0.47 . . . . 0.0 109.873 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.49 ' CG2' HD11 ' A' ' 99' ' ' ILE . 43.7 t -75.92 134.57 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.788 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -104.48 169.54 8.41 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 124.541 1.15 . . . . 0.0 111.451 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.622 ' OE1' ' HG3' ' A' ' 101' ' ' PRO . 51.0 tp60 -64.25 116.06 5.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.55 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.78 -4.56 57.85 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.291 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.39 122.4 43.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.764 0.316 . . . . 0.0 110.92 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.694 ' HA ' HG12 ' A' ' 99' ' ' ILE . 75.5 p -105.37 -177.83 3.48 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.536 HD13 ' HB ' ' A' ' 87' ' ' ILE . 1.4 mm? -52.58 -41.85 63.97 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 121.396 0.617 . . . . 0.0 109.384 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.403 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 39.4 ttm180 -64.34 -37.95 89.32 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.091 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -73.08 -38.59 66.35 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.102 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 72' ' ' THR . 46.0 mm -64.81 -48.21 85.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.649 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -54.65 -53.64 37.81 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.718 -0.674 . . . . 0.0 113.03 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -68.25 -25.23 65.08 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -78.35 -41.99 31.85 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.583 ' CE2' HG23 ' A' ' 65' ' ' VAL . 89.2 m-85 -107.6 12.71 27.39 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.4 t70 61.31 52.61 3.78 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.804 0.811 . . . . 0.0 111.046 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.649 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.0 p -134.72 169.66 17.0 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.403 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.635 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.6 t70 -95.94 121.08 37.3 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.708 -0.397 . . . . 0.0 109.992 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.585 ' HD2' ' HB2' ' A' ' 95' ' ' ASN . 17.7 p90 -50.63 -31.31 15.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.923 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.78 -42.87 76.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.309 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.688 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 11.6 mm-40 -68.22 -43.87 77.0 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.635 HG13 ' O ' ' A' ' 83' ' ' ASP . 6.5 mt -53.5 -47.82 59.06 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-O 121.435 0.636 . . . . 0.0 109.474 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.627 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.18 -50.88 70.06 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.529 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -59.98 -36.18 76.6 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.688 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 83.3 mmt-85 -68.08 -34.81 77.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.991 0.424 . . . . 0.0 110.622 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 4.5 t30 -91.3 -5.06 55.23 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.805 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 0.9 OUTLIER 78.55 13.48 1.42 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.451 179.385 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.627 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 19.0 pt -98.74 -171.36 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -117.84 151.17 37.89 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.253 -0.28 . . . . 0.0 110.548 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.585 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 21.1 p-10 -53.07 -56.97 12.13 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-O 122.088 0.947 . . . . 0.0 109.294 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -75.96 6.82 4.65 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.425 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -66.55 -35.8 81.11 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.4 mp 67.62 115.13 0.03 OUTLIER 'General case' 0 C--O 1.235 0.332 0 CA-C-O 122.138 0.971 . . . . 0.0 109.987 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.694 HG12 ' HA ' ' A' ' 72' ' ' THR . 7.8 pt -93.74 174.96 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.038 -177.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.539 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 64.4 m-85 -127.15 160.6 58.85 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.689 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.622 ' HG3' ' OE1' ' A' ' 69' ' ' GLN . 34.8 Cg_endo -67.22 137.6 44.31 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.063 2.509 . . . . 0.0 113.941 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.49 17.9 32.29 Favored Glycine 0 N--CA 1.44 -1.075 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.707 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.547 ' O ' ' HA ' ' A' ' 66' ' ' THR . 45.7 mt-30 -106.83 165.06 11.6 Favored 'General case' 0 C--O 1.216 -0.682 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.864 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.3 t -125.81 110.03 23.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.606 HD11 HG23 ' A' ' 99' ' ' ILE . 63.8 mt -105.25 152.01 23.41 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.21 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.426 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 38.5 mt-30 -89.84 114.6 26.37 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.747 0.784 . . . . 0.0 110.415 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.0 m -117.88 150.55 47.37 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.71 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.44 -16.34 43.05 Favored 'Trans proline' 0 C--N 1.331 -0.375 0 C-N-CA 123.004 2.469 . . . . 0.0 113.387 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.4 t . . . . . 0 C--N 1.318 -0.763 0 CA-C-O 121.001 0.429 . . . . 0.0 110.318 179.678 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.54 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.44 -1.049 0 N-CA-C 112.379 -0.289 . . . . 0.0 112.379 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 71.14 30.14 2.73 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 122.903 0.481 . . . . 0.0 111.215 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.721 ' HA ' HD21 ' A' ' 45' ' ' ASN . 25.6 p90 -57.44 -39.06 75.44 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.52 ' HA ' ' HB2' ' A' ' 124' ' ' ALA . 67.6 t-105 -62.33 -34.58 76.91 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.915 -1.038 . . . . 0.0 111.966 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.83 -25.69 20.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.986 0.422 . . . . 0.0 111.369 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.76 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 19.3 m -134.28 29.46 3.66 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.037 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.52 ' HB2' ' HA ' ' A' ' 121' ' ' TRP . . . -115.73 141.13 48.49 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.193 0.521 . . . . 0.0 111.48 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -129.77 149.32 51.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.07 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.06 50.58 16.33 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 123.614 0.571 . . . . 0.0 110.83 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.488 ' HA ' ' HB1' ' A' ' 138' ' ' ALA . 30.2 t -80.74 117.89 27.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.883 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 35.4 ptt85 -145.89 144.57 30.28 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.191 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.543 HD13 HG21 ' A' ' 14' ' ' ILE . 23.4 mt -84.61 131.12 34.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.291 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.456 HG22 ' HB ' ' A' ' 135' ' ' VAL . 34.4 m -126.54 167.57 20.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.403 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.566 ' HB3' ' CE ' ' A' ' 134' ' ' LYS . 1.2 m-20 64.45 10.18 5.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.612 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.629 ' O ' HD13 ' A' ' 14' ' ' ILE . . . 93.82 24.34 20.66 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.848 -0.692 . . . . 0.0 113.481 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.63 ' HA3' HG22 ' A' ' 14' ' ' ILE . . . 94.64 -18.88 56.24 Favored Glycine 0 C--O 1.268 2.241 0 CA-C-O 123.803 1.779 . . . . 0.0 111.914 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.699 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 65.4 pttt -69.52 -14.21 62.74 Favored 'General case' 0 C--N 1.313 -1.018 0 O-C-N 121.598 -0.942 . . . . 0.0 108.769 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.625 HG23 ' HG3' ' A' ' 134' ' ' LYS . 23.5 t -139.47 137.18 40.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 121.355 0.597 . . . . 0.0 110.513 177.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 30.3 tp -117.31 121.97 42.62 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.521 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 35.8 tt0 -115.01 134.81 54.87 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.864 0.364 . . . . 0.0 111.46 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.695 ' HB2' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.42 163.11 27.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.569 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 41.7 mt-10 -94.53 108.43 20.38 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.717 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 59.7 mt -94.99 130.59 41.59 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.338 0.59 . . . . 0.0 110.753 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.76 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 73.5 ttt180 -70.73 140.66 51.46 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.88 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.478 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 5.6 p90 -158.3 -171.91 3.67 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 18.4 m -54.85 -30.52 57.8 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.3 18.51 56.39 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.369 -0.92 . . . . 0.0 113.723 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 103.9 -120.67 6.77 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.278 -0.963 . . . . 0.0 112.332 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -123.57 124.28 42.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.944 0.372 . . . . 0.0 110.601 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.478 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 27.3 t-20 -118.81 125.83 50.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.465 ' HD3' ' OE2' ' A' ' 137' ' ' GLU . 55.1 ttm-85 -74.74 99.24 3.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.245 0.545 . . . . 0.0 110.033 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.45 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 7.3 t -112.3 173.08 6.54 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.105 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.529 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 15.6 mtm180 -145.2 163.84 33.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.107 0.479 . . . . 0.0 111.398 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.696 ' HB ' ' HB2' ' A' ' 50' ' ' PHE . 9.1 tt -143.24 148.98 18.74 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.392 178.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.583 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 12.6 m-85 -92.06 103.93 16.38 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 122.028 -0.42 . . . . 0.0 110.964 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.859 HD13 HD21 ' A' ' 21' ' ' LEU . 22.5 mt -67.15 -34.14 76.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.111 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.699 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 7.7 t70 -58.32 -7.76 0.96 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.274 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.555 ' HG2' ' CD1' ' A' ' 3' ' ' TYR . 40.5 mt-10 -72.39 -51.03 22.25 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 121.91 -0.494 . . . . 0.0 111.976 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -119.26 -5.6 10.41 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 120.499 -0.481 . . . . 0.0 112.285 -177.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.465 ' CG2' ' HG ' ' A' ' 164' ' ' LEU . 48.9 mm -100.21 114.23 38.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.841 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.454 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -118.79 176.44 16.09 Favored Glycine 0 C--O 1.225 -0.422 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.289 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.566 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.0 t30 -112.1 123.81 51.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.943 0.401 . . . . 0.0 110.149 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -118.63 85.88 2.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.928 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 52.2 43.72 30.36 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.479 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 103.29 -4.82 48.41 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.294 -0.955 . . . . 0.0 114.085 178.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -121.92 129.43 52.53 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 117.223 0.512 . . . . 0.0 111.426 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.777 HD12 ' HD2' ' A' ' 7' ' ' PHE . 1.8 tp -71.12 113.32 8.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.553 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 11.0 tp . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.392 -179.027 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -111.8 -25.41 9.48 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -66.8 -72.75 0.72 Allowed Glycine 0 N--CA 1.433 -1.503 0 C-N-CA 119.366 -1.397 . . . . 0.0 112.405 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 60.69 17.16 7.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.74 0.305 . . . . 0.0 110.725 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.69 ' CE2' HD12 ' A' ' 14' ' ' ILE . 0.4 OUTLIER -60.92 -32.57 72.05 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.398 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.484 ' OG ' ' HG2' ' A' ' 134' ' ' LYS . 23.1 t -66.0 -19.84 65.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.037 0.446 . . . . 0.0 110.375 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.7 -20.6 78.69 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.079 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 51.2 p -129.4 -24.66 2.77 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 117.241 0.521 . . . . 0.0 111.375 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.43 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 5.9 m -96.71 130.88 43.86 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -115.07 -174.18 2.45 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 47.69 40.77 12.65 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 123.513 0.508 . . . . 0.0 111.225 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.69 HD12 ' CE2' ' A' ' 7' ' ' PHE . 7.7 mt -80.71 103.31 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-O 120.832 0.348 . . . . 0.0 110.164 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.585 ' HA ' HD13 ' A' ' 129' ' ' LEU . 79.0 m -146.9 128.09 14.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.809 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.709 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -99.41 152.89 19.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.701 0.762 . . . . 0.0 112.956 -179.844 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -93.85 75.87 4.22 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.33 -55.08 4.82 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.542 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.572 ' HB2' ' HB2' ' A' ' 40' ' ' ASN . . . -148.69 -7.86 0.38 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.901 0.381 . . . . 0.0 110.507 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.41 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 3.4 mmm-85 -89.27 90.53 8.38 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.748 ' HB2' HD21 ' A' ' 39' ' ' LEU . 55.0 tp -62.67 127.79 32.92 Favored 'General case' 0 C--O 1.213 -0.839 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.562 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 42.9 ttt180 -133.34 131.75 40.48 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.441 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.632 ' HB3' HG12 ' A' ' 14' ' ' ILE . . . -150.84 145.93 26.01 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.744 0.783 . . . . 0.0 111.516 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.502 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 1.7 mm-40 -82.97 74.58 9.92 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.34 178.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.542 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 60.0 m -60.74 124.2 19.72 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.143 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 10' ' ' SER . 19.7 ttp180 -70.57 127.43 32.66 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.13 0.491 . . . . 0.0 110.749 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.467 ' HG3' ' CG ' ' A' ' 161' ' ' ASN . 37.2 ttp180 -97.29 151.9 19.42 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.32 -15.86 1.96 Allowed Glycine 0 N--CA 1.46 0.278 0 O-C-N 124.717 1.261 . . . . 0.0 115.006 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -75.96 -9.01 58.26 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.054 0.454 . . . . 0.0 110.432 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.66 6.86 60.59 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -112.27 161.69 12.64 Favored Glycine 0 C--O 1.224 -0.525 0 C-N-CA 120.455 -0.878 . . . . 0.0 112.202 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.502 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 86.2 m-85 -100.38 139.1 36.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.005 0.403 . . . . 0.0 110.856 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.1 t -122.89 120.64 34.05 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 m -63.73 115.53 4.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.157 0.503 . . . . 0.0 110.487 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.4 t -120.99 152.82 38.11 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.063 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.562 ' HB ' ' HG3' ' A' ' 22' ' ' ARG . 3.2 p -145.05 138.66 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 120.855 0.359 . . . . 0.0 111.433 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.5 tt -135.5 147.8 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.486 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -80.74 105.34 11.9 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.748 HD21 ' HB2' ' A' ' 21' ' ' LEU . 1.5 tp -84.71 -6.14 59.35 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.441 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.572 ' HB2' ' HB2' ' A' ' 19' ' ' ALA . 64.2 t30 -73.45 -14.31 61.22 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -105.88 15.37 26.74 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.427 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 66.3 m-85 -131.44 -32.67 1.52 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.635 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.613 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 33.2 mt -106.48 136.49 46.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.025 0.441 . . . . 0.0 111.423 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.795 ' HG ' ' HA2' ' A' ' 118' ' ' GLY . 9.0 m -125.74 146.81 49.6 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.701 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.591 ' ND2' ' HB2' ' A' ' 123' ' ' SER . 21.4 p-10 -95.13 93.7 7.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.669 0.747 . . . . 0.0 109.585 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -94.64 95.83 9.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.059 0.457 . . . . 0.0 111.758 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.431 ' HA ' ' HB2' ' A' ' 142' ' ' TYR . 62.5 t30 47.67 44.19 17.23 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.172 178.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.78 34.04 14.32 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.751 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -150.61 131.12 13.85 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.817 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 24.8 m-85 -75.34 138.3 41.68 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.8 mtt-85 -140.7 136.38 32.55 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.5 ' CH2' HG12 ' A' ' 157' ' ' ILE . 98.2 m95 . . . . . 0 C--N 1.322 -0.616 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.353 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.0 m . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 120.92 0.391 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.89 177.37 4.99 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.164 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.526 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 10.6 p -127.7 117.08 21.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.856 0.36 . . . . 0.0 110.835 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.448 HG21 ' CE2' ' A' ' 80' ' ' PHE . 8.9 p -103.0 142.29 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.19 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 24.9 m -88.1 127.67 35.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.249 0.547 . . . . 0.0 110.095 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.505 HG21 HD11 ' A' ' 99' ' ' ILE . 48.7 t -79.16 134.67 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.364 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -107.4 171.08 7.58 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.307 1.004 . . . . 0.0 109.458 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.67 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 59.4 tt0 -65.85 123.18 19.1 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.794 -178.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.12 -4.23 58.71 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.348 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -105.77 122.68 46.57 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.89 0.376 . . . . 0.0 111.132 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.644 ' HA ' HG12 ' A' ' 99' ' ' ILE . 68.5 p -106.49 179.94 4.12 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.528 HD11 ' HB ' ' A' ' 87' ' ' ILE . 1.5 mm? -51.66 -43.4 62.65 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.461 0.648 . . . . 0.0 109.752 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -60.65 -38.98 86.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.424 -178.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -72.18 -45.67 59.43 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 72' ' ' THR . 45.0 mm -57.82 -47.66 85.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.003 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.667 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.19 -53.05 47.67 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.109 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -69.73 -26.43 64.32 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 122.469 -0.43 . . . . 0.0 111.786 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -75.87 -38.84 57.52 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.06 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.6 ' HB2' ' HG ' ' A' ' 82' ' ' CYS . 72.4 m-85 -111.16 19.62 18.2 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.7 t70 53.25 47.91 23.26 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.548 0.69 . . . . 0.0 111.783 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.667 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 3.3 p -127.88 171.05 12.14 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.637 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.1 t0 -96.75 117.89 32.03 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.707 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.425 ' HA ' HD11 ' A' ' 87' ' ' ILE . 3.3 p90 -50.49 -33.19 20.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.909 -1.042 . . . . 0.0 111.803 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.93 -41.44 91.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.17 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.645 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 33.0 tt0 -71.78 -46.64 57.7 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.695 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.637 HG13 ' O ' ' A' ' 83' ' ' ASP . 6.5 mt -49.7 -45.74 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.615 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.22 -51.1 69.13 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.416 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -63.67 -28.93 70.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.645 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 22.1 mmt180 -65.08 -39.79 93.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.288 0.566 . . . . 0.0 110.248 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 12.5 m120 -94.12 -3.6 50.76 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.677 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 93.7 m-20 79.08 11.01 1.51 Allowed 'General case' 0 N--CA 1.47 0.571 0 O-C-N 123.859 0.724 . . . . 0.0 111.455 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.615 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 18.9 pt -93.92 -173.48 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.484 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . 30.1 mm-40 -114.81 157.6 23.04 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 122.108 -0.37 . . . . 0.0 110.636 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.509 ' O ' HD22 ' A' ' 73' ' ' LEU . 3.4 p30 -55.62 -69.05 0.15 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.836 0.826 . . . . 0.0 109.728 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.417 ' H ' ' CG ' ' A' ' 95' ' ' ASN . 0.6 OUTLIER -74.59 13.43 0.62 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.335 179.623 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.484 ' HB2' ' HB2' ' A' ' 94' ' ' GLN . 5.6 t70 -64.3 -30.16 71.22 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.1 mp 68.55 113.5 0.04 OUTLIER 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.195 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.644 HG12 ' HA ' ' A' ' 72' ' ' THR . 8.5 pt -93.85 175.83 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.227 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.492 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 85.7 m-85 -125.95 158.06 67.13 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.585 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.67 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 22.3 Cg_endo -67.28 139.16 49.08 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 123.135 2.557 . . . . 0.0 113.395 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.21 23.7 24.0 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.547 ' O ' ' HA ' ' A' ' 66' ' ' THR . 70.4 mt-30 -112.11 166.07 11.57 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.526 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 66.9 t -125.89 110.36 23.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.491 HD12 HG21 ' A' ' 99' ' ' ILE . 75.8 mt -103.95 151.04 23.65 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.4 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.612 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 62.7 mt-30 -90.74 117.58 29.49 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.832 0.825 . . . . 0.0 110.6 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.8 m -125.65 150.56 68.66 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.702 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.38 -19.34 67.91 Favored 'Trans proline' 0 C--N 1.332 -0.325 0 C-N-CA 123.262 2.641 . . . . 0.0 113.722 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.5 t . . . . . 0 C--N 1.324 -0.528 0 CA-C-O 121.059 0.457 . . . . 0.0 111.088 179.961 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.795 ' HA2' ' HG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.443 -0.871 0 N-CA-C 112.726 -0.15 . . . . 0.0 112.726 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 72.02 27.43 2.7 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.406 0.683 . . . . 0.0 111.011 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.613 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 22.6 p90 -60.36 -40.67 91.59 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.087 0.47 . . . . 0.0 109.798 178.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.531 ' HA ' ' HB2' ' A' ' 124' ' ' ALA . 43.1 t-105 -65.29 -28.87 69.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.913 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.17 -19.49 54.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.737 0.303 . . . . 0.0 111.013 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.591 ' HB2' ' ND2' ' A' ' 45' ' ' ASN . 22.9 m -139.15 27.62 2.34 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 120.899 0.381 . . . . 0.0 110.252 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.531 ' HB2' ' HA ' ' A' ' 121' ' ' TRP . . . -110.54 148.26 32.49 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.37 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 125' ' ' ARG . 11.6 ttm180 -133.14 140.28 47.53 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.952 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.428 ' HB3' ' NH2' ' A' ' 128' ' ' ARG . 69.7 m-20 58.04 58.76 3.4 Favored 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 123.787 0.68 . . . . 0.0 111.123 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.484 ' CG1' HD11 ' A' ' 136' ' ' LEU . 40.5 t -86.79 115.88 28.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.839 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.428 ' NH2' ' HB3' ' A' ' 126' ' ' ASP . 0.0 OUTLIER -138.13 145.41 41.57 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.344 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.769 HD22 HD12 ' A' ' 153' ' ' LEU . 16.1 mt -85.23 133.26 34.18 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.747 HG23 ' HB ' ' A' ' 135' ' ' VAL . 27.3 m -125.27 159.37 32.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.347 -179.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.572 ' O ' ' HE2' ' A' ' 134' ' ' LYS . 0.3 OUTLIER 69.99 1.74 3.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.89 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.689 ' O ' HD13 ' A' ' 14' ' ' ILE . . . 94.74 33.37 6.74 Favored Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.097 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.662 ' HA3' HG22 ' A' ' 14' ' ' ILE . . . 94.65 -20.89 46.2 Favored Glycine 0 C--O 1.263 1.936 0 CA-C-O 122.997 1.332 . . . . 0.0 113.21 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.739 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 0.2 OUTLIER -66.77 -16.43 64.25 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 121.307 -1.114 . . . . 0.0 109.214 178.591 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.747 ' HB ' HG23 ' A' ' 130' ' ' VAL . 9.4 t -141.72 145.57 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.262 0.553 . . . . 0.0 109.824 177.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.585 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 30.1 tp -125.72 121.04 32.3 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.448 ' HG3' ' HE ' ' A' ' 150' ' ' ARG . 20.8 tt0 -110.28 135.39 51.09 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.818 0.342 . . . . 0.0 111.632 -177.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.624 ' HB1' ' HZ ' ' A' ' 50' ' ' PHE . . . -163.66 157.14 18.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.541 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -95.81 108.12 20.43 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 45' ' ' ASN . 58.6 mt -92.57 131.45 37.68 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.415 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.504 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 64.3 ttt180 -70.41 139.63 51.88 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.295 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.584 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 4.9 p90 -154.71 -164.11 1.74 Allowed 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.005 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.2 m -62.76 -14.62 46.94 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -125.83 36.45 2.74 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.416 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.77 -122.81 7.32 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.761 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -122.7 125.85 46.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.755 0.312 . . . . 0.0 110.399 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.584 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 46.5 t-20 -111.32 133.84 53.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.616 -178.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -73.49 98.01 2.69 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -113.55 160.66 18.28 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.899 -177.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.585 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 34.0 mtt180 -146.48 158.02 43.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.732 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.817 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 9.2 tt -141.67 142.11 28.98 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.02 178.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.577 ' O ' ' HG3' ' A' ' 155' ' ' GLU . 27.7 m-85 -87.53 102.54 14.68 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.817 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.769 HD12 HD22 ' A' ' 129' ' ' LEU . 22.1 mt -63.96 -34.8 78.8 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.59 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.739 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 5.6 t70 -56.41 -9.4 0.69 Allowed 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.265 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.577 ' HG3' ' O ' ' A' ' 152' ' ' TYR . 40.4 mt-10 -72.27 -52.71 15.08 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 121.923 -0.486 . . . . 0.0 112.287 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -124.43 3.23 8.4 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.549 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.5 HG12 ' CH2' ' A' ' 52' ' ' TRP . 39.7 mm -103.59 108.6 24.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.478 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -116.33 166.44 12.35 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.239 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.542 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.3 t30 -102.22 130.8 48.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.782 0.325 . . . . 0.0 110.232 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 25.7 ttp85 -118.19 85.9 2.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.878 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.467 ' CG ' ' HG3' ' A' ' 27' ' ' ARG . 21.7 t30 53.13 47.22 24.97 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.378 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 96.46 9.05 57.05 Favored Glycine 0 C--O 1.229 -0.185 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.611 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -122.79 142.37 50.81 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.682 HD12 ' CD2' ' A' ' 7' ' ' PHE . 11.8 tp -99.61 111.34 23.69 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.953 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.417 -179.798 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.783 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 37.0 m-85 . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 121.189 0.519 . . . . 0.0 109.718 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.53 -27.71 0.67 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.457 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 6' ' ' ASN . . . -69.56 -68.74 1.55 Allowed Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 119.931 -1.128 . . . . 0.0 113.643 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 42.1 m-80 68.73 16.98 8.93 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 122.268 0.227 . . . . 0.0 110.497 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.735 ' CD2' HD13 ' A' ' 164' ' ' LEU . 1.2 p90 -64.22 -32.64 74.3 Favored 'General case' 0 C--O 1.218 -0.581 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.032 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.496 ' HA ' HD11 ' A' ' 14' ' ' ILE . 22.7 t -70.37 -16.29 62.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.73 0.776 . . . . 0.0 109.606 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.65 -20.67 73.7 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 115.129 -0.942 . . . . 0.0 113.241 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.539 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 75.5 p -127.49 -22.84 3.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.405 0.602 . . . . 0.0 111.365 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.424 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 9.2 m -98.15 133.98 41.84 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.945 0.402 . . . . 0.0 109.956 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.526 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 35.2 ptt180 -110.54 -177.37 3.22 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.427 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 12.7 m-20 43.85 44.54 5.83 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 123.714 0.634 . . . . 0.0 112.213 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.636 HG12 ' HB1' ' A' ' 23' ' ' ALA . 5.8 mt -78.95 104.86 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -178.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.561 ' HA ' HD12 ' A' ' 129' ' ' LEU . 72.7 m -146.4 126.38 13.66 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.298 0.639 . . . . 0.0 109.651 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.713 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -98.93 152.83 19.35 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.673 0.749 . . . . 0.0 112.773 -179.646 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -96.07 74.99 3.03 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.55 -54.44 4.95 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.43 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.513 ' HB3' ' HB2' ' A' ' 40' ' ' ASN . . . -148.58 -10.09 0.36 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 36.8 mtp-105 -83.13 86.17 7.06 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.618 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.778 HD23 HD12 ' A' ' 153' ' ' LEU . 51.1 tp -62.1 116.7 5.17 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-O 121.301 0.572 . . . . 0.0 111.578 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 33.9 ttp-105 -122.58 131.29 53.76 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.556 -177.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.636 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -152.34 146.89 25.72 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.452 0.644 . . . . 0.0 111.246 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.526 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 1.6 mm-40 -80.73 77.29 7.59 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.412 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.585 ' SG ' HD11 ' A' ' 164' ' ' LEU . 64.3 m -61.98 125.68 24.68 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.748 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.539 ' HB2' ' O ' ' A' ' 10' ' ' SER . 35.3 ttm180 -74.44 115.17 13.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.098 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 16.8 ptm180 -79.2 151.37 31.28 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -50.67 -18.97 2.9 Favored Glycine 0 C--N 1.339 0.697 0 O-C-N 124.338 1.024 . . . . 0.0 114.195 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.63 -12.89 61.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.15 0.5 . . . . 0.0 110.451 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.62 7.89 56.39 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.527 ' O ' ' HG2' ' A' ' 27' ' ' ARG . . . -104.48 157.49 16.87 Favored Glycine 0 C--O 1.223 -0.563 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.246 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.482 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 62.7 m-85 -100.85 129.81 46.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.901 0.381 . . . . 0.0 110.906 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.3 m -122.15 130.09 52.91 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.097 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -69.08 110.44 4.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.111 0.482 . . . . 0.0 111.449 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.744 ' HG ' ' HB2' ' A' ' 164' ' ' LEU . 29.2 t -114.79 151.53 33.65 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.931 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.9 p -145.7 135.51 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 120.879 0.371 . . . . 0.0 110.58 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.51 HG21 ' HB3' ' A' ' 21' ' ' LEU . 8.6 tt -134.92 144.34 34.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.734 -178.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.583 ' HB3' ' CD ' ' A' ' 41' ' ' ARG . 5.1 t70 -78.84 106.42 10.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.848 0.356 . . . . 0.0 110.605 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.573 HD22 ' HB3' ' A' ' 21' ' ' LEU . 2.1 mm? -85.97 -0.41 55.42 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.453 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.513 ' HB2' ' HB3' ' A' ' 19' ' ' ALA . 64.4 t30 -71.91 -22.35 61.5 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.583 ' CD ' ' HB3' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -103.87 16.5 26.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.406 0.622 . . . . 0.0 110.191 178.291 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -125.89 -35.27 2.5 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.146 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.622 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 36.6 mt -106.54 142.27 36.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.377 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.44 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 0.7 OUTLIER -133.1 140.8 47.84 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.492 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.539 ' CG ' ' HB3' ' A' ' 140' ' ' LEU . 9.0 t30 -88.54 108.1 19.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.989 0.423 . . . . 0.0 109.925 177.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -109.33 91.04 3.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.344 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 54.46 47.49 22.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.195 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.712 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 78.56 33.32 38.95 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.746 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.491 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 68.6 m80 -147.59 127.64 13.7 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.717 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 50.4 m-85 -68.78 146.01 53.28 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.901 0.382 . . . . 0.0 110.963 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -145.49 130.7 18.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.838 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.476 ' CZ2' ' HA ' ' A' ' 153' ' ' LEU . 97.0 m95 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.841 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.7 m . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 120.925 0.393 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -129.07 177.77 6.89 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.167 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.505 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 10.0 p -127.98 118.22 23.14 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.896 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.441 HG21 ' CE2' ' A' ' 80' ' ' PHE . 10.1 p -106.22 142.65 18.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.81 0.338 . . . . 0.0 111.004 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 9.1 m -88.6 125.08 34.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.272 0.558 . . . . 0.0 109.884 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.475 ' CG2' HD13 ' A' ' 99' ' ' ILE . 53.4 t -73.67 133.09 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.623 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -102.85 168.87 8.95 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 124.723 1.264 . . . . 0.0 110.845 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.575 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 25.3 tt0 -62.69 122.21 15.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.151 -178.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.39 -8.77 72.07 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.868 -0.605 . . . . 0.0 113.186 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.25 122.86 36.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.744 0.272 . . . . 0.0 111.453 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.589 ' HA ' HG12 ' A' ' 99' ' ' ILE . 81.2 p -105.67 -179.44 3.94 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.573 HD23 HG21 ' A' ' 99' ' ' ILE . 1.1 mm? -52.5 -41.39 63.37 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.299 0.571 . . . . 0.0 109.836 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.499 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 83.6 mtp180 -64.44 -36.99 85.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.335 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -72.14 -42.9 65.46 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.77 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 72' ' ' THR . 39.2 mm -61.03 -47.0 95.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.679 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.58 -50.56 64.19 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.85 -0.614 . . . . 0.0 113.07 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.463 ' NE ' ' HA ' ' A' ' 78' ' ' ARG . 3.5 tpm_? -71.1 -25.44 62.6 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 122.462 -0.434 . . . . 0.0 111.713 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -79.23 -42.39 26.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.193 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.458 ' HB2' ' HG ' ' A' ' 82' ' ' CYS . 99.2 m-85 -108.06 18.94 20.61 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.2 t70 55.75 51.13 12.89 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.735 0.778 . . . . 0.0 111.86 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.679 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.6 p -131.99 171.75 13.2 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.321 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.66 ' O ' HG13 ' A' ' 87' ' ' ILE . 14.9 t0 -97.63 120.4 37.94 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.747 -0.381 . . . . 0.0 109.99 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.499 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 17.8 p90 -51.51 -31.93 25.72 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.797 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.454 ' HB2' ' OD1' ' A' ' 83' ' ' ASP . 0.2 OUTLIER -68.29 -41.96 80.18 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.323 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.596 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 40.2 mt-10 -68.68 -47.05 67.46 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.9 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.66 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.9 mt -51.31 -46.02 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.559 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.36 -51.89 65.82 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.182 178.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 66.0 mtp180 -62.82 -30.46 71.5 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.596 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 8.2 mmp_? -73.07 -28.17 62.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.254 0.55 . . . . 0.0 110.327 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.481 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 6.7 t30 -96.14 -4.79 42.09 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.831 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 17.7 m120 80.24 13.44 0.91 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.69 0.796 . . . . 0.0 111.222 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.559 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 14.5 pt -105.58 -171.23 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.497 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.577 ' H ' ' HB2' ' A' ' 97' ' ' ASP . 3.8 mm-40 -118.72 163.63 16.56 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.498 ' O ' HD22 ' A' ' 73' ' ' LEU . 5.9 p30 -55.07 -55.15 34.3 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 122.535 1.16 . . . . 0.0 109.167 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -78.63 11.98 2.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.573 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.577 ' HB2' ' H ' ' A' ' 94' ' ' GLN . 4.9 t70 -63.29 -33.64 75.95 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.6 mt 68.75 112.38 0.04 OUTLIER 'General case' 0 C--O 1.232 0.163 0 O-C-N 124.382 1.051 . . . . 0.0 109.99 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.774 HG23 HD11 ' A' ' 105' ' ' LEU . 10.0 pt -95.31 175.3 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.458 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.476 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 67.9 m-85 -128.8 157.59 74.98 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.779 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.575 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 22.0 Cg_endo -66.71 133.08 30.58 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.957 2.438 . . . . 0.0 113.152 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.49 14.08 39.25 Favored Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.472 ' O ' ' HA ' ' A' ' 66' ' ' THR . 33.6 tt0 -103.35 162.93 12.59 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.505 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 91.9 t -122.17 118.25 54.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.774 HD11 HG23 ' A' ' 99' ' ' ILE . 96.9 mt -111.89 152.01 28.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.948 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -89.91 113.98 25.7 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.689 0.757 . . . . 0.0 110.975 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.9 m -123.35 152.07 63.75 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 114.178 -1.373 . . . . 0.0 109.983 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -64.77 -15.59 51.0 Favored 'Trans proline' 0 N--CA 1.472 0.248 0 C-N-CA 123.633 2.889 . . . . 0.0 114.869 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 C--N 1.322 -0.604 0 CA-C-O 120.931 0.396 . . . . 0.0 111.128 179.897 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 119' ' ' ASN . . . . . . . . 0 N--CA 1.443 -0.877 0 N-CA-C 112.293 -0.323 . . . . 0.0 112.293 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 18.1 m120 74.81 34.7 0.69 Allowed 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 123.158 0.583 . . . . 0.0 111.536 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.622 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 19.3 p90 -64.31 -36.53 84.42 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.454 ' HA ' ' HB2' ' A' ' 124' ' ' ALA . 50.5 t-105 -64.6 -26.26 68.32 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.667 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.49 -13.56 52.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.131 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.5 p -142.87 22.37 1.94 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.462 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.529 ' O ' ' HD2' ' A' ' 125' ' ' ARG . . . -113.24 144.67 42.31 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.055 0.455 . . . . 0.0 111.753 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.529 ' HD2' ' O ' ' A' ' 124' ' ' ALA . 1.3 mpt_? -136.55 150.8 48.81 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.665 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 53.8 53.84 10.75 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.165 0.507 . . . . 0.0 111.609 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.502 ' CG1' HD12 ' A' ' 136' ' ' LEU . 41.8 t -80.19 128.31 38.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.264 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.404 ' O ' HD11 ' A' ' 136' ' ' LEU . 2.0 ptp180 -146.43 140.51 26.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.951 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.577 HD11 HG22 ' A' ' 14' ' ' ILE . 16.5 mt -86.6 126.96 34.85 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 177.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.725 HG23 ' HB ' ' A' ' 135' ' ' VAL . 27.6 m -118.33 165.46 13.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.817 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.575 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 0.2 OUTLIER 68.58 2.4 3.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.521 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.585 ' O ' HD13 ' A' ' 14' ' ' ILE . . . 91.87 25.43 22.53 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.988 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.619 ' HA3' HG23 ' A' ' 14' ' ' ILE . . . 104.66 -21.33 36.92 Favored Glycine 0 C--O 1.267 2.182 0 CA-C-O 123.128 1.404 . . . . 0.0 112.721 178.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.666 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 0.0 OUTLIER -71.06 -10.37 59.63 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.177 -1.19 . . . . 0.0 109.775 179.083 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.725 ' HB ' HG23 ' A' ' 130' ' ' VAL . 20.4 t -143.08 146.94 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.585 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 35.1 tp -127.31 124.47 38.8 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -113.24 133.02 55.3 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 123.33 0.394 . . . . 0.0 110.478 -177.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.63 ' HB2' ' HZ ' ' A' ' 50' ' ' PHE . . . -161.66 158.19 25.67 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.876 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -95.18 108.42 20.55 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.712 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 36.2 mt -97.06 133.14 42.12 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.389 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 145' ' ' GLY . 40.2 ttt180 -73.81 141.36 46.2 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.87 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.634 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 0.7 OUTLIER -158.67 -166.8 1.97 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 4.6 m -53.64 -30.86 44.97 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.43 0.456 . . . . 0.0 112.089 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -103.35 30.34 10.55 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.587 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 141' ' ' ARG . . . 89.91 -114.07 4.3 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.007 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -122.73 125.27 45.2 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.709 0.254 . . . . 0.0 110.563 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.634 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 27.7 t-20 -119.29 131.39 55.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.344 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -78.19 96.84 5.3 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.114 0.483 . . . . 0.0 110.041 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.491 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 23.5 t -103.36 170.18 8.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.342 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.585 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 36.5 ptt180 -148.95 154.94 40.11 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.752 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.717 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 10.7 tt -139.86 150.9 21.89 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.001 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.669 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 9.1 m-85 -92.33 104.88 17.18 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 122.003 -0.436 . . . . 0.0 110.56 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.778 HD12 HD23 ' A' ' 21' ' ' LEU . 21.2 mt -66.61 -35.46 80.25 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.929 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.666 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 10.5 t70 -57.61 -12.58 2.93 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.879 178.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.783 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 42.1 mt-10 -61.55 -56.08 23.83 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 121.121 0.486 . . . . 0.0 111.909 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -119.86 -4.6 10.16 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.59 -177.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.486 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 46.7 mm -94.44 112.32 26.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.33 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -117.78 166.84 12.71 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.383 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.551 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 1.5 t30 -107.24 132.21 53.33 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 122.403 0.281 . . . . 0.0 110.416 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -122.26 90.06 3.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.07 0.462 . . . . 0.0 110.123 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 47.0 m-80 54.9 40.42 31.98 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.22 2.16 44.74 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.824 177.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -119.69 140.23 50.99 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.933 0.396 . . . . 0.0 110.235 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.744 ' HB2' ' HG ' ' A' ' 35' ' ' SER . 7.6 tp -96.78 111.23 23.49 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.304 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 34.2 pt . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.428 -179.905 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.02 -28.28 14.23 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.0 -75.55 0.38 Allowed Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 119.649 -1.262 . . . . 0.0 113.139 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 64.09 16.38 9.94 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 122.463 0.305 . . . . 0.0 110.893 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.682 ' CD2' HD13 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -62.2 -30.98 71.46 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 116.75 -0.204 . . . . 0.0 111.251 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.0 t -67.8 -16.37 64.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.4 0.619 . . . . 0.0 110.084 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.09 -22.94 67.29 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.744 -0.662 . . . . 0.0 113.319 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 16.8 p -126.29 -17.74 5.11 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 122.12 -0.635 . . . . 0.0 111.51 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.432 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 3.3 m -105.18 133.48 49.88 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.3 ptt85 -114.36 -175.7 2.74 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 46.3 45.06 13.08 Favored 'General case' 0 C--N 1.316 -0.891 0 O-C-N 123.858 0.724 . . . . 0.0 111.518 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.676 HD11 ' O ' ' A' ' 132' ' ' GLY . 6.6 mt -81.14 100.7 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-O 120.938 0.399 . . . . 0.0 109.972 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.57 ' HA ' HD11 ' A' ' 129' ' ' LEU . 74.0 m -142.78 126.42 16.93 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.748 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -93.67 158.87 15.47 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.883 0.849 . . . . 0.0 113.037 -179.087 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -99.44 74.99 1.94 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 113.995 -1.457 . . . . 0.0 107.623 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.91 -57.68 4.56 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.947 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.714 ' HB2' ' HB3' ' A' ' 40' ' ' ASN . . . -143.47 -9.22 0.74 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 120.676 0.274 . . . . 0.0 110.898 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -96.59 97.74 9.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.276 0.56 . . . . 0.0 110.906 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.901 ' HB2' HD22 ' A' ' 39' ' ' LEU . 46.5 tp -61.75 121.68 13.47 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.966 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.536 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 53.5 ttt180 -126.61 127.87 45.9 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.506 -0.477 . . . . 0.0 110.813 -178.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.562 ' CB ' HG12 ' A' ' 14' ' ' ILE . . . -146.59 150.08 34.79 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.608 0.718 . . . . 0.0 111.069 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 3.0 mm-40 -83.94 71.34 10.5 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.122 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.555 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 34.7 m -60.01 125.75 24.88 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.741 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 10' ' ' SER . 27.7 ttp180 -66.77 126.59 29.5 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.151 178.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -102.37 155.11 18.46 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -52.52 -17.62 4.58 Favored Glycine 0 C--N 1.337 0.584 0 O-C-N 124.582 1.176 . . . . 0.0 114.747 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.21 -9.12 58.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.054 0.454 . . . . 0.0 110.216 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.47 11.44 62.45 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -119.87 165.56 13.5 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.558 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.491 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 88.4 m-85 -100.22 129.19 46.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.007 0.432 . . . . 0.0 110.847 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 75.1 m -113.68 126.03 54.79 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.959 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 m -67.27 114.65 6.16 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.217 0.532 . . . . 0.0 109.768 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 39.7 t -120.4 150.94 39.98 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.265 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.4 p -142.34 140.86 28.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.862 0.363 . . . . 0.0 110.86 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.8 tt -134.86 144.79 33.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.109 -178.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.4 94.02 2.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.385 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.901 HD22 ' HB2' ' A' ' 21' ' ' LEU . 0.9 OUTLIER -76.35 -14.91 60.07 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 120.915 0.388 . . . . 0.0 111.351 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.714 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 26.8 p-10 -67.75 -10.96 57.14 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.202 0.525 . . . . 0.0 109.939 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 37.4 mtt180 -106.58 11.3 30.69 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.482 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -135.8 -26.2 1.22 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.715 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.564 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 33.2 mt -109.83 134.46 52.02 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.962 0.41 . . . . 0.0 110.919 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.527 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 47.7 m -126.1 146.52 49.89 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.695 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.61 HD21 ' HA ' ' A' ' 120' ' ' PHE . 8.7 p30 -86.2 101.06 12.68 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -102.63 92.59 4.7 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.453 -178.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.0 t30 51.52 43.81 29.44 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.626 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.561 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 82.84 28.13 39.23 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.571 -0.824 . . . . 0.0 113.003 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.705 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 17.6 t-80 -149.88 126.43 10.91 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.693 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 72.6 m-85 -60.54 152.22 26.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.615 0.245 . . . . 0.0 111.026 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 11.4 ttm180 -141.68 132.18 25.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.087 0.47 . . . . 0.0 111.9 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.49 ' HZ2' ' HA ' ' A' ' 153' ' ' LEU . 57.4 m95 . . . . . 0 C--N 1.318 -0.783 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.729 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.446 -0.658 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.95 177.55 5.45 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.328 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.4 p -128.87 115.37 17.78 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.45 HG23 ' CE2' ' A' ' 80' ' ' PHE . 10.7 p -106.68 140.0 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.844 0.354 . . . . 0.0 111.105 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 14.0 m -88.55 130.31 35.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.047 0.451 . . . . 0.0 110.231 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.562 ' CG2' HD12 ' A' ' 99' ' ' ILE . 52.2 t -80.8 131.92 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.251 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -99.09 171.47 8.0 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 124.342 1.026 . . . . 0.0 109.705 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.722 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 35.0 tt0 -65.66 124.49 22.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.44 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.5 -1.21 66.28 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.531 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.411 ' CG ' HH22 ' A' ' 79' ' ' ARG . 85.7 m-20 -88.52 147.54 24.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.233 0.539 . . . . 0.0 111.531 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.684 ' HA ' HG12 ' A' ' 99' ' ' ILE . 38.1 p -133.06 168.21 18.9 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.579 HD13 HD12 ' A' ' 93' ' ' ILE . 1.8 mm? -49.76 -45.54 49.62 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.551 0.614 . . . . 0.0 110.307 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.58 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 65.8 mtt180 -63.58 -34.73 78.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.8 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.55 -37.24 65.62 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 72' ' ' THR . 47.8 mm -68.05 -48.76 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.587 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.723 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -59.34 -49.43 78.63 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.705 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.623 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -63.37 -33.02 74.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.081 0.467 . . . . 0.0 110.786 -179.428 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.411 HH22 ' CG ' ' A' ' 71' ' ' ASP . 32.9 ttm180 -74.31 -41.95 60.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.554 -178.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.625 ' HB2' ' HG ' ' A' ' 82' ' ' CYS . 98.8 m-85 -104.64 20.09 19.24 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 54.15 37.57 27.38 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.293 0.568 . . . . 0.0 112.349 178.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.723 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -119.17 167.16 12.1 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.584 ' O ' HG13 ' A' ' 87' ' ' ILE . 8.4 t0 -90.93 119.35 31.06 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.758 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.581 ' HD2' ' HB2' ' A' ' 95' ' ' ASN . 10.4 p90 -51.49 -32.63 28.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.191 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -62.91 -46.31 88.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.203 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.624 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 30.4 tt0 -66.87 -44.19 81.61 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.723 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.4 mt -52.12 -45.94 42.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.609 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.24 -50.12 71.46 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.987 177.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -58.45 -34.11 70.47 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.624 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 28.3 mmt180 -68.33 -38.52 81.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.101 0.477 . . . . 0.0 110.482 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 2.8 t-20 -91.53 -5.26 54.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.32 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 48.9 m-80 76.98 16.46 1.77 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.086 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.609 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 16.9 pt -101.25 -176.39 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.533 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 80.4 mm-40 -107.42 158.85 16.85 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.581 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 5.8 p30 -61.24 -55.4 32.41 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 122.137 0.97 . . . . 0.0 108.832 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -79.86 11.91 3.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.427 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.9 t70 -63.35 -35.44 80.39 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 7.6 mp 69.69 115.47 0.04 OUTLIER 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.74 -177.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.686 HG21 HD13 ' A' ' 105' ' ' LEU . 6.8 pt -94.64 175.74 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.472 -178.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.534 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 89.2 m-85 -124.35 160.29 53.48 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.957 -178.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.722 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 37.6 Cg_endo -69.74 133.06 24.7 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.082 2.521 . . . . 0.0 114.016 -178.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.76 14.63 33.91 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.583 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.457 ' O ' ' HA ' ' A' ' 66' ' ' THR . 44.0 mt-30 -102.41 164.19 11.81 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.83 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 67.1 t -123.56 116.31 47.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.686 HD13 HG21 ' A' ' 99' ' ' ILE . 89.4 mt -110.33 151.33 27.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.024 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.601 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 71.2 mt-30 -90.3 117.48 29.07 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.703 0.763 . . . . 0.0 110.872 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.31 150.42 60.32 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.467 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.43 -17.62 58.07 Favored 'Trans proline' 0 C--N 1.332 -0.318 0 C-N-CA 123.498 2.799 . . . . 0.0 114.017 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.4 t . . . . . 0 C--N 1.324 -0.519 0 CA-C-O 121.041 0.448 . . . . 0.0 111.131 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.527 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.446 -0.694 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 78.37 27.51 0.51 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.858 0.863 . . . . 0.0 112.461 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.61 ' HA ' HD21 ' A' ' 45' ' ' ASN . 26.5 p90 -63.87 -38.62 91.76 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.695 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.482 ' HA ' ' HB1' ' A' ' 124' ' ' ALA . 61.2 t-105 -63.02 -29.14 70.6 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.881 -178.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -57.11 -20.97 28.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.738 0.304 . . . . 0.0 111.112 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.626 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 57.6 m -141.9 30.82 1.63 Allowed 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.493 178.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.482 ' HB1' ' HA ' ' A' ' 121' ' ' TRP . . . -113.31 138.64 49.74 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.847 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -126.95 146.05 50.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.262 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.5 t70 51.12 56.65 7.66 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 123.831 0.707 . . . . 0.0 110.659 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.514 ' CG1' HD12 ' A' ' 136' ' ' LEU . 45.0 t -79.66 120.32 30.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.44 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.85 141.34 34.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.177 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.629 HD22 HD11 ' A' ' 153' ' ' LEU . 17.8 mt -85.91 128.29 34.8 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.82 HG22 HG12 ' A' ' 135' ' ' VAL . 31.0 m -123.68 157.54 30.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.358 0.599 . . . . 0.0 111.224 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.922 ' HB3' ' HE3' ' A' ' 134' ' ' LYS . 5.9 m-20 65.67 16.98 10.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.897 178.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.676 ' O ' HD11 ' A' ' 14' ' ' ILE . . . 91.8 25.3 23.08 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.942 178.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.673 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 91.16 -15.31 61.37 Favored Glycine 0 C--O 1.269 2.322 0 CA-C-O 123.638 1.688 . . . . 0.0 112.384 177.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.922 ' HE3' ' HB3' ' A' ' 131' ' ' ASP . 20.0 pttp -65.12 -15.71 62.69 Favored 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 121.463 -1.022 . . . . 0.0 108.929 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.82 HG12 HG22 ' A' ' 130' ' ' VAL . 2.2 p -149.03 135.58 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.547 0.689 . . . . 0.0 110.83 176.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 29.6 tp -110.3 125.08 52.77 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.073 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -117.92 139.95 50.42 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.861 0.363 . . . . 0.0 111.52 -177.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.653 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.96 168.8 20.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.17 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -95.25 107.55 19.66 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.561 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 57.1 mt -98.93 131.89 44.66 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.277 0.561 . . . . 0.0 111.168 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.626 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 33.7 ttt180 -72.28 142.01 48.89 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.071 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -153.89 -173.89 4.75 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.917 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 13.4 m -58.6 -22.71 57.03 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -105.39 20.02 38.38 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.233 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 106.73 -115.33 4.66 Favored Glycine 0 C--O 1.229 -0.212 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.298 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -130.31 138.07 50.27 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -132.18 141.44 49.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.924 0.392 . . . . 0.0 111.701 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -74.76 103.53 5.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.146 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.705 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 32.6 t -121.65 162.08 21.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.326 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 10.3 ptt180 -148.55 152.6 37.11 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 120.957 0.408 . . . . 0.0 111.474 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.693 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 8.7 tt -132.36 131.96 60.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.73 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 135' ' ' VAL . 89.8 m-85 -75.89 101.22 5.08 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.56 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.675 HD12 HD22 ' A' ' 21' ' ' LEU . 35.7 mt -64.45 -36.22 83.47 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.191 178.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.774 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 11.7 t70 -55.35 -11.49 0.81 Allowed 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.425 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.537 ' HG3' ' O ' ' A' ' 152' ' ' TYR . 38.0 mt-10 -71.41 -49.39 42.38 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 121.93 -0.481 . . . . 0.0 112.224 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -127.02 5.68 6.51 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 119.963 -0.695 . . . . 0.0 112.611 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.414 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 46.9 mm -106.58 109.65 28.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.474 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -116.38 166.22 12.34 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.187 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.555 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.9 t30 -100.79 123.21 44.66 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 14.2 ttt85 -119.17 86.52 2.56 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.155 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 59.61 49.12 8.72 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.496 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 79.92 13.14 82.61 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.489 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -122.67 120.24 33.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.026 0.441 . . . . 0.0 110.037 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.682 HD13 ' CD2' ' A' ' 7' ' ' PHE . 8.5 tp -77.25 120.73 22.71 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.072 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 12.6 tt . . . . . 0 C--N 1.323 -0.581 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.987 -179.096 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 . . . . . 0 N--CA 1.453 -0.319 0 CA-C-O 121.36 0.6 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -125.29 -25.58 3.77 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.642 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -84.09 -70.93 1.33 Allowed Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 118.771 -1.68 . . . . 0.0 113.488 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.626 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 63.0 t30 57.3 31.95 20.95 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.207 0.603 . . . . 0.0 110.283 -178.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.601 ' CE2' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -60.28 -32.91 71.64 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.028 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.46 ' HA ' HD11 ' A' ' 14' ' ' ILE . 34.0 t -59.17 -20.8 57.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.523 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.52 -42.17 93.76 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.836 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.467 ' HB3' ' HB3' ' A' ' 26' ' ' ARG . 49.4 m -114.97 -18.05 11.35 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.9 m -92.38 134.86 34.53 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.462 ' CG ' ' HB2' ' A' ' 24' ' ' GLU . 16.7 ptt180 -113.27 -177.54 3.16 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.461 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 0.4 OUTLIER 42.61 44.63 3.72 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 123.873 0.733 . . . . 0.0 112.457 179.18 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.682 HG23 ' HA3' ' A' ' 133' ' ' GLY . 5.8 mt -78.98 105.14 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 CA-C-O 120.953 0.406 . . . . 0.0 110.292 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.533 ' HA ' HD13 ' A' ' 129' ' ' LEU . 80.4 m -146.82 127.62 14.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.37 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.71 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -96.97 155.86 16.6 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.621 0.724 . . . . 0.0 112.779 -179.279 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -96.22 75.1 2.97 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.433 -1.258 . . . . 0.0 107.958 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.51 -58.35 4.88 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.893 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.539 ' HB2' ' HB3' ' A' ' 40' ' ' ASN . . . -149.19 5.97 0.66 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.199 0.523 . . . . 0.0 110.21 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.559 ' HG2' ' CG2' ' A' ' 36' ' ' VAL . 32.3 ttt85 -108.32 93.99 4.82 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.806 ' HB2' HD22 ' A' ' 39' ' ' LEU . 55.0 tp -63.18 129.6 41.02 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -177.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.538 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 34.8 ttt180 -134.04 129.26 35.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.159 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.615 ' HB3' HG12 ' A' ' 14' ' ' ILE . . . -148.58 149.98 32.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.471 0.653 . . . . 0.0 110.983 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 3.3 mt-10 -87.64 80.67 7.91 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.773 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.575 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 58.7 m -63.47 127.86 33.23 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.408 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.467 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 36.8 ttm180 -71.13 114.93 9.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.364 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 9.0 ptp180 -79.6 152.6 29.97 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 179.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.36 -19.5 12.79 Favored Glycine 0 C--N 1.336 0.549 0 O-C-N 124.369 1.043 . . . . 0.0 114.03 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.58 -12.03 60.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.446 0.641 . . . . 0.0 109.821 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.29 5.22 56.05 Favored Glycine 0 CA--C 1.505 -0.589 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.526 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.442 ' O ' ' HG2' ' A' ' 27' ' ' ARG . . . -105.61 167.78 14.92 Favored Glycine 0 C--O 1.222 -0.649 0 C-N-CA 120.065 -1.064 . . . . 0.0 113.14 -178.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.525 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 57.9 m-85 -101.27 131.47 47.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.166 0.483 . . . . 0.0 110.907 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.9 m -118.49 123.35 44.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.191 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.5 m -69.1 112.31 5.63 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.9 t -118.25 155.41 30.61 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.028 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.559 ' CG2' ' HG2' ' A' ' 20' ' ' ARG . 2.6 p -145.43 139.08 21.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.878 0.371 . . . . 0.0 111.662 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.424 HG22 ' HB3' ' A' ' 21' ' ' LEU . 14.0 tt -135.13 148.06 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.471 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.437 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 17.7 m-20 -84.41 104.53 14.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.862 0.363 . . . . 0.0 111.475 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.806 HD22 ' HB2' ' A' ' 21' ' ' LEU . 3.0 mp -83.69 -12.15 56.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.428 0.632 . . . . 0.0 110.417 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.539 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 16.5 p30 -62.84 -19.09 63.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.021 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -112.92 19.9 16.88 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.968 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.641 ' HD2' ' CE3' ' A' ' 52' ' ' TRP . 0.1 OUTLIER -138.12 -27.6 0.89 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.366 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.575 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 62.5 mt -106.09 132.21 52.44 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.611 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 3.2 m -129.35 141.92 50.95 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.541 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.693 ' CB ' ' HG ' ' A' ' 140' ' ' LEU . 8.5 p30 -79.36 115.77 19.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.149 177.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -114.82 89.34 3.07 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.907 0.384 . . . . 0.0 110.248 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.3 t30 51.78 45.02 28.85 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.242 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.0 32.18 30.02 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.808 -0.711 . . . . 0.0 113.131 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.62 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 16.0 t-80 -150.85 125.19 9.45 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.767 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 45.3 m-85 -63.08 141.84 58.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.886 0.374 . . . . 0.0 111.672 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.643 ' HA ' ' NE ' ' A' ' 51' ' ' ARG . 3.4 mmp_? -146.26 135.82 23.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.841 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.641 ' CE3' ' HD2' ' A' ' 42' ' ' TYR . 95.0 m95 . . . . . 0 C--N 1.32 -0.682 0 CA-C-O 121.124 0.488 . . . . 0.0 109.743 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.45 -0.446 0 CA-C-O 120.861 0.362 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -127.8 176.11 7.81 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.75 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.52 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 6.8 p -127.93 116.11 19.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.533 HG23 ' CE2' ' A' ' 80' ' ' PHE . 7.9 p -103.61 142.41 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 120.887 0.375 . . . . 0.0 110.844 178.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 9.8 m -88.38 130.95 35.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.161 0.505 . . . . 0.0 109.929 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.447 ' CG2' HD11 ' A' ' 99' ' ' ILE . 56.6 t -82.33 133.58 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.854 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.419 ' HG3' ' H ' ' A' ' 69' ' ' GLN . 2.4 tp-100 -103.86 171.34 7.41 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.985 0.803 . . . . 0.0 110.2 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.611 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 53.7 tt0 -61.27 119.39 8.35 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.122 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.17 -9.91 63.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.888 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.441 ' HB3' HD13 ' A' ' 76' ' ' ILE . 84.9 m-20 -75.44 146.65 40.54 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.147 0.499 . . . . 0.0 111.529 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.627 ' HA ' HG12 ' A' ' 99' ' ' ILE . 24.3 p -135.99 163.15 30.96 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.557 HD11 ' HB ' ' A' ' 87' ' ' ILE . 1.6 mm? -49.18 -44.22 42.84 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.363 0.529 . . . . 0.0 110.634 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.409 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 70.1 mtp180 -59.96 -43.39 95.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.276 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -72.94 -33.88 66.21 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.537 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.547 HG12 ' O ' ' A' ' 72' ' ' THR . 44.0 mm -66.6 -46.91 84.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.713 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.48 -49.08 76.15 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.91 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -65.41 -32.43 74.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.059 0.456 . . . . 0.0 111.151 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.416 HH22 ' CG ' ' A' ' 71' ' ' ASP . 34.5 ttm180 -70.65 -40.33 73.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.73 -178.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.533 ' CE2' HG23 ' A' ' 65' ' ' VAL . 94.6 m-85 -110.42 16.91 21.32 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 56.22 37.56 28.96 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.445 0.64 . . . . 0.0 111.411 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.713 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.9 p -116.28 166.1 12.42 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.373 -0.83 . . . . 0.0 108.901 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.636 ' O ' HG13 ' A' ' 87' ' ' ILE . 3.7 t70 -92.22 124.6 36.42 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.101 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.409 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 9.7 p90 -52.28 -31.35 32.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.753 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 23.0 t-80 -66.79 -43.26 84.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.949 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.763 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 10.1 mm-40 -63.2 -51.54 65.93 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.361 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.636 HG13 ' O ' ' A' ' 83' ' ' ASP . 3.5 mt -50.94 -48.12 29.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 O-C-N 124.139 0.899 . . . . 0.0 109.475 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.617 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.51 -49.5 75.09 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.268 178.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -61.79 -34.05 75.21 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.763 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 14.7 mmt85 -65.28 -38.19 89.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.08 0.467 . . . . 0.0 110.525 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 11.5 m120 -93.13 -3.36 54.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.61 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 76.5 m-20 73.72 19.67 3.17 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.247 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.617 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 16.9 pt -100.68 -177.29 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.688 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.499 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 35.6 mt-30 -108.17 155.57 20.28 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.539 ' O ' HD22 ' A' ' 73' ' ' LEU . 3.1 p30 -54.94 -62.6 1.55 Allowed 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 122.116 0.96 . . . . 0.0 108.937 178.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -76.4 12.23 1.3 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.385 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.4 t70 -63.63 -34.5 77.96 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 8.7 mp 73.03 116.63 0.05 Allowed 'General case' 0 N--CA 1.462 0.136 0 O-C-N 124.399 1.062 . . . . 0.0 109.598 -177.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.65 HG21 HD13 ' A' ' 105' ' ' LEU . 11.2 pt -93.83 177.68 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.208 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.495 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 40.5 m-85 -129.48 157.76 75.37 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-O 120.892 0.377 . . . . 0.0 111.413 -178.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.611 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 25.7 Cg_endo -65.72 137.75 51.0 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.229 2.619 . . . . 0.0 113.905 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.12 13.65 57.25 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.867 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.497 ' O ' ' HA ' ' A' ' 66' ' ' THR . 95.5 mt-30 -100.87 168.39 9.67 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.216 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.52 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 63.2 t -127.6 110.61 22.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-O 120.921 0.391 . . . . 0.0 109.974 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.65 HD13 HG21 ' A' ' 99' ' ' ILE . 89.0 mt -103.6 150.4 24.0 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.678 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.479 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 75.8 mt-30 -91.34 116.47 28.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.973 0.892 . . . . 0.0 111.38 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.1 m -124.12 151.5 65.71 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 114.207 -1.36 . . . . 0.0 109.691 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -65.07 -15.03 48.44 Favored 'Trans proline' 0 N--CA 1.476 0.445 0 C-N-CA 123.571 2.847 . . . . 0.0 114.855 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.0 t . . . . . 0 C--N 1.322 -0.61 0 CA-C-O 121.008 0.433 . . . . 0.0 111.197 179.624 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.611 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.441 -0.993 0 N-CA-C 112.618 -0.193 . . . . 0.0 112.618 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 73.41 23.45 2.51 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.437 0.695 . . . . 0.0 111.931 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.65 ' HA ' HD21 ' A' ' 45' ' ' ASN . 22.7 p90 -61.62 -38.51 87.92 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.549 -0.46 . . . . 0.0 109.854 178.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.498 ' HA ' ' HB2' ' A' ' 124' ' ' ALA . 63.5 t-105 -59.87 -33.86 72.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.474 -178.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -54.59 -25.95 29.51 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.101 0.476 . . . . 0.0 111.124 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.677 ' HB2' ' HB3' ' A' ' 141' ' ' ARG . 19.4 p -136.98 30.12 2.78 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.512 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.498 ' HB2' ' HA ' ' A' ' 121' ' ' TRP . . . -109.29 140.3 43.13 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.889 0.376 . . . . 0.0 110.835 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -127.51 138.91 53.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.932 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 55.36 54.47 8.58 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.244 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.498 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 29.7 t -76.67 121.43 28.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.643 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -144.94 146.01 31.8 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.65 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.753 HD22 HD11 ' A' ' 153' ' ' LEU . 18.4 mt -86.75 128.85 35.04 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 120.973 0.416 . . . . 0.0 110.157 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.599 HG23 ' HB ' ' A' ' 135' ' ' VAL . 35.1 m -125.75 160.18 32.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.646 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 69.04 5.77 5.26 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.389 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.656 ' O ' HD13 ' A' ' 14' ' ' ILE . . . 97.32 29.06 8.12 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.439 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.682 ' HA3' HG23 ' A' ' 14' ' ' ILE . . . 91.8 -16.27 59.74 Favored Glycine 0 C--O 1.265 2.045 0 CA-C-O 123.689 1.716 . . . . 0.0 112.494 178.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.645 ' O ' ' HA ' ' A' ' 152' ' ' TYR . 5.8 ptpp? -70.87 -17.44 62.72 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 121.433 -1.039 . . . . 0.0 108.454 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.599 ' HB ' HG23 ' A' ' 130' ' ' VAL . 17.5 t -138.73 137.92 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.314 0.578 . . . . 0.0 110.736 178.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.68 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 29.6 tp -117.58 118.36 31.92 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -108.4 130.25 55.23 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.772 0.32 . . . . 0.0 111.276 -176.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.758 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.35 161.56 27.5 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.72 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.818 ' HG3' HH11 ' A' ' 148' ' ' ARG . 49.3 mt-10 -96.01 108.5 20.9 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.422 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.693 ' HG ' ' CB ' ' A' ' 45' ' ' ASN . 1.0 OUTLIER -90.96 126.78 36.17 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.959 178.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.677 ' HB3' ' HB2' ' A' ' 123' ' ' SER . 76.1 ttt180 -69.59 140.81 53.82 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.164 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.612 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 2.3 p90 -156.83 -165.98 1.99 Allowed 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.074 -179.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.2 t -58.42 -32.53 68.75 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.319 0.387 . . . . 0.0 111.121 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.19 28.88 13.26 Favored Glycine 0 C--N 1.329 0.182 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.478 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 89.52 -118.95 5.35 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.591 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -120.03 129.32 54.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.699 0.25 . . . . 0.0 110.73 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.612 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 53.7 t30 -121.34 134.18 55.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.74 0.305 . . . . 0.0 110.766 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.818 HH11 ' HG3' ' A' ' 139' ' ' GLU . 19.8 tpt180 -75.0 96.94 3.27 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.591 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.62 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 11.6 t -109.41 168.03 9.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.428 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.68 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 36.5 ptt180 -148.11 149.65 32.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.444 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.767 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 12.1 tt -132.98 140.72 46.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.581 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.645 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 26.6 m-85 -83.17 102.97 12.23 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.852 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.753 HD11 HD22 ' A' ' 129' ' ' LEU . 26.8 mt -65.25 -36.7 84.95 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.127 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.626 ' HB2' ' HA ' ' A' ' 6' ' ' ASN . 13.8 p-10 -61.69 2.83 0.16 Allowed 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.545 ' HG3' ' CB ' ' A' ' 152' ' ' TYR . 43.1 mt-10 -76.24 -52.43 10.03 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 121.729 -0.607 . . . . 0.0 110.758 178.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -118.02 -12.26 10.11 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.633 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.437 ' O ' ' HA3' ' A' ' 5' ' ' GLY . 50.8 mm -91.86 114.74 29.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 116.77 -0.196 . . . . 0.0 110.754 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -122.28 167.63 14.8 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.115 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.575 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 3.3 t30 -103.46 123.29 46.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.025 0.44 . . . . 0.0 109.959 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 29.5 ttt85 -124.68 93.08 3.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.341 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 60.61 45.04 10.84 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.215 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 84.81 10.75 78.43 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.684 -0.769 . . . . 0.0 113.197 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -122.74 152.82 40.23 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.512 HD23 ' HD2' ' A' ' 7' ' ' PHE . 24.4 mt -97.17 119.65 36.05 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.492 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 43.0 pt . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.148 -179.759 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.681 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 32.6 m-85 . . . . . 0 CA--C 1.516 -0.34 0 CA-C-O 120.801 0.334 . . . . 0.0 110.499 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -137.68 -25.93 0.99 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.569 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 6' ' ' ASN . . . -68.88 -72.63 0.81 Allowed Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 119.738 -1.22 . . . . 0.0 113.597 -178.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 25.5 m-80 69.69 10.31 7.53 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 122.498 0.319 . . . . 0.0 110.219 -178.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.775 ' CD2' HD13 ' A' ' 164' ' ' LEU . 0.9 OUTLIER -61.59 -34.93 76.46 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.61 -178.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.44 ' HA ' HD11 ' A' ' 14' ' ' ILE . 35.0 t -67.81 -14.87 63.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.476 0.655 . . . . 0.0 109.877 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.68 -27.76 64.5 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.964 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 20.9 p -125.69 -19.57 4.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 117.225 0.512 . . . . 0.0 111.992 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 11.8 m -94.99 129.04 42.22 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.656 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 35.4 ptt180 -108.01 -178.36 3.59 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.446 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 1.6 m-20 41.11 47.58 2.8 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 124.068 0.855 . . . . 0.0 112.489 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.748 HG12 ' HB1' ' A' ' 23' ' ' ALA . 8.1 mt -80.65 107.44 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-O 120.877 0.37 . . . . 0.0 110.292 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.498 ' HA ' HD12 ' A' ' 129' ' ' LEU . 46.1 t -150.2 128.53 12.11 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.676 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -96.7 158.56 15.37 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 122.047 0.927 . . . . 0.0 113.012 -178.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -99.51 76.4 2.02 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.14 -53.57 4.77 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.879 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 40' ' ' ASN . . . -149.55 -12.41 0.29 Allowed 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 120.746 0.308 . . . . 0.0 110.195 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -86.1 90.13 8.03 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.448 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.676 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 8.5 tp -61.64 112.97 2.46 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.671 -179.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.457 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 18.8 ttt85 -118.28 130.59 56.13 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.277 -178.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.748 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -149.65 150.9 32.86 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.407 0.623 . . . . 0.0 110.997 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.656 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 1.6 mm-40 -83.39 73.83 10.13 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.145 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.64 ' SG ' HD11 ' A' ' 164' ' ' LEU . 67.8 m -61.22 117.06 5.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.595 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 10' ' ' SER . 44.5 ttt180 -64.59 116.75 6.5 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.804 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.7 ttt85 -90.86 152.49 20.73 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.044 0.45 . . . . 0.0 109.957 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.63 -13.83 4.56 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 114.353 -1.294 . . . . 0.0 114.037 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -73.85 -11.08 60.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.114 0.483 . . . . 0.0 110.321 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.5 8.49 57.36 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -123.78 154.39 17.54 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.099 -1.048 . . . . 0.0 112.837 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.459 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 88.0 m-85 -87.87 125.49 34.51 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.712 0.291 . . . . 0.0 110.446 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.7 m -109.19 131.94 54.59 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.453 ' CG2' ' HE ' ' A' ' 22' ' ' ARG . 2.5 m -73.72 110.71 8.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.229 0.538 . . . . 0.0 109.98 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.652 ' HG ' ' HB2' ' A' ' 164' ' ' LEU . 30.3 t -115.5 153.59 30.87 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.635 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.7 p -146.14 137.27 18.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.794 0.331 . . . . 0.0 110.869 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.509 HG21 ' HB3' ' A' ' 21' ' ' LEU . 8.7 tt -134.68 137.05 51.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.733 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.639 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 13.3 m-20 -75.22 103.1 5.24 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.826 0.345 . . . . 0.0 111.558 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.811 ' HG ' HD11 ' A' ' 153' ' ' LEU . 3.4 mm? -83.11 -5.37 59.08 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.926 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.639 ' OD1' ' HB3' ' A' ' 38' ' ' ASP . 34.5 p-10 -67.06 -14.07 62.54 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.519 ' HE ' ' HB2' ' A' ' 38' ' ' ASP . 27.8 mtm180 -106.65 7.75 30.76 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.962 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.694 ' HB2' HD12 ' A' ' 39' ' ' LEU . 88.5 m-85 -130.95 -29.34 1.89 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.777 ' HG ' HD13 ' A' ' 39' ' ' LEU . 60.9 mt -106.22 132.69 51.98 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.779 0.323 . . . . 0.0 110.405 -179.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.719 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 1.0 OUTLIER -123.44 143.03 50.4 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.603 -179.496 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.451 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 7.0 p-10 -88.25 93.61 9.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.791 0.805 . . . . 0.0 109.176 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -93.27 93.63 8.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.297 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.452 ' HA ' ' HB2' ' A' ' 142' ' ' TYR . 8.6 t-20 51.25 48.49 22.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.092 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.59 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 76.64 32.42 50.66 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.049 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.642 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 59.9 t60 -152.12 124.69 8.35 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.781 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 48.5 m-85 -60.71 144.15 52.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.887 0.375 . . . . 0.0 111.483 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -143.03 131.74 22.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.475 -178.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.491 ' HZ2' ' O ' ' A' ' 152' ' ' TYR . 99.6 m95 . . . . . 0 C--N 1.322 -0.608 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 36.0 m . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 121.108 0.48 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -130.9 178.59 6.55 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.191 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.479 HG21 ' HG2' ' A' ' 106' ' ' GLN . 4.6 p -128.33 115.56 18.46 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.77 143.25 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 120.869 0.366 . . . . 0.0 111.086 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 3.5 m -87.98 129.25 35.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.47 ' CG2' HD12 ' A' ' 99' ' ' ILE . 57.4 t -79.66 132.25 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.647 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -101.03 168.61 9.49 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 124.254 0.971 . . . . 0.0 110.475 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.659 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 35.1 tt0 -66.03 120.21 12.74 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.87 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.85 -11.07 52.76 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.771 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.06 130.26 45.38 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.134 0.467 . . . . 0.0 111.402 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.613 ' HA ' HG12 ' A' ' 99' ' ' ILE . 82.6 p -107.41 179.76 4.15 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.583 HD23 ' O ' ' A' ' 95' ' ' ASN . 1.4 mm? -53.64 -43.64 68.9 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.436 0.636 . . . . 0.0 109.511 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.532 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 7.0 ttp85 -63.31 -36.05 82.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.39 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -73.77 -41.83 61.9 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.55 HG12 ' O ' ' A' ' 72' ' ' THR . 45.3 mm -61.32 -47.68 92.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.605 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.718 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.19 -51.34 58.11 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.651 -0.704 . . . . 0.0 113.083 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 78' ' ' ARG . 47.1 mtp85 -70.21 -23.71 62.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.796 0.331 . . . . 0.0 111.691 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -78.91 -39.37 35.02 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -110.97 19.45 18.48 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t70 55.22 59.24 4.09 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.693 0.759 . . . . 0.0 111.335 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.718 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.4 p -142.35 164.59 29.72 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.364 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.564 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.8 t0 -91.04 120.89 32.39 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.532 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 5.0 p90 -52.19 -30.47 27.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.429 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -66.66 -41.87 87.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.602 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.69 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 64.3 mm-40 -66.06 -49.62 67.0 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.485 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.564 HG13 ' O ' ' A' ' 83' ' ' ASP . 4.1 mt -51.93 -47.53 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.523 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.578 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.77 -50.4 71.2 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.112 178.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -60.3 -33.82 72.91 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.69 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 27.4 mmt180 -71.19 -31.83 68.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.914 0.388 . . . . 0.0 110.44 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 3.7 t-20 -91.73 -5.97 52.74 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.615 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.497 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 90.7 m-20 77.15 17.76 1.54 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.033 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.578 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 14.2 pt -105.69 -174.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.577 178.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.436 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 64.6 mt-30 -110.25 162.57 14.49 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.583 ' O ' HD23 ' A' ' 73' ' ' LEU . 4.2 p-10 -58.59 -68.67 0.24 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.317 1.055 . . . . 0.0 110.003 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -74.33 13.47 0.58 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.545 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 95' ' ' ASN . 2.5 t70 -59.65 -29.39 68.0 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 34.1 mt 72.4 110.6 0.06 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.816 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.613 HG12 ' HA ' ' A' ' 72' ' ' THR . 10.2 pt -95.62 172.56 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.405 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.554 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 73.7 m-85 -126.74 161.45 53.12 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.31 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.659 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 24.8 Cg_endo -66.31 139.6 55.32 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.203 2.602 . . . . 0.0 113.843 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.07 16.72 43.23 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.521 ' O ' ' HA ' ' A' ' 66' ' ' THR . 25.8 mt-30 -103.18 166.57 10.36 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.082 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.415 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 82.5 t -126.91 114.43 37.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.471 HD13 HG23 ' A' ' 99' ' ' ILE . 88.1 mt -112.2 151.65 29.31 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.801 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.479 ' HG2' HG21 ' A' ' 64' ' ' THR . 34.3 mt-30 -90.47 117.26 29.03 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.615 0.721 . . . . 0.0 110.923 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.418 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 35.2 m -126.27 152.59 73.92 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.634 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 107' ' ' VAL . 18.0 Cg_endo -57.52 -48.04 19.04 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.353 2.035 . . . . 0.0 113.578 -177.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 C--N 1.323 -0.564 0 CA-C-O 121.254 0.55 . . . . 0.0 111.635 -178.824 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.719 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.443 -0.878 0 N-CA-C 113.184 0.034 . . . . 0.0 113.184 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 19.5 m120 73.29 29.09 1.72 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.054 0.542 . . . . 0.0 111.418 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.574 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 21.8 p90 -60.59 -37.92 82.94 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.48 ' HA ' ' HB2' ' A' ' 124' ' ' ALA . 47.8 t-105 -60.57 -30.39 69.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.559 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.47 -33.02 58.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.939 0.399 . . . . 0.0 110.537 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.727 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 6.7 m -131.28 28.84 4.68 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.852 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.48 ' HB2' ' HA ' ' A' ' 121' ' ' TRP . . . -108.65 140.78 41.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.896 0.379 . . . . 0.0 110.889 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.546 ' HB3' ' HB2' ' A' ' 139' ' ' GLU . 11.3 tpp85 -124.09 135.2 53.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.462 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 54.85 55.46 7.78 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.765 0.666 . . . . 0.0 111.849 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.514 HG13 ' HE2' ' A' ' 120' ' ' PHE . 40.1 t -78.03 123.58 35.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.822 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.432 ' O ' HD12 ' A' ' 136' ' ' LEU . 8.9 ptp180 -149.49 149.0 30.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.827 0.346 . . . . 0.0 110.589 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.572 HD12 ' C ' ' A' ' 14' ' ' ILE . 92.5 mt -86.6 134.85 33.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.056 0.455 . . . . 0.0 110.495 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.621 HG22 ' HB ' ' A' ' 135' ' ' VAL . 26.8 m -124.61 157.67 32.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.921 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.697 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 0.3 OUTLIER 72.99 -4.41 2.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.059 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.634 ' O ' HD13 ' A' ' 14' ' ' ILE . . . 104.18 32.0 4.48 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.821 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.672 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 94.88 -22.72 36.51 Favored Glycine 0 C--O 1.262 1.869 0 CA-C-O 123.203 1.446 . . . . 0.0 112.588 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.697 ' HG3' ' HB3' ' A' ' 131' ' ' ASP . 13.4 ptmt -65.73 -17.66 64.77 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 121.872 -0.781 . . . . 0.0 109.086 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.621 ' HB ' HG22 ' A' ' 130' ' ' VAL . 8.4 t -140.82 146.53 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.831 177.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.631 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 41.1 tp -126.13 124.69 41.1 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.516 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 34.1 tt0 -114.43 137.83 51.34 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.85 0.357 . . . . 0.0 111.403 -177.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.506 ' HB2' ' HZ ' ' A' ' 50' ' ' PHE . . . -163.21 164.69 25.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.177 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.546 ' HB2' ' HB3' ' A' ' 125' ' ' ARG . 17.5 mm-40 -94.9 106.41 18.4 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 177.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.59 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 59.0 mt -96.71 130.03 44.01 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.2 0.524 . . . . 0.0 111.197 -178.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.727 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 42.6 ttt180 -77.09 141.29 40.3 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.688 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.452 ' HB2' ' HA ' ' A' ' 47' ' ' ASN . 6.8 p90 -155.65 -169.21 3.04 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.976 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.9 p -58.22 -22.53 52.36 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -109.19 28.24 11.36 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.31 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.63 -123.19 7.45 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.858 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -123.19 135.55 54.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.56 0.219 . . . . 0.0 110.51 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.411 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 57.9 t30 -134.91 142.61 46.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.898 0.38 . . . . 0.0 110.828 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.9 tpp85 -76.61 110.47 11.2 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.066 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.642 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 9.2 t -124.9 165.53 17.91 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.631 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 35.2 mtt85 -146.37 152.37 38.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.712 0.292 . . . . 0.0 110.881 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.781 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 12.4 tt -135.77 142.76 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.022 178.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.573 ' CB ' ' HG3' ' A' ' 155' ' ' GLU . 8.5 m-85 -86.35 101.84 13.46 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 122.471 -0.143 . . . . 0.0 111.31 -178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.811 HD11 ' HG ' ' A' ' 39' ' ' LEU . 3.9 mm? -61.14 -37.53 83.17 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.079 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.593 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 13.1 t70 -55.2 -16.24 3.01 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.209 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.681 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 41.2 mt-10 -63.28 -54.01 43.93 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -124.48 2.92 8.37 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.786 -0.766 . . . . 0.0 112.404 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.583 HG13 HD13 ' A' ' 153' ' ' LEU . 43.5 mm -104.03 112.96 39.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.357 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.565 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -118.73 168.33 13.24 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.562 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.543 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.8 t30 -104.71 122.16 45.1 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 15.7 ttm-85 -123.85 93.68 4.0 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.29 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 59.23 41.54 19.94 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.478 -0.783 . . . . 0.0 113.063 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 90.45 10.05 64.17 Favored Glycine 0 C--O 1.229 -0.193 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.211 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -121.43 134.21 55.09 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.216 0.531 . . . . 0.0 110.211 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.775 HD13 ' CD2' ' A' ' 7' ' ' PHE . 8.1 tp -96.35 107.31 19.66 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.741 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.409 ' HA ' HD11 ' A' ' 37' ' ' ILE . 19.8 pt . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.003 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.548 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 13.6 m-85 . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 120.97 0.414 . . . . 0.0 111.684 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -109.18 -28.45 9.02 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -62.4 -70.98 0.89 Allowed Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 119.495 -1.336 . . . . 0.0 112.694 -178.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 65.08 18.93 11.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.803 0.335 . . . . 0.0 110.498 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.756 ' HD2' HD11 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -65.19 -30.69 71.62 Favored 'General case' 0 C--O 1.217 -0.647 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.73 179.815 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.9 t -71.53 -9.32 58.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.705 0.764 . . . . 0.0 109.512 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.49 -23.01 57.51 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 115.12 -0.945 . . . . 0.0 113.054 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 20.2 m -129.39 -22.0 3.12 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 117.287 0.544 . . . . 0.0 111.26 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.512 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 13.0 m -99.31 133.49 43.53 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 12' ' ' ARG . 4.3 ptp180 -113.45 -174.49 2.47 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 42.61 45.52 4.02 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 123.854 0.721 . . . . 0.0 111.489 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.652 HG12 ' HB2' ' A' ' 23' ' ' ALA . 6.7 mt -79.54 109.26 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.008 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.522 ' HA ' HD12 ' A' ' 129' ' ' LEU . 53.8 t -149.54 127.24 11.7 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.42 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.714 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -94.7 154.7 17.19 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.584 0.706 . . . . 0.0 111.832 -179.547 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -97.47 75.49 2.5 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 114.42 -1.264 . . . . 0.0 107.65 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.13 -55.51 5.04 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.431 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.48 ' HA ' ' HZ ' ' A' ' 120' ' ' PHE . . . -148.51 -12.89 0.34 Allowed 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -87.15 91.64 8.78 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.893 0.377 . . . . 0.0 110.792 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.848 HD21 HD11 ' A' ' 153' ' ' LEU . 42.7 tp -60.86 124.65 21.07 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.138 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 54.5 ttp180 -128.35 131.94 48.58 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.773 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.652 ' HB2' HG12 ' A' ' 14' ' ' ILE . . . -149.72 145.9 26.93 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.612 0.72 . . . . 0.0 111.431 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.549 ' O ' ' HD2' ' A' ' 32' ' ' TYR . 19.8 mm-40 -78.73 71.26 5.18 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.645 178.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.687 ' SG ' HD12 ' A' ' 164' ' ' LEU . 61.6 m -60.08 121.65 12.4 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.717 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 10' ' ' SER . 25.0 ttt85 -67.91 132.08 46.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.038 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.713 ' HG2' ' HA3' ' A' ' 162' ' ' GLY . 18.8 mtm180 -103.75 155.88 18.25 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.27 -11.48 3.49 Favored Glycine 0 C--N 1.336 0.548 0 O-C-N 124.383 1.052 . . . . 0.0 114.389 -178.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -80.25 -4.46 53.33 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.19 10.97 73.59 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -179.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.66 152.68 17.37 Favored Glycine 0 C--O 1.225 -0.456 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.97 -178.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.549 ' HD2' ' O ' ' A' ' 24' ' ' GLU . 70.9 m-85 -101.55 125.31 48.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.721 0.296 . . . . 0.0 110.247 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.7 p -117.8 141.13 48.76 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.046 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.8 m -72.66 111.99 8.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.262 0.553 . . . . 0.0 111.219 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.401 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 44.2 t -115.32 148.61 39.02 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.343 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.6 p -144.97 137.96 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.944 0.402 . . . . 0.0 111.561 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.544 HG22 HD21 ' A' ' 164' ' ' LEU . 14.0 tt -134.5 154.2 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.341 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -89.17 110.24 21.01 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 121.836 -0.54 . . . . 0.0 111.487 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.562 HD23 ' HB3' ' A' ' 21' ' ' LEU . 2.9 mm? -87.55 -6.81 58.17 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.512 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.59 -17.27 64.57 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.1 mtt-85 -95.08 2.7 55.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.992 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 96.1 m-85 -131.36 -23.23 2.41 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.601 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 63.2 mt -105.98 136.59 45.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.845 0.355 . . . . 0.0 111.576 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.502 ' HG ' ' HA2' ' A' ' 118' ' ' GLY . 15.8 m -134.79 136.35 42.49 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.15 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.82 ' CB ' ' HG ' ' A' ' 140' ' ' LEU . 8.3 p30 -80.2 107.77 13.27 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.418 177.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -113.87 94.96 5.07 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.478 ' HA ' ' HB2' ' A' ' 142' ' ' TYR . 7.7 t30 56.95 49.41 14.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.756 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.539 ' O ' ' HB2' ' A' ' 149' ' ' SER . . . 71.91 31.12 64.87 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.201 178.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.523 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 38.8 m80 -144.45 129.04 18.11 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.718 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 26.3 m-85 -68.4 136.96 54.13 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.589 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -144.0 132.49 22.19 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.069 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.502 ' CD1' HD12 ' A' ' 151' ' ' ILE . 99.8 m95 . . . . . 0 C--O 1.236 0.359 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.163 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 87.9 m . . . . . 0 N--CA 1.452 -0.329 0 CA-C-O 121.057 0.456 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.65 176.32 8.55 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.263 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.429 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 4.8 p -127.41 121.33 30.6 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.794 0.331 . . . . 0.0 111.602 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.488 HG22 ' CZ ' ' A' ' 80' ' ' PHE . 9.8 p -109.73 144.47 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.75 0.31 . . . . 0.0 110.411 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 18.1 m -88.19 128.07 35.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.101 0.477 . . . . 0.0 110.395 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.482 ' CG2' HD13 ' A' ' 99' ' ' ILE . 57.1 t -73.16 128.11 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.743 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -100.83 169.2 9.16 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 124.577 1.173 . . . . 0.0 111.196 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.605 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 26.4 tp60 -68.19 112.17 4.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.75 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.38 18.55 16.37 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.71 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -125.38 117.57 24.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.619 0.247 . . . . 0.0 110.463 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.685 ' HA ' HG12 ' A' ' 99' ' ' ILE . 81.9 p -104.9 -179.03 3.82 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.559 HD23 HG23 ' A' ' 99' ' ' ILE . 0.9 OUTLIER -52.88 -41.01 63.94 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.419 178.826 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 46.5 mtm105 -63.51 -39.02 93.34 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.168 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 79' ' ' ARG . 19.6 m-20 -70.95 -41.18 71.46 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.338 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 72' ' ' THR . 35.8 mm -63.92 -46.99 92.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.655 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -56.66 -54.76 34.02 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.75 -0.659 . . . . 0.0 113.02 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -64.86 -27.41 68.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.977 0.417 . . . . 0.0 111.734 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 71.9 ttt180 -74.24 -42.21 60.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.172 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.709 ' HB2' ' HG ' ' A' ' 82' ' ' CYS . 68.2 m-85 -111.45 19.75 17.9 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.2 t70 54.26 36.54 25.35 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.966 0.889 . . . . 0.0 111.316 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.709 ' HG ' ' HB2' ' A' ' 80' ' ' PHE . 3.6 p -113.79 163.5 14.97 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.604 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.0 t70 -92.71 124.69 36.9 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.935 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.474 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 4.0 p90 -51.67 -30.34 21.47 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.255 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -64.71 -44.36 90.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.029 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.697 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 28.0 mm-40 -67.02 -48.25 68.93 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.934 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.604 HG13 ' O ' ' A' ' 83' ' ' ASP . 3.4 mt -53.46 -46.19 58.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.586 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.1 -51.28 67.21 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.35 178.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -57.35 -39.56 76.21 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.618 0.246 . . . . 0.0 111.53 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.697 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 63.9 mmt-85 -63.06 -37.51 87.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.009 0.433 . . . . 0.0 110.778 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.669 HD21 HD13 ' A' ' 93' ' ' ILE . 64.0 t30 -89.38 -5.34 57.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.948 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 95.2 m-20 74.46 22.16 2.18 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.556 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.669 HD13 HD21 ' A' ' 91' ' ' ASN . 14.8 pt -108.18 -176.98 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.212 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.419 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 85.1 mm-40 -108.98 155.96 20.27 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.492 ' O ' HD22 ' A' ' 73' ' ' LEU . 2.7 p30 -55.12 -60.43 3.39 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-O 122.104 0.954 . . . . 0.0 109.119 178.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -74.09 11.5 0.9 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.036 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 5.3 t70 -64.86 -33.15 75.32 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 51.0 mt 70.05 111.84 0.05 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.11 -178.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.685 HG12 ' HA ' ' A' ' 72' ' ' THR . 9.2 pt -94.7 172.54 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.158 -178.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.48 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 19.3 m-85 -125.43 157.97 66.01 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.86 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.605 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 23.2 Cg_endo -65.25 132.63 32.28 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.986 2.458 . . . . 0.0 113.492 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.78 21.05 10.67 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.843 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.541 ' O ' ' HA ' ' A' ' 66' ' ' THR . 51.2 mt-30 -110.46 167.72 10.0 Favored 'General case' 0 C--O 1.215 -0.712 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.044 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.429 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 81.5 t -125.84 111.0 25.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.485 HD12 HG22 ' A' ' 99' ' ' ILE . 90.7 mt -107.16 150.63 26.39 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.155 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.597 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 47.4 mt-30 -89.41 114.92 26.44 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.713 0.768 . . . . 0.0 110.927 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.6 m -121.06 150.86 54.32 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 114.358 -1.292 . . . . 0.0 109.794 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.66 -19.81 59.74 Favored 'Trans proline' 0 N--CA 1.472 0.211 0 C-N-CA 123.458 2.772 . . . . 0.0 114.351 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.5 t . . . . . 0 C--N 1.323 -0.581 0 CA-C-O 120.975 0.417 . . . . 0.0 110.382 179.693 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.502 ' HA2' ' HG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.441 -0.993 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 74.51 27.49 1.37 Allowed 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.607 0.763 . . . . 0.0 112.636 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.801 ' HA ' HD21 ' A' ' 45' ' ' ASN . 19.4 p90 -62.36 -38.32 89.07 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.006 178.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.414 ' HA ' ' HB2' ' A' ' 124' ' ' ALA . 58.2 t-105 -61.72 -29.78 70.33 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 123.63 0.581 . . . . 0.0 111.634 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.15 -34.64 45.61 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.355 0.597 . . . . 0.0 110.539 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.889 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 17.8 m -132.64 32.34 3.88 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.414 ' HB2' ' HA ' ' A' ' 121' ' ' TRP . . . -114.37 137.36 51.91 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.403 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -131.95 151.3 51.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.183 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.6 t70 55.79 49.09 16.86 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.845 0.831 . . . . 0.0 109.763 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.482 ' HA ' ' HB3' ' A' ' 138' ' ' ALA . 29.6 t -77.2 119.29 25.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.746 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -142.36 144.21 33.06 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.79 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.566 HD13 ' CD1' ' A' ' 21' ' ' LEU . 19.8 mt -87.76 125.46 34.44 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.62 HG21 ' HB ' ' A' ' 135' ' ' VAL . 30.4 m -118.11 158.2 19.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.809 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 69.06 4.78 4.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.157 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.624 ' O ' HD11 ' A' ' 14' ' ' ILE . . . 97.37 30.69 7.19 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.81 -0.709 . . . . 0.0 113.384 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.634 ' HA3' HG23 ' A' ' 14' ' ' ILE . . . 93.66 -21.38 41.48 Favored Glycine 0 C--O 1.266 2.097 0 CA-C-O 123.043 1.357 . . . . 0.0 113.112 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.78 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 15.8 ptpt -65.81 -17.88 64.94 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 121.785 -0.832 . . . . 0.0 108.834 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.62 ' HB ' HG21 ' A' ' 130' ' ' VAL . 17.2 t -139.47 141.62 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.676 177.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 24.4 tp -121.12 123.15 41.6 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.559 ' OE2' ' HD2' ' A' ' 148' ' ' ARG . 23.1 tt0 -117.26 131.34 56.85 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.1 0.476 . . . . 0.0 111.182 -177.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.572 ' HB1' ' CZ ' ' A' ' 50' ' ' PHE . . . -159.98 160.3 33.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.433 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -94.67 109.14 21.1 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.82 ' HG ' ' CB ' ' A' ' 45' ' ' ASN . 0.8 OUTLIER -91.7 131.04 37.37 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.016 -179.528 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.889 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 36.5 ttt180 -75.98 140.56 42.09 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.6 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.478 ' HB2' ' HA ' ' A' ' 47' ' ' ASN . 3.5 p90 -154.46 -176.23 5.79 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.852 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 46.6 m -56.28 -27.96 57.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.859 0.361 . . . . 0.0 111.686 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -97.35 25.76 25.77 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.283 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.85 -120.08 6.33 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.756 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -126.72 137.26 53.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.575 0.226 . . . . 0.0 110.473 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -133.93 132.9 40.78 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.369 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.559 ' HD2' ' OE2' ' A' ' 137' ' ' GLU . 16.3 ttp180 -74.87 98.11 3.47 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.56 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.539 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 35.1 t -106.15 164.38 12.04 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.907 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 15.8 ptt180 -147.62 145.94 29.17 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.694 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.718 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 14.7 tt -129.85 150.62 34.8 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.576 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.778 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 80.7 m-85 -89.46 103.88 16.48 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 122.144 -0.347 . . . . 0.0 111.079 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.848 HD11 HD21 ' A' ' 21' ' ' LEU . 34.2 mt -66.68 -33.78 76.41 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.299 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.78 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 10.1 t70 -58.42 -8.18 1.11 Allowed 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.159 178.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.778 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 38.8 mt-10 -68.77 -51.88 36.41 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 121.117 0.484 . . . . 0.0 111.785 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -119.25 -15.03 9.2 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.156 -177.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.475 HG22 HD22 ' A' ' 21' ' ' LEU . 50.2 mm -88.21 112.95 24.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.153 -179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.497 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -119.49 173.71 15.18 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.715 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.554 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.7 t30 -113.3 127.71 56.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -122.26 93.15 3.89 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 66.6 t30 53.05 58.15 5.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.545 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.713 ' HA3' ' HG2' ' A' ' 27' ' ' ARG . . . 78.91 11.41 85.24 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.567 -0.742 . . . . 0.0 114.821 178.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -123.75 143.66 50.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 117.542 0.671 . . . . 0.0 110.958 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.756 HD11 ' HD2' ' A' ' 7' ' ' PHE . 5.5 tp -91.58 118.8 30.93 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.944 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.7 pp . . . . . 0 C--N 1.325 -0.461 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.807 -178.658 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.666 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 55.4 m-85 . . . . . 0 C--O 1.232 0.132 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -108.52 -30.74 8.1 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.96 -69.97 1.22 Allowed Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 119.825 -1.178 . . . . 0.0 112.448 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 62.18 21.15 12.24 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 122.606 0.362 . . . . 0.0 111.229 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.697 ' CD2' HD13 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -64.32 -33.34 75.61 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 121.12 -0.232 . . . . 0.0 110.873 179.368 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.413 ' HA ' HD13 ' A' ' 14' ' ' ILE . 42.6 t -61.95 -18.24 59.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.47 0.653 . . . . 0.0 110.188 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.17 -31.46 69.14 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.124 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.463 ' HB2' ' HB3' ' A' ' 26' ' ' ARG . 21.6 p -126.67 -8.22 6.2 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 117.399 0.6 . . . . 0.0 111.742 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.1 m -105.32 128.95 53.74 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.425 ' CG ' ' HB2' ' A' ' 24' ' ' GLU . 13.8 ptm180 -110.05 -176.71 3.07 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.423 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 21.7 m-20 43.27 44.47 4.61 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 124.036 0.835 . . . . 0.0 112.306 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.672 HD12 ' O ' ' A' ' 132' ' ' GLY . 8.3 mt -79.6 103.2 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -178.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.538 ' HA ' HD13 ' A' ' 129' ' ' LEU . 57.7 m -147.1 127.2 13.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.707 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.705 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -96.98 151.29 19.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.711 0.767 . . . . 0.0 112.805 -179.604 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.458 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 21.7 t70 -93.82 74.74 4.24 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 177.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.42 -54.44 4.9 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.155 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.544 ' HB1' ' HB2' ' A' ' 40' ' ' ASN . . . -147.97 -12.83 0.37 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.264 -0.468 . . . . 0.0 109.742 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.458 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -82.55 86.74 6.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.545 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.705 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 35.9 tp -60.95 124.45 20.53 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.485 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.55 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 34.7 ttt180 -132.17 127.59 36.23 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.877 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.627 ' HB2' HG12 ' A' ' 14' ' ' ILE . . . -146.0 145.98 30.82 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.668 0.747 . . . . 0.0 111.421 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.425 ' HB2' ' CG ' ' A' ' 12' ' ' ARG . 2.1 mm-40 -83.68 76.4 9.98 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.411 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.582 ' SG ' HD11 ' A' ' 164' ' ' LEU . 35.8 m -66.54 125.57 26.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.393 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.467 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 30.3 ttt180 -70.41 121.75 18.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.651 178.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -100.05 163.84 12.25 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.755 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.4 -15.95 4.54 Favored Glycine 0 C--N 1.34 0.782 0 O-C-N 124.934 1.396 . . . . 0.0 114.114 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.6 -12.49 61.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.516 0.674 . . . . 0.0 109.417 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.57 9.52 62.86 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.654 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -119.93 162.26 14.11 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.08 -1.057 . . . . 0.0 113.286 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.467 ' CE2' ' HB2' ' A' ' 26' ' ' ARG . 84.2 m-85 -100.44 125.2 46.71 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.0 p -116.6 140.76 49.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.393 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -73.58 113.92 11.23 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.17 0.51 . . . . 0.0 111.43 -178.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 32.9 t -116.14 151.02 36.46 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.649 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.6 p -144.77 139.6 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.308 0.575 . . . . 0.0 112.091 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.7 tt -135.47 143.38 36.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.479 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -76.34 96.85 4.08 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.512 ' HG ' ' HG ' ' A' ' 43' ' ' LEU . 5.3 tp -73.5 -4.54 34.47 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.046 0.45 . . . . 0.0 110.408 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.544 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 64.3 t30 -73.83 -11.7 60.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 74.0 mtt180 -102.48 5.08 39.32 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.233 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 13.7 m-85 -127.57 -26.09 3.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.778 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.65 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 49.3 mt -105.02 138.76 40.73 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.8 0.333 . . . . 0.0 110.899 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.436 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 4.0 m -134.68 134.76 41.46 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.678 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.716 ' ND2' HD21 ' A' ' 140' ' ' LEU . 1.0 OUTLIER -73.33 110.37 7.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.685 177.221 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -111.9 86.95 2.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.245 0.545 . . . . 0.0 110.407 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 51.82 46.22 26.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.23 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.48 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 82.98 40.01 9.7 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.573 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.413 ' HA ' ' HB3' ' A' ' 149' ' ' SER . 16.5 t60 -162.2 128.63 3.64 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.865 ' HB2' ' HB ' ' A' ' 151' ' ' ILE . 96.2 m-85 -67.6 156.81 35.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.817 0.342 . . . . 0.0 111.146 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.43 ' HA ' ' HD3' ' A' ' 51' ' ' ARG . 16.7 mmt180 -148.91 126.89 11.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.169 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.98 ' HZ2' ' HA ' ' A' ' 153' ' ' LEU . 72.9 m95 . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.511 178.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 83.6 m . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.088 0.47 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.26 176.38 5.88 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.586 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.458 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 13.2 p -127.73 111.03 13.23 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.905 0.383 . . . . 0.0 111.176 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.561 HG23 ' CE2' ' A' ' 80' ' ' PHE . 9.1 p -97.54 144.37 11.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.042 0.448 . . . . 0.0 111.218 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 8.2 m -91.09 127.46 36.52 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.465 ' CG2' HD12 ' A' ' 99' ' ' ILE . 49.1 t -75.87 131.68 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.585 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -98.08 168.95 9.95 Favored 'General case' 0 N--CA 1.445 -0.679 0 O-C-N 124.657 1.223 . . . . 0.0 110.569 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.58 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 52.3 tt0 -69.65 119.75 14.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.781 -178.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.39 -1.67 50.1 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.475 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -110.12 131.71 54.82 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.084 0.469 . . . . 0.0 111.687 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.646 ' HA ' HG12 ' A' ' 99' ' ' ILE . 67.5 p -108.59 -177.62 3.37 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.56 HD23 ' O ' ' A' ' 95' ' ' ASN . 1.4 mm? -52.85 -40.81 63.71 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.454 0.645 . . . . 0.0 109.889 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.0 ttm-85 -62.9 -37.16 85.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.211 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -74.15 -42.0 60.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.905 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 72' ' ' THR . 44.7 mm -62.0 -48.31 89.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.713 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -54.44 -52.87 41.87 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.688 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -64.5 -33.7 76.5 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 35.7 ttm-85 -68.69 -37.46 79.56 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.812 ' HB2' ' HG ' ' A' ' 82' ' ' CYS . 87.1 m-85 -111.72 18.37 19.03 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 55.02 34.07 21.67 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.236 0.541 . . . . 0.0 111.794 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.812 ' HG ' ' HB2' ' A' ' 80' ' ' PHE . 3.0 p -111.37 170.49 8.09 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.613 ' HB3' ' HG3' ' A' ' 86' ' ' GLU . 32.6 t0 -98.26 121.53 40.3 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.419 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.466 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 4.3 p90 -51.82 -29.72 20.42 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.586 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.457 ' HB2' ' OD2' ' A' ' 83' ' ' ASP . 69.2 m80 -63.8 -47.22 81.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.513 177.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.745 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 41.6 mt-10 -62.05 -53.49 54.75 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.942 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.578 HG13 ' O ' ' A' ' 83' ' ' ASP . 3.3 mt -48.0 -46.6 12.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.275 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.591 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.72 -51.06 68.64 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.211 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 89' ' ' ARG . 49.4 mtp85 -59.16 -36.77 75.85 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.745 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 12.3 mmt85 -69.43 -30.44 68.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.699 0.285 . . . . 0.0 110.98 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 2.6 t-20 -95.1 -4.72 45.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.825 0.345 . . . . 0.0 110.871 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 15.9 m120 78.25 13.81 1.52 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.769 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.591 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 19.6 pt -101.64 -173.55 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.288 179.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . 64.4 mt-30 -113.88 157.64 22.1 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.126 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.56 ' O ' HD23 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -56.54 -69.73 0.14 Allowed 'General case' 0 C--O 1.244 0.778 0 CA-C-O 122.061 0.934 . . . . 0.0 110.101 179.663 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -73.28 13.91 0.38 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.716 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.496 ' HB2' ' HB2' ' A' ' 94' ' ' GLN . 1.9 t70 -65.99 -29.32 69.69 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.094 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 8.8 mp 71.33 112.3 0.06 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 122.033 0.921 . . . . 0.0 110.55 -178.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.646 HG12 ' HA ' ' A' ' 72' ' ' THR . 9.0 pt -94.59 177.22 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.155 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.505 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 79.2 m-85 -128.7 158.77 71.09 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.58 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 28.1 Cg_endo -67.0 138.96 49.56 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.949 2.433 . . . . 0.0 113.056 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.35 18.49 42.07 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.512 ' O ' ' HA ' ' A' ' 66' ' ' THR . 41.4 tt0 -103.89 164.28 11.8 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.458 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 69.7 t -125.58 118.2 51.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 120.938 0.399 . . . . 0.0 109.978 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.499 ' HB3' HG22 ' A' ' 87' ' ' ILE . 78.9 mt -114.44 151.07 33.77 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.147 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.523 ' HB2' ' CB ' ' A' ' 90' ' ' ARG . 75.8 mt-30 -90.91 115.2 27.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.668 0.747 . . . . 0.0 110.92 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.437 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 34.0 m -126.99 151.97 74.91 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.843 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 107' ' ' VAL . 29.7 Cg_endo -63.8 -15.37 48.55 Favored 'Trans proline' 0 N--CA 1.474 0.352 0 C-N-CA 123.624 2.883 . . . . 0.0 115.207 -177.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 C--N 1.322 -0.616 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.225 179.813 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.444 -0.799 0 N-CA-C 112.257 -0.337 . . . . 0.0 112.257 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 71.89 29.4 2.45 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 123.055 0.542 . . . . 0.0 111.373 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.65 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 12.5 p90 -61.19 -37.98 84.88 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.107 0.48 . . . . 0.0 110.183 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 -64.85 -26.25 68.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.636 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.46 -18.3 61.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.213 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.74 ' HB2' ' HB3' ' A' ' 141' ' ' ARG . 11.2 p -140.07 22.67 2.42 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.971 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.73 141.96 44.69 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.901 0.382 . . . . 0.0 111.091 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -133.74 151.2 51.54 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 58.83 34.81 23.94 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.363 0.414 . . . . 0.0 111.646 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.484 ' HA ' ' HB1' ' A' ' 138' ' ' ALA . 30.8 t -66.92 123.82 20.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.81 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.481 ' O ' HD11 ' A' ' 136' ' ' LEU . 39.1 ptt180 -148.12 142.71 26.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.088 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.558 HD12 HG22 ' A' ' 14' ' ' ILE . 22.3 mt -85.52 131.79 34.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.081 0.467 . . . . 0.0 110.044 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.609 HG22 ' HB ' ' A' ' 135' ' ' VAL . 27.5 m -126.92 162.36 31.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.825 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 67.16 7.26 5.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.785 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.672 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 95.39 31.35 7.58 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.914 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.768 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 90.03 -19.28 43.23 Favored Glycine 0 CA--C 1.541 1.671 0 CA-C-O 123.226 1.459 . . . . 0.0 112.824 177.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.712 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 0.7 OUTLIER -68.18 -14.92 63.34 Favored 'General case' 0 C--N 1.314 -0.952 0 O-C-N 121.121 -1.223 . . . . 0.0 109.564 178.071 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.609 ' HB ' HG22 ' A' ' 130' ' ' VAL . 14.6 t -140.49 149.06 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.783 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 39.0 tp -130.72 125.25 33.4 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -114.65 136.25 53.25 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.622 0.249 . . . . 0.0 111.363 -177.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.787 ' HB2' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.73 163.51 26.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.105 0.479 . . . . 0.0 111.323 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -94.72 106.5 18.49 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.716 HD21 ' ND2' ' A' ' 45' ' ' ASN . 36.6 mt -96.25 132.23 41.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.104 0.478 . . . . 0.0 111.316 -178.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.74 ' HB3' ' HB2' ' A' ' 123' ' ' SER . 42.5 ttt180 -75.82 140.55 42.34 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.256 -0.883 . . . . 0.0 110.674 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.488 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.7 p90 -160.3 -170.3 2.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.429 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 6.1 p -56.12 -29.29 60.46 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -94.49 11.67 69.84 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.726 -0.749 . . . . 0.0 113.171 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 141' ' ' ARG . . . 101.08 -111.46 4.14 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.039 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -126.75 129.85 49.17 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.488 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 9.1 t30 -125.55 140.19 52.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.992 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 148' ' ' ARG . 12.5 tpp85 -73.49 100.04 3.16 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.413 ' HB3' ' HA ' ' A' ' 49' ' ' HIS . 1.0 OUTLIER -111.62 155.43 23.38 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.425 -177.709 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.599 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 4.8 ptp180 -146.51 145.28 30.1 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.135 0.493 . . . . 0.0 111.274 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.865 ' HB ' ' HB2' ' A' ' 50' ' ' PHE . 15.4 tt -126.47 159.74 35.22 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.81 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.489 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.825 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 68.5 m-85 -103.94 107.15 17.9 Favored 'General case' 0 C--N 1.311 -1.106 0 O-C-N 122.361 -0.212 . . . . 0.0 110.655 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.98 ' HA ' ' HZ2' ' A' ' 52' ' ' TRP . 8.4 mp -68.9 -37.18 78.81 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.221 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.712 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 6.1 t70 -57.08 -8.41 0.66 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.869 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.825 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 61.0 mt-10 -73.78 -55.43 6.24 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 121.972 -0.455 . . . . 0.0 111.811 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -122.0 9.8 10.02 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.114 -0.634 . . . . 0.0 112.671 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 153' ' ' LEU . 45.1 mm -110.95 109.62 29.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.356 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.484 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -115.58 166.65 12.26 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.048 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.561 ' CG ' ' HB3' ' A' ' 25' ' ' CYS . 1.8 t30 -101.51 124.84 47.83 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.406 ' NH2' ' HG2' ' A' ' 163' ' ' GLU . 48.3 ttp180 -112.99 86.12 2.31 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.694 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 50.26 51.06 17.48 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 92.87 6.64 63.41 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.762 178.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.406 ' HG2' ' NH2' ' A' ' 160' ' ' ARG . 6.7 tp10 -122.16 149.75 43.17 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.697 HD13 ' CD2' ' A' ' 7' ' ' PHE . 5.3 tp -99.11 118.16 35.22 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 12.2 tt . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.673 -178.542 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.527 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 53.5 m-85 . . . . . 0 N--CA 1.457 -0.116 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.31 -29.39 10.8 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.66 -73.41 0.58 Allowed Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 119.772 -1.204 . . . . 0.0 113.154 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 65.26 15.61 10.1 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 122.46 0.304 . . . . 0.0 110.484 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.599 ' CE2' HD12 ' A' ' 14' ' ' ILE . 1.4 p90 -60.14 -37.26 79.53 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.562 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.573 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.7 OUTLIER -59.85 -24.05 63.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.268 0.556 . . . . 0.0 110.604 -179.427 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.87 -33.96 87.25 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.404 -0.816 . . . . 0.0 113.44 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 18.8 p -121.12 -3.74 9.55 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 117.188 0.494 . . . . 0.0 111.689 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.7 m -110.39 131.85 54.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.119 0.485 . . . . 0.0 109.997 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.553 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 18.8 ptt180 -107.95 179.94 4.08 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 42.52 47.79 4.48 Favored 'General case' 0 C--N 1.316 -0.867 0 O-C-N 123.883 0.739 . . . . 0.0 112.767 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.686 HG23 ' HA3' ' A' ' 133' ' ' GLY . 7.3 mt -81.49 102.44 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-O 121.043 0.449 . . . . 0.0 109.919 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.503 ' HA ' HD12 ' A' ' 129' ' ' LEU . 46.4 t -147.76 128.69 14.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.457 -0.792 . . . . 0.0 108.985 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.7 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -92.99 159.48 15.29 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.629 0.728 . . . . 0.0 112.007 -179.241 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -104.31 77.64 1.42 Allowed 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.22 -61.02 4.52 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.134 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' A' ' 40' ' ' ASN . . . -146.02 -13.36 0.48 Allowed 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.282 -0.459 . . . . 0.0 109.913 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -86.16 95.15 9.48 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.81 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.878 ' HB2' HD21 ' A' ' 39' ' ' LEU . 33.8 tp -59.75 128.27 36.11 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.758 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 35' ' ' SER . 34.8 ttp180 -133.17 128.03 35.13 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.939 -178.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.679 ' HB2' HG12 ' A' ' 14' ' ' ILE . . . -149.47 147.29 28.05 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.546 0.688 . . . . 0.0 111.144 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.553 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 2.1 mm-40 -82.96 79.62 9.26 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.464 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.57 ' HB3' ' CG ' ' A' ' 159' ' ' ASN . 61.4 m -67.34 129.43 39.89 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.762 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 10' ' ' SER . 43.1 ttp180 -72.35 120.8 18.46 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.251 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.7 ttt-85 -96.05 153.71 17.63 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.09 -16.37 4.33 Favored Glycine 0 C--N 1.335 0.493 0 O-C-N 124.611 1.194 . . . . 0.0 114.765 -177.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.87 -13.88 61.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.238 0.542 . . . . 0.0 110.001 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.38 10.13 56.09 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.59 160.64 13.9 Favored Glycine 0 C--O 1.225 -0.461 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.485 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.503 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 88.5 m-85 -97.98 130.59 44.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.955 0.407 . . . . 0.0 110.685 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.0 m -110.69 129.1 55.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.364 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.36 110.37 5.26 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 29.4 t -112.46 147.17 37.08 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.219 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.643 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.3 p -144.76 133.09 17.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.027 0.441 . . . . 0.0 110.686 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.408 HG23 ' HB3' ' A' ' 21' ' ' LEU . 11.0 tt -133.93 146.83 30.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.648 -177.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -78.96 103.74 9.11 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.924 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.878 HD21 ' HB2' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -78.96 -5.17 53.13 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 120.858 0.361 . . . . 0.0 110.245 178.601 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.581 HD21 ' HB3' ' A' ' 121' ' ' TRP . 25.1 t-20 -70.9 -17.88 62.69 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -106.07 17.49 23.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.382 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 41.3 m-85 -135.97 -34.7 0.8 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.314 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.57 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 38.6 mt -106.09 136.32 45.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.867 -179.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.666 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 3.0 m -126.6 143.59 51.17 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.78 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.604 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 6.8 p-10 -93.23 93.56 8.31 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 122.01 0.909 . . . . 0.0 108.568 178.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -94.3 95.74 9.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.16 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 54.68 45.65 26.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.525 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.687 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 77.87 29.94 53.23 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.467 178.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.552 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 23.7 t-160 -148.03 124.93 11.27 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.787 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 25.3 m-85 -62.54 136.42 57.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.248 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -145.01 133.12 21.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.701 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.446 ' HZ2' ' O ' ' A' ' 152' ' ' TYR . 98.6 m95 . . . . . 0 C--N 1.326 -0.433 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.6 m . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 121.067 0.46 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -126.46 176.76 6.92 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.665 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.1 p -128.37 118.01 22.42 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 t -107.06 137.2 39.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.802 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 18.9 m -87.78 124.82 34.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.081 0.467 . . . . 0.0 109.916 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.49 ' CG2' HD13 ' A' ' 99' ' ' ILE . 42.2 t -71.06 133.91 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.125 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.472 ' HB3' ' OD2' ' A' ' 71' ' ' ASP . 4.5 tt0 -104.16 171.33 7.4 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 124.464 1.103 . . . . 0.0 110.411 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.637 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 58.9 tp60 -60.22 119.68 8.35 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.374 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.94 6.53 79.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.996 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.472 ' OD2' ' HB3' ' A' ' 68' ' ' GLN . 27.6 m-20 -103.82 124.03 48.17 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 117.393 0.597 . . . . 0.0 110.581 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.621 ' HA ' HG12 ' A' ' 99' ' ' ILE . 80.3 p -105.18 179.44 4.27 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.53 HD13 ' HB ' ' A' ' 87' ' ' ILE . 2.2 mm? -51.6 -41.57 61.32 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.59 0.709 . . . . 0.0 109.403 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -59.61 -39.36 83.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.384 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 79' ' ' ARG . 13.4 m-20 -73.85 -46.65 43.68 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.119 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 72' ' ' THR . 42.4 mm -57.12 -48.05 82.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.709 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.731 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -59.78 -54.28 38.9 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.852 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -33.04 74.39 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.92 0.39 . . . . 0.0 111.524 -178.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 35.6 ttt180 -74.0 -39.82 63.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.031 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.506 ' HB2' ' HG ' ' A' ' 82' ' ' CYS . 97.4 m-85 -105.78 19.33 20.73 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 59.26 26.82 15.71 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.731 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -110.12 168.64 9.29 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.489 ' O ' HG13 ' A' ' 87' ' ' ILE . 4.3 p-10 -96.65 122.17 39.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.71 0.767 . . . . 0.0 109.836 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.422 ' HA ' HD13 ' A' ' 87' ' ' ILE . 3.0 p90 -48.64 -32.16 7.83 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.036 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.416 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 10.9 m80 -60.36 -48.93 79.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.991 178.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.61 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 28.4 tt0 -63.18 -46.33 87.62 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.205 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.53 ' HB ' HD13 ' A' ' 73' ' ' LEU . 3.5 mt -52.51 -49.58 43.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.577 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.27 -49.21 74.97 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.408 178.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' A' ' 85' ' ' HIS . 62.0 mtm180 -56.67 -38.13 71.77 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.61 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 13.0 mtt180 -70.02 -36.29 74.98 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.158 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.756 HD21 HD11 ' A' ' 93' ' ' ILE . 66.8 t30 -85.76 -5.51 59.24 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.964 0.411 . . . . 0.0 110.276 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 15.9 m120 75.5 18.92 2.2 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.611 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.756 HD11 HD21 ' A' ' 91' ' ' ASN . 14.3 pt -105.66 -170.38 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.204 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.541 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 28.5 mm-40 -117.97 158.72 24.41 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.479 ' O ' HD22 ' A' ' 73' ' ' LEU . 6.3 p30 -55.72 -57.62 11.26 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-O 121.877 0.846 . . . . 0.0 109.956 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.12 12.51 2.78 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 121.831 -0.543 . . . . 0.0 111.294 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.541 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 0.8 OUTLIER -62.69 -31.2 72.06 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.617 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 7.0 mp 71.38 111.18 0.06 Allowed 'General case' 0 C--N 1.338 0.108 0 O-C-N 124.358 1.037 . . . . 0.0 110.732 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.621 HG12 ' HA ' ' A' ' 72' ' ' THR . 6.4 pt -94.43 176.0 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.977 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.466 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 92.7 m-85 -121.07 158.2 53.28 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.91 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.637 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 43.4 Cg_endo -72.3 133.36 20.88 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 123.042 2.495 . . . . 0.0 112.889 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 101.59 14.12 30.7 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.514 ' O ' ' HA ' ' A' ' 66' ' ' THR . 40.0 mt-30 -102.92 168.44 9.2 Favored 'General case' 0 C--O 1.216 -0.699 0 C-N-CA 120.641 -0.424 . . . . 0.0 109.956 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 63.5 t -126.15 118.48 51.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.561 HD11 HG22 ' A' ' 99' ' ' ILE . 95.8 mt -113.93 150.07 34.28 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.188 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -89.58 110.72 21.55 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.986 0.898 . . . . 0.0 111.21 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.1 m -115.59 151.57 46.28 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.555 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.71 -18.06 53.02 Favored 'Trans proline' 0 C--N 1.331 -0.349 0 C-N-CA 123.069 2.513 . . . . 0.0 114.376 -178.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.0 t . . . . . 0 C--N 1.32 -0.681 0 CA-C-O 120.875 0.369 . . . . 0.0 111.225 -179.777 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.666 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.444 -0.778 0 N-CA-C 112.676 -0.169 . . . . 0.0 112.676 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 73.18 29.1 1.77 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.278 0.631 . . . . 0.0 111.554 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.57 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 20.0 p90 -59.87 -37.69 80.05 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-O 121.108 0.48 . . . . 0.0 110.06 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.636 ' HE3' ' HB2' ' A' ' 124' ' ' ALA . 4.1 t-105 -66.27 -26.55 67.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.195 -178.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.89 -25.49 66.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.139 0.495 . . . . 0.0 110.143 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.647 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 4.2 m -133.42 27.03 4.11 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.323 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.636 ' HB2' ' HE3' ' A' ' 121' ' ' TRP . . . -105.65 155.82 18.87 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.001 0.429 . . . . 0.0 110.898 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.0 mmm-85 -146.43 142.35 28.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.755 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 53.55 35.57 21.21 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.246 0.546 . . . . 0.0 111.371 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.567 ' HB ' ' CB ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -79.74 127.36 39.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.812 -179.848 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.446 ' O ' HD13 ' A' ' 136' ' ' LEU . 15.6 ptt180 -151.31 158.82 44.32 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.571 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.815 HD23 HD13 ' A' ' 153' ' ' LEU . 17.1 mt -86.1 136.59 33.16 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 120.996 0.427 . . . . 0.0 110.825 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.572 HG21 ' HB ' ' A' ' 135' ' ' VAL . 31.2 m -132.35 159.48 43.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.471 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.479 ' HB3' ' HD3' ' A' ' 134' ' ' LYS . 4.6 m-20 69.63 4.87 4.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.398 178.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.651 ' O ' HD13 ' A' ' 14' ' ' ILE . . . 98.04 28.84 7.96 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.597 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.686 ' HA3' HG23 ' A' ' 14' ' ' ILE . . . 93.07 -18.85 55.26 Favored Glycine 0 C--O 1.269 2.283 0 CA-C-O 123.773 1.763 . . . . 0.0 112.623 177.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.667 ' HG3' HG22 ' A' ' 135' ' ' VAL . 20.9 ptmt -67.52 -19.97 65.37 Favored 'General case' 0 C--N 1.313 -0.986 0 O-C-N 121.452 -1.028 . . . . 0.0 108.82 178.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.667 HG22 ' HG3' ' A' ' 134' ' ' LYS . 4.2 t -138.15 146.67 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 121.279 0.561 . . . . 0.0 110.874 178.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.623 HD12 HD21 ' A' ' 129' ' ' LEU . 50.6 tp -126.46 116.31 20.93 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.479 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 32.5 tt0 -105.05 137.15 43.25 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.437 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.567 ' CB ' ' HB ' ' A' ' 127' ' ' VAL . . . -161.96 164.07 28.62 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.185 0.517 . . . . 0.0 112.283 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -95.9 106.25 18.37 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.687 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 50.2 mt -98.24 129.79 44.97 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.307 0.575 . . . . 0.0 111.244 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.647 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 62.4 ttt180 -71.32 141.18 50.47 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.5 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.415 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.6 p90 -159.09 -173.78 4.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.226 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 17.0 m -61.04 -26.21 67.47 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -94.83 16.12 61.93 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.875 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 102.1 -114.99 5.1 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.412 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -128.69 128.84 44.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.931 0.396 . . . . 0.0 110.371 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.415 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 47.0 t30 -124.25 130.86 53.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.218 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 138' ' ' ALA . 13.8 ttp180 -78.15 96.58 5.21 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.266 0.555 . . . . 0.0 110.617 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.552 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 20.0 t -104.13 170.43 7.92 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.172 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.621 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 8.7 mtp85 -146.22 147.73 31.75 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 121.155 -0.218 . . . . 0.0 110.615 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.787 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 9.9 tt -131.34 152.62 37.62 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.538 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.146 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.633 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 84.4 m-85 -96.65 105.02 17.06 Favored 'General case' 0 C--N 1.313 -1.012 0 O-C-N 122.286 -0.259 . . . . 0.0 111.024 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.815 HD13 HD23 ' A' ' 129' ' ' LEU . 16.9 mt -65.72 -37.24 85.86 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.11 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.606 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 9.4 t70 -53.59 -14.4 0.85 Allowed 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.144 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.633 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 41.1 mt-10 -66.51 -54.79 19.99 Favored 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 121.682 -0.636 . . . . 0.0 112.715 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -122.18 1.05 9.69 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.141 -0.624 . . . . 0.0 112.492 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 45.5 mm -104.09 110.78 31.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.484 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.59 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -118.69 166.41 12.97 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.232 -0.985 . . . . 0.0 113.105 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.57 ' CG ' ' HB3' ' A' ' 25' ' ' CYS . 2.6 t30 -98.25 122.26 41.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.415 -0.393 . . . . 0.0 110.077 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -117.81 86.77 2.58 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 58.86 47.37 12.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.184 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.518 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 87.67 7.55 75.0 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.485 178.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -124.09 132.74 53.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.04 0.447 . . . . 0.0 111.567 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.574 HD21 ' HD2' ' A' ' 7' ' ' PHE . 30.0 mt -84.63 114.31 21.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.642 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 46.0 pt . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.222 178.783 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.465 ' CD1' ' HG2' ' A' ' 155' ' ' GLU . 28.9 m-85 . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.54 -27.41 12.37 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.2 -76.39 0.27 Allowed Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.13 -1.033 . . . . 0.0 112.91 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 65.66 11.03 7.22 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.547 0.339 . . . . 0.0 111.138 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.633 ' CE2' HD13 ' A' ' 14' ' ' ILE . 1.6 p90 -61.33 -33.02 72.91 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 121.133 -0.227 . . . . 0.0 111.281 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.512 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.8 OUTLIER -62.58 -25.41 68.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.326 0.584 . . . . 0.0 110.562 -178.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.73 -22.99 77.0 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.183 -0.917 . . . . 0.0 113.596 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.496 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 22.9 p -125.73 -16.39 5.73 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 117.722 0.761 . . . . 0.0 111.72 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.6 m -99.72 131.71 45.53 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.413 ' CG ' ' HB2' ' A' ' 24' ' ' GLU . 15.2 ptm180 -109.18 178.82 4.34 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 44.67 47.57 8.71 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.454 0.701 . . . . 0.0 112.56 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.677 HG12 ' HB3' ' A' ' 23' ' ' ALA . 10.2 mt -80.77 106.18 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.518 ' HA ' HD11 ' A' ' 129' ' ' LEU . 72.2 m -147.8 128.04 13.85 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.712 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -94.04 154.62 17.54 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.22 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -96.21 73.93 2.93 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.002 -1.453 . . . . 0.0 107.694 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.17 -60.17 4.72 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.793 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.418 ' HB3' ' HB3' ' A' ' 40' ' ' ASN . . . -145.42 0.46 0.89 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.135 0.493 . . . . 0.0 110.47 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -104.48 93.82 4.99 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.005 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.712 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 2.8 tm? -60.06 132.45 53.97 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.671 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.697 ' H ' HD21 ' A' ' 21' ' ' LEU . 33.2 ttm105 -134.52 128.0 32.48 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.198 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.677 ' HB3' HG12 ' A' ' 14' ' ' ILE . . . -148.39 148.49 30.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.679 0.752 . . . . 0.0 111.141 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.459 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 2.6 mm-40 -82.85 76.95 9.66 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.196 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.504 ' HB3' ' CG ' ' A' ' 159' ' ' ASN . 84.8 m -63.36 126.74 28.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.717 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 10' ' ' SER . 37.2 ttt180 -69.54 122.57 19.3 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.353 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.547 ' HG3' ' OD1' ' A' ' 161' ' ' ASN . 20.4 ttt85 -99.3 152.06 20.36 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.891 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -52.19 -17.9 4.33 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 114.119 -1.4 . . . . 0.0 114.712 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.414 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 4.6 m-20 -74.94 -7.46 53.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.103 0.478 . . . . 0.0 110.696 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.51 8.13 62.75 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.64 154.95 16.38 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.368 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.459 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 80.8 m-85 -92.4 125.53 37.09 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.3 m -108.23 130.35 55.16 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.332 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.2 m -68.98 112.44 5.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.862 0.363 . . . . 0.0 110.588 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.48 ' HB3' HD22 ' A' ' 164' ' ' LEU . 32.2 t -116.44 151.24 36.43 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.265 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.547 ' HB ' ' HG3' ' A' ' 22' ' ' ARG . 1.4 p -144.38 130.93 15.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.964 0.411 . . . . 0.0 110.675 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.421 ' CG2' ' HB3' ' A' ' 21' ' ' LEU . 17.8 tt -122.95 149.23 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.98 -178.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.459 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 22.7 m-20 -82.78 93.57 7.46 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.563 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.654 HD11 HD23 ' A' ' 16' ' ' LEU . 39.2 mt -73.27 -13.38 61.12 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.019 0.438 . . . . 0.0 109.997 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.491 ' OD1' ' HG3' ' A' ' 41' ' ' ARG . 23.8 p30 -66.27 -16.22 63.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.432 0.634 . . . . 0.0 109.625 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.491 ' HG3' ' OD1' ' A' ' 40' ' ' ASN . 48.0 mtm180 -117.29 20.28 13.73 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.418 178.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.556 ' HB2' ' HA ' ' A' ' 39' ' ' LEU . 9.6 m-85 -133.4 -30.92 1.26 Allowed 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.295 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.535 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 42.2 mt -114.63 135.8 53.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.854 0.359 . . . . 0.0 110.781 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.727 ' HG ' ' HA2' ' A' ' 118' ' ' GLY . 1.9 m -124.21 147.66 47.87 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.038 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.547 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 7.5 p-10 -94.86 98.77 10.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.596 0.713 . . . . 0.0 110.478 178.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -99.99 94.41 6.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.191 0.519 . . . . 0.0 110.824 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.478 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 64.0 t30 52.68 45.37 28.8 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.213 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.697 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 79.96 32.57 35.81 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.608 178.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -149.14 131.34 15.47 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.795 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 58.7 m-85 -72.63 145.37 47.35 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.955 0.407 . . . . 0.0 111.427 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -143.5 133.62 24.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.063 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.554 ' HZ2' ' O ' ' A' ' 152' ' ' TYR . 97.9 m95 . . . . . 0 C--N 1.323 -0.582 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.451 -0.424 0 CA-C-O 120.944 0.402 . . . . 0.0 110.069 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -131.46 177.47 7.47 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.933 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.405 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 21.2 p -128.23 121.29 29.02 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 t -107.36 134.3 49.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.928 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.555 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 7.2 m -87.51 125.82 34.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.486 ' CG2' HD11 ' A' ' 99' ' ' ILE . 42.0 t -73.14 132.29 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.103 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -104.19 170.63 7.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 124.388 1.055 . . . . 0.0 109.47 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.585 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 58.8 tt0 -66.63 124.28 22.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.51 -178.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.05 3.22 73.45 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.978 -0.63 . . . . 0.0 113.592 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -109.59 121.4 45.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.035 0.418 . . . . 0.0 111.231 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.593 ' HA ' HG12 ' A' ' 99' ' ' ILE . 81.4 p -102.56 -178.11 3.59 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.547 HD23 ' O ' ' A' ' 95' ' ' ASN . 1.1 mm? -51.99 -40.98 61.79 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.347 0.594 . . . . 0.0 109.834 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.422 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 48.7 ttm-85 -62.95 -39.65 95.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.164 -178.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -71.7 -42.93 66.8 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.959 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.539 HG12 ' O ' ' A' ' 72' ' ' THR . 45.6 mm -61.72 -48.79 87.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.796 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.666 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -58.33 -54.09 40.47 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.422 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -58.5 -41.17 84.76 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.761 0.315 . . . . 0.0 111.77 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -65.1 -43.98 90.31 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.546 ' HB2' ' HG ' ' A' ' 82' ' ' CYS . 96.8 m-85 -98.43 11.79 37.05 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.9 t70 63.4 23.12 13.58 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.359 0.599 . . . . 0.0 112.106 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.666 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.3 p -104.37 171.67 7.21 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.563 ' O ' HG13 ' A' ' 87' ' ' ILE . 5.8 t70 -98.01 125.31 42.89 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.9 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.486 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 9.3 p90 -50.78 -29.68 12.19 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.366 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -65.12 -46.21 81.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.541 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.734 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 56.7 mm-40 -69.14 -41.44 77.31 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.314 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.563 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.8 mt -54.87 -47.5 75.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.644 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.53 -48.58 76.93 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.5 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -54.4 -43.01 71.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.351 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.734 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 24.7 mmm-85 -72.82 -27.4 61.94 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 3.3 t-20 -94.01 -4.79 48.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.892 0.377 . . . . 0.0 111.103 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 90.1 m-20 75.61 17.49 2.37 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.756 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.644 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 19.2 pt -105.67 -172.44 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.519 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 18.1 mm-40 -116.31 154.46 30.15 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.547 ' O ' HD23 ' A' ' 73' ' ' LEU . 1.2 p30 -52.25 -65.96 0.47 Allowed 'General case' 0 C--O 1.244 0.777 0 CA-C-O 122.225 1.012 . . . . 0.0 109.872 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -76.06 13.42 0.89 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.824 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 4.6 t0 -63.59 -31.48 72.66 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 7.9 mp 72.06 112.35 0.06 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.611 -178.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.593 HG12 ' HA ' ' A' ' 72' ' ' THR . 9.8 pt -94.85 176.63 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.815 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.549 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 94.1 m-85 -131.16 158.01 76.45 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.743 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.585 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 18.4 Cg_endo -63.98 138.26 61.66 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 123.301 2.667 . . . . 0.0 113.823 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.41 20.8 31.23 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.79 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.555 ' O ' ' HA ' ' A' ' 66' ' ' THR . 77.2 mt-30 -110.4 166.07 11.28 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.178 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.405 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 95.6 t -125.09 118.51 53.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.486 HD13 HG22 ' A' ' 99' ' ' ILE . 76.9 mt -112.35 150.59 30.84 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.35 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -90.8 116.93 29.03 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.582 0.706 . . . . 0.0 110.656 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 33.6 m -119.83 151.27 52.12 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.454 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.06 -18.98 51.9 Favored 'Trans proline' 0 C--N 1.332 -0.33 0 C-N-CA 123.098 2.532 . . . . 0.0 114.332 -178.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.9 t . . . . . 0 C--N 1.326 -0.448 0 CA-C-O 121.032 0.444 . . . . 0.0 111.131 -179.806 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.727 ' HA2' ' HG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.445 -0.712 0 CA-C-O 120.19 -0.228 . . . . 0.0 113.155 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 14.0 m120 73.94 26.71 1.73 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.059 0.544 . . . . 0.0 112.111 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.535 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 20.7 p90 -60.65 -37.23 80.82 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.04 0.448 . . . . 0.0 110.348 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 124' ' ' ALA . 71.0 t-105 -61.79 -34.43 75.88 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.404 -178.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -54.02 -27.42 31.88 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.143 0.277 . . . . 0.0 110.894 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.619 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 9.3 m -132.85 28.54 4.2 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.479 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.506 ' HB2' ' HA ' ' A' ' 121' ' ' TRP . . . -107.51 143.89 35.25 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.968 0.413 . . . . 0.0 111.387 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -126.69 143.05 51.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.817 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 49.12 57.47 6.43 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.668 0.605 . . . . 0.0 112.01 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.424 ' CG1' HD11 ' A' ' 136' ' ' LEU . 40.3 t -80.45 121.76 34.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.841 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.66 148.14 29.72 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.292 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.688 HD23 HD12 ' A' ' 153' ' ' LEU . 33.6 mt -85.54 145.23 27.48 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.137 0.494 . . . . 0.0 111.411 -179.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.949 HG23 ' HB ' ' A' ' 135' ' ' VAL . 29.0 m -132.31 157.1 43.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.64 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 71.83 1.12 3.77 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.772 0.829 . . . . 0.0 110.387 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.611 ' O ' HD11 ' A' ' 14' ' ' ILE . . . 93.14 28.42 11.83 Favored Glycine 0 N--CA 1.433 -1.535 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.165 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.67 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 104.66 -18.19 44.56 Favored Glycine 0 C--O 1.271 2.44 0 CA-C-O 123.45 1.583 . . . . 0.0 113.165 178.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.702 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 1.6 mttp -72.16 -13.58 61.59 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 121.221 -1.164 . . . . 0.0 108.854 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.949 ' HB ' HG23 ' A' ' 130' ' ' VAL . 3.2 t -143.28 151.36 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.443 177.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.519 HD12 HD21 ' A' ' 129' ' ' LEU . 33.1 tp -131.26 125.77 33.7 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -116.07 131.62 56.89 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.175 0.512 . . . . 0.0 110.911 -177.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.781 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -159.64 155.15 25.66 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.38 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 15.3 mt-10 -94.64 106.33 18.31 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.697 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 47.0 mt -91.41 134.32 34.72 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.154 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.619 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 72.4 ttt180 -69.99 140.84 53.0 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.932 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.518 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.5 p90 -156.04 -169.75 3.17 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.458 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 23.0 t -57.58 -30.81 65.57 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.297 0.373 . . . . 0.0 111.545 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -98.24 23.5 35.89 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.171 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 98.77 -107.83 3.49 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.217 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -133.0 127.71 34.75 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.518 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 10.9 t30 -123.18 129.99 52.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.665 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 32.9 ttm180 -76.44 102.81 6.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.138 0.494 . . . . 0.0 109.807 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 48' ' ' GLY . 18.1 p -114.96 172.3 7.13 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.232 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 6.3 ptp180 -148.55 152.62 37.12 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.565 -0.454 . . . . 0.0 112.051 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.795 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 12.1 tt -130.64 160.97 41.38 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.824 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.908 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 79.8 m-85 -107.55 106.74 17.25 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 121.856 -0.527 . . . . 0.0 110.25 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.688 HD12 HD23 ' A' ' 129' ' ' LEU . 23.8 mt -62.89 -36.01 81.93 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.213 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.702 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 9.5 t70 -57.39 -8.58 0.81 Allowed 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.504 178.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.908 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 46.7 mt-10 -75.05 -50.83 15.19 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 121.831 -0.543 . . . . 0.0 111.962 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -125.94 7.38 7.34 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -177.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.5 HG12 ' CH2' ' A' ' 52' ' ' TRP . 43.5 mm -107.58 106.07 19.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.169 178.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.405 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -111.35 161.88 12.64 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.637 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.504 ' CG ' ' HB3' ' A' ' 25' ' ' CYS . 1.4 t30 -100.55 120.37 39.92 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 31.9 ttp-105 -112.38 87.24 2.53 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.535 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.547 ' OD1' ' HG3' ' A' ' 27' ' ' ARG . 3.0 t-20 59.26 35.79 23.5 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.437 178.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 35' ' ' SER . . . 105.29 -0.07 40.69 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.972 178.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -123.3 134.2 54.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.717 0.758 . . . . 0.0 111.768 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.548 HD13 ' HD2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -74.89 129.46 37.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.895 178.701 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 9.4 tp . . . . . 0 C--N 1.321 -0.633 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.205 -179.718 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.956 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 66.8 m-85 . . . . . 0 CA--C 1.516 -0.357 0 CA-C-O 120.925 0.393 . . . . 0.0 110.313 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -123.22 -30.02 3.77 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.762 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.91 -69.24 1.41 Allowed Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 119.56 -1.305 . . . . 0.0 112.689 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 68.16 14.81 9.33 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.889 0.476 . . . . 0.0 111.3 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.589 ' CE2' HD12 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -58.9 -33.91 71.08 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 -179.279 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.469 ' HA ' HD11 ' A' ' 14' ' ' ILE . 8.8 p -61.2 -27.62 68.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.135 0.493 . . . . 0.0 111.579 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.79 -20.64 79.77 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.574 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 5.1 m -120.67 -19.61 7.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.45 0.625 . . . . 0.0 111.455 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 m -104.33 135.6 45.48 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -112.47 177.58 4.59 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 43.43 50.47 6.15 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 124.037 0.836 . . . . 0.0 111.878 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.673 HD13 ' O ' ' A' ' 132' ' ' GLY . 12.3 mt -82.05 104.82 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.571 ' CA ' HD11 ' A' ' 129' ' ' LEU . 71.0 m -146.23 128.67 15.94 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 122.823 0.449 . . . . 0.0 109.83 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.77 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -100.23 158.62 15.74 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 121.628 0.727 . . . . 0.0 112.717 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -100.57 76.57 1.84 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.328 -1.305 . . . . 0.0 107.551 176.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.28 -54.11 4.85 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.779 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.576 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -149.04 -13.16 0.31 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.892 0.377 . . . . 0.0 110.184 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.62 88.37 7.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.587 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.77 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 44.0 tp -61.79 121.02 11.84 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.868 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.535 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 39.9 ttt180 -128.49 130.27 47.27 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.432 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.659 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -148.89 150.59 33.22 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.673 0.749 . . . . 0.0 111.076 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.423 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 5.0 mm-40 -85.48 74.53 10.32 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.163 -1.38 . . . . 0.0 108.413 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.679 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 65.0 m -64.97 129.62 40.39 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.829 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 10' ' ' SER . 26.7 ttm180 -65.33 131.65 47.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.328 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 35.1 ttt85 -108.86 151.46 26.23 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -52.99 -16.74 4.44 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 114.319 -1.31 . . . . 0.0 114.519 -178.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -72.74 -6.15 42.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.112 0.482 . . . . 0.0 110.416 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.99 6.68 66.74 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -120.5 169.66 14.16 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.412 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.423 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 69.0 m-85 -96.93 140.05 32.04 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.869 0.366 . . . . 0.0 110.555 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.4 t -121.72 130.23 53.29 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.4 m -72.5 112.89 8.96 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.268 0.556 . . . . 0.0 110.969 -178.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 162' ' ' GLY . 40.5 t -116.65 148.38 41.04 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.465 -179.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.4 p -144.32 136.44 22.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-O 120.775 0.321 . . . . 0.0 111.156 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.6 tt -136.19 146.44 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.516 -178.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.59 97.12 4.97 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.671 HD22 ' HB2' ' A' ' 21' ' ' LEU . 1.6 tp -79.96 -6.51 57.64 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.014 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.576 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 15.2 p30 -65.03 -20.24 66.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.167 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -105.58 16.53 25.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.298 0.571 . . . . 0.0 110.857 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -127.46 -33.6 2.32 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.131 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.625 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 31.9 mt -106.07 144.11 33.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.358 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.54 147.63 52.55 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.849 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.438 ' ND2' ' HB2' ' A' ' 123' ' ' SER . 23.2 p-10 -98.38 94.12 6.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.504 0.668 . . . . 0.0 109.811 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -94.78 93.6 7.59 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.977 0.418 . . . . 0.0 111.49 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.5 t30 52.83 47.0 25.64 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.16 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.722 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 78.04 29.93 52.67 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.791 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.546 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 33.7 m80 -141.99 125.64 16.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.788 ' HB3' ' HB ' ' A' ' 151' ' ' ILE . 14.2 m-85 -68.3 136.55 53.64 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.802 0.334 . . . . 0.0 111.103 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.8 mtp180 -141.76 135.32 29.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.579 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.47 ' CZ2' ' HA ' ' A' ' 153' ' ' LEU . 96.7 m95 . . . . . 0 C--N 1.323 -0.583 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.4 m . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 121.197 0.523 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -133.56 176.67 8.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.835 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.464 HG21 ' HG2' ' A' ' 106' ' ' GLN . 6.9 p -129.34 118.07 21.65 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 122.413 -0.18 . . . . 0.0 111.357 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.558 HG22 ' CE2' ' A' ' 80' ' ' PHE . 9.0 p -110.43 145.03 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.886 0.374 . . . . 0.0 111.386 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.2 m -91.22 123.51 34.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.711 HG21 HD13 ' A' ' 99' ' ' ILE . 63.7 t -76.69 130.26 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.244 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -101.72 169.99 8.46 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 124.455 1.097 . . . . 0.0 110.008 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.605 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 9.6 tt0 -63.22 114.46 3.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.251 -178.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.0 -5.83 27.26 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.878 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.46 124.44 49.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 117.284 0.542 . . . . 0.0 112.188 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.53 ' O ' HG12 ' A' ' 76' ' ' ILE . 81.0 p -101.24 -178.97 3.9 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.582 HD21 HG23 ' A' ' 99' ' ' ILE . 0.7 OUTLIER -53.59 -40.46 65.71 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.555 0.693 . . . . 0.0 109.809 179.179 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.625 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -69.81 -34.37 73.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.041 -178.204 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -72.71 -38.98 67.31 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 72' ' ' THR . 45.1 mm -62.4 -47.17 94.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 177.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.765 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -56.68 -48.37 77.95 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.401 178.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.2 mtm180 -66.99 -35.98 81.16 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 122.515 -0.403 . . . . 0.0 111.923 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -69.66 -38.73 77.19 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.558 ' CE2' HG22 ' A' ' 65' ' ' VAL . 89.0 m-85 -110.52 16.71 21.37 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -178.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.0 t70 53.42 47.75 23.41 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.751 0.786 . . . . 0.0 110.852 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.765 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.8 p -124.42 170.97 10.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.591 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.632 ' O ' HG13 ' A' ' 87' ' ' ILE . 8.9 t70 -96.85 120.1 36.55 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.467 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.625 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 14.3 p90 -51.13 -32.61 23.46 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.708 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.426 ' HB2' ' OD1' ' A' ' 83' ' ' ASP . 0.3 OUTLIER -67.7 -42.93 81.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.76 179.733 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.677 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 8.7 mm-40 -66.67 -43.75 83.68 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.974 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.632 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.8 mt -53.52 -47.04 60.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.604 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.93 -51.14 68.06 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.15 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -57.38 -43.07 83.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.677 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 78.1 mtt180 -68.18 -23.27 64.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.055 0.455 . . . . 0.0 110.987 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.496 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 21.8 t-20 -99.04 -5.72 29.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.853 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.496 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 5.2 m-20 77.91 15.96 1.45 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.783 0.833 . . . . 0.0 111.637 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.604 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 10.4 pt -106.24 -176.42 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 17.9 mm-40 -111.65 158.22 19.53 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.609 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 16.7 p-10 -55.87 -60.45 3.44 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 122.103 0.954 . . . . 0.0 109.47 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -76.6 12.53 1.25 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.116 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 3.9 t70 -65.17 -33.58 76.35 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 9.1 mp 72.43 112.42 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 124.301 1.001 . . . . 0.0 110.16 -177.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.711 HD13 HG21 ' A' ' 67' ' ' VAL . 10.6 pt -95.32 175.91 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.407 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.488 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 83.0 m-85 -128.68 158.59 71.61 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.583 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.605 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 19.9 Cg_endo -67.6 134.97 34.52 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.994 2.463 . . . . 0.0 112.997 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.84 17.54 25.33 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.384 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -110.66 157.5 19.64 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 120.619 -0.433 . . . . 0.0 109.948 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.3 t -116.73 116.6 52.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.519 HD12 HG22 ' A' ' 99' ' ' ILE . 69.3 mt -109.92 151.0 27.63 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.57 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.464 ' HG2' HG21 ' A' ' 64' ' ' THR . 66.3 mt-30 -89.88 107.42 19.1 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.894 0.854 . . . . 0.0 111.146 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.4 m -112.62 151.32 43.82 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-N 113.934 -1.484 . . . . 0.0 109.151 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.19 -18.88 65.03 Favored 'Trans proline' 0 C--N 1.332 -0.325 0 C-N-CA 123.146 2.564 . . . . 0.0 114.158 -177.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.6 t . . . . . 0 C--N 1.323 -0.551 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.3 -179.435 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 112.069 -0.412 . . . . 0.0 112.069 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 74.97 32.78 0.78 Allowed 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.268 0.627 . . . . 0.0 111.902 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.625 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 20.0 p90 -66.36 -35.96 81.67 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.301 0.572 . . . . 0.0 109.865 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.47 ' HB2' ' HB2' ' A' ' 19' ' ' ALA . 24.5 t-105 -66.39 -21.87 66.23 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.239 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.94 -24.97 60.21 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.828 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.589 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 50.5 m -143.76 33.59 1.27 Allowed 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.689 178.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.431 ' HB2' ' HA ' ' A' ' 121' ' ' TRP . . . -102.01 147.58 26.4 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 177.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.702 ' HD2' ' HB2' ' A' ' 126' ' ' ASP . 8.0 tmm_? -143.71 140.86 30.23 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.702 ' HB2' ' HD2' ' A' ' 125' ' ' ARG . 1.2 t70 58.3 25.65 12.99 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.789 0.681 . . . . 0.0 110.765 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.584 ' HB ' ' CB ' ' A' ' 138' ' ' ALA . 0.4 OUTLIER -67.06 119.75 13.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.926 -179.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.25 151.62 46.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.302 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.739 HD23 HD11 ' A' ' 153' ' ' LEU . 15.9 mt -85.44 131.21 34.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.261 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.602 HG23 ' HB ' ' A' ' 135' ' ' VAL . 26.9 m -126.55 163.9 27.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.234 -178.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.406 ' HB3' ' HD2' ' A' ' 134' ' ' LYS . 9.7 m-20 64.13 7.72 3.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.97 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.673 ' O ' HD13 ' A' ' 14' ' ' ILE . . . 97.24 31.04 7.05 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.273 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.671 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 87.93 -13.74 60.45 Favored Glycine 0 C--O 1.259 1.69 0 CA-C-O 123.506 1.614 . . . . 0.0 112.474 177.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.639 ' O ' ' HA ' ' A' ' 152' ' ' TYR . 17.4 ptpt -72.33 -17.09 61.87 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.602 ' HB ' HG23 ' A' ' 130' ' ' VAL . 17.5 t -139.92 138.77 38.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.328 177.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.582 ' CD1' HD11 ' A' ' 16' ' ' LEU . 36.5 tp -119.91 115.21 23.33 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -107.57 126.26 52.33 Favored 'General case' 0 C--N 1.316 -0.884 0 O-C-N 123.28 0.362 . . . . 0.0 110.213 -177.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.584 ' CB ' ' HB ' ' A' ' 127' ' ' VAL . . . -150.07 160.25 43.79 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.277 0.56 . . . . 0.0 111.89 -178.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -96.29 106.8 19.06 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.722 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 50.0 mt -97.03 129.02 44.53 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.39 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.589 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 22.1 ttt180 -70.05 139.72 52.69 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.224 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.622 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.9 p90 -155.78 -167.94 2.64 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.163 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 4.3 m -56.32 -29.55 61.41 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -104.72 29.84 11.11 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.388 -0.91 . . . . 0.0 113.53 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.7 -112.52 4.38 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.631 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -125.6 126.46 44.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.741 0.305 . . . . 0.0 110.689 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.622 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 63.2 t30 -118.53 129.23 55.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.495 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -78.38 98.73 6.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.205 0.526 . . . . 0.0 109.956 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.546 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 21.7 t -109.45 168.21 9.56 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.178 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.563 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 16.5 ptt180 -149.1 152.76 36.72 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.468 -0.493 . . . . 0.0 112.12 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.788 ' HB ' ' HB3' ' A' ' 50' ' ' PHE . 6.1 tt -133.02 152.84 36.7 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.92 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.639 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 95.8 m-85 -95.44 103.4 15.27 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.771 -0.195 . . . . 0.0 110.666 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.739 HD11 HD23 ' A' ' 129' ' ' LEU . 19.9 mt -67.06 -35.83 80.71 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.169 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -52.91 -19.26 2.44 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.189 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.956 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 36.0 mt-10 -63.39 -55.86 20.98 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -121.88 5.7 9.91 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 119.655 -0.818 . . . . 0.0 112.705 -176.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.423 ' HB ' ' O ' ' A' ' 153' ' ' LEU . 45.0 mm -107.25 111.68 36.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.689 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.45 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -113.55 -178.17 19.35 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.57 178.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.679 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -124.86 136.67 54.01 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.773 0.32 . . . . 0.0 110.548 179.753 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -124.82 86.78 2.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.047 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 90.3 m-20 54.39 50.96 15.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.37 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.551 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 89.8 7.82 68.15 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.496 178.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -123.65 117.12 24.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.984 0.392 . . . . 0.0 111.367 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.499 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 25.0 mt -67.23 123.15 19.49 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.518 178.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 13.4 tt . . . . . 0 C--N 1.323 -0.58 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.891 -179.537 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 1.056 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 21.9 m-85 . . . . . 0 C--O 1.234 0.247 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -102.07 -31.56 10.57 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -70.77 -65.71 2.4 Favored Glycine 0 N--CA 1.434 -1.437 0 C-N-CA 119.511 -1.328 . . . . 0.0 112.205 -178.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 64.37 19.66 11.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.631 -0.285 . . . . 0.0 110.895 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.708 ' CD2' HD12 ' A' ' 164' ' ' LEU . 0.7 OUTLIER -58.44 -42.62 87.76 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.542 -179.664 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.428 ' HA ' HD13 ' A' ' 14' ' ' ILE . 8.9 m -62.11 -13.31 25.59 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.03 0.443 . . . . 0.0 110.851 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -64.27 -30.51 78.01 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.18 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.614 ' HB3' ' HB3' ' A' ' 26' ' ' ARG . 49.7 m -131.76 -18.54 2.73 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.677 0.275 . . . . 0.0 111.282 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.482 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 18.7 m -89.8 129.92 36.12 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -112.43 -177.65 3.21 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 43.69 45.36 5.89 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 123.832 0.708 . . . . 0.0 111.728 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.687 HG12 ' HB3' ' A' ' 23' ' ' ALA . 5.3 mt -79.8 103.89 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 CA-C-O 120.921 0.391 . . . . 0.0 110.402 -178.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.571 ' HA ' HD12 ' A' ' 129' ' ' LEU . 73.4 m -143.76 126.79 16.42 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.725 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -92.47 153.77 18.9 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.839 0.828 . . . . 0.0 112.861 -178.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -94.38 74.27 3.88 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.228 -1.351 . . . . 0.0 107.756 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.21 -55.87 4.96 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.068 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.655 ' HB3' ' HB3' ' A' ' 40' ' ' ASN . . . -148.6 -7.12 0.39 Allowed 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.035 0.445 . . . . 0.0 109.913 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -94.6 95.46 8.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.453 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.849 HD23 HD12 ' A' ' 153' ' ' LEU . 41.8 tp -60.27 118.12 6.01 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.807 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.531 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 34.0 ttt180 -123.02 129.84 52.02 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.35 -178.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.687 ' HB3' HG12 ' A' ' 14' ' ' ILE . . . -148.39 149.28 31.48 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.573 0.701 . . . . 0.0 111.178 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 69.7 mm-40 -82.48 70.52 9.45 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.011 178.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.625 ' SG ' HD13 ' A' ' 164' ' ' LEU . 59.1 m -57.84 114.41 2.3 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.953 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.614 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 10.8 ttp180 -67.11 125.99 27.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.392 178.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.548 ' HG2' ' CA ' ' A' ' 162' ' ' GLY . 7.1 mtm180 -96.34 162.77 13.35 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.85 -10.09 6.17 Favored Glycine 0 C--N 1.339 0.705 0 O-C-N 124.37 1.044 . . . . 0.0 113.759 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -76.97 -8.31 57.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.442 0.639 . . . . 0.0 109.43 178.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.38 14.21 66.59 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.01 161.06 13.2 Favored Glycine 0 C--O 1.225 -0.42 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.177 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.512 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 75.8 m-85 -101.15 133.14 46.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.701 0.286 . . . . 0.0 110.565 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.437 ' OG ' ' HD3' ' A' ' 27' ' ' ARG . 74.0 m -126.22 133.3 51.55 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.099 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 m -70.28 116.17 10.32 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.33 0.586 . . . . 0.0 111.367 -178.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 46.6 t -122.59 152.27 40.6 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.458 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.609 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 5.8 p -145.21 140.33 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 120.933 0.397 . . . . 0.0 112.032 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.511 HG21 ' HB3' ' A' ' 21' ' ' LEU . 10.2 tt -135.65 145.69 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.983 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.13 99.25 7.65 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.568 HD22 ' HB3' ' A' ' 21' ' ' LEU . 3.5 mm? -81.18 -8.7 59.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.09 0.471 . . . . 0.0 110.808 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.655 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 7.1 p30 -67.58 -13.15 61.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.453 179.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -114.32 22.43 13.74 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -136.18 -31.09 0.92 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.67 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.557 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 35.9 mt -110.15 133.38 53.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.728 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.704 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 1.4 m -123.65 138.3 54.56 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.211 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.84 ' CB ' ' HG ' ' A' ' 140' ' ' LEU . 6.7 p-10 -79.66 93.26 5.49 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.82 0.819 . . . . 0.0 110.329 177.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -96.2 92.79 6.56 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 121.916 -0.49 . . . . 0.0 111.326 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.481 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 64.8 t30 49.19 47.54 21.96 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.361 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.66 43.5 18.51 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.964 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -161.98 123.41 2.74 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.681 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 55.8 m-85 -65.4 151.28 46.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.726 0.298 . . . . 0.0 110.574 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -141.51 128.65 20.89 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.518 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.663 ' HZ2' ' HA ' ' A' ' 153' ' ' LEU . 44.6 m95 . . . . . 0 C--N 1.323 -0.558 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.847 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.4 m . . . . . 0 N--CA 1.45 -0.438 0 CA-C-O 121.168 0.508 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 106' ' ' GLN . . . -128.63 177.28 7.14 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.872 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.423 ' HB ' ' CG2' ' A' ' 104' ' ' VAL . 6.6 p -128.58 114.34 16.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.769 0.319 . . . . 0.0 111.626 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.454 HG22 ' CE1' ' A' ' 80' ' ' PHE . 11.8 p -101.67 143.38 14.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.937 0.399 . . . . 0.0 110.621 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 3.7 m -89.95 127.48 36.03 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.7 t -72.07 132.12 33.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.721 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.434 ' HG2' ' H ' ' A' ' 69' ' ' GLN . 3.4 tt0 -98.11 171.1 8.46 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 125.043 1.464 . . . . 0.0 109.813 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.578 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 24.6 tt0 -71.03 129.69 39.63 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.895 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.05 13.92 82.48 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.585 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -114.37 121.39 43.44 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.826 0.346 . . . . 0.0 110.248 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.571 ' HA ' HG12 ' A' ' 99' ' ' ILE . 80.0 p -103.38 -179.68 4.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.54 HD21 ' O ' ' A' ' 95' ' ' ASN . 1.5 mm? -51.94 -42.03 62.51 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -60.01 -40.07 87.97 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 114.506 -1.224 . . . . 0.0 111.257 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -71.4 -40.37 70.55 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.671 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.434 HG12 ' O ' ' A' ' 72' ' ' THR . 32.5 mm -64.44 -48.38 85.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.664 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -58.8 -45.34 95.06 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.425 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -65.27 -37.08 86.09 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.866 0.365 . . . . 0.0 111.259 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -73.96 -40.24 63.16 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.454 ' CE1' HG22 ' A' ' 65' ' ' VAL . 95.4 m-85 -102.82 13.15 35.08 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.0 t70 58.07 27.57 15.09 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.558 0.694 . . . . 0.0 111.526 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.664 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 3.1 p -105.52 171.59 7.25 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.622 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.3 t0 -94.38 120.16 34.2 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.156 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.51 ' HD2' ' HB2' ' A' ' 95' ' ' ASN . 10.9 p90 -53.12 -30.3 35.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.588 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.419 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -68.57 -41.74 79.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.678 179.17 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -67.75 -48.33 66.71 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.664 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.622 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.4 mt -49.99 -43.79 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.574 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.59 -51.76 66.05 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.427 178.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 85' ' ' HIS . 61.4 mtp180 -64.23 -25.93 68.28 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.829 ' HB3' ' HB2' ' A' ' 106' ' ' GLN . 1.0 OUTLIER -72.66 -28.14 62.54 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.24 0.543 . . . . 0.0 110.161 179.183 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 18.0 t-20 -101.12 -5.33 25.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.319 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 23.4 m120 79.4 15.92 0.93 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.006 0.922 . . . . 0.0 111.148 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.574 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 15.1 pt -103.14 -169.79 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.597 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.521 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 55.1 mt-30 -116.66 161.21 19.56 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.54 ' O ' HD21 ' A' ' 73' ' ' LEU . 6.7 p30 -57.39 -58.74 6.95 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-O 122.245 1.021 . . . . 0.0 109.277 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -78.44 12.22 2.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.065 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.521 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 1.8 t70 -62.93 -31.57 72.68 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 6.8 mp 70.78 112.33 0.06 Allowed 'General case' 0 C--O 1.234 0.245 0 O-C-N 124.37 1.044 . . . . 0.0 110.503 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.571 HG12 ' HA ' ' A' ' 72' ' ' THR . 9.4 pt -95.84 172.07 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 114.497 -1.228 . . . . 0.0 110.505 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.45 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 69.4 m-85 -125.52 156.36 70.67 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.305 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.578 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 39.2 Cg_endo -68.75 134.49 30.32 Favored 'Trans proline' 0 CA--C 1.517 -0.361 0 C-N-CA 123.042 2.494 . . . . 0.0 113.642 -177.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.85 13.4 37.38 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' A' ' 66' ' ' THR . 49.2 mt-30 -104.76 170.87 7.63 Favored 'General case' 0 C--O 1.216 -0.67 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.138 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.423 ' CG2' ' HB ' ' A' ' 64' ' ' THR . 9.9 p -126.49 131.03 71.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-O 121.441 0.639 . . . . 0.0 110.612 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.51 HD11 HG23 ' A' ' 99' ' ' ILE . 80.0 mt -125.09 151.32 45.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.759 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.829 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 38.7 mt-30 -89.75 113.4 24.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 122.031 0.92 . . . . 0.0 111.649 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.439 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 35.8 m -123.02 152.07 62.49 Favored Pre-proline 0 C--N 1.314 -0.976 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.013 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 107' ' ' VAL . 32.0 Cg_endo -64.37 -17.61 60.26 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 123.425 2.75 . . . . 0.0 115.37 -176.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.7 t . . . . . 0 C--N 1.323 -0.584 0 CA-C-O 121.189 0.519 . . . . 0.0 112.112 -179.391 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.704 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.446 -0.686 0 CA-C-O 120.442 -0.088 . . . . 0.0 112.973 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 16.0 m120 75.34 24.92 1.34 Allowed 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 123.575 0.75 . . . . 0.0 112.261 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.557 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 25.0 p90 -58.44 -39.37 79.66 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.288 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.462 ' HA ' ' HB2' ' A' ' 124' ' ' ALA . 60.3 t-105 -58.71 -31.89 68.68 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.01 -178.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.68 -30.43 61.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.839 0.352 . . . . 0.0 110.672 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.51 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 11.0 m -132.79 30.46 4.04 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.581 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.462 ' HB2' ' HA ' ' A' ' 121' ' ' TRP . . . -118.09 138.51 52.2 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 120.784 0.326 . . . . 0.0 110.743 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -128.55 147.51 50.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.134 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 56.43 45.06 23.34 Favored 'General case' 0 CA--C 1.518 -0.264 0 O-C-N 123.695 0.622 . . . . 0.0 112.007 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.516 ' HA ' ' HB1' ' A' ' 138' ' ' ALA . 39.5 t -69.98 116.24 10.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.658 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -138.5 143.45 39.56 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.639 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.576 ' HG ' ' HG ' ' A' ' 16' ' ' LEU . 29.5 mt -86.38 138.71 31.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.345 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.67 HG21 ' HB ' ' A' ' 135' ' ' VAL . 26.7 m -131.08 160.97 41.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.431 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.431 ' HB3' ' HG2' ' A' ' 134' ' ' LYS . 0.7 OUTLIER 65.16 13.43 8.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.015 179.133 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.674 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 91.9 26.46 19.41 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.507 -0.854 . . . . 0.0 113.265 178.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.68 ' HA3' HG23 ' A' ' 14' ' ' ILE . . . 92.45 -18.02 55.86 Favored Glycine 0 C--O 1.265 2.074 0 CA-C-O 123.9 1.833 . . . . 0.0 112.225 177.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.725 ' HG3' HG22 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -67.98 -17.6 64.48 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.255 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.725 HG22 ' HG3' ' A' ' 134' ' ' LYS . 15.0 t -135.94 144.6 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.388 176.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.611 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 26.0 tp -127.49 124.69 38.94 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -120.58 134.63 55.26 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.212 0.529 . . . . 0.0 110.979 -177.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.625 ' HB2' ' HZ ' ' A' ' 50' ' ' PHE . . . -157.58 162.74 38.77 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.864 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.537 ' HG2' ' HG3' ' A' ' 148' ' ' ARG . 45.1 mt-10 -94.71 105.14 17.06 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.84 ' HG ' ' CB ' ' A' ' 45' ' ' ASN . 1.4 mp -90.4 128.97 36.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.485 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.51 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 67.1 ttt180 -69.77 140.86 53.44 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.037 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.481 ' HB2' ' OD1' ' A' ' 47' ' ' ASN . 1.2 p90 -156.08 -167.81 2.57 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.139 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.3 t -60.41 -27.49 67.5 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.971 0.415 . . . . 0.0 111.123 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -101.91 27.19 21.52 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.348 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 92.67 -119.94 6.01 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.751 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -124.64 125.68 44.51 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.453 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 25.0 t-20 -129.01 142.39 50.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.817 0.342 . . . . 0.0 111.095 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.537 ' HG3' ' HG2' ' A' ' 139' ' ' GLU . 25.1 mtp180 -74.12 108.47 6.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.716 0.769 . . . . 0.0 110.481 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.473 ' HB2' HD22 ' A' ' 140' ' ' LEU . 1.1 m -113.03 157.6 21.35 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.078 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.611 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 9.1 ptt180 -145.95 147.49 31.77 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.381 0.61 . . . . 0.0 112.343 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.681 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 8.7 tt -132.37 151.88 35.53 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.99 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.573 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 9.0 m-85 -92.24 104.85 17.16 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.871 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.849 HD12 HD23 ' A' ' 21' ' ' LEU . 30.5 mt -68.5 -32.59 72.67 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.131 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.581 ' HB3' ' HA ' ' A' ' 134' ' ' LYS . 1.4 p30 -54.7 -18.44 4.63 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.853 177.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 1.056 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 37.2 mt-10 -64.63 -52.26 58.31 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -122.49 6.4 9.54 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.734 -0.786 . . . . 0.0 112.87 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.426 ' O ' ' HA3' ' A' ' 5' ' ' GLY . 47.8 mm -107.15 110.38 31.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.663 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -115.24 156.11 15.87 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.451 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.527 ' HA ' ' O ' ' A' ' 163' ' ' GLU . 1.7 t30 -97.13 127.91 43.55 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 122.518 0.327 . . . . 0.0 110.151 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 -115.68 87.43 2.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.257 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 65.4 t30 50.43 52.63 14.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.81 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.548 ' CA ' ' HG2' ' A' ' 27' ' ' ARG . . . 95.07 7.1 59.87 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.968 -0.634 . . . . 0.0 114.343 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 159' ' ' ASN . 44.6 mt-10 -122.55 154.77 37.46 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 117.415 0.608 . . . . 0.0 110.509 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.708 HD12 ' CD2' ' A' ' 7' ' ' PHE . 7.7 tp -111.3 110.16 20.5 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.89 0.376 . . . . 0.0 110.561 -178.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 38.9 pt . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.018 -179.515 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.951 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 30.7 m-85 . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.742 0.306 . . . . 0.0 111.459 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -110.44 -30.68 7.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.712 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -71.37 -63.45 3.09 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 119.732 -1.223 . . . . 0.0 112.39 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 66.03 15.66 10.16 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 122.526 0.33 . . . . 0.0 111.432 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.674 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.2 OUTLIER -60.51 -39.68 88.66 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.082 -179.323 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.78 -16.81 62.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.006 0.431 . . . . 0.0 111.554 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.55 -20.01 79.77 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.077 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 45.8 m -140.41 -13.03 1.02 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 117.33 0.565 . . . . 0.0 112.081 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.7 m -98.66 133.25 43.27 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.589 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 25.0 ptt180 -110.1 -172.13 1.98 Allowed 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.9 t70 42.05 40.31 1.61 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.829 0.852 . . . . 0.0 111.976 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.683 HG21 ' HA3' ' A' ' 133' ' ' GLY . 6.4 mt -77.02 99.26 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 CA-C-O 121.104 0.478 . . . . 0.0 109.917 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.546 ' CA ' HD13 ' A' ' 129' ' ' LEU . 73.1 m -147.68 124.67 11.34 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.353 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.715 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -94.03 152.69 18.62 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.84 0.829 . . . . 0.0 112.985 -179.006 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -93.27 75.2 4.59 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.043 -1.435 . . . . 0.0 107.233 177.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.21 -53.31 4.63 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.735 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.498 ' HB2' ' HB3' ' A' ' 40' ' ' ASN . . . -149.07 -11.35 0.32 Allowed 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 120.94 0.4 . . . . 0.0 110.234 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.423 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 3.4 mpt_? -89.48 92.55 9.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.87 0.367 . . . . 0.0 110.389 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.789 HD22 HD22 ' A' ' 153' ' ' LEU . 46.8 tp -61.36 123.98 19.33 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.716 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.653 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 41.9 ttp180 -125.03 137.22 54.23 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.266 -0.573 . . . . 0.0 110.257 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.582 ' CB ' HG12 ' A' ' 14' ' ' ILE . . . -157.29 145.84 19.55 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.587 0.708 . . . . 0.0 111.084 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.589 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 3.5 mt-10 -84.52 77.03 10.1 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.504 -1.225 . . . . 0.0 108.706 178.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.604 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 55.9 m -62.78 120.67 11.72 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.899 -178.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 10' ' ' SER . 9.0 tmm_? -70.76 114.89 9.3 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.914 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -89.17 159.0 17.69 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.041 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.46 -15.95 6.41 Favored Glycine 0 C--N 1.339 0.732 0 O-C-N 124.713 1.258 . . . . 0.0 114.067 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -72.38 -12.5 61.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.618 0.723 . . . . 0.0 109.417 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.7 8.8 60.5 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.933 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -112.77 160.62 13.04 Favored Glycine 0 CA--C 1.512 -0.151 0 C-N-CA 120.199 -1.001 . . . . 0.0 113.657 -178.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.439 ' CE1' ' HB2' ' A' ' 26' ' ' ARG . 89.3 m-85 -101.39 124.7 47.49 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.1 p -118.68 133.23 56.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.438 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.1 m -71.0 111.38 6.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.062 0.458 . . . . 0.0 110.843 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.2 t -117.4 152.1 35.67 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.481 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.549 ' HB ' ' HG3' ' A' ' 22' ' ' ARG . 3.9 p -145.04 136.38 20.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.788 0.328 . . . . 0.0 110.224 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.496 HG23 HD21 ' A' ' 39' ' ' LEU . 11.8 tt -135.29 151.65 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.075 -177.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.562 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 1.6 m-20 -79.61 105.88 11.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.684 0.278 . . . . 0.0 111.36 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.596 HD11 ' HB2' ' A' ' 42' ' ' TYR . 1.5 mm? -88.93 -1.64 58.2 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.198 0.523 . . . . 0.0 110.333 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.562 ' OD1' ' HB3' ' A' ' 38' ' ' ASP . 32.3 p-10 -69.55 -14.62 62.94 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 38' ' ' ASP . 6.1 ptp180 -109.9 11.87 24.04 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.609 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.596 ' HB2' HD11 ' A' ' 39' ' ' LEU . 41.4 m-85 -127.36 -31.63 2.52 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.868 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.583 HD22 HG21 ' A' ' 151' ' ' ILE . 39.8 mt -108.96 139.02 44.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.084 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.533 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 4.1 m -129.71 149.09 51.61 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.518 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.727 HD21 ' HA ' ' A' ' 120' ' ' PHE . 7.6 p30 -98.51 104.83 16.9 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -108.03 91.97 3.87 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 121.85 -0.531 . . . . 0.0 111.092 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.522 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 62.4 t30 57.08 45.04 21.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.015 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.793 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 78.67 31.68 44.03 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.795 178.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.591 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 22.4 t-80 -148.69 122.17 9.11 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.739 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 38.1 m-85 -64.04 138.61 58.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.617 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -144.97 139.15 27.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.687 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.716 ' CZ2' ' HA ' ' A' ' 153' ' ' LEU . 99.2 m95 . . . . . 0 C--N 1.321 -0.643 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 177.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 87.3 m . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 121.324 0.583 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -123.07 178.26 5.16 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.356 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.0 p -128.77 122.77 31.3 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.403 HG11 ' CE2' ' A' ' 80' ' ' PHE . 10.1 t -111.45 135.6 50.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.096 178.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.1 m -87.48 127.36 35.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.342 0.592 . . . . 0.0 110.034 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.538 ' CG2' HD12 ' A' ' 99' ' ' ILE . 44.5 t -74.64 131.78 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.538 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.401 ' HG2' ' H ' ' A' ' 69' ' ' GLN . 4.2 tt0 -101.19 172.03 7.25 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 124.854 1.346 . . . . 0.0 109.905 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.56 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 6.9 tt0 -59.04 125.86 25.33 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.144 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.88 2.74 88.39 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.091 -0.576 . . . . 0.0 114.092 177.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -92.34 138.04 31.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 117.246 0.523 . . . . 0.0 111.315 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.555 ' HA ' HG12 ' A' ' 99' ' ' ILE . 55.1 p -119.5 173.98 6.66 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.559 HD13 ' HB ' ' A' ' 87' ' ' ILE . 1.3 mm? -52.6 -40.5 62.75 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.182 0.515 . . . . 0.0 110.416 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.528 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 13.7 mtp180 -67.01 -35.47 80.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.787 -178.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -72.31 -38.22 68.75 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.505 HG12 ' O ' ' A' ' 72' ' ' THR . 42.0 mm -67.15 -45.83 85.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.709 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -55.14 -55.82 26.29 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.579 179.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -59.79 -42.94 94.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.91 0.386 . . . . 0.0 112.04 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -64.01 -36.27 83.45 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.652 ' HB2' ' HG ' ' A' ' 82' ' ' CYS . 97.8 m-85 -110.35 19.99 18.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.8 t70 56.3 30.55 16.96 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.448 0.642 . . . . 0.0 111.717 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.709 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 3.6 p -112.85 171.31 7.61 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.578 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.9 t70 -99.24 127.18 45.19 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.528 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 4.8 p90 -51.43 -30.55 19.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.226 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -65.43 -44.79 86.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.719 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.717 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 24.2 mm-40 -63.22 -51.0 68.04 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.801 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.578 HG13 ' O ' ' A' ' 83' ' ' ASP . 2.7 mt -52.76 -47.04 51.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.64 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.584 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.59 -50.74 70.07 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.617 178.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -56.47 -40.12 74.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.138 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.717 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 13.8 mmt85 -65.83 -33.48 75.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.102 0.477 . . . . 0.0 111.071 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.634 HD21 HD13 ' A' ' 93' ' ' ILE . 66.3 t30 -92.13 -4.76 53.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.792 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 92.3 m-20 75.94 19.14 1.94 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.487 0.715 . . . . 0.0 110.777 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.634 HD13 HD21 ' A' ' 91' ' ' ASN . 14.4 pt -106.18 -176.26 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.739 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.541 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 49.2 mt-30 -107.36 166.06 10.93 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.532 ' O ' HD22 ' A' ' 73' ' ' LEU . 6.1 p30 -63.83 -53.5 49.78 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-O 122.141 0.972 . . . . 0.0 108.407 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.56 11.06 3.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.785 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.541 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.8 t70 -61.54 -32.23 72.28 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.1 mt 68.84 114.07 0.04 OUTLIER 'General case' 0 C--O 1.233 0.21 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.061 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.682 HG22 HD13 ' A' ' 105' ' ' LEU . 9.2 pt -94.56 175.64 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.238 -178.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.461 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 41.3 m-85 -128.72 156.54 77.4 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.83 -178.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.56 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 32.0 Cg_endo -67.07 133.02 29.6 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 123.286 2.658 . . . . 0.0 113.241 -178.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.43 19.29 25.85 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -112.54 155.74 23.81 Favored 'General case' 0 C--O 1.212 -0.901 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.2 t -116.18 122.68 70.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 O-C-N 121.789 -0.569 . . . . 0.0 110.405 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.682 HD13 HG22 ' A' ' 99' ' ' ILE . 95.9 mt -113.42 151.25 31.59 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.92 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.544 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 78.2 mt-30 -90.22 116.27 28.08 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.642 0.734 . . . . 0.0 110.801 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.4 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 31.5 m -123.23 151.84 62.89 Favored Pre-proline 0 C--N 1.31 -1.119 0 CA-C-N 114.173 -1.376 . . . . 0.0 109.441 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.4 ' HD2' ' HB ' ' A' ' 107' ' ' VAL . 37.9 Cg_endo -65.07 -22.32 62.17 Favored 'Trans proline' 0 N--CA 1.473 0.282 0 C-N-CA 123.147 2.565 . . . . 0.0 114.952 -177.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.0 t . . . . . 0 C--N 1.322 -0.604 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.586 -179.42 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.533 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.444 -0.83 0 N-CA-C 112.221 -0.351 . . . . 0.0 112.221 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 15.2 m120 73.63 31.33 1.3 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.007 0.523 . . . . 0.0 112.122 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.727 ' HA ' HD21 ' A' ' 45' ' ' ASN . 27.5 p90 -59.6 -35.84 75.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.95 0.405 . . . . 0.0 110.141 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.507 ' HA ' ' HB1' ' A' ' 124' ' ' ALA . 61.8 t-105 -63.09 -31.71 72.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.068 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.88 -31.51 40.04 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.852 0.358 . . . . 0.0 110.99 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.802 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 18.5 m -131.19 28.26 4.75 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.691 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.507 ' HB1' ' HA ' ' A' ' 121' ' ' TRP . . . -110.48 142.95 41.53 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.395 178.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.43 ' HD2' ' OD2' ' A' ' 126' ' ' ASP . 6.6 tmm_? -137.15 139.24 41.02 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.43 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 3.6 m-20 63.08 54.54 2.1 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.261 0.553 . . . . 0.0 110.567 -178.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.455 ' HA ' ' HB1' ' A' ' 138' ' ' ALA . 38.3 t -85.69 122.83 38.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.402 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.417 ' O ' HD13 ' A' ' 136' ' ' LEU . 16.2 ptt180 -144.84 142.7 30.15 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.754 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.724 HD11 ' CD1' ' A' ' 21' ' ' LEU . 16.5 mt -85.42 130.38 34.6 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.533 HG23 ' HB ' ' A' ' 135' ' ' VAL . 27.8 m -124.49 163.47 24.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.512 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.705 ' HB3' ' HZ1' ' A' ' 134' ' ' LYS . 5.3 m-20 68.08 6.0 4.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.203 178.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.627 ' O ' HD13 ' A' ' 14' ' ' ILE . . . 93.66 28.25 11.59 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.181 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.683 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 96.89 -19.27 55.46 Favored Glycine 0 C--O 1.264 1.978 0 CA-C-O 123.08 1.378 . . . . 0.0 113.145 177.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.705 ' HZ1' ' HB3' ' A' ' 131' ' ' ASP . 10.5 pttp -72.75 -10.91 60.34 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 121.196 -1.179 . . . . 0.0 109.665 178.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.533 ' HB ' HG23 ' A' ' 130' ' ' VAL . 22.3 t -144.26 140.44 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 121.383 0.611 . . . . 0.0 110.444 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.607 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 44.1 tp -121.14 125.28 46.81 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -114.75 131.36 56.81 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.989 0.423 . . . . 0.0 110.893 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.63 ' HB2' ' HZ ' ' A' ' 50' ' ' PHE . . . -161.44 157.8 25.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.675 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 36.9 mt-10 -95.56 109.95 22.11 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.793 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 46.3 mt -95.74 134.17 38.99 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.956 -178.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.802 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 36.1 ttt180 -70.76 141.09 51.47 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.701 179.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.583 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.7 p90 -161.83 -170.49 2.57 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.593 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 45.5 t -54.31 -28.68 43.95 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.41 0.444 . . . . 0.0 111.883 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -105.45 30.38 9.96 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.461 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 91.55 -114.93 4.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.518 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -126.8 128.15 46.13 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.583 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 57.3 t30 -117.62 143.67 45.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.957 0.408 . . . . 0.0 111.988 -178.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -76.75 94.57 3.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.122 178.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.591 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 35.8 t -111.11 160.88 16.49 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.445 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.607 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 28.6 ptt180 -148.59 154.58 39.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.548 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.739 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 8.0 tt -136.96 151.95 27.89 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.565 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.078 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.613 ' HB3' ' OD1' ' A' ' 154' ' ' ASP . 26.3 m-85 -95.08 103.27 15.12 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.839 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.789 HD22 HD22 ' A' ' 21' ' ' LEU . 7.1 mp -70.64 -29.27 65.58 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.976 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.613 ' OD1' ' HB3' ' A' ' 152' ' ' TYR . 21.9 p-10 -56.27 -13.96 2.5 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.914 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.951 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 31.1 mt-10 -68.96 -54.11 17.1 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -123.11 3.73 9.29 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.719 -0.792 . . . . 0.0 112.576 -176.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.473 HG22 HD23 ' A' ' 21' ' ' LEU . 43.2 mm -105.32 112.85 40.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.127 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.448 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -118.47 178.53 16.79 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.878 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.604 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -109.6 125.71 52.85 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.86 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.91 85.06 2.04 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 65.0 t30 52.2 49.59 20.26 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.388 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 94.11 2.22 64.44 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.707 -0.758 . . . . 0.0 114.338 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -122.31 126.04 47.25 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.982 0.42 . . . . 0.0 109.894 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.674 HD11 ' CD2' ' A' ' 7' ' ' PHE . 7.6 tp -73.78 128.45 35.56 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.754 -178.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 10.8 tp . . . . . 0 C--O 1.223 -0.33 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -179.103 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.734 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 27.9 m-85 . . . . . 0 CA--C 1.517 -0.312 0 CA-C-O 121.187 0.518 . . . . 0.0 110.304 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.3 -26.69 0.9 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.525 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -72.7 -69.76 1.34 Allowed Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 119.541 -1.314 . . . . 0.0 113.376 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 68.39 16.73 9.23 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 122.624 0.37 . . . . 0.0 110.366 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.65 ' CD2' HD12 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -63.63 -30.54 71.64 Favored 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -178.801 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 97.2 p -70.37 -12.39 61.55 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.715 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.22 -26.03 60.5 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.283 -0.872 . . . . 0.0 112.782 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.431 ' O ' ' HE1' ' A' ' 32' ' ' TYR . 35.0 p -126.49 -23.65 3.75 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.221 0.51 . . . . 0.0 112.069 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.0 m -90.09 135.28 33.75 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.52 ' HG2' ' N ' ' A' ' 13' ' ' ASP . 44.3 ttt-85 -110.86 171.08 7.68 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.539 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.52 ' N ' ' HG2' ' A' ' 12' ' ' ARG . 48.7 m-20 46.01 48.65 12.45 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.349 0.659 . . . . 0.0 111.999 178.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.679 HG12 ' HB2' ' A' ' 23' ' ' ALA . 9.4 mt -79.36 105.71 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.5 m -147.18 126.81 13.33 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.011 0.524 . . . . 0.0 109.977 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.719 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -97.79 156.61 16.49 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -179.07 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -96.88 74.4 2.64 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.063 -1.426 . . . . 0.0 107.669 177.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.12 -52.89 4.57 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.031 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.563 ' HB3' ' HB3' ' A' ' 40' ' ' ASN . . . -149.26 -13.36 0.3 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.183 0.516 . . . . 0.0 110.004 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -90.89 92.63 8.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.331 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.773 HD22 HD13 ' A' ' 153' ' ' LEU . 37.3 tp -63.46 130.49 44.6 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.736 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -134.17 127.05 31.23 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.033 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.679 ' HB2' HG12 ' A' ' 14' ' ' ILE . . . -146.72 147.02 30.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.244 0.545 . . . . 0.0 111.501 -178.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.727 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 7.2 mm-40 -78.59 74.7 5.12 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.392 177.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.605 ' SG ' HD13 ' A' ' 164' ' ' LEU . 68.9 m -60.3 126.9 29.24 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 120.971 0.415 . . . . 0.0 111.029 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 10' ' ' SER . 65.6 ttt180 -68.51 121.67 16.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.237 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.523 ' HD3' ' HB3' ' A' ' 29' ' ' ASP . 6.0 ptp180 -94.91 149.59 21.08 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 177.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.42 -11.33 3.58 Favored Glycine 0 C--N 1.34 0.775 0 O-C-N 124.35 1.031 . . . . 0.0 113.642 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.523 ' HB3' ' HD3' ' A' ' 27' ' ' ARG . 19.8 t70 -71.68 -15.64 62.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.441 0.639 . . . . 0.0 109.548 178.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.13 5.4 53.01 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.048 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.22 172.41 14.26 Favored Glycine 0 C--N 1.322 -0.197 0 C-N-CA 119.959 -1.115 . . . . 0.0 113.517 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.727 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 41.2 m-85 -101.87 128.92 48.03 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 178.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.6 m -114.45 130.81 56.75 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.267 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 m -67.47 110.01 3.45 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.092 0.473 . . . . 0.0 110.846 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.489 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 41.7 t -115.06 151.93 33.39 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.512 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -145.94 133.66 15.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.08 0.467 . . . . 0.0 111.824 -178.777 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.504 HG23 ' HB3' ' A' ' 21' ' ' LEU . 10.7 tt -135.4 141.23 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.869 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.02 108.84 15.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.07 0.462 . . . . 0.0 111.052 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.581 HD22 ' HB3' ' A' ' 21' ' ' LEU . 3.1 mm? -81.14 -7.33 59.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.621 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.563 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 26.9 p30 -68.62 -9.6 50.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.57 0.7 . . . . 0.0 109.364 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -104.94 0.15 27.53 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.617 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.539 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 75.8 m-85 -126.06 -28.09 3.2 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.649 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 36.5 mt -106.31 142.84 35.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.988 0.423 . . . . 0.0 112.023 -178.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.2 m -135.43 139.78 44.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.446 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.819 ' CB ' ' HG ' ' A' ' 140' ' ' LEU . 7.8 p-10 -83.48 93.93 7.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.522 0.677 . . . . 0.0 110.286 178.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.44 ' CB ' ' HD2' ' A' ' 51' ' ' ARG . 9.1 t0 -99.88 94.79 6.49 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 122.1 -0.375 . . . . 0.0 110.63 -179.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.491 ' HA ' ' HB2' ' A' ' 142' ' ' TYR . 10.2 t-20 52.47 49.28 20.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.52 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 149' ' ' SER . . . 72.0 38.98 59.63 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.696 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -157.29 123.02 4.69 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.746 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 65.4 m-85 -62.46 144.9 55.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.191 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.44 ' HD2' ' CB ' ' A' ' 46' ' ' ASP . 70.0 mtt180 -148.0 133.02 18.19 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.38 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.539 ' HA ' ' O ' ' A' ' 42' ' ' TYR . 97.3 m95 . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.273 178.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.5 m . . . . . 0 C--O 1.234 0.25 0 CA-C-O 120.951 0.405 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -133.53 176.55 8.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.545 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.415 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 2.4 p -128.8 117.97 21.98 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.218 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.506 HG21 ' CE2' ' A' ' 80' ' ' PHE . 14.2 p -104.68 141.17 20.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.003 0.43 . . . . 0.0 111.575 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 5.6 m -93.09 126.7 38.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.236 0.541 . . . . 0.0 109.691 178.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.581 ' CG2' HD11 ' A' ' 99' ' ' ILE . 53.9 t -79.59 135.22 26.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.092 -179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -100.83 169.84 8.72 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 124.355 1.034 . . . . 0.0 110.643 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.695 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 50.1 tt0 -66.15 116.71 7.52 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.978 -177.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.25 -3.29 47.36 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.321 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -100.29 139.32 36.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.999 0.428 . . . . 0.0 111.213 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.688 ' HA ' HG12 ' A' ' 99' ' ' ILE . 69.6 p -120.29 179.43 4.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.542 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.595 HD21 HG23 ' A' ' 99' ' ' ILE . 1.1 mm? -51.5 -40.61 59.9 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.19 0.519 . . . . 0.0 110.191 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -61.75 -38.47 88.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.354 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -72.3 -40.21 67.68 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.666 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 72' ' ' THR . 41.7 mm -64.96 -47.38 88.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.886 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.642 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -61.23 -44.29 98.3 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.92 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -65.54 -36.38 83.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.075 0.464 . . . . 0.0 111.251 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -75.27 -44.21 47.02 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.506 ' CE2' HG21 ' A' ' 65' ' ' VAL . 89.7 m-85 -101.91 17.32 23.42 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -176.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.4 t70 54.33 42.72 31.29 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.527 0.679 . . . . 0.0 111.521 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.642 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.1 p -123.07 166.2 15.53 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.658 ' O ' HG13 ' A' ' 87' ' ' ILE . 6.8 t70 -93.88 124.52 37.94 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.599 -0.841 . . . . 0.0 110.115 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.538 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 18.9 p90 -51.5 -31.78 25.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.19 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.495 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 3.7 t60 -66.58 -44.1 83.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.727 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.666 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 17.9 mm-40 -67.61 -47.35 69.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.254 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.658 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.8 mt -51.06 -45.34 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.435 0.636 . . . . 0.0 109.336 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.611 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.63 -50.77 69.93 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.935 178.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.495 ' HG3' ' O ' ' A' ' 85' ' ' HIS . 74.6 mtp180 -57.32 -41.98 80.96 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.666 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 15.4 mtp180 -70.89 -21.78 62.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.852 0.358 . . . . 0.0 111.376 -178.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 17.4 t-20 -101.13 -5.23 25.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.951 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.497 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 16.0 m120 78.0 14.58 1.55 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.49 0.716 . . . . 0.0 111.494 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.611 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 16.7 pt -106.27 -174.64 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.562 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 78.6 mm-40 -113.48 155.37 25.44 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.527 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 4.5 p30 -54.07 -58.87 5.7 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-O 122.259 1.028 . . . . 0.0 109.058 178.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -75.33 12.26 1.0 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.747 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.1 t0 -69.49 -34.09 73.81 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 10.3 mp 70.22 116.62 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 O-C-N 124.21 0.944 . . . . 0.0 108.98 -176.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.688 HG12 ' HA ' ' A' ' 72' ' ' THR . 7.5 pt -93.56 177.07 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.993 -177.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -123.87 156.04 66.03 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.401 -177.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.695 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 32.6 Cg_endo -68.71 130.6 20.97 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.258 2.639 . . . . 0.0 113.062 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.05 12.54 49.14 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.429 ' O ' ' HA ' ' A' ' 66' ' ' THR . 63.4 tt0 -101.0 159.72 14.98 Favored 'General case' 0 C--O 1.214 -0.792 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.415 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 85.6 t -120.59 120.47 62.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.04 0.448 . . . . 0.0 110.203 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.633 HD11 HG22 ' A' ' 99' ' ' ILE . 68.4 mt -111.49 152.0 27.97 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.549 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -90.78 115.81 28.14 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.564 0.697 . . . . 0.0 111.208 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.2 m -124.57 151.26 67.03 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.407 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -63.32 -17.08 58.41 Favored 'Trans proline' 0 C--N 1.332 -0.302 0 C-N-CA 123.305 2.67 . . . . 0.0 114.92 -177.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.9 t . . . . . 0 C--N 1.32 -0.676 0 C-N-CA 120.551 -0.459 . . . . 0.0 111.462 -179.91 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.445 -0.724 0 N-CA-C 111.349 -0.701 . . . . 0.0 111.349 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 22.3 m120 73.74 27.22 1.75 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 177.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.649 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 22.5 p90 -58.39 -36.72 73.97 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.376 -0.53 . . . . 0.0 109.886 178.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.512 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 52.8 t-105 -63.79 -34.62 78.31 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.854 -178.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -56.86 -19.78 19.4 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.155 0.502 . . . . 0.0 110.788 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.758 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 13.0 m -138.75 29.12 2.35 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.444 178.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.45 ' HB1' ' HA ' ' A' ' 121' ' ' TRP . . . -116.22 145.83 42.81 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.2 0.524 . . . . 0.0 111.94 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.44 HH11 ' HD3' ' A' ' 125' ' ' ARG . 29.1 mtp-105 -133.69 153.88 51.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.378 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 52.03 39.91 27.3 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 123.713 0.633 . . . . 0.0 112.128 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.499 ' HA ' ' HB3' ' A' ' 138' ' ' ALA . 22.5 t -67.19 121.51 16.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.056 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -144.83 140.5 28.45 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.689 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.582 ' CD1' HG22 ' A' ' 14' ' ' ILE . 16.4 mt -86.36 122.39 30.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.147 0.498 . . . . 0.0 109.912 178.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.631 HG23 ' HB ' ' A' ' 135' ' ' VAL . 35.2 m -115.63 159.36 15.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.367 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.559 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 1.4 m-20 71.06 -0.7 2.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.212 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.553 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 98.6 28.18 8.09 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.033 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.559 ' HA3' HG23 ' A' ' 14' ' ' ILE . . . 100.24 -23.94 33.98 Favored Glycine 0 C--O 1.264 1.98 0 CA-C-O 123.192 1.44 . . . . 0.0 112.618 178.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.675 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 6.9 ptmm? -65.08 -18.85 65.65 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 121.803 -0.822 . . . . 0.0 109.601 178.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.631 ' HB ' HG23 ' A' ' 130' ' ' VAL . 15.1 t -139.08 141.19 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.289 0.566 . . . . 0.0 109.976 177.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 30.1 tp -121.66 121.16 36.73 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.501 ' OE2' ' HD3' ' A' ' 150' ' ' ARG . 36.7 tt0 -111.93 132.53 54.69 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.209 -177.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.745 ' HB1' ' HZ ' ' A' ' 50' ' ' PHE . . . -163.22 161.89 25.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.594 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -94.65 105.85 17.82 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.819 ' HG ' ' CB ' ' A' ' 45' ' ' ASN . 1.9 mp -89.82 128.52 36.18 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.543 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.758 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 41.0 ttt180 -70.61 140.53 51.67 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.097 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.649 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.3 p90 -157.22 -171.81 3.76 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.951 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.1 p -56.44 -29.2 61.35 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.168 0.293 . . . . 0.0 111.601 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.03 26.12 25.52 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.142 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.87 -110.98 4.1 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.365 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -130.05 133.31 46.62 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.649 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 14.4 t-20 -123.93 136.92 54.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.764 0.316 . . . . 0.0 111.361 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -76.7 93.73 3.7 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.497 ' OG ' HD23 ' A' ' 140' ' ' LEU . 24.2 p -110.71 162.91 14.29 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.506 -178.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.593 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 14.0 mtm-85 -143.91 152.37 41.02 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.858 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.746 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 11.1 tt -137.95 143.2 33.97 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.467 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.686 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 35.7 m-85 -83.89 101.66 11.83 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 122.195 -0.316 . . . . 0.0 110.925 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.773 HD13 HD22 ' A' ' 21' ' ' LEU . 20.4 mt -62.92 -33.6 75.67 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.116 178.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.675 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 12.7 t70 -56.13 -14.11 2.48 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.805 178.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.734 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 38.9 mt-10 -64.3 -55.8 18.87 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 53.6 m-70 -121.54 2.35 10.15 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 119.851 -0.74 . . . . 0.0 112.111 -177.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.435 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 47.0 mm -103.95 112.76 38.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.605 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.584 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -121.52 164.76 14.61 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.36 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.559 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.9 t30 -99.63 130.64 45.87 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.65 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 28.8 ttm180 -122.78 87.02 2.68 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.205 0.526 . . . . 0.0 110.425 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 64.9 t30 53.93 44.05 29.99 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.654 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.95 -6.78 47.96 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.127 -1.035 . . . . 0.0 114.733 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.65 ' HG2' ' O ' ' A' ' 160' ' ' ARG . 12.9 pt-20 -118.99 138.4 52.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 117.81 0.805 . . . . 0.0 110.696 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.65 HD12 ' CD2' ' A' ' 7' ' ' PHE . 7.4 tp -91.7 118.63 30.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.075 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 12.0 tt . . . . . 0 C--N 1.323 -0.585 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.272 -179.06 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.795 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 56.3 m-85 . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 120.873 0.368 . . . . 0.0 111.731 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.84 -29.99 10.15 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.459 -179.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.21 -69.15 1.45 Allowed Glycine 0 N--CA 1.436 -1.324 0 C-N-CA 119.948 -1.12 . . . . 0.0 113.051 -178.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 69.55 11.81 8.05 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.564 0.345 . . . . 0.0 110.94 -179.475 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.582 ' CE2' HD13 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -59.64 -35.0 73.53 Favored 'General case' 0 C--O 1.214 -0.786 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.635 -179.004 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.3 p -64.87 -13.77 57.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.04 0.447 . . . . 0.0 111.502 -179.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.64 -12.42 62.63 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.98 179.37 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.451 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 14.8 m -126.67 -34.11 2.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.491 0.663 . . . . 0.0 110.732 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.0 m -92.77 133.59 35.89 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.685 -179.042 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -111.76 -173.65 2.29 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.427 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 2.3 m-20 44.76 39.65 3.64 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 123.607 0.567 . . . . 0.0 112.419 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.682 HG21 ' HA3' ' A' ' 133' ' ' GLY . 5.0 mt -78.74 103.86 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 CA-C-O 120.951 0.405 . . . . 0.0 110.503 -178.564 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.544 ' CA ' HD12 ' A' ' 129' ' ' LEU . 71.2 m -147.63 126.53 12.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.284 178.663 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.747 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -101.03 155.16 18.14 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.904 0.859 . . . . 0.0 112.951 -179.373 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -99.02 77.0 2.15 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.036 -1.438 . . . . 0.0 107.559 176.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.06 -56.76 5.0 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.856 179.177 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.507 ' HB1' ' HB2' ' A' ' 40' ' ' ASN . . . -148.66 -12.28 0.34 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.087 0.47 . . . . 0.0 109.918 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.44 HH11 ' HD3' ' A' ' 20' ' ' ARG . 44.0 mtp-105 -81.75 86.43 6.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.343 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.747 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 42.1 tp -62.0 116.07 4.6 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 122.825 0.45 . . . . 0.0 111.884 -179.497 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.545 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 39.1 ttt180 -122.99 127.89 49.45 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.226 -179.104 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.622 ' HB2' HG12 ' A' ' 14' ' ' ILE . . . -148.66 146.65 28.26 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.506 0.67 . . . . 0.0 111.107 -179.339 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.45 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 1.2 mm-40 -85.53 79.88 9.25 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.643 178.39 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.614 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 37.6 m -65.63 126.73 29.3 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.213 -178.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 10' ' ' SER . 30.8 ttm180 -65.47 124.07 21.31 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.311 178.535 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.552 ' HD3' ' O ' ' A' ' 161' ' ' ASN . 18.4 ttp180 -105.08 151.2 24.28 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.524 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.9 2.61 0.56 Allowed Glycine 0 C--N 1.334 0.432 0 CA-C-N 114.525 -1.216 . . . . 0.0 113.944 -178.314 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 27' ' ' ARG . 33.1 t70 -84.73 -9.25 58.39 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.454 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.5 10.64 57.89 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -133.9 162.99 24.53 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.155 -1.021 . . . . 0.0 112.867 -179.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.45 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 71.2 m-85 -88.71 146.39 25.07 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.525 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.4 t -127.83 126.13 41.09 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.569 178.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.6 m -67.26 117.24 9.01 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 41.6 t -124.32 151.95 43.68 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.179 -179.403 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.676 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.4 p -144.31 134.92 20.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.904 0.383 . . . . 0.0 111.196 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.441 HG22 ' HB3' ' A' ' 21' ' ' LEU . 11.2 tt -135.62 152.94 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.878 -178.372 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.41 ' OD2' ' HB3' ' A' ' 40' ' ' ASN . 19.3 t70 -82.81 112.77 19.94 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.647 0.26 . . . . 0.0 110.451 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.488 HD23 ' HB3' ' A' ' 21' ' ' LEU . 2.7 mm? -92.81 0.89 57.49 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.356 0.598 . . . . 0.0 109.562 178.075 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.507 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 11.1 t30 -76.17 -19.57 58.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.202 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 41' ' ' ARG . 4.7 ptp180 -97.89 6.14 48.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.329 178.652 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.554 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 33.3 m-85 -129.25 -27.7 2.42 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.554 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.619 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 53.3 mt -105.96 137.94 42.99 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.134 0.492 . . . . 0.0 110.807 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m -131.78 143.59 50.33 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.414 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.541 ' CG ' ' HB3' ' A' ' 140' ' ' LEU . 7.9 t30 -90.47 110.92 22.02 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.481 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.443 ' CB ' ' HD3' ' A' ' 51' ' ' ARG . 35.4 t70 -115.61 92.72 4.0 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.238 179.663 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 65.1 t30 57.99 45.23 18.37 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.099 179.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.742 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 73.6 38.25 51.46 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.304 -0.951 . . . . 0.0 112.009 179.107 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.621 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 23.8 t60 -151.12 121.43 7.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.754 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 38.1 m-85 -65.6 139.49 58.44 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.142 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.443 ' HD3' ' CB ' ' A' ' 46' ' ' ASP . 78.1 mtp180 -147.17 133.3 19.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.708 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.554 ' HA ' ' O ' ' A' ' 42' ' ' TYR . 98.3 m95 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.037 178.13 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 88.8 m . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 120.865 0.364 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.84 177.09 4.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.19 -179.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.515 HG22 ' HG2' ' A' ' 106' ' ' GLN . 12.3 p -128.58 119.47 24.84 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.678 0.275 . . . . 0.0 111.711 -179.354 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.46 HG21 ' CE2' ' A' ' 80' ' ' PHE . 8.3 p -105.89 141.52 21.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 120.793 0.33 . . . . 0.0 111.086 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.2 m -89.75 128.41 36.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.424 0.63 . . . . 0.0 109.996 179.109 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.586 ' CG2' HD13 ' A' ' 99' ' ' ILE . 48.8 t -79.71 138.22 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.072 -179.387 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -108.55 171.26 7.52 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 124.06 0.85 . . . . 0.0 111.09 -179.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.668 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 36.5 tt0 -54.28 114.31 1.59 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.539 -178.536 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.4 2.69 63.53 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 121.151 -0.547 . . . . 0.0 113.793 178.319 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -91.28 143.82 26.25 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 117.163 0.482 . . . . 0.0 111.537 -179.405 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.765 ' HA ' HG12 ' A' ' 99' ' ' ILE . 35.0 p -130.69 169.13 16.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.274 178.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.626 HD21 HG23 ' A' ' 99' ' ' ILE . 1.0 OUTLIER -49.77 -43.38 48.15 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.202 0.455 . . . . 0.0 111.512 -179.516 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -65.06 -35.88 82.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.542 -177.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -74.07 -37.71 64.14 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 72' ' ' THR . 45.0 mm -67.86 -47.9 77.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.367 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.713 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -58.13 -48.25 84.22 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.751 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -34.56 78.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.785 0.326 . . . . 0.0 111.341 -179.186 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -71.37 -47.54 55.7 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.604 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.642 ' HB2' ' HG ' ' A' ' 82' ' ' CYS . 86.2 m-85 -100.5 19.85 16.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -177.217 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 53.38 45.49 28.27 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.233 0.54 . . . . 0.0 112.012 178.805 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.713 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.2 p -126.14 168.0 14.63 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.315 179.497 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.64 ' O ' HG13 ' A' ' 87' ' ' ILE . 9.2 t70 -93.33 123.46 36.63 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 121.846 -0.534 . . . . 0.0 109.647 179.176 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.526 ' HD2' ' HB2' ' A' ' 95' ' ' ASN . 2.5 p90 -52.0 -27.07 12.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.011 179.735 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.93 -37.65 54.92 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.062 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.678 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 3.8 tp10 -64.86 -47.78 76.66 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.64 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.2 mt -53.86 -45.77 63.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.853 178.63 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.565 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.36 -52.07 65.07 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.91 178.511 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.1 mtt-85 -61.22 -30.18 70.27 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.678 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 32.8 mmt180 -72.73 -31.81 65.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.096 0.474 . . . . 0.0 110.395 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 21.1 t-20 -93.61 -6.02 47.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.754 179.349 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 92.0 m-20 79.04 17.12 0.93 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.092 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.565 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 16.1 pt -107.22 -173.03 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.843 178.509 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.522 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 3.5 mm100 -112.61 161.4 16.85 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.433 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.526 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 16.4 p-10 -62.36 -52.41 63.76 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.581 1.182 . . . . 0.0 108.394 179.473 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.486 ' O ' ' HG2' ' A' ' 96' ' ' GLU . 35.2 tt0 -73.64 4.74 4.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 113.867 -1.515 . . . . 0.0 110.822 179.814 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.522 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 0.9 OUTLIER -64.76 -37.45 87.64 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.625 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 7.9 mp 70.24 116.42 0.04 OUTLIER 'General case' 0 C--O 1.231 0.12 0 O-C-N 124.12 0.888 . . . . 0.0 109.716 -177.682 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.788 HG22 HD13 ' A' ' 105' ' ' LEU . 8.0 pt -93.95 175.72 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.881 -177.617 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.516 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 14.2 m-85 -126.04 158.85 64.69 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.921 -178.585 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.668 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 28.8 Cg_endo -64.98 136.07 46.86 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.298 2.665 . . . . 0.0 113.212 -179.747 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.7 15.58 56.38 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -103.8 153.68 20.45 Favored 'General case' 0 C--O 1.209 -1.036 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.494 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 62.0 t -116.12 119.55 62.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 O-C-N 121.75 -0.594 . . . . 0.0 110.567 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.788 HD13 HG22 ' A' ' 99' ' ' ILE . 77.5 mt -113.49 152.09 30.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.572 -179.229 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.632 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 71.2 mt-30 -90.78 122.4 33.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.546 0.688 . . . . 0.0 110.729 179.644 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.7 m -129.98 151.18 77.83 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.585 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.23 -20.45 70.74 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 123.734 2.956 . . . . 0.0 114.793 -177.21 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.7 t . . . . . 0 C--N 1.324 -0.525 0 CA-C-O 120.924 0.392 . . . . 0.0 110.725 179.817 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.445 -0.717 0 N-CA-C 111.619 -0.592 . . . . 0.0 111.619 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.436 ' HA ' ' OD1' ' A' ' 40' ' ' ASN . 17.9 m120 69.43 31.64 3.73 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 123.019 0.528 . . . . 0.0 112.176 178.156 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.619 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 24.5 p90 -60.07 -34.95 74.13 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.527 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.407 ' HA ' ' HB2' ' A' ' 124' ' ' ALA . 20.7 t-105 -63.44 -33.16 74.96 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.821 -178.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.27 -23.62 49.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.981 0.42 . . . . 0.0 110.929 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.0 p -133.19 24.35 4.17 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.052 179.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.407 ' HB2' ' HA ' ' A' ' 121' ' ' TRP . . . -108.99 146.43 33.9 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.02 0.438 . . . . 0.0 111.5 179.026 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -146.41 146.01 30.45 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 61.26 26.22 16.1 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.73 0.776 . . . . 0.0 110.53 -179.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.558 ' HB ' ' CB ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -75.81 125.48 35.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.833 -179.93 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -150.06 155.67 40.29 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.654 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.6 ' HG ' ' HG ' ' A' ' 16' ' ' LEU . 30.5 mt -86.54 131.41 34.18 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.966 0.412 . . . . 0.0 110.102 179.573 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.438 HG22 ' HB ' ' A' ' 135' ' ' VAL . 33.3 m -125.79 158.59 34.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.918 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.568 ' HB3' ' HD2' ' A' ' 134' ' ' LYS . 3.7 m-20 68.84 7.34 6.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.448 178.486 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.652 ' O ' HD11 ' A' ' 14' ' ' ILE . . . 96.32 32.9 6.45 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.561 178.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.682 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 87.56 -15.81 52.77 Favored Glycine 0 C--O 1.266 2.151 0 CA-C-O 123.579 1.655 . . . . 0.0 112.833 177.361 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.827 ' HG3' HG23 ' A' ' 135' ' ' VAL . 18.2 ptpt -67.41 -24.23 65.63 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.233 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.827 HG23 ' HG3' ' A' ' 134' ' ' LYS . 26.1 t -136.36 137.13 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 121.43 0.633 . . . . 0.0 110.806 178.811 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.605 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 36.0 tp -112.26 114.83 27.82 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.366 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -104.47 125.99 51.16 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.357 -177.317 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.607 ' HB1' ' CZ ' ' A' ' 50' ' ' PHE . . . -154.38 161.75 41.55 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.158 0.504 . . . . 0.0 111.256 -179.264 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -103.28 106.37 16.87 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 177.448 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.742 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 38.6 mt -94.07 135.37 35.5 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.722 -178.146 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -69.84 140.96 53.32 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.355 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.582 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.0 OUTLIER -157.92 -167.81 2.34 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.849 -0.341 . . . . 0.0 111.549 -179.165 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.7 m -56.02 -26.91 50.83 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.053 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -106.35 27.35 17.26 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.13 -1.033 . . . . 0.0 113.238 -178.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 95.1 -106.35 3.39 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.101 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -127.81 129.95 47.84 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.582 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 56.4 t30 -123.6 137.29 54.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.047 0.451 . . . . 0.0 111.517 -179.114 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 39.8 ttt180 -76.31 105.88 7.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.925 178.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.621 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 10.2 t -121.47 165.44 15.62 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.605 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -146.4 158.12 43.85 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.125 -179.558 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.754 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 9.8 tt -141.89 145.55 24.02 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.37 179.193 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.649 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 23.3 m-85 -86.86 104.8 16.55 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 121.069 -0.253 . . . . 0.0 111.088 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.682 HD12 HD22 ' A' ' 21' ' ' LEU . 16.4 mt -67.68 -31.97 72.3 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.242 178.295 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.424 ' OD2' ' HB2' ' A' ' 134' ' ' LYS . 2.1 p30 -55.0 -17.33 3.64 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.129 177.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.795 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 35.1 mt-10 -63.18 -53.08 58.84 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.222 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -123.3 5.01 9.12 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.728 -177.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.418 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 48.3 mm -105.69 110.34 30.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.693 178.794 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -115.97 172.84 14.41 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.632 178.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.614 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.2 OUTLIER -112.26 130.03 56.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.984 0.421 . . . . 0.0 110.983 179.893 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -125.41 94.01 4.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.327 179.098 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.552 ' O ' ' HD3' ' A' ' 27' ' ' ARG . 2.3 m-20 62.88 39.68 10.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.678 178.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.5 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 88.36 13.45 63.57 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.902 179.196 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -122.97 135.85 54.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.759 0.314 . . . . 0.0 111.299 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.498 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 37.4 mt -82.16 121.39 26.55 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.107 178.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 12.6 tt . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.197 -179.463 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 1.008 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 38.0 m-85 . . . . . 0 CA--C 1.519 -0.224 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.63 -33.55 4.82 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.341 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -70.63 -62.47 3.62 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 119.763 -1.208 . . . . 0.0 112.694 -179.035 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 65.48 16.52 10.56 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 122.532 0.333 . . . . 0.0 111.041 -179.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.716 ' HD2' HD11 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -63.74 -34.95 79.02 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.732 -179.277 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.41 ' HA ' HD12 ' A' ' 14' ' ' ILE . 16.6 p -63.79 -18.83 64.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.139 0.495 . . . . 0.0 110.988 -179.494 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.92 -26.29 69.41 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 115.682 -0.69 . . . . 0.0 113.341 179.226 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.555 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 33.5 p -127.12 -20.33 4.17 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 117.583 0.691 . . . . 0.0 111.819 -179.224 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.6 t -96.62 131.3 43.41 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -112.54 -176.99 3.04 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.419 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 16.6 m-20 43.62 45.55 5.81 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 123.971 0.794 . . . . 0.0 111.874 -179.802 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.683 HD11 ' O ' ' A' ' 132' ' ' GLY . 7.6 mt -78.32 102.66 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-O 120.904 0.383 . . . . 0.0 110.075 -178.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.437 ' HA ' HD12 ' A' ' 129' ' ' LEU . 56.9 m -144.73 128.43 17.21 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.168 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.737 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -97.44 157.81 15.8 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.941 0.877 . . . . 0.0 112.956 -179.24 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -99.45 74.87 1.93 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 113.994 -1.457 . . . . 0.0 107.779 177.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.52 -53.22 4.66 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.137 179.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.547 ' HB2' ' HB3' ' A' ' 40' ' ' ASN . . . -149.07 -13.57 0.31 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 120.951 0.405 . . . . 0.0 110.147 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -85.86 92.92 8.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.604 179.067 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.737 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 9.5 tp -62.91 114.81 3.88 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.713 -179.786 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 35' ' ' SER . 43.7 ttp180 -119.62 133.94 55.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.612 -178.265 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.576 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -152.78 148.13 26.86 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.402 179.791 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.51 ' O ' ' HD1' ' A' ' 32' ' ' TYR . 1.8 mm-40 -83.82 79.73 9.38 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.814 179.148 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.659 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 67.2 m -61.45 121.68 13.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.013 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.555 ' HB2' ' O ' ' A' ' 10' ' ' SER . 36.4 ttt-85 -70.64 122.21 19.34 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.273 178.532 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.7 ttt-85 -93.53 154.59 17.8 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.272 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.03 -15.0 6.23 Favored Glycine 0 C--N 1.335 0.509 0 O-C-N 124.36 1.037 . . . . 0.0 114.164 -178.251 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -79.27 -3.48 46.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.198 0.523 . . . . 0.0 109.788 178.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.46 9.51 72.32 Favored Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.97 144.31 17.31 Favored Glycine 0 C--O 1.227 -0.343 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.998 -179.067 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.51 ' HD1' ' O ' ' A' ' 24' ' ' GLU . 74.3 m-85 -90.46 125.69 35.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.788 0.328 . . . . 0.0 110.277 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.7 m -115.75 130.5 56.87 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.638 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.7 m -65.63 124.32 22.06 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.8 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.769 ' HG ' ' HB2' ' A' ' 164' ' ' LEU . 42.5 t -129.31 147.07 51.11 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.139 179.331 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 7.7 p -144.66 137.8 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.705 0.288 . . . . 0.0 110.967 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.537 HG21 HD22 ' A' ' 164' ' ' LEU . 8.5 tt -135.32 147.42 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.605 -178.357 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -76.38 99.77 4.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.723 0.297 . . . . 0.0 111.338 179.277 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.82 HD11 ' HG ' ' A' ' 43' ' ' LEU . 1.2 mm? -82.83 -4.41 58.02 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.102 0.477 . . . . 0.0 111.089 179.887 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.547 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 7.0 p30 -69.87 -10.68 59.39 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.369 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.9 mtt85 -102.54 6.06 39.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.829 179.17 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.493 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 7.1 m-85 -134.18 -24.75 1.61 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.569 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.82 ' HG ' HD11 ' A' ' 39' ' ' LEU . 61.7 mt -105.83 128.74 53.93 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.752 0.31 . . . . 0.0 110.522 179.433 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.641 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 1.0 OUTLIER -125.1 135.95 53.18 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.487 -179.845 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.822 ' HB3' ' HG ' ' A' ' 140' ' ' LEU . 18.8 p-10 -79.26 92.45 5.12 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.359 0.6 . . . . 0.0 110.033 178.336 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -86.82 86.85 7.35 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.307 0.575 . . . . 0.0 110.333 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.478 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 64.5 t30 50.22 44.62 26.24 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.253 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.71 34.82 10.87 Favored Glycine 0 C--O 1.221 -0.657 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.725 178.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -150.68 131.56 14.19 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.429 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.695 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 21.3 m-85 -72.21 140.0 48.47 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.559 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.432 ' HD3' ' HA ' ' A' ' 51' ' ' ARG . 10.5 mmt180 -143.88 134.15 24.47 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.087 -179.448 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.63 ' HH2' HD11 ' A' ' 153' ' ' LEU . 96.5 m95 . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.258 177.53 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 37.7 m . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 121.193 0.521 . . . . 0.0 111.671 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.64 176.62 8.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.009 179.085 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.5 HG21 ' HG2' ' A' ' 106' ' ' GLN . 7.8 p -129.59 122.16 28.55 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.208 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.536 HG22 ' CE2' ' A' ' 80' ' ' PHE . 8.2 p -113.02 147.44 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 120.751 0.31 . . . . 0.0 111.072 179.26 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 4.9 m -90.52 129.95 36.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.099 0.476 . . . . 0.0 110.284 179.101 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.477 ' CG2' HD13 ' A' ' 99' ' ' ILE . 54.0 t -78.78 133.48 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.485 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -104.17 169.34 8.55 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.333 1.021 . . . . 0.0 110.486 -179.496 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.612 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 63.4 tt0 -68.13 120.16 13.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.292 -178.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.33 9.36 55.5 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.856 179.332 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -116.88 128.35 55.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.964 0.412 . . . . 0.0 111.494 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.58 ' HA ' HG12 ' A' ' 99' ' ' ILE . 67.8 p -106.68 -179.2 3.87 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.329 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.553 HD22 HG21 ' A' ' 99' ' ' ILE . 1.4 mm? -52.21 -43.1 64.07 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.404 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 3.4 tmt_? -59.38 -41.64 89.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.366 -179.292 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -73.12 -38.2 66.4 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.595 -178.345 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 72' ' ' THR . 45.8 mm -63.83 -48.89 84.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.542 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.734 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -59.23 -47.24 91.8 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.391 179.206 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -25.49 64.78 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.796 0.332 . . . . 0.0 111.838 -178.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 48.9 ttm-85 -82.51 -34.51 27.92 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.576 ' HB2' ' HG ' ' A' ' 82' ' ' CYS . 95.0 m-85 -110.83 20.26 17.74 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.321 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.9 t70 55.06 42.1 31.18 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.62 0.724 . . . . 0.0 111.711 178.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.734 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -125.26 170.98 10.75 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.348 179.255 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.556 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.4 t70 -98.39 123.15 42.35 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.87 179.366 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.485 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 5.9 p90 -50.97 -30.37 14.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.99 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -67.24 -43.73 81.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.229 179.525 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.687 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 26.3 mt-10 -64.9 -48.27 74.8 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.355 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.1 mt -49.59 -50.21 17.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.458 179.196 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.602 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.63 -50.74 68.15 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.295 178.681 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -56.56 -37.63 70.8 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.687 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 75.3 mtt180 -73.91 -29.48 62.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.841 0.353 . . . . 0.0 111.03 -179.407 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.491 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 15.1 t-20 -93.19 -5.16 50.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.031 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 93.4 m-20 79.23 12.46 1.27 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.586 0.754 . . . . 0.0 111.497 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.602 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 14.8 pt -102.8 179.43 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.445 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.552 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 2.6 mp0 -105.96 155.94 18.87 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.462 ' O ' HD21 ' A' ' 73' ' ' LEU . 2.3 p-10 -56.82 -56.09 26.07 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.226 1.012 . . . . 0.0 108.82 179.21 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -77.95 12.03 1.96 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.438 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.552 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.9 t70 -65.34 -34.9 79.41 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.469 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 8.2 mp 70.78 115.3 0.05 OUTLIER 'General case' 0 C--O 1.233 0.215 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.107 -178.117 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.744 HG23 HD11 ' A' ' 105' ' ' LEU . 7.5 pt -95.29 178.66 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.538 -178.526 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.542 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 61.8 m-85 -130.53 158.34 74.89 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.478 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.612 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 22.9 Cg_endo -64.95 139.21 60.73 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 123.323 2.682 . . . . 0.0 114.402 -178.414 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.39 20.22 33.07 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.014 178.085 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.569 ' O ' ' HA ' ' A' ' 66' ' ' THR . 79.2 mt-30 -109.59 168.21 9.57 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.413 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 77.8 t -126.36 112.06 28.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.047 0.451 . . . . 0.0 110.042 179.1 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.744 HD11 HG23 ' A' ' 99' ' ' ILE . 87.2 mt -107.23 151.42 25.46 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.581 -179.645 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.5 ' HG2' HG21 ' A' ' 64' ' ' THR . 37.4 mt-30 -91.06 112.38 24.26 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.741 0.781 . . . . 0.0 111.387 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.7 m -115.78 152.0 46.92 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.459 179.701 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.37 -21.94 60.43 Favored 'Trans proline' 0 C--N 1.332 -0.315 0 C-N-CA 122.909 2.406 . . . . 0.0 114.409 -177.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.9 t . . . . . 0 C--N 1.323 -0.57 0 CA-C-O 120.86 0.362 . . . . 0.0 110.987 -179.755 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.641 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.441 -1.03 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 20.9 m120 70.7 27.03 3.75 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 122.998 0.519 . . . . 0.0 112.118 178.595 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.608 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 17.2 p90 -60.07 -39.47 86.17 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.658 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.495 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 38.9 t-105 -61.75 -29.88 70.42 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.208 -178.267 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -55.96 -28.31 56.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.665 0.269 . . . . 0.0 110.803 -179.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.632 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 3.9 m -135.25 28.74 3.39 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.855 0.36 . . . . 0.0 110.48 178.497 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.495 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -110.61 144.34 39.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.766 0.317 . . . . 0.0 110.706 178.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -136.64 149.72 48.13 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.137 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 59.34 45.23 14.2 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.693 0.62 . . . . 0.0 111.139 179.343 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.462 ' CG1' HD11 ' A' ' 136' ' ' LEU . 21.4 t -74.84 121.37 26.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.194 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -145.17 140.65 28.1 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.036 -179.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.656 HD13 ' HG ' ' A' ' 16' ' ' LEU . 54.1 mt -86.76 127.11 34.98 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.038 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.518 HG22 ' HB ' ' A' ' 135' ' ' VAL . 34.6 m -119.95 163.17 17.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.854 -178.701 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 66.27 9.23 6.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.474 178.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.683 ' O ' HD11 ' A' ' 14' ' ' ILE . . . 94.69 31.83 7.59 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.116 179.487 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.695 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 86.8 -13.92 57.7 Favored Glycine 0 C--O 1.256 1.521 0 CA-C-O 123.274 1.485 . . . . 0.0 112.812 177.548 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.584 ' HG3' HG21 ' A' ' 135' ' ' VAL . 19.0 ptpt -72.86 -14.22 61.45 Favored 'General case' 0 C--N 1.311 -1.098 0 O-C-N 121.592 -0.946 . . . . 0.0 108.76 178.155 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.584 HG21 ' HG3' ' A' ' 134' ' ' LYS . 22.7 t -141.68 138.73 31.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.638 177.478 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 27.8 tp -119.99 125.39 48.26 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.527 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.512 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 28.3 tt0 -114.98 132.52 56.56 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 123.504 0.503 . . . . 0.0 110.948 -177.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.608 ' HB1' ' CZ ' ' A' ' 50' ' ' PHE . . . -161.39 158.52 26.96 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.247 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 30.5 mt-10 -94.88 106.82 18.83 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.773 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.822 ' HG ' ' HB3' ' A' ' 45' ' ' ASN . 0.4 OUTLIER -89.54 123.37 33.57 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.435 -179.877 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.632 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 36.6 ttt180 -69.29 140.81 54.42 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.591 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 2.5 p90 -155.53 -170.39 3.43 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.429 -179.008 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 3.1 m -56.96 -27.94 61.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.106 0.479 . . . . 0.0 112.0 -179.36 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.29 17.2 58.21 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.598 -0.811 . . . . 0.0 113.19 -179.312 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 103.41 -107.9 3.13 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.031 179.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -129.6 127.69 41.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.785 0.292 . . . . 0.0 110.639 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.591 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 52.0 t-20 -120.88 117.18 26.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.76 0.314 . . . . 0.0 110.534 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 31.6 ttm180 -74.99 94.74 2.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.886 178.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.3 m -111.54 174.02 6.07 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.403 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.592 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 44.6 mtt85 -142.37 165.68 26.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.058 0.456 . . . . 0.0 112.003 -177.611 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.695 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 14.3 tt -145.44 161.98 12.38 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.372 179.169 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.58 ' CB ' ' HG3' ' A' ' 155' ' ' GLU . 12.1 m-85 -104.43 104.27 14.12 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 122.144 -0.347 . . . . 0.0 111.72 -178.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.695 HD13 ' HG ' ' A' ' 39' ' ' LEU . 4.1 mm? -65.65 -36.43 83.67 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.328 179.071 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' A' ' 152' ' ' TYR . 6.0 p-10 -57.34 -11.96 2.17 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.18 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 1.008 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 36.1 mt-10 -67.76 -54.89 15.65 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -121.33 3.6 10.29 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.041 -0.664 . . . . 0.0 112.467 -177.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.597 HG13 HD12 ' A' ' 153' ' ' LEU . 45.9 mm -104.26 114.16 43.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 C-N-CA 120.181 -0.607 . . . . 0.0 110.585 179.023 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -115.14 175.79 16.21 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.928 -0.654 . . . . 0.0 113.159 179.52 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.659 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.0 t30 -117.4 129.05 55.6 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.5 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.657 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 40.8 ttm180 -124.67 88.32 2.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.712 179.674 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 51.95 46.15 27.07 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 178.636 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.9 -8.98 50.94 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.285 -0.96 . . . . 0.0 115.019 177.404 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.657 ' HG2' ' O ' ' A' ' 160' ' ' ARG . 12.9 pt-20 -114.18 146.6 40.13 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 117.901 0.851 . . . . 0.0 110.634 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.769 ' HB2' ' HG ' ' A' ' 35' ' ' SER . 4.6 tp -91.15 106.92 18.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.675 -179.578 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.551 HD11 ' HB2' ' A' ' 160' ' ' ARG . 31.7 pt . . . . . 0 C--N 1.322 -0.6 0 CA-C-O 121.366 0.603 . . . . 0.0 112.149 -178.474 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 1.03 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 35.3 m-85 . . . . . 0 CA--C 1.52 -0.202 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -121.87 -31.32 3.96 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.021 178.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -78.55 -66.44 1.73 Allowed Glycine 0 N--CA 1.436 -1.352 0 C-N-CA 119.525 -1.322 . . . . 0.0 112.046 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 65.96 15.26 10.0 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.605 0.362 . . . . 0.0 111.018 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.727 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -58.31 -37.27 74.75 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -178.972 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.8 t -60.04 -18.25 45.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.379 0.609 . . . . 0.0 110.816 -179.649 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.52 -33.32 61.13 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.578 179.008 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.507 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 20.2 m -120.9 -17.98 7.72 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 117.683 0.741 . . . . 0.0 111.32 -179.461 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.419 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 15.6 m -97.99 131.46 44.4 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -114.19 -175.64 2.72 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 46.03 42.37 9.43 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 123.76 0.663 . . . . 0.0 111.87 179.284 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.711 HG23 ' HA3' ' A' ' 133' ' ' GLY . 7.5 mt -78.82 105.48 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-O 121.18 0.514 . . . . 0.0 110.063 -178.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.531 ' HA ' HD13 ' A' ' 129' ' ' LEU . 65.3 m -147.72 128.6 14.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.887 179.433 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.719 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -97.97 159.87 14.66 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -178.711 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 20' ' ' ARG . 24.1 m-20 -99.1 73.77 1.94 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.129 177.113 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.86 -59.46 4.72 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.742 179.645 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.629 ' HB3' ' HB3' ' A' ' 40' ' ' ASN . . . -147.8 10.96 0.95 Allowed 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.273 0.558 . . . . 0.0 110.274 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.412 ' HB2' ' HB2' ' A' ' 17' ' ' ASP . 72.1 mtm180 -110.05 91.24 3.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.86 179.428 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.931 ' HB2' HD22 ' A' ' 39' ' ' LEU . 44.3 tp -60.47 122.47 14.69 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.636 -178.646 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 48.7 ttp180 -127.51 132.17 49.98 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.345 -178.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.637 ' HB2' HG12 ' A' ' 14' ' ' ILE . . . -149.83 145.25 26.48 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.511 0.672 . . . . 0.0 110.74 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.507 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 3.8 mm-40 -80.54 68.51 6.77 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.671 178.283 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.68 ' SG ' HD12 ' A' ' 164' ' ' LEU . 57.5 m -57.28 124.47 18.95 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.018 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.507 ' HB2' ' O ' ' A' ' 10' ' ' SER . 42.6 ttt-85 -65.75 126.36 28.19 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.414 179.241 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 33.9 ptt180 -98.48 155.29 17.33 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.063 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.93 -11.95 4.89 Favored Glycine 0 C--N 1.338 0.689 0 O-C-N 124.513 1.133 . . . . 0.0 113.919 -179.024 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.01 -11.65 60.86 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.048 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.35 8.27 60.04 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.857 179.531 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.412 ' O ' ' HG2' ' A' ' 27' ' ' ARG . . . -123.7 178.07 16.5 Favored Glycine 0 C--O 1.225 -0.432 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.392 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.507 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 83.2 m-85 -101.58 140.99 35.11 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.912 0.387 . . . . 0.0 111.168 179.573 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 p -128.93 133.97 48.05 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.904 179.231 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 m -71.32 111.07 6.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.094 0.473 . . . . 0.0 111.608 -178.383 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.4 t -116.27 147.57 41.37 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.948 179.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 5.4 p -143.14 137.55 26.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 120.867 0.365 . . . . 0.0 111.152 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.6 tt -132.66 154.32 39.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.012 -177.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -81.15 95.12 6.79 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.931 HD22 ' HB2' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -76.1 -14.23 60.19 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.697 0.76 . . . . 0.0 109.461 178.355 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.629 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 5.2 p30 -66.62 -15.96 63.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.803 178.377 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -114.24 31.03 6.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.1 179.071 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -150.45 -30.97 0.2 Allowed 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.208 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.614 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 41.7 mt -105.94 127.5 53.19 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.775 0.321 . . . . 0.0 110.495 179.273 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.644 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 1.0 OUTLIER -123.91 137.78 54.58 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.452 179.984 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.795 ' HB3' ' HG ' ' A' ' 140' ' ' LEU . 19.4 p-10 -78.34 92.21 4.52 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.484 0.659 . . . . 0.0 110.831 178.59 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -87.5 86.71 7.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.072 0.463 . . . . 0.0 110.725 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 52.03 43.66 30.19 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.312 179.24 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.55 40.04 9.27 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.995 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -157.81 118.98 3.54 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.746 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.79 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 29.7 m-85 -62.44 140.88 58.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.28 -179.358 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.416 ' HD2' ' O ' ' A' ' 50' ' ' PHE . 16.3 mmm180 -140.41 139.03 35.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.235 179.508 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.651 ' CZ2' ' HA ' ' A' ' 153' ' ' LEU . 86.2 m95 . . . . . 0 C--N 1.325 -0.471 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.449 -0.523 0 CA-C-O 121.176 0.512 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -121.98 176.58 5.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.431 179.525 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.2 p -126.81 120.8 30.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.028 0.442 . . . . 0.0 112.151 -179.093 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.9 p -110.18 144.85 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.006 178.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 5.7 m -89.19 127.27 35.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.079 179.044 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.537 ' CG2' HD13 ' A' ' 99' ' ' ILE . 60.5 t -73.38 131.66 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.55 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -101.0 170.08 8.52 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 124.485 1.115 . . . . 0.0 111.136 -178.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.682 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 57.7 tp60 -58.76 118.56 5.84 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.682 -178.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.81 -5.36 85.04 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 121.106 -0.568 . . . . 0.0 113.705 177.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -90.36 127.56 36.22 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 117.084 0.442 . . . . 0.0 111.056 -179.662 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.686 ' HA ' HG12 ' A' ' 99' ' ' ILE . 68.9 p -107.93 -179.33 3.87 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.728 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.553 HD13 ' HB ' ' A' ' 87' ' ' ILE . 1.2 mm? -53.02 -42.73 65.96 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.538 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -62.43 -35.33 78.93 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.145 -178.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -74.06 -46.7 41.47 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.585 179.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 72' ' ' THR . 43.8 mm -58.31 -48.4 85.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.209 -179.649 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.69 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -58.64 -55.55 30.17 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.112 179.464 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -33.95 75.98 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.047 0.451 . . . . 0.0 111.114 -178.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -73.5 -40.41 64.09 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -106.57 15.17 26.14 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -178.403 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.0 t70 60.33 49.89 6.64 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.589 0.709 . . . . 0.0 111.826 178.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.69 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.5 p -134.55 165.59 24.85 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.495 ' O ' HG13 ' A' ' 87' ' ' ILE . 3.9 p-10 -95.24 121.43 36.87 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.775 0.797 . . . . 0.0 109.689 178.67 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.521 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 5.9 p90 -48.11 -31.36 5.48 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.174 -1.375 . . . . 0.0 112.115 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.43 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 22.4 t-80 -60.23 -50.28 74.27 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.963 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.486 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 7.9 tp10 -65.39 -45.65 83.18 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.107 179.712 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.553 ' HB ' HD13 ' A' ' 73' ' ' LEU . 4.3 mt -51.4 -46.16 34.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.725 0.774 . . . . 0.0 109.51 179.446 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.56 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.98 -50.75 69.54 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.719 178.611 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.416 HH21 ' CD ' ' A' ' 86' ' ' GLU . 52.2 ttp180 -59.2 -37.15 76.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.758 0.313 . . . . 0.0 111.794 -179.381 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.664 ' HB3' ' HB2' ' A' ' 106' ' ' GLN . 2.0 mmp_? -65.11 -32.32 73.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.928 0.394 . . . . 0.0 110.903 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.551 HD21 HG23 ' A' ' 93' ' ' ILE . 6.0 t30 -96.09 -5.03 41.8 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.959 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 17.3 m120 77.36 18.3 1.4 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.355 0.662 . . . . 0.0 111.029 -179.228 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.56 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 10.6 pt -105.84 179.53 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.827 178.913 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.542 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 12.0 mm100 -102.93 154.55 19.1 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.675 HD21 ' HG3' ' A' ' 96' ' ' GLU . 1.1 p-10 -55.7 -61.5 2.31 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-O 122.259 1.028 . . . . 0.0 109.696 179.036 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.675 ' HG3' HD21 ' A' ' 95' ' ' ASN . 43.6 mt-10 -78.49 12.48 1.98 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.582 -179.461 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 4.3 t0 -61.89 -32.43 72.8 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.127 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.463 HD21 HG23 ' A' ' 72' ' ' THR . 41.2 mt 71.78 114.38 0.05 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.176 -178.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.686 HG12 ' HA ' ' A' ' 72' ' ' THR . 8.2 pt -95.2 175.54 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.354 -179.152 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.482 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 40.4 m-85 -124.71 157.44 65.88 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.21 -178.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.682 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 40.7 Cg_endo -67.85 138.71 45.42 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 123.122 2.548 . . . . 0.0 113.456 -178.526 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.76 13.59 43.24 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.374 179.159 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.526 ' O ' ' HA ' ' A' ' 66' ' ' THR . 44.1 mt-30 -100.44 168.69 9.59 Favored 'General case' 0 C--O 1.217 -0.658 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.297 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 89.5 t -128.53 109.16 18.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.583 HD11 HG22 ' A' ' 99' ' ' ILE . 82.0 mt -107.15 151.56 25.23 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.019 -178.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.664 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 39.6 mt-30 -89.89 116.44 27.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.598 0.713 . . . . 0.0 110.859 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.0 m -121.98 150.74 56.88 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 114.37 -1.287 . . . . 0.0 109.544 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.99 -18.4 62.05 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 123.352 2.701 . . . . 0.0 114.29 -177.699 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 C--N 1.325 -0.48 0 CA-C-O 121.255 0.55 . . . . 0.0 111.139 -179.656 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.644 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.445 -0.711 0 N-CA-C 112.211 -0.355 . . . . 0.0 112.211 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.3 m120 70.9 21.13 5.16 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 178.741 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.614 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 21.6 p90 -58.02 -37.5 74.44 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.045 0.45 . . . . 0.0 109.941 178.883 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.488 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 58.3 t-105 -59.93 -32.21 70.57 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.144 -178.495 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.9 -28.31 56.14 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.946 0.403 . . . . 0.0 110.392 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.902 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 69.7 m -133.26 30.12 3.93 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.921 179.135 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 139' ' ' GLU . . . -115.88 136.48 53.0 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.981 0.42 . . . . 0.0 111.731 178.845 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -129.32 151.35 50.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.963 178.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 40.8 t0 56.22 51.36 11.83 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.742 0.782 . . . . 0.0 110.575 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.44 ' CG1' HD12 ' A' ' 136' ' ' LEU . 21.9 t -83.98 127.15 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.588 -179.644 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 25.0 ptt-85 -154.38 146.88 24.04 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.95 0.405 . . . . 0.0 110.358 179.164 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.745 HD21 HD12 ' A' ' 153' ' ' LEU . 19.5 mt -86.17 130.67 34.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.83 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.696 HG23 ' HB ' ' A' ' 135' ' ' VAL . 28.0 m -123.88 156.95 30.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.003 -178.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.459 ' HB3' ' CG ' ' A' ' 134' ' ' LYS . 0.7 OUTLIER 65.65 16.87 10.7 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.043 179.145 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.688 ' O ' HD13 ' A' ' 14' ' ' ILE . . . 88.31 30.79 15.43 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.625 178.119 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.711 ' HA3' HG23 ' A' ' 14' ' ' ILE . . . 89.75 -14.44 61.63 Favored Glycine 0 C--O 1.26 1.735 0 CA-C-O 123.442 1.579 . . . . 0.0 113.031 177.112 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.758 ' HG3' HG21 ' A' ' 135' ' ' VAL . 21.5 ptmt -69.85 -17.35 63.37 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 121.334 -1.098 . . . . 0.0 108.384 178.396 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.758 HG21 ' HG3' ' A' ' 134' ' ' LYS . 3.9 t -140.17 144.72 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.083 177.79 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.573 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 28.3 tp -126.14 121.91 34.2 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.749 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.467 ' HG3' ' HG3' ' A' ' 150' ' ' ARG . 30.9 tt0 -112.58 133.34 54.68 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.883 0.373 . . . . 0.0 111.285 -177.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.54 ' HB2' ' HZ ' ' A' ' 50' ' ' PHE . . . -161.86 163.8 29.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.62 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 124' ' ' ALA . 46.7 mt-10 -96.33 105.79 17.92 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 178.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.795 ' HG ' ' HB3' ' A' ' 45' ' ' ASN . 1.6 mp -89.85 125.2 35.24 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.927 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.902 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 74.7 ttt180 -70.87 140.86 51.21 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.047 178.669 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -155.59 -175.84 5.64 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.186 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 6.0 m -56.89 -31.46 64.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.759 0.314 . . . . 0.0 111.485 -179.256 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -88.33 7.65 81.0 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.766 -179.032 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 109.7 -121.83 6.2 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.127 179.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -122.86 125.1 44.74 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.629 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -123.3 140.39 53.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.874 0.368 . . . . 0.0 111.549 -179.092 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -72.55 102.37 3.23 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.824 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.449 ' HB2' HD21 ' A' ' 140' ' ' LEU . 1.4 m -113.07 156.34 23.3 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.351 -178.052 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.573 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -145.53 153.85 41.55 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.961 0.41 . . . . 0.0 111.065 179.84 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.79 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 9.4 tt -136.24 152.06 29.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.971 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.56 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 92.4 m-85 -97.11 104.49 16.51 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.419 0.152 . . . . 0.0 110.701 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.745 HD12 HD21 ' A' ' 129' ' ' LEU . 22.5 mt -68.74 -33.46 73.95 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.331 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.504 ' OD1' ' HB3' ' A' ' 152' ' ' TYR . 10.2 p-10 -56.84 -13.19 2.38 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.713 178.119 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 1.03 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 37.8 mt-10 -70.0 -55.42 9.62 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -122.98 11.32 9.56 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.72 -0.792 . . . . 0.0 113.048 -176.232 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.524 HG12 ' CH2' ' A' ' 52' ' ' TRP . 38.0 mm -112.94 111.94 38.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.421 178.196 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -115.05 175.62 16.11 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.191 179.093 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.541 ' CG ' ' HB3' ' A' ' 25' ' ' CYS . 3.3 t30 -115.11 129.51 56.7 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 122.651 0.38 . . . . 0.0 110.278 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 41.0 ttt85 -125.94 97.75 5.24 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.258 179.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 61.83 32.39 18.09 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.149 179.24 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 93.68 12.31 57.03 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.495 -0.86 . . . . 0.0 113.093 179.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -122.48 134.21 54.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.069 0.462 . . . . 0.0 110.814 179.628 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.727 HD11 ' CD2' ' A' ' 7' ' ' PHE . 4.4 tp -78.24 118.73 20.74 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.983 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 10.3 tp . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.356 -178.988 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.499 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 34.0 m-85 . . . . . 0 N--CA 1.458 -0.053 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -96.07 -31.11 13.19 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.065 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.56 -74.62 0.48 Allowed Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 119.879 -1.153 . . . . 0.0 113.227 -179.071 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 64.69 16.67 10.51 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 122.488 0.315 . . . . 0.0 110.25 -179.286 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.905 ' HD2' HD13 ' A' ' 164' ' ' LEU . 0.2 OUTLIER -61.14 -34.79 75.57 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.679 -179.316 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.416 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.7 OUTLIER -64.76 -17.51 64.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.331 0.586 . . . . 0.0 110.246 -179.262 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.15 -37.18 92.78 Favored Glycine 0 CA--C 1.523 0.544 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.647 178.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 30.9 m -118.06 -27.64 6.07 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 120.985 0.421 . . . . 0.0 111.404 -179.419 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 t -88.94 128.9 35.7 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.502 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 12' ' ' ARG . 11.3 ptm85 -114.41 -177.05 3.04 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.74 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 46.09 43.18 10.56 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 123.759 0.662 . . . . 0.0 111.675 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.671 HG12 ' HB2' ' A' ' 23' ' ' ALA . 6.1 mt -78.44 103.61 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.261 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.541 ' CA ' HD13 ' A' ' 129' ' ' LEU . 58.4 m -143.34 127.77 17.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.612 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.763 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -101.14 156.61 17.32 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.892 0.853 . . . . 0.0 113.15 -179.725 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -98.71 74.58 2.09 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 113.914 -1.494 . . . . 0.0 107.468 177.236 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.5 -54.53 4.6 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.622 179.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.745 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -147.05 -13.04 0.42 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 120.954 0.406 . . . . 0.0 110.294 179.55 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.99 86.81 6.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.444 179.14 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.763 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 45.2 tp -62.47 119.78 9.82 Favored 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 122.949 0.499 . . . . 0.0 112.158 -179.691 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 15.9 ttp180 -124.31 135.87 53.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.358 -178.585 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.671 ' HB2' HG12 ' A' ' 14' ' ' ILE . . . -155.42 140.36 17.27 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.498 0.666 . . . . 0.0 111.374 179.714 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 3.5 mm-40 -77.94 82.23 4.31 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.901 178.198 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.617 ' SG ' HD11 ' A' ' 164' ' ' LEU . 34.5 m -69.85 120.58 15.8 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.886 -178.04 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 10' ' ' SER . 50.6 ttp85 -72.42 114.9 11.04 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.76 178.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -92.1 160.6 15.13 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.233 179.242 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.75 -14.0 4.87 Favored Glycine 0 C--N 1.335 0.485 0 O-C-N 124.806 1.316 . . . . 0.0 113.902 -178.21 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -71.82 -12.47 61.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.789 0.804 . . . . 0.0 109.646 178.519 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.79 10.36 58.97 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.005 179.591 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -122.37 167.05 14.85 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 119.872 -1.156 . . . . 0.0 113.762 -179.011 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.559 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 78.1 m-85 -99.4 126.82 45.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.686 0.279 . . . . 0.0 110.516 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.5 t -113.71 126.18 54.94 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.398 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.7 m -66.59 114.36 5.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.092 0.472 . . . . 0.0 110.746 -179.291 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 36.2 t -119.04 148.85 42.56 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.405 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.9 p -145.3 138.47 21.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.693 0.282 . . . . 0.0 110.601 179.395 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.2 tt -135.32 153.52 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.627 -178.197 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.74 92.56 6.06 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.392 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.721 HD21 HD22 ' A' ' 153' ' ' LEU . 6.8 tp -78.6 -9.59 59.42 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.686 -177.46 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.745 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 28.4 p-10 -70.64 -12.99 61.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.497 0.665 . . . . 0.0 109.73 179.373 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.449 HH11 ' HD3' ' A' ' 41' ' ' ARG . 40.3 mtt180 -100.09 7.49 44.61 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.192 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.408 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 52.3 m-85 -129.44 -27.17 2.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.16 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.638 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 35.3 mt -107.25 140.16 40.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.069 0.461 . . . . 0.0 110.899 179.556 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 50' ' ' PHE . 5.4 m -127.17 149.09 50.13 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.915 -179.869 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.562 ' C ' HD21 ' A' ' 45' ' ' ASN . 0.1 OUTLIER -91.67 94.41 9.37 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.255 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -103.41 92.15 4.36 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.12 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.424 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 64.3 t30 46.95 44.61 14.88 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 114.749 -1.114 . . . . 0.0 112.324 178.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.24 42.74 7.82 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.957 178.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.434 ' HD2' ' O ' ' A' ' 50' ' ' PHE . 7.8 t60 -167.43 123.62 1.12 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.75 ' HZ ' ' HB2' ' A' ' 138' ' ' ALA . 62.0 m-85 -62.6 154.6 28.5 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.787 0.327 . . . . 0.0 110.602 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -148.11 133.79 18.86 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.974 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.474 ' CZ2' ' HA ' ' A' ' 153' ' ' LEU . 93.9 m95 . . . . . 0 C--N 1.315 -0.892 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.448 -0.533 0 CA-C-O 121.052 0.453 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -125.2 174.14 8.29 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.456 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 1.2 p -129.83 114.25 15.68 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.782 0.325 . . . . 0.0 111.567 -179.07 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.482 HG22 ' CE2' ' A' ' 80' ' ' PHE . 11.5 p -99.81 135.07 36.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.936 0.398 . . . . 0.0 110.988 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 14.5 m -88.7 121.84 31.5 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.623 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.596 HG22 HD12 ' A' ' 99' ' ' ILE . 46.2 t -72.6 130.54 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.373 -179.428 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -100.85 169.15 9.18 Favored 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 124.149 0.906 . . . . 0.0 110.661 179.362 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.724 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 29.9 tt0 -60.21 108.69 0.83 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.524 -179.038 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.83 -10.97 20.93 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.296 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.514 ' HB3' HD13 ' A' ' 76' ' ' ILE . 68.3 m-20 -85.66 148.5 25.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.176 0.512 . . . . 0.0 111.79 -179.146 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.528 ' O ' HG12 ' A' ' 76' ' ' ILE . 23.4 p -133.93 158.48 43.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.434 178.795 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.678 HD21 ' HA ' ' A' ' 95' ' ' ASN . 1.8 tp -48.56 -45.27 37.49 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.039 0.447 . . . . 0.0 111.289 -179.651 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.527 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 43.7 ttp180 -60.13 -40.82 91.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.308 -179.628 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -74.31 -40.63 62.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.367 -178.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.528 HG12 ' O ' ' A' ' 72' ' ' THR . 47.6 mm -60.21 -46.47 94.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.159 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.711 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -55.44 -58.83 12.03 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.421 178.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -59.9 -33.18 71.51 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.675 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -66.55 -48.85 68.36 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.559 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.482 ' CE2' HG22 ' A' ' 65' ' ' VAL . 96.2 m-85 -97.52 13.23 30.67 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.196 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.7 t70 60.33 36.69 20.52 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.132 0.968 . . . . 0.0 110.711 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.711 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.1 p -114.54 171.79 7.42 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.548 179.229 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.695 ' O ' HG13 ' A' ' 87' ' ' ILE . 5.9 t0 -99.66 125.33 45.48 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 121.78 -0.575 . . . . 0.0 109.888 -179.702 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.527 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 31.9 p90 -54.3 -29.52 47.84 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.663 0.744 . . . . 0.0 109.938 178.64 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.531 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 22.3 t-80 -69.77 -41.37 75.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.544 178.6 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.694 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 36.8 tt0 -69.16 -48.9 61.03 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.638 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.695 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.2 mt -51.87 -43.31 34.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.678 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.551 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.61 -51.58 66.74 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.452 178.556 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 85' ' ' HIS . 41.2 mtm180 -61.62 -33.4 73.85 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.883 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.694 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 47.0 mmm-85 -73.36 -35.09 65.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.922 0.392 . . . . 0.0 110.896 -179.497 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.52 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 3.0 t-20 -88.11 -5.15 58.61 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.812 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.52 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 91.0 m-20 79.43 10.68 1.44 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.53 0.732 . . . . 0.0 111.085 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.551 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 21.9 pt -100.84 -174.01 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.783 179.25 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.6 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 66.2 mm-40 -110.54 162.34 14.8 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.087 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.678 ' HA ' HD21 ' A' ' 73' ' ' LEU . 1.4 p30 -55.5 -69.9 0.12 Allowed 'General case' 0 C--O 1.244 0.804 0 CA-C-O 122.336 1.065 . . . . 0.0 109.977 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -72.86 12.8 0.46 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.656 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.6 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.8 t70 -57.36 -33.21 67.55 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.389 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 55.4 mt 71.8 115.14 0.05 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-N 114.286 -1.324 . . . . 0.0 109.89 -178.621 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.596 HD12 HG22 ' A' ' 67' ' ' VAL . 17.1 pt -94.07 174.35 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.043 -178.64 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.435 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 17.3 m-85 -129.08 158.58 72.39 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.696 -178.603 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.724 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 25.5 Cg_endo -67.11 131.41 25.17 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.839 2.359 . . . . 0.0 112.438 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.33 15.12 36.26 Favored Glycine 0 N--CA 1.438 -1.177 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 -179.59 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 66' ' ' THR . 47.1 tt0 -103.08 155.63 18.26 Favored 'General case' 0 C--O 1.214 -0.799 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.306 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.456 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 59.4 t -117.89 120.83 65.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 O-C-N 121.993 -0.442 . . . . 0.0 109.815 179.368 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.421 HD11 ' CD1' ' A' ' 73' ' ' LEU . 77.9 mt -112.07 150.84 30.12 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.397 -178.827 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.406 ' HB2' ' CB ' ' A' ' 90' ' ' ARG . 74.1 mt-30 -90.9 112.84 24.86 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.729 0.776 . . . . 0.0 110.781 179.065 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.407 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 34.0 m -126.45 151.08 72.18 Favored Pre-proline 0 C--N 1.313 -0.998 0 CA-C-N 114.214 -1.357 . . . . 0.0 109.019 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.407 ' HD2' ' HB ' ' A' ' 107' ' ' VAL . 32.2 Cg_endo -63.2 -18.56 65.51 Favored 'Trans proline' 0 N--CA 1.473 0.321 0 C-N-CA 123.561 2.841 . . . . 0.0 115.259 -176.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.9 t . . . . . 0 C--N 1.323 -0.579 0 C-N-CA 120.374 -0.531 . . . . 0.0 111.48 -179.547 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.447 -0.573 0 N-CA-C 112.239 -0.345 . . . . 0.0 112.239 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 72.65 29.23 2.03 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.989 0.515 . . . . 0.0 111.327 178.337 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.638 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 22.7 p90 -59.48 -36.52 76.18 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 121.304 0.573 . . . . 0.0 109.963 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.411 ' HB2' ' HB2' ' A' ' 19' ' ' ALA . 24.0 t-105 -65.15 -24.6 67.45 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.113 -178.363 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.94 -14.06 60.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.856 0.36 . . . . 0.0 110.925 -179.746 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.7 p -144.65 22.32 1.63 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.926 179.011 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -104.48 151.53 23.45 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.782 0.325 . . . . 0.0 110.915 179.08 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 63.0 ttp180 -141.5 144.53 34.4 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.106 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 57.73 52.53 8.06 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.197 0.522 . . . . 0.0 111.123 179.578 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.484 ' CG1' HD11 ' A' ' 136' ' ' LEU . 21.3 t -81.65 119.12 30.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.526 -179.565 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -143.4 142.43 31.24 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.344 -179.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.723 HD21 HD12 ' A' ' 153' ' ' LEU . 27.3 mt -86.18 129.55 34.81 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.952 178.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.559 HG21 ' HB ' ' A' ' 135' ' ' VAL . 34.6 m -121.72 154.78 26.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.175 0.512 . . . . 0.0 111.046 -178.845 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.541 ' HB3' ' HD3' ' A' ' 134' ' ' LYS . 9.6 m-20 71.41 3.65 4.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.953 179.054 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.655 ' O ' HD11 ' A' ' 14' ' ' ILE . . . 98.41 31.95 6.25 Favored Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.554 178.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.638 ' HA3' HG22 ' A' ' 14' ' ' ILE . . . 92.95 -19.73 50.14 Favored Glycine 0 C--O 1.263 1.91 0 CA-C-O 122.966 1.315 . . . . 0.0 113.272 177.545 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.701 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 18.6 ptmt -66.31 -18.97 65.67 Favored 'General case' 0 C--N 1.318 -0.795 0 O-C-N 121.634 -0.921 . . . . 0.0 108.991 178.104 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.559 ' HB ' HG21 ' A' ' 130' ' ' VAL . 11.7 t -140.24 141.58 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.688 177.667 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.635 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 22.7 tp -121.2 121.97 38.95 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.368 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.518 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 35.0 tt0 -111.02 132.97 53.77 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 120.858 0.361 . . . . 0.0 111.297 -177.336 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.75 ' HB2' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.55 155.24 19.44 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.678 179.153 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -94.05 106.84 18.8 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.515 HD13 ' HA ' ' A' ' 45' ' ' ASN . 59.8 mt -90.7 131.77 36.19 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.308 -178.864 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 49.8 ttt85 -73.33 141.81 47.09 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.422 179.513 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.424 ' HB2' ' OD1' ' A' ' 47' ' ' ASN . 10.7 p90 -151.14 -165.08 2.16 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.72 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.4 m -70.52 2.44 3.99 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -135.88 31.73 2.6 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.675 -179.663 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 97.57 -134.62 11.81 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.766 179.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -117.03 124.95 50.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.569 0.223 . . . . 0.0 110.791 -179.655 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -115.0 131.55 56.89 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.106 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 31.2 ttm-85 -76.06 94.67 3.48 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.236 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.406 ' HB3' ' HA ' ' A' ' 49' ' ' HIS . 1.1 m -102.9 164.31 11.7 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.49 -178.725 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.635 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 39.1 mtt85 -145.5 149.42 34.62 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.008 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.702 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 9.3 tt -131.28 148.7 32.81 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.282 179.383 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.707 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 70.9 m-85 -92.54 102.53 14.98 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 122.277 -0.265 . . . . 0.0 111.293 -178.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.723 HD12 HD21 ' A' ' 129' ' ' LEU . 19.9 mt -67.49 -35.91 80.06 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.214 179.437 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.701 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 8.2 t70 -56.48 -10.1 0.87 Allowed 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.159 178.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.707 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 46.8 mt-10 -73.44 -48.67 31.84 Favored 'General case' 0 CA--C 1.509 -0.603 0 O-C-N 121.847 -0.533 . . . . 0.0 112.151 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -124.86 3.64 8.1 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.563 -177.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 45.6 mm -109.79 111.68 37.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.293 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.565 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -116.55 166.44 12.38 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.384 179.318 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.601 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -98.41 124.91 43.35 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.316 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -112.69 86.63 2.4 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.029 -179.678 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 56.9 t30 51.87 43.52 30.1 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.257 179.267 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.526 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 101.68 -3.79 53.34 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 119.985 -1.103 . . . . 0.0 114.063 178.659 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -122.38 128.67 51.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 117.062 0.431 . . . . 0.0 111.192 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.905 HD13 ' HD2' ' A' ' 7' ' ' PHE . 3.3 tp -70.6 129.23 38.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.158 -179.817 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 11.0 tp . . . . . 0 C--N 1.326 -0.431 0 CA-C-O 120.983 0.42 . . . . 0.0 111.297 -178.757 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.746 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 53.6 m-85 . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 120.695 0.283 . . . . 0.0 111.28 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.28 -34.83 10.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.321 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -69.55 -65.01 2.72 Favored Glycine 0 N--CA 1.435 -1.427 0 C-N-CA 119.594 -1.289 . . . . 0.0 112.907 -178.626 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 67.84 15.68 9.62 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 122.289 0.236 . . . . 0.0 110.906 -179.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.642 ' CE2' HD13 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -64.87 -33.4 75.93 Favored 'General case' 0 C--O 1.215 -0.717 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.189 -179.345 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.2 t -67.72 -7.73 29.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.104 0.478 . . . . 0.0 110.582 -179.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.1 -7.33 58.53 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.584 178.574 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.536 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 49.0 m -135.11 -28.18 1.19 Allowed 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 117.026 0.413 . . . . 0.0 111.387 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.5 m -84.51 145.7 27.97 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.375 0.607 . . . . 0.0 109.625 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -116.82 160.49 20.75 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.841 -179.06 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 45.73 55.24 7.01 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 123.245 0.618 . . . . 0.0 112.544 178.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.696 HG12 ' HB2' ' A' ' 23' ' ' ALA . 8.5 mt -80.22 103.62 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 120.8 0.333 . . . . 0.0 110.35 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.531 ' HA ' HD11 ' A' ' 129' ' ' LEU . 69.3 m -145.47 128.29 16.33 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.508 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.694 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -92.34 158.31 16.16 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.227 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -100.0 76.13 1.91 Allowed 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.248 -1.342 . . . . 0.0 107.626 177.338 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.98 -61.99 4.65 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 114.788 -1.097 . . . . 0.0 111.555 179.097 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.678 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -144.82 -2.64 0.82 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.367 -0.416 . . . . 0.0 110.221 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.472 ' HB3' ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -97.59 96.06 8.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.397 178.99 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.813 ' HB2' HD22 ' A' ' 39' ' ' LEU . 4.8 tp -60.33 117.12 4.83 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 123.39 0.676 . . . . 0.0 111.441 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.576 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 25.8 ttt180 -120.23 126.73 51.34 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.965 0.412 . . . . 0.0 110.845 -178.311 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.696 ' HB2' HG12 ' A' ' 14' ' ' ILE . . . -147.51 142.49 26.97 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.727 0.775 . . . . 0.0 111.32 -179.698 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 7.7 mm-40 -77.24 76.12 3.79 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.716 178.029 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.673 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 65.2 m -62.17 128.02 34.11 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.214 -178.852 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' A' ' 10' ' ' SER . 17.1 ttp180 -73.54 116.45 14.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.421 179.634 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -86.22 156.31 20.35 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.324 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.44 -14.96 3.73 Favored Glycine 0 C--N 1.338 0.68 0 O-C-N 124.631 1.207 . . . . 0.0 114.433 -177.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -73.15 -13.6 61.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.504 0.668 . . . . 0.0 109.617 178.16 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.92 6.65 59.12 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.569 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.42 164.78 12.4 Favored Glycine 0 C--O 1.225 -0.416 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.545 -179.156 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.52 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 84.3 m-85 -100.94 138.17 38.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.918 0.359 . . . . 0.0 110.83 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.1 m -126.89 126.91 44.08 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.102 179.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.9 m -65.26 116.12 6.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.065 0.46 . . . . 0.0 111.056 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 45.8 t -122.64 152.45 40.47 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.536 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.622 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 5.3 p -144.54 138.81 23.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.557 0.218 . . . . 0.0 111.04 -179.771 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.434 HG23 HD13 ' A' ' 39' ' ' LEU . 15.2 tt -133.12 148.58 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 120.929 0.395 . . . . 0.0 111.099 -178.725 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.71 95.43 5.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.969 -179.482 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.813 HD22 ' HB2' ' A' ' 21' ' ' LEU . 1.8 mp -75.48 -18.11 59.93 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 120.945 0.403 . . . . 0.0 111.023 178.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.678 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 27.8 p-10 -67.6 -7.4 26.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.423 179.785 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.1 mtt180 -114.22 14.66 18.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.146 179.445 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.635 ' HD1' ' HE3' ' A' ' 52' ' ' TRP . 0.2 OUTLIER -141.78 -23.31 0.71 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.097 -179.27 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.512 HD23 HD12 ' A' ' 151' ' ' ILE . 57.5 mt -110.07 131.55 54.96 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.474 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.529 ' HB3' ' HA2' ' A' ' 118' ' ' GLY . 0.5 OUTLIER -127.51 141.35 51.68 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.147 -179.12 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.573 ' OD1' HD23 ' A' ' 140' ' ' LEU . 12.3 m-20 -81.25 90.81 6.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.756 177.512 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -85.01 86.89 7.34 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.952 0.406 . . . . 0.0 110.389 177.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.538 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 16.6 t-20 50.85 45.8 26.92 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.272 179.25 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.628 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 83.02 40.13 9.57 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.183 179.012 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -155.13 121.32 5.22 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.723 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.722 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 25.8 m-85 -65.59 135.37 54.99 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.147 179.492 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 40.1 mmm-85 -136.64 141.32 43.19 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.856 0.36 . . . . 0.0 111.4 -179.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.717 ' HH2' HD13 ' A' ' 153' ' ' LEU . 92.6 m95 . . . . . 0 C--N 1.323 -0.566 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.919 178.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.449 -0.487 0 CA-C-O 120.947 0.403 . . . . 0.0 110.361 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.62 176.46 5.37 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.039 -179.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.444 ' HB ' ' CG2' ' A' ' 104' ' ' VAL . 4.5 p -129.18 116.43 19.18 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.74 0.305 . . . . 0.0 111.707 -178.831 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.446 HG21 ' CE1' ' A' ' 80' ' ' PHE . 14.5 p -104.57 139.53 25.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.922 0.392 . . . . 0.0 111.018 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 6.2 m -88.68 127.23 35.58 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.8 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.55 ' CG2' HD12 ' A' ' 99' ' ' ILE . 43.1 t -75.28 133.58 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.358 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -99.18 170.4 8.7 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 124.727 1.267 . . . . 0.0 110.32 -179.489 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.755 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 29.2 tp60 -61.05 110.4 1.35 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.227 -178.834 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.12 -12.27 58.79 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.493 178.384 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -81.77 129.49 34.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.93 0.395 . . . . 0.0 111.288 -179.435 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.571 ' HA ' HG12 ' A' ' 99' ' ' ILE . 67.4 p -109.2 178.11 4.55 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.774 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.544 HD21 ' O ' ' A' ' 95' ' ' ASN . 1.6 mm? -53.25 -41.89 65.92 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.444 0.64 . . . . 0.0 109.599 178.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -61.67 -41.49 97.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.105 -179.599 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 79' ' ' ARG . 24.3 m-20 -67.31 -43.59 81.27 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.773 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 72' ' ' THR . 37.2 mm -61.67 -48.2 89.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.147 179.586 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.604 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.74 -47.58 87.66 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.893 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.479 ' NE ' ' HA ' ' A' ' 78' ' ' ARG . 5.4 tpm_? -71.48 -29.91 65.37 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 122.47 -0.429 . . . . 0.0 111.601 -179.27 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 40.8 ttt180 -75.04 -39.39 61.03 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.106 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.446 ' CE1' HG21 ' A' ' 65' ' ' VAL . 97.1 m-85 -110.45 15.17 22.33 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.515 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.4 t70 56.33 53.79 8.38 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 122.025 0.917 . . . . 0.0 111.969 179.028 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.604 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -134.24 170.97 14.91 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.61 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.624 ' O ' HG13 ' A' ' 87' ' ' ILE . 5.5 t70 -97.38 123.0 41.07 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.428 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -49.6 -31.12 9.97 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 124.579 1.174 . . . . 0.0 111.327 179.263 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -63.42 -48.85 76.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.856 179.281 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.705 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 19.2 mm-40 -67.65 -43.5 80.17 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.363 -178.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.624 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.1 mt -53.61 -46.91 61.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.703 0.763 . . . . 0.0 108.948 179.005 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.6 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.21 -51.49 66.08 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.344 178.598 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -61.55 -33.43 73.83 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -177.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.705 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 15.9 mmp_? -68.26 -32.06 71.96 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.289 0.566 . . . . 0.0 110.041 179.275 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.793 HD21 HD11 ' A' ' 93' ' ' ILE . 65.1 t30 -91.28 -4.88 55.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.479 179.474 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 51.5 m-80 77.57 15.96 1.59 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.534 0.733 . . . . 0.0 110.7 -179.432 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.793 HD11 HD21 ' A' ' 91' ' ' ASN . 15.6 pt -105.16 -173.32 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.781 178.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -115.49 154.46 29.28 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.235 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.544 ' O ' HD21 ' A' ' 73' ' ' LEU . 2.5 p-10 -51.59 -63.3 1.18 Allowed 'General case' 0 C--O 1.244 0.77 0 CA-C-O 121.964 0.888 . . . . 0.0 110.176 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.18 13.5 0.9 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.143 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 8.4 t70 -66.16 -32.35 73.73 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.689 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 8.3 mp 70.46 113.97 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.956 -177.549 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.571 HG12 ' HA ' ' A' ' 72' ' ' THR . 7.4 pt -94.17 175.92 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.671 -178.337 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.504 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 96.6 m-85 -120.5 159.25 48.86 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.088 -178.731 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.755 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 50.9 Cg_endo -72.57 135.73 24.62 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.177 2.585 . . . . 0.0 112.425 -179.827 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.99 17.87 36.22 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.659 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.437 ' O ' ' HA ' ' A' ' 66' ' ' THR . 96.5 mt-30 -110.17 159.49 17.31 Favored 'General case' 0 C--O 1.209 -1.038 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.848 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.444 ' CG2' ' HB ' ' A' ' 64' ' ' THR . 8.4 p -116.46 131.24 69.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.553 0.692 . . . . 0.0 110.695 178.621 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.406 ' HB3' HG22 ' A' ' 87' ' ' ILE . 90.8 mt -121.38 151.02 40.63 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.573 -179.569 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.531 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 41.4 mt-30 -90.74 112.23 23.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.79 0.805 . . . . 0.0 110.917 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.8 m -120.74 151.28 54.23 Favored Pre-proline 0 C--N 1.315 -0.911 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.674 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -65.02 -17.95 60.73 Favored 'Trans proline' 0 C--N 1.332 -0.315 0 C-N-CA 123.147 2.565 . . . . 0.0 114.645 -177.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 C--N 1.323 -0.565 0 CA-C-O 120.869 0.366 . . . . 0.0 111.066 179.964 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.443 -0.84 0 N-CA-C 112.751 -0.14 . . . . 0.0 112.751 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 70.7 26.92 3.77 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.854 0.462 . . . . 0.0 111.35 179.168 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.556 ' HB2' ' OD1' ' A' ' 45' ' ' ASN . 20.2 p90 -57.12 -35.86 69.98 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 121.078 0.466 . . . . 0.0 110.325 179.219 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -59.13 -35.98 74.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.069 -178.194 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -66.56 -13.47 61.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.082 0.467 . . . . 0.0 111.386 -179.005 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.46 ' OG ' ' HB3' ' A' ' 141' ' ' ARG . 29.9 t -129.7 8.14 5.31 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.386 -179.71 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -104.35 149.35 25.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.073 0.464 . . . . 0.0 111.573 -179.489 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.523 ' HB2' ' CZ3' ' A' ' 146' ' ' TRP . 1.3 tmm_? -135.76 132.79 37.23 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.178 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 125' ' ' ARG . 34.6 t70 54.95 67.64 0.99 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.775 0.798 . . . . 0.0 110.693 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.498 ' CG1' HD13 ' A' ' 136' ' ' LEU . 42.0 t -84.68 126.66 40.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.86 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -144.04 141.12 29.92 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.229 -179.052 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.586 HD13 HG21 ' A' ' 14' ' ' ILE . 30.9 mt -86.55 125.31 33.69 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.637 HG23 ' HB ' ' A' ' 135' ' ' VAL . 35.6 m -118.6 161.2 17.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.691 -179.228 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.797 ' HB3' ' HE2' ' A' ' 134' ' ' LYS . 6.1 m-20 66.17 12.51 8.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.597 178.682 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.666 ' O ' HD11 ' A' ' 14' ' ' ILE . . . 90.75 28.43 16.14 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.395 178.413 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.635 ' HA3' HG22 ' A' ' 14' ' ' ILE . . . 93.13 -16.78 59.72 Favored Glycine 0 C--O 1.261 1.812 0 CA-C-O 123.378 1.543 . . . . 0.0 112.92 177.246 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.797 ' HE2' ' HB3' ' A' ' 131' ' ' ASP . 17.5 pttm -71.31 -12.57 61.51 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 121.348 -1.09 . . . . 0.0 109.283 177.964 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.637 ' HB ' HG23 ' A' ' 130' ' ' VAL . 18.3 t -142.31 139.34 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.27 177.433 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.507 HD22 HD11 ' A' ' 43' ' ' LEU . 48.9 tp -118.66 122.54 42.78 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.356 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.428 ' OE2' ' HD3' ' A' ' 148' ' ' ARG . 17.1 tt0 -118.51 130.59 56.01 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.986 0.422 . . . . 0.0 110.903 -176.539 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.441 ' HB1' ' HA ' ' A' ' 127' ' ' VAL . . . -156.49 166.24 33.97 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.186 -179.645 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 44.4 mt-10 -94.44 111.33 23.08 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.718 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.628 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 19.8 mt -98.17 132.14 43.94 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.325 -178.333 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.46 ' HB3' ' OG ' ' A' ' 123' ' ' SER . 72.2 ttt180 -73.98 141.23 45.88 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.601 179.667 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.538 ' HB2' ' OD1' ' A' ' 47' ' ' ASN . 1.4 p90 -157.65 -172.94 4.15 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.804 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.2 m -55.21 -31.95 61.85 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.211 0.319 . . . . 0.0 111.728 -179.539 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -93.41 15.29 63.32 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.253 -178.604 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 103.22 -110.99 3.83 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.293 179.664 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.523 ' CZ3' ' HB2' ' A' ' 125' ' ' ARG . 80.0 m95 -131.56 128.32 39.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.785 0.293 . . . . 0.0 110.706 -179.956 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -128.38 135.11 49.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.173 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.428 ' HD3' ' OE2' ' A' ' 137' ' ' GLU . 36.4 ttm180 -74.13 106.42 5.79 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.879 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 8.2 m -116.18 165.81 12.74 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.702 -178.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 15.2 ptt180 -147.0 164.78 31.91 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -178.55 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.722 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 8.3 tt -141.27 161.52 22.15 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.335 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.576 ' O ' ' HZ2' ' A' ' 52' ' ' TRP . 20.3 m-85 -104.58 104.36 14.18 Favored 'General case' 0 C--N 1.316 -0.868 0 O-C-N 122.307 -0.246 . . . . 0.0 110.699 -179.768 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.797 HD11 HG13 ' A' ' 157' ' ' ILE . 4.4 mm? -66.19 -36.19 82.43 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.218 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.407 ' OD1' ' HB3' ' A' ' 152' ' ' TYR . 16.6 p-10 -57.42 -9.85 1.21 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 179.035 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.746 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 32.9 mt-10 -71.93 -50.74 26.48 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 179.801 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -121.52 0.03 9.85 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.333 -0.547 . . . . 0.0 112.371 -177.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.797 HG13 HD11 ' A' ' 153' ' ' LEU . 45.1 mm -106.97 117.17 52.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.517 179.1 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.589 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -123.29 173.8 16.4 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.93 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.673 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.4 OUTLIER -106.13 126.45 52.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.987 0.423 . . . . 0.0 110.258 179.229 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.526 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 8.7 tpt180 -117.44 86.93 2.61 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.801 179.612 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 65.9 t30 55.26 40.65 31.65 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.463 178.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 105.61 -7.45 42.5 Favored Glycine 0 C--O 1.228 -0.25 0 C-N-CA 120.138 -1.029 . . . . 0.0 114.978 177.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 160' ' ' ARG . 13.2 pt-20 -122.04 141.44 51.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 117.936 0.868 . . . . 0.0 111.2 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.577 HD11 HD21 ' A' ' 21' ' ' LEU . 30.8 mt -74.98 122.22 23.16 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.867 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 6.5 tp . . . . . 0 C--N 1.323 -0.557 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.902 -179.533 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.845 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.612 ' HB2' ' ND2' ' A' ' 6' ' ' ASN . 22.4 m120 -88.07 -175.38 5.06 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.945 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 27.7 m-85 -96.51 -89.43 0.26 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.104 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.15 -30.62 4.61 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.045 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -70.82 -66.77 2.08 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 119.796 -1.192 . . . . 0.0 113.383 -178.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.612 ' ND2' ' HB2' ' A' ' 2' ' ' ASN . 16.1 m120 68.37 11.99 8.56 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.515 0.326 . . . . 0.0 110.677 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.637 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.9 OUTLIER -58.47 -35.93 72.94 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 121.076 -0.25 . . . . 0.0 111.135 -179.221 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.6 p -62.81 -19.52 64.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.388 0.613 . . . . 0.0 110.788 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.78 -22.05 78.63 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.801 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.491 ' HB3' ' HB3' ' A' ' 26' ' ' ARG . 67.4 m -132.67 -16.88 2.58 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 117.584 0.692 . . . . 0.0 111.877 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.483 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 19.4 m -94.81 133.86 38.06 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -111.38 179.87 3.91 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 41.77 48.32 3.7 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 124.089 0.868 . . . . 0.0 111.984 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.751 HG21 ' HA3' ' A' ' 133' ' ' GLY . 7.4 mt -80.6 104.14 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 109.695 -0.484 . . . . 0.0 109.695 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.556 ' HA ' HD13 ' A' ' 129' ' ' LEU . 78.0 m -146.57 127.06 14.09 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.705 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -95.66 155.7 16.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.718 0.77 . . . . 0.0 113.068 -179.122 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.422 ' HB2' HH22 ' A' ' 22' ' ' ARG . 31.0 t70 -94.28 75.63 3.96 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.428 177.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.7 -53.82 4.74 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.747 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.602 ' CB ' ' HB3' ' A' ' 40' ' ' ASN . . . -149.62 -10.8 0.3 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 120.781 0.324 . . . . 0.0 110.455 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -92.55 96.27 10.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.138 0.494 . . . . 0.0 110.814 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.781 HD21 HD11 ' A' ' 153' ' ' LEU . 45.4 tp -59.65 129.01 39.8 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.329 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.599 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 26.7 ttm180 -133.34 120.02 20.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.195 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.685 ' HB3' HG12 ' A' ' 14' ' ' ILE . . . -142.15 149.43 39.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.648 0.737 . . . . 0.0 112.053 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 63.3 mm-40 -83.65 75.46 10.05 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.365 -1.288 . . . . 0.0 108.873 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.845 ' SG ' HD12 ' A' ' 164' ' ' LEU . 56.0 m -62.96 124.24 20.59 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.86 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.491 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 16.2 ttm180 -76.51 118.01 18.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.736 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.605 ' HG2' ' HA3' ' A' ' 162' ' ' GLY . 10.7 mtm180 -84.1 163.96 19.5 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.76 -16.22 11.33 Favored Glycine 0 C--N 1.338 0.648 0 O-C-N 124.374 1.046 . . . . 0.0 113.387 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -72.39 -10.34 59.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.346 0.593 . . . . 0.0 109.819 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.48 13.98 64.48 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -114.2 162.29 12.45 Favored Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.208 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.492 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 61.5 m-85 -100.99 138.78 37.58 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.959 0.409 . . . . 0.0 111.138 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.8 m -132.5 132.21 42.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.589 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 m -69.39 110.44 4.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.185 0.517 . . . . 0.0 111.635 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.425 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 40.4 t -114.51 142.31 46.57 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.784 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.599 ' HB ' ' HG3' ' A' ' 22' ' ' ARG . 1.9 p -139.52 135.44 40.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.098 0.475 . . . . 0.0 111.35 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.489 HG22 ' HB3' ' A' ' 21' ' ' LEU . 12.3 tt -134.42 150.5 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.087 -177.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.497 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 2.7 m-20 -84.87 97.98 10.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.546 HD22 ' HB3' ' A' ' 21' ' ' LEU . 3.9 mm? -79.58 -8.93 59.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.242 0.544 . . . . 0.0 110.545 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.602 ' HB3' ' CB ' ' A' ' 19' ' ' ALA . 12.9 p30 -65.22 -15.75 62.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.766 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.536 ' HD3' ' O ' ' A' ' 114' ' ' GLY . 58.6 mtt85 -113.97 20.07 16.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.557 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -136.82 -31.7 0.84 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.346 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.586 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 48.3 mt -103.8 133.58 48.55 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.118 0.485 . . . . 0.0 110.044 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.704 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 6.1 m -122.31 146.78 46.98 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.306 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.419 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 8.1 p-10 -94.78 91.81 6.66 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.754 ' HB3' ' HD2' ' A' ' 51' ' ' ARG . 15.1 t70 -93.51 97.6 10.63 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.741 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.6 t30 53.2 46.96 25.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.396 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.536 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 75.44 29.37 60.04 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.957 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.575 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 70.5 m-70 -142.68 122.59 13.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.942 ' HB3' ' HB ' ' A' ' 151' ' ' ILE . 14.7 m-85 -62.5 126.12 26.27 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.754 ' HD2' ' HB3' ' A' ' 46' ' ' ASP . 54.3 mtt85 -143.98 137.71 27.92 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.344 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.446 ' CD1' HD13 ' A' ' 151' ' ' ILE . 86.6 m95 -73.45 110.91 8.1 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.7 t 65.29 -76.25 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.258 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.4 t -156.44 26.86 0.34 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.47 0.652 . . . . 0.0 109.409 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.8 -73.17 1.19 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.992 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -117.51 -52.57 0.33 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.158 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -173.61 -129.9 1.21 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.139 -0.553 . . . . 0.0 111.769 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.43 161.69 22.43 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.182 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.904 ' HA3' ' HB ' ' A' ' 109' ' ' THR . . . -164.32 -156.54 8.94 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.342 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 164.0 118.15 0.43 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.789 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.64 -143.44 17.83 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.896 -0.668 . . . . 0.0 111.808 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.6 m -141.26 114.31 8.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.151 0.501 . . . . 0.0 111.033 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 106' ' ' GLN . . . -124.59 177.15 6.09 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.112 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 p -129.46 120.18 25.01 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.474 HG21 ' CE1' ' A' ' 80' ' ' PHE . 7.9 p -107.05 147.39 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.565 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 13.4 m -95.37 124.87 39.62 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.554 ' CG2' HD12 ' A' ' 99' ' ' ILE . 47.9 t -73.99 133.13 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.362 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -99.16 170.2 8.85 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 124.384 1.052 . . . . 0.0 111.17 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.811 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 41.5 tt0 -61.48 119.63 8.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.645 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.55 18.78 51.23 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.67 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -110.36 148.02 32.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.15 0.475 . . . . 0.0 111.014 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.637 ' HA ' HG12 ' A' ' 99' ' ' ILE . 74.3 p -126.57 173.17 9.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.367 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.56 HD13 HD13 ' A' ' 93' ' ' ILE . 1.5 mm? -52.75 -43.03 65.49 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.539 0.685 . . . . 0.0 109.701 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.457 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 65.1 mtp180 -61.8 -38.26 87.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.744 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -72.9 -41.01 65.07 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.537 HG12 ' O ' ' A' ' 72' ' ' THR . 42.8 mm -62.71 -47.98 90.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.731 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -55.49 -50.38 60.42 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.213 178.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.13 -36.74 84.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.754 0.312 . . . . 0.0 111.432 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -70.32 -42.82 71.45 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.65 ' HB2' ' HG ' ' A' ' 82' ' ' CYS . 97.5 m-85 -105.08 18.72 21.87 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.5 t70 52.94 39.08 28.65 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.681 0.753 . . . . 0.0 111.528 178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.731 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 3.4 p -116.86 170.88 8.28 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.218 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.65 ' O ' HG13 ' A' ' 87' ' ' ILE . 6.1 t70 -96.06 124.4 40.05 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.031 -0.667 . . . . 0.0 110.199 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.457 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 5.7 p90 -52.29 -29.49 23.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.512 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -68.86 -43.22 75.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.425 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.666 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 14.0 tp10 -65.31 -45.56 83.85 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.65 HG13 ' O ' ' A' ' 83' ' ' ASP . 4.8 mt -54.97 -46.42 76.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.18 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.585 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.01 -50.01 72.37 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.889 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.427 ' HA ' ' NE ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -55.61 -39.67 71.09 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.666 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 10.9 mmt180 -69.91 -30.98 68.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.688 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.705 HD21 HD11 ' A' ' 93' ' ' ILE . 66.1 t30 -95.39 -3.85 46.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.154 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 50.4 m-80 74.9 17.82 2.72 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.935 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.705 HD11 HD21 ' A' ' 91' ' ' ASN . 14.3 pt -105.55 -179.77 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.538 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 2.3 mp0 -104.69 161.52 14.07 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.496 ' O ' HD21 ' A' ' 73' ' ' LEU . 15.9 p-10 -60.33 -59.65 5.06 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 122.027 0.917 . . . . 0.0 109.284 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -75.78 12.28 1.12 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.602 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 3.8 t70 -63.62 -35.62 81.11 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 9.5 mp 72.17 117.16 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 O-C-N 124.193 0.933 . . . . 0.0 109.313 -176.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.637 HG12 ' HA ' ' A' ' 72' ' ' THR . 7.5 pt -95.72 178.97 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.918 -178.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.441 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 91.3 m-85 -124.35 157.6 64.16 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.751 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.811 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 53.6 Cg_endo -72.4 131.93 18.39 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 123.198 2.598 . . . . 0.0 113.044 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.42 18.96 24.54 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 66' ' ' THR . 33.9 tt0 -105.79 158.71 16.54 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 83.0 t -119.21 118.75 58.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 109.722 -0.474 . . . . 0.0 109.722 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.543 HD12 HG23 ' A' ' 99' ' ' ILE . 94.9 mt -112.52 150.55 31.12 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.035 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.599 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 40.8 mt-30 -90.56 111.74 23.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.781 0.8 . . . . 0.0 110.964 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.0 m -119.55 151.23 51.41 Favored Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.608 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.45 -16.13 53.49 Favored 'Trans proline' 0 N--CA 1.475 0.389 0 C-N-CA 123.542 2.828 . . . . 0.0 114.975 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.904 ' HB ' ' HA3' ' A' ' 59' ' ' GLY . 6.6 t -153.15 152.68 31.54 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.01 0.433 . . . . 0.0 111.39 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -97.55 -176.57 3.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.0 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -86.08 -45.09 5.76 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.352 -0.928 . . . . 0.0 111.45 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.06 179.16 35.88 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.986 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 51.0 m -152.36 -47.2 0.1 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.909 0.385 . . . . 0.0 110.291 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.536 ' O ' ' HD3' ' A' ' 41' ' ' ARG . . . 166.1 49.7 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.239 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -143.16 91.39 0.17 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.799 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.45 60.22 2.88 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.467 ' HB1' ' O ' ' A' ' 41' ' ' ARG . . . -123.36 -28.62 3.93 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.38 -0.41 . . . . 0.0 111.735 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.704 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -109.0 -84.61 1.61 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.121 -1.038 . . . . 0.0 113.18 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 15.5 m120 75.25 24.39 1.44 Allowed 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.457 0.703 . . . . 0.0 112.099 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.586 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 23.8 p90 -59.62 -40.19 86.74 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.069 0.461 . . . . 0.0 110.019 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.441 ' HA ' ' HB1' ' A' ' 124' ' ' ALA . 66.0 t-105 -56.69 -34.58 67.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.386 -178.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -57.03 -25.81 59.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.86 0.362 . . . . 0.0 111.028 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.757 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 9.7 m -132.01 25.45 4.61 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.477 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.441 ' HB1' ' HA ' ' A' ' 121' ' ' TRP . . . -115.89 139.87 49.79 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 120.98 0.419 . . . . 0.0 110.816 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.442 ' HA ' ' HD3' ' A' ' 125' ' ' ARG . 17.8 mmt180 -128.98 146.72 50.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.486 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.7 t70 51.35 59.31 4.69 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 124.014 0.821 . . . . 0.0 110.745 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.481 HG11 HD12 ' A' ' 136' ' ' LEU . 35.1 t -82.78 124.65 39.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.598 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -145.66 144.01 30.16 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.07 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.556 HD13 ' HA ' ' A' ' 15' ' ' CYS . 21.3 mt -86.25 138.85 31.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.29 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.631 HG21 ' HB ' ' A' ' 135' ' ' VAL . 34.4 m -132.6 157.56 43.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.92 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.441 ' O ' ' HG2' ' A' ' 134' ' ' LYS . 0.7 OUTLIER 65.37 18.08 11.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.387 178.578 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.727 ' O ' HD13 ' A' ' 14' ' ' ILE . . . 90.42 30.46 12.09 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.222 -0.99 . . . . 0.0 113.829 178.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.751 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 86.69 -9.87 69.73 Favored Glycine 0 C--O 1.261 1.832 0 CA-C-O 123.011 1.339 . . . . 0.0 113.213 176.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.708 ' HG3' HG21 ' A' ' 135' ' ' VAL . 8.4 ptpp? -74.18 -17.4 60.91 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.708 HG21 ' HG3' ' A' ' 134' ' ' LYS . 22.8 t -137.79 143.13 34.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.782 177.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.661 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 34.1 tp -126.24 119.15 26.7 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.489 ' OE2' ' HD3' ' A' ' 148' ' ' ARG . 16.2 tt0 -112.15 138.26 49.08 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.76 0.314 . . . . 0.0 111.357 -176.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . . . -162.86 167.04 23.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.988 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -94.36 106.17 18.14 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.536 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 67.0 mt -96.96 130.5 44.26 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.268 0.556 . . . . 0.0 111.567 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.757 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 74.4 ttt180 -73.28 141.32 47.19 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.128 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.51 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 2.0 p90 -159.06 -169.94 2.84 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 121.081 -0.247 . . . . 0.0 111.352 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.7 m -56.01 -29.65 60.67 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -101.14 27.16 21.87 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.243 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 93.68 -111.1 4.07 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.363 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -128.88 133.32 47.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.717 0.258 . . . . 0.0 110.339 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.51 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 54.0 t30 -133.01 141.42 48.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.712 0.291 . . . . 0.0 110.497 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.489 ' HD3' ' OE2' ' A' ' 137' ' ' GLU . 24.9 ttm180 -79.6 114.73 18.75 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.921 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.575 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 36.2 t -125.78 168.26 14.05 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.698 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.661 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -146.73 163.05 37.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.082 0.468 . . . . 0.0 111.978 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.942 ' HB ' ' HB3' ' A' ' 50' ' ' PHE . 9.0 tt -145.47 152.9 14.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.302 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.654 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 15.1 m-85 -93.32 105.84 17.87 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.781 HD11 HD21 ' A' ' 21' ' ' LEU . 22.2 mt -67.25 -34.09 76.7 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.243 178.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.455 ' HA ' ' CD1' ' A' ' 7' ' ' PHE . 1.9 p-10 -57.41 -11.93 2.22 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.908 178.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.945 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 36.5 mt-10 -62.3 -55.27 29.84 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.106 0.479 . . . . 0.0 111.938 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -118.34 -12.13 9.94 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.959 -0.697 . . . . 0.0 111.828 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.435 ' CG2' ' HG ' ' A' ' 164' ' ' LEU . 49.6 mm -87.2 108.84 18.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.298 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -115.25 154.86 16.7 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.562 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.536 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.0 t30 -94.47 113.68 25.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.107 0.479 . . . . 0.0 109.891 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 160' ' ' ARG . 15.2 tpt180 -110.97 86.72 2.37 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.92 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.0 t30 55.17 55.9 7.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.368 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.605 ' HA3' ' HG2' ' A' ' 27' ' ' ARG . . . 79.99 7.63 88.35 Favored Glycine 0 C--O 1.228 -0.231 0 CA-C-N 115.509 -0.769 . . . . 0.0 113.781 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -123.47 125.16 44.41 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.855 0.359 . . . . 0.0 111.397 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.845 HD12 ' SG ' ' A' ' 25' ' ' CYS . 0.2 OUTLIER -73.87 112.09 9.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.591 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 47.9 mm -118.95 140.08 44.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.166 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -91.18 134.48 34.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.29 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 4.6 p . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.12 178.923 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.627 ' HA3' ' OD1' ' A' ' 6' ' ' ASN . . . . . . . . 0 N--CA 1.482 1.735 0 N-CA-C 111.699 -0.56 . . . . 0.0 111.699 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.825 HD21 ' HG2' ' A' ' 155' ' ' GLU . 5.5 t30 -86.82 -69.93 0.64 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.766 0.317 . . . . 0.0 111.296 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -126.74 -94.05 0.47 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.75 -26.66 12.18 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.22 -72.63 0.64 Allowed Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 119.66 -1.257 . . . . 0.0 112.61 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.627 ' OD1' ' HA3' ' A' ' 1' ' ' GLY . 39.1 m-80 64.53 14.43 8.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.615 0.245 . . . . 0.0 110.677 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.564 ' CE2' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -64.05 -32.5 74.07 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.994 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.5 t -70.7 -11.1 60.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.359 0.6 . . . . 0.0 109.728 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.58 -16.92 72.13 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.418 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.455 ' HB2' ' HB3' ' A' ' 26' ' ' ARG . 33.3 p -137.21 -11.27 1.68 Allowed 'General case' 0 C--O 1.221 -0.419 0 O-C-N 122.507 -0.408 . . . . 0.0 111.928 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 12.1 m -105.18 132.53 51.28 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.535 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 25.1 ptt180 -108.89 -176.77 3.13 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 44.28 42.3 5.08 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 123.913 0.758 . . . . 0.0 112.058 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.736 HG21 ' HA3' ' A' ' 133' ' ' GLY . 5.6 mt -80.2 100.97 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 121.108 0.48 . . . . 0.0 110.889 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.537 ' HA ' HD13 ' A' ' 129' ' ' LEU . 71.7 m -147.82 127.13 13.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.515 -0.766 . . . . 0.0 108.984 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.701 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -92.57 158.36 16.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.676 0.75 . . . . 0.0 112.782 -179.046 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -96.13 74.31 2.98 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.18 -55.41 5.03 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.226 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.448 ' HB1' ' HB2' ' A' ' 40' ' ' ASN . . . -148.67 -12.42 0.34 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -85.89 92.37 8.63 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.798 HD22 HD21 ' A' ' 153' ' ' LEU . 43.2 tp -58.87 125.2 22.57 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.548 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 2.3 ttt180 -133.08 122.64 24.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.14 0.495 . . . . 0.0 110.703 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.615 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -138.83 176.24 8.86 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.243 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.535 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 6.2 mt-10 -115.61 80.07 1.38 Allowed 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.587 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 55.6 m -64.77 126.69 28.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.691 -178.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 10' ' ' SER . 43.5 ttt-85 -74.73 114.68 13.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.676 178.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.6 ttm180 -82.57 154.9 24.76 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -48.75 -22.47 2.82 Favored Glycine 0 C--N 1.332 0.325 0 O-C-N 124.633 1.208 . . . . 0.0 115.115 -177.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -72.48 -14.41 61.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.509 0.671 . . . . 0.0 110.574 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.31 7.78 53.97 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -102.74 147.44 17.03 Favored Glycine 0 C--O 1.225 -0.445 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.511 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.437 ' HD1' ' O ' ' A' ' 24' ' ' GLU . 84.4 m-85 -96.57 124.63 40.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.02 0.41 . . . . 0.0 110.318 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.9 m -117.01 126.44 52.89 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.339 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.3 m -67.09 126.25 28.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.253 0.549 . . . . 0.0 110.245 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 46.8 t -129.86 152.69 49.06 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.763 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 5.3 p -144.12 133.77 19.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.044 0.45 . . . . 0.0 111.171 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.451 HG23 ' HB3' ' A' ' 21' ' ' LEU . 11.2 tt -135.07 153.53 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.226 -178.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -82.97 111.6 18.98 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 122.041 -0.412 . . . . 0.0 111.157 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.517 HD23 ' HB3' ' A' ' 21' ' ' LEU . 2.0 mm? -88.83 -2.0 58.37 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.448 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 66.9 t30 -74.78 -14.73 60.74 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.747 ' HD3' ' HA2' ' A' ' 115' ' ' GLY . 50.9 mtm180 -107.18 17.25 23.17 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.296 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.433 ' HB2' HD11 ' A' ' 39' ' ' LEU . 39.8 m-85 -134.01 -33.86 1.02 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.339 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.577 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 35.8 mt -105.73 137.18 44.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.926 0.394 . . . . 0.0 111.624 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.657 ' HG ' ' HA2' ' A' ' 118' ' ' GLY . 5.9 m -129.94 140.76 50.88 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.677 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.804 ' CB ' ' HG ' ' A' ' 140' ' ' LEU . 21.2 p-10 -80.71 93.79 6.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.36 0.6 . . . . 0.0 110.542 178.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -92.78 91.24 7.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.981 0.42 . . . . 0.0 111.065 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.9 t30 51.86 45.23 28.58 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.361 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.35 34.4 29.26 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.728 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.653 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 32.8 t60 -155.35 122.0 5.33 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.724 ' HZ ' ' HB1' ' A' ' 138' ' ' ALA . 55.3 m-85 -58.44 143.98 43.65 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.93 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.647 ' HA ' ' NE ' ' A' ' 51' ' ' ARG . 4.4 mmp_? -146.14 134.26 21.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.449 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.8 ' HZ2' ' HA ' ' A' ' 153' ' ' LEU . 95.0 m95 -77.38 114.24 16.01 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.107 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.5 t -129.58 85.06 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.8 m -81.61 60.79 4.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.983 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.57 38.22 94.46 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.959 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.53 142.39 48.26 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.442 -0.408 . . . . 0.0 112.3 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.873 ' HA3' ' HB1' ' A' ' 63' ' ' ALA . . . 77.4 62.26 2.46 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.767 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -127.1 90.37 0.35 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.732 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.8 10.81 66.5 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.437 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.5 169.65 20.78 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.424 -0.893 . . . . 0.0 112.75 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.33 -143.56 16.6 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.069 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.2 m -134.17 126.65 30.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.95 0.405 . . . . 0.0 110.081 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.873 ' HB1' ' HA3' ' A' ' 57' ' ' GLY . . . -132.3 177.16 7.79 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.203 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.44 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 8.9 p -130.32 119.73 23.27 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.404 HG23 ' CE1' ' A' ' 80' ' ' PHE . 8.2 p -109.48 140.51 27.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.685 0.278 . . . . 0.0 110.623 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 7.1 m -88.27 131.1 34.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.246 0.546 . . . . 0.0 110.28 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.489 ' CG2' HD12 ' A' ' 99' ' ' ILE . 43.0 t -81.1 134.93 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.9 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.58 HE21 ' HA ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -108.8 170.61 7.93 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 124.1 0.875 . . . . 0.0 109.939 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.655 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 34.7 tt0 -65.12 120.13 12.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.834 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.67 -7.19 45.52 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.879 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -95.04 148.15 22.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.331 0.586 . . . . 0.0 112.029 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.605 ' HA ' HG12 ' A' ' 99' ' ' ILE . 74.5 p -133.38 170.75 15.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 99' ' ' ILE . 1.1 mm? -52.18 -45.9 65.32 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.899 0.772 . . . . 0.0 109.453 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -57.49 -38.64 74.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.367 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.66 -43.74 46.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.594 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 72' ' ' THR . 43.5 mm -59.83 -46.55 93.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.885 0.374 . . . . 0.0 110.059 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.642 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.86 -51.73 56.39 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.555 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -66.85 -30.81 71.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.025 0.44 . . . . 0.0 111.43 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -70.12 -46.82 63.99 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.404 ' CE1' HG23 ' A' ' 65' ' ' VAL . 89.7 m-85 -103.59 12.62 34.72 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.0 t0 60.21 57.88 2.8 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.96 0.886 . . . . 0.0 110.812 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.642 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -140.02 164.88 28.85 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.065 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.677 ' O ' HG13 ' A' ' 87' ' ' ILE . 6.8 m-20 -83.05 114.95 21.64 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.622 ' HD1' ' HB2' ' A' ' 95' ' ' ASN . 10.6 p90 -54.57 -31.53 56.86 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.724 0.64 . . . . 0.0 111.142 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.512 ' HA ' ' HB3' ' A' ' 95' ' ' ASN . 51.0 t-80 -71.86 -36.03 70.01 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.719 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.592 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 9.9 tp10 -68.77 -47.0 67.3 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.677 HG13 ' O ' ' A' ' 83' ' ' ASP . 7.1 mt -51.91 -47.94 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.017 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.589 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.83 -50.92 69.05 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.345 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -56.8 -39.79 74.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.934 0.397 . . . . 0.0 111.418 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.592 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 21.7 mmt180 -70.17 -31.07 68.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.108 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.508 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 17.5 t-20 -90.74 -6.04 54.93 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.985 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.508 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 93.0 m-20 79.5 17.75 0.8 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.524 0.73 . . . . 0.0 111.089 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.589 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 14.5 pt -110.68 -173.17 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.585 178.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.526 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 52.5 mt-30 -115.1 154.42 28.94 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.622 ' HB2' ' HD1' ' A' ' 84' ' ' PHE . 6.9 p-10 -56.6 -55.1 38.25 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 122.199 1.0 . . . . 0.0 109.329 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -78.52 12.92 1.78 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.091 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.526 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 0.7 OUTLIER -70.96 -29.96 66.1 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.093 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 9.6 mp 69.88 114.61 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 O-C-N 124.266 0.979 . . . . 0.0 110.433 -177.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.605 HG12 ' HA ' ' A' ' 72' ' ' THR . 9.5 pt -94.63 176.03 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 114.81 -1.087 . . . . 0.0 111.338 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.543 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 90.5 m-85 -130.71 160.03 68.28 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.941 -178.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.655 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 20.1 Cg_endo -66.05 135.28 40.03 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.299 2.666 . . . . 0.0 114.048 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.73 23.38 18.5 Favored Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.397 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.512 ' O ' ' HA ' ' A' ' 66' ' ' THR . 46.1 mt-30 -111.88 165.35 12.16 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 120.574 -0.45 . . . . 0.0 109.837 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.44 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 65.6 t -125.45 115.73 44.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.477 ' HB3' HG21 ' A' ' 87' ' ' ILE . 81.7 mt -108.19 150.87 26.69 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.711 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -90.62 115.41 27.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.394 0.616 . . . . 0.0 110.613 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.0 m -120.37 150.5 51.95 Favored Pre-proline 0 C--N 1.311 -1.08 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.388 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.93 -19.28 58.27 Favored 'Trans proline' 0 C--N 1.332 -0.304 0 C-N-CA 123.195 2.597 . . . . 0.0 113.96 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.7 t -152.53 147.61 26.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.356 0.598 . . . . 0.0 111.351 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.47 ' HG2' ' CB ' ' A' ' 63' ' ' ALA . 13.8 mmmm -99.34 -169.84 1.82 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.965 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.91 -48.57 74.94 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 65.42 35.57 91.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.378 -0.439 . . . . 0.0 113.467 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.9 m -73.1 -37.12 66.84 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.955 0.407 . . . . 0.0 110.184 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 127.14 -67.96 0.54 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.732 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.747 ' HA2' ' HD3' ' A' ' 41' ' ' ARG . . . -78.72 68.49 3.01 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.62 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 159.27 71.51 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.924 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -114.74 -34.28 5.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.288 0.566 . . . . 0.0 109.605 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.657 ' HA2' ' HG ' ' A' ' 44' ' ' SER . . . -103.36 -76.09 1.11 Allowed Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.088 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 21.6 m120 75.24 27.16 1.12 Allowed 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.751 0.82 . . . . 0.0 112.476 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.577 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 18.8 p90 -63.46 -39.29 94.07 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.484 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 63.7 t-105 -61.94 -31.44 71.77 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.133 -178.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -58.75 -16.22 15.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 111.27 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.673 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 36.3 m -145.75 30.55 1.08 Allowed 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.164 177.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.484 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -110.38 136.47 49.49 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.595 177.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.4 tmm_? -125.03 137.04 54.23 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.61 57.99 3.52 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.625 0.578 . . . . 0.0 111.164 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.504 ' HA ' ' HB3' ' A' ' 138' ' ' ALA . 34.6 t -85.53 124.96 40.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.114 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.477 ' O ' HD11 ' A' ' 136' ' ' LEU . 38.7 ptt180 -148.98 142.97 25.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.956 0.408 . . . . 0.0 111.143 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.724 HD11 ' CD1' ' A' ' 21' ' ' LEU . 23.1 mt -85.09 131.97 34.38 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.726 HG23 ' HB ' ' A' ' 135' ' ' VAL . 28.9 m -125.28 158.98 33.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.712 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.667 ' HB3' ' CG ' ' A' ' 134' ' ' LYS . 0.2 OUTLIER 68.55 11.13 8.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.152 179.52 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.654 ' O ' HD13 ' A' ' 14' ' ' ILE . . . 91.28 31.33 9.77 Favored Glycine 0 N--CA 1.437 -1.251 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.092 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.736 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 93.25 -14.91 64.17 Favored Glycine 0 C--O 1.265 2.062 0 CA-C-O 123.005 1.336 . . . . 0.0 113.627 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.667 ' CG ' ' HB3' ' A' ' 131' ' ' ASP . 7.8 ptpp? -72.99 -15.63 61.53 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 121.241 -1.153 . . . . 0.0 109.024 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.726 ' HB ' HG23 ' A' ' 130' ' ' VAL . 12.0 t -139.27 147.37 24.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.718 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 47.9 tp -128.95 123.14 31.73 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -112.46 130.94 55.82 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 123.273 0.358 . . . . 0.0 110.772 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.724 ' HB1' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.72 161.6 26.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.188 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.633 ' HG2' ' HG3' ' A' ' 148' ' ' ARG . 39.3 mt-10 -98.0 106.17 18.43 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.628 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.804 ' HG ' ' CB ' ' A' ' 45' ' ' ASN . 0.5 OUTLIER -89.71 126.03 35.5 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.852 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.673 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 52.3 ttt-85 -69.97 140.38 52.97 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.647 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.647 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 2.9 p90 -151.6 -164.94 2.11 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.148 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.3 t -59.78 -25.61 65.05 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -107.65 28.88 11.29 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.591 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 96.46 -114.45 4.94 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.485 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -125.27 129.38 49.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.78 0.29 . . . . 0.0 110.666 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.647 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 22.9 t-20 -123.56 132.87 54.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.711 0.291 . . . . 0.0 111.114 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.633 ' HG3' ' HG2' ' A' ' 139' ' ' GLU . 38.2 mtp85 -74.86 113.18 11.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.533 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.653 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 33.7 t -128.9 165.53 20.88 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.047 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.56 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 19.4 ptt180 -147.74 148.69 31.25 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.138 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.724 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 11.6 tt -130.68 161.67 40.15 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.428 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.537 ' O ' ' HG3' ' A' ' 155' ' ' GLU . 14.6 m-85 -104.88 105.46 15.53 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 122.265 -0.272 . . . . 0.0 110.991 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.8 ' HA ' ' HZ2' ' A' ' 52' ' ' TRP . 9.9 mp -69.27 -31.62 70.25 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.502 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.556 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 11.1 t70 -58.99 -7.84 1.21 Allowed 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.932 178.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.825 ' HG2' HD21 ' A' ' 2' ' ' ASN . 37.0 mt-10 -72.73 -51.78 17.81 Favored 'General case' 0 CA--C 1.508 -0.635 0 O-C-N 121.862 -0.523 . . . . 0.0 112.31 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.52 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 53.8 m-70 -122.55 2.22 9.57 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.126 -177.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.423 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 46.2 mm -106.26 110.44 31.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.431 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.466 ' HA3' ' OXT' ' A' ' 167' ' ' CYS . . . -113.43 168.77 12.68 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.28 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.587 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 1.6 t30 -100.83 119.8 39.19 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.654 ' HD3' HD13 ' A' ' 165' ' ' ILE . 58.5 ttt180 -115.12 88.68 2.92 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.807 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 17.8 m120 59.55 34.7 22.49 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.937 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.58 -4.55 43.34 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.023 -1.084 . . . . 0.0 114.243 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' A' ' 160' ' ' ARG . 14.4 pt-20 -122.02 139.79 53.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.683 0.742 . . . . 0.0 110.9 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.401 ' CD2' ' HD2' ' A' ' 7' ' ' PHE . 76.0 mt -76.23 115.12 15.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.386 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.654 HD13 ' HD3' ' A' ' 160' ' ' ARG . 47.7 mt -141.08 146.71 23.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.953 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.52 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 14.0 p80 -56.66 124.32 17.95 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.466 ' OXT' ' HA3' ' A' ' 158' ' ' GLY . 42.6 t . . . . . 0 C--O 1.254 1.294 0 O-C-N 123.958 0.786 . . . . 0.0 110.987 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -89.78 179.54 5.98 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.678 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 33.9 m-85 -121.94 -89.12 0.61 Allowed 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.488 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.39 -26.99 6.51 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -76.09 -67.85 1.63 Allowed Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 119.069 -1.539 . . . . 0.0 112.363 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 63.94 15.01 8.84 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 122.973 0.509 . . . . 0.0 110.71 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.674 ' CE2' HD13 ' A' ' 14' ' ' ILE . 2.1 p90 -56.4 -37.23 69.85 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.533 ' HA ' HD12 ' A' ' 14' ' ' ILE . 3.9 m -60.2 -23.05 63.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.841 0.353 . . . . 0.0 111.745 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.19 -21.66 77.2 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.974 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 33.2 p -125.19 -24.88 3.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.12 0.486 . . . . 0.0 111.321 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.2 m -94.64 131.63 40.22 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.815 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 12' ' ' ARG . 10.5 ptm180 -113.4 -179.54 3.67 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 47.53 44.65 17.12 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 123.832 0.708 . . . . 0.0 111.41 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.784 HG22 ' HA3' ' A' ' 133' ' ' GLY . 7.2 mt -80.22 103.25 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-O 121.039 0.447 . . . . 0.0 110.425 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.571 ' O ' ' HB3' ' A' ' 22' ' ' ARG . 72.0 m -146.95 127.5 14.15 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.792 HD21 HD12 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -91.91 157.99 16.53 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.086 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -97.24 76.08 2.6 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 113.958 -1.474 . . . . 0.0 107.815 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.44 -58.92 5.01 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.994 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.504 ' HB2' ' HB3' ' A' ' 40' ' ' ASN . . . -148.66 -6.45 0.4 Allowed 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -97.81 98.03 9.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.117 0.484 . . . . 0.0 110.382 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.875 ' HB2' HD21 ' A' ' 39' ' ' LEU . 42.9 tp -54.25 129.88 36.74 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 114.871 -1.058 . . . . 0.0 112.489 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.571 ' HB3' ' O ' ' A' ' 15' ' ' CYS . 16.2 ttp180 -132.62 124.1 27.67 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.601 -0.439 . . . . 0.0 110.089 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.633 ' HB3' HG12 ' A' ' 14' ' ' ILE . . . -147.23 144.43 28.89 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.663 0.744 . . . . 0.0 111.682 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.601 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 2.3 mm-40 -79.27 75.66 5.84 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.882 178.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.566 ' HB2' ' HA2' ' A' ' 162' ' ' GLY . 46.2 m -62.43 124.57 21.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.49 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' A' ' 10' ' ' SER . 58.6 ttp180 -68.92 119.92 14.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.336 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -90.27 153.5 20.42 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.93 -13.07 4.23 Favored Glycine 0 C--N 1.33 0.232 0 O-C-N 124.443 1.09 . . . . 0.0 115.005 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -83.52 -2.91 57.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.978 0.418 . . . . 0.0 110.554 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.59 10.99 66.79 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -112.4 145.29 18.02 Favored Glycine 0 C--O 1.226 -0.387 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.408 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.601 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 69.4 m-85 -89.35 133.36 34.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.878 0.339 . . . . 0.0 110.433 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.8 m -115.16 124.75 52.28 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.307 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.0 m -68.31 107.42 2.82 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.09 0.472 . . . . 0.0 109.938 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 48.0 t -113.18 152.58 29.53 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.062 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.639 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.2 p -145.13 130.61 13.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.097 0.475 . . . . 0.0 110.757 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.3 tt -130.11 143.23 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.676 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.15 101.37 3.92 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.71 0.29 . . . . 0.0 111.572 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.875 HD21 ' HB2' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -82.44 -9.78 59.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.079 0.466 . . . . 0.0 110.301 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 2.1 p-10 -62.59 -18.13 61.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.215 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.575 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 18.1 ptt180 -112.63 20.7 16.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.303 0.573 . . . . 0.0 110.179 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 27.4 m-85 -131.34 -33.35 1.48 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.001 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.586 HD22 HG22 ' A' ' 151' ' ' ILE . 50.3 mt -106.25 135.01 48.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.689 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.622 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 3.3 m -126.34 138.15 53.54 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.033 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.888 ' CB ' ' HG ' ' A' ' 140' ' ' LEU . 16.1 p-10 -86.75 102.14 13.96 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.524 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.452 ' CB ' ' HD3' ' A' ' 51' ' ' ARG . 17.1 t70 -107.05 93.2 4.42 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.083 0.468 . . . . 0.0 110.507 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.7 t30 55.99 43.15 27.69 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.096 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 149' ' ' SER . . . 83.06 27.36 41.03 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.697 -0.764 . . . . 0.0 113.649 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.45 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 69.9 m-70 -144.47 139.06 28.06 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.968 ' HZ ' ' HB3' ' A' ' 138' ' ' ALA . 49.8 m-85 -80.88 144.25 32.11 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.206 0.527 . . . . 0.0 111.892 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.452 ' HD3' ' CB ' ' A' ' 46' ' ' ASP . 26.6 mtp180 -146.6 132.82 19.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.711 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.64 ' HZ2' ' HA ' ' A' ' 153' ' ' LEU . 97.2 m95 -73.83 133.1 43.15 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.315 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.509 HG23 ' HD3' ' A' ' 79' ' ' ARG . 14.8 m 30.45 62.09 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.871 1.269 . . . . 0.0 113.603 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.8 m -106.84 20.85 18.43 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.084 0.469 . . . . 0.0 110.818 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.15 -36.22 60.37 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.467 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.66 175.65 14.27 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.506 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -136.43 -98.92 0.54 Allowed Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.46 131.2 7.12 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.521 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.786 ' HA3' ' HB ' ' A' ' 109' ' ' THR . . . -169.86 -171.2 35.17 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.798 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -158.83 52.68 0.39 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.253 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.95 -137.17 2.3 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.383 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 55.3 m -140.92 117.35 10.78 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.077 0.465 . . . . 0.0 110.732 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.488 ' HB3' ' HG2' ' A' ' 110' ' ' LYS . . . -133.89 176.59 8.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.642 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.505 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 20.7 p -129.62 122.58 29.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.885 0.374 . . . . 0.0 111.124 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.472 HG23 ' CE2' ' A' ' 80' ' ' PHE . 10.8 p -108.22 139.79 29.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.838 0.352 . . . . 0.0 111.46 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.0 m -91.62 125.64 36.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.242 0.544 . . . . 0.0 109.648 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.826 HG21 HD13 ' A' ' 99' ' ' ILE . 86.6 t -84.06 131.14 34.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.341 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -106.1 169.46 8.49 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 124.059 0.849 . . . . 0.0 110.688 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.671 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 33.0 tt0 -55.65 117.67 3.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.295 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.36 4.89 40.52 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.34 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.418 ' HB2' HG11 ' A' ' 67' ' ' VAL . 95.3 m-20 -109.75 138.44 46.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.065 0.46 . . . . 0.0 111.939 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.677 ' HA ' HG12 ' A' ' 99' ' ' ILE . 68.6 p -122.84 173.99 7.42 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.652 HD21 HG21 ' A' ' 99' ' ' ILE . 0.7 OUTLIER -51.34 -43.06 61.66 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.525 0.602 . . . . 0.0 110.372 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -62.07 -35.89 79.99 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.883 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -73.89 -40.63 63.06 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 72' ' ' THR . 46.1 mm -63.14 -49.25 84.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.688 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -59.31 -52.57 52.46 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.652 -0.704 . . . . 0.0 113.539 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -64.5 -25.59 68.06 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.509 ' HD3' HG23 ' A' ' 53' ' ' VAL . 40.2 ttm180 -81.57 -49.5 10.47 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.561 ' HB2' ' HG ' ' A' ' 82' ' ' CYS . 96.2 m-85 -94.13 12.95 24.7 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.8 t70 60.59 44.32 11.74 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.998 0.904 . . . . 0.0 110.797 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.688 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.8 p -126.19 162.4 25.5 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.865 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.457 ' O ' HG13 ' A' ' 87' ' ' ILE . 4.1 p-10 -92.91 119.09 31.85 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.558 0.694 . . . . 0.0 109.437 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.666 ' HD2' ' HB2' ' A' ' 95' ' ' ASN . 7.7 p90 -47.86 -32.57 6.34 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 114.431 -1.258 . . . . 0.0 111.895 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.401 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 40.7 t-80 -60.48 -47.85 84.33 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.951 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.601 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 6.2 tp10 -63.54 -47.04 83.24 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.928 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.483 HD13 ' HA ' ' A' ' 84' ' ' PHE . 5.1 mt -49.7 -47.06 21.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.413 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.607 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.84 -50.3 71.48 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.907 178.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 85' ' ' HIS . 48.6 mtm180 -58.9 -34.48 71.73 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 11.5 mmt180 -74.98 -28.22 60.47 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.914 0.388 . . . . 0.0 111.538 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.459 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 5.4 t30 -96.43 -5.1 40.48 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.622 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 89.6 m-20 78.2 15.66 1.36 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.313 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.607 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 17.0 pt -103.57 -169.22 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.388 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.421 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 41.6 mt-30 -120.42 153.35 36.69 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.666 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 4.4 p30 -56.94 -57.5 12.27 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 121.826 0.822 . . . . 0.0 109.6 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.68 11.93 2.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.495 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.485 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 0.7 OUTLIER -71.48 -35.08 70.69 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.369 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 9.7 mp 72.65 119.46 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.367 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.826 HD13 HG21 ' A' ' 67' ' ' VAL . 7.1 pt -94.55 176.68 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.328 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.507 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 92.7 m-85 -124.44 160.39 53.25 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.977 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.671 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 28.9 Cg_endo -70.66 132.04 21.13 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.958 2.439 . . . . 0.0 113.143 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.47 9.29 41.55 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -100.46 148.03 25.2 Favored 'General case' 0 C--O 1.215 -0.757 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.505 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 61.1 t -114.6 111.15 34.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.589 HD12 HG23 ' A' ' 99' ' ' ILE . 64.3 mt -101.08 151.66 21.54 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.086 -177.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.43 ' HG2' HG23 ' A' ' 64' ' ' THR . 17.8 mt-30 -90.29 113.72 25.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.702 0.763 . . . . 0.0 110.786 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.8 m -120.19 151.1 52.69 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.607 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.99 -16.35 54.42 Favored 'Trans proline' 0 C--N 1.333 -0.262 0 C-N-CA 123.392 2.728 . . . . 0.0 114.201 -177.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.786 ' HB ' ' HA3' ' A' ' 59' ' ' GLY . 14.2 t -157.26 157.58 34.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.939 0.399 . . . . 0.0 111.088 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.488 ' HG2' ' HB3' ' A' ' 63' ' ' ALA . 12.6 mmmm -99.63 -170.38 1.89 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.469 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -102.39 -151.72 23.88 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.75 77.7 0.61 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.739 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.5 p -86.38 -27.74 24.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.919 0.39 . . . . 0.0 110.391 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 124.26 -66.07 0.53 Allowed Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.808 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -152.58 31.39 0.84 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.017 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -145.75 52.65 0.57 Allowed Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.724 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 41' ' ' ARG . . . -109.81 -17.95 13.54 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.504 0.669 . . . . 0.0 109.745 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.622 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -118.59 -82.9 0.85 Allowed Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.891 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 19.7 m120 74.35 25.77 1.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.465 0.706 . . . . 0.0 112.241 178.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.616 ' CD2' ' HE1' ' A' ' 50' ' ' PHE . 12.4 p90 -64.14 -40.43 96.14 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.501 ' HA ' ' HB1' ' A' ' 124' ' ' ALA . 62.7 t-105 -59.17 -31.01 68.6 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.081 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -53.77 -28.02 32.32 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.739 0.304 . . . . 0.0 110.834 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.696 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 16.2 m -137.63 31.18 2.55 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.281 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.501 ' HB1' ' HA ' ' A' ' 121' ' ' TRP . . . -111.65 146.69 37.01 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.15 0.5 . . . . 0.0 111.318 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -132.34 148.02 52.41 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.558 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 50.66 50.82 18.18 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 124.053 0.846 . . . . 0.0 112.116 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.425 HG22 ' HB1' ' A' ' 138' ' ' ALA . 31.6 t -74.22 125.24 33.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -149.59 153.51 37.22 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.126 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.691 HD21 HD13 ' A' ' 153' ' ' LEU . 25.8 mt -97.5 139.71 33.01 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.807 0.337 . . . . 0.0 110.799 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.538 HG23 ' HB ' ' A' ' 135' ' ' VAL . 33.7 m -133.44 156.04 41.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.789 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.586 ' HB3' ' HD2' ' A' ' 134' ' ' LYS . 1.4 m-20 70.13 5.74 5.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.663 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.721 ' O ' HD11 ' A' ' 14' ' ' ILE . . . 99.35 35.59 4.66 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.289 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.784 ' HA3' HG22 ' A' ' 14' ' ' ILE . . . 82.48 -9.58 58.08 Favored Glycine 0 C--O 1.256 1.523 0 CA-C-O 123.003 1.335 . . . . 0.0 113.198 176.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.642 ' O ' ' HA ' ' A' ' 152' ' ' TYR . 18.1 ptpt -74.47 -16.23 60.86 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.563 HG22 ' HG3' ' A' ' 134' ' ' LYS . 24.4 t -140.69 140.21 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.075 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.792 HD12 HD21 ' A' ' 16' ' ' LEU . 7.7 tt -119.01 125.15 48.7 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -110.35 124.45 51.71 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.968 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -157.46 155.67 30.82 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.939 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 31.1 mt-10 -95.0 108.33 20.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.272 0.558 . . . . 0.0 110.605 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.888 ' HG ' ' CB ' ' A' ' 45' ' ' ASN . 0.2 OUTLIER -90.24 128.7 36.46 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.752 -179.81 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.696 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 75.7 ttt180 -70.04 140.69 52.87 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.403 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.458 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.7 p90 -156.46 -171.95 3.89 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.383 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.8 m -55.87 -29.9 60.65 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.787 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -97.67 20.75 49.42 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.204 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 98.75 -110.12 3.94 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.251 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -129.44 133.1 47.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.636 0.255 . . . . 0.0 110.786 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.458 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 11.8 t30 -134.43 127.37 31.39 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.622 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 29.7 ttp180 -79.93 102.35 9.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.448 0.642 . . . . 0.0 110.759 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.45 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 11.4 t -105.27 174.62 5.8 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.124 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.647 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 34.7 ptt180 -147.43 148.24 31.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.918 0.389 . . . . 0.0 111.787 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.709 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 10.9 tt -131.6 159.59 42.96 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.512 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.643 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 44.0 m-85 -99.79 106.04 17.88 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.341 0.115 . . . . 0.0 110.775 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.691 HD13 HD21 ' A' ' 129' ' ' LEU . 16.5 mt -68.74 -35.86 77.66 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.312 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.425 ' HA ' ' HD1' ' A' ' 7' ' ' PHE . 8.3 p-10 -58.26 -8.05 1.02 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.976 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.678 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 41.8 mt-10 -69.41 -55.2 11.02 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.236 0.541 . . . . 0.0 111.912 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.454 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 77.5 m-70 -122.23 6.02 9.7 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.306 -177.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.455 HG12 ' CH2' ' A' ' 52' ' ' TRP . 44.3 mm -107.15 113.2 42.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.88 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 167' ' ' CYS . . . -112.71 173.04 14.95 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.965 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.528 ' CG ' ' HB3' ' A' ' 25' ' ' CYS . 0.9 OUTLIER -110.95 128.27 55.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.674 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.96 89.14 3.07 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.37 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 56.99 42.16 26.58 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.442 0.464 . . . . 0.0 111.794 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.566 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 92.51 7.93 62.93 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.928 -0.654 . . . . 0.0 113.406 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -123.59 127.01 47.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.147 0.473 . . . . 0.0 112.094 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.41 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 42.1 mt -70.82 110.39 5.56 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.481 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 63.3 mt -135.15 141.31 43.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.382 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.454 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 9.7 p-80 -54.73 123.83 14.54 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.448 ' O ' ' HA3' ' A' ' 158' ' ' GLY . 43.3 t . . . . . 0 C--O 1.249 1.058 0 O-C-N 123.714 0.634 . . . . 0.0 111.217 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.619 ' HA2' ' OD1' ' A' ' 6' ' ' ASN . . . . . . . . 0 N--CA 1.483 1.822 0 N-CA-C 112.34 -0.304 . . . . 0.0 112.34 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.44 ' HB2' ' HB3' ' A' ' 154' ' ' ASP . 1.0 OUTLIER -90.05 -59.96 2.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.742 0.306 . . . . 0.0 110.571 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.487 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 45.3 m-85 -139.75 -83.59 0.25 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.854 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.539 ' HB1' ' SG ' ' A' ' 167' ' ' CYS . . . -118.73 -27.75 5.78 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.54 -71.24 0.85 Allowed Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 119.988 -1.101 . . . . 0.0 112.784 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.619 ' OD1' ' HA2' ' A' ' 1' ' ' GLY . 74.1 m-20 65.78 10.47 6.85 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 122.455 0.302 . . . . 0.0 110.749 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.624 ' CE2' HD11 ' A' ' 14' ' ' ILE . 1.1 p90 -61.08 -34.08 74.36 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.3 t -68.02 -16.88 64.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.106 0.479 . . . . 0.0 110.279 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.24 -21.16 79.94 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.746 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 11.1 m -130.45 -19.17 3.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.978 0.389 . . . . 0.0 111.622 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 m -94.41 135.09 36.23 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.514 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 11.7 ptm180 -112.72 -178.91 3.51 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 40.75 47.98 2.57 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 123.909 0.755 . . . . 0.0 112.343 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.687 HG12 ' HB3' ' A' ' 23' ' ' ALA . 7.9 mt -80.66 103.83 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.511 ' HA ' HD11 ' A' ' 129' ' ' LEU . 45.4 t -147.95 126.19 12.23 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.738 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -92.34 154.93 18.26 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.559 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -95.09 74.66 3.45 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.4 -57.87 4.88 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.925 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.442 ' HA ' ' HZ ' ' A' ' 120' ' ' PHE . . . -145.28 -9.31 0.58 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.816 0.341 . . . . 0.0 110.257 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -94.98 95.59 8.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.823 0.344 . . . . 0.0 110.089 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.824 ' HB2' HD23 ' A' ' 39' ' ' LEU . 42.8 tp -59.28 128.12 35.53 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.369 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.545 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 51.1 ttt180 -131.1 129.83 42.38 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.05 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.687 ' HB3' HG12 ' A' ' 14' ' ' ILE . . . -150.61 147.34 27.3 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.383 0.611 . . . . 0.0 111.19 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.552 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 1.3 mm-40 -84.49 81.31 8.9 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.842 178.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.533 ' HB2' ' HA2' ' A' ' 162' ' ' GLY . 58.6 m -67.6 128.08 35.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.494 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 10' ' ' SER . 51.1 ttt-85 -74.37 116.19 14.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.793 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -89.5 159.02 17.45 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.092 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.48 -18.23 3.52 Favored Glycine 0 C--N 1.337 0.592 0 O-C-N 124.861 1.351 . . . . 0.0 114.442 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -71.64 -12.37 61.31 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.03 9.62 60.58 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.39 163.69 12.12 Favored Glycine 0 C--O 1.228 -0.238 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.032 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.552 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 70.2 m-85 -100.02 134.03 43.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.63 0.252 . . . . 0.0 110.499 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.6 m -123.79 128.68 49.9 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.271 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.4 114.72 6.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.02 0.438 . . . . 0.0 110.771 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 29.7 t -119.89 149.56 41.89 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.777 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 2.8 p -142.04 136.48 29.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.002 0.43 . . . . 0.0 111.204 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.421 HG22 HD11 ' A' ' 39' ' ' LEU . 13.4 tt -134.06 144.38 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.73 -177.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -77.84 98.81 5.71 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.798 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.824 HD23 ' HB2' ' A' ' 21' ' ' LEU . 1.3 mp -76.25 -6.4 51.25 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.272 0.558 . . . . 0.0 110.153 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.582 HD22 ' HA ' ' A' ' 119' ' ' ASN . 4.8 t-20 -63.61 -21.65 66.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.65 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.717 ' HD3' ' HA2' ' A' ' 115' ' ' GLY . 16.8 ptt85 -111.32 19.35 18.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.039 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 38.6 m-85 -131.44 -32.66 1.52 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.638 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.584 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 51.7 mt -109.71 138.53 45.95 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.036 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 m -132.79 144.22 50.09 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.612 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.459 ' ND2' ' HB2' ' A' ' 123' ' ' SER . 21.6 p-10 -88.27 106.5 18.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.425 0.631 . . . . 0.0 110.205 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -103.24 92.43 4.51 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 122.133 -0.354 . . . . 0.0 110.906 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 49.51 44.29 24.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.78 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.575 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 85.82 30.0 24.8 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.486 178.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.672 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 21.9 t-160 -152.58 124.6 8.01 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.754 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 63.6 m-85 -62.26 143.3 57.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.791 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.4 mtm180 -144.8 134.32 23.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.409 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.559 ' HA ' ' O ' ' A' ' 42' ' ' TYR . 99.4 m95 -75.58 141.76 42.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.882 177.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.492 HG21 ' HA ' ' A' ' 42' ' ' TYR . 17.5 m -64.28 115.93 3.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.329 0.585 . . . . 0.0 110.747 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.8 t -95.7 -10.35 29.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.497 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -105.08 -4.61 41.46 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.455 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.6 -136.92 15.12 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.981 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -88.7 -141.15 7.73 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.33 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -142.61 -164.69 10.25 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.029 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -102.18 -14.5 28.34 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.142 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 114.06 -110.58 2.43 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.339 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.31 -111.48 4.18 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.285 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.8 m -119.4 114.45 22.35 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.177 0.513 . . . . 0.0 110.539 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.504 ' HB1' ' HG2' ' A' ' 110' ' ' LYS . . . -106.43 176.55 5.13 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.68 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.538 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 10.0 p -126.85 115.89 20.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.957 0.408 . . . . 0.0 112.074 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.554 HG21 ' CE2' ' A' ' 80' ' ' PHE . 7.4 p -106.29 148.04 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.062 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 10.3 m -93.04 130.27 38.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.172 0.51 . . . . 0.0 110.454 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.579 HG23 HD13 ' A' ' 99' ' ' ILE . 58.2 t -83.26 138.39 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.185 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.41 ' HG3' ' H ' ' A' ' 69' ' ' GLN . 21.1 tp60 -108.4 171.2 7.55 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 124.373 1.045 . . . . 0.0 109.61 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.69 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 63.7 tt0 -68.95 126.05 28.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.395 -178.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.44 8.55 59.71 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.988 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -119.84 123.18 43.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.902 0.382 . . . . 0.0 110.962 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.549 ' HA ' HG12 ' A' ' 99' ' ' ILE . 69.3 p -104.76 -176.91 3.21 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.551 HD13 ' HB ' ' A' ' 87' ' ' ILE . 1.3 mm? -51.53 -40.79 60.34 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.392 0.615 . . . . 0.0 109.55 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.421 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 38.8 ttm180 -60.06 -42.47 94.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.253 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -70.66 -43.39 69.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.355 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.503 HG12 ' O ' ' A' ' 72' ' ' THR . 38.3 mm -62.96 -45.33 99.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.729 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.95 -56.22 26.36 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.654 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -64.72 -26.73 68.49 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 45.6 ttm-85 -72.98 -38.86 66.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.565 ' HB2' ' HG ' ' A' ' 82' ' ' CYS . 96.8 m-85 -111.02 19.64 18.26 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.9 t70 55.27 36.17 26.48 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.679 0.752 . . . . 0.0 111.776 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.729 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.5 p -113.72 171.19 7.73 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.666 ' O ' HG13 ' A' ' 87' ' ' ILE . 6.9 t70 -97.77 127.34 43.65 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.91 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.47 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 11.1 p90 -52.92 -30.12 32.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.287 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -73.33 -38.01 65.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.975 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -68.16 -45.91 72.21 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.666 HG13 ' O ' ' A' ' 83' ' ' ASP . 6.0 mt -54.67 -47.03 73.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.603 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.93 -47.89 81.28 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.679 177.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -56.75 -42.41 79.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.981 0.42 . . . . 0.0 111.369 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -69.79 -36.24 75.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.759 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.496 HD21 HG21 ' A' ' 93' ' ' ILE . 7.2 t30 -89.4 -5.33 57.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.387 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 94.0 m-20 74.8 21.05 2.17 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.587 0.755 . . . . 0.0 111.425 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.603 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 17.6 pt -108.89 -173.48 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.495 ' H ' ' HB2' ' A' ' 97' ' ' ASP . 88.7 mt-30 -110.62 158.15 18.9 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.528 ' O ' HD21 ' A' ' 73' ' ' LEU . 3.2 p-10 -58.98 -55.34 36.46 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-O 122.221 1.01 . . . . 0.0 108.43 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -79.68 12.06 2.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.666 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.495 ' HB2' ' H ' ' A' ' 94' ' ' GLN . 4.4 t70 -63.73 -32.57 74.1 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.1 mt 70.68 112.44 0.05 Allowed 'General case' 0 C--O 1.234 0.249 0 O-C-N 124.465 1.103 . . . . 0.0 110.123 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.739 HG21 HD13 ' A' ' 105' ' ' LEU . 14.4 pt -95.33 175.14 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.155 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.524 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 97.5 m-85 -128.96 158.8 71.52 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.969 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.69 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 20.8 Cg_endo -66.97 138.81 49.19 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.508 2.806 . . . . 0.0 114.307 -178.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.07 11.3 57.72 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.702 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.473 ' O ' ' HA ' ' A' ' 66' ' ' THR . 74.1 mt-30 -102.64 166.04 10.73 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.352 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.538 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 80.9 t -122.39 114.78 43.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-O 120.931 0.396 . . . . 0.0 110.198 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.739 HD13 HG21 ' A' ' 99' ' ' ILE . 79.0 mt -107.26 152.01 24.68 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.823 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -89.9 116.22 27.81 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.795 0.807 . . . . 0.0 111.45 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.9 m -126.29 150.91 71.42 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 114.253 -1.339 . . . . 0.0 109.954 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.68 -17.41 59.82 Favored 'Trans proline' 0 N--CA 1.476 0.442 0 C-N-CA 123.735 2.957 . . . . 0.0 114.952 -177.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.6 t -148.54 153.01 37.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.942 0.401 . . . . 0.0 111.268 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.504 ' HG2' ' HB1' ' A' ' 63' ' ' ALA . 11.1 mmmm -101.63 -170.05 1.77 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.265 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.74 118.61 14.67 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.975 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 81.62 -80.85 1.7 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.849 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.6 t -142.93 -87.98 0.14 Allowed 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.18 48.14 1.0 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.388 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.717 ' HA2' ' HD3' ' A' ' 41' ' ' ARG . . . -77.68 61.23 3.66 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.616 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 174.76 56.95 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.414 ' H ' ' HA ' ' A' ' 41' ' ' ARG . . . -99.23 -39.0 8.66 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.097 -0.552 . . . . 0.0 110.353 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . -85.77 -60.92 1.73 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.905 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.582 ' HA ' HD22 ' A' ' 40' ' ' ASN . 6.9 m-20 72.28 25.55 2.84 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 178.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.584 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 25.3 p90 -55.78 -39.14 70.84 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.537 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 62.2 t-105 -59.03 -32.96 70.21 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.67 -178.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -52.31 -38.6 58.91 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 121.7 0.762 . . . . 0.0 110.77 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.892 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 17.2 m -122.91 25.85 8.42 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.503 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.59 ' O ' ' HD2' ' A' ' 125' ' ' ARG . . . -114.72 134.61 54.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.857 0.36 . . . . 0.0 111.05 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.59 ' HD2' ' O ' ' A' ' 124' ' ' ALA . 7.1 mpt_? -131.33 158.61 40.23 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.631 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.9 t70 53.94 46.1 26.32 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.761 0.791 . . . . 0.0 110.214 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.477 ' CG1' HD11 ' A' ' 136' ' ' LEU . 22.5 t -79.85 122.09 34.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.614 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 128' ' ' ARG . 1.3 ptp85 -146.55 147.8 31.5 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.286 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.689 HD22 HD13 ' A' ' 153' ' ' LEU . 19.4 mt -86.97 127.84 35.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.204 0.526 . . . . 0.0 110.072 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.847 HG22 ' HB ' ' A' ' 135' ' ' VAL . 27.6 m -116.79 157.17 17.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.909 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.454 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 0.9 OUTLIER 68.42 3.23 3.67 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.584 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.635 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 97.91 29.24 7.78 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.32 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.657 ' HA3' HG23 ' A' ' 14' ' ' ILE . . . 98.34 -22.05 42.89 Favored Glycine 0 C--O 1.261 1.828 0 CA-C-O 123.014 1.341 . . . . 0.0 113.098 177.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.591 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 40.5 pttt -67.97 -14.79 63.24 Favored 'General case' 0 C--N 1.317 -0.814 0 O-C-N 121.279 -1.13 . . . . 0.0 109.271 177.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.847 ' HB ' HG22 ' A' ' 130' ' ' VAL . 3.1 t -140.85 146.91 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.895 177.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 26.5 tp -129.33 122.62 29.91 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -117.49 137.62 52.41 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.884 0.373 . . . . 0.0 110.988 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.606 ' HB2' ' HZ ' ' A' ' 50' ' ' PHE . . . -160.09 169.32 23.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.575 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 124' ' ' ALA . 8.5 mm-40 -95.33 106.45 18.5 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.575 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 58.8 mt -97.81 125.06 42.46 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.457 0.646 . . . . 0.0 111.468 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.892 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 65.4 ttt180 -70.28 141.34 52.41 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.933 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.401 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 4.8 p90 -152.35 -173.73 4.65 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.868 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.0 m -56.2 -24.66 43.3 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -108.56 27.98 12.5 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.502 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 102.43 -117.89 5.94 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.161 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.422 ' CH2' ' HD3' ' A' ' 125' ' ' ARG . 80.0 m95 -127.2 142.14 51.56 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.401 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 54.6 t30 -138.02 137.74 38.16 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.8 ttt85 -85.03 113.75 21.68 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.065 0.46 . . . . 0.0 110.72 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.672 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 47.5 t -122.75 166.61 14.67 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.943 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 10.2 ptt180 -147.37 145.25 29.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.205 0.526 . . . . 0.0 111.677 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.754 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 6.9 tt -124.79 150.56 29.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.676 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.326 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.567 ' CB ' ' HG3' ' A' ' 155' ' ' GLU . 18.1 m-85 -94.74 103.96 15.87 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 122.166 -0.334 . . . . 0.0 110.921 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.736 HD11 HD21 ' A' ' 21' ' ' LEU . 25.4 mt -65.07 -36.51 84.57 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.09 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.591 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 8.8 t70 -57.61 -7.97 0.77 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.943 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.567 ' HG3' ' CB ' ' A' ' 152' ' ' TYR . 42.0 mt-10 -70.63 -54.31 12.46 Favored 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 122.002 -0.436 . . . . 0.0 112.081 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.486 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 80.7 m-70 -125.57 5.03 7.54 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.165 -177.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.482 HG12 ' CH2' ' A' ' 52' ' ' TRP . 41.7 mm -101.87 106.47 19.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.504 ' HA3' ' OXT' ' A' ' 167' ' ' CYS . . . -110.89 161.88 12.68 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.978 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER -103.61 136.36 43.46 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.791 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -119.01 86.55 2.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.621 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 48.6 50.48 17.01 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.533 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 99.55 6.01 55.18 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.318 -0.944 . . . . 0.0 113.815 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' A' ' 159' ' ' ASN . 37.8 mt-10 -123.25 153.81 39.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 117.121 0.461 . . . . 0.0 111.288 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.46 HD22 ' HD2' ' A' ' 7' ' ' PHE . 30.8 mt -103.58 121.61 43.26 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.581 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.711 HG12 ' H ' ' A' ' 166' ' ' HIS . 13.8 tt -148.04 -179.47 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.956 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.711 ' H ' HG12 ' A' ' 165' ' ' ILE . 4.9 t60 -78.16 107.56 10.83 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.539 ' SG ' ' HB1' ' A' ' 4' ' ' ALA . 47.3 t . . . . . 0 C--O 1.251 1.156 0 O-C-N 123.788 0.68 . . . . 0.0 111.778 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.646 ' HA2' ' OD1' ' A' ' 6' ' ' ASN . . . . . . . . 0 N--CA 1.484 1.834 0 N-CA-C 112.371 -0.292 . . . . 0.0 112.371 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.497 ' HB2' ' HB3' ' A' ' 154' ' ' ASP . 0.9 OUTLIER -91.85 -69.41 0.74 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 122.792 -0.24 . . . . 0.0 111.546 -179.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.559 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 58.0 m-85 -132.55 -100.46 0.28 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.546 ' HB1' ' SG ' ' A' ' 167' ' ' CYS . . . -96.2 -32.45 12.45 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -177.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.91 -74.94 0.37 Allowed Glycine 0 N--CA 1.436 -1.345 0 C-N-CA 119.994 -1.098 . . . . 0.0 113.275 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.646 ' OD1' ' HA2' ' A' ' 1' ' ' GLY . 39.0 m-80 66.46 15.72 10.19 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 122.332 0.253 . . . . 0.0 110.83 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.597 ' CE2' HD11 ' A' ' 14' ' ' ILE . 1.4 p90 -61.43 -35.11 76.64 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.509 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.561 ' HA ' HD13 ' A' ' 14' ' ' ILE . 0.9 OUTLIER -64.48 -21.43 66.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.246 0.546 . . . . 0.0 110.419 -179.001 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.47 -25.3 75.89 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.265 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 18.4 p -125.72 -10.93 6.72 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 117.135 0.467 . . . . 0.0 111.173 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 6.8 m -107.98 132.33 53.63 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -111.81 -179.46 3.7 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 45.37 46.3 10.36 Favored 'General case' 0 C--N 1.315 -0.933 0 O-C-N 123.859 0.724 . . . . 0.0 111.762 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.714 HG12 ' HB1' ' A' ' 23' ' ' ALA . 8.0 mt -80.92 106.82 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.529 ' HA ' HD12 ' A' ' 129' ' ' LEU . 73.5 m -147.78 126.98 12.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.064 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.732 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -102.47 158.89 15.9 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 121.431 0.634 . . . . 0.0 111.991 179.447 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -103.47 77.63 1.52 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.77 -54.71 4.98 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.589 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -149.53 -13.44 0.29 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.146 0.498 . . . . 0.0 110.291 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.56 ' HG3' ' CG2' ' A' ' 36' ' ' VAL . 21.0 tpt180 -83.25 85.75 7.16 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.316 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.732 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 54.0 tp -62.78 128.4 35.75 Favored 'General case' 0 C--O 1.213 -0.838 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -133.66 121.88 22.64 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.797 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.714 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -143.22 147.31 34.65 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.452 0.644 . . . . 0.0 111.54 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.513 ' O ' ' HD2' ' A' ' 32' ' ' TYR . 4.7 mm-40 -82.21 76.76 9.08 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.561 -1.199 . . . . 0.0 109.376 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.565 ' HB3' ' CG ' ' A' ' 159' ' ' ASN . 69.5 m -65.04 124.81 23.05 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.194 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 10' ' ' SER . 72.0 ttt180 -64.67 134.59 54.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.89 178.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -115.05 151.87 33.48 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.65 -10.62 6.4 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 114.495 -1.23 . . . . 0.0 113.737 -178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -79.22 1.46 24.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.17 0.51 . . . . 0.0 110.155 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.95 12.15 74.93 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.963 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -130.21 160.56 23.01 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 119.984 -1.103 . . . . 0.0 112.953 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.513 ' HD2' ' O ' ' A' ' 24' ' ' GLU . 76.7 m-85 -95.85 125.15 40.21 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.9 m -108.4 137.34 46.52 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.733 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.1 m -71.93 112.74 8.28 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.151 0.5 . . . . 0.0 110.387 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.478 ' HG ' ' HG ' ' A' ' 164' ' ' LEU . 28.0 t -114.32 146.45 40.49 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.19 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.9 p -143.37 133.71 21.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.062 0.458 . . . . 0.0 110.981 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.461 HG22 ' HB3' ' A' ' 21' ' ' LEU . 9.3 tt -135.18 154.0 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.892 -177.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.541 ' OD1' ' HB3' ' A' ' 40' ' ' ASN . 35.2 t0 -89.46 112.4 23.54 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.079 -0.388 . . . . 0.0 110.664 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.511 HD22 ' CB ' ' A' ' 21' ' ' LEU . 3.6 mm? -86.46 -4.83 59.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.927 0.394 . . . . 0.0 110.149 178.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.541 ' HB3' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -71.68 -15.45 62.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.805 0.812 . . . . 0.0 108.892 179.058 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.532 ' HD3' ' O ' ' A' ' 114' ' ' GLY . 30.8 mtt180 -105.87 13.22 29.77 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.527 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.409 ' HB2' HD11 ' A' ' 39' ' ' LEU . 48.2 m-85 -133.96 -29.51 1.29 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.712 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.625 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 31.9 mt -109.2 140.62 42.57 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.107 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.47 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 3.1 m -128.56 145.36 51.15 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.842 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.607 HD21 ' HA ' ' A' ' 120' ' ' PHE . 8.1 p30 -89.93 104.43 16.99 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -106.67 94.26 5.03 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.373 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 50.08 42.93 25.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.225 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.647 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 86.2 29.7 24.54 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.241 -0.98 . . . . 0.0 113.125 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.626 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 16.9 t-80 -153.71 127.33 8.72 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.806 ' HZ ' ' HB2' ' A' ' 138' ' ' ALA . 81.4 m-85 -64.08 149.53 47.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.929 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -144.63 129.5 18.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.82 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.468 ' HZ2' ' O ' ' A' ' 152' ' ' TYR . 94.2 m95 -76.07 133.57 40.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.971 177.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.4 m -122.67 54.06 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.316 0.579 . . . . 0.0 110.205 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.9 m -75.8 7.37 3.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.378 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -130.36 26.0 4.21 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.947 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.12 56.75 5.04 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.354 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.552 ' HA3' ' HA3' ' A' ' 112' ' ' GLY . . . 128.66 -119.18 2.96 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.883 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.4 -178.23 40.52 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -149.83 49.1 0.57 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.287 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.96 167.4 31.87 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.076 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 108' ' ' PRO . . . 101.68 -140.34 14.82 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.011 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 49.2 m -126.14 119.65 28.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.127 0.489 . . . . 0.0 110.555 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -124.28 176.72 6.26 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.873 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.452 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 17.4 p -128.06 113.67 16.09 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.355 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.438 ' HA ' ' HE3' ' A' ' 110' ' ' LYS . 9.7 p -102.63 139.78 22.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.918 0.389 . . . . 0.0 110.957 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 8.2 m -88.47 126.16 35.1 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.536 ' CG2' HD12 ' A' ' 99' ' ' ILE . 43.9 t -75.33 130.23 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.132 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -103.6 169.43 8.53 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 124.258 0.974 . . . . 0.0 110.344 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.585 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 6.1 tp-100 -62.0 121.29 12.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.265 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.03 16.04 39.84 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.908 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -121.04 129.54 53.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.862 0.331 . . . . 0.0 111.075 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.657 ' HA ' HG12 ' A' ' 99' ' ' ILE . 74.4 p -115.02 178.05 4.42 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.537 HD11 ' HB ' ' A' ' 87' ' ' ILE . 1.3 mm? -52.24 -42.71 63.84 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.641 0.734 . . . . 0.0 109.31 178.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.681 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 65.8 mtt180 -59.74 -41.12 90.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.4 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -71.61 -44.48 64.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.278 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.538 HG12 ' O ' ' A' ' 72' ' ' THR . 37.8 mm -58.83 -45.28 91.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.627 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.44 -49.96 68.88 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.693 -0.685 . . . . 0.0 113.321 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.681 ' HD3' ' O ' ' A' ' 74' ' ' ARG . 1.0 OUTLIER -73.84 -27.04 60.89 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 122.434 -0.451 . . . . 0.0 111.632 -179.011 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -76.54 -38.48 54.97 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.452 ' HB2' ' HG ' ' A' ' 82' ' ' CYS . 95.6 m-85 -112.47 19.94 17.11 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.2 t70 53.55 55.0 9.17 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 122.072 0.939 . . . . 0.0 111.701 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.627 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -136.32 172.87 12.38 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.235 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.666 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.9 t70 -98.73 122.66 42.24 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.905 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.423 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 14.1 p90 -53.16 -27.56 21.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.091 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.78 -34.61 58.0 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.923 0.392 . . . . 0.0 109.954 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.491 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 39.7 tt0 -69.42 -48.56 60.6 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.666 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.4 mt -53.36 -43.89 52.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.973 178.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.593 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.44 -52.0 65.29 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.322 178.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -61.25 -32.41 72.21 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.816 ' HB3' ' HB2' ' A' ' 106' ' ' GLN . 1.9 mmp_? -65.34 -37.11 86.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.08 0.467 . . . . 0.0 110.491 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.649 HD21 HG21 ' A' ' 93' ' ' ILE . 9.9 t30 -93.62 -4.35 50.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.928 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 17.3 m120 78.34 16.82 1.21 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.491 0.716 . . . . 0.0 111.178 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.649 HG21 HD21 ' A' ' 91' ' ' ASN . 11.1 pt -102.57 -175.88 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.548 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 26.2 mt-30 -112.29 160.89 17.21 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.738 -0.385 . . . . 0.0 109.969 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.433 ' O ' HD22 ' A' ' 73' ' ' LEU . 11.2 p-10 -55.82 -58.26 8.6 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 122.36 1.076 . . . . 0.0 109.277 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -76.39 12.0 1.38 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.859 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 1.9 t70 -66.17 -35.92 81.75 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.9 mp 68.71 115.88 0.04 OUTLIER 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.097 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.689 HG21 HD11 ' A' ' 105' ' ' LEU . 10.1 pt -94.54 176.6 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.665 -178.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.439 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 15.3 m-85 -129.25 157.22 76.78 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.624 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.585 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 17.9 Cg_endo -64.93 135.82 45.97 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 122.889 2.393 . . . . 0.0 112.863 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.68 20.95 22.94 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.53 ' O ' ' HA ' ' A' ' 66' ' ' THR . 92.6 mt-30 -109.77 165.81 11.4 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.452 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 88.5 t -125.52 115.21 42.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.689 HD11 HG21 ' A' ' 99' ' ' ILE . 87.1 mt -110.77 151.2 28.06 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.952 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.816 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 71.2 mt-30 -90.19 115.08 27.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.872 0.844 . . . . 0.0 110.581 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.1 151.25 68.92 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.36 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 32.2 Cg_endo -62.22 -21.03 71.91 Favored 'Trans proline' 0 N--CA 1.474 0.346 0 C-N-CA 123.395 2.73 . . . . 0.0 114.673 -177.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.9 t -153.89 156.56 37.78 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.079 0.466 . . . . 0.0 111.184 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.438 ' HE3' ' HA ' ' A' ' 65' ' ' VAL . 13.3 mmmm -96.25 -165.98 1.36 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.444 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -76.3 63.51 2.93 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.68 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.552 ' HA3' ' HA3' ' A' ' 57' ' ' GLY . . . -152.83 134.93 4.67 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.5 m -133.8 12.48 4.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.045 0.45 . . . . 0.0 110.616 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.532 ' O ' ' HD3' ' A' ' 41' ' ' ARG . . . 68.03 41.71 86.66 Favored Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.545 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -124.91 93.9 0.45 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.676 -0.774 . . . . 0.0 111.885 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.33 53.3 13.88 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -79.58 -29.97 41.44 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.97 -0.615 . . . . 0.0 110.171 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . -106.91 -68.46 0.68 Allowed Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.483 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 90.9 m-20 74.21 29.8 1.26 Allowed 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 122.94 0.496 . . . . 0.0 111.459 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.625 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 19.6 p90 -62.75 -39.36 93.89 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.076 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.539 ' HA ' ' HB2' ' A' ' 124' ' ' ALA . 42.8 t-105 -62.35 -32.39 73.16 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.848 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -52.58 -37.69 58.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.796 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.623 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 31.3 m -123.29 26.62 7.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.462 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.539 ' HB2' ' HA ' ' A' ' 121' ' ' TRP . . . -107.42 144.64 34.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.251 177.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.465 ' HB2' ' CZ3' ' A' ' 146' ' ' TRP . 1.8 tpt180 -129.75 137.85 50.77 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.7 t70 54.53 67.66 0.98 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.481 0.658 . . . . 0.0 110.659 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.467 ' CG1' HD12 ' A' ' 136' ' ' LEU . 39.2 t -91.79 124.51 44.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.866 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -148.0 148.11 30.36 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.972 0.415 . . . . 0.0 110.559 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.588 ' HG ' ' HG ' ' A' ' 16' ' ' LEU . 30.4 mt -86.68 134.83 33.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.674 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.593 HG22 ' HB ' ' A' ' 135' ' ' VAL . 35.6 m -127.82 157.31 39.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.18 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.498 ' HB3' ' HD3' ' A' ' 134' ' ' LYS . 6.4 m-20 72.38 1.88 4.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.931 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.618 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 99.09 28.03 7.93 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.628 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.623 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 98.07 -23.14 37.34 Favored Glycine 0 C--O 1.266 2.13 0 CA-C-O 123.282 1.49 . . . . 0.0 112.654 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.738 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 15.9 ptmt -64.72 -20.0 66.09 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 121.721 -0.87 . . . . 0.0 108.933 177.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.593 ' HB ' HG22 ' A' ' 130' ' ' VAL . 6.8 t -136.94 146.01 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.324 0.583 . . . . 0.0 110.378 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 30.5 tp -124.95 121.54 34.74 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.491 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 40.2 tt0 -112.02 134.46 53.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.951 0.405 . . . . 0.0 111.788 -177.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.806 ' HB2' ' HZ ' ' A' ' 50' ' ' PHE . . . -163.29 161.85 24.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.749 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -96.06 110.29 22.56 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.647 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 50.8 mt -96.19 137.04 35.85 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.175 0.512 . . . . 0.0 111.115 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.623 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 56.4 ttt180 -72.59 140.74 48.23 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.942 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.476 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 3.3 p90 -159.42 -170.34 2.92 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.563 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.4 m -54.66 -32.46 59.24 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 123.349 0.406 . . . . 0.0 111.789 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -97.51 16.52 60.43 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.404 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 141' ' ' ARG . . . 101.58 -110.23 3.8 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.266 -0.968 . . . . 0.0 112.395 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.465 ' CZ3' ' HB2' ' A' ' 125' ' ' ARG . 70.7 m95 -132.93 129.39 38.24 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.476 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 65.7 t30 -130.35 145.02 51.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.721 0.295 . . . . 0.0 110.617 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -73.88 109.28 7.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.272 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.626 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 35.8 t -122.6 165.32 16.64 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 27.7 mtt85 -145.98 158.82 43.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.09 0.471 . . . . 0.0 111.026 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.737 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 10.2 tt -140.21 146.87 24.06 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.063 178.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.66 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 69.4 m-85 -90.71 102.76 15.51 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.301 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.681 HD11 HD23 ' A' ' 21' ' ' LEU . 20.6 mt -63.21 -34.16 77.05 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.813 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.738 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 6.1 t70 -58.52 -9.09 1.45 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.156 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.66 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 43.6 mt-10 -74.2 -50.69 18.11 Favored 'General case' 0 CA--C 1.508 -0.663 0 O-C-N 121.92 -0.488 . . . . 0.0 112.156 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.509 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 13.1 m170 -120.53 1.25 10.62 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.39 -177.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.428 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 47.5 mm -105.93 110.79 32.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.029 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.457 ' HA3' ' OXT' ' A' ' 167' ' ' CYS . . . -114.98 160.14 13.36 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.174 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.565 ' CG ' ' HB3' ' A' ' 25' ' ' CYS . 2.8 t30 -102.53 128.31 49.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.925 0.393 . . . . 0.0 109.972 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -124.46 91.39 3.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.451 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 58.82 42.23 20.24 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.34 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.489 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 92.19 15.39 53.87 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.882 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 159' ' ' ASN . 10.5 tp10 -124.09 143.86 50.21 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.674 -0.309 . . . . 0.0 111.225 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.553 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 18.6 mt -103.31 110.49 22.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.927 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.45 HD11 ' H ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -138.28 178.31 4.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.818 179.751 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.509 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 9.1 p80 -72.9 113.78 10.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.822 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.546 ' SG ' ' HB1' ' A' ' 4' ' ' ALA . 46.9 t . . . . . 0 C--O 1.252 1.197 0 O-C-N 123.871 0.732 . . . . 0.0 111.63 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.812 0 N-CA-C 112.09 -0.404 . . . . 0.0 112.09 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.564 ' HB3' ' OD2' ' A' ' 154' ' ' ASP . 19.6 p-10 -88.12 151.74 22.5 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.457 0.646 . . . . 0.0 111.297 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.465 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 22.7 m-85 -133.16 -61.34 0.83 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.554 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.56 ' HB3' ' SG ' ' A' ' 167' ' ' CYS . . . -131.76 -25.92 2.04 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.642 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.06 -70.17 1.25 Allowed Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 119.576 -1.297 . . . . 0.0 112.718 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.433 ' OD1' ' HB2' ' A' ' 2' ' ' ASN . 2.4 m-20 66.08 10.85 7.37 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 122.535 0.334 . . . . 0.0 110.619 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.663 ' CE2' HD11 ' A' ' 14' ' ' ILE . 1.0 OUTLIER -58.5 -33.53 69.93 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.54 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.507 ' HG ' ' CG ' ' A' ' 154' ' ' ASP . 59.2 p -63.32 -22.35 66.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.507 0.594 . . . . 0.0 110.398 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.03 -21.73 79.02 Favored Glycine 0 CA--C 1.522 0.519 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.421 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.435 ' HB3' ' HB3' ' A' ' 26' ' ' ARG . 59.4 m -127.84 -18.18 4.31 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 117.15 0.475 . . . . 0.0 111.485 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.8 m -101.42 129.98 47.55 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.973 0.416 . . . . 0.0 109.97 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.437 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 2.8 ptm180 -110.08 -178.47 3.53 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 42.89 47.72 4.9 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 123.748 0.655 . . . . 0.0 112.358 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.723 HG21 ' HA3' ' A' ' 133' ' ' GLY . 6.3 mt -81.76 103.39 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-O 121.253 0.549 . . . . 0.0 109.833 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.603 ' CA ' HD11 ' A' ' 129' ' ' LEU . 82.6 m -145.67 125.1 13.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.858 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.734 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -93.39 153.42 18.52 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 122.021 0.915 . . . . 0.0 113.1 -178.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -94.05 73.92 4.08 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.956 -1.474 . . . . 0.0 107.835 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.03 -55.2 4.78 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.946 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.501 ' HB3' ' HB3' ' A' ' 40' ' ' ASN . . . -146.33 -12.4 0.47 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.083 0.468 . . . . 0.0 110.102 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -88.89 94.49 9.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.898 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.853 ' HB2' HD23 ' A' ' 39' ' ' LEU . 46.7 tp -60.15 122.86 15.46 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.473 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.461 ' HB3' ' O ' ' A' ' 15' ' ' CYS . 51.4 ttp180 -126.25 125.58 42.61 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.581 -178.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.67 ' HB2' HG12 ' A' ' 14' ' ' ILE . . . -148.25 145.91 28.41 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.63 0.728 . . . . 0.0 111.323 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.566 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 2.3 mm-40 -81.17 76.04 8.13 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.386 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.642 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 54.9 m -64.99 130.44 43.37 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.306 0.574 . . . . 0.0 111.336 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.435 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 3.8 tmm_? -72.18 118.88 15.61 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.394 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 14.0 ptm180 -87.17 156.44 19.69 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -50.92 -20.44 4.32 Favored Glycine 0 C--N 1.339 0.702 0 O-C-N 124.672 1.232 . . . . 0.0 114.768 -177.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -72.22 -9.96 59.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.236 0.541 . . . . 0.0 110.057 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.13 6.43 63.15 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.408 ' O ' ' HG2' ' A' ' 27' ' ' ARG . . . -106.36 164.9 13.53 Favored Glycine 0 C--O 1.224 -0.506 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.524 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.566 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 71.0 m-85 -101.61 130.34 47.92 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.878 0.37 . . . . 0.0 110.912 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.4 m -119.1 133.46 55.78 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.873 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.8 m -71.48 110.4 6.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.279 0.561 . . . . 0.0 111.079 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.4 t -113.61 150.88 32.46 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.665 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.611 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 5.1 p -144.88 137.02 21.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.937 0.399 . . . . 0.0 110.676 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.431 HG21 ' HB3' ' A' ' 21' ' ' LEU . 10.6 tt -133.98 144.77 34.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.267 -177.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.0 92.71 3.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.025 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.853 HD23 ' HB2' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -71.87 -11.13 60.65 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.139 0.495 . . . . 0.0 110.669 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 26.5 p30 -67.25 -8.64 33.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.909 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.431 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 30.5 ttm180 -108.25 -0.91 20.58 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.729 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.471 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 91.4 m-85 -125.64 -23.03 4.12 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.634 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.602 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 48.7 mt -111.02 137.66 48.39 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.19 0.519 . . . . 0.0 111.207 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.407 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 5.2 m -130.61 146.16 52.06 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.051 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.632 HD21 ' HA ' ' A' ' 120' ' ' PHE . 7.2 p30 -94.91 106.05 18.01 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -102.42 90.03 3.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.976 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.468 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 66.9 t30 52.5 43.23 31.26 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.138 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.555 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 84.75 38.64 9.33 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.644 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -150.9 137.61 18.9 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.702 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 15.0 m-85 -80.51 141.76 34.84 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.298 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -141.03 131.55 25.39 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.487 ' CZ2' ' HA ' ' A' ' 153' ' ' LEU . 86.1 m95 -76.04 136.81 39.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.598 177.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.68 88.01 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.9 m -115.09 30.53 7.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.6 0.714 . . . . 0.0 110.268 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -153.87 47.69 0.53 Allowed Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.182 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -129.2 144.67 15.63 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.795 -0.716 . . . . 0.0 111.992 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -120.21 -156.96 10.06 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.486 -0.645 . . . . 0.0 111.486 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.21 -118.02 1.4 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.031 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.01 -142.03 6.28 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.12 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -130.0 84.27 0.32 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.279 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 108' ' ' PRO . . . -145.59 -125.97 1.79 Allowed Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 91.0 m -140.81 118.0 11.3 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.168 0.508 . . . . 0.0 110.467 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.45 ' HB2' ' HG2' ' A' ' 110' ' ' LYS . . . -132.89 177.9 7.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.743 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.422 HG21 ' HG2' ' A' ' 106' ' ' GLN . 11.5 p -128.8 115.78 18.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.72 0.295 . . . . 0.0 111.284 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.487 HG22 ' CE2' ' A' ' 80' ' ' PHE . 12.0 p -102.07 145.41 11.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.066 0.46 . . . . 0.0 111.447 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 3.8 m -92.96 131.33 38.06 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.938 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.534 HG22 HD13 ' A' ' 99' ' ' ILE . 49.2 t -83.31 135.62 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.808 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -102.63 169.42 8.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 124.349 1.03 . . . . 0.0 111.051 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.632 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 6.5 tp-100 -63.39 116.66 5.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.389 -178.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.68 -16.47 58.67 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.96 -0.564 . . . . 0.0 113.151 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -82.38 134.96 35.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.027 0.441 . . . . 0.0 110.979 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.587 ' HA ' HG12 ' A' ' 99' ' ' ILE . 68.6 p -113.37 178.64 4.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.692 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.552 HD23 ' O ' ' A' ' 95' ' ' ASN . 1.7 mm? -52.96 -41.18 64.29 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.216 0.532 . . . . 0.0 110.198 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.507 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 43.1 ttm105 -65.65 -36.88 84.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.282 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -68.47 -39.4 81.42 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 72' ' ' THR . 42.2 mm -66.41 -49.55 74.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.504 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.765 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -58.07 -45.84 93.38 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.67 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 78' ' ' ARG . 24.8 ttm180 -64.68 -37.24 86.9 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.899 0.381 . . . . 0.0 111.815 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -77.92 -33.87 51.56 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.647 ' HB2' ' HG ' ' A' ' 82' ' ' CYS . 96.4 m-85 -110.3 20.46 17.79 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.5 t0 53.87 46.32 25.95 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.9 0.857 . . . . 0.0 111.135 178.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.765 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.8 p -130.09 170.77 13.59 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.425 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.602 ' O ' HG13 ' A' ' 87' ' ' ILE . 6.2 t70 -100.16 122.55 43.17 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.507 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 8.8 p90 -51.09 -30.19 15.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.512 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -63.67 -48.1 78.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.62 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.696 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 16.5 mm-40 -67.7 -43.39 80.2 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.337 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.602 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.3 mt -53.68 -48.36 60.38 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.773 0.797 . . . . 0.0 109.01 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.623 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.17 -48.43 78.42 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.827 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -37.85 78.19 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.696 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 68.7 mmt-85 -67.92 -33.6 75.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.822 0.344 . . . . 0.0 110.994 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.523 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 11.4 t-20 -92.8 -5.33 51.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.535 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.523 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 5.6 m-20 78.2 15.3 1.4 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.359 0.664 . . . . 0.0 111.031 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.623 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 15.4 pt -100.83 -177.78 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.603 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . 16.7 mm100 -110.83 152.51 26.59 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.022 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.552 ' O ' HD23 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -53.87 -68.71 0.16 Allowed 'General case' 0 C--O 1.243 0.711 0 CA-C-O 122.194 0.997 . . . . 0.0 110.252 179.688 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -73.75 13.4 0.5 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.547 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.603 ' HB2' ' HB2' ' A' ' 94' ' ' GLN . 7.3 t70 -66.84 -31.79 72.64 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 8.5 mp 73.97 114.17 0.06 Allowed 'General case' 0 N--CA 1.463 0.206 0 O-C-N 124.361 1.038 . . . . 0.0 109.829 -177.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.587 HG12 ' HA ' ' A' ' 72' ' ' THR . 7.1 pt -94.61 176.36 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.651 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.514 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 92.3 m-85 -123.25 160.04 51.91 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.598 -178.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.632 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 42.1 Cg_endo -70.55 139.19 36.93 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 123.43 2.753 . . . . 0.0 113.716 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.6 9.56 61.28 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.475 ' O ' ' HA ' ' A' ' 66' ' ' THR . 27.1 tt0 -94.09 162.85 13.71 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 115.16 -0.52 . . . . 0.0 109.754 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 72.9 t -127.43 118.95 50.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.417 ' HB3' HG23 ' A' ' 87' ' ' ILE . 69.8 mt -115.38 151.66 34.26 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.124 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.422 ' HG2' HG21 ' A' ' 64' ' ' THR . 71.8 mt-30 -89.65 118.33 29.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.67 0.747 . . . . 0.0 110.987 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.403 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 29.6 m -125.19 151.88 70.08 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.43 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 29.9 Cg_endo -62.92 -16.89 56.96 Favored 'Trans proline' 0 N--CA 1.472 0.253 0 C-N-CA 123.196 2.597 . . . . 0.0 114.392 -177.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.4 t -160.81 150.88 17.64 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.035 0.445 . . . . 0.0 111.056 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.45 ' HG2' ' HB2' ' A' ' 63' ' ' ALA . 11.9 mmmm -93.32 -171.97 2.8 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.6 -43.65 94.1 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.09 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -116.72 -155.65 10.41 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.1 p -66.89 -47.55 71.45 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.325 0.583 . . . . 0.0 110.892 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.56 -60.12 0.34 Allowed Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.799 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -164.17 129.93 2.1 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.223 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.27 60.64 2.34 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.502 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -98.77 -29.68 12.86 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.197 0.522 . . . . 0.0 110.281 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . -106.63 -56.3 0.64 Allowed Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.396 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.6 m120 69.42 31.18 3.89 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 122.943 0.497 . . . . 0.0 111.96 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.632 ' HA ' HD21 ' A' ' 45' ' ' ASN . 24.0 p90 -59.38 -35.78 74.58 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.515 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 57.5 t-105 -64.97 -33.23 75.53 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.826 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.52 -22.69 45.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.293 0.568 . . . . 0.0 110.954 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.723 ' OG ' ' HB3' ' A' ' 141' ' ' ARG . 47.9 t -133.64 23.98 4.01 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.179 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.515 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -111.02 144.5 40.04 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.334 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.598 ' HB2' ' CZ3' ' A' ' 146' ' ' TRP . 0.1 OUTLIER -129.52 128.03 41.99 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.421 ' N ' ' HD3' ' A' ' 125' ' ' ARG . 24.6 t0 56.94 62.92 2.07 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 124.071 0.857 . . . . 0.0 111.626 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.54 ' CG1' HD11 ' A' ' 136' ' ' LEU . 60.5 t -76.06 131.05 35.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.525 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -140.88 138.42 33.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.449 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.661 HD23 HD13 ' A' ' 153' ' ' LEU . 13.7 mt -86.91 131.9 33.97 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 177.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.644 HG23 ' HB ' ' A' ' 135' ' ' VAL . 33.9 m -128.74 158.61 41.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.213 0.53 . . . . 0.0 111.189 -178.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 67.46 11.54 8.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.014 -0.993 . . . . 0.0 111.889 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.7 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 92.73 31.22 8.87 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.203 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.723 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 88.23 -16.62 51.7 Favored Glycine 0 C--O 1.263 1.944 0 CA-C-O 123.441 1.578 . . . . 0.0 112.687 177.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.861 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 14.8 ptpt -68.09 -16.42 64.01 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 121.381 -1.07 . . . . 0.0 109.1 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.644 ' HB ' HG23 ' A' ' 130' ' ' VAL . 14.3 t -140.55 141.76 31.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.981 177.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.54 HD11 ' CG1' ' A' ' 127' ' ' VAL . 42.6 tp -120.53 126.88 51.45 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -120.16 134.64 55.21 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.746 0.308 . . . . 0.0 110.455 -177.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.405 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . . . -160.63 158.98 29.85 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.675 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -95.05 108.68 20.77 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.555 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 56.0 mt -94.19 131.29 39.91 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.699 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.723 ' HB3' ' OG ' ' A' ' 123' ' ' SER . 65.2 ttt180 -73.46 141.23 46.85 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.443 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.621 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 0.8 OUTLIER -154.56 -170.68 3.6 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.583 -179.748 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.2 m -58.34 -26.55 63.24 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -95.0 6.25 69.19 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.389 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 141' ' ' ARG . . . 111.26 -112.49 3.19 Favored Glycine 0 C--O 1.224 -0.491 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.746 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.598 ' CZ3' ' HB2' ' A' ' 125' ' ' ARG . 93.4 m95 -124.85 126.04 44.94 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.621 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 60.6 t30 -118.27 140.27 50.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.445 -178.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -73.55 104.74 4.62 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.2 m -118.55 156.3 29.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.577 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 17.4 ptt180 -148.79 163.43 37.38 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.535 -0.466 . . . . 0.0 112.16 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.702 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 8.9 tt -148.42 144.77 18.71 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.612 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.608 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.603 ' CB ' ' HG3' ' A' ' 155' ' ' GLU . 38.0 m-85 -88.76 104.42 16.88 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 122.154 -0.341 . . . . 0.0 110.929 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.661 HD13 HD23 ' A' ' 129' ' ' LEU . 27.8 mt -66.69 -35.31 79.83 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.904 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.861 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 4.8 t0 -55.91 -10.24 0.74 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.947 178.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.603 ' HG3' ' CB ' ' A' ' 152' ' ' TYR . 45.4 mt-10 -71.74 -55.09 8.29 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -125.22 8.58 7.91 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.884 -0.726 . . . . 0.0 112.388 -176.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.447 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 41.1 mm -106.65 107.81 23.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 167' ' ' CYS . . . -110.54 178.04 19.73 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.656 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.642 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -117.75 134.44 54.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.893 0.377 . . . . 0.0 110.808 179.364 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.447 ' HB2' HD13 ' A' ' 165' ' ' ILE . 43.9 ttm180 -125.2 92.68 3.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.363 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 66.9 t30 57.9 46.35 16.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.83 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.441 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 87.52 11.56 68.55 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.613 178.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -122.69 133.03 54.51 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 117.19 0.495 . . . . 0.0 110.956 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.478 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 29.7 mt -76.03 122.59 24.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.471 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.447 HD13 ' HB2' ' A' ' 160' ' ' ARG . 43.7 pt -138.96 -174.55 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.646 0.736 . . . . 0.0 111.765 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -95.08 110.98 22.84 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.133 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.56 ' SG ' ' HB3' ' A' ' 4' ' ' ALA . 53.6 t . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.501 -0.761 . . . . 0.0 111.034 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.665 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.403 ' HB3' ' HD1' ' A' ' 3' ' ' TYR . 21.6 m-80 -138.25 -75.64 0.39 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.555 ' CD1' ' HG2' ' A' ' 155' ' ' GLU . 64.7 m-85 -128.7 -97.0 0.39 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.878 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.72 -27.89 11.52 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -71.02 -73.87 0.76 Allowed Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 119.068 -1.539 . . . . 0.0 112.16 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 65.44 23.07 11.94 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 122.711 0.404 . . . . 0.0 110.145 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.777 ' HD2' HD12 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -64.62 -34.96 79.51 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.531 179.725 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.416 ' HA ' HD11 ' A' ' 14' ' ' ILE . 28.8 t -66.02 -15.47 63.06 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.487 0.66 . . . . 0.0 109.916 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.55 -28.42 72.34 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.113 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 28.6 m -136.33 -3.22 2.18 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 117.413 0.607 . . . . 0.0 111.494 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.422 ' OG ' ' HB3' ' A' ' 23' ' ' ALA . 6.0 t -105.92 133.72 50.19 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.471 ' CG ' ' HB2' ' A' ' 24' ' ' GLU . 14.9 ptm180 -112.02 -176.39 2.91 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 42.61 44.52 3.68 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 124.04 0.837 . . . . 0.0 112.177 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.63 HG22 ' HA3' ' A' ' 133' ' ' GLY . 6.4 mt -78.17 102.86 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-O 121.012 0.434 . . . . 0.0 109.886 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.537 ' HA ' HD11 ' A' ' 129' ' ' LEU . 80.0 m -147.35 126.1 12.63 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.685 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -89.12 153.57 20.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.007 0.908 . . . . 0.0 113.191 -178.322 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.651 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 21.3 t70 -92.96 72.07 4.72 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 113.726 -1.579 . . . . 0.0 107.166 177.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.56 -56.69 5.03 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.939 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -148.56 -12.1 0.34 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.651 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 56.3 mtp180 -84.4 89.51 7.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.017 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.859 HD21 HD13 ' A' ' 153' ' ' LEU . 42.6 tp -57.24 123.46 15.41 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.155 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.58 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 22.2 ttp180 -125.74 134.73 51.67 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.141 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.518 ' HB3' HG12 ' A' ' 14' ' ' ILE . . . -155.63 141.69 18.28 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.695 0.759 . . . . 0.0 111.363 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.471 ' HB2' ' CG ' ' A' ' 12' ' ' ARG . 78.2 mm-40 -78.93 79.58 5.32 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.367 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.736 ' SG ' HD13 ' A' ' 164' ' ' LEU . 25.6 m -67.09 122.49 17.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.183 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 10' ' ' SER . 58.1 ttt-85 -68.69 118.85 12.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.391 178.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.1 ttt180 -88.0 155.1 20.0 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -47.25 -25.05 2.59 Favored Glycine 0 N--CA 1.463 0.459 0 O-C-N 124.598 1.187 . . . . 0.0 115.533 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -75.24 -5.77 46.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.205 0.526 . . . . 0.0 110.89 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.85 5.98 65.86 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -101.63 135.22 12.08 Favored Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.585 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.432 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 94.8 m-85 -87.81 130.52 34.84 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.776 0.322 . . . . 0.0 110.366 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 41.7 m -118.08 137.05 53.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.525 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.5 m -71.18 111.25 6.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.286 0.565 . . . . 0.0 111.16 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 162' ' ' GLY . 32.3 t -117.46 149.75 40.06 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.474 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.7 p -144.77 137.02 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.969 0.414 . . . . 0.0 111.633 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.632 HG21 HD22 ' A' ' 164' ' ' LEU . 12.4 tt -135.36 148.14 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.32 -178.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.462 ' OD2' ' HB3' ' A' ' 40' ' ' ASN . 25.2 t70 -81.89 109.24 16.08 Favored 'General case' 0 CA--C 1.516 -0.363 0 O-C-N 121.938 -0.476 . . . . 0.0 111.3 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.608 HD23 ' HB3' ' A' ' 21' ' ' LEU . 3.4 mm? -88.3 0.93 55.59 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.119 0.485 . . . . 0.0 110.092 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.462 ' HB3' ' OD2' ' A' ' 38' ' ' ASP . 26.2 t-20 -73.86 -24.5 59.76 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.684 ' HG2' ' H ' ' A' ' 116' ' ' GLY . 60.7 mtt85 -100.63 13.41 34.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.248 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -132.02 -31.24 1.5 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.295 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.57 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 49.3 mt -105.85 134.79 48.41 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.999 0.428 . . . . 0.0 110.8 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.54 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 1.9 m -126.79 146.36 50.28 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.288 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.721 HD21 ' HA ' ' A' ' 120' ' ' PHE . 8.0 p30 -91.98 100.93 13.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.743 0.782 . . . . 0.0 109.498 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -100.89 94.06 5.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.042 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.409 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 64.3 t30 52.18 43.87 30.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.486 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.717 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 80.29 41.09 12.19 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.644 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.45 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 34.3 t-80 -160.69 127.69 4.23 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.696 ' HB2' ' HB ' ' A' ' 151' ' ' ILE . 87.6 m-85 -67.52 151.44 47.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.892 0.377 . . . . 0.0 111.547 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -148.39 130.47 15.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.038 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -76.1 120.4 21.36 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.094 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.0 m -107.68 113.39 43.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.244 0.545 . . . . 0.0 110.847 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.4 m -82.93 60.21 5.29 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.828 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.21 64.51 1.46 Allowed Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.224 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.98 58.36 4.93 Favored Glycine 0 CA--C 1.518 0.225 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.408 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.9 -156.85 29.05 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.703 ' HA2' ' HB3' ' A' ' 113' ' ' SER . . . 124.52 174.59 14.09 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.477 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.43 154.96 12.8 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.811 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.48 -168.01 16.07 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.797 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 108' ' ' PRO . . . 84.51 -100.54 2.38 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.652 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.9 m -122.1 114.48 20.97 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.016 0.436 . . . . 0.0 110.005 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.35 176.14 6.04 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.966 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.4 p -130.93 125.49 33.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.599 0.238 . . . . 0.0 111.111 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.583 HG23 ' CE2' ' A' ' 80' ' ' PHE . 8.4 p -115.46 143.33 25.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.959 0.409 . . . . 0.0 111.285 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 16.3 m -88.53 127.11 35.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.087 0.47 . . . . 0.0 109.873 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.49 ' CG2' HD11 ' A' ' 99' ' ' ILE . 43.7 t -75.92 134.57 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.788 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -104.48 169.54 8.41 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 124.541 1.15 . . . . 0.0 111.451 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.622 ' OE1' ' HG3' ' A' ' 101' ' ' PRO . 51.0 tp60 -64.25 116.06 5.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.55 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.78 -4.56 57.85 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.291 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.39 122.4 43.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.764 0.316 . . . . 0.0 110.92 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.694 ' HA ' HG12 ' A' ' 99' ' ' ILE . 75.5 p -105.37 -177.83 3.48 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.536 HD13 ' HB ' ' A' ' 87' ' ' ILE . 1.4 mm? -52.58 -41.85 63.97 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 121.396 0.617 . . . . 0.0 109.384 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.403 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 39.4 ttm180 -64.34 -37.95 89.32 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.091 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -73.08 -38.59 66.35 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.102 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 72' ' ' THR . 46.0 mm -64.81 -48.21 85.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.649 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -54.65 -53.64 37.81 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.718 -0.674 . . . . 0.0 113.03 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -68.25 -25.23 65.08 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -78.35 -41.99 31.85 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.583 ' CE2' HG23 ' A' ' 65' ' ' VAL . 89.2 m-85 -107.6 12.71 27.39 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.4 t70 61.31 52.61 3.78 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.804 0.811 . . . . 0.0 111.046 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.649 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.0 p -134.72 169.66 17.0 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.403 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.635 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.6 t70 -95.94 121.08 37.3 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.708 -0.397 . . . . 0.0 109.992 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.585 ' HD2' ' HB2' ' A' ' 95' ' ' ASN . 17.7 p90 -50.63 -31.31 15.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.923 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.78 -42.87 76.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.309 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.688 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 11.6 mm-40 -68.22 -43.87 77.0 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.635 HG13 ' O ' ' A' ' 83' ' ' ASP . 6.5 mt -53.5 -47.82 59.06 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-O 121.435 0.636 . . . . 0.0 109.474 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.627 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.18 -50.88 70.06 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.529 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -59.98 -36.18 76.6 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.688 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 83.3 mmt-85 -68.08 -34.81 77.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.991 0.424 . . . . 0.0 110.622 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 4.5 t30 -91.3 -5.06 55.23 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.805 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 0.9 OUTLIER 78.55 13.48 1.42 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.451 179.385 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.627 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 19.0 pt -98.74 -171.36 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -117.84 151.17 37.89 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.253 -0.28 . . . . 0.0 110.548 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.585 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 21.1 p-10 -53.07 -56.97 12.13 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-O 122.088 0.947 . . . . 0.0 109.294 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -75.96 6.82 4.65 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.425 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -66.55 -35.8 81.11 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.4 mp 67.62 115.13 0.03 OUTLIER 'General case' 0 C--O 1.235 0.332 0 CA-C-O 122.138 0.971 . . . . 0.0 109.987 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.694 HG12 ' HA ' ' A' ' 72' ' ' THR . 7.8 pt -93.74 174.96 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.038 -177.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.539 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 64.4 m-85 -127.15 160.6 58.85 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.689 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.622 ' HG3' ' OE1' ' A' ' 69' ' ' GLN . 34.8 Cg_endo -67.22 137.6 44.31 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.063 2.509 . . . . 0.0 113.941 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.49 17.9 32.29 Favored Glycine 0 N--CA 1.44 -1.075 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.707 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.547 ' O ' ' HA ' ' A' ' 66' ' ' THR . 45.7 mt-30 -106.83 165.06 11.6 Favored 'General case' 0 C--O 1.216 -0.682 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.864 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.3 t -125.81 110.03 23.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.606 HD11 HG23 ' A' ' 99' ' ' ILE . 63.8 mt -105.25 152.01 23.41 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.21 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.426 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 38.5 mt-30 -89.84 114.6 26.37 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.747 0.784 . . . . 0.0 110.415 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.0 m -117.88 150.55 47.37 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.71 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 41.8 Cg_endo -68.44 -16.34 43.05 Favored 'Trans proline' 0 C--N 1.331 -0.375 0 C-N-CA 123.004 2.469 . . . . 0.0 113.387 -178.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.4 t -156.78 148.7 22.82 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.001 0.429 . . . . 0.0 110.318 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -92.19 -172.81 3.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.484 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -80.22 -78.21 0.92 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.466 -0.874 . . . . 0.0 111.721 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -102.97 103.48 2.4 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.965 -0.635 . . . . 0.0 111.568 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.703 ' HB3' ' HA2' ' A' ' 58' ' ' GLY . 24.5 m -61.56 -40.84 96.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.792 0.33 . . . . 0.0 110.818 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -82.27 40.76 2.73 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.293 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -72.59 98.43 0.84 Allowed Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.684 ' H ' ' HG2' ' A' ' 41' ' ' ARG . . . 81.06 53.3 3.97 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -80.05 -29.07 39.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.013 -0.594 . . . . 0.0 110.61 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.54 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -105.75 -68.51 0.71 Allowed Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.379 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 71.14 30.14 2.73 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 122.903 0.481 . . . . 0.0 111.215 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.721 ' HA ' HD21 ' A' ' 45' ' ' ASN . 25.6 p90 -57.44 -39.06 75.44 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.52 ' HA ' ' HB2' ' A' ' 124' ' ' ALA . 67.6 t-105 -62.33 -34.58 76.91 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.915 -1.038 . . . . 0.0 111.966 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.83 -25.69 20.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.986 0.422 . . . . 0.0 111.369 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.76 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 19.3 m -134.28 29.46 3.66 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.037 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.52 ' HB2' ' HA ' ' A' ' 121' ' ' TRP . . . -115.73 141.13 48.49 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.193 0.521 . . . . 0.0 111.48 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -129.77 149.32 51.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.07 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.06 50.58 16.33 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 123.614 0.571 . . . . 0.0 110.83 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.488 ' HA ' ' HB1' ' A' ' 138' ' ' ALA . 30.2 t -80.74 117.89 27.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.883 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 35.4 ptt85 -145.89 144.57 30.28 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.191 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.543 HD13 HG21 ' A' ' 14' ' ' ILE . 23.4 mt -84.61 131.12 34.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.291 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.456 HG22 ' HB ' ' A' ' 135' ' ' VAL . 34.4 m -126.54 167.57 20.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.403 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.566 ' HB3' ' CE ' ' A' ' 134' ' ' LYS . 1.2 m-20 64.45 10.18 5.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.612 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.629 ' O ' HD13 ' A' ' 14' ' ' ILE . . . 93.82 24.34 20.66 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.848 -0.692 . . . . 0.0 113.481 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.63 ' HA3' HG22 ' A' ' 14' ' ' ILE . . . 94.64 -18.88 56.24 Favored Glycine 0 C--O 1.268 2.241 0 CA-C-O 123.803 1.779 . . . . 0.0 111.914 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.699 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 65.4 pttt -69.52 -14.21 62.74 Favored 'General case' 0 C--N 1.313 -1.018 0 O-C-N 121.598 -0.942 . . . . 0.0 108.769 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.625 HG23 ' HG3' ' A' ' 134' ' ' LYS . 23.5 t -139.47 137.18 40.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 121.355 0.597 . . . . 0.0 110.513 177.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 30.3 tp -117.31 121.97 42.62 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.521 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 35.8 tt0 -115.01 134.81 54.87 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.864 0.364 . . . . 0.0 111.46 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.695 ' HB2' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.42 163.11 27.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.569 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 41.7 mt-10 -94.53 108.43 20.38 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.717 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 59.7 mt -94.99 130.59 41.59 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.338 0.59 . . . . 0.0 110.753 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.76 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 73.5 ttt180 -70.73 140.66 51.46 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.88 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.478 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 5.6 p90 -158.3 -171.91 3.67 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 18.4 m -54.85 -30.52 57.8 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.3 18.51 56.39 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.369 -0.92 . . . . 0.0 113.723 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 103.9 -120.67 6.77 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.278 -0.963 . . . . 0.0 112.332 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -123.57 124.28 42.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.944 0.372 . . . . 0.0 110.601 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.478 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 27.3 t-20 -118.81 125.83 50.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.465 ' HD3' ' OE2' ' A' ' 137' ' ' GLU . 55.1 ttm-85 -74.74 99.24 3.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.245 0.545 . . . . 0.0 110.033 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.45 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 7.3 t -112.3 173.08 6.54 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.105 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.529 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 15.6 mtm180 -145.2 163.84 33.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.107 0.479 . . . . 0.0 111.398 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.696 ' HB ' ' HB2' ' A' ' 50' ' ' PHE . 9.1 tt -143.24 148.98 18.74 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.392 178.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.583 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 12.6 m-85 -92.06 103.93 16.38 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 122.028 -0.42 . . . . 0.0 110.964 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.859 HD13 HD21 ' A' ' 21' ' ' LEU . 22.5 mt -67.15 -34.14 76.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.111 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.699 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 7.7 t70 -58.32 -7.76 0.96 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.274 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.555 ' HG2' ' CD1' ' A' ' 3' ' ' TYR . 40.5 mt-10 -72.39 -51.03 22.25 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 121.91 -0.494 . . . . 0.0 111.976 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -119.26 -5.6 10.41 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 120.499 -0.481 . . . . 0.0 112.285 -177.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.465 ' CG2' ' HG ' ' A' ' 164' ' ' LEU . 48.9 mm -100.21 114.23 38.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.841 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.454 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -118.79 176.44 16.09 Favored Glycine 0 C--O 1.225 -0.422 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.289 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.566 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.0 t30 -112.1 123.81 51.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.943 0.401 . . . . 0.0 110.149 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -118.63 85.88 2.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.928 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 52.2 43.72 30.36 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.479 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 103.29 -4.82 48.41 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.294 -0.955 . . . . 0.0 114.085 178.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -121.92 129.43 52.53 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 117.223 0.512 . . . . 0.0 111.426 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.777 HD12 ' HD2' ' A' ' 7' ' ' PHE . 1.8 tp -71.12 113.32 8.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.553 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.432 HG13 ' N ' ' A' ' 166' ' ' HIS . 11.0 tp -102.78 164.55 3.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.392 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.432 ' N ' HG13 ' A' ' 165' ' ' ILE . 39.4 p-80 -125.72 130.32 51.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.736 0.303 . . . . 0.0 110.386 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 40.6 t . . . . . 0 C--O 1.251 1.181 0 CA-C-O 118.905 -0.569 . . . . 0.0 109.798 179.791 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.738 0 N-CA-C 111.884 -0.487 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.81 -73.6 0.39 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.739 0.304 . . . . 0.0 111.741 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -130.12 -88.02 0.5 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -111.8 -25.41 9.48 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -66.8 -72.75 0.72 Allowed Glycine 0 N--CA 1.433 -1.503 0 C-N-CA 119.366 -1.397 . . . . 0.0 112.405 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 60.69 17.16 7.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.74 0.305 . . . . 0.0 110.725 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.69 ' CE2' HD12 ' A' ' 14' ' ' ILE . 0.4 OUTLIER -60.92 -32.57 72.05 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.398 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.484 ' OG ' ' HG2' ' A' ' 134' ' ' LYS . 23.1 t -66.0 -19.84 65.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.037 0.446 . . . . 0.0 110.375 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.7 -20.6 78.69 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.079 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 51.2 p -129.4 -24.66 2.77 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 117.241 0.521 . . . . 0.0 111.375 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.43 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 5.9 m -96.71 130.88 43.86 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -115.07 -174.18 2.45 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 47.69 40.77 12.65 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 123.513 0.508 . . . . 0.0 111.225 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.69 HD12 ' CE2' ' A' ' 7' ' ' PHE . 7.7 mt -80.71 103.31 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-O 120.832 0.348 . . . . 0.0 110.164 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.585 ' HA ' HD13 ' A' ' 129' ' ' LEU . 79.0 m -146.9 128.09 14.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.809 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.709 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -99.41 152.89 19.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.701 0.762 . . . . 0.0 112.956 -179.844 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -93.85 75.87 4.22 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.33 -55.08 4.82 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.542 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.572 ' HB2' ' HB2' ' A' ' 40' ' ' ASN . . . -148.69 -7.86 0.38 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.901 0.381 . . . . 0.0 110.507 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.41 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 3.4 mmm-85 -89.27 90.53 8.38 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.748 ' HB2' HD21 ' A' ' 39' ' ' LEU . 55.0 tp -62.67 127.79 32.92 Favored 'General case' 0 C--O 1.213 -0.839 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.562 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 42.9 ttt180 -133.34 131.75 40.48 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.441 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.632 ' HB3' HG12 ' A' ' 14' ' ' ILE . . . -150.84 145.93 26.01 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.744 0.783 . . . . 0.0 111.516 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.502 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 1.7 mm-40 -82.97 74.58 9.92 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.34 178.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.542 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 60.0 m -60.74 124.2 19.72 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.143 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 10' ' ' SER . 19.7 ttp180 -70.57 127.43 32.66 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.13 0.491 . . . . 0.0 110.749 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.467 ' HG3' ' CG ' ' A' ' 161' ' ' ASN . 37.2 ttp180 -97.29 151.9 19.42 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.32 -15.86 1.96 Allowed Glycine 0 N--CA 1.46 0.278 0 O-C-N 124.717 1.261 . . . . 0.0 115.006 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -75.96 -9.01 58.26 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.054 0.454 . . . . 0.0 110.432 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.66 6.86 60.59 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -112.27 161.69 12.64 Favored Glycine 0 C--O 1.224 -0.525 0 C-N-CA 120.455 -0.878 . . . . 0.0 112.202 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.502 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 86.2 m-85 -100.38 139.1 36.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.005 0.403 . . . . 0.0 110.856 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.1 t -122.89 120.64 34.05 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 m -63.73 115.53 4.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.157 0.503 . . . . 0.0 110.487 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.4 t -120.99 152.82 38.11 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.063 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.562 ' HB ' ' HG3' ' A' ' 22' ' ' ARG . 3.2 p -145.05 138.66 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 120.855 0.359 . . . . 0.0 111.433 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.5 tt -135.5 147.8 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.486 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -80.74 105.34 11.9 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.748 HD21 ' HB2' ' A' ' 21' ' ' LEU . 1.5 tp -84.71 -6.14 59.35 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.441 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.572 ' HB2' ' HB2' ' A' ' 19' ' ' ALA . 64.2 t30 -73.45 -14.31 61.22 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.91 ' HG2' ' HA3' ' A' ' 116' ' ' GLY . 98.1 mtt180 -105.88 15.37 26.74 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.427 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 66.3 m-85 -131.44 -32.67 1.52 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.635 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.613 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 33.2 mt -106.48 136.49 46.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.025 0.441 . . . . 0.0 111.423 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.795 ' HG ' ' HA2' ' A' ' 118' ' ' GLY . 9.0 m -125.74 146.81 49.6 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.701 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.591 ' ND2' ' HB2' ' A' ' 123' ' ' SER . 21.4 p-10 -95.13 93.7 7.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.669 0.747 . . . . 0.0 109.585 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -94.64 95.83 9.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.059 0.457 . . . . 0.0 111.758 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.431 ' HA ' ' HB2' ' A' ' 142' ' ' TYR . 62.5 t30 47.67 44.19 17.23 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.172 178.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.78 34.04 14.32 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.751 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -150.61 131.12 13.85 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.817 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 24.8 m-85 -75.34 138.3 41.68 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.8 mtt-85 -140.7 136.38 32.55 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.5 ' CH2' HG12 ' A' ' 157' ' ' ILE . 98.2 m95 -76.01 107.23 8.07 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.353 177.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.44 ' HB ' ' OG ' ' A' ' 44' ' ' SER . 92.5 t -133.52 129.1 55.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.861 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.7 m -122.25 12.42 10.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.111 0.482 . . . . 0.0 110.605 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.32 -76.71 1.0 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.173 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.751 ' HA2' ' HA ' ' A' ' 117' ' ' ALA . . . 172.95 177.82 42.51 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.522 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.04 -170.01 43.04 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -126.41 153.34 18.63 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.299 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -148.28 -140.63 3.36 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.24 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.2 35.84 0.32 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.981 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.93 -105.24 1.33 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.492 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.0 m -138.28 114.11 9.9 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.92 0.391 . . . . 0.0 110.281 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.89 177.37 4.99 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.164 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.526 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 10.6 p -127.7 117.08 21.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.856 0.36 . . . . 0.0 110.835 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.448 HG21 ' CE2' ' A' ' 80' ' ' PHE . 8.9 p -103.0 142.29 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.19 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 24.9 m -88.1 127.67 35.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.249 0.547 . . . . 0.0 110.095 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.505 HG21 HD11 ' A' ' 99' ' ' ILE . 48.7 t -79.16 134.67 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.364 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -107.4 171.08 7.58 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.307 1.004 . . . . 0.0 109.458 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.67 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 59.4 tt0 -65.85 123.18 19.1 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.794 -178.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.12 -4.23 58.71 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.348 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -105.77 122.68 46.57 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.89 0.376 . . . . 0.0 111.132 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.644 ' HA ' HG12 ' A' ' 99' ' ' ILE . 68.5 p -106.49 179.94 4.12 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.528 HD11 ' HB ' ' A' ' 87' ' ' ILE . 1.5 mm? -51.66 -43.4 62.65 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.461 0.648 . . . . 0.0 109.752 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -60.65 -38.98 86.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.424 -178.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -72.18 -45.67 59.43 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 72' ' ' THR . 45.0 mm -57.82 -47.66 85.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.003 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.667 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.19 -53.05 47.67 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.109 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -69.73 -26.43 64.32 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 122.469 -0.43 . . . . 0.0 111.786 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -75.87 -38.84 57.52 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.06 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.6 ' HB2' ' HG ' ' A' ' 82' ' ' CYS . 72.4 m-85 -111.16 19.62 18.2 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.7 t70 53.25 47.91 23.26 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.548 0.69 . . . . 0.0 111.783 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.667 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 3.3 p -127.88 171.05 12.14 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.637 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.1 t0 -96.75 117.89 32.03 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.707 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.425 ' HA ' HD11 ' A' ' 87' ' ' ILE . 3.3 p90 -50.49 -33.19 20.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.909 -1.042 . . . . 0.0 111.803 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.93 -41.44 91.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.17 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.645 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 33.0 tt0 -71.78 -46.64 57.7 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.695 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.637 HG13 ' O ' ' A' ' 83' ' ' ASP . 6.5 mt -49.7 -45.74 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.615 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.22 -51.1 69.13 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.416 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -63.67 -28.93 70.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.645 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 22.1 mmt180 -65.08 -39.79 93.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.288 0.566 . . . . 0.0 110.248 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 12.5 m120 -94.12 -3.6 50.76 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.677 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 93.7 m-20 79.08 11.01 1.51 Allowed 'General case' 0 N--CA 1.47 0.571 0 O-C-N 123.859 0.724 . . . . 0.0 111.455 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.615 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 18.9 pt -93.92 -173.48 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.484 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . 30.1 mm-40 -114.81 157.6 23.04 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 122.108 -0.37 . . . . 0.0 110.636 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.509 ' O ' HD22 ' A' ' 73' ' ' LEU . 3.4 p30 -55.62 -69.05 0.15 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.836 0.826 . . . . 0.0 109.728 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.417 ' H ' ' CG ' ' A' ' 95' ' ' ASN . 0.6 OUTLIER -74.59 13.43 0.62 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.335 179.623 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.484 ' HB2' ' HB2' ' A' ' 94' ' ' GLN . 5.6 t70 -64.3 -30.16 71.22 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.1 mp 68.55 113.5 0.04 OUTLIER 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.195 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.644 HG12 ' HA ' ' A' ' 72' ' ' THR . 8.5 pt -93.85 175.83 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.227 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.492 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 85.7 m-85 -125.95 158.06 67.13 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.585 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.67 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 22.3 Cg_endo -67.28 139.16 49.08 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 123.135 2.557 . . . . 0.0 113.395 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.21 23.7 24.0 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.547 ' O ' ' HA ' ' A' ' 66' ' ' THR . 70.4 mt-30 -112.11 166.07 11.57 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.526 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 66.9 t -125.89 110.36 23.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.491 HD12 HG21 ' A' ' 99' ' ' ILE . 75.8 mt -103.95 151.04 23.65 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.4 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.612 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 62.7 mt-30 -90.74 117.58 29.49 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.832 0.825 . . . . 0.0 110.6 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.8 m -125.65 150.56 68.66 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.702 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.38 -19.34 67.91 Favored 'Trans proline' 0 C--N 1.332 -0.325 0 C-N-CA 123.262 2.641 . . . . 0.0 113.722 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.5 t -155.96 149.11 24.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.059 0.457 . . . . 0.0 111.088 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.726 ' HB2' ' HA2' ' A' ' 114' ' ' GLY . 12.4 mmmm -85.73 174.19 9.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.513 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -89.36 69.62 2.53 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 104.14 92.76 2.26 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 43.5 m 75.89 83.23 0.09 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.32 0.581 . . . . 0.0 110.562 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.726 ' HA2' ' HB2' ' A' ' 110' ' ' LYS . . . -60.12 -55.46 30.11 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.092 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.89 -121.94 2.24 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.91 ' HA3' ' HG2' ' A' ' 41' ' ' ARG . . . 174.93 -82.38 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.066 -1.064 . . . . 0.0 113.172 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.751 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . . . -131.49 -35.69 1.3 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.795 ' HA2' ' HG ' ' A' ' 44' ' ' SER . . . -91.76 -66.42 1.14 Allowed Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.726 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 72.02 27.43 2.7 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.406 0.683 . . . . 0.0 111.011 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.613 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 22.6 p90 -60.36 -40.67 91.59 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.087 0.47 . . . . 0.0 109.798 178.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.531 ' HA ' ' HB2' ' A' ' 124' ' ' ALA . 43.1 t-105 -65.29 -28.87 69.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.913 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.17 -19.49 54.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.737 0.303 . . . . 0.0 111.013 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.591 ' HB2' ' ND2' ' A' ' 45' ' ' ASN . 22.9 m -139.15 27.62 2.34 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 120.899 0.381 . . . . 0.0 110.252 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.531 ' HB2' ' HA ' ' A' ' 121' ' ' TRP . . . -110.54 148.26 32.49 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.37 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 125' ' ' ARG . 11.6 ttm180 -133.14 140.28 47.53 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.952 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.428 ' HB3' ' NH2' ' A' ' 128' ' ' ARG . 69.7 m-20 58.04 58.76 3.4 Favored 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 123.787 0.68 . . . . 0.0 111.123 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.484 ' CG1' HD11 ' A' ' 136' ' ' LEU . 40.5 t -86.79 115.88 28.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.839 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.428 ' NH2' ' HB3' ' A' ' 126' ' ' ASP . 0.0 OUTLIER -138.13 145.41 41.57 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.344 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.769 HD22 HD12 ' A' ' 153' ' ' LEU . 16.1 mt -85.23 133.26 34.18 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.747 HG23 ' HB ' ' A' ' 135' ' ' VAL . 27.3 m -125.27 159.37 32.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.347 -179.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.572 ' O ' ' HE2' ' A' ' 134' ' ' LYS . 0.3 OUTLIER 69.99 1.74 3.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.89 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.689 ' O ' HD13 ' A' ' 14' ' ' ILE . . . 94.74 33.37 6.74 Favored Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.097 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.662 ' HA3' HG22 ' A' ' 14' ' ' ILE . . . 94.65 -20.89 46.2 Favored Glycine 0 C--O 1.263 1.936 0 CA-C-O 122.997 1.332 . . . . 0.0 113.21 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.739 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 0.2 OUTLIER -66.77 -16.43 64.25 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 121.307 -1.114 . . . . 0.0 109.214 178.591 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.747 ' HB ' HG23 ' A' ' 130' ' ' VAL . 9.4 t -141.72 145.57 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.262 0.553 . . . . 0.0 109.824 177.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.585 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 30.1 tp -125.72 121.04 32.3 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.448 ' HG3' ' HE ' ' A' ' 150' ' ' ARG . 20.8 tt0 -110.28 135.39 51.09 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.818 0.342 . . . . 0.0 111.632 -177.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.624 ' HB1' ' HZ ' ' A' ' 50' ' ' PHE . . . -163.66 157.14 18.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.541 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -95.81 108.12 20.43 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 45' ' ' ASN . 58.6 mt -92.57 131.45 37.68 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.415 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.504 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 64.3 ttt180 -70.41 139.63 51.88 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.295 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.584 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 4.9 p90 -154.71 -164.11 1.74 Allowed 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.005 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.2 m -62.76 -14.62 46.94 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -125.83 36.45 2.74 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.416 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.77 -122.81 7.32 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.761 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -122.7 125.85 46.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.755 0.312 . . . . 0.0 110.399 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.584 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 46.5 t-20 -111.32 133.84 53.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.616 -178.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -73.49 98.01 2.69 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -113.55 160.66 18.28 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.899 -177.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.585 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 34.0 mtt180 -146.48 158.02 43.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.732 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.817 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 9.2 tt -141.67 142.11 28.98 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.02 178.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.577 ' O ' ' HG3' ' A' ' 155' ' ' GLU . 27.7 m-85 -87.53 102.54 14.68 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.817 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.769 HD12 HD22 ' A' ' 129' ' ' LEU . 22.1 mt -63.96 -34.8 78.8 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.59 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.739 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 5.6 t70 -56.41 -9.4 0.69 Allowed 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.265 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.577 ' HG3' ' O ' ' A' ' 152' ' ' TYR . 40.4 mt-10 -72.27 -52.71 15.08 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 121.923 -0.486 . . . . 0.0 112.287 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.516 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 43.6 m80 -124.43 3.23 8.4 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.549 -177.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.5 HG12 ' CH2' ' A' ' 52' ' ' TRP . 39.7 mm -103.59 108.6 24.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.617 ' HA3' ' OXT' ' A' ' 167' ' ' CYS . . . -116.33 166.44 12.35 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.239 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.542 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.3 t30 -102.22 130.8 48.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.782 0.325 . . . . 0.0 110.232 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 25.7 ttp85 -118.19 85.9 2.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.878 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.467 ' CG ' ' HG3' ' A' ' 27' ' ' ARG . 21.7 t30 53.13 47.22 24.97 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.378 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 96.46 9.05 57.05 Favored Glycine 0 C--O 1.229 -0.185 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.611 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -122.79 142.37 50.81 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.682 HD12 ' CD2' ' A' ' 7' ' ' PHE . 11.8 tp -99.61 111.34 23.69 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.953 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.0 pp -141.27 -170.02 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.417 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.516 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 6.7 p80 -86.66 123.52 31.92 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.256 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.617 ' OXT' ' HA3' ' A' ' 158' ' ' GLY . 51.0 t . . . . . 0 C--O 1.249 1.031 0 O-C-N 123.896 0.748 . . . . 0.0 111.55 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.748 0 N-CA-C 111.546 -0.621 . . . . 0.0 111.546 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -109.72 171.65 7.32 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.783 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 37.0 m-85 -132.88 -65.44 0.71 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.718 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.53 -27.71 0.67 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.457 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 6' ' ' ASN . . . -69.56 -68.74 1.55 Allowed Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 119.931 -1.128 . . . . 0.0 113.643 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 42.1 m-80 68.73 16.98 8.93 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 122.268 0.227 . . . . 0.0 110.497 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.735 ' CD2' HD13 ' A' ' 164' ' ' LEU . 1.2 p90 -64.22 -32.64 74.3 Favored 'General case' 0 C--O 1.218 -0.581 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.032 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.496 ' HA ' HD11 ' A' ' 14' ' ' ILE . 22.7 t -70.37 -16.29 62.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.73 0.776 . . . . 0.0 109.606 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.65 -20.67 73.7 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 115.129 -0.942 . . . . 0.0 113.241 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.539 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 75.5 p -127.49 -22.84 3.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.405 0.602 . . . . 0.0 111.365 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.424 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 9.2 m -98.15 133.98 41.84 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.945 0.402 . . . . 0.0 109.956 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.526 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 35.2 ptt180 -110.54 -177.37 3.22 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.427 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 12.7 m-20 43.85 44.54 5.83 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 123.714 0.634 . . . . 0.0 112.213 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.636 HG12 ' HB1' ' A' ' 23' ' ' ALA . 5.8 mt -78.95 104.86 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -178.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.561 ' HA ' HD12 ' A' ' 129' ' ' LEU . 72.7 m -146.4 126.38 13.66 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.298 0.639 . . . . 0.0 109.651 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.713 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -98.93 152.83 19.35 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.673 0.749 . . . . 0.0 112.773 -179.646 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -96.07 74.99 3.03 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.55 -54.44 4.95 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.43 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.513 ' HB3' ' HB2' ' A' ' 40' ' ' ASN . . . -148.58 -10.09 0.36 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 36.8 mtp-105 -83.13 86.17 7.06 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.618 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.778 HD23 HD12 ' A' ' 153' ' ' LEU . 51.1 tp -62.1 116.7 5.17 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-O 121.301 0.572 . . . . 0.0 111.578 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 33.9 ttp-105 -122.58 131.29 53.76 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.556 -177.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.636 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -152.34 146.89 25.72 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.452 0.644 . . . . 0.0 111.246 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.526 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 1.6 mm-40 -80.73 77.29 7.59 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.412 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.585 ' SG ' HD11 ' A' ' 164' ' ' LEU . 64.3 m -61.98 125.68 24.68 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.748 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.539 ' HB2' ' O ' ' A' ' 10' ' ' SER . 35.3 ttm180 -74.44 115.17 13.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.098 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 16.8 ptm180 -79.2 151.37 31.28 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -50.67 -18.97 2.9 Favored Glycine 0 C--N 1.339 0.697 0 O-C-N 124.338 1.024 . . . . 0.0 114.195 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.63 -12.89 61.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.15 0.5 . . . . 0.0 110.451 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.62 7.89 56.39 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.527 ' O ' ' HG2' ' A' ' 27' ' ' ARG . . . -104.48 157.49 16.87 Favored Glycine 0 C--O 1.223 -0.563 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.246 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.482 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 62.7 m-85 -100.85 129.81 46.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.901 0.381 . . . . 0.0 110.906 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.3 m -122.15 130.09 52.91 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.097 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -69.08 110.44 4.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.111 0.482 . . . . 0.0 111.449 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.744 ' HG ' ' HB2' ' A' ' 164' ' ' LEU . 29.2 t -114.79 151.53 33.65 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.931 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.9 p -145.7 135.51 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 120.879 0.371 . . . . 0.0 110.58 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.51 HG21 ' HB3' ' A' ' 21' ' ' LEU . 8.6 tt -134.92 144.34 34.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.734 -178.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.583 ' HB3' ' CD ' ' A' ' 41' ' ' ARG . 5.1 t70 -78.84 106.42 10.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.848 0.356 . . . . 0.0 110.605 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.573 HD22 ' HB3' ' A' ' 21' ' ' LEU . 2.1 mm? -85.97 -0.41 55.42 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.453 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.513 ' HB2' ' HB3' ' A' ' 19' ' ' ALA . 64.4 t30 -71.91 -22.35 61.5 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.583 ' CD ' ' HB3' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -103.87 16.5 26.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.406 0.622 . . . . 0.0 110.191 178.291 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -125.89 -35.27 2.5 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.146 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.622 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 36.6 mt -106.54 142.27 36.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.377 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.44 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 0.7 OUTLIER -133.1 140.8 47.84 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.492 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.539 ' CG ' ' HB3' ' A' ' 140' ' ' LEU . 9.0 t30 -88.54 108.1 19.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.989 0.423 . . . . 0.0 109.925 177.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -109.33 91.04 3.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.344 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 54.46 47.49 22.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.195 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.712 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 78.56 33.32 38.95 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.746 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.491 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 68.6 m80 -147.59 127.64 13.7 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.717 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 50.4 m-85 -68.78 146.01 53.28 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.901 0.382 . . . . 0.0 110.963 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.429 ' HB3' ' OG ' ' A' ' 54' ' ' SER . 16.6 mmt180 -145.49 130.7 18.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.838 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.476 ' CZ2' ' HA ' ' A' ' 153' ' ' LEU . 97.0 m95 -75.72 110.82 10.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.841 177.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.4 m 32.78 47.35 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.582 1.153 . . . . 0.0 113.744 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.429 ' OG ' ' HB3' ' A' ' 51' ' ' ARG . 26.1 m -83.33 69.13 9.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.477 0.656 . . . . 0.0 110.389 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.21 -60.05 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.27 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.63 128.21 4.51 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.491 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -175.4 73.52 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.147 -0.549 . . . . 0.0 111.877 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.03 169.58 30.1 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.928 -0.654 . . . . 0.0 111.845 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -86.08 69.77 3.12 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.328 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.82 -162.58 12.83 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.123 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.42 -136.91 14.03 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.36 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.7 m -135.03 128.43 32.32 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.925 0.393 . . . . 0.0 110.278 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.476 ' HB3' ' HG2' ' A' ' 110' ' ' LYS . . . -129.07 177.77 6.89 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.167 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.505 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 10.0 p -127.98 118.22 23.14 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.896 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.458 ' HA ' ' HE3' ' A' ' 110' ' ' LYS . 10.1 p -106.22 142.65 18.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.81 0.338 . . . . 0.0 111.004 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 9.1 m -88.6 125.08 34.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.272 0.558 . . . . 0.0 109.884 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.475 ' CG2' HD13 ' A' ' 99' ' ' ILE . 53.4 t -73.67 133.09 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.623 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -102.85 168.87 8.95 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 124.723 1.264 . . . . 0.0 110.845 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.575 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 25.3 tt0 -62.69 122.21 15.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.151 -178.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.39 -8.77 72.07 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.868 -0.605 . . . . 0.0 113.186 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.25 122.86 36.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.744 0.272 . . . . 0.0 111.453 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.589 ' HA ' HG12 ' A' ' 99' ' ' ILE . 81.2 p -105.67 -179.44 3.94 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.573 HD23 HG21 ' A' ' 99' ' ' ILE . 1.1 mm? -52.5 -41.39 63.37 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.299 0.571 . . . . 0.0 109.836 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.499 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 83.6 mtp180 -64.44 -36.99 85.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.335 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -72.14 -42.9 65.46 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.77 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 72' ' ' THR . 39.2 mm -61.03 -47.0 95.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.679 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.58 -50.56 64.19 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.85 -0.614 . . . . 0.0 113.07 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.463 ' NE ' ' HA ' ' A' ' 78' ' ' ARG . 3.5 tpm_? -71.1 -25.44 62.6 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 122.462 -0.434 . . . . 0.0 111.713 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -79.23 -42.39 26.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.193 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.458 ' HB2' ' HG ' ' A' ' 82' ' ' CYS . 99.2 m-85 -108.06 18.94 20.61 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.2 t70 55.75 51.13 12.89 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.735 0.778 . . . . 0.0 111.86 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.679 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.6 p -131.99 171.75 13.2 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.321 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.66 ' O ' HG13 ' A' ' 87' ' ' ILE . 14.9 t0 -97.63 120.4 37.94 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.747 -0.381 . . . . 0.0 109.99 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.499 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 17.8 p90 -51.51 -31.93 25.72 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.797 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.454 ' HB2' ' OD1' ' A' ' 83' ' ' ASP . 0.2 OUTLIER -68.29 -41.96 80.18 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.323 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.596 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 40.2 mt-10 -68.68 -47.05 67.46 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.9 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.66 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.9 mt -51.31 -46.02 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.559 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.36 -51.89 65.82 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.182 178.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 66.0 mtp180 -62.82 -30.46 71.5 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.596 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 8.2 mmp_? -73.07 -28.17 62.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.254 0.55 . . . . 0.0 110.327 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.481 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 6.7 t30 -96.14 -4.79 42.09 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.831 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 17.7 m120 80.24 13.44 0.91 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.69 0.796 . . . . 0.0 111.222 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.559 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 14.5 pt -105.58 -171.23 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.497 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.577 ' H ' ' HB2' ' A' ' 97' ' ' ASP . 3.8 mm-40 -118.72 163.63 16.56 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.498 ' O ' HD22 ' A' ' 73' ' ' LEU . 5.9 p30 -55.07 -55.15 34.3 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 122.535 1.16 . . . . 0.0 109.167 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -78.63 11.98 2.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.573 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.577 ' HB2' ' H ' ' A' ' 94' ' ' GLN . 4.9 t70 -63.29 -33.64 75.95 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.6 mt 68.75 112.38 0.04 OUTLIER 'General case' 0 C--O 1.232 0.163 0 O-C-N 124.382 1.051 . . . . 0.0 109.99 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.774 HG23 HD11 ' A' ' 105' ' ' LEU . 10.0 pt -95.31 175.3 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.458 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.476 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 67.9 m-85 -128.8 157.59 74.98 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.779 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.575 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 22.0 Cg_endo -66.71 133.08 30.58 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.957 2.438 . . . . 0.0 113.152 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.49 14.08 39.25 Favored Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.472 ' O ' ' HA ' ' A' ' 66' ' ' THR . 33.6 tt0 -103.35 162.93 12.59 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.505 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 91.9 t -122.17 118.25 54.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.774 HD11 HG23 ' A' ' 99' ' ' ILE . 96.9 mt -111.89 152.01 28.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.948 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -89.91 113.98 25.7 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.689 0.757 . . . . 0.0 110.975 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.9 m -123.35 152.07 63.75 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 114.178 -1.373 . . . . 0.0 109.983 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -64.77 -15.59 51.0 Favored 'Trans proline' 0 N--CA 1.472 0.248 0 C-N-CA 123.633 2.889 . . . . 0.0 114.869 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.2 t -155.74 156.89 35.64 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.931 0.396 . . . . 0.0 111.128 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.476 ' HG2' ' HB3' ' A' ' 63' ' ' ALA . 13.0 mmmm -105.83 170.39 7.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.376 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -81.58 -81.82 0.85 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.039 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -112.15 156.8 15.35 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 34.8 m -129.83 -23.11 2.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 117.176 0.488 . . . . 0.0 111.534 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.55 -45.48 1.62 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.124 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -152.48 -71.96 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -125.38 -108.63 1.7 Allowed Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.537 ' HB2' ' O ' ' A' ' 41' ' ' ARG . . . -125.7 -22.7 4.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.869 0.366 . . . . 0.0 110.422 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 119' ' ' ASN . . . -123.72 -71.9 0.24 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.293 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 18.1 m120 74.81 34.7 0.69 Allowed 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 123.158 0.583 . . . . 0.0 111.536 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.622 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 19.3 p90 -64.31 -36.53 84.42 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.454 ' HA ' ' HB2' ' A' ' 124' ' ' ALA . 50.5 t-105 -64.6 -26.26 68.32 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.667 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.49 -13.56 52.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.131 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.5 p -142.87 22.37 1.94 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.462 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.529 ' O ' ' HD2' ' A' ' 125' ' ' ARG . . . -113.24 144.67 42.31 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.055 0.455 . . . . 0.0 111.753 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.529 ' HD2' ' O ' ' A' ' 124' ' ' ALA . 1.3 mpt_? -136.55 150.8 48.81 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.665 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 53.8 53.84 10.75 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.165 0.507 . . . . 0.0 111.609 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.502 ' CG1' HD12 ' A' ' 136' ' ' LEU . 41.8 t -80.19 128.31 38.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.264 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.404 ' O ' HD11 ' A' ' 136' ' ' LEU . 2.0 ptp180 -146.43 140.51 26.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.951 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.577 HD11 HG22 ' A' ' 14' ' ' ILE . 16.5 mt -86.6 126.96 34.85 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 177.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.725 HG23 ' HB ' ' A' ' 135' ' ' VAL . 27.6 m -118.33 165.46 13.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.817 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.575 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 0.2 OUTLIER 68.58 2.4 3.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.521 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.585 ' O ' HD13 ' A' ' 14' ' ' ILE . . . 91.87 25.43 22.53 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.988 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.619 ' HA3' HG23 ' A' ' 14' ' ' ILE . . . 104.66 -21.33 36.92 Favored Glycine 0 C--O 1.267 2.182 0 CA-C-O 123.128 1.404 . . . . 0.0 112.721 178.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.666 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 0.0 OUTLIER -71.06 -10.37 59.63 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.177 -1.19 . . . . 0.0 109.775 179.083 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.725 ' HB ' HG23 ' A' ' 130' ' ' VAL . 20.4 t -143.08 146.94 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.585 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 35.1 tp -127.31 124.47 38.8 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -113.24 133.02 55.3 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 123.33 0.394 . . . . 0.0 110.478 -177.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.63 ' HB2' ' HZ ' ' A' ' 50' ' ' PHE . . . -161.66 158.19 25.67 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.876 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -95.18 108.42 20.55 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.712 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 36.2 mt -97.06 133.14 42.12 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.389 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 145' ' ' GLY . 40.2 ttt180 -73.81 141.36 46.2 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.87 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.634 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 0.7 OUTLIER -158.67 -166.8 1.97 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 4.6 m -53.64 -30.86 44.97 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.43 0.456 . . . . 0.0 112.089 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -103.35 30.34 10.55 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.587 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 141' ' ' ARG . . . 89.91 -114.07 4.3 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.007 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -122.73 125.27 45.2 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.709 0.254 . . . . 0.0 110.563 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.634 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 27.7 t-20 -119.29 131.39 55.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.344 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -78.19 96.84 5.3 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.114 0.483 . . . . 0.0 110.041 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.491 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 23.5 t -103.36 170.18 8.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.342 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.585 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 36.5 ptt180 -148.95 154.94 40.11 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.752 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.717 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 10.7 tt -139.86 150.9 21.89 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.001 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.669 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 9.1 m-85 -92.33 104.88 17.18 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 122.003 -0.436 . . . . 0.0 110.56 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.778 HD12 HD23 ' A' ' 21' ' ' LEU . 21.2 mt -66.61 -35.46 80.25 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.929 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.666 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 10.5 t70 -57.61 -12.58 2.93 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.879 178.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.783 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 42.1 mt-10 -61.55 -56.08 23.83 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 121.121 0.486 . . . . 0.0 111.909 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.562 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 51.7 m-70 -119.86 -4.6 10.16 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.59 -177.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.486 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 46.7 mm -94.44 112.32 26.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.33 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.644 ' HA3' ' OXT' ' A' ' 167' ' ' CYS . . . -117.78 166.84 12.71 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.383 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.551 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 1.5 t30 -107.24 132.21 53.33 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 122.403 0.281 . . . . 0.0 110.416 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -122.26 90.06 3.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.07 0.462 . . . . 0.0 110.123 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 47.0 m-80 54.9 40.42 31.98 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.22 2.16 44.74 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.824 177.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -119.69 140.23 50.99 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.933 0.396 . . . . 0.0 110.235 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.744 ' HB2' ' HG ' ' A' ' 35' ' ' SER . 7.6 tp -96.78 111.23 23.49 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.304 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 34.2 pt -138.73 -166.92 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.428 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.562 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 3.5 p80 -88.85 129.37 35.6 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.604 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.644 ' OXT' ' HA3' ' A' ' 158' ' ' GLY . 49.1 t . . . . . 0 C--O 1.25 1.089 0 O-C-N 123.895 0.747 . . . . 0.0 111.861 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.536 ' HA2' ' OD1' ' A' ' 6' ' ' ASN . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 112.0 -0.44 . . . . 0.0 112.0 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -83.91 -69.11 0.66 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.7 0.286 . . . . 0.0 111.109 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -138.39 -99.73 0.18 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.44 ' HB2' ' SG ' ' A' ' 167' ' ' CYS . . . -97.02 -28.28 14.23 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.0 -75.55 0.38 Allowed Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 119.649 -1.262 . . . . 0.0 113.139 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.536 ' OD1' ' HA2' ' A' ' 1' ' ' GLY . 37.2 m-80 64.09 16.38 9.94 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 122.463 0.305 . . . . 0.0 110.893 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.682 ' CD2' HD13 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -62.2 -30.98 71.46 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 116.75 -0.204 . . . . 0.0 111.251 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.0 t -67.8 -16.37 64.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.4 0.619 . . . . 0.0 110.084 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.09 -22.94 67.29 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.744 -0.662 . . . . 0.0 113.319 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 16.8 p -126.29 -17.74 5.11 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 122.12 -0.635 . . . . 0.0 111.51 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.432 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 3.3 m -105.18 133.48 49.88 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.3 ptt85 -114.36 -175.7 2.74 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 46.3 45.06 13.08 Favored 'General case' 0 C--N 1.316 -0.891 0 O-C-N 123.858 0.724 . . . . 0.0 111.518 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.676 HD11 ' O ' ' A' ' 132' ' ' GLY . 6.6 mt -81.14 100.7 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-O 120.938 0.399 . . . . 0.0 109.972 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.57 ' HA ' HD11 ' A' ' 129' ' ' LEU . 74.0 m -142.78 126.42 16.93 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.748 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -93.67 158.87 15.47 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.883 0.849 . . . . 0.0 113.037 -179.087 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -99.44 74.99 1.94 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 113.995 -1.457 . . . . 0.0 107.623 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.91 -57.68 4.56 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.947 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.714 ' HB2' ' HB3' ' A' ' 40' ' ' ASN . . . -143.47 -9.22 0.74 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 120.676 0.274 . . . . 0.0 110.898 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -96.59 97.74 9.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.276 0.56 . . . . 0.0 110.906 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.901 ' HB2' HD22 ' A' ' 39' ' ' LEU . 46.5 tp -61.75 121.68 13.47 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.966 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.536 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 53.5 ttt180 -126.61 127.87 45.9 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.506 -0.477 . . . . 0.0 110.813 -178.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.562 ' CB ' HG12 ' A' ' 14' ' ' ILE . . . -146.59 150.08 34.79 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.608 0.718 . . . . 0.0 111.069 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 3.0 mm-40 -83.94 71.34 10.5 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.122 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.555 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 34.7 m -60.01 125.75 24.88 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.741 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 10' ' ' SER . 27.7 ttp180 -66.77 126.59 29.5 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.151 178.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -102.37 155.11 18.46 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -52.52 -17.62 4.58 Favored Glycine 0 C--N 1.337 0.584 0 O-C-N 124.582 1.176 . . . . 0.0 114.747 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.21 -9.12 58.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.054 0.454 . . . . 0.0 110.216 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.47 11.44 62.45 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -119.87 165.56 13.5 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.558 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.491 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 88.4 m-85 -100.22 129.19 46.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.007 0.432 . . . . 0.0 110.847 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 75.1 m -113.68 126.03 54.79 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.959 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 m -67.27 114.65 6.16 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.217 0.532 . . . . 0.0 109.768 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 39.7 t -120.4 150.94 39.98 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.265 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.4 p -142.34 140.86 28.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.862 0.363 . . . . 0.0 110.86 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.8 tt -134.86 144.79 33.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.109 -178.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.4 94.02 2.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.385 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.901 HD22 ' HB2' ' A' ' 21' ' ' LEU . 0.9 OUTLIER -76.35 -14.91 60.07 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 120.915 0.388 . . . . 0.0 111.351 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.714 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 26.8 p-10 -67.75 -10.96 57.14 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.202 0.525 . . . . 0.0 109.939 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.42 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 37.4 mtt180 -106.58 11.3 30.69 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.482 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -135.8 -26.2 1.22 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.715 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.564 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 33.2 mt -109.83 134.46 52.02 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.962 0.41 . . . . 0.0 110.919 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.527 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 47.7 m -126.1 146.52 49.89 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.695 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.61 HD21 ' HA ' ' A' ' 120' ' ' PHE . 8.7 p30 -86.2 101.06 12.68 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -102.63 92.59 4.7 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.453 -178.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.0 t30 51.52 43.81 29.44 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.626 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.561 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 82.84 28.13 39.23 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.571 -0.824 . . . . 0.0 113.003 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.705 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 17.6 t-80 -149.88 126.43 10.91 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.693 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 72.6 m-85 -60.54 152.22 26.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.615 0.245 . . . . 0.0 111.026 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 11.4 ttm180 -141.68 132.18 25.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.087 0.47 . . . . 0.0 111.9 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.49 ' HZ2' ' HA ' ' A' ' 153' ' ' LEU . 57.4 m95 -79.23 114.61 18.3 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.729 177.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.6 t -93.55 -44.95 13.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.8 m 55.32 84.83 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.114 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.18 -72.41 0.28 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.776 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.66 135.85 9.03 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.954 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.92 51.18 0.9 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.637 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 160.77 -156.4 27.73 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.837 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.38 -15.02 80.43 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.584 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.54 139.45 10.73 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.283 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.39 -44.04 3.25 Favored Glycine 0 CA--C 1.504 -0.637 0 CA-C-O 122.016 0.786 . . . . 0.0 111.866 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.0 m -138.04 130.06 28.66 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 113.97 -1.115 . . . . 0.0 109.364 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.461 ' HB2' ' HG2' ' A' ' 110' ' ' LYS . . . -122.95 177.55 5.45 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.328 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.4 p -128.87 115.37 17.78 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.45 HG23 ' CE2' ' A' ' 80' ' ' PHE . 10.7 p -106.68 140.0 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.844 0.354 . . . . 0.0 111.105 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 14.0 m -88.55 130.31 35.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.047 0.451 . . . . 0.0 110.231 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.562 ' CG2' HD12 ' A' ' 99' ' ' ILE . 52.2 t -80.8 131.92 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.251 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -99.09 171.47 8.0 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 124.342 1.026 . . . . 0.0 109.705 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.722 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 35.0 tt0 -65.66 124.49 22.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.44 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.5 -1.21 66.28 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.531 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.411 ' CG ' HH22 ' A' ' 79' ' ' ARG . 85.7 m-20 -88.52 147.54 24.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.233 0.539 . . . . 0.0 111.531 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.684 ' HA ' HG12 ' A' ' 99' ' ' ILE . 38.1 p -133.06 168.21 18.9 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.579 HD13 HD12 ' A' ' 93' ' ' ILE . 1.8 mm? -49.76 -45.54 49.62 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.551 0.614 . . . . 0.0 110.307 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.58 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 65.8 mtt180 -63.58 -34.73 78.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.8 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.55 -37.24 65.62 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 72' ' ' THR . 47.8 mm -68.05 -48.76 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.587 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.723 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -59.34 -49.43 78.63 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.705 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.623 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -63.37 -33.02 74.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.081 0.467 . . . . 0.0 110.786 -179.428 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.411 HH22 ' CG ' ' A' ' 71' ' ' ASP . 32.9 ttm180 -74.31 -41.95 60.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.554 -178.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.625 ' HB2' ' HG ' ' A' ' 82' ' ' CYS . 98.8 m-85 -104.64 20.09 19.24 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 54.15 37.57 27.38 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.293 0.568 . . . . 0.0 112.349 178.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.723 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -119.17 167.16 12.1 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.584 ' O ' HG13 ' A' ' 87' ' ' ILE . 8.4 t0 -90.93 119.35 31.06 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.758 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.581 ' HD2' ' HB2' ' A' ' 95' ' ' ASN . 10.4 p90 -51.49 -32.63 28.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.191 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -62.91 -46.31 88.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.203 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.624 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 30.4 tt0 -66.87 -44.19 81.61 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.723 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.4 mt -52.12 -45.94 42.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.609 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.24 -50.12 71.46 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.987 177.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -58.45 -34.11 70.47 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.624 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 28.3 mmt180 -68.33 -38.52 81.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.101 0.477 . . . . 0.0 110.482 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 2.8 t-20 -91.53 -5.26 54.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.32 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 48.9 m-80 76.98 16.46 1.77 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.086 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.609 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 16.9 pt -101.25 -176.39 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.533 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 80.4 mm-40 -107.42 158.85 16.85 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.581 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 5.8 p30 -61.24 -55.4 32.41 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 122.137 0.97 . . . . 0.0 108.832 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -79.86 11.91 3.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.427 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.9 t70 -63.35 -35.44 80.39 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 7.6 mp 69.69 115.47 0.04 OUTLIER 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.74 -177.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.686 HG21 HD13 ' A' ' 105' ' ' LEU . 6.8 pt -94.64 175.74 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.472 -178.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.534 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 89.2 m-85 -124.35 160.29 53.48 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.957 -178.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.722 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 37.6 Cg_endo -69.74 133.06 24.7 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.082 2.521 . . . . 0.0 114.016 -178.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.76 14.63 33.91 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.583 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.457 ' O ' ' HA ' ' A' ' 66' ' ' THR . 44.0 mt-30 -102.41 164.19 11.81 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.83 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 67.1 t -123.56 116.31 47.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.686 HD13 HG21 ' A' ' 99' ' ' ILE . 89.4 mt -110.33 151.33 27.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.024 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.601 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 71.2 mt-30 -90.3 117.48 29.07 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.703 0.763 . . . . 0.0 110.872 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.31 150.42 60.32 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.467 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.43 -17.62 58.07 Favored 'Trans proline' 0 C--N 1.332 -0.318 0 C-N-CA 123.498 2.799 . . . . 0.0 114.017 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.4 t -152.7 152.59 31.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.041 0.448 . . . . 0.0 111.131 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.461 ' HG2' ' HB2' ' A' ' 63' ' ' ALA . 13.2 mmmm -100.62 -178.33 3.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.602 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -88.03 110.79 3.66 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.017 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -71.3 118.1 7.11 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.35 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.6 m -74.57 -34.7 62.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.811 0.339 . . . . 0.0 111.078 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.96 -50.79 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.59 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 132.03 144.21 5.29 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.507 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 122.73 61.7 0.21 Allowed Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.42 ' HB1' ' O ' ' A' ' 41' ' ' ARG . . . -91.27 -30.4 16.63 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.801 0.334 . . . . 0.0 111.53 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.527 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -94.71 -74.18 1.23 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.49 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 78.37 27.51 0.51 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.858 0.863 . . . . 0.0 112.461 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.61 ' HA ' HD21 ' A' ' 45' ' ' ASN . 26.5 p90 -63.87 -38.62 91.76 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.695 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.482 ' HA ' ' HB1' ' A' ' 124' ' ' ALA . 61.2 t-105 -63.02 -29.14 70.6 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.881 -178.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -57.11 -20.97 28.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.738 0.304 . . . . 0.0 111.112 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.626 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 57.6 m -141.9 30.82 1.63 Allowed 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.493 178.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.482 ' HB1' ' HA ' ' A' ' 121' ' ' TRP . . . -113.31 138.64 49.74 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.847 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -126.95 146.05 50.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.262 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.5 t70 51.12 56.65 7.66 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 123.831 0.707 . . . . 0.0 110.659 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.514 ' CG1' HD12 ' A' ' 136' ' ' LEU . 45.0 t -79.66 120.32 30.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.44 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.85 141.34 34.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.177 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.629 HD22 HD11 ' A' ' 153' ' ' LEU . 17.8 mt -85.91 128.29 34.8 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.82 HG22 HG12 ' A' ' 135' ' ' VAL . 31.0 m -123.68 157.54 30.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.358 0.599 . . . . 0.0 111.224 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.922 ' HB3' ' HE3' ' A' ' 134' ' ' LYS . 5.9 m-20 65.67 16.98 10.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.897 178.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.676 ' O ' HD11 ' A' ' 14' ' ' ILE . . . 91.8 25.3 23.08 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.942 178.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.673 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 91.16 -15.31 61.37 Favored Glycine 0 C--O 1.269 2.322 0 CA-C-O 123.638 1.688 . . . . 0.0 112.384 177.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.922 ' HE3' ' HB3' ' A' ' 131' ' ' ASP . 20.0 pttp -65.12 -15.71 62.69 Favored 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 121.463 -1.022 . . . . 0.0 108.929 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.82 HG12 HG22 ' A' ' 130' ' ' VAL . 2.2 p -149.03 135.58 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.547 0.689 . . . . 0.0 110.83 176.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 29.6 tp -110.3 125.08 52.77 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.073 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -117.92 139.95 50.42 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.861 0.363 . . . . 0.0 111.52 -177.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.653 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.96 168.8 20.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.17 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -95.25 107.55 19.66 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.561 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 57.1 mt -98.93 131.89 44.66 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.277 0.561 . . . . 0.0 111.168 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.626 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 33.7 ttt180 -72.28 142.01 48.89 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.071 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -153.89 -173.89 4.75 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.917 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 13.4 m -58.6 -22.71 57.03 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -105.39 20.02 38.38 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.233 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 106.73 -115.33 4.66 Favored Glycine 0 C--O 1.229 -0.212 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.298 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -130.31 138.07 50.27 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -132.18 141.44 49.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.924 0.392 . . . . 0.0 111.701 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -74.76 103.53 5.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.146 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.705 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 32.6 t -121.65 162.08 21.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.326 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 10.3 ptt180 -148.55 152.6 37.11 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 120.957 0.408 . . . . 0.0 111.474 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.693 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 8.7 tt -132.36 131.96 60.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.73 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 135' ' ' VAL . 89.8 m-85 -75.89 101.22 5.08 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.56 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.675 HD12 HD22 ' A' ' 21' ' ' LEU . 35.7 mt -64.45 -36.22 83.47 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.191 178.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.774 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 11.7 t70 -55.35 -11.49 0.81 Allowed 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.425 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.537 ' HG3' ' O ' ' A' ' 152' ' ' TYR . 38.0 mt-10 -71.41 -49.39 42.38 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 121.93 -0.481 . . . . 0.0 112.224 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.553 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 50.6 m80 -127.02 5.68 6.51 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 119.963 -0.695 . . . . 0.0 112.611 -177.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.414 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 46.9 mm -106.58 109.65 28.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.631 ' HA3' ' O ' ' A' ' 167' ' ' CYS . . . -116.38 166.22 12.34 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.187 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.555 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.9 t30 -100.79 123.21 44.66 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 14.2 ttt85 -119.17 86.52 2.56 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.155 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 59.61 49.12 8.72 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.496 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 79.92 13.14 82.61 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.489 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -122.67 120.24 33.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.026 0.441 . . . . 0.0 110.037 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.682 HD13 ' CD2' ' A' ' 7' ' ' PHE . 8.5 tp -77.25 120.73 22.71 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.072 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.858 HG12 ' H ' ' A' ' 166' ' ' HIS . 12.6 tt -150.46 -172.21 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.987 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.858 ' H ' HG12 ' A' ' 165' ' ' ILE . 3.4 m-70 -85.84 124.0 31.83 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.214 -0.304 . . . . 0.0 110.426 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.631 ' O ' ' HA3' ' A' ' 158' ' ' GLY . 53.3 t . . . . . 0 C--O 1.245 0.857 0 O-C-N 124.079 0.862 . . . . 0.0 111.26 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.471 ' HA2' ' CD2' ' A' ' 152' ' ' TYR . . . . . . . . 0 N--CA 1.482 1.732 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -66.35 136.9 56.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.441 0.638 . . . . 0.0 111.109 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -120.38 -64.71 1.22 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.101 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -125.29 -25.58 3.77 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.642 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -84.09 -70.93 1.33 Allowed Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 118.771 -1.68 . . . . 0.0 113.488 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.626 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 63.0 t30 57.3 31.95 20.95 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.207 0.603 . . . . 0.0 110.283 -178.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.601 ' CE2' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -60.28 -32.91 71.64 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.028 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.46 ' HA ' HD11 ' A' ' 14' ' ' ILE . 34.0 t -59.17 -20.8 57.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.523 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.52 -42.17 93.76 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.836 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.467 ' HB3' ' HB3' ' A' ' 26' ' ' ARG . 49.4 m -114.97 -18.05 11.35 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.9 m -92.38 134.86 34.53 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.462 ' CG ' ' HB2' ' A' ' 24' ' ' GLU . 16.7 ptt180 -113.27 -177.54 3.16 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.461 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 0.4 OUTLIER 42.61 44.63 3.72 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 123.873 0.733 . . . . 0.0 112.457 179.18 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.682 HG23 ' HA3' ' A' ' 133' ' ' GLY . 5.8 mt -78.98 105.14 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 CA-C-O 120.953 0.406 . . . . 0.0 110.292 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.533 ' HA ' HD13 ' A' ' 129' ' ' LEU . 80.4 m -146.82 127.62 14.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.37 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.71 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -96.97 155.86 16.6 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.621 0.724 . . . . 0.0 112.779 -179.279 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -96.22 75.1 2.97 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.433 -1.258 . . . . 0.0 107.958 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.51 -58.35 4.88 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.893 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.539 ' HB2' ' HB3' ' A' ' 40' ' ' ASN . . . -149.19 5.97 0.66 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.199 0.523 . . . . 0.0 110.21 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.559 ' HG2' ' CG2' ' A' ' 36' ' ' VAL . 32.3 ttt85 -108.32 93.99 4.82 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.806 ' HB2' HD22 ' A' ' 39' ' ' LEU . 55.0 tp -63.18 129.6 41.02 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -177.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.538 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 34.8 ttt180 -134.04 129.26 35.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.159 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.615 ' HB3' HG12 ' A' ' 14' ' ' ILE . . . -148.58 149.98 32.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.471 0.653 . . . . 0.0 110.983 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 3.3 mt-10 -87.64 80.67 7.91 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.773 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.575 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 58.7 m -63.47 127.86 33.23 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.408 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.467 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 36.8 ttm180 -71.13 114.93 9.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.364 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 9.0 ptp180 -79.6 152.6 29.97 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 179.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.36 -19.5 12.79 Favored Glycine 0 C--N 1.336 0.549 0 O-C-N 124.369 1.043 . . . . 0.0 114.03 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.58 -12.03 60.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.446 0.641 . . . . 0.0 109.821 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.29 5.22 56.05 Favored Glycine 0 CA--C 1.505 -0.589 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.526 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.442 ' O ' ' HG2' ' A' ' 27' ' ' ARG . . . -105.61 167.78 14.92 Favored Glycine 0 C--O 1.222 -0.649 0 C-N-CA 120.065 -1.064 . . . . 0.0 113.14 -178.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.525 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 57.9 m-85 -101.27 131.47 47.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.166 0.483 . . . . 0.0 110.907 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.9 m -118.49 123.35 44.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.191 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.5 m -69.1 112.31 5.63 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.9 t -118.25 155.41 30.61 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.028 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.559 ' CG2' ' HG2' ' A' ' 20' ' ' ARG . 2.6 p -145.43 139.08 21.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.878 0.371 . . . . 0.0 111.662 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.424 HG22 ' HB3' ' A' ' 21' ' ' LEU . 14.0 tt -135.13 148.06 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.471 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.437 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 17.7 m-20 -84.41 104.53 14.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.862 0.363 . . . . 0.0 111.475 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.806 HD22 ' HB2' ' A' ' 21' ' ' LEU . 3.0 mp -83.69 -12.15 56.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.428 0.632 . . . . 0.0 110.417 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.539 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 16.5 p30 -62.84 -19.09 63.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.021 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.443 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 13.2 ptm180 -112.92 19.9 16.88 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.968 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.641 ' HD2' ' CE3' ' A' ' 52' ' ' TRP . 0.1 OUTLIER -138.12 -27.6 0.89 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.366 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.575 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 62.5 mt -106.09 132.21 52.44 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.611 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 3.2 m -129.35 141.92 50.95 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.541 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.693 ' CB ' ' HG ' ' A' ' 140' ' ' LEU . 8.5 p30 -79.36 115.77 19.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.149 177.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -114.82 89.34 3.07 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.907 0.384 . . . . 0.0 110.248 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.3 t30 51.78 45.02 28.85 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.242 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.0 32.18 30.02 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.808 -0.711 . . . . 0.0 113.131 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.62 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 16.0 t-80 -150.85 125.19 9.45 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.767 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 45.3 m-85 -63.08 141.84 58.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.886 0.374 . . . . 0.0 111.672 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.643 ' HA ' ' NE ' ' A' ' 51' ' ' ARG . 3.4 mmp_? -146.26 135.82 23.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.841 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.641 ' CE3' ' HD2' ' A' ' 42' ' ' TYR . 95.0 m95 -74.36 105.95 5.75 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.124 0.488 . . . . 0.0 109.743 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.582 HG12 ' HB3' ' A' ' 117' ' ' ALA . 11.0 t 56.31 54.56 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.377 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.476 ' HG ' ' C ' ' A' ' 53' ' ' VAL . 58.6 p 60.29 -59.9 0.07 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.39 1.476 . . . . 0.0 113.165 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -166.18 36.65 0.25 Allowed Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.81 41.53 14.79 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -79.34 152.86 36.56 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.273 -0.489 . . . . 0.0 112.755 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.86 144.53 18.46 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.152 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.19 146.39 22.83 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.045 -0.597 . . . . 0.0 112.403 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 163.92 -176.98 39.88 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.376 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.35 -127.47 8.8 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 121.075 -0.583 . . . . 0.0 111.829 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.3 m -134.25 130.52 37.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.861 0.362 . . . . 0.0 110.252 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.426 ' HB3' ' HG2' ' A' ' 110' ' ' LYS . . . -127.8 176.11 7.81 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.75 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.52 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 6.8 p -127.93 116.11 19.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.533 HG23 ' CE2' ' A' ' 80' ' ' PHE . 7.9 p -103.61 142.41 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 120.887 0.375 . . . . 0.0 110.844 178.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 9.8 m -88.38 130.95 35.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.161 0.505 . . . . 0.0 109.929 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.447 ' CG2' HD11 ' A' ' 99' ' ' ILE . 56.6 t -82.33 133.58 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.854 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.419 ' HG3' ' H ' ' A' ' 69' ' ' GLN . 2.4 tp-100 -103.86 171.34 7.41 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.985 0.803 . . . . 0.0 110.2 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.611 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 53.7 tt0 -61.27 119.39 8.35 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.122 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.17 -9.91 63.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.888 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.441 ' HB3' HD13 ' A' ' 76' ' ' ILE . 84.9 m-20 -75.44 146.65 40.54 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.147 0.499 . . . . 0.0 111.529 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.627 ' HA ' HG12 ' A' ' 99' ' ' ILE . 24.3 p -135.99 163.15 30.96 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.557 HD11 ' HB ' ' A' ' 87' ' ' ILE . 1.6 mm? -49.18 -44.22 42.84 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.363 0.529 . . . . 0.0 110.634 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.409 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 70.1 mtp180 -59.96 -43.39 95.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.276 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -72.94 -33.88 66.21 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.537 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.547 HG12 ' O ' ' A' ' 72' ' ' THR . 44.0 mm -66.6 -46.91 84.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.713 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.48 -49.08 76.15 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.91 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -65.41 -32.43 74.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.059 0.456 . . . . 0.0 111.151 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.416 HH22 ' CG ' ' A' ' 71' ' ' ASP . 34.5 ttm180 -70.65 -40.33 73.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.73 -178.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.533 ' CE2' HG23 ' A' ' 65' ' ' VAL . 94.6 m-85 -110.42 16.91 21.32 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 56.22 37.56 28.96 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.445 0.64 . . . . 0.0 111.411 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.713 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.9 p -116.28 166.1 12.42 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.373 -0.83 . . . . 0.0 108.901 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.636 ' O ' HG13 ' A' ' 87' ' ' ILE . 3.7 t70 -92.22 124.6 36.42 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.101 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.409 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 9.7 p90 -52.28 -31.35 32.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.753 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 23.0 t-80 -66.79 -43.26 84.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.949 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.763 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 10.1 mm-40 -63.2 -51.54 65.93 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.361 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.636 HG13 ' O ' ' A' ' 83' ' ' ASP . 3.5 mt -50.94 -48.12 29.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 O-C-N 124.139 0.899 . . . . 0.0 109.475 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.617 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.51 -49.5 75.09 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.268 178.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -61.79 -34.05 75.21 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.763 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 14.7 mmt85 -65.28 -38.19 89.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.08 0.467 . . . . 0.0 110.525 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 11.5 m120 -93.13 -3.36 54.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.61 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 76.5 m-20 73.72 19.67 3.17 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.247 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.617 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 16.9 pt -100.68 -177.29 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.688 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.499 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 35.6 mt-30 -108.17 155.57 20.28 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.539 ' O ' HD22 ' A' ' 73' ' ' LEU . 3.1 p30 -54.94 -62.6 1.55 Allowed 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 122.116 0.96 . . . . 0.0 108.937 178.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -76.4 12.23 1.3 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.385 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.4 t70 -63.63 -34.5 77.96 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 8.7 mp 73.03 116.63 0.05 Allowed 'General case' 0 N--CA 1.462 0.136 0 O-C-N 124.399 1.062 . . . . 0.0 109.598 -177.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.65 HG21 HD13 ' A' ' 105' ' ' LEU . 11.2 pt -93.83 177.68 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.208 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.495 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 40.5 m-85 -129.48 157.76 75.37 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-O 120.892 0.377 . . . . 0.0 111.413 -178.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.611 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 25.7 Cg_endo -65.72 137.75 51.0 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.229 2.619 . . . . 0.0 113.905 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.12 13.65 57.25 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.867 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.497 ' O ' ' HA ' ' A' ' 66' ' ' THR . 95.5 mt-30 -100.87 168.39 9.67 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.216 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.52 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 63.2 t -127.6 110.61 22.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-O 120.921 0.391 . . . . 0.0 109.974 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.65 HD13 HG21 ' A' ' 99' ' ' ILE . 89.0 mt -103.6 150.4 24.0 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.678 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.479 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 75.8 mt-30 -91.34 116.47 28.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.973 0.892 . . . . 0.0 111.38 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.1 m -124.12 151.5 65.71 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 114.207 -1.36 . . . . 0.0 109.691 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -65.07 -15.03 48.44 Favored 'Trans proline' 0 N--CA 1.476 0.445 0 C-N-CA 123.571 2.847 . . . . 0.0 114.855 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.0 t -152.9 155.71 37.55 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.008 0.433 . . . . 0.0 111.197 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.426 ' HG2' ' HB3' ' A' ' 63' ' ' ALA . 12.9 mmmm -100.31 -180.0 4.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.816 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -161.94 90.39 0.11 Allowed Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.531 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -107.6 129.01 9.44 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.176 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.0 m -84.67 28.78 0.65 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.173 0.511 . . . . 0.0 110.756 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -170.64 42.89 0.19 Allowed Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.625 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 141.01 -161.5 26.78 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 127.44 -67.08 0.55 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.8 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.582 ' HB3' HG12 ' A' ' 53' ' ' VAL . . . -100.57 -22.58 14.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.983 0.42 . . . . 0.0 111.715 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.611 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -102.51 -82.31 1.63 Allowed Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.26 -0.971 . . . . 0.0 112.618 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 73.41 23.45 2.51 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.437 0.695 . . . . 0.0 111.931 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.65 ' HA ' HD21 ' A' ' 45' ' ' ASN . 22.7 p90 -61.62 -38.51 87.92 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.549 -0.46 . . . . 0.0 109.854 178.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.498 ' HA ' ' HB2' ' A' ' 124' ' ' ALA . 63.5 t-105 -59.87 -33.86 72.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.474 -178.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -54.59 -25.95 29.51 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.101 0.476 . . . . 0.0 111.124 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.677 ' HB2' ' HB3' ' A' ' 141' ' ' ARG . 19.4 p -136.98 30.12 2.78 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.512 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.498 ' HB2' ' HA ' ' A' ' 121' ' ' TRP . . . -109.29 140.3 43.13 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.889 0.376 . . . . 0.0 110.835 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -127.51 138.91 53.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.932 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 55.36 54.47 8.58 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.244 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.498 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 29.7 t -76.67 121.43 28.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.643 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -144.94 146.01 31.8 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.65 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.753 HD22 HD11 ' A' ' 153' ' ' LEU . 18.4 mt -86.75 128.85 35.04 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 120.973 0.416 . . . . 0.0 110.157 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.599 HG23 ' HB ' ' A' ' 135' ' ' VAL . 35.1 m -125.75 160.18 32.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.646 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 69.04 5.77 5.26 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.389 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.656 ' O ' HD13 ' A' ' 14' ' ' ILE . . . 97.32 29.06 8.12 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.439 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.682 ' HA3' HG23 ' A' ' 14' ' ' ILE . . . 91.8 -16.27 59.74 Favored Glycine 0 C--O 1.265 2.045 0 CA-C-O 123.689 1.716 . . . . 0.0 112.494 178.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.645 ' O ' ' HA ' ' A' ' 152' ' ' TYR . 5.8 ptpp? -70.87 -17.44 62.72 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 121.433 -1.039 . . . . 0.0 108.454 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.599 ' HB ' HG23 ' A' ' 130' ' ' VAL . 17.5 t -138.73 137.92 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.314 0.578 . . . . 0.0 110.736 178.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.68 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 29.6 tp -117.58 118.36 31.92 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -108.4 130.25 55.23 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.772 0.32 . . . . 0.0 111.276 -176.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.758 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.35 161.56 27.5 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.72 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.818 ' HG3' HH11 ' A' ' 148' ' ' ARG . 49.3 mt-10 -96.01 108.5 20.9 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.422 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.693 ' HG ' ' CB ' ' A' ' 45' ' ' ASN . 1.0 OUTLIER -90.96 126.78 36.17 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.959 178.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.677 ' HB3' ' HB2' ' A' ' 123' ' ' SER . 76.1 ttt180 -69.59 140.81 53.82 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.164 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.612 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 2.3 p90 -156.83 -165.98 1.99 Allowed 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.074 -179.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.2 t -58.42 -32.53 68.75 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.319 0.387 . . . . 0.0 111.121 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.19 28.88 13.26 Favored Glycine 0 C--N 1.329 0.182 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.478 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 89.52 -118.95 5.35 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.591 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -120.03 129.32 54.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.699 0.25 . . . . 0.0 110.73 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.612 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 53.7 t30 -121.34 134.18 55.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.74 0.305 . . . . 0.0 110.766 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.818 HH11 ' HG3' ' A' ' 139' ' ' GLU . 19.8 tpt180 -75.0 96.94 3.27 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.591 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.62 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 11.6 t -109.41 168.03 9.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.428 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.68 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 36.5 ptt180 -148.11 149.65 32.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.444 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.767 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 12.1 tt -132.98 140.72 46.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.581 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.645 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 26.6 m-85 -83.17 102.97 12.23 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.852 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.753 HD11 HD22 ' A' ' 129' ' ' LEU . 26.8 mt -65.25 -36.7 84.95 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.127 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.626 ' HB2' ' HA ' ' A' ' 6' ' ' ASN . 13.8 p-10 -61.69 2.83 0.16 Allowed 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.545 ' HG3' ' CB ' ' A' ' 152' ' ' TYR . 43.1 mt-10 -76.24 -52.43 10.03 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 121.729 -0.607 . . . . 0.0 110.758 178.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -118.02 -12.26 10.11 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.633 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.437 ' O ' ' HA3' ' A' ' 5' ' ' GLY . 50.8 mm -91.86 114.74 29.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 116.77 -0.196 . . . . 0.0 110.754 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -122.28 167.63 14.8 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.115 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.575 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 3.3 t30 -103.46 123.29 46.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.025 0.44 . . . . 0.0 109.959 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 29.5 ttt85 -124.68 93.08 3.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.341 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 60.61 45.04 10.84 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.215 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 84.81 10.75 78.43 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.684 -0.769 . . . . 0.0 113.197 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -122.74 152.82 40.23 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.512 HD23 ' HD2' ' A' ' 7' ' ' PHE . 24.4 mt -97.17 119.65 36.05 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.492 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 43.0 pt -114.31 170.29 4.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.148 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -130.09 116.86 19.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.035 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 41.6 t . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.706 -0.664 . . . . 0.0 110.178 -179.668 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.669 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -92.92 168.77 10.93 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.681 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 32.6 m-85 -103.16 -76.75 0.58 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.499 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -137.68 -25.93 0.99 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.569 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 6' ' ' ASN . . . -68.88 -72.63 0.81 Allowed Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 119.738 -1.22 . . . . 0.0 113.597 -178.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 25.5 m-80 69.69 10.31 7.53 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 122.498 0.319 . . . . 0.0 110.219 -178.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.775 ' CD2' HD13 ' A' ' 164' ' ' LEU . 0.9 OUTLIER -61.59 -34.93 76.46 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.61 -178.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.44 ' HA ' HD11 ' A' ' 14' ' ' ILE . 35.0 t -67.81 -14.87 63.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.476 0.655 . . . . 0.0 109.877 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.68 -27.76 64.5 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.964 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 20.9 p -125.69 -19.57 4.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 117.225 0.512 . . . . 0.0 111.992 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 11.8 m -94.99 129.04 42.22 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.656 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 35.4 ptt180 -108.01 -178.36 3.59 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.446 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 1.6 m-20 41.11 47.58 2.8 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 124.068 0.855 . . . . 0.0 112.489 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.748 HG12 ' HB1' ' A' ' 23' ' ' ALA . 8.1 mt -80.65 107.44 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-O 120.877 0.37 . . . . 0.0 110.292 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.498 ' HA ' HD12 ' A' ' 129' ' ' LEU . 46.1 t -150.2 128.53 12.11 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.676 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -96.7 158.56 15.37 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 122.047 0.927 . . . . 0.0 113.012 -178.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -99.51 76.4 2.02 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.14 -53.57 4.77 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.879 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 40' ' ' ASN . . . -149.55 -12.41 0.29 Allowed 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 120.746 0.308 . . . . 0.0 110.195 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -86.1 90.13 8.03 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.448 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.676 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 8.5 tp -61.64 112.97 2.46 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.671 -179.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.457 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 18.8 ttt85 -118.28 130.59 56.13 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.277 -178.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.748 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -149.65 150.9 32.86 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.407 0.623 . . . . 0.0 110.997 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.656 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 1.6 mm-40 -83.39 73.83 10.13 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.145 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.64 ' SG ' HD11 ' A' ' 164' ' ' LEU . 67.8 m -61.22 117.06 5.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.595 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 10' ' ' SER . 44.5 ttt180 -64.59 116.75 6.5 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.804 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.7 ttt85 -90.86 152.49 20.73 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.044 0.45 . . . . 0.0 109.957 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.63 -13.83 4.56 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 114.353 -1.294 . . . . 0.0 114.037 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -73.85 -11.08 60.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.114 0.483 . . . . 0.0 110.321 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.5 8.49 57.36 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -123.78 154.39 17.54 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.099 -1.048 . . . . 0.0 112.837 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.459 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 88.0 m-85 -87.87 125.49 34.51 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.712 0.291 . . . . 0.0 110.446 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.7 m -109.19 131.94 54.59 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.453 ' CG2' ' HE ' ' A' ' 22' ' ' ARG . 2.5 m -73.72 110.71 8.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.229 0.538 . . . . 0.0 109.98 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.652 ' HG ' ' HB2' ' A' ' 164' ' ' LEU . 30.3 t -115.5 153.59 30.87 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.635 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.7 p -146.14 137.27 18.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.794 0.331 . . . . 0.0 110.869 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.509 HG21 ' HB3' ' A' ' 21' ' ' LEU . 8.7 tt -134.68 137.05 51.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.733 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.639 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 13.3 m-20 -75.22 103.1 5.24 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.826 0.345 . . . . 0.0 111.558 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.811 ' HG ' HD11 ' A' ' 153' ' ' LEU . 3.4 mm? -83.11 -5.37 59.08 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.926 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.639 ' OD1' ' HB3' ' A' ' 38' ' ' ASP . 34.5 p-10 -67.06 -14.07 62.54 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.519 ' HE ' ' HB2' ' A' ' 38' ' ' ASP . 27.8 mtm180 -106.65 7.75 30.76 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.962 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.694 ' HB2' HD12 ' A' ' 39' ' ' LEU . 88.5 m-85 -130.95 -29.34 1.89 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.777 ' HG ' HD13 ' A' ' 39' ' ' LEU . 60.9 mt -106.22 132.69 51.98 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.779 0.323 . . . . 0.0 110.405 -179.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.719 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 1.0 OUTLIER -123.44 143.03 50.4 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.603 -179.496 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.451 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 7.0 p-10 -88.25 93.61 9.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.791 0.805 . . . . 0.0 109.176 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -93.27 93.63 8.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.297 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.452 ' HA ' ' HB2' ' A' ' 142' ' ' TYR . 8.6 t-20 51.25 48.49 22.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.092 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.59 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 76.64 32.42 50.66 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.049 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.642 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 59.9 t60 -152.12 124.69 8.35 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.781 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 48.5 m-85 -60.71 144.15 52.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.887 0.375 . . . . 0.0 111.483 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.672 ' HG3' ' HA3' ' A' ' 55' ' ' GLY . 0.2 OUTLIER -143.03 131.74 22.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.475 -178.792 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.491 ' HZ2' ' O ' ' A' ' 152' ' ' TYR . 99.6 m95 -75.59 111.41 10.87 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 176.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.3 t 66.48 -80.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 123.704 0.802 . . . . 0.0 111.532 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.6 p -127.2 -22.63 3.7 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.98 0.419 . . . . 0.0 111.368 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.672 ' HA3' ' HG3' ' A' ' 51' ' ' ARG . . . 71.52 22.57 78.61 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.018 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.54 118.48 9.2 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.427 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -83.87 157.96 34.55 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.591 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.32 9.24 48.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.022 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.51 175.61 47.5 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.366 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.64 20.2 32.72 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.35 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 112.38 124.49 4.35 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.161 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 36.0 m -141.3 114.85 8.91 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.108 0.48 . . . . 0.0 110.323 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.436 ' HB2' ' HG2' ' A' ' 110' ' ' LYS . . . -130.9 178.59 6.55 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.191 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.479 HG21 ' HG2' ' A' ' 106' ' ' GLN . 4.6 p -128.33 115.56 18.46 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.501 ' HA ' ' HE3' ' A' ' 110' ' ' LYS . 7.3 p -102.77 143.25 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 120.869 0.366 . . . . 0.0 111.086 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 3.5 m -87.98 129.25 35.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.47 ' CG2' HD12 ' A' ' 99' ' ' ILE . 57.4 t -79.66 132.25 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.647 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -101.03 168.61 9.49 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 124.254 0.971 . . . . 0.0 110.475 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.659 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 35.1 tt0 -66.03 120.21 12.74 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.87 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.85 -11.07 52.76 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.771 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.06 130.26 45.38 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.134 0.467 . . . . 0.0 111.402 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.613 ' HA ' HG12 ' A' ' 99' ' ' ILE . 82.6 p -107.41 179.76 4.15 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.583 HD23 ' O ' ' A' ' 95' ' ' ASN . 1.4 mm? -53.64 -43.64 68.9 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.436 0.636 . . . . 0.0 109.511 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.532 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 7.0 ttp85 -63.31 -36.05 82.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.39 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -73.77 -41.83 61.9 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.55 HG12 ' O ' ' A' ' 72' ' ' THR . 45.3 mm -61.32 -47.68 92.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.605 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.718 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.19 -51.34 58.11 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.651 -0.704 . . . . 0.0 113.083 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 78' ' ' ARG . 47.1 mtp85 -70.21 -23.71 62.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.796 0.331 . . . . 0.0 111.691 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -78.91 -39.37 35.02 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -110.97 19.45 18.48 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t70 55.22 59.24 4.09 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.693 0.759 . . . . 0.0 111.335 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.718 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.4 p -142.35 164.59 29.72 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.364 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.564 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.8 t0 -91.04 120.89 32.39 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.532 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 5.0 p90 -52.19 -30.47 27.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.429 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -66.66 -41.87 87.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.602 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.69 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 64.3 mm-40 -66.06 -49.62 67.0 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.485 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.564 HG13 ' O ' ' A' ' 83' ' ' ASP . 4.1 mt -51.93 -47.53 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.523 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.578 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.77 -50.4 71.2 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.112 178.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -60.3 -33.82 72.91 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.69 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 27.4 mmt180 -71.19 -31.83 68.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.914 0.388 . . . . 0.0 110.44 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 3.7 t-20 -91.73 -5.97 52.74 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.615 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.497 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 90.7 m-20 77.15 17.76 1.54 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.033 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.578 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 14.2 pt -105.69 -174.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.577 178.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.436 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 64.6 mt-30 -110.25 162.57 14.49 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.583 ' O ' HD23 ' A' ' 73' ' ' LEU . 4.2 p-10 -58.59 -68.67 0.24 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.317 1.055 . . . . 0.0 110.003 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -74.33 13.47 0.58 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.545 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 95' ' ' ASN . 2.5 t70 -59.65 -29.39 68.0 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 34.1 mt 72.4 110.6 0.06 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.816 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.613 HG12 ' HA ' ' A' ' 72' ' ' THR . 10.2 pt -95.62 172.56 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.405 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.554 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 73.7 m-85 -126.74 161.45 53.12 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.31 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.659 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 24.8 Cg_endo -66.31 139.6 55.32 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.203 2.602 . . . . 0.0 113.843 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.07 16.72 43.23 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.521 ' O ' ' HA ' ' A' ' 66' ' ' THR . 25.8 mt-30 -103.18 166.57 10.36 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.082 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.415 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 82.5 t -126.91 114.43 37.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.471 HD13 HG23 ' A' ' 99' ' ' ILE . 88.1 mt -112.2 151.65 29.31 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.801 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.479 ' HG2' HG21 ' A' ' 64' ' ' THR . 34.3 mt-30 -90.47 117.26 29.03 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.615 0.721 . . . . 0.0 110.923 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.418 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 35.2 m -126.27 152.59 73.92 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.634 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 107' ' ' VAL . 18.0 Cg_endo -57.52 -48.04 19.04 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.353 2.035 . . . . 0.0 113.578 -177.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.1 t -123.72 155.22 38.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.254 0.55 . . . . 0.0 111.635 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.501 ' HE3' ' HA ' ' A' ' 65' ' ' VAL . 11.3 mmmm -99.38 -170.23 1.88 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.697 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -175.32 -45.36 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 63.65 -113.71 6.15 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.282 -0.485 . . . . 0.0 112.8 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 19.5 m -119.08 12.38 12.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.936 0.398 . . . . 0.0 110.771 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.421 ' O ' ' HD2' ' A' ' 41' ' ' ARG . . . 166.4 -42.26 0.26 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.211 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.25 -117.88 0.67 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.65 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.42 47.04 60.01 Favored Glycine 0 CA--C 1.502 -0.778 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -111.18 -52.74 2.77 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.825 -0.687 . . . . 0.0 110.732 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.719 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -83.01 -77.87 1.08 Allowed Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.523 -0.762 . . . . 0.0 113.184 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 19.5 m120 73.29 29.09 1.72 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.054 0.542 . . . . 0.0 111.418 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.574 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 21.8 p90 -60.59 -37.92 82.94 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.48 ' HA ' ' HB2' ' A' ' 124' ' ' ALA . 47.8 t-105 -60.57 -30.39 69.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.559 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.47 -33.02 58.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.939 0.399 . . . . 0.0 110.537 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.727 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 6.7 m -131.28 28.84 4.68 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.852 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.48 ' HB2' ' HA ' ' A' ' 121' ' ' TRP . . . -108.65 140.78 41.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.896 0.379 . . . . 0.0 110.889 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.546 ' HB3' ' HB2' ' A' ' 139' ' ' GLU . 11.3 tpp85 -124.09 135.2 53.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.462 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 54.85 55.46 7.78 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.765 0.666 . . . . 0.0 111.849 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.514 HG13 ' HE2' ' A' ' 120' ' ' PHE . 40.1 t -78.03 123.58 35.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.822 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.432 ' O ' HD12 ' A' ' 136' ' ' LEU . 8.9 ptp180 -149.49 149.0 30.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.827 0.346 . . . . 0.0 110.589 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.572 HD12 ' C ' ' A' ' 14' ' ' ILE . 92.5 mt -86.6 134.85 33.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.056 0.455 . . . . 0.0 110.495 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.621 HG22 ' HB ' ' A' ' 135' ' ' VAL . 26.8 m -124.61 157.67 32.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.921 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.697 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 0.3 OUTLIER 72.99 -4.41 2.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.059 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.634 ' O ' HD13 ' A' ' 14' ' ' ILE . . . 104.18 32.0 4.48 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.821 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.672 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 94.88 -22.72 36.51 Favored Glycine 0 C--O 1.262 1.869 0 CA-C-O 123.203 1.446 . . . . 0.0 112.588 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.697 ' HG3' ' HB3' ' A' ' 131' ' ' ASP . 13.4 ptmt -65.73 -17.66 64.77 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 121.872 -0.781 . . . . 0.0 109.086 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.621 ' HB ' HG22 ' A' ' 130' ' ' VAL . 8.4 t -140.82 146.53 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.831 177.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.631 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 41.1 tp -126.13 124.69 41.1 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.516 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 34.1 tt0 -114.43 137.83 51.34 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.85 0.357 . . . . 0.0 111.403 -177.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.506 ' HB2' ' HZ ' ' A' ' 50' ' ' PHE . . . -163.21 164.69 25.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.177 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.546 ' HB2' ' HB3' ' A' ' 125' ' ' ARG . 17.5 mm-40 -94.9 106.41 18.4 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 177.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.59 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 59.0 mt -96.71 130.03 44.01 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.2 0.524 . . . . 0.0 111.197 -178.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.727 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 42.6 ttt180 -77.09 141.29 40.3 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.688 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.452 ' HB2' ' HA ' ' A' ' 47' ' ' ASN . 6.8 p90 -155.65 -169.21 3.04 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.976 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.9 p -58.22 -22.53 52.36 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -109.19 28.24 11.36 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.31 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.63 -123.19 7.45 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.858 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -123.19 135.55 54.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.56 0.219 . . . . 0.0 110.51 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.411 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 57.9 t30 -134.91 142.61 46.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.898 0.38 . . . . 0.0 110.828 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.9 tpp85 -76.61 110.47 11.2 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.066 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.642 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 9.2 t -124.9 165.53 17.91 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.631 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 35.2 mtt85 -146.37 152.37 38.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.712 0.292 . . . . 0.0 110.881 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.781 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 12.4 tt -135.77 142.76 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.022 178.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.573 ' CB ' ' HG3' ' A' ' 155' ' ' GLU . 8.5 m-85 -86.35 101.84 13.46 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 122.471 -0.143 . . . . 0.0 111.31 -178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.811 HD11 ' HG ' ' A' ' 39' ' ' LEU . 3.9 mm? -61.14 -37.53 83.17 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.079 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.593 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 13.1 t70 -55.2 -16.24 3.01 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.209 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.681 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 41.2 mt-10 -63.28 -54.01 43.93 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.504 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 48.4 m80 -124.48 2.92 8.37 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.786 -0.766 . . . . 0.0 112.404 -177.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.583 HG13 HD13 ' A' ' 153' ' ' LEU . 43.5 mm -104.03 112.96 39.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.357 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.632 ' HA3' ' OXT' ' A' ' 167' ' ' CYS . . . -118.73 168.33 13.24 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.562 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.543 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.8 t30 -104.71 122.16 45.1 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 15.7 ttm-85 -123.85 93.68 4.0 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.29 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 59.23 41.54 19.94 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.478 -0.783 . . . . 0.0 113.063 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 90.45 10.05 64.17 Favored Glycine 0 C--O 1.229 -0.193 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.211 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -121.43 134.21 55.09 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.216 0.531 . . . . 0.0 110.211 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.775 HD13 ' CD2' ' A' ' 7' ' ' PHE . 8.1 tp -96.35 107.31 19.66 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.741 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.409 ' HA ' HD11 ' A' ' 37' ' ' ILE . 19.8 pt -140.9 -176.59 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.003 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.504 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 7.9 p80 -71.49 124.65 25.12 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.632 ' OXT' ' HA3' ' A' ' 158' ' ' GLY . 42.6 t . . . . . 0 C--O 1.247 0.965 0 O-C-N 123.804 0.69 . . . . 0.0 111.553 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.717 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.498 ' HB3' ' HD1' ' A' ' 3' ' ' TYR . 19.0 m-80 -90.55 -80.47 0.33 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.548 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 13.6 m-85 -118.24 -94.48 0.5 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.97 0.414 . . . . 0.0 111.684 -178.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -109.18 -28.45 9.02 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -62.4 -70.98 0.89 Allowed Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 119.495 -1.336 . . . . 0.0 112.694 -178.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 65.08 18.93 11.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.803 0.335 . . . . 0.0 110.498 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.756 ' HD2' HD11 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -65.19 -30.69 71.62 Favored 'General case' 0 C--O 1.217 -0.647 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.73 179.815 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.9 t -71.53 -9.32 58.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.705 0.764 . . . . 0.0 109.512 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.49 -23.01 57.51 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 115.12 -0.945 . . . . 0.0 113.054 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 20.2 m -129.39 -22.0 3.12 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 117.287 0.544 . . . . 0.0 111.26 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.512 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 13.0 m -99.31 133.49 43.53 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 12' ' ' ARG . 4.3 ptp180 -113.45 -174.49 2.47 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 42.61 45.52 4.02 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 123.854 0.721 . . . . 0.0 111.489 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.652 HG12 ' HB2' ' A' ' 23' ' ' ALA . 6.7 mt -79.54 109.26 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.008 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.522 ' HA ' HD12 ' A' ' 129' ' ' LEU . 53.8 t -149.54 127.24 11.7 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.42 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.714 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -94.7 154.7 17.19 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.584 0.706 . . . . 0.0 111.832 -179.547 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -97.47 75.49 2.5 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 114.42 -1.264 . . . . 0.0 107.65 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.13 -55.51 5.04 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.431 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.48 ' HA ' ' HZ ' ' A' ' 120' ' ' PHE . . . -148.51 -12.89 0.34 Allowed 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -87.15 91.64 8.78 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.893 0.377 . . . . 0.0 110.792 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.848 HD21 HD11 ' A' ' 153' ' ' LEU . 42.7 tp -60.86 124.65 21.07 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.138 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 54.5 ttp180 -128.35 131.94 48.58 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.773 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.652 ' HB2' HG12 ' A' ' 14' ' ' ILE . . . -149.72 145.9 26.93 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.612 0.72 . . . . 0.0 111.431 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.549 ' O ' ' HD2' ' A' ' 32' ' ' TYR . 19.8 mm-40 -78.73 71.26 5.18 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.645 178.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.687 ' SG ' HD12 ' A' ' 164' ' ' LEU . 61.6 m -60.08 121.65 12.4 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.717 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 10' ' ' SER . 25.0 ttt85 -67.91 132.08 46.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.038 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.713 ' HG2' ' HA3' ' A' ' 162' ' ' GLY . 18.8 mtm180 -103.75 155.88 18.25 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.27 -11.48 3.49 Favored Glycine 0 C--N 1.336 0.548 0 O-C-N 124.383 1.052 . . . . 0.0 114.389 -178.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -80.25 -4.46 53.33 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.19 10.97 73.59 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -179.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.66 152.68 17.37 Favored Glycine 0 C--O 1.225 -0.456 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.97 -178.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.549 ' HD2' ' O ' ' A' ' 24' ' ' GLU . 70.9 m-85 -101.55 125.31 48.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.721 0.296 . . . . 0.0 110.247 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.7 p -117.8 141.13 48.76 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.046 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.8 m -72.66 111.99 8.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.262 0.553 . . . . 0.0 111.219 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.401 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 44.2 t -115.32 148.61 39.02 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.343 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.6 p -144.97 137.96 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.944 0.402 . . . . 0.0 111.561 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.544 HG22 HD21 ' A' ' 164' ' ' LEU . 14.0 tt -134.5 154.2 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.341 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -89.17 110.24 21.01 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 121.836 -0.54 . . . . 0.0 111.487 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.562 HD23 ' HB3' ' A' ' 21' ' ' LEU . 2.9 mm? -87.55 -6.81 58.17 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.512 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.59 -17.27 64.57 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.1 mtt-85 -95.08 2.7 55.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.992 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 96.1 m-85 -131.36 -23.23 2.41 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.601 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 63.2 mt -105.98 136.59 45.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.845 0.355 . . . . 0.0 111.576 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.502 ' HG ' ' HA2' ' A' ' 118' ' ' GLY . 15.8 m -134.79 136.35 42.49 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.15 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.82 ' CB ' ' HG ' ' A' ' 140' ' ' LEU . 8.3 p30 -80.2 107.77 13.27 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.418 177.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -113.87 94.96 5.07 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.478 ' HA ' ' HB2' ' A' ' 142' ' ' TYR . 7.7 t30 56.95 49.41 14.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.756 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.539 ' O ' ' HB2' ' A' ' 149' ' ' SER . . . 71.91 31.12 64.87 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.201 178.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.523 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 38.8 m80 -144.45 129.04 18.11 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.718 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 26.3 m-85 -68.4 136.96 54.13 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.589 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -144.0 132.49 22.19 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.069 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.502 ' CD1' HD12 ' A' ' 151' ' ' ILE . 99.8 m95 -75.11 134.41 41.32 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.163 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.2 m -111.24 154.22 12.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.985 0.421 . . . . 0.0 109.91 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.0 t -97.36 1.19 49.1 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.7 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 167.41 -31.22 0.19 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.263 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.29 -173.31 28.66 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.091 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -164.42 96.27 0.13 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.881 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.98 49.89 0.27 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.276 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -118.98 -40.5 0.64 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.155 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.27 64.73 0.61 Allowed Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.615 -0.803 . . . . 0.0 112.486 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -178.14 -121.3 0.69 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.858 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 87.9 m -131.13 126.43 35.69 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.057 0.456 . . . . 0.0 110.581 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.458 ' HB3' ' HG2' ' A' ' 110' ' ' LYS . . . -132.65 176.32 8.55 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.263 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.429 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 4.8 p -127.41 121.33 30.6 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.794 0.331 . . . . 0.0 111.602 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.52 ' HA ' ' HZ2' ' A' ' 110' ' ' LYS . 9.8 p -109.73 144.47 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.75 0.31 . . . . 0.0 110.411 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 18.1 m -88.19 128.07 35.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.101 0.477 . . . . 0.0 110.395 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.482 ' CG2' HD13 ' A' ' 99' ' ' ILE . 57.1 t -73.16 128.11 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.743 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -100.83 169.2 9.16 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 124.577 1.173 . . . . 0.0 111.196 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.605 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 26.4 tp60 -68.19 112.17 4.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.75 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.38 18.55 16.37 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.71 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -125.38 117.57 24.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.619 0.247 . . . . 0.0 110.463 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.685 ' HA ' HG12 ' A' ' 99' ' ' ILE . 81.9 p -104.9 -179.03 3.82 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.559 HD23 HG23 ' A' ' 99' ' ' ILE . 0.9 OUTLIER -52.88 -41.01 63.94 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.419 178.826 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 46.5 mtm105 -63.51 -39.02 93.34 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.168 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 79' ' ' ARG . 19.6 m-20 -70.95 -41.18 71.46 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.338 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 72' ' ' THR . 35.8 mm -63.92 -46.99 92.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.655 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -56.66 -54.76 34.02 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.75 -0.659 . . . . 0.0 113.02 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -64.86 -27.41 68.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.977 0.417 . . . . 0.0 111.734 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 71.9 ttt180 -74.24 -42.21 60.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.172 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.709 ' HB2' ' HG ' ' A' ' 82' ' ' CYS . 68.2 m-85 -111.45 19.75 17.9 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.2 t70 54.26 36.54 25.35 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.966 0.889 . . . . 0.0 111.316 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.709 ' HG ' ' HB2' ' A' ' 80' ' ' PHE . 3.6 p -113.79 163.5 14.97 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.604 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.0 t70 -92.71 124.69 36.9 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.935 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.474 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 4.0 p90 -51.67 -30.34 21.47 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.255 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -64.71 -44.36 90.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.029 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.697 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 28.0 mm-40 -67.02 -48.25 68.93 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.934 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.604 HG13 ' O ' ' A' ' 83' ' ' ASP . 3.4 mt -53.46 -46.19 58.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.586 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.1 -51.28 67.21 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.35 178.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -57.35 -39.56 76.21 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.618 0.246 . . . . 0.0 111.53 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.697 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 63.9 mmt-85 -63.06 -37.51 87.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.009 0.433 . . . . 0.0 110.778 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.669 HD21 HD13 ' A' ' 93' ' ' ILE . 64.0 t30 -89.38 -5.34 57.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.948 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 95.2 m-20 74.46 22.16 2.18 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.556 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.669 HD13 HD21 ' A' ' 91' ' ' ASN . 14.8 pt -108.18 -176.98 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.212 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.419 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 85.1 mm-40 -108.98 155.96 20.27 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.492 ' O ' HD22 ' A' ' 73' ' ' LEU . 2.7 p30 -55.12 -60.43 3.39 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-O 122.104 0.954 . . . . 0.0 109.119 178.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -74.09 11.5 0.9 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.036 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 5.3 t70 -64.86 -33.15 75.32 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 51.0 mt 70.05 111.84 0.05 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.11 -178.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.685 HG12 ' HA ' ' A' ' 72' ' ' THR . 9.2 pt -94.7 172.54 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.158 -178.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.48 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 19.3 m-85 -125.43 157.97 66.01 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.86 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.605 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 23.2 Cg_endo -65.25 132.63 32.28 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.986 2.458 . . . . 0.0 113.492 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.78 21.05 10.67 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.843 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.541 ' O ' ' HA ' ' A' ' 66' ' ' THR . 51.2 mt-30 -110.46 167.72 10.0 Favored 'General case' 0 C--O 1.215 -0.712 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.044 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.429 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 81.5 t -125.84 111.0 25.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.485 HD12 HG22 ' A' ' 99' ' ' ILE . 90.7 mt -107.16 150.63 26.39 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.155 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.597 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 47.4 mt-30 -89.41 114.92 26.44 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.713 0.768 . . . . 0.0 110.927 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.6 m -121.06 150.86 54.32 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 114.358 -1.292 . . . . 0.0 109.794 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.66 -19.81 59.74 Favored 'Trans proline' 0 N--CA 1.472 0.211 0 C-N-CA 123.458 2.772 . . . . 0.0 114.351 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.5 t -151.54 145.85 25.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.975 0.417 . . . . 0.0 110.382 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.52 ' HZ2' ' HA ' ' A' ' 65' ' ' VAL . 19.9 mmmt -88.6 177.01 6.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.309 0.576 . . . . 0.0 111.566 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.59 153.23 10.45 Favored Glycine 0 N--CA 1.439 -1.106 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -177.08 -170.7 39.84 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.222 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.1 p -80.87 -18.35 47.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.998 0.427 . . . . 0.0 111.298 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -129.31 46.09 1.1 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.027 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.66 -70.7 1.67 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.439 -0.41 . . . . 0.0 112.865 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.49 61.33 1.18 Allowed Glycine 0 N--CA 1.442 -0.923 0 N-CA-C 111.746 -0.541 . . . . 0.0 111.746 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -93.05 -38.09 11.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.405 0.621 . . . . 0.0 109.533 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.502 ' HA2' ' HG ' ' A' ' 44' ' ' SER . . . -93.56 -59.74 1.19 Allowed Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.474 ' OD1' ' HE2' ' A' ' 110' ' ' LYS . 40.1 m-80 74.51 27.49 1.37 Allowed 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.607 0.763 . . . . 0.0 112.636 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.801 ' HA ' HD21 ' A' ' 45' ' ' ASN . 19.4 p90 -62.36 -38.32 89.07 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.006 178.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.414 ' HA ' ' HB2' ' A' ' 124' ' ' ALA . 58.2 t-105 -61.72 -29.78 70.33 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 123.63 0.581 . . . . 0.0 111.634 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.15 -34.64 45.61 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.355 0.597 . . . . 0.0 110.539 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.889 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 17.8 m -132.64 32.34 3.88 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.414 ' HB2' ' HA ' ' A' ' 121' ' ' TRP . . . -114.37 137.36 51.91 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.403 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -131.95 151.3 51.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.183 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.6 t70 55.79 49.09 16.86 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.845 0.831 . . . . 0.0 109.763 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.482 ' HA ' ' HB3' ' A' ' 138' ' ' ALA . 29.6 t -77.2 119.29 25.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.746 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -142.36 144.21 33.06 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.79 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.566 HD13 ' CD1' ' A' ' 21' ' ' LEU . 19.8 mt -87.76 125.46 34.44 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.62 HG21 ' HB ' ' A' ' 135' ' ' VAL . 30.4 m -118.11 158.2 19.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.809 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 69.06 4.78 4.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.157 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.624 ' O ' HD11 ' A' ' 14' ' ' ILE . . . 97.37 30.69 7.19 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.81 -0.709 . . . . 0.0 113.384 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.634 ' HA3' HG23 ' A' ' 14' ' ' ILE . . . 93.66 -21.38 41.48 Favored Glycine 0 C--O 1.266 2.097 0 CA-C-O 123.043 1.357 . . . . 0.0 113.112 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.78 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 15.8 ptpt -65.81 -17.88 64.94 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 121.785 -0.832 . . . . 0.0 108.834 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.62 ' HB ' HG21 ' A' ' 130' ' ' VAL . 17.2 t -139.47 141.62 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.676 177.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 24.4 tp -121.12 123.15 41.6 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.559 ' OE2' ' HD2' ' A' ' 148' ' ' ARG . 23.1 tt0 -117.26 131.34 56.85 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.1 0.476 . . . . 0.0 111.182 -177.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.572 ' HB1' ' CZ ' ' A' ' 50' ' ' PHE . . . -159.98 160.3 33.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.433 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -94.67 109.14 21.1 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.82 ' HG ' ' CB ' ' A' ' 45' ' ' ASN . 0.8 OUTLIER -91.7 131.04 37.37 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.016 -179.528 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.889 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 36.5 ttt180 -75.98 140.56 42.09 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.6 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.478 ' HB2' ' HA ' ' A' ' 47' ' ' ASN . 3.5 p90 -154.46 -176.23 5.79 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.852 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 46.6 m -56.28 -27.96 57.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.859 0.361 . . . . 0.0 111.686 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -97.35 25.76 25.77 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.283 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.85 -120.08 6.33 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.756 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -126.72 137.26 53.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.575 0.226 . . . . 0.0 110.473 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -133.93 132.9 40.78 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.369 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.559 ' HD2' ' OE2' ' A' ' 137' ' ' GLU . 16.3 ttp180 -74.87 98.11 3.47 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.56 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.539 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 35.1 t -106.15 164.38 12.04 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.907 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 15.8 ptt180 -147.62 145.94 29.17 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.694 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.718 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 14.7 tt -129.85 150.62 34.8 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.576 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.778 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 80.7 m-85 -89.46 103.88 16.48 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 122.144 -0.347 . . . . 0.0 111.079 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.848 HD11 HD21 ' A' ' 21' ' ' LEU . 34.2 mt -66.68 -33.78 76.41 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.299 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.78 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 10.1 t70 -58.42 -8.18 1.11 Allowed 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.159 178.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.778 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 38.8 mt-10 -68.77 -51.88 36.41 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 121.117 0.484 . . . . 0.0 111.785 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.425 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 88.6 m-70 -119.25 -15.03 9.2 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.156 -177.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.475 HG22 HD22 ' A' ' 21' ' ' LEU . 50.2 mm -88.21 112.95 24.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.153 -179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.497 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -119.49 173.71 15.18 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.715 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.554 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.7 t30 -113.3 127.71 56.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -122.26 93.15 3.89 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 66.6 t30 53.05 58.15 5.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.545 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.713 ' HA3' ' HG2' ' A' ' 27' ' ' ARG . . . 78.91 11.41 85.24 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.567 -0.742 . . . . 0.0 114.821 178.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -123.75 143.66 50.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 117.542 0.671 . . . . 0.0 110.958 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.756 HD11 ' HD2' ' A' ' 7' ' ' PHE . 5.5 tp -91.58 118.8 30.93 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.944 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.7 pp -129.3 175.36 10.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.807 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.425 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 25.9 p80 -118.22 138.03 52.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.546 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 6.2 p . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.563 -0.732 . . . . 0.0 110.722 -178.83 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.663 0 N-CA-C 111.454 -0.658 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.514 ' HB2' ' HB3' ' A' ' 154' ' ' ASP . 4.0 m120 -78.11 -72.82 0.35 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.86 0.33 . . . . 0.0 111.366 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.666 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 55.4 m-85 -134.9 -92.3 0.3 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.443 ' HB1' ' SG ' ' A' ' 167' ' ' CYS . . . -108.52 -30.74 8.1 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -178.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.96 -69.97 1.22 Allowed Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 119.825 -1.178 . . . . 0.0 112.448 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 62.18 21.15 12.24 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 122.606 0.362 . . . . 0.0 111.229 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.697 ' CD2' HD13 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -64.32 -33.34 75.61 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 121.12 -0.232 . . . . 0.0 110.873 179.368 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.413 ' HA ' HD13 ' A' ' 14' ' ' ILE . 42.6 t -61.95 -18.24 59.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.47 0.653 . . . . 0.0 110.188 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.17 -31.46 69.14 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.124 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.463 ' HB2' ' HB3' ' A' ' 26' ' ' ARG . 21.6 p -126.67 -8.22 6.2 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 117.399 0.6 . . . . 0.0 111.742 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.1 m -105.32 128.95 53.74 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.425 ' CG ' ' HB2' ' A' ' 24' ' ' GLU . 13.8 ptm180 -110.05 -176.71 3.07 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.423 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 21.7 m-20 43.27 44.47 4.61 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 124.036 0.835 . . . . 0.0 112.306 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.672 HD12 ' O ' ' A' ' 132' ' ' GLY . 8.3 mt -79.6 103.2 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -178.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.538 ' HA ' HD13 ' A' ' 129' ' ' LEU . 57.7 m -147.1 127.2 13.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.707 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.705 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -96.98 151.29 19.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.711 0.767 . . . . 0.0 112.805 -179.604 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.458 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 21.7 t70 -93.82 74.74 4.24 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 177.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.42 -54.44 4.9 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.155 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.544 ' HB1' ' HB2' ' A' ' 40' ' ' ASN . . . -147.97 -12.83 0.37 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.264 -0.468 . . . . 0.0 109.742 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.458 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -82.55 86.74 6.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.545 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.705 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 35.9 tp -60.95 124.45 20.53 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.485 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.55 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 34.7 ttt180 -132.17 127.59 36.23 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.877 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.627 ' HB2' HG12 ' A' ' 14' ' ' ILE . . . -146.0 145.98 30.82 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.668 0.747 . . . . 0.0 111.421 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.425 ' HB2' ' CG ' ' A' ' 12' ' ' ARG . 2.1 mm-40 -83.68 76.4 9.98 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.411 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.582 ' SG ' HD11 ' A' ' 164' ' ' LEU . 35.8 m -66.54 125.57 26.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.393 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.467 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 30.3 ttt180 -70.41 121.75 18.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.651 178.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -100.05 163.84 12.25 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.755 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.4 -15.95 4.54 Favored Glycine 0 C--N 1.34 0.782 0 O-C-N 124.934 1.396 . . . . 0.0 114.114 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.6 -12.49 61.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.516 0.674 . . . . 0.0 109.417 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.57 9.52 62.86 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.654 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -119.93 162.26 14.11 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.08 -1.057 . . . . 0.0 113.286 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.467 ' CE2' ' HB2' ' A' ' 26' ' ' ARG . 84.2 m-85 -100.44 125.2 46.71 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.0 p -116.6 140.76 49.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.393 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -73.58 113.92 11.23 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.17 0.51 . . . . 0.0 111.43 -178.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 32.9 t -116.14 151.02 36.46 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.649 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.6 p -144.77 139.6 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.308 0.575 . . . . 0.0 112.091 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.7 tt -135.47 143.38 36.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.479 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -76.34 96.85 4.08 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.512 ' HG ' ' HG ' ' A' ' 43' ' ' LEU . 5.3 tp -73.5 -4.54 34.47 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.046 0.45 . . . . 0.0 110.408 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.544 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 64.3 t30 -73.83 -11.7 60.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.498 ' HG2' ' HA3' ' A' ' 116' ' ' GLY . 74.0 mtt180 -102.48 5.08 39.32 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.233 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 13.7 m-85 -127.57 -26.09 3.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.778 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.65 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 49.3 mt -105.02 138.76 40.73 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.8 0.333 . . . . 0.0 110.899 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.436 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 4.0 m -134.68 134.76 41.46 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.678 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.716 ' ND2' HD21 ' A' ' 140' ' ' LEU . 1.0 OUTLIER -73.33 110.37 7.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.685 177.221 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -111.9 86.95 2.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.245 0.545 . . . . 0.0 110.407 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 51.82 46.22 26.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.23 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.48 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 82.98 40.01 9.7 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.573 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.413 ' HA ' ' HB3' ' A' ' 149' ' ' SER . 16.5 t60 -162.2 128.63 3.64 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.865 ' HB2' ' HB ' ' A' ' 151' ' ' ILE . 96.2 m-85 -67.6 156.81 35.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.817 0.342 . . . . 0.0 111.146 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.43 ' HA ' ' HD3' ' A' ' 51' ' ' ARG . 16.7 mmt180 -148.91 126.89 11.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.169 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.98 ' HZ2' ' HA ' ' A' ' 153' ' ' LEU . 72.9 m95 -75.94 125.15 28.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.511 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.6 m -119.92 113.18 39.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.409 0.623 . . . . 0.0 110.096 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.1 m -92.74 48.93 1.4 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.26 0.552 . . . . 0.0 110.271 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.97 1.76 88.68 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.279 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.44 71.28 2.52 Favored Glycine 0 C--O 1.237 0.32 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.455 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -91.7 -31.88 9.05 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.476 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -79.32 79.24 1.65 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.234 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.15 75.86 2.13 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.356 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.03 -145.63 17.81 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.334 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.03 -124.01 6.3 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.113 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 83.6 m -130.11 120.08 24.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.088 0.47 . . . . 0.0 110.595 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.467 ' HB1' ' HG2' ' A' ' 110' ' ' LYS . . . -122.26 176.38 5.88 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.586 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.458 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 13.2 p -127.73 111.03 13.23 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.905 0.383 . . . . 0.0 111.176 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.561 HG23 ' CE2' ' A' ' 80' ' ' PHE . 9.1 p -97.54 144.37 11.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.042 0.448 . . . . 0.0 111.218 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 8.2 m -91.09 127.46 36.52 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.465 ' CG2' HD12 ' A' ' 99' ' ' ILE . 49.1 t -75.87 131.68 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.585 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -98.08 168.95 9.95 Favored 'General case' 0 N--CA 1.445 -0.679 0 O-C-N 124.657 1.223 . . . . 0.0 110.569 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.58 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 52.3 tt0 -69.65 119.75 14.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.781 -178.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.39 -1.67 50.1 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.475 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -110.12 131.71 54.82 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.084 0.469 . . . . 0.0 111.687 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.646 ' HA ' HG12 ' A' ' 99' ' ' ILE . 67.5 p -108.59 -177.62 3.37 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.56 HD23 ' O ' ' A' ' 95' ' ' ASN . 1.4 mm? -52.85 -40.81 63.71 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.454 0.645 . . . . 0.0 109.889 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.0 ttm-85 -62.9 -37.16 85.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.211 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -74.15 -42.0 60.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.905 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 72' ' ' THR . 44.7 mm -62.0 -48.31 89.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.713 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -54.44 -52.87 41.87 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.688 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -64.5 -33.7 76.5 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 35.7 ttm-85 -68.69 -37.46 79.56 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.812 ' HB2' ' HG ' ' A' ' 82' ' ' CYS . 87.1 m-85 -111.72 18.37 19.03 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 55.02 34.07 21.67 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.236 0.541 . . . . 0.0 111.794 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.812 ' HG ' ' HB2' ' A' ' 80' ' ' PHE . 3.0 p -111.37 170.49 8.09 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.613 ' HB3' ' HG3' ' A' ' 86' ' ' GLU . 32.6 t0 -98.26 121.53 40.3 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.419 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.466 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 4.3 p90 -51.82 -29.72 20.42 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.586 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.457 ' HB2' ' OD2' ' A' ' 83' ' ' ASP . 69.2 m80 -63.8 -47.22 81.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.513 177.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.745 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 41.6 mt-10 -62.05 -53.49 54.75 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.942 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.578 HG13 ' O ' ' A' ' 83' ' ' ASP . 3.3 mt -48.0 -46.6 12.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.275 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.591 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.72 -51.06 68.64 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.211 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 89' ' ' ARG . 49.4 mtp85 -59.16 -36.77 75.85 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.745 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 12.3 mmt85 -69.43 -30.44 68.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.699 0.285 . . . . 0.0 110.98 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 2.6 t-20 -95.1 -4.72 45.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.825 0.345 . . . . 0.0 110.871 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 15.9 m120 78.25 13.81 1.52 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.769 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.591 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 19.6 pt -101.64 -173.55 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.288 179.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . 64.4 mt-30 -113.88 157.64 22.1 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.126 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.56 ' O ' HD23 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -56.54 -69.73 0.14 Allowed 'General case' 0 C--O 1.244 0.778 0 CA-C-O 122.061 0.934 . . . . 0.0 110.101 179.663 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -73.28 13.91 0.38 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.716 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.496 ' HB2' ' HB2' ' A' ' 94' ' ' GLN . 1.9 t70 -65.99 -29.32 69.69 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.094 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 8.8 mp 71.33 112.3 0.06 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 122.033 0.921 . . . . 0.0 110.55 -178.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.646 HG12 ' HA ' ' A' ' 72' ' ' THR . 9.0 pt -94.59 177.22 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.155 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.505 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 79.2 m-85 -128.7 158.77 71.09 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.58 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 28.1 Cg_endo -67.0 138.96 49.56 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.949 2.433 . . . . 0.0 113.056 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.35 18.49 42.07 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.512 ' O ' ' HA ' ' A' ' 66' ' ' THR . 41.4 tt0 -103.89 164.28 11.8 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.458 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 69.7 t -125.58 118.2 51.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 120.938 0.399 . . . . 0.0 109.978 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.499 ' HB3' HG22 ' A' ' 87' ' ' ILE . 78.9 mt -114.44 151.07 33.77 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.147 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.523 ' HB2' ' CB ' ' A' ' 90' ' ' ARG . 75.8 mt-30 -90.91 115.2 27.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.668 0.747 . . . . 0.0 110.92 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.437 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 34.0 m -126.99 151.97 74.91 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.843 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 107' ' ' VAL . 29.7 Cg_endo -63.8 -15.37 48.55 Favored 'Trans proline' 0 N--CA 1.474 0.352 0 C-N-CA 123.624 2.883 . . . . 0.0 115.207 -177.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.6 t -153.2 150.75 29.34 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.225 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.542 ' HE3' ' HA ' ' A' ' 65' ' ' VAL . 12.6 mmmm -98.46 170.32 8.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.069 0.461 . . . . 0.0 110.942 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.61 ' HA3' ' HE1' ' A' ' 80' ' ' PHE . . . -132.34 144.84 16.71 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -74.66 -82.43 0.42 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.586 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 19.5 m 55.25 47.01 22.51 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.25 0.548 . . . . 0.0 110.636 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 122.28 47.48 0.28 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.387 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 117.17 156.64 10.54 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.001 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.498 ' HA3' ' HG2' ' A' ' 41' ' ' ARG . . . -152.07 -71.14 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.459 -0.657 . . . . 0.0 111.459 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.62 -44.44 0.4 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.064 0.459 . . . . 0.0 110.853 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . -87.76 -57.63 1.92 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.257 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 71.89 29.4 2.45 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 123.055 0.542 . . . . 0.0 111.373 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.65 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 12.5 p90 -61.19 -37.98 84.88 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.107 0.48 . . . . 0.0 110.183 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 -64.85 -26.25 68.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.636 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.46 -18.3 61.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.213 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.74 ' HB2' ' HB3' ' A' ' 141' ' ' ARG . 11.2 p -140.07 22.67 2.42 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.971 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.73 141.96 44.69 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.901 0.382 . . . . 0.0 111.091 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -133.74 151.2 51.54 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 58.83 34.81 23.94 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.363 0.414 . . . . 0.0 111.646 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.484 ' HA ' ' HB1' ' A' ' 138' ' ' ALA . 30.8 t -66.92 123.82 20.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.81 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.481 ' O ' HD11 ' A' ' 136' ' ' LEU . 39.1 ptt180 -148.12 142.71 26.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.088 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.558 HD12 HG22 ' A' ' 14' ' ' ILE . 22.3 mt -85.52 131.79 34.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.081 0.467 . . . . 0.0 110.044 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.609 HG22 ' HB ' ' A' ' 135' ' ' VAL . 27.5 m -126.92 162.36 31.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.825 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 67.16 7.26 5.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.785 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.672 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 95.39 31.35 7.58 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.914 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.768 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 90.03 -19.28 43.23 Favored Glycine 0 CA--C 1.541 1.671 0 CA-C-O 123.226 1.459 . . . . 0.0 112.824 177.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.712 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 0.7 OUTLIER -68.18 -14.92 63.34 Favored 'General case' 0 C--N 1.314 -0.952 0 O-C-N 121.121 -1.223 . . . . 0.0 109.564 178.071 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.609 ' HB ' HG22 ' A' ' 130' ' ' VAL . 14.6 t -140.49 149.06 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.783 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 39.0 tp -130.72 125.25 33.4 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -114.65 136.25 53.25 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.622 0.249 . . . . 0.0 111.363 -177.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.787 ' HB2' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.73 163.51 26.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.105 0.479 . . . . 0.0 111.323 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -94.72 106.5 18.49 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.716 HD21 ' ND2' ' A' ' 45' ' ' ASN . 36.6 mt -96.25 132.23 41.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.104 0.478 . . . . 0.0 111.316 -178.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.74 ' HB3' ' HB2' ' A' ' 123' ' ' SER . 42.5 ttt180 -75.82 140.55 42.34 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.256 -0.883 . . . . 0.0 110.674 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.488 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.7 p90 -160.3 -170.3 2.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.429 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 6.1 p -56.12 -29.29 60.46 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -94.49 11.67 69.84 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.726 -0.749 . . . . 0.0 113.171 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 141' ' ' ARG . . . 101.08 -111.46 4.14 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.039 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -126.75 129.85 49.17 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.488 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 9.1 t30 -125.55 140.19 52.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.992 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 148' ' ' ARG . 12.5 tpp85 -73.49 100.04 3.16 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.413 ' HB3' ' HA ' ' A' ' 49' ' ' HIS . 1.0 OUTLIER -111.62 155.43 23.38 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.425 -177.709 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.599 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 4.8 ptp180 -146.51 145.28 30.1 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.135 0.493 . . . . 0.0 111.274 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.865 ' HB ' ' HB2' ' A' ' 50' ' ' PHE . 15.4 tt -126.47 159.74 35.22 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.81 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.489 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.825 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 68.5 m-85 -103.94 107.15 17.9 Favored 'General case' 0 C--N 1.311 -1.106 0 O-C-N 122.361 -0.212 . . . . 0.0 110.655 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.98 ' HA ' ' HZ2' ' A' ' 52' ' ' TRP . 8.4 mp -68.9 -37.18 78.81 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.221 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.712 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 6.1 t70 -57.08 -8.41 0.66 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.869 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.825 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 61.0 mt-10 -73.78 -55.43 6.24 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 121.972 -0.455 . . . . 0.0 111.811 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.523 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 88.7 m-70 -122.0 9.8 10.02 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.114 -0.634 . . . . 0.0 112.671 -177.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 153' ' ' LEU . 45.1 mm -110.95 109.62 29.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.356 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 167' ' ' CYS . . . -115.58 166.65 12.26 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.048 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.561 ' CG ' ' HB3' ' A' ' 25' ' ' CYS . 1.8 t30 -101.51 124.84 47.83 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.406 ' NH2' ' HG2' ' A' ' 163' ' ' GLU . 48.3 ttp180 -112.99 86.12 2.31 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.694 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 50.26 51.06 17.48 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 92.87 6.64 63.41 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.762 178.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.406 ' HG2' ' NH2' ' A' ' 160' ' ' ARG . 6.7 tp10 -122.16 149.75 43.17 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.697 HD13 ' CD2' ' A' ' 7' ' ' PHE . 5.3 tp -99.11 118.16 35.22 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.485 HG12 ' H ' ' A' ' 166' ' ' HIS . 12.2 tt -145.16 170.21 6.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.673 -178.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.523 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 19.3 p80 -70.87 123.18 21.38 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.563 ' O ' ' HA3' ' A' ' 158' ' ' GLY . 53.3 t . . . . . 0 C--O 1.247 0.941 0 O-C-N 123.852 0.72 . . . . 0.0 111.576 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.644 ' HA3' ' OD1' ' A' ' 6' ' ' ASN . . . . . . . . 0 N--CA 1.483 1.811 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -100.72 -68.51 0.81 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.527 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 53.5 m-85 -128.97 -94.6 0.42 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.31 -29.39 10.8 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.66 -73.41 0.58 Allowed Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 119.772 -1.204 . . . . 0.0 113.154 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.644 ' OD1' ' HA3' ' A' ' 1' ' ' GLY . 36.5 m-80 65.26 15.61 10.1 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 122.46 0.304 . . . . 0.0 110.484 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.599 ' CE2' HD12 ' A' ' 14' ' ' ILE . 1.4 p90 -60.14 -37.26 79.53 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.562 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.573 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.7 OUTLIER -59.85 -24.05 63.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.268 0.556 . . . . 0.0 110.604 -179.427 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.87 -33.96 87.25 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.404 -0.816 . . . . 0.0 113.44 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 18.8 p -121.12 -3.74 9.55 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 117.188 0.494 . . . . 0.0 111.689 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.7 m -110.39 131.85 54.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.119 0.485 . . . . 0.0 109.997 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.553 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 18.8 ptt180 -107.95 179.94 4.08 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 42.52 47.79 4.48 Favored 'General case' 0 C--N 1.316 -0.867 0 O-C-N 123.883 0.739 . . . . 0.0 112.767 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.686 HG23 ' HA3' ' A' ' 133' ' ' GLY . 7.3 mt -81.49 102.44 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-O 121.043 0.449 . . . . 0.0 109.919 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.503 ' HA ' HD12 ' A' ' 129' ' ' LEU . 46.4 t -147.76 128.69 14.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.457 -0.792 . . . . 0.0 108.985 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.7 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -92.99 159.48 15.29 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.629 0.728 . . . . 0.0 112.007 -179.241 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -104.31 77.64 1.42 Allowed 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.22 -61.02 4.52 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.134 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' A' ' 40' ' ' ASN . . . -146.02 -13.36 0.48 Allowed 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.282 -0.459 . . . . 0.0 109.913 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -86.16 95.15 9.48 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.81 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.878 ' HB2' HD21 ' A' ' 39' ' ' LEU . 33.8 tp -59.75 128.27 36.11 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.758 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 35' ' ' SER . 34.8 ttp180 -133.17 128.03 35.13 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.939 -178.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.679 ' HB2' HG12 ' A' ' 14' ' ' ILE . . . -149.47 147.29 28.05 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.546 0.688 . . . . 0.0 111.144 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.553 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 2.1 mm-40 -82.96 79.62 9.26 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.464 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.57 ' HB3' ' CG ' ' A' ' 159' ' ' ASN . 61.4 m -67.34 129.43 39.89 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.762 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 10' ' ' SER . 43.1 ttp180 -72.35 120.8 18.46 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.251 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.7 ttt-85 -96.05 153.71 17.63 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.09 -16.37 4.33 Favored Glycine 0 C--N 1.335 0.493 0 O-C-N 124.611 1.194 . . . . 0.0 114.765 -177.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.87 -13.88 61.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.238 0.542 . . . . 0.0 110.001 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.38 10.13 56.09 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.59 160.64 13.9 Favored Glycine 0 C--O 1.225 -0.461 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.485 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.503 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 88.5 m-85 -97.98 130.59 44.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.955 0.407 . . . . 0.0 110.685 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.0 m -110.69 129.1 55.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.364 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.36 110.37 5.26 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 29.4 t -112.46 147.17 37.08 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.219 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.643 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.3 p -144.76 133.09 17.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.027 0.441 . . . . 0.0 110.686 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.408 HG23 ' HB3' ' A' ' 21' ' ' LEU . 11.0 tt -133.93 146.83 30.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.648 -177.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -78.96 103.74 9.11 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.924 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.878 HD21 ' HB2' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -78.96 -5.17 53.13 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 120.858 0.361 . . . . 0.0 110.245 178.601 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.581 HD21 ' HB3' ' A' ' 121' ' ' TRP . 25.1 t-20 -70.9 -17.88 62.69 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -106.07 17.49 23.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.382 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 41.3 m-85 -135.97 -34.7 0.8 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.314 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.57 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 38.6 mt -106.09 136.32 45.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.867 -179.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.666 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 3.0 m -126.6 143.59 51.17 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.78 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.604 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 6.8 p-10 -93.23 93.56 8.31 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 122.01 0.909 . . . . 0.0 108.568 178.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -94.3 95.74 9.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.16 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 54.68 45.65 26.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.525 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.687 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 77.87 29.94 53.23 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.467 178.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.552 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 23.7 t-160 -148.03 124.93 11.27 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.787 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 25.3 m-85 -62.54 136.42 57.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.248 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.401 ' CZ ' ' HA3' ' A' ' 55' ' ' GLY . 17.1 mmm180 -145.01 133.12 21.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.701 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.446 ' HZ2' ' O ' ' A' ' 152' ' ' TYR . 98.6 m95 -73.47 109.64 7.15 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.8 t 64.76 -78.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 O-C-N 123.865 0.728 . . . . 0.0 110.986 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.0 t -138.91 12.76 2.67 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.442 0.639 . . . . 0.0 109.495 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.401 ' HA3' ' CZ ' ' A' ' 51' ' ' ARG . . . 81.67 100.25 0.4 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.668 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.9 167.76 20.95 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.984 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.52 -156.62 7.61 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.94 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.07 155.52 53.56 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.537 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.54 -88.97 0.9 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.575 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 152.63 -132.76 3.81 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.821 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -169.43 169.69 42.15 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.168 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.6 m -129.05 124.75 35.67 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.067 0.46 . . . . 0.0 110.472 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -126.46 176.76 6.92 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.665 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.1 p -128.37 118.01 22.42 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 t -107.06 137.2 39.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.802 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 18.9 m -87.78 124.82 34.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.081 0.467 . . . . 0.0 109.916 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.49 ' CG2' HD13 ' A' ' 99' ' ' ILE . 42.2 t -71.06 133.91 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.125 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.472 ' HB3' ' OD2' ' A' ' 71' ' ' ASP . 4.5 tt0 -104.16 171.33 7.4 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 124.464 1.103 . . . . 0.0 110.411 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.637 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 58.9 tp60 -60.22 119.68 8.35 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.374 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.94 6.53 79.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.996 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.472 ' OD2' ' HB3' ' A' ' 68' ' ' GLN . 27.6 m-20 -103.82 124.03 48.17 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 117.393 0.597 . . . . 0.0 110.581 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.621 ' HA ' HG12 ' A' ' 99' ' ' ILE . 80.3 p -105.18 179.44 4.27 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.53 HD13 ' HB ' ' A' ' 87' ' ' ILE . 2.2 mm? -51.6 -41.57 61.32 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.59 0.709 . . . . 0.0 109.403 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -59.61 -39.36 83.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.384 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 79' ' ' ARG . 13.4 m-20 -73.85 -46.65 43.68 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.119 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 72' ' ' THR . 42.4 mm -57.12 -48.05 82.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.709 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.731 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -59.78 -54.28 38.9 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.852 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -33.04 74.39 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.92 0.39 . . . . 0.0 111.524 -178.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 35.6 ttt180 -74.0 -39.82 63.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.031 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.506 ' HB2' ' HG ' ' A' ' 82' ' ' CYS . 97.4 m-85 -105.78 19.33 20.73 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 59.26 26.82 15.71 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.731 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -110.12 168.64 9.29 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.489 ' O ' HG13 ' A' ' 87' ' ' ILE . 4.3 p-10 -96.65 122.17 39.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.71 0.767 . . . . 0.0 109.836 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.422 ' HA ' HD13 ' A' ' 87' ' ' ILE . 3.0 p90 -48.64 -32.16 7.83 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.036 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.416 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 10.9 m80 -60.36 -48.93 79.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.991 178.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.61 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 28.4 tt0 -63.18 -46.33 87.62 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.205 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.53 ' HB ' HD13 ' A' ' 73' ' ' LEU . 3.5 mt -52.51 -49.58 43.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.577 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.27 -49.21 74.97 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.408 178.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' A' ' 85' ' ' HIS . 62.0 mtm180 -56.67 -38.13 71.77 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.61 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 13.0 mtt180 -70.02 -36.29 74.98 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.158 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.756 HD21 HD11 ' A' ' 93' ' ' ILE . 66.8 t30 -85.76 -5.51 59.24 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.964 0.411 . . . . 0.0 110.276 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 15.9 m120 75.5 18.92 2.2 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.611 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.756 HD11 HD21 ' A' ' 91' ' ' ASN . 14.3 pt -105.66 -170.38 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.204 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.541 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 28.5 mm-40 -117.97 158.72 24.41 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.479 ' O ' HD22 ' A' ' 73' ' ' LEU . 6.3 p30 -55.72 -57.62 11.26 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-O 121.877 0.846 . . . . 0.0 109.956 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.12 12.51 2.78 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 121.831 -0.543 . . . . 0.0 111.294 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.541 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 0.8 OUTLIER -62.69 -31.2 72.06 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.617 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 7.0 mp 71.38 111.18 0.06 Allowed 'General case' 0 C--N 1.338 0.108 0 O-C-N 124.358 1.037 . . . . 0.0 110.732 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.621 HG12 ' HA ' ' A' ' 72' ' ' THR . 6.4 pt -94.43 176.0 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.977 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.466 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 92.7 m-85 -121.07 158.2 53.28 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.91 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.637 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 43.4 Cg_endo -72.3 133.36 20.88 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 123.042 2.495 . . . . 0.0 112.889 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 101.59 14.12 30.7 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.514 ' O ' ' HA ' ' A' ' 66' ' ' THR . 40.0 mt-30 -102.92 168.44 9.2 Favored 'General case' 0 C--O 1.216 -0.699 0 C-N-CA 120.641 -0.424 . . . . 0.0 109.956 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 63.5 t -126.15 118.48 51.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.561 HD11 HG22 ' A' ' 99' ' ' ILE . 95.8 mt -113.93 150.07 34.28 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.188 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -89.58 110.72 21.55 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.986 0.898 . . . . 0.0 111.21 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.1 m -115.59 151.57 46.28 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.555 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.71 -18.06 53.02 Favored 'Trans proline' 0 C--N 1.331 -0.349 0 C-N-CA 123.069 2.513 . . . . 0.0 114.376 -178.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.0 t -154.13 148.02 25.53 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.875 0.369 . . . . 0.0 111.225 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -90.26 -172.23 3.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.09 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.55 -51.99 5.32 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.805 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 167.04 173.22 35.11 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.952 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 26.0 t -110.08 -29.83 8.04 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.066 0.46 . . . . 0.0 109.857 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.8 -52.14 4.16 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.126 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -159.86 151.22 21.89 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.6 56.85 3.04 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.045 -0.597 . . . . 0.0 111.632 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -118.49 -28.78 5.62 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.791 0.329 . . . . 0.0 110.868 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.666 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -120.47 -75.97 0.44 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.321 -0.942 . . . . 0.0 112.676 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 73.18 29.1 1.77 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.278 0.631 . . . . 0.0 111.554 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.57 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 20.0 p90 -59.87 -37.69 80.05 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-O 121.108 0.48 . . . . 0.0 110.06 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.636 ' HE3' ' HB2' ' A' ' 124' ' ' ALA . 4.1 t-105 -66.27 -26.55 67.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.195 -178.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.89 -25.49 66.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.139 0.495 . . . . 0.0 110.143 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.647 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 4.2 m -133.42 27.03 4.11 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.323 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.636 ' HB2' ' HE3' ' A' ' 121' ' ' TRP . . . -105.65 155.82 18.87 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.001 0.429 . . . . 0.0 110.898 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.0 mmm-85 -146.43 142.35 28.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.755 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 53.55 35.57 21.21 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.246 0.546 . . . . 0.0 111.371 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.567 ' HB ' ' CB ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -79.74 127.36 39.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.812 -179.848 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.446 ' O ' HD13 ' A' ' 136' ' ' LEU . 15.6 ptt180 -151.31 158.82 44.32 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.571 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.815 HD23 HD13 ' A' ' 153' ' ' LEU . 17.1 mt -86.1 136.59 33.16 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 120.996 0.427 . . . . 0.0 110.825 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.572 HG21 ' HB ' ' A' ' 135' ' ' VAL . 31.2 m -132.35 159.48 43.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.471 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.479 ' HB3' ' HD3' ' A' ' 134' ' ' LYS . 4.6 m-20 69.63 4.87 4.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.398 178.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.651 ' O ' HD13 ' A' ' 14' ' ' ILE . . . 98.04 28.84 7.96 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.597 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.686 ' HA3' HG23 ' A' ' 14' ' ' ILE . . . 93.07 -18.85 55.26 Favored Glycine 0 C--O 1.269 2.283 0 CA-C-O 123.773 1.763 . . . . 0.0 112.623 177.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.667 ' HG3' HG22 ' A' ' 135' ' ' VAL . 20.9 ptmt -67.52 -19.97 65.37 Favored 'General case' 0 C--N 1.313 -0.986 0 O-C-N 121.452 -1.028 . . . . 0.0 108.82 178.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.667 HG22 ' HG3' ' A' ' 134' ' ' LYS . 4.2 t -138.15 146.67 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 121.279 0.561 . . . . 0.0 110.874 178.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.623 HD12 HD21 ' A' ' 129' ' ' LEU . 50.6 tp -126.46 116.31 20.93 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.479 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 32.5 tt0 -105.05 137.15 43.25 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.437 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.567 ' CB ' ' HB ' ' A' ' 127' ' ' VAL . . . -161.96 164.07 28.62 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.185 0.517 . . . . 0.0 112.283 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -95.9 106.25 18.37 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.687 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 50.2 mt -98.24 129.79 44.97 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.307 0.575 . . . . 0.0 111.244 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.647 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 62.4 ttt180 -71.32 141.18 50.47 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.5 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.415 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.6 p90 -159.09 -173.78 4.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.226 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 17.0 m -61.04 -26.21 67.47 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -94.83 16.12 61.93 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.875 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 102.1 -114.99 5.1 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.412 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -128.69 128.84 44.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.931 0.396 . . . . 0.0 110.371 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.415 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 47.0 t30 -124.25 130.86 53.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.218 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 138' ' ' ALA . 13.8 ttp180 -78.15 96.58 5.21 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.266 0.555 . . . . 0.0 110.617 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.552 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 20.0 t -104.13 170.43 7.92 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.172 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.621 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 8.7 mtp85 -146.22 147.73 31.75 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 121.155 -0.218 . . . . 0.0 110.615 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.787 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 9.9 tt -131.34 152.62 37.62 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.538 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.146 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.633 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 84.4 m-85 -96.65 105.02 17.06 Favored 'General case' 0 C--N 1.313 -1.012 0 O-C-N 122.286 -0.259 . . . . 0.0 111.024 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.815 HD13 HD23 ' A' ' 129' ' ' LEU . 16.9 mt -65.72 -37.24 85.86 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.11 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.606 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 9.4 t70 -53.59 -14.4 0.85 Allowed 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.144 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.633 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 41.1 mt-10 -66.51 -54.79 19.99 Favored 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 121.682 -0.636 . . . . 0.0 112.715 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.497 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 77.3 m-70 -122.18 1.05 9.69 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.141 -0.624 . . . . 0.0 112.492 -176.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 45.5 mm -104.09 110.78 31.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.484 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.727 ' HA3' ' O ' ' A' ' 167' ' ' CYS . . . -118.69 166.41 12.97 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.232 -0.985 . . . . 0.0 113.105 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.57 ' CG ' ' HB3' ' A' ' 25' ' ' CYS . 2.6 t30 -98.25 122.26 41.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.415 -0.393 . . . . 0.0 110.077 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -117.81 86.77 2.58 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 58.86 47.37 12.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.184 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.518 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 87.67 7.55 75.0 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.485 178.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -124.09 132.74 53.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.04 0.447 . . . . 0.0 111.567 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.574 HD21 ' HD2' ' A' ' 7' ' ' PHE . 30.0 mt -84.63 114.31 21.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.642 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 46.0 pt -142.24 176.66 3.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.222 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.497 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 3.6 p80 -66.68 118.6 10.47 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.44 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.727 ' O ' ' HA3' ' A' ' 158' ' ' GLY . 39.5 t . . . . . 0 C--O 1.242 0.678 0 CA-C-O 118.521 -0.752 . . . . 0.0 112.166 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.46 ' HA3' ' OD1' ' A' ' 6' ' ' ASN . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 111.659 -0.577 . . . . 0.0 111.659 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.507 ' HB3' ' HD1' ' A' ' 3' ' ' TYR . 19.0 m-80 -77.27 -76.68 0.17 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.746 0.273 . . . . 0.0 111.664 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.507 ' HD1' ' HB3' ' A' ' 2' ' ' ASN . 28.9 m-85 -129.75 -97.55 0.36 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.54 -27.41 12.37 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.2 -76.39 0.27 Allowed Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.13 -1.033 . . . . 0.0 112.91 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.46 ' OD1' ' HA3' ' A' ' 1' ' ' GLY . 30.0 m-80 65.66 11.03 7.22 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.547 0.339 . . . . 0.0 111.138 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.633 ' CE2' HD13 ' A' ' 14' ' ' ILE . 1.6 p90 -61.33 -33.02 72.91 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 121.133 -0.227 . . . . 0.0 111.281 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.512 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.8 OUTLIER -62.58 -25.41 68.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.326 0.584 . . . . 0.0 110.562 -178.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.73 -22.99 77.0 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.183 -0.917 . . . . 0.0 113.596 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.496 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 22.9 p -125.73 -16.39 5.73 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 117.722 0.761 . . . . 0.0 111.72 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.6 m -99.72 131.71 45.53 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.413 ' CG ' ' HB2' ' A' ' 24' ' ' GLU . 15.2 ptm180 -109.18 178.82 4.34 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 44.67 47.57 8.71 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.454 0.701 . . . . 0.0 112.56 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.677 HG12 ' HB3' ' A' ' 23' ' ' ALA . 10.2 mt -80.77 106.18 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.518 ' HA ' HD11 ' A' ' 129' ' ' LEU . 72.2 m -147.8 128.04 13.85 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.712 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -94.04 154.62 17.54 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.22 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -96.21 73.93 2.93 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.002 -1.453 . . . . 0.0 107.694 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.17 -60.17 4.72 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.793 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.418 ' HB3' ' HB3' ' A' ' 40' ' ' ASN . . . -145.42 0.46 0.89 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.135 0.493 . . . . 0.0 110.47 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -104.48 93.82 4.99 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.005 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.712 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 2.8 tm? -60.06 132.45 53.97 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.671 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.697 ' H ' HD21 ' A' ' 21' ' ' LEU . 33.2 ttm105 -134.52 128.0 32.48 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.198 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.677 ' HB3' HG12 ' A' ' 14' ' ' ILE . . . -148.39 148.49 30.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.679 0.752 . . . . 0.0 111.141 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.459 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 2.6 mm-40 -82.85 76.95 9.66 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.196 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.504 ' HB3' ' CG ' ' A' ' 159' ' ' ASN . 84.8 m -63.36 126.74 28.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.717 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 10' ' ' SER . 37.2 ttt180 -69.54 122.57 19.3 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.353 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.547 ' HG3' ' OD1' ' A' ' 161' ' ' ASN . 20.4 ttt85 -99.3 152.06 20.36 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.891 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -52.19 -17.9 4.33 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 114.119 -1.4 . . . . 0.0 114.712 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.414 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 4.6 m-20 -74.94 -7.46 53.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.103 0.478 . . . . 0.0 110.696 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.51 8.13 62.75 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.64 154.95 16.38 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.368 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.459 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 80.8 m-85 -92.4 125.53 37.09 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.3 m -108.23 130.35 55.16 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.332 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.2 m -68.98 112.44 5.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.862 0.363 . . . . 0.0 110.588 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.48 ' HB3' HD22 ' A' ' 164' ' ' LEU . 32.2 t -116.44 151.24 36.43 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.265 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.547 ' HB ' ' HG3' ' A' ' 22' ' ' ARG . 1.4 p -144.38 130.93 15.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.964 0.411 . . . . 0.0 110.675 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.421 ' CG2' ' HB3' ' A' ' 21' ' ' LEU . 17.8 tt -122.95 149.23 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.98 -178.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.459 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 22.7 m-20 -82.78 93.57 7.46 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.563 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.654 HD11 HD23 ' A' ' 16' ' ' LEU . 39.2 mt -73.27 -13.38 61.12 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.019 0.438 . . . . 0.0 109.997 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.491 ' OD1' ' HG3' ' A' ' 41' ' ' ARG . 23.8 p30 -66.27 -16.22 63.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.432 0.634 . . . . 0.0 109.625 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.673 ' HG2' ' HA3' ' A' ' 116' ' ' GLY . 48.0 mtm180 -117.29 20.28 13.73 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.418 178.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.556 ' HB2' ' HA ' ' A' ' 39' ' ' LEU . 9.6 m-85 -133.4 -30.92 1.26 Allowed 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.295 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.535 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 42.2 mt -114.63 135.8 53.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.854 0.359 . . . . 0.0 110.781 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.727 ' HG ' ' HA2' ' A' ' 118' ' ' GLY . 1.9 m -124.21 147.66 47.87 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.038 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.547 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 7.5 p-10 -94.86 98.77 10.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.596 0.713 . . . . 0.0 110.478 178.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -99.99 94.41 6.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.191 0.519 . . . . 0.0 110.824 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.478 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 64.0 t30 52.68 45.37 28.8 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.213 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.697 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 79.96 32.57 35.81 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.608 178.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -149.14 131.34 15.47 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.795 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 58.7 m-85 -72.63 145.37 47.35 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.955 0.407 . . . . 0.0 111.427 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -143.5 133.62 24.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.063 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.554 ' HZ2' ' O ' ' A' ' 152' ' ' TYR . 97.9 m95 -75.27 126.43 31.0 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.2 t 65.72 -68.12 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.931 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.609 ' O ' ' HE2' ' A' ' 110' ' ' LYS . 49.1 m 65.29 -56.95 0.3 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -117.85 -12.97 7.48 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.319 -0.943 . . . . 0.0 114.555 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.04 128.08 36.5 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.371 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.75 86.15 1.39 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.096 -0.574 . . . . 0.0 112.332 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -148.46 178.25 26.16 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.57 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.41 -79.66 0.58 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.646 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -144.4 119.34 1.26 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.237 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.13 -141.71 10.14 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.786 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.1 m -133.59 129.77 37.44 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.944 0.402 . . . . 0.0 110.069 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.464 ' HB2' ' HG2' ' A' ' 110' ' ' LYS . . . -131.46 177.47 7.47 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.933 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.405 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 21.2 p -128.23 121.29 29.02 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 t -107.36 134.3 49.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.928 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.555 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 7.2 m -87.51 125.82 34.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.486 ' CG2' HD11 ' A' ' 99' ' ' ILE . 42.0 t -73.14 132.29 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.103 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -104.19 170.63 7.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 124.388 1.055 . . . . 0.0 109.47 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.585 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 58.8 tt0 -66.63 124.28 22.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.51 -178.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.05 3.22 73.45 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.978 -0.63 . . . . 0.0 113.592 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -109.59 121.4 45.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.035 0.418 . . . . 0.0 111.231 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.593 ' HA ' HG12 ' A' ' 99' ' ' ILE . 81.4 p -102.56 -178.11 3.59 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.547 HD23 ' O ' ' A' ' 95' ' ' ASN . 1.1 mm? -51.99 -40.98 61.79 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.347 0.594 . . . . 0.0 109.834 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.422 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 48.7 ttm-85 -62.95 -39.65 95.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.164 -178.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -71.7 -42.93 66.8 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.959 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.539 HG12 ' O ' ' A' ' 72' ' ' THR . 45.6 mm -61.72 -48.79 87.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.796 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.666 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -58.33 -54.09 40.47 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.422 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -58.5 -41.17 84.76 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.761 0.315 . . . . 0.0 111.77 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -65.1 -43.98 90.31 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.546 ' HB2' ' HG ' ' A' ' 82' ' ' CYS . 96.8 m-85 -98.43 11.79 37.05 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.9 t70 63.4 23.12 13.58 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.359 0.599 . . . . 0.0 112.106 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.666 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.3 p -104.37 171.67 7.21 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.563 ' O ' HG13 ' A' ' 87' ' ' ILE . 5.8 t70 -98.01 125.31 42.89 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.9 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.486 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 9.3 p90 -50.78 -29.68 12.19 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.366 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -65.12 -46.21 81.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.541 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.734 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 56.7 mm-40 -69.14 -41.44 77.31 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.314 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.563 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.8 mt -54.87 -47.5 75.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.644 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.53 -48.58 76.93 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.5 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -54.4 -43.01 71.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.351 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.734 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 24.7 mmm-85 -72.82 -27.4 61.94 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 3.3 t-20 -94.01 -4.79 48.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.892 0.377 . . . . 0.0 111.103 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 90.1 m-20 75.61 17.49 2.37 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.756 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.644 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 19.2 pt -105.67 -172.44 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.519 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 18.1 mm-40 -116.31 154.46 30.15 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.547 ' O ' HD23 ' A' ' 73' ' ' LEU . 1.2 p30 -52.25 -65.96 0.47 Allowed 'General case' 0 C--O 1.244 0.777 0 CA-C-O 122.225 1.012 . . . . 0.0 109.872 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -76.06 13.42 0.89 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.824 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 4.6 t0 -63.59 -31.48 72.66 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 7.9 mp 72.06 112.35 0.06 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.611 -178.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.593 HG12 ' HA ' ' A' ' 72' ' ' THR . 9.8 pt -94.85 176.63 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.815 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.549 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 94.1 m-85 -131.16 158.01 76.45 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.743 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.585 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 18.4 Cg_endo -63.98 138.26 61.66 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 123.301 2.667 . . . . 0.0 113.823 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.41 20.8 31.23 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.79 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.555 ' O ' ' HA ' ' A' ' 66' ' ' THR . 77.2 mt-30 -110.4 166.07 11.28 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.178 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.405 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 95.6 t -125.09 118.51 53.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.486 HD13 HG22 ' A' ' 99' ' ' ILE . 76.9 mt -112.35 150.59 30.84 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.35 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -90.8 116.93 29.03 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.582 0.706 . . . . 0.0 110.656 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 33.6 m -119.83 151.27 52.12 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.454 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.06 -18.98 51.9 Favored 'Trans proline' 0 C--N 1.332 -0.33 0 C-N-CA 123.098 2.532 . . . . 0.0 114.332 -178.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.9 t -154.5 147.53 24.63 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.032 0.444 . . . . 0.0 111.131 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.609 ' HE2' ' O ' ' A' ' 54' ' ' SER . 12.2 mmmm -93.42 -176.23 4.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.026 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -131.6 99.07 0.4 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.077 -178.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 156.82 109.52 0.3 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.05 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 19.6 m -136.96 55.62 1.82 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.872 0.368 . . . . 0.0 111.109 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -82.31 -93.48 0.56 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.043 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -96.9 -67.98 0.96 Allowed Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.673 ' HA3' ' HG2' ' A' ' 41' ' ' ARG . . . -112.19 -75.12 0.73 Allowed Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -148.55 -51.63 0.17 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.024 0.44 . . . . 0.0 110.265 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.727 ' HA2' ' HG ' ' A' ' 44' ' ' SER . . . -85.87 -72.18 1.3 Allowed Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.155 -179.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 14.0 m120 73.94 26.71 1.73 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.059 0.544 . . . . 0.0 112.111 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.535 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 20.7 p90 -60.65 -37.23 80.82 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.04 0.448 . . . . 0.0 110.348 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 124' ' ' ALA . 71.0 t-105 -61.79 -34.43 75.88 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.404 -178.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -54.02 -27.42 31.88 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.143 0.277 . . . . 0.0 110.894 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.619 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 9.3 m -132.85 28.54 4.2 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.479 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.506 ' HB2' ' HA ' ' A' ' 121' ' ' TRP . . . -107.51 143.89 35.25 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.968 0.413 . . . . 0.0 111.387 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -126.69 143.05 51.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.817 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 49.12 57.47 6.43 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.668 0.605 . . . . 0.0 112.01 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.424 ' CG1' HD11 ' A' ' 136' ' ' LEU . 40.3 t -80.45 121.76 34.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.841 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.66 148.14 29.72 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.292 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.688 HD23 HD12 ' A' ' 153' ' ' LEU . 33.6 mt -85.54 145.23 27.48 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.137 0.494 . . . . 0.0 111.411 -179.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.949 HG23 ' HB ' ' A' ' 135' ' ' VAL . 29.0 m -132.31 157.1 43.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.64 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 71.83 1.12 3.77 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.772 0.829 . . . . 0.0 110.387 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.611 ' O ' HD11 ' A' ' 14' ' ' ILE . . . 93.14 28.42 11.83 Favored Glycine 0 N--CA 1.433 -1.535 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.165 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.67 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 104.66 -18.19 44.56 Favored Glycine 0 C--O 1.271 2.44 0 CA-C-O 123.45 1.583 . . . . 0.0 113.165 178.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.702 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 1.6 mttp -72.16 -13.58 61.59 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 121.221 -1.164 . . . . 0.0 108.854 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.949 ' HB ' HG23 ' A' ' 130' ' ' VAL . 3.2 t -143.28 151.36 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.443 177.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.519 HD12 HD21 ' A' ' 129' ' ' LEU . 33.1 tp -131.26 125.77 33.7 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -116.07 131.62 56.89 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.175 0.512 . . . . 0.0 110.911 -177.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.781 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -159.64 155.15 25.66 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.38 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 15.3 mt-10 -94.64 106.33 18.31 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.697 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 47.0 mt -91.41 134.32 34.72 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.154 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.619 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 72.4 ttt180 -69.99 140.84 53.0 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.932 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.518 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.5 p90 -156.04 -169.75 3.17 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.458 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 23.0 t -57.58 -30.81 65.57 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.297 0.373 . . . . 0.0 111.545 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -98.24 23.5 35.89 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.171 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 98.77 -107.83 3.49 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.217 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -133.0 127.71 34.75 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.518 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 10.9 t30 -123.18 129.99 52.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.665 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 32.9 ttm180 -76.44 102.81 6.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.138 0.494 . . . . 0.0 109.807 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 48' ' ' GLY . 18.1 p -114.96 172.3 7.13 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.232 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 6.3 ptp180 -148.55 152.62 37.12 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.565 -0.454 . . . . 0.0 112.051 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.795 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 12.1 tt -130.64 160.97 41.38 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.824 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.908 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 79.8 m-85 -107.55 106.74 17.25 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 121.856 -0.527 . . . . 0.0 110.25 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.688 HD12 HD23 ' A' ' 129' ' ' LEU . 23.8 mt -62.89 -36.01 81.93 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.213 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.702 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 9.5 t70 -57.39 -8.58 0.81 Allowed 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.504 178.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.908 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 46.7 mt-10 -75.05 -50.83 15.19 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 121.831 -0.543 . . . . 0.0 111.962 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.592 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 91.3 m-70 -125.94 7.38 7.34 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -177.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.5 HG12 ' CH2' ' A' ' 52' ' ' TRP . 43.5 mm -107.58 106.07 19.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.169 178.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' A' ' 167' ' ' CYS . . . -111.35 161.88 12.64 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.637 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.504 ' CG ' ' HB3' ' A' ' 25' ' ' CYS . 1.4 t30 -100.55 120.37 39.92 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 31.9 ttp-105 -112.38 87.24 2.53 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.535 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.547 ' OD1' ' HG3' ' A' ' 27' ' ' ARG . 3.0 t-20 59.26 35.79 23.5 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.437 178.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 35' ' ' SER . . . 105.29 -0.07 40.69 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.972 178.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -123.3 134.2 54.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.717 0.758 . . . . 0.0 111.768 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.548 HD13 ' HD2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -74.89 129.46 37.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.895 178.701 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.419 HG13 ' N ' ' A' ' 166' ' ' HIS . 9.4 tp -154.7 157.68 4.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.205 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.592 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 4.1 p-80 -61.19 111.42 1.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.582 ' O ' ' HA3' ' A' ' 158' ' ' GLY . 43.1 t . . . . . 0 C--O 1.247 0.958 0 O-C-N 123.852 0.72 . . . . 0.0 111.024 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.543 0 N-CA-C 112.336 -0.305 . . . . 0.0 112.336 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.617 ' HB3' ' OD1' ' A' ' 154' ' ' ASP . 17.8 m120 -93.3 -95.61 0.15 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 122.298 0.239 . . . . 0.0 110.409 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.956 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 66.8 m-85 -125.22 -90.56 0.55 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.925 0.393 . . . . 0.0 110.313 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -123.22 -30.02 3.77 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.762 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.91 -69.24 1.41 Allowed Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 119.56 -1.305 . . . . 0.0 112.689 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 68.16 14.81 9.33 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.889 0.476 . . . . 0.0 111.3 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.589 ' CE2' HD12 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -58.9 -33.91 71.08 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 -179.279 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.469 ' HA ' HD11 ' A' ' 14' ' ' ILE . 8.8 p -61.2 -27.62 68.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.135 0.493 . . . . 0.0 111.579 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.79 -20.64 79.77 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.574 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 5.1 m -120.67 -19.61 7.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.45 0.625 . . . . 0.0 111.455 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 m -104.33 135.6 45.48 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -112.47 177.58 4.59 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 43.43 50.47 6.15 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 124.037 0.836 . . . . 0.0 111.878 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.673 HD13 ' O ' ' A' ' 132' ' ' GLY . 12.3 mt -82.05 104.82 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.571 ' CA ' HD11 ' A' ' 129' ' ' LEU . 71.0 m -146.23 128.67 15.94 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 122.823 0.449 . . . . 0.0 109.83 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.77 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -100.23 158.62 15.74 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 121.628 0.727 . . . . 0.0 112.717 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -100.57 76.57 1.84 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.328 -1.305 . . . . 0.0 107.551 176.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.28 -54.11 4.85 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.779 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.576 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -149.04 -13.16 0.31 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.892 0.377 . . . . 0.0 110.184 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.62 88.37 7.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.587 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.77 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 44.0 tp -61.79 121.02 11.84 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.868 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.535 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 39.9 ttt180 -128.49 130.27 47.27 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.432 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.659 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -148.89 150.59 33.22 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.673 0.749 . . . . 0.0 111.076 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.423 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 5.0 mm-40 -85.48 74.53 10.32 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.163 -1.38 . . . . 0.0 108.413 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.679 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 65.0 m -64.97 129.62 40.39 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.829 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 10' ' ' SER . 26.7 ttm180 -65.33 131.65 47.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.328 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 35.1 ttt85 -108.86 151.46 26.23 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -52.99 -16.74 4.44 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 114.319 -1.31 . . . . 0.0 114.519 -178.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -72.74 -6.15 42.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.112 0.482 . . . . 0.0 110.416 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.99 6.68 66.74 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -120.5 169.66 14.16 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.412 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.423 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 69.0 m-85 -96.93 140.05 32.04 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.869 0.366 . . . . 0.0 110.555 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.4 t -121.72 130.23 53.29 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.4 m -72.5 112.89 8.96 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.268 0.556 . . . . 0.0 110.969 -178.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 162' ' ' GLY . 40.5 t -116.65 148.38 41.04 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.465 -179.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.4 p -144.32 136.44 22.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-O 120.775 0.321 . . . . 0.0 111.156 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.6 tt -136.19 146.44 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.516 -178.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.59 97.12 4.97 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.671 HD22 ' HB2' ' A' ' 21' ' ' LEU . 1.6 tp -79.96 -6.51 57.64 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.014 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.576 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 15.2 p30 -65.03 -20.24 66.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.167 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.533 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 10.8 ptp180 -105.58 16.53 25.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.298 0.571 . . . . 0.0 110.857 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -127.46 -33.6 2.32 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.131 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.625 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 31.9 mt -106.07 144.11 33.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.358 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.54 147.63 52.55 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.849 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.438 ' ND2' ' HB2' ' A' ' 123' ' ' SER . 23.2 p-10 -98.38 94.12 6.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.504 0.668 . . . . 0.0 109.811 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -94.78 93.6 7.59 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.977 0.418 . . . . 0.0 111.49 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.5 t30 52.83 47.0 25.64 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.16 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.722 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 78.04 29.93 52.67 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.791 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.546 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 33.7 m80 -141.99 125.64 16.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.788 ' HB3' ' HB ' ' A' ' 151' ' ' ILE . 14.2 m-85 -68.3 136.55 53.64 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.802 0.334 . . . . 0.0 111.103 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.8 mtp180 -141.76 135.32 29.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.579 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.47 ' CZ2' ' HA ' ' A' ' 153' ' ' LEU . 96.7 m95 -74.68 136.62 41.87 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 176.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.588 HG21 ' HB2' ' A' ' 117' ' ' ALA . 4.6 p -54.65 116.28 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.638 0.732 . . . . 0.0 111.008 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.5 m -117.44 31.2 6.86 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.745 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 145.11 -33.76 1.59 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.973 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.23 -54.52 3.56 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.226 -0.512 . . . . 0.0 112.707 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -164.02 -41.65 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.23 -141.95 18.62 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.223 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.84 -154.31 25.29 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.189 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.3 149.82 15.68 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.198 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 108' ' ' PRO . . . 124.19 -142.47 14.16 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.788 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.4 m -139.17 113.79 9.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.197 0.523 . . . . 0.0 110.824 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.496 ' HB3' ' HG2' ' A' ' 110' ' ' LYS . . . -133.56 176.67 8.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.835 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.464 HG21 ' HG2' ' A' ' 106' ' ' GLN . 6.9 p -129.34 118.07 21.65 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 122.413 -0.18 . . . . 0.0 111.357 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.558 HG22 ' CE2' ' A' ' 80' ' ' PHE . 9.0 p -110.43 145.03 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.886 0.374 . . . . 0.0 111.386 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.2 m -91.22 123.51 34.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.711 HG21 HD13 ' A' ' 99' ' ' ILE . 63.7 t -76.69 130.26 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.244 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -101.72 169.99 8.46 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 124.455 1.097 . . . . 0.0 110.008 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.605 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 9.6 tt0 -63.22 114.46 3.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.251 -178.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.0 -5.83 27.26 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.878 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.46 124.44 49.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 117.284 0.542 . . . . 0.0 112.188 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.53 ' O ' HG12 ' A' ' 76' ' ' ILE . 81.0 p -101.24 -178.97 3.9 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.582 HD21 HG23 ' A' ' 99' ' ' ILE . 0.7 OUTLIER -53.59 -40.46 65.71 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.555 0.693 . . . . 0.0 109.809 179.179 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.625 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -69.81 -34.37 73.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.041 -178.204 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -72.71 -38.98 67.31 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 72' ' ' THR . 45.1 mm -62.4 -47.17 94.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 177.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.765 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -56.68 -48.37 77.95 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.401 178.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.2 mtm180 -66.99 -35.98 81.16 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 122.515 -0.403 . . . . 0.0 111.923 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -69.66 -38.73 77.19 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.558 ' CE2' HG22 ' A' ' 65' ' ' VAL . 89.0 m-85 -110.52 16.71 21.37 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -178.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.0 t70 53.42 47.75 23.41 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.751 0.786 . . . . 0.0 110.852 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.765 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.8 p -124.42 170.97 10.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.591 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.632 ' O ' HG13 ' A' ' 87' ' ' ILE . 8.9 t70 -96.85 120.1 36.55 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.467 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.625 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 14.3 p90 -51.13 -32.61 23.46 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.708 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.426 ' HB2' ' OD1' ' A' ' 83' ' ' ASP . 0.3 OUTLIER -67.7 -42.93 81.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.76 179.733 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.677 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 8.7 mm-40 -66.67 -43.75 83.68 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.974 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.632 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.8 mt -53.52 -47.04 60.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.604 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.93 -51.14 68.06 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.15 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -57.38 -43.07 83.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.677 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 78.1 mtt180 -68.18 -23.27 64.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.055 0.455 . . . . 0.0 110.987 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.496 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 21.8 t-20 -99.04 -5.72 29.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.853 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.496 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 5.2 m-20 77.91 15.96 1.45 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.783 0.833 . . . . 0.0 111.637 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.604 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 10.4 pt -106.24 -176.42 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 17.9 mm-40 -111.65 158.22 19.53 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.609 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 16.7 p-10 -55.87 -60.45 3.44 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 122.103 0.954 . . . . 0.0 109.47 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -76.6 12.53 1.25 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.116 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 3.9 t70 -65.17 -33.58 76.35 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 9.1 mp 72.43 112.42 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 124.301 1.001 . . . . 0.0 110.16 -177.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.711 HD13 HG21 ' A' ' 67' ' ' VAL . 10.6 pt -95.32 175.91 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.407 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.488 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 83.0 m-85 -128.68 158.59 71.61 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.583 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.605 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 19.9 Cg_endo -67.6 134.97 34.52 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.994 2.463 . . . . 0.0 112.997 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.84 17.54 25.33 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.384 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -110.66 157.5 19.64 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 120.619 -0.433 . . . . 0.0 109.948 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.3 t -116.73 116.6 52.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.519 HD12 HG22 ' A' ' 99' ' ' ILE . 69.3 mt -109.92 151.0 27.63 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.57 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.464 ' HG2' HG21 ' A' ' 64' ' ' THR . 66.3 mt-30 -89.88 107.42 19.1 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.894 0.854 . . . . 0.0 111.146 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.4 m -112.62 151.32 43.82 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-N 113.934 -1.484 . . . . 0.0 109.151 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 32.5 Cg_endo -64.19 -18.88 65.03 Favored 'Trans proline' 0 C--N 1.332 -0.325 0 C-N-CA 123.146 2.564 . . . . 0.0 114.158 -177.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.6 t -150.42 155.22 39.16 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.3 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.496 ' HG2' ' HB3' ' A' ' 63' ' ' ALA . 12.9 mmmm -103.38 168.99 8.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.129 0.49 . . . . 0.0 111.29 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -88.48 127.65 8.71 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.699 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 129.52 121.43 2.34 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.09 -0.576 . . . . 0.0 111.679 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 51.1 m -136.01 -33.12 0.85 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.799 0.333 . . . . 0.0 111.138 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.29 -68.65 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.53 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -93.32 -115.78 2.46 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -105.59 -109.93 3.45 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.444 -0.884 . . . . 0.0 110.988 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.588 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -141.24 -26.52 0.7 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.643 0.259 . . . . 0.0 111.408 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . -106.45 -62.95 0.6 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.069 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 74.97 32.78 0.78 Allowed 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.268 0.627 . . . . 0.0 111.902 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.625 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 20.0 p90 -66.36 -35.96 81.67 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.301 0.572 . . . . 0.0 109.865 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.47 ' HB2' ' HB2' ' A' ' 19' ' ' ALA . 24.5 t-105 -66.39 -21.87 66.23 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.239 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.94 -24.97 60.21 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.828 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.589 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 50.5 m -143.76 33.59 1.27 Allowed 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.689 178.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.431 ' HB2' ' HA ' ' A' ' 121' ' ' TRP . . . -102.01 147.58 26.4 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 177.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.702 ' HD2' ' HB2' ' A' ' 126' ' ' ASP . 8.0 tmm_? -143.71 140.86 30.23 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.702 ' HB2' ' HD2' ' A' ' 125' ' ' ARG . 1.2 t70 58.3 25.65 12.99 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.789 0.681 . . . . 0.0 110.765 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.584 ' HB ' ' CB ' ' A' ' 138' ' ' ALA . 0.4 OUTLIER -67.06 119.75 13.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.926 -179.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.25 151.62 46.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.302 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.739 HD23 HD11 ' A' ' 153' ' ' LEU . 15.9 mt -85.44 131.21 34.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.261 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.602 HG23 ' HB ' ' A' ' 135' ' ' VAL . 26.9 m -126.55 163.9 27.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.234 -178.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.406 ' HB3' ' HD2' ' A' ' 134' ' ' LYS . 9.7 m-20 64.13 7.72 3.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.97 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.673 ' O ' HD13 ' A' ' 14' ' ' ILE . . . 97.24 31.04 7.05 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.273 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.671 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 87.93 -13.74 60.45 Favored Glycine 0 C--O 1.259 1.69 0 CA-C-O 123.506 1.614 . . . . 0.0 112.474 177.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.639 ' O ' ' HA ' ' A' ' 152' ' ' TYR . 17.4 ptpt -72.33 -17.09 61.87 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.602 ' HB ' HG23 ' A' ' 130' ' ' VAL . 17.5 t -139.92 138.77 38.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.328 177.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.582 ' CD1' HD11 ' A' ' 16' ' ' LEU . 36.5 tp -119.91 115.21 23.33 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -107.57 126.26 52.33 Favored 'General case' 0 C--N 1.316 -0.884 0 O-C-N 123.28 0.362 . . . . 0.0 110.213 -177.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.584 ' CB ' ' HB ' ' A' ' 127' ' ' VAL . . . -150.07 160.25 43.79 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.277 0.56 . . . . 0.0 111.89 -178.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -96.29 106.8 19.06 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.722 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 50.0 mt -97.03 129.02 44.53 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.39 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.589 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 22.1 ttt180 -70.05 139.72 52.69 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.224 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.622 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.9 p90 -155.78 -167.94 2.64 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.163 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 4.3 m -56.32 -29.55 61.41 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -104.72 29.84 11.11 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.388 -0.91 . . . . 0.0 113.53 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.7 -112.52 4.38 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.631 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -125.6 126.46 44.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.741 0.305 . . . . 0.0 110.689 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.622 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 63.2 t30 -118.53 129.23 55.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.495 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -78.38 98.73 6.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.205 0.526 . . . . 0.0 109.956 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.546 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 21.7 t -109.45 168.21 9.56 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.178 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.563 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 16.5 ptt180 -149.1 152.76 36.72 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.468 -0.493 . . . . 0.0 112.12 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.788 ' HB ' ' HB3' ' A' ' 50' ' ' PHE . 6.1 tt -133.02 152.84 36.7 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.92 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.639 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 95.8 m-85 -95.44 103.4 15.27 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.771 -0.195 . . . . 0.0 110.666 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.739 HD11 HD23 ' A' ' 129' ' ' LEU . 19.9 mt -67.06 -35.83 80.71 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.169 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.617 ' OD1' ' HB3' ' A' ' 2' ' ' ASN . 2.8 p30 -52.91 -19.26 2.44 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.189 178.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.956 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 36.0 mt-10 -63.39 -55.86 20.98 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.487 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 76.4 m-70 -121.88 5.7 9.91 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 119.655 -0.818 . . . . 0.0 112.705 -176.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.423 ' HB ' ' O ' ' A' ' 153' ' ' LEU . 45.0 mm -107.25 111.68 36.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.689 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.636 ' HA3' ' O ' ' A' ' 167' ' ' CYS . . . -113.55 -178.17 19.35 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.57 178.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.679 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -124.86 136.67 54.01 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.773 0.32 . . . . 0.0 110.548 179.753 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -124.82 86.78 2.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.047 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 90.3 m-20 54.39 50.96 15.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.37 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.551 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 89.8 7.82 68.15 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.496 178.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -123.65 117.12 24.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.984 0.392 . . . . 0.0 111.367 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.499 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 25.0 mt -67.23 123.15 19.49 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.518 178.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 13.4 tt -151.06 147.42 15.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.891 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.487 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 44.9 p-80 -55.68 126.86 27.26 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.636 ' O ' ' HA3' ' A' ' 158' ' ' GLY . 42.4 t . . . . . 0 C--O 1.247 0.934 0 O-C-N 123.839 0.712 . . . . 0.0 111.238 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.599 0 N-CA-C 111.839 -0.504 . . . . 0.0 111.839 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.622 ' HB2' ' OD1' ' A' ' 6' ' ' ASN . 36.1 m-20 -111.56 177.99 4.47 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 1.056 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 21.9 m-85 -108.42 -98.96 0.37 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.511 -0.476 . . . . 0.0 112.022 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.434 ' HB2' ' SG ' ' A' ' 167' ' ' CYS . . . -102.07 -31.56 10.57 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -70.77 -65.71 2.4 Favored Glycine 0 N--CA 1.434 -1.437 0 C-N-CA 119.511 -1.328 . . . . 0.0 112.205 -178.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.622 ' OD1' ' HB2' ' A' ' 2' ' ' ASN . 37.2 m-80 64.37 19.66 11.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.631 -0.285 . . . . 0.0 110.895 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.708 ' CD2' HD12 ' A' ' 164' ' ' LEU . 0.7 OUTLIER -58.44 -42.62 87.76 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.542 -179.664 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.428 ' HA ' HD13 ' A' ' 14' ' ' ILE . 8.9 m -62.11 -13.31 25.59 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.03 0.443 . . . . 0.0 110.851 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -64.27 -30.51 78.01 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.18 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.614 ' HB3' ' HB3' ' A' ' 26' ' ' ARG . 49.7 m -131.76 -18.54 2.73 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.677 0.275 . . . . 0.0 111.282 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.482 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 18.7 m -89.8 129.92 36.12 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -112.43 -177.65 3.21 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 43.69 45.36 5.89 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 123.832 0.708 . . . . 0.0 111.728 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.687 HG12 ' HB3' ' A' ' 23' ' ' ALA . 5.3 mt -79.8 103.89 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 CA-C-O 120.921 0.391 . . . . 0.0 110.402 -178.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.571 ' HA ' HD12 ' A' ' 129' ' ' LEU . 73.4 m -143.76 126.79 16.42 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.725 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -92.47 153.77 18.9 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.839 0.828 . . . . 0.0 112.861 -178.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -94.38 74.27 3.88 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.228 -1.351 . . . . 0.0 107.756 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.21 -55.87 4.96 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.068 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.655 ' HB3' ' HB3' ' A' ' 40' ' ' ASN . . . -148.6 -7.12 0.39 Allowed 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.035 0.445 . . . . 0.0 109.913 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -94.6 95.46 8.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.453 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.849 HD23 HD12 ' A' ' 153' ' ' LEU . 41.8 tp -60.27 118.12 6.01 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.807 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.531 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 34.0 ttt180 -123.02 129.84 52.02 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.35 -178.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.687 ' HB3' HG12 ' A' ' 14' ' ' ILE . . . -148.39 149.28 31.48 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.573 0.701 . . . . 0.0 111.178 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 69.7 mm-40 -82.48 70.52 9.45 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.011 178.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.625 ' SG ' HD13 ' A' ' 164' ' ' LEU . 59.1 m -57.84 114.41 2.3 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.953 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.614 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 10.8 ttp180 -67.11 125.99 27.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.392 178.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.548 ' HG2' ' CA ' ' A' ' 162' ' ' GLY . 7.1 mtm180 -96.34 162.77 13.35 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.85 -10.09 6.17 Favored Glycine 0 C--N 1.339 0.705 0 O-C-N 124.37 1.044 . . . . 0.0 113.759 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -76.97 -8.31 57.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.442 0.639 . . . . 0.0 109.43 178.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.38 14.21 66.59 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.01 161.06 13.2 Favored Glycine 0 C--O 1.225 -0.42 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.177 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.512 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 75.8 m-85 -101.15 133.14 46.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.701 0.286 . . . . 0.0 110.565 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.437 ' OG ' ' HD3' ' A' ' 27' ' ' ARG . 74.0 m -126.22 133.3 51.55 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.099 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 m -70.28 116.17 10.32 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.33 0.586 . . . . 0.0 111.367 -178.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 46.6 t -122.59 152.27 40.6 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.458 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.609 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 5.8 p -145.21 140.33 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 120.933 0.397 . . . . 0.0 112.032 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.511 HG21 ' HB3' ' A' ' 21' ' ' LEU . 10.2 tt -135.65 145.69 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.983 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.13 99.25 7.65 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.568 HD22 ' HB3' ' A' ' 21' ' ' LEU . 3.5 mm? -81.18 -8.7 59.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.09 0.471 . . . . 0.0 110.808 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.655 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 7.1 p30 -67.58 -13.15 61.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.453 179.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -114.32 22.43 13.74 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -136.18 -31.09 0.92 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.67 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.557 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 35.9 mt -110.15 133.38 53.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.728 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.704 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 1.4 m -123.65 138.3 54.56 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.211 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.84 ' CB ' ' HG ' ' A' ' 140' ' ' LEU . 6.7 p-10 -79.66 93.26 5.49 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.82 0.819 . . . . 0.0 110.329 177.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -96.2 92.79 6.56 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 121.916 -0.49 . . . . 0.0 111.326 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.481 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 64.8 t30 49.19 47.54 21.96 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.361 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.66 43.5 18.51 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.964 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -161.98 123.41 2.74 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.681 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 55.8 m-85 -65.4 151.28 46.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.726 0.298 . . . . 0.0 110.574 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -141.51 128.65 20.89 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.518 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.663 ' HZ2' ' HA ' ' A' ' 153' ' ' LEU . 44.6 m95 -76.69 118.34 19.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.847 177.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.441 ' C ' ' H ' ' A' ' 55' ' ' GLY . 6.0 m -125.39 56.43 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.342 0.591 . . . . 0.0 110.475 178.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.0 p -75.91 36.86 0.14 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.138 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.533 ' HA3' ' HB3' ' A' ' 63' ' ' ALA . . . -151.65 27.99 0.94 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -130.85 168.98 21.68 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.997 -0.62 . . . . 0.0 111.697 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.36 -50.28 2.12 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.034 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 168.89 144.9 4.38 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.172 -0.537 . . . . 0.0 111.916 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.29 96.43 2.26 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.73 -0.747 . . . . 0.0 111.924 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.94 138.62 37.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.604 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.584 ' O ' ' HA ' ' A' ' 108' ' ' PRO . . . -170.13 -123.39 0.68 Allowed Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.4 m -124.89 116.54 22.38 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.168 0.508 . . . . 0.0 110.417 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.56 ' HB2' ' HG2' ' A' ' 110' ' ' LYS . . . -128.63 177.28 7.14 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.872 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.423 ' HB ' ' CG2' ' A' ' 104' ' ' VAL . 6.6 p -128.58 114.34 16.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.769 0.319 . . . . 0.0 111.626 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.454 HG22 ' CE1' ' A' ' 80' ' ' PHE . 11.8 p -101.67 143.38 14.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.937 0.399 . . . . 0.0 110.621 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 3.7 m -89.95 127.48 36.03 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.7 t -72.07 132.12 33.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.721 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.434 ' HG2' ' H ' ' A' ' 69' ' ' GLN . 3.4 tt0 -98.11 171.1 8.46 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 125.043 1.464 . . . . 0.0 109.813 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.578 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 24.6 tt0 -71.03 129.69 39.63 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.895 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.05 13.92 82.48 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.585 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -114.37 121.39 43.44 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.826 0.346 . . . . 0.0 110.248 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.571 ' HA ' HG12 ' A' ' 99' ' ' ILE . 80.0 p -103.38 -179.68 4.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.54 HD21 ' O ' ' A' ' 95' ' ' ASN . 1.5 mm? -51.94 -42.03 62.51 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -60.01 -40.07 87.97 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 114.506 -1.224 . . . . 0.0 111.257 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -71.4 -40.37 70.55 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.671 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.434 HG12 ' O ' ' A' ' 72' ' ' THR . 32.5 mm -64.44 -48.38 85.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.664 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -58.8 -45.34 95.06 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.425 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -65.27 -37.08 86.09 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.866 0.365 . . . . 0.0 111.259 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -73.96 -40.24 63.16 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.454 ' CE1' HG22 ' A' ' 65' ' ' VAL . 95.4 m-85 -102.82 13.15 35.08 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.0 t70 58.07 27.57 15.09 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.558 0.694 . . . . 0.0 111.526 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.664 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 3.1 p -105.52 171.59 7.25 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.622 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.3 t0 -94.38 120.16 34.2 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.156 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.51 ' HD2' ' HB2' ' A' ' 95' ' ' ASN . 10.9 p90 -53.12 -30.3 35.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.588 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.419 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -68.57 -41.74 79.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.678 179.17 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -67.75 -48.33 66.71 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.664 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.622 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.4 mt -49.99 -43.79 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.574 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.59 -51.76 66.05 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.427 178.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 85' ' ' HIS . 61.4 mtp180 -64.23 -25.93 68.28 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.829 ' HB3' ' HB2' ' A' ' 106' ' ' GLN . 1.0 OUTLIER -72.66 -28.14 62.54 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.24 0.543 . . . . 0.0 110.161 179.183 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 18.0 t-20 -101.12 -5.33 25.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.319 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 23.4 m120 79.4 15.92 0.93 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.006 0.922 . . . . 0.0 111.148 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.574 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 15.1 pt -103.14 -169.79 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.597 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.521 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 55.1 mt-30 -116.66 161.21 19.56 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.54 ' O ' HD21 ' A' ' 73' ' ' LEU . 6.7 p30 -57.39 -58.74 6.95 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-O 122.245 1.021 . . . . 0.0 109.277 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -78.44 12.22 2.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.065 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.521 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 1.8 t70 -62.93 -31.57 72.68 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 6.8 mp 70.78 112.33 0.06 Allowed 'General case' 0 C--O 1.234 0.245 0 O-C-N 124.37 1.044 . . . . 0.0 110.503 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.571 HG12 ' HA ' ' A' ' 72' ' ' THR . 9.4 pt -95.84 172.07 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 114.497 -1.228 . . . . 0.0 110.505 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.45 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 69.4 m-85 -125.52 156.36 70.67 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.305 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.578 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 39.2 Cg_endo -68.75 134.49 30.32 Favored 'Trans proline' 0 CA--C 1.517 -0.361 0 C-N-CA 123.042 2.494 . . . . 0.0 113.642 -177.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.85 13.4 37.38 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' A' ' 66' ' ' THR . 49.2 mt-30 -104.76 170.87 7.63 Favored 'General case' 0 C--O 1.216 -0.67 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.138 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.423 ' CG2' ' HB ' ' A' ' 64' ' ' THR . 9.9 p -126.49 131.03 71.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-O 121.441 0.639 . . . . 0.0 110.612 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.51 HD11 HG23 ' A' ' 99' ' ' ILE . 80.0 mt -125.09 151.32 45.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.759 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.829 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 38.7 mt-30 -89.75 113.4 24.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 122.031 0.92 . . . . 0.0 111.649 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.439 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 35.8 m -123.02 152.07 62.49 Favored Pre-proline 0 C--N 1.314 -0.976 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.013 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.584 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 32.0 Cg_endo -64.37 -17.61 60.26 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 123.425 2.75 . . . . 0.0 115.37 -176.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.7 t -149.56 152.72 35.99 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.189 0.519 . . . . 0.0 112.112 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.56 ' HG2' ' HB2' ' A' ' 63' ' ' ALA . 11.6 mmmm -107.11 175.23 5.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.969 178.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -119.47 107.95 1.44 Allowed Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -97.45 95.72 1.73 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.749 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 18.2 m -80.08 -22.02 42.69 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.652 0.263 . . . . 0.0 111.396 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.02 -48.72 38.54 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.621 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 176.23 -60.84 0.1 Allowed Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -104.39 -81.45 1.5 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -143.42 -49.82 0.32 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.178 0.513 . . . . 0.0 109.899 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.704 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -89.62 -81.27 1.33 Allowed Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.973 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 16.0 m120 75.34 24.92 1.34 Allowed 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 123.575 0.75 . . . . 0.0 112.261 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.557 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 25.0 p90 -58.44 -39.37 79.66 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.288 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.462 ' HA ' ' HB2' ' A' ' 124' ' ' ALA . 60.3 t-105 -58.71 -31.89 68.68 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.01 -178.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.68 -30.43 61.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.839 0.352 . . . . 0.0 110.672 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.51 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 11.0 m -132.79 30.46 4.04 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.581 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.462 ' HB2' ' HA ' ' A' ' 121' ' ' TRP . . . -118.09 138.51 52.2 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 120.784 0.326 . . . . 0.0 110.743 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -128.55 147.51 50.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.134 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 56.43 45.06 23.34 Favored 'General case' 0 CA--C 1.518 -0.264 0 O-C-N 123.695 0.622 . . . . 0.0 112.007 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.516 ' HA ' ' HB1' ' A' ' 138' ' ' ALA . 39.5 t -69.98 116.24 10.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.658 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -138.5 143.45 39.56 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.639 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.576 ' HG ' ' HG ' ' A' ' 16' ' ' LEU . 29.5 mt -86.38 138.71 31.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.345 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.67 HG21 ' HB ' ' A' ' 135' ' ' VAL . 26.7 m -131.08 160.97 41.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.431 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.431 ' HB3' ' HG2' ' A' ' 134' ' ' LYS . 0.7 OUTLIER 65.16 13.43 8.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.015 179.133 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.674 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 91.9 26.46 19.41 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.507 -0.854 . . . . 0.0 113.265 178.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.68 ' HA3' HG23 ' A' ' 14' ' ' ILE . . . 92.45 -18.02 55.86 Favored Glycine 0 C--O 1.265 2.074 0 CA-C-O 123.9 1.833 . . . . 0.0 112.225 177.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.725 ' HG3' HG22 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -67.98 -17.6 64.48 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.255 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.725 HG22 ' HG3' ' A' ' 134' ' ' LYS . 15.0 t -135.94 144.6 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.388 176.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.611 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 26.0 tp -127.49 124.69 38.94 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -120.58 134.63 55.26 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.212 0.529 . . . . 0.0 110.979 -177.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.625 ' HB2' ' HZ ' ' A' ' 50' ' ' PHE . . . -157.58 162.74 38.77 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.864 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.537 ' HG2' ' HG3' ' A' ' 148' ' ' ARG . 45.1 mt-10 -94.71 105.14 17.06 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.84 ' HG ' ' CB ' ' A' ' 45' ' ' ASN . 1.4 mp -90.4 128.97 36.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.485 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.51 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 67.1 ttt180 -69.77 140.86 53.44 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.037 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.481 ' HB2' ' OD1' ' A' ' 47' ' ' ASN . 1.2 p90 -156.08 -167.81 2.57 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.139 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.3 t -60.41 -27.49 67.5 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.971 0.415 . . . . 0.0 111.123 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -101.91 27.19 21.52 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.348 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 92.67 -119.94 6.01 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.751 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -124.64 125.68 44.51 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.453 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 25.0 t-20 -129.01 142.39 50.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.817 0.342 . . . . 0.0 111.095 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.537 ' HG3' ' HG2' ' A' ' 139' ' ' GLU . 25.1 mtp180 -74.12 108.47 6.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.716 0.769 . . . . 0.0 110.481 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.473 ' HB2' HD22 ' A' ' 140' ' ' LEU . 1.1 m -113.03 157.6 21.35 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.078 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.611 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 9.1 ptt180 -145.95 147.49 31.77 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.381 0.61 . . . . 0.0 112.343 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.681 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 8.7 tt -132.37 151.88 35.53 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.99 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.573 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 9.0 m-85 -92.24 104.85 17.16 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.871 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.849 HD12 HD23 ' A' ' 21' ' ' LEU . 30.5 mt -68.5 -32.59 72.67 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.131 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.581 ' HB3' ' HA ' ' A' ' 134' ' ' LYS . 1.4 p30 -54.7 -18.44 4.63 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.853 177.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 1.056 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 37.2 mt-10 -64.63 -52.26 58.31 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.51 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 65.5 m-70 -122.49 6.4 9.54 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.734 -0.786 . . . . 0.0 112.87 -178.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.426 ' O ' ' HA3' ' A' ' 5' ' ' GLY . 47.8 mm -107.15 110.38 31.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.663 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.537 ' HA3' ' OXT' ' A' ' 167' ' ' CYS . . . -115.24 156.11 15.87 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.451 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.527 ' HA ' ' O ' ' A' ' 163' ' ' GLU . 1.7 t30 -97.13 127.91 43.55 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 122.518 0.327 . . . . 0.0 110.151 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 -115.68 87.43 2.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.257 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 65.4 t30 50.43 52.63 14.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.81 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.548 ' CA ' ' HG2' ' A' ' 27' ' ' ARG . . . 95.07 7.1 59.87 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.968 -0.634 . . . . 0.0 114.343 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 159' ' ' ASN . 44.6 mt-10 -122.55 154.77 37.46 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 117.415 0.608 . . . . 0.0 110.509 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.708 HD12 ' CD2' ' A' ' 7' ' ' PHE . 7.7 tp -111.3 110.16 20.5 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.89 0.376 . . . . 0.0 110.561 -178.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 38.9 pt -134.6 -173.73 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.018 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.51 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 1.9 p-80 -83.43 122.03 27.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.671 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.537 ' OXT' ' HA3' ' A' ' 158' ' ' GLY . 46.2 t . . . . . 0 C--O 1.251 1.148 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.805 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.484 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.602 ' HB3' ' HA ' ' A' ' 6' ' ' ASN . 1.7 m-80 -61.51 152.36 30.37 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.047 0.451 . . . . 0.0 110.543 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.951 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 30.7 m-85 -101.74 -84.98 0.44 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.459 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -110.44 -30.68 7.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.712 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.508 ' HA2' ' HA ' ' A' ' 167' ' ' CYS . . . -71.37 -63.45 3.09 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 119.732 -1.223 . . . . 0.0 112.39 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.602 ' HA ' ' HB3' ' A' ' 2' ' ' ASN . 2.4 m-20 66.03 15.66 10.16 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 122.526 0.33 . . . . 0.0 111.432 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.674 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.2 OUTLIER -60.51 -39.68 88.66 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.082 -179.323 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.78 -16.81 62.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.006 0.431 . . . . 0.0 111.554 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.55 -20.01 79.77 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.077 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 45.8 m -140.41 -13.03 1.02 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 117.33 0.565 . . . . 0.0 112.081 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.7 m -98.66 133.25 43.27 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.589 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 25.0 ptt180 -110.1 -172.13 1.98 Allowed 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.9 t70 42.05 40.31 1.61 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.829 0.852 . . . . 0.0 111.976 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.683 HG21 ' HA3' ' A' ' 133' ' ' GLY . 6.4 mt -77.02 99.26 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 CA-C-O 121.104 0.478 . . . . 0.0 109.917 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.546 ' CA ' HD13 ' A' ' 129' ' ' LEU . 73.1 m -147.68 124.67 11.34 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.353 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.715 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -94.03 152.69 18.62 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.84 0.829 . . . . 0.0 112.985 -179.006 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -93.27 75.2 4.59 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.043 -1.435 . . . . 0.0 107.233 177.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.21 -53.31 4.63 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.735 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.498 ' HB2' ' HB3' ' A' ' 40' ' ' ASN . . . -149.07 -11.35 0.32 Allowed 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 120.94 0.4 . . . . 0.0 110.234 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.423 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 3.4 mpt_? -89.48 92.55 9.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.87 0.367 . . . . 0.0 110.389 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.789 HD22 HD22 ' A' ' 153' ' ' LEU . 46.8 tp -61.36 123.98 19.33 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.716 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.653 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 41.9 ttp180 -125.03 137.22 54.23 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.266 -0.573 . . . . 0.0 110.257 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.582 ' CB ' HG12 ' A' ' 14' ' ' ILE . . . -157.29 145.84 19.55 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.587 0.708 . . . . 0.0 111.084 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.589 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 3.5 mt-10 -84.52 77.03 10.1 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.504 -1.225 . . . . 0.0 108.706 178.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.604 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 55.9 m -62.78 120.67 11.72 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.899 -178.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 10' ' ' SER . 9.0 tmm_? -70.76 114.89 9.3 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.914 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -89.17 159.0 17.69 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.041 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.46 -15.95 6.41 Favored Glycine 0 C--N 1.339 0.732 0 O-C-N 124.713 1.258 . . . . 0.0 114.067 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -72.38 -12.5 61.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.618 0.723 . . . . 0.0 109.417 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.7 8.8 60.5 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.933 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -112.77 160.62 13.04 Favored Glycine 0 CA--C 1.512 -0.151 0 C-N-CA 120.199 -1.001 . . . . 0.0 113.657 -178.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.439 ' CE1' ' HB2' ' A' ' 26' ' ' ARG . 89.3 m-85 -101.39 124.7 47.49 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.1 p -118.68 133.23 56.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.438 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.1 m -71.0 111.38 6.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.062 0.458 . . . . 0.0 110.843 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.2 t -117.4 152.1 35.67 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.481 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.549 ' HB ' ' HG3' ' A' ' 22' ' ' ARG . 3.9 p -145.04 136.38 20.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.788 0.328 . . . . 0.0 110.224 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.496 HG23 HD21 ' A' ' 39' ' ' LEU . 11.8 tt -135.29 151.65 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.075 -177.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.562 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 1.6 m-20 -79.61 105.88 11.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.684 0.278 . . . . 0.0 111.36 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.596 HD11 ' HB2' ' A' ' 42' ' ' TYR . 1.5 mm? -88.93 -1.64 58.2 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.198 0.523 . . . . 0.0 110.333 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.562 ' OD1' ' HB3' ' A' ' 38' ' ' ASP . 32.3 p-10 -69.55 -14.62 62.94 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 38' ' ' ASP . 6.1 ptp180 -109.9 11.87 24.04 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.609 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.596 ' HB2' HD11 ' A' ' 39' ' ' LEU . 41.4 m-85 -127.36 -31.63 2.52 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.868 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.583 HD22 HG21 ' A' ' 151' ' ' ILE . 39.8 mt -108.96 139.02 44.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.084 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.533 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 4.1 m -129.71 149.09 51.61 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.518 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.727 HD21 ' HA ' ' A' ' 120' ' ' PHE . 7.6 p30 -98.51 104.83 16.9 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -108.03 91.97 3.87 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 121.85 -0.531 . . . . 0.0 111.092 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.522 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 62.4 t30 57.08 45.04 21.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.015 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.793 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 78.67 31.68 44.03 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.795 178.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.591 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 22.4 t-80 -148.69 122.17 9.11 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.739 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 38.1 m-85 -64.04 138.61 58.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.617 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -144.97 139.15 27.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.687 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.716 ' CZ2' ' HA ' ' A' ' 153' ' ' LEU . 99.2 m95 -75.08 128.93 36.66 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.52 HG22 ' H ' ' A' ' 55' ' ' GLY . 15.9 m 41.77 -128.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 O-C-N 124.414 1.071 . . . . 0.0 111.999 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.6 m -120.28 8.59 10.88 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.939 0.4 . . . . 0.0 110.456 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.52 ' H ' HG22 ' A' ' 53' ' ' VAL . . . 79.18 -43.84 2.55 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.305 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 142.56 91.33 0.16 Allowed Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.812 -0.515 . . . . 0.0 111.812 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -139.65 157.68 25.29 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.95 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.96 162.34 34.05 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.32 -170.73 39.33 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.074 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.18 34.72 1.09 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.355 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 108' ' ' PRO . . . -89.38 -115.8 1.5 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.897 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 87.3 m -128.37 113.57 15.74 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.324 0.583 . . . . 0.0 110.428 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.487 ' HB2' ' HG2' ' A' ' 110' ' ' LYS . . . -123.07 178.26 5.16 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.356 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.0 p -128.77 122.77 31.3 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.403 HG11 ' CE2' ' A' ' 80' ' ' PHE . 10.1 t -111.45 135.6 50.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.096 178.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.1 m -87.48 127.36 35.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.342 0.592 . . . . 0.0 110.034 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.538 ' CG2' HD12 ' A' ' 99' ' ' ILE . 44.5 t -74.64 131.78 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.538 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.401 ' HG2' ' H ' ' A' ' 69' ' ' GLN . 4.2 tt0 -101.19 172.03 7.25 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 124.854 1.346 . . . . 0.0 109.905 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.56 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 6.9 tt0 -59.04 125.86 25.33 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.144 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.88 2.74 88.39 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.091 -0.576 . . . . 0.0 114.092 177.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -92.34 138.04 31.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 117.246 0.523 . . . . 0.0 111.315 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.555 ' HA ' HG12 ' A' ' 99' ' ' ILE . 55.1 p -119.5 173.98 6.66 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.559 HD13 ' HB ' ' A' ' 87' ' ' ILE . 1.3 mm? -52.6 -40.5 62.75 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.182 0.515 . . . . 0.0 110.416 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.528 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 13.7 mtp180 -67.01 -35.47 80.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.787 -178.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -72.31 -38.22 68.75 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.505 HG12 ' O ' ' A' ' 72' ' ' THR . 42.0 mm -67.15 -45.83 85.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.709 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -55.14 -55.82 26.29 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.579 179.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -59.79 -42.94 94.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.91 0.386 . . . . 0.0 112.04 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.522 ' HD3' ' HB3' ' A' ' 113' ' ' SER . 40.2 ttm180 -64.01 -36.27 83.45 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.652 ' HB2' ' HG ' ' A' ' 82' ' ' CYS . 97.8 m-85 -110.35 19.99 18.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.8 t70 56.3 30.55 16.96 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.448 0.642 . . . . 0.0 111.717 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.709 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 3.6 p -112.85 171.31 7.61 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.578 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.9 t70 -99.24 127.18 45.19 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.528 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 4.8 p90 -51.43 -30.55 19.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.226 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -65.43 -44.79 86.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.719 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.717 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 24.2 mm-40 -63.22 -51.0 68.04 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.801 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.578 HG13 ' O ' ' A' ' 83' ' ' ASP . 2.7 mt -52.76 -47.04 51.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.64 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.584 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.59 -50.74 70.07 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.617 178.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -56.47 -40.12 74.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.138 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.717 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 13.8 mmt85 -65.83 -33.48 75.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.102 0.477 . . . . 0.0 111.071 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.634 HD21 HD13 ' A' ' 93' ' ' ILE . 66.3 t30 -92.13 -4.76 53.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.792 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 92.3 m-20 75.94 19.14 1.94 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.487 0.715 . . . . 0.0 110.777 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.634 HD13 HD21 ' A' ' 91' ' ' ASN . 14.4 pt -106.18 -176.26 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.739 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.541 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 49.2 mt-30 -107.36 166.06 10.93 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.532 ' O ' HD22 ' A' ' 73' ' ' LEU . 6.1 p30 -63.83 -53.5 49.78 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-O 122.141 0.972 . . . . 0.0 108.407 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.56 11.06 3.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.785 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.541 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.8 t70 -61.54 -32.23 72.28 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.1 mt 68.84 114.07 0.04 OUTLIER 'General case' 0 C--O 1.233 0.21 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.061 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.682 HG22 HD13 ' A' ' 105' ' ' LEU . 9.2 pt -94.56 175.64 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.238 -178.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.461 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 41.3 m-85 -128.72 156.54 77.4 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.83 -178.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.56 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 32.0 Cg_endo -67.07 133.02 29.6 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 123.286 2.658 . . . . 0.0 113.241 -178.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.43 19.29 25.85 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -112.54 155.74 23.81 Favored 'General case' 0 C--O 1.212 -0.901 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.2 t -116.18 122.68 70.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 O-C-N 121.789 -0.569 . . . . 0.0 110.405 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.682 HD13 HG22 ' A' ' 99' ' ' ILE . 95.9 mt -113.42 151.25 31.59 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.92 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.544 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 78.2 mt-30 -90.22 116.27 28.08 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.642 0.734 . . . . 0.0 110.801 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.4 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 31.5 m -123.23 151.84 62.89 Favored Pre-proline 0 C--N 1.31 -1.119 0 CA-C-N 114.173 -1.376 . . . . 0.0 109.441 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 37.9 Cg_endo -65.07 -22.32 62.17 Favored 'Trans proline' 0 N--CA 1.473 0.282 0 C-N-CA 123.147 2.565 . . . . 0.0 114.952 -177.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.0 t -147.11 155.1 41.89 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.586 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.487 ' HG2' ' HB2' ' A' ' 63' ' ' ALA . 12.3 mmmm -104.06 174.0 6.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.429 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.3 145.33 5.97 Favored Glycine 0 N--CA 1.439 -1.165 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.528 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -74.45 90.29 0.73 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.082 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.522 ' HB3' ' HD3' ' A' ' 79' ' ' ARG . 29.8 m -119.13 49.47 1.33 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.171 0.51 . . . . 0.0 110.689 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 149.31 -65.21 0.39 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.06 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -178.4 -170.35 40.38 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 121.02 -0.61 . . . . 0.0 111.842 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.35 54.15 6.35 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.95 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -102.95 -33.34 9.34 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.345 -0.428 . . . . 0.0 110.803 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.533 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -104.18 -70.14 0.8 Allowed Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.221 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 15.2 m120 73.63 31.33 1.3 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.007 0.523 . . . . 0.0 112.122 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.727 ' HA ' HD21 ' A' ' 45' ' ' ASN . 27.5 p90 -59.6 -35.84 75.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.95 0.405 . . . . 0.0 110.141 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.507 ' HA ' ' HB1' ' A' ' 124' ' ' ALA . 61.8 t-105 -63.09 -31.71 72.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.068 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.88 -31.51 40.04 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.852 0.358 . . . . 0.0 110.99 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.802 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 18.5 m -131.19 28.26 4.75 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.691 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.507 ' HB1' ' HA ' ' A' ' 121' ' ' TRP . . . -110.48 142.95 41.53 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.395 178.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.43 ' HD2' ' OD2' ' A' ' 126' ' ' ASP . 6.6 tmm_? -137.15 139.24 41.02 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.43 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 3.6 m-20 63.08 54.54 2.1 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.261 0.553 . . . . 0.0 110.567 -178.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.455 ' HA ' ' HB1' ' A' ' 138' ' ' ALA . 38.3 t -85.69 122.83 38.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.402 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.417 ' O ' HD13 ' A' ' 136' ' ' LEU . 16.2 ptt180 -144.84 142.7 30.15 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.754 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.724 HD11 ' CD1' ' A' ' 21' ' ' LEU . 16.5 mt -85.42 130.38 34.6 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.533 HG23 ' HB ' ' A' ' 135' ' ' VAL . 27.8 m -124.49 163.47 24.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.512 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.705 ' HB3' ' HZ1' ' A' ' 134' ' ' LYS . 5.3 m-20 68.08 6.0 4.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.203 178.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.627 ' O ' HD13 ' A' ' 14' ' ' ILE . . . 93.66 28.25 11.59 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.181 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.683 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 96.89 -19.27 55.46 Favored Glycine 0 C--O 1.264 1.978 0 CA-C-O 123.08 1.378 . . . . 0.0 113.145 177.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.705 ' HZ1' ' HB3' ' A' ' 131' ' ' ASP . 10.5 pttp -72.75 -10.91 60.34 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 121.196 -1.179 . . . . 0.0 109.665 178.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.533 ' HB ' HG23 ' A' ' 130' ' ' VAL . 22.3 t -144.26 140.44 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 121.383 0.611 . . . . 0.0 110.444 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.607 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 44.1 tp -121.14 125.28 46.81 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -114.75 131.36 56.81 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.989 0.423 . . . . 0.0 110.893 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.63 ' HB2' ' HZ ' ' A' ' 50' ' ' PHE . . . -161.44 157.8 25.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.675 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 36.9 mt-10 -95.56 109.95 22.11 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.793 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 46.3 mt -95.74 134.17 38.99 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.956 -178.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.802 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 36.1 ttt180 -70.76 141.09 51.47 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.701 179.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.583 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.7 p90 -161.83 -170.49 2.57 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.593 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 45.5 t -54.31 -28.68 43.95 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.41 0.444 . . . . 0.0 111.883 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -105.45 30.38 9.96 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.461 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 91.55 -114.93 4.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.518 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -126.8 128.15 46.13 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.583 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 57.3 t30 -117.62 143.67 45.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.957 0.408 . . . . 0.0 111.988 -178.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -76.75 94.57 3.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.122 178.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.591 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 35.8 t -111.11 160.88 16.49 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.445 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.607 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 28.6 ptt180 -148.59 154.58 39.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.548 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.739 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 8.0 tt -136.96 151.95 27.89 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.565 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.078 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.613 ' HB3' ' OD1' ' A' ' 154' ' ' ASP . 26.3 m-85 -95.08 103.27 15.12 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.839 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.789 HD22 HD22 ' A' ' 21' ' ' LEU . 7.1 mp -70.64 -29.27 65.58 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.976 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.613 ' OD1' ' HB3' ' A' ' 152' ' ' TYR . 21.9 p-10 -56.27 -13.96 2.5 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.914 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.951 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 31.1 mt-10 -68.96 -54.11 17.1 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.488 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 76.2 m-70 -123.11 3.73 9.29 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.719 -0.792 . . . . 0.0 112.576 -176.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.473 HG22 HD23 ' A' ' 21' ' ' LEU . 43.2 mm -105.32 112.85 40.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.127 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.541 ' HA3' ' OXT' ' A' ' 167' ' ' CYS . . . -118.47 178.53 16.79 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.878 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.604 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -109.6 125.71 52.85 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.86 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.91 85.06 2.04 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 65.0 t30 52.2 49.59 20.26 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.388 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 94.11 2.22 64.44 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.707 -0.758 . . . . 0.0 114.338 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -122.31 126.04 47.25 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.982 0.42 . . . . 0.0 109.894 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.674 HD11 ' CD2' ' A' ' 7' ' ' PHE . 7.6 tp -73.78 128.45 35.56 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.754 -178.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.862 HG13 ' H ' ' A' ' 166' ' ' HIS . 10.8 tp -159.36 -173.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -179.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.862 ' H ' HG13 ' A' ' 165' ' ' ILE . 19.1 p80 -82.49 125.45 31.11 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.131 -0.356 . . . . 0.0 110.163 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.541 ' OXT' ' HA3' ' A' ' 158' ' ' GLY . 53.1 t . . . . . 0 C--O 1.254 1.329 0 O-C-N 123.907 0.754 . . . . 0.0 112.121 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.69 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.4 167.5 11.48 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.04 0.448 . . . . 0.0 109.959 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.734 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 27.9 m-85 -128.84 -68.34 0.75 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.304 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.3 -26.69 0.9 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.525 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -72.7 -69.76 1.34 Allowed Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 119.541 -1.314 . . . . 0.0 113.376 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 68.39 16.73 9.23 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 122.624 0.37 . . . . 0.0 110.366 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.65 ' CD2' HD12 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -63.63 -30.54 71.64 Favored 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -178.801 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 97.2 p -70.37 -12.39 61.55 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.715 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.22 -26.03 60.5 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.283 -0.872 . . . . 0.0 112.782 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.431 ' O ' ' HE1' ' A' ' 32' ' ' TYR . 35.0 p -126.49 -23.65 3.75 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.221 0.51 . . . . 0.0 112.069 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.0 m -90.09 135.28 33.75 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.52 ' HG2' ' N ' ' A' ' 13' ' ' ASP . 44.3 ttt-85 -110.86 171.08 7.68 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.539 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.52 ' N ' ' HG2' ' A' ' 12' ' ' ARG . 48.7 m-20 46.01 48.65 12.45 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.349 0.659 . . . . 0.0 111.999 178.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.679 HG12 ' HB2' ' A' ' 23' ' ' ALA . 9.4 mt -79.36 105.71 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.5 m -147.18 126.81 13.33 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.011 0.524 . . . . 0.0 109.977 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.719 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -97.79 156.61 16.49 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -179.07 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -96.88 74.4 2.64 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.063 -1.426 . . . . 0.0 107.669 177.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.12 -52.89 4.57 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.031 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.563 ' HB3' ' HB3' ' A' ' 40' ' ' ASN . . . -149.26 -13.36 0.3 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.183 0.516 . . . . 0.0 110.004 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -90.89 92.63 8.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.331 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.773 HD22 HD13 ' A' ' 153' ' ' LEU . 37.3 tp -63.46 130.49 44.6 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.736 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -134.17 127.05 31.23 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.033 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.679 ' HB2' HG12 ' A' ' 14' ' ' ILE . . . -146.72 147.02 30.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.244 0.545 . . . . 0.0 111.501 -178.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.727 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 7.2 mm-40 -78.59 74.7 5.12 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.392 177.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.605 ' SG ' HD13 ' A' ' 164' ' ' LEU . 68.9 m -60.3 126.9 29.24 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 120.971 0.415 . . . . 0.0 111.029 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 10' ' ' SER . 65.6 ttt180 -68.51 121.67 16.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.237 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.523 ' HD3' ' HB3' ' A' ' 29' ' ' ASP . 6.0 ptp180 -94.91 149.59 21.08 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 177.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.42 -11.33 3.58 Favored Glycine 0 C--N 1.34 0.775 0 O-C-N 124.35 1.031 . . . . 0.0 113.642 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.523 ' HB3' ' HD3' ' A' ' 27' ' ' ARG . 19.8 t70 -71.68 -15.64 62.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.441 0.639 . . . . 0.0 109.548 178.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.13 5.4 53.01 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.048 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.22 172.41 14.26 Favored Glycine 0 C--N 1.322 -0.197 0 C-N-CA 119.959 -1.115 . . . . 0.0 113.517 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.727 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 41.2 m-85 -101.87 128.92 48.03 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 178.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.6 m -114.45 130.81 56.75 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.267 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 m -67.47 110.01 3.45 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.092 0.473 . . . . 0.0 110.846 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.489 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 41.7 t -115.06 151.93 33.39 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.512 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -145.94 133.66 15.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.08 0.467 . . . . 0.0 111.824 -178.777 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.504 HG23 ' HB3' ' A' ' 21' ' ' LEU . 10.7 tt -135.4 141.23 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.869 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.02 108.84 15.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.07 0.462 . . . . 0.0 111.052 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.581 HD22 ' HB3' ' A' ' 21' ' ' LEU . 3.1 mm? -81.14 -7.33 59.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.621 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.563 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 26.9 p30 -68.62 -9.6 50.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.57 0.7 . . . . 0.0 109.364 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.401 ' HA ' ' H ' ' A' ' 117' ' ' ALA . 15.4 ttm180 -104.94 0.15 27.53 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.617 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.573 ' HA ' HG22 ' A' ' 53' ' ' VAL . 75.8 m-85 -126.06 -28.09 3.2 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.649 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 36.5 mt -106.31 142.84 35.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.988 0.423 . . . . 0.0 112.023 -178.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.2 m -135.43 139.78 44.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.446 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.819 ' CB ' ' HG ' ' A' ' 140' ' ' LEU . 7.8 p-10 -83.48 93.93 7.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.522 0.677 . . . . 0.0 110.286 178.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.44 ' CB ' ' HD2' ' A' ' 51' ' ' ARG . 9.1 t0 -99.88 94.79 6.49 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 122.1 -0.375 . . . . 0.0 110.63 -179.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.491 ' HA ' ' HB2' ' A' ' 142' ' ' TYR . 10.2 t-20 52.47 49.28 20.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.52 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 149' ' ' SER . . . 72.0 38.98 59.63 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.696 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -157.29 123.02 4.69 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.746 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 65.4 m-85 -62.46 144.9 55.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.191 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.44 ' HD2' ' CB ' ' A' ' 46' ' ' ASP . 70.0 mtt180 -148.0 133.02 18.19 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.38 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.539 ' HA ' ' O ' ' A' ' 42' ' ' TYR . 97.3 m95 -74.44 135.36 42.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.273 178.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.573 HG22 ' HA ' ' A' ' 42' ' ' TYR . 13.7 m -58.81 105.93 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.531 0.682 . . . . 0.0 110.946 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.6 m -89.69 -14.24 35.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.651 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -96.16 -60.28 1.02 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.177 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.48 -147.45 19.02 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.262 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.68 -135.48 2.01 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.012 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.72 42.17 62.49 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.425 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.09 121.47 11.71 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.204 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.08 -177.74 19.56 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.361 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.29 -66.84 0.46 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.862 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.5 m -139.64 113.85 8.96 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.805 -0.697 . . . . 0.0 110.639 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.563 ' HB3' ' HG2' ' A' ' 110' ' ' LYS . . . -133.53 176.55 8.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.545 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.415 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 2.4 p -128.8 117.97 21.98 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.218 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.506 HG21 ' CE2' ' A' ' 80' ' ' PHE . 14.2 p -104.68 141.17 20.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.003 0.43 . . . . 0.0 111.575 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 5.6 m -93.09 126.7 38.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.236 0.541 . . . . 0.0 109.691 178.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.581 ' CG2' HD11 ' A' ' 99' ' ' ILE . 53.9 t -79.59 135.22 26.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.092 -179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -100.83 169.84 8.72 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 124.355 1.034 . . . . 0.0 110.643 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.695 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 50.1 tt0 -66.15 116.71 7.52 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.978 -177.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.25 -3.29 47.36 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.321 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -100.29 139.32 36.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.999 0.428 . . . . 0.0 111.213 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.688 ' HA ' HG12 ' A' ' 99' ' ' ILE . 69.6 p -120.29 179.43 4.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.542 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.595 HD21 HG23 ' A' ' 99' ' ' ILE . 1.1 mm? -51.5 -40.61 59.9 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.19 0.519 . . . . 0.0 110.191 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -61.75 -38.47 88.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.354 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -72.3 -40.21 67.68 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.666 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 72' ' ' THR . 41.7 mm -64.96 -47.38 88.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.886 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.642 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -61.23 -44.29 98.3 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.92 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -65.54 -36.38 83.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.075 0.464 . . . . 0.0 111.251 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -75.27 -44.21 47.02 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.506 ' CE2' HG21 ' A' ' 65' ' ' VAL . 89.7 m-85 -101.91 17.32 23.42 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -176.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.4 t70 54.33 42.72 31.29 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.527 0.679 . . . . 0.0 111.521 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.642 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.1 p -123.07 166.2 15.53 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.658 ' O ' HG13 ' A' ' 87' ' ' ILE . 6.8 t70 -93.88 124.52 37.94 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.599 -0.841 . . . . 0.0 110.115 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.538 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 18.9 p90 -51.5 -31.78 25.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.19 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.495 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 3.7 t60 -66.58 -44.1 83.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.727 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.666 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 17.9 mm-40 -67.61 -47.35 69.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.254 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.658 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.8 mt -51.06 -45.34 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.435 0.636 . . . . 0.0 109.336 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.611 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.63 -50.77 69.93 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.935 178.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.495 ' HG3' ' O ' ' A' ' 85' ' ' HIS . 74.6 mtp180 -57.32 -41.98 80.96 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.666 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 15.4 mtp180 -70.89 -21.78 62.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.852 0.358 . . . . 0.0 111.376 -178.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 17.4 t-20 -101.13 -5.23 25.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.951 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.497 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 16.0 m120 78.0 14.58 1.55 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.49 0.716 . . . . 0.0 111.494 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.611 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 16.7 pt -106.27 -174.64 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.562 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 78.6 mm-40 -113.48 155.37 25.44 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.527 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 4.5 p30 -54.07 -58.87 5.7 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-O 122.259 1.028 . . . . 0.0 109.058 178.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -75.33 12.26 1.0 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.747 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.1 t0 -69.49 -34.09 73.81 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 10.3 mp 70.22 116.62 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 O-C-N 124.21 0.944 . . . . 0.0 108.98 -176.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.688 HG12 ' HA ' ' A' ' 72' ' ' THR . 7.5 pt -93.56 177.07 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.993 -177.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -123.87 156.04 66.03 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.401 -177.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.695 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 32.6 Cg_endo -68.71 130.6 20.97 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.258 2.639 . . . . 0.0 113.062 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.05 12.54 49.14 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.429 ' O ' ' HA ' ' A' ' 66' ' ' THR . 63.4 tt0 -101.0 159.72 14.98 Favored 'General case' 0 C--O 1.214 -0.792 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.415 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 85.6 t -120.59 120.47 62.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.04 0.448 . . . . 0.0 110.203 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.633 HD11 HG22 ' A' ' 99' ' ' ILE . 68.4 mt -111.49 152.0 27.97 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.549 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -90.78 115.81 28.14 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.564 0.697 . . . . 0.0 111.208 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.2 m -124.57 151.26 67.03 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.407 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -63.32 -17.08 58.41 Favored 'Trans proline' 0 C--N 1.332 -0.302 0 C-N-CA 123.305 2.67 . . . . 0.0 114.92 -177.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.9 t -157.69 154.32 28.11 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.551 -0.459 . . . . 0.0 111.462 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.563 ' HG2' ' HB3' ' A' ' 63' ' ' ALA . 12.8 mmmm -101.28 174.82 5.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.741 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -175.62 93.58 0.09 OUTLIER Glycine 0 N--CA 1.443 -0.833 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.154 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 83.4 68.2 1.43 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.178 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.9 m -151.51 47.34 0.81 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.988 0.423 . . . . 0.0 110.366 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.05 -50.43 4.29 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.023 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 137.97 -97.39 0.25 Allowed Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.294 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.35 69.72 1.02 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.504 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.401 ' H ' ' HA ' ' A' ' 41' ' ' ARG . . . -119.66 -39.67 2.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.951 0.405 . . . . 0.0 110.707 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . -90.42 -53.54 2.28 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.59 -0.815 . . . . 0.0 111.349 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 22.3 m120 73.74 27.22 1.75 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 177.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.649 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 22.5 p90 -58.39 -36.72 73.97 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.376 -0.53 . . . . 0.0 109.886 178.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.512 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 52.8 t-105 -63.79 -34.62 78.31 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.854 -178.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -56.86 -19.78 19.4 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.155 0.502 . . . . 0.0 110.788 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.758 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 13.0 m -138.75 29.12 2.35 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.444 178.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.45 ' HB1' ' HA ' ' A' ' 121' ' ' TRP . . . -116.22 145.83 42.81 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.2 0.524 . . . . 0.0 111.94 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.44 HH11 ' HD3' ' A' ' 125' ' ' ARG . 29.1 mtp-105 -133.69 153.88 51.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.378 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 52.03 39.91 27.3 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 123.713 0.633 . . . . 0.0 112.128 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.499 ' HA ' ' HB3' ' A' ' 138' ' ' ALA . 22.5 t -67.19 121.51 16.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.056 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -144.83 140.5 28.45 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.689 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.582 ' CD1' HG22 ' A' ' 14' ' ' ILE . 16.4 mt -86.36 122.39 30.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.147 0.498 . . . . 0.0 109.912 178.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.631 HG23 ' HB ' ' A' ' 135' ' ' VAL . 35.2 m -115.63 159.36 15.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.367 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.559 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 1.4 m-20 71.06 -0.7 2.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.212 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.553 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 98.6 28.18 8.09 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.033 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.559 ' HA3' HG23 ' A' ' 14' ' ' ILE . . . 100.24 -23.94 33.98 Favored Glycine 0 C--O 1.264 1.98 0 CA-C-O 123.192 1.44 . . . . 0.0 112.618 178.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.675 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 6.9 ptmm? -65.08 -18.85 65.65 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 121.803 -0.822 . . . . 0.0 109.601 178.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.631 ' HB ' HG23 ' A' ' 130' ' ' VAL . 15.1 t -139.08 141.19 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.289 0.566 . . . . 0.0 109.976 177.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 30.1 tp -121.66 121.16 36.73 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.501 ' OE2' ' HD3' ' A' ' 150' ' ' ARG . 36.7 tt0 -111.93 132.53 54.69 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.209 -177.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.745 ' HB1' ' HZ ' ' A' ' 50' ' ' PHE . . . -163.22 161.89 25.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.594 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -94.65 105.85 17.82 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.819 ' HG ' ' CB ' ' A' ' 45' ' ' ASN . 1.9 mp -89.82 128.52 36.18 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.543 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.758 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 41.0 ttt180 -70.61 140.53 51.67 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.097 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.649 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.3 p90 -157.22 -171.81 3.76 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.951 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.1 p -56.44 -29.2 61.35 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.168 0.293 . . . . 0.0 111.601 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.03 26.12 25.52 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.142 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.87 -110.98 4.1 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.365 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -130.05 133.31 46.62 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.649 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 14.4 t-20 -123.93 136.92 54.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.764 0.316 . . . . 0.0 111.361 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -76.7 93.73 3.7 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.497 ' OG ' HD23 ' A' ' 140' ' ' LEU . 24.2 p -110.71 162.91 14.29 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.506 -178.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.593 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 14.0 mtm-85 -143.91 152.37 41.02 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.858 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.746 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 11.1 tt -137.95 143.2 33.97 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.467 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.686 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 35.7 m-85 -83.89 101.66 11.83 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 122.195 -0.316 . . . . 0.0 110.925 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.773 HD13 HD22 ' A' ' 21' ' ' LEU . 20.4 mt -62.92 -33.6 75.67 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.116 178.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.675 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 12.7 t70 -56.13 -14.11 2.48 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.805 178.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.734 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 38.9 mt-10 -64.3 -55.8 18.87 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.592 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 53.6 m-70 -121.54 2.35 10.15 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 119.851 -0.74 . . . . 0.0 112.111 -177.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.435 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 47.0 mm -103.95 112.76 38.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.605 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.584 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -121.52 164.76 14.61 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.36 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.559 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.9 t30 -99.63 130.64 45.87 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.65 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 28.8 ttm180 -122.78 87.02 2.68 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.205 0.526 . . . . 0.0 110.425 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 64.9 t30 53.93 44.05 29.99 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.654 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.95 -6.78 47.96 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.127 -1.035 . . . . 0.0 114.733 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.65 ' HG2' ' O ' ' A' ' 160' ' ' ARG . 12.9 pt-20 -118.99 138.4 52.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 117.81 0.805 . . . . 0.0 110.696 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.65 HD12 ' CD2' ' A' ' 7' ' ' PHE . 7.4 tp -91.7 118.63 30.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.075 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.489 HG12 ' N ' ' A' ' 166' ' ' HIS . 12.0 tt -149.04 167.31 3.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.272 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.592 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 10.9 p-80 -61.9 123.19 17.37 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.519 ' OXT' ' HA3' ' A' ' 158' ' ' GLY . 50.8 t . . . . . 0 C--O 1.252 1.235 0 O-C-N 123.799 0.687 . . . . 0.0 111.348 -179.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.775 ' HA ' ' OD1' ' A' ' 154' ' ' ASP . 1.2 m-80 -75.96 137.86 40.59 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.602 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.795 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 56.3 m-85 -91.62 -90.32 0.17 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.731 -178.741 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.84 -29.99 10.15 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.459 -179.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.21 -69.15 1.45 Allowed Glycine 0 N--CA 1.436 -1.324 0 C-N-CA 119.948 -1.12 . . . . 0.0 113.051 -178.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.473 ' OD1' ' HB2' ' A' ' 2' ' ' ASN . 37.1 m-80 69.55 11.81 8.05 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.564 0.345 . . . . 0.0 110.94 -179.475 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.582 ' CE2' HD13 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -59.64 -35.0 73.53 Favored 'General case' 0 C--O 1.214 -0.786 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.635 -179.004 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.3 p -64.87 -13.77 57.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.04 0.447 . . . . 0.0 111.502 -179.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.64 -12.42 62.63 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.98 179.37 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.451 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 14.8 m -126.67 -34.11 2.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.491 0.663 . . . . 0.0 110.732 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.0 m -92.77 133.59 35.89 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.685 -179.042 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -111.76 -173.65 2.29 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.427 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 2.3 m-20 44.76 39.65 3.64 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 123.607 0.567 . . . . 0.0 112.419 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.682 HG21 ' HA3' ' A' ' 133' ' ' GLY . 5.0 mt -78.74 103.86 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 CA-C-O 120.951 0.405 . . . . 0.0 110.503 -178.564 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.544 ' CA ' HD12 ' A' ' 129' ' ' LEU . 71.2 m -147.63 126.53 12.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.284 178.663 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.747 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -101.03 155.16 18.14 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.904 0.859 . . . . 0.0 112.951 -179.373 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -99.02 77.0 2.15 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.036 -1.438 . . . . 0.0 107.559 176.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.06 -56.76 5.0 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.856 179.177 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.507 ' HB1' ' HB2' ' A' ' 40' ' ' ASN . . . -148.66 -12.28 0.34 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.087 0.47 . . . . 0.0 109.918 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.44 HH11 ' HD3' ' A' ' 20' ' ' ARG . 44.0 mtp-105 -81.75 86.43 6.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.343 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.747 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 42.1 tp -62.0 116.07 4.6 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 122.825 0.45 . . . . 0.0 111.884 -179.497 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.545 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 39.1 ttt180 -122.99 127.89 49.45 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.226 -179.104 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.622 ' HB2' HG12 ' A' ' 14' ' ' ILE . . . -148.66 146.65 28.26 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.506 0.67 . . . . 0.0 111.107 -179.339 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.45 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 1.2 mm-40 -85.53 79.88 9.25 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.643 178.39 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.614 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 37.6 m -65.63 126.73 29.3 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.213 -178.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 10' ' ' SER . 30.8 ttm180 -65.47 124.07 21.31 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.311 178.535 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.552 ' HD3' ' O ' ' A' ' 161' ' ' ASN . 18.4 ttp180 -105.08 151.2 24.28 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.524 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.9 2.61 0.56 Allowed Glycine 0 C--N 1.334 0.432 0 CA-C-N 114.525 -1.216 . . . . 0.0 113.944 -178.314 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 27' ' ' ARG . 33.1 t70 -84.73 -9.25 58.39 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.454 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.5 10.64 57.89 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -133.9 162.99 24.53 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.155 -1.021 . . . . 0.0 112.867 -179.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.45 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 71.2 m-85 -88.71 146.39 25.07 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.525 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.4 t -127.83 126.13 41.09 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.569 178.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.6 m -67.26 117.24 9.01 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 41.6 t -124.32 151.95 43.68 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.179 -179.403 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.676 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.4 p -144.31 134.92 20.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.904 0.383 . . . . 0.0 111.196 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.441 HG22 ' HB3' ' A' ' 21' ' ' LEU . 11.2 tt -135.62 152.94 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.878 -178.372 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.41 ' OD2' ' HB3' ' A' ' 40' ' ' ASN . 19.3 t70 -82.81 112.77 19.94 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.647 0.26 . . . . 0.0 110.451 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.488 HD23 ' HB3' ' A' ' 21' ' ' LEU . 2.7 mm? -92.81 0.89 57.49 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.356 0.598 . . . . 0.0 109.562 178.075 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.507 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 11.1 t30 -76.17 -19.57 58.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.202 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 41' ' ' ARG . 4.7 ptp180 -97.89 6.14 48.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.329 178.652 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.554 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 33.3 m-85 -129.25 -27.7 2.42 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.554 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.619 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 53.3 mt -105.96 137.94 42.99 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.134 0.492 . . . . 0.0 110.807 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m -131.78 143.59 50.33 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.414 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.541 ' CG ' ' HB3' ' A' ' 140' ' ' LEU . 7.9 t30 -90.47 110.92 22.02 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.481 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.443 ' CB ' ' HD3' ' A' ' 51' ' ' ARG . 35.4 t70 -115.61 92.72 4.0 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.238 179.663 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 65.1 t30 57.99 45.23 18.37 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.099 179.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.742 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 73.6 38.25 51.46 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.304 -0.951 . . . . 0.0 112.009 179.107 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.621 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 23.8 t60 -151.12 121.43 7.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.754 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 38.1 m-85 -65.6 139.49 58.44 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.142 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.443 ' HD3' ' CB ' ' A' ' 46' ' ' ASP . 78.1 mtp180 -147.17 133.3 19.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.708 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.554 ' HA ' ' O ' ' A' ' 42' ' ' TYR . 98.3 m95 -75.22 133.04 41.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.037 178.13 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.428 HG22 ' H ' ' A' ' 55' ' ' GLY . 7.5 p -98.84 129.14 49.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.057 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.4 p -81.32 -18.5 45.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.414 -178.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.428 ' H ' HG22 ' A' ' 53' ' ' VAL . . . -137.08 -80.08 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.725 -179.418 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.463 ' HA2' ' HB1' ' A' ' 117' ' ' ALA . . . 171.46 169.66 34.61 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.9 -179.652 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.1 -149.15 14.82 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.449 -0.661 . . . . 0.0 111.449 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.66 -85.71 0.61 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.02 179.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.43 -71.19 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.058 -0.592 . . . . 0.0 111.967 179.438 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.3 -73.99 0.31 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.14 -117.72 4.75 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.005 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 88.8 m -135.54 114.58 12.2 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.865 0.364 . . . . 0.0 110.085 179.416 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.46 ' HB2' ' HG2' ' A' ' 110' ' ' LYS . . . -117.84 177.09 4.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.19 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.515 HG22 ' HG2' ' A' ' 106' ' ' GLN . 12.3 p -128.58 119.47 24.84 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.678 0.275 . . . . 0.0 111.711 -179.354 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.46 HG21 ' CE2' ' A' ' 80' ' ' PHE . 8.3 p -105.89 141.52 21.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 120.793 0.33 . . . . 0.0 111.086 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.2 m -89.75 128.41 36.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.424 0.63 . . . . 0.0 109.996 179.109 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.586 ' CG2' HD13 ' A' ' 99' ' ' ILE . 48.8 t -79.71 138.22 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.072 -179.387 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -108.55 171.26 7.52 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 124.06 0.85 . . . . 0.0 111.09 -179.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.668 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 36.5 tt0 -54.28 114.31 1.59 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.539 -178.536 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.4 2.69 63.53 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 121.151 -0.547 . . . . 0.0 113.793 178.319 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -91.28 143.82 26.25 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 117.163 0.482 . . . . 0.0 111.537 -179.405 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.765 ' HA ' HG12 ' A' ' 99' ' ' ILE . 35.0 p -130.69 169.13 16.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.274 178.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.626 HD21 HG23 ' A' ' 99' ' ' ILE . 1.0 OUTLIER -49.77 -43.38 48.15 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.202 0.455 . . . . 0.0 111.512 -179.516 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -65.06 -35.88 82.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.542 -177.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -74.07 -37.71 64.14 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 72' ' ' THR . 45.0 mm -67.86 -47.9 77.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.367 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.713 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -58.13 -48.25 84.22 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.751 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -34.56 78.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.785 0.326 . . . . 0.0 111.341 -179.186 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -71.37 -47.54 55.7 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.604 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.642 ' HB2' ' HG ' ' A' ' 82' ' ' CYS . 86.2 m-85 -100.5 19.85 16.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -177.217 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 53.38 45.49 28.27 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.233 0.54 . . . . 0.0 112.012 178.805 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.713 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.2 p -126.14 168.0 14.63 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.315 179.497 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.64 ' O ' HG13 ' A' ' 87' ' ' ILE . 9.2 t70 -93.33 123.46 36.63 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 121.846 -0.534 . . . . 0.0 109.647 179.176 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.526 ' HD2' ' HB2' ' A' ' 95' ' ' ASN . 2.5 p90 -52.0 -27.07 12.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.011 179.735 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.93 -37.65 54.92 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.062 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.678 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 3.8 tp10 -64.86 -47.78 76.66 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.64 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.2 mt -53.86 -45.77 63.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.853 178.63 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.565 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.36 -52.07 65.07 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.91 178.511 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.1 mtt-85 -61.22 -30.18 70.27 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.678 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 32.8 mmt180 -72.73 -31.81 65.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.096 0.474 . . . . 0.0 110.395 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 21.1 t-20 -93.61 -6.02 47.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.754 179.349 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 92.0 m-20 79.04 17.12 0.93 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.092 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.565 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 16.1 pt -107.22 -173.03 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.843 178.509 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.522 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 3.5 mm100 -112.61 161.4 16.85 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.433 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.526 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 16.4 p-10 -62.36 -52.41 63.76 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.581 1.182 . . . . 0.0 108.394 179.473 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.486 ' O ' ' HG2' ' A' ' 96' ' ' GLU . 35.2 tt0 -73.64 4.74 4.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 113.867 -1.515 . . . . 0.0 110.822 179.814 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.522 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 0.9 OUTLIER -64.76 -37.45 87.64 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.625 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 7.9 mp 70.24 116.42 0.04 OUTLIER 'General case' 0 C--O 1.231 0.12 0 O-C-N 124.12 0.888 . . . . 0.0 109.716 -177.682 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.788 HG22 HD13 ' A' ' 105' ' ' LEU . 8.0 pt -93.95 175.72 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.881 -177.617 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.516 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 14.2 m-85 -126.04 158.85 64.69 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.921 -178.585 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.668 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 28.8 Cg_endo -64.98 136.07 46.86 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.298 2.665 . . . . 0.0 113.212 -179.747 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.7 15.58 56.38 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -103.8 153.68 20.45 Favored 'General case' 0 C--O 1.209 -1.036 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.494 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 62.0 t -116.12 119.55 62.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 O-C-N 121.75 -0.594 . . . . 0.0 110.567 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.788 HD13 HG22 ' A' ' 99' ' ' ILE . 77.5 mt -113.49 152.09 30.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.572 -179.229 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.632 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 71.2 mt-30 -90.78 122.4 33.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.546 0.688 . . . . 0.0 110.729 179.644 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.7 m -129.98 151.18 77.83 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.585 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.23 -20.45 70.74 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 123.734 2.956 . . . . 0.0 114.793 -177.21 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.7 t -147.79 152.56 37.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.924 0.392 . . . . 0.0 110.725 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.844 ' HB3' ' HA3' ' A' ' 114' ' ' GLY . 11.3 mmmm -98.56 164.64 12.18 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.194 0.521 . . . . 0.0 111.131 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -151.02 152.46 24.27 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.272 179.564 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.82 -101.5 0.72 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.088 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 21.8 m -77.69 1.93 18.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.902 0.382 . . . . 0.0 110.843 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.844 ' HA3' ' HB3' ' A' ' 110' ' ' LYS . . . -97.42 -88.35 1.86 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.844 179.448 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 109.78 -153.27 17.01 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.097 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 111.43 59.68 0.47 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.722 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.463 ' HB1' ' HA2' ' A' ' 56' ' ' GLY . . . -117.32 -41.38 2.98 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.02 0.438 . . . . 0.0 110.539 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . -99.7 -58.24 0.9 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.619 179.703 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.436 ' HA ' ' OD1' ' A' ' 40' ' ' ASN . 17.9 m120 69.43 31.64 3.73 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 123.019 0.528 . . . . 0.0 112.176 178.156 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.619 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 24.5 p90 -60.07 -34.95 74.13 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.527 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.407 ' HA ' ' HB2' ' A' ' 124' ' ' ALA . 20.7 t-105 -63.44 -33.16 74.96 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.821 -178.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.27 -23.62 49.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.981 0.42 . . . . 0.0 110.929 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.0 p -133.19 24.35 4.17 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.052 179.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.407 ' HB2' ' HA ' ' A' ' 121' ' ' TRP . . . -108.99 146.43 33.9 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.02 0.438 . . . . 0.0 111.5 179.026 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -146.41 146.01 30.45 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 61.26 26.22 16.1 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.73 0.776 . . . . 0.0 110.53 -179.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.558 ' HB ' ' CB ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -75.81 125.48 35.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.833 -179.93 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -150.06 155.67 40.29 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.654 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.6 ' HG ' ' HG ' ' A' ' 16' ' ' LEU . 30.5 mt -86.54 131.41 34.18 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.966 0.412 . . . . 0.0 110.102 179.573 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.438 HG22 ' HB ' ' A' ' 135' ' ' VAL . 33.3 m -125.79 158.59 34.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.918 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.568 ' HB3' ' HD2' ' A' ' 134' ' ' LYS . 3.7 m-20 68.84 7.34 6.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.448 178.486 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.652 ' O ' HD11 ' A' ' 14' ' ' ILE . . . 96.32 32.9 6.45 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.561 178.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.682 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 87.56 -15.81 52.77 Favored Glycine 0 C--O 1.266 2.151 0 CA-C-O 123.579 1.655 . . . . 0.0 112.833 177.361 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.827 ' HG3' HG23 ' A' ' 135' ' ' VAL . 18.2 ptpt -67.41 -24.23 65.63 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.233 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.827 HG23 ' HG3' ' A' ' 134' ' ' LYS . 26.1 t -136.36 137.13 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 121.43 0.633 . . . . 0.0 110.806 178.811 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.605 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 36.0 tp -112.26 114.83 27.82 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.366 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -104.47 125.99 51.16 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.357 -177.317 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.607 ' HB1' ' CZ ' ' A' ' 50' ' ' PHE . . . -154.38 161.75 41.55 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.158 0.504 . . . . 0.0 111.256 -179.264 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -103.28 106.37 16.87 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 177.448 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.742 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 38.6 mt -94.07 135.37 35.5 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.722 -178.146 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -69.84 140.96 53.32 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.355 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.582 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.0 OUTLIER -157.92 -167.81 2.34 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.849 -0.341 . . . . 0.0 111.549 -179.165 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.7 m -56.02 -26.91 50.83 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.053 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -106.35 27.35 17.26 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.13 -1.033 . . . . 0.0 113.238 -178.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 95.1 -106.35 3.39 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.101 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -127.81 129.95 47.84 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.582 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 56.4 t30 -123.6 137.29 54.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.047 0.451 . . . . 0.0 111.517 -179.114 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 39.8 ttt180 -76.31 105.88 7.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.925 178.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.621 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 10.2 t -121.47 165.44 15.62 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.605 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -146.4 158.12 43.85 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.125 -179.558 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.754 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 9.8 tt -141.89 145.55 24.02 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.37 179.193 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.649 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 23.3 m-85 -86.86 104.8 16.55 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 121.069 -0.253 . . . . 0.0 111.088 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.682 HD12 HD22 ' A' ' 21' ' ' LEU . 16.4 mt -67.68 -31.97 72.3 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.242 178.295 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.775 ' OD1' ' HA ' ' A' ' 2' ' ' ASN . 2.1 p30 -55.0 -17.33 3.64 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.129 177.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.795 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 35.1 mt-10 -63.18 -53.08 58.84 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.222 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.574 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 58.1 m80 -123.3 5.01 9.12 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.728 -177.567 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.418 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 48.3 mm -105.69 110.34 30.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.693 178.794 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 167' ' ' CYS . . . -115.97 172.84 14.41 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.632 178.445 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.614 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.2 OUTLIER -112.26 130.03 56.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.984 0.421 . . . . 0.0 110.983 179.893 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -125.41 94.01 4.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.327 179.098 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.552 ' O ' ' HD3' ' A' ' 27' ' ' ARG . 2.3 m-20 62.88 39.68 10.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.678 178.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.5 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 88.36 13.45 63.57 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.902 179.196 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -122.97 135.85 54.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.759 0.314 . . . . 0.0 111.299 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.498 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 37.4 mt -82.16 121.39 26.55 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.107 178.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 12.6 tt -149.89 155.58 7.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.197 -179.463 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.574 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 1.5 p-80 -56.85 117.15 3.66 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.522 0.201 . . . . 0.0 110.519 179.503 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.572 ' O ' ' HA3' ' A' ' 158' ' ' GLY . 41.5 t . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.609 -0.71 . . . . 0.0 111.635 -179.672 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.593 0 N-CA-C 111.731 -0.547 . . . . 0.0 111.731 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.426 ' HB2' ' HA ' ' A' ' 6' ' ' ASN . 20.1 m120 -125.41 -153.29 0.55 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 1.008 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 38.0 m-85 -91.61 -89.37 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.193 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.63 -33.55 4.82 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.341 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -70.63 -62.47 3.62 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 119.763 -1.208 . . . . 0.0 112.694 -179.035 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.426 ' HA ' ' HB2' ' A' ' 2' ' ' ASN . 37.7 m-80 65.48 16.52 10.56 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 122.532 0.333 . . . . 0.0 111.041 -179.498 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.716 ' HD2' HD11 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -63.74 -34.95 79.02 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.732 -179.277 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.41 ' HA ' HD12 ' A' ' 14' ' ' ILE . 16.6 p -63.79 -18.83 64.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.139 0.495 . . . . 0.0 110.988 -179.494 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.92 -26.29 69.41 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 115.682 -0.69 . . . . 0.0 113.341 179.226 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.555 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 33.5 p -127.12 -20.33 4.17 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 117.583 0.691 . . . . 0.0 111.819 -179.224 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.6 t -96.62 131.3 43.41 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -112.54 -176.99 3.04 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.419 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 16.6 m-20 43.62 45.55 5.81 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 123.971 0.794 . . . . 0.0 111.874 -179.802 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.683 HD11 ' O ' ' A' ' 132' ' ' GLY . 7.6 mt -78.32 102.66 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-O 120.904 0.383 . . . . 0.0 110.075 -178.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.437 ' HA ' HD12 ' A' ' 129' ' ' LEU . 56.9 m -144.73 128.43 17.21 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.168 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.737 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -97.44 157.81 15.8 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.941 0.877 . . . . 0.0 112.956 -179.24 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -99.45 74.87 1.93 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 113.994 -1.457 . . . . 0.0 107.779 177.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.52 -53.22 4.66 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.137 179.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.547 ' HB2' ' HB3' ' A' ' 40' ' ' ASN . . . -149.07 -13.57 0.31 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 120.951 0.405 . . . . 0.0 110.147 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -85.86 92.92 8.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.604 179.067 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.737 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 9.5 tp -62.91 114.81 3.88 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.713 -179.786 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 35' ' ' SER . 43.7 ttp180 -119.62 133.94 55.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.612 -178.265 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.576 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -152.78 148.13 26.86 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.402 179.791 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.51 ' O ' ' HD1' ' A' ' 32' ' ' TYR . 1.8 mm-40 -83.82 79.73 9.38 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.814 179.148 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.659 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 67.2 m -61.45 121.68 13.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.013 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.555 ' HB2' ' O ' ' A' ' 10' ' ' SER . 36.4 ttt-85 -70.64 122.21 19.34 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.273 178.532 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.7 ttt-85 -93.53 154.59 17.8 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.272 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.03 -15.0 6.23 Favored Glycine 0 C--N 1.335 0.509 0 O-C-N 124.36 1.037 . . . . 0.0 114.164 -178.251 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -79.27 -3.48 46.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.198 0.523 . . . . 0.0 109.788 178.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.46 9.51 72.32 Favored Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.97 144.31 17.31 Favored Glycine 0 C--O 1.227 -0.343 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.998 -179.067 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.51 ' HD1' ' O ' ' A' ' 24' ' ' GLU . 74.3 m-85 -90.46 125.69 35.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.788 0.328 . . . . 0.0 110.277 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.7 m -115.75 130.5 56.87 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.638 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.7 m -65.63 124.32 22.06 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.8 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.769 ' HG ' ' HB2' ' A' ' 164' ' ' LEU . 42.5 t -129.31 147.07 51.11 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.139 179.331 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 7.7 p -144.66 137.8 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.705 0.288 . . . . 0.0 110.967 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.537 HG21 HD22 ' A' ' 164' ' ' LEU . 8.5 tt -135.32 147.42 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.605 -178.357 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -76.38 99.77 4.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.723 0.297 . . . . 0.0 111.338 179.277 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.82 HD11 ' HG ' ' A' ' 43' ' ' LEU . 1.2 mm? -82.83 -4.41 58.02 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.102 0.477 . . . . 0.0 111.089 179.887 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.547 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 7.0 p30 -69.87 -10.68 59.39 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.369 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.484 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 57.9 mtt85 -102.54 6.06 39.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.829 179.17 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.493 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 7.1 m-85 -134.18 -24.75 1.61 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.569 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.82 ' HG ' HD11 ' A' ' 39' ' ' LEU . 61.7 mt -105.83 128.74 53.93 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.752 0.31 . . . . 0.0 110.522 179.433 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.641 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 1.0 OUTLIER -125.1 135.95 53.18 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.487 -179.845 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.822 ' HB3' ' HG ' ' A' ' 140' ' ' LEU . 18.8 p-10 -79.26 92.45 5.12 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.359 0.6 . . . . 0.0 110.033 178.336 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -86.82 86.85 7.35 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.307 0.575 . . . . 0.0 110.333 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.478 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 64.5 t30 50.22 44.62 26.24 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.253 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.71 34.82 10.87 Favored Glycine 0 C--O 1.221 -0.657 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.725 178.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -150.68 131.56 14.19 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.429 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.695 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 21.3 m-85 -72.21 140.0 48.47 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.559 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.432 ' HD3' ' HA ' ' A' ' 51' ' ' ARG . 10.5 mmt180 -143.88 134.15 24.47 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.087 -179.448 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.63 ' HH2' HD11 ' A' ' 153' ' ' LEU . 96.5 m95 -75.33 104.61 5.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.258 177.53 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.409 ' C ' ' HG ' ' A' ' 54' ' ' SER . 57.3 t 68.01 -61.78 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.042 0.839 . . . . 0.0 112.42 179.053 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.409 ' HG ' ' C ' ' A' ' 53' ' ' VAL . 66.8 p 49.06 62.07 2.8 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.899 0.857 . . . . 0.0 110.402 -178.627 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.538 ' O ' ' HA3' ' A' ' 59' ' ' GLY . . . 91.29 -48.34 2.91 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.702 -178.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.28 26.66 11.87 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.399 179.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.42 56.2 3.47 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.161 179.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.77 17.96 19.61 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.524 179.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 55' ' ' GLY . . . -83.35 125.52 7.06 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.099 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.63 165.61 14.17 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -179.354 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 108' ' ' PRO . . . 118.96 -122.2 5.26 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.046 -179.475 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 37.7 m -134.94 117.53 15.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.193 0.521 . . . . 0.0 111.671 -179.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.64 176.62 8.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.009 179.085 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.5 HG21 ' HG2' ' A' ' 106' ' ' GLN . 7.8 p -129.59 122.16 28.55 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.208 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.536 HG22 ' CE2' ' A' ' 80' ' ' PHE . 8.2 p -113.02 147.44 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 120.751 0.31 . . . . 0.0 111.072 179.26 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 4.9 m -90.52 129.95 36.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.099 0.476 . . . . 0.0 110.284 179.101 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.477 ' CG2' HD13 ' A' ' 99' ' ' ILE . 54.0 t -78.78 133.48 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.485 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -104.17 169.34 8.55 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.333 1.021 . . . . 0.0 110.486 -179.496 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.612 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 63.4 tt0 -68.13 120.16 13.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.292 -178.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.33 9.36 55.5 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.856 179.332 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -116.88 128.35 55.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.964 0.412 . . . . 0.0 111.494 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.58 ' HA ' HG12 ' A' ' 99' ' ' ILE . 67.8 p -106.68 -179.2 3.87 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.329 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.553 HD22 HG21 ' A' ' 99' ' ' ILE . 1.4 mm? -52.21 -43.1 64.07 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.404 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 3.4 tmt_? -59.38 -41.64 89.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.366 -179.292 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -73.12 -38.2 66.4 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.595 -178.345 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 72' ' ' THR . 45.8 mm -63.83 -48.89 84.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.542 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.734 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -59.23 -47.24 91.8 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.391 179.206 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -25.49 64.78 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.796 0.332 . . . . 0.0 111.838 -178.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 48.9 ttm-85 -82.51 -34.51 27.92 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.576 ' HB2' ' HG ' ' A' ' 82' ' ' CYS . 95.0 m-85 -110.83 20.26 17.74 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.321 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.9 t70 55.06 42.1 31.18 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.62 0.724 . . . . 0.0 111.711 178.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.734 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -125.26 170.98 10.75 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.348 179.255 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.556 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.4 t70 -98.39 123.15 42.35 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.87 179.366 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.485 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 5.9 p90 -50.97 -30.37 14.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.99 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -67.24 -43.73 81.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.229 179.525 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.687 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 26.3 mt-10 -64.9 -48.27 74.8 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.355 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.1 mt -49.59 -50.21 17.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.458 179.196 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.602 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.63 -50.74 68.15 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.295 178.681 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -56.56 -37.63 70.8 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.687 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 75.3 mtt180 -73.91 -29.48 62.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.841 0.353 . . . . 0.0 111.03 -179.407 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.491 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 15.1 t-20 -93.19 -5.16 50.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.031 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 93.4 m-20 79.23 12.46 1.27 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.586 0.754 . . . . 0.0 111.497 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.602 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 14.8 pt -102.8 179.43 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.445 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.552 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 2.6 mp0 -105.96 155.94 18.87 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.462 ' O ' HD21 ' A' ' 73' ' ' LEU . 2.3 p-10 -56.82 -56.09 26.07 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.226 1.012 . . . . 0.0 108.82 179.21 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -77.95 12.03 1.96 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.438 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.552 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.9 t70 -65.34 -34.9 79.41 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.469 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 8.2 mp 70.78 115.3 0.05 OUTLIER 'General case' 0 C--O 1.233 0.215 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.107 -178.117 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.744 HG23 HD11 ' A' ' 105' ' ' LEU . 7.5 pt -95.29 178.66 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.538 -178.526 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.542 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 61.8 m-85 -130.53 158.34 74.89 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.478 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.612 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 22.9 Cg_endo -64.95 139.21 60.73 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 123.323 2.682 . . . . 0.0 114.402 -178.414 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.39 20.22 33.07 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.014 178.085 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.569 ' O ' ' HA ' ' A' ' 66' ' ' THR . 79.2 mt-30 -109.59 168.21 9.57 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.413 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 77.8 t -126.36 112.06 28.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.047 0.451 . . . . 0.0 110.042 179.1 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.744 HD11 HG23 ' A' ' 99' ' ' ILE . 87.2 mt -107.23 151.42 25.46 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.581 -179.645 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.5 ' HG2' HG21 ' A' ' 64' ' ' THR . 37.4 mt-30 -91.06 112.38 24.26 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.741 0.781 . . . . 0.0 111.387 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.7 m -115.78 152.0 46.92 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.459 179.701 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 37.8 Cg_endo -65.37 -21.94 60.43 Favored 'Trans proline' 0 C--N 1.332 -0.315 0 C-N-CA 122.909 2.406 . . . . 0.0 114.409 -177.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.9 t -148.66 151.25 34.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.86 0.362 . . . . 0.0 110.987 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.438 ' HD2' ' HA ' ' A' ' 110' ' ' LYS . 12.0 mmmm -95.57 169.08 10.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.053 178.692 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -101.96 64.94 0.46 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.76 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 166.34 139.98 2.78 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.935 179.669 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.6 p -139.89 -72.64 0.37 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.718 0.294 . . . . 0.0 110.633 -179.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 149.61 -73.07 0.29 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.067 179.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.36 142.74 9.92 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.128 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.95 62.11 2.16 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.54 179.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 41' ' ' ARG . . . -109.06 -30.64 7.96 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.234 0.54 . . . . 0.0 109.841 179.326 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.641 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -110.22 -69.64 0.61 Allowed Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.723 179.622 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 20.9 m120 70.7 27.03 3.75 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 122.998 0.519 . . . . 0.0 112.118 178.595 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.608 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 17.2 p90 -60.07 -39.47 86.17 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.658 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.495 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 38.9 t-105 -61.75 -29.88 70.42 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.208 -178.267 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -55.96 -28.31 56.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.665 0.269 . . . . 0.0 110.803 -179.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.632 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 3.9 m -135.25 28.74 3.39 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.855 0.36 . . . . 0.0 110.48 178.497 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.495 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -110.61 144.34 39.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.766 0.317 . . . . 0.0 110.706 178.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -136.64 149.72 48.13 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.137 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 59.34 45.23 14.2 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.693 0.62 . . . . 0.0 111.139 179.343 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.462 ' CG1' HD11 ' A' ' 136' ' ' LEU . 21.4 t -74.84 121.37 26.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.194 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -145.17 140.65 28.1 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.036 -179.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.656 HD13 ' HG ' ' A' ' 16' ' ' LEU . 54.1 mt -86.76 127.11 34.98 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.038 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.518 HG22 ' HB ' ' A' ' 135' ' ' VAL . 34.6 m -119.95 163.17 17.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.854 -178.701 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 66.27 9.23 6.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.474 178.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.683 ' O ' HD11 ' A' ' 14' ' ' ILE . . . 94.69 31.83 7.59 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.116 179.487 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.695 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 86.8 -13.92 57.7 Favored Glycine 0 C--O 1.256 1.521 0 CA-C-O 123.274 1.485 . . . . 0.0 112.812 177.548 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.584 ' HG3' HG21 ' A' ' 135' ' ' VAL . 19.0 ptpt -72.86 -14.22 61.45 Favored 'General case' 0 C--N 1.311 -1.098 0 O-C-N 121.592 -0.946 . . . . 0.0 108.76 178.155 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.584 HG21 ' HG3' ' A' ' 134' ' ' LYS . 22.7 t -141.68 138.73 31.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.638 177.478 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 27.8 tp -119.99 125.39 48.26 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.527 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.512 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 28.3 tt0 -114.98 132.52 56.56 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 123.504 0.503 . . . . 0.0 110.948 -177.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.608 ' HB1' ' CZ ' ' A' ' 50' ' ' PHE . . . -161.39 158.52 26.96 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.247 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 30.5 mt-10 -94.88 106.82 18.83 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.773 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.822 ' HG ' ' HB3' ' A' ' 45' ' ' ASN . 0.4 OUTLIER -89.54 123.37 33.57 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.435 -179.877 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.632 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 36.6 ttt180 -69.29 140.81 54.42 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.591 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 2.5 p90 -155.53 -170.39 3.43 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.429 -179.008 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 3.1 m -56.96 -27.94 61.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.106 0.479 . . . . 0.0 112.0 -179.36 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.29 17.2 58.21 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.598 -0.811 . . . . 0.0 113.19 -179.312 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 103.41 -107.9 3.13 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.031 179.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -129.6 127.69 41.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.785 0.292 . . . . 0.0 110.639 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.591 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 52.0 t-20 -120.88 117.18 26.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.76 0.314 . . . . 0.0 110.534 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 31.6 ttm180 -74.99 94.74 2.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.886 178.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.3 m -111.54 174.02 6.07 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.403 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.592 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 44.6 mtt85 -142.37 165.68 26.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.058 0.456 . . . . 0.0 112.003 -177.611 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.695 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 14.3 tt -145.44 161.98 12.38 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.372 179.169 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.58 ' CB ' ' HG3' ' A' ' 155' ' ' GLU . 12.1 m-85 -104.43 104.27 14.12 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 122.144 -0.347 . . . . 0.0 111.72 -178.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.695 HD13 ' HG ' ' A' ' 39' ' ' LEU . 4.1 mm? -65.65 -36.43 83.67 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.328 179.071 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' A' ' 152' ' ' TYR . 6.0 p-10 -57.34 -11.96 2.17 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.18 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 1.008 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 36.1 mt-10 -67.76 -54.89 15.65 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.419 ' HA ' ' OXT' ' A' ' 167' ' ' CYS . 90.4 m-70 -121.33 3.6 10.29 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.041 -0.664 . . . . 0.0 112.467 -177.37 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.597 HG13 HD12 ' A' ' 153' ' ' LEU . 45.9 mm -104.26 114.16 43.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 C-N-CA 120.181 -0.607 . . . . 0.0 110.585 179.023 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -115.14 175.79 16.21 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.928 -0.654 . . . . 0.0 113.159 179.52 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.659 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.0 t30 -117.4 129.05 55.6 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.5 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.657 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 40.8 ttm180 -124.67 88.32 2.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.712 179.674 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 51.95 46.15 27.07 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 178.636 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.9 -8.98 50.94 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.285 -0.96 . . . . 0.0 115.019 177.404 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.657 ' HG2' ' O ' ' A' ' 160' ' ' ARG . 12.9 pt-20 -114.18 146.6 40.13 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 117.901 0.851 . . . . 0.0 110.634 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.769 ' HB2' ' HG ' ' A' ' 35' ' ' SER . 4.6 tp -91.15 106.92 18.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.675 -179.578 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.551 HD11 ' HB2' ' A' ' 160' ' ' ARG . 31.7 pt -100.84 173.43 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.366 0.603 . . . . 0.0 112.149 -178.474 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 36.8 p-80 -126.75 129.8 49.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.991 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.419 ' OXT' ' HA ' ' A' ' 156' ' ' HIS . 22.7 p . . . . . 0 C--O 1.247 0.923 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -94.1 -95.78 0.16 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.771 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 1.03 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 35.3 m-85 -139.21 -90.62 0.19 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -121.87 -31.32 3.96 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.021 178.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -78.55 -66.44 1.73 Allowed Glycine 0 N--CA 1.436 -1.352 0 C-N-CA 119.525 -1.322 . . . . 0.0 112.046 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 65.96 15.26 10.0 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.605 0.362 . . . . 0.0 111.018 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.727 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -58.31 -37.27 74.75 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -178.972 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.8 t -60.04 -18.25 45.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.379 0.609 . . . . 0.0 110.816 -179.649 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.52 -33.32 61.13 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.578 179.008 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.507 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 20.2 m -120.9 -17.98 7.72 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 117.683 0.741 . . . . 0.0 111.32 -179.461 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.419 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 15.6 m -97.99 131.46 44.4 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -114.19 -175.64 2.72 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 46.03 42.37 9.43 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 123.76 0.663 . . . . 0.0 111.87 179.284 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.711 HG23 ' HA3' ' A' ' 133' ' ' GLY . 7.5 mt -78.82 105.48 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-O 121.18 0.514 . . . . 0.0 110.063 -178.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.531 ' HA ' HD13 ' A' ' 129' ' ' LEU . 65.3 m -147.72 128.6 14.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.887 179.433 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.719 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -97.97 159.87 14.66 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -178.711 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 20' ' ' ARG . 24.1 m-20 -99.1 73.77 1.94 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.129 177.113 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.86 -59.46 4.72 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.742 179.645 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.629 ' HB3' ' HB3' ' A' ' 40' ' ' ASN . . . -147.8 10.96 0.95 Allowed 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.273 0.558 . . . . 0.0 110.274 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.412 ' HB2' ' HB2' ' A' ' 17' ' ' ASP . 72.1 mtm180 -110.05 91.24 3.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.86 179.428 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.931 ' HB2' HD22 ' A' ' 39' ' ' LEU . 44.3 tp -60.47 122.47 14.69 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.636 -178.646 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 48.7 ttp180 -127.51 132.17 49.98 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.345 -178.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.637 ' HB2' HG12 ' A' ' 14' ' ' ILE . . . -149.83 145.25 26.48 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.511 0.672 . . . . 0.0 110.74 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.507 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 3.8 mm-40 -80.54 68.51 6.77 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.671 178.283 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.68 ' SG ' HD12 ' A' ' 164' ' ' LEU . 57.5 m -57.28 124.47 18.95 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.018 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.507 ' HB2' ' O ' ' A' ' 10' ' ' SER . 42.6 ttt-85 -65.75 126.36 28.19 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.414 179.241 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 33.9 ptt180 -98.48 155.29 17.33 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.063 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.93 -11.95 4.89 Favored Glycine 0 C--N 1.338 0.689 0 O-C-N 124.513 1.133 . . . . 0.0 113.919 -179.024 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.01 -11.65 60.86 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.048 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.35 8.27 60.04 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.857 179.531 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.412 ' O ' ' HG2' ' A' ' 27' ' ' ARG . . . -123.7 178.07 16.5 Favored Glycine 0 C--O 1.225 -0.432 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.392 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.507 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 83.2 m-85 -101.58 140.99 35.11 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.912 0.387 . . . . 0.0 111.168 179.573 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 p -128.93 133.97 48.05 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.904 179.231 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 m -71.32 111.07 6.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.094 0.473 . . . . 0.0 111.608 -178.383 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.4 t -116.27 147.57 41.37 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.948 179.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 5.4 p -143.14 137.55 26.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 120.867 0.365 . . . . 0.0 111.152 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.6 tt -132.66 154.32 39.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.012 -177.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -81.15 95.12 6.79 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.931 HD22 ' HB2' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -76.1 -14.23 60.19 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.697 0.76 . . . . 0.0 109.461 178.355 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.629 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 5.2 p30 -66.62 -15.96 63.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.803 178.377 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.439 ' HD2' ' O ' ' A' ' 114' ' ' GLY . 56.6 mtm180 -114.24 31.03 6.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.1 179.071 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -150.45 -30.97 0.2 Allowed 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.208 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.614 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 41.7 mt -105.94 127.5 53.19 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.775 0.321 . . . . 0.0 110.495 179.273 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.644 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 1.0 OUTLIER -123.91 137.78 54.58 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.452 179.984 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.795 ' HB3' ' HG ' ' A' ' 140' ' ' LEU . 19.4 p-10 -78.34 92.21 4.52 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.484 0.659 . . . . 0.0 110.831 178.59 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -87.5 86.71 7.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.072 0.463 . . . . 0.0 110.725 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 52.03 43.66 30.19 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.312 179.24 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.55 40.04 9.27 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.995 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -157.81 118.98 3.54 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.746 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.79 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 29.7 m-85 -62.44 140.88 58.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.28 -179.358 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.574 ' HB3' ' HA2' ' A' ' 55' ' ' GLY . 16.3 mmm180 -140.41 139.03 35.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.235 179.508 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.651 ' CZ2' ' HA ' ' A' ' 153' ' ' LEU . 86.2 m95 -76.86 153.1 35.12 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 t 64.64 -92.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 113.763 -1.562 . . . . 0.0 112.841 177.243 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.4 m -129.26 34.76 4.35 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.029 0.443 . . . . 0.0 110.362 -178.272 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.574 ' HA2' ' HB3' ' A' ' 51' ' ' ARG . . . 72.14 32.0 63.44 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.84 -179.695 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.28 128.73 44.62 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.899 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.32 28.36 15.11 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.795 -0.716 . . . . 0.0 111.917 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.51 -126.03 3.32 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -139.49 -60.25 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.137 179.545 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.54 176.38 16.11 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.898 -0.667 . . . . 0.0 111.77 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 108' ' ' PRO . . . -176.25 -115.63 0.43 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.067 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.3 m -129.59 116.78 19.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.176 0.512 . . . . 0.0 110.549 179.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -121.98 176.58 5.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.431 179.525 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.2 p -126.81 120.8 30.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.028 0.442 . . . . 0.0 112.151 -179.093 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.9 p -110.18 144.85 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.006 178.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 5.7 m -89.19 127.27 35.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.079 179.044 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.537 ' CG2' HD13 ' A' ' 99' ' ' ILE . 60.5 t -73.38 131.66 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.55 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -101.0 170.08 8.52 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 124.485 1.115 . . . . 0.0 111.136 -178.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.682 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 57.7 tp60 -58.76 118.56 5.84 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.682 -178.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.81 -5.36 85.04 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 121.106 -0.568 . . . . 0.0 113.705 177.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -90.36 127.56 36.22 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 117.084 0.442 . . . . 0.0 111.056 -179.662 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.686 ' HA ' HG12 ' A' ' 99' ' ' ILE . 68.9 p -107.93 -179.33 3.87 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.728 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.553 HD13 ' HB ' ' A' ' 87' ' ' ILE . 1.2 mm? -53.02 -42.73 65.96 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.538 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -62.43 -35.33 78.93 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.145 -178.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -74.06 -46.7 41.47 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.585 179.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 72' ' ' THR . 43.8 mm -58.31 -48.4 85.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.209 -179.649 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.69 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -58.64 -55.55 30.17 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.112 179.464 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -33.95 75.98 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.047 0.451 . . . . 0.0 111.114 -178.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -73.5 -40.41 64.09 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -106.57 15.17 26.14 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -178.403 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.0 t70 60.33 49.89 6.64 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.589 0.709 . . . . 0.0 111.826 178.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.69 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.5 p -134.55 165.59 24.85 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.495 ' O ' HG13 ' A' ' 87' ' ' ILE . 3.9 p-10 -95.24 121.43 36.87 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.775 0.797 . . . . 0.0 109.689 178.67 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.521 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 5.9 p90 -48.11 -31.36 5.48 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.174 -1.375 . . . . 0.0 112.115 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.43 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 22.4 t-80 -60.23 -50.28 74.27 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.963 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.486 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 7.9 tp10 -65.39 -45.65 83.18 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.107 179.712 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.553 ' HB ' HD13 ' A' ' 73' ' ' LEU . 4.3 mt -51.4 -46.16 34.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.725 0.774 . . . . 0.0 109.51 179.446 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.56 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.98 -50.75 69.54 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.719 178.611 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.416 HH21 ' CD ' ' A' ' 86' ' ' GLU . 52.2 ttp180 -59.2 -37.15 76.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.758 0.313 . . . . 0.0 111.794 -179.381 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.664 ' HB3' ' HB2' ' A' ' 106' ' ' GLN . 2.0 mmp_? -65.11 -32.32 73.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.928 0.394 . . . . 0.0 110.903 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.551 HD21 HG23 ' A' ' 93' ' ' ILE . 6.0 t30 -96.09 -5.03 41.8 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.959 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 17.3 m120 77.36 18.3 1.4 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.355 0.662 . . . . 0.0 111.029 -179.228 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.56 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 10.6 pt -105.84 179.53 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.827 178.913 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.542 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 12.0 mm100 -102.93 154.55 19.1 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.675 HD21 ' HG3' ' A' ' 96' ' ' GLU . 1.1 p-10 -55.7 -61.5 2.31 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-O 122.259 1.028 . . . . 0.0 109.696 179.036 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.675 ' HG3' HD21 ' A' ' 95' ' ' ASN . 43.6 mt-10 -78.49 12.48 1.98 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.582 -179.461 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 4.3 t0 -61.89 -32.43 72.8 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.127 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.463 HD21 HG23 ' A' ' 72' ' ' THR . 41.2 mt 71.78 114.38 0.05 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.176 -178.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.686 HG12 ' HA ' ' A' ' 72' ' ' THR . 8.2 pt -95.2 175.54 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.354 -179.152 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.482 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 40.4 m-85 -124.71 157.44 65.88 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.21 -178.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.682 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 40.7 Cg_endo -67.85 138.71 45.42 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 123.122 2.548 . . . . 0.0 113.456 -178.526 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.76 13.59 43.24 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.374 179.159 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.526 ' O ' ' HA ' ' A' ' 66' ' ' THR . 44.1 mt-30 -100.44 168.69 9.59 Favored 'General case' 0 C--O 1.217 -0.658 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.297 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 89.5 t -128.53 109.16 18.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.583 HD11 HG22 ' A' ' 99' ' ' ILE . 82.0 mt -107.15 151.56 25.23 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.019 -178.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.664 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 39.6 mt-30 -89.89 116.44 27.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.598 0.713 . . . . 0.0 110.859 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.0 m -121.98 150.74 56.88 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 114.37 -1.287 . . . . 0.0 109.544 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 34.8 Cg_endo -64.99 -18.4 62.05 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 123.352 2.701 . . . . 0.0 114.29 -177.699 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.2 t -148.18 152.55 37.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.255 0.55 . . . . 0.0 111.139 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.615 ' HZ3' ' HA ' ' A' ' 110' ' ' LYS . 0.1 OUTLIER -94.02 -166.16 1.45 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.339 179.682 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -103.79 -115.6 4.1 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.532 -178.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.879 ' HA2' ' HB3' ' A' ' 117' ' ' ALA . . . 147.39 -17.89 1.5 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.349 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.4 m -67.44 -24.64 65.65 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.444 -0.378 . . . . 0.0 111.504 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.439 ' O ' ' HD2' ' A' ' 41' ' ' ARG . . . -145.45 -83.62 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.293 179.765 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -122.25 150.42 16.97 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.137 -0.554 . . . . 0.0 111.823 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.577 ' O ' ' HB3' ' A' ' 110' ' ' LYS . . . 78.49 67.5 1.61 Allowed Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.879 ' HB3' ' HA2' ' A' ' 112' ' ' GLY . . . -122.15 -47.57 2.14 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.125 0.488 . . . . 0.0 110.364 -179.755 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.644 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -96.96 -74.36 1.19 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.211 -179.566 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.3 m120 70.9 21.13 5.16 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 178.741 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.614 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 21.6 p90 -58.02 -37.5 74.44 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.045 0.45 . . . . 0.0 109.941 178.883 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.488 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 58.3 t-105 -59.93 -32.21 70.57 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.144 -178.495 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.9 -28.31 56.14 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.946 0.403 . . . . 0.0 110.392 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.902 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 69.7 m -133.26 30.12 3.93 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.921 179.135 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 139' ' ' GLU . . . -115.88 136.48 53.0 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.981 0.42 . . . . 0.0 111.731 178.845 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -129.32 151.35 50.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.963 178.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 40.8 t0 56.22 51.36 11.83 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.742 0.782 . . . . 0.0 110.575 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.44 ' CG1' HD12 ' A' ' 136' ' ' LEU . 21.9 t -83.98 127.15 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.588 -179.644 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 25.0 ptt-85 -154.38 146.88 24.04 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.95 0.405 . . . . 0.0 110.358 179.164 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.745 HD21 HD12 ' A' ' 153' ' ' LEU . 19.5 mt -86.17 130.67 34.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.83 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.696 HG23 ' HB ' ' A' ' 135' ' ' VAL . 28.0 m -123.88 156.95 30.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.003 -178.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.459 ' HB3' ' CG ' ' A' ' 134' ' ' LYS . 0.7 OUTLIER 65.65 16.87 10.7 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.043 179.145 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.688 ' O ' HD13 ' A' ' 14' ' ' ILE . . . 88.31 30.79 15.43 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.625 178.119 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.711 ' HA3' HG23 ' A' ' 14' ' ' ILE . . . 89.75 -14.44 61.63 Favored Glycine 0 C--O 1.26 1.735 0 CA-C-O 123.442 1.579 . . . . 0.0 113.031 177.112 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.758 ' HG3' HG21 ' A' ' 135' ' ' VAL . 21.5 ptmt -69.85 -17.35 63.37 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 121.334 -1.098 . . . . 0.0 108.384 178.396 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.758 HG21 ' HG3' ' A' ' 134' ' ' LYS . 3.9 t -140.17 144.72 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.083 177.79 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.573 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 28.3 tp -126.14 121.91 34.2 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.749 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.467 ' HG3' ' HG3' ' A' ' 150' ' ' ARG . 30.9 tt0 -112.58 133.34 54.68 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.883 0.373 . . . . 0.0 111.285 -177.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.54 ' HB2' ' HZ ' ' A' ' 50' ' ' PHE . . . -161.86 163.8 29.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.62 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 124' ' ' ALA . 46.7 mt-10 -96.33 105.79 17.92 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 178.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.795 ' HG ' ' HB3' ' A' ' 45' ' ' ASN . 1.6 mp -89.85 125.2 35.24 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.927 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.902 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 74.7 ttt180 -70.87 140.86 51.21 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.047 178.669 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -155.59 -175.84 5.64 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.186 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 6.0 m -56.89 -31.46 64.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.759 0.314 . . . . 0.0 111.485 -179.256 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -88.33 7.65 81.0 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.766 -179.032 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 109.7 -121.83 6.2 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.127 179.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -122.86 125.1 44.74 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.629 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -123.3 140.39 53.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.874 0.368 . . . . 0.0 111.549 -179.092 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -72.55 102.37 3.23 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.824 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.449 ' HB2' HD21 ' A' ' 140' ' ' LEU . 1.4 m -113.07 156.34 23.3 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.351 -178.052 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.573 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -145.53 153.85 41.55 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.961 0.41 . . . . 0.0 111.065 179.84 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.79 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 9.4 tt -136.24 152.06 29.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.971 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.56 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 92.4 m-85 -97.11 104.49 16.51 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.419 0.152 . . . . 0.0 110.701 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.745 HD12 HD21 ' A' ' 129' ' ' LEU . 22.5 mt -68.74 -33.46 73.95 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.331 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.504 ' OD1' ' HB3' ' A' ' 152' ' ' TYR . 10.2 p-10 -56.84 -13.19 2.38 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.713 178.119 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 1.03 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 37.8 mt-10 -70.0 -55.42 9.62 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.417 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 88.0 m-70 -122.98 11.32 9.56 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.72 -0.792 . . . . 0.0 113.048 -176.232 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.524 HG12 ' CH2' ' A' ' 52' ' ' TRP . 38.0 mm -112.94 111.94 38.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.421 178.196 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.605 ' HA3' ' OXT' ' A' ' 167' ' ' CYS . . . -115.05 175.62 16.11 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.191 179.093 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.541 ' CG ' ' HB3' ' A' ' 25' ' ' CYS . 3.3 t30 -115.11 129.51 56.7 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 122.651 0.38 . . . . 0.0 110.278 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 41.0 ttt85 -125.94 97.75 5.24 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.258 179.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 61.83 32.39 18.09 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.149 179.24 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 93.68 12.31 57.03 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.495 -0.86 . . . . 0.0 113.093 179.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -122.48 134.21 54.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.069 0.462 . . . . 0.0 110.814 179.628 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.727 HD11 ' CD2' ' A' ' 7' ' ' PHE . 4.4 tp -78.24 118.73 20.74 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.983 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 10.3 tp -144.78 151.92 15.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.356 -178.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.417 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 29.7 p-80 -59.81 125.6 24.28 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.521 -0.177 . . . . 0.0 110.521 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.605 ' OXT' ' HA3' ' A' ' 158' ' ' GLY . 44.7 t . . . . . 0 C--O 1.253 1.256 0 O-C-N 123.922 0.764 . . . . 0.0 111.273 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.509 ' HA3' ' OD1' ' A' ' 6' ' ' ASN . . . . . . . . 0 N--CA 1.48 1.612 0 N-CA-C 112.08 -0.408 . . . . 0.0 112.08 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.662 HD21 ' HB3' ' A' ' 152' ' ' TYR . 6.2 m-20 -88.43 -71.06 0.6 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 122.155 0.182 . . . . 0.0 111.472 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.499 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 34.0 m-85 -139.14 -98.25 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.145 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -96.07 -31.11 13.19 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.065 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.56 -74.62 0.48 Allowed Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 119.879 -1.153 . . . . 0.0 113.227 -179.071 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.509 ' OD1' ' HA3' ' A' ' 1' ' ' GLY . 35.3 m-80 64.69 16.67 10.51 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 122.488 0.315 . . . . 0.0 110.25 -179.286 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.905 ' HD2' HD13 ' A' ' 164' ' ' LEU . 0.2 OUTLIER -61.14 -34.79 75.57 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.679 -179.316 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.416 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.7 OUTLIER -64.76 -17.51 64.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.331 0.586 . . . . 0.0 110.246 -179.262 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.15 -37.18 92.78 Favored Glycine 0 CA--C 1.523 0.544 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.647 178.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 30.9 m -118.06 -27.64 6.07 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 120.985 0.421 . . . . 0.0 111.404 -179.419 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 t -88.94 128.9 35.7 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.502 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 12' ' ' ARG . 11.3 ptm85 -114.41 -177.05 3.04 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.74 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 46.09 43.18 10.56 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 123.759 0.662 . . . . 0.0 111.675 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.671 HG12 ' HB2' ' A' ' 23' ' ' ALA . 6.1 mt -78.44 103.61 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.261 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.541 ' CA ' HD13 ' A' ' 129' ' ' LEU . 58.4 m -143.34 127.77 17.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.612 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.763 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -101.14 156.61 17.32 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.892 0.853 . . . . 0.0 113.15 -179.725 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -98.71 74.58 2.09 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 113.914 -1.494 . . . . 0.0 107.468 177.236 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.5 -54.53 4.6 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.622 179.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.745 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -147.05 -13.04 0.42 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 120.954 0.406 . . . . 0.0 110.294 179.55 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.99 86.81 6.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.444 179.14 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.763 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 45.2 tp -62.47 119.78 9.82 Favored 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 122.949 0.499 . . . . 0.0 112.158 -179.691 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 15.9 ttp180 -124.31 135.87 53.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.358 -178.585 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.671 ' HB2' HG12 ' A' ' 14' ' ' ILE . . . -155.42 140.36 17.27 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.498 0.666 . . . . 0.0 111.374 179.714 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 3.5 mm-40 -77.94 82.23 4.31 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.901 178.198 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.617 ' SG ' HD11 ' A' ' 164' ' ' LEU . 34.5 m -69.85 120.58 15.8 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.886 -178.04 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 10' ' ' SER . 50.6 ttp85 -72.42 114.9 11.04 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.76 178.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -92.1 160.6 15.13 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.233 179.242 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.75 -14.0 4.87 Favored Glycine 0 C--N 1.335 0.485 0 O-C-N 124.806 1.316 . . . . 0.0 113.902 -178.21 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -71.82 -12.47 61.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.789 0.804 . . . . 0.0 109.646 178.519 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.79 10.36 58.97 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.005 179.591 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -122.37 167.05 14.85 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 119.872 -1.156 . . . . 0.0 113.762 -179.011 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.559 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 78.1 m-85 -99.4 126.82 45.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.686 0.279 . . . . 0.0 110.516 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.5 t -113.71 126.18 54.94 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.398 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.7 m -66.59 114.36 5.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.092 0.472 . . . . 0.0 110.746 -179.291 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 36.2 t -119.04 148.85 42.56 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.405 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.9 p -145.3 138.47 21.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.693 0.282 . . . . 0.0 110.601 179.395 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.2 tt -135.32 153.52 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.627 -178.197 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.74 92.56 6.06 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.392 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.721 HD21 HD22 ' A' ' 153' ' ' LEU . 6.8 tp -78.6 -9.59 59.42 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.686 -177.46 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.745 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 28.4 p-10 -70.64 -12.99 61.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.497 0.665 . . . . 0.0 109.73 179.373 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.772 ' HG2' ' HA3' ' A' ' 116' ' ' GLY . 40.3 mtt180 -100.09 7.49 44.61 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.192 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.408 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 52.3 m-85 -129.44 -27.17 2.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.16 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.638 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 35.3 mt -107.25 140.16 40.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.069 0.461 . . . . 0.0 110.899 179.556 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 50' ' ' PHE . 5.4 m -127.17 149.09 50.13 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.915 -179.869 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.562 ' C ' HD21 ' A' ' 45' ' ' ASN . 0.1 OUTLIER -91.67 94.41 9.37 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.255 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -103.41 92.15 4.36 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.12 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.424 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 64.3 t30 46.95 44.61 14.88 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 114.749 -1.114 . . . . 0.0 112.324 178.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.24 42.74 7.82 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.957 178.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.434 ' HD2' ' O ' ' A' ' 50' ' ' PHE . 7.8 t60 -167.43 123.62 1.12 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.75 ' HZ ' ' HB2' ' A' ' 138' ' ' ALA . 62.0 m-85 -62.6 154.6 28.5 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.787 0.327 . . . . 0.0 110.602 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -148.11 133.79 18.86 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.974 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.474 ' CZ2' ' HA ' ' A' ' 153' ' ' LEU . 93.9 m95 -75.48 110.42 9.85 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.659 HG23 ' H ' ' A' ' 54' ' ' SER . 4.6 m 40.91 -99.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 O-C-N 124.402 1.064 . . . . 0.0 112.368 -178.543 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.659 ' H ' HG23 ' A' ' 53' ' ' VAL . 24.5 t -140.75 21.72 2.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.172 0.51 . . . . 0.0 109.962 179.511 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.9 -27.45 11.11 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.018 -179.368 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -146.72 -155.96 6.74 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.222 -0.513 . . . . 0.0 111.834 179.705 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.42 169.78 36.35 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.205 -179.661 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -118.3 128.11 7.59 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.131 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -104.81 -122.73 5.12 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.06 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -176.65 142.35 5.86 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 108' ' ' PRO . . . -159.29 -105.67 0.21 Allowed Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.534 -179.765 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 16.5 m -115.06 126.2 54.43 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.052 0.453 . . . . 0.0 110.819 179.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -125.2 174.14 8.29 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.456 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 1.2 p -129.83 114.25 15.68 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.782 0.325 . . . . 0.0 111.567 -179.07 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.482 HG22 ' CE2' ' A' ' 80' ' ' PHE . 11.5 p -99.81 135.07 36.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.936 0.398 . . . . 0.0 110.988 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 14.5 m -88.7 121.84 31.5 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.623 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.596 HG22 HD12 ' A' ' 99' ' ' ILE . 46.2 t -72.6 130.54 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.373 -179.428 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -100.85 169.15 9.18 Favored 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 124.149 0.906 . . . . 0.0 110.661 179.362 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.724 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 29.9 tt0 -60.21 108.69 0.83 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.524 -179.038 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.83 -10.97 20.93 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.296 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.514 ' HB3' HD13 ' A' ' 76' ' ' ILE . 68.3 m-20 -85.66 148.5 25.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.176 0.512 . . . . 0.0 111.79 -179.146 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.528 ' O ' HG12 ' A' ' 76' ' ' ILE . 23.4 p -133.93 158.48 43.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.434 178.795 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.678 HD21 ' HA ' ' A' ' 95' ' ' ASN . 1.8 tp -48.56 -45.27 37.49 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.039 0.447 . . . . 0.0 111.289 -179.651 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.527 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 43.7 ttp180 -60.13 -40.82 91.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.308 -179.628 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -74.31 -40.63 62.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.367 -178.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.528 HG12 ' O ' ' A' ' 72' ' ' THR . 47.6 mm -60.21 -46.47 94.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.159 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.711 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -55.44 -58.83 12.03 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.421 178.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -59.9 -33.18 71.51 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.675 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -66.55 -48.85 68.36 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.559 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.482 ' CE2' HG22 ' A' ' 65' ' ' VAL . 96.2 m-85 -97.52 13.23 30.67 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.196 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.7 t70 60.33 36.69 20.52 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.132 0.968 . . . . 0.0 110.711 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.711 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.1 p -114.54 171.79 7.42 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.548 179.229 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.695 ' O ' HG13 ' A' ' 87' ' ' ILE . 5.9 t0 -99.66 125.33 45.48 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 121.78 -0.575 . . . . 0.0 109.888 -179.702 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.527 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 31.9 p90 -54.3 -29.52 47.84 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.663 0.744 . . . . 0.0 109.938 178.64 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.531 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 22.3 t-80 -69.77 -41.37 75.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.544 178.6 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.694 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 36.8 tt0 -69.16 -48.9 61.03 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.638 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.695 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.2 mt -51.87 -43.31 34.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.678 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.551 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.61 -51.58 66.74 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.452 178.556 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 85' ' ' HIS . 41.2 mtm180 -61.62 -33.4 73.85 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.883 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.694 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 47.0 mmm-85 -73.36 -35.09 65.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.922 0.392 . . . . 0.0 110.896 -179.497 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.52 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 3.0 t-20 -88.11 -5.15 58.61 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.812 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.52 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 91.0 m-20 79.43 10.68 1.44 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.53 0.732 . . . . 0.0 111.085 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.551 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 21.9 pt -100.84 -174.01 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.783 179.25 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.6 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 66.2 mm-40 -110.54 162.34 14.8 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.087 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.678 ' HA ' HD21 ' A' ' 73' ' ' LEU . 1.4 p30 -55.5 -69.9 0.12 Allowed 'General case' 0 C--O 1.244 0.804 0 CA-C-O 122.336 1.065 . . . . 0.0 109.977 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -72.86 12.8 0.46 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.656 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.6 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.8 t70 -57.36 -33.21 67.55 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.389 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 55.4 mt 71.8 115.14 0.05 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-N 114.286 -1.324 . . . . 0.0 109.89 -178.621 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.596 HD12 HG22 ' A' ' 67' ' ' VAL . 17.1 pt -94.07 174.35 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.043 -178.64 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.435 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 17.3 m-85 -129.08 158.58 72.39 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.696 -178.603 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.724 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 25.5 Cg_endo -67.11 131.41 25.17 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.839 2.359 . . . . 0.0 112.438 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.33 15.12 36.26 Favored Glycine 0 N--CA 1.438 -1.177 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 -179.59 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 66' ' ' THR . 47.1 tt0 -103.08 155.63 18.26 Favored 'General case' 0 C--O 1.214 -0.799 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.306 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.456 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 59.4 t -117.89 120.83 65.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 O-C-N 121.993 -0.442 . . . . 0.0 109.815 179.368 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.421 HD11 ' CD1' ' A' ' 73' ' ' LEU . 77.9 mt -112.07 150.84 30.12 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.397 -178.827 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.406 ' HB2' ' CB ' ' A' ' 90' ' ' ARG . 74.1 mt-30 -90.9 112.84 24.86 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.729 0.776 . . . . 0.0 110.781 179.065 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.407 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 34.0 m -126.45 151.08 72.18 Favored Pre-proline 0 C--N 1.313 -0.998 0 CA-C-N 114.214 -1.357 . . . . 0.0 109.019 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.407 ' HD2' ' HB ' ' A' ' 107' ' ' VAL . 32.2 Cg_endo -63.2 -18.56 65.51 Favored 'Trans proline' 0 N--CA 1.473 0.321 0 C-N-CA 123.561 2.841 . . . . 0.0 115.259 -176.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.9 t -154.22 155.54 35.43 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.374 -0.531 . . . . 0.0 111.48 -179.547 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -98.9 -174.59 2.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.152 179.344 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -90.16 -52.31 2.58 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.356 179.425 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 178.88 169.69 39.85 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 179.661 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.9 p -100.18 -56.65 2.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.945 0.403 . . . . 0.0 110.689 179.525 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -162.26 -83.83 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.803 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -99.31 -50.97 1.38 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.18 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.772 ' HA3' ' HG2' ' A' ' 41' ' ' ARG . . . -149.77 -85.88 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.389 179.861 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -130.02 -50.73 1.12 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.833 0.349 . . . . 0.0 111.105 -179.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . -79.88 -60.37 2.45 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.239 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 72.65 29.23 2.03 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.989 0.515 . . . . 0.0 111.327 178.337 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.638 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 22.7 p90 -59.48 -36.52 76.18 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 121.304 0.573 . . . . 0.0 109.963 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.411 ' HB2' ' HB2' ' A' ' 19' ' ' ALA . 24.0 t-105 -65.15 -24.6 67.45 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.113 -178.363 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.94 -14.06 60.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.856 0.36 . . . . 0.0 110.925 -179.746 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.7 p -144.65 22.32 1.63 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.926 179.011 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -104.48 151.53 23.45 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.782 0.325 . . . . 0.0 110.915 179.08 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 63.0 ttp180 -141.5 144.53 34.4 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.106 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 57.73 52.53 8.06 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.197 0.522 . . . . 0.0 111.123 179.578 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.484 ' CG1' HD11 ' A' ' 136' ' ' LEU . 21.3 t -81.65 119.12 30.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.526 -179.565 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -143.4 142.43 31.24 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.344 -179.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.723 HD21 HD12 ' A' ' 153' ' ' LEU . 27.3 mt -86.18 129.55 34.81 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.952 178.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.559 HG21 ' HB ' ' A' ' 135' ' ' VAL . 34.6 m -121.72 154.78 26.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.175 0.512 . . . . 0.0 111.046 -178.845 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.541 ' HB3' ' HD3' ' A' ' 134' ' ' LYS . 9.6 m-20 71.41 3.65 4.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.953 179.054 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.655 ' O ' HD11 ' A' ' 14' ' ' ILE . . . 98.41 31.95 6.25 Favored Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.554 178.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.638 ' HA3' HG22 ' A' ' 14' ' ' ILE . . . 92.95 -19.73 50.14 Favored Glycine 0 C--O 1.263 1.91 0 CA-C-O 122.966 1.315 . . . . 0.0 113.272 177.545 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.701 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 18.6 ptmt -66.31 -18.97 65.67 Favored 'General case' 0 C--N 1.318 -0.795 0 O-C-N 121.634 -0.921 . . . . 0.0 108.991 178.104 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.559 ' HB ' HG21 ' A' ' 130' ' ' VAL . 11.7 t -140.24 141.58 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.688 177.667 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.635 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 22.7 tp -121.2 121.97 38.95 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.368 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.518 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 35.0 tt0 -111.02 132.97 53.77 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 120.858 0.361 . . . . 0.0 111.297 -177.336 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.75 ' HB2' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.55 155.24 19.44 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.678 179.153 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -94.05 106.84 18.8 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.515 HD13 ' HA ' ' A' ' 45' ' ' ASN . 59.8 mt -90.7 131.77 36.19 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.308 -178.864 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 49.8 ttt85 -73.33 141.81 47.09 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.422 179.513 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.424 ' HB2' ' OD1' ' A' ' 47' ' ' ASN . 10.7 p90 -151.14 -165.08 2.16 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.72 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.4 m -70.52 2.44 3.99 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -135.88 31.73 2.6 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.675 -179.663 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 97.57 -134.62 11.81 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.766 179.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -117.03 124.95 50.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.569 0.223 . . . . 0.0 110.791 -179.655 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -115.0 131.55 56.89 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.106 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 31.2 ttm-85 -76.06 94.67 3.48 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.236 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.406 ' HB3' ' HA ' ' A' ' 49' ' ' HIS . 1.1 m -102.9 164.31 11.7 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.49 -178.725 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.635 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 39.1 mtt85 -145.5 149.42 34.62 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.008 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.702 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 9.3 tt -131.28 148.7 32.81 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.282 179.383 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.707 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 70.9 m-85 -92.54 102.53 14.98 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 122.277 -0.265 . . . . 0.0 111.293 -178.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.723 HD12 HD21 ' A' ' 129' ' ' LEU . 19.9 mt -67.49 -35.91 80.06 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.214 179.437 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.701 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 8.2 t70 -56.48 -10.1 0.87 Allowed 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.159 178.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.707 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 46.8 mt-10 -73.44 -48.67 31.84 Favored 'General case' 0 CA--C 1.509 -0.603 0 O-C-N 121.847 -0.533 . . . . 0.0 112.151 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -124.86 3.64 8.1 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.563 -177.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 45.6 mm -109.79 111.68 37.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.293 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.565 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -116.55 166.44 12.38 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.384 179.318 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.601 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -98.41 124.91 43.35 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.316 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -112.69 86.63 2.4 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.029 -179.678 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 56.9 t30 51.87 43.52 30.1 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.257 179.267 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.526 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 101.68 -3.79 53.34 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 119.985 -1.103 . . . . 0.0 114.063 178.659 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -122.38 128.67 51.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 117.062 0.431 . . . . 0.0 111.192 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.905 HD13 ' HD2' ' A' ' 7' ' ' PHE . 3.3 tp -70.6 129.23 38.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.158 -179.817 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.543 HG13 ' H ' ' A' ' 166' ' ' HIS . 11.0 tp -152.93 170.39 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.983 0.42 . . . . 0.0 111.297 -178.757 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.543 ' H ' HG13 ' A' ' 165' ' ' ILE . 19.7 t-80 -69.45 110.45 4.74 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.364 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.558 ' O ' ' HA3' ' A' ' 158' ' ' GLY . 51.9 t . . . . . 0 C--O 1.246 0.884 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.531 -178.465 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.747 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.533 ' HA ' ' OD2' ' A' ' 154' ' ' ASP . 1.8 m120 -71.52 155.84 40.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.94 0.4 . . . . 0.0 110.348 -178.614 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.746 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 53.6 m-85 -105.19 -90.93 0.4 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.28 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.28 -34.83 10.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.321 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -69.55 -65.01 2.72 Favored Glycine 0 N--CA 1.435 -1.427 0 C-N-CA 119.594 -1.289 . . . . 0.0 112.907 -178.626 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.511 ' HA ' ' CB ' ' A' ' 2' ' ' ASN . 37.9 m-80 67.84 15.68 9.62 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 122.289 0.236 . . . . 0.0 110.906 -179.663 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.642 ' CE2' HD13 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -64.87 -33.4 75.93 Favored 'General case' 0 C--O 1.215 -0.717 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.189 -179.345 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.2 t -67.72 -7.73 29.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.104 0.478 . . . . 0.0 110.582 -179.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.1 -7.33 58.53 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.584 178.574 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.536 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 49.0 m -135.11 -28.18 1.19 Allowed 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 117.026 0.413 . . . . 0.0 111.387 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.5 m -84.51 145.7 27.97 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.375 0.607 . . . . 0.0 109.625 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -116.82 160.49 20.75 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.841 -179.06 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 45.73 55.24 7.01 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 123.245 0.618 . . . . 0.0 112.544 178.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.696 HG12 ' HB2' ' A' ' 23' ' ' ALA . 8.5 mt -80.22 103.62 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 120.8 0.333 . . . . 0.0 110.35 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.531 ' HA ' HD11 ' A' ' 129' ' ' LEU . 69.3 m -145.47 128.29 16.33 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.508 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.694 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -92.34 158.31 16.16 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.227 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -100.0 76.13 1.91 Allowed 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.248 -1.342 . . . . 0.0 107.626 177.338 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.98 -61.99 4.65 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 114.788 -1.097 . . . . 0.0 111.555 179.097 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.678 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -144.82 -2.64 0.82 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.367 -0.416 . . . . 0.0 110.221 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.472 ' HB3' ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -97.59 96.06 8.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.397 178.99 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.813 ' HB2' HD22 ' A' ' 39' ' ' LEU . 4.8 tp -60.33 117.12 4.83 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 123.39 0.676 . . . . 0.0 111.441 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.576 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 25.8 ttt180 -120.23 126.73 51.34 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.965 0.412 . . . . 0.0 110.845 -178.311 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.696 ' HB2' HG12 ' A' ' 14' ' ' ILE . . . -147.51 142.49 26.97 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.727 0.775 . . . . 0.0 111.32 -179.698 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 7.7 mm-40 -77.24 76.12 3.79 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.716 178.029 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.673 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 65.2 m -62.17 128.02 34.11 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.214 -178.852 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' A' ' 10' ' ' SER . 17.1 ttp180 -73.54 116.45 14.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.421 179.634 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -86.22 156.31 20.35 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.324 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.44 -14.96 3.73 Favored Glycine 0 C--N 1.338 0.68 0 O-C-N 124.631 1.207 . . . . 0.0 114.433 -177.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -73.15 -13.6 61.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.504 0.668 . . . . 0.0 109.617 178.16 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.92 6.65 59.12 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.569 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.42 164.78 12.4 Favored Glycine 0 C--O 1.225 -0.416 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.545 -179.156 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.52 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 84.3 m-85 -100.94 138.17 38.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.918 0.359 . . . . 0.0 110.83 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.1 m -126.89 126.91 44.08 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.102 179.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.9 m -65.26 116.12 6.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.065 0.46 . . . . 0.0 111.056 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 45.8 t -122.64 152.45 40.47 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.536 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.622 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 5.3 p -144.54 138.81 23.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.557 0.218 . . . . 0.0 111.04 -179.771 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.434 HG23 HD13 ' A' ' 39' ' ' LEU . 15.2 tt -133.12 148.58 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 120.929 0.395 . . . . 0.0 111.099 -178.725 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.71 95.43 5.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.969 -179.482 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.813 HD22 ' HB2' ' A' ' 21' ' ' LEU . 1.8 mp -75.48 -18.11 59.93 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 120.945 0.403 . . . . 0.0 111.023 178.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.678 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 27.8 p-10 -67.6 -7.4 26.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.423 179.785 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.526 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 33.1 mtt180 -114.22 14.66 18.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.146 179.445 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.635 ' HD1' ' HE3' ' A' ' 52' ' ' TRP . 0.2 OUTLIER -141.78 -23.31 0.71 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.097 -179.27 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.512 HD23 HD12 ' A' ' 151' ' ' ILE . 57.5 mt -110.07 131.55 54.96 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.474 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.529 ' HB3' ' HA2' ' A' ' 118' ' ' GLY . 0.5 OUTLIER -127.51 141.35 51.68 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.147 -179.12 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.573 ' OD1' HD23 ' A' ' 140' ' ' LEU . 12.3 m-20 -81.25 90.81 6.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.756 177.512 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -85.01 86.89 7.34 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.952 0.406 . . . . 0.0 110.389 177.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.538 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 16.6 t-20 50.85 45.8 26.92 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.272 179.25 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.628 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 83.02 40.13 9.57 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.183 179.012 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -155.13 121.32 5.22 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.723 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.722 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 25.8 m-85 -65.59 135.37 54.99 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.147 179.492 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 40.1 mmm-85 -136.64 141.32 43.19 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.856 0.36 . . . . 0.0 111.4 -179.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.717 ' HH2' HD13 ' A' ' 153' ' ' LEU . 92.6 m95 -75.82 143.12 42.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.919 178.544 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.6 t 64.08 -87.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 123.978 0.911 . . . . 0.0 110.824 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 62.2 m -158.03 22.64 0.26 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.737 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.63 -56.07 4.69 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.642 -178.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.44 149.72 19.23 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.215 -0.517 . . . . 0.0 111.858 179.555 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.411 ' H ' ' HB3' ' A' ' 81' ' ' ASP . . . -87.8 -31.76 14.57 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.16 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.98 -102.15 2.46 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.317 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.33 -145.29 4.88 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 143.78 -33.8 1.73 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.927 179.639 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -175.6 -132.18 1.56 Allowed Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.692 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.1 m -130.08 113.81 14.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.947 0.403 . . . . 0.0 110.361 -179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.62 176.46 5.37 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.039 -179.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.444 ' HB ' ' CG2' ' A' ' 104' ' ' VAL . 4.5 p -129.18 116.43 19.18 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.74 0.305 . . . . 0.0 111.707 -178.831 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.446 HG21 ' CE1' ' A' ' 80' ' ' PHE . 14.5 p -104.57 139.53 25.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.922 0.392 . . . . 0.0 111.018 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 6.2 m -88.68 127.23 35.58 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.8 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.55 ' CG2' HD12 ' A' ' 99' ' ' ILE . 43.1 t -75.28 133.58 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.358 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -99.18 170.4 8.7 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 124.727 1.267 . . . . 0.0 110.32 -179.489 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.755 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 29.2 tp60 -61.05 110.4 1.35 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.227 -178.834 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.12 -12.27 58.79 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.493 178.384 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -81.77 129.49 34.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.93 0.395 . . . . 0.0 111.288 -179.435 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.571 ' HA ' HG12 ' A' ' 99' ' ' ILE . 67.4 p -109.2 178.11 4.55 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.774 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.544 HD21 ' O ' ' A' ' 95' ' ' ASN . 1.6 mm? -53.25 -41.89 65.92 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.444 0.64 . . . . 0.0 109.599 178.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -61.67 -41.49 97.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.105 -179.599 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 79' ' ' ARG . 24.3 m-20 -67.31 -43.59 81.27 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.773 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 72' ' ' THR . 37.2 mm -61.67 -48.2 89.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.147 179.586 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.604 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.74 -47.58 87.66 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.893 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.479 ' NE ' ' HA ' ' A' ' 78' ' ' ARG . 5.4 tpm_? -71.48 -29.91 65.37 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 122.47 -0.429 . . . . 0.0 111.601 -179.27 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 40.8 ttt180 -75.04 -39.39 61.03 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.106 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.446 ' CE1' HG21 ' A' ' 65' ' ' VAL . 97.1 m-85 -110.45 15.17 22.33 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.515 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.411 ' HB3' ' H ' ' A' ' 57' ' ' GLY . 37.4 t70 56.33 53.79 8.38 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 122.025 0.917 . . . . 0.0 111.969 179.028 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.604 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -134.24 170.97 14.91 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.61 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.624 ' O ' HG13 ' A' ' 87' ' ' ILE . 5.5 t70 -97.38 123.0 41.07 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.428 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -49.6 -31.12 9.97 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 124.579 1.174 . . . . 0.0 111.327 179.263 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -63.42 -48.85 76.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.856 179.281 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.705 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 19.2 mm-40 -67.65 -43.5 80.17 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.363 -178.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.624 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.1 mt -53.61 -46.91 61.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.703 0.763 . . . . 0.0 108.948 179.005 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.6 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.21 -51.49 66.08 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.344 178.598 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -61.55 -33.43 73.83 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -177.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.705 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 15.9 mmp_? -68.26 -32.06 71.96 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.289 0.566 . . . . 0.0 110.041 179.275 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.793 HD21 HD11 ' A' ' 93' ' ' ILE . 65.1 t30 -91.28 -4.88 55.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.479 179.474 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 51.5 m-80 77.57 15.96 1.59 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.534 0.733 . . . . 0.0 110.7 -179.432 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.793 HD11 HD21 ' A' ' 91' ' ' ASN . 15.6 pt -105.16 -173.32 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.781 178.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -115.49 154.46 29.28 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.235 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.544 ' O ' HD21 ' A' ' 73' ' ' LEU . 2.5 p-10 -51.59 -63.3 1.18 Allowed 'General case' 0 C--O 1.244 0.77 0 CA-C-O 121.964 0.888 . . . . 0.0 110.176 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.18 13.5 0.9 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.143 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 8.4 t70 -66.16 -32.35 73.73 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.689 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 8.3 mp 70.46 113.97 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.956 -177.549 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.571 HG12 ' HA ' ' A' ' 72' ' ' THR . 7.4 pt -94.17 175.92 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.671 -178.337 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.504 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 96.6 m-85 -120.5 159.25 48.86 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.088 -178.731 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.755 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 50.9 Cg_endo -72.57 135.73 24.62 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.177 2.585 . . . . 0.0 112.425 -179.827 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.99 17.87 36.22 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.659 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.437 ' O ' ' HA ' ' A' ' 66' ' ' THR . 96.5 mt-30 -110.17 159.49 17.31 Favored 'General case' 0 C--O 1.209 -1.038 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.848 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.444 ' CG2' ' HB ' ' A' ' 64' ' ' THR . 8.4 p -116.46 131.24 69.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.553 0.692 . . . . 0.0 110.695 178.621 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.406 ' HB3' HG22 ' A' ' 87' ' ' ILE . 90.8 mt -121.38 151.02 40.63 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.573 -179.569 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.531 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 41.4 mt-30 -90.74 112.23 23.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.79 0.805 . . . . 0.0 110.917 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.8 m -120.74 151.28 54.23 Favored Pre-proline 0 C--N 1.315 -0.911 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.674 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -65.02 -17.95 60.73 Favored 'Trans proline' 0 C--N 1.332 -0.315 0 C-N-CA 123.147 2.565 . . . . 0.0 114.645 -177.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.1 t -153.83 152.52 30.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.869 0.366 . . . . 0.0 111.066 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.406 ' HD2' ' HA ' ' A' ' 110' ' ' LYS . 13.8 mmmm -96.75 -165.14 1.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.276 179.387 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.93 -47.14 20.32 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.214 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 127.09 -152.22 18.59 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 -179.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.5 t -112.78 -38.87 4.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.948 0.374 . . . . 0.0 110.152 179.597 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.526 ' O ' ' HB3' ' A' ' 41' ' ' ARG . . . 111.48 -47.49 1.04 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.824 179.408 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -58.0 104.75 0.5 Allowed Glycine 0 CA--C 1.516 0.123 0 C-N-CA 121.271 -0.49 . . . . 0.0 112.931 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.66 49.92 6.88 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -179.652 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -103.5 -52.71 2.94 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.311 -0.444 . . . . 0.0 110.596 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 44' ' ' SER . . . -82.85 -74.64 1.19 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.751 -179.095 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 70.7 26.92 3.77 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.854 0.462 . . . . 0.0 111.35 179.168 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.556 ' HB2' ' OD1' ' A' ' 45' ' ' ASN . 20.2 p90 -57.12 -35.86 69.98 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 121.078 0.466 . . . . 0.0 110.325 179.219 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -59.13 -35.98 74.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.069 -178.194 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -66.56 -13.47 61.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.082 0.467 . . . . 0.0 111.386 -179.005 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.46 ' OG ' ' HB3' ' A' ' 141' ' ' ARG . 29.9 t -129.7 8.14 5.31 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.386 -179.71 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -104.35 149.35 25.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.073 0.464 . . . . 0.0 111.573 -179.489 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.523 ' HB2' ' CZ3' ' A' ' 146' ' ' TRP . 1.3 tmm_? -135.76 132.79 37.23 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.178 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 125' ' ' ARG . 34.6 t70 54.95 67.64 0.99 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.775 0.798 . . . . 0.0 110.693 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.498 ' CG1' HD13 ' A' ' 136' ' ' LEU . 42.0 t -84.68 126.66 40.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.86 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -144.04 141.12 29.92 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.229 -179.052 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.586 HD13 HG21 ' A' ' 14' ' ' ILE . 30.9 mt -86.55 125.31 33.69 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.637 HG23 ' HB ' ' A' ' 135' ' ' VAL . 35.6 m -118.6 161.2 17.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.691 -179.228 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.797 ' HB3' ' HE2' ' A' ' 134' ' ' LYS . 6.1 m-20 66.17 12.51 8.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.597 178.682 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.666 ' O ' HD11 ' A' ' 14' ' ' ILE . . . 90.75 28.43 16.14 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.395 178.413 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.635 ' HA3' HG22 ' A' ' 14' ' ' ILE . . . 93.13 -16.78 59.72 Favored Glycine 0 C--O 1.261 1.812 0 CA-C-O 123.378 1.543 . . . . 0.0 112.92 177.246 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.797 ' HE2' ' HB3' ' A' ' 131' ' ' ASP . 17.5 pttm -71.31 -12.57 61.51 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 121.348 -1.09 . . . . 0.0 109.283 177.964 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.637 ' HB ' HG23 ' A' ' 130' ' ' VAL . 18.3 t -142.31 139.34 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.27 177.433 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.507 HD22 HD11 ' A' ' 43' ' ' LEU . 48.9 tp -118.66 122.54 42.78 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.356 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.428 ' OE2' ' HD3' ' A' ' 148' ' ' ARG . 17.1 tt0 -118.51 130.59 56.01 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.986 0.422 . . . . 0.0 110.903 -176.539 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.441 ' HB1' ' HA ' ' A' ' 127' ' ' VAL . . . -156.49 166.24 33.97 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.186 -179.645 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 44.4 mt-10 -94.44 111.33 23.08 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.718 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.628 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 19.8 mt -98.17 132.14 43.94 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.325 -178.333 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.46 ' HB3' ' OG ' ' A' ' 123' ' ' SER . 72.2 ttt180 -73.98 141.23 45.88 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.601 179.667 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.538 ' HB2' ' OD1' ' A' ' 47' ' ' ASN . 1.4 p90 -157.65 -172.94 4.15 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.804 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.2 m -55.21 -31.95 61.85 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.211 0.319 . . . . 0.0 111.728 -179.539 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -93.41 15.29 63.32 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.253 -178.604 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 103.22 -110.99 3.83 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.293 179.664 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.523 ' CZ3' ' HB2' ' A' ' 125' ' ' ARG . 80.0 m95 -131.56 128.32 39.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.785 0.293 . . . . 0.0 110.706 -179.956 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -128.38 135.11 49.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.173 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.428 ' HD3' ' OE2' ' A' ' 137' ' ' GLU . 36.4 ttm180 -74.13 106.42 5.79 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.879 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 8.2 m -116.18 165.81 12.74 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.702 -178.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 15.2 ptt180 -147.0 164.78 31.91 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -178.55 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.722 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 8.3 tt -141.27 161.52 22.15 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.335 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.576 ' O ' ' HZ2' ' A' ' 52' ' ' TRP . 20.3 m-85 -104.58 104.36 14.18 Favored 'General case' 0 C--N 1.316 -0.868 0 O-C-N 122.307 -0.246 . . . . 0.0 110.699 -179.768 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.797 HD11 HG13 ' A' ' 157' ' ' ILE . 4.4 mm? -66.19 -36.19 82.43 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.218 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.533 ' OD2' ' HA ' ' A' ' 2' ' ' ASN . 16.6 p-10 -57.42 -9.85 1.21 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 179.035 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.746 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 32.9 mt-10 -71.93 -50.74 26.48 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 179.801 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -121.52 0.03 9.85 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.333 -0.547 . . . . 0.0 112.371 -177.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.797 HG13 HD11 ' A' ' 153' ' ' LEU . 45.1 mm -106.97 117.17 52.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.517 179.1 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.589 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -123.29 173.8 16.4 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.93 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.673 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.4 OUTLIER -106.13 126.45 52.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.987 0.423 . . . . 0.0 110.258 179.229 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.526 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 8.7 tpt180 -117.44 86.93 2.61 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.801 179.612 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 65.9 t30 55.26 40.65 31.65 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.463 178.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 105.61 -7.45 42.5 Favored Glycine 0 C--O 1.228 -0.25 0 C-N-CA 120.138 -1.029 . . . . 0.0 114.978 177.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 160' ' ' ARG . 13.2 pt-20 -122.04 141.44 51.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 117.936 0.868 . . . . 0.0 111.2 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.577 HD11 HD21 ' A' ' 21' ' ' LEU . 30.8 mt -74.98 122.22 23.16 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.867 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 6.5 tp -122.48 141.06 44.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.902 -179.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 37.8 p-80 -97.02 128.5 44.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.837 179.289 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 20.6 p . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.741 -0.647 . . . . 0.0 110.213 -179.551 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.912 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 27.7 m-85 . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.782 0.325 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.15 -30.62 4.61 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.045 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -70.82 -66.77 2.08 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 119.796 -1.192 . . . . 0.0 113.383 -178.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 16.1 m120 68.37 11.99 8.56 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.515 0.326 . . . . 0.0 110.677 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.647 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.9 OUTLIER -58.47 -35.93 72.94 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 121.076 -0.25 . . . . 0.0 111.135 -179.221 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.6 p -62.81 -19.52 64.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.388 0.613 . . . . 0.0 110.788 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.78 -22.05 78.63 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.801 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.536 ' HB3' ' HB3' ' A' ' 26' ' ' ARG . 67.4 m -132.67 -16.88 2.58 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 117.584 0.692 . . . . 0.0 111.877 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.468 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 19.4 m -94.81 133.86 38.06 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.428 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 14.4 ptt180 -111.38 179.87 3.91 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 41.77 48.32 3.7 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 124.089 0.868 . . . . 0.0 111.984 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.883 HG22 HD13 ' A' ' 129' ' ' LEU . 7.4 mt -80.6 104.14 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 109.695 -0.484 . . . . 0.0 109.695 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.589 ' HA ' HD12 ' A' ' 129' ' ' LEU . 78.0 m -146.57 127.06 14.09 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.735 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -95.66 155.7 16.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.718 0.77 . . . . 0.0 113.068 -179.122 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.454 ' HB2' HH22 ' A' ' 22' ' ' ARG . 31.0 t70 -94.28 75.63 3.96 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.428 177.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.7 -53.82 4.74 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.747 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.605 ' CB ' ' HB3' ' A' ' 40' ' ' ASN . . . -149.62 -10.8 0.3 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 120.781 0.324 . . . . 0.0 110.455 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -92.55 96.27 10.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.138 0.494 . . . . 0.0 110.814 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.811 HD22 HD13 ' A' ' 153' ' ' LEU . 45.4 tp -59.65 129.01 39.8 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.329 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.614 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 26.7 ttm180 -133.34 120.02 20.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.195 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.615 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -142.15 149.43 39.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.648 0.737 . . . . 0.0 112.053 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.497 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 63.3 mm-40 -83.65 75.46 10.05 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.365 -1.288 . . . . 0.0 108.873 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.856 ' SG ' HD13 ' A' ' 164' ' ' LEU . 56.0 m -62.96 124.24 20.59 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.86 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.536 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 16.2 ttm180 -76.51 118.01 18.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.736 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.618 ' HG2' ' HA3' ' A' ' 162' ' ' GLY . 10.7 mtm180 -84.1 163.96 19.5 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.76 -16.22 11.33 Favored Glycine 0 C--N 1.338 0.648 0 O-C-N 124.374 1.046 . . . . 0.0 113.387 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -72.39 -10.34 59.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.346 0.593 . . . . 0.0 109.819 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.48 13.98 64.48 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -114.2 162.29 12.45 Favored Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.208 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.497 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 61.5 m-85 -100.99 138.78 37.58 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.959 0.409 . . . . 0.0 111.138 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.8 m -132.5 132.21 42.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.589 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 m -69.39 110.44 4.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.185 0.517 . . . . 0.0 111.635 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.436 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 40.4 t -114.51 142.31 46.57 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.784 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.614 ' HB ' ' HG3' ' A' ' 22' ' ' ARG . 1.9 p -139.52 135.44 40.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.098 0.475 . . . . 0.0 111.35 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.484 HG23 ' HB3' ' A' ' 21' ' ' LEU . 12.3 tt -134.42 150.5 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.087 -177.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.498 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 2.7 m-20 -84.87 97.98 10.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.564 HD23 ' HB3' ' A' ' 21' ' ' LEU . 3.9 mm? -79.58 -8.93 59.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.242 0.544 . . . . 0.0 110.545 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.605 ' HB3' ' CB ' ' A' ' 19' ' ' ALA . 12.9 p30 -65.22 -15.75 62.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.766 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.6 mtt85 -113.97 20.07 16.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.557 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -136.82 -31.7 0.84 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.346 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.857 HD22 HD13 ' A' ' 151' ' ' ILE . 48.3 mt -103.8 133.58 48.55 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.118 0.485 . . . . 0.0 110.044 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.715 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 6.1 m -122.31 146.78 46.98 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.306 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.444 ' HB3' HD22 ' A' ' 140' ' ' LEU . 8.1 p-10 -94.78 91.81 6.66 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.758 ' HB3' ' HD2' ' A' ' 51' ' ' ARG . 15.1 t70 -93.51 97.6 10.63 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.741 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.6 t30 53.2 46.96 25.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.396 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.562 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 75.44 29.37 60.04 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.957 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.571 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 70.5 m-70 -142.68 122.59 13.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.954 ' HB3' ' HB ' ' A' ' 151' ' ' ILE . 14.7 m-85 -62.5 126.12 26.27 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.758 ' HD2' ' HB3' ' A' ' 46' ' ' ASP . 54.3 mtt85 -143.98 137.71 27.92 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.344 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.523 ' CD1' HD11 ' A' ' 151' ' ' ILE . 86.6 m95 . . . . . 0 C--N 1.325 -0.474 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.6 m . . . . . 0 N--CA 1.45 -0.435 0 CA-C-O 121.151 0.501 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 106' ' ' GLN . . . -124.59 177.15 6.09 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.112 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.4 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 1.9 p -129.46 120.18 25.01 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.485 HG21 ' CE1' ' A' ' 80' ' ' PHE . 7.9 p -107.05 147.39 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.565 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 13.4 m -95.37 124.87 39.62 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.586 HG21 HD12 ' A' ' 99' ' ' ILE . 47.9 t -73.99 133.13 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.362 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -99.16 170.2 8.85 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 124.384 1.052 . . . . 0.0 111.17 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.853 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 41.5 tt0 -61.48 119.63 8.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.645 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.55 18.78 51.23 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.67 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -110.36 148.02 32.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.15 0.475 . . . . 0.0 111.014 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.647 ' HA ' HG12 ' A' ' 99' ' ' ILE . 74.3 p -126.57 173.17 9.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.367 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.61 HD22 HG23 ' A' ' 99' ' ' ILE . 1.5 mm? -52.75 -43.03 65.49 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.539 0.685 . . . . 0.0 109.701 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.458 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 65.1 mtp180 -61.8 -38.26 87.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.744 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -72.9 -41.01 65.07 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 72' ' ' THR . 42.8 mm -62.71 -47.98 90.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.735 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -55.49 -50.38 60.42 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.213 178.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.13 -36.74 84.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.754 0.312 . . . . 0.0 111.432 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -70.32 -42.82 71.45 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.485 ' CE1' HG21 ' A' ' 65' ' ' VAL . 97.5 m-85 -105.08 18.72 21.87 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.5 t70 52.94 39.08 28.65 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.681 0.753 . . . . 0.0 111.528 178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.735 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 3.4 p -116.86 170.88 8.28 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.218 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.66 ' O ' HG13 ' A' ' 87' ' ' ILE . 6.1 t70 -96.06 124.4 40.05 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.031 -0.667 . . . . 0.0 110.199 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.458 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 5.7 p90 -52.29 -29.49 23.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.512 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -68.86 -43.22 75.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.425 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.668 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 14.0 tp10 -65.31 -45.56 83.85 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.66 HG13 ' O ' ' A' ' 83' ' ' ASP . 4.8 mt -54.97 -46.42 76.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.18 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.596 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.01 -50.01 72.37 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.889 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.414 ' NE ' ' HA ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -55.61 -39.67 71.09 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.668 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 10.9 mmt180 -69.91 -30.98 68.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.688 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.464 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 3.0 t-20 -95.39 -3.85 46.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.154 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 50.4 m-80 74.9 17.82 2.72 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.935 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.596 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 14.3 pt -105.55 -179.77 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.549 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 2.3 mp0 -104.69 161.52 14.07 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.505 ' O ' HD23 ' A' ' 73' ' ' LEU . 15.9 p-10 -60.33 -59.65 5.06 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 122.027 0.917 . . . . 0.0 109.284 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -75.78 12.28 1.12 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.602 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.549 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 3.8 t70 -63.62 -35.62 81.11 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 9.5 mp 72.17 117.16 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 O-C-N 124.193 0.933 . . . . 0.0 109.313 -176.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.647 HG12 ' HA ' ' A' ' 72' ' ' THR . 7.5 pt -95.72 178.97 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.918 -178.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.456 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 91.3 m-85 -124.35 157.6 64.16 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.751 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.853 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 53.6 Cg_endo -72.4 131.93 18.39 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 123.198 2.598 . . . . 0.0 113.044 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.42 18.96 24.54 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' A' ' 66' ' ' THR . 33.9 tt0 -105.79 158.71 16.54 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 83.0 t -119.21 118.75 58.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 109.722 -0.474 . . . . 0.0 109.722 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.596 HD11 HG21 ' A' ' 99' ' ' ILE . 94.9 mt -112.52 150.55 31.12 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.035 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.625 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 40.8 mt-30 -90.56 111.74 23.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.781 0.8 . . . . 0.0 110.964 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.0 m -119.55 151.23 51.41 Favored Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.608 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.45 -16.13 53.49 Favored 'Trans proline' 0 N--CA 1.475 0.389 0 C-N-CA 123.542 2.828 . . . . 0.0 114.975 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.6 t . . . . . 0 C--N 1.322 -0.611 0 CA-C-O 121.01 0.433 . . . . 0.0 111.39 179.842 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.715 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.446 -0.699 0 N-CA-C 113.18 0.032 . . . . 0.0 113.18 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 15.5 m120 75.25 24.39 1.44 Allowed 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.457 0.703 . . . . 0.0 112.099 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.602 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 23.8 p90 -59.62 -40.19 86.74 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.069 0.461 . . . . 0.0 110.019 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.51 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 66.0 t-105 -56.69 -34.58 67.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.386 -178.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -57.03 -25.81 59.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.86 0.362 . . . . 0.0 111.028 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.815 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 9.7 m -132.01 25.45 4.61 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.477 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.51 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -115.89 139.87 49.79 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 120.98 0.419 . . . . 0.0 110.816 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.462 ' HD3' ' HA ' ' A' ' 125' ' ' ARG . 17.8 mmt180 -128.98 146.72 50.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.486 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.7 t70 51.35 59.31 4.69 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 124.014 0.821 . . . . 0.0 110.745 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.534 HG12 HD11 ' A' ' 136' ' ' LEU . 35.1 t -82.78 124.65 39.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.598 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -145.66 144.01 30.16 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.07 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.883 HD13 HG22 ' A' ' 14' ' ' ILE . 21.3 mt -86.25 138.85 31.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.29 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.64 HG23 ' HB ' ' A' ' 135' ' ' VAL . 34.4 m -132.6 157.56 43.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.92 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.447 ' O ' ' HG2' ' A' ' 134' ' ' LYS . 0.7 OUTLIER 65.37 18.08 11.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.387 178.578 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.736 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 90.42 30.46 12.09 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.222 -0.99 . . . . 0.0 113.829 178.075 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.565 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 86.69 -9.87 69.73 Favored Glycine 0 C--O 1.261 1.832 0 CA-C-O 123.011 1.339 . . . . 0.0 113.213 176.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.728 ' HG3' HG23 ' A' ' 135' ' ' VAL . 8.4 ptpp? -74.18 -17.4 60.91 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.728 HG23 ' HG3' ' A' ' 134' ' ' LYS . 22.8 t -137.79 143.13 34.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.782 177.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.671 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 34.1 tp -126.24 119.15 26.7 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.5 ' OE2' ' HD3' ' A' ' 148' ' ' ARG . 16.2 tt0 -112.15 138.26 49.08 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.76 0.314 . . . . 0.0 111.357 -176.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . . . -162.86 167.04 23.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.988 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 124' ' ' ALA . 3.9 mm-40 -94.36 106.17 18.14 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.562 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 67.0 mt -96.96 130.5 44.26 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.268 0.556 . . . . 0.0 111.567 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.815 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 74.4 ttt180 -73.28 141.32 47.19 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.128 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.531 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 2.0 p90 -159.06 -169.94 2.84 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 121.081 -0.247 . . . . 0.0 111.352 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.7 m -56.01 -29.65 60.67 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -101.14 27.16 21.87 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.243 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 93.68 -111.1 4.07 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.363 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -128.88 133.32 47.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.717 0.258 . . . . 0.0 110.339 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.531 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 54.0 t30 -133.01 141.42 48.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.712 0.291 . . . . 0.0 110.497 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.5 ' HD3' ' OE2' ' A' ' 137' ' ' GLU . 24.9 ttm180 -79.6 114.73 18.75 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.921 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.571 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 36.2 t -125.78 168.26 14.05 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.698 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.671 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -146.73 163.05 37.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.082 0.468 . . . . 0.0 111.978 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.954 ' HB ' ' HB3' ' A' ' 50' ' ' PHE . 9.0 tt -145.47 152.9 14.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.302 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.675 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 15.1 m-85 -93.32 105.84 17.87 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.811 HD13 HD22 ' A' ' 21' ' ' LEU . 22.2 mt -67.25 -34.09 76.7 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.243 178.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.46 ' HA ' ' CD1' ' A' ' 7' ' ' PHE . 1.9 p-10 -57.41 -11.93 2.22 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.908 178.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.912 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 36.5 mt-10 -62.3 -55.27 29.84 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.106 0.479 . . . . 0.0 111.938 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -118.34 -12.13 9.94 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.959 -0.697 . . . . 0.0 111.828 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.438 ' CG2' ' HG ' ' A' ' 164' ' ' LEU . 49.6 mm -87.2 108.84 18.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.298 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -115.25 154.86 16.7 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.562 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.552 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.0 t30 -94.47 113.68 25.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.107 0.479 . . . . 0.0 109.891 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.459 HH11 ' HD2' ' A' ' 160' ' ' ARG . 15.2 tpt180 -110.97 86.72 2.37 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.92 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.0 t30 55.17 55.9 7.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.368 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.618 ' HA3' ' HG2' ' A' ' 27' ' ' ARG . . . 79.99 7.63 88.35 Favored Glycine 0 C--O 1.228 -0.231 0 CA-C-N 115.509 -0.769 . . . . 0.0 113.781 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -123.47 125.16 44.41 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.855 0.359 . . . . 0.0 111.397 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.856 HD13 ' SG ' ' A' ' 25' ' ' CYS . 0.2 OUTLIER -73.87 112.09 9.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.591 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 47.9 mm . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.166 -179.125 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.75 -26.66 12.18 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.22 -72.63 0.64 Allowed Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 119.66 -1.257 . . . . 0.0 112.61 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 64.53 14.43 8.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.615 0.245 . . . . 0.0 110.677 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.581 ' CE2' HD13 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -64.05 -32.5 74.07 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.994 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.5 t -70.7 -11.1 60.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.359 0.6 . . . . 0.0 109.728 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.58 -16.92 72.13 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.418 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.494 ' HB2' ' HB3' ' A' ' 26' ' ' ARG . 33.3 p -137.21 -11.27 1.68 Allowed 'General case' 0 C--O 1.221 -0.419 0 O-C-N 122.507 -0.408 . . . . 0.0 111.928 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 12.1 m -105.18 132.53 51.28 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.585 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 25.1 ptt180 -108.89 -176.77 3.13 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 44.28 42.3 5.08 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 123.913 0.758 . . . . 0.0 112.058 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.93 HG22 HD13 ' A' ' 129' ' ' LEU . 5.6 mt -80.2 100.97 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 121.108 0.48 . . . . 0.0 110.889 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.621 ' CA ' HD12 ' A' ' 129' ' ' LEU . 71.7 m -147.82 127.13 13.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.515 -0.766 . . . . 0.0 108.984 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.751 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -92.57 158.36 16.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.676 0.75 . . . . 0.0 112.782 -179.046 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -96.13 74.31 2.98 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.18 -55.41 5.03 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.226 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 40' ' ' ASN . . . -148.67 -12.42 0.34 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -85.89 92.37 8.63 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.78 HD22 HD23 ' A' ' 153' ' ' LEU . 43.2 tp -58.87 125.2 22.57 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.546 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 2.3 ttt180 -133.08 122.64 24.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.14 0.495 . . . . 0.0 110.703 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.621 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -138.83 176.24 8.86 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.243 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.585 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 6.2 mt-10 -115.61 80.07 1.38 Allowed 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.601 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 55.6 m -64.77 126.69 28.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.691 -178.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.494 ' HB3' ' HB2' ' A' ' 10' ' ' SER . 43.5 ttt-85 -74.73 114.68 13.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.676 178.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.6 ttm180 -82.57 154.9 24.76 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -48.75 -22.47 2.82 Favored Glycine 0 C--N 1.332 0.325 0 O-C-N 124.633 1.208 . . . . 0.0 115.115 -177.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -72.48 -14.41 61.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.509 0.671 . . . . 0.0 110.574 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.31 7.78 53.97 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -102.74 147.44 17.03 Favored Glycine 0 C--O 1.225 -0.445 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.511 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.438 ' HD1' ' O ' ' A' ' 24' ' ' GLU . 84.4 m-85 -96.57 124.63 40.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.02 0.41 . . . . 0.0 110.318 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.9 m -117.01 126.44 52.89 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.339 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.3 m -67.09 126.25 28.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.253 0.549 . . . . 0.0 110.245 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 46.8 t -129.86 152.69 49.06 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.763 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.667 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 5.3 p -144.12 133.77 19.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.044 0.45 . . . . 0.0 111.171 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.441 HG23 ' HB3' ' A' ' 21' ' ' LEU . 11.2 tt -135.07 153.53 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.226 -178.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -82.97 111.6 18.98 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 122.041 -0.412 . . . . 0.0 111.157 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.538 HD23 ' HB3' ' A' ' 21' ' ' LEU . 2.0 mm? -88.83 -2.0 58.37 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.456 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 66.9 t30 -74.78 -14.73 60.74 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -107.18 17.25 23.17 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.296 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.464 ' HB2' HD13 ' A' ' 39' ' ' LEU . 39.8 m-85 -134.01 -33.86 1.02 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.339 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.64 HD22 HD13 ' A' ' 151' ' ' ILE . 35.8 mt -105.73 137.18 44.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.926 0.394 . . . . 0.0 111.624 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.634 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 5.9 m -129.94 140.76 50.88 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.677 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.803 ' CB ' ' HG ' ' A' ' 140' ' ' LEU . 21.2 p-10 -80.71 93.79 6.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.36 0.6 . . . . 0.0 110.542 178.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -92.78 91.24 7.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.981 0.42 . . . . 0.0 111.065 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.9 t30 51.86 45.23 28.58 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.361 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.35 34.4 29.26 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.728 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.658 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 32.8 t60 -155.35 122.0 5.33 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.741 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 55.3 m-85 -58.44 143.98 43.65 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.93 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.648 ' NE ' ' HA ' ' A' ' 51' ' ' ARG . 4.4 mmp_? -146.14 134.26 21.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.449 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.772 ' HZ2' ' HA ' ' A' ' 153' ' ' LEU . 95.0 m95 . . . . . 0 C--N 1.322 -0.62 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.107 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.2 m . . . . . 0 N--CA 1.45 -0.462 0 CA-C-O 120.95 0.405 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.3 177.16 7.79 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.203 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.449 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 8.9 p -130.32 119.73 23.27 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.415 HG21 ' CE1' ' A' ' 80' ' ' PHE . 8.2 p -109.48 140.51 27.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.685 0.278 . . . . 0.0 110.623 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 7.1 m -88.27 131.1 34.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.246 0.546 . . . . 0.0 110.28 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.499 ' CG2' HD12 ' A' ' 99' ' ' ILE . 43.0 t -81.1 134.93 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.9 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -108.8 170.61 7.93 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 124.1 0.875 . . . . 0.0 109.939 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.667 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 34.7 tt0 -65.12 120.13 12.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.834 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.67 -7.19 45.52 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.879 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -95.04 148.15 22.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.331 0.586 . . . . 0.0 112.029 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.609 ' HA ' HG12 ' A' ' 99' ' ' ILE . 74.5 p -133.38 170.75 15.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.695 HD22 HG23 ' A' ' 99' ' ' ILE . 1.1 mm? -52.18 -45.9 65.32 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.899 0.772 . . . . 0.0 109.453 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -57.49 -38.64 74.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.367 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.66 -43.74 46.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.594 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.557 HG12 ' O ' ' A' ' 72' ' ' THR . 43.5 mm -59.83 -46.55 93.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.885 0.374 . . . . 0.0 110.059 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.645 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.86 -51.73 56.39 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.555 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -66.85 -30.81 71.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.025 0.44 . . . . 0.0 111.43 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -70.12 -46.82 63.99 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.415 ' CE1' HG21 ' A' ' 65' ' ' VAL . 89.7 m-85 -103.59 12.62 34.72 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.0 t0 60.21 57.88 2.8 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.96 0.886 . . . . 0.0 110.812 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.645 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -140.02 164.88 28.85 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.065 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.686 ' O ' HG13 ' A' ' 87' ' ' ILE . 6.8 m-20 -83.05 114.95 21.64 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.643 ' HD1' ' HB2' ' A' ' 95' ' ' ASN . 10.6 p90 -54.57 -31.53 56.86 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.724 0.64 . . . . 0.0 111.142 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.528 ' HA ' ' HB3' ' A' ' 95' ' ' ASN . 71.1 t60 -71.86 -36.03 70.01 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.719 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.595 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 9.9 tp10 -68.77 -47.0 67.3 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.686 HG13 ' O ' ' A' ' 83' ' ' ASP . 7.1 mt -51.91 -47.94 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.017 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.593 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.83 -50.92 69.05 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.345 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -56.8 -39.79 74.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.934 0.397 . . . . 0.0 111.418 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.595 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 21.7 mmt180 -70.17 -31.07 68.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.108 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 17.5 t-20 -90.74 -6.04 54.93 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.985 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 93.0 m-20 79.5 17.75 0.8 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.524 0.73 . . . . 0.0 111.089 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.593 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 14.5 pt -110.68 -173.17 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.585 178.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.539 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 52.5 mt-30 -115.1 154.42 28.94 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.643 ' HB2' ' HD1' ' A' ' 84' ' ' PHE . 6.9 p-10 -56.6 -55.1 38.25 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 122.199 1.0 . . . . 0.0 109.329 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -78.52 12.92 1.78 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.091 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.539 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 0.7 OUTLIER -70.96 -29.96 66.1 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.093 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 9.6 mp 69.88 114.61 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 O-C-N 124.266 0.979 . . . . 0.0 110.433 -177.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.695 HG23 HD22 ' A' ' 73' ' ' LEU . 9.5 pt -94.63 176.03 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 114.81 -1.087 . . . . 0.0 111.338 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.556 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 90.5 m-85 -130.71 160.03 68.28 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.941 -178.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.667 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 20.1 Cg_endo -66.05 135.28 40.03 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.299 2.666 . . . . 0.0 114.048 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.73 23.38 18.5 Favored Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.397 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.49 ' O ' ' HA ' ' A' ' 66' ' ' THR . 46.1 mt-30 -111.88 165.35 12.16 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 120.574 -0.45 . . . . 0.0 109.837 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.449 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 65.6 t -125.45 115.73 44.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.496 ' HB3' HG22 ' A' ' 87' ' ' ILE . 81.7 mt -108.19 150.87 26.69 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.711 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -90.62 115.41 27.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.394 0.616 . . . . 0.0 110.613 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.0 m -120.37 150.5 51.95 Favored Pre-proline 0 C--N 1.311 -1.08 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.388 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.93 -19.28 58.27 Favored 'Trans proline' 0 C--N 1.332 -0.304 0 C-N-CA 123.195 2.597 . . . . 0.0 113.96 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 C--N 1.32 -0.694 0 CA-C-O 121.356 0.598 . . . . 0.0 111.351 179.937 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.634 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.444 -0.809 0 N-CA-C 112.088 -0.405 . . . . 0.0 112.088 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 21.6 m120 75.24 27.16 1.12 Allowed 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.751 0.82 . . . . 0.0 112.476 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.593 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 18.8 p90 -63.46 -39.29 94.07 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.546 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 63.7 t-105 -61.94 -31.44 71.77 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.133 -178.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -58.75 -16.22 15.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 111.27 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.729 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 36.3 m -145.75 30.55 1.08 Allowed 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.164 177.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.546 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -110.38 136.47 49.49 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.595 177.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.4 tmm_? -125.03 137.04 54.23 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.61 57.99 3.52 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.625 0.578 . . . . 0.0 111.164 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.505 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 34.6 t -85.53 124.96 40.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.114 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.486 ' O ' HD12 ' A' ' 136' ' ' LEU . 38.7 ptt180 -148.98 142.97 25.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.956 0.408 . . . . 0.0 111.143 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.93 HD13 HG22 ' A' ' 14' ' ' ILE . 23.1 mt -85.09 131.97 34.38 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.74 HG23 ' HB ' ' A' ' 135' ' ' VAL . 28.9 m -125.28 158.98 33.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.712 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.68 ' HB3' ' CG ' ' A' ' 134' ' ' LYS . 0.2 OUTLIER 68.55 11.13 8.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.152 179.52 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.664 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 91.28 31.33 9.77 Favored Glycine 0 N--CA 1.437 -1.251 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.092 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.508 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 93.25 -14.91 64.17 Favored Glycine 0 C--O 1.265 2.062 0 CA-C-O 123.005 1.336 . . . . 0.0 113.627 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.68 ' CG ' ' HB3' ' A' ' 131' ' ' ASP . 7.8 ptpp? -72.99 -15.63 61.53 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 121.241 -1.153 . . . . 0.0 109.024 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.74 ' HB ' HG23 ' A' ' 130' ' ' VAL . 12.0 t -139.27 147.37 24.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.718 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.579 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 47.9 tp -128.95 123.14 31.73 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -112.46 130.94 55.82 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 123.273 0.358 . . . . 0.0 110.772 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.727 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.72 161.6 26.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.188 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.668 ' HG2' ' HG3' ' A' ' 148' ' ' ARG . 39.3 mt-10 -98.0 106.17 18.43 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.628 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.803 ' HG ' ' CB ' ' A' ' 45' ' ' ASN . 0.5 OUTLIER -89.71 126.03 35.5 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.852 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.729 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 52.3 ttt-85 -69.97 140.38 52.97 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.647 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.664 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 2.9 p90 -151.6 -164.94 2.11 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.148 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.3 t -59.78 -25.61 65.05 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -107.65 28.88 11.29 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.591 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 96.46 -114.45 4.94 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.485 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -125.27 129.38 49.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.78 0.29 . . . . 0.0 110.666 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.664 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 22.9 t-20 -123.56 132.87 54.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.711 0.291 . . . . 0.0 111.114 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.668 ' HG3' ' HG2' ' A' ' 139' ' ' GLU . 38.2 mtp85 -74.86 113.18 11.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.533 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.658 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 33.7 t -128.9 165.53 20.88 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.047 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.579 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 19.4 ptt180 -147.74 148.69 31.25 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.138 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.741 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 11.6 tt -130.68 161.67 40.15 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.428 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.531 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 14.6 m-85 -104.88 105.46 15.53 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 122.265 -0.272 . . . . 0.0 110.991 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.78 HD23 HD22 ' A' ' 21' ' ' LEU . 9.9 mp -69.27 -31.62 70.25 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.502 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.626 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 11.1 t70 -58.99 -7.84 1.21 Allowed 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.932 178.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.528 ' HG3' ' O ' ' A' ' 152' ' ' TYR . 37.0 mt-10 -72.73 -51.78 17.81 Favored 'General case' 0 CA--C 1.508 -0.635 0 O-C-N 121.862 -0.523 . . . . 0.0 112.31 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -122.55 2.22 9.57 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.126 -177.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.412 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 46.2 mm -106.26 110.44 31.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.431 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.449 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -113.43 168.77 12.68 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.28 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.601 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 1.6 t30 -100.83 119.8 39.19 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.666 ' HD3' HD12 ' A' ' 165' ' ' ILE . 58.5 ttt180 -115.12 88.68 2.92 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.807 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 17.8 m120 59.55 34.7 22.49 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.937 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.58 -4.55 43.34 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.023 -1.084 . . . . 0.0 114.243 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.603 ' HG2' ' O ' ' A' ' 160' ' ' ARG . 14.4 pt-20 -122.02 139.79 53.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.683 0.742 . . . . 0.0 110.9 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.404 ' CD2' ' HD2' ' A' ' 7' ' ' PHE . 76.0 mt -76.23 115.12 15.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.386 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.666 HD12 ' HD3' ' A' ' 160' ' ' ARG . 47.7 mt . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.953 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.634 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 33.9 m-85 . . . . . 0 N--CA 1.452 -0.37 0 CA-C-O 120.703 0.287 . . . . 0.0 111.488 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.39 -26.99 6.51 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -76.09 -67.85 1.63 Allowed Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 119.069 -1.539 . . . . 0.0 112.363 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 63.94 15.01 8.84 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 122.973 0.509 . . . . 0.0 110.71 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.685 ' CE2' HD13 ' A' ' 14' ' ' ILE . 2.1 p90 -56.4 -37.23 69.85 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.549 ' HA ' HD11 ' A' ' 14' ' ' ILE . 3.9 m -60.2 -23.05 63.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.841 0.353 . . . . 0.0 111.745 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.19 -21.66 77.2 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.974 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.517 ' HB2' ' HB3' ' A' ' 26' ' ' ARG . 33.2 p -125.19 -24.88 3.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.12 0.486 . . . . 0.0 111.321 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.2 m -94.64 131.63 40.22 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.815 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 12' ' ' ARG . 10.5 ptm180 -113.4 -179.54 3.67 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.426 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 9.0 m-20 47.53 44.65 17.12 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 123.832 0.708 . . . . 0.0 111.41 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.762 HG22 ' CD1' ' A' ' 129' ' ' LEU . 7.2 mt -80.22 103.25 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-O 121.039 0.447 . . . . 0.0 110.425 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.586 ' O ' ' HB3' ' A' ' 22' ' ' ARG . 72.0 m -146.95 127.5 14.15 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.85 HD21 HD12 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -91.91 157.99 16.53 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.086 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -97.24 76.08 2.6 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 113.958 -1.474 . . . . 0.0 107.815 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.44 -58.92 5.01 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.994 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -148.66 -6.45 0.4 Allowed 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -97.81 98.03 9.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.117 0.484 . . . . 0.0 110.382 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.901 ' HB2' HD22 ' A' ' 39' ' ' LEU . 42.9 tp -54.25 129.88 36.74 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 114.871 -1.058 . . . . 0.0 112.489 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.586 ' HB3' ' O ' ' A' ' 15' ' ' CYS . 16.2 ttp180 -132.62 124.1 27.67 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.601 -0.439 . . . . 0.0 110.089 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.639 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -147.23 144.43 28.89 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.663 0.744 . . . . 0.0 111.682 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.623 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 2.3 mm-40 -79.27 75.66 5.84 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.882 178.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.598 ' HB2' ' HA2' ' A' ' 162' ' ' GLY . 46.2 m -62.43 124.57 21.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.49 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.517 ' HB3' ' HB2' ' A' ' 10' ' ' SER . 58.6 ttp180 -68.92 119.92 14.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.336 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -90.27 153.5 20.42 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.93 -13.07 4.23 Favored Glycine 0 C--N 1.33 0.232 0 O-C-N 124.443 1.09 . . . . 0.0 115.005 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -83.52 -2.91 57.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.978 0.418 . . . . 0.0 110.554 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.59 10.99 66.79 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -112.4 145.29 18.02 Favored Glycine 0 C--O 1.226 -0.387 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.408 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.623 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 69.4 m-85 -89.35 133.36 34.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.878 0.339 . . . . 0.0 110.433 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.8 m -115.16 124.75 52.28 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.307 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.0 m -68.31 107.42 2.82 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.09 0.472 . . . . 0.0 109.938 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 48.0 t -113.18 152.58 29.53 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.062 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.664 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.2 p -145.13 130.61 13.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.097 0.475 . . . . 0.0 110.757 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.4 HG23 ' HB3' ' A' ' 21' ' ' LEU . 15.3 tt -130.11 143.23 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.676 -177.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.15 101.37 3.92 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.71 0.29 . . . . 0.0 111.572 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.901 HD22 ' HB2' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -82.44 -9.78 59.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.079 0.466 . . . . 0.0 110.301 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.528 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 2.1 p-10 -62.59 -18.13 61.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.215 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -112.63 20.7 16.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.303 0.573 . . . . 0.0 110.179 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 27.4 m-85 -131.34 -33.35 1.48 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.001 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.751 HD22 HD13 ' A' ' 151' ' ' ILE . 50.3 mt -106.25 135.01 48.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.689 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.632 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 3.3 m -126.34 138.15 53.54 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.033 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.901 ' CB ' ' HG ' ' A' ' 140' ' ' LEU . 16.1 p-10 -86.75 102.14 13.96 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.524 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.467 ' CB ' ' HD3' ' A' ' 51' ' ' ARG . 17.1 t70 -107.05 93.2 4.42 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.083 0.468 . . . . 0.0 110.507 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.7 t30 55.99 43.15 27.69 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.096 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 149' ' ' SER . . . 83.06 27.36 41.03 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.697 -0.764 . . . . 0.0 113.649 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.443 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 69.9 m-70 -144.47 139.06 28.06 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.974 ' HZ ' ' HB3' ' A' ' 138' ' ' ALA . 49.8 m-85 -80.88 144.25 32.11 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.206 0.527 . . . . 0.0 111.892 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.467 ' HD3' ' CB ' ' A' ' 46' ' ' ASP . 26.6 mtp180 -146.6 132.82 19.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.711 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.624 ' HZ2' ' HA ' ' A' ' 153' ' ' LEU . 97.2 m95 . . . . . 0 C--N 1.32 -0.708 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.315 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 55.3 m . . . . . 0 N--CA 1.453 -0.321 0 CA-C-O 121.077 0.465 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -133.89 176.59 8.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.642 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.512 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 20.7 p -129.62 122.58 29.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.885 0.374 . . . . 0.0 111.124 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.479 HG21 ' CE2' ' A' ' 80' ' ' PHE . 10.8 p -108.22 139.79 29.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.838 0.352 . . . . 0.0 111.46 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.0 m -91.62 125.64 36.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.242 0.544 . . . . 0.0 109.648 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.872 HG21 HD12 ' A' ' 99' ' ' ILE . 86.6 t -84.06 131.14 34.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.341 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -106.1 169.46 8.49 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 124.059 0.849 . . . . 0.0 110.688 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.686 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 19.8 tt0 -55.65 117.67 3.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.295 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.36 4.89 40.52 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.34 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.452 ' HB2' HG13 ' A' ' 67' ' ' VAL . 95.3 m-20 -109.75 138.44 46.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.065 0.46 . . . . 0.0 111.939 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.671 ' HA ' HG12 ' A' ' 99' ' ' ILE . 68.6 p -122.84 173.99 7.42 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.744 HD22 HG23 ' A' ' 99' ' ' ILE . 0.7 OUTLIER -51.34 -43.06 61.66 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.525 0.602 . . . . 0.0 110.372 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -62.07 -35.89 79.99 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.883 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -73.89 -40.63 63.06 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.441 HG12 ' O ' ' A' ' 72' ' ' THR . 46.1 mm -63.14 -49.25 84.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.692 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -59.31 -52.57 52.46 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.652 -0.704 . . . . 0.0 113.539 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -64.5 -25.59 68.06 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -81.57 -49.5 10.47 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.479 ' CE2' HG21 ' A' ' 65' ' ' VAL . 96.2 m-85 -94.13 12.95 24.7 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.8 t70 60.59 44.32 11.74 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.998 0.904 . . . . 0.0 110.797 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.692 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.8 p -126.19 162.4 25.5 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.865 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.471 ' O ' HG13 ' A' ' 87' ' ' ILE . 4.1 p-10 -92.91 119.09 31.85 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.558 0.694 . . . . 0.0 109.437 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.694 ' HD2' ' HB2' ' A' ' 95' ' ' ASN . 7.7 p90 -47.86 -32.57 6.34 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 114.431 -1.258 . . . . 0.0 111.895 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.412 ' HA ' ' HB3' ' A' ' 95' ' ' ASN . 83.1 t60 -60.48 -47.85 84.33 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.951 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.604 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 6.2 tp10 -63.54 -47.04 83.24 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.928 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.493 HD12 ' HA ' ' A' ' 84' ' ' PHE . 5.1 mt -49.7 -47.06 21.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.413 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.612 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.84 -50.3 71.48 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.907 178.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 85' ' ' HIS . 48.6 mtm180 -58.9 -34.48 71.73 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.604 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 11.5 mmt180 -74.98 -28.22 60.47 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.914 0.388 . . . . 0.0 111.538 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.451 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 6.3 t-20 -96.43 -5.1 40.48 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.622 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 89.6 m-20 78.2 15.66 1.36 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.313 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.612 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 17.0 pt -103.57 -169.22 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.388 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 41.6 mt-30 -120.42 153.35 36.69 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.694 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 4.0 p-10 -56.94 -57.5 12.27 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 121.826 0.822 . . . . 0.0 109.6 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.68 11.93 2.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.495 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 0.7 OUTLIER -71.48 -35.08 70.69 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.369 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.487 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 9.7 mp 72.65 119.46 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.367 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.872 HD12 HG21 ' A' ' 67' ' ' VAL . 7.1 pt -94.55 176.68 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.328 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.507 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 92.7 m-85 -124.44 160.39 53.25 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.977 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.686 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 28.9 Cg_endo -70.66 132.04 21.13 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.958 2.439 . . . . 0.0 113.143 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.47 9.29 41.55 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -100.46 148.03 25.2 Favored 'General case' 0 C--O 1.215 -0.757 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.512 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 61.1 t -114.6 111.15 34.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.658 HD11 HG21 ' A' ' 99' ' ' ILE . 64.3 mt -101.08 151.66 21.54 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.086 -177.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.452 ' HG2' HG22 ' A' ' 64' ' ' THR . 67.1 mt-30 -90.29 113.72 25.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.702 0.763 . . . . 0.0 110.786 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.8 m -120.19 151.1 52.69 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.607 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.99 -16.35 54.42 Favored 'Trans proline' 0 C--N 1.333 -0.262 0 C-N-CA 123.392 2.728 . . . . 0.0 114.201 -177.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.2 t . . . . . 0 C--N 1.321 -0.654 0 CA-C-O 120.939 0.399 . . . . 0.0 111.088 -179.969 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.632 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.442 -0.957 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 19.7 m120 74.35 25.77 1.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.465 0.706 . . . . 0.0 112.241 178.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.613 ' CD2' ' HE1' ' A' ' 50' ' ' PHE . 12.4 p90 -64.14 -40.43 96.14 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.591 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 62.7 t-105 -59.17 -31.01 68.6 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.081 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -53.77 -28.02 32.32 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.739 0.304 . . . . 0.0 110.834 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.752 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 16.2 m -137.63 31.18 2.55 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.281 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.591 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -111.65 146.69 37.01 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.15 0.5 . . . . 0.0 111.318 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -132.34 148.02 52.41 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.558 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 50.66 50.82 18.18 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 124.053 0.846 . . . . 0.0 112.116 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.483 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 31.6 t -74.22 125.24 33.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -149.59 153.51 37.22 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.126 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.762 ' CD1' HG22 ' A' ' 14' ' ' ILE . 25.8 mt -97.5 139.71 33.01 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.807 0.337 . . . . 0.0 110.799 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.541 HG23 ' HB ' ' A' ' 135' ' ' VAL . 33.7 m -133.44 156.04 41.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.789 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.592 ' HB3' ' HD2' ' A' ' 134' ' ' LYS . 1.4 m-20 70.13 5.74 5.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.663 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.73 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 99.35 35.59 4.66 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.289 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.61 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 82.48 -9.58 58.08 Favored Glycine 0 C--O 1.256 1.523 0 CA-C-O 123.003 1.335 . . . . 0.0 113.198 176.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.648 ' O ' ' HA ' ' A' ' 152' ' ' TYR . 18.1 ptpt -74.47 -16.23 60.86 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.569 HG23 ' HG3' ' A' ' 134' ' ' LYS . 24.4 t -140.69 140.21 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.075 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.85 HD12 HD21 ' A' ' 16' ' ' LEU . 7.7 tt -119.01 125.15 48.7 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -110.35 124.45 51.71 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.974 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -157.46 155.67 30.82 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.939 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 31.1 mt-10 -95.0 108.33 20.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.272 0.558 . . . . 0.0 110.605 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.901 ' HG ' ' CB ' ' A' ' 45' ' ' ASN . 0.2 OUTLIER -90.24 128.7 36.46 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.752 -179.81 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.752 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 75.7 ttt180 -70.04 140.69 52.87 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.403 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.481 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.7 p90 -156.46 -171.95 3.89 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.383 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.8 m -55.87 -29.9 60.65 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.787 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -97.67 20.75 49.42 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.204 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 98.75 -110.12 3.94 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.251 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -129.44 133.1 47.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.636 0.255 . . . . 0.0 110.786 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.481 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 11.8 t30 -134.43 127.37 31.39 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.642 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 29.7 ttp180 -79.93 102.35 9.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.448 0.642 . . . . 0.0 110.759 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.443 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 11.4 t -105.27 174.62 5.8 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.124 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.662 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 34.7 ptt180 -147.43 148.24 31.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.918 0.389 . . . . 0.0 111.787 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.751 HD13 HD22 ' A' ' 43' ' ' LEU . 10.9 tt -131.6 159.59 42.96 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.512 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.689 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 44.0 m-85 -99.79 106.04 17.88 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.341 0.115 . . . . 0.0 110.775 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.71 HD11 HD21 ' A' ' 129' ' ' LEU . 16.5 mt -68.74 -35.86 77.66 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.312 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.431 ' HA ' ' HD1' ' A' ' 7' ' ' PHE . 8.3 p-10 -58.26 -8.05 1.02 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.976 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.689 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 41.8 mt-10 -69.41 -55.2 11.02 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.236 0.541 . . . . 0.0 111.912 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -122.23 6.02 9.7 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.306 -177.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.471 HG12 ' CH2' ' A' ' 52' ' ' TRP . 44.3 mm -107.15 113.2 42.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.88 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -112.71 173.04 14.95 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.965 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.535 ' CG ' ' HB3' ' A' ' 25' ' ' CYS . 0.9 OUTLIER -110.95 128.27 55.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.674 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.96 89.14 3.07 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.37 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 56.99 42.16 26.58 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.442 0.464 . . . . 0.0 111.794 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.598 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 92.51 7.93 62.93 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.928 -0.654 . . . . 0.0 113.406 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -123.59 127.01 47.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.147 0.473 . . . . 0.0 112.094 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.405 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 42.1 mt -70.82 110.39 5.56 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.481 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 63.3 mt . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.382 179.854 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.478 ' HD2' ' HG2' ' A' ' 155' ' ' GLU . 45.3 m-85 . . . . . 0 N--CA 1.456 -0.154 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -118.73 -27.75 5.78 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.54 -71.24 0.85 Allowed Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 119.988 -1.101 . . . . 0.0 112.784 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 65.78 10.47 6.85 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 122.455 0.302 . . . . 0.0 110.749 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.634 ' CE2' HD13 ' A' ' 14' ' ' ILE . 1.1 p90 -61.08 -34.08 74.36 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.404 ' HA ' HD11 ' A' ' 14' ' ' ILE . 23.3 t -68.02 -16.88 64.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.106 0.479 . . . . 0.0 110.279 -178.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.24 -21.16 79.94 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.746 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 11.1 m -130.45 -19.17 3.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.978 0.389 . . . . 0.0 111.622 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 m -94.41 135.09 36.23 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.561 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 11.7 ptm180 -112.72 -178.91 3.51 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.432 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 0.6 OUTLIER 40.75 47.98 2.57 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 123.909 0.755 . . . . 0.0 112.343 -179.648 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.825 HG22 HD13 ' A' ' 129' ' ' LEU . 7.9 mt -80.66 103.83 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.597 ' HA ' HD12 ' A' ' 129' ' ' LEU . 45.4 t -147.95 126.19 12.23 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.78 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -92.34 154.93 18.26 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.559 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -95.09 74.66 3.45 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.4 -57.87 4.88 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.925 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.453 ' HA ' ' HZ ' ' A' ' 120' ' ' PHE . . . -145.28 -9.31 0.58 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.816 0.341 . . . . 0.0 110.257 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -94.98 95.59 8.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.823 0.344 . . . . 0.0 110.089 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.857 ' HB2' HD22 ' A' ' 39' ' ' LEU . 42.8 tp -59.28 128.12 35.53 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.369 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.543 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 51.1 ttt180 -131.1 129.83 42.38 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.05 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.62 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -150.61 147.34 27.3 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.383 0.611 . . . . 0.0 111.19 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.571 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 1.3 mm-40 -84.49 81.31 8.9 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.842 178.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.553 ' HB2' ' HA2' ' A' ' 162' ' ' GLY . 58.6 m -67.6 128.08 35.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.494 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 10' ' ' SER . 51.1 ttt-85 -74.37 116.19 14.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.793 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -89.5 159.02 17.45 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.092 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.48 -18.23 3.52 Favored Glycine 0 C--N 1.337 0.592 0 O-C-N 124.861 1.351 . . . . 0.0 114.442 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -71.64 -12.37 61.31 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.03 9.62 60.58 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.39 163.69 12.12 Favored Glycine 0 C--O 1.228 -0.238 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.032 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.571 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 70.2 m-85 -100.02 134.03 43.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.63 0.252 . . . . 0.0 110.499 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.6 m -123.79 128.68 49.9 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.271 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.4 114.72 6.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.02 0.438 . . . . 0.0 110.771 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 29.7 t -119.89 149.56 41.89 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.777 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 2.8 p -142.04 136.48 29.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.002 0.43 . . . . 0.0 111.204 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.444 HG23 ' HB3' ' A' ' 21' ' ' LEU . 13.4 tt -134.06 144.38 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.73 -177.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -77.84 98.81 5.71 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.798 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.857 HD22 ' HB2' ' A' ' 21' ' ' LEU . 1.3 mp -76.25 -6.4 51.25 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.272 0.558 . . . . 0.0 110.153 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -63.61 -21.65 66.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.65 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.8 ptt85 -111.32 19.35 18.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.039 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.553 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 38.6 m-85 -131.44 -32.66 1.52 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.638 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.739 HD22 HD13 ' A' ' 151' ' ' ILE . 51.7 mt -109.71 138.53 45.95 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.036 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 m -132.79 144.22 50.09 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.612 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.467 ' ND2' ' HB2' ' A' ' 123' ' ' SER . 21.6 p-10 -88.27 106.5 18.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.425 0.631 . . . . 0.0 110.205 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -103.24 92.43 4.51 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 122.133 -0.354 . . . . 0.0 110.906 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 49.51 44.29 24.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.78 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.595 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 85.82 30.0 24.8 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.486 178.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.675 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 2.5 t60 -152.58 124.6 8.01 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.766 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 63.6 m-85 -62.26 143.3 57.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.791 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.4 mtm180 -144.8 134.32 23.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.409 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.553 ' HA ' ' O ' ' A' ' 42' ' ' TYR . 99.4 m95 . . . . . 0 C--N 1.323 -0.563 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.882 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.8 m . . . . . 0 N--CA 1.448 -0.554 0 CA-C-O 121.177 0.513 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 106' ' ' GLN . . . -106.43 176.55 5.13 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.68 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.55 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 10.0 p -126.85 115.89 20.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.957 0.408 . . . . 0.0 112.074 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.562 HG21 ' CE2' ' A' ' 80' ' ' PHE . 7.4 p -106.29 148.04 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.062 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 10.3 m -93.04 130.27 38.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.172 0.51 . . . . 0.0 110.454 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.553 HG21 HD12 ' A' ' 99' ' ' ILE . 58.2 t -83.26 138.39 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.185 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -108.4 171.2 7.55 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 124.373 1.045 . . . . 0.0 109.61 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.7 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 63.7 tt0 -68.95 126.05 28.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.395 -178.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.44 8.55 59.71 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.988 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -119.84 123.18 43.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.902 0.382 . . . . 0.0 110.962 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.557 ' HA ' HG12 ' A' ' 99' ' ' ILE . 69.3 p -104.76 -176.91 3.21 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.61 HD22 HG23 ' A' ' 99' ' ' ILE . 1.3 mm? -51.53 -40.79 60.34 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.392 0.615 . . . . 0.0 109.55 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.443 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 38.8 ttm180 -60.06 -42.47 94.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.253 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -70.66 -43.39 69.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.355 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 72' ' ' THR . 38.3 mm -62.96 -45.33 99.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.732 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.95 -56.22 26.36 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.654 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -64.72 -26.73 68.49 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 45.6 ttm-85 -72.98 -38.86 66.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.562 ' CE2' HG21 ' A' ' 65' ' ' VAL . 96.8 m-85 -111.02 19.64 18.26 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.9 t70 55.27 36.17 26.48 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.679 0.752 . . . . 0.0 111.776 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.732 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.5 p -113.72 171.19 7.73 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.672 ' O ' HG13 ' A' ' 87' ' ' ILE . 6.9 t70 -97.77 127.34 43.65 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.91 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.503 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 11.1 p90 -52.92 -30.12 32.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.287 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -73.33 -38.01 65.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.975 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -68.16 -45.91 72.21 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.672 HG13 ' O ' ' A' ' 83' ' ' ASP . 6.0 mt -54.67 -47.03 73.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.61 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.93 -47.89 81.28 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.679 177.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -56.75 -42.41 79.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.981 0.42 . . . . 0.0 111.369 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -69.79 -36.24 75.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.759 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 6.9 t-20 -89.4 -5.33 57.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.387 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 94.0 m-20 74.8 21.05 2.17 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.587 0.755 . . . . 0.0 111.425 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.61 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 17.6 pt -108.89 -173.48 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.581 ' H ' ' HB2' ' A' ' 97' ' ' ASP . 88.7 mt-30 -110.62 158.15 18.9 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.535 ' O ' HD23 ' A' ' 73' ' ' LEU . 3.2 p-10 -58.98 -55.34 36.46 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-O 122.221 1.01 . . . . 0.0 108.43 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -79.68 12.06 2.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.666 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.581 ' HB2' ' H ' ' A' ' 94' ' ' GLN . 4.4 t70 -63.73 -32.57 74.1 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.1 mt 70.68 112.44 0.05 Allowed 'General case' 0 C--O 1.234 0.249 0 O-C-N 124.465 1.103 . . . . 0.0 110.123 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.835 HG21 HD11 ' A' ' 105' ' ' LEU . 14.4 pt -95.33 175.14 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.155 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.512 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 97.5 m-85 -128.96 158.8 71.52 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.969 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.7 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 20.8 Cg_endo -66.97 138.81 49.19 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.508 2.806 . . . . 0.0 114.307 -178.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.07 11.3 57.72 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.702 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 66' ' ' THR . 74.1 mt-30 -102.64 166.04 10.73 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.352 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.55 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 80.9 t -122.39 114.78 43.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-O 120.931 0.396 . . . . 0.0 110.198 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.835 HD11 HG21 ' A' ' 99' ' ' ILE . 79.0 mt -107.26 152.01 24.68 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.823 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 63' ' ' ALA . 72.9 mt-30 -89.9 116.22 27.81 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.795 0.807 . . . . 0.0 111.45 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.9 m -126.29 150.91 71.42 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 114.253 -1.339 . . . . 0.0 109.954 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.68 -17.41 59.82 Favored 'Trans proline' 0 N--CA 1.476 0.442 0 C-N-CA 123.735 2.957 . . . . 0.0 114.952 -177.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.6 t . . . . . 0 C--N 1.324 -0.542 0 CA-C-O 120.942 0.401 . . . . 0.0 111.268 -179.859 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.445 -0.718 0 N-CA-C 111.905 -0.478 . . . . 0.0 111.905 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 6.9 m-20 72.28 25.55 2.84 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 178.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.6 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 25.3 p90 -55.78 -39.14 70.84 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.627 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 62.2 t-105 -59.03 -32.96 70.21 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.67 -178.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -52.31 -38.6 58.91 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 121.7 0.762 . . . . 0.0 110.77 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.946 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 17.2 m -122.91 25.85 8.42 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.503 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.627 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -114.72 134.61 54.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.857 0.36 . . . . 0.0 111.05 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.602 ' HD2' ' O ' ' A' ' 124' ' ' ALA . 7.1 mpt_? -131.33 158.61 40.23 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.631 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.9 t70 53.94 46.1 26.32 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.761 0.791 . . . . 0.0 110.214 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.493 ' CG1' HD11 ' A' ' 136' ' ' LEU . 22.5 t -79.85 122.09 34.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.614 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 128' ' ' ARG . 1.3 ptp85 -146.55 147.8 31.5 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.286 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.825 HD13 HG22 ' A' ' 14' ' ' ILE . 19.4 mt -86.97 127.84 35.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.204 0.526 . . . . 0.0 110.072 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.853 HG23 ' HB ' ' A' ' 135' ' ' VAL . 27.6 m -116.79 157.17 17.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.909 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.501 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 0.9 OUTLIER 68.42 3.23 3.67 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.584 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.642 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 97.91 29.24 7.78 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.32 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 98.34 -22.05 42.89 Favored Glycine 0 C--O 1.261 1.828 0 CA-C-O 123.014 1.341 . . . . 0.0 113.098 177.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.66 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 40.5 pttt -67.97 -14.79 63.24 Favored 'General case' 0 C--N 1.317 -0.814 0 O-C-N 121.279 -1.13 . . . . 0.0 109.271 177.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.853 ' HB ' HG23 ' A' ' 130' ' ' VAL . 3.1 t -140.85 146.91 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.895 177.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 26.5 tp -129.33 122.62 29.91 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -117.49 137.62 52.41 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.884 0.373 . . . . 0.0 110.988 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.636 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -160.09 169.32 23.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.575 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 124' ' ' ALA . 8.5 mm-40 -95.33 106.45 18.5 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.595 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 58.8 mt -97.81 125.06 42.46 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.457 0.646 . . . . 0.0 111.468 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.946 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 65.4 ttt180 -70.28 141.34 52.41 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.933 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.42 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 4.8 p90 -152.35 -173.73 4.65 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.868 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.0 m -56.2 -24.66 43.3 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -108.56 27.98 12.5 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.502 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 102.43 -117.89 5.94 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.161 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.431 ' CH2' ' HD3' ' A' ' 125' ' ' ARG . 80.0 m95 -127.2 142.14 51.56 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.42 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 54.6 t30 -138.02 137.74 38.16 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.8 ttt85 -85.03 113.75 21.68 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.065 0.46 . . . . 0.0 110.72 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.675 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 47.5 t -122.75 166.61 14.67 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.943 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 10.2 ptt180 -147.37 145.25 29.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.205 0.526 . . . . 0.0 111.677 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.766 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 6.9 tt -124.79 150.56 29.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.676 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.326 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.584 ' CB ' ' HG3' ' A' ' 155' ' ' GLU . 18.1 m-85 -94.74 103.96 15.87 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 122.166 -0.334 . . . . 0.0 110.921 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.743 HD13 HD22 ' A' ' 21' ' ' LEU . 25.4 mt -65.07 -36.51 84.57 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.09 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.66 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 8.8 t70 -57.61 -7.97 0.77 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.943 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.584 ' HG3' ' CB ' ' A' ' 152' ' ' TYR . 42.0 mt-10 -70.63 -54.31 12.46 Favored 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 122.002 -0.436 . . . . 0.0 112.081 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 54.1 m80 -125.57 5.03 7.54 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.165 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.498 HG12 ' CH2' ' A' ' 52' ' ' TRP . 41.7 mm -101.87 106.47 19.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -110.89 161.88 12.68 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.978 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.506 ' HA ' ' O ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER -103.61 136.36 43.46 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.791 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -119.01 86.55 2.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.621 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 48.6 50.48 17.01 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.553 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 99.55 6.01 55.18 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.318 -0.944 . . . . 0.0 113.815 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 159' ' ' ASN . 37.8 mt-10 -123.25 153.81 39.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 117.121 0.461 . . . . 0.0 111.288 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.454 HD21 ' HD2' ' A' ' 7' ' ' PHE . 30.8 mt -103.58 121.61 43.26 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.581 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 13.8 tt . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.956 -179.416 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.525 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 58.0 m-85 . . . . . 0 C--O 1.233 0.198 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -96.2 -32.45 12.45 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.91 -74.94 0.37 Allowed Glycine 0 N--CA 1.436 -1.345 0 C-N-CA 119.994 -1.098 . . . . 0.0 113.275 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 66.46 15.72 10.19 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 122.332 0.253 . . . . 0.0 110.83 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.608 ' CE2' HD13 ' A' ' 14' ' ' ILE . 1.4 p90 -61.43 -35.11 76.64 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.509 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.572 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.9 OUTLIER -64.48 -21.43 66.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.246 0.546 . . . . 0.0 110.419 -179.001 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.47 -25.3 75.89 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.265 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 18.4 p -125.72 -10.93 6.72 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 117.135 0.467 . . . . 0.0 111.173 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 6.8 m -107.98 132.33 53.63 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -111.81 -179.46 3.7 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 45.37 46.3 10.36 Favored 'General case' 0 C--N 1.315 -0.933 0 O-C-N 123.859 0.724 . . . . 0.0 111.762 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.875 HG22 HD13 ' A' ' 129' ' ' LEU . 8.0 mt -80.92 106.82 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.6 ' HA ' HD12 ' A' ' 129' ' ' LEU . 73.5 m -147.78 126.98 12.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.064 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.787 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -102.47 158.89 15.9 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 121.431 0.634 . . . . 0.0 111.991 179.447 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -103.47 77.63 1.52 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.77 -54.71 4.98 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.589 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -149.53 -13.44 0.29 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.146 0.498 . . . . 0.0 110.291 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.57 ' HG3' ' CG2' ' A' ' 36' ' ' VAL . 21.0 tpt180 -83.25 85.75 7.16 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.316 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.787 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 54.0 tp -62.78 128.4 35.75 Favored 'General case' 0 C--O 1.213 -0.838 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -133.66 121.88 22.64 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.797 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.623 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -143.22 147.31 34.65 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.452 0.644 . . . . 0.0 111.54 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.514 ' O ' ' HD2' ' A' ' 32' ' ' TYR . 4.7 mm-40 -82.21 76.76 9.08 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.561 -1.199 . . . . 0.0 109.376 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.566 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 69.5 m -65.04 124.81 23.05 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.194 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 10' ' ' SER . 72.0 ttt180 -64.67 134.59 54.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.89 178.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -115.05 151.87 33.48 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.65 -10.62 6.4 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 114.495 -1.23 . . . . 0.0 113.737 -178.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -79.22 1.46 24.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.17 0.51 . . . . 0.0 110.155 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.95 12.15 74.93 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.963 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -130.21 160.56 23.01 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 119.984 -1.103 . . . . 0.0 112.953 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.514 ' HD2' ' O ' ' A' ' 24' ' ' GLU . 76.7 m-85 -95.85 125.15 40.21 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.9 m -108.4 137.34 46.52 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.733 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.1 m -71.93 112.74 8.28 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.151 0.5 . . . . 0.0 110.387 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.432 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 28.0 t -114.32 146.45 40.49 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.19 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.9 p -143.37 133.71 21.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.062 0.458 . . . . 0.0 110.981 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.451 HG23 ' HB3' ' A' ' 21' ' ' LEU . 9.3 tt -135.18 154.0 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.892 -177.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.547 ' OD1' ' HB3' ' A' ' 40' ' ' ASN . 35.2 t0 -89.46 112.4 23.54 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.079 -0.388 . . . . 0.0 110.664 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.521 HD23 ' CB ' ' A' ' 21' ' ' LEU . 3.6 mm? -86.46 -4.83 59.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.927 0.394 . . . . 0.0 110.149 178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.547 ' HB3' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -71.68 -15.45 62.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.805 0.812 . . . . 0.0 108.892 179.058 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.8 mtt180 -105.87 13.22 29.77 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.527 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.426 ' HB2' HD13 ' A' ' 39' ' ' LEU . 48.2 m-85 -133.96 -29.51 1.29 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.712 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.872 HD22 HD13 ' A' ' 151' ' ' ILE . 31.9 mt -109.2 140.62 42.57 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.107 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.487 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 3.1 m -128.56 145.36 51.15 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.842 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.475 ' HA ' HD13 ' A' ' 140' ' ' LEU . 3.2 p-10 -89.93 104.43 16.99 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -106.67 94.26 5.03 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.373 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 50.08 42.93 25.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.225 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.659 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 86.2 29.7 24.54 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.241 -0.98 . . . . 0.0 113.125 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.628 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 16.9 t-80 -153.71 127.33 8.72 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.806 ' HZ ' ' HB3' ' A' ' 138' ' ' ALA . 81.4 m-85 -64.08 149.53 47.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.929 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -144.63 129.5 18.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.82 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.474 ' HZ2' ' O ' ' A' ' 152' ' ' TYR . 94.2 m95 . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.971 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 49.2 m . . . . . 0 N--CA 1.451 -0.416 0 CA-C-O 121.127 0.489 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -124.28 176.72 6.26 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.873 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.464 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 17.4 p -128.06 113.67 16.09 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.355 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.432 HG21 ' CE2' ' A' ' 80' ' ' PHE . 9.7 p -102.63 139.78 22.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.918 0.389 . . . . 0.0 110.957 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 8.2 m -88.47 126.16 35.1 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.546 ' CG2' HD12 ' A' ' 99' ' ' ILE . 43.9 t -75.33 130.23 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.132 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -103.6 169.43 8.53 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 124.258 0.974 . . . . 0.0 110.344 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.6 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 6.1 tp-100 -62.0 121.29 12.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.265 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.03 16.04 39.84 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.908 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -121.04 129.54 53.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.862 0.331 . . . . 0.0 111.075 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.655 ' HA ' HG12 ' A' ' 99' ' ' ILE . 74.4 p -115.02 178.05 4.42 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.587 HD22 HG23 ' A' ' 99' ' ' ILE . 1.3 mm? -52.24 -42.71 63.84 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.641 0.734 . . . . 0.0 109.31 178.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.698 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 65.8 mtt180 -59.74 -41.12 90.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.4 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -71.61 -44.48 64.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.278 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.555 HG12 ' O ' ' A' ' 72' ' ' THR . 37.8 mm -58.83 -45.28 91.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.628 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.44 -49.96 68.88 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.693 -0.685 . . . . 0.0 113.321 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.698 ' HD3' ' O ' ' A' ' 74' ' ' ARG . 1.0 OUTLIER -73.84 -27.04 60.89 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 122.434 -0.451 . . . . 0.0 111.632 -179.011 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -76.54 -38.48 54.97 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.432 ' CE2' HG21 ' A' ' 65' ' ' VAL . 95.6 m-85 -112.47 19.94 17.11 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.2 t70 53.55 55.0 9.17 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 122.072 0.939 . . . . 0.0 111.701 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.628 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -136.32 172.87 12.38 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.235 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.678 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.9 t70 -98.73 122.66 42.24 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.905 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.442 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 14.1 p90 -53.16 -27.56 21.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.091 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.78 -34.61 58.0 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.923 0.392 . . . . 0.0 109.954 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.506 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 39.7 tt0 -69.42 -48.56 60.6 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.678 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.4 mt -53.36 -43.89 52.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.973 178.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.601 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.44 -52.0 65.29 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.322 178.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -61.25 -32.41 72.21 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.846 ' HB3' ' HB2' ' A' ' 106' ' ' GLN . 1.9 mmp_? -65.34 -37.11 86.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.08 0.467 . . . . 0.0 110.491 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 12.7 t-20 -93.62 -4.35 50.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.928 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 17.3 m120 78.34 16.82 1.21 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.491 0.716 . . . . 0.0 111.178 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.601 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 11.1 pt -102.57 -175.88 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.56 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 77.4 mt-30 -112.29 160.89 17.21 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.738 -0.385 . . . . 0.0 109.969 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.442 ' O ' HD23 ' A' ' 73' ' ' LEU . 11.2 p-10 -55.82 -58.26 8.6 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 122.36 1.076 . . . . 0.0 109.277 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -76.39 12.0 1.38 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.859 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.56 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 1.9 t70 -66.17 -35.92 81.75 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.9 mp 68.71 115.88 0.04 OUTLIER 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.097 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.741 HG21 HD11 ' A' ' 105' ' ' LEU . 10.1 pt -94.54 176.6 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.665 -178.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.458 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 15.3 m-85 -129.25 157.22 76.78 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.624 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.6 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 17.9 Cg_endo -64.93 135.82 45.97 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 122.889 2.393 . . . . 0.0 112.863 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.68 20.95 22.94 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' ' 66' ' ' THR . 92.6 mt-30 -109.77 165.81 11.4 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.464 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 88.5 t -125.52 115.21 42.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.741 HD11 HG21 ' A' ' 99' ' ' ILE . 87.1 mt -110.77 151.2 28.06 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.952 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.846 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 71.2 mt-30 -90.19 115.08 27.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.872 0.844 . . . . 0.0 110.581 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.1 151.25 68.92 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.36 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.22 -21.03 71.91 Favored 'Trans proline' 0 N--CA 1.474 0.346 0 C-N-CA 123.395 2.73 . . . . 0.0 114.673 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.9 t . . . . . 0 C--N 1.32 -0.688 0 CA-C-O 121.079 0.466 . . . . 0.0 111.184 179.735 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.444 -0.785 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 90.9 m-20 74.21 29.8 1.26 Allowed 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 122.94 0.496 . . . . 0.0 111.459 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.638 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 19.6 p90 -62.75 -39.36 93.89 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.076 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.639 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 42.8 t-105 -62.35 -32.39 73.16 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.848 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -52.58 -37.69 58.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.796 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.67 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 31.3 m -123.29 26.62 7.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.462 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.639 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -107.42 144.64 34.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.251 177.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.471 ' HB2' ' CZ3' ' A' ' 146' ' ' TRP . 1.8 tpt180 -129.75 137.85 50.77 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.7 t70 54.53 67.66 0.98 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.481 0.658 . . . . 0.0 110.659 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.501 HG12 HD11 ' A' ' 136' ' ' LEU . 39.2 t -91.79 124.51 44.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.866 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -148.0 148.11 30.36 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.972 0.415 . . . . 0.0 110.559 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.875 HD13 HG22 ' A' ' 14' ' ' ILE . 30.4 mt -86.68 134.83 33.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.674 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.599 HG23 ' HB ' ' A' ' 135' ' ' VAL . 35.6 m -127.82 157.31 39.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.18 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.49 ' HB3' ' HD3' ' A' ' 134' ' ' LYS . 6.4 m-20 72.38 1.88 4.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.931 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.628 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 99.09 28.03 7.93 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.628 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.522 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 98.07 -23.14 37.34 Favored Glycine 0 C--O 1.266 2.13 0 CA-C-O 123.282 1.49 . . . . 0.0 112.654 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.789 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 15.9 ptmt -64.72 -20.0 66.09 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 121.721 -0.87 . . . . 0.0 108.933 177.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.599 ' HB ' HG23 ' A' ' 130' ' ' VAL . 6.8 t -136.94 146.01 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.324 0.583 . . . . 0.0 110.378 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.561 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 30.5 tp -124.95 121.54 34.74 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.5 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 40.2 tt0 -112.02 134.46 53.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.951 0.405 . . . . 0.0 111.788 -177.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.806 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -163.29 161.85 24.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.749 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -96.06 110.29 22.56 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.659 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 50.8 mt -96.19 137.04 35.85 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.175 0.512 . . . . 0.0 111.115 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.67 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 56.4 ttt180 -72.59 140.74 48.23 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.942 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.498 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 3.3 p90 -159.42 -170.34 2.92 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.563 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.4 m -54.66 -32.46 59.24 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 123.349 0.406 . . . . 0.0 111.789 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -97.51 16.52 60.43 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.404 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 141' ' ' ARG . . . 101.58 -110.23 3.8 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.266 -0.968 . . . . 0.0 112.395 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.471 ' CZ3' ' HB2' ' A' ' 125' ' ' ARG . 70.7 m95 -132.93 129.39 38.24 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.498 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 65.7 t30 -130.35 145.02 51.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.721 0.295 . . . . 0.0 110.617 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -73.88 109.28 7.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.272 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.628 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 35.8 t -122.6 165.32 16.64 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.561 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 27.7 mtt85 -145.98 158.82 43.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.09 0.471 . . . . 0.0 111.026 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.872 HD13 HD22 ' A' ' 43' ' ' LEU . 10.2 tt -140.21 146.87 24.06 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.063 178.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.708 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 69.4 m-85 -90.71 102.76 15.51 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.301 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.733 HD13 HD22 ' A' ' 21' ' ' LEU . 20.6 mt -63.21 -34.16 77.05 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.813 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.789 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 6.1 t70 -58.52 -9.09 1.45 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.156 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.708 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 43.6 mt-10 -74.2 -50.69 18.11 Favored 'General case' 0 CA--C 1.508 -0.663 0 O-C-N 121.92 -0.488 . . . . 0.0 112.156 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.53 1.25 10.62 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.39 -177.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.419 HG12 ' HH2' ' A' ' 52' ' ' TRP . 47.5 mm -105.93 110.79 32.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.029 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -114.98 160.14 13.36 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.174 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.566 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.8 t30 -102.53 128.31 49.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.925 0.393 . . . . 0.0 109.972 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.416 ' HB2' HD11 ' A' ' 165' ' ' ILE . 58.6 ttt-85 -124.46 91.39 3.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.451 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 58.82 42.23 20.24 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.34 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.519 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 92.19 15.39 53.87 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.882 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 159' ' ' ASN . 10.5 tp10 -124.09 143.86 50.21 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.674 -0.309 . . . . 0.0 111.225 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.555 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 18.6 mt -103.31 110.49 22.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.927 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.504 HD13 ' H ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.818 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.4 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 22.7 m-85 . . . . . 0 CA--C 1.516 -0.345 0 CA-C-O 121.65 0.738 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.76 -25.92 2.04 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.642 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.06 -70.17 1.25 Allowed Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 119.576 -1.297 . . . . 0.0 112.718 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 66.08 10.85 7.37 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 122.535 0.334 . . . . 0.0 110.619 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.672 ' CE2' HD13 ' A' ' 14' ' ' ILE . 1.0 OUTLIER -58.5 -33.53 69.93 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.54 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.2 p -63.32 -22.35 66.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.507 0.594 . . . . 0.0 110.398 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.03 -21.73 79.02 Favored Glycine 0 CA--C 1.522 0.519 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.421 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 26' ' ' ARG . 59.4 m -127.84 -18.18 4.31 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 117.15 0.475 . . . . 0.0 111.485 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.8 m -101.42 129.98 47.55 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.973 0.416 . . . . 0.0 109.97 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.478 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 2.8 ptm180 -110.08 -178.47 3.53 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 42.89 47.72 4.9 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 123.748 0.655 . . . . 0.0 112.358 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.858 HG22 HD13 ' A' ' 129' ' ' LEU . 6.3 mt -81.76 103.39 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-O 121.253 0.549 . . . . 0.0 109.833 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.602 ' CA ' HD12 ' A' ' 129' ' ' LEU . 82.6 m -145.67 125.1 13.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.858 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.769 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -93.39 153.42 18.52 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 122.021 0.915 . . . . 0.0 113.1 -178.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -94.05 73.92 4.08 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.956 -1.474 . . . . 0.0 107.835 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.03 -55.2 4.78 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.946 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.526 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -146.33 -12.4 0.47 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.083 0.468 . . . . 0.0 110.102 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -88.89 94.49 9.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.898 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.911 ' HB2' HD22 ' A' ' 39' ' ' LEU . 46.7 tp -60.15 122.86 15.46 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.473 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 15' ' ' CYS . 51.4 ttp180 -126.25 125.58 42.61 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.581 -178.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.636 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -148.25 145.91 28.41 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.63 0.728 . . . . 0.0 111.323 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.591 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 2.3 mm-40 -81.17 76.04 8.13 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.386 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.658 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 54.9 m -64.99 130.44 43.37 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.306 0.574 . . . . 0.0 111.336 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.472 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 3.8 tmm_? -72.18 118.88 15.61 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.394 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 14.0 ptm180 -87.17 156.44 19.69 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -50.92 -20.44 4.32 Favored Glycine 0 C--N 1.339 0.702 0 O-C-N 124.672 1.232 . . . . 0.0 114.768 -177.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -72.22 -9.96 59.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.236 0.541 . . . . 0.0 110.057 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.13 6.43 63.15 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.429 ' O ' ' HG2' ' A' ' 27' ' ' ARG . . . -106.36 164.9 13.53 Favored Glycine 0 C--O 1.224 -0.506 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.524 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.591 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 71.0 m-85 -101.61 130.34 47.92 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.878 0.37 . . . . 0.0 110.912 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.4 m -119.1 133.46 55.78 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.873 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.8 m -71.48 110.4 6.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.279 0.561 . . . . 0.0 111.079 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.4 t -113.61 150.88 32.46 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.665 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 5.1 p -144.88 137.02 21.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.937 0.399 . . . . 0.0 110.676 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.474 HG23 ' HB3' ' A' ' 21' ' ' LEU . 10.6 tt -133.98 144.77 34.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.267 -177.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.0 92.71 3.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.025 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.911 HD22 ' HB2' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -71.87 -11.13 60.65 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.139 0.495 . . . . 0.0 110.669 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.526 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 26.5 p30 -67.25 -8.64 33.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.909 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.434 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 30.5 ttm180 -108.25 -0.91 20.58 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.729 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 91.4 m-85 -125.64 -23.03 4.12 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.634 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.645 HD22 HD13 ' A' ' 151' ' ' ILE . 48.7 mt -111.02 137.66 48.39 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.19 0.519 . . . . 0.0 111.207 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.428 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 5.2 m -130.61 146.16 52.06 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.051 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.458 ' CG ' ' HB3' ' A' ' 123' ' ' SER . 3.8 p-10 -94.91 106.05 18.01 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -102.42 90.03 3.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.976 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.477 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 66.9 t30 52.5 43.23 31.26 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.138 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.579 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 84.75 38.64 9.33 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.644 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -150.9 137.61 18.9 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.716 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 15.0 m-85 -80.51 141.76 34.84 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.298 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -141.03 131.55 25.39 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.489 ' CD1' HD11 ' A' ' 151' ' ' ILE . 86.1 m95 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.598 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 91.0 m . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 121.168 0.508 . . . . 0.0 110.467 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.89 177.9 7.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.743 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.459 HG22 ' HG2' ' A' ' 106' ' ' GLN . 11.5 p -128.8 115.78 18.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.72 0.295 . . . . 0.0 111.284 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.495 HG21 ' CE2' ' A' ' 80' ' ' PHE . 12.0 p -102.07 145.41 11.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.066 0.46 . . . . 0.0 111.447 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 3.8 m -92.96 131.33 38.06 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.938 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.535 ' CG2' HD12 ' A' ' 99' ' ' ILE . 49.2 t -83.31 135.62 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.808 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -102.63 169.42 8.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 124.349 1.03 . . . . 0.0 111.051 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.651 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 6.5 tp-100 -63.39 116.66 5.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.389 -178.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.68 -16.47 58.67 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.96 -0.564 . . . . 0.0 113.151 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -82.38 134.96 35.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.027 0.441 . . . . 0.0 110.979 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.59 ' HA ' HG12 ' A' ' 99' ' ' ILE . 68.6 p -113.37 178.64 4.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.692 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.683 HD22 HG23 ' A' ' 99' ' ' ILE . 1.7 mm? -52.96 -41.18 64.29 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.216 0.532 . . . . 0.0 110.198 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.518 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 43.1 ttm105 -65.65 -36.88 84.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.282 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -68.47 -39.4 81.42 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 72' ' ' THR . 42.2 mm -66.41 -49.55 74.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.504 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.767 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -58.07 -45.84 93.38 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.67 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 78' ' ' ARG . 24.8 ttm180 -64.68 -37.24 86.9 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.899 0.381 . . . . 0.0 111.815 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -77.92 -33.87 51.56 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.495 ' CE2' HG21 ' A' ' 65' ' ' VAL . 96.4 m-85 -110.3 20.46 17.79 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.5 t0 53.87 46.32 25.95 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.9 0.857 . . . . 0.0 111.135 178.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.767 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.8 p -130.09 170.77 13.59 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.425 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.619 ' O ' HG13 ' A' ' 87' ' ' ILE . 6.2 t70 -100.16 122.55 43.17 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.542 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 8.8 p90 -51.09 -30.19 15.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.512 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -63.67 -48.1 78.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.62 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.697 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 16.5 mm-40 -67.7 -43.39 80.2 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.337 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.619 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.3 mt -53.68 -48.36 60.38 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.773 0.797 . . . . 0.0 109.01 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.634 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.17 -48.43 78.42 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.827 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -37.85 78.19 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.697 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 68.7 mmt-85 -67.92 -33.6 75.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.822 0.344 . . . . 0.0 110.994 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.525 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 11.4 t-20 -92.8 -5.33 51.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.535 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 5.6 m-20 78.2 15.3 1.4 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.359 0.664 . . . . 0.0 111.031 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.634 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 15.4 pt -100.83 -177.78 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.621 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . 86.1 mm-40 -110.83 152.51 26.59 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.022 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.566 ' O ' HD23 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -53.87 -68.71 0.16 Allowed 'General case' 0 C--O 1.243 0.711 0 CA-C-O 122.194 0.997 . . . . 0.0 110.252 179.688 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -73.75 13.4 0.5 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.547 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.621 ' HB2' ' HB2' ' A' ' 94' ' ' GLN . 7.3 t70 -66.84 -31.79 72.64 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 8.5 mp 73.97 114.17 0.06 Allowed 'General case' 0 N--CA 1.463 0.206 0 O-C-N 124.361 1.038 . . . . 0.0 109.829 -177.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.683 HG23 HD22 ' A' ' 73' ' ' LEU . 7.1 pt -94.61 176.36 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.651 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.506 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 92.3 m-85 -123.25 160.04 51.91 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.598 -178.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.651 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 42.1 Cg_endo -70.55 139.19 36.93 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 123.43 2.753 . . . . 0.0 113.716 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.6 9.56 61.28 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.463 ' O ' ' HA ' ' A' ' 66' ' ' THR . 27.1 tt0 -94.09 162.85 13.71 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 115.16 -0.52 . . . . 0.0 109.754 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 72.9 t -127.43 118.95 50.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.53 HD11 HG21 ' A' ' 99' ' ' ILE . 69.8 mt -115.38 151.66 34.26 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.124 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.459 ' HG2' HG22 ' A' ' 64' ' ' THR . 71.8 mt-30 -89.65 118.33 29.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.67 0.747 . . . . 0.0 110.987 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.408 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 29.6 m -125.19 151.88 70.08 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.43 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.408 ' HD2' ' HB ' ' A' ' 107' ' ' VAL . 29.9 Cg_endo -62.92 -16.89 56.96 Favored 'Trans proline' 0 N--CA 1.472 0.253 0 C-N-CA 123.196 2.597 . . . . 0.0 114.392 -177.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.4 t . . . . . 0 C--N 1.323 -0.568 0 CA-C-O 121.035 0.445 . . . . 0.0 111.056 179.829 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.441 -1.018 0 N-CA-C 111.396 -0.681 . . . . 0.0 111.396 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.6 m120 69.42 31.18 3.89 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 122.943 0.497 . . . . 0.0 111.96 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.617 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 24.0 p90 -59.38 -35.78 74.58 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.585 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 57.5 t-105 -64.97 -33.23 75.53 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.826 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.52 -22.69 45.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.293 0.568 . . . . 0.0 110.954 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.745 ' OG ' ' HB3' ' A' ' 141' ' ' ARG . 47.9 t -133.64 23.98 4.01 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.179 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.585 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -111.02 144.5 40.04 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.334 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.615 ' HB2' ' CZ3' ' A' ' 146' ' ' TRP . 0.1 OUTLIER -129.52 128.03 41.99 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.437 ' N ' ' HD3' ' A' ' 125' ' ' ARG . 24.6 t0 56.94 62.92 2.07 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 124.071 0.857 . . . . 0.0 111.626 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.57 ' CG1' HD11 ' A' ' 136' ' ' LEU . 60.5 t -76.06 131.05 35.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.525 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -140.88 138.42 33.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.449 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.858 HD13 HG22 ' A' ' 14' ' ' ILE . 13.7 mt -86.91 131.9 33.97 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 177.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.639 HG23 ' HB ' ' A' ' 135' ' ' VAL . 33.9 m -128.74 158.61 41.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.213 0.53 . . . . 0.0 111.189 -178.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 67.46 11.54 8.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.014 -0.993 . . . . 0.0 111.889 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.702 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 92.73 31.22 8.87 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.203 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.536 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 88.23 -16.62 51.7 Favored Glycine 0 C--O 1.263 1.944 0 CA-C-O 123.441 1.578 . . . . 0.0 112.687 177.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.913 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 14.8 ptpt -68.09 -16.42 64.01 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 121.381 -1.07 . . . . 0.0 109.1 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.639 ' HB ' HG23 ' A' ' 130' ' ' VAL . 14.3 t -140.55 141.76 31.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.981 177.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.57 HD11 ' CG1' ' A' ' 127' ' ' VAL . 42.6 tp -120.53 126.88 51.45 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -120.16 134.64 55.21 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.746 0.308 . . . . 0.0 110.455 -177.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . . . -160.63 158.98 29.85 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.675 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -95.05 108.68 20.77 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.579 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 56.0 mt -94.19 131.29 39.91 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.699 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.745 ' HB3' ' OG ' ' A' ' 123' ' ' SER . 65.2 ttt180 -73.46 141.23 46.85 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.443 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.637 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 0.8 OUTLIER -154.56 -170.68 3.6 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.583 -179.748 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.2 m -58.34 -26.55 63.24 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -95.0 6.25 69.19 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.389 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 141' ' ' ARG . . . 111.26 -112.49 3.19 Favored Glycine 0 C--O 1.224 -0.491 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.746 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.615 ' CZ3' ' HB2' ' A' ' 125' ' ' ARG . 93.4 m95 -124.85 126.04 44.94 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.637 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 60.6 t30 -118.27 140.27 50.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.445 -178.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -73.55 104.74 4.62 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.2 m -118.55 156.3 29.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.577 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 17.4 ptt180 -148.79 163.43 37.38 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.535 -0.466 . . . . 0.0 112.16 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.716 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 8.9 tt -148.42 144.77 18.71 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.612 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.608 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.631 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 38.0 m-85 -88.76 104.42 16.88 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 122.154 -0.341 . . . . 0.0 110.929 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.695 HD11 HD21 ' A' ' 129' ' ' LEU . 27.8 mt -66.69 -35.31 79.83 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.904 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.913 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 4.8 t0 -55.91 -10.24 0.74 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.947 178.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.631 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 45.4 mt-10 -71.74 -55.09 8.29 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -125.22 8.58 7.91 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.884 -0.726 . . . . 0.0 112.388 -176.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.454 HG12 ' CH2' ' A' ' 52' ' ' TRP . 41.1 mm -106.65 107.81 23.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -110.54 178.04 19.73 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.656 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.658 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -117.75 134.44 54.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.893 0.377 . . . . 0.0 110.808 179.364 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.482 ' HB2' HD13 ' A' ' 165' ' ' ILE . 43.9 ttm180 -125.2 92.68 3.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.363 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 66.9 t30 57.9 46.35 16.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.83 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.464 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 87.52 11.56 68.55 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.613 178.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -122.69 133.03 54.51 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 117.19 0.495 . . . . 0.0 110.956 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.478 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 29.7 mt -76.03 122.59 24.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.471 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.482 HD13 ' HB2' ' A' ' 160' ' ' ARG . 43.7 pt . . . . . 0 C--N 1.323 -0.565 0 CA-C-O 121.646 0.736 . . . . 0.0 111.765 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.559 ' CD1' ' HG2' ' A' ' 155' ' ' GLU . 64.7 m-85 . . . . . 0 N--CA 1.455 -0.221 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.72 -27.89 11.52 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -71.02 -73.87 0.76 Allowed Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 119.068 -1.539 . . . . 0.0 112.16 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 65.44 23.07 11.94 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 122.711 0.404 . . . . 0.0 110.145 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.793 ' HD2' HD11 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -64.62 -34.96 79.51 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.531 179.725 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.415 ' HA ' HD11 ' A' ' 14' ' ' ILE . 28.8 t -66.02 -15.47 63.06 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.487 0.66 . . . . 0.0 109.916 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.55 -28.42 72.34 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.113 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 28.6 m -136.33 -3.22 2.18 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 117.413 0.607 . . . . 0.0 111.494 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.407 ' OG ' ' HB1' ' A' ' 23' ' ' ALA . 6.0 t -105.92 133.72 50.19 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.486 ' CG ' ' HB2' ' A' ' 24' ' ' GLU . 14.9 ptm180 -112.02 -176.39 2.91 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.428 ' HB2' ' HG2' ' A' ' 24' ' ' GLU . 2.3 m-20 42.61 44.52 3.68 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 124.04 0.837 . . . . 0.0 112.177 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.885 HG22 HD13 ' A' ' 129' ' ' LEU . 6.4 mt -78.17 102.86 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-O 121.012 0.434 . . . . 0.0 109.886 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.599 ' HA ' HD12 ' A' ' 129' ' ' LEU . 80.0 m -147.35 126.1 12.63 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.702 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -89.12 153.57 20.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.007 0.908 . . . . 0.0 113.191 -178.322 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.668 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 21.3 t70 -92.96 72.07 4.72 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 113.726 -1.579 . . . . 0.0 107.166 177.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.56 -56.69 5.03 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.939 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.429 ' H ' ' H ' ' A' ' 20' ' ' ARG . . . -148.56 -12.1 0.34 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.668 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 56.3 mtp180 -84.4 89.51 7.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.017 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.88 HD22 HD13 ' A' ' 153' ' ' LEU . 42.6 tp -57.24 123.46 15.41 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.155 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.593 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 22.2 ttp180 -125.74 134.73 51.67 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.141 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.583 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -155.63 141.69 18.28 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.695 0.759 . . . . 0.0 111.363 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.486 ' HB2' ' CG ' ' A' ' 12' ' ' ARG . 78.2 mm-40 -78.93 79.58 5.32 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.367 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.754 ' SG ' HD13 ' A' ' 164' ' ' LEU . 25.6 m -67.09 122.49 17.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.183 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 10' ' ' SER . 58.1 ttt-85 -68.69 118.85 12.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.391 178.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.1 ttt180 -88.0 155.1 20.0 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -47.25 -25.05 2.59 Favored Glycine 0 N--CA 1.463 0.459 0 O-C-N 124.598 1.187 . . . . 0.0 115.533 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -75.24 -5.77 46.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.205 0.526 . . . . 0.0 110.89 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.85 5.98 65.86 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -101.63 135.22 12.08 Favored Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.585 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 94.8 m-85 -87.81 130.52 34.84 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.776 0.322 . . . . 0.0 110.366 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 41.7 m -118.08 137.05 53.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.525 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.5 m -71.18 111.25 6.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.286 0.565 . . . . 0.0 111.16 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 162' ' ' GLY . 32.3 t -117.46 149.75 40.06 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.474 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.7 p -144.77 137.02 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.969 0.414 . . . . 0.0 111.633 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.624 HG22 HD23 ' A' ' 164' ' ' LEU . 12.4 tt -135.36 148.14 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.32 -178.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.47 ' OD2' ' HB3' ' A' ' 40' ' ' ASN . 25.2 t70 -81.89 109.24 16.08 Favored 'General case' 0 CA--C 1.516 -0.363 0 O-C-N 121.938 -0.476 . . . . 0.0 111.3 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.629 HD23 ' HB3' ' A' ' 21' ' ' LEU . 3.4 mm? -88.3 0.93 55.59 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.119 0.485 . . . . 0.0 110.092 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.47 ' HB3' ' OD2' ' A' ' 38' ' ' ASP . 3.8 t30 -73.86 -24.5 59.76 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.7 mtt85 -100.63 13.41 34.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.248 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -132.02 -31.24 1.5 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.295 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.872 HD22 HD13 ' A' ' 151' ' ' ILE . 49.3 mt -105.85 134.79 48.41 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.999 0.428 . . . . 0.0 110.8 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.558 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 1.9 m -126.79 146.36 50.28 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.288 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.487 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 4.0 p-10 -91.98 100.93 13.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.743 0.782 . . . . 0.0 109.498 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -100.89 94.06 5.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.042 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.418 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 64.3 t30 52.18 43.87 30.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.486 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.741 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 80.29 41.09 12.19 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.644 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.461 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 34.3 t-80 -160.69 127.69 4.23 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.713 ' HB2' ' HB ' ' A' ' 151' ' ' ILE . 87.6 m-85 -67.52 151.44 47.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.892 0.377 . . . . 0.0 111.547 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -148.39 130.47 15.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.038 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.429 ' CD1' HD11 ' A' ' 151' ' ' ILE . 96.3 m95 . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.094 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.45 -0.443 0 CA-C-O 121.016 0.436 . . . . 0.0 110.005 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.35 176.14 6.04 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.966 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.4 p -130.93 125.49 33.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.599 0.238 . . . . 0.0 111.111 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.588 HG21 ' CE2' ' A' ' 80' ' ' PHE . 8.4 p -115.46 143.33 25.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.959 0.409 . . . . 0.0 111.285 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 16.3 m -88.53 127.11 35.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.087 0.47 . . . . 0.0 109.873 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.497 ' CG2' HD12 ' A' ' 99' ' ' ILE . 43.7 t -75.92 134.57 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.788 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -104.48 169.54 8.41 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 124.541 1.15 . . . . 0.0 111.451 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.635 ' OE1' ' HG3' ' A' ' 101' ' ' PRO . 51.0 tp60 -64.25 116.06 5.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.55 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.78 -4.56 57.85 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.291 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.39 122.4 43.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.764 0.316 . . . . 0.0 110.92 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.688 ' HA ' HG12 ' A' ' 99' ' ' ILE . 75.5 p -105.37 -177.83 3.48 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.659 HD22 HG23 ' A' ' 99' ' ' ILE . 1.4 mm? -52.58 -41.85 63.97 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 121.396 0.617 . . . . 0.0 109.384 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.422 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 39.4 ttm180 -64.34 -37.95 89.32 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.091 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -73.08 -38.59 66.35 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.102 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.558 HG12 ' O ' ' A' ' 72' ' ' THR . 46.0 mm -64.81 -48.21 85.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.649 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -54.65 -53.64 37.81 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.718 -0.674 . . . . 0.0 113.03 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -68.25 -25.23 65.08 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -78.35 -41.99 31.85 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.588 ' CE2' HG21 ' A' ' 65' ' ' VAL . 89.2 m-85 -107.6 12.71 27.39 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.4 t70 61.31 52.61 3.78 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.804 0.811 . . . . 0.0 111.046 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.649 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.0 p -134.72 169.66 17.0 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.403 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.656 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.6 t70 -95.94 121.08 37.3 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.708 -0.397 . . . . 0.0 109.992 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.613 ' HD2' ' HB2' ' A' ' 95' ' ' ASN . 17.7 p90 -50.63 -31.31 15.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.923 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.78 -42.87 76.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.309 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.694 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 11.6 mm-40 -68.22 -43.87 77.0 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.656 HG13 ' O ' ' A' ' 83' ' ' ASP . 6.5 mt -53.5 -47.82 59.06 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-O 121.435 0.636 . . . . 0.0 109.474 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.632 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.18 -50.88 70.06 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.529 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -59.98 -36.18 76.6 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.694 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 83.3 mmt-85 -68.08 -34.81 77.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.991 0.424 . . . . 0.0 110.622 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.456 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 4.2 t-20 -91.3 -5.06 55.23 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.805 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 4.7 m-20 78.55 13.48 1.42 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.451 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.632 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 19.0 pt -98.74 -171.36 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -117.84 151.17 37.89 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.253 -0.28 . . . . 0.0 110.548 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.613 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 21.1 p-10 -53.07 -56.97 12.13 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-O 122.088 0.947 . . . . 0.0 109.294 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -75.96 6.82 4.65 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.425 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -66.55 -35.8 81.11 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.4 mp 67.62 115.13 0.03 OUTLIER 'General case' 0 C--O 1.235 0.332 0 CA-C-O 122.138 0.971 . . . . 0.0 109.987 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.688 HG12 ' HA ' ' A' ' 72' ' ' THR . 7.8 pt -93.74 174.96 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.038 -177.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.553 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 64.4 m-85 -127.15 160.6 58.85 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.689 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.635 ' HG3' ' OE1' ' A' ' 69' ' ' GLN . 34.8 Cg_endo -67.22 137.6 44.31 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.063 2.509 . . . . 0.0 113.941 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.49 17.9 32.29 Favored Glycine 0 N--CA 1.44 -1.075 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.707 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.537 ' O ' ' HA ' ' A' ' 66' ' ' THR . 45.7 mt-30 -106.83 165.06 11.6 Favored 'General case' 0 C--O 1.216 -0.682 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.864 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.3 t -125.81 110.03 23.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.652 HD11 HG21 ' A' ' 99' ' ' ILE . 63.8 mt -105.25 152.01 23.41 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.21 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 38.5 mt-30 -89.84 114.6 26.37 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.747 0.784 . . . . 0.0 110.415 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.0 m -117.88 150.55 47.37 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.71 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.44 -16.34 43.05 Favored 'Trans proline' 0 C--N 1.331 -0.375 0 C-N-CA 123.004 2.469 . . . . 0.0 113.387 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.4 t . . . . . 0 C--N 1.318 -0.763 0 CA-C-O 121.001 0.429 . . . . 0.0 110.318 179.678 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.558 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.44 -1.049 0 N-CA-C 112.379 -0.289 . . . . 0.0 112.379 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 71.14 30.14 2.73 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 122.903 0.481 . . . . 0.0 111.215 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.591 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 25.6 p90 -57.44 -39.06 75.44 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.603 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 67.6 t-105 -62.33 -34.58 76.91 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.915 -1.038 . . . . 0.0 111.966 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.83 -25.69 20.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.986 0.422 . . . . 0.0 111.369 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.814 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 19.3 m -134.28 29.46 3.66 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.037 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.603 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -115.73 141.13 48.49 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.193 0.521 . . . . 0.0 111.48 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -129.77 149.32 51.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.07 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.06 50.58 16.33 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 123.614 0.571 . . . . 0.0 110.83 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.476 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 30.2 t -80.74 117.89 27.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.883 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 35.4 ptt85 -145.89 144.57 30.28 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.191 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.885 HD13 HG22 ' A' ' 14' ' ' ILE . 23.4 mt -84.61 131.12 34.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.291 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.472 HG23 ' HB ' ' A' ' 135' ' ' VAL . 34.4 m -126.54 167.57 20.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.403 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.573 ' HB3' ' CE ' ' A' ' 134' ' ' LYS . 1.2 m-20 64.45 10.18 5.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.612 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.651 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 93.82 24.34 20.66 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.848 -0.692 . . . . 0.0 113.481 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 94.64 -18.88 56.24 Favored Glycine 0 C--O 1.268 2.241 0 CA-C-O 123.803 1.779 . . . . 0.0 111.914 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.763 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 65.4 pttt -69.52 -14.21 62.74 Favored 'General case' 0 C--N 1.313 -1.018 0 O-C-N 121.598 -0.942 . . . . 0.0 108.769 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.647 HG23 ' HG3' ' A' ' 134' ' ' LYS . 23.5 t -139.47 137.18 40.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 121.355 0.597 . . . . 0.0 110.513 177.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 30.3 tp -117.31 121.97 42.62 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.541 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 35.8 tt0 -115.01 134.81 54.87 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.864 0.364 . . . . 0.0 111.46 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.685 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.42 163.11 27.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.569 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 41.7 mt-10 -94.53 108.43 20.38 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.741 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 59.7 mt -94.99 130.59 41.59 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.338 0.59 . . . . 0.0 110.753 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.814 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 73.5 ttt180 -70.73 140.66 51.46 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.88 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.501 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 5.6 p90 -158.3 -171.91 3.67 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 18.4 m -54.85 -30.52 57.8 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.3 18.51 56.39 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.369 -0.92 . . . . 0.0 113.723 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 103.9 -120.67 6.77 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.278 -0.963 . . . . 0.0 112.332 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -123.57 124.28 42.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.944 0.372 . . . . 0.0 110.601 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.501 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 27.3 t-20 -118.81 125.83 50.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.473 ' HD3' ' OE2' ' A' ' 137' ' ' GLU . 55.1 ttm-85 -74.74 99.24 3.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.245 0.545 . . . . 0.0 110.033 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.461 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 7.3 t -112.3 173.08 6.54 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.105 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.541 ' HG2' ' HG3' ' A' ' 137' ' ' GLU . 15.6 mtm180 -145.2 163.84 33.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.107 0.479 . . . . 0.0 111.398 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.872 HD13 HD22 ' A' ' 43' ' ' LEU . 9.1 tt -143.24 148.98 18.74 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.392 178.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.597 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 12.6 m-85 -92.06 103.93 16.38 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 122.028 -0.42 . . . . 0.0 110.964 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.88 HD13 HD22 ' A' ' 21' ' ' LEU . 22.5 mt -67.15 -34.14 76.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.111 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.763 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 7.7 t70 -58.32 -7.76 0.96 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.274 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.56 ' HG3' ' CB ' ' A' ' 152' ' ' TYR . 40.5 mt-10 -72.39 -51.03 22.25 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 121.91 -0.494 . . . . 0.0 111.976 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -119.26 -5.6 10.41 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 120.499 -0.481 . . . . 0.0 112.285 -177.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.463 ' CG2' ' HG ' ' A' ' 164' ' ' LEU . 48.9 mm -100.21 114.23 38.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.841 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -118.79 176.44 16.09 Favored Glycine 0 C--O 1.225 -0.422 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.289 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.586 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.0 t30 -112.1 123.81 51.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.943 0.401 . . . . 0.0 110.149 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -118.63 85.88 2.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.928 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 52.2 43.72 30.36 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.497 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 103.29 -4.82 48.41 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.294 -0.955 . . . . 0.0 114.085 178.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -121.92 129.43 52.53 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 117.223 0.512 . . . . 0.0 111.426 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.793 HD11 ' HD2' ' A' ' 7' ' ' PHE . 1.8 tp -71.12 113.32 8.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.553 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 11.0 tp . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.392 -179.027 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -111.8 -25.41 9.48 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -66.8 -72.75 0.72 Allowed Glycine 0 N--CA 1.433 -1.503 0 C-N-CA 119.366 -1.397 . . . . 0.0 112.405 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 60.69 17.16 7.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.74 0.305 . . . . 0.0 110.725 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.7 ' CE2' HD13 ' A' ' 14' ' ' ILE . 0.4 OUTLIER -60.92 -32.57 72.05 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.398 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.491 ' OG ' ' HG2' ' A' ' 134' ' ' LYS . 23.1 t -66.0 -19.84 65.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.037 0.446 . . . . 0.0 110.375 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.7 -20.6 78.69 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.079 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.515 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 51.2 p -129.4 -24.66 2.77 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 117.241 0.521 . . . . 0.0 111.375 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.422 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 5.9 m -96.71 130.88 43.86 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 12' ' ' ARG . 12.5 ptm180 -115.07 -174.18 2.45 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 47.69 40.77 12.65 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 123.513 0.508 . . . . 0.0 111.225 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.876 HG22 HD13 ' A' ' 129' ' ' LEU . 7.7 mt -80.71 103.31 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-O 120.832 0.348 . . . . 0.0 110.164 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.605 ' HA ' HD12 ' A' ' 129' ' ' LEU . 79.0 m -146.9 128.09 14.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.809 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.749 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -99.41 152.89 19.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.701 0.762 . . . . 0.0 112.956 -179.844 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -93.85 75.87 4.22 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.33 -55.08 4.82 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.542 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.577 ' HB1' ' HB2' ' A' ' 40' ' ' ASN . . . -148.69 -7.86 0.38 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.901 0.381 . . . . 0.0 110.507 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.4 mmm-85 -89.27 90.53 8.38 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.767 ' HB2' HD22 ' A' ' 39' ' ' LEU . 55.0 tp -62.67 127.79 32.92 Favored 'General case' 0 C--O 1.213 -0.839 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.566 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 42.9 ttt180 -133.34 131.75 40.48 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.441 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.631 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -150.84 145.93 26.01 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.744 0.783 . . . . 0.0 111.516 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 1.7 mm-40 -82.97 74.58 9.92 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.34 178.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.556 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 60.0 m -60.74 124.2 19.72 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.143 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.515 ' HB2' ' O ' ' A' ' 10' ' ' SER . 19.7 ttp180 -70.57 127.43 32.66 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.13 0.491 . . . . 0.0 110.749 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.484 ' HG3' ' CG ' ' A' ' 161' ' ' ASN . 37.2 ttp180 -97.29 151.9 19.42 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.32 -15.86 1.96 Allowed Glycine 0 N--CA 1.46 0.278 0 O-C-N 124.717 1.261 . . . . 0.0 115.006 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -75.96 -9.01 58.26 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.054 0.454 . . . . 0.0 110.432 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.66 6.86 60.59 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -112.27 161.69 12.64 Favored Glycine 0 C--O 1.224 -0.525 0 C-N-CA 120.455 -0.878 . . . . 0.0 112.202 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.513 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 86.2 m-85 -100.38 139.1 36.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.005 0.403 . . . . 0.0 110.856 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.1 t -122.89 120.64 34.05 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 m -63.73 115.53 4.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.157 0.503 . . . . 0.0 110.487 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.4 t -120.99 152.82 38.11 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.063 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.566 ' HB ' ' HG3' ' A' ' 22' ' ' ARG . 3.2 p -145.05 138.66 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 120.855 0.359 . . . . 0.0 111.433 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.5 tt -135.5 147.8 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.486 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -80.74 105.34 11.9 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.767 HD22 ' HB2' ' A' ' 21' ' ' LEU . 1.5 tp -84.71 -6.14 59.35 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.441 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.577 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 64.2 t30 -73.45 -14.31 61.22 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -105.88 15.37 26.74 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.427 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 66.3 m-85 -131.44 -32.67 1.52 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.635 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.773 HD22 HD13 ' A' ' 151' ' ' ILE . 33.2 mt -106.48 136.49 46.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.025 0.441 . . . . 0.0 111.423 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.637 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 9.0 m -125.74 146.81 49.6 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.701 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.608 ' ND2' ' HB2' ' A' ' 123' ' ' SER . 21.4 p-10 -95.13 93.7 7.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.669 0.747 . . . . 0.0 109.585 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -94.64 95.83 9.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.059 0.457 . . . . 0.0 111.758 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.465 ' HA ' ' HB2' ' A' ' 142' ' ' TYR . 62.5 t30 47.67 44.19 17.23 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.172 178.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.78 34.04 14.32 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.751 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -150.61 131.12 13.85 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.831 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 24.8 m-85 -75.34 138.3 41.68 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 51' ' ' ARG . 53.8 mtt-85 -140.7 136.38 32.55 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.518 ' CH2' HG12 ' A' ' 157' ' ' ILE . 98.2 m95 . . . . . 0 C--N 1.322 -0.616 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.353 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.0 m . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 120.92 0.391 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.89 177.37 4.99 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.164 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.544 HG22 ' HG2' ' A' ' 106' ' ' GLN . 10.6 p -127.7 117.08 21.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.856 0.36 . . . . 0.0 110.835 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.459 HG21 ' CE2' ' A' ' 80' ' ' PHE . 8.9 p -103.0 142.29 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.19 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 24.9 m -88.1 127.67 35.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.249 0.547 . . . . 0.0 110.095 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.511 HG21 HD12 ' A' ' 99' ' ' ILE . 48.7 t -79.16 134.67 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.364 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -107.4 171.08 7.58 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.307 1.004 . . . . 0.0 109.458 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.681 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 59.4 tt0 -65.85 123.18 19.1 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.794 -178.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.12 -4.23 58.71 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.348 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -105.77 122.68 46.57 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.89 0.376 . . . . 0.0 111.132 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.651 ' HA ' HG12 ' A' ' 99' ' ' ILE . 68.5 p -106.49 179.94 4.12 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.659 HD22 HG23 ' A' ' 99' ' ' ILE . 1.5 mm? -51.66 -43.4 62.65 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.461 0.648 . . . . 0.0 109.752 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 74' ' ' ARG . 42.8 ttt180 -60.65 -38.98 86.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.424 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -72.18 -45.67 59.43 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 72' ' ' THR . 45.0 mm -57.82 -47.66 85.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.003 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.672 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.19 -53.05 47.67 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.109 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -69.73 -26.43 64.32 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 122.469 -0.43 . . . . 0.0 111.786 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -75.87 -38.84 57.52 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.06 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.459 ' CE2' HG21 ' A' ' 65' ' ' VAL . 72.4 m-85 -111.16 19.62 18.2 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.7 t70 53.25 47.91 23.26 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.548 0.69 . . . . 0.0 111.783 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.672 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 3.3 p -127.88 171.05 12.14 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.651 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.1 t0 -96.75 117.89 32.03 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.707 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.432 ' HA ' HD12 ' A' ' 87' ' ' ILE . 3.3 p90 -50.49 -33.19 20.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.909 -1.042 . . . . 0.0 111.803 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.93 -41.44 91.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.17 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.654 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 33.0 tt0 -71.78 -46.64 57.7 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.695 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.651 HG13 ' O ' ' A' ' 83' ' ' ASP . 6.5 mt -49.7 -45.74 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.625 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.22 -51.1 69.13 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.416 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -63.67 -28.93 70.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.654 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 22.1 mmt180 -65.08 -39.79 93.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.288 0.566 . . . . 0.0 110.248 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 12.5 m120 -94.12 -3.6 50.76 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.677 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 93.7 m-20 79.08 11.01 1.51 Allowed 'General case' 0 N--CA 1.47 0.571 0 O-C-N 123.859 0.724 . . . . 0.0 111.455 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.625 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 18.9 pt -93.92 -173.48 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.509 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . 30.1 mm-40 -114.81 157.6 23.04 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 122.108 -0.37 . . . . 0.0 110.636 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.52 ' O ' HD23 ' A' ' 73' ' ' LEU . 3.4 p30 -55.62 -69.05 0.15 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.836 0.826 . . . . 0.0 109.728 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.59 13.43 0.62 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.335 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.509 ' HB2' ' HB2' ' A' ' 94' ' ' GLN . 5.6 t70 -64.3 -30.16 71.22 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.1 mp 68.55 113.5 0.04 OUTLIER 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.195 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.659 HG23 HD22 ' A' ' 73' ' ' LEU . 8.5 pt -93.85 175.83 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.227 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.501 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 85.7 m-85 -125.95 158.06 67.13 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.585 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.681 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 22.3 Cg_endo -67.28 139.16 49.08 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 123.135 2.557 . . . . 0.0 113.395 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.21 23.7 24.0 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.537 ' O ' ' HA ' ' A' ' 66' ' ' THR . 25.1 mt-30 -112.11 166.07 11.57 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.533 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 66.9 t -125.89 110.36 23.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.58 HD11 HG21 ' A' ' 99' ' ' ILE . 75.8 mt -103.95 151.04 23.65 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.4 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.637 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 62.7 mt-30 -90.74 117.58 29.49 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.832 0.825 . . . . 0.0 110.6 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.8 m -125.65 150.56 68.66 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.702 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.38 -19.34 67.91 Favored 'Trans proline' 0 C--N 1.332 -0.325 0 C-N-CA 123.262 2.641 . . . . 0.0 113.722 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.5 t . . . . . 0 C--N 1.324 -0.528 0 CA-C-O 121.059 0.457 . . . . 0.0 111.088 179.961 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.637 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.443 -0.871 0 N-CA-C 112.726 -0.15 . . . . 0.0 112.726 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 72.02 27.43 2.7 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.406 0.683 . . . . 0.0 111.011 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.63 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 22.6 p90 -60.36 -40.67 91.59 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.087 0.47 . . . . 0.0 109.798 178.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.616 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 43.1 t-105 -65.29 -28.87 69.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.913 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.17 -19.49 54.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.737 0.303 . . . . 0.0 111.013 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.608 ' HB2' ' ND2' ' A' ' 45' ' ' ASN . 22.9 m -139.15 27.62 2.34 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 120.899 0.381 . . . . 0.0 110.252 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.616 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -110.54 148.26 32.49 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.37 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 125' ' ' ARG . 11.6 ttm180 -133.14 140.28 47.53 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.952 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.433 ' HB3' ' NH2' ' A' ' 128' ' ' ARG . 69.7 m-20 58.04 58.76 3.4 Favored 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 123.787 0.68 . . . . 0.0 111.123 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.499 ' CG1' HD11 ' A' ' 136' ' ' LEU . 40.5 t -86.79 115.88 28.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.839 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.433 ' NH2' ' HB3' ' A' ' 126' ' ' ASP . 0.0 OUTLIER -138.13 145.41 41.57 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.344 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.876 HD13 HG22 ' A' ' 14' ' ' ILE . 16.1 mt -85.23 133.26 34.18 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.757 HG23 ' HB ' ' A' ' 135' ' ' VAL . 27.3 m -125.27 159.37 32.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.347 -179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.569 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 0.3 OUTLIER 69.99 1.74 3.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.89 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.697 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 94.74 33.37 6.74 Favored Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.097 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 94.65 -20.89 46.2 Favored Glycine 0 C--O 1.263 1.936 0 CA-C-O 122.997 1.332 . . . . 0.0 113.21 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.777 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 0.2 OUTLIER -66.77 -16.43 64.25 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 121.307 -1.114 . . . . 0.0 109.214 178.591 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.757 ' HB ' HG23 ' A' ' 130' ' ' VAL . 9.4 t -141.72 145.57 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.262 0.553 . . . . 0.0 109.824 177.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 30.1 tp -125.72 121.04 32.3 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.469 ' HG3' ' HE ' ' A' ' 150' ' ' ARG . 20.8 tt0 -110.28 135.39 51.09 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.818 0.342 . . . . 0.0 111.632 -177.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.638 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -163.66 157.14 18.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.541 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.442 ' HG2' ' HD2' ' A' ' 148' ' ' ARG . 18.1 mt-10 -95.81 108.12 20.43 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 45' ' ' ASN . 58.6 mt -92.57 131.45 37.68 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.415 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.547 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 64.3 ttt180 -70.41 139.63 51.88 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.295 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.598 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 4.9 p90 -154.71 -164.11 1.74 Allowed 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.005 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.2 m -62.76 -14.62 46.94 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -125.83 36.45 2.74 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.416 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.77 -122.81 7.32 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.761 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -122.7 125.85 46.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.755 0.312 . . . . 0.0 110.399 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.598 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 46.5 t-20 -111.32 133.84 53.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.616 -178.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.442 ' HD2' ' HG2' ' A' ' 139' ' ' GLU . 4.1 tpt180 -73.49 98.01 2.69 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -113.55 160.66 18.28 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.899 -177.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.572 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 34.0 mtt180 -146.48 158.02 43.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.732 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.831 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 9.2 tt -141.67 142.11 28.98 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.02 178.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.607 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 27.7 m-85 -87.53 102.54 14.68 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.817 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.786 HD11 HD21 ' A' ' 129' ' ' LEU . 22.1 mt -63.96 -34.8 78.8 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.59 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.777 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 5.6 t70 -56.41 -9.4 0.69 Allowed 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.265 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.607 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 40.4 mt-10 -72.27 -52.71 15.08 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 121.923 -0.486 . . . . 0.0 112.287 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -124.43 3.23 8.4 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.549 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.518 HG12 ' CH2' ' A' ' 52' ' ' TRP . 39.7 mm -103.59 108.6 24.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.484 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -116.33 166.44 12.35 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.239 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.556 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.3 t30 -102.22 130.8 48.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.782 0.325 . . . . 0.0 110.232 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 160' ' ' ARG . 25.7 ttp85 -118.19 85.9 2.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.878 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.484 ' CG ' ' HG3' ' A' ' 27' ' ' ARG . 21.7 t30 53.13 47.22 24.97 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.378 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 96.46 9.05 57.05 Favored Glycine 0 C--O 1.229 -0.185 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.611 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -122.79 142.37 50.81 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.691 HD11 ' CD2' ' A' ' 7' ' ' PHE . 11.8 tp -99.61 111.34 23.69 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.953 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.417 -179.798 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.759 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 37.0 m-85 . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 121.189 0.519 . . . . 0.0 109.718 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.53 -27.71 0.67 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.457 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -69.56 -68.74 1.55 Allowed Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 119.931 -1.128 . . . . 0.0 113.643 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 42.1 m-80 68.73 16.98 8.93 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 122.268 0.227 . . . . 0.0 110.497 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.746 ' CD2' HD11 ' A' ' 164' ' ' LEU . 1.2 p90 -64.22 -32.64 74.3 Favored 'General case' 0 C--O 1.218 -0.581 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.032 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.512 ' HA ' HD11 ' A' ' 14' ' ' ILE . 22.7 t -70.37 -16.29 62.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.73 0.776 . . . . 0.0 109.606 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.65 -20.67 73.7 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 115.129 -0.942 . . . . 0.0 113.241 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.553 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 75.5 p -127.49 -22.84 3.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.405 0.602 . . . . 0.0 111.365 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 9.2 m -98.15 133.98 41.84 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.945 0.402 . . . . 0.0 109.956 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.573 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 35.2 ptt180 -110.54 -177.37 3.22 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.459 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 12.7 m-20 43.85 44.54 5.83 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 123.714 0.634 . . . . 0.0 112.213 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.899 HG22 HD13 ' A' ' 129' ' ' LEU . 5.8 mt -78.95 104.86 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.607 ' CA ' HD12 ' A' ' 129' ' ' LEU . 72.7 m -146.4 126.38 13.66 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.298 0.639 . . . . 0.0 109.651 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.753 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -98.93 152.83 19.35 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.673 0.749 . . . . 0.0 112.773 -179.646 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -96.07 74.99 3.03 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.55 -54.44 4.95 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.43 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.515 ' HB1' ' HB2' ' A' ' 40' ' ' ASN . . . -148.58 -10.09 0.36 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 36.8 mtp-105 -83.13 86.17 7.06 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.618 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.793 HD22 HD13 ' A' ' 153' ' ' LEU . 51.1 tp -62.1 116.7 5.17 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-O 121.301 0.572 . . . . 0.0 111.578 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.506 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 33.9 ttp-105 -122.58 131.29 53.76 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.556 -177.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.587 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -152.34 146.89 25.72 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.452 0.644 . . . . 0.0 111.246 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.573 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 1.6 mm-40 -80.73 77.29 7.59 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.412 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.597 ' SG ' HD13 ' A' ' 164' ' ' LEU . 64.3 m -61.98 125.68 24.68 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.748 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.553 ' HB2' ' O ' ' A' ' 10' ' ' SER . 35.3 ttm180 -74.44 115.17 13.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.098 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.543 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 16.8 ptm180 -79.2 151.37 31.28 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -50.67 -18.97 2.9 Favored Glycine 0 C--N 1.339 0.697 0 O-C-N 124.338 1.024 . . . . 0.0 114.195 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.63 -12.89 61.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.15 0.5 . . . . 0.0 110.451 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.62 7.89 56.39 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.543 ' O ' ' HG2' ' A' ' 27' ' ' ARG . . . -104.48 157.49 16.87 Favored Glycine 0 C--O 1.223 -0.563 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.246 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.49 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 62.7 m-85 -100.85 129.81 46.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.901 0.381 . . . . 0.0 110.906 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.3 m -122.15 130.09 52.91 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.097 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -69.08 110.44 4.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.111 0.482 . . . . 0.0 111.449 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.2 t -114.79 151.53 33.65 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.931 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.9 p -145.7 135.51 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 120.879 0.371 . . . . 0.0 110.58 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.496 HG23 ' HB3' ' A' ' 21' ' ' LEU . 8.6 tt -134.92 144.34 34.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.734 -178.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.591 ' HB3' ' CD ' ' A' ' 41' ' ' ARG . 5.1 t70 -78.84 106.42 10.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.848 0.356 . . . . 0.0 110.605 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.569 HD23 ' HB3' ' A' ' 21' ' ' LEU . 2.1 mm? -85.97 -0.41 55.42 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.453 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.515 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 64.4 t30 -71.91 -22.35 61.5 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.591 ' CD ' ' HB3' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -103.87 16.5 26.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.406 0.622 . . . . 0.0 110.191 178.291 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.411 ' HB2' HD13 ' A' ' 39' ' ' LEU . 14.0 m-85 -125.89 -35.27 2.5 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.146 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.826 HD22 HD13 ' A' ' 151' ' ' ILE . 36.6 mt -106.54 142.27 36.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.377 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.458 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 0.7 OUTLIER -133.1 140.8 47.84 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.492 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.551 ' CG ' ' HB3' ' A' ' 140' ' ' LEU . 9.0 t30 -88.54 108.1 19.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.989 0.423 . . . . 0.0 109.925 177.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -109.33 91.04 3.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.344 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 54.46 47.49 22.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.195 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.727 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 78.56 33.32 38.95 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.746 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.485 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 68.6 m80 -147.59 127.64 13.7 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.731 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 50.4 m-85 -68.78 146.01 53.28 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.901 0.382 . . . . 0.0 110.963 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -145.49 130.7 18.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.838 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.527 ' CD1' HD11 ' A' ' 151' ' ' ILE . 97.0 m95 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.841 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.7 m . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 120.925 0.393 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -129.07 177.77 6.89 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.167 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.515 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 10.0 p -127.98 118.22 23.14 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.896 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.453 HG21 ' CE2' ' A' ' 80' ' ' PHE . 10.1 p -106.22 142.65 18.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.81 0.338 . . . . 0.0 111.004 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 9.1 m -88.6 125.08 34.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.272 0.558 . . . . 0.0 109.884 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.486 ' CG2' HD12 ' A' ' 99' ' ' ILE . 53.4 t -73.67 133.09 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.623 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -102.85 168.87 8.95 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 124.723 1.264 . . . . 0.0 110.845 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.592 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 25.3 tt0 -62.69 122.21 15.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.151 -178.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.39 -8.77 72.07 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.868 -0.605 . . . . 0.0 113.186 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.25 122.86 36.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.744 0.272 . . . . 0.0 111.453 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.588 ' HA ' HG12 ' A' ' 99' ' ' ILE . 81.2 p -105.67 -179.44 3.94 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.613 HD22 HG23 ' A' ' 99' ' ' ILE . 1.1 mm? -52.5 -41.39 63.37 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.299 0.571 . . . . 0.0 109.836 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.512 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 83.6 mtp180 -64.44 -36.99 85.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.335 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -72.14 -42.9 65.46 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.77 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 72' ' ' THR . 39.2 mm -61.03 -47.0 95.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.683 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.58 -50.56 64.19 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.85 -0.614 . . . . 0.0 113.07 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.459 ' HA ' ' NE ' ' A' ' 78' ' ' ARG . 3.5 tpm_? -71.1 -25.44 62.6 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 122.462 -0.434 . . . . 0.0 111.713 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -79.23 -42.39 26.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.193 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.453 ' CE2' HG21 ' A' ' 65' ' ' VAL . 99.2 m-85 -108.06 18.94 20.61 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.2 t70 55.75 51.13 12.89 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.735 0.778 . . . . 0.0 111.86 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.683 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.6 p -131.99 171.75 13.2 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.321 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.674 ' O ' HG13 ' A' ' 87' ' ' ILE . 14.9 t0 -97.63 120.4 37.94 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.747 -0.381 . . . . 0.0 109.99 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.512 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 17.8 p90 -51.51 -31.93 25.72 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.797 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.474 ' HB2' ' OD1' ' A' ' 83' ' ' ASP . 0.2 OUTLIER -68.29 -41.96 80.18 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.323 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.606 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 40.2 mt-10 -68.68 -47.05 67.46 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.9 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.674 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.9 mt -51.31 -46.02 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.555 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.36 -51.89 65.82 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.182 178.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 66.0 mtp180 -62.82 -30.46 71.5 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.606 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 8.2 mmp_? -73.07 -28.17 62.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.254 0.55 . . . . 0.0 110.327 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 7.1 t-20 -96.14 -4.79 42.09 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.831 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 17.7 m120 80.24 13.44 0.91 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.69 0.796 . . . . 0.0 111.222 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.555 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 14.5 pt -105.58 -171.23 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.497 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.658 ' H ' ' HB2' ' A' ' 97' ' ' ASP . 3.8 mm-40 -118.72 163.63 16.56 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.501 ' O ' HD23 ' A' ' 73' ' ' LEU . 5.9 p30 -55.07 -55.15 34.3 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 122.535 1.16 . . . . 0.0 109.167 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -78.63 11.98 2.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.573 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.658 ' HB2' ' H ' ' A' ' 94' ' ' GLN . 4.9 t70 -63.29 -33.64 75.95 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.6 mt 68.75 112.38 0.04 OUTLIER 'General case' 0 C--O 1.232 0.163 0 O-C-N 124.382 1.051 . . . . 0.0 109.99 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.788 HG21 HD11 ' A' ' 105' ' ' LEU . 10.0 pt -95.31 175.3 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.458 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.494 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 67.9 m-85 -128.8 157.59 74.98 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.779 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.592 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 22.0 Cg_endo -66.71 133.08 30.58 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.957 2.438 . . . . 0.0 113.152 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.49 14.08 39.25 Favored Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 66' ' ' THR . 33.6 tt0 -103.35 162.93 12.59 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.515 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 91.9 t -122.17 118.25 54.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.788 HD11 HG21 ' A' ' 99' ' ' ILE . 96.9 mt -111.89 152.01 28.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.948 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -89.91 113.98 25.7 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.689 0.757 . . . . 0.0 110.975 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.4 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 24.9 m -123.35 152.07 63.75 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 114.178 -1.373 . . . . 0.0 109.983 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.4 ' HD2' ' HB ' ' A' ' 107' ' ' VAL . 34.1 Cg_endo -64.77 -15.59 51.0 Favored 'Trans proline' 0 N--CA 1.472 0.248 0 C-N-CA 123.633 2.889 . . . . 0.0 114.869 -177.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 C--N 1.322 -0.604 0 CA-C-O 120.931 0.396 . . . . 0.0 111.128 179.897 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.458 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.443 -0.877 0 N-CA-C 112.293 -0.323 . . . . 0.0 112.293 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 18.1 m120 74.81 34.7 0.69 Allowed 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 123.158 0.583 . . . . 0.0 111.536 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.635 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 19.3 p90 -64.31 -36.53 84.42 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.514 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 50.5 t-105 -64.6 -26.26 68.32 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.667 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.49 -13.56 52.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.131 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.5 p -142.87 22.37 1.94 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.462 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.551 ' O ' ' HD2' ' A' ' 125' ' ' ARG . . . -113.24 144.67 42.31 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.055 0.455 . . . . 0.0 111.753 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.551 ' HD2' ' O ' ' A' ' 124' ' ' ALA . 1.3 mpt_? -136.55 150.8 48.81 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.665 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 53.8 53.84 10.75 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.165 0.507 . . . . 0.0 111.609 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.517 ' CG1' HD11 ' A' ' 136' ' ' LEU . 41.8 t -80.19 128.31 38.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.264 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.414 ' O ' HD12 ' A' ' 136' ' ' LEU . 2.0 ptp180 -146.43 140.51 26.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.951 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.899 HD13 HG22 ' A' ' 14' ' ' ILE . 16.5 mt -86.6 126.96 34.85 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 177.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.749 HG23 ' HB ' ' A' ' 135' ' ' VAL . 27.6 m -118.33 165.46 13.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.817 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.575 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 0.2 OUTLIER 68.58 2.4 3.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.521 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.594 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 91.87 25.43 22.53 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.988 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 104.66 -21.33 36.92 Favored Glycine 0 C--O 1.267 2.182 0 CA-C-O 123.128 1.404 . . . . 0.0 112.721 178.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.734 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 0.0 OUTLIER -71.06 -10.37 59.63 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.177 -1.19 . . . . 0.0 109.775 179.083 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.749 ' HB ' HG23 ' A' ' 130' ' ' VAL . 20.4 t -143.08 146.94 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.601 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 35.1 tp -127.31 124.47 38.8 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -113.24 133.02 55.3 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 123.33 0.394 . . . . 0.0 110.478 -177.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.651 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -161.66 158.19 25.67 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.876 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -95.18 108.42 20.55 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.727 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 36.2 mt -97.06 133.14 42.12 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.389 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 145' ' ' GLY . 40.2 ttt180 -73.81 141.36 46.2 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.87 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.655 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 0.7 OUTLIER -158.67 -166.8 1.97 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 4.6 m -53.64 -30.86 44.97 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.43 0.456 . . . . 0.0 112.089 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -103.35 30.34 10.55 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.587 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 141' ' ' ARG . . . 89.91 -114.07 4.3 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.007 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -122.73 125.27 45.2 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.709 0.254 . . . . 0.0 110.563 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.655 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 27.7 t-20 -119.29 131.39 55.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.344 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -78.19 96.84 5.3 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.114 0.483 . . . . 0.0 110.041 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.485 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 23.5 t -103.36 170.18 8.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.342 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.601 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 36.5 ptt180 -148.95 154.94 40.11 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.752 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.826 HD13 HD22 ' A' ' 43' ' ' LEU . 10.7 tt -139.86 150.9 21.89 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.001 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.704 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 9.1 m-85 -92.33 104.88 17.18 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 122.003 -0.436 . . . . 0.0 110.56 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.793 HD13 HD22 ' A' ' 21' ' ' LEU . 21.2 mt -66.61 -35.46 80.25 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.929 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.734 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 10.5 t70 -57.61 -12.58 2.93 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.879 178.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.759 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 42.1 mt-10 -61.55 -56.08 23.83 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 121.121 0.486 . . . . 0.0 111.909 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -119.86 -4.6 10.16 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.59 -177.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.477 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 46.7 mm -94.44 112.32 26.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.33 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -117.78 166.84 12.71 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.383 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.565 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 1.5 t30 -107.24 132.21 53.33 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 122.403 0.281 . . . . 0.0 110.416 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -122.26 90.06 3.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.07 0.462 . . . . 0.0 110.123 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 47.0 m-80 54.9 40.42 31.98 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.22 2.16 44.74 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.824 177.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -119.69 140.23 50.99 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.933 0.396 . . . . 0.0 110.235 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.746 HD11 ' CD2' ' A' ' 7' ' ' PHE . 7.6 tp -96.78 111.23 23.49 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.304 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 34.2 pt . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.428 -179.905 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.02 -28.28 14.23 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.0 -75.55 0.38 Allowed Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 119.649 -1.262 . . . . 0.0 113.139 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 64.09 16.38 9.94 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 122.463 0.305 . . . . 0.0 110.893 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.697 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -62.2 -30.98 71.46 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 116.75 -0.204 . . . . 0.0 111.251 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.0 t -67.8 -16.37 64.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.4 0.619 . . . . 0.0 110.084 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.09 -22.94 67.29 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.744 -0.662 . . . . 0.0 113.319 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 16.8 p -126.29 -17.74 5.11 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 122.12 -0.635 . . . . 0.0 111.51 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.421 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 3.3 m -105.18 133.48 49.88 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.3 ptt85 -114.36 -175.7 2.74 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 46.3 45.06 13.08 Favored 'General case' 0 C--N 1.316 -0.891 0 O-C-N 123.858 0.724 . . . . 0.0 111.518 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.887 HG22 HD13 ' A' ' 129' ' ' LEU . 6.6 mt -81.14 100.7 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-O 120.938 0.399 . . . . 0.0 109.972 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.571 ' CA ' HD12 ' A' ' 129' ' ' LEU . 74.0 m -142.78 126.42 16.93 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.773 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -93.67 158.87 15.47 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.883 0.849 . . . . 0.0 113.037 -179.087 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -99.44 74.99 1.94 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 113.995 -1.457 . . . . 0.0 107.623 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.91 -57.68 4.56 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.947 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.735 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -143.47 -9.22 0.74 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 120.676 0.274 . . . . 0.0 110.898 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -96.59 97.74 9.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.276 0.56 . . . . 0.0 110.906 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.913 ' HB2' HD22 ' A' ' 39' ' ' LEU . 46.5 tp -61.75 121.68 13.47 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.966 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.529 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 53.5 ttt180 -126.61 127.87 45.9 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.506 -0.477 . . . . 0.0 110.813 -178.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.597 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -146.59 150.08 34.79 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.608 0.718 . . . . 0.0 111.069 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 3.0 mm-40 -83.94 71.34 10.5 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.122 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.572 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 34.7 m -60.01 125.75 24.88 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.741 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 10' ' ' SER . 27.7 ttp180 -66.77 126.59 29.5 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.151 178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -102.37 155.11 18.46 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -52.52 -17.62 4.58 Favored Glycine 0 C--N 1.337 0.584 0 O-C-N 124.582 1.176 . . . . 0.0 114.747 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.21 -9.12 58.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.054 0.454 . . . . 0.0 110.216 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.47 11.44 62.45 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -119.87 165.56 13.5 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.558 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.513 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 88.4 m-85 -100.22 129.19 46.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.007 0.432 . . . . 0.0 110.847 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 75.1 m -113.68 126.03 54.79 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.959 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 m -67.27 114.65 6.16 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.217 0.532 . . . . 0.0 109.768 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 39.7 t -120.4 150.94 39.98 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.265 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.4 p -142.34 140.86 28.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.862 0.363 . . . . 0.0 110.86 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.431 HG22 HD23 ' A' ' 164' ' ' LEU . 15.8 tt -134.86 144.79 33.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.109 -178.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.4 94.02 2.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.385 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.913 HD22 ' HB2' ' A' ' 21' ' ' LEU . 0.9 OUTLIER -76.35 -14.91 60.07 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 120.915 0.388 . . . . 0.0 111.351 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.735 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 26.8 p-10 -67.75 -10.96 57.14 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.202 0.525 . . . . 0.0 109.939 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.411 ' HG3' ' OD1' ' A' ' 40' ' ' ASN . 37.4 mtt180 -106.58 11.3 30.69 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.482 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -135.8 -26.2 1.22 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.715 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.816 HD22 HD13 ' A' ' 151' ' ' ILE . 33.2 mt -109.83 134.46 52.02 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.962 0.41 . . . . 0.0 110.919 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.537 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 47.7 m -126.1 146.52 49.89 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.695 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.464 ' HA ' HD13 ' A' ' 140' ' ' LEU . 3.4 p-10 -86.2 101.06 12.68 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -102.63 92.59 4.7 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.453 -178.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.0 t30 51.52 43.81 29.44 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.626 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.573 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 82.84 28.13 39.23 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.571 -0.824 . . . . 0.0 113.003 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.71 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 17.6 t-80 -149.88 126.43 10.91 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.705 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 72.6 m-85 -60.54 152.22 26.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.615 0.245 . . . . 0.0 111.026 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 11.4 ttm180 -141.68 132.18 25.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.087 0.47 . . . . 0.0 111.9 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.488 ' CZ2' ' HA ' ' A' ' 153' ' ' LEU . 57.4 m95 . . . . . 0 C--N 1.318 -0.783 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.729 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.446 -0.658 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.95 177.55 5.45 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.328 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.4 p -128.87 115.37 17.78 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.463 HG21 ' CE2' ' A' ' 80' ' ' PHE . 10.7 p -106.68 140.0 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.844 0.354 . . . . 0.0 111.105 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 14.0 m -88.55 130.31 35.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.047 0.451 . . . . 0.0 110.231 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.569 ' CG2' HD12 ' A' ' 99' ' ' ILE . 52.2 t -80.8 131.92 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.251 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -99.09 171.47 8.0 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 124.342 1.026 . . . . 0.0 109.705 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.728 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 35.0 tt0 -65.66 124.49 22.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.44 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.5 -1.21 66.28 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.531 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.426 ' CG ' HH22 ' A' ' 79' ' ' ARG . 85.7 m-20 -88.52 147.54 24.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.233 0.539 . . . . 0.0 111.531 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.687 ' HA ' HG12 ' A' ' 99' ' ' ILE . 38.1 p -133.06 168.21 18.9 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.618 HD22 HG23 ' A' ' 99' ' ' ILE . 1.8 mm? -49.76 -45.54 49.62 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.551 0.614 . . . . 0.0 110.307 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.598 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 65.8 mtt180 -63.58 -34.73 78.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.8 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.55 -37.24 65.62 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 72' ' ' THR . 47.8 mm -68.05 -48.76 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.587 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.729 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -59.34 -49.43 78.63 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.705 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.634 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -63.37 -33.02 74.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.081 0.467 . . . . 0.0 110.786 -179.428 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.426 HH22 ' CG ' ' A' ' 71' ' ' ASP . 32.9 ttm180 -74.31 -41.95 60.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.554 -178.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.463 ' CE2' HG21 ' A' ' 65' ' ' VAL . 98.8 m-85 -104.64 20.09 19.24 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 54.15 37.57 27.38 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.293 0.568 . . . . 0.0 112.349 178.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.729 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -119.17 167.16 12.1 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.599 ' O ' HG13 ' A' ' 87' ' ' ILE . 8.4 t0 -90.93 119.35 31.06 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.758 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.608 ' HD2' ' HB2' ' A' ' 95' ' ' ASN . 10.4 p90 -51.49 -32.63 28.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.191 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -62.91 -46.31 88.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.203 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.641 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 30.4 tt0 -66.87 -44.19 81.61 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.723 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.599 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.4 mt -52.12 -45.94 42.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.622 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.24 -50.12 71.46 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.987 177.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -58.45 -34.11 70.47 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.641 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 28.3 mmt180 -68.33 -38.52 81.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.101 0.477 . . . . 0.0 110.482 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 2.8 t-20 -91.53 -5.26 54.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.32 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 48.9 m-80 76.98 16.46 1.77 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.086 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.622 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 16.9 pt -101.25 -176.39 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.55 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 80.4 mm-40 -107.42 158.85 16.85 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.608 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 5.8 p30 -61.24 -55.4 32.41 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 122.137 0.97 . . . . 0.0 108.832 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -79.86 11.91 3.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.427 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.9 t70 -63.35 -35.44 80.39 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 7.6 mp 69.69 115.47 0.04 OUTLIER 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.74 -177.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.731 HG21 HD11 ' A' ' 105' ' ' LEU . 6.8 pt -94.64 175.74 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.472 -178.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.543 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 89.2 m-85 -124.35 160.29 53.48 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.957 -178.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.728 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 37.6 Cg_endo -69.74 133.06 24.7 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.082 2.521 . . . . 0.0 114.016 -178.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.76 14.63 33.91 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.583 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 66' ' ' THR . 44.0 mt-30 -102.41 164.19 11.81 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.83 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 67.1 t -123.56 116.31 47.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.731 HD11 HG21 ' A' ' 99' ' ' ILE . 89.4 mt -110.33 151.33 27.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.024 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.627 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 71.2 mt-30 -90.3 117.48 29.07 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.703 0.763 . . . . 0.0 110.872 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.31 150.42 60.32 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.467 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.43 -17.62 58.07 Favored 'Trans proline' 0 C--N 1.332 -0.318 0 C-N-CA 123.498 2.799 . . . . 0.0 114.017 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.4 t . . . . . 0 C--N 1.324 -0.519 0 CA-C-O 121.041 0.448 . . . . 0.0 111.131 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.537 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.446 -0.694 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 78.37 27.51 0.51 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.858 0.863 . . . . 0.0 112.461 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.577 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 26.5 p90 -63.87 -38.62 91.76 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.695 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.539 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 61.2 t-105 -63.02 -29.14 70.6 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.881 -178.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -57.11 -20.97 28.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.738 0.304 . . . . 0.0 111.112 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.678 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 57.6 m -141.9 30.82 1.63 Allowed 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.493 178.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.539 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -113.31 138.64 49.74 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.847 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 125' ' ' ARG . 11.4 mmt180 -126.95 146.05 50.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.262 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.5 t70 51.12 56.65 7.66 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 123.831 0.707 . . . . 0.0 110.659 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.53 ' CG1' HD11 ' A' ' 136' ' ' LEU . 45.0 t -79.66 120.32 30.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.44 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.85 141.34 34.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.177 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.887 HD13 HG22 ' A' ' 14' ' ' ILE . 17.8 mt -85.91 128.29 34.8 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.83 HG23 HG13 ' A' ' 135' ' ' VAL . 31.0 m -123.68 157.54 30.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.358 0.599 . . . . 0.0 111.224 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.925 ' HB3' ' HE3' ' A' ' 134' ' ' LYS . 5.9 m-20 65.67 16.98 10.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.897 178.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.694 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 91.8 25.3 23.08 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.942 178.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 91.16 -15.31 61.37 Favored Glycine 0 C--O 1.269 2.322 0 CA-C-O 123.638 1.688 . . . . 0.0 112.384 177.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.925 ' HE3' ' HB3' ' A' ' 131' ' ' ASP . 20.0 pttp -65.12 -15.71 62.69 Favored 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 121.463 -1.022 . . . . 0.0 108.929 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.83 HG13 HG23 ' A' ' 130' ' ' VAL . 2.2 p -149.03 135.58 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.547 0.689 . . . . 0.0 110.83 176.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 29.6 tp -110.3 125.08 52.77 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.073 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.406 ' CD ' ' HE ' ' A' ' 148' ' ' ARG . 31.9 tt0 -117.92 139.95 50.42 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.861 0.363 . . . . 0.0 111.52 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.663 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.96 168.8 20.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.17 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -95.25 107.55 19.66 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.573 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 57.1 mt -98.93 131.89 44.66 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.277 0.561 . . . . 0.0 111.168 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.678 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 33.7 ttt180 -72.28 142.01 48.89 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.071 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -153.89 -173.89 4.75 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.917 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 13.4 m -58.6 -22.71 57.03 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -105.39 20.02 38.38 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.233 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 106.73 -115.33 4.66 Favored Glycine 0 C--O 1.229 -0.212 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.298 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -130.31 138.07 50.27 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -132.18 141.44 49.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.924 0.392 . . . . 0.0 111.701 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.406 ' HE ' ' CD ' ' A' ' 137' ' ' GLU . 69.5 ttt180 -74.76 103.53 5.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.146 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.71 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 32.6 t -121.65 162.08 21.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.326 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 10.3 ptt180 -148.55 152.6 37.11 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 120.957 0.408 . . . . 0.0 111.474 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.816 HD13 HD22 ' A' ' 43' ' ' LEU . 8.7 tt -132.36 131.96 60.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.73 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 135' ' ' VAL . 89.8 m-85 -75.89 101.22 5.08 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.56 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.727 HD13 HD22 ' A' ' 21' ' ' LEU . 35.7 mt -64.45 -36.22 83.47 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.191 178.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.845 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 11.7 t70 -55.35 -11.49 0.81 Allowed 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.425 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.539 ' HG3' ' CB ' ' A' ' 152' ' ' TYR . 38.0 mt-10 -71.41 -49.39 42.38 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 121.93 -0.481 . . . . 0.0 112.224 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -127.02 5.68 6.51 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 119.963 -0.695 . . . . 0.0 112.611 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.403 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 46.9 mm -106.58 109.65 28.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.478 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -116.38 166.22 12.34 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.187 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.572 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.9 t30 -100.79 123.21 44.66 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.41 ' O ' ' HB3' ' A' ' 163' ' ' GLU . 14.2 ttt85 -119.17 86.52 2.56 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.155 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 59.61 49.12 8.72 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 79.92 13.14 82.61 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.489 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 160' ' ' ARG . 28.2 tt0 -122.67 120.24 33.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.026 0.441 . . . . 0.0 110.037 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.697 HD11 ' CD2' ' A' ' 7' ' ' PHE . 8.5 tp -77.25 120.73 22.71 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.072 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 12.6 tt . . . . . 0 C--N 1.323 -0.581 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.987 -179.096 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 . . . . . 0 N--CA 1.453 -0.319 0 CA-C-O 121.36 0.6 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -125.29 -25.58 3.77 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.642 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -84.09 -70.93 1.33 Allowed Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 118.771 -1.68 . . . . 0.0 113.488 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.628 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 63.0 t30 57.3 31.95 20.95 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.207 0.603 . . . . 0.0 110.283 -178.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.611 ' CE2' HD13 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -60.28 -32.91 71.64 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.028 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.458 ' HA ' HD11 ' A' ' 14' ' ' ILE . 34.0 t -59.17 -20.8 57.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.523 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.52 -42.17 93.76 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.836 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 26' ' ' ARG . 49.4 m -114.97 -18.05 11.35 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.9 m -92.38 134.86 34.53 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.471 ' CG ' ' HB2' ' A' ' 24' ' ' GLU . 16.7 ptt180 -113.27 -177.54 3.16 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.494 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 0.4 OUTLIER 42.61 44.63 3.72 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 123.873 0.733 . . . . 0.0 112.457 179.18 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.916 HG22 HD13 ' A' ' 129' ' ' LEU . 5.8 mt -78.98 105.14 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 CA-C-O 120.953 0.406 . . . . 0.0 110.292 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.607 ' HA ' HD12 ' A' ' 129' ' ' LEU . 80.4 m -146.82 127.62 14.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.37 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.749 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -96.97 155.86 16.6 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.621 0.724 . . . . 0.0 112.779 -179.279 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -96.22 75.1 2.97 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.433 -1.258 . . . . 0.0 107.958 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.51 -58.35 4.88 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.893 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -149.19 5.97 0.66 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.199 0.523 . . . . 0.0 110.21 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.575 ' HG2' ' CG2' ' A' ' 36' ' ' VAL . 32.3 ttt85 -108.32 93.99 4.82 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.825 ' HB2' HD22 ' A' ' 39' ' ' LEU . 55.0 tp -63.18 129.6 41.02 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -177.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.535 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 34.8 ttt180 -134.04 129.26 35.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.159 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.624 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -148.58 149.98 32.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.471 0.653 . . . . 0.0 110.983 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.55 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 3.3 mt-10 -87.64 80.67 7.91 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.773 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.587 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 58.7 m -63.47 127.86 33.23 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.408 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.5 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 36.8 ttm180 -71.13 114.93 9.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.364 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 9.0 ptp180 -79.6 152.6 29.97 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 179.024 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.36 -19.5 12.79 Favored Glycine 0 C--N 1.336 0.549 0 O-C-N 124.369 1.043 . . . . 0.0 114.03 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.58 -12.03 60.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.446 0.641 . . . . 0.0 109.821 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.29 5.22 56.05 Favored Glycine 0 CA--C 1.505 -0.589 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.526 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.454 ' O ' ' HG2' ' A' ' 27' ' ' ARG . . . -105.61 167.78 14.92 Favored Glycine 0 C--O 1.222 -0.649 0 C-N-CA 120.065 -1.064 . . . . 0.0 113.14 -178.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.55 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 57.9 m-85 -101.27 131.47 47.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.166 0.483 . . . . 0.0 110.907 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.9 m -118.49 123.35 44.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.191 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.5 m -69.1 112.31 5.63 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.9 t -118.25 155.41 30.61 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.028 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.575 ' CG2' ' HG2' ' A' ' 20' ' ' ARG . 2.6 p -145.43 139.08 21.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.878 0.371 . . . . 0.0 111.662 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.449 HG23 ' HB3' ' A' ' 21' ' ' LEU . 14.0 tt -135.13 148.06 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.471 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.439 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 17.7 m-20 -84.41 104.53 14.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.862 0.363 . . . . 0.0 111.475 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.825 HD22 ' HB2' ' A' ' 21' ' ' LEU . 3.0 mp -83.69 -12.15 56.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.428 0.632 . . . . 0.0 110.417 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.528 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 16.5 p30 -62.84 -19.09 63.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.021 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -112.92 19.9 16.88 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.968 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.644 ' HD2' ' CE3' ' A' ' 52' ' ' TRP . 0.1 OUTLIER -138.12 -27.6 0.89 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.366 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.863 HD22 HD13 ' A' ' 151' ' ' ILE . 62.5 mt -106.09 132.21 52.44 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.619 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 3.2 m -129.35 141.92 50.95 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.541 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.709 ' HB3' ' HG ' ' A' ' 140' ' ' LEU . 3.7 p-10 -79.36 115.77 19.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.149 177.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -114.82 89.34 3.07 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.907 0.384 . . . . 0.0 110.248 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.3 t30 51.78 45.02 28.85 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.242 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.0 32.18 30.02 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.808 -0.711 . . . . 0.0 113.131 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.616 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 16.0 t-80 -150.85 125.19 9.45 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.78 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 45.3 m-85 -63.08 141.84 58.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.886 0.374 . . . . 0.0 111.672 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.647 ' NE ' ' HA ' ' A' ' 51' ' ' ARG . 3.4 mmp_? -146.26 135.82 23.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.841 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.644 ' CE3' ' HD2' ' A' ' 42' ' ' TYR . 95.0 m95 . . . . . 0 C--N 1.32 -0.682 0 CA-C-O 121.124 0.488 . . . . 0.0 109.743 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.45 -0.446 0 CA-C-O 120.861 0.362 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -127.8 176.11 7.81 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.75 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.529 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 6.8 p -127.93 116.11 19.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.543 HG21 ' CE2' ' A' ' 80' ' ' PHE . 7.9 p -103.61 142.41 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 120.887 0.375 . . . . 0.0 110.844 178.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 9.8 m -88.38 130.95 35.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.161 0.505 . . . . 0.0 109.929 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.458 ' CG2' HD12 ' A' ' 99' ' ' ILE . 56.6 t -82.33 133.58 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.854 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -103.86 171.34 7.41 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.985 0.803 . . . . 0.0 110.2 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.621 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 53.7 tt0 -61.27 119.39 8.35 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.122 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.17 -9.91 63.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.888 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.455 ' HB3' HD11 ' A' ' 76' ' ' ILE . 84.9 m-20 -75.44 146.65 40.54 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.147 0.499 . . . . 0.0 111.529 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.624 ' HA ' HG12 ' A' ' 99' ' ' ILE . 24.3 p -135.99 163.15 30.96 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.615 HD22 HG23 ' A' ' 99' ' ' ILE . 1.6 mm? -49.18 -44.22 42.84 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.363 0.529 . . . . 0.0 110.634 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.442 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 70.1 mtp180 -59.96 -43.39 95.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.276 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -72.94 -33.88 66.21 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.537 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 72' ' ' THR . 44.0 mm -66.6 -46.91 84.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.716 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.48 -49.08 76.15 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.91 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -65.41 -32.43 74.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.059 0.456 . . . . 0.0 111.151 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.429 HH22 ' CG ' ' A' ' 71' ' ' ASP . 34.5 ttm180 -70.65 -40.33 73.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.73 -178.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.543 ' CE2' HG21 ' A' ' 65' ' ' VAL . 94.6 m-85 -110.42 16.91 21.32 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 56.22 37.56 28.96 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.445 0.64 . . . . 0.0 111.411 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.716 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.9 p -116.28 166.1 12.42 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.373 -0.83 . . . . 0.0 108.901 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.65 ' O ' HG13 ' A' ' 87' ' ' ILE . 3.7 t70 -92.22 124.6 36.42 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.101 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.442 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 9.7 p90 -52.28 -31.35 32.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.753 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 23.0 t-80 -66.79 -43.26 84.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.949 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.77 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 10.1 mm-40 -63.2 -51.54 65.93 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.361 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.65 HG13 ' O ' ' A' ' 83' ' ' ASP . 3.5 mt -50.94 -48.12 29.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 O-C-N 124.139 0.899 . . . . 0.0 109.475 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.625 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.51 -49.5 75.09 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.268 178.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -61.79 -34.05 75.21 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.77 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 14.7 mmt85 -65.28 -38.19 89.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.08 0.467 . . . . 0.0 110.525 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.428 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 11.5 m120 -93.13 -3.36 54.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.61 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 76.5 m-20 73.72 19.67 3.17 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.247 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.625 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 16.9 pt -100.68 -177.29 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.688 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.506 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 35.6 mt-30 -108.17 155.57 20.28 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.55 ' O ' HD23 ' A' ' 73' ' ' LEU . 3.1 p30 -54.94 -62.6 1.55 Allowed 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 122.116 0.96 . . . . 0.0 108.937 178.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -76.4 12.23 1.3 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.385 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.506 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.4 t70 -63.63 -34.5 77.96 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 8.7 mp 73.03 116.63 0.05 Allowed 'General case' 0 N--CA 1.462 0.136 0 O-C-N 124.399 1.062 . . . . 0.0 109.598 -177.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.744 HG21 HD11 ' A' ' 105' ' ' LEU . 11.2 pt -93.83 177.68 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.208 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.509 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 40.5 m-85 -129.48 157.76 75.37 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-O 120.892 0.377 . . . . 0.0 111.413 -178.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.621 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 25.7 Cg_endo -65.72 137.75 51.0 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.229 2.619 . . . . 0.0 113.905 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.12 13.65 57.25 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.867 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.479 ' O ' ' HA ' ' A' ' 66' ' ' THR . 95.5 mt-30 -100.87 168.39 9.67 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.216 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.529 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 63.2 t -127.6 110.61 22.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-O 120.921 0.391 . . . . 0.0 109.974 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.744 HD11 HG21 ' A' ' 99' ' ' ILE . 89.0 mt -103.6 150.4 24.0 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.678 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 75.8 mt-30 -91.34 116.47 28.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.973 0.892 . . . . 0.0 111.38 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.1 m -124.12 151.5 65.71 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 114.207 -1.36 . . . . 0.0 109.691 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -65.07 -15.03 48.44 Favored 'Trans proline' 0 N--CA 1.476 0.445 0 C-N-CA 123.571 2.847 . . . . 0.0 114.855 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.0 t . . . . . 0 C--N 1.322 -0.61 0 CA-C-O 121.008 0.433 . . . . 0.0 111.197 179.624 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.619 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.441 -0.993 0 N-CA-C 112.618 -0.193 . . . . 0.0 112.618 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 73.41 23.45 2.51 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.437 0.695 . . . . 0.0 111.931 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.589 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 22.7 p90 -61.62 -38.51 87.92 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.549 -0.46 . . . . 0.0 109.854 178.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.553 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 63.5 t-105 -59.87 -33.86 72.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.474 -178.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -54.59 -25.95 29.51 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.101 0.476 . . . . 0.0 111.124 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.722 ' HB2' ' HB3' ' A' ' 141' ' ' ARG . 19.4 p -136.98 30.12 2.78 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.512 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.553 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -109.29 140.3 43.13 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.889 0.376 . . . . 0.0 110.835 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.412 ' HB3' ' HB2' ' A' ' 139' ' ' GLU . 61.0 ttp180 -127.51 138.91 53.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.932 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 55.36 54.47 8.58 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.244 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.501 ' CG1' HD11 ' A' ' 136' ' ' LEU . 29.7 t -76.67 121.43 28.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.643 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -144.94 146.01 31.8 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.65 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.916 HD13 HG22 ' A' ' 14' ' ' ILE . 18.4 mt -86.75 128.85 35.04 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 120.973 0.416 . . . . 0.0 110.157 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.597 HG23 ' HB ' ' A' ' 135' ' ' VAL . 35.1 m -125.75 160.18 32.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.646 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 69.04 5.77 5.26 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.389 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.665 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 97.32 29.06 8.12 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.439 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.536 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 91.8 -16.27 59.74 Favored Glycine 0 C--O 1.265 2.045 0 CA-C-O 123.689 1.716 . . . . 0.0 112.494 178.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.662 ' O ' ' HA ' ' A' ' 152' ' ' TYR . 5.8 ptpp? -70.87 -17.44 62.72 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 121.433 -1.039 . . . . 0.0 108.454 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.597 ' HB ' HG23 ' A' ' 130' ' ' VAL . 17.5 t -138.73 137.92 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.314 0.578 . . . . 0.0 110.736 178.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.693 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 29.6 tp -117.58 118.36 31.92 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -108.4 130.25 55.23 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.772 0.32 . . . . 0.0 111.276 -176.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.758 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.35 161.56 27.5 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.72 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.849 ' HG3' HH11 ' A' ' 148' ' ' ARG . 49.3 mt-10 -96.01 108.5 20.9 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.422 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.709 ' HG ' ' HB3' ' A' ' 45' ' ' ASN . 1.0 OUTLIER -90.96 126.78 36.17 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.959 178.957 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.722 ' HB3' ' HB2' ' A' ' 123' ' ' SER . 76.1 ttt180 -69.59 140.81 53.82 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.164 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.633 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 2.3 p90 -156.83 -165.98 1.99 Allowed 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.074 -179.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.2 t -58.42 -32.53 68.75 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.319 0.387 . . . . 0.0 111.121 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.19 28.88 13.26 Favored Glycine 0 C--N 1.329 0.182 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.478 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 89.52 -118.95 5.35 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.591 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -120.03 129.32 54.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.699 0.25 . . . . 0.0 110.73 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.633 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 53.7 t30 -121.34 134.18 55.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.74 0.305 . . . . 0.0 110.766 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.849 HH11 ' HG3' ' A' ' 139' ' ' GLU . 19.8 tpt180 -75.0 96.94 3.27 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.591 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.616 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 11.6 t -109.41 168.03 9.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.428 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.693 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 36.5 ptt180 -148.11 149.65 32.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.444 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.863 HD13 HD22 ' A' ' 43' ' ' LEU . 12.1 tt -132.98 140.72 46.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.581 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.662 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 26.6 m-85 -83.17 102.97 12.23 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.852 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.774 HD11 HD21 ' A' ' 129' ' ' LEU . 26.8 mt -65.25 -36.7 84.95 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.127 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.628 ' HB2' ' HA ' ' A' ' 6' ' ' ASN . 13.8 p-10 -61.69 2.83 0.16 Allowed 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.561 ' HG3' ' CB ' ' A' ' 152' ' ' TYR . 43.1 mt-10 -76.24 -52.43 10.03 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 121.729 -0.607 . . . . 0.0 110.758 178.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -118.02 -12.26 10.11 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.633 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.443 ' O ' ' HA3' ' A' ' 5' ' ' GLY . 50.8 mm -91.86 114.74 29.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 116.77 -0.196 . . . . 0.0 110.754 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -122.28 167.63 14.8 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.115 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.587 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 3.3 t30 -103.46 123.29 46.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.025 0.44 . . . . 0.0 109.959 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 29.5 ttt85 -124.68 93.08 3.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.341 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 16.2 m120 60.61 45.04 10.84 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.215 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 84.81 10.75 78.43 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.684 -0.769 . . . . 0.0 113.197 178.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -122.74 152.82 40.23 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.511 HD21 ' HD2' ' A' ' 7' ' ' PHE . 24.4 mt -97.17 119.65 36.05 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.492 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 43.0 pt . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.148 -179.759 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.655 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 32.6 m-85 . . . . . 0 CA--C 1.516 -0.34 0 CA-C-O 120.801 0.334 . . . . 0.0 110.499 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -137.68 -25.93 0.99 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.569 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 6' ' ' ASN . . . -68.88 -72.63 0.81 Allowed Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 119.738 -1.22 . . . . 0.0 113.597 -178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 25.5 m-80 69.69 10.31 7.53 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 122.498 0.319 . . . . 0.0 110.219 -178.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.785 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.9 OUTLIER -61.59 -34.93 76.46 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.61 -178.969 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.45 ' HA ' HD11 ' A' ' 14' ' ' ILE . 35.0 t -67.81 -14.87 63.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.476 0.655 . . . . 0.0 109.877 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.68 -27.76 64.5 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.964 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 20.9 p -125.69 -19.57 4.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 117.225 0.512 . . . . 0.0 111.992 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 11.8 m -94.99 129.04 42.22 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.698 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 35.4 ptt180 -108.01 -178.36 3.59 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.481 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 1.6 m-20 41.11 47.58 2.8 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 124.068 0.855 . . . . 0.0 112.489 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.924 HG22 HD13 ' A' ' 129' ' ' LEU . 8.1 mt -80.65 107.44 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-O 120.877 0.37 . . . . 0.0 110.292 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.713 ' CA ' HD12 ' A' ' 129' ' ' LEU . 46.1 t -150.2 128.53 12.11 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.701 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -96.7 158.56 15.37 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 122.047 0.927 . . . . 0.0 113.012 -178.819 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -99.51 76.4 2.02 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.14 -53.57 4.77 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.879 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.46 ' CB ' ' HB3' ' A' ' 40' ' ' ASN . . . -149.55 -12.41 0.29 Allowed 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 120.746 0.308 . . . . 0.0 110.195 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -86.1 90.13 8.03 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.448 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.003 HD12 HD11 ' A' ' 129' ' ' LEU . 8.5 tp -61.64 112.97 2.46 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.671 -179.044 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.495 ' HE ' ' CG2' ' A' ' 34' ' ' THR . 18.8 ttt85 -118.28 130.59 56.13 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.277 -178.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.679 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -149.65 150.9 32.86 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.407 0.623 . . . . 0.0 110.997 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.698 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 1.6 mm-40 -83.39 73.83 10.13 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.145 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.651 ' SG ' HD13 ' A' ' 164' ' ' LEU . 67.8 m -61.22 117.06 5.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.595 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 10' ' ' SER . 44.5 ttt180 -64.59 116.75 6.5 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.804 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.7 ttt85 -90.86 152.49 20.73 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.044 0.45 . . . . 0.0 109.957 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.63 -13.83 4.56 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 114.353 -1.294 . . . . 0.0 114.037 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -73.85 -11.08 60.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.114 0.483 . . . . 0.0 110.321 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.5 8.49 57.36 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -123.78 154.39 17.54 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.099 -1.048 . . . . 0.0 112.837 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.475 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 88.0 m-85 -87.87 125.49 34.51 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.712 0.291 . . . . 0.0 110.446 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.7 m -109.19 131.94 54.59 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.495 ' CG2' ' HE ' ' A' ' 22' ' ' ARG . 2.5 m -73.72 110.71 8.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.229 0.538 . . . . 0.0 109.98 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 30.3 t -115.5 153.59 30.87 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.635 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.7 p -146.14 137.27 18.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.794 0.331 . . . . 0.0 110.869 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.514 HG23 ' HB3' ' A' ' 21' ' ' LEU . 8.7 tt -134.68 137.05 51.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.733 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.643 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 13.3 m-20 -75.22 103.1 5.24 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.826 0.345 . . . . 0.0 111.558 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.818 ' HG ' HD11 ' A' ' 153' ' ' LEU . 3.4 mm? -83.11 -5.37 59.08 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.926 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.643 ' OD1' ' HB3' ' A' ' 38' ' ' ASP . 34.5 p-10 -67.06 -14.07 62.54 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.574 ' HE ' ' HB2' ' A' ' 38' ' ' ASP . 27.8 mtm180 -106.65 7.75 30.76 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.962 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.703 ' HB2' HD13 ' A' ' 39' ' ' LEU . 88.5 m-85 -130.95 -29.34 1.89 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.862 HD22 HD13 ' A' ' 151' ' ' ILE . 60.9 mt -106.22 132.69 51.98 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.779 0.323 . . . . 0.0 110.405 -179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.734 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 1.0 OUTLIER -123.44 143.03 50.4 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.603 -179.496 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 7.0 p-10 -88.25 93.61 9.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.791 0.805 . . . . 0.0 109.176 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -93.27 93.63 8.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.297 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.487 ' HA ' ' HB2' ' A' ' 142' ' ' TYR . 8.6 t-20 51.25 48.49 22.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.092 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.611 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 76.64 32.42 50.66 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.049 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.639 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 59.9 t60 -152.12 124.69 8.35 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.796 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 48.5 m-85 -60.71 144.15 52.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.887 0.375 . . . . 0.0 111.483 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -143.03 131.74 22.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.475 -178.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.495 ' HZ2' ' O ' ' A' ' 152' ' ' TYR . 99.6 m95 . . . . . 0 C--N 1.322 -0.608 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 36.0 m . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 121.108 0.48 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -130.9 178.59 6.55 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.191 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.516 HG22 ' HG2' ' A' ' 106' ' ' GLN . 4.6 p -128.33 115.56 18.46 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.77 143.25 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 120.869 0.366 . . . . 0.0 111.086 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 3.5 m -87.98 129.25 35.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.481 ' CG2' HD12 ' A' ' 99' ' ' ILE . 57.4 t -79.66 132.25 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.647 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -101.03 168.61 9.49 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 124.254 0.971 . . . . 0.0 110.475 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.668 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 35.1 tt0 -66.03 120.21 12.74 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.87 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.85 -11.07 52.76 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.771 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.06 130.26 45.38 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.134 0.467 . . . . 0.0 111.402 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.618 ' HA ' HG12 ' A' ' 99' ' ' ILE . 82.6 p -107.41 179.76 4.15 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.668 HD22 HG23 ' A' ' 99' ' ' ILE . 1.4 mm? -53.64 -43.64 68.9 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.436 0.636 . . . . 0.0 109.511 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.523 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 7.0 ttp85 -63.31 -36.05 82.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.39 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 79' ' ' ARG . 50.2 m-20 -73.77 -41.83 61.9 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.568 HG12 ' O ' ' A' ' 72' ' ' THR . 45.3 mm -61.32 -47.68 92.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.605 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.723 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.19 -51.34 58.11 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.651 -0.704 . . . . 0.0 113.083 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.448 HH11 ' HD2' ' A' ' 78' ' ' ARG . 47.1 mtp85 -70.21 -23.71 62.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.796 0.331 . . . . 0.0 111.691 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 37.2 ttt180 -78.91 -39.37 35.02 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -110.97 19.45 18.48 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t70 55.22 59.24 4.09 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.693 0.759 . . . . 0.0 111.335 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.723 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.4 p -142.35 164.59 29.72 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.364 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.574 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.8 t0 -91.04 120.89 32.39 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.523 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 5.0 p90 -52.19 -30.47 27.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.429 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -66.66 -41.87 87.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.602 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.695 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 64.3 mm-40 -66.06 -49.62 67.0 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.485 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.574 HG13 ' O ' ' A' ' 83' ' ' ASP . 4.1 mt -51.93 -47.53 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.523 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.58 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.77 -50.4 71.2 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.112 178.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -60.3 -33.82 72.91 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.695 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 27.4 mmt180 -71.19 -31.83 68.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.914 0.388 . . . . 0.0 110.44 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 3.7 t-20 -91.73 -5.97 52.74 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.615 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 90.7 m-20 77.15 17.76 1.54 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.033 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.58 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 14.2 pt -105.69 -174.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.577 178.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.449 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 64.6 mt-30 -110.25 162.57 14.49 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.614 ' O ' HD23 ' A' ' 73' ' ' LEU . 4.2 p-10 -58.59 -68.67 0.24 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.317 1.055 . . . . 0.0 110.003 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -74.33 13.47 0.58 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.545 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.5 t70 -59.65 -29.39 68.0 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.407 HD22 HG21 ' A' ' 72' ' ' THR . 34.1 mt 72.4 110.6 0.06 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.816 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.668 HG23 HD22 ' A' ' 73' ' ' LEU . 10.2 pt -95.62 172.56 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.405 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.58 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 73.7 m-85 -126.74 161.45 53.12 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.31 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.668 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 24.8 Cg_endo -66.31 139.6 55.32 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.203 2.602 . . . . 0.0 113.843 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.07 16.72 43.23 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' A' ' 66' ' ' THR . 25.8 mt-30 -103.18 166.57 10.36 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.082 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.426 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 82.5 t -126.91 114.43 37.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.56 HD11 HG21 ' A' ' 99' ' ' ILE . 88.1 mt -112.2 151.65 29.31 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.801 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.516 ' HG2' HG22 ' A' ' 64' ' ' THR . 34.3 mt-30 -90.47 117.26 29.03 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.615 0.721 . . . . 0.0 110.923 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.423 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 35.2 m -126.27 152.59 73.92 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.634 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 107' ' ' VAL . 18.0 Cg_endo -57.52 -48.04 19.04 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.353 2.035 . . . . 0.0 113.578 -177.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 C--N 1.323 -0.564 0 CA-C-O 121.254 0.55 . . . . 0.0 111.635 -178.824 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.734 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.443 -0.878 0 N-CA-C 113.184 0.034 . . . . 0.0 113.184 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 19.5 m120 73.29 29.09 1.72 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.054 0.542 . . . . 0.0 111.418 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.592 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 21.8 p90 -60.59 -37.92 82.94 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.519 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 47.8 t-105 -60.57 -30.39 69.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.559 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.47 -33.02 58.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.939 0.399 . . . . 0.0 110.537 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.775 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 6.7 m -131.28 28.84 4.68 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.852 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.519 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -108.65 140.78 41.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.896 0.379 . . . . 0.0 110.889 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.565 ' HB3' ' HB2' ' A' ' 139' ' ' GLU . 11.3 tpp85 -124.09 135.2 53.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.462 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 54.85 55.46 7.78 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.765 0.666 . . . . 0.0 111.849 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.526 HG12 HD11 ' A' ' 136' ' ' LEU . 40.1 t -78.03 123.58 35.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.822 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.435 ' O ' HD12 ' A' ' 136' ' ' LEU . 8.9 ptp180 -149.49 149.0 30.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.827 0.346 . . . . 0.0 110.589 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 1.003 HD11 HD12 ' A' ' 21' ' ' LEU . 92.5 mt -86.6 134.85 33.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.056 0.455 . . . . 0.0 110.495 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.626 HG23 ' HB ' ' A' ' 135' ' ' VAL . 26.8 m -124.61 157.67 32.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.921 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.739 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 0.3 OUTLIER 72.99 -4.41 2.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.059 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.644 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 104.18 32.0 4.48 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.821 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.682 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 94.88 -22.72 36.51 Favored Glycine 0 C--O 1.262 1.869 0 CA-C-O 123.203 1.446 . . . . 0.0 112.588 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.739 ' HG3' ' HB3' ' A' ' 131' ' ' ASP . 13.4 ptmt -65.73 -17.66 64.77 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 121.872 -0.781 . . . . 0.0 109.086 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.626 ' HB ' HG23 ' A' ' 130' ' ' VAL . 8.4 t -140.82 146.53 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.831 177.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.615 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 41.1 tp -126.13 124.69 41.1 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.534 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 34.1 tt0 -114.43 137.83 51.34 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.85 0.357 . . . . 0.0 111.403 -177.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.556 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -163.21 164.69 25.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.177 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.565 ' HB2' ' HB3' ' A' ' 125' ' ' ARG . 17.5 mm-40 -94.9 106.41 18.4 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 177.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.611 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 59.0 mt -96.71 130.03 44.01 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.2 0.524 . . . . 0.0 111.197 -178.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.775 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 42.6 ttt180 -77.09 141.29 40.3 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.688 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.487 ' HB2' ' HA ' ' A' ' 47' ' ' ASN . 6.8 p90 -155.65 -169.21 3.04 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.976 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.9 p -58.22 -22.53 52.36 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -109.19 28.24 11.36 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.31 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.63 -123.19 7.45 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.858 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -123.19 135.55 54.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.56 0.219 . . . . 0.0 110.51 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.436 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 57.9 t30 -134.91 142.61 46.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.898 0.38 . . . . 0.0 110.828 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.9 tpp85 -76.61 110.47 11.2 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.066 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.639 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 9.2 t -124.9 165.53 17.91 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.615 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 35.2 mtt85 -146.37 152.37 38.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.712 0.292 . . . . 0.0 110.881 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.862 HD13 HD22 ' A' ' 43' ' ' LEU . 12.4 tt -135.77 142.76 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.022 178.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.589 ' CB ' ' HG3' ' A' ' 155' ' ' GLU . 8.5 m-85 -86.35 101.84 13.46 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 122.471 -0.143 . . . . 0.0 111.31 -178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.818 HD11 ' HG ' ' A' ' 39' ' ' LEU . 3.9 mm? -61.14 -37.53 83.17 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.079 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.654 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 13.1 t70 -55.2 -16.24 3.01 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.209 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.655 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 41.2 mt-10 -63.28 -54.01 43.93 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -124.48 2.92 8.37 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.786 -0.766 . . . . 0.0 112.404 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.617 HG13 HD12 ' A' ' 153' ' ' LEU . 43.5 mm -104.03 112.96 39.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.357 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.557 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -118.73 168.33 13.24 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.562 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.554 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.8 t30 -104.71 122.16 45.1 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 15.7 ttm-85 -123.85 93.68 4.0 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.29 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 59.23 41.54 19.94 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.478 -0.783 . . . . 0.0 113.063 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 90.45 10.05 64.17 Favored Glycine 0 C--O 1.229 -0.193 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.211 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -121.43 134.21 55.09 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.216 0.531 . . . . 0.0 110.211 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.785 HD11 ' CD2' ' A' ' 7' ' ' PHE . 8.1 tp -96.35 107.31 19.66 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.741 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.444 ' HA ' HD12 ' A' ' 37' ' ' ILE . 19.8 pt . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.003 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.514 ' CD1' ' HG2' ' A' ' 155' ' ' GLU . 13.6 m-85 . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 120.97 0.414 . . . . 0.0 111.684 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -109.18 -28.45 9.02 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -62.4 -70.98 0.89 Allowed Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 119.495 -1.336 . . . . 0.0 112.694 -178.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 65.08 18.93 11.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.803 0.335 . . . . 0.0 110.498 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.742 ' HD2' HD11 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -65.19 -30.69 71.62 Favored 'General case' 0 C--O 1.217 -0.647 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.73 179.815 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.9 t -71.53 -9.32 58.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.705 0.764 . . . . 0.0 109.512 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.49 -23.01 57.51 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 115.12 -0.945 . . . . 0.0 113.054 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.484 ' HB2' HD22 ' A' ' 159' ' ' ASN . 20.2 m -129.39 -22.0 3.12 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 117.287 0.544 . . . . 0.0 111.26 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.505 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 13.0 m -99.31 133.49 43.53 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 12' ' ' ARG . 4.3 ptp180 -113.45 -174.49 2.47 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 42.61 45.52 4.02 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 123.854 0.721 . . . . 0.0 111.489 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.867 HG22 HD13 ' A' ' 129' ' ' LEU . 6.7 mt -79.54 109.26 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.008 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.638 ' CA ' HD12 ' A' ' 129' ' ' LEU . 53.8 t -149.54 127.24 11.7 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.42 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.742 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -94.7 154.7 17.19 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.584 0.706 . . . . 0.0 111.832 -179.547 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -97.47 75.49 2.5 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 114.42 -1.264 . . . . 0.0 107.65 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.13 -55.51 5.04 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.431 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.495 ' HA ' ' HZ ' ' A' ' 120' ' ' PHE . . . -148.51 -12.89 0.34 Allowed 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -87.15 91.64 8.78 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.893 0.377 . . . . 0.0 110.792 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.847 HD22 HD13 ' A' ' 153' ' ' LEU . 42.7 tp -60.86 124.65 21.07 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.138 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 54.5 ttp180 -128.35 131.94 48.58 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.773 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.635 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -149.72 145.9 26.93 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.612 0.72 . . . . 0.0 111.431 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.549 ' O ' ' HD2' ' A' ' 32' ' ' TYR . 19.8 mm-40 -78.73 71.26 5.18 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.645 178.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.681 ' SG ' HD13 ' A' ' 164' ' ' LEU . 61.6 m -60.08 121.65 12.4 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.717 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 10' ' ' SER . 25.0 ttt85 -67.91 132.08 46.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.038 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.718 ' HG2' ' HA3' ' A' ' 162' ' ' GLY . 18.8 mtm180 -103.75 155.88 18.25 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.27 -11.48 3.49 Favored Glycine 0 C--N 1.336 0.548 0 O-C-N 124.383 1.052 . . . . 0.0 114.389 -178.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -80.25 -4.46 53.33 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.19 10.97 73.59 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -179.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.66 152.68 17.37 Favored Glycine 0 C--O 1.225 -0.456 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.97 -178.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.549 ' HD2' ' O ' ' A' ' 24' ' ' GLU . 70.9 m-85 -101.55 125.31 48.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.721 0.296 . . . . 0.0 110.247 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.7 p -117.8 141.13 48.76 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.046 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.8 m -72.66 111.99 8.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.262 0.553 . . . . 0.0 111.219 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.416 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 44.2 t -115.32 148.61 39.02 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.343 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.6 p -144.97 137.96 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.944 0.402 . . . . 0.0 111.561 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.595 HG22 HD23 ' A' ' 164' ' ' LEU . 14.0 tt -134.5 154.2 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.341 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -89.17 110.24 21.01 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 121.836 -0.54 . . . . 0.0 111.487 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.569 HD23 ' HB3' ' A' ' 21' ' ' LEU . 2.9 mm? -87.55 -6.81 58.17 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.512 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.59 -17.27 64.57 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.1 mtt-85 -95.08 2.7 55.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.992 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 96.1 m-85 -131.36 -23.23 2.41 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.689 HD22 HD13 ' A' ' 151' ' ' ILE . 63.2 mt -105.98 136.59 45.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.845 0.355 . . . . 0.0 111.576 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.469 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 15.8 m -134.79 136.35 42.49 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.15 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.819 ' CB ' ' HG ' ' A' ' 140' ' ' LEU . 3.5 p-10 -80.2 107.77 13.27 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.418 177.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -113.87 94.96 5.07 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.503 ' HA ' ' HB2' ' A' ' 142' ' ' TYR . 7.7 t30 56.95 49.41 14.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.756 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.552 ' O ' ' HB2' ' A' ' 149' ' ' SER . . . 71.91 31.12 64.87 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.201 178.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.511 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 38.8 m80 -144.45 129.04 18.11 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.732 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 26.3 m-85 -68.4 136.96 54.13 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.589 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -144.0 132.49 22.19 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.069 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.618 ' CD1' HD11 ' A' ' 151' ' ' ILE . 99.8 m95 . . . . . 0 C--O 1.236 0.359 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.163 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 87.9 m . . . . . 0 N--CA 1.452 -0.329 0 CA-C-O 121.057 0.456 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.65 176.32 8.55 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.263 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.439 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 4.8 p -127.41 121.33 30.6 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.794 0.331 . . . . 0.0 111.602 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.5 HG21 ' CE2' ' A' ' 80' ' ' PHE . 9.8 p -109.73 144.47 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.75 0.31 . . . . 0.0 110.411 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 18.1 m -88.19 128.07 35.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.101 0.477 . . . . 0.0 110.395 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.492 ' CG2' HD12 ' A' ' 99' ' ' ILE . 57.1 t -73.16 128.11 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.743 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -100.83 169.2 9.16 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 124.577 1.173 . . . . 0.0 111.196 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.618 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 26.4 tp60 -68.19 112.17 4.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.75 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.38 18.55 16.37 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.71 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -125.38 117.57 24.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.619 0.247 . . . . 0.0 110.463 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.687 ' HA ' HG12 ' A' ' 99' ' ' ILE . 81.9 p -104.9 -179.03 3.82 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.665 HD22 HG23 ' A' ' 99' ' ' ILE . 0.9 OUTLIER -52.88 -41.01 63.94 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.419 178.826 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 46.5 mtm105 -63.51 -39.02 93.34 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.168 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 79' ' ' ARG . 19.6 m-20 -70.95 -41.18 71.46 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.338 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 72' ' ' THR . 35.8 mm -63.92 -46.99 92.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.656 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -56.66 -54.76 34.02 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.75 -0.659 . . . . 0.0 113.02 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -64.86 -27.41 68.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.977 0.417 . . . . 0.0 111.734 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 71.9 ttt180 -74.24 -42.21 60.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.172 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.5 ' CE2' HG21 ' A' ' 65' ' ' VAL . 68.2 m-85 -111.45 19.75 17.9 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.2 t70 54.26 36.54 25.35 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.966 0.889 . . . . 0.0 111.316 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.656 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 3.6 p -113.79 163.5 14.97 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.615 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.0 t70 -92.71 124.69 36.9 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.935 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.515 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 4.0 p90 -51.67 -30.34 21.47 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.255 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 35.3 t60 -64.71 -44.36 90.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.029 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.702 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 28.0 mm-40 -67.02 -48.25 68.93 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.934 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.615 HG13 ' O ' ' A' ' 83' ' ' ASP . 3.4 mt -53.46 -46.19 58.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.592 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.1 -51.28 67.21 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.35 178.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -57.35 -39.56 76.21 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.618 0.246 . . . . 0.0 111.53 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.702 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 63.9 mmt-85 -63.06 -37.51 87.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.009 0.433 . . . . 0.0 110.778 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.428 ' HB3' HG12 ' A' ' 93' ' ' ILE . 3.0 t-20 -89.38 -5.34 57.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.948 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 95.2 m-20 74.46 22.16 2.18 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.556 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.592 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 14.8 pt -108.18 -176.98 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.212 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.454 ' H ' ' HB2' ' A' ' 97' ' ' ASP . 85.1 mm-40 -108.98 155.96 20.27 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.493 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.7 p30 -55.12 -60.43 3.39 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-O 122.104 0.954 . . . . 0.0 109.119 178.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -74.09 11.5 0.9 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.036 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.454 ' HB2' ' H ' ' A' ' 94' ' ' GLN . 5.3 t70 -64.86 -33.15 75.32 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.425 HD22 HG21 ' A' ' 72' ' ' THR . 51.0 mt 70.05 111.84 0.05 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.11 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.687 HG12 ' HA ' ' A' ' 72' ' ' THR . 9.2 pt -94.7 172.54 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.158 -178.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.499 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 19.3 m-85 -125.43 157.97 66.01 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.86 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.618 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 23.2 Cg_endo -65.25 132.63 32.28 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.986 2.458 . . . . 0.0 113.492 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.78 21.05 10.67 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.843 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.531 ' O ' ' HA ' ' A' ' 66' ' ' THR . 51.2 mt-30 -110.46 167.72 10.0 Favored 'General case' 0 C--O 1.215 -0.712 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.044 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.439 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 81.5 t -125.84 111.0 25.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.543 HD11 HG21 ' A' ' 99' ' ' ILE . 90.7 mt -107.16 150.63 26.39 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.155 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.614 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 47.4 mt-30 -89.41 114.92 26.44 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.713 0.768 . . . . 0.0 110.927 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.6 m -121.06 150.86 54.32 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 114.358 -1.292 . . . . 0.0 109.794 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.66 -19.81 59.74 Favored 'Trans proline' 0 N--CA 1.472 0.211 0 C-N-CA 123.458 2.772 . . . . 0.0 114.351 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.5 t . . . . . 0 C--N 1.323 -0.581 0 CA-C-O 120.975 0.417 . . . . 0.0 110.382 179.693 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.469 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.441 -0.993 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 74.51 27.49 1.37 Allowed 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.607 0.763 . . . . 0.0 112.636 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.615 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 19.4 p90 -62.36 -38.32 89.07 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.006 178.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.484 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 58.2 t-105 -61.72 -29.78 70.33 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 123.63 0.581 . . . . 0.0 111.634 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.15 -34.64 45.61 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.355 0.597 . . . . 0.0 110.539 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.956 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 17.8 m -132.64 32.34 3.88 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.484 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -114.37 137.36 51.91 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.403 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -131.95 151.3 51.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.183 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.6 t70 55.79 49.09 16.86 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.845 0.831 . . . . 0.0 109.763 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.496 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 29.6 t -77.2 119.29 25.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.746 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -142.36 144.21 33.06 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.79 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.867 HD13 HG22 ' A' ' 14' ' ' ILE . 19.8 mt -87.76 125.46 34.44 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.613 HG23 ' HB ' ' A' ' 135' ' ' VAL . 30.4 m -118.11 158.2 19.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.809 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 69.06 4.78 4.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.157 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.634 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 97.37 30.69 7.19 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.81 -0.709 . . . . 0.0 113.384 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 93.66 -21.38 41.48 Favored Glycine 0 C--O 1.266 2.097 0 CA-C-O 123.043 1.357 . . . . 0.0 113.112 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.849 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 15.8 ptpt -65.81 -17.88 64.94 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 121.785 -0.832 . . . . 0.0 108.834 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.613 ' HB ' HG23 ' A' ' 130' ' ' VAL . 17.2 t -139.47 141.62 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.676 177.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.587 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 24.4 tp -121.12 123.15 41.6 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.567 ' OE2' ' HD2' ' A' ' 148' ' ' ARG . 23.1 tt0 -117.26 131.34 56.85 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.1 0.476 . . . . 0.0 111.182 -177.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . . . -159.98 160.3 33.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.433 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -94.67 109.14 21.1 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.819 ' HG ' ' CB ' ' A' ' 45' ' ' ASN . 0.8 OUTLIER -91.7 131.04 37.37 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.016 -179.528 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.956 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 36.5 ttt180 -75.98 140.56 42.09 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.6 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.503 ' HB2' ' HA ' ' A' ' 47' ' ' ASN . 3.5 p90 -154.46 -176.23 5.79 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.852 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 46.6 m -56.28 -27.96 57.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.859 0.361 . . . . 0.0 111.686 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -97.35 25.76 25.77 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.283 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.85 -120.08 6.33 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.756 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -126.72 137.26 53.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.575 0.226 . . . . 0.0 110.473 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -133.93 132.9 40.78 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.369 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.567 ' HD2' ' OE2' ' A' ' 137' ' ' GLU . 16.3 ttp180 -74.87 98.11 3.47 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.56 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.552 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 35.1 t -106.15 164.38 12.04 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.907 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 15.8 ptt180 -147.62 145.94 29.17 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.694 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.732 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 14.7 tt -129.85 150.62 34.8 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.576 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.827 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 80.7 m-85 -89.46 103.88 16.48 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 122.144 -0.347 . . . . 0.0 111.079 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.847 HD13 HD22 ' A' ' 21' ' ' LEU . 34.2 mt -66.68 -33.78 76.41 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.299 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.849 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 10.1 t70 -58.42 -8.18 1.11 Allowed 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.159 178.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.827 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 38.8 mt-10 -68.77 -51.88 36.41 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 121.117 0.484 . . . . 0.0 111.785 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -119.25 -15.03 9.2 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.156 -177.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.466 HG21 HD21 ' A' ' 21' ' ' LEU . 50.2 mm -88.21 112.95 24.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.153 -179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.499 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -119.49 173.71 15.18 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.715 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.566 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.7 t30 -113.3 127.71 56.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -122.26 93.15 3.89 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 66.6 t30 53.05 58.15 5.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.545 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.718 ' HA3' ' HG2' ' A' ' 27' ' ' ARG . . . 78.91 11.41 85.24 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.567 -0.742 . . . . 0.0 114.821 178.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -123.75 143.66 50.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 117.542 0.671 . . . . 0.0 110.958 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.742 HD11 ' HD2' ' A' ' 7' ' ' PHE . 5.5 tp -91.58 118.8 30.93 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.944 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.7 pp . . . . . 0 C--N 1.325 -0.461 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.807 -178.658 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.629 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 55.4 m-85 . . . . . 0 C--O 1.232 0.132 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -108.52 -30.74 8.1 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.96 -69.97 1.22 Allowed Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 119.825 -1.178 . . . . 0.0 112.448 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 62.18 21.15 12.24 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 122.606 0.362 . . . . 0.0 111.229 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.713 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -64.32 -33.34 75.61 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 121.12 -0.232 . . . . 0.0 110.873 179.368 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.409 ' HA ' HD11 ' A' ' 14' ' ' ILE . 42.6 t -61.95 -18.24 59.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.47 0.653 . . . . 0.0 110.188 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.17 -31.46 69.14 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.124 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.502 ' HB2' ' HB3' ' A' ' 26' ' ' ARG . 21.6 p -126.67 -8.22 6.2 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 117.399 0.6 . . . . 0.0 111.742 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.1 m -105.32 128.95 53.74 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.44 ' CG ' ' HB2' ' A' ' 24' ' ' GLU . 13.8 ptm180 -110.05 -176.71 3.07 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.452 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 21.7 m-20 43.27 44.47 4.61 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 124.036 0.835 . . . . 0.0 112.306 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.901 HG22 HD13 ' A' ' 129' ' ' LEU . 8.3 mt -79.6 103.2 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -178.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.57 ' CA ' HD12 ' A' ' 129' ' ' LEU . 57.7 m -147.1 127.2 13.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.707 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.743 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -96.98 151.29 19.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.711 0.767 . . . . 0.0 112.805 -179.604 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 21.7 t70 -93.82 74.74 4.24 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 177.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.42 -54.44 4.9 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.155 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.559 ' HB1' ' HB2' ' A' ' 40' ' ' ASN . . . -147.97 -12.83 0.37 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.264 -0.468 . . . . 0.0 109.742 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.482 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -82.55 86.74 6.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.545 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.743 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 35.9 tp -60.95 124.45 20.53 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.485 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.546 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 34.7 ttt180 -132.17 127.59 36.23 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.877 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.604 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -146.0 145.98 30.82 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.668 0.747 . . . . 0.0 111.421 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.452 ' HG3' ' HB2' ' A' ' 13' ' ' ASP . 2.1 mm-40 -83.68 76.4 9.98 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.411 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.601 ' SG ' HD13 ' A' ' 164' ' ' LEU . 35.8 m -66.54 125.57 26.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.393 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.502 ' HB3' ' HB2' ' A' ' 10' ' ' SER . 30.3 ttt180 -70.41 121.75 18.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.651 178.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 27' ' ' ARG . 10.7 ptp180 -100.05 163.84 12.25 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.755 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.4 -15.95 4.54 Favored Glycine 0 C--N 1.34 0.782 0 O-C-N 124.934 1.396 . . . . 0.0 114.114 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.6 -12.49 61.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.516 0.674 . . . . 0.0 109.417 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.57 9.52 62.86 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.654 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -119.93 162.26 14.11 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.08 -1.057 . . . . 0.0 113.286 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.473 ' CE2' ' HB2' ' A' ' 26' ' ' ARG . 84.2 m-85 -100.44 125.2 46.71 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.0 p -116.6 140.76 49.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.393 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -73.58 113.92 11.23 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.17 0.51 . . . . 0.0 111.43 -178.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 32.9 t -116.14 151.02 36.46 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.649 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.6 p -144.77 139.6 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.308 0.575 . . . . 0.0 112.091 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.408 HG23 ' HB3' ' A' ' 21' ' ' LEU . 13.7 tt -135.47 143.38 36.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.479 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -76.34 96.85 4.08 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.603 HD23 HD11 ' A' ' 43' ' ' LEU . 5.3 tp -73.5 -4.54 34.47 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.046 0.45 . . . . 0.0 110.408 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.559 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 64.3 t30 -73.83 -11.7 60.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 74.0 mtt180 -102.48 5.08 39.32 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.233 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 13.7 m-85 -127.57 -26.09 3.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.778 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.665 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 49.3 mt -105.02 138.76 40.73 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.8 0.333 . . . . 0.0 110.899 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.454 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 4.0 m -134.68 134.76 41.46 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.678 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.529 ' OD1' HD22 ' A' ' 140' ' ' LEU . 9.3 m-20 -73.33 110.37 7.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.685 177.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -111.9 86.95 2.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.245 0.545 . . . . 0.0 110.407 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.41 ' HA ' ' HB2' ' A' ' 142' ' ' TYR . 21.5 t-20 51.82 46.22 26.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.23 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.498 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 82.98 40.01 9.7 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.573 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.415 ' HA ' ' HB3' ' A' ' 149' ' ' SER . 16.5 t60 -162.2 128.63 3.64 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.886 ' HB2' ' HB ' ' A' ' 151' ' ' ILE . 96.2 m-85 -67.6 156.81 35.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.817 0.342 . . . . 0.0 111.146 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.433 ' HA ' ' HD3' ' A' ' 51' ' ' ARG . 16.7 mmt180 -148.91 126.89 11.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.169 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.976 ' HZ2' ' HA ' ' A' ' 153' ' ' LEU . 72.9 m95 . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.511 178.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 83.6 m . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.088 0.47 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.26 176.38 5.88 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.586 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.466 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 13.2 p -127.73 111.03 13.23 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.905 0.383 . . . . 0.0 111.176 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.568 HG21 ' CE2' ' A' ' 80' ' ' PHE . 9.1 p -97.54 144.37 11.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.042 0.448 . . . . 0.0 111.218 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 8.2 m -91.09 127.46 36.52 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.478 ' CG2' HD12 ' A' ' 99' ' ' ILE . 49.1 t -75.87 131.68 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.585 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -98.08 168.95 9.95 Favored 'General case' 0 N--CA 1.445 -0.679 0 O-C-N 124.657 1.223 . . . . 0.0 110.569 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.593 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 52.3 tt0 -69.65 119.75 14.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.781 -178.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.39 -1.67 50.1 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.475 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -110.12 131.71 54.82 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.084 0.469 . . . . 0.0 111.687 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.652 ' HA ' HG12 ' A' ' 99' ' ' ILE . 67.5 p -108.59 -177.62 3.37 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.14 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.651 HD22 HG23 ' A' ' 99' ' ' ILE . 1.4 mm? -52.85 -40.81 63.71 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.454 0.645 . . . . 0.0 109.889 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.0 ttm-85 -62.9 -37.16 85.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.211 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -74.15 -42.0 60.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.905 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 72' ' ' THR . 44.7 mm -62.0 -48.31 89.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.715 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -54.44 -52.87 41.87 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.688 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -64.5 -33.7 76.5 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 35.7 ttm-85 -68.69 -37.46 79.56 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.568 ' CE2' HG21 ' A' ' 65' ' ' VAL . 87.1 m-85 -111.72 18.37 19.03 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 55.02 34.07 21.67 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.236 0.541 . . . . 0.0 111.794 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.715 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 3.0 p -111.37 170.49 8.09 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.608 ' HB3' ' HG3' ' A' ' 86' ' ' GLU . 32.6 t0 -98.26 121.53 40.3 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.419 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.503 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 4.3 p90 -51.82 -29.72 20.42 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.586 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.461 ' HB2' ' OD2' ' A' ' 83' ' ' ASP . 69.2 m80 -63.8 -47.22 81.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.513 177.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.748 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 41.6 mt-10 -62.05 -53.49 54.75 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.942 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.587 HG13 ' O ' ' A' ' 83' ' ' ASP . 3.3 mt -48.0 -46.6 12.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.275 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.601 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.72 -51.06 68.64 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.211 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 89' ' ' ARG . 49.4 mtp85 -59.16 -36.77 75.85 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.748 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 12.3 mmt85 -69.43 -30.44 68.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.699 0.285 . . . . 0.0 110.98 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 2.6 t-20 -95.1 -4.72 45.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.825 0.345 . . . . 0.0 110.871 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 15.9 m120 78.25 13.81 1.52 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.769 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.601 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 19.6 pt -101.64 -173.55 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.288 179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.508 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . 64.4 mt-30 -113.88 157.64 22.1 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.126 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.574 ' O ' HD23 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -56.54 -69.73 0.14 Allowed 'General case' 0 C--O 1.244 0.778 0 CA-C-O 122.061 0.934 . . . . 0.0 110.101 179.663 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -73.28 13.91 0.38 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.716 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.508 ' HB2' ' HB2' ' A' ' 94' ' ' GLN . 1.9 t70 -65.99 -29.32 69.69 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.094 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 8.8 mp 71.33 112.3 0.06 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 122.033 0.921 . . . . 0.0 110.55 -178.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.652 HG12 ' HA ' ' A' ' 72' ' ' THR . 9.0 pt -94.59 177.22 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.155 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.519 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 79.2 m-85 -128.7 158.77 71.09 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.593 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 28.1 Cg_endo -67.0 138.96 49.56 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.949 2.433 . . . . 0.0 113.056 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.35 18.49 42.07 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.508 ' O ' ' HA ' ' A' ' 66' ' ' THR . 41.4 tt0 -103.89 164.28 11.8 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.466 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 69.7 t -125.58 118.2 51.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 120.938 0.399 . . . . 0.0 109.978 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.509 ' HB3' HG22 ' A' ' 87' ' ' ILE . 78.9 mt -114.44 151.07 33.77 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.147 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.534 ' HB2' ' CB ' ' A' ' 90' ' ' ARG . 75.8 mt-30 -90.91 115.2 27.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.668 0.747 . . . . 0.0 110.92 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.444 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 34.0 m -126.99 151.97 74.91 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.843 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.444 ' HD2' ' HB ' ' A' ' 107' ' ' VAL . 29.7 Cg_endo -63.8 -15.37 48.55 Favored 'Trans proline' 0 N--CA 1.474 0.352 0 C-N-CA 123.624 2.883 . . . . 0.0 115.207 -177.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 C--N 1.322 -0.616 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.225 179.813 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.444 -0.799 0 N-CA-C 112.257 -0.337 . . . . 0.0 112.257 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 71.89 29.4 2.45 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 123.055 0.542 . . . . 0.0 111.373 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.665 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 12.5 p90 -61.19 -37.98 84.88 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.107 0.48 . . . . 0.0 110.183 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.452 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 48.6 t-105 -64.85 -26.25 68.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.636 -178.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.46 -18.3 61.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.213 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.78 ' HB2' ' HB3' ' A' ' 141' ' ' ARG . 11.2 p -140.07 22.67 2.42 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.971 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.452 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -111.73 141.96 44.69 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.901 0.382 . . . . 0.0 111.091 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -133.74 151.2 51.54 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 58.83 34.81 23.94 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.363 0.414 . . . . 0.0 111.646 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.498 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 30.8 t -66.92 123.82 20.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.81 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.491 ' O ' HD12 ' A' ' 136' ' ' LEU . 39.1 ptt180 -148.12 142.71 26.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.088 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.901 HD13 HG22 ' A' ' 14' ' ' ILE . 22.3 mt -85.52 131.79 34.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.081 0.467 . . . . 0.0 110.044 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.617 HG23 ' HB ' ' A' ' 135' ' ' VAL . 27.5 m -126.92 162.36 31.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.825 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 67.16 7.26 5.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.785 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.686 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 95.39 31.35 7.58 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.914 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.777 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 90.03 -19.28 43.23 Favored Glycine 0 CA--C 1.541 1.671 0 CA-C-O 123.226 1.459 . . . . 0.0 112.824 177.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.773 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 0.7 OUTLIER -68.18 -14.92 63.34 Favored 'General case' 0 C--N 1.314 -0.952 0 O-C-N 121.121 -1.223 . . . . 0.0 109.564 178.071 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.617 ' HB ' HG23 ' A' ' 130' ' ' VAL . 14.6 t -140.49 149.06 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.783 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 39.0 tp -130.72 125.25 33.4 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.403 ' HG2' ' HD2' ' A' ' 148' ' ' ARG . 33.6 tt0 -114.65 136.25 53.25 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.622 0.249 . . . . 0.0 111.363 -177.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.802 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.73 163.51 26.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.105 0.479 . . . . 0.0 111.323 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -94.72 106.5 18.49 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.529 HD22 ' OD1' ' A' ' 45' ' ' ASN . 36.6 mt -96.25 132.23 41.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.104 0.478 . . . . 0.0 111.316 -178.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.78 ' HB3' ' HB2' ' A' ' 123' ' ' SER . 42.5 ttt180 -75.82 140.55 42.34 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.256 -0.883 . . . . 0.0 110.674 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.509 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.7 p90 -160.3 -170.3 2.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.429 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 6.1 p -56.12 -29.29 60.46 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -94.49 11.67 69.84 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.726 -0.749 . . . . 0.0 113.171 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 141' ' ' ARG . . . 101.08 -111.46 4.14 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.039 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -126.75 129.85 49.17 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.509 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 9.1 t30 -125.55 140.19 52.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.992 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.403 ' HD2' ' HG2' ' A' ' 137' ' ' GLU . 12.5 tpp85 -73.49 100.04 3.16 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.415 ' HB3' ' HA ' ' A' ' 49' ' ' HIS . 1.0 OUTLIER -111.62 155.43 23.38 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.425 -177.709 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 4.8 ptp180 -146.51 145.28 30.1 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.135 0.493 . . . . 0.0 111.274 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.886 ' HB ' ' HB2' ' A' ' 50' ' ' PHE . 15.4 tt -126.47 159.74 35.22 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.81 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.489 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.871 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 68.5 m-85 -103.94 107.15 17.9 Favored 'General case' 0 C--N 1.311 -1.106 0 O-C-N 122.361 -0.212 . . . . 0.0 110.655 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.976 ' HA ' ' HZ2' ' A' ' 52' ' ' TRP . 8.4 mp -68.9 -37.18 78.81 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.221 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.773 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 6.1 t70 -57.08 -8.41 0.66 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.869 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.871 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 61.0 mt-10 -73.78 -55.43 6.24 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 121.972 -0.455 . . . . 0.0 111.811 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -122.0 9.8 10.02 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.114 -0.634 . . . . 0.0 112.671 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.446 ' HB ' ' O ' ' A' ' 153' ' ' LEU . 45.1 mm -110.95 109.62 29.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.356 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.488 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -115.58 166.65 12.26 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.048 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.565 ' CG ' ' HB3' ' A' ' 25' ' ' CYS . 1.8 t30 -101.51 124.84 47.83 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.413 ' NH2' ' HG2' ' A' ' 163' ' ' GLU . 48.3 ttp180 -112.99 86.12 2.31 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.694 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 50.26 51.06 17.48 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 92.87 6.64 63.41 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.762 178.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.413 ' HG2' ' NH2' ' A' ' 160' ' ' ARG . 6.7 tp10 -122.16 149.75 43.17 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.713 HD11 ' CD2' ' A' ' 7' ' ' PHE . 5.3 tp -99.11 118.16 35.22 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 12.2 tt . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.673 -178.542 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.479 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 53.5 m-85 . . . . . 0 N--CA 1.457 -0.116 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.31 -29.39 10.8 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.66 -73.41 0.58 Allowed Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 119.772 -1.204 . . . . 0.0 113.154 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 65.26 15.61 10.1 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 122.46 0.304 . . . . 0.0 110.484 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.61 ' CE2' HD13 ' A' ' 14' ' ' ILE . 1.4 p90 -60.14 -37.26 79.53 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.562 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.588 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.7 OUTLIER -59.85 -24.05 63.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.268 0.556 . . . . 0.0 110.604 -179.427 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.87 -33.96 87.25 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.404 -0.816 . . . . 0.0 113.44 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 18.8 p -121.12 -3.74 9.55 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 117.188 0.494 . . . . 0.0 111.689 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.7 m -110.39 131.85 54.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.119 0.485 . . . . 0.0 109.997 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.597 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 18.8 ptt180 -107.95 179.94 4.08 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 42.52 47.79 4.48 Favored 'General case' 0 C--N 1.316 -0.867 0 O-C-N 123.883 0.739 . . . . 0.0 112.767 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.777 HG22 HD13 ' A' ' 129' ' ' LEU . 7.3 mt -81.49 102.44 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-O 121.043 0.449 . . . . 0.0 109.919 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.562 ' HA ' HD12 ' A' ' 129' ' ' LEU . 46.4 t -147.76 128.69 14.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.457 -0.792 . . . . 0.0 108.985 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.741 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -92.99 159.48 15.29 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.629 0.728 . . . . 0.0 112.007 -179.241 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -104.31 77.64 1.42 Allowed 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.22 -61.02 4.52 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.134 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' A' ' 40' ' ' ASN . . . -146.02 -13.36 0.48 Allowed 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.282 -0.459 . . . . 0.0 109.913 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -86.16 95.15 9.48 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.81 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.894 ' HB2' HD22 ' A' ' 39' ' ' LEU . 33.8 tp -59.75 128.27 36.11 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.758 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 35' ' ' SER . 34.8 ttp180 -133.17 128.03 35.13 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.939 -178.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.621 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -149.47 147.29 28.05 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.546 0.688 . . . . 0.0 111.144 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.597 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 2.1 mm-40 -82.96 79.62 9.26 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.464 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.574 ' HB3' ' CG ' ' A' ' 159' ' ' ASN . 61.4 m -67.34 129.43 39.89 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.762 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 10' ' ' SER . 43.1 ttp180 -72.35 120.8 18.46 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.251 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.7 ttt-85 -96.05 153.71 17.63 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.09 -16.37 4.33 Favored Glycine 0 C--N 1.335 0.493 0 O-C-N 124.611 1.194 . . . . 0.0 114.765 -177.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.87 -13.88 61.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.238 0.542 . . . . 0.0 110.001 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.38 10.13 56.09 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.59 160.64 13.9 Favored Glycine 0 C--O 1.225 -0.461 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.485 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.522 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 88.5 m-85 -97.98 130.59 44.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.955 0.407 . . . . 0.0 110.685 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.0 m -110.69 129.1 55.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.364 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.36 110.37 5.26 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 29.4 t -112.46 147.17 37.08 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.219 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.668 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.3 p -144.76 133.09 17.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.027 0.441 . . . . 0.0 110.686 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.407 HG23 ' HB3' ' A' ' 21' ' ' LEU . 11.0 tt -133.93 146.83 30.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.648 -177.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -78.96 103.74 9.11 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.924 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.894 HD22 ' HB2' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -78.96 -5.17 53.13 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 120.858 0.361 . . . . 0.0 110.245 178.601 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.43 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 4.2 t30 -70.9 -17.88 62.69 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.049 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -106.07 17.49 23.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.382 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 41.3 m-85 -135.97 -34.7 0.8 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.314 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.856 HD22 HD13 ' A' ' 151' ' ' ILE . 38.6 mt -106.09 136.32 45.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.867 -179.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.681 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 3.0 m -126.6 143.59 51.17 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.78 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.629 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 6.8 p-10 -93.23 93.56 8.31 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 122.01 0.909 . . . . 0.0 108.568 178.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.422 ' HB3' ' HG3' ' A' ' 51' ' ' ARG . 31.9 t70 -94.3 95.74 9.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.16 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 54.68 45.65 26.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.525 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.703 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 77.87 29.94 53.23 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.467 178.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.556 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 23.7 t-160 -148.03 124.93 11.27 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.799 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 25.3 m-85 -62.54 136.42 57.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.248 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.422 ' HG3' ' HB3' ' A' ' 46' ' ' ASP . 17.1 mmm180 -145.01 133.12 21.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.701 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.469 ' CD1' HD11 ' A' ' 151' ' ' ILE . 98.6 m95 . . . . . 0 C--N 1.326 -0.433 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.6 m . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 121.067 0.46 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -126.46 176.76 6.92 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.665 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.1 p -128.37 118.01 22.42 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 t -107.06 137.2 39.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.802 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 18.9 m -87.78 124.82 34.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.081 0.467 . . . . 0.0 109.916 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.501 ' CG2' HD12 ' A' ' 99' ' ' ILE . 42.2 t -71.06 133.91 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.125 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.494 ' HB3' ' OD2' ' A' ' 71' ' ' ASP . 16.3 tt0 -104.16 171.33 7.4 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 124.464 1.103 . . . . 0.0 110.411 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.673 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 58.9 tp60 -60.22 119.68 8.35 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.374 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.94 6.53 79.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.996 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.494 ' OD2' ' HB3' ' A' ' 68' ' ' GLN . 27.6 m-20 -103.82 124.03 48.17 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 117.393 0.597 . . . . 0.0 110.581 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.625 ' HA ' HG12 ' A' ' 99' ' ' ILE . 80.3 p -105.18 179.44 4.27 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.571 ' CD2' HG23 ' A' ' 99' ' ' ILE . 2.2 mm? -51.6 -41.57 61.32 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.59 0.709 . . . . 0.0 109.403 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -59.61 -39.36 83.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.384 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 79' ' ' ARG . 13.4 m-20 -73.85 -46.65 43.68 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.119 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 72' ' ' THR . 42.4 mm -57.12 -48.05 82.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.709 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.736 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -59.78 -54.28 38.9 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.852 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -33.04 74.39 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.92 0.39 . . . . 0.0 111.524 -178.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 35.6 ttt180 -74.0 -39.82 63.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.031 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -105.78 19.33 20.73 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 59.26 26.82 15.71 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.736 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -110.12 168.64 9.29 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.503 ' O ' HG13 ' A' ' 87' ' ' ILE . 4.3 p-10 -96.65 122.17 39.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.71 0.767 . . . . 0.0 109.836 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.422 ' HA ' HD12 ' A' ' 87' ' ' ILE . 3.0 p90 -48.64 -32.16 7.83 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.036 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.41 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 10.9 m80 -60.36 -48.93 79.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.991 178.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.608 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 28.4 tt0 -63.18 -46.33 87.62 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.205 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.54 ' HB ' HD12 ' A' ' 73' ' ' LEU . 3.5 mt -52.51 -49.58 43.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.572 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.27 -49.21 74.97 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.408 178.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 85' ' ' HIS . 62.0 mtm180 -56.67 -38.13 71.77 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.608 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 13.0 mtt180 -70.02 -36.29 74.98 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.158 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.424 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 2.5 t-20 -85.76 -5.51 59.24 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.964 0.411 . . . . 0.0 110.276 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 90.3 m-20 75.5 18.92 2.2 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.611 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.572 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 14.3 pt -105.66 -170.38 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.204 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.556 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 28.5 mm-40 -117.97 158.72 24.41 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.506 ' O ' HD23 ' A' ' 73' ' ' LEU . 6.3 p30 -55.72 -57.62 11.26 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-O 121.877 0.846 . . . . 0.0 109.956 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.12 12.51 2.78 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 121.831 -0.543 . . . . 0.0 111.294 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.556 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 0.8 OUTLIER -62.69 -31.2 72.06 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.617 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 7.0 mp 71.38 111.18 0.06 Allowed 'General case' 0 C--N 1.338 0.108 0 O-C-N 124.358 1.037 . . . . 0.0 110.732 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.649 HG21 HD11 ' A' ' 105' ' ' LEU . 6.4 pt -94.43 176.0 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.977 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.476 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 92.7 m-85 -121.07 158.2 53.28 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.91 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.673 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 43.4 Cg_endo -72.3 133.36 20.88 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 123.042 2.495 . . . . 0.0 112.889 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 101.59 14.12 30.7 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' A' ' 66' ' ' THR . 40.0 mt-30 -102.92 168.44 9.2 Favored 'General case' 0 C--O 1.216 -0.699 0 C-N-CA 120.641 -0.424 . . . . 0.0 109.956 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 63.5 t -126.15 118.48 51.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.649 HD11 HG21 ' A' ' 99' ' ' ILE . 95.8 mt -113.93 150.07 34.28 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.188 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -89.58 110.72 21.55 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.986 0.898 . . . . 0.0 111.21 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.1 m -115.59 151.57 46.28 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.555 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.71 -18.06 53.02 Favored 'Trans proline' 0 C--N 1.331 -0.349 0 C-N-CA 123.069 2.513 . . . . 0.0 114.376 -178.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.0 t . . . . . 0 C--N 1.32 -0.681 0 CA-C-O 120.875 0.369 . . . . 0.0 111.225 -179.777 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.681 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.444 -0.778 0 N-CA-C 112.676 -0.169 . . . . 0.0 112.676 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 73.18 29.1 1.77 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.278 0.631 . . . . 0.0 111.554 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.585 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 20.0 p90 -59.87 -37.69 80.05 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-O 121.108 0.48 . . . . 0.0 110.06 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.617 ' HE3' ' HB3' ' A' ' 124' ' ' ALA . 4.1 t-105 -66.27 -26.55 67.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.195 -178.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.89 -25.49 66.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.139 0.495 . . . . 0.0 110.143 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.697 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 4.2 m -133.42 27.03 4.11 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.323 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.617 ' HB3' ' HE3' ' A' ' 121' ' ' TRP . . . -105.65 155.82 18.87 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.001 0.429 . . . . 0.0 110.898 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.0 mmm-85 -146.43 142.35 28.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.755 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 53.55 35.57 21.21 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.246 0.546 . . . . 0.0 111.371 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.585 ' HB ' ' CB ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -79.74 127.36 39.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.812 -179.848 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.45 ' O ' HD12 ' A' ' 136' ' ' LEU . 15.6 ptt180 -151.31 158.82 44.32 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.571 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.835 HD21 HD11 ' A' ' 153' ' ' LEU . 17.1 mt -86.1 136.59 33.16 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 120.996 0.427 . . . . 0.0 110.825 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.573 HG23 ' HB ' ' A' ' 135' ' ' VAL . 31.2 m -132.35 159.48 43.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.471 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.481 ' HB3' ' HD3' ' A' ' 134' ' ' LYS . 4.6 m-20 69.63 4.87 4.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.398 178.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.661 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 98.04 28.84 7.96 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.597 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.517 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 93.07 -18.85 55.26 Favored Glycine 0 C--O 1.269 2.283 0 CA-C-O 123.773 1.763 . . . . 0.0 112.623 177.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.695 ' HG3' HG23 ' A' ' 135' ' ' VAL . 20.9 ptmt -67.52 -19.97 65.37 Favored 'General case' 0 C--N 1.313 -0.986 0 O-C-N 121.452 -1.028 . . . . 0.0 108.82 178.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.695 HG23 ' HG3' ' A' ' 134' ' ' LYS . 4.2 t -138.15 146.67 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 121.279 0.561 . . . . 0.0 110.874 178.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.625 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 50.6 tp -126.46 116.31 20.93 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.484 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 32.5 tt0 -105.05 137.15 43.25 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.437 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.585 ' CB ' ' HB ' ' A' ' 127' ' ' VAL . . . -161.96 164.07 28.62 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.185 0.517 . . . . 0.0 112.283 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -95.9 106.25 18.37 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.703 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 50.2 mt -98.24 129.79 44.97 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.307 0.575 . . . . 0.0 111.244 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.697 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 62.4 ttt180 -71.32 141.18 50.47 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.5 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.437 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.6 p90 -159.09 -173.78 4.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.226 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 17.0 m -61.04 -26.21 67.47 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -94.83 16.12 61.93 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.875 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 102.1 -114.99 5.1 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.412 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -128.69 128.84 44.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.931 0.396 . . . . 0.0 110.371 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.437 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 47.0 t30 -124.25 130.86 53.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.218 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.474 ' HA ' ' O ' ' A' ' 138' ' ' ALA . 13.8 ttp180 -78.15 96.58 5.21 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.266 0.555 . . . . 0.0 110.617 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.556 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 20.0 t -104.13 170.43 7.92 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.172 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 8.7 mtp85 -146.22 147.73 31.75 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 121.155 -0.218 . . . . 0.0 110.615 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.856 HD13 HD22 ' A' ' 43' ' ' LEU . 9.9 tt -131.34 152.62 37.62 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.538 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.146 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.672 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 84.4 m-85 -96.65 105.02 17.06 Favored 'General case' 0 C--N 1.313 -1.012 0 O-C-N 122.286 -0.259 . . . . 0.0 111.024 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.835 HD11 HD21 ' A' ' 129' ' ' LEU . 16.9 mt -65.72 -37.24 85.86 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.11 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.663 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 9.4 t70 -53.59 -14.4 0.85 Allowed 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.144 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.672 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 41.1 mt-10 -66.51 -54.79 19.99 Favored 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 121.682 -0.636 . . . . 0.0 112.715 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -122.18 1.05 9.69 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.141 -0.624 . . . . 0.0 112.492 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 45.5 mm -104.09 110.78 31.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.484 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.597 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -118.69 166.41 12.97 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.232 -0.985 . . . . 0.0 113.105 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.574 ' CG ' ' HB3' ' A' ' 25' ' ' CYS . 2.6 t30 -98.25 122.26 41.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.415 -0.393 . . . . 0.0 110.077 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -117.81 86.77 2.58 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 58.86 47.37 12.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.184 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.549 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 87.67 7.55 75.0 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.485 178.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -124.09 132.74 53.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.04 0.447 . . . . 0.0 111.567 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.578 HD21 ' HD2' ' A' ' 7' ' ' PHE . 30.0 mt -84.63 114.31 21.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.642 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 46.0 pt . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.222 178.783 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.471 ' CD1' ' HG2' ' A' ' 155' ' ' GLU . 28.9 m-85 . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.54 -27.41 12.37 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.2 -76.39 0.27 Allowed Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.13 -1.033 . . . . 0.0 112.91 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 65.66 11.03 7.22 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.547 0.339 . . . . 0.0 111.138 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.644 ' CE2' HD13 ' A' ' 14' ' ' ILE . 1.6 p90 -61.33 -33.02 72.91 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 121.133 -0.227 . . . . 0.0 111.281 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.533 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.8 OUTLIER -62.58 -25.41 68.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.326 0.584 . . . . 0.0 110.562 -178.882 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.73 -22.99 77.0 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.183 -0.917 . . . . 0.0 113.596 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.516 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 22.9 p -125.73 -16.39 5.73 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 117.722 0.761 . . . . 0.0 111.72 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.6 m -99.72 131.71 45.53 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.427 ' CG ' ' HB2' ' A' ' 24' ' ' GLU . 15.2 ptm180 -109.18 178.82 4.34 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.412 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 7.8 m-20 44.67 47.57 8.71 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.454 0.701 . . . . 0.0 112.56 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.679 HG22 HD13 ' A' ' 129' ' ' LEU . 10.2 mt -80.77 106.18 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.758 ' HA ' HD12 ' A' ' 129' ' ' LEU . 72.2 m -147.8 128.04 13.85 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.733 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -94.04 154.62 17.54 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.22 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -96.21 73.93 2.93 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.002 -1.453 . . . . 0.0 107.694 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.17 -60.17 4.72 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.793 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.445 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -145.42 0.46 0.89 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.135 0.493 . . . . 0.0 110.47 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -104.48 93.82 4.99 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.005 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.815 HD23 HD11 ' A' ' 129' ' ' LEU . 2.8 tm? -60.06 132.45 53.97 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.671 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.618 ' H ' HD22 ' A' ' 21' ' ' LEU . 33.2 ttm105 -134.52 128.0 32.48 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.198 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.635 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -148.39 148.49 30.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.679 0.752 . . . . 0.0 111.141 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 2.6 mm-40 -82.85 76.95 9.66 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.196 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.517 ' SG ' HD13 ' A' ' 164' ' ' LEU . 84.8 m -63.36 126.74 28.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.717 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.516 ' HB2' ' O ' ' A' ' 10' ' ' SER . 37.2 ttt180 -69.54 122.57 19.3 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.353 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.567 ' HG3' ' OD1' ' A' ' 161' ' ' ASN . 20.4 ttt85 -99.3 152.06 20.36 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.891 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -52.19 -17.9 4.33 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 114.119 -1.4 . . . . 0.0 114.712 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.451 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 4.6 m-20 -74.94 -7.46 53.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.103 0.478 . . . . 0.0 110.696 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.51 8.13 62.75 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.64 154.95 16.38 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.368 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.477 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 80.8 m-85 -92.4 125.53 37.09 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.3 m -108.23 130.35 55.16 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.332 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.2 m -68.98 112.44 5.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.862 0.363 . . . . 0.0 110.588 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.472 ' HB3' HD22 ' A' ' 164' ' ' LEU . 32.2 t -116.44 151.24 36.43 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.265 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 1.4 p -144.38 130.93 15.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.964 0.411 . . . . 0.0 110.675 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.438 ' CG2' ' HB3' ' A' ' 21' ' ' LEU . 17.8 tt -122.95 149.23 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.98 -178.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.471 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 22.7 m-20 -82.78 93.57 7.46 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.563 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.67 HD13 HD11 ' A' ' 43' ' ' LEU . 39.2 mt -73.27 -13.38 61.12 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.019 0.438 . . . . 0.0 109.997 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.5 ' OD1' ' HG3' ' A' ' 41' ' ' ARG . 23.8 p30 -66.27 -16.22 63.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.432 0.634 . . . . 0.0 109.625 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.5 ' HG3' ' OD1' ' A' ' 40' ' ' ASN . 48.0 mtm180 -117.29 20.28 13.73 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.418 178.064 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.573 ' HB2' ' HA ' ' A' ' 39' ' ' LEU . 9.6 m-85 -133.4 -30.92 1.26 Allowed 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.295 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.965 HD22 HD13 ' A' ' 151' ' ' ILE . 42.2 mt -114.63 135.8 53.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.854 0.359 . . . . 0.0 110.781 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.66 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 1.9 m -124.21 147.66 47.87 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.038 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.571 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 7.5 p-10 -94.86 98.77 10.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.596 0.713 . . . . 0.0 110.478 178.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -99.99 94.41 6.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.191 0.519 . . . . 0.0 110.824 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.488 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 64.0 t30 52.68 45.37 28.8 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.213 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.711 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 79.96 32.57 35.81 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.608 178.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -149.14 131.34 15.47 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.808 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 58.7 m-85 -72.63 145.37 47.35 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.955 0.407 . . . . 0.0 111.427 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -143.5 133.62 24.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.063 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.559 ' HZ2' ' O ' ' A' ' 152' ' ' TYR . 97.9 m95 . . . . . 0 C--N 1.323 -0.582 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.451 -0.424 0 CA-C-O 120.944 0.402 . . . . 0.0 110.069 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -131.46 177.47 7.47 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.933 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.416 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 21.2 p -128.23 121.29 29.02 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.411 HG23 HG21 ' A' ' 107' ' ' VAL . 4.2 t -107.36 134.3 49.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.928 178.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 7.2 m -87.51 125.82 34.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.494 ' CG2' HD12 ' A' ' 99' ' ' ILE . 42.0 t -73.14 132.29 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.103 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -104.19 170.63 7.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 124.388 1.055 . . . . 0.0 109.47 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.594 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 58.8 tt0 -66.63 124.28 22.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.51 -178.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.05 3.22 73.45 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.978 -0.63 . . . . 0.0 113.592 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -109.59 121.4 45.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.035 0.418 . . . . 0.0 111.231 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.59 ' HA ' HG12 ' A' ' 99' ' ' ILE . 81.4 p -102.56 -178.11 3.59 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.647 HD22 HG23 ' A' ' 99' ' ' ILE . 1.1 mm? -51.99 -40.98 61.79 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.347 0.594 . . . . 0.0 109.834 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.43 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 48.7 ttm-85 -62.95 -39.65 95.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.164 -178.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -71.7 -42.93 66.8 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.959 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.556 HG12 ' O ' ' A' ' 72' ' ' THR . 45.6 mm -61.72 -48.79 87.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.796 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.674 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -58.33 -54.09 40.47 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.422 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -58.5 -41.17 84.76 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.761 0.315 . . . . 0.0 111.77 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -65.1 -43.98 90.31 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -98.43 11.79 37.05 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.9 t70 63.4 23.12 13.58 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.359 0.599 . . . . 0.0 112.106 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.674 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.3 p -104.37 171.67 7.21 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.577 ' O ' HG13 ' A' ' 87' ' ' ILE . 5.8 t70 -98.01 125.31 42.89 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.9 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.524 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 9.3 p90 -50.78 -29.68 12.19 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.366 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -65.12 -46.21 81.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.541 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.734 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 56.7 mm-40 -69.14 -41.44 77.31 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.314 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.577 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.8 mt -54.87 -47.5 75.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.657 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.53 -48.58 76.93 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.5 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -54.4 -43.01 71.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.351 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.734 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 24.7 mmm-85 -72.82 -27.4 61.94 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 3.3 t-20 -94.01 -4.79 48.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.892 0.377 . . . . 0.0 111.103 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 90.1 m-20 75.61 17.49 2.37 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.756 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.657 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 19.2 pt -105.67 -172.44 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.534 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 18.1 mm-40 -116.31 154.46 30.15 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.561 ' O ' HD23 ' A' ' 73' ' ' LEU . 1.2 p30 -52.25 -65.96 0.47 Allowed 'General case' 0 C--O 1.244 0.777 0 CA-C-O 122.225 1.012 . . . . 0.0 109.872 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -76.06 13.42 0.89 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.824 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 4.6 t0 -63.59 -31.48 72.66 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 7.9 mp 72.06 112.35 0.06 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.611 -178.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.647 HG23 HD22 ' A' ' 73' ' ' LEU . 9.8 pt -94.85 176.63 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.815 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.556 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 94.1 m-85 -131.16 158.01 76.45 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.743 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.594 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 18.4 Cg_endo -63.98 138.26 61.66 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 123.301 2.667 . . . . 0.0 113.823 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.41 20.8 31.23 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.79 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.542 ' O ' ' HA ' ' A' ' 66' ' ' THR . 27.6 mt-30 -110.4 166.07 11.28 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.178 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.416 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 95.6 t -125.09 118.51 53.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.566 HD11 HG21 ' A' ' 99' ' ' ILE . 76.9 mt -112.35 150.59 30.84 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.35 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -90.8 116.93 29.03 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.582 0.706 . . . . 0.0 110.656 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.411 HG21 HG23 ' A' ' 65' ' ' VAL . 33.6 m -119.83 151.27 52.12 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.454 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.06 -18.98 51.9 Favored 'Trans proline' 0 C--N 1.332 -0.33 0 C-N-CA 123.098 2.532 . . . . 0.0 114.332 -178.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.9 t . . . . . 0 C--N 1.326 -0.448 0 CA-C-O 121.032 0.444 . . . . 0.0 111.131 -179.806 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.66 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.445 -0.712 0 CA-C-O 120.19 -0.228 . . . . 0.0 113.155 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 14.0 m120 73.94 26.71 1.73 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.059 0.544 . . . . 0.0 112.111 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.551 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 20.7 p90 -60.65 -37.23 80.82 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.04 0.448 . . . . 0.0 110.348 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.571 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 71.0 t-105 -61.79 -34.43 75.88 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.404 -178.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -54.02 -27.42 31.88 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.143 0.277 . . . . 0.0 110.894 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.666 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 9.3 m -132.85 28.54 4.2 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.479 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.571 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -107.51 143.89 35.25 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.968 0.413 . . . . 0.0 111.387 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -126.69 143.05 51.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.817 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 49.12 57.47 6.43 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.668 0.605 . . . . 0.0 112.01 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.434 ' CG1' HD11 ' A' ' 136' ' ' LEU . 40.3 t -80.45 121.76 34.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.841 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.66 148.14 29.72 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.292 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.815 HD11 HD23 ' A' ' 21' ' ' LEU . 33.6 mt -85.54 145.23 27.48 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.137 0.494 . . . . 0.0 111.411 -179.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.944 HG23 ' HB ' ' A' ' 135' ' ' VAL . 29.0 m -132.31 157.1 43.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.64 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 71.83 1.12 3.77 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.772 0.829 . . . . 0.0 110.387 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.619 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 93.14 28.42 11.83 Favored Glycine 0 N--CA 1.433 -1.535 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.165 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.527 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 104.66 -18.19 44.56 Favored Glycine 0 C--O 1.271 2.44 0 CA-C-O 123.45 1.583 . . . . 0.0 113.165 178.011 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.758 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 1.6 mttp -72.16 -13.58 61.59 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 121.221 -1.164 . . . . 0.0 108.854 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.944 ' HB ' HG23 ' A' ' 130' ' ' VAL . 3.2 t -143.28 151.36 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.443 177.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.542 HD13 HD23 ' A' ' 129' ' ' LEU . 33.1 tp -131.26 125.77 33.7 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -116.07 131.62 56.89 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.175 0.512 . . . . 0.0 110.911 -177.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.779 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -159.64 155.15 25.66 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.38 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 15.3 mt-10 -94.64 106.33 18.31 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.711 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 47.0 mt -91.41 134.32 34.72 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.154 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.666 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 72.4 ttt180 -69.99 140.84 53.0 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.932 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.539 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.5 p90 -156.04 -169.75 3.17 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.458 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 23.0 t -57.58 -30.81 65.57 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.297 0.373 . . . . 0.0 111.545 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -98.24 23.5 35.89 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.171 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 98.77 -107.83 3.49 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.217 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -133.0 127.71 34.75 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.539 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 10.9 t30 -123.18 129.99 52.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.665 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 32.9 ttm180 -76.44 102.81 6.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.138 0.494 . . . . 0.0 109.807 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.473 ' HB3' ' O ' ' A' ' 48' ' ' GLY . 18.1 p -114.96 172.3 7.13 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.232 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 6.3 ptp180 -148.55 152.62 37.12 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.565 -0.454 . . . . 0.0 112.051 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.965 HD13 HD22 ' A' ' 43' ' ' LEU . 12.1 tt -130.64 160.97 41.38 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.824 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.948 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 79.8 m-85 -107.55 106.74 17.25 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 121.856 -0.527 . . . . 0.0 110.25 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.683 HD11 HD21 ' A' ' 129' ' ' LEU . 23.8 mt -62.89 -36.01 81.93 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.213 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.758 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 9.5 t70 -57.39 -8.58 0.81 Allowed 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.504 178.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.948 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 46.7 mt-10 -75.05 -50.83 15.19 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 121.831 -0.543 . . . . 0.0 111.962 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -125.94 7.38 7.34 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -177.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.516 HG12 ' CH2' ' A' ' 52' ' ' TRP . 43.5 mm -107.58 106.07 19.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.169 178.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -111.35 161.88 12.64 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.637 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.509 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 1.4 t30 -100.55 120.37 39.92 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 31.9 ttp-105 -112.38 87.24 2.53 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.535 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.567 ' OD1' ' HG3' ' A' ' 27' ' ' ARG . 3.0 t-20 59.26 35.79 23.5 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.437 178.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 35' ' ' SER . . . 105.29 -0.07 40.69 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.972 178.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -123.3 134.2 54.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.717 0.758 . . . . 0.0 111.768 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.596 HD11 ' CD2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -74.89 129.46 37.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.895 178.701 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 9.4 tp . . . . . 0 C--N 1.321 -0.633 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.205 -179.718 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.91 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 66.8 m-85 . . . . . 0 CA--C 1.516 -0.357 0 CA-C-O 120.925 0.393 . . . . 0.0 110.313 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -123.22 -30.02 3.77 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.762 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -77.91 -69.24 1.41 Allowed Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 119.56 -1.305 . . . . 0.0 112.689 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 68.16 14.81 9.33 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.889 0.476 . . . . 0.0 111.3 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.598 ' CE2' HD13 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -58.9 -33.91 71.08 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 -179.279 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.482 ' HA ' HD11 ' A' ' 14' ' ' ILE . 8.8 p -61.2 -27.62 68.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.135 0.493 . . . . 0.0 111.579 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.79 -20.64 79.77 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.574 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 5.1 m -120.67 -19.61 7.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.45 0.625 . . . . 0.0 111.455 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 m -104.33 135.6 45.48 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -112.47 177.58 4.59 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 43.43 50.47 6.15 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 124.037 0.836 . . . . 0.0 111.878 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.914 HG22 HD13 ' A' ' 129' ' ' LEU . 12.3 mt -82.05 104.82 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.593 ' CA ' HD12 ' A' ' 129' ' ' LEU . 71.0 m -146.23 128.67 15.94 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 122.823 0.449 . . . . 0.0 109.83 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.827 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -100.23 158.62 15.74 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 121.628 0.727 . . . . 0.0 112.717 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -100.57 76.57 1.84 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.328 -1.305 . . . . 0.0 107.551 176.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.28 -54.11 4.85 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.779 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.558 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -149.04 -13.16 0.31 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.892 0.377 . . . . 0.0 110.184 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.62 88.37 7.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.587 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.827 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 44.0 tp -61.79 121.02 11.84 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.868 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.529 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 39.9 ttt180 -128.49 130.27 47.27 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.432 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.657 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -148.89 150.59 33.22 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.673 0.749 . . . . 0.0 111.076 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.447 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 5.0 mm-40 -85.48 74.53 10.32 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.163 -1.38 . . . . 0.0 108.413 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.693 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 65.0 m -64.97 129.62 40.39 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.829 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 10' ' ' SER . 26.7 ttm180 -65.33 131.65 47.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.328 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 35.1 ttt85 -108.86 151.46 26.23 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -52.99 -16.74 4.44 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 114.319 -1.31 . . . . 0.0 114.519 -178.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -72.74 -6.15 42.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.112 0.482 . . . . 0.0 110.416 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.99 6.68 66.74 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -120.5 169.66 14.16 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.412 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.447 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 69.0 m-85 -96.93 140.05 32.04 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.869 0.366 . . . . 0.0 110.555 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.41 ' HB3' ' HA3' ' A' ' 162' ' ' GLY . 9.4 t -121.72 130.23 53.29 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.4 m -72.5 112.89 8.96 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.268 0.556 . . . . 0.0 110.969 -178.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 40.5 t -116.65 148.38 41.04 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.465 -179.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.657 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.4 p -144.32 136.44 22.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-O 120.775 0.321 . . . . 0.0 111.156 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.6 tt -136.19 146.44 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.516 -178.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.59 97.12 4.97 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.689 HD22 ' HB2' ' A' ' 21' ' ' LEU . 1.6 tp -79.96 -6.51 57.64 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.014 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.558 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 15.2 p30 -65.03 -20.24 66.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.167 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 41' ' ' ARG . 10.8 ptp180 -105.58 16.53 25.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.298 0.571 . . . . 0.0 110.857 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -127.46 -33.6 2.32 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.131 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.672 HD22 HD13 ' A' ' 151' ' ' ILE . 31.9 mt -106.07 144.11 33.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.358 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.54 147.63 52.55 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.849 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.45 ' ND2' ' HB2' ' A' ' 123' ' ' SER . 23.2 p-10 -98.38 94.12 6.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.504 0.668 . . . . 0.0 109.811 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -94.78 93.6 7.59 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.977 0.418 . . . . 0.0 111.49 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.4 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 66.5 t30 52.83 47.0 25.64 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.16 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.736 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 78.04 29.93 52.67 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.791 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.531 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 33.7 m80 -141.99 125.64 16.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.811 ' HB3' ' HB ' ' A' ' 151' ' ' ILE . 14.2 m-85 -68.3 136.55 53.64 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.802 0.334 . . . . 0.0 111.103 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.8 mtp180 -141.76 135.32 29.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.579 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.472 ' CD1' HD11 ' A' ' 151' ' ' ILE . 96.7 m95 . . . . . 0 C--N 1.323 -0.583 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.4 m . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 121.197 0.523 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -133.56 176.67 8.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.835 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.493 HG22 ' HG2' ' A' ' 106' ' ' GLN . 6.9 p -129.34 118.07 21.65 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 122.413 -0.18 . . . . 0.0 111.357 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.565 HG21 ' CE2' ' A' ' 80' ' ' PHE . 9.0 p -110.43 145.03 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.886 0.374 . . . . 0.0 111.386 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.2 m -91.22 123.51 34.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.716 HG21 HD12 ' A' ' 99' ' ' ILE . 63.7 t -76.69 130.26 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.244 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -101.72 169.99 8.46 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 124.455 1.097 . . . . 0.0 110.008 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.619 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 64.6 tt0 -63.22 114.46 3.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.251 -178.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.0 -5.83 27.26 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.878 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.46 124.44 49.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 117.284 0.542 . . . . 0.0 112.188 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.546 ' O ' HG12 ' A' ' 76' ' ' ILE . 81.0 p -101.24 -178.97 3.9 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.664 HD22 HG23 ' A' ' 99' ' ' ILE . 0.7 OUTLIER -53.59 -40.46 65.71 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.555 0.693 . . . . 0.0 109.809 179.179 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.64 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -69.81 -34.37 73.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.041 -178.204 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -72.71 -38.98 67.31 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 72' ' ' THR . 45.1 mm -62.4 -47.17 94.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 177.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.767 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -56.68 -48.37 77.95 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.401 178.003 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.2 mtm180 -66.99 -35.98 81.16 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 122.515 -0.403 . . . . 0.0 111.923 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -69.66 -38.73 77.19 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.565 ' CE2' HG21 ' A' ' 65' ' ' VAL . 89.0 m-85 -110.52 16.71 21.37 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -178.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.0 t70 53.42 47.75 23.41 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.751 0.786 . . . . 0.0 110.852 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.767 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.8 p -124.42 170.97 10.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.591 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.65 ' O ' HG13 ' A' ' 87' ' ' ILE . 8.9 t70 -96.85 120.1 36.55 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.467 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.64 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 14.3 p90 -51.13 -32.61 23.46 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.708 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.446 ' HB2' ' OD1' ' A' ' 83' ' ' ASP . 0.3 OUTLIER -67.7 -42.93 81.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.76 179.733 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.678 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 8.7 mm-40 -66.67 -43.75 83.68 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.974 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.65 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.8 mt -53.52 -47.04 60.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.609 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.93 -51.14 68.06 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.15 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -57.38 -43.07 83.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.678 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 78.1 mtt180 -68.18 -23.27 64.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.055 0.455 . . . . 0.0 110.987 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 21.8 t-20 -99.04 -5.72 29.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.853 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 5.2 m-20 77.91 15.96 1.45 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.783 0.833 . . . . 0.0 111.637 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.609 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 10.4 pt -106.24 -176.42 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 17.9 mm-40 -111.65 158.22 19.53 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.633 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 16.7 p-10 -55.87 -60.45 3.44 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 122.103 0.954 . . . . 0.0 109.47 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -76.6 12.53 1.25 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.116 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 3.9 t70 -65.17 -33.58 76.35 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 9.1 mp 72.43 112.42 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 124.301 1.001 . . . . 0.0 110.16 -177.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.716 HD12 HG21 ' A' ' 67' ' ' VAL . 10.6 pt -95.32 175.91 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.407 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.489 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 83.0 m-85 -128.68 158.59 71.61 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.583 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.619 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 19.9 Cg_endo -67.6 134.97 34.52 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.994 2.463 . . . . 0.0 112.997 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.84 17.54 25.33 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.384 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -110.66 157.5 19.64 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 120.619 -0.433 . . . . 0.0 109.948 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.405 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 61.3 t -116.73 116.6 52.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.587 HD11 HG21 ' A' ' 99' ' ' ILE . 69.3 mt -109.92 151.0 27.63 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.57 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.493 ' HG2' HG22 ' A' ' 64' ' ' THR . 66.3 mt-30 -89.88 107.42 19.1 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.894 0.854 . . . . 0.0 111.146 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.4 m -112.62 151.32 43.82 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-N 113.934 -1.484 . . . . 0.0 109.151 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.19 -18.88 65.03 Favored 'Trans proline' 0 C--N 1.332 -0.325 0 C-N-CA 123.146 2.564 . . . . 0.0 114.158 -177.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.6 t . . . . . 0 C--N 1.323 -0.551 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.3 -179.435 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 112.069 -0.412 . . . . 0.0 112.069 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 74.97 32.78 0.78 Allowed 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.268 0.627 . . . . 0.0 111.902 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.638 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 20.0 p90 -66.36 -35.96 81.67 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.301 0.572 . . . . 0.0 109.865 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.493 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 24.5 t-105 -66.39 -21.87 66.23 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.239 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.94 -24.97 60.21 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.828 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.646 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 50.5 m -143.76 33.59 1.27 Allowed 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.689 178.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.493 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -102.01 147.58 26.4 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 177.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.717 ' HD2' ' HB2' ' A' ' 126' ' ' ASP . 8.0 tmm_? -143.71 140.86 30.23 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.717 ' HB2' ' HD2' ' A' ' 125' ' ' ARG . 1.2 t70 58.3 25.65 12.99 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.789 0.681 . . . . 0.0 110.765 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.599 ' HB ' ' CB ' ' A' ' 138' ' ' ALA . 0.4 OUTLIER -67.06 119.75 13.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.926 -179.937 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.25 151.62 46.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.302 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.914 HD13 HG22 ' A' ' 14' ' ' ILE . 15.9 mt -85.44 131.21 34.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.261 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.605 HG23 ' HB ' ' A' ' 135' ' ' VAL . 26.9 m -126.55 163.9 27.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.234 -178.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.414 ' HB3' ' HD2' ' A' ' 134' ' ' LYS . 9.7 m-20 64.13 7.72 3.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.97 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.683 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 97.24 31.04 7.05 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.273 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 87.93 -13.74 60.45 Favored Glycine 0 C--O 1.259 1.69 0 CA-C-O 123.506 1.614 . . . . 0.0 112.474 177.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.653 ' O ' ' HA ' ' A' ' 152' ' ' TYR . 17.4 ptpt -72.33 -17.09 61.87 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.605 ' HB ' HG23 ' A' ' 130' ' ' VAL . 17.5 t -139.92 138.77 38.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.328 177.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.599 ' CD1' HD11 ' A' ' 16' ' ' LEU . 36.5 tp -119.91 115.21 23.33 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -107.57 126.26 52.33 Favored 'General case' 0 C--N 1.316 -0.884 0 O-C-N 123.28 0.362 . . . . 0.0 110.213 -177.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.599 ' CB ' ' HB ' ' A' ' 127' ' ' VAL . . . -150.07 160.25 43.79 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.277 0.56 . . . . 0.0 111.89 -178.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -96.29 106.8 19.06 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.736 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 50.0 mt -97.03 129.02 44.53 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.39 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.646 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 22.1 ttt180 -70.05 139.72 52.69 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.224 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.637 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.9 p90 -155.78 -167.94 2.64 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.163 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 4.3 m -56.32 -29.55 61.41 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -104.72 29.84 11.11 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.388 -0.91 . . . . 0.0 113.53 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.7 -112.52 4.38 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.631 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -125.6 126.46 44.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.741 0.305 . . . . 0.0 110.689 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.637 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 63.2 t30 -118.53 129.23 55.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.495 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -78.38 98.73 6.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.205 0.526 . . . . 0.0 109.956 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.531 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 21.7 t -109.45 168.21 9.56 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.178 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.581 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 16.5 ptt180 -149.1 152.76 36.72 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.468 -0.493 . . . . 0.0 112.12 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.811 ' HB ' ' HB3' ' A' ' 50' ' ' PHE . 6.1 tt -133.02 152.84 36.7 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.92 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.653 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 95.8 m-85 -95.44 103.4 15.27 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.771 -0.195 . . . . 0.0 110.666 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.764 HD11 HD21 ' A' ' 129' ' ' LEU . 19.9 mt -67.06 -35.83 80.71 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.169 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -52.91 -19.26 2.44 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.189 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.91 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 36.0 mt-10 -63.39 -55.86 20.98 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -121.88 5.7 9.91 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 119.655 -0.818 . . . . 0.0 112.705 -176.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.432 HG12 ' CH2' ' A' ' 52' ' ' TRP . 45.0 mm -107.25 111.68 36.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.689 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -113.55 -178.17 19.35 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.57 178.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.693 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -124.86 136.67 54.01 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.773 0.32 . . . . 0.0 110.548 179.753 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -124.82 86.78 2.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.047 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.533 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 90.3 m-20 54.39 50.96 15.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.37 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.578 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 89.8 7.82 68.15 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.496 178.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -123.65 117.12 24.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.984 0.392 . . . . 0.0 111.367 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.499 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 25.0 mt -67.23 123.15 19.49 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.518 178.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 13.4 tt . . . . . 0 C--N 1.323 -0.58 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.891 -179.537 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 1.015 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 21.9 m-85 . . . . . 0 C--O 1.234 0.247 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -102.07 -31.56 10.57 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -70.77 -65.71 2.4 Favored Glycine 0 N--CA 1.434 -1.437 0 C-N-CA 119.511 -1.328 . . . . 0.0 112.205 -178.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 64.37 19.66 11.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.631 -0.285 . . . . 0.0 110.895 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.712 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.7 OUTLIER -58.44 -42.62 87.76 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.542 -179.664 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.451 ' HA ' HD11 ' A' ' 14' ' ' ILE . 8.9 m -62.11 -13.31 25.59 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.03 0.443 . . . . 0.0 110.851 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -64.27 -30.51 78.01 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.18 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.653 ' HB3' ' HB3' ' A' ' 26' ' ' ARG . 49.7 m -131.76 -18.54 2.73 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.677 0.275 . . . . 0.0 111.282 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.471 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 18.7 m -89.8 129.92 36.12 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -112.43 -177.65 3.21 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 43.69 45.36 5.89 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 123.832 0.708 . . . . 0.0 111.728 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.909 HG22 HD13 ' A' ' 129' ' ' LEU . 5.3 mt -79.8 103.89 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 CA-C-O 120.921 0.391 . . . . 0.0 110.402 -178.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.593 ' CA ' HD12 ' A' ' 129' ' ' LEU . 73.4 m -143.76 126.79 16.42 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.749 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -92.47 153.77 18.9 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.839 0.828 . . . . 0.0 112.861 -178.845 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -94.38 74.27 3.88 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.228 -1.351 . . . . 0.0 107.756 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.21 -55.87 4.96 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.068 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.651 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -148.6 -7.12 0.39 Allowed 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.035 0.445 . . . . 0.0 109.913 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -94.6 95.46 8.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.453 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.872 HD22 HD13 ' A' ' 153' ' ' LEU . 41.8 tp -60.27 118.12 6.01 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.807 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.531 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 34.0 ttt180 -123.02 129.84 52.02 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.35 -178.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.676 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -148.39 149.28 31.48 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.573 0.701 . . . . 0.0 111.178 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 69.7 mm-40 -82.48 70.52 9.45 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.011 178.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.632 ' SG ' HD13 ' A' ' 164' ' ' LEU . 59.1 m -57.84 114.41 2.3 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.953 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.653 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 10.8 ttp180 -67.11 125.99 27.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.392 178.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.547 ' HG2' ' CA ' ' A' ' 162' ' ' GLY . 7.1 mtm180 -96.34 162.77 13.35 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.85 -10.09 6.17 Favored Glycine 0 C--N 1.339 0.705 0 O-C-N 124.37 1.044 . . . . 0.0 113.759 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -76.97 -8.31 57.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.442 0.639 . . . . 0.0 109.43 178.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.38 14.21 66.59 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.01 161.06 13.2 Favored Glycine 0 C--O 1.225 -0.42 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.177 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.534 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 75.8 m-85 -101.15 133.14 46.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.701 0.286 . . . . 0.0 110.565 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.436 ' OG ' ' HD3' ' A' ' 27' ' ' ARG . 74.0 m -126.22 133.3 51.55 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.099 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 m -70.28 116.17 10.32 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.33 0.586 . . . . 0.0 111.367 -178.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 46.6 t -122.59 152.27 40.6 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.458 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 5.8 p -145.21 140.33 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 120.933 0.397 . . . . 0.0 112.032 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.531 HG23 ' HB3' ' A' ' 21' ' ' LEU . 10.2 tt -135.65 145.69 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.983 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.13 99.25 7.65 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.59 HD23 ' HB3' ' A' ' 21' ' ' LEU . 3.5 mm? -81.18 -8.7 59.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.09 0.471 . . . . 0.0 110.808 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.651 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 7.1 p30 -67.58 -13.15 61.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.453 179.13 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 41' ' ' ARG . 19.2 mtp180 -114.32 22.43 13.74 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.007 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -136.18 -31.09 0.92 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.67 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.828 HD22 HD13 ' A' ' 151' ' ' ILE . 35.9 mt -110.15 133.38 53.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.728 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.715 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 1.4 m -123.65 138.3 54.56 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.211 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.84 ' CB ' ' HG ' ' A' ' 140' ' ' LEU . 6.7 p-10 -79.66 93.26 5.49 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.82 0.819 . . . . 0.0 110.329 177.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.406 ' HB2' ' HG3' ' A' ' 51' ' ' ARG . 21.8 t70 -96.2 92.79 6.56 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 121.916 -0.49 . . . . 0.0 111.326 -179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.494 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 64.8 t30 49.19 47.54 21.96 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.361 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.66 43.5 18.51 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.964 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -161.98 123.41 2.74 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.694 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 55.8 m-85 -65.4 151.28 46.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.726 0.298 . . . . 0.0 110.574 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.406 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 37.7 mmt180 -141.51 128.65 20.89 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.518 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.649 ' HZ2' ' HA ' ' A' ' 153' ' ' LEU . 44.6 m95 . . . . . 0 C--N 1.323 -0.558 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.847 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.4 m . . . . . 0 N--CA 1.45 -0.438 0 CA-C-O 121.168 0.508 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 106' ' ' GLN . . . -128.63 177.28 7.14 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.872 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.433 ' HB ' ' CG2' ' A' ' 104' ' ' VAL . 6.6 p -128.58 114.34 16.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.769 0.319 . . . . 0.0 111.626 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.463 HG21 ' CE1' ' A' ' 80' ' ' PHE . 11.8 p -101.67 143.38 14.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.937 0.399 . . . . 0.0 110.621 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 3.7 m -89.95 127.48 36.03 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.403 ' CG2' HD12 ' A' ' 99' ' ' ILE . 45.7 t -72.07 132.12 33.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.721 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.411 ' HG2' ' H ' ' A' ' 69' ' ' GLN . 18.9 tt0 -98.11 171.1 8.46 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 125.043 1.464 . . . . 0.0 109.813 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.595 ' CA ' ' HB3' ' A' ' 101' ' ' PRO . 24.6 tt0 -71.03 129.69 39.63 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.895 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.05 13.92 82.48 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.585 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -114.37 121.39 43.44 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.826 0.346 . . . . 0.0 110.248 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.58 ' HA ' HG12 ' A' ' 99' ' ' ILE . 80.0 p -103.38 -179.68 4.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.595 HD22 HG23 ' A' ' 99' ' ' ILE . 1.5 mm? -51.94 -42.03 62.51 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -60.01 -40.07 87.97 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 114.506 -1.224 . . . . 0.0 111.257 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -71.4 -40.37 70.55 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.671 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 72' ' ' THR . 32.5 mm -64.44 -48.38 85.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.669 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -58.8 -45.34 95.06 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.425 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -65.27 -37.08 86.09 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.866 0.365 . . . . 0.0 111.259 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -73.96 -40.24 63.16 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.463 ' CE1' HG21 ' A' ' 65' ' ' VAL . 95.4 m-85 -102.82 13.15 35.08 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.0 t70 58.07 27.57 15.09 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.558 0.694 . . . . 0.0 111.526 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.669 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 3.1 p -105.52 171.59 7.25 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.64 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.3 t0 -94.38 120.16 34.2 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.156 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.543 ' HD2' ' HB2' ' A' ' 95' ' ' ASN . 10.9 p90 -53.12 -30.3 35.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.588 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.429 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -68.57 -41.74 79.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.678 179.17 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -67.75 -48.33 66.71 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.664 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.64 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.4 mt -49.99 -43.79 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.577 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.59 -51.76 66.05 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.427 178.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 85' ' ' HIS . 61.4 mtp180 -64.23 -25.93 68.28 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.854 ' HB3' ' HB2' ' A' ' 106' ' ' GLN . 1.0 OUTLIER -72.66 -28.14 62.54 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.24 0.543 . . . . 0.0 110.161 179.183 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 18.0 t-20 -101.12 -5.33 25.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.319 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 23.4 m120 79.4 15.92 0.93 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.006 0.922 . . . . 0.0 111.148 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.577 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 15.1 pt -103.14 -169.79 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.597 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.534 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 55.1 mt-30 -116.66 161.21 19.56 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.559 ' O ' HD23 ' A' ' 73' ' ' LEU . 6.7 p30 -57.39 -58.74 6.95 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-O 122.245 1.021 . . . . 0.0 109.277 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -78.44 12.22 2.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.065 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 1.8 t70 -62.93 -31.57 72.68 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 6.8 mp 70.78 112.33 0.06 Allowed 'General case' 0 C--O 1.234 0.245 0 O-C-N 124.37 1.044 . . . . 0.0 110.503 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.595 HG23 HD22 ' A' ' 73' ' ' LEU . 9.4 pt -95.84 172.07 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 114.497 -1.228 . . . . 0.0 110.505 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.458 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 69.4 m-85 -125.52 156.36 70.67 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.305 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.595 ' HB3' ' CA ' ' A' ' 69' ' ' GLN . 39.2 Cg_endo -68.75 134.49 30.32 Favored 'Trans proline' 0 CA--C 1.517 -0.361 0 C-N-CA 123.042 2.494 . . . . 0.0 113.642 -177.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.85 13.4 37.38 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' A' ' 66' ' ' THR . 49.2 mt-30 -104.76 170.87 7.63 Favored 'General case' 0 C--O 1.216 -0.67 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.138 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.433 ' CG2' ' HB ' ' A' ' 64' ' ' THR . 9.9 p -126.49 131.03 71.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-O 121.441 0.639 . . . . 0.0 110.612 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.586 HD11 HG21 ' A' ' 99' ' ' ILE . 80.0 mt -125.09 151.32 45.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.759 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.854 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 38.7 mt-30 -89.75 113.4 24.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 122.031 0.92 . . . . 0.0 111.649 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.432 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 35.8 m -123.02 152.07 62.49 Favored Pre-proline 0 C--N 1.314 -0.976 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.013 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.432 ' HD2' ' HB ' ' A' ' 107' ' ' VAL . 32.0 Cg_endo -64.37 -17.61 60.26 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 123.425 2.75 . . . . 0.0 115.37 -176.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.7 t . . . . . 0 C--N 1.323 -0.584 0 CA-C-O 121.189 0.519 . . . . 0.0 112.112 -179.391 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.715 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.446 -0.686 0 CA-C-O 120.442 -0.088 . . . . 0.0 112.973 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 16.0 m120 75.34 24.92 1.34 Allowed 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 123.575 0.75 . . . . 0.0 112.261 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.565 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 25.0 p90 -58.44 -39.37 79.66 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.288 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.516 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 60.3 t-105 -58.71 -31.89 68.68 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.01 -178.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.68 -30.43 61.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.839 0.352 . . . . 0.0 110.672 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.571 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 11.0 m -132.79 30.46 4.04 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.581 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.516 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -118.09 138.51 52.2 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 120.784 0.326 . . . . 0.0 110.743 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.413 ' HG2' ' CZ3' ' A' ' 146' ' ' TRP . 2.3 mmp_? -128.55 147.51 50.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.134 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 56.43 45.06 23.34 Favored 'General case' 0 CA--C 1.518 -0.264 0 O-C-N 123.695 0.622 . . . . 0.0 112.007 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.513 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 39.5 t -69.98 116.24 10.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.658 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -138.5 143.45 39.56 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.639 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.909 HD13 HG22 ' A' ' 14' ' ' ILE . 29.5 mt -86.38 138.71 31.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.345 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.681 HG23 ' HB ' ' A' ' 135' ' ' VAL . 26.7 m -131.08 160.97 41.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.431 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.471 ' HB3' ' HG2' ' A' ' 134' ' ' LYS . 0.7 OUTLIER 65.16 13.43 8.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.015 179.133 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.676 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 91.9 26.46 19.41 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.507 -0.854 . . . . 0.0 113.265 178.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.555 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 92.45 -18.02 55.86 Favored Glycine 0 C--O 1.265 2.074 0 CA-C-O 123.9 1.833 . . . . 0.0 112.225 177.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.755 ' HG3' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -67.98 -17.6 64.48 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.255 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.755 HG23 ' HG3' ' A' ' 134' ' ' LYS . 15.0 t -135.94 144.6 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.388 176.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.619 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 26.0 tp -127.49 124.69 38.94 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -120.58 134.63 55.26 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.212 0.529 . . . . 0.0 110.979 -177.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.623 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -157.58 162.74 38.77 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.864 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.574 ' HG2' ' HG3' ' A' ' 148' ' ' ARG . 45.1 mt-10 -94.71 105.14 17.06 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.84 ' HG ' ' CB ' ' A' ' 45' ' ' ASN . 1.4 mp -90.4 128.97 36.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.485 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.571 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 67.1 ttt180 -69.77 140.86 53.44 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.037 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.494 ' HB2' ' OD1' ' A' ' 47' ' ' ASN . 1.2 p90 -156.08 -167.81 2.57 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.139 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.3 t -60.41 -27.49 67.5 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.971 0.415 . . . . 0.0 111.123 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -101.91 27.19 21.52 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.348 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 92.67 -119.94 6.01 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.751 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.413 ' CZ3' ' HG2' ' A' ' 125' ' ' ARG . 79.2 m95 -124.64 125.68 44.51 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.477 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 25.0 t-20 -129.01 142.39 50.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.817 0.342 . . . . 0.0 111.095 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.574 ' HG3' ' HG2' ' A' ' 139' ' ' GLU . 25.1 mtp180 -74.12 108.47 6.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.716 0.769 . . . . 0.0 110.481 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.487 ' HB2' HD22 ' A' ' 140' ' ' LEU . 1.1 m -113.03 157.6 21.35 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.078 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.619 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 9.1 ptt180 -145.95 147.49 31.77 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.381 0.61 . . . . 0.0 112.343 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.828 HD13 HD22 ' A' ' 43' ' ' LEU . 8.7 tt -132.37 151.88 35.53 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.99 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 9.0 m-85 -92.24 104.85 17.16 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.871 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.872 HD13 HD22 ' A' ' 21' ' ' LEU . 30.5 mt -68.5 -32.59 72.67 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.131 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.639 ' HB3' ' HA ' ' A' ' 134' ' ' LYS . 1.4 p30 -54.7 -18.44 4.63 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.853 177.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 1.015 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 37.2 mt-10 -64.63 -52.26 58.31 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -122.49 6.4 9.54 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.734 -0.786 . . . . 0.0 112.87 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.435 ' O ' ' HA3' ' A' ' 5' ' ' GLY . 47.8 mm -107.15 110.38 31.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.663 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -115.24 156.11 15.87 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.451 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.547 ' HA ' ' O ' ' A' ' 163' ' ' GLU . 1.7 t30 -97.13 127.91 43.55 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 122.518 0.327 . . . . 0.0 110.151 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 -115.68 87.43 2.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.257 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 65.4 t30 50.43 52.63 14.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.81 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.547 ' CA ' ' HG2' ' A' ' 27' ' ' ARG . . . 95.07 7.1 59.87 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.968 -0.634 . . . . 0.0 114.343 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 159' ' ' ASN . 44.6 mt-10 -122.55 154.77 37.46 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 117.415 0.608 . . . . 0.0 110.509 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.712 HD11 ' CD2' ' A' ' 7' ' ' PHE . 7.7 tp -111.3 110.16 20.5 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.89 0.376 . . . . 0.0 110.561 -178.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 38.9 pt . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.018 -179.515 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.948 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 30.7 m-85 . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.742 0.306 . . . . 0.0 111.459 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -110.44 -30.68 7.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.712 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -71.37 -63.45 3.09 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 119.732 -1.223 . . . . 0.0 112.39 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 66.03 15.66 10.16 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 122.526 0.33 . . . . 0.0 111.432 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.689 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.2 OUTLIER -60.51 -39.68 88.66 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.082 -179.323 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.78 -16.81 62.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.006 0.431 . . . . 0.0 111.554 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.55 -20.01 79.77 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.077 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 45.8 m -140.41 -13.03 1.02 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 117.33 0.565 . . . . 0.0 112.081 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.7 m -98.66 133.25 43.27 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.635 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 25.0 ptt180 -110.1 -172.13 1.98 Allowed 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.434 ' HB3' ' HG3' ' A' ' 24' ' ' GLU . 20.9 t70 42.05 40.31 1.61 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.829 0.852 . . . . 0.0 111.976 -179.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.877 HG22 HD13 ' A' ' 129' ' ' LEU . 6.4 mt -77.02 99.26 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 CA-C-O 121.104 0.478 . . . . 0.0 109.917 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.639 ' CA ' HD12 ' A' ' 129' ' ' LEU . 73.1 m -147.68 124.67 11.34 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.353 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.752 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -94.03 152.69 18.62 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.84 0.829 . . . . 0.0 112.985 -179.006 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -93.27 75.2 4.59 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.043 -1.435 . . . . 0.0 107.233 177.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.21 -53.31 4.63 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.735 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.497 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -149.07 -11.35 0.32 Allowed 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 120.94 0.4 . . . . 0.0 110.234 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.432 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 3.4 mpt_? -89.48 92.55 9.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.87 0.367 . . . . 0.0 110.389 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.819 HD22 HD23 ' A' ' 153' ' ' LEU . 46.8 tp -61.36 123.98 19.33 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.716 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.653 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 41.9 ttp180 -125.03 137.22 54.23 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.266 -0.573 . . . . 0.0 110.257 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.587 ' CB ' HG12 ' A' ' 14' ' ' ILE . . . -157.29 145.84 19.55 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.587 0.708 . . . . 0.0 111.084 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.635 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 3.5 mt-10 -84.52 77.03 10.1 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.504 -1.225 . . . . 0.0 108.706 178.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.621 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 55.9 m -62.78 120.67 11.72 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.899 -178.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 10' ' ' SER . 9.0 tmm_? -70.76 114.89 9.3 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.914 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 10.2 ptp180 -89.17 159.0 17.69 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.041 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.46 -15.95 6.41 Favored Glycine 0 C--N 1.339 0.732 0 O-C-N 124.713 1.258 . . . . 0.0 114.067 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -72.38 -12.5 61.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.618 0.723 . . . . 0.0 109.417 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.7 8.8 60.5 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.933 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' A' ' 27' ' ' ARG . . . -112.77 160.62 13.04 Favored Glycine 0 CA--C 1.512 -0.151 0 C-N-CA 120.199 -1.001 . . . . 0.0 113.657 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.449 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 89.3 m-85 -101.39 124.7 47.49 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.1 p -118.68 133.23 56.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.438 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.1 m -71.0 111.38 6.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.062 0.458 . . . . 0.0 110.843 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.2 t -117.4 152.1 35.67 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.481 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.56 ' HB ' ' HG3' ' A' ' 22' ' ' ARG . 3.9 p -145.04 136.38 20.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.788 0.328 . . . . 0.0 110.224 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.528 HG23 HD23 ' A' ' 39' ' ' LEU . 11.8 tt -135.29 151.65 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.075 -177.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.565 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 1.6 m-20 -79.61 105.88 11.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.684 0.278 . . . . 0.0 111.36 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.637 HD13 ' HB2' ' A' ' 42' ' ' TYR . 1.5 mm? -88.93 -1.64 58.2 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.198 0.523 . . . . 0.0 110.333 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.565 ' OD1' ' HB3' ' A' ' 38' ' ' ASP . 32.3 p-10 -69.55 -14.62 62.94 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 38' ' ' ASP . 6.1 ptp180 -109.9 11.87 24.04 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.609 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.637 ' HB2' HD13 ' A' ' 39' ' ' LEU . 41.4 m-85 -127.36 -31.63 2.52 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.868 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.631 HD22 HD13 ' A' ' 151' ' ' ILE . 39.8 mt -108.96 139.02 44.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.084 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.551 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 4.1 m -129.71 149.09 51.61 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.518 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.455 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 3.0 p-10 -98.51 104.83 16.9 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -108.03 91.97 3.87 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 121.85 -0.531 . . . . 0.0 111.092 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.537 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 62.4 t30 57.08 45.04 21.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.015 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.816 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 78.67 31.68 44.03 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.795 178.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.586 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 22.4 t-80 -148.69 122.17 9.11 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.756 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 38.1 m-85 -64.04 138.61 58.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.617 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -144.97 139.15 27.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.687 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.718 ' CZ2' ' HA ' ' A' ' 153' ' ' LEU . 99.2 m95 . . . . . 0 C--N 1.321 -0.643 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 177.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 87.3 m . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 121.324 0.583 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -123.07 178.26 5.16 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.356 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.404 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 2.0 p -128.77 122.77 31.3 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.1 t -111.45 135.6 50.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.096 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.1 m -87.48 127.36 35.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.342 0.592 . . . . 0.0 110.034 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.549 ' CG2' HD12 ' A' ' 99' ' ' ILE . 44.5 t -74.64 131.78 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.538 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -101.19 172.03 7.25 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 124.854 1.346 . . . . 0.0 109.905 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.582 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 41.0 tt0 -59.04 125.86 25.33 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.144 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.88 2.74 88.39 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.091 -0.576 . . . . 0.0 114.092 177.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -92.34 138.04 31.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 117.246 0.523 . . . . 0.0 111.315 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.551 ' HA ' HG12 ' A' ' 99' ' ' ILE . 55.1 p -119.5 173.98 6.66 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.599 HD12 ' HB ' ' A' ' 87' ' ' ILE . 1.3 mm? -52.6 -40.5 62.75 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.182 0.515 . . . . 0.0 110.416 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.53 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 13.7 mtp180 -67.01 -35.47 80.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.787 -178.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -72.31 -38.22 68.75 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.521 HG12 ' O ' ' A' ' 72' ' ' THR . 42.0 mm -67.15 -45.83 85.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.715 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -55.14 -55.82 26.29 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.579 179.081 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -59.79 -42.94 94.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.91 0.386 . . . . 0.0 112.04 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -64.01 -36.27 83.45 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -110.35 19.99 18.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.8 t70 56.3 30.55 16.96 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.448 0.642 . . . . 0.0 111.717 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.715 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 3.6 p -112.85 171.31 7.61 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.59 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.9 t70 -99.24 127.18 45.19 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.53 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 4.8 p90 -51.43 -30.55 19.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.226 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -65.43 -44.79 86.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.719 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.721 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 24.2 mm-40 -63.22 -51.0 68.04 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.801 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.599 ' HB ' HD12 ' A' ' 73' ' ' LEU . 2.7 mt -52.76 -47.04 51.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.64 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.595 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.59 -50.74 70.07 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.617 178.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -56.47 -40.12 74.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.138 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.721 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 13.8 mmt85 -65.83 -33.48 75.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.102 0.477 . . . . 0.0 111.071 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 2.4 t-20 -92.13 -4.76 53.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.792 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 92.3 m-20 75.94 19.14 1.94 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.487 0.715 . . . . 0.0 110.777 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.595 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 14.4 pt -106.18 -176.26 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.739 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.555 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 49.2 mt-30 -107.36 166.06 10.93 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.539 ' O ' HD23 ' A' ' 73' ' ' LEU . 6.1 p30 -63.83 -53.5 49.78 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-O 122.141 0.972 . . . . 0.0 108.407 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.4 ' OE1' ' HB3' ' A' ' 94' ' ' GLN . 0.8 OUTLIER -79.56 11.06 3.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.785 -179.67 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.555 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.8 t70 -61.54 -32.23 72.28 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.1 mt 68.84 114.07 0.04 OUTLIER 'General case' 0 C--O 1.233 0.21 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.061 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.734 HG21 HD11 ' A' ' 105' ' ' LEU . 9.2 pt -94.56 175.64 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.238 -178.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.474 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 41.3 m-85 -128.72 156.54 77.4 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.83 -178.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.582 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 32.0 Cg_endo -67.07 133.02 29.6 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 123.286 2.658 . . . . 0.0 113.241 -178.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.43 19.29 25.85 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -112.54 155.74 23.81 Favored 'General case' 0 C--O 1.212 -0.901 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.404 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 88.2 t -116.18 122.68 70.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 O-C-N 121.789 -0.569 . . . . 0.0 110.405 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.734 HD11 HG21 ' A' ' 99' ' ' ILE . 95.9 mt -113.42 151.25 31.59 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.92 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.569 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 78.2 mt-30 -90.22 116.27 28.08 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.642 0.734 . . . . 0.0 110.801 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.406 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 31.5 m -123.23 151.84 62.89 Favored Pre-proline 0 C--N 1.31 -1.119 0 CA-C-N 114.173 -1.376 . . . . 0.0 109.441 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' A' ' 107' ' ' VAL . 37.9 Cg_endo -65.07 -22.32 62.17 Favored 'Trans proline' 0 N--CA 1.473 0.282 0 C-N-CA 123.147 2.565 . . . . 0.0 114.952 -177.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.0 t . . . . . 0 C--N 1.322 -0.604 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.586 -179.42 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.551 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.444 -0.83 0 N-CA-C 112.221 -0.351 . . . . 0.0 112.221 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 15.2 m120 73.63 31.33 1.3 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.007 0.523 . . . . 0.0 112.122 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.573 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 27.5 p90 -59.6 -35.84 75.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.95 0.405 . . . . 0.0 110.141 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.56 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 61.8 t-105 -63.09 -31.71 72.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.068 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.88 -31.51 40.04 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.852 0.358 . . . . 0.0 110.99 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.85 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 18.5 m -131.19 28.26 4.75 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.691 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.56 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -110.48 142.95 41.53 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.395 178.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.45 ' HD2' ' OD2' ' A' ' 126' ' ' ASP . 6.6 tmm_? -137.15 139.24 41.02 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.45 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 3.6 m-20 63.08 54.54 2.1 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.261 0.553 . . . . 0.0 110.567 -178.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.466 ' CG1' HD11 ' A' ' 136' ' ' LEU . 38.3 t -85.69 122.83 38.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.402 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.424 ' O ' HD12 ' A' ' 136' ' ' LEU . 16.2 ptt180 -144.84 142.7 30.15 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.754 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.877 HD13 HG22 ' A' ' 14' ' ' ILE . 16.5 mt -85.42 130.38 34.6 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.532 HG23 ' HB ' ' A' ' 135' ' ' VAL . 27.8 m -124.49 163.47 24.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.512 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.473 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 5.3 m-20 68.08 6.0 4.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.203 178.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.635 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 93.66 28.25 11.59 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.181 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.495 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 96.89 -19.27 55.46 Favored Glycine 0 C--O 1.264 1.978 0 CA-C-O 123.08 1.378 . . . . 0.0 113.145 177.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.574 ' O ' ' HA ' ' A' ' 152' ' ' TYR . 10.5 pttp -72.75 -10.91 60.34 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 121.196 -1.179 . . . . 0.0 109.665 178.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.532 ' HB ' HG23 ' A' ' 130' ' ' VAL . 22.3 t -144.26 140.44 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 121.383 0.611 . . . . 0.0 110.444 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.624 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 44.1 tp -121.14 125.28 46.81 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -114.75 131.36 56.81 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.989 0.423 . . . . 0.0 110.893 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.627 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -161.44 157.8 25.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.675 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.522 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 36.9 mt-10 -95.56 109.95 22.11 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.816 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 46.3 mt -95.74 134.17 38.99 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.956 -178.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.85 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 36.1 ttt180 -70.76 141.09 51.47 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.701 179.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.601 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.7 p90 -161.83 -170.49 2.57 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.593 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 45.5 t -54.31 -28.68 43.95 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.41 0.444 . . . . 0.0 111.883 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -105.45 30.38 9.96 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.461 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 141' ' ' ARG . . . 91.55 -114.93 4.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.518 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -126.8 128.15 46.13 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.601 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 57.3 t30 -117.62 143.67 45.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.957 0.408 . . . . 0.0 111.988 -178.318 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -76.75 94.57 3.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.122 178.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.586 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 35.8 t -111.11 160.88 16.49 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.445 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.624 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 28.6 ptt180 -148.59 154.58 39.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.548 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.756 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 8.0 tt -136.96 151.95 27.89 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.565 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.078 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.621 ' HB3' ' OD1' ' A' ' 154' ' ' ASP . 26.3 m-85 -95.08 103.27 15.12 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.839 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.819 HD23 HD22 ' A' ' 21' ' ' LEU . 7.1 mp -70.64 -29.27 65.58 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.976 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.621 ' OD1' ' HB3' ' A' ' 152' ' ' TYR . 21.9 p-10 -56.27 -13.96 2.5 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.914 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.948 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 31.1 mt-10 -68.96 -54.11 17.1 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -123.11 3.73 9.29 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.719 -0.792 . . . . 0.0 112.576 -176.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.492 HG21 HD21 ' A' ' 21' ' ' LEU . 43.2 mm -105.32 112.85 40.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.127 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.448 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -118.47 178.53 16.79 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.878 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.621 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -109.6 125.71 52.85 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.86 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.91 85.06 2.04 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 65.0 t30 52.2 49.59 20.26 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.388 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 94.11 2.22 64.44 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.707 -0.758 . . . . 0.0 114.338 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -122.31 126.04 47.25 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.982 0.42 . . . . 0.0 109.894 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.689 HD11 ' CD2' ' A' ' 7' ' ' PHE . 7.6 tp -73.78 128.45 35.56 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.754 -178.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 10.8 tp . . . . . 0 C--O 1.223 -0.33 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -179.103 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.689 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 27.9 m-85 . . . . . 0 CA--C 1.517 -0.312 0 CA-C-O 121.187 0.518 . . . . 0.0 110.304 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.3 -26.69 0.9 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.525 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -72.7 -69.76 1.34 Allowed Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 119.541 -1.314 . . . . 0.0 113.376 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 68.39 16.73 9.23 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 122.624 0.37 . . . . 0.0 110.366 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.669 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -63.63 -30.54 71.64 Favored 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -178.801 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.402 ' HA ' HD11 ' A' ' 14' ' ' ILE . 97.2 p -70.37 -12.39 61.55 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.715 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.22 -26.03 60.5 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.283 -0.872 . . . . 0.0 112.782 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.444 ' HB2' ' HB3' ' A' ' 26' ' ' ARG . 35.0 p -126.49 -23.65 3.75 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.221 0.51 . . . . 0.0 112.069 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.0 m -90.09 135.28 33.75 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.532 ' HG2' ' N ' ' A' ' 13' ' ' ASP . 44.3 ttt-85 -110.86 171.08 7.68 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.539 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.532 ' N ' ' HG2' ' A' ' 12' ' ' ARG . 48.7 m-20 46.01 48.65 12.45 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.349 0.659 . . . . 0.0 111.999 178.088 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.877 HG22 HD13 ' A' ' 129' ' ' LEU . 9.4 mt -79.36 105.71 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.657 ' HA ' HD12 ' A' ' 129' ' ' LEU . 75.5 m -147.18 126.81 13.33 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.011 0.524 . . . . 0.0 109.977 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.768 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -97.79 156.61 16.49 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -179.07 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -96.88 74.4 2.64 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.063 -1.426 . . . . 0.0 107.669 177.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.12 -52.89 4.57 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.031 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.574 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -149.26 -13.36 0.3 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.183 0.516 . . . . 0.0 110.004 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 20' ' ' ARG . 23.4 ttm180 -90.89 92.63 8.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.331 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.812 HD13 HD11 ' A' ' 129' ' ' LEU . 37.3 tp -63.46 130.49 44.6 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.736 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -134.17 127.05 31.23 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.033 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.656 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -146.72 147.02 30.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.244 0.545 . . . . 0.0 111.501 -178.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.737 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 7.2 mm-40 -78.59 74.7 5.12 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.392 177.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.625 ' SG ' HD13 ' A' ' 164' ' ' LEU . 68.9 m -60.3 126.9 29.24 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 120.971 0.415 . . . . 0.0 111.029 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.444 ' HB3' ' HB2' ' A' ' 10' ' ' SER . 65.6 ttt180 -68.51 121.67 16.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.237 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.559 ' HD3' ' HB3' ' A' ' 29' ' ' ASP . 6.0 ptp180 -94.91 149.59 21.08 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 177.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.42 -11.33 3.58 Favored Glycine 0 C--N 1.34 0.775 0 O-C-N 124.35 1.031 . . . . 0.0 113.642 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.559 ' HB3' ' HD3' ' A' ' 27' ' ' ARG . 19.8 t70 -71.68 -15.64 62.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.441 0.639 . . . . 0.0 109.548 178.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.13 5.4 53.01 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.048 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.22 172.41 14.26 Favored Glycine 0 C--N 1.322 -0.197 0 C-N-CA 119.959 -1.115 . . . . 0.0 113.517 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.737 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 41.2 m-85 -101.87 128.92 48.03 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 178.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.6 m -114.45 130.81 56.75 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.267 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 m -67.47 110.01 3.45 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.092 0.473 . . . . 0.0 110.846 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.505 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 41.7 t -115.06 151.93 33.39 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.512 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -145.94 133.66 15.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.08 0.467 . . . . 0.0 111.824 -178.777 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.475 HG22 HD23 ' A' ' 164' ' ' LEU . 10.7 tt -135.4 141.23 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.869 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.02 108.84 15.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.07 0.462 . . . . 0.0 111.052 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.587 HD23 ' HB3' ' A' ' 21' ' ' LEU . 3.1 mm? -81.14 -7.33 59.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.621 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.574 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 26.9 p30 -68.62 -9.6 50.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.57 0.7 . . . . 0.0 109.364 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -104.94 0.15 27.53 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.617 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.545 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 75.8 m-85 -126.06 -28.09 3.2 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.842 HD22 HD13 ' A' ' 151' ' ' ILE . 36.5 mt -106.31 142.84 35.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.988 0.423 . . . . 0.0 112.023 -178.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.2 m -135.43 139.78 44.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.446 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.815 ' CB ' ' HG ' ' A' ' 140' ' ' LEU . 7.8 p-10 -83.48 93.93 7.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.522 0.677 . . . . 0.0 110.286 178.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.44 ' CB ' ' HD2' ' A' ' 51' ' ' ARG . 9.1 t0 -99.88 94.79 6.49 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 122.1 -0.375 . . . . 0.0 110.63 -179.138 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.519 ' HA ' ' HB2' ' A' ' 142' ' ' TYR . 10.2 t-20 52.47 49.28 20.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.52 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 149' ' ' SER . . . 72.0 38.98 59.63 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.696 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -157.29 123.02 4.69 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.756 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 65.4 m-85 -62.46 144.9 55.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.191 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.44 ' HD2' ' CB ' ' A' ' 46' ' ' ASP . 70.0 mtt180 -148.0 133.02 18.19 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.38 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.545 ' HA ' ' O ' ' A' ' 42' ' ' TYR . 97.3 m95 . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.273 178.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.5 m . . . . . 0 C--O 1.234 0.25 0 CA-C-O 120.951 0.405 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -133.53 176.55 8.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.545 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.427 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 2.4 p -128.8 117.97 21.98 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.218 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.514 HG21 ' CE2' ' A' ' 80' ' ' PHE . 14.2 p -104.68 141.17 20.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.003 0.43 . . . . 0.0 111.575 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 5.6 m -93.09 126.7 38.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.236 0.541 . . . . 0.0 109.691 178.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.593 ' CG2' HD12 ' A' ' 99' ' ' ILE . 53.9 t -79.59 135.22 26.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.092 -179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -100.83 169.84 8.72 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 124.355 1.034 . . . . 0.0 110.643 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.713 ' CA ' ' HB3' ' A' ' 101' ' ' PRO . 50.1 tt0 -66.15 116.71 7.52 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.978 -177.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.25 -3.29 47.36 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.321 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -100.29 139.32 36.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.999 0.428 . . . . 0.0 111.213 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.692 ' HA ' HG12 ' A' ' 99' ' ' ILE . 69.6 p -120.29 179.43 4.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.542 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.663 HD22 HG23 ' A' ' 99' ' ' ILE . 1.1 mm? -51.5 -40.61 59.9 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.19 0.519 . . . . 0.0 110.191 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -61.75 -38.47 88.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.354 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -72.3 -40.21 67.68 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.666 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 72' ' ' THR . 41.7 mm -64.96 -47.38 88.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.886 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.646 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -61.23 -44.29 98.3 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.92 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -65.54 -36.38 83.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.075 0.464 . . . . 0.0 111.251 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -75.27 -44.21 47.02 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.514 ' CE2' HG21 ' A' ' 65' ' ' VAL . 89.7 m-85 -101.91 17.32 23.42 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -176.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.4 t70 54.33 42.72 31.29 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.527 0.679 . . . . 0.0 111.521 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.646 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.1 p -123.07 166.2 15.53 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.672 ' O ' HG13 ' A' ' 87' ' ' ILE . 6.8 t70 -93.88 124.52 37.94 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.599 -0.841 . . . . 0.0 110.115 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.574 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 18.9 p90 -51.5 -31.78 25.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.19 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.494 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 38.8 t-80 -66.58 -44.1 83.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.727 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.67 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 17.9 mm-40 -67.61 -47.35 69.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.254 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.672 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.8 mt -51.06 -45.34 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.435 0.636 . . . . 0.0 109.336 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.623 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.63 -50.77 69.93 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.935 178.268 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' A' ' 85' ' ' HIS . 74.6 mtp180 -57.32 -41.98 80.96 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.67 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 15.4 mtp180 -70.89 -21.78 62.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.852 0.358 . . . . 0.0 111.376 -178.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 17.4 t-20 -101.13 -5.23 25.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.951 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 16.0 m120 78.0 14.58 1.55 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.49 0.716 . . . . 0.0 111.494 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.623 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 16.7 pt -106.27 -174.64 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.576 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 78.6 mm-40 -113.48 155.37 25.44 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.555 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 4.5 p30 -54.07 -58.87 5.7 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-O 122.259 1.028 . . . . 0.0 109.058 178.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -75.33 12.26 1.0 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.747 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.576 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.1 t0 -69.49 -34.09 73.81 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 10.3 mp 70.22 116.62 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 O-C-N 124.21 0.944 . . . . 0.0 108.98 -176.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.696 HG21 HD11 ' A' ' 105' ' ' LEU . 7.5 pt -93.56 177.07 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.993 -177.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.405 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 2.3 m-85 -123.87 156.04 66.03 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.401 -177.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.713 ' HB3' ' CA ' ' A' ' 69' ' ' GLN . 32.6 Cg_endo -68.71 130.6 20.97 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.258 2.639 . . . . 0.0 113.062 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.05 12.54 49.14 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 66' ' ' THR . 63.4 tt0 -101.0 159.72 14.98 Favored 'General case' 0 C--O 1.214 -0.792 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.427 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 85.6 t -120.59 120.47 62.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.04 0.448 . . . . 0.0 110.203 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.696 HD11 HG21 ' A' ' 99' ' ' ILE . 68.4 mt -111.49 152.0 27.97 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.549 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -90.78 115.81 28.14 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.564 0.697 . . . . 0.0 111.208 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.2 m -124.57 151.26 67.03 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.407 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -63.32 -17.08 58.41 Favored 'Trans proline' 0 C--N 1.332 -0.302 0 C-N-CA 123.305 2.67 . . . . 0.0 114.92 -177.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.9 t . . . . . 0 C--N 1.32 -0.676 0 C-N-CA 120.551 -0.459 . . . . 0.0 111.462 -179.91 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.445 -0.724 0 N-CA-C 111.349 -0.701 . . . . 0.0 111.349 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.3 m120 73.74 27.22 1.75 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 177.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.662 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 22.5 p90 -58.39 -36.72 73.97 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.376 -0.53 . . . . 0.0 109.886 178.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.531 ' HB2' ' HB2' ' A' ' 19' ' ' ALA . 52.8 t-105 -63.79 -34.62 78.31 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.854 -178.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -56.86 -19.78 19.4 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.155 0.502 . . . . 0.0 110.788 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.813 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 13.0 m -138.75 29.12 2.35 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.444 178.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.529 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -116.22 145.83 42.81 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.2 0.524 . . . . 0.0 111.94 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.45 HH11 ' HD3' ' A' ' 125' ' ' ARG . 29.1 mtp-105 -133.69 153.88 51.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.378 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 52.03 39.91 27.3 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 123.713 0.633 . . . . 0.0 112.128 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.504 ' CG1' HD11 ' A' ' 136' ' ' LEU . 22.5 t -67.19 121.51 16.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.056 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -144.83 140.5 28.45 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.689 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.877 HD13 HG22 ' A' ' 14' ' ' ILE . 16.4 mt -86.36 122.39 30.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.147 0.498 . . . . 0.0 109.912 178.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.635 HG23 ' HB ' ' A' ' 135' ' ' VAL . 35.2 m -115.63 159.36 15.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.367 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.601 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 1.4 m-20 71.06 -0.7 2.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.212 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.562 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 98.6 28.18 8.09 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.033 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.506 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 100.24 -23.94 33.98 Favored Glycine 0 C--O 1.264 1.98 0 CA-C-O 123.192 1.44 . . . . 0.0 112.618 178.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.73 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 6.9 ptmm? -65.08 -18.85 65.65 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 121.803 -0.822 . . . . 0.0 109.601 178.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.635 ' HB ' HG23 ' A' ' 130' ' ' VAL . 15.1 t -139.08 141.19 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.289 0.566 . . . . 0.0 109.976 177.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 30.1 tp -121.66 121.16 36.73 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.507 ' OE2' ' HD3' ' A' ' 150' ' ' ARG . 36.7 tt0 -111.93 132.53 54.69 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.209 -177.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.748 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -163.22 161.89 25.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.594 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -94.65 105.85 17.82 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.815 ' HG ' ' CB ' ' A' ' 45' ' ' ASN . 1.9 mp -89.82 128.52 36.18 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.543 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.813 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 41.0 ttt180 -70.61 140.53 51.67 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.097 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.663 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.3 p90 -157.22 -171.81 3.76 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.951 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.1 p -56.44 -29.2 61.35 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.168 0.293 . . . . 0.0 111.601 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.03 26.12 25.52 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.142 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.87 -110.98 4.1 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.365 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -130.05 133.31 46.62 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.663 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 14.4 t-20 -123.93 136.92 54.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.764 0.316 . . . . 0.0 111.361 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -76.7 93.73 3.7 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.505 ' OG ' HD22 ' A' ' 140' ' ' LEU . 24.2 p -110.71 162.91 14.29 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.506 -178.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.597 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 14.0 mtm-85 -143.91 152.37 41.02 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.858 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.842 HD13 HD22 ' A' ' 43' ' ' LEU . 11.1 tt -137.95 143.2 33.97 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.467 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.735 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 35.7 m-85 -83.89 101.66 11.83 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 122.195 -0.316 . . . . 0.0 110.925 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.772 HD13 HD22 ' A' ' 21' ' ' LEU . 20.4 mt -62.92 -33.6 75.67 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.116 178.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.73 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 12.7 t70 -56.13 -14.11 2.48 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.805 178.159 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.735 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 38.9 mt-10 -64.3 -55.8 18.87 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 53.6 m-70 -121.54 2.35 10.15 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 119.851 -0.74 . . . . 0.0 112.111 -177.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' A' ' 153' ' ' LEU . 47.0 mm -103.95 112.76 38.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.605 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.58 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -121.52 164.76 14.61 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.36 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.574 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.9 t30 -99.63 130.64 45.87 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.665 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 28.8 ttm180 -122.78 87.02 2.68 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.205 0.526 . . . . 0.0 110.425 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 64.9 t30 53.93 44.05 29.99 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.654 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.95 -6.78 47.96 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.127 -1.035 . . . . 0.0 114.733 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.665 ' HG2' ' O ' ' A' ' 160' ' ' ARG . 12.9 pt-20 -118.99 138.4 52.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 117.81 0.805 . . . . 0.0 110.696 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.669 HD11 ' CD2' ' A' ' 7' ' ' PHE . 7.4 tp -91.7 118.63 30.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.075 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 12.0 tt . . . . . 0 C--N 1.323 -0.585 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.272 -179.06 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.747 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 56.3 m-85 . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 120.873 0.368 . . . . 0.0 111.731 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.84 -29.99 10.15 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.459 -179.392 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.21 -69.15 1.45 Allowed Glycine 0 N--CA 1.436 -1.324 0 C-N-CA 119.948 -1.12 . . . . 0.0 113.051 -178.649 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 69.55 11.81 8.05 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.564 0.345 . . . . 0.0 110.94 -179.475 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.593 ' CE2' HD13 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -59.64 -35.0 73.53 Favored 'General case' 0 C--O 1.214 -0.786 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.635 -179.004 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.3 p -64.87 -13.77 57.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.04 0.447 . . . . 0.0 111.502 -179.469 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.64 -12.42 62.63 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.98 179.37 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 14.8 m -126.67 -34.11 2.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.491 0.663 . . . . 0.0 110.732 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 9.0 m -92.77 133.59 35.89 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.685 -179.042 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.435 ' HG3' ' HB2' ' A' ' 24' ' ' GLU . 9.1 ptp180 -111.76 -173.65 2.29 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.756 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.455 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 2.3 m-20 44.76 39.65 3.64 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 123.607 0.567 . . . . 0.0 112.419 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.972 HG22 HD13 ' A' ' 129' ' ' LEU . 5.0 mt -78.74 103.86 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 CA-C-O 120.951 0.405 . . . . 0.0 110.503 -178.564 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.593 ' CA ' HD12 ' A' ' 129' ' ' LEU . 71.2 m -147.63 126.53 12.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.284 178.663 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.801 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -101.03 155.16 18.14 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.904 0.859 . . . . 0.0 112.951 -179.373 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -99.02 77.0 2.15 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.036 -1.438 . . . . 0.0 107.559 176.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.06 -56.76 5.0 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.856 179.177 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.524 ' HB1' ' HB2' ' A' ' 40' ' ' ASN . . . -148.66 -12.28 0.34 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.087 0.47 . . . . 0.0 109.918 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.454 HH11 ' HD3' ' A' ' 20' ' ' ARG . 44.0 mtp-105 -81.75 86.43 6.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.343 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.801 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 42.1 tp -62.0 116.07 4.6 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 122.825 0.45 . . . . 0.0 111.884 -179.497 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.547 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 39.1 ttt180 -122.99 127.89 49.45 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.226 -179.104 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.64 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -148.66 146.65 28.26 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.506 0.67 . . . . 0.0 111.107 -179.339 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 1.2 mm-40 -85.53 79.88 9.25 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.643 178.39 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.629 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 37.6 m -65.63 126.73 29.3 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.213 -178.847 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 10' ' ' SER . 30.8 ttm180 -65.47 124.07 21.31 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.311 178.535 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.555 ' HD3' ' O ' ' A' ' 161' ' ' ASN . 18.4 ttp180 -105.08 151.2 24.28 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.524 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.9 2.61 0.56 Allowed Glycine 0 C--N 1.334 0.432 0 CA-C-N 114.525 -1.216 . . . . 0.0 113.944 -178.314 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.42 ' H ' ' C ' ' A' ' 27' ' ' ARG . 33.1 t70 -84.73 -9.25 58.39 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.454 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.5 10.64 57.89 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -133.9 162.99 24.53 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.155 -1.021 . . . . 0.0 112.867 -179.666 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.469 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 71.2 m-85 -88.71 146.39 25.07 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.525 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.4 t -127.83 126.13 41.09 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.569 178.742 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.6 m -67.26 117.24 9.01 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.768 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 41.6 t -124.32 151.95 43.68 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.179 -179.403 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.689 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.4 p -144.31 134.92 20.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.904 0.383 . . . . 0.0 111.196 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.472 HG23 ' HB3' ' A' ' 21' ' ' LEU . 11.2 tt -135.62 152.94 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.878 -178.372 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.414 ' OD2' ' HB3' ' A' ' 40' ' ' ASN . 19.3 t70 -82.81 112.77 19.94 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.647 0.26 . . . . 0.0 110.451 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.492 HD23 ' HB3' ' A' ' 21' ' ' LEU . 2.7 mm? -92.81 0.89 57.49 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.356 0.598 . . . . 0.0 109.562 178.075 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.524 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 11.1 t30 -76.17 -19.57 58.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.202 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' A' ' 41' ' ' ARG . 4.7 ptp180 -97.89 6.14 48.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.329 178.652 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.55 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 33.3 m-85 -129.25 -27.7 2.42 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.554 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.82 HD22 HD13 ' A' ' 151' ' ' ILE . 53.3 mt -105.96 137.94 42.99 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.134 0.492 . . . . 0.0 110.807 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m -131.78 143.59 50.33 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.414 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.553 ' CG ' ' HB3' ' A' ' 140' ' ' LEU . 7.9 t30 -90.47 110.92 22.02 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.481 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.461 ' CB ' ' HD3' ' A' ' 51' ' ' ARG . 35.4 t70 -115.61 92.72 4.0 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.238 179.663 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 65.1 t30 57.99 45.23 18.37 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.099 179.682 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.765 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 73.6 38.25 51.46 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.304 -0.951 . . . . 0.0 112.009 179.107 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.625 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 23.8 t60 -151.12 121.43 7.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.768 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 38.1 m-85 -65.6 139.49 58.44 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.142 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.461 ' HD3' ' CB ' ' A' ' 46' ' ' ASP . 78.1 mtp180 -147.17 133.3 19.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.708 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.55 ' HA ' ' O ' ' A' ' 42' ' ' TYR . 98.3 m95 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.037 178.13 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 88.8 m . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 120.865 0.364 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.84 177.09 4.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.19 -179.658 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.536 HG22 ' HG2' ' A' ' 106' ' ' GLN . 12.3 p -128.58 119.47 24.84 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.678 0.275 . . . . 0.0 111.711 -179.354 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.468 HG21 ' CE2' ' A' ' 80' ' ' PHE . 8.3 p -105.89 141.52 21.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 120.793 0.33 . . . . 0.0 111.086 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.2 m -89.75 128.41 36.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.424 0.63 . . . . 0.0 109.996 179.109 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.597 ' CG2' HD12 ' A' ' 99' ' ' ILE . 48.8 t -79.71 138.22 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.072 -179.387 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -108.55 171.26 7.52 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 124.06 0.85 . . . . 0.0 111.09 -179.525 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.646 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 36.5 tt0 -54.28 114.31 1.59 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.539 -178.536 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.4 2.69 63.53 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 121.151 -0.547 . . . . 0.0 113.793 178.319 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -91.28 143.82 26.25 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 117.163 0.482 . . . . 0.0 111.537 -179.405 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.774 ' HA ' HG12 ' A' ' 99' ' ' ILE . 35.0 p -130.69 169.13 16.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.274 178.845 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.669 HD22 HG23 ' A' ' 99' ' ' ILE . 1.0 OUTLIER -49.77 -43.38 48.15 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.202 0.455 . . . . 0.0 111.512 -179.516 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -65.06 -35.88 82.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.542 -177.585 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -74.07 -37.71 64.14 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.577 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 72' ' ' THR . 45.0 mm -67.86 -47.9 77.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.367 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.719 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -58.13 -48.25 84.22 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.751 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -34.56 78.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.785 0.326 . . . . 0.0 111.341 -179.186 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -71.37 -47.54 55.7 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.604 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.468 ' CE2' HG21 ' A' ' 65' ' ' VAL . 86.2 m-85 -100.5 19.85 16.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -177.217 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 53.38 45.49 28.27 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.233 0.54 . . . . 0.0 112.012 178.805 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.719 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.2 p -126.14 168.0 14.63 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.315 179.497 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.65 ' O ' HG13 ' A' ' 87' ' ' ILE . 9.2 t70 -93.33 123.46 36.63 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 121.846 -0.534 . . . . 0.0 109.647 179.176 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.545 ' HD2' ' HB2' ' A' ' 95' ' ' ASN . 2.5 p90 -52.0 -27.07 12.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.011 179.735 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.93 -37.65 54.92 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.062 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.683 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 3.8 tp10 -64.86 -47.78 76.66 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.893 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.65 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.2 mt -53.86 -45.77 63.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.853 178.63 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.574 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.36 -52.07 65.07 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.91 178.511 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.1 mtt-85 -61.22 -30.18 70.27 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.722 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.683 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 32.8 mmt180 -72.73 -31.81 65.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.096 0.474 . . . . 0.0 110.395 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 21.1 t-20 -93.61 -6.02 47.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.754 179.349 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 92.0 m-20 79.04 17.12 0.93 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.092 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.574 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 16.1 pt -107.22 -173.03 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.843 178.509 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.536 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 3.5 mm100 -112.61 161.4 16.85 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.433 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.545 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 16.4 p-10 -62.36 -52.41 63.76 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.581 1.182 . . . . 0.0 108.394 179.473 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 96' ' ' GLU . 35.2 tt0 -73.64 4.74 4.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 113.867 -1.515 . . . . 0.0 110.822 179.814 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 0.9 OUTLIER -64.76 -37.45 87.64 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.625 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.41 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 7.9 mp 70.24 116.42 0.04 OUTLIER 'General case' 0 C--O 1.231 0.12 0 O-C-N 124.12 0.888 . . . . 0.0 109.716 -177.682 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.81 HG21 HD11 ' A' ' 105' ' ' LEU . 8.0 pt -93.95 175.72 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.881 -177.617 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.527 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 14.2 m-85 -126.04 158.85 64.69 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.921 -178.585 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.646 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 28.8 Cg_endo -64.98 136.07 46.86 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.298 2.665 . . . . 0.0 113.212 -179.747 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.7 15.58 56.38 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.467 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -103.8 153.68 20.45 Favored 'General case' 0 C--O 1.209 -1.036 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.386 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.502 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 62.0 t -116.12 119.55 62.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 O-C-N 121.75 -0.594 . . . . 0.0 110.567 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.81 HD11 HG21 ' A' ' 99' ' ' ILE . 77.5 mt -113.49 152.09 30.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.572 -179.229 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.656 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 71.2 mt-30 -90.78 122.4 33.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.546 0.688 . . . . 0.0 110.729 179.644 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.7 m -129.98 151.18 77.83 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.585 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.23 -20.45 70.74 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 123.734 2.956 . . . . 0.0 114.793 -177.21 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.7 t . . . . . 0 C--N 1.324 -0.525 0 CA-C-O 120.924 0.392 . . . . 0.0 110.725 179.817 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.445 -0.717 0 N-CA-C 111.619 -0.592 . . . . 0.0 111.619 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.448 ' HA ' ' OD1' ' A' ' 40' ' ' ASN . 17.9 m120 69.43 31.64 3.73 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 123.019 0.528 . . . . 0.0 112.176 178.156 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.637 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 24.5 p90 -60.07 -34.95 74.13 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.527 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.507 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 20.7 t-105 -63.44 -33.16 74.96 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.821 -178.917 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.27 -23.62 49.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.981 0.42 . . . . 0.0 110.929 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.0 p -133.19 24.35 4.17 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.052 179.812 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.507 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -108.99 146.43 33.9 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.02 0.438 . . . . 0.0 111.5 179.026 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -146.41 146.01 30.45 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 61.26 26.22 16.1 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.73 0.776 . . . . 0.0 110.53 -179.433 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.574 ' HB ' ' CB ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -75.81 125.48 35.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.833 -179.93 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -150.06 155.67 40.29 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.654 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.972 HD13 HG22 ' A' ' 14' ' ' ILE . 30.5 mt -86.54 131.41 34.18 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.966 0.412 . . . . 0.0 110.102 179.573 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.442 HG23 ' HB ' ' A' ' 135' ' ' VAL . 33.3 m -125.79 158.59 34.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.918 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.559 ' HB3' ' HD2' ' A' ' 134' ' ' LYS . 3.7 m-20 68.84 7.34 6.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.448 178.486 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.665 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 96.32 32.9 6.45 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.561 178.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 87.56 -15.81 52.77 Favored Glycine 0 C--O 1.266 2.151 0 CA-C-O 123.579 1.655 . . . . 0.0 112.833 177.361 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.84 ' HG3' HG23 ' A' ' 135' ' ' VAL . 18.2 ptpt -67.41 -24.23 65.63 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.233 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.84 HG23 ' HG3' ' A' ' 134' ' ' LYS . 26.1 t -136.36 137.13 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 121.43 0.633 . . . . 0.0 110.806 178.811 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.6 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 36.0 tp -112.26 114.83 27.82 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.366 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -104.47 125.99 51.16 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.357 -177.317 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.614 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . . . -154.38 161.75 41.55 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.158 0.504 . . . . 0.0 111.256 -179.264 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -103.28 106.37 16.87 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 177.448 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.765 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 38.6 mt -94.07 135.37 35.5 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.722 -178.146 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 145' ' ' GLY . 70.3 ttt180 -69.84 140.96 53.32 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.355 179.656 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.599 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.0 OUTLIER -157.92 -167.81 2.34 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.849 -0.341 . . . . 0.0 111.549 -179.165 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.7 m -56.02 -26.91 50.83 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.053 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -106.35 27.35 17.26 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.13 -1.033 . . . . 0.0 113.238 -178.98 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 141' ' ' ARG . . . 95.1 -106.35 3.39 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.101 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -127.81 129.95 47.84 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.599 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 56.4 t30 -123.6 137.29 54.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.047 0.451 . . . . 0.0 111.517 -179.114 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 39.8 ttt180 -76.31 105.88 7.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.925 178.838 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.625 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 10.2 t -121.47 165.44 15.62 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -146.4 158.12 43.85 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.125 -179.558 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.82 HD13 HD22 ' A' ' 43' ' ' LEU . 9.8 tt -141.89 145.55 24.02 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.37 179.193 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.66 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 23.3 m-85 -86.86 104.8 16.55 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 121.069 -0.253 . . . . 0.0 111.088 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.694 HD13 HD22 ' A' ' 21' ' ' LEU . 16.4 mt -67.68 -31.97 72.3 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.242 178.295 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.435 ' OD2' ' HB2' ' A' ' 134' ' ' LYS . 2.1 p30 -55.0 -17.33 3.64 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.129 177.934 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.747 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 35.1 mt-10 -63.18 -53.08 58.84 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.222 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -123.3 5.01 9.12 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.728 -177.567 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.431 HG21 HD21 ' A' ' 21' ' ' LEU . 48.3 mm -105.69 110.34 30.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.693 178.794 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -115.97 172.84 14.41 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.632 178.445 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.629 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.2 OUTLIER -112.26 130.03 56.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.984 0.421 . . . . 0.0 110.983 179.893 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -125.41 94.01 4.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.327 179.098 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.555 ' O ' ' HD3' ' A' ' 27' ' ' ARG . 2.3 m-20 62.88 39.68 10.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.678 178.987 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.525 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 88.36 13.45 63.57 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.902 179.196 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -122.97 135.85 54.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.759 0.314 . . . . 0.0 111.299 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.499 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 37.4 mt -82.16 121.39 26.55 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.107 178.833 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 12.6 tt . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.197 -179.463 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.986 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 38.0 m-85 . . . . . 0 CA--C 1.519 -0.224 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.63 -33.55 4.82 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.341 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -70.63 -62.47 3.62 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 119.763 -1.208 . . . . 0.0 112.694 -179.035 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 65.48 16.52 10.56 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 122.532 0.333 . . . . 0.0 111.041 -179.498 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.732 ' HD2' HD11 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -63.74 -34.95 79.02 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.732 -179.277 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.43 ' HA ' HD11 ' A' ' 14' ' ' ILE . 16.6 p -63.79 -18.83 64.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.139 0.495 . . . . 0.0 110.988 -179.494 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.92 -26.29 69.41 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 115.682 -0.69 . . . . 0.0 113.341 179.226 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.568 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 33.5 p -127.12 -20.33 4.17 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 117.583 0.691 . . . . 0.0 111.819 -179.224 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.6 t -96.62 131.3 43.41 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -112.54 -176.99 3.04 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.451 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 16.6 m-20 43.62 45.55 5.81 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 123.971 0.794 . . . . 0.0 111.874 -179.802 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 1.08 HG22 HD13 ' A' ' 129' ' ' LEU . 7.6 mt -78.32 102.66 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-O 120.904 0.383 . . . . 0.0 110.075 -178.789 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.647 ' CA ' HD12 ' A' ' 129' ' ' LEU . 56.9 m -144.73 128.43 17.21 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.168 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.767 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -97.44 157.81 15.8 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.941 0.877 . . . . 0.0 112.956 -179.24 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -99.45 74.87 1.93 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 113.994 -1.457 . . . . 0.0 107.779 177.457 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.52 -53.22 4.66 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.137 179.38 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.541 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -149.07 -13.57 0.31 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 120.951 0.405 . . . . 0.0 110.147 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -85.86 92.92 8.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.604 179.067 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.013 HD12 HD11 ' A' ' 129' ' ' LEU . 9.5 tp -62.91 114.81 3.88 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.713 -179.786 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' A' ' 35' ' ' SER . 43.7 ttp180 -119.62 133.94 55.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.612 -178.265 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.628 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -152.78 148.13 26.86 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.402 179.791 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.51 ' O ' ' HD1' ' A' ' 32' ' ' TYR . 1.8 mm-40 -83.82 79.73 9.38 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.814 179.148 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.668 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 67.2 m -61.45 121.68 13.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.013 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.568 ' HB2' ' O ' ' A' ' 10' ' ' SER . 36.4 ttt-85 -70.64 122.21 19.34 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.273 178.532 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.7 ttt-85 -93.53 154.59 17.8 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.272 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.03 -15.0 6.23 Favored Glycine 0 C--N 1.335 0.509 0 O-C-N 124.36 1.037 . . . . 0.0 114.164 -178.251 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -79.27 -3.48 46.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.198 0.523 . . . . 0.0 109.788 178.848 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.46 9.51 72.32 Favored Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.97 144.31 17.31 Favored Glycine 0 C--O 1.227 -0.343 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.998 -179.067 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.51 ' HD1' ' O ' ' A' ' 24' ' ' GLU . 74.3 m-85 -90.46 125.69 35.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.788 0.328 . . . . 0.0 110.277 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.7 m -115.75 130.5 56.87 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.638 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.7 m -65.63 124.32 22.06 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.8 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 42.5 t -129.31 147.07 51.11 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.139 179.331 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.59 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 7.7 p -144.66 137.8 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.705 0.288 . . . . 0.0 110.967 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.534 HG22 HD23 ' A' ' 164' ' ' LEU . 8.5 tt -135.32 147.42 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.605 -178.357 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -76.38 99.77 4.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.723 0.297 . . . . 0.0 111.338 179.277 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.822 HD12 ' HG ' ' A' ' 43' ' ' LEU . 1.2 mm? -82.83 -4.41 58.02 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.102 0.477 . . . . 0.0 111.089 179.887 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.541 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 7.0 p30 -69.87 -10.68 59.39 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.369 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.9 mtt85 -102.54 6.06 39.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.829 179.17 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.494 ' HB2' HD13 ' A' ' 39' ' ' LEU . 7.1 m-85 -134.18 -24.75 1.61 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.569 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.822 ' HG ' HD12 ' A' ' 39' ' ' LEU . 61.7 mt -105.83 128.74 53.93 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.752 0.31 . . . . 0.0 110.522 179.433 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.66 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 1.0 OUTLIER -125.1 135.95 53.18 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.487 -179.845 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.841 ' HB3' ' HG ' ' A' ' 140' ' ' LEU . 18.8 p-10 -79.26 92.45 5.12 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.359 0.6 . . . . 0.0 110.033 178.336 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -86.82 86.85 7.35 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.307 0.575 . . . . 0.0 110.333 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.486 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 64.5 t30 50.22 44.62 26.24 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.253 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.71 34.82 10.87 Favored Glycine 0 C--O 1.221 -0.657 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.725 178.368 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -150.68 131.56 14.19 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.429 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.724 ' HB3' ' HB ' ' A' ' 151' ' ' ILE . 21.3 m-85 -72.21 140.0 48.47 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.559 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.426 ' HD3' ' HA ' ' A' ' 51' ' ' ARG . 10.5 mmt180 -143.88 134.15 24.47 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.087 -179.448 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.626 ' HH2' HD13 ' A' ' 153' ' ' LEU . 96.5 m95 . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.258 177.53 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 37.7 m . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 121.193 0.521 . . . . 0.0 111.671 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.64 176.62 8.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.009 179.085 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.514 HG22 ' HG2' ' A' ' 106' ' ' GLN . 7.8 p -129.59 122.16 28.55 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.208 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.545 HG21 ' CE2' ' A' ' 80' ' ' PHE . 8.2 p -113.02 147.44 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 120.751 0.31 . . . . 0.0 111.072 179.26 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 4.9 m -90.52 129.95 36.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.099 0.476 . . . . 0.0 110.284 179.101 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.483 ' CG2' HD12 ' A' ' 99' ' ' ILE . 54.0 t -78.78 133.48 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.485 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -104.17 169.34 8.55 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.333 1.021 . . . . 0.0 110.486 -179.496 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.629 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 63.4 tt0 -68.13 120.16 13.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.292 -178.945 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.33 9.36 55.5 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.856 179.332 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -116.88 128.35 55.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.964 0.412 . . . . 0.0 111.494 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.584 ' HA ' HG12 ' A' ' 99' ' ' ILE . 67.8 p -106.68 -179.2 3.87 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.329 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.64 HD22 HG23 ' A' ' 99' ' ' ILE . 1.4 mm? -52.21 -43.1 64.07 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.823 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.406 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 3.4 tmt_? -59.38 -41.64 89.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.366 -179.292 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -73.12 -38.2 66.4 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.595 -178.345 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.532 HG12 ' O ' ' A' ' 72' ' ' THR . 45.8 mm -63.83 -48.89 84.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.542 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.741 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -59.23 -47.24 91.8 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.391 179.206 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -25.49 64.78 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.796 0.332 . . . . 0.0 111.838 -178.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 48.9 ttm-85 -82.51 -34.51 27.92 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.116 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.545 ' CE2' HG21 ' A' ' 65' ' ' VAL . 95.0 m-85 -110.83 20.26 17.74 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.321 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.9 t70 55.06 42.1 31.18 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.62 0.724 . . . . 0.0 111.711 178.472 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.741 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -125.26 170.98 10.75 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.348 179.255 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.574 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.4 t70 -98.39 123.15 42.35 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.87 179.366 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.52 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 5.9 p90 -50.97 -30.37 14.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.99 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -67.24 -43.73 81.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.229 179.525 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.688 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 26.3 mt-10 -64.9 -48.27 74.8 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.355 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.574 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.1 mt -49.59 -50.21 17.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.458 179.196 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.604 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.63 -50.74 68.15 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.295 178.681 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -56.56 -37.63 70.8 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.688 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 75.3 mtt180 -73.91 -29.48 62.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.841 0.353 . . . . 0.0 111.03 -179.407 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 15.1 t-20 -93.19 -5.16 50.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.031 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 93.4 m-20 79.23 12.46 1.27 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.586 0.754 . . . . 0.0 111.497 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.604 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 14.8 pt -102.8 179.43 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.445 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.565 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 2.6 mp0 -105.96 155.94 18.87 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.667 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.468 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.3 p-10 -56.82 -56.09 26.07 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.226 1.012 . . . . 0.0 108.82 179.21 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -77.95 12.03 1.96 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.438 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.565 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.9 t70 -65.34 -34.9 79.41 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.469 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.413 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 8.2 mp 70.78 115.3 0.05 OUTLIER 'General case' 0 C--O 1.233 0.215 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.107 -178.117 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.778 HG21 HD11 ' A' ' 105' ' ' LEU . 7.5 pt -95.29 178.66 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.538 -178.526 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.554 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 61.8 m-85 -130.53 158.34 74.89 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.478 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.629 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 22.9 Cg_endo -64.95 139.21 60.73 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 123.323 2.682 . . . . 0.0 114.402 -178.414 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.39 20.22 33.07 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.014 178.085 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.552 ' O ' ' HA ' ' A' ' 66' ' ' THR . 28.4 mt-30 -109.59 168.21 9.57 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.413 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 77.8 t -126.36 112.06 28.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.047 0.451 . . . . 0.0 110.042 179.1 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.778 HD11 HG21 ' A' ' 99' ' ' ILE . 87.2 mt -107.23 151.42 25.46 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.581 -179.645 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.514 ' HG2' HG22 ' A' ' 64' ' ' THR . 37.4 mt-30 -91.06 112.38 24.26 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.741 0.781 . . . . 0.0 111.387 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.7 m -115.78 152.0 46.92 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.459 179.701 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.37 -21.94 60.43 Favored 'Trans proline' 0 C--N 1.332 -0.315 0 C-N-CA 122.909 2.406 . . . . 0.0 114.409 -177.981 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.9 t . . . . . 0 C--N 1.323 -0.57 0 CA-C-O 120.86 0.362 . . . . 0.0 110.987 -179.755 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.66 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.441 -1.03 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 20.9 m120 70.7 27.03 3.75 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 122.998 0.519 . . . . 0.0 112.118 178.595 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.623 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 17.2 p90 -60.07 -39.47 86.17 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.658 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.55 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 38.9 t-105 -61.75 -29.88 70.42 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.208 -178.267 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -55.96 -28.31 56.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.665 0.269 . . . . 0.0 110.803 -179.746 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.7 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 3.9 m -135.25 28.74 3.39 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.855 0.36 . . . . 0.0 110.48 178.497 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.55 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -110.61 144.34 39.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.766 0.317 . . . . 0.0 110.706 178.873 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -136.64 149.72 48.13 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.137 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 59.34 45.23 14.2 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.693 0.62 . . . . 0.0 111.139 179.343 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.475 ' CG1' HD11 ' A' ' 136' ' ' LEU . 21.4 t -74.84 121.37 26.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.194 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -145.17 140.65 28.1 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.036 -179.375 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 1.08 HD13 HG22 ' A' ' 14' ' ' ILE . 54.1 mt -86.76 127.11 34.98 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.038 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.535 HG23 ' HB ' ' A' ' 135' ' ' VAL . 34.6 m -119.95 163.17 17.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.854 -178.701 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 66.27 9.23 6.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.474 178.654 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.687 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 94.69 31.83 7.59 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.116 179.487 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.706 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 86.8 -13.92 57.7 Favored Glycine 0 C--O 1.256 1.521 0 CA-C-O 123.274 1.485 . . . . 0.0 112.812 177.548 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.607 ' HG3' HG23 ' A' ' 135' ' ' VAL . 19.0 ptpt -72.86 -14.22 61.45 Favored 'General case' 0 C--N 1.311 -1.098 0 O-C-N 121.592 -0.946 . . . . 0.0 108.76 178.155 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.607 HG23 ' HG3' ' A' ' 134' ' ' LYS . 22.7 t -141.68 138.73 31.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.638 177.478 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.58 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 27.8 tp -119.99 125.39 48.26 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.527 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.527 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 28.3 tt0 -114.98 132.52 56.56 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 123.504 0.503 . . . . 0.0 110.948 -177.869 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . . . -161.39 158.52 26.96 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.247 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 30.5 mt-10 -94.88 106.82 18.83 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.773 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.841 ' HG ' ' HB3' ' A' ' 45' ' ' ASN . 0.4 OUTLIER -89.54 123.37 33.57 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.435 -179.877 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.7 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 36.6 ttt180 -69.29 140.81 54.42 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.606 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 2.5 p90 -155.53 -170.39 3.43 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.429 -179.008 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 3.1 m -56.96 -27.94 61.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.106 0.479 . . . . 0.0 112.0 -179.36 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.29 17.2 58.21 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.598 -0.811 . . . . 0.0 113.19 -179.312 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 103.41 -107.9 3.13 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.031 179.768 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -129.6 127.69 41.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.785 0.292 . . . . 0.0 110.639 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.606 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 52.0 t-20 -120.88 117.18 26.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.76 0.314 . . . . 0.0 110.534 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 31.6 ttm180 -74.99 94.74 2.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.886 178.916 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.3 m -111.54 174.02 6.07 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.403 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.58 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 44.6 mtt85 -142.37 165.68 26.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.058 0.456 . . . . 0.0 112.003 -177.611 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.724 ' HB ' ' HB3' ' A' ' 50' ' ' PHE . 14.3 tt -145.44 161.98 12.38 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.372 179.169 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.599 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 12.1 m-85 -104.43 104.27 14.12 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 122.144 -0.347 . . . . 0.0 111.72 -178.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.708 HD11 ' HG ' ' A' ' 39' ' ' LEU . 4.1 mm? -65.65 -36.43 83.67 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.328 179.071 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.472 ' HB3' ' HA ' ' A' ' 134' ' ' LYS . 6.0 p-10 -57.34 -11.96 2.17 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.18 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.986 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 36.1 mt-10 -67.76 -54.89 15.65 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -121.33 3.6 10.29 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.041 -0.664 . . . . 0.0 112.467 -177.37 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.639 HG13 HD12 ' A' ' 153' ' ' LEU . 45.9 mm -104.26 114.16 43.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 C-N-CA 120.181 -0.607 . . . . 0.0 110.585 179.023 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.407 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -115.14 175.79 16.21 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.928 -0.654 . . . . 0.0 113.159 179.52 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.668 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.0 t30 -117.4 129.05 55.6 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.5 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.671 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 40.8 ttm180 -124.67 88.32 2.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.712 179.674 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 51.95 46.15 27.07 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 178.636 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.9 -8.98 50.94 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.285 -0.96 . . . . 0.0 115.019 177.404 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.671 ' HG2' ' O ' ' A' ' 160' ' ' ARG . 12.9 pt-20 -114.18 146.6 40.13 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 117.901 0.851 . . . . 0.0 110.634 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.732 HD11 ' HD2' ' A' ' 7' ' ' PHE . 4.6 tp -91.15 106.92 18.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.675 -179.578 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.562 HD13 ' HB2' ' A' ' 160' ' ' ARG . 31.7 pt . . . . . 0 C--N 1.322 -0.6 0 CA-C-O 121.366 0.603 . . . . 0.0 112.149 -178.474 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 1.012 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 35.3 m-85 . . . . . 0 CA--C 1.52 -0.202 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -121.87 -31.32 3.96 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.021 178.888 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -78.55 -66.44 1.73 Allowed Glycine 0 N--CA 1.436 -1.352 0 C-N-CA 119.525 -1.322 . . . . 0.0 112.046 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 65.96 15.26 10.0 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.605 0.362 . . . . 0.0 111.018 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.741 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -58.31 -37.27 74.75 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -178.972 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.4 ' HA ' HD11 ' A' ' 14' ' ' ILE . 28.8 t -60.04 -18.25 45.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.379 0.609 . . . . 0.0 110.816 -179.649 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.52 -33.32 61.13 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.578 179.008 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.521 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 20.2 m -120.9 -17.98 7.72 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 117.683 0.741 . . . . 0.0 111.32 -179.461 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.415 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 15.6 m -97.99 131.46 44.4 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -114.19 -175.64 2.72 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.425 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 0.9 OUTLIER 46.03 42.37 9.43 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 123.76 0.663 . . . . 0.0 111.87 179.284 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.906 HG22 HD13 ' A' ' 129' ' ' LEU . 7.5 mt -78.82 105.48 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-O 121.18 0.514 . . . . 0.0 110.063 -178.868 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.57 ' CA ' HD12 ' A' ' 129' ' ' LEU . 65.3 m -147.72 128.6 14.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.887 179.433 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.761 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -97.97 159.87 14.66 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -178.711 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.431 ' HB2' ' HB2' ' A' ' 20' ' ' ARG . 24.1 m-20 -99.1 73.77 1.94 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.129 177.113 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.86 -59.46 4.72 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.742 179.645 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.649 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -147.8 10.96 0.95 Allowed 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.273 0.558 . . . . 0.0 110.274 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.431 ' HB2' ' HB2' ' A' ' 17' ' ' ASP . 72.1 mtm180 -110.05 91.24 3.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.86 179.428 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.97 ' HB2' HD22 ' A' ' 39' ' ' LEU . 44.3 tp -60.47 122.47 14.69 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.636 -178.646 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 48.7 ttp180 -127.51 132.17 49.98 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.345 -178.888 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.629 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -149.83 145.25 26.48 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.511 0.672 . . . . 0.0 110.74 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.528 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 3.8 mm-40 -80.54 68.51 6.77 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.671 178.283 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.7 ' SG ' HD13 ' A' ' 164' ' ' LEU . 57.5 m -57.28 124.47 18.95 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.018 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.521 ' HB2' ' O ' ' A' ' 10' ' ' SER . 42.6 ttt-85 -65.75 126.36 28.19 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.414 179.241 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 33.9 ptt180 -98.48 155.29 17.33 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.063 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.93 -11.95 4.89 Favored Glycine 0 C--N 1.338 0.689 0 O-C-N 124.513 1.133 . . . . 0.0 113.919 -179.024 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.01 -11.65 60.86 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.048 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.35 8.27 60.04 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.857 179.531 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.435 ' O ' ' HG2' ' A' ' 27' ' ' ARG . . . -123.7 178.07 16.5 Favored Glycine 0 C--O 1.225 -0.432 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.392 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.528 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 83.2 m-85 -101.58 140.99 35.11 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.912 0.387 . . . . 0.0 111.168 179.573 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 p -128.93 133.97 48.05 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.904 179.231 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 m -71.32 111.07 6.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.094 0.473 . . . . 0.0 111.608 -178.383 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 36.4 t -116.27 147.57 41.37 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.948 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 5.4 p -143.14 137.55 26.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 120.867 0.365 . . . . 0.0 111.152 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.6 tt -132.66 154.32 39.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.012 -177.511 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -81.15 95.12 6.79 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.97 HD22 ' HB2' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -76.1 -14.23 60.19 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.697 0.76 . . . . 0.0 109.461 178.355 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.649 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 5.2 p30 -66.62 -15.96 63.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.803 178.377 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -114.24 31.03 6.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.1 179.071 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.428 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 24.4 m-85 -150.45 -30.97 0.2 Allowed 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.208 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.902 HD22 HD13 ' A' ' 151' ' ' ILE . 41.7 mt -105.94 127.5 53.19 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.775 0.321 . . . . 0.0 110.495 179.273 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.657 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 1.0 OUTLIER -123.91 137.78 54.58 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.452 179.984 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.813 ' HB3' ' HG ' ' A' ' 140' ' ' LEU . 19.4 p-10 -78.34 92.21 4.52 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.484 0.659 . . . . 0.0 110.831 178.59 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -87.5 86.71 7.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.072 0.463 . . . . 0.0 110.725 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 52.03 43.66 30.19 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.312 179.24 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.55 40.04 9.27 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.995 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -157.81 118.98 3.54 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.746 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.804 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 29.7 m-85 -62.44 140.88 58.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.28 -179.358 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.425 ' HD2' ' O ' ' A' ' 50' ' ' PHE . 16.3 mmm180 -140.41 139.03 35.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.235 179.508 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.653 ' CZ2' ' HA ' ' A' ' 153' ' ' LEU . 86.2 m95 . . . . . 0 C--N 1.325 -0.471 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.449 -0.523 0 CA-C-O 121.176 0.512 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -121.98 176.58 5.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.431 179.525 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.2 p -126.81 120.8 30.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.028 0.442 . . . . 0.0 112.151 -179.093 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.9 p -110.18 144.85 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.006 178.854 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 5.7 m -89.19 127.27 35.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.079 179.044 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.548 ' CG2' HD12 ' A' ' 99' ' ' ILE . 60.5 t -73.38 131.66 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.55 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -101.0 170.08 8.52 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 124.485 1.115 . . . . 0.0 111.136 -178.806 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.71 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 57.7 tp60 -58.76 118.56 5.84 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.682 -178.896 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.81 -5.36 85.04 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 121.106 -0.568 . . . . 0.0 113.705 177.836 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -90.36 127.56 36.22 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 117.084 0.442 . . . . 0.0 111.056 -179.662 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.69 ' HA ' HG12 ' A' ' 99' ' ' ILE . 68.9 p -107.93 -179.33 3.87 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.728 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.68 HD22 HG23 ' A' ' 99' ' ' ILE . 1.2 mm? -53.02 -42.73 65.96 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.538 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 74' ' ' ARG . 42.2 ttm180 -62.43 -35.33 78.93 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.145 -178.955 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -74.06 -46.7 41.47 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.585 179.626 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.528 HG12 ' O ' ' A' ' 72' ' ' THR . 43.8 mm -58.31 -48.4 85.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.209 -179.649 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.692 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -58.64 -55.55 30.17 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.112 179.464 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -33.95 75.98 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.047 0.451 . . . . 0.0 111.114 -178.983 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -73.5 -40.41 64.09 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.935 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -106.57 15.17 26.14 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -178.403 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.0 t70 60.33 49.89 6.64 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.589 0.709 . . . . 0.0 111.826 178.925 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.692 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.5 p -134.55 165.59 24.85 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.786 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.512 ' O ' HG13 ' A' ' 87' ' ' ILE . 3.9 p-10 -95.24 121.43 36.87 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.775 0.797 . . . . 0.0 109.689 178.67 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.561 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 5.9 p90 -48.11 -31.36 5.48 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.174 -1.375 . . . . 0.0 112.115 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.44 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 76.3 t60 -60.23 -50.28 74.27 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.963 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.497 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 7.9 tp10 -65.39 -45.65 83.18 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.107 179.712 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.567 ' HB ' HD12 ' A' ' 73' ' ' LEU . 4.3 mt -51.4 -46.16 34.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.725 0.774 . . . . 0.0 109.51 179.446 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.572 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.98 -50.75 69.54 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.719 178.611 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.421 HH21 ' CD ' ' A' ' 86' ' ' GLU . 52.2 ttp180 -59.2 -37.15 76.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.758 0.313 . . . . 0.0 111.794 -179.381 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.683 ' HB3' ' HB2' ' A' ' 106' ' ' GLN . 2.0 mmp_? -65.11 -32.32 73.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.928 0.394 . . . . 0.0 110.903 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 8.4 t-20 -96.09 -5.03 41.8 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.959 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 17.3 m120 77.36 18.3 1.4 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.355 0.662 . . . . 0.0 111.029 -179.228 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.572 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 10.6 pt -105.84 179.53 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.827 178.913 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.552 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 77.6 mm-40 -102.93 154.55 19.1 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.938 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.505 ' O ' HD23 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -55.7 -61.5 2.31 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-O 122.259 1.028 . . . . 0.0 109.696 179.036 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -78.49 12.48 1.98 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.582 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.552 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 4.3 t0 -61.89 -32.43 72.8 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.127 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.491 HD22 HG21 ' A' ' 72' ' ' THR . 41.2 mt 71.78 114.38 0.05 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.176 -178.899 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.69 HG12 ' HA ' ' A' ' 72' ' ' THR . 8.2 pt -95.2 175.54 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.354 -179.152 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.497 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 40.4 m-85 -124.71 157.44 65.88 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.21 -178.978 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.71 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 40.7 Cg_endo -67.85 138.71 45.42 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 123.122 2.548 . . . . 0.0 113.456 -178.526 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.76 13.59 43.24 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.374 179.159 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.516 ' O ' ' HA ' ' A' ' 66' ' ' THR . 44.1 mt-30 -100.44 168.69 9.59 Favored 'General case' 0 C--O 1.217 -0.658 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.297 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 89.5 t -128.53 109.16 18.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.7 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.657 HD11 HG21 ' A' ' 99' ' ' ILE . 82.0 mt -107.15 151.56 25.23 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.019 -178.827 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.683 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 39.6 mt-30 -89.89 116.44 27.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.598 0.713 . . . . 0.0 110.859 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.0 m -121.98 150.74 56.88 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 114.37 -1.287 . . . . 0.0 109.544 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.99 -18.4 62.05 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 123.352 2.701 . . . . 0.0 114.29 -177.699 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 C--N 1.325 -0.48 0 CA-C-O 121.255 0.55 . . . . 0.0 111.139 -179.656 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.657 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.445 -0.711 0 N-CA-C 112.211 -0.355 . . . . 0.0 112.211 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.3 m120 70.9 21.13 5.16 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 178.741 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.626 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 21.6 p90 -58.02 -37.5 74.44 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.045 0.45 . . . . 0.0 109.941 178.883 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.511 ' HB2' ' HB2' ' A' ' 19' ' ' ALA . 58.3 t-105 -59.93 -32.21 70.57 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.144 -178.495 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.9 -28.31 56.14 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.946 0.403 . . . . 0.0 110.392 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.951 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 69.7 m -133.26 30.12 3.93 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.921 179.135 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.491 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -115.88 136.48 53.0 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.981 0.42 . . . . 0.0 111.731 178.845 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -129.32 151.35 50.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.963 178.877 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 40.8 t0 56.22 51.36 11.83 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.742 0.782 . . . . 0.0 110.575 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.483 HG22 ' HB1' ' A' ' 138' ' ' ALA . 21.9 t -83.98 127.15 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.588 -179.644 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 25.0 ptt-85 -154.38 146.88 24.04 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.95 0.405 . . . . 0.0 110.358 179.164 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.906 HD13 HG22 ' A' ' 14' ' ' ILE . 19.5 mt -86.17 130.67 34.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.83 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.717 HG23 ' HB ' ' A' ' 135' ' ' VAL . 28.0 m -123.88 156.95 30.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.003 -178.998 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.482 ' HB3' ' CG ' ' A' ' 134' ' ' LYS . 0.7 OUTLIER 65.65 16.87 10.7 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.043 179.145 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.698 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 88.31 30.79 15.43 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.625 178.119 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.521 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 89.75 -14.44 61.63 Favored Glycine 0 C--O 1.26 1.735 0 CA-C-O 123.442 1.579 . . . . 0.0 113.031 177.112 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.786 ' HG3' HG23 ' A' ' 135' ' ' VAL . 21.5 ptmt -69.85 -17.35 63.37 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 121.334 -1.098 . . . . 0.0 108.384 178.396 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.786 HG23 ' HG3' ' A' ' 134' ' ' LYS . 3.9 t -140.17 144.72 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.083 177.79 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 28.3 tp -126.14 121.91 34.2 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.749 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.497 ' HG3' ' HG3' ' A' ' 150' ' ' ARG . 30.9 tt0 -112.58 133.34 54.68 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.883 0.373 . . . . 0.0 111.285 -177.88 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.537 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -161.86 163.8 29.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.62 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 124' ' ' ALA . 46.7 mt-10 -96.33 105.79 17.92 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 178.739 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.813 ' HG ' ' HB3' ' A' ' 45' ' ' ASN . 1.6 mp -89.85 125.2 35.24 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.927 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.951 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 74.7 ttt180 -70.87 140.86 51.21 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.047 178.669 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -155.59 -175.84 5.64 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.186 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 6.0 m -56.89 -31.46 64.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.759 0.314 . . . . 0.0 111.485 -179.256 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -88.33 7.65 81.0 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.766 -179.032 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 109.7 -121.83 6.2 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.127 179.733 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -122.86 125.1 44.74 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.629 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -123.3 140.39 53.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.874 0.368 . . . . 0.0 111.549 -179.092 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -72.55 102.37 3.23 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.824 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.473 ' HB2' HD22 ' A' ' 140' ' ' LEU . 1.4 m -113.07 156.34 23.3 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.351 -178.052 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -145.53 153.85 41.55 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.961 0.41 . . . . 0.0 111.065 179.84 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.902 HD13 HD22 ' A' ' 43' ' ' LEU . 9.4 tt -136.24 152.06 29.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.971 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.606 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 92.4 m-85 -97.11 104.49 16.51 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.419 0.152 . . . . 0.0 110.701 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.762 HD11 HD21 ' A' ' 129' ' ' LEU . 22.5 mt -68.74 -33.46 73.95 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.331 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.534 ' HB3' ' HA ' ' A' ' 134' ' ' LYS . 10.2 p-10 -56.84 -13.19 2.38 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.713 178.119 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 1.012 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 37.8 mt-10 -70.0 -55.42 9.62 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -122.98 11.32 9.56 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.72 -0.792 . . . . 0.0 113.048 -176.232 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.54 HG12 ' CH2' ' A' ' 52' ' ' TRP . 38.0 mm -112.94 111.94 38.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.421 178.196 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.433 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -115.05 175.62 16.11 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.191 179.093 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.545 ' CG ' ' HB3' ' A' ' 25' ' ' CYS . 3.3 t30 -115.11 129.51 56.7 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 122.651 0.38 . . . . 0.0 110.278 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 41.0 ttt85 -125.94 97.75 5.24 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.258 179.434 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 61.83 32.39 18.09 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.149 179.24 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 93.68 12.31 57.03 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.495 -0.86 . . . . 0.0 113.093 179.287 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -122.48 134.21 54.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.069 0.462 . . . . 0.0 110.814 179.628 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.741 HD11 ' CD2' ' A' ' 7' ' ' PHE . 4.4 tp -78.24 118.73 20.74 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.983 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 10.3 tp . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.356 -178.988 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.466 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 34.0 m-85 . . . . . 0 N--CA 1.458 -0.053 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -96.07 -31.11 13.19 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.065 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.56 -74.62 0.48 Allowed Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 119.879 -1.153 . . . . 0.0 113.227 -179.071 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 64.69 16.67 10.51 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 122.488 0.315 . . . . 0.0 110.25 -179.286 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.904 ' HD2' HD11 ' A' ' 164' ' ' LEU . 0.2 OUTLIER -61.14 -34.79 75.57 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.679 -179.316 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.433 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.7 OUTLIER -64.76 -17.51 64.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.331 0.586 . . . . 0.0 110.246 -179.262 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.15 -37.18 92.78 Favored Glycine 0 CA--C 1.523 0.544 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.647 178.882 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.498 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 30.9 m -118.06 -27.64 6.07 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 120.985 0.421 . . . . 0.0 111.404 -179.419 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 5.8 t -88.94 128.9 35.7 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 12' ' ' ARG . 11.3 ptm85 -114.41 -177.05 3.04 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.74 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.425 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 3.8 m-20 46.09 43.18 10.56 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 123.759 0.662 . . . . 0.0 111.675 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.924 HG22 HD13 ' A' ' 129' ' ' LEU . 6.1 mt -78.44 103.61 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.261 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.576 ' CA ' HD12 ' A' ' 129' ' ' LEU . 58.4 m -143.34 127.77 17.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.612 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.804 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -101.14 156.61 17.32 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.892 0.853 . . . . 0.0 113.15 -179.725 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 22.3 t70 -98.71 74.58 2.09 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 113.914 -1.494 . . . . 0.0 107.468 177.236 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.5 -54.53 4.6 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.622 179.859 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.75 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -147.05 -13.04 0.42 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 120.954 0.406 . . . . 0.0 110.294 179.55 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.415 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 0.4 OUTLIER -82.99 86.81 6.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.444 179.14 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.804 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 45.2 tp -62.47 119.78 9.82 Favored 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 122.949 0.499 . . . . 0.0 112.158 -179.691 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 15.9 ttp180 -124.31 135.87 53.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.358 -178.585 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.657 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -155.42 140.36 17.27 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.498 0.666 . . . . 0.0 111.374 179.714 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.572 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 3.5 mm-40 -77.94 82.23 4.31 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.901 178.198 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.635 ' SG ' HD13 ' A' ' 164' ' ' LEU . 34.5 m -69.85 120.58 15.8 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.886 -178.04 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 10' ' ' SER . 50.6 ttp85 -72.42 114.9 11.04 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.76 178.971 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.405 ' HB3' ' C ' ' A' ' 161' ' ' ASN . 2.9 ptp180 -92.1 160.6 15.13 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.233 179.242 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.75 -14.0 4.87 Favored Glycine 0 C--N 1.335 0.485 0 O-C-N 124.806 1.316 . . . . 0.0 113.902 -178.21 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -71.82 -12.47 61.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.789 0.804 . . . . 0.0 109.646 178.519 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.79 10.36 58.97 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.005 179.591 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -122.37 167.05 14.85 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 119.872 -1.156 . . . . 0.0 113.762 -179.011 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.572 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 78.1 m-85 -99.4 126.82 45.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.686 0.279 . . . . 0.0 110.516 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.5 t -113.71 126.18 54.94 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.398 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.7 m -66.59 114.36 5.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.092 0.472 . . . . 0.0 110.746 -179.291 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 36.2 t -119.04 148.85 42.56 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.405 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.9 p -145.3 138.47 21.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.693 0.282 . . . . 0.0 110.601 179.395 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.2 tt -135.32 153.52 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.627 -178.197 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.74 92.56 6.06 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.392 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.738 HD21 HD22 ' A' ' 153' ' ' LEU . 6.8 tp -78.6 -9.59 59.42 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.686 -177.46 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.75 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 28.4 p-10 -70.64 -12.99 61.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.497 0.665 . . . . 0.0 109.73 179.373 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.457 HH11 ' HD3' ' A' ' 41' ' ' ARG . 40.3 mtt180 -100.09 7.49 44.61 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.192 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 52.3 m-85 -129.44 -27.17 2.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.16 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.731 HD22 HD13 ' A' ' 151' ' ' ILE . 35.3 mt -107.25 140.16 40.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.069 0.461 . . . . 0.0 110.899 179.556 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 50' ' ' PHE . 5.4 m -127.17 149.09 50.13 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.915 -179.869 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.584 HD22 ' C ' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -91.67 94.41 9.37 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.255 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -103.41 92.15 4.36 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.12 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.433 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 64.3 t30 46.95 44.61 14.88 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 114.749 -1.114 . . . . 0.0 112.324 178.846 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.24 42.74 7.82 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.957 178.898 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.415 ' HA ' ' HB3' ' A' ' 149' ' ' SER . 62.2 t-80 -167.43 123.62 1.12 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.978 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.751 ' HZ ' ' HB3' ' A' ' 138' ' ' ALA . 62.0 m-85 -62.6 154.6 28.5 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.787 0.327 . . . . 0.0 110.602 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -148.11 133.79 18.86 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.974 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.473 ' CZ2' ' HA ' ' A' ' 153' ' ' LEU . 93.9 m95 . . . . . 0 C--N 1.315 -0.892 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.846 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.448 -0.533 0 CA-C-O 121.052 0.453 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -125.2 174.14 8.29 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.718 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.466 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 1.2 p -129.83 114.25 15.68 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.782 0.325 . . . . 0.0 111.567 -179.07 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.485 HG21 ' CE2' ' A' ' 80' ' ' PHE . 11.5 p -99.81 135.07 36.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.936 0.398 . . . . 0.0 110.988 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.5 m -88.7 121.84 31.5 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.623 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.607 HG21 HD12 ' A' ' 99' ' ' ILE . 46.2 t -72.6 130.54 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.373 -179.428 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -100.85 169.15 9.18 Favored 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 124.149 0.906 . . . . 0.0 110.661 179.362 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.728 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 29.9 tt0 -60.21 108.69 0.83 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.524 -179.038 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.83 -10.97 20.93 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.296 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.556 ' HB3' HD11 ' A' ' 76' ' ' ILE . 68.3 m-20 -85.66 148.5 25.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.176 0.512 . . . . 0.0 111.79 -179.146 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.543 ' O ' HG12 ' A' ' 76' ' ' ILE . 23.4 p -133.93 158.48 43.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.434 178.795 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.69 HD23 ' HA ' ' A' ' 95' ' ' ASN . 1.8 tp -48.56 -45.27 37.49 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.039 0.447 . . . . 0.0 111.289 -179.651 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.544 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 43.7 ttp180 -60.13 -40.82 91.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.308 -179.628 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -74.31 -40.63 62.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.367 -178.826 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.556 HD11 ' HB3' ' A' ' 71' ' ' ASP . 47.6 mm -60.21 -46.47 94.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.159 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.713 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -55.44 -58.83 12.03 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.421 178.893 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -59.9 -33.18 71.51 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.675 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -66.55 -48.85 68.36 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.559 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.485 ' CE2' HG21 ' A' ' 65' ' ' VAL . 96.2 m-85 -97.52 13.23 30.67 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.196 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.7 t70 60.33 36.69 20.52 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.132 0.968 . . . . 0.0 110.711 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.713 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.1 p -114.54 171.79 7.42 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.548 179.229 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.714 ' O ' HG13 ' A' ' 87' ' ' ILE . 5.9 t0 -99.66 125.33 45.48 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 121.78 -0.575 . . . . 0.0 109.888 -179.702 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.544 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 31.9 p90 -54.3 -29.52 47.84 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.663 0.744 . . . . 0.0 109.938 178.64 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.536 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 22.3 t-80 -69.77 -41.37 75.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.544 178.6 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.699 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 36.8 tt0 -69.16 -48.9 61.03 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.638 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.714 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.2 mt -51.87 -43.31 34.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.678 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.564 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.61 -51.58 66.74 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.452 178.556 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.536 ' HG3' ' O ' ' A' ' 85' ' ' HIS . 41.2 mtm180 -61.62 -33.4 73.85 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.883 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.699 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 47.0 mmm-85 -73.36 -35.09 65.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.922 0.392 . . . . 0.0 110.896 -179.497 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.517 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 3.0 t-20 -88.11 -5.15 58.61 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.812 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.517 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 91.0 m-20 79.43 10.68 1.44 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.53 0.732 . . . . 0.0 111.085 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.564 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 21.9 pt -100.84 -174.01 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.783 179.25 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.611 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 66.2 mm-40 -110.54 162.34 14.8 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.087 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.69 ' HA ' HD23 ' A' ' 73' ' ' LEU . 1.4 p30 -55.5 -69.9 0.12 Allowed 'General case' 0 C--O 1.244 0.804 0 CA-C-O 122.336 1.065 . . . . 0.0 109.977 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -72.86 12.8 0.46 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.656 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.611 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.8 t70 -57.36 -33.21 67.55 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.389 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 55.4 mt 71.8 115.14 0.05 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-N 114.286 -1.324 . . . . 0.0 109.89 -178.621 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.607 HD12 HG21 ' A' ' 67' ' ' VAL . 17.1 pt -94.07 174.35 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.043 -178.64 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.456 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 17.3 m-85 -129.08 158.58 72.39 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.696 -178.603 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.728 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 25.5 Cg_endo -67.11 131.41 25.17 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.839 2.359 . . . . 0.0 112.438 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.33 15.12 36.26 Favored Glycine 0 N--CA 1.438 -1.177 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 -179.59 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -103.08 155.63 18.26 Favored 'General case' 0 C--O 1.214 -0.799 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.306 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.466 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 59.4 t -117.89 120.83 65.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 O-C-N 121.993 -0.442 . . . . 0.0 109.815 179.368 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.429 ' HB3' ' CG2' ' A' ' 87' ' ' ILE . 77.9 mt -112.07 150.84 30.12 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.397 -178.827 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.423 ' HB2' ' CB ' ' A' ' 90' ' ' ARG . 74.1 mt-30 -90.9 112.84 24.86 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.729 0.776 . . . . 0.0 110.781 179.065 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.41 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 34.0 m -126.45 151.08 72.18 Favored Pre-proline 0 C--N 1.313 -0.998 0 CA-C-N 114.214 -1.357 . . . . 0.0 109.019 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 107' ' ' VAL . 32.2 Cg_endo -63.2 -18.56 65.51 Favored 'Trans proline' 0 N--CA 1.473 0.321 0 C-N-CA 123.561 2.841 . . . . 0.0 115.259 -176.854 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.9 t . . . . . 0 C--N 1.323 -0.579 0 C-N-CA 120.374 -0.531 . . . . 0.0 111.48 -179.547 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.447 -0.573 0 N-CA-C 112.239 -0.345 . . . . 0.0 112.239 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 72.65 29.23 2.03 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.989 0.515 . . . . 0.0 111.327 178.337 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.655 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 22.7 p90 -59.48 -36.52 76.18 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 121.304 0.573 . . . . 0.0 109.963 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.443 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 24.0 t-105 -65.15 -24.6 67.45 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.113 -178.363 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.94 -14.06 60.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.856 0.36 . . . . 0.0 110.925 -179.746 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.428 ' HB2' ' HB3' ' A' ' 141' ' ' ARG . 9.7 p -144.65 22.32 1.63 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.926 179.011 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -104.48 151.53 23.45 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.782 0.325 . . . . 0.0 110.915 179.08 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 63.0 ttp180 -141.5 144.53 34.4 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.106 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 57.73 52.53 8.06 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.197 0.522 . . . . 0.0 111.123 179.578 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.504 ' CG1' HD11 ' A' ' 136' ' ' LEU . 21.3 t -81.65 119.12 30.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.526 -179.565 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -143.4 142.43 31.24 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.344 -179.85 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.924 HD13 HG22 ' A' ' 14' ' ' ILE . 27.3 mt -86.18 129.55 34.81 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.952 178.988 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.57 HG23 ' HB ' ' A' ' 135' ' ' VAL . 34.6 m -121.72 154.78 26.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.175 0.512 . . . . 0.0 111.046 -178.845 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.546 ' HB3' ' HD3' ' A' ' 134' ' ' LYS . 9.6 m-20 71.41 3.65 4.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.953 179.054 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.662 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 98.41 31.95 6.25 Favored Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.554 178.897 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.482 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 92.95 -19.73 50.14 Favored Glycine 0 C--O 1.263 1.91 0 CA-C-O 122.966 1.315 . . . . 0.0 113.272 177.545 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.756 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 18.6 ptmt -66.31 -18.97 65.67 Favored 'General case' 0 C--N 1.318 -0.795 0 O-C-N 121.634 -0.921 . . . . 0.0 108.991 178.104 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.57 ' HB ' HG23 ' A' ' 130' ' ' VAL . 11.7 t -140.24 141.58 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.688 177.667 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.635 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 22.7 tp -121.2 121.97 38.95 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.368 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.531 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 35.0 tt0 -111.02 132.97 53.77 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 120.858 0.361 . . . . 0.0 111.297 -177.336 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.751 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.55 155.24 19.44 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.678 179.153 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -94.05 106.84 18.8 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.793 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.549 HD13 ' HA ' ' A' ' 45' ' ' ASN . 59.8 mt -90.7 131.77 36.19 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.308 -178.864 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.428 ' HB3' ' HB2' ' A' ' 123' ' ' SER . 49.8 ttt85 -73.33 141.81 47.09 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.422 179.513 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.433 ' HB2' ' OD1' ' A' ' 47' ' ' ASN . 10.7 p90 -151.14 -165.08 2.16 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.72 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.4 m -70.52 2.44 3.99 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.684 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -135.88 31.73 2.6 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.675 -179.663 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 97.57 -134.62 11.81 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.766 179.436 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -117.03 124.95 50.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.569 0.223 . . . . 0.0 110.791 -179.655 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -115.0 131.55 56.89 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.106 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 31.2 ttm-85 -76.06 94.67 3.48 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.236 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.415 ' HB3' ' HA ' ' A' ' 49' ' ' HIS . 1.1 m -102.9 164.31 11.7 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.49 -178.725 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.635 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 39.1 mtt85 -145.5 149.42 34.62 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.008 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.731 HD13 HD22 ' A' ' 43' ' ' LEU . 9.3 tt -131.28 148.7 32.81 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.282 179.383 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.75 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 70.9 m-85 -92.54 102.53 14.98 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 122.277 -0.265 . . . . 0.0 111.293 -178.908 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.738 HD22 HD21 ' A' ' 39' ' ' LEU . 19.9 mt -67.49 -35.91 80.06 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.214 179.437 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.756 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 8.2 t70 -56.48 -10.1 0.87 Allowed 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.159 178.826 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.75 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 46.8 mt-10 -73.44 -48.67 31.84 Favored 'General case' 0 CA--C 1.509 -0.603 0 O-C-N 121.847 -0.533 . . . . 0.0 112.151 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -124.86 3.64 8.1 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.563 -177.6 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.4 HG12 ' CH2' ' A' ' 52' ' ' TRP . 45.6 mm -109.79 111.68 37.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.293 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.569 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -116.55 166.44 12.38 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.384 179.318 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.62 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -98.41 124.91 43.35 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.316 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 160' ' ' ARG . 22.0 ttt180 -112.69 86.63 2.4 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.029 -179.678 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.405 ' C ' ' HB3' ' A' ' 27' ' ' ARG . 56.9 t30 51.87 43.52 30.1 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.257 179.267 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.551 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 101.68 -3.79 53.34 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 119.985 -1.103 . . . . 0.0 114.063 178.659 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -122.38 128.67 51.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 117.062 0.431 . . . . 0.0 111.192 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.904 HD11 ' HD2' ' A' ' 7' ' ' PHE . 3.3 tp -70.6 129.23 38.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.158 -179.817 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 11.0 tp . . . . . 0 C--N 1.326 -0.431 0 CA-C-O 120.983 0.42 . . . . 0.0 111.297 -178.757 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.709 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 53.6 m-85 . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 120.695 0.283 . . . . 0.0 111.28 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.28 -34.83 10.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.321 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -69.55 -65.01 2.72 Favored Glycine 0 N--CA 1.435 -1.427 0 C-N-CA 119.594 -1.289 . . . . 0.0 112.907 -178.626 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 67.84 15.68 9.62 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 122.289 0.236 . . . . 0.0 110.906 -179.663 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.653 ' CE2' HD13 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -64.87 -33.4 75.93 Favored 'General case' 0 C--O 1.215 -0.717 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.189 -179.345 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.2 t -67.72 -7.73 29.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.104 0.478 . . . . 0.0 110.582 -179.7 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.1 -7.33 58.53 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.584 178.574 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.551 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 49.0 m -135.11 -28.18 1.19 Allowed 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 117.026 0.413 . . . . 0.0 111.387 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.471 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 33.5 m -84.51 145.7 27.97 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.375 0.607 . . . . 0.0 109.625 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -116.82 160.49 20.75 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.841 -179.06 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 45.73 55.24 7.01 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 123.245 0.618 . . . . 0.0 112.544 178.658 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.989 HG22 HD13 ' A' ' 129' ' ' LEU . 8.5 mt -80.22 103.62 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 120.8 0.333 . . . . 0.0 110.35 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.636 ' CA ' HD12 ' A' ' 129' ' ' LEU . 69.3 m -145.47 128.29 16.33 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.508 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.723 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -92.34 158.31 16.16 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.227 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -100.0 76.13 1.91 Allowed 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.248 -1.342 . . . . 0.0 107.626 177.338 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.98 -61.99 4.65 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 114.788 -1.097 . . . . 0.0 111.555 179.097 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.706 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -144.82 -2.64 0.82 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.367 -0.416 . . . . 0.0 110.221 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.481 ' HB3' ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -97.59 96.06 8.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.397 178.99 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.986 HD12 HD11 ' A' ' 129' ' ' LEU . 4.8 tp -60.33 117.12 4.83 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 123.39 0.676 . . . . 0.0 111.441 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.584 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 25.8 ttt180 -120.23 126.73 51.34 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.965 0.412 . . . . 0.0 110.845 -178.311 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.662 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -147.51 142.49 26.97 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.727 0.775 . . . . 0.0 111.32 -179.698 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.548 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 7.7 mm-40 -77.24 76.12 3.79 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.716 178.029 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.692 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 65.2 m -62.17 128.02 34.11 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.214 -178.852 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.551 ' HB2' ' O ' ' A' ' 10' ' ' SER . 17.1 ttp180 -73.54 116.45 14.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.421 179.634 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 27' ' ' ARG . 14.9 ptt180 -86.22 156.31 20.35 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.324 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.44 -14.96 3.73 Favored Glycine 0 C--N 1.338 0.68 0 O-C-N 124.631 1.207 . . . . 0.0 114.433 -177.917 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -73.15 -13.6 61.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.504 0.668 . . . . 0.0 109.617 178.16 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.92 6.65 59.12 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.569 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.42 164.78 12.4 Favored Glycine 0 C--O 1.225 -0.416 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.545 -179.156 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.548 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 84.3 m-85 -100.94 138.17 38.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.918 0.359 . . . . 0.0 110.83 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.1 m -126.89 126.91 44.08 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.102 179.566 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.9 m -65.26 116.12 6.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.065 0.46 . . . . 0.0 111.056 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 45.8 t -122.64 152.45 40.47 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.536 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.637 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 5.3 p -144.54 138.81 23.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.557 0.218 . . . . 0.0 111.04 -179.771 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.447 HG23 HD13 ' A' ' 39' ' ' LEU . 15.2 tt -133.12 148.58 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 120.929 0.395 . . . . 0.0 111.099 -178.725 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.71 95.43 5.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.969 -179.482 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.827 HD22 ' HB2' ' A' ' 21' ' ' LEU . 1.8 mp -75.48 -18.11 59.93 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 120.945 0.403 . . . . 0.0 111.023 178.988 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.706 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 27.8 p-10 -67.6 -7.4 26.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.423 179.785 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.1 mtt180 -114.22 14.66 18.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.146 179.445 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.632 ' HD1' ' HE3' ' A' ' 52' ' ' TRP . 0.2 OUTLIER -141.78 -23.31 0.71 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.097 -179.27 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.867 HD22 HD13 ' A' ' 151' ' ' ILE . 57.5 mt -110.07 131.55 54.96 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.474 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.529 ' HB3' ' HA2' ' A' ' 118' ' ' GLY . 0.5 OUTLIER -127.51 141.35 51.68 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.147 -179.12 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.605 ' ND2' HD22 ' A' ' 140' ' ' LEU . 12.3 m-20 -81.25 90.81 6.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.756 177.512 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -85.01 86.89 7.34 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.952 0.406 . . . . 0.0 110.389 177.923 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.55 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 16.6 t-20 50.85 45.8 26.92 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.272 179.25 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.646 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 83.02 40.13 9.57 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.183 179.012 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -155.13 121.32 5.22 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.723 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.739 ' HB3' ' HB ' ' A' ' 151' ' ' ILE . 25.8 m-85 -65.59 135.37 54.99 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.147 179.492 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 40.1 mmm-85 -136.64 141.32 43.19 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.856 0.36 . . . . 0.0 111.4 -179.694 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.717 ' HH2' HD13 ' A' ' 153' ' ' LEU . 92.6 m95 . . . . . 0 C--N 1.323 -0.566 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.919 178.544 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.449 -0.487 0 CA-C-O 120.947 0.403 . . . . 0.0 110.361 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.62 176.46 5.37 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.039 -179.699 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.454 ' HB ' ' CG2' ' A' ' 104' ' ' VAL . 4.5 p -129.18 116.43 19.18 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.74 0.305 . . . . 0.0 111.707 -178.831 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.449 HG21 ' CE1' ' A' ' 80' ' ' PHE . 14.5 p -104.57 139.53 25.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.922 0.392 . . . . 0.0 111.018 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 6.2 m -88.68 127.23 35.58 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.8 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.566 ' CG2' HD12 ' A' ' 99' ' ' ILE . 43.1 t -75.28 133.58 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.358 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -99.18 170.4 8.7 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 124.727 1.267 . . . . 0.0 110.32 -179.489 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.766 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 29.2 tp60 -61.05 110.4 1.35 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.227 -178.834 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.12 -12.27 58.79 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.493 178.384 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -81.77 129.49 34.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.93 0.395 . . . . 0.0 111.288 -179.435 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.57 ' HA ' HG12 ' A' ' 99' ' ' ILE . 67.4 p -109.2 178.11 4.55 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.774 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.604 HD22 HG23 ' A' ' 99' ' ' ILE . 1.6 mm? -53.25 -41.89 65.92 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.444 0.64 . . . . 0.0 109.599 178.958 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.414 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 28.6 ttm180 -61.67 -41.49 97.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.105 -179.599 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 79' ' ' ARG . 24.3 m-20 -67.31 -43.59 81.27 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.773 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.535 HG12 ' O ' ' A' ' 72' ' ' THR . 37.2 mm -61.67 -48.2 89.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.147 179.586 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.608 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.74 -47.58 87.66 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.893 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.481 ' HA ' ' NE ' ' A' ' 78' ' ' ARG . 5.4 tpm_? -71.48 -29.91 65.37 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 122.47 -0.429 . . . . 0.0 111.601 -179.27 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 40.8 ttt180 -75.04 -39.39 61.03 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.106 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.449 ' CE1' HG21 ' A' ' 65' ' ' VAL . 97.1 m-85 -110.45 15.17 22.33 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.515 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.4 t70 56.33 53.79 8.38 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 122.025 0.917 . . . . 0.0 111.969 179.028 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.608 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -134.24 170.97 14.91 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.61 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.635 ' O ' HG13 ' A' ' 87' ' ' ILE . 5.5 t70 -97.38 123.0 41.07 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.428 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.43 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 6.7 p90 -49.6 -31.12 9.97 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 124.579 1.174 . . . . 0.0 111.327 179.263 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -63.42 -48.85 76.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.856 179.281 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.721 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 19.2 mm-40 -67.65 -43.5 80.17 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.363 -178.839 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.635 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.1 mt -53.61 -46.91 61.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.703 0.763 . . . . 0.0 108.948 179.005 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.605 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.21 -51.49 66.08 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.344 178.598 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -61.55 -33.43 73.83 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -177.873 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.721 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 15.9 mmp_? -68.26 -32.06 71.96 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.289 0.566 . . . . 0.0 110.041 179.275 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 3.4 t-20 -91.28 -4.88 55.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.479 179.474 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 51.5 m-80 77.57 15.96 1.59 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.534 0.733 . . . . 0.0 110.7 -179.432 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.605 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 15.6 pt -105.16 -173.32 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.781 178.926 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.407 ' HA ' ' OE1' ' A' ' 94' ' ' GLN . 16.5 mm-40 -115.49 154.46 29.28 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.235 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.552 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.5 p-10 -51.59 -63.3 1.18 Allowed 'General case' 0 C--O 1.244 0.77 0 CA-C-O 121.964 0.888 . . . . 0.0 110.176 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.18 13.5 0.9 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.143 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 8.4 t70 -66.16 -32.35 73.73 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.689 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 8.3 mp 70.46 113.97 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.956 -177.549 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.604 HG23 HD22 ' A' ' 73' ' ' LEU . 7.4 pt -94.17 175.92 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.671 -178.337 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.509 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 96.6 m-85 -120.5 159.25 48.86 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.088 -178.731 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.766 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 50.9 Cg_endo -72.57 135.73 24.62 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.177 2.585 . . . . 0.0 112.425 -179.827 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.99 17.87 36.22 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.659 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 66' ' ' THR . 96.5 mt-30 -110.17 159.49 17.31 Favored 'General case' 0 C--O 1.209 -1.038 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.848 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.454 ' CG2' ' HB ' ' A' ' 64' ' ' THR . 8.4 p -116.46 131.24 69.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.553 0.692 . . . . 0.0 110.695 178.621 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.45 HD11 HG21 ' A' ' 99' ' ' ILE . 90.8 mt -121.38 151.02 40.63 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.573 -179.569 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.562 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 41.4 mt-30 -90.74 112.23 23.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.79 0.805 . . . . 0.0 110.917 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.8 m -120.74 151.28 54.23 Favored Pre-proline 0 C--N 1.315 -0.911 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.674 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -65.02 -17.95 60.73 Favored 'Trans proline' 0 C--N 1.332 -0.315 0 C-N-CA 123.147 2.565 . . . . 0.0 114.645 -177.704 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 C--N 1.323 -0.565 0 CA-C-O 120.869 0.366 . . . . 0.0 111.066 179.964 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.443 -0.84 0 N-CA-C 112.751 -0.14 . . . . 0.0 112.751 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 70.7 26.92 3.77 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.854 0.462 . . . . 0.0 111.35 179.168 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.568 ' HB2' ' OD1' ' A' ' 45' ' ' ASN . 20.2 p90 -57.12 -35.86 69.98 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 121.078 0.466 . . . . 0.0 110.325 179.219 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -59.13 -35.98 74.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.069 -178.194 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -66.56 -13.47 61.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.082 0.467 . . . . 0.0 111.386 -179.005 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.481 ' OG ' ' HB3' ' A' ' 141' ' ' ARG . 29.9 t -129.7 8.14 5.31 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.386 -179.71 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -104.35 149.35 25.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.073 0.464 . . . . 0.0 111.573 -179.489 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.536 ' HB2' ' CZ3' ' A' ' 146' ' ' TRP . 1.3 tmm_? -135.76 132.79 37.23 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.178 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.456 ' HB2' ' CZ ' ' A' ' 125' ' ' ARG . 34.6 t70 54.95 67.64 0.99 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.775 0.798 . . . . 0.0 110.693 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.513 ' CG1' HD11 ' A' ' 136' ' ' LEU . 42.0 t -84.68 126.66 40.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.86 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -144.04 141.12 29.92 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.229 -179.052 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.989 HD13 HG22 ' A' ' 14' ' ' ILE . 30.9 mt -86.55 125.31 33.69 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.961 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.627 HG23 ' HB ' ' A' ' 135' ' ' VAL . 35.6 m -118.6 161.2 17.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.691 -179.228 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.777 ' HB3' ' HE2' ' A' ' 134' ' ' LYS . 6.1 m-20 66.17 12.51 8.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.597 178.682 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.679 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 90.75 28.43 16.14 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.395 178.413 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.641 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 93.13 -16.78 59.72 Favored Glycine 0 C--O 1.261 1.812 0 CA-C-O 123.378 1.543 . . . . 0.0 112.92 177.246 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.777 ' HE2' ' HB3' ' A' ' 131' ' ' ASP . 17.5 pttm -71.31 -12.57 61.51 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 121.348 -1.09 . . . . 0.0 109.283 177.964 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.627 ' HB ' HG23 ' A' ' 130' ' ' VAL . 18.3 t -142.31 139.34 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.27 177.433 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.522 HD13 HD21 ' A' ' 16' ' ' LEU . 48.9 tp -118.66 122.54 42.78 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.356 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.444 ' OE2' ' HD3' ' A' ' 148' ' ' ARG . 17.1 tt0 -118.51 130.59 56.01 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.986 0.422 . . . . 0.0 110.903 -176.539 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 127' ' ' VAL . . . -156.49 166.24 33.97 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.186 -179.645 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 44.4 mt-10 -94.44 111.33 23.08 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.718 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.646 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 19.8 mt -98.17 132.14 43.94 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.325 -178.333 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.481 ' HB3' ' OG ' ' A' ' 123' ' ' SER . 72.2 ttt180 -73.98 141.23 45.88 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.601 179.667 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.55 ' HB2' ' OD1' ' A' ' 47' ' ' ASN . 1.4 p90 -157.65 -172.94 4.15 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.804 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.2 m -55.21 -31.95 61.85 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.211 0.319 . . . . 0.0 111.728 -179.539 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -93.41 15.29 63.32 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.253 -178.604 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 103.22 -110.99 3.83 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.293 179.664 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.536 ' CZ3' ' HB2' ' A' ' 125' ' ' ARG . 80.0 m95 -131.56 128.32 39.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.785 0.293 . . . . 0.0 110.706 -179.956 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -128.38 135.11 49.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.173 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.444 ' HD3' ' OE2' ' A' ' 137' ' ' GLU . 36.4 ttm180 -74.13 106.42 5.79 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.879 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 8.2 m -116.18 165.81 12.74 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.702 -178.98 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 15.2 ptt180 -147.0 164.78 31.91 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -178.55 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.867 HD13 HD22 ' A' ' 43' ' ' LEU . 8.3 tt -141.27 161.52 22.15 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.335 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.58 ' O ' ' HZ2' ' A' ' 52' ' ' TRP . 20.3 m-85 -104.58 104.36 14.18 Favored 'General case' 0 C--N 1.316 -0.868 0 O-C-N 122.307 -0.246 . . . . 0.0 110.699 -179.768 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.839 HD12 HG13 ' A' ' 157' ' ' ILE . 4.4 mm? -66.19 -36.19 82.43 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.218 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.411 ' OD1' ' HB3' ' A' ' 152' ' ' TYR . 16.6 p-10 -57.42 -9.85 1.21 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 179.035 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.709 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 32.9 mt-10 -71.93 -50.74 26.48 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 179.801 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -121.52 0.03 9.85 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.333 -0.547 . . . . 0.0 112.371 -177.366 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.839 HG13 HD12 ' A' ' 153' ' ' LEU . 45.1 mm -106.97 117.17 52.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.517 179.1 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.595 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -123.29 173.8 16.4 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.93 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.692 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.4 OUTLIER -106.13 126.45 52.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.987 0.423 . . . . 0.0 110.258 179.229 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.543 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 8.7 tpt180 -117.44 86.93 2.61 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.801 179.612 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 65.9 t30 55.26 40.65 31.65 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.463 178.864 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 105.61 -7.45 42.5 Favored Glycine 0 C--O 1.228 -0.25 0 C-N-CA 120.138 -1.029 . . . . 0.0 114.978 177.701 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 160' ' ' ARG . 13.2 pt-20 -122.04 141.44 51.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 117.936 0.868 . . . . 0.0 111.2 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.585 HD13 HD23 ' A' ' 21' ' ' LEU . 30.8 mt -74.98 122.22 23.16 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.867 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 6.5 tp . . . . . 0 C--N 1.323 -0.557 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.902 -179.533 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.845 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.47 ' HB2' ' OD1' ' A' ' 6' ' ' ASN . 49.6 m-80 -88.07 -175.38 5.06 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.912 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 27.7 m-85 -96.51 -89.43 0.26 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.104 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.15 -30.62 4.61 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.045 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -70.82 -66.77 2.08 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 119.796 -1.192 . . . . 0.0 113.383 -178.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.47 ' OD1' ' HB2' ' A' ' 2' ' ' ASN . 26.4 m-80 68.37 11.99 8.56 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.515 0.326 . . . . 0.0 110.677 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.647 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.9 OUTLIER -58.47 -35.93 72.94 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 121.076 -0.25 . . . . 0.0 111.135 -179.221 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.6 p -62.81 -19.52 64.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.388 0.613 . . . . 0.0 110.788 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.78 -22.05 78.63 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.801 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.536 ' HB3' ' HB3' ' A' ' 26' ' ' ARG . 67.4 m -132.67 -16.88 2.58 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 117.584 0.692 . . . . 0.0 111.877 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.468 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 19.4 m -94.81 133.86 38.06 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.428 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 14.4 ptt180 -111.38 179.87 3.91 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 41.77 48.32 3.7 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 124.089 0.868 . . . . 0.0 111.984 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.883 HG22 HD13 ' A' ' 129' ' ' LEU . 7.4 mt -80.6 104.14 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 109.695 -0.484 . . . . 0.0 109.695 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.589 ' HA ' HD12 ' A' ' 129' ' ' LEU . 78.0 m -146.57 127.06 14.09 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.735 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -95.66 155.7 16.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.718 0.77 . . . . 0.0 113.068 -179.122 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.454 ' HB2' HH22 ' A' ' 22' ' ' ARG . 31.0 t70 -94.28 75.63 3.96 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.428 177.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.7 -53.82 4.74 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.747 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.605 ' CB ' ' HB3' ' A' ' 40' ' ' ASN . . . -149.62 -10.8 0.3 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 120.781 0.324 . . . . 0.0 110.455 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -92.55 96.27 10.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.138 0.494 . . . . 0.0 110.814 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.811 HD22 HD13 ' A' ' 153' ' ' LEU . 45.4 tp -59.65 129.01 39.8 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.329 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.614 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 26.7 ttm180 -133.34 120.02 20.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.195 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.615 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -142.15 149.43 39.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.648 0.737 . . . . 0.0 112.053 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.497 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 63.3 mm-40 -83.65 75.46 10.05 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.365 -1.288 . . . . 0.0 108.873 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.856 ' SG ' HD13 ' A' ' 164' ' ' LEU . 56.0 m -62.96 124.24 20.59 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.86 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.536 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 16.2 ttm180 -76.51 118.01 18.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.736 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.618 ' HG2' ' HA3' ' A' ' 162' ' ' GLY . 10.7 mtm180 -84.1 163.96 19.5 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.76 -16.22 11.33 Favored Glycine 0 C--N 1.338 0.648 0 O-C-N 124.374 1.046 . . . . 0.0 113.387 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -72.39 -10.34 59.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.346 0.593 . . . . 0.0 109.819 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.48 13.98 64.48 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -114.2 162.29 12.45 Favored Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.208 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.497 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 61.5 m-85 -100.99 138.78 37.58 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.959 0.409 . . . . 0.0 111.138 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.8 m -132.5 132.21 42.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.589 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 m -69.39 110.44 4.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.185 0.517 . . . . 0.0 111.635 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.436 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 40.4 t -114.51 142.31 46.57 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.784 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.614 ' HB ' ' HG3' ' A' ' 22' ' ' ARG . 1.9 p -139.52 135.44 40.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.098 0.475 . . . . 0.0 111.35 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.484 HG23 ' HB3' ' A' ' 21' ' ' LEU . 12.3 tt -134.42 150.5 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.087 -177.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.498 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 2.7 m-20 -84.87 97.98 10.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.564 HD23 ' HB3' ' A' ' 21' ' ' LEU . 3.9 mm? -79.58 -8.93 59.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.242 0.544 . . . . 0.0 110.545 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.605 ' HB3' ' CB ' ' A' ' 19' ' ' ALA . 12.9 p30 -65.22 -15.75 62.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.766 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.545 ' HD3' ' O ' ' A' ' 114' ' ' GLY . 58.6 mtt85 -113.97 20.07 16.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.557 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -136.82 -31.7 0.84 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.346 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.857 HD22 HD13 ' A' ' 151' ' ' ILE . 48.3 mt -103.8 133.58 48.55 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.118 0.485 . . . . 0.0 110.044 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.715 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 6.1 m -122.31 146.78 46.98 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.306 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.444 ' HB3' HD22 ' A' ' 140' ' ' LEU . 8.1 p-10 -94.78 91.81 6.66 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.758 ' HB3' ' HD2' ' A' ' 51' ' ' ARG . 15.1 t70 -93.51 97.6 10.63 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.741 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.6 t30 53.2 46.96 25.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.396 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.562 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 75.44 29.37 60.04 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.957 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.571 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 70.5 m-70 -142.68 122.59 13.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.954 ' HB3' ' HB ' ' A' ' 151' ' ' ILE . 14.7 m-85 -62.5 126.12 26.27 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.758 ' HD2' ' HB3' ' A' ' 46' ' ' ASP . 54.3 mtt85 -143.98 137.71 27.92 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.344 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.523 ' CD1' HD11 ' A' ' 151' ' ' ILE . 86.6 m95 -73.45 110.91 8.1 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.7 t 65.29 -76.25 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.258 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.4 t -156.44 26.86 0.34 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.47 0.652 . . . . 0.0 109.409 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.8 -73.17 1.19 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.992 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -117.51 -52.57 0.33 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.158 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -173.61 -129.9 1.21 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.139 -0.553 . . . . 0.0 111.769 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.43 161.69 22.43 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.182 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.933 ' HA3' ' HB ' ' A' ' 109' ' ' THR . . . -164.32 -156.54 8.94 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.342 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 164.0 118.15 0.43 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.789 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.64 -143.44 17.83 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.896 -0.668 . . . . 0.0 111.808 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.6 m -141.26 114.31 8.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.151 0.501 . . . . 0.0 111.033 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 106' ' ' GLN . . . -124.59 177.15 6.09 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.112 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.4 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 1.9 p -129.46 120.18 25.01 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.485 HG21 ' CE1' ' A' ' 80' ' ' PHE . 7.9 p -107.05 147.39 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.565 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 13.4 m -95.37 124.87 39.62 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.586 HG21 HD12 ' A' ' 99' ' ' ILE . 47.9 t -73.99 133.13 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.362 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -99.16 170.2 8.85 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 124.384 1.052 . . . . 0.0 111.17 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.853 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 41.5 tt0 -61.48 119.63 8.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.645 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.55 18.78 51.23 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.67 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -110.36 148.02 32.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.15 0.475 . . . . 0.0 111.014 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.647 ' HA ' HG12 ' A' ' 99' ' ' ILE . 74.3 p -126.57 173.17 9.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.367 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.61 HD22 HG23 ' A' ' 99' ' ' ILE . 1.5 mm? -52.75 -43.03 65.49 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.539 0.685 . . . . 0.0 109.701 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.458 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 65.1 mtp180 -61.8 -38.26 87.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.744 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -72.9 -41.01 65.07 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 72' ' ' THR . 42.8 mm -62.71 -47.98 90.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.735 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -55.49 -50.38 60.42 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.213 178.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.13 -36.74 84.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.754 0.312 . . . . 0.0 111.432 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -70.32 -42.82 71.45 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.485 ' CE1' HG21 ' A' ' 65' ' ' VAL . 97.5 m-85 -105.08 18.72 21.87 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.5 t70 52.94 39.08 28.65 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.681 0.753 . . . . 0.0 111.528 178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.735 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 3.4 p -116.86 170.88 8.28 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.218 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.66 ' O ' HG13 ' A' ' 87' ' ' ILE . 6.1 t70 -96.06 124.4 40.05 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.031 -0.667 . . . . 0.0 110.199 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.458 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 5.7 p90 -52.29 -29.49 23.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.512 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -68.86 -43.22 75.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.425 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.668 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 14.0 tp10 -65.31 -45.56 83.85 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.66 HG13 ' O ' ' A' ' 83' ' ' ASP . 4.8 mt -54.97 -46.42 76.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.18 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.596 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.01 -50.01 72.37 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.889 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.414 ' NE ' ' HA ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -55.61 -39.67 71.09 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.668 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 10.9 mmt180 -69.91 -30.98 68.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.688 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.464 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 3.0 t-20 -95.39 -3.85 46.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.154 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 50.4 m-80 74.9 17.82 2.72 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.935 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.596 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 14.3 pt -105.55 -179.77 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.549 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 2.3 mp0 -104.69 161.52 14.07 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.505 ' O ' HD23 ' A' ' 73' ' ' LEU . 15.9 p-10 -60.33 -59.65 5.06 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 122.027 0.917 . . . . 0.0 109.284 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -75.78 12.28 1.12 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.602 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.549 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 3.8 t70 -63.62 -35.62 81.11 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 9.5 mp 72.17 117.16 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 O-C-N 124.193 0.933 . . . . 0.0 109.313 -176.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.647 HG12 ' HA ' ' A' ' 72' ' ' THR . 7.5 pt -95.72 178.97 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.918 -178.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.456 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 91.3 m-85 -124.35 157.6 64.16 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.751 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.853 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 53.6 Cg_endo -72.4 131.93 18.39 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 123.198 2.598 . . . . 0.0 113.044 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.42 18.96 24.54 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' A' ' 66' ' ' THR . 33.9 tt0 -105.79 158.71 16.54 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 83.0 t -119.21 118.75 58.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 109.722 -0.474 . . . . 0.0 109.722 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.596 HD11 HG21 ' A' ' 99' ' ' ILE . 94.9 mt -112.52 150.55 31.12 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.035 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.625 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 40.8 mt-30 -90.56 111.74 23.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.781 0.8 . . . . 0.0 110.964 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.0 m -119.55 151.23 51.41 Favored Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.608 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.45 -16.13 53.49 Favored 'Trans proline' 0 N--CA 1.475 0.389 0 C-N-CA 123.542 2.828 . . . . 0.0 114.975 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.933 ' HB ' ' HA3' ' A' ' 59' ' ' GLY . 6.6 t -153.15 152.68 31.54 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.01 0.433 . . . . 0.0 111.39 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -97.55 -176.57 3.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.0 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -86.08 -45.09 5.76 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.352 -0.928 . . . . 0.0 111.45 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.06 179.16 35.88 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.986 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 51.0 m -152.36 -47.2 0.1 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.909 0.385 . . . . 0.0 110.291 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.545 ' O ' ' HD3' ' A' ' 41' ' ' ARG . . . 166.1 49.7 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.239 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -143.16 91.39 0.17 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.799 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.45 60.22 2.88 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 41' ' ' ARG . . . -123.36 -28.62 3.93 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.38 -0.41 . . . . 0.0 111.735 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.715 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -109.0 -84.61 1.61 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.121 -1.038 . . . . 0.0 113.18 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 15.5 m120 75.25 24.39 1.44 Allowed 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.457 0.703 . . . . 0.0 112.099 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.602 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 23.8 p90 -59.62 -40.19 86.74 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.069 0.461 . . . . 0.0 110.019 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.51 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 66.0 t-105 -56.69 -34.58 67.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.386 -178.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -57.03 -25.81 59.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.86 0.362 . . . . 0.0 111.028 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.815 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 9.7 m -132.01 25.45 4.61 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.477 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.51 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -115.89 139.87 49.79 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 120.98 0.419 . . . . 0.0 110.816 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.462 ' HD3' ' HA ' ' A' ' 125' ' ' ARG . 17.8 mmt180 -128.98 146.72 50.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.486 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.7 t70 51.35 59.31 4.69 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 124.014 0.821 . . . . 0.0 110.745 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.534 HG12 HD11 ' A' ' 136' ' ' LEU . 35.1 t -82.78 124.65 39.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.598 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -145.66 144.01 30.16 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.07 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.883 HD13 HG22 ' A' ' 14' ' ' ILE . 21.3 mt -86.25 138.85 31.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.29 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.64 HG23 ' HB ' ' A' ' 135' ' ' VAL . 34.4 m -132.6 157.56 43.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.92 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.447 ' O ' ' HG2' ' A' ' 134' ' ' LYS . 0.7 OUTLIER 65.37 18.08 11.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.387 178.578 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.736 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 90.42 30.46 12.09 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.222 -0.99 . . . . 0.0 113.829 178.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.565 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 86.69 -9.87 69.73 Favored Glycine 0 C--O 1.261 1.832 0 CA-C-O 123.011 1.339 . . . . 0.0 113.213 176.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.728 ' HG3' HG23 ' A' ' 135' ' ' VAL . 8.4 ptpp? -74.18 -17.4 60.91 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.728 HG23 ' HG3' ' A' ' 134' ' ' LYS . 22.8 t -137.79 143.13 34.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.782 177.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.671 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 34.1 tp -126.24 119.15 26.7 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.5 ' OE2' ' HD3' ' A' ' 148' ' ' ARG . 16.2 tt0 -112.15 138.26 49.08 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.76 0.314 . . . . 0.0 111.357 -176.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . . . -162.86 167.04 23.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.988 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 124' ' ' ALA . 3.9 mm-40 -94.36 106.17 18.14 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.562 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 67.0 mt -96.96 130.5 44.26 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.268 0.556 . . . . 0.0 111.567 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.815 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 74.4 ttt180 -73.28 141.32 47.19 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.128 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.531 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 2.0 p90 -159.06 -169.94 2.84 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 121.081 -0.247 . . . . 0.0 111.352 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.7 m -56.01 -29.65 60.67 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -101.14 27.16 21.87 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.243 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 93.68 -111.1 4.07 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.363 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -128.88 133.32 47.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.717 0.258 . . . . 0.0 110.339 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.531 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 54.0 t30 -133.01 141.42 48.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.712 0.291 . . . . 0.0 110.497 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.5 ' HD3' ' OE2' ' A' ' 137' ' ' GLU . 24.9 ttm180 -79.6 114.73 18.75 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.921 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.571 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 36.2 t -125.78 168.26 14.05 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.698 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.671 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -146.73 163.05 37.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.082 0.468 . . . . 0.0 111.978 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.954 ' HB ' ' HB3' ' A' ' 50' ' ' PHE . 9.0 tt -145.47 152.9 14.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.302 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.675 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 15.1 m-85 -93.32 105.84 17.87 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.811 HD13 HD22 ' A' ' 21' ' ' LEU . 22.2 mt -67.25 -34.09 76.7 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.243 178.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.46 ' HA ' ' CD1' ' A' ' 7' ' ' PHE . 1.9 p-10 -57.41 -11.93 2.22 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.908 178.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.912 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 36.5 mt-10 -62.3 -55.27 29.84 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.106 0.479 . . . . 0.0 111.938 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -118.34 -12.13 9.94 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.959 -0.697 . . . . 0.0 111.828 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.438 ' CG2' ' HG ' ' A' ' 164' ' ' LEU . 49.6 mm -87.2 108.84 18.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.298 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -115.25 154.86 16.7 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.562 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.552 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.0 t30 -94.47 113.68 25.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.107 0.479 . . . . 0.0 109.891 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.459 HH11 ' HD2' ' A' ' 160' ' ' ARG . 15.2 tpt180 -110.97 86.72 2.37 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.92 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.0 t30 55.17 55.9 7.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.368 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.618 ' HA3' ' HG2' ' A' ' 27' ' ' ARG . . . 79.99 7.63 88.35 Favored Glycine 0 C--O 1.228 -0.231 0 CA-C-N 115.509 -0.769 . . . . 0.0 113.781 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -123.47 125.16 44.41 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.855 0.359 . . . . 0.0 111.397 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.856 HD13 ' SG ' ' A' ' 25' ' ' CYS . 0.2 OUTLIER -73.87 112.09 9.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.591 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 47.9 mm -118.95 140.08 44.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.166 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -91.18 134.48 34.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.29 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 4.6 p . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.12 178.923 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.628 ' HA3' ' OD1' ' A' ' 6' ' ' ASN . . . . . . . . 0 N--CA 1.482 1.735 0 N-CA-C 111.699 -0.56 . . . . 0.0 111.699 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -86.82 -69.93 0.64 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.766 0.317 . . . . 0.0 111.296 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -126.74 -94.05 0.47 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.75 -26.66 12.18 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.22 -72.63 0.64 Allowed Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 119.66 -1.257 . . . . 0.0 112.61 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.628 ' OD1' ' HA3' ' A' ' 1' ' ' GLY . 39.1 m-80 64.53 14.43 8.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.615 0.245 . . . . 0.0 110.677 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.581 ' CE2' HD13 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -64.05 -32.5 74.07 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.994 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.5 t -70.7 -11.1 60.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.359 0.6 . . . . 0.0 109.728 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.58 -16.92 72.13 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.418 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.494 ' HB2' ' HB3' ' A' ' 26' ' ' ARG . 33.3 p -137.21 -11.27 1.68 Allowed 'General case' 0 C--O 1.221 -0.419 0 O-C-N 122.507 -0.408 . . . . 0.0 111.928 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 12.1 m -105.18 132.53 51.28 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.585 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 25.1 ptt180 -108.89 -176.77 3.13 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 44.28 42.3 5.08 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 123.913 0.758 . . . . 0.0 112.058 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.93 HG22 HD13 ' A' ' 129' ' ' LEU . 5.6 mt -80.2 100.97 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 121.108 0.48 . . . . 0.0 110.889 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.621 ' CA ' HD12 ' A' ' 129' ' ' LEU . 71.7 m -147.82 127.13 13.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.515 -0.766 . . . . 0.0 108.984 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.751 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -92.57 158.36 16.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.676 0.75 . . . . 0.0 112.782 -179.046 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -96.13 74.31 2.98 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.18 -55.41 5.03 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.226 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 40' ' ' ASN . . . -148.67 -12.42 0.34 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -85.89 92.37 8.63 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.78 HD22 HD23 ' A' ' 153' ' ' LEU . 43.2 tp -58.87 125.2 22.57 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.546 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 2.3 ttt180 -133.08 122.64 24.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.14 0.495 . . . . 0.0 110.703 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.621 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -138.83 176.24 8.86 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.243 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.585 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 6.2 mt-10 -115.61 80.07 1.38 Allowed 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.601 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 55.6 m -64.77 126.69 28.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.691 -178.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.494 ' HB3' ' HB2' ' A' ' 10' ' ' SER . 43.5 ttt-85 -74.73 114.68 13.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.676 178.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.6 ttm180 -82.57 154.9 24.76 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -48.75 -22.47 2.82 Favored Glycine 0 C--N 1.332 0.325 0 O-C-N 124.633 1.208 . . . . 0.0 115.115 -177.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -72.48 -14.41 61.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.509 0.671 . . . . 0.0 110.574 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.31 7.78 53.97 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -102.74 147.44 17.03 Favored Glycine 0 C--O 1.225 -0.445 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.511 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.438 ' HD1' ' O ' ' A' ' 24' ' ' GLU . 84.4 m-85 -96.57 124.63 40.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.02 0.41 . . . . 0.0 110.318 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.9 m -117.01 126.44 52.89 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.339 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.3 m -67.09 126.25 28.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.253 0.549 . . . . 0.0 110.245 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 46.8 t -129.86 152.69 49.06 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.763 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.667 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 5.3 p -144.12 133.77 19.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.044 0.45 . . . . 0.0 111.171 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.441 HG23 ' HB3' ' A' ' 21' ' ' LEU . 11.2 tt -135.07 153.53 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.226 -178.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -82.97 111.6 18.98 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 122.041 -0.412 . . . . 0.0 111.157 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.538 HD23 ' HB3' ' A' ' 21' ' ' LEU . 2.0 mm? -88.83 -2.0 58.37 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.456 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 66.9 t30 -74.78 -14.73 60.74 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.767 ' HD3' ' HA2' ' A' ' 115' ' ' GLY . 50.9 mtm180 -107.18 17.25 23.17 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.296 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.464 ' HB2' HD13 ' A' ' 39' ' ' LEU . 39.8 m-85 -134.01 -33.86 1.02 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.339 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.64 HD22 HD13 ' A' ' 151' ' ' ILE . 35.8 mt -105.73 137.18 44.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.926 0.394 . . . . 0.0 111.624 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.634 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 5.9 m -129.94 140.76 50.88 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.677 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.803 ' CB ' ' HG ' ' A' ' 140' ' ' LEU . 21.2 p-10 -80.71 93.79 6.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.36 0.6 . . . . 0.0 110.542 178.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -92.78 91.24 7.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.981 0.42 . . . . 0.0 111.065 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.9 t30 51.86 45.23 28.58 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.361 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.35 34.4 29.26 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.728 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.658 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 32.8 t60 -155.35 122.0 5.33 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.741 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 55.3 m-85 -58.44 143.98 43.65 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.93 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.648 ' NE ' ' HA ' ' A' ' 51' ' ' ARG . 4.4 mmp_? -146.14 134.26 21.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.449 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.772 ' HZ2' ' HA ' ' A' ' 153' ' ' LEU . 95.0 m95 -77.38 114.24 16.01 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.107 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.5 t -129.58 85.06 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.8 m -81.61 60.79 4.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.983 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.57 38.22 94.46 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.959 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.53 142.39 48.26 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.442 -0.408 . . . . 0.0 112.3 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.901 ' HA3' ' HB2' ' A' ' 63' ' ' ALA . . . 77.4 62.26 2.46 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.767 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -127.1 90.37 0.35 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.732 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.8 10.81 66.5 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.437 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.5 169.65 20.78 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.424 -0.893 . . . . 0.0 112.75 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.33 -143.56 16.6 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.069 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.2 m -134.17 126.65 30.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.95 0.405 . . . . 0.0 110.081 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.901 ' HB2' ' HA3' ' A' ' 57' ' ' GLY . . . -132.3 177.16 7.79 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.203 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.449 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 8.9 p -130.32 119.73 23.27 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.415 HG21 ' CE1' ' A' ' 80' ' ' PHE . 8.2 p -109.48 140.51 27.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.685 0.278 . . . . 0.0 110.623 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 7.1 m -88.27 131.1 34.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.246 0.546 . . . . 0.0 110.28 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.499 ' CG2' HD12 ' A' ' 99' ' ' ILE . 43.0 t -81.1 134.93 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.9 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -108.8 170.61 7.93 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 124.1 0.875 . . . . 0.0 109.939 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.667 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 34.7 tt0 -65.12 120.13 12.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.834 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.67 -7.19 45.52 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.879 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -95.04 148.15 22.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.331 0.586 . . . . 0.0 112.029 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.609 ' HA ' HG12 ' A' ' 99' ' ' ILE . 74.5 p -133.38 170.75 15.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.695 HD22 HG23 ' A' ' 99' ' ' ILE . 1.1 mm? -52.18 -45.9 65.32 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.899 0.772 . . . . 0.0 109.453 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -57.49 -38.64 74.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.367 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.66 -43.74 46.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.594 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.557 HG12 ' O ' ' A' ' 72' ' ' THR . 43.5 mm -59.83 -46.55 93.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.885 0.374 . . . . 0.0 110.059 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.645 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.86 -51.73 56.39 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.555 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -66.85 -30.81 71.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.025 0.44 . . . . 0.0 111.43 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -70.12 -46.82 63.99 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.415 ' CE1' HG21 ' A' ' 65' ' ' VAL . 89.7 m-85 -103.59 12.62 34.72 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.0 t0 60.21 57.88 2.8 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.96 0.886 . . . . 0.0 110.812 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.645 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -140.02 164.88 28.85 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.065 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.686 ' O ' HG13 ' A' ' 87' ' ' ILE . 6.8 m-20 -83.05 114.95 21.64 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.643 ' HD1' ' HB2' ' A' ' 95' ' ' ASN . 10.6 p90 -54.57 -31.53 56.86 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.724 0.64 . . . . 0.0 111.142 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.528 ' HA ' ' HB3' ' A' ' 95' ' ' ASN . 71.1 t60 -71.86 -36.03 70.01 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.719 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.595 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 9.9 tp10 -68.77 -47.0 67.3 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.686 HG13 ' O ' ' A' ' 83' ' ' ASP . 7.1 mt -51.91 -47.94 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.017 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.593 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.83 -50.92 69.05 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.345 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -56.8 -39.79 74.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.934 0.397 . . . . 0.0 111.418 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.595 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 21.7 mmt180 -70.17 -31.07 68.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.108 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 17.5 t-20 -90.74 -6.04 54.93 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.985 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 93.0 m-20 79.5 17.75 0.8 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.524 0.73 . . . . 0.0 111.089 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.593 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 14.5 pt -110.68 -173.17 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.585 178.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.539 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 52.5 mt-30 -115.1 154.42 28.94 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.643 ' HB2' ' HD1' ' A' ' 84' ' ' PHE . 6.9 p-10 -56.6 -55.1 38.25 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 122.199 1.0 . . . . 0.0 109.329 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -78.52 12.92 1.78 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.091 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.539 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 0.7 OUTLIER -70.96 -29.96 66.1 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.093 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 9.6 mp 69.88 114.61 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 O-C-N 124.266 0.979 . . . . 0.0 110.433 -177.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.695 HG23 HD22 ' A' ' 73' ' ' LEU . 9.5 pt -94.63 176.03 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 114.81 -1.087 . . . . 0.0 111.338 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.556 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 90.5 m-85 -130.71 160.03 68.28 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.941 -178.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.667 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 20.1 Cg_endo -66.05 135.28 40.03 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.299 2.666 . . . . 0.0 114.048 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.73 23.38 18.5 Favored Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.397 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.49 ' O ' ' HA ' ' A' ' 66' ' ' THR . 46.1 mt-30 -111.88 165.35 12.16 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 120.574 -0.45 . . . . 0.0 109.837 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.449 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 65.6 t -125.45 115.73 44.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.496 ' HB3' HG22 ' A' ' 87' ' ' ILE . 81.7 mt -108.19 150.87 26.69 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.711 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -90.62 115.41 27.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.394 0.616 . . . . 0.0 110.613 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.0 m -120.37 150.5 51.95 Favored Pre-proline 0 C--N 1.311 -1.08 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.388 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.93 -19.28 58.27 Favored 'Trans proline' 0 C--N 1.332 -0.304 0 C-N-CA 123.195 2.597 . . . . 0.0 113.96 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.7 t -152.53 147.61 26.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.356 0.598 . . . . 0.0 111.351 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.5 ' HG2' ' HB1' ' A' ' 63' ' ' ALA . 13.8 mmmm -99.34 -169.84 1.82 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.965 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.91 -48.57 74.94 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 65.42 35.57 91.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.378 -0.439 . . . . 0.0 113.467 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.9 m -73.1 -37.12 66.84 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.955 0.407 . . . . 0.0 110.184 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 127.14 -67.96 0.54 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.732 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.767 ' HA2' ' HD3' ' A' ' 41' ' ' ARG . . . -78.72 68.49 3.01 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.62 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 159.27 71.51 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.924 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -114.74 -34.28 5.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.288 0.566 . . . . 0.0 109.605 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.634 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -103.36 -76.09 1.11 Allowed Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.088 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 21.6 m120 75.24 27.16 1.12 Allowed 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.751 0.82 . . . . 0.0 112.476 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.593 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 18.8 p90 -63.46 -39.29 94.07 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.546 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 63.7 t-105 -61.94 -31.44 71.77 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.133 -178.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -58.75 -16.22 15.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 111.27 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.729 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 36.3 m -145.75 30.55 1.08 Allowed 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.164 177.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.546 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -110.38 136.47 49.49 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.595 177.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.4 tmm_? -125.03 137.04 54.23 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.61 57.99 3.52 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.625 0.578 . . . . 0.0 111.164 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.505 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 34.6 t -85.53 124.96 40.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.114 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.486 ' O ' HD12 ' A' ' 136' ' ' LEU . 38.7 ptt180 -148.98 142.97 25.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.956 0.408 . . . . 0.0 111.143 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.93 HD13 HG22 ' A' ' 14' ' ' ILE . 23.1 mt -85.09 131.97 34.38 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.74 HG23 ' HB ' ' A' ' 135' ' ' VAL . 28.9 m -125.28 158.98 33.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.712 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.68 ' HB3' ' CG ' ' A' ' 134' ' ' LYS . 0.2 OUTLIER 68.55 11.13 8.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.152 179.52 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.664 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 91.28 31.33 9.77 Favored Glycine 0 N--CA 1.437 -1.251 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.092 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.508 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 93.25 -14.91 64.17 Favored Glycine 0 C--O 1.265 2.062 0 CA-C-O 123.005 1.336 . . . . 0.0 113.627 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.68 ' CG ' ' HB3' ' A' ' 131' ' ' ASP . 7.8 ptpp? -72.99 -15.63 61.53 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 121.241 -1.153 . . . . 0.0 109.024 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.74 ' HB ' HG23 ' A' ' 130' ' ' VAL . 12.0 t -139.27 147.37 24.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.718 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.579 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 47.9 tp -128.95 123.14 31.73 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -112.46 130.94 55.82 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 123.273 0.358 . . . . 0.0 110.772 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.727 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.72 161.6 26.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.188 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.668 ' HG2' ' HG3' ' A' ' 148' ' ' ARG . 39.3 mt-10 -98.0 106.17 18.43 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.628 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.803 ' HG ' ' CB ' ' A' ' 45' ' ' ASN . 0.5 OUTLIER -89.71 126.03 35.5 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.852 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.729 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 52.3 ttt-85 -69.97 140.38 52.97 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.647 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.664 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 2.9 p90 -151.6 -164.94 2.11 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.148 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.3 t -59.78 -25.61 65.05 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -107.65 28.88 11.29 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.591 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 96.46 -114.45 4.94 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.485 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -125.27 129.38 49.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.78 0.29 . . . . 0.0 110.666 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.664 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 22.9 t-20 -123.56 132.87 54.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.711 0.291 . . . . 0.0 111.114 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.668 ' HG3' ' HG2' ' A' ' 139' ' ' GLU . 38.2 mtp85 -74.86 113.18 11.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.533 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.658 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 33.7 t -128.9 165.53 20.88 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.047 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.579 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 19.4 ptt180 -147.74 148.69 31.25 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.138 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.741 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 11.6 tt -130.68 161.67 40.15 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.428 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.531 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 14.6 m-85 -104.88 105.46 15.53 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 122.265 -0.272 . . . . 0.0 110.991 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.78 HD23 HD22 ' A' ' 21' ' ' LEU . 9.9 mp -69.27 -31.62 70.25 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.502 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.626 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 11.1 t70 -58.99 -7.84 1.21 Allowed 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.932 178.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.528 ' HG3' ' O ' ' A' ' 152' ' ' TYR . 37.0 mt-10 -72.73 -51.78 17.81 Favored 'General case' 0 CA--C 1.508 -0.635 0 O-C-N 121.862 -0.523 . . . . 0.0 112.31 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.537 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 53.8 m-70 -122.55 2.22 9.57 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.126 -177.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.412 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 46.2 mm -106.26 110.44 31.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.431 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.469 ' HA3' ' OXT' ' A' ' 167' ' ' CYS . . . -113.43 168.77 12.68 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.28 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.601 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 1.6 t30 -100.83 119.8 39.19 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.666 ' HD3' HD12 ' A' ' 165' ' ' ILE . 58.5 ttt180 -115.12 88.68 2.92 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.807 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 17.8 m120 59.55 34.7 22.49 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.937 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.58 -4.55 43.34 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.023 -1.084 . . . . 0.0 114.243 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.603 ' HG2' ' O ' ' A' ' 160' ' ' ARG . 14.4 pt-20 -122.02 139.79 53.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.683 0.742 . . . . 0.0 110.9 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.404 ' CD2' ' HD2' ' A' ' 7' ' ' PHE . 76.0 mt -76.23 115.12 15.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.386 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.666 HD12 ' HD3' ' A' ' 160' ' ' ARG . 47.7 mt -141.08 146.71 23.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.953 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.537 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 14.0 p80 -56.66 124.32 17.95 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.469 ' OXT' ' HA3' ' A' ' 158' ' ' GLY . 42.6 t . . . . . 0 C--O 1.254 1.294 0 O-C-N 123.958 0.786 . . . . 0.0 110.987 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -89.78 179.54 5.98 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.634 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 33.9 m-85 -121.94 -89.12 0.61 Allowed 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.488 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.39 -26.99 6.51 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -76.09 -67.85 1.63 Allowed Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 119.069 -1.539 . . . . 0.0 112.363 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 63.94 15.01 8.84 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 122.973 0.509 . . . . 0.0 110.71 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.685 ' CE2' HD13 ' A' ' 14' ' ' ILE . 2.1 p90 -56.4 -37.23 69.85 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.549 ' HA ' HD11 ' A' ' 14' ' ' ILE . 3.9 m -60.2 -23.05 63.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.841 0.353 . . . . 0.0 111.745 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.19 -21.66 77.2 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.974 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.517 ' HB2' ' HB3' ' A' ' 26' ' ' ARG . 33.2 p -125.19 -24.88 3.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.12 0.486 . . . . 0.0 111.321 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.2 m -94.64 131.63 40.22 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.815 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 12' ' ' ARG . 10.5 ptm180 -113.4 -179.54 3.67 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.426 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 9.0 m-20 47.53 44.65 17.12 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 123.832 0.708 . . . . 0.0 111.41 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.762 HG22 ' CD1' ' A' ' 129' ' ' LEU . 7.2 mt -80.22 103.25 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-O 121.039 0.447 . . . . 0.0 110.425 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.586 ' O ' ' HB3' ' A' ' 22' ' ' ARG . 72.0 m -146.95 127.5 14.15 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.85 HD21 HD12 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -91.91 157.99 16.53 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.086 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -97.24 76.08 2.6 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 113.958 -1.474 . . . . 0.0 107.815 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.44 -58.92 5.01 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.994 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -148.66 -6.45 0.4 Allowed 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -97.81 98.03 9.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.117 0.484 . . . . 0.0 110.382 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.901 ' HB2' HD22 ' A' ' 39' ' ' LEU . 42.9 tp -54.25 129.88 36.74 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 114.871 -1.058 . . . . 0.0 112.489 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.586 ' HB3' ' O ' ' A' ' 15' ' ' CYS . 16.2 ttp180 -132.62 124.1 27.67 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.601 -0.439 . . . . 0.0 110.089 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.639 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -147.23 144.43 28.89 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.663 0.744 . . . . 0.0 111.682 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.623 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 2.3 mm-40 -79.27 75.66 5.84 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.882 178.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.598 ' HB2' ' HA2' ' A' ' 162' ' ' GLY . 46.2 m -62.43 124.57 21.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.49 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.517 ' HB3' ' HB2' ' A' ' 10' ' ' SER . 58.6 ttp180 -68.92 119.92 14.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.336 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -90.27 153.5 20.42 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.93 -13.07 4.23 Favored Glycine 0 C--N 1.33 0.232 0 O-C-N 124.443 1.09 . . . . 0.0 115.005 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -83.52 -2.91 57.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.978 0.418 . . . . 0.0 110.554 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.59 10.99 66.79 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -112.4 145.29 18.02 Favored Glycine 0 C--O 1.226 -0.387 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.408 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.623 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 69.4 m-85 -89.35 133.36 34.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.878 0.339 . . . . 0.0 110.433 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.8 m -115.16 124.75 52.28 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.307 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.0 m -68.31 107.42 2.82 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.09 0.472 . . . . 0.0 109.938 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 48.0 t -113.18 152.58 29.53 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.062 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.664 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.2 p -145.13 130.61 13.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.097 0.475 . . . . 0.0 110.757 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.4 HG23 ' HB3' ' A' ' 21' ' ' LEU . 15.3 tt -130.11 143.23 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.676 -177.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.15 101.37 3.92 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.71 0.29 . . . . 0.0 111.572 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.901 HD22 ' HB2' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -82.44 -9.78 59.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.079 0.466 . . . . 0.0 110.301 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.528 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 2.1 p-10 -62.59 -18.13 61.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.215 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.579 ' O ' ' HB3' ' A' ' 117' ' ' ALA . 18.1 ptt180 -112.63 20.7 16.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.303 0.573 . . . . 0.0 110.179 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 27.4 m-85 -131.34 -33.35 1.48 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.001 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.751 HD22 HD13 ' A' ' 151' ' ' ILE . 50.3 mt -106.25 135.01 48.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.689 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.632 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 3.3 m -126.34 138.15 53.54 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.033 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.901 ' CB ' ' HG ' ' A' ' 140' ' ' LEU . 16.1 p-10 -86.75 102.14 13.96 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.524 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.467 ' CB ' ' HD3' ' A' ' 51' ' ' ARG . 17.1 t70 -107.05 93.2 4.42 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.083 0.468 . . . . 0.0 110.507 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.7 t30 55.99 43.15 27.69 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.096 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 149' ' ' SER . . . 83.06 27.36 41.03 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.697 -0.764 . . . . 0.0 113.649 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.443 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 69.9 m-70 -144.47 139.06 28.06 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.974 ' HZ ' ' HB3' ' A' ' 138' ' ' ALA . 49.8 m-85 -80.88 144.25 32.11 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.206 0.527 . . . . 0.0 111.892 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.467 ' HD3' ' CB ' ' A' ' 46' ' ' ASP . 26.6 mtp180 -146.6 132.82 19.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.711 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.624 ' HZ2' ' HA ' ' A' ' 153' ' ' LEU . 97.2 m95 -73.83 133.1 43.15 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.315 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.493 HG23 ' HD3' ' A' ' 79' ' ' ARG . 14.8 m 30.45 62.09 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.871 1.269 . . . . 0.0 113.603 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.8 m -106.84 20.85 18.43 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.084 0.469 . . . . 0.0 110.818 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.15 -36.22 60.37 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.467 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.66 175.65 14.27 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.506 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.423 ' H ' ' HB2' ' A' ' 81' ' ' ASP . . . -136.43 -98.92 0.54 Allowed Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.419 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . 98.46 131.2 7.12 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.521 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.779 ' HA3' ' HB ' ' A' ' 109' ' ' THR . . . -169.86 -171.2 35.17 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.798 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -158.83 52.68 0.39 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.253 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.95 -137.17 2.3 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.383 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 55.3 m -140.92 117.35 10.78 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.077 0.465 . . . . 0.0 110.732 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.507 ' HB1' ' HG2' ' A' ' 110' ' ' LYS . . . -133.89 176.59 8.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.642 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.512 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 20.7 p -129.62 122.58 29.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.885 0.374 . . . . 0.0 111.124 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.479 HG21 ' CE2' ' A' ' 80' ' ' PHE . 10.8 p -108.22 139.79 29.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.838 0.352 . . . . 0.0 111.46 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.0 m -91.62 125.64 36.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.242 0.544 . . . . 0.0 109.648 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.872 HG21 HD12 ' A' ' 99' ' ' ILE . 86.6 t -84.06 131.14 34.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.341 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -106.1 169.46 8.49 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 124.059 0.849 . . . . 0.0 110.688 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.686 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 19.8 tt0 -55.65 117.67 3.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.295 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.36 4.89 40.52 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.34 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.452 ' HB2' HG13 ' A' ' 67' ' ' VAL . 95.3 m-20 -109.75 138.44 46.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.065 0.46 . . . . 0.0 111.939 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.671 ' HA ' HG12 ' A' ' 99' ' ' ILE . 68.6 p -122.84 173.99 7.42 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.744 HD22 HG23 ' A' ' 99' ' ' ILE . 0.7 OUTLIER -51.34 -43.06 61.66 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.525 0.602 . . . . 0.0 110.372 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -62.07 -35.89 79.99 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.883 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -73.89 -40.63 63.06 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.441 HG12 ' O ' ' A' ' 72' ' ' THR . 46.1 mm -63.14 -49.25 84.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.692 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -59.31 -52.57 52.46 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.652 -0.704 . . . . 0.0 113.539 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -64.5 -25.59 68.06 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.493 ' HD3' HG23 ' A' ' 53' ' ' VAL . 40.2 ttm180 -81.57 -49.5 10.47 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.479 ' CE2' HG21 ' A' ' 65' ' ' VAL . 96.2 m-85 -94.13 12.95 24.7 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.423 ' HB2' ' H ' ' A' ' 57' ' ' GLY . 15.8 t70 60.59 44.32 11.74 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.998 0.904 . . . . 0.0 110.797 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.692 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.8 p -126.19 162.4 25.5 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.865 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.471 ' O ' HG13 ' A' ' 87' ' ' ILE . 4.1 p-10 -92.91 119.09 31.85 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.558 0.694 . . . . 0.0 109.437 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.694 ' HD2' ' HB2' ' A' ' 95' ' ' ASN . 7.7 p90 -47.86 -32.57 6.34 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 114.431 -1.258 . . . . 0.0 111.895 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.412 ' HA ' ' HB3' ' A' ' 95' ' ' ASN . 83.1 t60 -60.48 -47.85 84.33 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.951 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.604 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 6.2 tp10 -63.54 -47.04 83.24 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.928 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.493 HD12 ' HA ' ' A' ' 84' ' ' PHE . 5.1 mt -49.7 -47.06 21.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.413 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.612 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.84 -50.3 71.48 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.907 178.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 85' ' ' HIS . 48.6 mtm180 -58.9 -34.48 71.73 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.604 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 11.5 mmt180 -74.98 -28.22 60.47 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.914 0.388 . . . . 0.0 111.538 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.451 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 6.3 t-20 -96.43 -5.1 40.48 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.622 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 89.6 m-20 78.2 15.66 1.36 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.313 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.612 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 17.0 pt -103.57 -169.22 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.388 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 41.6 mt-30 -120.42 153.35 36.69 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.694 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 4.0 p-10 -56.94 -57.5 12.27 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 121.826 0.822 . . . . 0.0 109.6 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.68 11.93 2.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.495 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 0.7 OUTLIER -71.48 -35.08 70.69 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.369 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.487 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 9.7 mp 72.65 119.46 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.367 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.872 HD12 HG21 ' A' ' 67' ' ' VAL . 7.1 pt -94.55 176.68 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.328 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.507 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 92.7 m-85 -124.44 160.39 53.25 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.977 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.686 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 28.9 Cg_endo -70.66 132.04 21.13 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.958 2.439 . . . . 0.0 113.143 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.47 9.29 41.55 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -100.46 148.03 25.2 Favored 'General case' 0 C--O 1.215 -0.757 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.512 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 61.1 t -114.6 111.15 34.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.658 HD11 HG21 ' A' ' 99' ' ' ILE . 64.3 mt -101.08 151.66 21.54 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.086 -177.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.452 ' HG2' HG22 ' A' ' 64' ' ' THR . 67.1 mt-30 -90.29 113.72 25.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.702 0.763 . . . . 0.0 110.786 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.8 m -120.19 151.1 52.69 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.607 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.99 -16.35 54.42 Favored 'Trans proline' 0 C--N 1.333 -0.262 0 C-N-CA 123.392 2.728 . . . . 0.0 114.201 -177.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.779 ' HB ' ' HA3' ' A' ' 59' ' ' GLY . 14.2 t -157.26 157.58 34.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.939 0.399 . . . . 0.0 111.088 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.507 ' HG2' ' HB1' ' A' ' 63' ' ' ALA . 12.6 mmmm -99.63 -170.38 1.89 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.469 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -102.39 -151.72 23.88 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.75 77.7 0.61 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.739 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.5 p -86.38 -27.74 24.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.919 0.39 . . . . 0.0 110.391 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 124.26 -66.07 0.53 Allowed Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.808 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -152.58 31.39 0.84 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.017 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -145.75 52.65 0.57 Allowed Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.724 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 41' ' ' ARG . . . -109.81 -17.95 13.54 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.504 0.669 . . . . 0.0 109.745 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.632 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -118.59 -82.9 0.85 Allowed Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.891 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 19.7 m120 74.35 25.77 1.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.465 0.706 . . . . 0.0 112.241 178.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.613 ' CD2' ' HE1' ' A' ' 50' ' ' PHE . 12.4 p90 -64.14 -40.43 96.14 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.591 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 62.7 t-105 -59.17 -31.01 68.6 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.081 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -53.77 -28.02 32.32 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.739 0.304 . . . . 0.0 110.834 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.752 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 16.2 m -137.63 31.18 2.55 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.281 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.591 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -111.65 146.69 37.01 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.15 0.5 . . . . 0.0 111.318 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -132.34 148.02 52.41 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.558 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 50.66 50.82 18.18 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 124.053 0.846 . . . . 0.0 112.116 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.483 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 31.6 t -74.22 125.24 33.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -149.59 153.51 37.22 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.126 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.762 ' CD1' HG22 ' A' ' 14' ' ' ILE . 25.8 mt -97.5 139.71 33.01 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.807 0.337 . . . . 0.0 110.799 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.541 HG23 ' HB ' ' A' ' 135' ' ' VAL . 33.7 m -133.44 156.04 41.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.789 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.592 ' HB3' ' HD2' ' A' ' 134' ' ' LYS . 1.4 m-20 70.13 5.74 5.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.663 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.73 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 99.35 35.59 4.66 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.289 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.61 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 82.48 -9.58 58.08 Favored Glycine 0 C--O 1.256 1.523 0 CA-C-O 123.003 1.335 . . . . 0.0 113.198 176.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.648 ' O ' ' HA ' ' A' ' 152' ' ' TYR . 18.1 ptpt -74.47 -16.23 60.86 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.569 HG23 ' HG3' ' A' ' 134' ' ' LYS . 24.4 t -140.69 140.21 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.075 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.85 HD12 HD21 ' A' ' 16' ' ' LEU . 7.7 tt -119.01 125.15 48.7 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -110.35 124.45 51.71 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.974 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -157.46 155.67 30.82 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.939 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 31.1 mt-10 -95.0 108.33 20.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.272 0.558 . . . . 0.0 110.605 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.901 ' HG ' ' CB ' ' A' ' 45' ' ' ASN . 0.2 OUTLIER -90.24 128.7 36.46 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.752 -179.81 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.752 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 75.7 ttt180 -70.04 140.69 52.87 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.403 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.481 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.7 p90 -156.46 -171.95 3.89 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.383 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.8 m -55.87 -29.9 60.65 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.787 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -97.67 20.75 49.42 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.204 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 98.75 -110.12 3.94 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.251 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -129.44 133.1 47.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.636 0.255 . . . . 0.0 110.786 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.481 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 11.8 t30 -134.43 127.37 31.39 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.642 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 29.7 ttp180 -79.93 102.35 9.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.448 0.642 . . . . 0.0 110.759 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.443 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 11.4 t -105.27 174.62 5.8 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.124 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.662 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 34.7 ptt180 -147.43 148.24 31.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.918 0.389 . . . . 0.0 111.787 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.751 HD13 HD22 ' A' ' 43' ' ' LEU . 10.9 tt -131.6 159.59 42.96 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.512 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.689 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 44.0 m-85 -99.79 106.04 17.88 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.341 0.115 . . . . 0.0 110.775 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.71 HD11 HD21 ' A' ' 129' ' ' LEU . 16.5 mt -68.74 -35.86 77.66 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.312 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.431 ' HA ' ' HD1' ' A' ' 7' ' ' PHE . 8.3 p-10 -58.26 -8.05 1.02 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.976 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.689 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 41.8 mt-10 -69.41 -55.2 11.02 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.236 0.541 . . . . 0.0 111.912 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.473 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 77.5 m-70 -122.23 6.02 9.7 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.306 -177.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.471 HG12 ' CH2' ' A' ' 52' ' ' TRP . 44.3 mm -107.15 113.2 42.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.88 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 167' ' ' CYS . . . -112.71 173.04 14.95 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.965 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.535 ' CG ' ' HB3' ' A' ' 25' ' ' CYS . 0.9 OUTLIER -110.95 128.27 55.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.674 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.96 89.14 3.07 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.37 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 56.99 42.16 26.58 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.442 0.464 . . . . 0.0 111.794 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.598 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 92.51 7.93 62.93 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.928 -0.654 . . . . 0.0 113.406 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -123.59 127.01 47.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.147 0.473 . . . . 0.0 112.094 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.405 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 42.1 mt -70.82 110.39 5.56 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.481 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 63.3 mt -135.15 141.31 43.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.382 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.473 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 9.7 p-80 -54.73 123.83 14.54 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.452 ' O ' ' HA3' ' A' ' 158' ' ' GLY . 43.3 t . . . . . 0 C--O 1.249 1.058 0 O-C-N 123.714 0.634 . . . . 0.0 111.217 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.618 ' HA2' ' OD1' ' A' ' 6' ' ' ASN . . . . . . . . 0 N--CA 1.483 1.822 0 N-CA-C 112.34 -0.304 . . . . 0.0 112.34 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 154' ' ' ASP . 1.0 OUTLIER -90.05 -59.96 2.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.742 0.306 . . . . 0.0 110.571 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.478 ' HD2' ' HG2' ' A' ' 155' ' ' GLU . 45.3 m-85 -139.75 -83.59 0.25 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.854 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.616 ' HB1' ' SG ' ' A' ' 167' ' ' CYS . . . -118.73 -27.75 5.78 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.54 -71.24 0.85 Allowed Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 119.988 -1.101 . . . . 0.0 112.784 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.618 ' OD1' ' HA2' ' A' ' 1' ' ' GLY . 74.1 m-20 65.78 10.47 6.85 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 122.455 0.302 . . . . 0.0 110.749 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.634 ' CE2' HD13 ' A' ' 14' ' ' ILE . 1.1 p90 -61.08 -34.08 74.36 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.404 ' HA ' HD11 ' A' ' 14' ' ' ILE . 23.3 t -68.02 -16.88 64.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.106 0.479 . . . . 0.0 110.279 -178.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.24 -21.16 79.94 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.746 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 11.1 m -130.45 -19.17 3.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.978 0.389 . . . . 0.0 111.622 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 m -94.41 135.09 36.23 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.561 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 11.7 ptm180 -112.72 -178.91 3.51 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.432 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 0.6 OUTLIER 40.75 47.98 2.57 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 123.909 0.755 . . . . 0.0 112.343 -179.648 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.825 HG22 HD13 ' A' ' 129' ' ' LEU . 7.9 mt -80.66 103.83 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.597 ' HA ' HD12 ' A' ' 129' ' ' LEU . 45.4 t -147.95 126.19 12.23 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.78 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -92.34 154.93 18.26 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.559 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -95.09 74.66 3.45 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.4 -57.87 4.88 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.925 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.453 ' HA ' ' HZ ' ' A' ' 120' ' ' PHE . . . -145.28 -9.31 0.58 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.816 0.341 . . . . 0.0 110.257 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -94.98 95.59 8.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.823 0.344 . . . . 0.0 110.089 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.857 ' HB2' HD22 ' A' ' 39' ' ' LEU . 42.8 tp -59.28 128.12 35.53 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.369 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.543 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 51.1 ttt180 -131.1 129.83 42.38 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.05 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.62 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -150.61 147.34 27.3 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.383 0.611 . . . . 0.0 111.19 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.571 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 1.3 mm-40 -84.49 81.31 8.9 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.842 178.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.553 ' HB2' ' HA2' ' A' ' 162' ' ' GLY . 58.6 m -67.6 128.08 35.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.494 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 10' ' ' SER . 51.1 ttt-85 -74.37 116.19 14.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.793 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -89.5 159.02 17.45 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.092 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.48 -18.23 3.52 Favored Glycine 0 C--N 1.337 0.592 0 O-C-N 124.861 1.351 . . . . 0.0 114.442 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -71.64 -12.37 61.31 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.03 9.62 60.58 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.39 163.69 12.12 Favored Glycine 0 C--O 1.228 -0.238 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.032 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.571 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 70.2 m-85 -100.02 134.03 43.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.63 0.252 . . . . 0.0 110.499 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.6 m -123.79 128.68 49.9 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.271 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.4 114.72 6.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.02 0.438 . . . . 0.0 110.771 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 29.7 t -119.89 149.56 41.89 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.777 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 2.8 p -142.04 136.48 29.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.002 0.43 . . . . 0.0 111.204 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.444 HG23 ' HB3' ' A' ' 21' ' ' LEU . 13.4 tt -134.06 144.38 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.73 -177.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -77.84 98.81 5.71 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.798 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.857 HD22 ' HB2' ' A' ' 21' ' ' LEU . 1.3 mp -76.25 -6.4 51.25 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.272 0.558 . . . . 0.0 110.153 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -63.61 -21.65 66.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.65 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.708 ' HD3' ' HA2' ' A' ' 115' ' ' GLY . 16.8 ptt85 -111.32 19.35 18.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.039 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.553 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 38.6 m-85 -131.44 -32.66 1.52 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.638 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.739 HD22 HD13 ' A' ' 151' ' ' ILE . 51.7 mt -109.71 138.53 45.95 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.036 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 m -132.79 144.22 50.09 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.612 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.467 ' ND2' ' HB2' ' A' ' 123' ' ' SER . 21.6 p-10 -88.27 106.5 18.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.425 0.631 . . . . 0.0 110.205 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -103.24 92.43 4.51 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 122.133 -0.354 . . . . 0.0 110.906 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 49.51 44.29 24.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.78 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.595 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 85.82 30.0 24.8 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.486 178.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.675 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 2.5 t60 -152.58 124.6 8.01 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.766 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 63.6 m-85 -62.26 143.3 57.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.791 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.4 mtm180 -144.8 134.32 23.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.409 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.553 ' HA ' ' O ' ' A' ' 42' ' ' TYR . 99.4 m95 -75.58 141.76 42.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.882 177.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.533 HG22 ' HA ' ' A' ' 42' ' ' TYR . 17.5 m -64.28 115.93 3.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.329 0.585 . . . . 0.0 110.747 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.8 t -95.7 -10.35 29.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.497 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -105.08 -4.61 41.46 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.455 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.6 -136.92 15.12 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.981 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -88.7 -141.15 7.73 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.33 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -142.61 -164.69 10.25 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.029 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -102.18 -14.5 28.34 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.142 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 114.06 -110.58 2.43 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.339 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.31 -111.48 4.18 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.285 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.8 m -119.4 114.45 22.35 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.177 0.513 . . . . 0.0 110.539 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.523 ' HB1' ' HG2' ' A' ' 110' ' ' LYS . . . -106.43 176.55 5.13 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.68 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.55 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 10.0 p -126.85 115.89 20.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.957 0.408 . . . . 0.0 112.074 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.562 HG21 ' CE2' ' A' ' 80' ' ' PHE . 7.4 p -106.29 148.04 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.062 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 10.3 m -93.04 130.27 38.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.172 0.51 . . . . 0.0 110.454 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.553 HG21 HD12 ' A' ' 99' ' ' ILE . 58.2 t -83.26 138.39 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.185 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -108.4 171.2 7.55 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 124.373 1.045 . . . . 0.0 109.61 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.7 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 63.7 tt0 -68.95 126.05 28.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.395 -178.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.44 8.55 59.71 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.988 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -119.84 123.18 43.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.902 0.382 . . . . 0.0 110.962 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.557 ' HA ' HG12 ' A' ' 99' ' ' ILE . 69.3 p -104.76 -176.91 3.21 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.61 HD22 HG23 ' A' ' 99' ' ' ILE . 1.3 mm? -51.53 -40.79 60.34 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.392 0.615 . . . . 0.0 109.55 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.443 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 38.8 ttm180 -60.06 -42.47 94.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.253 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -70.66 -43.39 69.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.355 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 72' ' ' THR . 38.3 mm -62.96 -45.33 99.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.732 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.95 -56.22 26.36 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.654 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -64.72 -26.73 68.49 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 45.6 ttm-85 -72.98 -38.86 66.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.562 ' CE2' HG21 ' A' ' 65' ' ' VAL . 96.8 m-85 -111.02 19.64 18.26 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.9 t70 55.27 36.17 26.48 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.679 0.752 . . . . 0.0 111.776 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.732 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.5 p -113.72 171.19 7.73 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.672 ' O ' HG13 ' A' ' 87' ' ' ILE . 6.9 t70 -97.77 127.34 43.65 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.91 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.503 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 11.1 p90 -52.92 -30.12 32.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.287 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -73.33 -38.01 65.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.975 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -68.16 -45.91 72.21 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.672 HG13 ' O ' ' A' ' 83' ' ' ASP . 6.0 mt -54.67 -47.03 73.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.61 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.93 -47.89 81.28 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.679 177.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -56.75 -42.41 79.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.981 0.42 . . . . 0.0 111.369 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -69.79 -36.24 75.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.759 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 6.9 t-20 -89.4 -5.33 57.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.387 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 94.0 m-20 74.8 21.05 2.17 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.587 0.755 . . . . 0.0 111.425 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.61 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 17.6 pt -108.89 -173.48 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.581 ' H ' ' HB2' ' A' ' 97' ' ' ASP . 88.7 mt-30 -110.62 158.15 18.9 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.535 ' O ' HD23 ' A' ' 73' ' ' LEU . 3.2 p-10 -58.98 -55.34 36.46 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-O 122.221 1.01 . . . . 0.0 108.43 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -79.68 12.06 2.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.666 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.581 ' HB2' ' H ' ' A' ' 94' ' ' GLN . 4.4 t70 -63.73 -32.57 74.1 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.1 mt 70.68 112.44 0.05 Allowed 'General case' 0 C--O 1.234 0.249 0 O-C-N 124.465 1.103 . . . . 0.0 110.123 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.835 HG21 HD11 ' A' ' 105' ' ' LEU . 14.4 pt -95.33 175.14 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.155 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.512 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 97.5 m-85 -128.96 158.8 71.52 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.969 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.7 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 20.8 Cg_endo -66.97 138.81 49.19 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.508 2.806 . . . . 0.0 114.307 -178.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.07 11.3 57.72 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.702 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 66' ' ' THR . 74.1 mt-30 -102.64 166.04 10.73 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.352 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.55 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 80.9 t -122.39 114.78 43.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-O 120.931 0.396 . . . . 0.0 110.198 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.835 HD11 HG21 ' A' ' 99' ' ' ILE . 79.0 mt -107.26 152.01 24.68 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.823 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 63' ' ' ALA . 72.9 mt-30 -89.9 116.22 27.81 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.795 0.807 . . . . 0.0 111.45 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.9 m -126.29 150.91 71.42 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 114.253 -1.339 . . . . 0.0 109.954 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.68 -17.41 59.82 Favored 'Trans proline' 0 N--CA 1.476 0.442 0 C-N-CA 123.735 2.957 . . . . 0.0 114.952 -177.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.6 t -148.54 153.01 37.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.942 0.401 . . . . 0.0 111.268 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.523 ' HG2' ' HB1' ' A' ' 63' ' ' ALA . 11.1 mmmm -101.63 -170.05 1.77 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.265 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.74 118.61 14.67 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.975 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 81.62 -80.85 1.7 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.849 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.6 t -142.93 -87.98 0.14 Allowed 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.18 48.14 1.0 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.388 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.708 ' HA2' ' HD3' ' A' ' 41' ' ' ARG . . . -77.68 61.23 3.66 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.616 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 174.76 56.95 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.499 ' H ' ' HA ' ' A' ' 41' ' ' ARG . . . -99.23 -39.0 8.66 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.097 -0.552 . . . . 0.0 110.353 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . -85.77 -60.92 1.73 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.905 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 6.9 m-20 72.28 25.55 2.84 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 178.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.6 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 25.3 p90 -55.78 -39.14 70.84 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.627 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 62.2 t-105 -59.03 -32.96 70.21 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.67 -178.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -52.31 -38.6 58.91 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 121.7 0.762 . . . . 0.0 110.77 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.946 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 17.2 m -122.91 25.85 8.42 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.503 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.627 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -114.72 134.61 54.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.857 0.36 . . . . 0.0 111.05 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.602 ' HD2' ' O ' ' A' ' 124' ' ' ALA . 7.1 mpt_? -131.33 158.61 40.23 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.631 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.9 t70 53.94 46.1 26.32 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.761 0.791 . . . . 0.0 110.214 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.493 ' CG1' HD11 ' A' ' 136' ' ' LEU . 22.5 t -79.85 122.09 34.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.614 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 128' ' ' ARG . 1.3 ptp85 -146.55 147.8 31.5 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.286 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.825 HD13 HG22 ' A' ' 14' ' ' ILE . 19.4 mt -86.97 127.84 35.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.204 0.526 . . . . 0.0 110.072 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.853 HG23 ' HB ' ' A' ' 135' ' ' VAL . 27.6 m -116.79 157.17 17.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.909 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.501 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 0.9 OUTLIER 68.42 3.23 3.67 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.584 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.642 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 97.91 29.24 7.78 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.32 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 98.34 -22.05 42.89 Favored Glycine 0 C--O 1.261 1.828 0 CA-C-O 123.014 1.341 . . . . 0.0 113.098 177.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.66 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 40.5 pttt -67.97 -14.79 63.24 Favored 'General case' 0 C--N 1.317 -0.814 0 O-C-N 121.279 -1.13 . . . . 0.0 109.271 177.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.853 ' HB ' HG23 ' A' ' 130' ' ' VAL . 3.1 t -140.85 146.91 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.895 177.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 26.5 tp -129.33 122.62 29.91 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -117.49 137.62 52.41 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.884 0.373 . . . . 0.0 110.988 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.636 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -160.09 169.32 23.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.575 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 124' ' ' ALA . 8.5 mm-40 -95.33 106.45 18.5 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.595 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 58.8 mt -97.81 125.06 42.46 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.457 0.646 . . . . 0.0 111.468 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.946 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 65.4 ttt180 -70.28 141.34 52.41 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.933 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.42 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 4.8 p90 -152.35 -173.73 4.65 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.868 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.0 m -56.2 -24.66 43.3 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -108.56 27.98 12.5 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.502 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 102.43 -117.89 5.94 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.161 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.431 ' CH2' ' HD3' ' A' ' 125' ' ' ARG . 80.0 m95 -127.2 142.14 51.56 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.42 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 54.6 t30 -138.02 137.74 38.16 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.8 ttt85 -85.03 113.75 21.68 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.065 0.46 . . . . 0.0 110.72 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.675 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 47.5 t -122.75 166.61 14.67 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.943 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 10.2 ptt180 -147.37 145.25 29.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.205 0.526 . . . . 0.0 111.677 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.766 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 6.9 tt -124.79 150.56 29.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.676 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.326 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.584 ' CB ' ' HG3' ' A' ' 155' ' ' GLU . 18.1 m-85 -94.74 103.96 15.87 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 122.166 -0.334 . . . . 0.0 110.921 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.743 HD13 HD22 ' A' ' 21' ' ' LEU . 25.4 mt -65.07 -36.51 84.57 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.09 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.66 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 8.8 t70 -57.61 -7.97 0.77 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.943 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.584 ' HG3' ' CB ' ' A' ' 152' ' ' TYR . 42.0 mt-10 -70.63 -54.31 12.46 Favored 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 122.002 -0.436 . . . . 0.0 112.081 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.506 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 54.1 m80 -125.57 5.03 7.54 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.165 -177.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.498 HG12 ' CH2' ' A' ' 52' ' ' TRP . 41.7 mm -101.87 106.47 19.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.506 ' HA3' ' OXT' ' A' ' 167' ' ' CYS . . . -110.89 161.88 12.68 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.978 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.506 ' HA ' ' O ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER -103.61 136.36 43.46 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.791 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -119.01 86.55 2.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.621 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 48.6 50.48 17.01 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.553 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 99.55 6.01 55.18 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.318 -0.944 . . . . 0.0 113.815 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 159' ' ' ASN . 37.8 mt-10 -123.25 153.81 39.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 117.121 0.461 . . . . 0.0 111.288 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.454 HD21 ' HD2' ' A' ' 7' ' ' PHE . 30.8 mt -103.58 121.61 43.26 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.581 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.73 HG12 ' H ' ' A' ' 166' ' ' HIS . 13.8 tt -148.04 -179.47 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.956 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.73 ' H ' HG12 ' A' ' 165' ' ' ILE . 4.9 t60 -78.16 107.56 10.83 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.616 ' SG ' ' HB1' ' A' ' 4' ' ' ALA . 47.3 t . . . . . 0 C--O 1.251 1.156 0 O-C-N 123.788 0.68 . . . . 0.0 111.778 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.654 ' HA2' ' OD1' ' A' ' 6' ' ' ASN . . . . . . . . 0 N--CA 1.484 1.834 0 N-CA-C 112.371 -0.292 . . . . 0.0 112.371 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 154' ' ' ASP . 0.9 OUTLIER -91.85 -69.41 0.74 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 122.792 -0.24 . . . . 0.0 111.546 -179.812 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.525 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 58.0 m-85 -132.55 -100.46 0.28 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.567 ' HB1' ' SG ' ' A' ' 167' ' ' CYS . . . -96.2 -32.45 12.45 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -177.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.91 -74.94 0.37 Allowed Glycine 0 N--CA 1.436 -1.345 0 C-N-CA 119.994 -1.098 . . . . 0.0 113.275 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.654 ' OD1' ' HA2' ' A' ' 1' ' ' GLY . 39.0 m-80 66.46 15.72 10.19 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 122.332 0.253 . . . . 0.0 110.83 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.608 ' CE2' HD13 ' A' ' 14' ' ' ILE . 1.4 p90 -61.43 -35.11 76.64 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.509 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.572 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.9 OUTLIER -64.48 -21.43 66.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.246 0.546 . . . . 0.0 110.419 -179.001 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.47 -25.3 75.89 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.265 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 18.4 p -125.72 -10.93 6.72 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 117.135 0.467 . . . . 0.0 111.173 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 6.8 m -107.98 132.33 53.63 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -111.81 -179.46 3.7 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 45.37 46.3 10.36 Favored 'General case' 0 C--N 1.315 -0.933 0 O-C-N 123.859 0.724 . . . . 0.0 111.762 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.875 HG22 HD13 ' A' ' 129' ' ' LEU . 8.0 mt -80.92 106.82 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.6 ' HA ' HD12 ' A' ' 129' ' ' LEU . 73.5 m -147.78 126.98 12.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.064 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.787 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -102.47 158.89 15.9 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 121.431 0.634 . . . . 0.0 111.991 179.447 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -103.47 77.63 1.52 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.77 -54.71 4.98 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.589 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -149.53 -13.44 0.29 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.146 0.498 . . . . 0.0 110.291 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.57 ' HG3' ' CG2' ' A' ' 36' ' ' VAL . 21.0 tpt180 -83.25 85.75 7.16 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.316 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.787 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 54.0 tp -62.78 128.4 35.75 Favored 'General case' 0 C--O 1.213 -0.838 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -133.66 121.88 22.64 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.797 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.623 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -143.22 147.31 34.65 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.452 0.644 . . . . 0.0 111.54 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.514 ' O ' ' HD2' ' A' ' 32' ' ' TYR . 4.7 mm-40 -82.21 76.76 9.08 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.561 -1.199 . . . . 0.0 109.376 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.566 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 69.5 m -65.04 124.81 23.05 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.194 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 10' ' ' SER . 72.0 ttt180 -64.67 134.59 54.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.89 178.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -115.05 151.87 33.48 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.65 -10.62 6.4 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 114.495 -1.23 . . . . 0.0 113.737 -178.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -79.22 1.46 24.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.17 0.51 . . . . 0.0 110.155 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.95 12.15 74.93 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.963 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -130.21 160.56 23.01 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 119.984 -1.103 . . . . 0.0 112.953 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.514 ' HD2' ' O ' ' A' ' 24' ' ' GLU . 76.7 m-85 -95.85 125.15 40.21 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.9 m -108.4 137.34 46.52 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.733 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.1 m -71.93 112.74 8.28 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.151 0.5 . . . . 0.0 110.387 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.432 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 28.0 t -114.32 146.45 40.49 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.19 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.9 p -143.37 133.71 21.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.062 0.458 . . . . 0.0 110.981 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.451 HG23 ' HB3' ' A' ' 21' ' ' LEU . 9.3 tt -135.18 154.0 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.892 -177.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.547 ' OD1' ' HB3' ' A' ' 40' ' ' ASN . 35.2 t0 -89.46 112.4 23.54 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.079 -0.388 . . . . 0.0 110.664 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.521 HD23 ' CB ' ' A' ' 21' ' ' LEU . 3.6 mm? -86.46 -4.83 59.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.927 0.394 . . . . 0.0 110.149 178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.547 ' HB3' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -71.68 -15.45 62.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.805 0.812 . . . . 0.0 108.892 179.058 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.54 ' HD3' ' O ' ' A' ' 114' ' ' GLY . 30.8 mtt180 -105.87 13.22 29.77 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.527 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.426 ' HB2' HD13 ' A' ' 39' ' ' LEU . 48.2 m-85 -133.96 -29.51 1.29 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.712 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.872 HD22 HD13 ' A' ' 151' ' ' ILE . 31.9 mt -109.2 140.62 42.57 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.107 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.487 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 3.1 m -128.56 145.36 51.15 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.842 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.475 ' HA ' HD13 ' A' ' 140' ' ' LEU . 3.2 p-10 -89.93 104.43 16.99 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -106.67 94.26 5.03 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.373 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 50.08 42.93 25.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.225 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.659 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 86.2 29.7 24.54 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.241 -0.98 . . . . 0.0 113.125 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.628 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 16.9 t-80 -153.71 127.33 8.72 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.806 ' HZ ' ' HB3' ' A' ' 138' ' ' ALA . 81.4 m-85 -64.08 149.53 47.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.929 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -144.63 129.5 18.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.82 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.474 ' HZ2' ' O ' ' A' ' 152' ' ' TYR . 94.2 m95 -76.07 133.57 40.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.971 177.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.4 m -122.67 54.06 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.316 0.579 . . . . 0.0 110.205 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.9 m -75.8 7.37 3.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.378 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -130.36 26.0 4.21 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.947 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.12 56.75 5.04 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.354 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.575 ' HA3' ' HA3' ' A' ' 112' ' ' GLY . . . 128.66 -119.18 2.96 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.883 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.4 -178.23 40.52 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -149.83 49.1 0.57 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.287 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.96 167.4 31.87 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.076 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 108' ' ' PRO . . . 101.68 -140.34 14.82 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.011 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 49.2 m -126.14 119.65 28.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.127 0.489 . . . . 0.0 110.555 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -124.28 176.72 6.26 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.873 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.464 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 17.4 p -128.06 113.67 16.09 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.355 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.443 ' HA ' ' HE3' ' A' ' 110' ' ' LYS . 9.7 p -102.63 139.78 22.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.918 0.389 . . . . 0.0 110.957 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 8.2 m -88.47 126.16 35.1 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.546 ' CG2' HD12 ' A' ' 99' ' ' ILE . 43.9 t -75.33 130.23 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.132 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -103.6 169.43 8.53 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 124.258 0.974 . . . . 0.0 110.344 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.6 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 6.1 tp-100 -62.0 121.29 12.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.265 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.03 16.04 39.84 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.908 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -121.04 129.54 53.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.862 0.331 . . . . 0.0 111.075 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.655 ' HA ' HG12 ' A' ' 99' ' ' ILE . 74.4 p -115.02 178.05 4.42 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.587 HD22 HG23 ' A' ' 99' ' ' ILE . 1.3 mm? -52.24 -42.71 63.84 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.641 0.734 . . . . 0.0 109.31 178.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.698 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 65.8 mtt180 -59.74 -41.12 90.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.4 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -71.61 -44.48 64.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.278 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.555 HG12 ' O ' ' A' ' 72' ' ' THR . 37.8 mm -58.83 -45.28 91.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.628 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.44 -49.96 68.88 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.693 -0.685 . . . . 0.0 113.321 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.698 ' HD3' ' O ' ' A' ' 74' ' ' ARG . 1.0 OUTLIER -73.84 -27.04 60.89 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 122.434 -0.451 . . . . 0.0 111.632 -179.011 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -76.54 -38.48 54.97 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.432 ' CE2' HG21 ' A' ' 65' ' ' VAL . 95.6 m-85 -112.47 19.94 17.11 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.2 t70 53.55 55.0 9.17 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 122.072 0.939 . . . . 0.0 111.701 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.628 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -136.32 172.87 12.38 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.235 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.678 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.9 t70 -98.73 122.66 42.24 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.905 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.442 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 14.1 p90 -53.16 -27.56 21.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.091 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.78 -34.61 58.0 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.923 0.392 . . . . 0.0 109.954 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.506 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 39.7 tt0 -69.42 -48.56 60.6 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.678 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.4 mt -53.36 -43.89 52.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.973 178.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.601 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.44 -52.0 65.29 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.322 178.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -61.25 -32.41 72.21 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.846 ' HB3' ' HB2' ' A' ' 106' ' ' GLN . 1.9 mmp_? -65.34 -37.11 86.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.08 0.467 . . . . 0.0 110.491 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 12.7 t-20 -93.62 -4.35 50.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.928 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 17.3 m120 78.34 16.82 1.21 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.491 0.716 . . . . 0.0 111.178 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.601 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 11.1 pt -102.57 -175.88 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.56 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 77.4 mt-30 -112.29 160.89 17.21 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.738 -0.385 . . . . 0.0 109.969 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.442 ' O ' HD23 ' A' ' 73' ' ' LEU . 11.2 p-10 -55.82 -58.26 8.6 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 122.36 1.076 . . . . 0.0 109.277 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -76.39 12.0 1.38 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.859 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.56 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 1.9 t70 -66.17 -35.92 81.75 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.9 mp 68.71 115.88 0.04 OUTLIER 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.097 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.741 HG21 HD11 ' A' ' 105' ' ' LEU . 10.1 pt -94.54 176.6 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.665 -178.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.458 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 15.3 m-85 -129.25 157.22 76.78 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.624 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.6 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 17.9 Cg_endo -64.93 135.82 45.97 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 122.889 2.393 . . . . 0.0 112.863 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.68 20.95 22.94 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' ' 66' ' ' THR . 92.6 mt-30 -109.77 165.81 11.4 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.464 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 88.5 t -125.52 115.21 42.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.741 HD11 HG21 ' A' ' 99' ' ' ILE . 87.1 mt -110.77 151.2 28.06 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.952 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.846 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 71.2 mt-30 -90.19 115.08 27.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.872 0.844 . . . . 0.0 110.581 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.1 151.25 68.92 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.36 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 32.2 Cg_endo -62.22 -21.03 71.91 Favored 'Trans proline' 0 N--CA 1.474 0.346 0 C-N-CA 123.395 2.73 . . . . 0.0 114.673 -177.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.9 t -153.89 156.56 37.78 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.079 0.466 . . . . 0.0 111.184 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.443 ' HE3' ' HA ' ' A' ' 65' ' ' VAL . 13.3 mmmm -96.25 -165.98 1.36 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.444 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -76.3 63.51 2.93 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.68 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.575 ' HA3' ' HA3' ' A' ' 57' ' ' GLY . . . -152.83 134.93 4.67 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.5 m -133.8 12.48 4.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.045 0.45 . . . . 0.0 110.616 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.54 ' O ' ' HD3' ' A' ' 41' ' ' ARG . . . 68.03 41.71 86.66 Favored Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.545 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -124.91 93.9 0.45 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.676 -0.774 . . . . 0.0 111.885 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.33 53.3 13.88 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -79.58 -29.97 41.44 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.97 -0.615 . . . . 0.0 110.171 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . -106.91 -68.46 0.68 Allowed Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.483 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 90.9 m-20 74.21 29.8 1.26 Allowed 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 122.94 0.496 . . . . 0.0 111.459 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.638 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 19.6 p90 -62.75 -39.36 93.89 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.076 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.639 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 42.8 t-105 -62.35 -32.39 73.16 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.848 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -52.58 -37.69 58.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.796 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.67 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 31.3 m -123.29 26.62 7.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.462 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.639 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -107.42 144.64 34.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.251 177.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.471 ' HB2' ' CZ3' ' A' ' 146' ' ' TRP . 1.8 tpt180 -129.75 137.85 50.77 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.7 t70 54.53 67.66 0.98 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.481 0.658 . . . . 0.0 110.659 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.501 HG12 HD11 ' A' ' 136' ' ' LEU . 39.2 t -91.79 124.51 44.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.866 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -148.0 148.11 30.36 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.972 0.415 . . . . 0.0 110.559 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.875 HD13 HG22 ' A' ' 14' ' ' ILE . 30.4 mt -86.68 134.83 33.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.674 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.599 HG23 ' HB ' ' A' ' 135' ' ' VAL . 35.6 m -127.82 157.31 39.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.18 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.49 ' HB3' ' HD3' ' A' ' 134' ' ' LYS . 6.4 m-20 72.38 1.88 4.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.931 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.628 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 99.09 28.03 7.93 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.628 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.522 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 98.07 -23.14 37.34 Favored Glycine 0 C--O 1.266 2.13 0 CA-C-O 123.282 1.49 . . . . 0.0 112.654 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.789 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 15.9 ptmt -64.72 -20.0 66.09 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 121.721 -0.87 . . . . 0.0 108.933 177.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.599 ' HB ' HG23 ' A' ' 130' ' ' VAL . 6.8 t -136.94 146.01 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.324 0.583 . . . . 0.0 110.378 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.561 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 30.5 tp -124.95 121.54 34.74 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.5 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 40.2 tt0 -112.02 134.46 53.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.951 0.405 . . . . 0.0 111.788 -177.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.806 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -163.29 161.85 24.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.749 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -96.06 110.29 22.56 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.659 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 50.8 mt -96.19 137.04 35.85 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.175 0.512 . . . . 0.0 111.115 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.67 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 56.4 ttt180 -72.59 140.74 48.23 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.942 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.498 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 3.3 p90 -159.42 -170.34 2.92 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.563 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.4 m -54.66 -32.46 59.24 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 123.349 0.406 . . . . 0.0 111.789 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -97.51 16.52 60.43 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.404 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 141' ' ' ARG . . . 101.58 -110.23 3.8 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.266 -0.968 . . . . 0.0 112.395 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.471 ' CZ3' ' HB2' ' A' ' 125' ' ' ARG . 70.7 m95 -132.93 129.39 38.24 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.498 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 65.7 t30 -130.35 145.02 51.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.721 0.295 . . . . 0.0 110.617 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -73.88 109.28 7.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.272 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.628 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 35.8 t -122.6 165.32 16.64 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.561 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 27.7 mtt85 -145.98 158.82 43.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.09 0.471 . . . . 0.0 111.026 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.872 HD13 HD22 ' A' ' 43' ' ' LEU . 10.2 tt -140.21 146.87 24.06 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.063 178.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.708 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 69.4 m-85 -90.71 102.76 15.51 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.301 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.733 HD13 HD22 ' A' ' 21' ' ' LEU . 20.6 mt -63.21 -34.16 77.05 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.813 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.789 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 6.1 t70 -58.52 -9.09 1.45 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.156 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.708 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 43.6 mt-10 -74.2 -50.69 18.11 Favored 'General case' 0 CA--C 1.508 -0.663 0 O-C-N 121.92 -0.488 . . . . 0.0 112.156 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.518 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 13.1 m170 -120.53 1.25 10.62 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.39 -177.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.419 HG12 ' HH2' ' A' ' 52' ' ' TRP . 47.5 mm -105.93 110.79 32.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.029 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.459 ' HA3' ' OXT' ' A' ' 167' ' ' CYS . . . -114.98 160.14 13.36 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.174 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.566 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.8 t30 -102.53 128.31 49.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.925 0.393 . . . . 0.0 109.972 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.416 ' HB2' HD11 ' A' ' 165' ' ' ILE . 58.6 ttt-85 -124.46 91.39 3.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.451 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 58.82 42.23 20.24 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.34 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.519 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 92.19 15.39 53.87 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.882 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 159' ' ' ASN . 10.5 tp10 -124.09 143.86 50.21 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.674 -0.309 . . . . 0.0 111.225 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.555 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 18.6 mt -103.31 110.49 22.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.927 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.504 HD13 ' H ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -138.28 178.31 4.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.818 179.751 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.518 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 36.4 p-80 -72.9 113.78 10.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.822 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.567 ' SG ' ' HB1' ' A' ' 4' ' ' ALA . 46.9 t . . . . . 0 C--O 1.252 1.197 0 O-C-N 123.871 0.732 . . . . 0.0 111.63 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.812 0 N-CA-C 112.09 -0.404 . . . . 0.0 112.09 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.877 HD21 ' H ' ' A' ' 2' ' ' ASN . 0.0 OUTLIER -88.12 151.74 22.5 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.457 0.646 . . . . 0.0 111.297 -179.734 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.4 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 22.7 m-85 -133.16 -61.34 0.83 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.554 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.579 ' HB1' ' SG ' ' A' ' 167' ' ' CYS . . . -131.76 -25.92 2.04 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.642 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.06 -70.17 1.25 Allowed Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 119.576 -1.297 . . . . 0.0 112.718 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.439 ' OD1' ' HB2' ' A' ' 2' ' ' ASN . 2.4 m-20 66.08 10.85 7.37 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 122.535 0.334 . . . . 0.0 110.619 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.672 ' CE2' HD13 ' A' ' 14' ' ' ILE . 1.0 OUTLIER -58.5 -33.53 69.93 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.54 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.2 p -63.32 -22.35 66.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.507 0.594 . . . . 0.0 110.398 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.03 -21.73 79.02 Favored Glycine 0 CA--C 1.522 0.519 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.421 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 26' ' ' ARG . 59.4 m -127.84 -18.18 4.31 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 117.15 0.475 . . . . 0.0 111.485 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.8 m -101.42 129.98 47.55 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.973 0.416 . . . . 0.0 109.97 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.478 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 2.8 ptm180 -110.08 -178.47 3.53 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 42.89 47.72 4.9 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 123.748 0.655 . . . . 0.0 112.358 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.858 HG22 HD13 ' A' ' 129' ' ' LEU . 6.3 mt -81.76 103.39 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-O 121.253 0.549 . . . . 0.0 109.833 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.602 ' CA ' HD12 ' A' ' 129' ' ' LEU . 82.6 m -145.67 125.1 13.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.858 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.769 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -93.39 153.42 18.52 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 122.021 0.915 . . . . 0.0 113.1 -178.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -94.05 73.92 4.08 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.956 -1.474 . . . . 0.0 107.835 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.03 -55.2 4.78 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.946 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.526 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -146.33 -12.4 0.47 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.083 0.468 . . . . 0.0 110.102 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -88.89 94.49 9.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.898 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.911 ' HB2' HD22 ' A' ' 39' ' ' LEU . 46.7 tp -60.15 122.86 15.46 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.473 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 15' ' ' CYS . 51.4 ttp180 -126.25 125.58 42.61 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.581 -178.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.636 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -148.25 145.91 28.41 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.63 0.728 . . . . 0.0 111.323 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.591 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 2.3 mm-40 -81.17 76.04 8.13 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.386 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.658 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 54.9 m -64.99 130.44 43.37 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.306 0.574 . . . . 0.0 111.336 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.472 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 3.8 tmm_? -72.18 118.88 15.61 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.394 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 14.0 ptm180 -87.17 156.44 19.69 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -50.92 -20.44 4.32 Favored Glycine 0 C--N 1.339 0.702 0 O-C-N 124.672 1.232 . . . . 0.0 114.768 -177.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -72.22 -9.96 59.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.236 0.541 . . . . 0.0 110.057 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.13 6.43 63.15 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.429 ' O ' ' HG2' ' A' ' 27' ' ' ARG . . . -106.36 164.9 13.53 Favored Glycine 0 C--O 1.224 -0.506 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.524 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.591 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 71.0 m-85 -101.61 130.34 47.92 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.878 0.37 . . . . 0.0 110.912 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.4 m -119.1 133.46 55.78 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.873 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.8 m -71.48 110.4 6.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.279 0.561 . . . . 0.0 111.079 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.4 t -113.61 150.88 32.46 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.665 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 5.1 p -144.88 137.02 21.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.937 0.399 . . . . 0.0 110.676 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.474 HG23 ' HB3' ' A' ' 21' ' ' LEU . 10.6 tt -133.98 144.77 34.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.267 -177.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.0 92.71 3.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.025 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.911 HD22 ' HB2' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -71.87 -11.13 60.65 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.139 0.495 . . . . 0.0 110.669 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.526 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 26.5 p30 -67.25 -8.64 33.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.909 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.434 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 30.5 ttm180 -108.25 -0.91 20.58 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.729 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 91.4 m-85 -125.64 -23.03 4.12 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.634 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.645 HD22 HD13 ' A' ' 151' ' ' ILE . 48.7 mt -111.02 137.66 48.39 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.19 0.519 . . . . 0.0 111.207 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.428 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 5.2 m -130.61 146.16 52.06 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.051 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.458 ' CG ' ' HB3' ' A' ' 123' ' ' SER . 3.8 p-10 -94.91 106.05 18.01 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -102.42 90.03 3.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.976 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.477 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 66.9 t30 52.5 43.23 31.26 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.138 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.579 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 84.75 38.64 9.33 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.644 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -150.9 137.61 18.9 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.716 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 15.0 m-85 -80.51 141.76 34.84 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.298 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -141.03 131.55 25.39 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.489 ' CD1' HD11 ' A' ' 151' ' ' ILE . 86.1 m95 -76.04 136.81 39.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.598 177.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.68 88.01 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.9 m -115.09 30.53 7.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.6 0.714 . . . . 0.0 110.268 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -153.87 47.69 0.53 Allowed Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.182 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -129.2 144.67 15.63 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.795 -0.716 . . . . 0.0 111.992 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -120.21 -156.96 10.06 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.486 -0.645 . . . . 0.0 111.486 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.21 -118.02 1.4 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.031 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.01 -142.03 6.28 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.12 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -130.0 84.27 0.32 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.279 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 108' ' ' PRO . . . -145.59 -125.97 1.79 Allowed Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 91.0 m -140.81 118.0 11.3 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.168 0.508 . . . . 0.0 110.467 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.463 ' HB1' ' HG2' ' A' ' 110' ' ' LYS . . . -132.89 177.9 7.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.743 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.459 HG22 ' HG2' ' A' ' 106' ' ' GLN . 11.5 p -128.8 115.78 18.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.72 0.295 . . . . 0.0 111.284 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.495 HG21 ' CE2' ' A' ' 80' ' ' PHE . 12.0 p -102.07 145.41 11.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.066 0.46 . . . . 0.0 111.447 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 3.8 m -92.96 131.33 38.06 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.938 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.535 ' CG2' HD12 ' A' ' 99' ' ' ILE . 49.2 t -83.31 135.62 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.808 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -102.63 169.42 8.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 124.349 1.03 . . . . 0.0 111.051 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.651 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 6.5 tp-100 -63.39 116.66 5.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.389 -178.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.68 -16.47 58.67 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.96 -0.564 . . . . 0.0 113.151 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -82.38 134.96 35.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.027 0.441 . . . . 0.0 110.979 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.59 ' HA ' HG12 ' A' ' 99' ' ' ILE . 68.6 p -113.37 178.64 4.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.692 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.683 HD22 HG23 ' A' ' 99' ' ' ILE . 1.7 mm? -52.96 -41.18 64.29 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.216 0.532 . . . . 0.0 110.198 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.518 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 43.1 ttm105 -65.65 -36.88 84.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.282 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -68.47 -39.4 81.42 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 72' ' ' THR . 42.2 mm -66.41 -49.55 74.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.504 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.767 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -58.07 -45.84 93.38 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.67 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 78' ' ' ARG . 24.8 ttm180 -64.68 -37.24 86.9 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.899 0.381 . . . . 0.0 111.815 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -77.92 -33.87 51.56 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.495 ' CE2' HG21 ' A' ' 65' ' ' VAL . 96.4 m-85 -110.3 20.46 17.79 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.5 t0 53.87 46.32 25.95 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.9 0.857 . . . . 0.0 111.135 178.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.767 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.8 p -130.09 170.77 13.59 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.425 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.619 ' O ' HG13 ' A' ' 87' ' ' ILE . 6.2 t70 -100.16 122.55 43.17 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.542 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 8.8 p90 -51.09 -30.19 15.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.512 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -63.67 -48.1 78.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.62 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.697 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 16.5 mm-40 -67.7 -43.39 80.2 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.337 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.619 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.3 mt -53.68 -48.36 60.38 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.773 0.797 . . . . 0.0 109.01 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.634 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.17 -48.43 78.42 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.827 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -37.85 78.19 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.697 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 68.7 mmt-85 -67.92 -33.6 75.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.822 0.344 . . . . 0.0 110.994 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.525 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 11.4 t-20 -92.8 -5.33 51.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.535 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 5.6 m-20 78.2 15.3 1.4 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.359 0.664 . . . . 0.0 111.031 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.634 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 15.4 pt -100.83 -177.78 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.621 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . 86.1 mm-40 -110.83 152.51 26.59 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.022 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.566 ' O ' HD23 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -53.87 -68.71 0.16 Allowed 'General case' 0 C--O 1.243 0.711 0 CA-C-O 122.194 0.997 . . . . 0.0 110.252 179.688 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -73.75 13.4 0.5 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.547 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.621 ' HB2' ' HB2' ' A' ' 94' ' ' GLN . 7.3 t70 -66.84 -31.79 72.64 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 8.5 mp 73.97 114.17 0.06 Allowed 'General case' 0 N--CA 1.463 0.206 0 O-C-N 124.361 1.038 . . . . 0.0 109.829 -177.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.683 HG23 HD22 ' A' ' 73' ' ' LEU . 7.1 pt -94.61 176.36 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.651 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.506 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 92.3 m-85 -123.25 160.04 51.91 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.598 -178.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.651 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 42.1 Cg_endo -70.55 139.19 36.93 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 123.43 2.753 . . . . 0.0 113.716 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.6 9.56 61.28 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.463 ' O ' ' HA ' ' A' ' 66' ' ' THR . 27.1 tt0 -94.09 162.85 13.71 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 115.16 -0.52 . . . . 0.0 109.754 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 72.9 t -127.43 118.95 50.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.53 HD11 HG21 ' A' ' 99' ' ' ILE . 69.8 mt -115.38 151.66 34.26 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.124 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.459 ' HG2' HG22 ' A' ' 64' ' ' THR . 71.8 mt-30 -89.65 118.33 29.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.67 0.747 . . . . 0.0 110.987 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.408 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 29.6 m -125.19 151.88 70.08 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.43 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 29.9 Cg_endo -62.92 -16.89 56.96 Favored 'Trans proline' 0 N--CA 1.472 0.253 0 C-N-CA 123.196 2.597 . . . . 0.0 114.392 -177.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.4 t -160.81 150.88 17.64 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.035 0.445 . . . . 0.0 111.056 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.463 ' HG2' ' HB1' ' A' ' 63' ' ' ALA . 11.9 mmmm -93.32 -171.97 2.8 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.6 -43.65 94.1 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.09 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -116.72 -155.65 10.41 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.1 p -66.89 -47.55 71.45 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.325 0.583 . . . . 0.0 110.892 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.56 -60.12 0.34 Allowed Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.799 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -164.17 129.93 2.1 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.223 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.27 60.64 2.34 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.502 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.429 ' H ' ' HA ' ' A' ' 41' ' ' ARG . . . -98.77 -29.68 12.86 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.197 0.522 . . . . 0.0 110.281 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . -106.63 -56.3 0.64 Allowed Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.396 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.6 m120 69.42 31.18 3.89 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 122.943 0.497 . . . . 0.0 111.96 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.617 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 24.0 p90 -59.38 -35.78 74.58 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.585 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 57.5 t-105 -64.97 -33.23 75.53 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.826 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.52 -22.69 45.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.293 0.568 . . . . 0.0 110.954 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.745 ' OG ' ' HB3' ' A' ' 141' ' ' ARG . 47.9 t -133.64 23.98 4.01 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.179 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.585 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -111.02 144.5 40.04 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.334 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.615 ' HB2' ' CZ3' ' A' ' 146' ' ' TRP . 0.1 OUTLIER -129.52 128.03 41.99 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.437 ' N ' ' HD3' ' A' ' 125' ' ' ARG . 24.6 t0 56.94 62.92 2.07 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 124.071 0.857 . . . . 0.0 111.626 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.57 ' CG1' HD11 ' A' ' 136' ' ' LEU . 60.5 t -76.06 131.05 35.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.525 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -140.88 138.42 33.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.449 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.858 HD13 HG22 ' A' ' 14' ' ' ILE . 13.7 mt -86.91 131.9 33.97 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 177.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.639 HG23 ' HB ' ' A' ' 135' ' ' VAL . 33.9 m -128.74 158.61 41.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.213 0.53 . . . . 0.0 111.189 -178.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 67.46 11.54 8.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.014 -0.993 . . . . 0.0 111.889 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.702 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 92.73 31.22 8.87 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.203 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.536 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 88.23 -16.62 51.7 Favored Glycine 0 C--O 1.263 1.944 0 CA-C-O 123.441 1.578 . . . . 0.0 112.687 177.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.913 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 14.8 ptpt -68.09 -16.42 64.01 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 121.381 -1.07 . . . . 0.0 109.1 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.639 ' HB ' HG23 ' A' ' 130' ' ' VAL . 14.3 t -140.55 141.76 31.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.981 177.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.57 HD11 ' CG1' ' A' ' 127' ' ' VAL . 42.6 tp -120.53 126.88 51.45 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -120.16 134.64 55.21 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.746 0.308 . . . . 0.0 110.455 -177.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . . . -160.63 158.98 29.85 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.675 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -95.05 108.68 20.77 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.579 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 56.0 mt -94.19 131.29 39.91 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.699 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.745 ' HB3' ' OG ' ' A' ' 123' ' ' SER . 65.2 ttt180 -73.46 141.23 46.85 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.443 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.637 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 0.8 OUTLIER -154.56 -170.68 3.6 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.583 -179.748 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.2 m -58.34 -26.55 63.24 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -95.0 6.25 69.19 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.389 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 141' ' ' ARG . . . 111.26 -112.49 3.19 Favored Glycine 0 C--O 1.224 -0.491 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.746 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.615 ' CZ3' ' HB2' ' A' ' 125' ' ' ARG . 93.4 m95 -124.85 126.04 44.94 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.637 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 60.6 t30 -118.27 140.27 50.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.445 -178.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -73.55 104.74 4.62 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.2 m -118.55 156.3 29.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.577 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 17.4 ptt180 -148.79 163.43 37.38 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.535 -0.466 . . . . 0.0 112.16 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.716 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 8.9 tt -148.42 144.77 18.71 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.612 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.608 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.631 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 38.0 m-85 -88.76 104.42 16.88 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 122.154 -0.341 . . . . 0.0 110.929 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.695 HD11 HD21 ' A' ' 129' ' ' LEU . 27.8 mt -66.69 -35.31 79.83 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.904 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.913 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 4.8 t0 -55.91 -10.24 0.74 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.947 178.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.631 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 45.4 mt-10 -71.74 -55.09 8.29 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.4 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 30.2 m80 -125.22 8.58 7.91 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.884 -0.726 . . . . 0.0 112.388 -176.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.454 HG12 ' CH2' ' A' ' 52' ' ' TRP . 41.1 mm -106.65 107.81 23.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 167' ' ' CYS . . . -110.54 178.04 19.73 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.656 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.658 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -117.75 134.44 54.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.893 0.377 . . . . 0.0 110.808 179.364 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.482 ' HB2' HD13 ' A' ' 165' ' ' ILE . 43.9 ttm180 -125.2 92.68 3.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.363 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 66.9 t30 57.9 46.35 16.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.83 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.464 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 87.52 11.56 68.55 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.613 178.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -122.69 133.03 54.51 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 117.19 0.495 . . . . 0.0 110.956 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.478 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 29.7 mt -76.03 122.59 24.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.471 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.482 HD13 ' HB2' ' A' ' 160' ' ' ARG . 43.7 pt -138.96 -174.55 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.646 0.736 . . . . 0.0 111.765 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.4 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 42.7 t-80 -95.08 110.98 22.84 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.133 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.579 ' SG ' ' HB1' ' A' ' 4' ' ' ALA . 53.6 t . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.501 -0.761 . . . . 0.0 111.034 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.665 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.42 ' HB3' ' HD1' ' A' ' 3' ' ' TYR . 21.6 m-80 -138.25 -75.64 0.39 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.559 ' CD1' ' HG2' ' A' ' 155' ' ' GLU . 64.7 m-85 -128.7 -97.0 0.39 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.878 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.72 -27.89 11.52 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -71.02 -73.87 0.76 Allowed Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 119.068 -1.539 . . . . 0.0 112.16 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 65.44 23.07 11.94 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 122.711 0.404 . . . . 0.0 110.145 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.793 ' HD2' HD11 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -64.62 -34.96 79.51 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.531 179.725 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.415 ' HA ' HD11 ' A' ' 14' ' ' ILE . 28.8 t -66.02 -15.47 63.06 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.487 0.66 . . . . 0.0 109.916 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.55 -28.42 72.34 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.113 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 28.6 m -136.33 -3.22 2.18 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 117.413 0.607 . . . . 0.0 111.494 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.407 ' OG ' ' HB1' ' A' ' 23' ' ' ALA . 6.0 t -105.92 133.72 50.19 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.486 ' CG ' ' HB2' ' A' ' 24' ' ' GLU . 14.9 ptm180 -112.02 -176.39 2.91 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.428 ' HB2' ' HG2' ' A' ' 24' ' ' GLU . 2.3 m-20 42.61 44.52 3.68 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 124.04 0.837 . . . . 0.0 112.177 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.885 HG22 HD13 ' A' ' 129' ' ' LEU . 6.4 mt -78.17 102.86 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-O 121.012 0.434 . . . . 0.0 109.886 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.599 ' HA ' HD12 ' A' ' 129' ' ' LEU . 80.0 m -147.35 126.1 12.63 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.702 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -89.12 153.57 20.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.007 0.908 . . . . 0.0 113.191 -178.322 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.668 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 21.3 t70 -92.96 72.07 4.72 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 113.726 -1.579 . . . . 0.0 107.166 177.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.56 -56.69 5.03 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.939 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.429 ' H ' ' H ' ' A' ' 20' ' ' ARG . . . -148.56 -12.1 0.34 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.668 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 56.3 mtp180 -84.4 89.51 7.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.017 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.88 HD22 HD13 ' A' ' 153' ' ' LEU . 42.6 tp -57.24 123.46 15.41 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.155 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.593 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 22.2 ttp180 -125.74 134.73 51.67 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.141 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.583 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -155.63 141.69 18.28 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.695 0.759 . . . . 0.0 111.363 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.486 ' HB2' ' CG ' ' A' ' 12' ' ' ARG . 78.2 mm-40 -78.93 79.58 5.32 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.367 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.754 ' SG ' HD13 ' A' ' 164' ' ' LEU . 25.6 m -67.09 122.49 17.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.183 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 10' ' ' SER . 58.1 ttt-85 -68.69 118.85 12.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.391 178.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.1 ttt180 -88.0 155.1 20.0 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -47.25 -25.05 2.59 Favored Glycine 0 N--CA 1.463 0.459 0 O-C-N 124.598 1.187 . . . . 0.0 115.533 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -75.24 -5.77 46.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.205 0.526 . . . . 0.0 110.89 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.85 5.98 65.86 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -101.63 135.22 12.08 Favored Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.585 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 94.8 m-85 -87.81 130.52 34.84 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.776 0.322 . . . . 0.0 110.366 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 41.7 m -118.08 137.05 53.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.525 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.5 m -71.18 111.25 6.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.286 0.565 . . . . 0.0 111.16 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 162' ' ' GLY . 32.3 t -117.46 149.75 40.06 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.474 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.7 p -144.77 137.02 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.969 0.414 . . . . 0.0 111.633 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.624 HG22 HD23 ' A' ' 164' ' ' LEU . 12.4 tt -135.36 148.14 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.32 -178.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.47 ' OD2' ' HB3' ' A' ' 40' ' ' ASN . 25.2 t70 -81.89 109.24 16.08 Favored 'General case' 0 CA--C 1.516 -0.363 0 O-C-N 121.938 -0.476 . . . . 0.0 111.3 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.629 HD23 ' HB3' ' A' ' 21' ' ' LEU . 3.4 mm? -88.3 0.93 55.59 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.119 0.485 . . . . 0.0 110.092 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.47 ' HB3' ' OD2' ' A' ' 38' ' ' ASP . 3.8 t30 -73.86 -24.5 59.76 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.765 ' HG2' ' H ' ' A' ' 116' ' ' GLY . 60.7 mtt85 -100.63 13.41 34.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.248 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -132.02 -31.24 1.5 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.295 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.872 HD22 HD13 ' A' ' 151' ' ' ILE . 49.3 mt -105.85 134.79 48.41 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.999 0.428 . . . . 0.0 110.8 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.558 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 1.9 m -126.79 146.36 50.28 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.288 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.487 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 4.0 p-10 -91.98 100.93 13.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.743 0.782 . . . . 0.0 109.498 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -100.89 94.06 5.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.042 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.418 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 64.3 t30 52.18 43.87 30.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.486 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.741 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 80.29 41.09 12.19 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.644 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.461 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 34.3 t-80 -160.69 127.69 4.23 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.713 ' HB2' ' HB ' ' A' ' 151' ' ' ILE . 87.6 m-85 -67.52 151.44 47.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.892 0.377 . . . . 0.0 111.547 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -148.39 130.47 15.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.038 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.429 ' CD1' HD11 ' A' ' 151' ' ' ILE . 96.3 m95 -76.1 120.4 21.36 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.094 177.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.0 m -107.68 113.39 43.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.244 0.545 . . . . 0.0 110.847 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.4 m -82.93 60.21 5.29 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.828 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.21 64.51 1.46 Allowed Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.224 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.98 58.36 4.93 Favored Glycine 0 CA--C 1.518 0.225 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.408 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.9 -156.85 29.05 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.728 ' HA2' ' HB3' ' A' ' 113' ' ' SER . . . 124.52 174.59 14.09 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.477 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.43 154.96 12.8 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.811 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.48 -168.01 16.07 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.797 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 108' ' ' PRO . . . 84.51 -100.54 2.38 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.652 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.9 m -122.1 114.48 20.97 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.016 0.436 . . . . 0.0 110.005 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.35 176.14 6.04 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.966 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.4 p -130.93 125.49 33.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.599 0.238 . . . . 0.0 111.111 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.588 HG21 ' CE2' ' A' ' 80' ' ' PHE . 8.4 p -115.46 143.33 25.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.959 0.409 . . . . 0.0 111.285 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 16.3 m -88.53 127.11 35.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.087 0.47 . . . . 0.0 109.873 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.497 ' CG2' HD12 ' A' ' 99' ' ' ILE . 43.7 t -75.92 134.57 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.788 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -104.48 169.54 8.41 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 124.541 1.15 . . . . 0.0 111.451 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.635 ' OE1' ' HG3' ' A' ' 101' ' ' PRO . 51.0 tp60 -64.25 116.06 5.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.55 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.78 -4.56 57.85 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.291 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.39 122.4 43.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.764 0.316 . . . . 0.0 110.92 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.688 ' HA ' HG12 ' A' ' 99' ' ' ILE . 75.5 p -105.37 -177.83 3.48 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.659 HD22 HG23 ' A' ' 99' ' ' ILE . 1.4 mm? -52.58 -41.85 63.97 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 121.396 0.617 . . . . 0.0 109.384 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.422 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 39.4 ttm180 -64.34 -37.95 89.32 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.091 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -73.08 -38.59 66.35 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.102 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.558 HG12 ' O ' ' A' ' 72' ' ' THR . 46.0 mm -64.81 -48.21 85.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.649 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -54.65 -53.64 37.81 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.718 -0.674 . . . . 0.0 113.03 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -68.25 -25.23 65.08 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -78.35 -41.99 31.85 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.588 ' CE2' HG21 ' A' ' 65' ' ' VAL . 89.2 m-85 -107.6 12.71 27.39 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.4 t70 61.31 52.61 3.78 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.804 0.811 . . . . 0.0 111.046 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.649 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.0 p -134.72 169.66 17.0 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.403 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.656 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.6 t70 -95.94 121.08 37.3 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.708 -0.397 . . . . 0.0 109.992 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.613 ' HD2' ' HB2' ' A' ' 95' ' ' ASN . 17.7 p90 -50.63 -31.31 15.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.923 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.78 -42.87 76.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.309 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.694 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 11.6 mm-40 -68.22 -43.87 77.0 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.656 HG13 ' O ' ' A' ' 83' ' ' ASP . 6.5 mt -53.5 -47.82 59.06 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-O 121.435 0.636 . . . . 0.0 109.474 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.632 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.18 -50.88 70.06 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.529 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -59.98 -36.18 76.6 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.694 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 83.3 mmt-85 -68.08 -34.81 77.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.991 0.424 . . . . 0.0 110.622 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.456 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 4.2 t-20 -91.3 -5.06 55.23 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.805 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 4.7 m-20 78.55 13.48 1.42 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.451 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.632 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 19.0 pt -98.74 -171.36 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -117.84 151.17 37.89 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.253 -0.28 . . . . 0.0 110.548 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.613 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 21.1 p-10 -53.07 -56.97 12.13 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-O 122.088 0.947 . . . . 0.0 109.294 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -75.96 6.82 4.65 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.425 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -66.55 -35.8 81.11 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.4 mp 67.62 115.13 0.03 OUTLIER 'General case' 0 C--O 1.235 0.332 0 CA-C-O 122.138 0.971 . . . . 0.0 109.987 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.688 HG12 ' HA ' ' A' ' 72' ' ' THR . 7.8 pt -93.74 174.96 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.038 -177.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.553 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 64.4 m-85 -127.15 160.6 58.85 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.689 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.635 ' HG3' ' OE1' ' A' ' 69' ' ' GLN . 34.8 Cg_endo -67.22 137.6 44.31 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.063 2.509 . . . . 0.0 113.941 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.49 17.9 32.29 Favored Glycine 0 N--CA 1.44 -1.075 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.707 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.537 ' O ' ' HA ' ' A' ' 66' ' ' THR . 45.7 mt-30 -106.83 165.06 11.6 Favored 'General case' 0 C--O 1.216 -0.682 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.864 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.3 t -125.81 110.03 23.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.652 HD11 HG21 ' A' ' 99' ' ' ILE . 63.8 mt -105.25 152.01 23.41 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.21 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 38.5 mt-30 -89.84 114.6 26.37 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.747 0.784 . . . . 0.0 110.415 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.0 m -117.88 150.55 47.37 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.71 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 41.8 Cg_endo -68.44 -16.34 43.05 Favored 'Trans proline' 0 C--N 1.331 -0.375 0 C-N-CA 123.004 2.469 . . . . 0.0 113.387 -178.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.4 t -156.78 148.7 22.82 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.001 0.429 . . . . 0.0 110.318 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -92.19 -172.81 3.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.484 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -80.22 -78.21 0.92 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.466 -0.874 . . . . 0.0 111.721 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -102.97 103.48 2.4 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.965 -0.635 . . . . 0.0 111.568 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.728 ' HB3' ' HA2' ' A' ' 58' ' ' GLY . 24.5 m -61.56 -40.84 96.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.792 0.33 . . . . 0.0 110.818 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -82.27 40.76 2.73 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.293 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -72.59 98.43 0.84 Allowed Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.765 ' H ' ' HG2' ' A' ' 41' ' ' ARG . . . 81.06 53.3 3.97 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -80.05 -29.07 39.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.013 -0.594 . . . . 0.0 110.61 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.558 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -105.75 -68.51 0.71 Allowed Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.379 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 71.14 30.14 2.73 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 122.903 0.481 . . . . 0.0 111.215 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.591 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 25.6 p90 -57.44 -39.06 75.44 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.603 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 67.6 t-105 -62.33 -34.58 76.91 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.915 -1.038 . . . . 0.0 111.966 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.83 -25.69 20.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.986 0.422 . . . . 0.0 111.369 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.814 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 19.3 m -134.28 29.46 3.66 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.037 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.603 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -115.73 141.13 48.49 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.193 0.521 . . . . 0.0 111.48 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -129.77 149.32 51.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.07 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.06 50.58 16.33 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 123.614 0.571 . . . . 0.0 110.83 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.476 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 30.2 t -80.74 117.89 27.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.883 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 35.4 ptt85 -145.89 144.57 30.28 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.191 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.885 HD13 HG22 ' A' ' 14' ' ' ILE . 23.4 mt -84.61 131.12 34.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.291 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.472 HG23 ' HB ' ' A' ' 135' ' ' VAL . 34.4 m -126.54 167.57 20.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.403 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.573 ' HB3' ' CE ' ' A' ' 134' ' ' LYS . 1.2 m-20 64.45 10.18 5.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.612 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.651 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 93.82 24.34 20.66 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.848 -0.692 . . . . 0.0 113.481 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 94.64 -18.88 56.24 Favored Glycine 0 C--O 1.268 2.241 0 CA-C-O 123.803 1.779 . . . . 0.0 111.914 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.763 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 65.4 pttt -69.52 -14.21 62.74 Favored 'General case' 0 C--N 1.313 -1.018 0 O-C-N 121.598 -0.942 . . . . 0.0 108.769 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.647 HG23 ' HG3' ' A' ' 134' ' ' LYS . 23.5 t -139.47 137.18 40.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 121.355 0.597 . . . . 0.0 110.513 177.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 30.3 tp -117.31 121.97 42.62 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.541 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 35.8 tt0 -115.01 134.81 54.87 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.864 0.364 . . . . 0.0 111.46 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.685 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.42 163.11 27.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.569 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 41.7 mt-10 -94.53 108.43 20.38 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.741 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 59.7 mt -94.99 130.59 41.59 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.338 0.59 . . . . 0.0 110.753 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.814 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 73.5 ttt180 -70.73 140.66 51.46 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.88 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.501 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 5.6 p90 -158.3 -171.91 3.67 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 18.4 m -54.85 -30.52 57.8 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.3 18.51 56.39 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.369 -0.92 . . . . 0.0 113.723 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 103.9 -120.67 6.77 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.278 -0.963 . . . . 0.0 112.332 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -123.57 124.28 42.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.944 0.372 . . . . 0.0 110.601 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.501 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 27.3 t-20 -118.81 125.83 50.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.473 ' HD3' ' OE2' ' A' ' 137' ' ' GLU . 55.1 ttm-85 -74.74 99.24 3.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.245 0.545 . . . . 0.0 110.033 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.461 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 7.3 t -112.3 173.08 6.54 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.105 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.541 ' HG2' ' HG3' ' A' ' 137' ' ' GLU . 15.6 mtm180 -145.2 163.84 33.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.107 0.479 . . . . 0.0 111.398 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.872 HD13 HD22 ' A' ' 43' ' ' LEU . 9.1 tt -143.24 148.98 18.74 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.392 178.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.597 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 12.6 m-85 -92.06 103.93 16.38 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 122.028 -0.42 . . . . 0.0 110.964 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.88 HD13 HD22 ' A' ' 21' ' ' LEU . 22.5 mt -67.15 -34.14 76.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.111 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.763 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 7.7 t70 -58.32 -7.76 0.96 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.274 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.56 ' HG3' ' CB ' ' A' ' 152' ' ' TYR . 40.5 mt-10 -72.39 -51.03 22.25 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 121.91 -0.494 . . . . 0.0 111.976 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -119.26 -5.6 10.41 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 120.499 -0.481 . . . . 0.0 112.285 -177.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.463 ' CG2' ' HG ' ' A' ' 164' ' ' LEU . 48.9 mm -100.21 114.23 38.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.841 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -118.79 176.44 16.09 Favored Glycine 0 C--O 1.225 -0.422 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.289 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.586 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.0 t30 -112.1 123.81 51.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.943 0.401 . . . . 0.0 110.149 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -118.63 85.88 2.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.928 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 52.2 43.72 30.36 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.497 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 103.29 -4.82 48.41 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.294 -0.955 . . . . 0.0 114.085 178.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -121.92 129.43 52.53 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 117.223 0.512 . . . . 0.0 111.426 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.793 HD11 ' HD2' ' A' ' 7' ' ' PHE . 1.8 tp -71.12 113.32 8.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.553 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.423 HG13 ' N ' ' A' ' 166' ' ' HIS . 11.0 tp -102.78 164.55 3.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.392 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.423 ' N ' HG13 ' A' ' 165' ' ' ILE . 39.4 p-80 -125.72 130.32 51.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.736 0.303 . . . . 0.0 110.386 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 40.6 t . . . . . 0 C--O 1.251 1.181 0 CA-C-O 118.905 -0.569 . . . . 0.0 109.798 179.791 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.738 0 N-CA-C 111.884 -0.487 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.81 -73.6 0.39 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.739 0.304 . . . . 0.0 111.741 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -130.12 -88.02 0.5 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.413 ' HB1' ' SG ' ' A' ' 167' ' ' CYS . . . -111.8 -25.41 9.48 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -66.8 -72.75 0.72 Allowed Glycine 0 N--CA 1.433 -1.503 0 C-N-CA 119.366 -1.397 . . . . 0.0 112.405 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 60.69 17.16 7.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.74 0.305 . . . . 0.0 110.725 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.7 ' CE2' HD13 ' A' ' 14' ' ' ILE . 0.4 OUTLIER -60.92 -32.57 72.05 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.398 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.491 ' OG ' ' HG2' ' A' ' 134' ' ' LYS . 23.1 t -66.0 -19.84 65.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.037 0.446 . . . . 0.0 110.375 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.7 -20.6 78.69 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.079 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.515 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 51.2 p -129.4 -24.66 2.77 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 117.241 0.521 . . . . 0.0 111.375 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.422 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 5.9 m -96.71 130.88 43.86 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 12' ' ' ARG . 12.5 ptm180 -115.07 -174.18 2.45 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 47.69 40.77 12.65 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 123.513 0.508 . . . . 0.0 111.225 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.876 HG22 HD13 ' A' ' 129' ' ' LEU . 7.7 mt -80.71 103.31 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-O 120.832 0.348 . . . . 0.0 110.164 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.605 ' HA ' HD12 ' A' ' 129' ' ' LEU . 79.0 m -146.9 128.09 14.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.809 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.749 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -99.41 152.89 19.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.701 0.762 . . . . 0.0 112.956 -179.844 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -93.85 75.87 4.22 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.33 -55.08 4.82 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.542 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.577 ' HB1' ' HB2' ' A' ' 40' ' ' ASN . . . -148.69 -7.86 0.38 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.901 0.381 . . . . 0.0 110.507 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.4 mmm-85 -89.27 90.53 8.38 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.767 ' HB2' HD22 ' A' ' 39' ' ' LEU . 55.0 tp -62.67 127.79 32.92 Favored 'General case' 0 C--O 1.213 -0.839 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.566 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 42.9 ttt180 -133.34 131.75 40.48 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.441 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.631 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -150.84 145.93 26.01 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.744 0.783 . . . . 0.0 111.516 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 1.7 mm-40 -82.97 74.58 9.92 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.34 178.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.556 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 60.0 m -60.74 124.2 19.72 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.143 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.515 ' HB2' ' O ' ' A' ' 10' ' ' SER . 19.7 ttp180 -70.57 127.43 32.66 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.13 0.491 . . . . 0.0 110.749 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.484 ' HG3' ' CG ' ' A' ' 161' ' ' ASN . 37.2 ttp180 -97.29 151.9 19.42 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.32 -15.86 1.96 Allowed Glycine 0 N--CA 1.46 0.278 0 O-C-N 124.717 1.261 . . . . 0.0 115.006 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -75.96 -9.01 58.26 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.054 0.454 . . . . 0.0 110.432 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.66 6.86 60.59 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -112.27 161.69 12.64 Favored Glycine 0 C--O 1.224 -0.525 0 C-N-CA 120.455 -0.878 . . . . 0.0 112.202 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.513 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 86.2 m-85 -100.38 139.1 36.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.005 0.403 . . . . 0.0 110.856 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.1 t -122.89 120.64 34.05 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 m -63.73 115.53 4.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.157 0.503 . . . . 0.0 110.487 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.4 t -120.99 152.82 38.11 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.063 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.566 ' HB ' ' HG3' ' A' ' 22' ' ' ARG . 3.2 p -145.05 138.66 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 120.855 0.359 . . . . 0.0 111.433 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.5 tt -135.5 147.8 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.486 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -80.74 105.34 11.9 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.767 HD22 ' HB2' ' A' ' 21' ' ' LEU . 1.5 tp -84.71 -6.14 59.35 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.441 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.577 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 64.2 t30 -73.45 -14.31 61.22 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.895 ' HG2' ' HA3' ' A' ' 116' ' ' GLY . 98.1 mtt180 -105.88 15.37 26.74 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.427 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 66.3 m-85 -131.44 -32.67 1.52 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.635 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.773 HD22 HD13 ' A' ' 151' ' ' ILE . 33.2 mt -106.48 136.49 46.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.025 0.441 . . . . 0.0 111.423 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.637 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 9.0 m -125.74 146.81 49.6 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.701 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.608 ' ND2' ' HB2' ' A' ' 123' ' ' SER . 21.4 p-10 -95.13 93.7 7.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.669 0.747 . . . . 0.0 109.585 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -94.64 95.83 9.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.059 0.457 . . . . 0.0 111.758 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.465 ' HA ' ' HB2' ' A' ' 142' ' ' TYR . 62.5 t30 47.67 44.19 17.23 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.172 178.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.78 34.04 14.32 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.751 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -150.61 131.12 13.85 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.831 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 24.8 m-85 -75.34 138.3 41.68 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 51' ' ' ARG . 53.8 mtt-85 -140.7 136.38 32.55 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.518 ' CH2' HG12 ' A' ' 157' ' ' ILE . 98.2 m95 -76.01 107.23 8.07 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.353 177.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.44 ' HB ' ' OG ' ' A' ' 44' ' ' SER . 92.5 t -133.52 129.1 55.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.861 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.7 m -122.25 12.42 10.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.111 0.482 . . . . 0.0 110.605 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.32 -76.71 1.0 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.173 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.743 ' HA2' ' HA ' ' A' ' 117' ' ' ALA . . . 172.95 177.82 42.51 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.522 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.04 -170.01 43.04 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -126.41 153.34 18.63 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.299 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -148.28 -140.63 3.36 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.24 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.2 35.84 0.32 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.981 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.93 -105.24 1.33 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.492 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.0 m -138.28 114.11 9.9 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.92 0.391 . . . . 0.0 110.281 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.89 177.37 4.99 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.164 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.544 HG22 ' HG2' ' A' ' 106' ' ' GLN . 10.6 p -127.7 117.08 21.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.856 0.36 . . . . 0.0 110.835 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.459 HG21 ' CE2' ' A' ' 80' ' ' PHE . 8.9 p -103.0 142.29 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.19 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 24.9 m -88.1 127.67 35.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.249 0.547 . . . . 0.0 110.095 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.511 HG21 HD12 ' A' ' 99' ' ' ILE . 48.7 t -79.16 134.67 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.364 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -107.4 171.08 7.58 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.307 1.004 . . . . 0.0 109.458 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.681 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 59.4 tt0 -65.85 123.18 19.1 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.794 -178.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.12 -4.23 58.71 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.348 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -105.77 122.68 46.57 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.89 0.376 . . . . 0.0 111.132 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.651 ' HA ' HG12 ' A' ' 99' ' ' ILE . 68.5 p -106.49 179.94 4.12 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.659 HD22 HG23 ' A' ' 99' ' ' ILE . 1.5 mm? -51.66 -43.4 62.65 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.461 0.648 . . . . 0.0 109.752 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 74' ' ' ARG . 42.8 ttt180 -60.65 -38.98 86.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.424 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -72.18 -45.67 59.43 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 72' ' ' THR . 45.0 mm -57.82 -47.66 85.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.003 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.672 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.19 -53.05 47.67 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.109 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -69.73 -26.43 64.32 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 122.469 -0.43 . . . . 0.0 111.786 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -75.87 -38.84 57.52 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.06 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.459 ' CE2' HG21 ' A' ' 65' ' ' VAL . 72.4 m-85 -111.16 19.62 18.2 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.7 t70 53.25 47.91 23.26 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.548 0.69 . . . . 0.0 111.783 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.672 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 3.3 p -127.88 171.05 12.14 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.651 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.1 t0 -96.75 117.89 32.03 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.707 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.432 ' HA ' HD12 ' A' ' 87' ' ' ILE . 3.3 p90 -50.49 -33.19 20.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.909 -1.042 . . . . 0.0 111.803 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.93 -41.44 91.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.17 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.654 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 33.0 tt0 -71.78 -46.64 57.7 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.695 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.651 HG13 ' O ' ' A' ' 83' ' ' ASP . 6.5 mt -49.7 -45.74 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.625 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.22 -51.1 69.13 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.416 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -63.67 -28.93 70.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.654 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 22.1 mmt180 -65.08 -39.79 93.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.288 0.566 . . . . 0.0 110.248 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 12.5 m120 -94.12 -3.6 50.76 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.677 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 93.7 m-20 79.08 11.01 1.51 Allowed 'General case' 0 N--CA 1.47 0.571 0 O-C-N 123.859 0.724 . . . . 0.0 111.455 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.625 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 18.9 pt -93.92 -173.48 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.509 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . 30.1 mm-40 -114.81 157.6 23.04 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 122.108 -0.37 . . . . 0.0 110.636 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.52 ' O ' HD23 ' A' ' 73' ' ' LEU . 3.4 p30 -55.62 -69.05 0.15 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.836 0.826 . . . . 0.0 109.728 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.59 13.43 0.62 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.335 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.509 ' HB2' ' HB2' ' A' ' 94' ' ' GLN . 5.6 t70 -64.3 -30.16 71.22 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.1 mp 68.55 113.5 0.04 OUTLIER 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.195 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.659 HG23 HD22 ' A' ' 73' ' ' LEU . 8.5 pt -93.85 175.83 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.227 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.501 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 85.7 m-85 -125.95 158.06 67.13 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.585 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.681 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 22.3 Cg_endo -67.28 139.16 49.08 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 123.135 2.557 . . . . 0.0 113.395 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.21 23.7 24.0 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.537 ' O ' ' HA ' ' A' ' 66' ' ' THR . 25.1 mt-30 -112.11 166.07 11.57 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.533 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 66.9 t -125.89 110.36 23.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.58 HD11 HG21 ' A' ' 99' ' ' ILE . 75.8 mt -103.95 151.04 23.65 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.4 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.637 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 62.7 mt-30 -90.74 117.58 29.49 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.832 0.825 . . . . 0.0 110.6 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.8 m -125.65 150.56 68.66 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.702 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.38 -19.34 67.91 Favored 'Trans proline' 0 C--N 1.332 -0.325 0 C-N-CA 123.262 2.641 . . . . 0.0 113.722 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.5 t -155.96 149.11 24.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.059 0.457 . . . . 0.0 111.088 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.716 ' HB2' ' HA2' ' A' ' 114' ' ' GLY . 12.4 mmmm -85.73 174.19 9.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.513 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -89.36 69.62 2.53 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 104.14 92.76 2.26 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 43.5 m 75.89 83.23 0.09 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.32 0.581 . . . . 0.0 110.562 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.716 ' HA2' ' HB2' ' A' ' 110' ' ' LYS . . . -60.12 -55.46 30.11 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.092 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.89 -121.94 2.24 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.895 ' HA3' ' HG2' ' A' ' 41' ' ' ARG . . . 174.93 -82.38 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.066 -1.064 . . . . 0.0 113.172 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.743 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . . . -131.49 -35.69 1.3 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.637 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -91.76 -66.42 1.14 Allowed Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.726 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 72.02 27.43 2.7 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.406 0.683 . . . . 0.0 111.011 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.63 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 22.6 p90 -60.36 -40.67 91.59 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.087 0.47 . . . . 0.0 109.798 178.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.616 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 43.1 t-105 -65.29 -28.87 69.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.913 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.17 -19.49 54.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.737 0.303 . . . . 0.0 111.013 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.608 ' HB2' ' ND2' ' A' ' 45' ' ' ASN . 22.9 m -139.15 27.62 2.34 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 120.899 0.381 . . . . 0.0 110.252 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.616 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -110.54 148.26 32.49 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.37 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 125' ' ' ARG . 11.6 ttm180 -133.14 140.28 47.53 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.952 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.433 ' HB3' ' NH2' ' A' ' 128' ' ' ARG . 69.7 m-20 58.04 58.76 3.4 Favored 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 123.787 0.68 . . . . 0.0 111.123 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.499 ' CG1' HD11 ' A' ' 136' ' ' LEU . 40.5 t -86.79 115.88 28.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.839 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.433 ' NH2' ' HB3' ' A' ' 126' ' ' ASP . 0.0 OUTLIER -138.13 145.41 41.57 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.344 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.876 HD13 HG22 ' A' ' 14' ' ' ILE . 16.1 mt -85.23 133.26 34.18 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.757 HG23 ' HB ' ' A' ' 135' ' ' VAL . 27.3 m -125.27 159.37 32.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.347 -179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.569 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 0.3 OUTLIER 69.99 1.74 3.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.89 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.697 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 94.74 33.37 6.74 Favored Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.097 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 94.65 -20.89 46.2 Favored Glycine 0 C--O 1.263 1.936 0 CA-C-O 122.997 1.332 . . . . 0.0 113.21 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.777 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 0.2 OUTLIER -66.77 -16.43 64.25 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 121.307 -1.114 . . . . 0.0 109.214 178.591 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.757 ' HB ' HG23 ' A' ' 130' ' ' VAL . 9.4 t -141.72 145.57 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.262 0.553 . . . . 0.0 109.824 177.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 30.1 tp -125.72 121.04 32.3 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.469 ' HG3' ' HE ' ' A' ' 150' ' ' ARG . 20.8 tt0 -110.28 135.39 51.09 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.818 0.342 . . . . 0.0 111.632 -177.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.638 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -163.66 157.14 18.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.541 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.442 ' HG2' ' HD2' ' A' ' 148' ' ' ARG . 18.1 mt-10 -95.81 108.12 20.43 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 45' ' ' ASN . 58.6 mt -92.57 131.45 37.68 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.415 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.547 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 64.3 ttt180 -70.41 139.63 51.88 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.295 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.598 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 4.9 p90 -154.71 -164.11 1.74 Allowed 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.005 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.2 m -62.76 -14.62 46.94 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -125.83 36.45 2.74 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.416 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.77 -122.81 7.32 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.761 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -122.7 125.85 46.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.755 0.312 . . . . 0.0 110.399 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.598 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 46.5 t-20 -111.32 133.84 53.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.616 -178.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.442 ' HD2' ' HG2' ' A' ' 139' ' ' GLU . 4.1 tpt180 -73.49 98.01 2.69 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -113.55 160.66 18.28 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.899 -177.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.572 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 34.0 mtt180 -146.48 158.02 43.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.732 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.831 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 9.2 tt -141.67 142.11 28.98 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.02 178.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.607 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 27.7 m-85 -87.53 102.54 14.68 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.817 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.786 HD11 HD21 ' A' ' 129' ' ' LEU . 22.1 mt -63.96 -34.8 78.8 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.59 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.777 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 5.6 t70 -56.41 -9.4 0.69 Allowed 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.265 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.607 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 40.4 mt-10 -72.27 -52.71 15.08 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 121.923 -0.486 . . . . 0.0 112.287 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.528 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 43.6 m80 -124.43 3.23 8.4 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.549 -177.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.518 HG12 ' CH2' ' A' ' 52' ' ' TRP . 39.7 mm -103.59 108.6 24.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.62 ' HA3' ' OXT' ' A' ' 167' ' ' CYS . . . -116.33 166.44 12.35 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.239 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.556 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.3 t30 -102.22 130.8 48.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.782 0.325 . . . . 0.0 110.232 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 160' ' ' ARG . 25.7 ttp85 -118.19 85.9 2.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.878 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.484 ' CG ' ' HG3' ' A' ' 27' ' ' ARG . 21.7 t30 53.13 47.22 24.97 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.378 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 96.46 9.05 57.05 Favored Glycine 0 C--O 1.229 -0.185 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.611 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -122.79 142.37 50.81 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.691 HD11 ' CD2' ' A' ' 7' ' ' PHE . 11.8 tp -99.61 111.34 23.69 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.953 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.0 pp -141.27 -170.02 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.417 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.528 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 6.7 p80 -86.66 123.52 31.92 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.256 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.62 ' OXT' ' HA3' ' A' ' 158' ' ' GLY . 51.0 t . . . . . 0 C--O 1.249 1.031 0 O-C-N 123.896 0.748 . . . . 0.0 111.55 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.748 0 N-CA-C 111.546 -0.621 . . . . 0.0 111.546 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -109.72 171.65 7.32 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.759 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 37.0 m-85 -132.88 -65.44 0.71 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.718 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.53 -27.71 0.67 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.457 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -69.56 -68.74 1.55 Allowed Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 119.931 -1.128 . . . . 0.0 113.643 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 42.1 m-80 68.73 16.98 8.93 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 122.268 0.227 . . . . 0.0 110.497 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.746 ' CD2' HD11 ' A' ' 164' ' ' LEU . 1.2 p90 -64.22 -32.64 74.3 Favored 'General case' 0 C--O 1.218 -0.581 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.032 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.512 ' HA ' HD11 ' A' ' 14' ' ' ILE . 22.7 t -70.37 -16.29 62.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.73 0.776 . . . . 0.0 109.606 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.65 -20.67 73.7 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 115.129 -0.942 . . . . 0.0 113.241 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.553 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 75.5 p -127.49 -22.84 3.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.405 0.602 . . . . 0.0 111.365 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 9.2 m -98.15 133.98 41.84 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.945 0.402 . . . . 0.0 109.956 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.573 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 35.2 ptt180 -110.54 -177.37 3.22 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.459 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 12.7 m-20 43.85 44.54 5.83 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 123.714 0.634 . . . . 0.0 112.213 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.899 HG22 HD13 ' A' ' 129' ' ' LEU . 5.8 mt -78.95 104.86 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.607 ' CA ' HD12 ' A' ' 129' ' ' LEU . 72.7 m -146.4 126.38 13.66 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.298 0.639 . . . . 0.0 109.651 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.753 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -98.93 152.83 19.35 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.673 0.749 . . . . 0.0 112.773 -179.646 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -96.07 74.99 3.03 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.55 -54.44 4.95 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.43 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.515 ' HB1' ' HB2' ' A' ' 40' ' ' ASN . . . -148.58 -10.09 0.36 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 36.8 mtp-105 -83.13 86.17 7.06 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.618 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.793 HD22 HD13 ' A' ' 153' ' ' LEU . 51.1 tp -62.1 116.7 5.17 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-O 121.301 0.572 . . . . 0.0 111.578 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.506 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 33.9 ttp-105 -122.58 131.29 53.76 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.556 -177.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.587 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -152.34 146.89 25.72 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.452 0.644 . . . . 0.0 111.246 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.573 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 1.6 mm-40 -80.73 77.29 7.59 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.412 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.597 ' SG ' HD13 ' A' ' 164' ' ' LEU . 64.3 m -61.98 125.68 24.68 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.748 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.553 ' HB2' ' O ' ' A' ' 10' ' ' SER . 35.3 ttm180 -74.44 115.17 13.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.098 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.543 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 16.8 ptm180 -79.2 151.37 31.28 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -50.67 -18.97 2.9 Favored Glycine 0 C--N 1.339 0.697 0 O-C-N 124.338 1.024 . . . . 0.0 114.195 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.63 -12.89 61.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.15 0.5 . . . . 0.0 110.451 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.62 7.89 56.39 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.543 ' O ' ' HG2' ' A' ' 27' ' ' ARG . . . -104.48 157.49 16.87 Favored Glycine 0 C--O 1.223 -0.563 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.246 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.49 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 62.7 m-85 -100.85 129.81 46.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.901 0.381 . . . . 0.0 110.906 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.3 m -122.15 130.09 52.91 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.097 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -69.08 110.44 4.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.111 0.482 . . . . 0.0 111.449 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.2 t -114.79 151.53 33.65 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.931 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.9 p -145.7 135.51 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 120.879 0.371 . . . . 0.0 110.58 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.496 HG23 ' HB3' ' A' ' 21' ' ' LEU . 8.6 tt -134.92 144.34 34.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.734 -178.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.591 ' HB3' ' CD ' ' A' ' 41' ' ' ARG . 5.1 t70 -78.84 106.42 10.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.848 0.356 . . . . 0.0 110.605 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.569 HD23 ' HB3' ' A' ' 21' ' ' LEU . 2.1 mm? -85.97 -0.41 55.42 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.453 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.515 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 64.4 t30 -71.91 -22.35 61.5 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.591 ' CD ' ' HB3' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -103.87 16.5 26.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.406 0.622 . . . . 0.0 110.191 178.291 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.411 ' HB2' HD13 ' A' ' 39' ' ' LEU . 14.0 m-85 -125.89 -35.27 2.5 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.146 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.826 HD22 HD13 ' A' ' 151' ' ' ILE . 36.6 mt -106.54 142.27 36.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.377 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.458 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 0.7 OUTLIER -133.1 140.8 47.84 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.492 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.551 ' CG ' ' HB3' ' A' ' 140' ' ' LEU . 9.0 t30 -88.54 108.1 19.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.989 0.423 . . . . 0.0 109.925 177.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -109.33 91.04 3.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.344 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 54.46 47.49 22.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.195 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.727 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 78.56 33.32 38.95 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.746 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.485 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 68.6 m80 -147.59 127.64 13.7 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.731 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 50.4 m-85 -68.78 146.01 53.28 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.901 0.382 . . . . 0.0 110.963 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.436 ' HB3' ' OG ' ' A' ' 54' ' ' SER . 16.6 mmt180 -145.49 130.7 18.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.838 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.527 ' CD1' HD11 ' A' ' 151' ' ' ILE . 97.0 m95 -75.72 110.82 10.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.841 177.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.4 m 32.78 47.35 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.582 1.153 . . . . 0.0 113.744 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.436 ' OG ' ' HB3' ' A' ' 51' ' ' ARG . 26.1 m -83.33 69.13 9.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.477 0.656 . . . . 0.0 110.389 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.21 -60.05 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.27 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.63 128.21 4.51 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.491 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -175.4 73.52 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.147 -0.549 . . . . 0.0 111.877 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.03 169.58 30.1 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.928 -0.654 . . . . 0.0 111.845 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -86.08 69.77 3.12 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.328 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.82 -162.58 12.83 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.123 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.42 -136.91 14.03 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.36 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.7 m -135.03 128.43 32.32 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.925 0.393 . . . . 0.0 110.278 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.496 ' HB1' ' HG2' ' A' ' 110' ' ' LYS . . . -129.07 177.77 6.89 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.167 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.515 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 10.0 p -127.98 118.22 23.14 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.896 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.457 ' HA ' ' HE3' ' A' ' 110' ' ' LYS . 10.1 p -106.22 142.65 18.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.81 0.338 . . . . 0.0 111.004 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 9.1 m -88.6 125.08 34.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.272 0.558 . . . . 0.0 109.884 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.486 ' CG2' HD12 ' A' ' 99' ' ' ILE . 53.4 t -73.67 133.09 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.623 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -102.85 168.87 8.95 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 124.723 1.264 . . . . 0.0 110.845 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.592 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 25.3 tt0 -62.69 122.21 15.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.151 -178.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.39 -8.77 72.07 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.868 -0.605 . . . . 0.0 113.186 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.25 122.86 36.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.744 0.272 . . . . 0.0 111.453 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.588 ' HA ' HG12 ' A' ' 99' ' ' ILE . 81.2 p -105.67 -179.44 3.94 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.613 HD22 HG23 ' A' ' 99' ' ' ILE . 1.1 mm? -52.5 -41.39 63.37 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.299 0.571 . . . . 0.0 109.836 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.512 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 83.6 mtp180 -64.44 -36.99 85.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.335 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -72.14 -42.9 65.46 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.77 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 72' ' ' THR . 39.2 mm -61.03 -47.0 95.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.683 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.58 -50.56 64.19 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.85 -0.614 . . . . 0.0 113.07 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.459 ' HA ' ' NE ' ' A' ' 78' ' ' ARG . 3.5 tpm_? -71.1 -25.44 62.6 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 122.462 -0.434 . . . . 0.0 111.713 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -79.23 -42.39 26.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.193 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.453 ' CE2' HG21 ' A' ' 65' ' ' VAL . 99.2 m-85 -108.06 18.94 20.61 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.2 t70 55.75 51.13 12.89 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.735 0.778 . . . . 0.0 111.86 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.683 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.6 p -131.99 171.75 13.2 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.321 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.674 ' O ' HG13 ' A' ' 87' ' ' ILE . 14.9 t0 -97.63 120.4 37.94 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.747 -0.381 . . . . 0.0 109.99 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.512 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 17.8 p90 -51.51 -31.93 25.72 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.797 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.474 ' HB2' ' OD1' ' A' ' 83' ' ' ASP . 0.2 OUTLIER -68.29 -41.96 80.18 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.323 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.606 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 40.2 mt-10 -68.68 -47.05 67.46 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.9 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.674 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.9 mt -51.31 -46.02 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.555 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.36 -51.89 65.82 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.182 178.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 66.0 mtp180 -62.82 -30.46 71.5 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.606 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 8.2 mmp_? -73.07 -28.17 62.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.254 0.55 . . . . 0.0 110.327 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 7.1 t-20 -96.14 -4.79 42.09 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.831 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 17.7 m120 80.24 13.44 0.91 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.69 0.796 . . . . 0.0 111.222 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.555 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 14.5 pt -105.58 -171.23 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.497 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.658 ' H ' ' HB2' ' A' ' 97' ' ' ASP . 3.8 mm-40 -118.72 163.63 16.56 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.501 ' O ' HD23 ' A' ' 73' ' ' LEU . 5.9 p30 -55.07 -55.15 34.3 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 122.535 1.16 . . . . 0.0 109.167 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -78.63 11.98 2.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.573 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.658 ' HB2' ' H ' ' A' ' 94' ' ' GLN . 4.9 t70 -63.29 -33.64 75.95 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.6 mt 68.75 112.38 0.04 OUTLIER 'General case' 0 C--O 1.232 0.163 0 O-C-N 124.382 1.051 . . . . 0.0 109.99 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.788 HG21 HD11 ' A' ' 105' ' ' LEU . 10.0 pt -95.31 175.3 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.458 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.494 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 67.9 m-85 -128.8 157.59 74.98 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.779 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.592 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 22.0 Cg_endo -66.71 133.08 30.58 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.957 2.438 . . . . 0.0 113.152 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.49 14.08 39.25 Favored Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 66' ' ' THR . 33.6 tt0 -103.35 162.93 12.59 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.515 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 91.9 t -122.17 118.25 54.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.788 HD11 HG21 ' A' ' 99' ' ' ILE . 96.9 mt -111.89 152.01 28.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.948 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -89.91 113.98 25.7 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.689 0.757 . . . . 0.0 110.975 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.4 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 24.9 m -123.35 152.07 63.75 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 114.178 -1.373 . . . . 0.0 109.983 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.4 ' HD2' ' HB ' ' A' ' 107' ' ' VAL . 34.1 Cg_endo -64.77 -15.59 51.0 Favored 'Trans proline' 0 N--CA 1.472 0.248 0 C-N-CA 123.633 2.889 . . . . 0.0 114.869 -177.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.2 t -155.74 156.89 35.64 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.931 0.396 . . . . 0.0 111.128 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.496 ' HG2' ' HB1' ' A' ' 63' ' ' ALA . 13.0 mmmm -105.83 170.39 7.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.376 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -81.58 -81.82 0.85 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.039 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -112.15 156.8 15.35 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 34.8 m -129.83 -23.11 2.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 117.176 0.488 . . . . 0.0 111.534 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.55 -45.48 1.62 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.124 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -152.48 -71.96 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -125.38 -108.63 1.7 Allowed Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 41' ' ' ARG . . . -125.7 -22.7 4.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.869 0.366 . . . . 0.0 110.422 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.458 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -123.72 -71.9 0.24 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.293 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 18.1 m120 74.81 34.7 0.69 Allowed 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 123.158 0.583 . . . . 0.0 111.536 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.635 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 19.3 p90 -64.31 -36.53 84.42 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.514 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 50.5 t-105 -64.6 -26.26 68.32 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.667 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.49 -13.56 52.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.131 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.5 p -142.87 22.37 1.94 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.462 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.551 ' O ' ' HD2' ' A' ' 125' ' ' ARG . . . -113.24 144.67 42.31 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.055 0.455 . . . . 0.0 111.753 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.551 ' HD2' ' O ' ' A' ' 124' ' ' ALA . 1.3 mpt_? -136.55 150.8 48.81 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.665 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 53.8 53.84 10.75 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.165 0.507 . . . . 0.0 111.609 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.517 ' CG1' HD11 ' A' ' 136' ' ' LEU . 41.8 t -80.19 128.31 38.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.264 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.414 ' O ' HD12 ' A' ' 136' ' ' LEU . 2.0 ptp180 -146.43 140.51 26.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.951 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.899 HD13 HG22 ' A' ' 14' ' ' ILE . 16.5 mt -86.6 126.96 34.85 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 177.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.749 HG23 ' HB ' ' A' ' 135' ' ' VAL . 27.6 m -118.33 165.46 13.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.817 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.575 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 0.2 OUTLIER 68.58 2.4 3.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.521 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.594 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 91.87 25.43 22.53 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.988 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 104.66 -21.33 36.92 Favored Glycine 0 C--O 1.267 2.182 0 CA-C-O 123.128 1.404 . . . . 0.0 112.721 178.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.734 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 0.0 OUTLIER -71.06 -10.37 59.63 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.177 -1.19 . . . . 0.0 109.775 179.083 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.749 ' HB ' HG23 ' A' ' 130' ' ' VAL . 20.4 t -143.08 146.94 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.601 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 35.1 tp -127.31 124.47 38.8 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -113.24 133.02 55.3 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 123.33 0.394 . . . . 0.0 110.478 -177.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.651 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -161.66 158.19 25.67 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.876 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -95.18 108.42 20.55 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.727 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 36.2 mt -97.06 133.14 42.12 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.389 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 145' ' ' GLY . 40.2 ttt180 -73.81 141.36 46.2 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.87 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.655 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 0.7 OUTLIER -158.67 -166.8 1.97 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 4.6 m -53.64 -30.86 44.97 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.43 0.456 . . . . 0.0 112.089 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -103.35 30.34 10.55 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.587 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 141' ' ' ARG . . . 89.91 -114.07 4.3 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.007 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -122.73 125.27 45.2 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.709 0.254 . . . . 0.0 110.563 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.655 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 27.7 t-20 -119.29 131.39 55.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.344 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -78.19 96.84 5.3 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.114 0.483 . . . . 0.0 110.041 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.485 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 23.5 t -103.36 170.18 8.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.342 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.601 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 36.5 ptt180 -148.95 154.94 40.11 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.752 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.826 HD13 HD22 ' A' ' 43' ' ' LEU . 10.7 tt -139.86 150.9 21.89 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.001 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.704 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 9.1 m-85 -92.33 104.88 17.18 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 122.003 -0.436 . . . . 0.0 110.56 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.793 HD13 HD22 ' A' ' 21' ' ' LEU . 21.2 mt -66.61 -35.46 80.25 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.929 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.734 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 10.5 t70 -57.61 -12.58 2.93 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.879 178.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.759 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 42.1 mt-10 -61.55 -56.08 23.83 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 121.121 0.486 . . . . 0.0 111.909 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.583 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 51.7 m-70 -119.86 -4.6 10.16 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.59 -177.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.477 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 46.7 mm -94.44 112.32 26.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.33 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.651 ' HA3' ' OXT' ' A' ' 167' ' ' CYS . . . -117.78 166.84 12.71 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.383 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.565 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 1.5 t30 -107.24 132.21 53.33 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 122.403 0.281 . . . . 0.0 110.416 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -122.26 90.06 3.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.07 0.462 . . . . 0.0 110.123 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 47.0 m-80 54.9 40.42 31.98 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.22 2.16 44.74 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.824 177.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -119.69 140.23 50.99 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.933 0.396 . . . . 0.0 110.235 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.746 HD11 ' CD2' ' A' ' 7' ' ' PHE . 7.6 tp -96.78 111.23 23.49 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.304 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 34.2 pt -138.73 -166.92 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.428 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.583 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 3.5 p80 -88.85 129.37 35.6 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.604 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.651 ' OXT' ' HA3' ' A' ' 158' ' ' GLY . 49.1 t . . . . . 0 C--O 1.25 1.089 0 O-C-N 123.895 0.747 . . . . 0.0 111.861 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.544 ' HA2' ' OD1' ' A' ' 6' ' ' ASN . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 112.0 -0.44 . . . . 0.0 112.0 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -83.91 -69.11 0.66 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.7 0.286 . . . . 0.0 111.109 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -138.39 -99.73 0.18 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.452 ' HB1' ' SG ' ' A' ' 167' ' ' CYS . . . -97.02 -28.28 14.23 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.0 -75.55 0.38 Allowed Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 119.649 -1.262 . . . . 0.0 113.139 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.544 ' OD1' ' HA2' ' A' ' 1' ' ' GLY . 37.2 m-80 64.09 16.38 9.94 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 122.463 0.305 . . . . 0.0 110.893 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.697 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -62.2 -30.98 71.46 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 116.75 -0.204 . . . . 0.0 111.251 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.0 t -67.8 -16.37 64.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.4 0.619 . . . . 0.0 110.084 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.09 -22.94 67.29 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.744 -0.662 . . . . 0.0 113.319 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 16.8 p -126.29 -17.74 5.11 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 122.12 -0.635 . . . . 0.0 111.51 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.421 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 3.3 m -105.18 133.48 49.88 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.3 ptt85 -114.36 -175.7 2.74 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 46.3 45.06 13.08 Favored 'General case' 0 C--N 1.316 -0.891 0 O-C-N 123.858 0.724 . . . . 0.0 111.518 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.887 HG22 HD13 ' A' ' 129' ' ' LEU . 6.6 mt -81.14 100.7 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-O 120.938 0.399 . . . . 0.0 109.972 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.571 ' CA ' HD12 ' A' ' 129' ' ' LEU . 74.0 m -142.78 126.42 16.93 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.773 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -93.67 158.87 15.47 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.883 0.849 . . . . 0.0 113.037 -179.087 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -99.44 74.99 1.94 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 113.995 -1.457 . . . . 0.0 107.623 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.91 -57.68 4.56 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.947 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.735 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -143.47 -9.22 0.74 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 120.676 0.274 . . . . 0.0 110.898 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -96.59 97.74 9.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.276 0.56 . . . . 0.0 110.906 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.913 ' HB2' HD22 ' A' ' 39' ' ' LEU . 46.5 tp -61.75 121.68 13.47 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.966 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.529 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 53.5 ttt180 -126.61 127.87 45.9 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.506 -0.477 . . . . 0.0 110.813 -178.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.597 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -146.59 150.08 34.79 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.608 0.718 . . . . 0.0 111.069 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 3.0 mm-40 -83.94 71.34 10.5 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.122 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.572 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 34.7 m -60.01 125.75 24.88 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.741 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 10' ' ' SER . 27.7 ttp180 -66.77 126.59 29.5 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.151 178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -102.37 155.11 18.46 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -52.52 -17.62 4.58 Favored Glycine 0 C--N 1.337 0.584 0 O-C-N 124.582 1.176 . . . . 0.0 114.747 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.21 -9.12 58.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.054 0.454 . . . . 0.0 110.216 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.47 11.44 62.45 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -119.87 165.56 13.5 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.558 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.513 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 88.4 m-85 -100.22 129.19 46.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.007 0.432 . . . . 0.0 110.847 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 75.1 m -113.68 126.03 54.79 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.959 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 m -67.27 114.65 6.16 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.217 0.532 . . . . 0.0 109.768 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 39.7 t -120.4 150.94 39.98 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.265 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.4 p -142.34 140.86 28.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.862 0.363 . . . . 0.0 110.86 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.431 HG22 HD23 ' A' ' 164' ' ' LEU . 15.8 tt -134.86 144.79 33.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.109 -178.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.4 94.02 2.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.385 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.913 HD22 ' HB2' ' A' ' 21' ' ' LEU . 0.9 OUTLIER -76.35 -14.91 60.07 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 120.915 0.388 . . . . 0.0 111.351 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.735 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 26.8 p-10 -67.75 -10.96 57.14 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.202 0.525 . . . . 0.0 109.939 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.42 ' O ' ' HB3' ' A' ' 117' ' ' ALA . 37.4 mtt180 -106.58 11.3 30.69 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.482 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -135.8 -26.2 1.22 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.715 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.816 HD22 HD13 ' A' ' 151' ' ' ILE . 33.2 mt -109.83 134.46 52.02 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.962 0.41 . . . . 0.0 110.919 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.537 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 47.7 m -126.1 146.52 49.89 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.695 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.464 ' HA ' HD13 ' A' ' 140' ' ' LEU . 3.4 p-10 -86.2 101.06 12.68 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -102.63 92.59 4.7 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.453 -178.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.0 t30 51.52 43.81 29.44 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.626 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.573 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 82.84 28.13 39.23 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.571 -0.824 . . . . 0.0 113.003 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.71 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 17.6 t-80 -149.88 126.43 10.91 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.705 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 72.6 m-85 -60.54 152.22 26.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.615 0.245 . . . . 0.0 111.026 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 11.4 ttm180 -141.68 132.18 25.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.087 0.47 . . . . 0.0 111.9 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.488 ' CZ2' ' HA ' ' A' ' 153' ' ' LEU . 57.4 m95 -79.23 114.61 18.3 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.729 177.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.6 t -93.55 -44.95 13.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.8 m 55.32 84.83 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.114 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.18 -72.41 0.28 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.776 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.66 135.85 9.03 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.954 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.92 51.18 0.9 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.637 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 160.77 -156.4 27.73 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.837 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.38 -15.02 80.43 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.584 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.54 139.45 10.73 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.283 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.39 -44.04 3.25 Favored Glycine 0 CA--C 1.504 -0.637 0 CA-C-O 122.016 0.786 . . . . 0.0 111.866 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.0 m -138.04 130.06 28.66 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 113.97 -1.115 . . . . 0.0 109.364 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.473 ' HB1' ' HG2' ' A' ' 110' ' ' LYS . . . -122.95 177.55 5.45 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.328 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.4 p -128.87 115.37 17.78 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.463 HG21 ' CE2' ' A' ' 80' ' ' PHE . 10.7 p -106.68 140.0 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.844 0.354 . . . . 0.0 111.105 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 14.0 m -88.55 130.31 35.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.047 0.451 . . . . 0.0 110.231 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.569 ' CG2' HD12 ' A' ' 99' ' ' ILE . 52.2 t -80.8 131.92 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.251 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -99.09 171.47 8.0 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 124.342 1.026 . . . . 0.0 109.705 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.728 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 35.0 tt0 -65.66 124.49 22.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.44 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.5 -1.21 66.28 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.531 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.426 ' CG ' HH22 ' A' ' 79' ' ' ARG . 85.7 m-20 -88.52 147.54 24.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.233 0.539 . . . . 0.0 111.531 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.687 ' HA ' HG12 ' A' ' 99' ' ' ILE . 38.1 p -133.06 168.21 18.9 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.618 HD22 HG23 ' A' ' 99' ' ' ILE . 1.8 mm? -49.76 -45.54 49.62 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.551 0.614 . . . . 0.0 110.307 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.598 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 65.8 mtt180 -63.58 -34.73 78.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.8 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.55 -37.24 65.62 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 72' ' ' THR . 47.8 mm -68.05 -48.76 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.587 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.729 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -59.34 -49.43 78.63 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.705 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.634 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -63.37 -33.02 74.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.081 0.467 . . . . 0.0 110.786 -179.428 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.426 HH22 ' CG ' ' A' ' 71' ' ' ASP . 32.9 ttm180 -74.31 -41.95 60.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.554 -178.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.463 ' CE2' HG21 ' A' ' 65' ' ' VAL . 98.8 m-85 -104.64 20.09 19.24 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 54.15 37.57 27.38 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.293 0.568 . . . . 0.0 112.349 178.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.729 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -119.17 167.16 12.1 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.599 ' O ' HG13 ' A' ' 87' ' ' ILE . 8.4 t0 -90.93 119.35 31.06 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.758 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.608 ' HD2' ' HB2' ' A' ' 95' ' ' ASN . 10.4 p90 -51.49 -32.63 28.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.191 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -62.91 -46.31 88.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.203 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.641 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 30.4 tt0 -66.87 -44.19 81.61 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.723 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.599 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.4 mt -52.12 -45.94 42.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.622 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.24 -50.12 71.46 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.987 177.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -58.45 -34.11 70.47 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.641 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 28.3 mmt180 -68.33 -38.52 81.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.101 0.477 . . . . 0.0 110.482 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 2.8 t-20 -91.53 -5.26 54.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.32 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 48.9 m-80 76.98 16.46 1.77 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.086 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.622 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 16.9 pt -101.25 -176.39 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.55 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 80.4 mm-40 -107.42 158.85 16.85 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.608 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 5.8 p30 -61.24 -55.4 32.41 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 122.137 0.97 . . . . 0.0 108.832 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -79.86 11.91 3.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.427 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.9 t70 -63.35 -35.44 80.39 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 7.6 mp 69.69 115.47 0.04 OUTLIER 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.74 -177.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.731 HG21 HD11 ' A' ' 105' ' ' LEU . 6.8 pt -94.64 175.74 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.472 -178.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.543 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 89.2 m-85 -124.35 160.29 53.48 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.957 -178.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.728 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 37.6 Cg_endo -69.74 133.06 24.7 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.082 2.521 . . . . 0.0 114.016 -178.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.76 14.63 33.91 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.583 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 66' ' ' THR . 44.0 mt-30 -102.41 164.19 11.81 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.83 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 67.1 t -123.56 116.31 47.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.731 HD11 HG21 ' A' ' 99' ' ' ILE . 89.4 mt -110.33 151.33 27.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.024 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.627 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 71.2 mt-30 -90.3 117.48 29.07 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.703 0.763 . . . . 0.0 110.872 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.31 150.42 60.32 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.467 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.43 -17.62 58.07 Favored 'Trans proline' 0 C--N 1.332 -0.318 0 C-N-CA 123.498 2.799 . . . . 0.0 114.017 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.4 t -152.7 152.59 31.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.041 0.448 . . . . 0.0 111.131 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.473 ' HG2' ' HB1' ' A' ' 63' ' ' ALA . 13.2 mmmm -100.62 -178.33 3.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.602 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -88.03 110.79 3.66 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.017 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -71.3 118.1 7.11 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.35 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.6 m -74.57 -34.7 62.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.811 0.339 . . . . 0.0 111.078 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.96 -50.79 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.59 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 132.03 144.21 5.29 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.507 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 122.73 61.7 0.21 Allowed Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 41' ' ' ARG . . . -91.27 -30.4 16.63 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.801 0.334 . . . . 0.0 111.53 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.537 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -94.71 -74.18 1.23 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.49 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 78.37 27.51 0.51 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.858 0.863 . . . . 0.0 112.461 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.577 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 26.5 p90 -63.87 -38.62 91.76 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.695 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.539 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 61.2 t-105 -63.02 -29.14 70.6 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.881 -178.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -57.11 -20.97 28.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.738 0.304 . . . . 0.0 111.112 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.678 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 57.6 m -141.9 30.82 1.63 Allowed 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.493 178.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.539 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -113.31 138.64 49.74 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.847 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 125' ' ' ARG . 11.4 mmt180 -126.95 146.05 50.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.262 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.5 t70 51.12 56.65 7.66 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 123.831 0.707 . . . . 0.0 110.659 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.53 ' CG1' HD11 ' A' ' 136' ' ' LEU . 45.0 t -79.66 120.32 30.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.44 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.85 141.34 34.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.177 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.887 HD13 HG22 ' A' ' 14' ' ' ILE . 17.8 mt -85.91 128.29 34.8 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.83 HG23 HG13 ' A' ' 135' ' ' VAL . 31.0 m -123.68 157.54 30.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.358 0.599 . . . . 0.0 111.224 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.925 ' HB3' ' HE3' ' A' ' 134' ' ' LYS . 5.9 m-20 65.67 16.98 10.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.897 178.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.694 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 91.8 25.3 23.08 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.942 178.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 91.16 -15.31 61.37 Favored Glycine 0 C--O 1.269 2.322 0 CA-C-O 123.638 1.688 . . . . 0.0 112.384 177.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.925 ' HE3' ' HB3' ' A' ' 131' ' ' ASP . 20.0 pttp -65.12 -15.71 62.69 Favored 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 121.463 -1.022 . . . . 0.0 108.929 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.83 HG13 HG23 ' A' ' 130' ' ' VAL . 2.2 p -149.03 135.58 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.547 0.689 . . . . 0.0 110.83 176.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 29.6 tp -110.3 125.08 52.77 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.073 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.406 ' CD ' ' HE ' ' A' ' 148' ' ' ARG . 31.9 tt0 -117.92 139.95 50.42 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.861 0.363 . . . . 0.0 111.52 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.663 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.96 168.8 20.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.17 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -95.25 107.55 19.66 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.573 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 57.1 mt -98.93 131.89 44.66 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.277 0.561 . . . . 0.0 111.168 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.678 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 33.7 ttt180 -72.28 142.01 48.89 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.071 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -153.89 -173.89 4.75 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.917 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 13.4 m -58.6 -22.71 57.03 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -105.39 20.02 38.38 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.233 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 106.73 -115.33 4.66 Favored Glycine 0 C--O 1.229 -0.212 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.298 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -130.31 138.07 50.27 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -132.18 141.44 49.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.924 0.392 . . . . 0.0 111.701 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.406 ' HE ' ' CD ' ' A' ' 137' ' ' GLU . 69.5 ttt180 -74.76 103.53 5.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.146 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.71 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 32.6 t -121.65 162.08 21.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.326 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 10.3 ptt180 -148.55 152.6 37.11 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 120.957 0.408 . . . . 0.0 111.474 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.816 HD13 HD22 ' A' ' 43' ' ' LEU . 8.7 tt -132.36 131.96 60.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.73 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 135' ' ' VAL . 89.8 m-85 -75.89 101.22 5.08 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.56 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.727 HD13 HD22 ' A' ' 21' ' ' LEU . 35.7 mt -64.45 -36.22 83.47 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.191 178.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.845 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 11.7 t70 -55.35 -11.49 0.81 Allowed 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.425 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.539 ' HG3' ' CB ' ' A' ' 152' ' ' TYR . 38.0 mt-10 -71.41 -49.39 42.38 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 121.93 -0.481 . . . . 0.0 112.224 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.567 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 50.6 m80 -127.02 5.68 6.51 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 119.963 -0.695 . . . . 0.0 112.611 -177.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.403 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 46.9 mm -106.58 109.65 28.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.631 ' HA3' ' O ' ' A' ' 167' ' ' CYS . . . -116.38 166.22 12.34 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.187 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.572 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.9 t30 -100.79 123.21 44.66 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.41 ' O ' ' HB3' ' A' ' 163' ' ' GLU . 14.2 ttt85 -119.17 86.52 2.56 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.155 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 59.61 49.12 8.72 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 79.92 13.14 82.61 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.489 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 160' ' ' ARG . 28.2 tt0 -122.67 120.24 33.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.026 0.441 . . . . 0.0 110.037 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.697 HD11 ' CD2' ' A' ' 7' ' ' PHE . 8.5 tp -77.25 120.73 22.71 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.072 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.843 HG12 ' H ' ' A' ' 166' ' ' HIS . 12.6 tt -150.46 -172.21 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.987 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.843 ' H ' HG12 ' A' ' 165' ' ' ILE . 3.4 m-70 -85.84 124.0 31.83 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.214 -0.304 . . . . 0.0 110.426 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.631 ' O ' ' HA3' ' A' ' 158' ' ' GLY . 53.3 t . . . . . 0 C--O 1.245 0.857 0 O-C-N 124.079 0.862 . . . . 0.0 111.26 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.464 ' HA2' ' CD2' ' A' ' 152' ' ' TYR . . . . . . . . 0 N--CA 1.482 1.732 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -66.35 136.9 56.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.441 0.638 . . . . 0.0 111.109 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -120.38 -64.71 1.22 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.101 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -125.29 -25.58 3.77 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.642 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -84.09 -70.93 1.33 Allowed Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 118.771 -1.68 . . . . 0.0 113.488 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.628 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 63.0 t30 57.3 31.95 20.95 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.207 0.603 . . . . 0.0 110.283 -178.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.611 ' CE2' HD13 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -60.28 -32.91 71.64 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.028 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.458 ' HA ' HD11 ' A' ' 14' ' ' ILE . 34.0 t -59.17 -20.8 57.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.523 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.52 -42.17 93.76 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.836 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 26' ' ' ARG . 49.4 m -114.97 -18.05 11.35 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.9 m -92.38 134.86 34.53 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.471 ' CG ' ' HB2' ' A' ' 24' ' ' GLU . 16.7 ptt180 -113.27 -177.54 3.16 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.494 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 0.4 OUTLIER 42.61 44.63 3.72 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 123.873 0.733 . . . . 0.0 112.457 179.18 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.916 HG22 HD13 ' A' ' 129' ' ' LEU . 5.8 mt -78.98 105.14 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 CA-C-O 120.953 0.406 . . . . 0.0 110.292 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.607 ' HA ' HD12 ' A' ' 129' ' ' LEU . 80.4 m -146.82 127.62 14.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.37 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.749 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -96.97 155.86 16.6 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.621 0.724 . . . . 0.0 112.779 -179.279 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -96.22 75.1 2.97 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.433 -1.258 . . . . 0.0 107.958 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.51 -58.35 4.88 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.893 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -149.19 5.97 0.66 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.199 0.523 . . . . 0.0 110.21 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.575 ' HG2' ' CG2' ' A' ' 36' ' ' VAL . 32.3 ttt85 -108.32 93.99 4.82 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.825 ' HB2' HD22 ' A' ' 39' ' ' LEU . 55.0 tp -63.18 129.6 41.02 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -177.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.535 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 34.8 ttt180 -134.04 129.26 35.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.159 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.624 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -148.58 149.98 32.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.471 0.653 . . . . 0.0 110.983 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.55 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 3.3 mt-10 -87.64 80.67 7.91 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.773 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.587 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 58.7 m -63.47 127.86 33.23 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.408 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.5 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 36.8 ttm180 -71.13 114.93 9.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.364 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 9.0 ptp180 -79.6 152.6 29.97 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 179.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.36 -19.5 12.79 Favored Glycine 0 C--N 1.336 0.549 0 O-C-N 124.369 1.043 . . . . 0.0 114.03 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.58 -12.03 60.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.446 0.641 . . . . 0.0 109.821 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.29 5.22 56.05 Favored Glycine 0 CA--C 1.505 -0.589 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.526 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.454 ' O ' ' HG2' ' A' ' 27' ' ' ARG . . . -105.61 167.78 14.92 Favored Glycine 0 C--O 1.222 -0.649 0 C-N-CA 120.065 -1.064 . . . . 0.0 113.14 -178.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.55 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 57.9 m-85 -101.27 131.47 47.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.166 0.483 . . . . 0.0 110.907 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.9 m -118.49 123.35 44.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.191 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.5 m -69.1 112.31 5.63 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.9 t -118.25 155.41 30.61 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.028 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.575 ' CG2' ' HG2' ' A' ' 20' ' ' ARG . 2.6 p -145.43 139.08 21.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.878 0.371 . . . . 0.0 111.662 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.449 HG23 ' HB3' ' A' ' 21' ' ' LEU . 14.0 tt -135.13 148.06 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.471 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.439 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 17.7 m-20 -84.41 104.53 14.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.862 0.363 . . . . 0.0 111.475 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.825 HD22 ' HB2' ' A' ' 21' ' ' LEU . 3.0 mp -83.69 -12.15 56.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.428 0.632 . . . . 0.0 110.417 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.528 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 16.5 p30 -62.84 -19.09 63.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.021 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.452 ' O ' ' HB3' ' A' ' 117' ' ' ALA . 13.2 ptm180 -112.92 19.9 16.88 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.968 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.644 ' HD2' ' CE3' ' A' ' 52' ' ' TRP . 0.1 OUTLIER -138.12 -27.6 0.89 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.366 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.863 HD22 HD13 ' A' ' 151' ' ' ILE . 62.5 mt -106.09 132.21 52.44 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.619 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 3.2 m -129.35 141.92 50.95 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.541 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.709 ' HB3' ' HG ' ' A' ' 140' ' ' LEU . 3.7 p-10 -79.36 115.77 19.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.149 177.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -114.82 89.34 3.07 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.907 0.384 . . . . 0.0 110.248 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.3 t30 51.78 45.02 28.85 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.242 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.0 32.18 30.02 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.808 -0.711 . . . . 0.0 113.131 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.616 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 16.0 t-80 -150.85 125.19 9.45 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.78 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 45.3 m-85 -63.08 141.84 58.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.886 0.374 . . . . 0.0 111.672 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.647 ' NE ' ' HA ' ' A' ' 51' ' ' ARG . 3.4 mmp_? -146.26 135.82 23.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.841 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.644 ' CE3' ' HD2' ' A' ' 42' ' ' TYR . 95.0 m95 -74.36 105.95 5.75 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.124 0.488 . . . . 0.0 109.743 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.604 HG13 ' HB1' ' A' ' 117' ' ' ALA . 11.0 t 56.31 54.56 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.377 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.6 p 60.29 -59.9 0.07 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.39 1.476 . . . . 0.0 113.165 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -166.18 36.65 0.25 Allowed Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.81 41.53 14.79 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -79.34 152.86 36.56 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.273 -0.489 . . . . 0.0 112.755 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.86 144.53 18.46 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.152 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.19 146.39 22.83 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.045 -0.597 . . . . 0.0 112.403 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 163.92 -176.98 39.88 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.376 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.35 -127.47 8.8 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 121.075 -0.583 . . . . 0.0 111.829 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.3 m -134.25 130.52 37.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.861 0.362 . . . . 0.0 110.252 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.444 ' HB1' ' HG2' ' A' ' 110' ' ' LYS . . . -127.8 176.11 7.81 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.75 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.529 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 6.8 p -127.93 116.11 19.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.543 HG21 ' CE2' ' A' ' 80' ' ' PHE . 7.9 p -103.61 142.41 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 120.887 0.375 . . . . 0.0 110.844 178.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 9.8 m -88.38 130.95 35.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.161 0.505 . . . . 0.0 109.929 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.458 ' CG2' HD12 ' A' ' 99' ' ' ILE . 56.6 t -82.33 133.58 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.854 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -103.86 171.34 7.41 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.985 0.803 . . . . 0.0 110.2 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.621 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 53.7 tt0 -61.27 119.39 8.35 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.122 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.17 -9.91 63.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.888 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.455 ' HB3' HD11 ' A' ' 76' ' ' ILE . 84.9 m-20 -75.44 146.65 40.54 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.147 0.499 . . . . 0.0 111.529 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.624 ' HA ' HG12 ' A' ' 99' ' ' ILE . 24.3 p -135.99 163.15 30.96 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.615 HD22 HG23 ' A' ' 99' ' ' ILE . 1.6 mm? -49.18 -44.22 42.84 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.363 0.529 . . . . 0.0 110.634 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.442 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 70.1 mtp180 -59.96 -43.39 95.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.276 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -72.94 -33.88 66.21 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.537 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 72' ' ' THR . 44.0 mm -66.6 -46.91 84.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.716 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.48 -49.08 76.15 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.91 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -65.41 -32.43 74.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.059 0.456 . . . . 0.0 111.151 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.429 HH22 ' CG ' ' A' ' 71' ' ' ASP . 34.5 ttm180 -70.65 -40.33 73.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.73 -178.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.543 ' CE2' HG21 ' A' ' 65' ' ' VAL . 94.6 m-85 -110.42 16.91 21.32 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 56.22 37.56 28.96 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.445 0.64 . . . . 0.0 111.411 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.716 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.9 p -116.28 166.1 12.42 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.373 -0.83 . . . . 0.0 108.901 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.65 ' O ' HG13 ' A' ' 87' ' ' ILE . 3.7 t70 -92.22 124.6 36.42 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.101 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.442 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 9.7 p90 -52.28 -31.35 32.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.753 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 23.0 t-80 -66.79 -43.26 84.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.949 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.77 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 10.1 mm-40 -63.2 -51.54 65.93 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.361 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.65 HG13 ' O ' ' A' ' 83' ' ' ASP . 3.5 mt -50.94 -48.12 29.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 O-C-N 124.139 0.899 . . . . 0.0 109.475 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.625 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.51 -49.5 75.09 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.268 178.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -61.79 -34.05 75.21 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.77 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 14.7 mmt85 -65.28 -38.19 89.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.08 0.467 . . . . 0.0 110.525 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.428 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 11.5 m120 -93.13 -3.36 54.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.61 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 76.5 m-20 73.72 19.67 3.17 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.247 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.625 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 16.9 pt -100.68 -177.29 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.688 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.506 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 35.6 mt-30 -108.17 155.57 20.28 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.55 ' O ' HD23 ' A' ' 73' ' ' LEU . 3.1 p30 -54.94 -62.6 1.55 Allowed 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 122.116 0.96 . . . . 0.0 108.937 178.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -76.4 12.23 1.3 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.385 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.506 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.4 t70 -63.63 -34.5 77.96 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 8.7 mp 73.03 116.63 0.05 Allowed 'General case' 0 N--CA 1.462 0.136 0 O-C-N 124.399 1.062 . . . . 0.0 109.598 -177.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.744 HG21 HD11 ' A' ' 105' ' ' LEU . 11.2 pt -93.83 177.68 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.208 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.509 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 40.5 m-85 -129.48 157.76 75.37 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-O 120.892 0.377 . . . . 0.0 111.413 -178.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.621 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 25.7 Cg_endo -65.72 137.75 51.0 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.229 2.619 . . . . 0.0 113.905 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.12 13.65 57.25 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.867 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.479 ' O ' ' HA ' ' A' ' 66' ' ' THR . 95.5 mt-30 -100.87 168.39 9.67 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.216 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.529 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 63.2 t -127.6 110.61 22.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-O 120.921 0.391 . . . . 0.0 109.974 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.744 HD11 HG21 ' A' ' 99' ' ' ILE . 89.0 mt -103.6 150.4 24.0 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.678 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 75.8 mt-30 -91.34 116.47 28.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.973 0.892 . . . . 0.0 111.38 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.1 m -124.12 151.5 65.71 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 114.207 -1.36 . . . . 0.0 109.691 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -65.07 -15.03 48.44 Favored 'Trans proline' 0 N--CA 1.476 0.445 0 C-N-CA 123.571 2.847 . . . . 0.0 114.855 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.0 t -152.9 155.71 37.55 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.008 0.433 . . . . 0.0 111.197 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 110' ' ' LYS . 12.9 mmmm -100.31 -180.0 4.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.816 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -161.94 90.39 0.11 Allowed Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.531 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -107.6 129.01 9.44 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.176 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.0 m -84.67 28.78 0.65 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.173 0.511 . . . . 0.0 110.756 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -170.64 42.89 0.19 Allowed Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.625 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 141.01 -161.5 26.78 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 127.44 -67.08 0.55 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.8 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.604 ' HB1' HG13 ' A' ' 53' ' ' VAL . . . -100.57 -22.58 14.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.983 0.42 . . . . 0.0 111.715 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.619 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -102.51 -82.31 1.63 Allowed Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.26 -0.971 . . . . 0.0 112.618 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 73.41 23.45 2.51 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.437 0.695 . . . . 0.0 111.931 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.589 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 22.7 p90 -61.62 -38.51 87.92 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.549 -0.46 . . . . 0.0 109.854 178.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.553 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 63.5 t-105 -59.87 -33.86 72.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.474 -178.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -54.59 -25.95 29.51 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.101 0.476 . . . . 0.0 111.124 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.722 ' HB2' ' HB3' ' A' ' 141' ' ' ARG . 19.4 p -136.98 30.12 2.78 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.512 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.553 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -109.29 140.3 43.13 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.889 0.376 . . . . 0.0 110.835 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.412 ' HB3' ' HB2' ' A' ' 139' ' ' GLU . 61.0 ttp180 -127.51 138.91 53.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.932 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 55.36 54.47 8.58 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.244 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.501 ' CG1' HD11 ' A' ' 136' ' ' LEU . 29.7 t -76.67 121.43 28.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.643 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -144.94 146.01 31.8 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.65 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.916 HD13 HG22 ' A' ' 14' ' ' ILE . 18.4 mt -86.75 128.85 35.04 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 120.973 0.416 . . . . 0.0 110.157 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.597 HG23 ' HB ' ' A' ' 135' ' ' VAL . 35.1 m -125.75 160.18 32.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.646 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 69.04 5.77 5.26 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.389 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.665 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 97.32 29.06 8.12 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.439 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.536 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 91.8 -16.27 59.74 Favored Glycine 0 C--O 1.265 2.045 0 CA-C-O 123.689 1.716 . . . . 0.0 112.494 178.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.662 ' O ' ' HA ' ' A' ' 152' ' ' TYR . 5.8 ptpp? -70.87 -17.44 62.72 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 121.433 -1.039 . . . . 0.0 108.454 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.597 ' HB ' HG23 ' A' ' 130' ' ' VAL . 17.5 t -138.73 137.92 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.314 0.578 . . . . 0.0 110.736 178.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.693 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 29.6 tp -117.58 118.36 31.92 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -108.4 130.25 55.23 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.772 0.32 . . . . 0.0 111.276 -176.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.758 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.35 161.56 27.5 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.72 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.849 ' HG3' HH11 ' A' ' 148' ' ' ARG . 49.3 mt-10 -96.01 108.5 20.9 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.422 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.709 ' HG ' ' HB3' ' A' ' 45' ' ' ASN . 1.0 OUTLIER -90.96 126.78 36.17 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.959 178.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.722 ' HB3' ' HB2' ' A' ' 123' ' ' SER . 76.1 ttt180 -69.59 140.81 53.82 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.164 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.633 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 2.3 p90 -156.83 -165.98 1.99 Allowed 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.074 -179.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.2 t -58.42 -32.53 68.75 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.319 0.387 . . . . 0.0 111.121 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.19 28.88 13.26 Favored Glycine 0 C--N 1.329 0.182 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.478 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 89.52 -118.95 5.35 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.591 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -120.03 129.32 54.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.699 0.25 . . . . 0.0 110.73 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.633 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 53.7 t30 -121.34 134.18 55.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.74 0.305 . . . . 0.0 110.766 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.849 HH11 ' HG3' ' A' ' 139' ' ' GLU . 19.8 tpt180 -75.0 96.94 3.27 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.591 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.616 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 11.6 t -109.41 168.03 9.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.428 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.693 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 36.5 ptt180 -148.11 149.65 32.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.444 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.863 HD13 HD22 ' A' ' 43' ' ' LEU . 12.1 tt -132.98 140.72 46.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.581 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.662 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 26.6 m-85 -83.17 102.97 12.23 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.852 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.774 HD11 HD21 ' A' ' 129' ' ' LEU . 26.8 mt -65.25 -36.7 84.95 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.127 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.628 ' HB2' ' HA ' ' A' ' 6' ' ' ASN . 13.8 p-10 -61.69 2.83 0.16 Allowed 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.561 ' HG3' ' CB ' ' A' ' 152' ' ' TYR . 43.1 mt-10 -76.24 -52.43 10.03 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 121.729 -0.607 . . . . 0.0 110.758 178.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -118.02 -12.26 10.11 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.633 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.443 ' O ' ' HA3' ' A' ' 5' ' ' GLY . 50.8 mm -91.86 114.74 29.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 116.77 -0.196 . . . . 0.0 110.754 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -122.28 167.63 14.8 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.115 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.587 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 3.3 t30 -103.46 123.29 46.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.025 0.44 . . . . 0.0 109.959 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 29.5 ttt85 -124.68 93.08 3.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.341 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 16.2 m120 60.61 45.04 10.84 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.215 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 84.81 10.75 78.43 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.684 -0.769 . . . . 0.0 113.197 178.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -122.74 152.82 40.23 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.511 HD21 ' HD2' ' A' ' 7' ' ' PHE . 24.4 mt -97.17 119.65 36.05 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.492 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 43.0 pt -114.31 170.29 4.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.148 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -130.09 116.86 19.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.035 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 41.6 t . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.706 -0.664 . . . . 0.0 110.178 -179.668 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.669 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -92.92 168.77 10.93 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.655 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 32.6 m-85 -103.16 -76.75 0.58 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.499 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -137.68 -25.93 0.99 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.569 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 6' ' ' ASN . . . -68.88 -72.63 0.81 Allowed Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 119.738 -1.22 . . . . 0.0 113.597 -178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 25.5 m-80 69.69 10.31 7.53 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 122.498 0.319 . . . . 0.0 110.219 -178.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.785 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.9 OUTLIER -61.59 -34.93 76.46 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.61 -178.969 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.45 ' HA ' HD11 ' A' ' 14' ' ' ILE . 35.0 t -67.81 -14.87 63.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.476 0.655 . . . . 0.0 109.877 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.68 -27.76 64.5 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.964 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 20.9 p -125.69 -19.57 4.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 117.225 0.512 . . . . 0.0 111.992 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 11.8 m -94.99 129.04 42.22 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.698 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 35.4 ptt180 -108.01 -178.36 3.59 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.481 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 1.6 m-20 41.11 47.58 2.8 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 124.068 0.855 . . . . 0.0 112.489 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.924 HG22 HD13 ' A' ' 129' ' ' LEU . 8.1 mt -80.65 107.44 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-O 120.877 0.37 . . . . 0.0 110.292 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.713 ' CA ' HD12 ' A' ' 129' ' ' LEU . 46.1 t -150.2 128.53 12.11 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.701 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -96.7 158.56 15.37 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 122.047 0.927 . . . . 0.0 113.012 -178.819 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -99.51 76.4 2.02 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.14 -53.57 4.77 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.879 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.46 ' CB ' ' HB3' ' A' ' 40' ' ' ASN . . . -149.55 -12.41 0.29 Allowed 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 120.746 0.308 . . . . 0.0 110.195 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -86.1 90.13 8.03 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.448 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.003 HD12 HD11 ' A' ' 129' ' ' LEU . 8.5 tp -61.64 112.97 2.46 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.671 -179.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.495 ' HE ' ' CG2' ' A' ' 34' ' ' THR . 18.8 ttt85 -118.28 130.59 56.13 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.277 -178.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.679 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -149.65 150.9 32.86 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.407 0.623 . . . . 0.0 110.997 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.698 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 1.6 mm-40 -83.39 73.83 10.13 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.145 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.651 ' SG ' HD13 ' A' ' 164' ' ' LEU . 67.8 m -61.22 117.06 5.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.595 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 10' ' ' SER . 44.5 ttt180 -64.59 116.75 6.5 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.804 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.7 ttt85 -90.86 152.49 20.73 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.044 0.45 . . . . 0.0 109.957 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.63 -13.83 4.56 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 114.353 -1.294 . . . . 0.0 114.037 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -73.85 -11.08 60.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.114 0.483 . . . . 0.0 110.321 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.5 8.49 57.36 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -123.78 154.39 17.54 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.099 -1.048 . . . . 0.0 112.837 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.475 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 88.0 m-85 -87.87 125.49 34.51 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.712 0.291 . . . . 0.0 110.446 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.7 m -109.19 131.94 54.59 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.495 ' CG2' ' HE ' ' A' ' 22' ' ' ARG . 2.5 m -73.72 110.71 8.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.229 0.538 . . . . 0.0 109.98 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 30.3 t -115.5 153.59 30.87 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.635 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.7 p -146.14 137.27 18.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.794 0.331 . . . . 0.0 110.869 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.514 HG23 ' HB3' ' A' ' 21' ' ' LEU . 8.7 tt -134.68 137.05 51.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.733 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.643 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 13.3 m-20 -75.22 103.1 5.24 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.826 0.345 . . . . 0.0 111.558 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.818 ' HG ' HD11 ' A' ' 153' ' ' LEU . 3.4 mm? -83.11 -5.37 59.08 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.926 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.643 ' OD1' ' HB3' ' A' ' 38' ' ' ASP . 34.5 p-10 -67.06 -14.07 62.54 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.574 ' HE ' ' HB2' ' A' ' 38' ' ' ASP . 27.8 mtm180 -106.65 7.75 30.76 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.962 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.703 ' HB2' HD13 ' A' ' 39' ' ' LEU . 88.5 m-85 -130.95 -29.34 1.89 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.862 HD22 HD13 ' A' ' 151' ' ' ILE . 60.9 mt -106.22 132.69 51.98 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.779 0.323 . . . . 0.0 110.405 -179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.734 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 1.0 OUTLIER -123.44 143.03 50.4 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.603 -179.496 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 7.0 p-10 -88.25 93.61 9.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.791 0.805 . . . . 0.0 109.176 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -93.27 93.63 8.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.297 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.487 ' HA ' ' HB2' ' A' ' 142' ' ' TYR . 8.6 t-20 51.25 48.49 22.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.092 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.611 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 76.64 32.42 50.66 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.049 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.639 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 59.9 t60 -152.12 124.69 8.35 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.796 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 48.5 m-85 -60.71 144.15 52.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.887 0.375 . . . . 0.0 111.483 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.715 ' HG3' ' HA3' ' A' ' 55' ' ' GLY . 0.2 OUTLIER -143.03 131.74 22.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.475 -178.792 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.495 ' HZ2' ' O ' ' A' ' 152' ' ' TYR . 99.6 m95 -75.59 111.41 10.87 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 176.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.3 t 66.48 -80.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 123.704 0.802 . . . . 0.0 111.532 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.6 p -127.2 -22.63 3.7 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.98 0.419 . . . . 0.0 111.368 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.715 ' HA3' ' HG3' ' A' ' 51' ' ' ARG . . . 71.52 22.57 78.61 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.018 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.54 118.48 9.2 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.427 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -83.87 157.96 34.55 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.591 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.32 9.24 48.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.022 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.51 175.61 47.5 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.366 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.64 20.2 32.72 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.35 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 112.38 124.49 4.35 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.161 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 36.0 m -141.3 114.85 8.91 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.108 0.48 . . . . 0.0 110.323 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.467 ' HB1' ' HG2' ' A' ' 110' ' ' LYS . . . -130.9 178.59 6.55 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.191 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.516 HG22 ' HG2' ' A' ' 106' ' ' GLN . 4.6 p -128.33 115.56 18.46 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.499 ' HA ' ' HE3' ' A' ' 110' ' ' LYS . 7.3 p -102.77 143.25 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 120.869 0.366 . . . . 0.0 111.086 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 3.5 m -87.98 129.25 35.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.481 ' CG2' HD12 ' A' ' 99' ' ' ILE . 57.4 t -79.66 132.25 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.647 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -101.03 168.61 9.49 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 124.254 0.971 . . . . 0.0 110.475 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.668 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 35.1 tt0 -66.03 120.21 12.74 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.87 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.85 -11.07 52.76 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.771 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.06 130.26 45.38 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.134 0.467 . . . . 0.0 111.402 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.618 ' HA ' HG12 ' A' ' 99' ' ' ILE . 82.6 p -107.41 179.76 4.15 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.668 HD22 HG23 ' A' ' 99' ' ' ILE . 1.4 mm? -53.64 -43.64 68.9 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.436 0.636 . . . . 0.0 109.511 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.523 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 7.0 ttp85 -63.31 -36.05 82.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.39 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 79' ' ' ARG . 50.2 m-20 -73.77 -41.83 61.9 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.568 HG12 ' O ' ' A' ' 72' ' ' THR . 45.3 mm -61.32 -47.68 92.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.605 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.723 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.19 -51.34 58.11 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.651 -0.704 . . . . 0.0 113.083 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.448 HH11 ' HD2' ' A' ' 78' ' ' ARG . 47.1 mtp85 -70.21 -23.71 62.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.796 0.331 . . . . 0.0 111.691 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 37.2 ttt180 -78.91 -39.37 35.02 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -110.97 19.45 18.48 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t70 55.22 59.24 4.09 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.693 0.759 . . . . 0.0 111.335 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.723 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.4 p -142.35 164.59 29.72 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.364 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.574 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.8 t0 -91.04 120.89 32.39 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.523 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 5.0 p90 -52.19 -30.47 27.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.429 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -66.66 -41.87 87.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.602 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.695 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 64.3 mm-40 -66.06 -49.62 67.0 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.485 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.574 HG13 ' O ' ' A' ' 83' ' ' ASP . 4.1 mt -51.93 -47.53 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.523 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.58 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.77 -50.4 71.2 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.112 178.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -60.3 -33.82 72.91 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.695 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 27.4 mmt180 -71.19 -31.83 68.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.914 0.388 . . . . 0.0 110.44 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 3.7 t-20 -91.73 -5.97 52.74 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.615 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 90.7 m-20 77.15 17.76 1.54 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.033 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.58 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 14.2 pt -105.69 -174.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.577 178.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.449 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 64.6 mt-30 -110.25 162.57 14.49 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.614 ' O ' HD23 ' A' ' 73' ' ' LEU . 4.2 p-10 -58.59 -68.67 0.24 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.317 1.055 . . . . 0.0 110.003 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -74.33 13.47 0.58 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.545 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.5 t70 -59.65 -29.39 68.0 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.407 HD22 HG21 ' A' ' 72' ' ' THR . 34.1 mt 72.4 110.6 0.06 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.816 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.668 HG23 HD22 ' A' ' 73' ' ' LEU . 10.2 pt -95.62 172.56 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.405 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.58 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 73.7 m-85 -126.74 161.45 53.12 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.31 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.668 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 24.8 Cg_endo -66.31 139.6 55.32 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.203 2.602 . . . . 0.0 113.843 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.07 16.72 43.23 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' A' ' 66' ' ' THR . 25.8 mt-30 -103.18 166.57 10.36 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.082 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.426 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 82.5 t -126.91 114.43 37.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.56 HD11 HG21 ' A' ' 99' ' ' ILE . 88.1 mt -112.2 151.65 29.31 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.801 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.516 ' HG2' HG22 ' A' ' 64' ' ' THR . 34.3 mt-30 -90.47 117.26 29.03 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.615 0.721 . . . . 0.0 110.923 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.423 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 35.2 m -126.27 152.59 73.92 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.634 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 107' ' ' VAL . 18.0 Cg_endo -57.52 -48.04 19.04 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.353 2.035 . . . . 0.0 113.578 -177.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.1 t -123.72 155.22 38.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.254 0.55 . . . . 0.0 111.635 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.499 ' HE3' ' HA ' ' A' ' 65' ' ' VAL . 11.3 mmmm -99.38 -170.23 1.88 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.697 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -175.32 -45.36 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 63.65 -113.71 6.15 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.282 -0.485 . . . . 0.0 112.8 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 19.5 m -119.08 12.38 12.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.936 0.398 . . . . 0.0 110.771 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.439 ' O ' ' HD2' ' A' ' 41' ' ' ARG . . . 166.4 -42.26 0.26 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.211 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.25 -117.88 0.67 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.65 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.42 47.04 60.01 Favored Glycine 0 CA--C 1.502 -0.778 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 41' ' ' ARG . . . -111.18 -52.74 2.77 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.825 -0.687 . . . . 0.0 110.732 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.734 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -83.01 -77.87 1.08 Allowed Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.523 -0.762 . . . . 0.0 113.184 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 19.5 m120 73.29 29.09 1.72 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.054 0.542 . . . . 0.0 111.418 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.592 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 21.8 p90 -60.59 -37.92 82.94 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.519 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 47.8 t-105 -60.57 -30.39 69.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.559 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.47 -33.02 58.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.939 0.399 . . . . 0.0 110.537 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.775 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 6.7 m -131.28 28.84 4.68 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.852 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.519 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -108.65 140.78 41.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.896 0.379 . . . . 0.0 110.889 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.565 ' HB3' ' HB2' ' A' ' 139' ' ' GLU . 11.3 tpp85 -124.09 135.2 53.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.462 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 54.85 55.46 7.78 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.765 0.666 . . . . 0.0 111.849 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.526 HG12 HD11 ' A' ' 136' ' ' LEU . 40.1 t -78.03 123.58 35.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.822 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.435 ' O ' HD12 ' A' ' 136' ' ' LEU . 8.9 ptp180 -149.49 149.0 30.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.827 0.346 . . . . 0.0 110.589 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 1.003 HD11 HD12 ' A' ' 21' ' ' LEU . 92.5 mt -86.6 134.85 33.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.056 0.455 . . . . 0.0 110.495 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.626 HG23 ' HB ' ' A' ' 135' ' ' VAL . 26.8 m -124.61 157.67 32.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.921 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.739 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 0.3 OUTLIER 72.99 -4.41 2.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.059 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.644 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 104.18 32.0 4.48 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.821 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.682 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 94.88 -22.72 36.51 Favored Glycine 0 C--O 1.262 1.869 0 CA-C-O 123.203 1.446 . . . . 0.0 112.588 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.739 ' HG3' ' HB3' ' A' ' 131' ' ' ASP . 13.4 ptmt -65.73 -17.66 64.77 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 121.872 -0.781 . . . . 0.0 109.086 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.626 ' HB ' HG23 ' A' ' 130' ' ' VAL . 8.4 t -140.82 146.53 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.831 177.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.615 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 41.1 tp -126.13 124.69 41.1 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.534 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 34.1 tt0 -114.43 137.83 51.34 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.85 0.357 . . . . 0.0 111.403 -177.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.556 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -163.21 164.69 25.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.177 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.565 ' HB2' ' HB3' ' A' ' 125' ' ' ARG . 17.5 mm-40 -94.9 106.41 18.4 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 177.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.611 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 59.0 mt -96.71 130.03 44.01 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.2 0.524 . . . . 0.0 111.197 -178.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.775 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 42.6 ttt180 -77.09 141.29 40.3 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.688 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.487 ' HB2' ' HA ' ' A' ' 47' ' ' ASN . 6.8 p90 -155.65 -169.21 3.04 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.976 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.9 p -58.22 -22.53 52.36 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -109.19 28.24 11.36 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.31 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.63 -123.19 7.45 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.858 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -123.19 135.55 54.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.56 0.219 . . . . 0.0 110.51 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.436 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 57.9 t30 -134.91 142.61 46.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.898 0.38 . . . . 0.0 110.828 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.9 tpp85 -76.61 110.47 11.2 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.066 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.639 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 9.2 t -124.9 165.53 17.91 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.615 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 35.2 mtt85 -146.37 152.37 38.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.712 0.292 . . . . 0.0 110.881 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.862 HD13 HD22 ' A' ' 43' ' ' LEU . 12.4 tt -135.77 142.76 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.022 178.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.589 ' CB ' ' HG3' ' A' ' 155' ' ' GLU . 8.5 m-85 -86.35 101.84 13.46 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 122.471 -0.143 . . . . 0.0 111.31 -178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.818 HD11 ' HG ' ' A' ' 39' ' ' LEU . 3.9 mm? -61.14 -37.53 83.17 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.079 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.654 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 13.1 t70 -55.2 -16.24 3.01 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.209 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.655 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 41.2 mt-10 -63.28 -54.01 43.93 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.521 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 48.4 m80 -124.48 2.92 8.37 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.786 -0.766 . . . . 0.0 112.404 -177.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.617 HG13 HD12 ' A' ' 153' ' ' LEU . 43.5 mm -104.03 112.96 39.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.357 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.638 ' HA3' ' OXT' ' A' ' 167' ' ' CYS . . . -118.73 168.33 13.24 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.562 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.554 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.8 t30 -104.71 122.16 45.1 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 15.7 ttm-85 -123.85 93.68 4.0 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.29 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 59.23 41.54 19.94 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.478 -0.783 . . . . 0.0 113.063 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 90.45 10.05 64.17 Favored Glycine 0 C--O 1.229 -0.193 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.211 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -121.43 134.21 55.09 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.216 0.531 . . . . 0.0 110.211 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.785 HD11 ' CD2' ' A' ' 7' ' ' PHE . 8.1 tp -96.35 107.31 19.66 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.741 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.444 ' HA ' HD12 ' A' ' 37' ' ' ILE . 19.8 pt -140.9 -176.59 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.003 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.521 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 7.9 p80 -71.49 124.65 25.12 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.638 ' OXT' ' HA3' ' A' ' 158' ' ' GLY . 42.6 t . . . . . 0 C--O 1.247 0.965 0 O-C-N 123.804 0.69 . . . . 0.0 111.553 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.717 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.511 ' HB3' ' HD1' ' A' ' 3' ' ' TYR . 6.5 m120 -90.55 -80.47 0.33 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.514 ' CD1' ' HG2' ' A' ' 155' ' ' GLU . 13.6 m-85 -118.24 -94.48 0.5 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.97 0.414 . . . . 0.0 111.684 -178.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -109.18 -28.45 9.02 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -62.4 -70.98 0.89 Allowed Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 119.495 -1.336 . . . . 0.0 112.694 -178.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 65.08 18.93 11.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.803 0.335 . . . . 0.0 110.498 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.742 ' HD2' HD11 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -65.19 -30.69 71.62 Favored 'General case' 0 C--O 1.217 -0.647 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.73 179.815 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.9 t -71.53 -9.32 58.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.705 0.764 . . . . 0.0 109.512 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.49 -23.01 57.51 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 115.12 -0.945 . . . . 0.0 113.054 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.484 ' HB2' HD22 ' A' ' 159' ' ' ASN . 20.2 m -129.39 -22.0 3.12 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 117.287 0.544 . . . . 0.0 111.26 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.505 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 13.0 m -99.31 133.49 43.53 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 12' ' ' ARG . 4.3 ptp180 -113.45 -174.49 2.47 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 42.61 45.52 4.02 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 123.854 0.721 . . . . 0.0 111.489 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.867 HG22 HD13 ' A' ' 129' ' ' LEU . 6.7 mt -79.54 109.26 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.008 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.638 ' CA ' HD12 ' A' ' 129' ' ' LEU . 53.8 t -149.54 127.24 11.7 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.42 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.742 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -94.7 154.7 17.19 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.584 0.706 . . . . 0.0 111.832 -179.547 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -97.47 75.49 2.5 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 114.42 -1.264 . . . . 0.0 107.65 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.13 -55.51 5.04 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.431 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.495 ' HA ' ' HZ ' ' A' ' 120' ' ' PHE . . . -148.51 -12.89 0.34 Allowed 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -87.15 91.64 8.78 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.893 0.377 . . . . 0.0 110.792 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.847 HD22 HD13 ' A' ' 153' ' ' LEU . 42.7 tp -60.86 124.65 21.07 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.138 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 54.5 ttp180 -128.35 131.94 48.58 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.773 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.635 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -149.72 145.9 26.93 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.612 0.72 . . . . 0.0 111.431 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.549 ' O ' ' HD2' ' A' ' 32' ' ' TYR . 19.8 mm-40 -78.73 71.26 5.18 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.645 178.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.681 ' SG ' HD13 ' A' ' 164' ' ' LEU . 61.6 m -60.08 121.65 12.4 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.717 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 10' ' ' SER . 25.0 ttt85 -67.91 132.08 46.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.038 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.718 ' HG2' ' HA3' ' A' ' 162' ' ' GLY . 18.8 mtm180 -103.75 155.88 18.25 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.27 -11.48 3.49 Favored Glycine 0 C--N 1.336 0.548 0 O-C-N 124.383 1.052 . . . . 0.0 114.389 -178.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -80.25 -4.46 53.33 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.19 10.97 73.59 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -179.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.66 152.68 17.37 Favored Glycine 0 C--O 1.225 -0.456 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.97 -178.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.549 ' HD2' ' O ' ' A' ' 24' ' ' GLU . 70.9 m-85 -101.55 125.31 48.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.721 0.296 . . . . 0.0 110.247 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.7 p -117.8 141.13 48.76 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.046 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.8 m -72.66 111.99 8.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.262 0.553 . . . . 0.0 111.219 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.416 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 44.2 t -115.32 148.61 39.02 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.343 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.6 p -144.97 137.96 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.944 0.402 . . . . 0.0 111.561 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.595 HG22 HD23 ' A' ' 164' ' ' LEU . 14.0 tt -134.5 154.2 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.341 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -89.17 110.24 21.01 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 121.836 -0.54 . . . . 0.0 111.487 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.569 HD23 ' HB3' ' A' ' 21' ' ' LEU . 2.9 mm? -87.55 -6.81 58.17 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.512 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.59 -17.27 64.57 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.1 mtt-85 -95.08 2.7 55.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.992 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 96.1 m-85 -131.36 -23.23 2.41 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.689 HD22 HD13 ' A' ' 151' ' ' ILE . 63.2 mt -105.98 136.59 45.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.845 0.355 . . . . 0.0 111.576 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.469 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 15.8 m -134.79 136.35 42.49 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.15 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.819 ' CB ' ' HG ' ' A' ' 140' ' ' LEU . 3.5 p-10 -80.2 107.77 13.27 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.418 177.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -113.87 94.96 5.07 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.503 ' HA ' ' HB2' ' A' ' 142' ' ' TYR . 7.7 t30 56.95 49.41 14.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.756 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.552 ' O ' ' HB2' ' A' ' 149' ' ' SER . . . 71.91 31.12 64.87 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.201 178.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.511 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 38.8 m80 -144.45 129.04 18.11 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.732 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 26.3 m-85 -68.4 136.96 54.13 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.589 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -144.0 132.49 22.19 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.069 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.618 ' CD1' HD11 ' A' ' 151' ' ' ILE . 99.8 m95 -75.11 134.41 41.32 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.163 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.2 m -111.24 154.22 12.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.985 0.421 . . . . 0.0 109.91 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.0 t -97.36 1.19 49.1 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.7 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 167.41 -31.22 0.19 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.263 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.29 -173.31 28.66 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.091 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -164.42 96.27 0.13 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.881 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.98 49.89 0.27 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.276 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -118.98 -40.5 0.64 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.155 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.27 64.73 0.61 Allowed Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.615 -0.803 . . . . 0.0 112.486 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -178.14 -121.3 0.69 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.858 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 87.9 m -131.13 126.43 35.69 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.057 0.456 . . . . 0.0 110.581 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.465 ' HB1' ' HG2' ' A' ' 110' ' ' LYS . . . -132.65 176.32 8.55 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.263 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.439 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 4.8 p -127.41 121.33 30.6 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.794 0.331 . . . . 0.0 111.602 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.5 HG21 ' CE2' ' A' ' 80' ' ' PHE . 9.8 p -109.73 144.47 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.75 0.31 . . . . 0.0 110.411 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 18.1 m -88.19 128.07 35.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.101 0.477 . . . . 0.0 110.395 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.492 ' CG2' HD12 ' A' ' 99' ' ' ILE . 57.1 t -73.16 128.11 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.743 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -100.83 169.2 9.16 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 124.577 1.173 . . . . 0.0 111.196 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.618 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 26.4 tp60 -68.19 112.17 4.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.75 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.38 18.55 16.37 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.71 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -125.38 117.57 24.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.619 0.247 . . . . 0.0 110.463 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.687 ' HA ' HG12 ' A' ' 99' ' ' ILE . 81.9 p -104.9 -179.03 3.82 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.665 HD22 HG23 ' A' ' 99' ' ' ILE . 0.9 OUTLIER -52.88 -41.01 63.94 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.419 178.826 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 46.5 mtm105 -63.51 -39.02 93.34 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.168 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 79' ' ' ARG . 19.6 m-20 -70.95 -41.18 71.46 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.338 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 72' ' ' THR . 35.8 mm -63.92 -46.99 92.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.656 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -56.66 -54.76 34.02 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.75 -0.659 . . . . 0.0 113.02 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -64.86 -27.41 68.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.977 0.417 . . . . 0.0 111.734 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 71.9 ttt180 -74.24 -42.21 60.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.172 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.5 ' CE2' HG21 ' A' ' 65' ' ' VAL . 68.2 m-85 -111.45 19.75 17.9 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.2 t70 54.26 36.54 25.35 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.966 0.889 . . . . 0.0 111.316 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.656 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 3.6 p -113.79 163.5 14.97 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.615 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.0 t70 -92.71 124.69 36.9 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.935 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.515 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 4.0 p90 -51.67 -30.34 21.47 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.255 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 35.3 t60 -64.71 -44.36 90.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.029 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.702 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 28.0 mm-40 -67.02 -48.25 68.93 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.934 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.615 HG13 ' O ' ' A' ' 83' ' ' ASP . 3.4 mt -53.46 -46.19 58.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.592 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.1 -51.28 67.21 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.35 178.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -57.35 -39.56 76.21 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.618 0.246 . . . . 0.0 111.53 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.702 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 63.9 mmt-85 -63.06 -37.51 87.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.009 0.433 . . . . 0.0 110.778 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.428 ' HB3' HG12 ' A' ' 93' ' ' ILE . 3.0 t-20 -89.38 -5.34 57.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.948 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 95.2 m-20 74.46 22.16 2.18 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.556 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.592 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 14.8 pt -108.18 -176.98 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.212 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.454 ' H ' ' HB2' ' A' ' 97' ' ' ASP . 85.1 mm-40 -108.98 155.96 20.27 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.493 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.7 p30 -55.12 -60.43 3.39 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-O 122.104 0.954 . . . . 0.0 109.119 178.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -74.09 11.5 0.9 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.036 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.454 ' HB2' ' H ' ' A' ' 94' ' ' GLN . 5.3 t70 -64.86 -33.15 75.32 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.425 HD22 HG21 ' A' ' 72' ' ' THR . 51.0 mt 70.05 111.84 0.05 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.11 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.687 HG12 ' HA ' ' A' ' 72' ' ' THR . 9.2 pt -94.7 172.54 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.158 -178.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.499 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 19.3 m-85 -125.43 157.97 66.01 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.86 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.618 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 23.2 Cg_endo -65.25 132.63 32.28 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.986 2.458 . . . . 0.0 113.492 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.78 21.05 10.67 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.843 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.531 ' O ' ' HA ' ' A' ' 66' ' ' THR . 51.2 mt-30 -110.46 167.72 10.0 Favored 'General case' 0 C--O 1.215 -0.712 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.044 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.439 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 81.5 t -125.84 111.0 25.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.543 HD11 HG21 ' A' ' 99' ' ' ILE . 90.7 mt -107.16 150.63 26.39 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.155 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.614 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 47.4 mt-30 -89.41 114.92 26.44 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.713 0.768 . . . . 0.0 110.927 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.6 m -121.06 150.86 54.32 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 114.358 -1.292 . . . . 0.0 109.794 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.66 -19.81 59.74 Favored 'Trans proline' 0 N--CA 1.472 0.211 0 C-N-CA 123.458 2.772 . . . . 0.0 114.351 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.5 t -151.54 145.85 25.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.975 0.417 . . . . 0.0 110.382 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.485 ' HE2' ' OD1' ' A' ' 119' ' ' ASN . 19.9 mmmt -88.6 177.01 6.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.309 0.576 . . . . 0.0 111.566 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.59 153.23 10.45 Favored Glycine 0 N--CA 1.439 -1.106 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -177.08 -170.7 39.84 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.222 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.1 p -80.87 -18.35 47.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.998 0.427 . . . . 0.0 111.298 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -129.31 46.09 1.1 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.027 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.66 -70.7 1.67 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.439 -0.41 . . . . 0.0 112.865 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.49 61.33 1.18 Allowed Glycine 0 N--CA 1.442 -0.923 0 N-CA-C 111.746 -0.541 . . . . 0.0 111.746 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -93.05 -38.09 11.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.405 0.621 . . . . 0.0 109.533 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.469 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -93.56 -59.74 1.19 Allowed Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.485 ' OD1' ' HE2' ' A' ' 110' ' ' LYS . 40.1 m-80 74.51 27.49 1.37 Allowed 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.607 0.763 . . . . 0.0 112.636 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.615 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 19.4 p90 -62.36 -38.32 89.07 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.006 178.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.484 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 58.2 t-105 -61.72 -29.78 70.33 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 123.63 0.581 . . . . 0.0 111.634 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.15 -34.64 45.61 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.355 0.597 . . . . 0.0 110.539 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.956 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 17.8 m -132.64 32.34 3.88 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.484 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -114.37 137.36 51.91 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.403 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -131.95 151.3 51.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.183 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.6 t70 55.79 49.09 16.86 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.845 0.831 . . . . 0.0 109.763 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.496 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 29.6 t -77.2 119.29 25.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.746 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -142.36 144.21 33.06 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.79 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.867 HD13 HG22 ' A' ' 14' ' ' ILE . 19.8 mt -87.76 125.46 34.44 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.613 HG23 ' HB ' ' A' ' 135' ' ' VAL . 30.4 m -118.11 158.2 19.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.809 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 69.06 4.78 4.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.157 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.634 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 97.37 30.69 7.19 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.81 -0.709 . . . . 0.0 113.384 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 93.66 -21.38 41.48 Favored Glycine 0 C--O 1.266 2.097 0 CA-C-O 123.043 1.357 . . . . 0.0 113.112 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.849 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 15.8 ptpt -65.81 -17.88 64.94 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 121.785 -0.832 . . . . 0.0 108.834 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.613 ' HB ' HG23 ' A' ' 130' ' ' VAL . 17.2 t -139.47 141.62 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.676 177.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.587 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 24.4 tp -121.12 123.15 41.6 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.567 ' OE2' ' HD2' ' A' ' 148' ' ' ARG . 23.1 tt0 -117.26 131.34 56.85 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.1 0.476 . . . . 0.0 111.182 -177.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . . . -159.98 160.3 33.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.433 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -94.67 109.14 21.1 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.819 ' HG ' ' CB ' ' A' ' 45' ' ' ASN . 0.8 OUTLIER -91.7 131.04 37.37 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.016 -179.528 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.956 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 36.5 ttt180 -75.98 140.56 42.09 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.6 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.503 ' HB2' ' HA ' ' A' ' 47' ' ' ASN . 3.5 p90 -154.46 -176.23 5.79 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.852 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 46.6 m -56.28 -27.96 57.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.859 0.361 . . . . 0.0 111.686 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -97.35 25.76 25.77 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.283 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.85 -120.08 6.33 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.756 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -126.72 137.26 53.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.575 0.226 . . . . 0.0 110.473 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -133.93 132.9 40.78 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.369 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.567 ' HD2' ' OE2' ' A' ' 137' ' ' GLU . 16.3 ttp180 -74.87 98.11 3.47 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.56 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.552 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 35.1 t -106.15 164.38 12.04 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.907 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 15.8 ptt180 -147.62 145.94 29.17 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.694 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.732 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 14.7 tt -129.85 150.62 34.8 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.576 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.827 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 80.7 m-85 -89.46 103.88 16.48 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 122.144 -0.347 . . . . 0.0 111.079 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.847 HD13 HD22 ' A' ' 21' ' ' LEU . 34.2 mt -66.68 -33.78 76.41 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.299 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.849 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 10.1 t70 -58.42 -8.18 1.11 Allowed 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.159 178.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.827 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 38.8 mt-10 -68.77 -51.88 36.41 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 121.117 0.484 . . . . 0.0 111.785 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.433 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 88.6 m-70 -119.25 -15.03 9.2 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.156 -177.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.466 HG21 HD21 ' A' ' 21' ' ' LEU . 50.2 mm -88.21 112.95 24.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.153 -179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.499 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -119.49 173.71 15.18 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.715 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.566 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.7 t30 -113.3 127.71 56.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -122.26 93.15 3.89 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 66.6 t30 53.05 58.15 5.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.545 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.718 ' HA3' ' HG2' ' A' ' 27' ' ' ARG . . . 78.91 11.41 85.24 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.567 -0.742 . . . . 0.0 114.821 178.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -123.75 143.66 50.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 117.542 0.671 . . . . 0.0 110.958 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.742 HD11 ' HD2' ' A' ' 7' ' ' PHE . 5.5 tp -91.58 118.8 30.93 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.944 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.7 pp -129.3 175.36 10.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.807 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.433 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 25.9 p80 -118.22 138.03 52.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.546 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 6.2 p . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.563 -0.732 . . . . 0.0 110.722 -178.83 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.663 0 N-CA-C 111.454 -0.658 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.507 ' HB2' ' HB3' ' A' ' 154' ' ' ASP . 4.0 m120 -78.11 -72.82 0.35 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.86 0.33 . . . . 0.0 111.366 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.629 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 55.4 m-85 -134.9 -92.3 0.3 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.502 ' HB1' ' SG ' ' A' ' 167' ' ' CYS . . . -108.52 -30.74 8.1 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -178.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.96 -69.97 1.22 Allowed Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 119.825 -1.178 . . . . 0.0 112.448 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 62.18 21.15 12.24 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 122.606 0.362 . . . . 0.0 111.229 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.713 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -64.32 -33.34 75.61 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 121.12 -0.232 . . . . 0.0 110.873 179.368 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.409 ' HA ' HD11 ' A' ' 14' ' ' ILE . 42.6 t -61.95 -18.24 59.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.47 0.653 . . . . 0.0 110.188 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.17 -31.46 69.14 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.124 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.502 ' HB2' ' HB3' ' A' ' 26' ' ' ARG . 21.6 p -126.67 -8.22 6.2 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 117.399 0.6 . . . . 0.0 111.742 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.1 m -105.32 128.95 53.74 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.44 ' CG ' ' HB2' ' A' ' 24' ' ' GLU . 13.8 ptm180 -110.05 -176.71 3.07 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.452 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 21.7 m-20 43.27 44.47 4.61 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 124.036 0.835 . . . . 0.0 112.306 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.901 HG22 HD13 ' A' ' 129' ' ' LEU . 8.3 mt -79.6 103.2 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -178.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.57 ' CA ' HD12 ' A' ' 129' ' ' LEU . 57.7 m -147.1 127.2 13.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.707 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.743 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -96.98 151.29 19.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.711 0.767 . . . . 0.0 112.805 -179.604 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 21.7 t70 -93.82 74.74 4.24 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 177.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.42 -54.44 4.9 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.155 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.559 ' HB1' ' HB2' ' A' ' 40' ' ' ASN . . . -147.97 -12.83 0.37 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.264 -0.468 . . . . 0.0 109.742 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.482 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -82.55 86.74 6.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.545 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.743 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 35.9 tp -60.95 124.45 20.53 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.485 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.546 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 34.7 ttt180 -132.17 127.59 36.23 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.877 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.604 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -146.0 145.98 30.82 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.668 0.747 . . . . 0.0 111.421 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.452 ' HG3' ' HB2' ' A' ' 13' ' ' ASP . 2.1 mm-40 -83.68 76.4 9.98 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.411 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.601 ' SG ' HD13 ' A' ' 164' ' ' LEU . 35.8 m -66.54 125.57 26.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.393 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.502 ' HB3' ' HB2' ' A' ' 10' ' ' SER . 30.3 ttt180 -70.41 121.75 18.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.651 178.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 27' ' ' ARG . 10.7 ptp180 -100.05 163.84 12.25 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.755 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.4 -15.95 4.54 Favored Glycine 0 C--N 1.34 0.782 0 O-C-N 124.934 1.396 . . . . 0.0 114.114 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.6 -12.49 61.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.516 0.674 . . . . 0.0 109.417 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.57 9.52 62.86 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.654 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -119.93 162.26 14.11 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.08 -1.057 . . . . 0.0 113.286 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.473 ' CE2' ' HB2' ' A' ' 26' ' ' ARG . 84.2 m-85 -100.44 125.2 46.71 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.0 p -116.6 140.76 49.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.393 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -73.58 113.92 11.23 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.17 0.51 . . . . 0.0 111.43 -178.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 32.9 t -116.14 151.02 36.46 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.649 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.6 p -144.77 139.6 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.308 0.575 . . . . 0.0 112.091 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.408 HG23 ' HB3' ' A' ' 21' ' ' LEU . 13.7 tt -135.47 143.38 36.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.479 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -76.34 96.85 4.08 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.603 HD23 HD11 ' A' ' 43' ' ' LEU . 5.3 tp -73.5 -4.54 34.47 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.046 0.45 . . . . 0.0 110.408 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.559 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 64.3 t30 -73.83 -11.7 60.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.511 ' HG2' ' HA3' ' A' ' 116' ' ' GLY . 74.0 mtt180 -102.48 5.08 39.32 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.233 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 13.7 m-85 -127.57 -26.09 3.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.778 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.665 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 49.3 mt -105.02 138.76 40.73 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.8 0.333 . . . . 0.0 110.899 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.454 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 4.0 m -134.68 134.76 41.46 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.678 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.529 ' OD1' HD22 ' A' ' 140' ' ' LEU . 9.3 m-20 -73.33 110.37 7.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.685 177.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -111.9 86.95 2.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.245 0.545 . . . . 0.0 110.407 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.41 ' HA ' ' HB2' ' A' ' 142' ' ' TYR . 21.5 t-20 51.82 46.22 26.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.23 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.498 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 82.98 40.01 9.7 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.573 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.415 ' HA ' ' HB3' ' A' ' 149' ' ' SER . 16.5 t60 -162.2 128.63 3.64 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.886 ' HB2' ' HB ' ' A' ' 151' ' ' ILE . 96.2 m-85 -67.6 156.81 35.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.817 0.342 . . . . 0.0 111.146 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.433 ' HA ' ' HD3' ' A' ' 51' ' ' ARG . 16.7 mmt180 -148.91 126.89 11.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.169 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.976 ' HZ2' ' HA ' ' A' ' 153' ' ' LEU . 72.9 m95 -75.94 125.15 28.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.511 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.6 m -119.92 113.18 39.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.409 0.623 . . . . 0.0 110.096 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.1 m -92.74 48.93 1.4 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.26 0.552 . . . . 0.0 110.271 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.97 1.76 88.68 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.279 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.44 71.28 2.52 Favored Glycine 0 C--O 1.237 0.32 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.455 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -91.7 -31.88 9.05 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.476 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -79.32 79.24 1.65 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.234 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.15 75.86 2.13 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.356 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.03 -145.63 17.81 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.334 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.03 -124.01 6.3 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.113 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 83.6 m -130.11 120.08 24.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.088 0.47 . . . . 0.0 110.595 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.486 ' HB1' ' HG2' ' A' ' 110' ' ' LYS . . . -122.26 176.38 5.88 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.586 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.466 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 13.2 p -127.73 111.03 13.23 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.905 0.383 . . . . 0.0 111.176 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.568 HG21 ' CE2' ' A' ' 80' ' ' PHE . 9.1 p -97.54 144.37 11.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.042 0.448 . . . . 0.0 111.218 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 8.2 m -91.09 127.46 36.52 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.478 ' CG2' HD12 ' A' ' 99' ' ' ILE . 49.1 t -75.87 131.68 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.585 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -98.08 168.95 9.95 Favored 'General case' 0 N--CA 1.445 -0.679 0 O-C-N 124.657 1.223 . . . . 0.0 110.569 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.593 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 52.3 tt0 -69.65 119.75 14.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.781 -178.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.39 -1.67 50.1 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.475 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -110.12 131.71 54.82 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.084 0.469 . . . . 0.0 111.687 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.652 ' HA ' HG12 ' A' ' 99' ' ' ILE . 67.5 p -108.59 -177.62 3.37 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.651 HD22 HG23 ' A' ' 99' ' ' ILE . 1.4 mm? -52.85 -40.81 63.71 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.454 0.645 . . . . 0.0 109.889 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.0 ttm-85 -62.9 -37.16 85.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.211 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -74.15 -42.0 60.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.905 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 72' ' ' THR . 44.7 mm -62.0 -48.31 89.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.715 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -54.44 -52.87 41.87 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.688 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -64.5 -33.7 76.5 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 35.7 ttm-85 -68.69 -37.46 79.56 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.609 ' HE1' ' HA3' ' A' ' 111' ' ' GLY . 87.1 m-85 -111.72 18.37 19.03 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 55.02 34.07 21.67 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.236 0.541 . . . . 0.0 111.794 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.715 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 3.0 p -111.37 170.49 8.09 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.608 ' HB3' ' HG3' ' A' ' 86' ' ' GLU . 32.6 t0 -98.26 121.53 40.3 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.419 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.503 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 4.3 p90 -51.82 -29.72 20.42 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.586 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.461 ' HB2' ' OD2' ' A' ' 83' ' ' ASP . 69.2 m80 -63.8 -47.22 81.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.513 177.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.748 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 41.6 mt-10 -62.05 -53.49 54.75 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.942 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.587 HG13 ' O ' ' A' ' 83' ' ' ASP . 3.3 mt -48.0 -46.6 12.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.275 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.601 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.72 -51.06 68.64 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.211 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 89' ' ' ARG . 49.4 mtp85 -59.16 -36.77 75.85 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.748 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 12.3 mmt85 -69.43 -30.44 68.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.699 0.285 . . . . 0.0 110.98 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 2.6 t-20 -95.1 -4.72 45.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.825 0.345 . . . . 0.0 110.871 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 15.9 m120 78.25 13.81 1.52 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.769 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.601 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 19.6 pt -101.64 -173.55 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.288 179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.508 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . 64.4 mt-30 -113.88 157.64 22.1 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.126 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.574 ' O ' HD23 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -56.54 -69.73 0.14 Allowed 'General case' 0 C--O 1.244 0.778 0 CA-C-O 122.061 0.934 . . . . 0.0 110.101 179.663 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -73.28 13.91 0.38 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.716 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.508 ' HB2' ' HB2' ' A' ' 94' ' ' GLN . 1.9 t70 -65.99 -29.32 69.69 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.094 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 8.8 mp 71.33 112.3 0.06 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 122.033 0.921 . . . . 0.0 110.55 -178.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.652 HG12 ' HA ' ' A' ' 72' ' ' THR . 9.0 pt -94.59 177.22 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.155 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.519 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 79.2 m-85 -128.7 158.77 71.09 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.593 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 28.1 Cg_endo -67.0 138.96 49.56 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.949 2.433 . . . . 0.0 113.056 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.35 18.49 42.07 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.508 ' O ' ' HA ' ' A' ' 66' ' ' THR . 41.4 tt0 -103.89 164.28 11.8 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.466 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 69.7 t -125.58 118.2 51.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 120.938 0.399 . . . . 0.0 109.978 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.509 ' HB3' HG22 ' A' ' 87' ' ' ILE . 78.9 mt -114.44 151.07 33.77 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.147 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.534 ' HB2' ' CB ' ' A' ' 90' ' ' ARG . 75.8 mt-30 -90.91 115.2 27.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.668 0.747 . . . . 0.0 110.92 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.444 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 34.0 m -126.99 151.97 74.91 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.843 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.444 ' HD2' ' HB ' ' A' ' 107' ' ' VAL . 29.7 Cg_endo -63.8 -15.37 48.55 Favored 'Trans proline' 0 N--CA 1.474 0.352 0 C-N-CA 123.624 2.883 . . . . 0.0 115.207 -177.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.6 t -153.2 150.75 29.34 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.225 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.539 ' HE3' ' HA ' ' A' ' 65' ' ' VAL . 12.6 mmmm -98.46 170.32 8.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.069 0.461 . . . . 0.0 110.942 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.609 ' HA3' ' HE1' ' A' ' 80' ' ' PHE . . . -132.34 144.84 16.71 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -74.66 -82.43 0.42 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.586 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 19.5 m 55.25 47.01 22.51 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.25 0.548 . . . . 0.0 110.636 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 122.28 47.48 0.28 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.387 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 117.17 156.64 10.54 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.001 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.511 ' HA3' ' HG2' ' A' ' 41' ' ' ARG . . . -152.07 -71.14 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.459 -0.657 . . . . 0.0 111.459 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 41' ' ' ARG . . . -140.62 -44.44 0.4 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.064 0.459 . . . . 0.0 110.853 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . -87.76 -57.63 1.92 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.257 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 71.89 29.4 2.45 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 123.055 0.542 . . . . 0.0 111.373 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.665 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 12.5 p90 -61.19 -37.98 84.88 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.107 0.48 . . . . 0.0 110.183 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.452 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 48.6 t-105 -64.85 -26.25 68.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.636 -178.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.46 -18.3 61.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.213 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.78 ' HB2' ' HB3' ' A' ' 141' ' ' ARG . 11.2 p -140.07 22.67 2.42 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.971 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.452 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -111.73 141.96 44.69 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.901 0.382 . . . . 0.0 111.091 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -133.74 151.2 51.54 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 58.83 34.81 23.94 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.363 0.414 . . . . 0.0 111.646 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.498 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 30.8 t -66.92 123.82 20.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.81 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.491 ' O ' HD12 ' A' ' 136' ' ' LEU . 39.1 ptt180 -148.12 142.71 26.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.088 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.901 HD13 HG22 ' A' ' 14' ' ' ILE . 22.3 mt -85.52 131.79 34.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.081 0.467 . . . . 0.0 110.044 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.617 HG23 ' HB ' ' A' ' 135' ' ' VAL . 27.5 m -126.92 162.36 31.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.825 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 67.16 7.26 5.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.785 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.686 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 95.39 31.35 7.58 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.914 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.777 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 90.03 -19.28 43.23 Favored Glycine 0 CA--C 1.541 1.671 0 CA-C-O 123.226 1.459 . . . . 0.0 112.824 177.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.773 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 0.7 OUTLIER -68.18 -14.92 63.34 Favored 'General case' 0 C--N 1.314 -0.952 0 O-C-N 121.121 -1.223 . . . . 0.0 109.564 178.071 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.617 ' HB ' HG23 ' A' ' 130' ' ' VAL . 14.6 t -140.49 149.06 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.783 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 39.0 tp -130.72 125.25 33.4 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.403 ' HG2' ' HD2' ' A' ' 148' ' ' ARG . 33.6 tt0 -114.65 136.25 53.25 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.622 0.249 . . . . 0.0 111.363 -177.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.802 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.73 163.51 26.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.105 0.479 . . . . 0.0 111.323 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -94.72 106.5 18.49 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.529 HD22 ' OD1' ' A' ' 45' ' ' ASN . 36.6 mt -96.25 132.23 41.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.104 0.478 . . . . 0.0 111.316 -178.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.78 ' HB3' ' HB2' ' A' ' 123' ' ' SER . 42.5 ttt180 -75.82 140.55 42.34 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.256 -0.883 . . . . 0.0 110.674 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.509 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.7 p90 -160.3 -170.3 2.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.429 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 6.1 p -56.12 -29.29 60.46 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -94.49 11.67 69.84 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.726 -0.749 . . . . 0.0 113.171 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 141' ' ' ARG . . . 101.08 -111.46 4.14 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.039 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -126.75 129.85 49.17 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.509 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 9.1 t30 -125.55 140.19 52.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.992 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.403 ' HD2' ' HG2' ' A' ' 137' ' ' GLU . 12.5 tpp85 -73.49 100.04 3.16 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.415 ' HB3' ' HA ' ' A' ' 49' ' ' HIS . 1.0 OUTLIER -111.62 155.43 23.38 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.425 -177.709 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 4.8 ptp180 -146.51 145.28 30.1 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.135 0.493 . . . . 0.0 111.274 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.886 ' HB ' ' HB2' ' A' ' 50' ' ' PHE . 15.4 tt -126.47 159.74 35.22 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.81 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.489 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.871 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 68.5 m-85 -103.94 107.15 17.9 Favored 'General case' 0 C--N 1.311 -1.106 0 O-C-N 122.361 -0.212 . . . . 0.0 110.655 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.976 ' HA ' ' HZ2' ' A' ' 52' ' ' TRP . 8.4 mp -68.9 -37.18 78.81 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.221 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.773 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 6.1 t70 -57.08 -8.41 0.66 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.869 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.871 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 61.0 mt-10 -73.78 -55.43 6.24 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 121.972 -0.455 . . . . 0.0 111.811 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.534 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 88.7 m-70 -122.0 9.8 10.02 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.114 -0.634 . . . . 0.0 112.671 -177.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.446 ' HB ' ' O ' ' A' ' 153' ' ' LEU . 45.1 mm -110.95 109.62 29.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.356 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 167' ' ' CYS . . . -115.58 166.65 12.26 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.048 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.565 ' CG ' ' HB3' ' A' ' 25' ' ' CYS . 1.8 t30 -101.51 124.84 47.83 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.413 ' NH2' ' HG2' ' A' ' 163' ' ' GLU . 48.3 ttp180 -112.99 86.12 2.31 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.694 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 50.26 51.06 17.48 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 92.87 6.64 63.41 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.762 178.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.413 ' HG2' ' NH2' ' A' ' 160' ' ' ARG . 6.7 tp10 -122.16 149.75 43.17 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.713 HD11 ' CD2' ' A' ' 7' ' ' PHE . 5.3 tp -99.11 118.16 35.22 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.503 HG12 ' H ' ' A' ' 166' ' ' HIS . 12.2 tt -145.16 170.21 6.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.673 -178.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.534 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 19.3 p80 -70.87 123.18 21.38 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.565 ' O ' ' HA3' ' A' ' 158' ' ' GLY . 53.3 t . . . . . 0 C--O 1.247 0.941 0 O-C-N 123.852 0.72 . . . . 0.0 111.576 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.645 ' HA3' ' OD1' ' A' ' 6' ' ' ASN . . . . . . . . 0 N--CA 1.483 1.811 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -100.72 -68.51 0.81 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.479 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 53.5 m-85 -128.97 -94.6 0.42 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.31 -29.39 10.8 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.66 -73.41 0.58 Allowed Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 119.772 -1.204 . . . . 0.0 113.154 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.645 ' OD1' ' HA3' ' A' ' 1' ' ' GLY . 36.5 m-80 65.26 15.61 10.1 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 122.46 0.304 . . . . 0.0 110.484 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.61 ' CE2' HD13 ' A' ' 14' ' ' ILE . 1.4 p90 -60.14 -37.26 79.53 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.562 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.588 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.7 OUTLIER -59.85 -24.05 63.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.268 0.556 . . . . 0.0 110.604 -179.427 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.87 -33.96 87.25 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.404 -0.816 . . . . 0.0 113.44 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 18.8 p -121.12 -3.74 9.55 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 117.188 0.494 . . . . 0.0 111.689 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.7 m -110.39 131.85 54.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.119 0.485 . . . . 0.0 109.997 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.597 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 18.8 ptt180 -107.95 179.94 4.08 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 42.52 47.79 4.48 Favored 'General case' 0 C--N 1.316 -0.867 0 O-C-N 123.883 0.739 . . . . 0.0 112.767 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.777 HG22 HD13 ' A' ' 129' ' ' LEU . 7.3 mt -81.49 102.44 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-O 121.043 0.449 . . . . 0.0 109.919 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.562 ' HA ' HD12 ' A' ' 129' ' ' LEU . 46.4 t -147.76 128.69 14.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.457 -0.792 . . . . 0.0 108.985 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.741 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -92.99 159.48 15.29 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.629 0.728 . . . . 0.0 112.007 -179.241 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -104.31 77.64 1.42 Allowed 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.22 -61.02 4.52 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.134 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' A' ' 40' ' ' ASN . . . -146.02 -13.36 0.48 Allowed 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.282 -0.459 . . . . 0.0 109.913 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -86.16 95.15 9.48 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.81 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.894 ' HB2' HD22 ' A' ' 39' ' ' LEU . 33.8 tp -59.75 128.27 36.11 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.758 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 35' ' ' SER . 34.8 ttp180 -133.17 128.03 35.13 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.939 -178.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.621 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -149.47 147.29 28.05 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.546 0.688 . . . . 0.0 111.144 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.597 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 2.1 mm-40 -82.96 79.62 9.26 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.464 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.574 ' HB3' ' CG ' ' A' ' 159' ' ' ASN . 61.4 m -67.34 129.43 39.89 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.762 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 10' ' ' SER . 43.1 ttp180 -72.35 120.8 18.46 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.251 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.7 ttt-85 -96.05 153.71 17.63 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.09 -16.37 4.33 Favored Glycine 0 C--N 1.335 0.493 0 O-C-N 124.611 1.194 . . . . 0.0 114.765 -177.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.87 -13.88 61.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.238 0.542 . . . . 0.0 110.001 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.38 10.13 56.09 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.59 160.64 13.9 Favored Glycine 0 C--O 1.225 -0.461 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.485 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.522 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 88.5 m-85 -97.98 130.59 44.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.955 0.407 . . . . 0.0 110.685 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.0 m -110.69 129.1 55.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.364 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.36 110.37 5.26 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 29.4 t -112.46 147.17 37.08 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.219 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.668 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.3 p -144.76 133.09 17.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.027 0.441 . . . . 0.0 110.686 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.407 HG23 ' HB3' ' A' ' 21' ' ' LEU . 11.0 tt -133.93 146.83 30.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.648 -177.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -78.96 103.74 9.11 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.924 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.894 HD22 ' HB2' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -78.96 -5.17 53.13 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 120.858 0.361 . . . . 0.0 110.245 178.601 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.43 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 4.2 t30 -70.9 -17.88 62.69 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -106.07 17.49 23.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.382 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 41.3 m-85 -135.97 -34.7 0.8 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.314 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.856 HD22 HD13 ' A' ' 151' ' ' ILE . 38.6 mt -106.09 136.32 45.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.867 -179.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.681 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 3.0 m -126.6 143.59 51.17 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.78 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.629 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 6.8 p-10 -93.23 93.56 8.31 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 122.01 0.909 . . . . 0.0 108.568 178.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.422 ' HB3' ' HG3' ' A' ' 51' ' ' ARG . 31.9 t70 -94.3 95.74 9.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.16 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 54.68 45.65 26.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.525 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.703 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 77.87 29.94 53.23 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.467 178.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.556 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 23.7 t-160 -148.03 124.93 11.27 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.799 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 25.3 m-85 -62.54 136.42 57.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.248 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.422 ' HG3' ' HB3' ' A' ' 46' ' ' ASP . 17.1 mmm180 -145.01 133.12 21.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.701 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.469 ' CD1' HD11 ' A' ' 151' ' ' ILE . 98.6 m95 -73.47 109.64 7.15 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.8 t 64.76 -78.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 O-C-N 123.865 0.728 . . . . 0.0 110.986 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.0 t -138.91 12.76 2.67 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.442 0.639 . . . . 0.0 109.495 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.417 ' HA3' ' CZ ' ' A' ' 51' ' ' ARG . . . 81.67 100.25 0.4 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.668 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.9 167.76 20.95 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.984 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.52 -156.62 7.61 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.94 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.07 155.52 53.56 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.537 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.54 -88.97 0.9 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.575 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 152.63 -132.76 3.81 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.821 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -169.43 169.69 42.15 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.168 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.6 m -129.05 124.75 35.67 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.067 0.46 . . . . 0.0 110.472 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -126.46 176.76 6.92 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.665 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.1 p -128.37 118.01 22.42 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 t -107.06 137.2 39.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.802 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 18.9 m -87.78 124.82 34.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.081 0.467 . . . . 0.0 109.916 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.501 ' CG2' HD12 ' A' ' 99' ' ' ILE . 42.2 t -71.06 133.91 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.125 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.494 ' HB3' ' OD2' ' A' ' 71' ' ' ASP . 16.3 tt0 -104.16 171.33 7.4 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 124.464 1.103 . . . . 0.0 110.411 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.673 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 58.9 tp60 -60.22 119.68 8.35 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.374 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.94 6.53 79.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.996 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.494 ' OD2' ' HB3' ' A' ' 68' ' ' GLN . 27.6 m-20 -103.82 124.03 48.17 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 117.393 0.597 . . . . 0.0 110.581 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.625 ' HA ' HG12 ' A' ' 99' ' ' ILE . 80.3 p -105.18 179.44 4.27 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.571 ' CD2' HG23 ' A' ' 99' ' ' ILE . 2.2 mm? -51.6 -41.57 61.32 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.59 0.709 . . . . 0.0 109.403 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -59.61 -39.36 83.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.384 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 79' ' ' ARG . 13.4 m-20 -73.85 -46.65 43.68 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.119 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 72' ' ' THR . 42.4 mm -57.12 -48.05 82.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.709 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.736 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -59.78 -54.28 38.9 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.852 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -33.04 74.39 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.92 0.39 . . . . 0.0 111.524 -178.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 35.6 ttt180 -74.0 -39.82 63.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.031 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -105.78 19.33 20.73 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 59.26 26.82 15.71 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.736 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -110.12 168.64 9.29 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.503 ' O ' HG13 ' A' ' 87' ' ' ILE . 4.3 p-10 -96.65 122.17 39.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.71 0.767 . . . . 0.0 109.836 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.422 ' HA ' HD12 ' A' ' 87' ' ' ILE . 3.0 p90 -48.64 -32.16 7.83 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.036 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.41 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 10.9 m80 -60.36 -48.93 79.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.991 178.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.608 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 28.4 tt0 -63.18 -46.33 87.62 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.205 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.54 ' HB ' HD12 ' A' ' 73' ' ' LEU . 3.5 mt -52.51 -49.58 43.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.572 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.27 -49.21 74.97 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.408 178.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 85' ' ' HIS . 62.0 mtm180 -56.67 -38.13 71.77 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.608 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 13.0 mtt180 -70.02 -36.29 74.98 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.158 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.424 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 2.5 t-20 -85.76 -5.51 59.24 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.964 0.411 . . . . 0.0 110.276 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 90.3 m-20 75.5 18.92 2.2 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.611 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.572 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 14.3 pt -105.66 -170.38 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.204 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.556 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 28.5 mm-40 -117.97 158.72 24.41 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.506 ' O ' HD23 ' A' ' 73' ' ' LEU . 6.3 p30 -55.72 -57.62 11.26 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-O 121.877 0.846 . . . . 0.0 109.956 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.12 12.51 2.78 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 121.831 -0.543 . . . . 0.0 111.294 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.556 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 0.8 OUTLIER -62.69 -31.2 72.06 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.617 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 7.0 mp 71.38 111.18 0.06 Allowed 'General case' 0 C--N 1.338 0.108 0 O-C-N 124.358 1.037 . . . . 0.0 110.732 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.649 HG21 HD11 ' A' ' 105' ' ' LEU . 6.4 pt -94.43 176.0 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.977 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.476 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 92.7 m-85 -121.07 158.2 53.28 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.91 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.673 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 43.4 Cg_endo -72.3 133.36 20.88 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 123.042 2.495 . . . . 0.0 112.889 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 101.59 14.12 30.7 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' A' ' 66' ' ' THR . 40.0 mt-30 -102.92 168.44 9.2 Favored 'General case' 0 C--O 1.216 -0.699 0 C-N-CA 120.641 -0.424 . . . . 0.0 109.956 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 63.5 t -126.15 118.48 51.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.649 HD11 HG21 ' A' ' 99' ' ' ILE . 95.8 mt -113.93 150.07 34.28 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.188 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -89.58 110.72 21.55 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.986 0.898 . . . . 0.0 111.21 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.1 m -115.59 151.57 46.28 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.555 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.71 -18.06 53.02 Favored 'Trans proline' 0 C--N 1.331 -0.349 0 C-N-CA 123.069 2.513 . . . . 0.0 114.376 -178.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.0 t -154.13 148.02 25.53 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.875 0.369 . . . . 0.0 111.225 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -90.26 -172.23 3.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.09 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.55 -51.99 5.32 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.805 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 167.04 173.22 35.11 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.952 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 26.0 t -110.08 -29.83 8.04 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.066 0.46 . . . . 0.0 109.857 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.8 -52.14 4.16 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.126 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -159.86 151.22 21.89 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.6 56.85 3.04 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.045 -0.597 . . . . 0.0 111.632 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -118.49 -28.78 5.62 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.791 0.329 . . . . 0.0 110.868 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.681 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -120.47 -75.97 0.44 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.321 -0.942 . . . . 0.0 112.676 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 73.18 29.1 1.77 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.278 0.631 . . . . 0.0 111.554 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.585 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 20.0 p90 -59.87 -37.69 80.05 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-O 121.108 0.48 . . . . 0.0 110.06 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.617 ' HE3' ' HB3' ' A' ' 124' ' ' ALA . 4.1 t-105 -66.27 -26.55 67.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.195 -178.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.89 -25.49 66.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.139 0.495 . . . . 0.0 110.143 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.697 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 4.2 m -133.42 27.03 4.11 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.323 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.617 ' HB3' ' HE3' ' A' ' 121' ' ' TRP . . . -105.65 155.82 18.87 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.001 0.429 . . . . 0.0 110.898 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.0 mmm-85 -146.43 142.35 28.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.755 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 53.55 35.57 21.21 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.246 0.546 . . . . 0.0 111.371 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.585 ' HB ' ' CB ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -79.74 127.36 39.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.812 -179.848 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.45 ' O ' HD12 ' A' ' 136' ' ' LEU . 15.6 ptt180 -151.31 158.82 44.32 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.571 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.835 HD21 HD11 ' A' ' 153' ' ' LEU . 17.1 mt -86.1 136.59 33.16 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 120.996 0.427 . . . . 0.0 110.825 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.573 HG23 ' HB ' ' A' ' 135' ' ' VAL . 31.2 m -132.35 159.48 43.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.471 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.481 ' HB3' ' HD3' ' A' ' 134' ' ' LYS . 4.6 m-20 69.63 4.87 4.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.398 178.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.661 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 98.04 28.84 7.96 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.597 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.517 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 93.07 -18.85 55.26 Favored Glycine 0 C--O 1.269 2.283 0 CA-C-O 123.773 1.763 . . . . 0.0 112.623 177.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.695 ' HG3' HG23 ' A' ' 135' ' ' VAL . 20.9 ptmt -67.52 -19.97 65.37 Favored 'General case' 0 C--N 1.313 -0.986 0 O-C-N 121.452 -1.028 . . . . 0.0 108.82 178.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.695 HG23 ' HG3' ' A' ' 134' ' ' LYS . 4.2 t -138.15 146.67 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 121.279 0.561 . . . . 0.0 110.874 178.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.625 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 50.6 tp -126.46 116.31 20.93 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.484 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 32.5 tt0 -105.05 137.15 43.25 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.437 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.585 ' CB ' ' HB ' ' A' ' 127' ' ' VAL . . . -161.96 164.07 28.62 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.185 0.517 . . . . 0.0 112.283 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -95.9 106.25 18.37 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.703 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 50.2 mt -98.24 129.79 44.97 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.307 0.575 . . . . 0.0 111.244 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.697 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 62.4 ttt180 -71.32 141.18 50.47 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.5 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.437 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.6 p90 -159.09 -173.78 4.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.226 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 17.0 m -61.04 -26.21 67.47 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -94.83 16.12 61.93 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.875 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 102.1 -114.99 5.1 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.412 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -128.69 128.84 44.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.931 0.396 . . . . 0.0 110.371 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.437 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 47.0 t30 -124.25 130.86 53.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.218 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.474 ' HA ' ' O ' ' A' ' 138' ' ' ALA . 13.8 ttp180 -78.15 96.58 5.21 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.266 0.555 . . . . 0.0 110.617 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.556 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 20.0 t -104.13 170.43 7.92 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.172 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 8.7 mtp85 -146.22 147.73 31.75 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 121.155 -0.218 . . . . 0.0 110.615 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.856 HD13 HD22 ' A' ' 43' ' ' LEU . 9.9 tt -131.34 152.62 37.62 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.538 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.146 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.672 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 84.4 m-85 -96.65 105.02 17.06 Favored 'General case' 0 C--N 1.313 -1.012 0 O-C-N 122.286 -0.259 . . . . 0.0 111.024 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.835 HD11 HD21 ' A' ' 129' ' ' LEU . 16.9 mt -65.72 -37.24 85.86 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.11 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.663 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 9.4 t70 -53.59 -14.4 0.85 Allowed 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.144 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.672 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 41.1 mt-10 -66.51 -54.79 19.99 Favored 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 121.682 -0.636 . . . . 0.0 112.715 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.509 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 77.3 m-70 -122.18 1.05 9.69 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.141 -0.624 . . . . 0.0 112.492 -176.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 45.5 mm -104.09 110.78 31.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.484 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.73 ' HA3' ' O ' ' A' ' 167' ' ' CYS . . . -118.69 166.41 12.97 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.232 -0.985 . . . . 0.0 113.105 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.574 ' CG ' ' HB3' ' A' ' 25' ' ' CYS . 2.6 t30 -98.25 122.26 41.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.415 -0.393 . . . . 0.0 110.077 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -117.81 86.77 2.58 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 58.86 47.37 12.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.184 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.549 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 87.67 7.55 75.0 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.485 178.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -124.09 132.74 53.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.04 0.447 . . . . 0.0 111.567 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.578 HD21 ' HD2' ' A' ' 7' ' ' PHE . 30.0 mt -84.63 114.31 21.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.642 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 46.0 pt -142.24 176.66 3.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.222 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.509 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 3.6 p80 -66.68 118.6 10.47 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.44 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.73 ' O ' ' HA3' ' A' ' 158' ' ' GLY . 39.5 t . . . . . 0 C--O 1.242 0.678 0 CA-C-O 118.521 -0.752 . . . . 0.0 112.166 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.455 ' HA3' ' OD1' ' A' ' 6' ' ' ASN . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 111.659 -0.577 . . . . 0.0 111.659 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.522 ' HB3' ' HD1' ' A' ' 3' ' ' TYR . 6.6 m120 -77.27 -76.68 0.17 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.746 0.273 . . . . 0.0 111.664 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.522 ' HD1' ' HB3' ' A' ' 2' ' ' ASN . 28.9 m-85 -129.75 -97.55 0.36 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.54 -27.41 12.37 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.2 -76.39 0.27 Allowed Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.13 -1.033 . . . . 0.0 112.91 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.455 ' OD1' ' HA3' ' A' ' 1' ' ' GLY . 30.0 m-80 65.66 11.03 7.22 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.547 0.339 . . . . 0.0 111.138 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.644 ' CE2' HD13 ' A' ' 14' ' ' ILE . 1.6 p90 -61.33 -33.02 72.91 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 121.133 -0.227 . . . . 0.0 111.281 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.533 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.8 OUTLIER -62.58 -25.41 68.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.326 0.584 . . . . 0.0 110.562 -178.882 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.73 -22.99 77.0 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.183 -0.917 . . . . 0.0 113.596 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.516 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 22.9 p -125.73 -16.39 5.73 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 117.722 0.761 . . . . 0.0 111.72 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.6 m -99.72 131.71 45.53 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.427 ' CG ' ' HB2' ' A' ' 24' ' ' GLU . 15.2 ptm180 -109.18 178.82 4.34 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.412 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 7.8 m-20 44.67 47.57 8.71 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.454 0.701 . . . . 0.0 112.56 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.679 HG22 HD13 ' A' ' 129' ' ' LEU . 10.2 mt -80.77 106.18 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.758 ' HA ' HD12 ' A' ' 129' ' ' LEU . 72.2 m -147.8 128.04 13.85 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.733 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -94.04 154.62 17.54 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.22 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -96.21 73.93 2.93 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.002 -1.453 . . . . 0.0 107.694 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.17 -60.17 4.72 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.793 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.445 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -145.42 0.46 0.89 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.135 0.493 . . . . 0.0 110.47 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -104.48 93.82 4.99 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.005 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.815 HD23 HD11 ' A' ' 129' ' ' LEU . 2.8 tm? -60.06 132.45 53.97 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.671 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.618 ' H ' HD22 ' A' ' 21' ' ' LEU . 33.2 ttm105 -134.52 128.0 32.48 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.198 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.635 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -148.39 148.49 30.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.679 0.752 . . . . 0.0 111.141 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 2.6 mm-40 -82.85 76.95 9.66 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.196 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.517 ' SG ' HD13 ' A' ' 164' ' ' LEU . 84.8 m -63.36 126.74 28.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.717 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.516 ' HB2' ' O ' ' A' ' 10' ' ' SER . 37.2 ttt180 -69.54 122.57 19.3 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.353 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.567 ' HG3' ' OD1' ' A' ' 161' ' ' ASN . 20.4 ttt85 -99.3 152.06 20.36 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.891 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -52.19 -17.9 4.33 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 114.119 -1.4 . . . . 0.0 114.712 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.451 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 4.6 m-20 -74.94 -7.46 53.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.103 0.478 . . . . 0.0 110.696 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.51 8.13 62.75 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.64 154.95 16.38 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.368 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.477 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 80.8 m-85 -92.4 125.53 37.09 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.3 m -108.23 130.35 55.16 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.332 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.2 m -68.98 112.44 5.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.862 0.363 . . . . 0.0 110.588 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.472 ' HB3' HD22 ' A' ' 164' ' ' LEU . 32.2 t -116.44 151.24 36.43 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.265 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 1.4 p -144.38 130.93 15.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.964 0.411 . . . . 0.0 110.675 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.438 ' CG2' ' HB3' ' A' ' 21' ' ' LEU . 17.8 tt -122.95 149.23 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.98 -178.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.471 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 22.7 m-20 -82.78 93.57 7.46 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.563 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.67 HD13 HD11 ' A' ' 43' ' ' LEU . 39.2 mt -73.27 -13.38 61.12 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.019 0.438 . . . . 0.0 109.997 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.5 ' OD1' ' HG3' ' A' ' 41' ' ' ARG . 23.8 p30 -66.27 -16.22 63.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.432 0.634 . . . . 0.0 109.625 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.684 ' HG2' ' HA3' ' A' ' 116' ' ' GLY . 48.0 mtm180 -117.29 20.28 13.73 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.418 178.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.573 ' HB2' ' HA ' ' A' ' 39' ' ' LEU . 9.6 m-85 -133.4 -30.92 1.26 Allowed 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.295 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.965 HD22 HD13 ' A' ' 151' ' ' ILE . 42.2 mt -114.63 135.8 53.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.854 0.359 . . . . 0.0 110.781 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.66 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 1.9 m -124.21 147.66 47.87 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.038 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.571 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 7.5 p-10 -94.86 98.77 10.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.596 0.713 . . . . 0.0 110.478 178.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -99.99 94.41 6.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.191 0.519 . . . . 0.0 110.824 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.488 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 64.0 t30 52.68 45.37 28.8 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.213 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.711 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 79.96 32.57 35.81 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.608 178.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -149.14 131.34 15.47 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.808 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 58.7 m-85 -72.63 145.37 47.35 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.955 0.407 . . . . 0.0 111.427 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -143.5 133.62 24.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.063 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.559 ' HZ2' ' O ' ' A' ' 152' ' ' TYR . 97.9 m95 -75.27 126.43 31.0 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.2 t 65.72 -68.12 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.931 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.621 ' O ' ' HE2' ' A' ' 110' ' ' LYS . 49.1 m 65.29 -56.95 0.3 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -117.85 -12.97 7.48 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.319 -0.943 . . . . 0.0 114.555 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.04 128.08 36.5 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.371 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.75 86.15 1.39 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.096 -0.574 . . . . 0.0 112.332 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -148.46 178.25 26.16 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.57 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.41 -79.66 0.58 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.646 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -144.4 119.34 1.26 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.237 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.13 -141.71 10.14 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.786 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.1 m -133.59 129.77 37.44 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.944 0.402 . . . . 0.0 110.069 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.49 ' HB1' ' HG2' ' A' ' 110' ' ' LYS . . . -131.46 177.47 7.47 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.933 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.416 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 21.2 p -128.23 121.29 29.02 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.441 HG22 ' HE3' ' A' ' 110' ' ' LYS . 4.2 t -107.36 134.3 49.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.928 178.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 7.2 m -87.51 125.82 34.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.494 ' CG2' HD12 ' A' ' 99' ' ' ILE . 42.0 t -73.14 132.29 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.103 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -104.19 170.63 7.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 124.388 1.055 . . . . 0.0 109.47 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.594 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 58.8 tt0 -66.63 124.28 22.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.51 -178.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.05 3.22 73.45 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.978 -0.63 . . . . 0.0 113.592 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -109.59 121.4 45.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.035 0.418 . . . . 0.0 111.231 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.59 ' HA ' HG12 ' A' ' 99' ' ' ILE . 81.4 p -102.56 -178.11 3.59 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.647 HD22 HG23 ' A' ' 99' ' ' ILE . 1.1 mm? -51.99 -40.98 61.79 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.347 0.594 . . . . 0.0 109.834 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.43 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 48.7 ttm-85 -62.95 -39.65 95.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.164 -178.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -71.7 -42.93 66.8 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.959 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.556 HG12 ' O ' ' A' ' 72' ' ' THR . 45.6 mm -61.72 -48.79 87.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.796 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.674 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -58.33 -54.09 40.47 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.422 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -58.5 -41.17 84.76 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.761 0.315 . . . . 0.0 111.77 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -65.1 -43.98 90.31 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -98.43 11.79 37.05 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.9 t70 63.4 23.12 13.58 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.359 0.599 . . . . 0.0 112.106 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.674 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.3 p -104.37 171.67 7.21 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.577 ' O ' HG13 ' A' ' 87' ' ' ILE . 5.8 t70 -98.01 125.31 42.89 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.9 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.524 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 9.3 p90 -50.78 -29.68 12.19 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.366 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -65.12 -46.21 81.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.541 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.734 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 56.7 mm-40 -69.14 -41.44 77.31 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.314 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.577 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.8 mt -54.87 -47.5 75.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.657 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.53 -48.58 76.93 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.5 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -54.4 -43.01 71.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.351 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.734 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 24.7 mmm-85 -72.82 -27.4 61.94 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 3.3 t-20 -94.01 -4.79 48.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.892 0.377 . . . . 0.0 111.103 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 90.1 m-20 75.61 17.49 2.37 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.756 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.657 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 19.2 pt -105.67 -172.44 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.534 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 18.1 mm-40 -116.31 154.46 30.15 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.561 ' O ' HD23 ' A' ' 73' ' ' LEU . 1.2 p30 -52.25 -65.96 0.47 Allowed 'General case' 0 C--O 1.244 0.777 0 CA-C-O 122.225 1.012 . . . . 0.0 109.872 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -76.06 13.42 0.89 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.824 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 4.6 t0 -63.59 -31.48 72.66 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 7.9 mp 72.06 112.35 0.06 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.611 -178.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.647 HG23 HD22 ' A' ' 73' ' ' LEU . 9.8 pt -94.85 176.63 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.815 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.556 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 94.1 m-85 -131.16 158.01 76.45 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.743 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.594 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 18.4 Cg_endo -63.98 138.26 61.66 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 123.301 2.667 . . . . 0.0 113.823 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.41 20.8 31.23 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.79 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.542 ' O ' ' HA ' ' A' ' 66' ' ' THR . 27.6 mt-30 -110.4 166.07 11.28 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.178 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.416 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 95.6 t -125.09 118.51 53.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.566 HD11 HG21 ' A' ' 99' ' ' ILE . 76.9 mt -112.35 150.59 30.84 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.35 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -90.8 116.93 29.03 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.582 0.706 . . . . 0.0 110.656 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.411 HG21 HG23 ' A' ' 65' ' ' VAL . 33.6 m -119.83 151.27 52.12 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.454 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.06 -18.98 51.9 Favored 'Trans proline' 0 C--N 1.332 -0.33 0 C-N-CA 123.098 2.532 . . . . 0.0 114.332 -178.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.9 t -154.5 147.53 24.63 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.032 0.444 . . . . 0.0 111.131 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.621 ' HE2' ' O ' ' A' ' 54' ' ' SER . 12.2 mmmm -93.42 -176.23 4.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.026 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -131.6 99.07 0.4 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.077 -178.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 156.82 109.52 0.3 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.05 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 19.6 m -136.96 55.62 1.82 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.872 0.368 . . . . 0.0 111.109 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -82.31 -93.48 0.56 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.043 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.41 ' HA3' HD21 ' A' ' 119' ' ' ASN . . . -96.9 -67.98 0.96 Allowed Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.684 ' HA3' ' HG2' ' A' ' 41' ' ' ARG . . . -112.19 -75.12 0.73 Allowed Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -148.55 -51.63 0.17 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.024 0.44 . . . . 0.0 110.265 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.66 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -85.87 -72.18 1.3 Allowed Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.155 -179.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 14.0 m120 73.94 26.71 1.73 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.059 0.544 . . . . 0.0 112.111 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.551 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 20.7 p90 -60.65 -37.23 80.82 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.04 0.448 . . . . 0.0 110.348 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.571 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 71.0 t-105 -61.79 -34.43 75.88 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.404 -178.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -54.02 -27.42 31.88 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.143 0.277 . . . . 0.0 110.894 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.666 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 9.3 m -132.85 28.54 4.2 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.479 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.571 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -107.51 143.89 35.25 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.968 0.413 . . . . 0.0 111.387 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -126.69 143.05 51.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.817 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 49.12 57.47 6.43 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.668 0.605 . . . . 0.0 112.01 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.434 ' CG1' HD11 ' A' ' 136' ' ' LEU . 40.3 t -80.45 121.76 34.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.841 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.66 148.14 29.72 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.292 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.815 HD11 HD23 ' A' ' 21' ' ' LEU . 33.6 mt -85.54 145.23 27.48 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.137 0.494 . . . . 0.0 111.411 -179.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.944 HG23 ' HB ' ' A' ' 135' ' ' VAL . 29.0 m -132.31 157.1 43.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.64 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 71.83 1.12 3.77 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.772 0.829 . . . . 0.0 110.387 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.619 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 93.14 28.42 11.83 Favored Glycine 0 N--CA 1.433 -1.535 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.165 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.527 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 104.66 -18.19 44.56 Favored Glycine 0 C--O 1.271 2.44 0 CA-C-O 123.45 1.583 . . . . 0.0 113.165 178.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.758 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 1.6 mttp -72.16 -13.58 61.59 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 121.221 -1.164 . . . . 0.0 108.854 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.944 ' HB ' HG23 ' A' ' 130' ' ' VAL . 3.2 t -143.28 151.36 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.443 177.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.542 HD13 HD23 ' A' ' 129' ' ' LEU . 33.1 tp -131.26 125.77 33.7 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -116.07 131.62 56.89 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.175 0.512 . . . . 0.0 110.911 -177.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.779 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -159.64 155.15 25.66 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.38 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 15.3 mt-10 -94.64 106.33 18.31 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.711 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 47.0 mt -91.41 134.32 34.72 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.154 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.666 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 72.4 ttt180 -69.99 140.84 53.0 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.932 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.539 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.5 p90 -156.04 -169.75 3.17 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.458 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 23.0 t -57.58 -30.81 65.57 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.297 0.373 . . . . 0.0 111.545 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -98.24 23.5 35.89 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.171 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 98.77 -107.83 3.49 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.217 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -133.0 127.71 34.75 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.539 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 10.9 t30 -123.18 129.99 52.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.665 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 32.9 ttm180 -76.44 102.81 6.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.138 0.494 . . . . 0.0 109.807 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.473 ' HB3' ' O ' ' A' ' 48' ' ' GLY . 18.1 p -114.96 172.3 7.13 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.232 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 6.3 ptp180 -148.55 152.62 37.12 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.565 -0.454 . . . . 0.0 112.051 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.965 HD13 HD22 ' A' ' 43' ' ' LEU . 12.1 tt -130.64 160.97 41.38 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.824 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.948 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 79.8 m-85 -107.55 106.74 17.25 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 121.856 -0.527 . . . . 0.0 110.25 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.683 HD11 HD21 ' A' ' 129' ' ' LEU . 23.8 mt -62.89 -36.01 81.93 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.213 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.758 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 9.5 t70 -57.39 -8.58 0.81 Allowed 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.504 178.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.948 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 46.7 mt-10 -75.05 -50.83 15.19 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 121.831 -0.543 . . . . 0.0 111.962 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.6 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 91.3 m-70 -125.94 7.38 7.34 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -177.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.516 HG12 ' CH2' ' A' ' 52' ' ' TRP . 43.5 mm -107.58 106.07 19.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.169 178.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' A' ' 167' ' ' CYS . . . -111.35 161.88 12.64 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.637 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.509 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 1.4 t30 -100.55 120.37 39.92 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 31.9 ttp-105 -112.38 87.24 2.53 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.535 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.567 ' OD1' ' HG3' ' A' ' 27' ' ' ARG . 3.0 t-20 59.26 35.79 23.5 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.437 178.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 35' ' ' SER . . . 105.29 -0.07 40.69 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.972 178.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -123.3 134.2 54.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.717 0.758 . . . . 0.0 111.768 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.596 HD11 ' CD2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -74.89 129.46 37.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.895 178.701 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.408 HG13 ' N ' ' A' ' 166' ' ' HIS . 9.4 tp -154.7 157.68 4.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.205 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.6 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 4.1 p-80 -61.19 111.42 1.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.582 ' O ' ' HA3' ' A' ' 158' ' ' GLY . 43.1 t . . . . . 0 C--O 1.247 0.958 0 O-C-N 123.852 0.72 . . . . 0.0 111.024 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.543 0 N-CA-C 112.336 -0.305 . . . . 0.0 112.336 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.628 ' HB3' ' OD1' ' A' ' 154' ' ' ASP . 17.8 m120 -93.3 -95.61 0.15 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 122.298 0.239 . . . . 0.0 110.409 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.91 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 66.8 m-85 -125.22 -90.56 0.55 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.925 0.393 . . . . 0.0 110.313 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -123.22 -30.02 3.77 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.762 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -77.91 -69.24 1.41 Allowed Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 119.56 -1.305 . . . . 0.0 112.689 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 68.16 14.81 9.33 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.889 0.476 . . . . 0.0 111.3 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.598 ' CE2' HD13 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -58.9 -33.91 71.08 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 -179.279 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.482 ' HA ' HD11 ' A' ' 14' ' ' ILE . 8.8 p -61.2 -27.62 68.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.135 0.493 . . . . 0.0 111.579 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.79 -20.64 79.77 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.574 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 5.1 m -120.67 -19.61 7.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.45 0.625 . . . . 0.0 111.455 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 m -104.33 135.6 45.48 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -112.47 177.58 4.59 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 43.43 50.47 6.15 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 124.037 0.836 . . . . 0.0 111.878 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.914 HG22 HD13 ' A' ' 129' ' ' LEU . 12.3 mt -82.05 104.82 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.593 ' CA ' HD12 ' A' ' 129' ' ' LEU . 71.0 m -146.23 128.67 15.94 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 122.823 0.449 . . . . 0.0 109.83 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.827 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -100.23 158.62 15.74 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 121.628 0.727 . . . . 0.0 112.717 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -100.57 76.57 1.84 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.328 -1.305 . . . . 0.0 107.551 176.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.28 -54.11 4.85 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.779 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.558 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -149.04 -13.16 0.31 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.892 0.377 . . . . 0.0 110.184 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.62 88.37 7.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.587 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.827 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 44.0 tp -61.79 121.02 11.84 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.868 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.529 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 39.9 ttt180 -128.49 130.27 47.27 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.432 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.657 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -148.89 150.59 33.22 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.673 0.749 . . . . 0.0 111.076 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.447 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 5.0 mm-40 -85.48 74.53 10.32 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.163 -1.38 . . . . 0.0 108.413 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.693 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 65.0 m -64.97 129.62 40.39 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.829 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 10' ' ' SER . 26.7 ttm180 -65.33 131.65 47.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.328 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 35.1 ttt85 -108.86 151.46 26.23 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -52.99 -16.74 4.44 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 114.319 -1.31 . . . . 0.0 114.519 -178.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -72.74 -6.15 42.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.112 0.482 . . . . 0.0 110.416 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.99 6.68 66.74 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -120.5 169.66 14.16 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.412 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.447 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 69.0 m-85 -96.93 140.05 32.04 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.869 0.366 . . . . 0.0 110.555 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.41 ' HB3' ' HA3' ' A' ' 162' ' ' GLY . 9.4 t -121.72 130.23 53.29 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.4 m -72.5 112.89 8.96 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.268 0.556 . . . . 0.0 110.969 -178.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 40.5 t -116.65 148.38 41.04 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.465 -179.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.657 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.4 p -144.32 136.44 22.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-O 120.775 0.321 . . . . 0.0 111.156 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.6 tt -136.19 146.44 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.516 -178.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.59 97.12 4.97 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.689 HD22 ' HB2' ' A' ' 21' ' ' LEU . 1.6 tp -79.96 -6.51 57.64 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.014 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.558 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 15.2 p30 -65.03 -20.24 66.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.167 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.542 ' O ' ' HB3' ' A' ' 117' ' ' ALA . 10.8 ptp180 -105.58 16.53 25.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.298 0.571 . . . . 0.0 110.857 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -127.46 -33.6 2.32 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.131 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.672 HD22 HD13 ' A' ' 151' ' ' ILE . 31.9 mt -106.07 144.11 33.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.358 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.54 147.63 52.55 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.849 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.45 ' ND2' ' HB2' ' A' ' 123' ' ' SER . 23.2 p-10 -98.38 94.12 6.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.504 0.668 . . . . 0.0 109.811 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -94.78 93.6 7.59 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.977 0.418 . . . . 0.0 111.49 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.4 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 66.5 t30 52.83 47.0 25.64 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.16 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.736 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 78.04 29.93 52.67 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.791 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.531 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 33.7 m80 -141.99 125.64 16.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.811 ' HB3' ' HB ' ' A' ' 151' ' ' ILE . 14.2 m-85 -68.3 136.55 53.64 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.802 0.334 . . . . 0.0 111.103 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.8 mtp180 -141.76 135.32 29.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.579 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.472 ' CD1' HD11 ' A' ' 151' ' ' ILE . 96.7 m95 -74.68 136.62 41.87 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 176.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.601 HG21 ' HB1' ' A' ' 117' ' ' ALA . 4.6 p -54.65 116.28 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.638 0.732 . . . . 0.0 111.008 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.5 m -117.44 31.2 6.86 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.745 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 145.11 -33.76 1.59 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.973 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.23 -54.52 3.56 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.226 -0.512 . . . . 0.0 112.707 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -164.02 -41.65 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.23 -141.95 18.62 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.223 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.84 -154.31 25.29 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.189 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.3 149.82 15.68 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.198 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 108' ' ' PRO . . . 124.19 -142.47 14.16 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.788 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.4 m -139.17 113.79 9.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.197 0.523 . . . . 0.0 110.824 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.518 ' HB1' ' HG2' ' A' ' 110' ' ' LYS . . . -133.56 176.67 8.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.835 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.493 HG22 ' HG2' ' A' ' 106' ' ' GLN . 6.9 p -129.34 118.07 21.65 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 122.413 -0.18 . . . . 0.0 111.357 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.565 HG21 ' CE2' ' A' ' 80' ' ' PHE . 9.0 p -110.43 145.03 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.886 0.374 . . . . 0.0 111.386 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.2 m -91.22 123.51 34.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.716 HG21 HD12 ' A' ' 99' ' ' ILE . 63.7 t -76.69 130.26 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.244 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -101.72 169.99 8.46 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 124.455 1.097 . . . . 0.0 110.008 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.619 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 64.6 tt0 -63.22 114.46 3.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.251 -178.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.0 -5.83 27.26 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.878 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.46 124.44 49.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 117.284 0.542 . . . . 0.0 112.188 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.546 ' O ' HG12 ' A' ' 76' ' ' ILE . 81.0 p -101.24 -178.97 3.9 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.664 HD22 HG23 ' A' ' 99' ' ' ILE . 0.7 OUTLIER -53.59 -40.46 65.71 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.555 0.693 . . . . 0.0 109.809 179.179 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.64 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -69.81 -34.37 73.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.041 -178.204 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -72.71 -38.98 67.31 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 72' ' ' THR . 45.1 mm -62.4 -47.17 94.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 177.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.767 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -56.68 -48.37 77.95 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.401 178.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.2 mtm180 -66.99 -35.98 81.16 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 122.515 -0.403 . . . . 0.0 111.923 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -69.66 -38.73 77.19 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.565 ' CE2' HG21 ' A' ' 65' ' ' VAL . 89.0 m-85 -110.52 16.71 21.37 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -178.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.0 t70 53.42 47.75 23.41 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.751 0.786 . . . . 0.0 110.852 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.767 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.8 p -124.42 170.97 10.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.591 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.65 ' O ' HG13 ' A' ' 87' ' ' ILE . 8.9 t70 -96.85 120.1 36.55 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.467 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.64 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 14.3 p90 -51.13 -32.61 23.46 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.708 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.446 ' HB2' ' OD1' ' A' ' 83' ' ' ASP . 0.3 OUTLIER -67.7 -42.93 81.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.76 179.733 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.678 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 8.7 mm-40 -66.67 -43.75 83.68 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.974 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.65 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.8 mt -53.52 -47.04 60.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.609 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.93 -51.14 68.06 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.15 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -57.38 -43.07 83.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.678 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 78.1 mtt180 -68.18 -23.27 64.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.055 0.455 . . . . 0.0 110.987 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 21.8 t-20 -99.04 -5.72 29.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.853 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 5.2 m-20 77.91 15.96 1.45 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.783 0.833 . . . . 0.0 111.637 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.609 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 10.4 pt -106.24 -176.42 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 17.9 mm-40 -111.65 158.22 19.53 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.633 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 16.7 p-10 -55.87 -60.45 3.44 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 122.103 0.954 . . . . 0.0 109.47 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -76.6 12.53 1.25 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.116 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 3.9 t70 -65.17 -33.58 76.35 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 9.1 mp 72.43 112.42 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 124.301 1.001 . . . . 0.0 110.16 -177.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.716 HD12 HG21 ' A' ' 67' ' ' VAL . 10.6 pt -95.32 175.91 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.407 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.489 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 83.0 m-85 -128.68 158.59 71.61 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.583 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.619 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 19.9 Cg_endo -67.6 134.97 34.52 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.994 2.463 . . . . 0.0 112.997 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.84 17.54 25.33 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.384 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -110.66 157.5 19.64 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 120.619 -0.433 . . . . 0.0 109.948 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.405 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 61.3 t -116.73 116.6 52.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.587 HD11 HG21 ' A' ' 99' ' ' ILE . 69.3 mt -109.92 151.0 27.63 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.57 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.493 ' HG2' HG22 ' A' ' 64' ' ' THR . 66.3 mt-30 -89.88 107.42 19.1 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.894 0.854 . . . . 0.0 111.146 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.4 m -112.62 151.32 43.82 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-N 113.934 -1.484 . . . . 0.0 109.151 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 32.5 Cg_endo -64.19 -18.88 65.03 Favored 'Trans proline' 0 C--N 1.332 -0.325 0 C-N-CA 123.146 2.564 . . . . 0.0 114.158 -177.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.6 t -150.42 155.22 39.16 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.3 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.518 ' HG2' ' HB1' ' A' ' 63' ' ' ALA . 12.9 mmmm -103.38 168.99 8.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.129 0.49 . . . . 0.0 111.29 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -88.48 127.65 8.71 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.699 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 129.52 121.43 2.34 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.09 -0.576 . . . . 0.0 111.679 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 51.1 m -136.01 -33.12 0.85 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.799 0.333 . . . . 0.0 111.138 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.29 -68.65 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.53 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -93.32 -115.78 2.46 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -105.59 -109.93 3.45 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.444 -0.884 . . . . 0.0 110.988 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.601 ' HB1' HG21 ' A' ' 53' ' ' VAL . . . -141.24 -26.52 0.7 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.643 0.259 . . . . 0.0 111.408 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . -106.45 -62.95 0.6 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.069 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 74.97 32.78 0.78 Allowed 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.268 0.627 . . . . 0.0 111.902 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.638 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 20.0 p90 -66.36 -35.96 81.67 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.301 0.572 . . . . 0.0 109.865 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.493 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 24.5 t-105 -66.39 -21.87 66.23 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.239 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.94 -24.97 60.21 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.828 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.646 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 50.5 m -143.76 33.59 1.27 Allowed 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.689 178.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.493 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -102.01 147.58 26.4 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 177.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.717 ' HD2' ' HB2' ' A' ' 126' ' ' ASP . 8.0 tmm_? -143.71 140.86 30.23 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.717 ' HB2' ' HD2' ' A' ' 125' ' ' ARG . 1.2 t70 58.3 25.65 12.99 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.789 0.681 . . . . 0.0 110.765 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.599 ' HB ' ' CB ' ' A' ' 138' ' ' ALA . 0.4 OUTLIER -67.06 119.75 13.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.926 -179.937 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.25 151.62 46.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.302 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.914 HD13 HG22 ' A' ' 14' ' ' ILE . 15.9 mt -85.44 131.21 34.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.261 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.605 HG23 ' HB ' ' A' ' 135' ' ' VAL . 26.9 m -126.55 163.9 27.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.234 -178.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.414 ' HB3' ' HD2' ' A' ' 134' ' ' LYS . 9.7 m-20 64.13 7.72 3.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.97 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.683 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 97.24 31.04 7.05 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.273 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 87.93 -13.74 60.45 Favored Glycine 0 C--O 1.259 1.69 0 CA-C-O 123.506 1.614 . . . . 0.0 112.474 177.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.653 ' O ' ' HA ' ' A' ' 152' ' ' TYR . 17.4 ptpt -72.33 -17.09 61.87 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.605 ' HB ' HG23 ' A' ' 130' ' ' VAL . 17.5 t -139.92 138.77 38.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.328 177.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.599 ' CD1' HD11 ' A' ' 16' ' ' LEU . 36.5 tp -119.91 115.21 23.33 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -107.57 126.26 52.33 Favored 'General case' 0 C--N 1.316 -0.884 0 O-C-N 123.28 0.362 . . . . 0.0 110.213 -177.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.599 ' CB ' ' HB ' ' A' ' 127' ' ' VAL . . . -150.07 160.25 43.79 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.277 0.56 . . . . 0.0 111.89 -178.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -96.29 106.8 19.06 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.736 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 50.0 mt -97.03 129.02 44.53 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.39 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.646 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 22.1 ttt180 -70.05 139.72 52.69 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.224 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.637 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.9 p90 -155.78 -167.94 2.64 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.163 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 4.3 m -56.32 -29.55 61.41 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -104.72 29.84 11.11 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.388 -0.91 . . . . 0.0 113.53 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.7 -112.52 4.38 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.631 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -125.6 126.46 44.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.741 0.305 . . . . 0.0 110.689 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.637 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 63.2 t30 -118.53 129.23 55.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.495 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -78.38 98.73 6.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.205 0.526 . . . . 0.0 109.956 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.531 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 21.7 t -109.45 168.21 9.56 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.178 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.581 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 16.5 ptt180 -149.1 152.76 36.72 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.468 -0.493 . . . . 0.0 112.12 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.811 ' HB ' ' HB3' ' A' ' 50' ' ' PHE . 6.1 tt -133.02 152.84 36.7 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.92 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.653 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 95.8 m-85 -95.44 103.4 15.27 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.771 -0.195 . . . . 0.0 110.666 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.764 HD11 HD21 ' A' ' 129' ' ' LEU . 19.9 mt -67.06 -35.83 80.71 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.169 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.628 ' OD1' ' HB3' ' A' ' 2' ' ' ASN . 2.8 p30 -52.91 -19.26 2.44 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.189 178.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.91 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 36.0 mt-10 -63.39 -55.86 20.98 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.504 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 76.4 m-70 -121.88 5.7 9.91 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 119.655 -0.818 . . . . 0.0 112.705 -176.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.432 HG12 ' CH2' ' A' ' 52' ' ' TRP . 45.0 mm -107.25 111.68 36.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.689 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.643 ' HA3' ' O ' ' A' ' 167' ' ' CYS . . . -113.55 -178.17 19.35 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.57 178.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.693 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -124.86 136.67 54.01 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.773 0.32 . . . . 0.0 110.548 179.753 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -124.82 86.78 2.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.047 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.533 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 90.3 m-20 54.39 50.96 15.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.37 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.578 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 89.8 7.82 68.15 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.496 178.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -123.65 117.12 24.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.984 0.392 . . . . 0.0 111.367 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.499 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 25.0 mt -67.23 123.15 19.49 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.518 178.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 13.4 tt -151.06 147.42 15.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.891 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.504 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 44.9 p-80 -55.68 126.86 27.26 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.643 ' O ' ' HA3' ' A' ' 158' ' ' GLY . 42.4 t . . . . . 0 C--O 1.247 0.934 0 O-C-N 123.839 0.712 . . . . 0.0 111.238 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.599 0 N-CA-C 111.839 -0.504 . . . . 0.0 111.839 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.633 ' HB2' ' OD1' ' A' ' 6' ' ' ASN . 36.1 m-20 -111.56 177.99 4.47 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 1.015 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 21.9 m-85 -108.42 -98.96 0.37 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.511 -0.476 . . . . 0.0 112.022 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.499 ' HB1' ' SG ' ' A' ' 167' ' ' CYS . . . -102.07 -31.56 10.57 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -70.77 -65.71 2.4 Favored Glycine 0 N--CA 1.434 -1.437 0 C-N-CA 119.511 -1.328 . . . . 0.0 112.205 -178.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.633 ' OD1' ' HB2' ' A' ' 2' ' ' ASN . 37.2 m-80 64.37 19.66 11.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.631 -0.285 . . . . 0.0 110.895 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.712 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.7 OUTLIER -58.44 -42.62 87.76 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.542 -179.664 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.451 ' HA ' HD11 ' A' ' 14' ' ' ILE . 8.9 m -62.11 -13.31 25.59 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.03 0.443 . . . . 0.0 110.851 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -64.27 -30.51 78.01 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.18 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.653 ' HB3' ' HB3' ' A' ' 26' ' ' ARG . 49.7 m -131.76 -18.54 2.73 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.677 0.275 . . . . 0.0 111.282 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.471 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 18.7 m -89.8 129.92 36.12 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -112.43 -177.65 3.21 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 43.69 45.36 5.89 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 123.832 0.708 . . . . 0.0 111.728 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.909 HG22 HD13 ' A' ' 129' ' ' LEU . 5.3 mt -79.8 103.89 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 CA-C-O 120.921 0.391 . . . . 0.0 110.402 -178.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.593 ' CA ' HD12 ' A' ' 129' ' ' LEU . 73.4 m -143.76 126.79 16.42 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.749 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -92.47 153.77 18.9 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.839 0.828 . . . . 0.0 112.861 -178.845 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -94.38 74.27 3.88 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.228 -1.351 . . . . 0.0 107.756 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.21 -55.87 4.96 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.068 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.651 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -148.6 -7.12 0.39 Allowed 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.035 0.445 . . . . 0.0 109.913 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -94.6 95.46 8.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.453 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.872 HD22 HD13 ' A' ' 153' ' ' LEU . 41.8 tp -60.27 118.12 6.01 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.807 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.531 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 34.0 ttt180 -123.02 129.84 52.02 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.35 -178.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.676 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -148.39 149.28 31.48 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.573 0.701 . . . . 0.0 111.178 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 69.7 mm-40 -82.48 70.52 9.45 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.011 178.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.632 ' SG ' HD13 ' A' ' 164' ' ' LEU . 59.1 m -57.84 114.41 2.3 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.953 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.653 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 10.8 ttp180 -67.11 125.99 27.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.392 178.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.547 ' HG2' ' CA ' ' A' ' 162' ' ' GLY . 7.1 mtm180 -96.34 162.77 13.35 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.85 -10.09 6.17 Favored Glycine 0 C--N 1.339 0.705 0 O-C-N 124.37 1.044 . . . . 0.0 113.759 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -76.97 -8.31 57.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.442 0.639 . . . . 0.0 109.43 178.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.38 14.21 66.59 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.01 161.06 13.2 Favored Glycine 0 C--O 1.225 -0.42 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.177 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.534 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 75.8 m-85 -101.15 133.14 46.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.701 0.286 . . . . 0.0 110.565 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.436 ' OG ' ' HD3' ' A' ' 27' ' ' ARG . 74.0 m -126.22 133.3 51.55 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.099 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 m -70.28 116.17 10.32 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.33 0.586 . . . . 0.0 111.367 -178.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 46.6 t -122.59 152.27 40.6 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.458 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 5.8 p -145.21 140.33 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 120.933 0.397 . . . . 0.0 112.032 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.531 HG23 ' HB3' ' A' ' 21' ' ' LEU . 10.2 tt -135.65 145.69 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.983 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.13 99.25 7.65 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.59 HD23 ' HB3' ' A' ' 21' ' ' LEU . 3.5 mm? -81.18 -8.7 59.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.09 0.471 . . . . 0.0 110.808 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.651 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 7.1 p30 -67.58 -13.15 61.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.453 179.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.424 ' O ' ' HB3' ' A' ' 117' ' ' ALA . 19.2 mtp180 -114.32 22.43 13.74 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -136.18 -31.09 0.92 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.67 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.828 HD22 HD13 ' A' ' 151' ' ' ILE . 35.9 mt -110.15 133.38 53.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.728 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.715 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 1.4 m -123.65 138.3 54.56 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.211 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.84 ' CB ' ' HG ' ' A' ' 140' ' ' LEU . 6.7 p-10 -79.66 93.26 5.49 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.82 0.819 . . . . 0.0 110.329 177.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.406 ' HB2' ' HG3' ' A' ' 51' ' ' ARG . 21.8 t70 -96.2 92.79 6.56 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 121.916 -0.49 . . . . 0.0 111.326 -179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.494 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 64.8 t30 49.19 47.54 21.96 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.361 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.66 43.5 18.51 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.964 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -161.98 123.41 2.74 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.694 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 55.8 m-85 -65.4 151.28 46.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.726 0.298 . . . . 0.0 110.574 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.406 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 37.7 mmt180 -141.51 128.65 20.89 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.518 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.649 ' HZ2' ' HA ' ' A' ' 153' ' ' LEU . 44.6 m95 -76.69 118.34 19.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.847 177.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.0 m -125.39 56.43 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.342 0.591 . . . . 0.0 110.475 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.0 p -75.91 36.86 0.14 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.138 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.566 ' HA3' ' HB2' ' A' ' 63' ' ' ALA . . . -151.65 27.99 0.94 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -130.85 168.98 21.68 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.997 -0.62 . . . . 0.0 111.697 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.36 -50.28 2.12 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.034 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 168.89 144.9 4.38 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.172 -0.537 . . . . 0.0 111.916 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.29 96.43 2.26 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.73 -0.747 . . . . 0.0 111.924 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.94 138.62 37.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.604 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 108' ' ' PRO . . . -170.13 -123.39 0.68 Allowed Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.4 m -124.89 116.54 22.38 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.168 0.508 . . . . 0.0 110.417 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.595 ' HB1' ' HG2' ' A' ' 110' ' ' LYS . . . -128.63 177.28 7.14 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.872 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.433 ' HB ' ' CG2' ' A' ' 104' ' ' VAL . 6.6 p -128.58 114.34 16.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.769 0.319 . . . . 0.0 111.626 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.463 HG21 ' CE1' ' A' ' 80' ' ' PHE . 11.8 p -101.67 143.38 14.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.937 0.399 . . . . 0.0 110.621 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 3.7 m -89.95 127.48 36.03 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.403 ' CG2' HD12 ' A' ' 99' ' ' ILE . 45.7 t -72.07 132.12 33.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.721 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.411 ' HG2' ' H ' ' A' ' 69' ' ' GLN . 18.9 tt0 -98.11 171.1 8.46 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 125.043 1.464 . . . . 0.0 109.813 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.595 ' CA ' ' HB3' ' A' ' 101' ' ' PRO . 24.6 tt0 -71.03 129.69 39.63 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.895 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.05 13.92 82.48 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.585 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -114.37 121.39 43.44 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.826 0.346 . . . . 0.0 110.248 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.58 ' HA ' HG12 ' A' ' 99' ' ' ILE . 80.0 p -103.38 -179.68 4.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.595 HD22 HG23 ' A' ' 99' ' ' ILE . 1.5 mm? -51.94 -42.03 62.51 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -60.01 -40.07 87.97 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 114.506 -1.224 . . . . 0.0 111.257 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -71.4 -40.37 70.55 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.671 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 72' ' ' THR . 32.5 mm -64.44 -48.38 85.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.669 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -58.8 -45.34 95.06 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.425 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -65.27 -37.08 86.09 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.866 0.365 . . . . 0.0 111.259 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -73.96 -40.24 63.16 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.463 ' CE1' HG21 ' A' ' 65' ' ' VAL . 95.4 m-85 -102.82 13.15 35.08 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.0 t70 58.07 27.57 15.09 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.558 0.694 . . . . 0.0 111.526 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.669 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 3.1 p -105.52 171.59 7.25 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.64 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.3 t0 -94.38 120.16 34.2 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.156 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.543 ' HD2' ' HB2' ' A' ' 95' ' ' ASN . 10.9 p90 -53.12 -30.3 35.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.588 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.429 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -68.57 -41.74 79.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.678 179.17 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -67.75 -48.33 66.71 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.664 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.64 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.4 mt -49.99 -43.79 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.577 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.59 -51.76 66.05 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.427 178.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 85' ' ' HIS . 61.4 mtp180 -64.23 -25.93 68.28 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.854 ' HB3' ' HB2' ' A' ' 106' ' ' GLN . 1.0 OUTLIER -72.66 -28.14 62.54 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.24 0.543 . . . . 0.0 110.161 179.183 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 18.0 t-20 -101.12 -5.33 25.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.319 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 23.4 m120 79.4 15.92 0.93 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.006 0.922 . . . . 0.0 111.148 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.577 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 15.1 pt -103.14 -169.79 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.597 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.534 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 55.1 mt-30 -116.66 161.21 19.56 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.559 ' O ' HD23 ' A' ' 73' ' ' LEU . 6.7 p30 -57.39 -58.74 6.95 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-O 122.245 1.021 . . . . 0.0 109.277 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -78.44 12.22 2.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.065 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 1.8 t70 -62.93 -31.57 72.68 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 6.8 mp 70.78 112.33 0.06 Allowed 'General case' 0 C--O 1.234 0.245 0 O-C-N 124.37 1.044 . . . . 0.0 110.503 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.595 HG23 HD22 ' A' ' 73' ' ' LEU . 9.4 pt -95.84 172.07 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 114.497 -1.228 . . . . 0.0 110.505 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.458 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 69.4 m-85 -125.52 156.36 70.67 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.305 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.595 ' HB3' ' CA ' ' A' ' 69' ' ' GLN . 39.2 Cg_endo -68.75 134.49 30.32 Favored 'Trans proline' 0 CA--C 1.517 -0.361 0 C-N-CA 123.042 2.494 . . . . 0.0 113.642 -177.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.85 13.4 37.38 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' A' ' 66' ' ' THR . 49.2 mt-30 -104.76 170.87 7.63 Favored 'General case' 0 C--O 1.216 -0.67 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.138 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.433 ' CG2' ' HB ' ' A' ' 64' ' ' THR . 9.9 p -126.49 131.03 71.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-O 121.441 0.639 . . . . 0.0 110.612 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.586 HD11 HG21 ' A' ' 99' ' ' ILE . 80.0 mt -125.09 151.32 45.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.759 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.854 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 38.7 mt-30 -89.75 113.4 24.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 122.031 0.92 . . . . 0.0 111.649 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.432 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 35.8 m -123.02 152.07 62.49 Favored Pre-proline 0 C--N 1.314 -0.976 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.013 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 32.0 Cg_endo -64.37 -17.61 60.26 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 123.425 2.75 . . . . 0.0 115.37 -176.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.7 t -149.56 152.72 35.99 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.189 0.519 . . . . 0.0 112.112 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.595 ' HG2' ' HB1' ' A' ' 63' ' ' ALA . 11.6 mmmm -107.11 175.23 5.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.969 178.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -119.47 107.95 1.44 Allowed Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -97.45 95.72 1.73 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.749 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 18.2 m -80.08 -22.02 42.69 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.652 0.263 . . . . 0.0 111.396 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.02 -48.72 38.54 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.621 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 176.23 -60.84 0.1 Allowed Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -104.39 -81.45 1.5 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 41' ' ' ARG . . . -143.42 -49.82 0.32 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.178 0.513 . . . . 0.0 109.899 178.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.715 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -89.62 -81.27 1.33 Allowed Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.973 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 16.0 m120 75.34 24.92 1.34 Allowed 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 123.575 0.75 . . . . 0.0 112.261 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.565 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 25.0 p90 -58.44 -39.37 79.66 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.288 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.516 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 60.3 t-105 -58.71 -31.89 68.68 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.01 -178.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.68 -30.43 61.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.839 0.352 . . . . 0.0 110.672 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.571 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 11.0 m -132.79 30.46 4.04 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.581 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.516 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -118.09 138.51 52.2 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 120.784 0.326 . . . . 0.0 110.743 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.413 ' HG2' ' CZ3' ' A' ' 146' ' ' TRP . 2.3 mmp_? -128.55 147.51 50.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.134 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 56.43 45.06 23.34 Favored 'General case' 0 CA--C 1.518 -0.264 0 O-C-N 123.695 0.622 . . . . 0.0 112.007 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.513 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 39.5 t -69.98 116.24 10.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.658 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -138.5 143.45 39.56 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.639 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.909 HD13 HG22 ' A' ' 14' ' ' ILE . 29.5 mt -86.38 138.71 31.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.345 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.681 HG23 ' HB ' ' A' ' 135' ' ' VAL . 26.7 m -131.08 160.97 41.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.431 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.471 ' HB3' ' HG2' ' A' ' 134' ' ' LYS . 0.7 OUTLIER 65.16 13.43 8.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.015 179.133 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.676 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 91.9 26.46 19.41 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.507 -0.854 . . . . 0.0 113.265 178.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.555 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 92.45 -18.02 55.86 Favored Glycine 0 C--O 1.265 2.074 0 CA-C-O 123.9 1.833 . . . . 0.0 112.225 177.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.755 ' HG3' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -67.98 -17.6 64.48 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.255 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.755 HG23 ' HG3' ' A' ' 134' ' ' LYS . 15.0 t -135.94 144.6 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.388 176.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.619 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 26.0 tp -127.49 124.69 38.94 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -120.58 134.63 55.26 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.212 0.529 . . . . 0.0 110.979 -177.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.623 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -157.58 162.74 38.77 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.864 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.574 ' HG2' ' HG3' ' A' ' 148' ' ' ARG . 45.1 mt-10 -94.71 105.14 17.06 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.84 ' HG ' ' CB ' ' A' ' 45' ' ' ASN . 1.4 mp -90.4 128.97 36.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.485 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.571 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 67.1 ttt180 -69.77 140.86 53.44 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.037 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.494 ' HB2' ' OD1' ' A' ' 47' ' ' ASN . 1.2 p90 -156.08 -167.81 2.57 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.139 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.3 t -60.41 -27.49 67.5 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.971 0.415 . . . . 0.0 111.123 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -101.91 27.19 21.52 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.348 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 92.67 -119.94 6.01 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.751 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.413 ' CZ3' ' HG2' ' A' ' 125' ' ' ARG . 79.2 m95 -124.64 125.68 44.51 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.477 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 25.0 t-20 -129.01 142.39 50.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.817 0.342 . . . . 0.0 111.095 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.574 ' HG3' ' HG2' ' A' ' 139' ' ' GLU . 25.1 mtp180 -74.12 108.47 6.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.716 0.769 . . . . 0.0 110.481 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.487 ' HB2' HD22 ' A' ' 140' ' ' LEU . 1.1 m -113.03 157.6 21.35 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.078 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.619 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 9.1 ptt180 -145.95 147.49 31.77 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.381 0.61 . . . . 0.0 112.343 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.828 HD13 HD22 ' A' ' 43' ' ' LEU . 8.7 tt -132.37 151.88 35.53 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.99 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 9.0 m-85 -92.24 104.85 17.16 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.871 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.872 HD13 HD22 ' A' ' 21' ' ' LEU . 30.5 mt -68.5 -32.59 72.67 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.131 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.639 ' HB3' ' HA ' ' A' ' 134' ' ' LYS . 1.4 p30 -54.7 -18.44 4.63 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.853 177.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 1.015 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 37.2 mt-10 -64.63 -52.26 58.31 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.523 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 65.5 m-70 -122.49 6.4 9.54 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.734 -0.786 . . . . 0.0 112.87 -178.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.435 ' O ' ' HA3' ' A' ' 5' ' ' GLY . 47.8 mm -107.15 110.38 31.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.663 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.54 ' HA3' ' OXT' ' A' ' 167' ' ' CYS . . . -115.24 156.11 15.87 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.451 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.547 ' HA ' ' O ' ' A' ' 163' ' ' GLU . 1.7 t30 -97.13 127.91 43.55 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 122.518 0.327 . . . . 0.0 110.151 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 -115.68 87.43 2.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.257 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 65.4 t30 50.43 52.63 14.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.81 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.547 ' CA ' ' HG2' ' A' ' 27' ' ' ARG . . . 95.07 7.1 59.87 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.968 -0.634 . . . . 0.0 114.343 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 159' ' ' ASN . 44.6 mt-10 -122.55 154.77 37.46 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 117.415 0.608 . . . . 0.0 110.509 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.712 HD11 ' CD2' ' A' ' 7' ' ' PHE . 7.7 tp -111.3 110.16 20.5 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.89 0.376 . . . . 0.0 110.561 -178.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 38.9 pt -134.6 -173.73 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.018 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.523 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 1.9 p-80 -83.43 122.03 27.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.671 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.54 ' OXT' ' HA3' ' A' ' 158' ' ' GLY . 46.2 t . . . . . 0 C--O 1.251 1.148 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.805 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.484 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.623 ' HB3' ' HA ' ' A' ' 6' ' ' ASN . 1.7 m-80 -61.51 152.36 30.37 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.047 0.451 . . . . 0.0 110.543 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.948 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 30.7 m-85 -101.74 -84.98 0.44 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.459 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -110.44 -30.68 7.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.712 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 167' ' ' CYS . . . -71.37 -63.45 3.09 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 119.732 -1.223 . . . . 0.0 112.39 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.623 ' HA ' ' HB3' ' A' ' 2' ' ' ASN . 2.4 m-20 66.03 15.66 10.16 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 122.526 0.33 . . . . 0.0 111.432 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.689 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.2 OUTLIER -60.51 -39.68 88.66 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.082 -179.323 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.78 -16.81 62.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.006 0.431 . . . . 0.0 111.554 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.55 -20.01 79.77 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.077 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 45.8 m -140.41 -13.03 1.02 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 117.33 0.565 . . . . 0.0 112.081 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.7 m -98.66 133.25 43.27 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.635 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 25.0 ptt180 -110.1 -172.13 1.98 Allowed 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.434 ' HB3' ' HG3' ' A' ' 24' ' ' GLU . 20.9 t70 42.05 40.31 1.61 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.829 0.852 . . . . 0.0 111.976 -179.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.877 HG22 HD13 ' A' ' 129' ' ' LEU . 6.4 mt -77.02 99.26 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 CA-C-O 121.104 0.478 . . . . 0.0 109.917 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.639 ' CA ' HD12 ' A' ' 129' ' ' LEU . 73.1 m -147.68 124.67 11.34 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.353 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.752 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -94.03 152.69 18.62 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.84 0.829 . . . . 0.0 112.985 -179.006 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -93.27 75.2 4.59 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.043 -1.435 . . . . 0.0 107.233 177.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.21 -53.31 4.63 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.735 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.497 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -149.07 -11.35 0.32 Allowed 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 120.94 0.4 . . . . 0.0 110.234 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.432 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 3.4 mpt_? -89.48 92.55 9.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.87 0.367 . . . . 0.0 110.389 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.819 HD22 HD23 ' A' ' 153' ' ' LEU . 46.8 tp -61.36 123.98 19.33 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.716 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.653 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 41.9 ttp180 -125.03 137.22 54.23 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.266 -0.573 . . . . 0.0 110.257 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.587 ' CB ' HG12 ' A' ' 14' ' ' ILE . . . -157.29 145.84 19.55 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.587 0.708 . . . . 0.0 111.084 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.635 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 3.5 mt-10 -84.52 77.03 10.1 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.504 -1.225 . . . . 0.0 108.706 178.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.621 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 55.9 m -62.78 120.67 11.72 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.899 -178.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 10' ' ' SER . 9.0 tmm_? -70.76 114.89 9.3 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.914 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 10.2 ptp180 -89.17 159.0 17.69 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.041 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.46 -15.95 6.41 Favored Glycine 0 C--N 1.339 0.732 0 O-C-N 124.713 1.258 . . . . 0.0 114.067 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -72.38 -12.5 61.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.618 0.723 . . . . 0.0 109.417 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.7 8.8 60.5 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.933 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' A' ' 27' ' ' ARG . . . -112.77 160.62 13.04 Favored Glycine 0 CA--C 1.512 -0.151 0 C-N-CA 120.199 -1.001 . . . . 0.0 113.657 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.449 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 89.3 m-85 -101.39 124.7 47.49 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.1 p -118.68 133.23 56.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.438 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.1 m -71.0 111.38 6.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.062 0.458 . . . . 0.0 110.843 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.2 t -117.4 152.1 35.67 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.481 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.56 ' HB ' ' HG3' ' A' ' 22' ' ' ARG . 3.9 p -145.04 136.38 20.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.788 0.328 . . . . 0.0 110.224 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.528 HG23 HD23 ' A' ' 39' ' ' LEU . 11.8 tt -135.29 151.65 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.075 -177.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.565 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 1.6 m-20 -79.61 105.88 11.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.684 0.278 . . . . 0.0 111.36 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.637 HD13 ' HB2' ' A' ' 42' ' ' TYR . 1.5 mm? -88.93 -1.64 58.2 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.198 0.523 . . . . 0.0 110.333 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.565 ' OD1' ' HB3' ' A' ' 38' ' ' ASP . 32.3 p-10 -69.55 -14.62 62.94 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 38' ' ' ASP . 6.1 ptp180 -109.9 11.87 24.04 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.609 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.637 ' HB2' HD13 ' A' ' 39' ' ' LEU . 41.4 m-85 -127.36 -31.63 2.52 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.868 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.631 HD22 HD13 ' A' ' 151' ' ' ILE . 39.8 mt -108.96 139.02 44.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.084 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.551 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 4.1 m -129.71 149.09 51.61 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.518 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.455 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 3.0 p-10 -98.51 104.83 16.9 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -108.03 91.97 3.87 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 121.85 -0.531 . . . . 0.0 111.092 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.537 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 62.4 t30 57.08 45.04 21.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.015 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.816 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 78.67 31.68 44.03 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.795 178.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.586 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 22.4 t-80 -148.69 122.17 9.11 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.756 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 38.1 m-85 -64.04 138.61 58.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.617 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -144.97 139.15 27.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.687 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.718 ' CZ2' ' HA ' ' A' ' 153' ' ' LEU . 99.2 m95 -75.08 128.93 36.66 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.578 HG23 ' H ' ' A' ' 55' ' ' GLY . 15.9 m 41.77 -128.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 O-C-N 124.414 1.071 . . . . 0.0 111.999 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.6 m -120.28 8.59 10.88 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.939 0.4 . . . . 0.0 110.456 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.578 ' H ' HG23 ' A' ' 53' ' ' VAL . . . 79.18 -43.84 2.55 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.305 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 142.56 91.33 0.16 Allowed Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.812 -0.515 . . . . 0.0 111.812 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -139.65 157.68 25.29 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.95 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.96 162.34 34.05 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.32 -170.73 39.33 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.074 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.18 34.72 1.09 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.355 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 108' ' ' PRO . . . -89.38 -115.8 1.5 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.897 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 87.3 m -128.37 113.57 15.74 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.324 0.583 . . . . 0.0 110.428 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.527 ' HB1' ' HG2' ' A' ' 110' ' ' LYS . . . -123.07 178.26 5.16 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.356 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.404 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 2.0 p -128.77 122.77 31.3 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.1 t -111.45 135.6 50.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.096 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.1 m -87.48 127.36 35.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.342 0.592 . . . . 0.0 110.034 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.549 ' CG2' HD12 ' A' ' 99' ' ' ILE . 44.5 t -74.64 131.78 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.538 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -101.19 172.03 7.25 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 124.854 1.346 . . . . 0.0 109.905 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.582 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 41.0 tt0 -59.04 125.86 25.33 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.144 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.88 2.74 88.39 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.091 -0.576 . . . . 0.0 114.092 177.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -92.34 138.04 31.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 117.246 0.523 . . . . 0.0 111.315 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.551 ' HA ' HG12 ' A' ' 99' ' ' ILE . 55.1 p -119.5 173.98 6.66 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.599 HD12 ' HB ' ' A' ' 87' ' ' ILE . 1.3 mm? -52.6 -40.5 62.75 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.182 0.515 . . . . 0.0 110.416 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.53 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 13.7 mtp180 -67.01 -35.47 80.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.787 -178.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -72.31 -38.22 68.75 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.521 HG12 ' O ' ' A' ' 72' ' ' THR . 42.0 mm -67.15 -45.83 85.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.715 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -55.14 -55.82 26.29 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.579 179.081 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -59.79 -42.94 94.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.91 0.386 . . . . 0.0 112.04 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.543 ' HD3' ' HB3' ' A' ' 113' ' ' SER . 40.2 ttm180 -64.01 -36.27 83.45 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -110.35 19.99 18.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.8 t70 56.3 30.55 16.96 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.448 0.642 . . . . 0.0 111.717 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.715 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 3.6 p -112.85 171.31 7.61 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.59 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.9 t70 -99.24 127.18 45.19 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.53 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 4.8 p90 -51.43 -30.55 19.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.226 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -65.43 -44.79 86.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.719 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.721 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 24.2 mm-40 -63.22 -51.0 68.04 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.801 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.599 ' HB ' HD12 ' A' ' 73' ' ' LEU . 2.7 mt -52.76 -47.04 51.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.64 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.595 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.59 -50.74 70.07 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.617 178.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -56.47 -40.12 74.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.138 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.721 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 13.8 mmt85 -65.83 -33.48 75.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.102 0.477 . . . . 0.0 111.071 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 2.4 t-20 -92.13 -4.76 53.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.792 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 92.3 m-20 75.94 19.14 1.94 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.487 0.715 . . . . 0.0 110.777 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.595 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 14.4 pt -106.18 -176.26 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.739 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.555 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 49.2 mt-30 -107.36 166.06 10.93 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.539 ' O ' HD23 ' A' ' 73' ' ' LEU . 6.1 p30 -63.83 -53.5 49.78 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-O 122.141 0.972 . . . . 0.0 108.407 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.4 ' OE1' ' HB3' ' A' ' 94' ' ' GLN . 0.8 OUTLIER -79.56 11.06 3.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.785 -179.67 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.555 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.8 t70 -61.54 -32.23 72.28 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.1 mt 68.84 114.07 0.04 OUTLIER 'General case' 0 C--O 1.233 0.21 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.061 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.734 HG21 HD11 ' A' ' 105' ' ' LEU . 9.2 pt -94.56 175.64 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.238 -178.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.474 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 41.3 m-85 -128.72 156.54 77.4 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.83 -178.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.582 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 32.0 Cg_endo -67.07 133.02 29.6 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 123.286 2.658 . . . . 0.0 113.241 -178.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.43 19.29 25.85 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -112.54 155.74 23.81 Favored 'General case' 0 C--O 1.212 -0.901 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.404 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 88.2 t -116.18 122.68 70.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 O-C-N 121.789 -0.569 . . . . 0.0 110.405 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.734 HD11 HG21 ' A' ' 99' ' ' ILE . 95.9 mt -113.42 151.25 31.59 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.92 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.569 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 78.2 mt-30 -90.22 116.27 28.08 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.642 0.734 . . . . 0.0 110.801 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.406 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 31.5 m -123.23 151.84 62.89 Favored Pre-proline 0 C--N 1.31 -1.119 0 CA-C-N 114.173 -1.376 . . . . 0.0 109.441 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 37.9 Cg_endo -65.07 -22.32 62.17 Favored 'Trans proline' 0 N--CA 1.473 0.282 0 C-N-CA 123.147 2.565 . . . . 0.0 114.952 -177.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.0 t -147.11 155.1 41.89 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.586 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.527 ' HG2' ' HB1' ' A' ' 63' ' ' ALA . 12.3 mmmm -104.06 174.0 6.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.429 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.3 145.33 5.97 Favored Glycine 0 N--CA 1.439 -1.165 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.528 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -74.45 90.29 0.73 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.082 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.543 ' HB3' ' HD3' ' A' ' 79' ' ' ARG . 29.8 m -119.13 49.47 1.33 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.171 0.51 . . . . 0.0 110.689 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 149.31 -65.21 0.39 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.06 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -178.4 -170.35 40.38 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 121.02 -0.61 . . . . 0.0 111.842 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.35 54.15 6.35 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.95 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -102.95 -33.34 9.34 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.345 -0.428 . . . . 0.0 110.803 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.551 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -104.18 -70.14 0.8 Allowed Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.221 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 15.2 m120 73.63 31.33 1.3 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.007 0.523 . . . . 0.0 112.122 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.573 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 27.5 p90 -59.6 -35.84 75.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.95 0.405 . . . . 0.0 110.141 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.56 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 61.8 t-105 -63.09 -31.71 72.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.068 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.88 -31.51 40.04 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.852 0.358 . . . . 0.0 110.99 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.85 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 18.5 m -131.19 28.26 4.75 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.691 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.56 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -110.48 142.95 41.53 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.395 178.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.45 ' HD2' ' OD2' ' A' ' 126' ' ' ASP . 6.6 tmm_? -137.15 139.24 41.02 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.45 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 3.6 m-20 63.08 54.54 2.1 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.261 0.553 . . . . 0.0 110.567 -178.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.466 ' CG1' HD11 ' A' ' 136' ' ' LEU . 38.3 t -85.69 122.83 38.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.402 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.424 ' O ' HD12 ' A' ' 136' ' ' LEU . 16.2 ptt180 -144.84 142.7 30.15 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.754 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.877 HD13 HG22 ' A' ' 14' ' ' ILE . 16.5 mt -85.42 130.38 34.6 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.532 HG23 ' HB ' ' A' ' 135' ' ' VAL . 27.8 m -124.49 163.47 24.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.512 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.473 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 5.3 m-20 68.08 6.0 4.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.203 178.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.635 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 93.66 28.25 11.59 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.181 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.495 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 96.89 -19.27 55.46 Favored Glycine 0 C--O 1.264 1.978 0 CA-C-O 123.08 1.378 . . . . 0.0 113.145 177.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.574 ' O ' ' HA ' ' A' ' 152' ' ' TYR . 10.5 pttp -72.75 -10.91 60.34 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 121.196 -1.179 . . . . 0.0 109.665 178.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.532 ' HB ' HG23 ' A' ' 130' ' ' VAL . 22.3 t -144.26 140.44 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 121.383 0.611 . . . . 0.0 110.444 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.624 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 44.1 tp -121.14 125.28 46.81 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -114.75 131.36 56.81 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.989 0.423 . . . . 0.0 110.893 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.627 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -161.44 157.8 25.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.675 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.522 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 36.9 mt-10 -95.56 109.95 22.11 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.816 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 46.3 mt -95.74 134.17 38.99 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.956 -178.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.85 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 36.1 ttt180 -70.76 141.09 51.47 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.701 179.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.601 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.7 p90 -161.83 -170.49 2.57 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.593 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 45.5 t -54.31 -28.68 43.95 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.41 0.444 . . . . 0.0 111.883 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -105.45 30.38 9.96 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.461 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 141' ' ' ARG . . . 91.55 -114.93 4.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.518 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -126.8 128.15 46.13 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.601 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 57.3 t30 -117.62 143.67 45.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.957 0.408 . . . . 0.0 111.988 -178.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -76.75 94.57 3.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.122 178.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.586 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 35.8 t -111.11 160.88 16.49 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.445 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.624 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 28.6 ptt180 -148.59 154.58 39.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.548 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.756 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 8.0 tt -136.96 151.95 27.89 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.565 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.078 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.621 ' HB3' ' OD1' ' A' ' 154' ' ' ASP . 26.3 m-85 -95.08 103.27 15.12 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.839 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.819 HD23 HD22 ' A' ' 21' ' ' LEU . 7.1 mp -70.64 -29.27 65.58 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.976 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.621 ' OD1' ' HB3' ' A' ' 152' ' ' TYR . 21.9 p-10 -56.27 -13.96 2.5 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.914 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.948 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 31.1 mt-10 -68.96 -54.11 17.1 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.505 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 50.1 m80 -123.11 3.73 9.29 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.719 -0.792 . . . . 0.0 112.576 -176.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.492 HG21 HD21 ' A' ' 21' ' ' LEU . 43.2 mm -105.32 112.85 40.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.127 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.541 ' HA3' ' OXT' ' A' ' 167' ' ' CYS . . . -118.47 178.53 16.79 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.878 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.621 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -109.6 125.71 52.85 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.86 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.91 85.06 2.04 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 65.0 t30 52.2 49.59 20.26 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.388 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 94.11 2.22 64.44 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.707 -0.758 . . . . 0.0 114.338 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -122.31 126.04 47.25 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.982 0.42 . . . . 0.0 109.894 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.689 HD11 ' CD2' ' A' ' 7' ' ' PHE . 7.6 tp -73.78 128.45 35.56 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.754 -178.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.817 HG13 ' H ' ' A' ' 166' ' ' HIS . 10.8 tp -159.36 -173.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -179.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.817 ' H ' HG13 ' A' ' 165' ' ' ILE . 37.8 p-80 -82.49 125.45 31.11 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.131 -0.356 . . . . 0.0 110.163 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.541 ' OXT' ' HA3' ' A' ' 158' ' ' GLY . 53.1 t . . . . . 0 C--O 1.254 1.329 0 O-C-N 123.907 0.754 . . . . 0.0 112.121 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.69 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.4 167.5 11.48 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.04 0.448 . . . . 0.0 109.959 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.689 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 27.9 m-85 -128.84 -68.34 0.75 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.304 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.3 -26.69 0.9 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.525 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -72.7 -69.76 1.34 Allowed Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 119.541 -1.314 . . . . 0.0 113.376 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 68.39 16.73 9.23 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 122.624 0.37 . . . . 0.0 110.366 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.669 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -63.63 -30.54 71.64 Favored 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -178.801 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.402 ' HA ' HD11 ' A' ' 14' ' ' ILE . 97.2 p -70.37 -12.39 61.55 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.715 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.22 -26.03 60.5 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.283 -0.872 . . . . 0.0 112.782 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.444 ' HB2' ' HB3' ' A' ' 26' ' ' ARG . 35.0 p -126.49 -23.65 3.75 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.221 0.51 . . . . 0.0 112.069 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.0 m -90.09 135.28 33.75 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.532 ' HG2' ' N ' ' A' ' 13' ' ' ASP . 44.3 ttt-85 -110.86 171.08 7.68 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.539 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.532 ' N ' ' HG2' ' A' ' 12' ' ' ARG . 48.7 m-20 46.01 48.65 12.45 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.349 0.659 . . . . 0.0 111.999 178.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.877 HG22 HD13 ' A' ' 129' ' ' LEU . 9.4 mt -79.36 105.71 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.657 ' HA ' HD12 ' A' ' 129' ' ' LEU . 75.5 m -147.18 126.81 13.33 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.011 0.524 . . . . 0.0 109.977 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.768 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -97.79 156.61 16.49 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -179.07 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -96.88 74.4 2.64 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.063 -1.426 . . . . 0.0 107.669 177.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.12 -52.89 4.57 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.031 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.574 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -149.26 -13.36 0.3 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.183 0.516 . . . . 0.0 110.004 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 20' ' ' ARG . 23.4 ttm180 -90.89 92.63 8.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.331 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.812 HD13 HD11 ' A' ' 129' ' ' LEU . 37.3 tp -63.46 130.49 44.6 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.736 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -134.17 127.05 31.23 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.033 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.656 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -146.72 147.02 30.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.244 0.545 . . . . 0.0 111.501 -178.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.737 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 7.2 mm-40 -78.59 74.7 5.12 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.392 177.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.625 ' SG ' HD13 ' A' ' 164' ' ' LEU . 68.9 m -60.3 126.9 29.24 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 120.971 0.415 . . . . 0.0 111.029 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.444 ' HB3' ' HB2' ' A' ' 10' ' ' SER . 65.6 ttt180 -68.51 121.67 16.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.237 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.559 ' HD3' ' HB3' ' A' ' 29' ' ' ASP . 6.0 ptp180 -94.91 149.59 21.08 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 177.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.42 -11.33 3.58 Favored Glycine 0 C--N 1.34 0.775 0 O-C-N 124.35 1.031 . . . . 0.0 113.642 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.559 ' HB3' ' HD3' ' A' ' 27' ' ' ARG . 19.8 t70 -71.68 -15.64 62.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.441 0.639 . . . . 0.0 109.548 178.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.13 5.4 53.01 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.048 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.22 172.41 14.26 Favored Glycine 0 C--N 1.322 -0.197 0 C-N-CA 119.959 -1.115 . . . . 0.0 113.517 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.737 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 41.2 m-85 -101.87 128.92 48.03 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 178.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.6 m -114.45 130.81 56.75 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.267 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 m -67.47 110.01 3.45 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.092 0.473 . . . . 0.0 110.846 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.505 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 41.7 t -115.06 151.93 33.39 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.512 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -145.94 133.66 15.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.08 0.467 . . . . 0.0 111.824 -178.777 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.475 HG22 HD23 ' A' ' 164' ' ' LEU . 10.7 tt -135.4 141.23 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.869 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.02 108.84 15.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.07 0.462 . . . . 0.0 111.052 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.587 HD23 ' HB3' ' A' ' 21' ' ' LEU . 3.1 mm? -81.14 -7.33 59.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.621 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.574 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 26.9 p30 -68.62 -9.6 50.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.57 0.7 . . . . 0.0 109.364 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.484 ' HA ' ' H ' ' A' ' 117' ' ' ALA . 15.4 ttm180 -104.94 0.15 27.53 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.617 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.548 ' HA ' HG22 ' A' ' 53' ' ' VAL . 75.8 m-85 -126.06 -28.09 3.2 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.842 HD22 HD13 ' A' ' 151' ' ' ILE . 36.5 mt -106.31 142.84 35.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.988 0.423 . . . . 0.0 112.023 -178.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.2 m -135.43 139.78 44.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.446 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.815 ' CB ' ' HG ' ' A' ' 140' ' ' LEU . 7.8 p-10 -83.48 93.93 7.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.522 0.677 . . . . 0.0 110.286 178.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.44 ' CB ' ' HD2' ' A' ' 51' ' ' ARG . 9.1 t0 -99.88 94.79 6.49 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 122.1 -0.375 . . . . 0.0 110.63 -179.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.519 ' HA ' ' HB2' ' A' ' 142' ' ' TYR . 10.2 t-20 52.47 49.28 20.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.52 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 149' ' ' SER . . . 72.0 38.98 59.63 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.696 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -157.29 123.02 4.69 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.756 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 65.4 m-85 -62.46 144.9 55.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.191 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.44 ' HD2' ' CB ' ' A' ' 46' ' ' ASP . 70.0 mtt180 -148.0 133.02 18.19 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.38 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.545 ' HA ' ' O ' ' A' ' 42' ' ' TYR . 97.3 m95 -74.44 135.36 42.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.273 178.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.548 HG22 ' HA ' ' A' ' 42' ' ' TYR . 13.7 m -58.81 105.93 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.531 0.682 . . . . 0.0 110.946 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.6 m -89.69 -14.24 35.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.651 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -96.16 -60.28 1.02 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.177 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.48 -147.45 19.02 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.262 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.68 -135.48 2.01 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.012 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.72 42.17 62.49 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.425 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.09 121.47 11.71 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.204 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.08 -177.74 19.56 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.361 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.29 -66.84 0.46 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.862 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.5 m -139.64 113.85 8.96 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.805 -0.697 . . . . 0.0 110.639 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.597 ' HB1' ' HG2' ' A' ' 110' ' ' LYS . . . -133.53 176.55 8.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.545 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.427 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 2.4 p -128.8 117.97 21.98 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.218 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.514 HG21 ' CE2' ' A' ' 80' ' ' PHE . 14.2 p -104.68 141.17 20.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.003 0.43 . . . . 0.0 111.575 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 5.6 m -93.09 126.7 38.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.236 0.541 . . . . 0.0 109.691 178.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.593 ' CG2' HD12 ' A' ' 99' ' ' ILE . 53.9 t -79.59 135.22 26.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.092 -179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -100.83 169.84 8.72 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 124.355 1.034 . . . . 0.0 110.643 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.713 ' CA ' ' HB3' ' A' ' 101' ' ' PRO . 50.1 tt0 -66.15 116.71 7.52 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.978 -177.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.25 -3.29 47.36 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.321 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -100.29 139.32 36.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.999 0.428 . . . . 0.0 111.213 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.692 ' HA ' HG12 ' A' ' 99' ' ' ILE . 69.6 p -120.29 179.43 4.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.542 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.663 HD22 HG23 ' A' ' 99' ' ' ILE . 1.1 mm? -51.5 -40.61 59.9 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.19 0.519 . . . . 0.0 110.191 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -61.75 -38.47 88.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.354 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -72.3 -40.21 67.68 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.666 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 72' ' ' THR . 41.7 mm -64.96 -47.38 88.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.886 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.646 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -61.23 -44.29 98.3 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.92 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -65.54 -36.38 83.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.075 0.464 . . . . 0.0 111.251 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -75.27 -44.21 47.02 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.514 ' CE2' HG21 ' A' ' 65' ' ' VAL . 89.7 m-85 -101.91 17.32 23.42 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -176.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.4 t70 54.33 42.72 31.29 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.527 0.679 . . . . 0.0 111.521 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.646 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.1 p -123.07 166.2 15.53 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.672 ' O ' HG13 ' A' ' 87' ' ' ILE . 6.8 t70 -93.88 124.52 37.94 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.599 -0.841 . . . . 0.0 110.115 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.574 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 18.9 p90 -51.5 -31.78 25.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.19 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.494 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 38.8 t-80 -66.58 -44.1 83.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.727 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.67 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 17.9 mm-40 -67.61 -47.35 69.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.254 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.672 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.8 mt -51.06 -45.34 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.435 0.636 . . . . 0.0 109.336 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.623 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.63 -50.77 69.93 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.935 178.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' A' ' 85' ' ' HIS . 74.6 mtp180 -57.32 -41.98 80.96 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.67 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 15.4 mtp180 -70.89 -21.78 62.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.852 0.358 . . . . 0.0 111.376 -178.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 17.4 t-20 -101.13 -5.23 25.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.951 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 16.0 m120 78.0 14.58 1.55 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.49 0.716 . . . . 0.0 111.494 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.623 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 16.7 pt -106.27 -174.64 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.576 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 78.6 mm-40 -113.48 155.37 25.44 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.555 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 4.5 p30 -54.07 -58.87 5.7 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-O 122.259 1.028 . . . . 0.0 109.058 178.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -75.33 12.26 1.0 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.747 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.576 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.1 t0 -69.49 -34.09 73.81 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 10.3 mp 70.22 116.62 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 O-C-N 124.21 0.944 . . . . 0.0 108.98 -176.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.696 HG21 HD11 ' A' ' 105' ' ' LEU . 7.5 pt -93.56 177.07 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.993 -177.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.405 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 2.3 m-85 -123.87 156.04 66.03 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.401 -177.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.713 ' HB3' ' CA ' ' A' ' 69' ' ' GLN . 32.6 Cg_endo -68.71 130.6 20.97 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.258 2.639 . . . . 0.0 113.062 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.05 12.54 49.14 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 66' ' ' THR . 63.4 tt0 -101.0 159.72 14.98 Favored 'General case' 0 C--O 1.214 -0.792 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.427 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 85.6 t -120.59 120.47 62.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.04 0.448 . . . . 0.0 110.203 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.696 HD11 HG21 ' A' ' 99' ' ' ILE . 68.4 mt -111.49 152.0 27.97 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.549 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -90.78 115.81 28.14 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.564 0.697 . . . . 0.0 111.208 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.2 m -124.57 151.26 67.03 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.407 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -63.32 -17.08 58.41 Favored 'Trans proline' 0 C--N 1.332 -0.302 0 C-N-CA 123.305 2.67 . . . . 0.0 114.92 -177.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.9 t -157.69 154.32 28.11 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.551 -0.459 . . . . 0.0 111.462 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.597 ' HG2' ' HB1' ' A' ' 63' ' ' ALA . 12.8 mmmm -101.28 174.82 5.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.741 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -175.62 93.58 0.09 OUTLIER Glycine 0 N--CA 1.443 -0.833 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.154 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 83.4 68.2 1.43 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.178 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.9 m -151.51 47.34 0.81 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.988 0.423 . . . . 0.0 110.366 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.05 -50.43 4.29 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.023 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 137.97 -97.39 0.25 Allowed Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.294 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.35 69.72 1.02 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.504 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.484 ' H ' ' HA ' ' A' ' 41' ' ' ARG . . . -119.66 -39.67 2.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.951 0.405 . . . . 0.0 110.707 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . -90.42 -53.54 2.28 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.59 -0.815 . . . . 0.0 111.349 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.3 m120 73.74 27.22 1.75 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 177.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.662 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 22.5 p90 -58.39 -36.72 73.97 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.376 -0.53 . . . . 0.0 109.886 178.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.531 ' HB2' ' HB2' ' A' ' 19' ' ' ALA . 52.8 t-105 -63.79 -34.62 78.31 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.854 -178.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -56.86 -19.78 19.4 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.155 0.502 . . . . 0.0 110.788 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.813 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 13.0 m -138.75 29.12 2.35 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.444 178.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.529 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -116.22 145.83 42.81 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.2 0.524 . . . . 0.0 111.94 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.45 HH11 ' HD3' ' A' ' 125' ' ' ARG . 29.1 mtp-105 -133.69 153.88 51.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.378 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 52.03 39.91 27.3 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 123.713 0.633 . . . . 0.0 112.128 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.504 ' CG1' HD11 ' A' ' 136' ' ' LEU . 22.5 t -67.19 121.51 16.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.056 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -144.83 140.5 28.45 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.689 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.877 HD13 HG22 ' A' ' 14' ' ' ILE . 16.4 mt -86.36 122.39 30.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.147 0.498 . . . . 0.0 109.912 178.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.635 HG23 ' HB ' ' A' ' 135' ' ' VAL . 35.2 m -115.63 159.36 15.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.367 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.601 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 1.4 m-20 71.06 -0.7 2.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.212 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.562 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 98.6 28.18 8.09 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.033 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.506 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 100.24 -23.94 33.98 Favored Glycine 0 C--O 1.264 1.98 0 CA-C-O 123.192 1.44 . . . . 0.0 112.618 178.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.73 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 6.9 ptmm? -65.08 -18.85 65.65 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 121.803 -0.822 . . . . 0.0 109.601 178.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.635 ' HB ' HG23 ' A' ' 130' ' ' VAL . 15.1 t -139.08 141.19 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.289 0.566 . . . . 0.0 109.976 177.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 30.1 tp -121.66 121.16 36.73 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.507 ' OE2' ' HD3' ' A' ' 150' ' ' ARG . 36.7 tt0 -111.93 132.53 54.69 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.209 -177.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.748 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -163.22 161.89 25.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.594 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -94.65 105.85 17.82 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.815 ' HG ' ' CB ' ' A' ' 45' ' ' ASN . 1.9 mp -89.82 128.52 36.18 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.543 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.813 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 41.0 ttt180 -70.61 140.53 51.67 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.097 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.663 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.3 p90 -157.22 -171.81 3.76 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.951 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.1 p -56.44 -29.2 61.35 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.168 0.293 . . . . 0.0 111.601 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.03 26.12 25.52 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.142 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.87 -110.98 4.1 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.365 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -130.05 133.31 46.62 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.663 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 14.4 t-20 -123.93 136.92 54.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.764 0.316 . . . . 0.0 111.361 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -76.7 93.73 3.7 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.505 ' OG ' HD22 ' A' ' 140' ' ' LEU . 24.2 p -110.71 162.91 14.29 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.506 -178.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.597 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 14.0 mtm-85 -143.91 152.37 41.02 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.858 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.842 HD13 HD22 ' A' ' 43' ' ' LEU . 11.1 tt -137.95 143.2 33.97 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.467 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.735 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 35.7 m-85 -83.89 101.66 11.83 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 122.195 -0.316 . . . . 0.0 110.925 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.772 HD13 HD22 ' A' ' 21' ' ' LEU . 20.4 mt -62.92 -33.6 75.67 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.116 178.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.73 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 12.7 t70 -56.13 -14.11 2.48 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.805 178.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.735 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 38.9 mt-10 -64.3 -55.8 18.87 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.617 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 53.6 m-70 -121.54 2.35 10.15 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 119.851 -0.74 . . . . 0.0 112.111 -177.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' A' ' 153' ' ' LEU . 47.0 mm -103.95 112.76 38.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.605 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.58 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -121.52 164.76 14.61 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.36 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.574 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.9 t30 -99.63 130.64 45.87 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.665 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 28.8 ttm180 -122.78 87.02 2.68 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.205 0.526 . . . . 0.0 110.425 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 64.9 t30 53.93 44.05 29.99 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.654 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.95 -6.78 47.96 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.127 -1.035 . . . . 0.0 114.733 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.665 ' HG2' ' O ' ' A' ' 160' ' ' ARG . 12.9 pt-20 -118.99 138.4 52.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 117.81 0.805 . . . . 0.0 110.696 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.669 HD11 ' CD2' ' A' ' 7' ' ' PHE . 7.4 tp -91.7 118.63 30.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.075 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.511 HG12 ' N ' ' A' ' 166' ' ' HIS . 12.0 tt -149.04 167.31 3.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.272 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.617 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 10.9 p-80 -61.9 123.19 17.37 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.523 ' OXT' ' HA3' ' A' ' 158' ' ' GLY . 50.8 t . . . . . 0 C--O 1.252 1.235 0 O-C-N 123.799 0.687 . . . . 0.0 111.348 -179.149 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.785 ' HA ' ' OD1' ' A' ' 154' ' ' ASP . 1.2 m-80 -75.96 137.86 40.59 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.602 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.747 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 56.3 m-85 -91.62 -90.32 0.17 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.731 -178.741 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.84 -29.99 10.15 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.459 -179.392 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.21 -69.15 1.45 Allowed Glycine 0 N--CA 1.436 -1.324 0 C-N-CA 119.948 -1.12 . . . . 0.0 113.051 -178.649 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.489 ' OD1' ' HB2' ' A' ' 2' ' ' ASN . 37.1 m-80 69.55 11.81 8.05 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.564 0.345 . . . . 0.0 110.94 -179.475 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.593 ' CE2' HD13 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -59.64 -35.0 73.53 Favored 'General case' 0 C--O 1.214 -0.786 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.635 -179.004 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.3 p -64.87 -13.77 57.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.04 0.447 . . . . 0.0 111.502 -179.469 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.64 -12.42 62.63 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.98 179.37 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 14.8 m -126.67 -34.11 2.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.491 0.663 . . . . 0.0 110.732 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 9.0 m -92.77 133.59 35.89 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.685 -179.042 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.435 ' HG3' ' HB2' ' A' ' 24' ' ' GLU . 9.1 ptp180 -111.76 -173.65 2.29 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.756 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.455 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 2.3 m-20 44.76 39.65 3.64 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 123.607 0.567 . . . . 0.0 112.419 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.972 HG22 HD13 ' A' ' 129' ' ' LEU . 5.0 mt -78.74 103.86 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 CA-C-O 120.951 0.405 . . . . 0.0 110.503 -178.564 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.593 ' CA ' HD12 ' A' ' 129' ' ' LEU . 71.2 m -147.63 126.53 12.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.284 178.663 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.801 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -101.03 155.16 18.14 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.904 0.859 . . . . 0.0 112.951 -179.373 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -99.02 77.0 2.15 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.036 -1.438 . . . . 0.0 107.559 176.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.06 -56.76 5.0 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.856 179.177 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.524 ' HB1' ' HB2' ' A' ' 40' ' ' ASN . . . -148.66 -12.28 0.34 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.087 0.47 . . . . 0.0 109.918 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.454 HH11 ' HD3' ' A' ' 20' ' ' ARG . 44.0 mtp-105 -81.75 86.43 6.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.343 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.801 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 42.1 tp -62.0 116.07 4.6 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 122.825 0.45 . . . . 0.0 111.884 -179.497 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.547 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 39.1 ttt180 -122.99 127.89 49.45 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.226 -179.104 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.64 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -148.66 146.65 28.26 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.506 0.67 . . . . 0.0 111.107 -179.339 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 1.2 mm-40 -85.53 79.88 9.25 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.643 178.39 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.629 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 37.6 m -65.63 126.73 29.3 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.213 -178.847 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 10' ' ' SER . 30.8 ttm180 -65.47 124.07 21.31 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.311 178.535 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.555 ' HD3' ' O ' ' A' ' 161' ' ' ASN . 18.4 ttp180 -105.08 151.2 24.28 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.524 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.9 2.61 0.56 Allowed Glycine 0 C--N 1.334 0.432 0 CA-C-N 114.525 -1.216 . . . . 0.0 113.944 -178.314 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.42 ' H ' ' C ' ' A' ' 27' ' ' ARG . 33.1 t70 -84.73 -9.25 58.39 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.454 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.5 10.64 57.89 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -133.9 162.99 24.53 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.155 -1.021 . . . . 0.0 112.867 -179.666 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.469 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 71.2 m-85 -88.71 146.39 25.07 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.525 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.4 t -127.83 126.13 41.09 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.569 178.742 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.6 m -67.26 117.24 9.01 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.768 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 41.6 t -124.32 151.95 43.68 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.179 -179.403 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.689 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.4 p -144.31 134.92 20.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.904 0.383 . . . . 0.0 111.196 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.472 HG23 ' HB3' ' A' ' 21' ' ' LEU . 11.2 tt -135.62 152.94 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.878 -178.372 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.414 ' OD2' ' HB3' ' A' ' 40' ' ' ASN . 19.3 t70 -82.81 112.77 19.94 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.647 0.26 . . . . 0.0 110.451 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.492 HD23 ' HB3' ' A' ' 21' ' ' LEU . 2.7 mm? -92.81 0.89 57.49 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.356 0.598 . . . . 0.0 109.562 178.075 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.524 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 11.1 t30 -76.17 -19.57 58.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.202 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' A' ' 41' ' ' ARG . 4.7 ptp180 -97.89 6.14 48.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.329 178.652 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.55 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 33.3 m-85 -129.25 -27.7 2.42 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.554 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.82 HD22 HD13 ' A' ' 151' ' ' ILE . 53.3 mt -105.96 137.94 42.99 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.134 0.492 . . . . 0.0 110.807 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m -131.78 143.59 50.33 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.414 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.553 ' CG ' ' HB3' ' A' ' 140' ' ' LEU . 7.9 t30 -90.47 110.92 22.02 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.481 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.461 ' CB ' ' HD3' ' A' ' 51' ' ' ARG . 35.4 t70 -115.61 92.72 4.0 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.238 179.663 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 65.1 t30 57.99 45.23 18.37 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.099 179.682 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.765 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 73.6 38.25 51.46 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.304 -0.951 . . . . 0.0 112.009 179.107 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.625 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 23.8 t60 -151.12 121.43 7.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.768 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 38.1 m-85 -65.6 139.49 58.44 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.142 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.461 ' HD3' ' CB ' ' A' ' 46' ' ' ASP . 78.1 mtp180 -147.17 133.3 19.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.708 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.55 ' HA ' ' O ' ' A' ' 42' ' ' TYR . 98.3 m95 -75.22 133.04 41.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.037 178.13 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.484 HG22 ' H ' ' A' ' 55' ' ' GLY . 7.5 p -98.84 129.14 49.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.057 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.4 p -81.32 -18.5 45.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.414 -178.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.484 ' H ' HG22 ' A' ' 53' ' ' VAL . . . -137.08 -80.08 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.725 -179.418 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.471 ' HA2' ' HB1' ' A' ' 117' ' ' ALA . . . 171.46 169.66 34.61 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.9 -179.652 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.1 -149.15 14.82 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.449 -0.661 . . . . 0.0 111.449 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.66 -85.71 0.61 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.02 179.639 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.43 -71.19 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.058 -0.592 . . . . 0.0 111.967 179.438 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.3 -73.99 0.31 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.14 -117.72 4.75 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.005 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 88.8 m -135.54 114.58 12.2 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.865 0.364 . . . . 0.0 110.085 179.416 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.477 ' HB1' ' HG2' ' A' ' 110' ' ' LYS . . . -117.84 177.09 4.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.19 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.536 HG22 ' HG2' ' A' ' 106' ' ' GLN . 12.3 p -128.58 119.47 24.84 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.678 0.275 . . . . 0.0 111.711 -179.354 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.468 HG21 ' CE2' ' A' ' 80' ' ' PHE . 8.3 p -105.89 141.52 21.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 120.793 0.33 . . . . 0.0 111.086 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.2 m -89.75 128.41 36.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.424 0.63 . . . . 0.0 109.996 179.109 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.597 ' CG2' HD12 ' A' ' 99' ' ' ILE . 48.8 t -79.71 138.22 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.072 -179.387 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -108.55 171.26 7.52 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 124.06 0.85 . . . . 0.0 111.09 -179.525 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.646 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 36.5 tt0 -54.28 114.31 1.59 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.539 -178.536 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.4 2.69 63.53 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 121.151 -0.547 . . . . 0.0 113.793 178.319 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -91.28 143.82 26.25 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 117.163 0.482 . . . . 0.0 111.537 -179.405 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.774 ' HA ' HG12 ' A' ' 99' ' ' ILE . 35.0 p -130.69 169.13 16.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.274 178.845 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.669 HD22 HG23 ' A' ' 99' ' ' ILE . 1.0 OUTLIER -49.77 -43.38 48.15 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.202 0.455 . . . . 0.0 111.512 -179.516 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -65.06 -35.88 82.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.542 -177.585 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -74.07 -37.71 64.14 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.577 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 72' ' ' THR . 45.0 mm -67.86 -47.9 77.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.367 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.719 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -58.13 -48.25 84.22 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.751 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -34.56 78.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.785 0.326 . . . . 0.0 111.341 -179.186 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -71.37 -47.54 55.7 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.604 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.468 ' CE2' HG21 ' A' ' 65' ' ' VAL . 86.2 m-85 -100.5 19.85 16.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -177.217 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 53.38 45.49 28.27 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.233 0.54 . . . . 0.0 112.012 178.805 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.719 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.2 p -126.14 168.0 14.63 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.315 179.497 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.65 ' O ' HG13 ' A' ' 87' ' ' ILE . 9.2 t70 -93.33 123.46 36.63 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 121.846 -0.534 . . . . 0.0 109.647 179.176 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.545 ' HD2' ' HB2' ' A' ' 95' ' ' ASN . 2.5 p90 -52.0 -27.07 12.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.011 179.735 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.93 -37.65 54.92 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.062 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.683 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 3.8 tp10 -64.86 -47.78 76.66 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.893 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.65 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.2 mt -53.86 -45.77 63.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.853 178.63 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.574 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.36 -52.07 65.07 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.91 178.511 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.1 mtt-85 -61.22 -30.18 70.27 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.722 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.683 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 32.8 mmt180 -72.73 -31.81 65.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.096 0.474 . . . . 0.0 110.395 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 21.1 t-20 -93.61 -6.02 47.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.754 179.349 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 92.0 m-20 79.04 17.12 0.93 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.092 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.574 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 16.1 pt -107.22 -173.03 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.843 178.509 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.536 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 3.5 mm100 -112.61 161.4 16.85 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.433 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.545 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 16.4 p-10 -62.36 -52.41 63.76 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.581 1.182 . . . . 0.0 108.394 179.473 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 96' ' ' GLU . 35.2 tt0 -73.64 4.74 4.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 113.867 -1.515 . . . . 0.0 110.822 179.814 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 0.9 OUTLIER -64.76 -37.45 87.64 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.625 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.41 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 7.9 mp 70.24 116.42 0.04 OUTLIER 'General case' 0 C--O 1.231 0.12 0 O-C-N 124.12 0.888 . . . . 0.0 109.716 -177.682 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.81 HG21 HD11 ' A' ' 105' ' ' LEU . 8.0 pt -93.95 175.72 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.881 -177.617 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.527 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 14.2 m-85 -126.04 158.85 64.69 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.921 -178.585 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.646 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 28.8 Cg_endo -64.98 136.07 46.86 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.298 2.665 . . . . 0.0 113.212 -179.747 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.7 15.58 56.38 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.467 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -103.8 153.68 20.45 Favored 'General case' 0 C--O 1.209 -1.036 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.386 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.502 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 62.0 t -116.12 119.55 62.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 O-C-N 121.75 -0.594 . . . . 0.0 110.567 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.81 HD11 HG21 ' A' ' 99' ' ' ILE . 77.5 mt -113.49 152.09 30.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.572 -179.229 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.656 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 71.2 mt-30 -90.78 122.4 33.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.546 0.688 . . . . 0.0 110.729 179.644 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.7 m -129.98 151.18 77.83 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.585 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.23 -20.45 70.74 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 123.734 2.956 . . . . 0.0 114.793 -177.21 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.7 t -147.79 152.56 37.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.924 0.392 . . . . 0.0 110.725 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.864 ' HB3' ' HA3' ' A' ' 114' ' ' GLY . 11.3 mmmm -98.56 164.64 12.18 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.194 0.521 . . . . 0.0 111.131 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -151.02 152.46 24.27 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.272 179.564 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.82 -101.5 0.72 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.088 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 21.8 m -77.69 1.93 18.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.902 0.382 . . . . 0.0 110.843 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.864 ' HA3' ' HB3' ' A' ' 110' ' ' LYS . . . -97.42 -88.35 1.86 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.844 179.448 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 109.78 -153.27 17.01 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.097 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 111.43 59.68 0.47 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.722 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.471 ' HB1' ' HA2' ' A' ' 56' ' ' GLY . . . -117.32 -41.38 2.98 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.02 0.438 . . . . 0.0 110.539 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . -99.7 -58.24 0.9 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.619 179.703 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.448 ' HA ' ' OD1' ' A' ' 40' ' ' ASN . 17.9 m120 69.43 31.64 3.73 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 123.019 0.528 . . . . 0.0 112.176 178.156 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.637 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 24.5 p90 -60.07 -34.95 74.13 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.527 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.507 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 20.7 t-105 -63.44 -33.16 74.96 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.821 -178.917 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.27 -23.62 49.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.981 0.42 . . . . 0.0 110.929 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.0 p -133.19 24.35 4.17 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.052 179.812 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.507 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -108.99 146.43 33.9 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.02 0.438 . . . . 0.0 111.5 179.026 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -146.41 146.01 30.45 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 61.26 26.22 16.1 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.73 0.776 . . . . 0.0 110.53 -179.433 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.574 ' HB ' ' CB ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -75.81 125.48 35.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.833 -179.93 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -150.06 155.67 40.29 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.654 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.972 HD13 HG22 ' A' ' 14' ' ' ILE . 30.5 mt -86.54 131.41 34.18 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.966 0.412 . . . . 0.0 110.102 179.573 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.442 HG23 ' HB ' ' A' ' 135' ' ' VAL . 33.3 m -125.79 158.59 34.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.918 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.559 ' HB3' ' HD2' ' A' ' 134' ' ' LYS . 3.7 m-20 68.84 7.34 6.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.448 178.486 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.665 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 96.32 32.9 6.45 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.561 178.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 87.56 -15.81 52.77 Favored Glycine 0 C--O 1.266 2.151 0 CA-C-O 123.579 1.655 . . . . 0.0 112.833 177.361 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.84 ' HG3' HG23 ' A' ' 135' ' ' VAL . 18.2 ptpt -67.41 -24.23 65.63 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.233 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.84 HG23 ' HG3' ' A' ' 134' ' ' LYS . 26.1 t -136.36 137.13 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 121.43 0.633 . . . . 0.0 110.806 178.811 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.6 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 36.0 tp -112.26 114.83 27.82 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.366 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -104.47 125.99 51.16 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.357 -177.317 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.614 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . . . -154.38 161.75 41.55 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.158 0.504 . . . . 0.0 111.256 -179.264 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -103.28 106.37 16.87 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 177.448 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.765 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 38.6 mt -94.07 135.37 35.5 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.722 -178.146 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 145' ' ' GLY . 70.3 ttt180 -69.84 140.96 53.32 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.355 179.656 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.599 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.0 OUTLIER -157.92 -167.81 2.34 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.849 -0.341 . . . . 0.0 111.549 -179.165 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.7 m -56.02 -26.91 50.83 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.053 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -106.35 27.35 17.26 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.13 -1.033 . . . . 0.0 113.238 -178.98 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 141' ' ' ARG . . . 95.1 -106.35 3.39 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.101 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -127.81 129.95 47.84 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.599 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 56.4 t30 -123.6 137.29 54.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.047 0.451 . . . . 0.0 111.517 -179.114 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 39.8 ttt180 -76.31 105.88 7.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.925 178.838 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.625 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 10.2 t -121.47 165.44 15.62 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -146.4 158.12 43.85 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.125 -179.558 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.82 HD13 HD22 ' A' ' 43' ' ' LEU . 9.8 tt -141.89 145.55 24.02 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.37 179.193 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.66 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 23.3 m-85 -86.86 104.8 16.55 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 121.069 -0.253 . . . . 0.0 111.088 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.694 HD13 HD22 ' A' ' 21' ' ' LEU . 16.4 mt -67.68 -31.97 72.3 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.242 178.295 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.785 ' OD1' ' HA ' ' A' ' 2' ' ' ASN . 2.1 p30 -55.0 -17.33 3.64 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.129 177.934 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.747 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 35.1 mt-10 -63.18 -53.08 58.84 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.222 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.586 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 58.1 m80 -123.3 5.01 9.12 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.728 -177.567 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.431 HG21 HD21 ' A' ' 21' ' ' LEU . 48.3 mm -105.69 110.34 30.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.693 178.794 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.569 ' HA3' ' O ' ' A' ' 167' ' ' CYS . . . -115.97 172.84 14.41 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.632 178.445 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.629 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.2 OUTLIER -112.26 130.03 56.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.984 0.421 . . . . 0.0 110.983 179.893 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -125.41 94.01 4.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.327 179.098 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.555 ' O ' ' HD3' ' A' ' 27' ' ' ARG . 2.3 m-20 62.88 39.68 10.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.678 178.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.525 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 88.36 13.45 63.57 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.902 179.196 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -122.97 135.85 54.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.759 0.314 . . . . 0.0 111.299 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.499 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 37.4 mt -82.16 121.39 26.55 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.107 178.833 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 12.6 tt -149.89 155.58 7.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.197 -179.463 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.586 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 1.5 p-80 -56.85 117.15 3.66 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.522 0.201 . . . . 0.0 110.519 179.503 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.569 ' O ' ' HA3' ' A' ' 158' ' ' GLY . 41.5 t . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.609 -0.71 . . . . 0.0 111.635 -179.672 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.593 0 N-CA-C 111.731 -0.547 . . . . 0.0 111.731 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.446 ' HB2' ' HA ' ' A' ' 6' ' ' ASN . 20.1 m120 -125.41 -153.29 0.55 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.986 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 38.0 m-85 -91.61 -89.37 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.193 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.63 -33.55 4.82 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.341 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -70.63 -62.47 3.62 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 119.763 -1.208 . . . . 0.0 112.694 -179.035 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.446 ' HA ' ' HB2' ' A' ' 2' ' ' ASN . 37.7 m-80 65.48 16.52 10.56 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 122.532 0.333 . . . . 0.0 111.041 -179.498 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.732 ' HD2' HD11 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -63.74 -34.95 79.02 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.732 -179.277 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.43 ' HA ' HD11 ' A' ' 14' ' ' ILE . 16.6 p -63.79 -18.83 64.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.139 0.495 . . . . 0.0 110.988 -179.494 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.92 -26.29 69.41 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 115.682 -0.69 . . . . 0.0 113.341 179.226 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.568 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 33.5 p -127.12 -20.33 4.17 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 117.583 0.691 . . . . 0.0 111.819 -179.224 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.6 t -96.62 131.3 43.41 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -112.54 -176.99 3.04 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.451 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 16.6 m-20 43.62 45.55 5.81 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 123.971 0.794 . . . . 0.0 111.874 -179.802 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 1.08 HG22 HD13 ' A' ' 129' ' ' LEU . 7.6 mt -78.32 102.66 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-O 120.904 0.383 . . . . 0.0 110.075 -178.789 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.647 ' CA ' HD12 ' A' ' 129' ' ' LEU . 56.9 m -144.73 128.43 17.21 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.168 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.767 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -97.44 157.81 15.8 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.941 0.877 . . . . 0.0 112.956 -179.24 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -99.45 74.87 1.93 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 113.994 -1.457 . . . . 0.0 107.779 177.457 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.52 -53.22 4.66 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.137 179.38 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.541 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -149.07 -13.57 0.31 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 120.951 0.405 . . . . 0.0 110.147 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -85.86 92.92 8.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.604 179.067 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.013 HD12 HD11 ' A' ' 129' ' ' LEU . 9.5 tp -62.91 114.81 3.88 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.713 -179.786 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' A' ' 35' ' ' SER . 43.7 ttp180 -119.62 133.94 55.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.612 -178.265 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.628 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -152.78 148.13 26.86 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.402 179.791 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.51 ' O ' ' HD1' ' A' ' 32' ' ' TYR . 1.8 mm-40 -83.82 79.73 9.38 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.814 179.148 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.668 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 67.2 m -61.45 121.68 13.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.013 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.568 ' HB2' ' O ' ' A' ' 10' ' ' SER . 36.4 ttt-85 -70.64 122.21 19.34 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.273 178.532 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.7 ttt-85 -93.53 154.59 17.8 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.272 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.03 -15.0 6.23 Favored Glycine 0 C--N 1.335 0.509 0 O-C-N 124.36 1.037 . . . . 0.0 114.164 -178.251 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -79.27 -3.48 46.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.198 0.523 . . . . 0.0 109.788 178.848 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.46 9.51 72.32 Favored Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.97 144.31 17.31 Favored Glycine 0 C--O 1.227 -0.343 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.998 -179.067 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.51 ' HD1' ' O ' ' A' ' 24' ' ' GLU . 74.3 m-85 -90.46 125.69 35.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.788 0.328 . . . . 0.0 110.277 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.7 m -115.75 130.5 56.87 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.638 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.7 m -65.63 124.32 22.06 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.8 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 42.5 t -129.31 147.07 51.11 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.139 179.331 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.59 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 7.7 p -144.66 137.8 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.705 0.288 . . . . 0.0 110.967 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.534 HG22 HD23 ' A' ' 164' ' ' LEU . 8.5 tt -135.32 147.42 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.605 -178.357 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -76.38 99.77 4.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.723 0.297 . . . . 0.0 111.338 179.277 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.822 HD12 ' HG ' ' A' ' 43' ' ' LEU . 1.2 mm? -82.83 -4.41 58.02 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.102 0.477 . . . . 0.0 111.089 179.887 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.541 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 7.0 p30 -69.87 -10.68 59.39 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.369 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.479 ' O ' ' HB3' ' A' ' 117' ' ' ALA . 57.9 mtt85 -102.54 6.06 39.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.829 179.17 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.494 ' HB2' HD13 ' A' ' 39' ' ' LEU . 7.1 m-85 -134.18 -24.75 1.61 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.569 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.822 ' HG ' HD12 ' A' ' 39' ' ' LEU . 61.7 mt -105.83 128.74 53.93 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.752 0.31 . . . . 0.0 110.522 179.433 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.66 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 1.0 OUTLIER -125.1 135.95 53.18 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.487 -179.845 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.841 ' HB3' ' HG ' ' A' ' 140' ' ' LEU . 18.8 p-10 -79.26 92.45 5.12 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.359 0.6 . . . . 0.0 110.033 178.336 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -86.82 86.85 7.35 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.307 0.575 . . . . 0.0 110.333 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.486 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 64.5 t30 50.22 44.62 26.24 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.253 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.71 34.82 10.87 Favored Glycine 0 C--O 1.221 -0.657 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.725 178.368 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -150.68 131.56 14.19 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.429 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.724 ' HB3' ' HB ' ' A' ' 151' ' ' ILE . 21.3 m-85 -72.21 140.0 48.47 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.559 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.426 ' HD3' ' HA ' ' A' ' 51' ' ' ARG . 10.5 mmt180 -143.88 134.15 24.47 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.087 -179.448 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.626 ' HH2' HD13 ' A' ' 153' ' ' LEU . 96.5 m95 -75.33 104.61 5.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.258 177.53 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.3 t 68.01 -61.78 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.042 0.839 . . . . 0.0 112.42 179.053 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.401 ' HB3' ' HB3' ' A' ' 51' ' ' ARG . 66.8 p 49.06 62.07 2.8 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.899 0.857 . . . . 0.0 110.402 -178.627 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.538 ' O ' ' HA3' ' A' ' 59' ' ' GLY . . . 91.29 -48.34 2.91 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.702 -178.856 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.28 26.66 11.87 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.399 179.784 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.42 56.2 3.47 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.161 179.544 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.77 17.96 19.61 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.524 179.694 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 55' ' ' GLY . . . -83.35 125.52 7.06 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.099 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.63 165.61 14.17 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -179.354 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 108' ' ' PRO . . . 118.96 -122.2 5.26 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.046 -179.475 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 37.7 m -134.94 117.53 15.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.193 0.521 . . . . 0.0 111.671 -179.595 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.64 176.62 8.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.009 179.085 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.514 HG22 ' HG2' ' A' ' 106' ' ' GLN . 7.8 p -129.59 122.16 28.55 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.208 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.545 HG21 ' CE2' ' A' ' 80' ' ' PHE . 8.2 p -113.02 147.44 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 120.751 0.31 . . . . 0.0 111.072 179.26 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 4.9 m -90.52 129.95 36.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.099 0.476 . . . . 0.0 110.284 179.101 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.483 ' CG2' HD12 ' A' ' 99' ' ' ILE . 54.0 t -78.78 133.48 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.485 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -104.17 169.34 8.55 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.333 1.021 . . . . 0.0 110.486 -179.496 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.629 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 63.4 tt0 -68.13 120.16 13.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.292 -178.945 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.33 9.36 55.5 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.856 179.332 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -116.88 128.35 55.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.964 0.412 . . . . 0.0 111.494 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.584 ' HA ' HG12 ' A' ' 99' ' ' ILE . 67.8 p -106.68 -179.2 3.87 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.329 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.64 HD22 HG23 ' A' ' 99' ' ' ILE . 1.4 mm? -52.21 -43.1 64.07 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.823 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.406 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 3.4 tmt_? -59.38 -41.64 89.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.366 -179.292 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -73.12 -38.2 66.4 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.595 -178.345 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.532 HG12 ' O ' ' A' ' 72' ' ' THR . 45.8 mm -63.83 -48.89 84.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.542 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.741 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -59.23 -47.24 91.8 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.391 179.206 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -25.49 64.78 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.796 0.332 . . . . 0.0 111.838 -178.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 48.9 ttm-85 -82.51 -34.51 27.92 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.116 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.545 ' CE2' HG21 ' A' ' 65' ' ' VAL . 95.0 m-85 -110.83 20.26 17.74 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.321 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.9 t70 55.06 42.1 31.18 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.62 0.724 . . . . 0.0 111.711 178.472 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.741 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -125.26 170.98 10.75 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.348 179.255 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.574 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.4 t70 -98.39 123.15 42.35 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.87 179.366 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.52 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 5.9 p90 -50.97 -30.37 14.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.99 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -67.24 -43.73 81.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.229 179.525 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.688 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 26.3 mt-10 -64.9 -48.27 74.8 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.355 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.574 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.1 mt -49.59 -50.21 17.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.458 179.196 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.604 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.63 -50.74 68.15 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.295 178.681 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -56.56 -37.63 70.8 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.688 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 75.3 mtt180 -73.91 -29.48 62.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.841 0.353 . . . . 0.0 111.03 -179.407 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 15.1 t-20 -93.19 -5.16 50.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.031 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 93.4 m-20 79.23 12.46 1.27 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.586 0.754 . . . . 0.0 111.497 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.604 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 14.8 pt -102.8 179.43 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.445 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.565 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 2.6 mp0 -105.96 155.94 18.87 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.667 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.468 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.3 p-10 -56.82 -56.09 26.07 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.226 1.012 . . . . 0.0 108.82 179.21 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -77.95 12.03 1.96 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.438 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.565 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.9 t70 -65.34 -34.9 79.41 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.469 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.413 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 8.2 mp 70.78 115.3 0.05 OUTLIER 'General case' 0 C--O 1.233 0.215 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.107 -178.117 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.778 HG21 HD11 ' A' ' 105' ' ' LEU . 7.5 pt -95.29 178.66 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.538 -178.526 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.554 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 61.8 m-85 -130.53 158.34 74.89 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.478 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.629 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 22.9 Cg_endo -64.95 139.21 60.73 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 123.323 2.682 . . . . 0.0 114.402 -178.414 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.39 20.22 33.07 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.014 178.085 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.552 ' O ' ' HA ' ' A' ' 66' ' ' THR . 28.4 mt-30 -109.59 168.21 9.57 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.413 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 77.8 t -126.36 112.06 28.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.047 0.451 . . . . 0.0 110.042 179.1 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.778 HD11 HG21 ' A' ' 99' ' ' ILE . 87.2 mt -107.23 151.42 25.46 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.581 -179.645 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.514 ' HG2' HG22 ' A' ' 64' ' ' THR . 37.4 mt-30 -91.06 112.38 24.26 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.741 0.781 . . . . 0.0 111.387 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.7 m -115.78 152.0 46.92 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.459 179.701 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 37.8 Cg_endo -65.37 -21.94 60.43 Favored 'Trans proline' 0 C--N 1.332 -0.315 0 C-N-CA 122.909 2.406 . . . . 0.0 114.409 -177.981 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.9 t -148.66 151.25 34.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.86 0.362 . . . . 0.0 110.987 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.431 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 12.0 mmmm -95.57 169.08 10.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.053 178.692 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -101.96 64.94 0.46 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.76 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 166.34 139.98 2.78 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.935 179.669 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.6 p -139.89 -72.64 0.37 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.718 0.294 . . . . 0.0 110.633 -179.886 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 149.61 -73.07 0.29 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.067 179.69 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.36 142.74 9.92 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.128 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.95 62.11 2.16 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.54 179.788 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 41' ' ' ARG . . . -109.06 -30.64 7.96 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.234 0.54 . . . . 0.0 109.841 179.326 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.66 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -110.22 -69.64 0.61 Allowed Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.723 179.622 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 20.9 m120 70.7 27.03 3.75 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 122.998 0.519 . . . . 0.0 112.118 178.595 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.623 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 17.2 p90 -60.07 -39.47 86.17 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.658 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.55 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 38.9 t-105 -61.75 -29.88 70.42 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.208 -178.267 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -55.96 -28.31 56.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.665 0.269 . . . . 0.0 110.803 -179.746 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.7 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 3.9 m -135.25 28.74 3.39 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.855 0.36 . . . . 0.0 110.48 178.497 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.55 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -110.61 144.34 39.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.766 0.317 . . . . 0.0 110.706 178.873 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -136.64 149.72 48.13 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.137 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 59.34 45.23 14.2 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.693 0.62 . . . . 0.0 111.139 179.343 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.475 ' CG1' HD11 ' A' ' 136' ' ' LEU . 21.4 t -74.84 121.37 26.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.194 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -145.17 140.65 28.1 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.036 -179.375 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 1.08 HD13 HG22 ' A' ' 14' ' ' ILE . 54.1 mt -86.76 127.11 34.98 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.038 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.535 HG23 ' HB ' ' A' ' 135' ' ' VAL . 34.6 m -119.95 163.17 17.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.854 -178.701 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 66.27 9.23 6.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.474 178.654 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.687 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 94.69 31.83 7.59 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.116 179.487 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.706 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 86.8 -13.92 57.7 Favored Glycine 0 C--O 1.256 1.521 0 CA-C-O 123.274 1.485 . . . . 0.0 112.812 177.548 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.607 ' HG3' HG23 ' A' ' 135' ' ' VAL . 19.0 ptpt -72.86 -14.22 61.45 Favored 'General case' 0 C--N 1.311 -1.098 0 O-C-N 121.592 -0.946 . . . . 0.0 108.76 178.155 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.607 HG23 ' HG3' ' A' ' 134' ' ' LYS . 22.7 t -141.68 138.73 31.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.638 177.478 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.58 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 27.8 tp -119.99 125.39 48.26 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.527 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.527 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 28.3 tt0 -114.98 132.52 56.56 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 123.504 0.503 . . . . 0.0 110.948 -177.869 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . . . -161.39 158.52 26.96 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.247 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 30.5 mt-10 -94.88 106.82 18.83 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.773 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.841 ' HG ' ' HB3' ' A' ' 45' ' ' ASN . 0.4 OUTLIER -89.54 123.37 33.57 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.435 -179.877 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.7 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 36.6 ttt180 -69.29 140.81 54.42 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.606 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 2.5 p90 -155.53 -170.39 3.43 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.429 -179.008 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 3.1 m -56.96 -27.94 61.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.106 0.479 . . . . 0.0 112.0 -179.36 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.29 17.2 58.21 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.598 -0.811 . . . . 0.0 113.19 -179.312 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 103.41 -107.9 3.13 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.031 179.768 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -129.6 127.69 41.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.785 0.292 . . . . 0.0 110.639 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.606 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 52.0 t-20 -120.88 117.18 26.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.76 0.314 . . . . 0.0 110.534 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 31.6 ttm180 -74.99 94.74 2.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.886 178.916 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.3 m -111.54 174.02 6.07 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.403 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.58 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 44.6 mtt85 -142.37 165.68 26.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.058 0.456 . . . . 0.0 112.003 -177.611 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.724 ' HB ' ' HB3' ' A' ' 50' ' ' PHE . 14.3 tt -145.44 161.98 12.38 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.372 179.169 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.599 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 12.1 m-85 -104.43 104.27 14.12 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 122.144 -0.347 . . . . 0.0 111.72 -178.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.708 HD11 ' HG ' ' A' ' 39' ' ' LEU . 4.1 mm? -65.65 -36.43 83.67 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.328 179.071 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.472 ' HB3' ' HA ' ' A' ' 134' ' ' LYS . 6.0 p-10 -57.34 -11.96 2.17 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.18 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.986 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 36.1 mt-10 -67.76 -54.89 15.65 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.416 ' HA ' ' OXT' ' A' ' 167' ' ' CYS . 90.4 m-70 -121.33 3.6 10.29 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.041 -0.664 . . . . 0.0 112.467 -177.37 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.639 HG13 HD12 ' A' ' 153' ' ' LEU . 45.9 mm -104.26 114.16 43.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 C-N-CA 120.181 -0.607 . . . . 0.0 110.585 179.023 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.407 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -115.14 175.79 16.21 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.928 -0.654 . . . . 0.0 113.159 179.52 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.668 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.0 t30 -117.4 129.05 55.6 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.5 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.671 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 40.8 ttm180 -124.67 88.32 2.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.712 179.674 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 51.95 46.15 27.07 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 178.636 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.9 -8.98 50.94 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.285 -0.96 . . . . 0.0 115.019 177.404 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.671 ' HG2' ' O ' ' A' ' 160' ' ' ARG . 12.9 pt-20 -114.18 146.6 40.13 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 117.901 0.851 . . . . 0.0 110.634 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.732 HD11 ' HD2' ' A' ' 7' ' ' PHE . 4.6 tp -91.15 106.92 18.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.675 -179.578 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.562 HD13 ' HB2' ' A' ' 160' ' ' ARG . 31.7 pt -100.84 173.43 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.366 0.603 . . . . 0.0 112.149 -178.474 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.414 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 15.2 p80 -126.75 129.8 49.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.991 -179.706 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.416 ' OXT' ' HA ' ' A' ' 156' ' ' HIS . 22.7 p . . . . . 0 C--O 1.247 0.923 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.436 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -94.1 -95.78 0.16 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.771 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 1.012 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 35.3 m-85 -139.21 -90.62 0.19 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.723 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -121.87 -31.32 3.96 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.021 178.888 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -78.55 -66.44 1.73 Allowed Glycine 0 N--CA 1.436 -1.352 0 C-N-CA 119.525 -1.322 . . . . 0.0 112.046 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 65.96 15.26 10.0 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.605 0.362 . . . . 0.0 111.018 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.741 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -58.31 -37.27 74.75 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -178.972 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.4 ' HA ' HD11 ' A' ' 14' ' ' ILE . 28.8 t -60.04 -18.25 45.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.379 0.609 . . . . 0.0 110.816 -179.649 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.52 -33.32 61.13 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.578 179.008 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.521 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 20.2 m -120.9 -17.98 7.72 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 117.683 0.741 . . . . 0.0 111.32 -179.461 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.415 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 15.6 m -97.99 131.46 44.4 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -114.19 -175.64 2.72 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.425 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 0.9 OUTLIER 46.03 42.37 9.43 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 123.76 0.663 . . . . 0.0 111.87 179.284 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.906 HG22 HD13 ' A' ' 129' ' ' LEU . 7.5 mt -78.82 105.48 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-O 121.18 0.514 . . . . 0.0 110.063 -178.868 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.57 ' CA ' HD12 ' A' ' 129' ' ' LEU . 65.3 m -147.72 128.6 14.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.887 179.433 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.761 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -97.97 159.87 14.66 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -178.711 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.431 ' HB2' ' HB2' ' A' ' 20' ' ' ARG . 24.1 m-20 -99.1 73.77 1.94 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.129 177.113 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.86 -59.46 4.72 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.742 179.645 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.649 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -147.8 10.96 0.95 Allowed 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.273 0.558 . . . . 0.0 110.274 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.431 ' HB2' ' HB2' ' A' ' 17' ' ' ASP . 72.1 mtm180 -110.05 91.24 3.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.86 179.428 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.97 ' HB2' HD22 ' A' ' 39' ' ' LEU . 44.3 tp -60.47 122.47 14.69 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.636 -178.646 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 48.7 ttp180 -127.51 132.17 49.98 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.345 -178.888 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.629 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -149.83 145.25 26.48 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.511 0.672 . . . . 0.0 110.74 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.528 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 3.8 mm-40 -80.54 68.51 6.77 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.671 178.283 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.7 ' SG ' HD13 ' A' ' 164' ' ' LEU . 57.5 m -57.28 124.47 18.95 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.018 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.521 ' HB2' ' O ' ' A' ' 10' ' ' SER . 42.6 ttt-85 -65.75 126.36 28.19 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.414 179.241 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 33.9 ptt180 -98.48 155.29 17.33 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.063 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.93 -11.95 4.89 Favored Glycine 0 C--N 1.338 0.689 0 O-C-N 124.513 1.133 . . . . 0.0 113.919 -179.024 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.01 -11.65 60.86 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.048 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.35 8.27 60.04 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.857 179.531 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.435 ' O ' ' HG2' ' A' ' 27' ' ' ARG . . . -123.7 178.07 16.5 Favored Glycine 0 C--O 1.225 -0.432 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.392 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.528 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 83.2 m-85 -101.58 140.99 35.11 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.912 0.387 . . . . 0.0 111.168 179.573 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 p -128.93 133.97 48.05 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.904 179.231 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 m -71.32 111.07 6.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.094 0.473 . . . . 0.0 111.608 -178.383 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 36.4 t -116.27 147.57 41.37 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.948 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 5.4 p -143.14 137.55 26.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 120.867 0.365 . . . . 0.0 111.152 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.6 tt -132.66 154.32 39.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.012 -177.511 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -81.15 95.12 6.79 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.97 HD22 ' HB2' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -76.1 -14.23 60.19 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.697 0.76 . . . . 0.0 109.461 178.355 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.649 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 5.2 p30 -66.62 -15.96 63.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.803 178.377 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.456 ' HD2' ' O ' ' A' ' 114' ' ' GLY . 56.6 mtm180 -114.24 31.03 6.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.1 179.071 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.428 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 24.4 m-85 -150.45 -30.97 0.2 Allowed 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.208 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.902 HD22 HD13 ' A' ' 151' ' ' ILE . 41.7 mt -105.94 127.5 53.19 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.775 0.321 . . . . 0.0 110.495 179.273 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.657 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 1.0 OUTLIER -123.91 137.78 54.58 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.452 179.984 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.813 ' HB3' ' HG ' ' A' ' 140' ' ' LEU . 19.4 p-10 -78.34 92.21 4.52 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.484 0.659 . . . . 0.0 110.831 178.59 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -87.5 86.71 7.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.072 0.463 . . . . 0.0 110.725 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 52.03 43.66 30.19 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.312 179.24 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.55 40.04 9.27 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.995 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -157.81 118.98 3.54 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.746 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.804 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 29.7 m-85 -62.44 140.88 58.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.28 -179.358 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.588 ' HB3' ' HA2' ' A' ' 55' ' ' GLY . 16.3 mmm180 -140.41 139.03 35.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.235 179.508 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.653 ' CZ2' ' HA ' ' A' ' 153' ' ' LEU . 86.2 m95 -76.86 153.1 35.12 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 t 64.64 -92.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 113.763 -1.562 . . . . 0.0 112.841 177.243 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.4 m -129.26 34.76 4.35 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.029 0.443 . . . . 0.0 110.362 -178.272 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.588 ' HA2' ' HB3' ' A' ' 51' ' ' ARG . . . 72.14 32.0 63.44 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.84 -179.695 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.28 128.73 44.62 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.899 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.32 28.36 15.11 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.795 -0.716 . . . . 0.0 111.917 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.51 -126.03 3.32 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -139.49 -60.25 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.137 179.545 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.54 176.38 16.11 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.898 -0.667 . . . . 0.0 111.77 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 108' ' ' PRO . . . -176.25 -115.63 0.43 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.067 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.3 m -129.59 116.78 19.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.176 0.512 . . . . 0.0 110.549 179.777 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -121.98 176.58 5.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.431 179.525 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.2 p -126.81 120.8 30.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.028 0.442 . . . . 0.0 112.151 -179.093 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.9 p -110.18 144.85 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.006 178.854 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 5.7 m -89.19 127.27 35.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.079 179.044 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.548 ' CG2' HD12 ' A' ' 99' ' ' ILE . 60.5 t -73.38 131.66 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.55 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -101.0 170.08 8.52 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 124.485 1.115 . . . . 0.0 111.136 -178.806 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.71 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 57.7 tp60 -58.76 118.56 5.84 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.682 -178.896 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.81 -5.36 85.04 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 121.106 -0.568 . . . . 0.0 113.705 177.836 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -90.36 127.56 36.22 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 117.084 0.442 . . . . 0.0 111.056 -179.662 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.69 ' HA ' HG12 ' A' ' 99' ' ' ILE . 68.9 p -107.93 -179.33 3.87 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.728 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.68 HD22 HG23 ' A' ' 99' ' ' ILE . 1.2 mm? -53.02 -42.73 65.96 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.538 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 74' ' ' ARG . 42.2 ttm180 -62.43 -35.33 78.93 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.145 -178.955 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -74.06 -46.7 41.47 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.585 179.626 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.528 HG12 ' O ' ' A' ' 72' ' ' THR . 43.8 mm -58.31 -48.4 85.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.209 -179.649 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.692 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -58.64 -55.55 30.17 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.112 179.464 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -33.95 75.98 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.047 0.451 . . . . 0.0 111.114 -178.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -73.5 -40.41 64.09 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.935 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -106.57 15.17 26.14 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -178.403 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.0 t70 60.33 49.89 6.64 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.589 0.709 . . . . 0.0 111.826 178.925 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.692 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.5 p -134.55 165.59 24.85 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.786 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.512 ' O ' HG13 ' A' ' 87' ' ' ILE . 3.9 p-10 -95.24 121.43 36.87 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.775 0.797 . . . . 0.0 109.689 178.67 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.561 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 5.9 p90 -48.11 -31.36 5.48 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.174 -1.375 . . . . 0.0 112.115 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.44 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 76.3 t60 -60.23 -50.28 74.27 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.963 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.497 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 7.9 tp10 -65.39 -45.65 83.18 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.107 179.712 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.567 ' HB ' HD12 ' A' ' 73' ' ' LEU . 4.3 mt -51.4 -46.16 34.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.725 0.774 . . . . 0.0 109.51 179.446 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.572 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.98 -50.75 69.54 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.719 178.611 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.421 HH21 ' CD ' ' A' ' 86' ' ' GLU . 52.2 ttp180 -59.2 -37.15 76.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.758 0.313 . . . . 0.0 111.794 -179.381 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.683 ' HB3' ' HB2' ' A' ' 106' ' ' GLN . 2.0 mmp_? -65.11 -32.32 73.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.928 0.394 . . . . 0.0 110.903 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 8.4 t-20 -96.09 -5.03 41.8 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.959 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 17.3 m120 77.36 18.3 1.4 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.355 0.662 . . . . 0.0 111.029 -179.228 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.572 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 10.6 pt -105.84 179.53 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.827 178.913 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.552 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 77.6 mm-40 -102.93 154.55 19.1 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.938 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.505 ' O ' HD23 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -55.7 -61.5 2.31 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-O 122.259 1.028 . . . . 0.0 109.696 179.036 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -78.49 12.48 1.98 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.582 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.552 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 4.3 t0 -61.89 -32.43 72.8 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.127 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.491 HD22 HG21 ' A' ' 72' ' ' THR . 41.2 mt 71.78 114.38 0.05 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.176 -178.899 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.69 HG12 ' HA ' ' A' ' 72' ' ' THR . 8.2 pt -95.2 175.54 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.354 -179.152 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.497 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 40.4 m-85 -124.71 157.44 65.88 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.21 -178.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.71 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 40.7 Cg_endo -67.85 138.71 45.42 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 123.122 2.548 . . . . 0.0 113.456 -178.526 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.76 13.59 43.24 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.374 179.159 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.516 ' O ' ' HA ' ' A' ' 66' ' ' THR . 44.1 mt-30 -100.44 168.69 9.59 Favored 'General case' 0 C--O 1.217 -0.658 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.297 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 89.5 t -128.53 109.16 18.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.7 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.657 HD11 HG21 ' A' ' 99' ' ' ILE . 82.0 mt -107.15 151.56 25.23 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.019 -178.827 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.683 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 39.6 mt-30 -89.89 116.44 27.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.598 0.713 . . . . 0.0 110.859 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.0 m -121.98 150.74 56.88 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 114.37 -1.287 . . . . 0.0 109.544 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 34.8 Cg_endo -64.99 -18.4 62.05 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 123.352 2.701 . . . . 0.0 114.29 -177.699 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.2 t -148.18 152.55 37.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.255 0.55 . . . . 0.0 111.139 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.586 ' HB3' ' O ' ' A' ' 116' ' ' GLY . 0.1 OUTLIER -94.02 -166.16 1.45 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.339 179.682 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -103.79 -115.6 4.1 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.532 -178.804 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.864 ' HA2' ' HB2' ' A' ' 117' ' ' ALA . . . 147.39 -17.89 1.5 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.349 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.4 m -67.44 -24.64 65.65 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.444 -0.378 . . . . 0.0 111.504 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.456 ' O ' ' HD2' ' A' ' 41' ' ' ARG . . . -145.45 -83.62 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.293 179.765 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -122.25 150.42 16.97 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.137 -0.554 . . . . 0.0 111.823 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.586 ' O ' ' HB3' ' A' ' 110' ' ' LYS . . . 78.49 67.5 1.61 Allowed Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.864 ' HB2' ' HA2' ' A' ' 112' ' ' GLY . . . -122.15 -47.57 2.14 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.125 0.488 . . . . 0.0 110.364 -179.755 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.657 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -96.96 -74.36 1.19 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.211 -179.566 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.3 m120 70.9 21.13 5.16 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 178.741 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.626 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 21.6 p90 -58.02 -37.5 74.44 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.045 0.45 . . . . 0.0 109.941 178.883 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.511 ' HB2' ' HB2' ' A' ' 19' ' ' ALA . 58.3 t-105 -59.93 -32.21 70.57 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.144 -178.495 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.9 -28.31 56.14 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.946 0.403 . . . . 0.0 110.392 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.951 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 69.7 m -133.26 30.12 3.93 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.921 179.135 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.491 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -115.88 136.48 53.0 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.981 0.42 . . . . 0.0 111.731 178.845 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -129.32 151.35 50.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.963 178.877 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 40.8 t0 56.22 51.36 11.83 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.742 0.782 . . . . 0.0 110.575 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.483 HG22 ' HB1' ' A' ' 138' ' ' ALA . 21.9 t -83.98 127.15 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.588 -179.644 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 25.0 ptt-85 -154.38 146.88 24.04 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.95 0.405 . . . . 0.0 110.358 179.164 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.906 HD13 HG22 ' A' ' 14' ' ' ILE . 19.5 mt -86.17 130.67 34.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.83 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.717 HG23 ' HB ' ' A' ' 135' ' ' VAL . 28.0 m -123.88 156.95 30.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.003 -178.998 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.482 ' HB3' ' CG ' ' A' ' 134' ' ' LYS . 0.7 OUTLIER 65.65 16.87 10.7 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.043 179.145 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.698 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 88.31 30.79 15.43 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.625 178.119 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.521 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 89.75 -14.44 61.63 Favored Glycine 0 C--O 1.26 1.735 0 CA-C-O 123.442 1.579 . . . . 0.0 113.031 177.112 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.786 ' HG3' HG23 ' A' ' 135' ' ' VAL . 21.5 ptmt -69.85 -17.35 63.37 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 121.334 -1.098 . . . . 0.0 108.384 178.396 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.786 HG23 ' HG3' ' A' ' 134' ' ' LYS . 3.9 t -140.17 144.72 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.083 177.79 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 28.3 tp -126.14 121.91 34.2 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.749 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.497 ' HG3' ' HG3' ' A' ' 150' ' ' ARG . 30.9 tt0 -112.58 133.34 54.68 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.883 0.373 . . . . 0.0 111.285 -177.88 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.537 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -161.86 163.8 29.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.62 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 124' ' ' ALA . 46.7 mt-10 -96.33 105.79 17.92 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 178.739 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.813 ' HG ' ' HB3' ' A' ' 45' ' ' ASN . 1.6 mp -89.85 125.2 35.24 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.927 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.951 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 74.7 ttt180 -70.87 140.86 51.21 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.047 178.669 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -155.59 -175.84 5.64 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.186 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 6.0 m -56.89 -31.46 64.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.759 0.314 . . . . 0.0 111.485 -179.256 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -88.33 7.65 81.0 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.766 -179.032 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 109.7 -121.83 6.2 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.127 179.733 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -122.86 125.1 44.74 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.629 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -123.3 140.39 53.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.874 0.368 . . . . 0.0 111.549 -179.092 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -72.55 102.37 3.23 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.824 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.473 ' HB2' HD22 ' A' ' 140' ' ' LEU . 1.4 m -113.07 156.34 23.3 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.351 -178.052 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -145.53 153.85 41.55 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.961 0.41 . . . . 0.0 111.065 179.84 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.902 HD13 HD22 ' A' ' 43' ' ' LEU . 9.4 tt -136.24 152.06 29.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.971 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.606 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 92.4 m-85 -97.11 104.49 16.51 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.419 0.152 . . . . 0.0 110.701 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.762 HD11 HD21 ' A' ' 129' ' ' LEU . 22.5 mt -68.74 -33.46 73.95 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.331 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.534 ' HB3' ' HA ' ' A' ' 134' ' ' LYS . 10.2 p-10 -56.84 -13.19 2.38 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.713 178.119 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 1.012 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 37.8 mt-10 -70.0 -55.42 9.62 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.431 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 88.0 m-70 -122.98 11.32 9.56 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.72 -0.792 . . . . 0.0 113.048 -176.232 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.54 HG12 ' CH2' ' A' ' 52' ' ' TRP . 38.0 mm -112.94 111.94 38.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.421 178.196 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.614 ' HA3' ' OXT' ' A' ' 167' ' ' CYS . . . -115.05 175.62 16.11 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.191 179.093 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.545 ' CG ' ' HB3' ' A' ' 25' ' ' CYS . 3.3 t30 -115.11 129.51 56.7 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 122.651 0.38 . . . . 0.0 110.278 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 41.0 ttt85 -125.94 97.75 5.24 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.258 179.434 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 61.83 32.39 18.09 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.149 179.24 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 93.68 12.31 57.03 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.495 -0.86 . . . . 0.0 113.093 179.287 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -122.48 134.21 54.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.069 0.462 . . . . 0.0 110.814 179.628 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.741 HD11 ' CD2' ' A' ' 7' ' ' PHE . 4.4 tp -78.24 118.73 20.74 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.983 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 10.3 tp -144.78 151.92 15.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.356 -178.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.431 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 29.7 p-80 -59.81 125.6 24.28 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.521 -0.177 . . . . 0.0 110.521 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.614 ' OXT' ' HA3' ' A' ' 158' ' ' GLY . 44.7 t . . . . . 0 C--O 1.253 1.256 0 O-C-N 123.922 0.764 . . . . 0.0 111.273 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.508 ' HA3' ' OD1' ' A' ' 6' ' ' ASN . . . . . . . . 0 N--CA 1.48 1.612 0 N-CA-C 112.08 -0.408 . . . . 0.0 112.08 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.443 ' OD1' ' HB3' ' A' ' 152' ' ' TYR . 0.9 OUTLIER -88.43 -71.06 0.6 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 122.155 0.182 . . . . 0.0 111.472 -179.849 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.466 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 34.0 m-85 -139.14 -98.25 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.145 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.415 ' HB1' ' SG ' ' A' ' 167' ' ' CYS . . . -96.07 -31.11 13.19 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.065 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.56 -74.62 0.48 Allowed Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 119.879 -1.153 . . . . 0.0 113.227 -179.071 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.508 ' OD1' ' HA3' ' A' ' 1' ' ' GLY . 35.3 m-80 64.69 16.67 10.51 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 122.488 0.315 . . . . 0.0 110.25 -179.286 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.904 ' HD2' HD11 ' A' ' 164' ' ' LEU . 0.2 OUTLIER -61.14 -34.79 75.57 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.679 -179.316 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.433 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.7 OUTLIER -64.76 -17.51 64.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.331 0.586 . . . . 0.0 110.246 -179.262 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.15 -37.18 92.78 Favored Glycine 0 CA--C 1.523 0.544 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.647 178.882 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.498 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 30.9 m -118.06 -27.64 6.07 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 120.985 0.421 . . . . 0.0 111.404 -179.419 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 5.8 t -88.94 128.9 35.7 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 12' ' ' ARG . 11.3 ptm85 -114.41 -177.05 3.04 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.74 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.425 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 3.8 m-20 46.09 43.18 10.56 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 123.759 0.662 . . . . 0.0 111.675 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.924 HG22 HD13 ' A' ' 129' ' ' LEU . 6.1 mt -78.44 103.61 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.261 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.576 ' CA ' HD12 ' A' ' 129' ' ' LEU . 58.4 m -143.34 127.77 17.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.612 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.804 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -101.14 156.61 17.32 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.892 0.853 . . . . 0.0 113.15 -179.725 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 22.3 t70 -98.71 74.58 2.09 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 113.914 -1.494 . . . . 0.0 107.468 177.236 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.5 -54.53 4.6 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.622 179.859 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.75 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -147.05 -13.04 0.42 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 120.954 0.406 . . . . 0.0 110.294 179.55 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.415 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 0.4 OUTLIER -82.99 86.81 6.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.444 179.14 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.804 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 45.2 tp -62.47 119.78 9.82 Favored 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 122.949 0.499 . . . . 0.0 112.158 -179.691 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 15.9 ttp180 -124.31 135.87 53.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.358 -178.585 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.657 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -155.42 140.36 17.27 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.498 0.666 . . . . 0.0 111.374 179.714 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.572 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 3.5 mm-40 -77.94 82.23 4.31 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.901 178.198 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.635 ' SG ' HD13 ' A' ' 164' ' ' LEU . 34.5 m -69.85 120.58 15.8 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.886 -178.04 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 10' ' ' SER . 50.6 ttp85 -72.42 114.9 11.04 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.76 178.971 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.405 ' HB3' ' C ' ' A' ' 161' ' ' ASN . 2.9 ptp180 -92.1 160.6 15.13 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.233 179.242 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.75 -14.0 4.87 Favored Glycine 0 C--N 1.335 0.485 0 O-C-N 124.806 1.316 . . . . 0.0 113.902 -178.21 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -71.82 -12.47 61.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.789 0.804 . . . . 0.0 109.646 178.519 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.79 10.36 58.97 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.005 179.591 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -122.37 167.05 14.85 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 119.872 -1.156 . . . . 0.0 113.762 -179.011 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.572 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 78.1 m-85 -99.4 126.82 45.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.686 0.279 . . . . 0.0 110.516 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.5 t -113.71 126.18 54.94 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.398 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.7 m -66.59 114.36 5.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.092 0.472 . . . . 0.0 110.746 -179.291 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 36.2 t -119.04 148.85 42.56 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.405 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.9 p -145.3 138.47 21.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.693 0.282 . . . . 0.0 110.601 179.395 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.2 tt -135.32 153.52 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.627 -178.197 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.74 92.56 6.06 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.392 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.738 HD21 HD22 ' A' ' 153' ' ' LEU . 6.8 tp -78.6 -9.59 59.42 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.686 -177.46 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.75 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 28.4 p-10 -70.64 -12.99 61.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.497 0.665 . . . . 0.0 109.73 179.373 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.779 ' HG2' ' HA3' ' A' ' 116' ' ' GLY . 40.3 mtt180 -100.09 7.49 44.61 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.192 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 52.3 m-85 -129.44 -27.17 2.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.16 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.731 HD22 HD13 ' A' ' 151' ' ' ILE . 35.3 mt -107.25 140.16 40.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.069 0.461 . . . . 0.0 110.899 179.556 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 50' ' ' PHE . 5.4 m -127.17 149.09 50.13 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.915 -179.869 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.584 HD22 ' C ' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -91.67 94.41 9.37 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.255 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -103.41 92.15 4.36 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.12 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.433 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 64.3 t30 46.95 44.61 14.88 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 114.749 -1.114 . . . . 0.0 112.324 178.846 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.24 42.74 7.82 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.957 178.898 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.415 ' HA ' ' HB3' ' A' ' 149' ' ' SER . 62.2 t-80 -167.43 123.62 1.12 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.978 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.751 ' HZ ' ' HB3' ' A' ' 138' ' ' ALA . 62.0 m-85 -62.6 154.6 28.5 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.787 0.327 . . . . 0.0 110.602 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -148.11 133.79 18.86 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.974 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.473 ' CZ2' ' HA ' ' A' ' 153' ' ' LEU . 93.9 m95 -75.48 110.42 9.85 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.846 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.664 HG23 ' H ' ' A' ' 54' ' ' SER . 4.6 m 40.91 -99.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 O-C-N 124.402 1.064 . . . . 0.0 112.368 -178.543 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.664 ' H ' HG23 ' A' ' 53' ' ' VAL . 24.5 t -140.75 21.72 2.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.172 0.51 . . . . 0.0 109.962 179.511 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.9 -27.45 11.11 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.018 -179.368 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -146.72 -155.96 6.74 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.222 -0.513 . . . . 0.0 111.834 179.705 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.42 169.78 36.35 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.205 -179.661 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -118.3 128.11 7.59 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.131 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -104.81 -122.73 5.12 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.06 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -176.65 142.35 5.86 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -159.29 -105.67 0.21 Allowed Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.534 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 16.5 m -115.06 126.2 54.43 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.052 0.453 . . . . 0.0 110.819 179.891 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -125.2 174.14 8.29 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.718 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.466 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 1.2 p -129.83 114.25 15.68 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.782 0.325 . . . . 0.0 111.567 -179.07 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.485 HG21 ' CE2' ' A' ' 80' ' ' PHE . 11.5 p -99.81 135.07 36.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.936 0.398 . . . . 0.0 110.988 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.5 m -88.7 121.84 31.5 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.623 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.607 HG21 HD12 ' A' ' 99' ' ' ILE . 46.2 t -72.6 130.54 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.373 -179.428 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -100.85 169.15 9.18 Favored 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 124.149 0.906 . . . . 0.0 110.661 179.362 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.728 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 29.9 tt0 -60.21 108.69 0.83 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.524 -179.038 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.83 -10.97 20.93 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.296 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.556 ' HB3' HD11 ' A' ' 76' ' ' ILE . 68.3 m-20 -85.66 148.5 25.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.176 0.512 . . . . 0.0 111.79 -179.146 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.543 ' O ' HG12 ' A' ' 76' ' ' ILE . 23.4 p -133.93 158.48 43.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.434 178.795 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.69 HD23 ' HA ' ' A' ' 95' ' ' ASN . 1.8 tp -48.56 -45.27 37.49 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.039 0.447 . . . . 0.0 111.289 -179.651 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.544 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 43.7 ttp180 -60.13 -40.82 91.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.308 -179.628 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -74.31 -40.63 62.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.367 -178.826 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.556 HD11 ' HB3' ' A' ' 71' ' ' ASP . 47.6 mm -60.21 -46.47 94.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.159 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.713 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -55.44 -58.83 12.03 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.421 178.893 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -59.9 -33.18 71.51 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.675 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -66.55 -48.85 68.36 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.559 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.485 ' CE2' HG21 ' A' ' 65' ' ' VAL . 96.2 m-85 -97.52 13.23 30.67 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.196 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.7 t70 60.33 36.69 20.52 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.132 0.968 . . . . 0.0 110.711 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.713 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.1 p -114.54 171.79 7.42 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.548 179.229 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.714 ' O ' HG13 ' A' ' 87' ' ' ILE . 5.9 t0 -99.66 125.33 45.48 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 121.78 -0.575 . . . . 0.0 109.888 -179.702 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.544 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 31.9 p90 -54.3 -29.52 47.84 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.663 0.744 . . . . 0.0 109.938 178.64 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.536 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 22.3 t-80 -69.77 -41.37 75.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.544 178.6 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.699 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 36.8 tt0 -69.16 -48.9 61.03 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.638 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.714 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.2 mt -51.87 -43.31 34.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.678 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.564 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.61 -51.58 66.74 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.452 178.556 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.536 ' HG3' ' O ' ' A' ' 85' ' ' HIS . 41.2 mtm180 -61.62 -33.4 73.85 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.883 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.699 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 47.0 mmm-85 -73.36 -35.09 65.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.922 0.392 . . . . 0.0 110.896 -179.497 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.517 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 3.0 t-20 -88.11 -5.15 58.61 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.812 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.517 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 91.0 m-20 79.43 10.68 1.44 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.53 0.732 . . . . 0.0 111.085 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.564 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 21.9 pt -100.84 -174.01 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.783 179.25 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.611 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 66.2 mm-40 -110.54 162.34 14.8 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.087 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.69 ' HA ' HD23 ' A' ' 73' ' ' LEU . 1.4 p30 -55.5 -69.9 0.12 Allowed 'General case' 0 C--O 1.244 0.804 0 CA-C-O 122.336 1.065 . . . . 0.0 109.977 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -72.86 12.8 0.46 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.656 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.611 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.8 t70 -57.36 -33.21 67.55 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.389 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 55.4 mt 71.8 115.14 0.05 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-N 114.286 -1.324 . . . . 0.0 109.89 -178.621 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.607 HD12 HG21 ' A' ' 67' ' ' VAL . 17.1 pt -94.07 174.35 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.043 -178.64 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.456 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 17.3 m-85 -129.08 158.58 72.39 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.696 -178.603 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.728 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 25.5 Cg_endo -67.11 131.41 25.17 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.839 2.359 . . . . 0.0 112.438 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.33 15.12 36.26 Favored Glycine 0 N--CA 1.438 -1.177 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 -179.59 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -103.08 155.63 18.26 Favored 'General case' 0 C--O 1.214 -0.799 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.306 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.466 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 59.4 t -117.89 120.83 65.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 O-C-N 121.993 -0.442 . . . . 0.0 109.815 179.368 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.429 ' HB3' ' CG2' ' A' ' 87' ' ' ILE . 77.9 mt -112.07 150.84 30.12 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.397 -178.827 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.423 ' HB2' ' CB ' ' A' ' 90' ' ' ARG . 74.1 mt-30 -90.9 112.84 24.86 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.729 0.776 . . . . 0.0 110.781 179.065 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.41 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 34.0 m -126.45 151.08 72.18 Favored Pre-proline 0 C--N 1.313 -0.998 0 CA-C-N 114.214 -1.357 . . . . 0.0 109.019 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 107' ' ' VAL . 32.2 Cg_endo -63.2 -18.56 65.51 Favored 'Trans proline' 0 N--CA 1.473 0.321 0 C-N-CA 123.561 2.841 . . . . 0.0 115.259 -176.854 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.9 t -154.22 155.54 35.43 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.374 -0.531 . . . . 0.0 111.48 -179.547 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -98.9 -174.59 2.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.152 179.344 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -90.16 -52.31 2.58 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.356 179.425 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 178.88 169.69 39.85 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 179.661 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.9 p -100.18 -56.65 2.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.945 0.403 . . . . 0.0 110.689 179.525 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -162.26 -83.83 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.803 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -99.31 -50.97 1.38 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.18 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.779 ' HA3' ' HG2' ' A' ' 41' ' ' ARG . . . -149.77 -85.88 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.389 179.861 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.469 ' H ' ' HA ' ' A' ' 41' ' ' ARG . . . -130.02 -50.73 1.12 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.833 0.349 . . . . 0.0 111.105 -179.604 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . -79.88 -60.37 2.45 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.239 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 72.65 29.23 2.03 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.989 0.515 . . . . 0.0 111.327 178.337 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.655 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 22.7 p90 -59.48 -36.52 76.18 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 121.304 0.573 . . . . 0.0 109.963 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.443 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 24.0 t-105 -65.15 -24.6 67.45 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.113 -178.363 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.94 -14.06 60.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.856 0.36 . . . . 0.0 110.925 -179.746 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.428 ' HB2' ' HB3' ' A' ' 141' ' ' ARG . 9.7 p -144.65 22.32 1.63 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.926 179.011 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -104.48 151.53 23.45 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.782 0.325 . . . . 0.0 110.915 179.08 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 63.0 ttp180 -141.5 144.53 34.4 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.106 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 57.73 52.53 8.06 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.197 0.522 . . . . 0.0 111.123 179.578 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.504 ' CG1' HD11 ' A' ' 136' ' ' LEU . 21.3 t -81.65 119.12 30.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.526 -179.565 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -143.4 142.43 31.24 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.344 -179.85 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.924 HD13 HG22 ' A' ' 14' ' ' ILE . 27.3 mt -86.18 129.55 34.81 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.952 178.988 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.57 HG23 ' HB ' ' A' ' 135' ' ' VAL . 34.6 m -121.72 154.78 26.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.175 0.512 . . . . 0.0 111.046 -178.845 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.546 ' HB3' ' HD3' ' A' ' 134' ' ' LYS . 9.6 m-20 71.41 3.65 4.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.953 179.054 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.662 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 98.41 31.95 6.25 Favored Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.554 178.897 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.482 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 92.95 -19.73 50.14 Favored Glycine 0 C--O 1.263 1.91 0 CA-C-O 122.966 1.315 . . . . 0.0 113.272 177.545 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.756 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 18.6 ptmt -66.31 -18.97 65.67 Favored 'General case' 0 C--N 1.318 -0.795 0 O-C-N 121.634 -0.921 . . . . 0.0 108.991 178.104 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.57 ' HB ' HG23 ' A' ' 130' ' ' VAL . 11.7 t -140.24 141.58 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.688 177.667 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.635 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 22.7 tp -121.2 121.97 38.95 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.368 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.531 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 35.0 tt0 -111.02 132.97 53.77 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 120.858 0.361 . . . . 0.0 111.297 -177.336 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.751 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.55 155.24 19.44 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.678 179.153 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -94.05 106.84 18.8 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.793 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.549 HD13 ' HA ' ' A' ' 45' ' ' ASN . 59.8 mt -90.7 131.77 36.19 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.308 -178.864 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.428 ' HB3' ' HB2' ' A' ' 123' ' ' SER . 49.8 ttt85 -73.33 141.81 47.09 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.422 179.513 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.433 ' HB2' ' OD1' ' A' ' 47' ' ' ASN . 10.7 p90 -151.14 -165.08 2.16 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.72 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.4 m -70.52 2.44 3.99 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.684 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -135.88 31.73 2.6 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.675 -179.663 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 97.57 -134.62 11.81 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.766 179.436 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -117.03 124.95 50.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.569 0.223 . . . . 0.0 110.791 -179.655 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -115.0 131.55 56.89 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.106 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 31.2 ttm-85 -76.06 94.67 3.48 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.236 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.415 ' HB3' ' HA ' ' A' ' 49' ' ' HIS . 1.1 m -102.9 164.31 11.7 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.49 -178.725 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.635 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 39.1 mtt85 -145.5 149.42 34.62 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.008 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.731 HD13 HD22 ' A' ' 43' ' ' LEU . 9.3 tt -131.28 148.7 32.81 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.282 179.383 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.75 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 70.9 m-85 -92.54 102.53 14.98 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 122.277 -0.265 . . . . 0.0 111.293 -178.908 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.738 HD22 HD21 ' A' ' 39' ' ' LEU . 19.9 mt -67.49 -35.91 80.06 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.214 179.437 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.756 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 8.2 t70 -56.48 -10.1 0.87 Allowed 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.159 178.826 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.75 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 46.8 mt-10 -73.44 -48.67 31.84 Favored 'General case' 0 CA--C 1.509 -0.603 0 O-C-N 121.847 -0.533 . . . . 0.0 112.151 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.407 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 58.3 m80 -124.86 3.64 8.1 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.563 -177.6 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.4 HG12 ' CH2' ' A' ' 52' ' ' TRP . 45.6 mm -109.79 111.68 37.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.293 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.569 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -116.55 166.44 12.38 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.384 179.318 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.62 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -98.41 124.91 43.35 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.316 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 160' ' ' ARG . 22.0 ttt180 -112.69 86.63 2.4 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.029 -179.678 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.405 ' C ' ' HB3' ' A' ' 27' ' ' ARG . 56.9 t30 51.87 43.52 30.1 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.257 179.267 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.551 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 101.68 -3.79 53.34 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 119.985 -1.103 . . . . 0.0 114.063 178.659 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -122.38 128.67 51.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 117.062 0.431 . . . . 0.0 111.192 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.904 HD11 ' HD2' ' A' ' 7' ' ' PHE . 3.3 tp -70.6 129.23 38.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.158 -179.817 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.509 HG13 ' N ' ' A' ' 166' ' ' HIS . 11.0 tp -152.93 170.39 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.983 0.42 . . . . 0.0 111.297 -178.757 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.509 ' N ' HG13 ' A' ' 165' ' ' ILE . 19.7 t-80 -69.45 110.45 4.74 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.364 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.557 ' O ' ' HA3' ' A' ' 158' ' ' GLY . 51.9 t . . . . . 0 C--O 1.246 0.884 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.531 -178.465 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.747 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.551 ' HA ' ' OD2' ' A' ' 154' ' ' ASP . 1.8 m120 -71.52 155.84 40.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.94 0.4 . . . . 0.0 110.348 -178.614 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.709 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 53.6 m-85 -105.19 -90.93 0.4 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.28 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.28 -34.83 10.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.321 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -69.55 -65.01 2.72 Favored Glycine 0 N--CA 1.435 -1.427 0 C-N-CA 119.594 -1.289 . . . . 0.0 112.907 -178.626 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.527 ' HA ' ' CB ' ' A' ' 2' ' ' ASN . 37.9 m-80 67.84 15.68 9.62 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 122.289 0.236 . . . . 0.0 110.906 -179.663 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.653 ' CE2' HD13 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -64.87 -33.4 75.93 Favored 'General case' 0 C--O 1.215 -0.717 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.189 -179.345 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.2 t -67.72 -7.73 29.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.104 0.478 . . . . 0.0 110.582 -179.7 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.1 -7.33 58.53 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.584 178.574 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.551 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 49.0 m -135.11 -28.18 1.19 Allowed 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 117.026 0.413 . . . . 0.0 111.387 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.471 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 33.5 m -84.51 145.7 27.97 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.375 0.607 . . . . 0.0 109.625 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -116.82 160.49 20.75 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.841 -179.06 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 45.73 55.24 7.01 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 123.245 0.618 . . . . 0.0 112.544 178.658 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.989 HG22 HD13 ' A' ' 129' ' ' LEU . 8.5 mt -80.22 103.62 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 120.8 0.333 . . . . 0.0 110.35 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.636 ' CA ' HD12 ' A' ' 129' ' ' LEU . 69.3 m -145.47 128.29 16.33 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.508 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.723 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -92.34 158.31 16.16 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.227 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -100.0 76.13 1.91 Allowed 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.248 -1.342 . . . . 0.0 107.626 177.338 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.98 -61.99 4.65 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 114.788 -1.097 . . . . 0.0 111.555 179.097 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.706 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -144.82 -2.64 0.82 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.367 -0.416 . . . . 0.0 110.221 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.481 ' HB3' ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -97.59 96.06 8.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.397 178.99 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.986 HD12 HD11 ' A' ' 129' ' ' LEU . 4.8 tp -60.33 117.12 4.83 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 123.39 0.676 . . . . 0.0 111.441 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.584 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 25.8 ttt180 -120.23 126.73 51.34 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.965 0.412 . . . . 0.0 110.845 -178.311 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.662 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -147.51 142.49 26.97 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.727 0.775 . . . . 0.0 111.32 -179.698 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.548 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 7.7 mm-40 -77.24 76.12 3.79 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.716 178.029 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.692 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 65.2 m -62.17 128.02 34.11 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.214 -178.852 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.551 ' HB2' ' O ' ' A' ' 10' ' ' SER . 17.1 ttp180 -73.54 116.45 14.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.421 179.634 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 27' ' ' ARG . 14.9 ptt180 -86.22 156.31 20.35 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.324 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.44 -14.96 3.73 Favored Glycine 0 C--N 1.338 0.68 0 O-C-N 124.631 1.207 . . . . 0.0 114.433 -177.917 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -73.15 -13.6 61.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.504 0.668 . . . . 0.0 109.617 178.16 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.92 6.65 59.12 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.569 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.42 164.78 12.4 Favored Glycine 0 C--O 1.225 -0.416 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.545 -179.156 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.548 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 84.3 m-85 -100.94 138.17 38.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.918 0.359 . . . . 0.0 110.83 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.1 m -126.89 126.91 44.08 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.102 179.566 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.9 m -65.26 116.12 6.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.065 0.46 . . . . 0.0 111.056 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 45.8 t -122.64 152.45 40.47 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.536 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.637 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 5.3 p -144.54 138.81 23.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.557 0.218 . . . . 0.0 111.04 -179.771 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.447 HG23 HD13 ' A' ' 39' ' ' LEU . 15.2 tt -133.12 148.58 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 120.929 0.395 . . . . 0.0 111.099 -178.725 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.71 95.43 5.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.969 -179.482 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.827 HD22 ' HB2' ' A' ' 21' ' ' LEU . 1.8 mp -75.48 -18.11 59.93 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 120.945 0.403 . . . . 0.0 111.023 178.988 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.706 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 27.8 p-10 -67.6 -7.4 26.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.423 179.785 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.528 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 33.1 mtt180 -114.22 14.66 18.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.146 179.445 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.632 ' HD1' ' HE3' ' A' ' 52' ' ' TRP . 0.2 OUTLIER -141.78 -23.31 0.71 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.097 -179.27 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.867 HD22 HD13 ' A' ' 151' ' ' ILE . 57.5 mt -110.07 131.55 54.96 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.474 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.529 ' HB3' ' HA2' ' A' ' 118' ' ' GLY . 0.5 OUTLIER -127.51 141.35 51.68 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.147 -179.12 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.605 ' ND2' HD22 ' A' ' 140' ' ' LEU . 12.3 m-20 -81.25 90.81 6.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.756 177.512 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -85.01 86.89 7.34 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.952 0.406 . . . . 0.0 110.389 177.923 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.55 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 16.6 t-20 50.85 45.8 26.92 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.272 179.25 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.646 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 83.02 40.13 9.57 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.183 179.012 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -155.13 121.32 5.22 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.723 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.739 ' HB3' ' HB ' ' A' ' 151' ' ' ILE . 25.8 m-85 -65.59 135.37 54.99 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.147 179.492 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 40.1 mmm-85 -136.64 141.32 43.19 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.856 0.36 . . . . 0.0 111.4 -179.694 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.717 ' HH2' HD13 ' A' ' 153' ' ' LEU . 92.6 m95 -75.82 143.12 42.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.919 178.544 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.6 t 64.08 -87.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 123.978 0.911 . . . . 0.0 110.824 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 62.2 m -158.03 22.64 0.26 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.737 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.63 -56.07 4.69 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.642 -178.855 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.44 149.72 19.23 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.215 -0.517 . . . . 0.0 111.858 179.555 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.469 ' H ' ' HB3' ' A' ' 81' ' ' ASP . . . -87.8 -31.76 14.57 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.16 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.98 -102.15 2.46 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.317 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.33 -145.29 4.88 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.888 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 143.78 -33.8 1.73 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.927 179.639 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -175.6 -132.18 1.56 Allowed Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.692 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.1 m -130.08 113.81 14.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.947 0.403 . . . . 0.0 110.361 -179.971 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.62 176.46 5.37 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.039 -179.699 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.454 ' HB ' ' CG2' ' A' ' 104' ' ' VAL . 4.5 p -129.18 116.43 19.18 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.74 0.305 . . . . 0.0 111.707 -178.831 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.449 HG21 ' CE1' ' A' ' 80' ' ' PHE . 14.5 p -104.57 139.53 25.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.922 0.392 . . . . 0.0 111.018 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 6.2 m -88.68 127.23 35.58 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.8 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.566 ' CG2' HD12 ' A' ' 99' ' ' ILE . 43.1 t -75.28 133.58 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.358 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -99.18 170.4 8.7 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 124.727 1.267 . . . . 0.0 110.32 -179.489 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.766 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 29.2 tp60 -61.05 110.4 1.35 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.227 -178.834 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.12 -12.27 58.79 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.493 178.384 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -81.77 129.49 34.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.93 0.395 . . . . 0.0 111.288 -179.435 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.57 ' HA ' HG12 ' A' ' 99' ' ' ILE . 67.4 p -109.2 178.11 4.55 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.774 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.604 HD22 HG23 ' A' ' 99' ' ' ILE . 1.6 mm? -53.25 -41.89 65.92 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.444 0.64 . . . . 0.0 109.599 178.958 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.414 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 28.6 ttm180 -61.67 -41.49 97.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.105 -179.599 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 79' ' ' ARG . 24.3 m-20 -67.31 -43.59 81.27 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.773 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.535 HG12 ' O ' ' A' ' 72' ' ' THR . 37.2 mm -61.67 -48.2 89.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.147 179.586 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.608 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.74 -47.58 87.66 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.893 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.481 ' HA ' ' NE ' ' A' ' 78' ' ' ARG . 5.4 tpm_? -71.48 -29.91 65.37 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 122.47 -0.429 . . . . 0.0 111.601 -179.27 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 40.8 ttt180 -75.04 -39.39 61.03 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.106 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.449 ' CE1' HG21 ' A' ' 65' ' ' VAL . 97.1 m-85 -110.45 15.17 22.33 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.515 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.469 ' HB3' ' H ' ' A' ' 57' ' ' GLY . 37.4 t70 56.33 53.79 8.38 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 122.025 0.917 . . . . 0.0 111.969 179.028 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.608 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -134.24 170.97 14.91 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.61 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.635 ' O ' HG13 ' A' ' 87' ' ' ILE . 5.5 t70 -97.38 123.0 41.07 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.428 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.43 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 6.7 p90 -49.6 -31.12 9.97 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 124.579 1.174 . . . . 0.0 111.327 179.263 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -63.42 -48.85 76.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.856 179.281 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.721 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 19.2 mm-40 -67.65 -43.5 80.17 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.363 -178.839 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.635 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.1 mt -53.61 -46.91 61.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.703 0.763 . . . . 0.0 108.948 179.005 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.605 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.21 -51.49 66.08 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.344 178.598 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -61.55 -33.43 73.83 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -177.873 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.721 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 15.9 mmp_? -68.26 -32.06 71.96 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.289 0.566 . . . . 0.0 110.041 179.275 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 3.4 t-20 -91.28 -4.88 55.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.479 179.474 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 51.5 m-80 77.57 15.96 1.59 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.534 0.733 . . . . 0.0 110.7 -179.432 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.605 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 15.6 pt -105.16 -173.32 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.781 178.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.407 ' HA ' ' OE1' ' A' ' 94' ' ' GLN . 16.5 mm-40 -115.49 154.46 29.28 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.235 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.552 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.5 p-10 -51.59 -63.3 1.18 Allowed 'General case' 0 C--O 1.244 0.77 0 CA-C-O 121.964 0.888 . . . . 0.0 110.176 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.18 13.5 0.9 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.143 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 8.4 t70 -66.16 -32.35 73.73 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.689 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 8.3 mp 70.46 113.97 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.956 -177.549 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.604 HG23 HD22 ' A' ' 73' ' ' LEU . 7.4 pt -94.17 175.92 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.671 -178.337 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.509 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 96.6 m-85 -120.5 159.25 48.86 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.088 -178.731 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.766 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 50.9 Cg_endo -72.57 135.73 24.62 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.177 2.585 . . . . 0.0 112.425 -179.827 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.99 17.87 36.22 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.659 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 66' ' ' THR . 96.5 mt-30 -110.17 159.49 17.31 Favored 'General case' 0 C--O 1.209 -1.038 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.848 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.454 ' CG2' ' HB ' ' A' ' 64' ' ' THR . 8.4 p -116.46 131.24 69.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.553 0.692 . . . . 0.0 110.695 178.621 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.45 HD11 HG21 ' A' ' 99' ' ' ILE . 90.8 mt -121.38 151.02 40.63 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.573 -179.569 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.562 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 41.4 mt-30 -90.74 112.23 23.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.79 0.805 . . . . 0.0 110.917 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.8 m -120.74 151.28 54.23 Favored Pre-proline 0 C--N 1.315 -0.911 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.674 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -65.02 -17.95 60.73 Favored 'Trans proline' 0 C--N 1.332 -0.315 0 C-N-CA 123.147 2.565 . . . . 0.0 114.645 -177.704 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.1 t -153.83 152.52 30.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.869 0.366 . . . . 0.0 111.066 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -96.75 -165.14 1.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.276 179.387 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.93 -47.14 20.32 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.214 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 127.09 -152.22 18.59 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 -179.768 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.5 t -112.78 -38.87 4.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.948 0.374 . . . . 0.0 110.152 179.597 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.528 ' O ' ' HB3' ' A' ' 41' ' ' ARG . . . 111.48 -47.49 1.04 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.824 179.408 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -58.0 104.75 0.5 Allowed Glycine 0 CA--C 1.516 0.123 0 C-N-CA 121.271 -0.49 . . . . 0.0 112.931 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.66 49.92 6.88 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -179.652 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -103.5 -52.71 2.94 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.311 -0.444 . . . . 0.0 110.596 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 44' ' ' SER . . . -82.85 -74.64 1.19 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.751 -179.095 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 70.7 26.92 3.77 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.854 0.462 . . . . 0.0 111.35 179.168 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.568 ' HB2' ' OD1' ' A' ' 45' ' ' ASN . 20.2 p90 -57.12 -35.86 69.98 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 121.078 0.466 . . . . 0.0 110.325 179.219 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -59.13 -35.98 74.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.069 -178.194 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -66.56 -13.47 61.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.082 0.467 . . . . 0.0 111.386 -179.005 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.481 ' OG ' ' HB3' ' A' ' 141' ' ' ARG . 29.9 t -129.7 8.14 5.31 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.386 -179.71 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -104.35 149.35 25.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.073 0.464 . . . . 0.0 111.573 -179.489 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.536 ' HB2' ' CZ3' ' A' ' 146' ' ' TRP . 1.3 tmm_? -135.76 132.79 37.23 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.178 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.456 ' HB2' ' CZ ' ' A' ' 125' ' ' ARG . 34.6 t70 54.95 67.64 0.99 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.775 0.798 . . . . 0.0 110.693 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.513 ' CG1' HD11 ' A' ' 136' ' ' LEU . 42.0 t -84.68 126.66 40.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.86 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -144.04 141.12 29.92 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.229 -179.052 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.989 HD13 HG22 ' A' ' 14' ' ' ILE . 30.9 mt -86.55 125.31 33.69 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.961 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.627 HG23 ' HB ' ' A' ' 135' ' ' VAL . 35.6 m -118.6 161.2 17.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.691 -179.228 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.777 ' HB3' ' HE2' ' A' ' 134' ' ' LYS . 6.1 m-20 66.17 12.51 8.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.597 178.682 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.679 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 90.75 28.43 16.14 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.395 178.413 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.641 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 93.13 -16.78 59.72 Favored Glycine 0 C--O 1.261 1.812 0 CA-C-O 123.378 1.543 . . . . 0.0 112.92 177.246 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.777 ' HE2' ' HB3' ' A' ' 131' ' ' ASP . 17.5 pttm -71.31 -12.57 61.51 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 121.348 -1.09 . . . . 0.0 109.283 177.964 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.627 ' HB ' HG23 ' A' ' 130' ' ' VAL . 18.3 t -142.31 139.34 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.27 177.433 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.522 HD13 HD21 ' A' ' 16' ' ' LEU . 48.9 tp -118.66 122.54 42.78 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.356 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.444 ' OE2' ' HD3' ' A' ' 148' ' ' ARG . 17.1 tt0 -118.51 130.59 56.01 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.986 0.422 . . . . 0.0 110.903 -176.539 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 127' ' ' VAL . . . -156.49 166.24 33.97 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.186 -179.645 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 44.4 mt-10 -94.44 111.33 23.08 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.718 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.646 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 19.8 mt -98.17 132.14 43.94 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.325 -178.333 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.481 ' HB3' ' OG ' ' A' ' 123' ' ' SER . 72.2 ttt180 -73.98 141.23 45.88 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.601 179.667 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.55 ' HB2' ' OD1' ' A' ' 47' ' ' ASN . 1.4 p90 -157.65 -172.94 4.15 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.804 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.2 m -55.21 -31.95 61.85 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.211 0.319 . . . . 0.0 111.728 -179.539 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -93.41 15.29 63.32 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.253 -178.604 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 103.22 -110.99 3.83 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.293 179.664 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.536 ' CZ3' ' HB2' ' A' ' 125' ' ' ARG . 80.0 m95 -131.56 128.32 39.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.785 0.293 . . . . 0.0 110.706 -179.956 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -128.38 135.11 49.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.173 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.444 ' HD3' ' OE2' ' A' ' 137' ' ' GLU . 36.4 ttm180 -74.13 106.42 5.79 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.879 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 8.2 m -116.18 165.81 12.74 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.702 -178.98 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 15.2 ptt180 -147.0 164.78 31.91 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -178.55 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.867 HD13 HD22 ' A' ' 43' ' ' LEU . 8.3 tt -141.27 161.52 22.15 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.335 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.58 ' O ' ' HZ2' ' A' ' 52' ' ' TRP . 20.3 m-85 -104.58 104.36 14.18 Favored 'General case' 0 C--N 1.316 -0.868 0 O-C-N 122.307 -0.246 . . . . 0.0 110.699 -179.768 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.839 HD12 HG13 ' A' ' 157' ' ' ILE . 4.4 mm? -66.19 -36.19 82.43 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.218 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.551 ' OD2' ' HA ' ' A' ' 2' ' ' ASN . 16.6 p-10 -57.42 -9.85 1.21 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 179.035 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.709 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 32.9 mt-10 -71.93 -50.74 26.48 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 179.801 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -121.52 0.03 9.85 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.333 -0.547 . . . . 0.0 112.371 -177.366 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.839 HG13 HD12 ' A' ' 153' ' ' LEU . 45.1 mm -106.97 117.17 52.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.517 179.1 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.595 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -123.29 173.8 16.4 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.93 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.692 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.4 OUTLIER -106.13 126.45 52.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.987 0.423 . . . . 0.0 110.258 179.229 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.543 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 8.7 tpt180 -117.44 86.93 2.61 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.801 179.612 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 65.9 t30 55.26 40.65 31.65 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.463 178.864 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 105.61 -7.45 42.5 Favored Glycine 0 C--O 1.228 -0.25 0 C-N-CA 120.138 -1.029 . . . . 0.0 114.978 177.701 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 160' ' ' ARG . 13.2 pt-20 -122.04 141.44 51.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 117.936 0.868 . . . . 0.0 111.2 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.585 HD13 HD23 ' A' ' 21' ' ' LEU . 30.8 mt -74.98 122.22 23.16 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.867 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 6.5 tp -122.48 141.06 44.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.902 -179.533 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 37.8 p-80 -97.02 128.5 44.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.837 179.289 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 20.6 p . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.741 -0.647 . . . . 0.0 110.213 -179.551 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.912 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 27.7 m-85 . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.782 0.325 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.15 -30.62 4.61 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.045 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -70.82 -66.77 2.08 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 119.796 -1.192 . . . . 0.0 113.383 -178.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 16.1 m120 68.37 11.99 8.56 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.515 0.326 . . . . 0.0 110.677 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.647 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.9 OUTLIER -58.47 -35.93 72.94 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 121.076 -0.25 . . . . 0.0 111.135 -179.221 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.6 p -62.81 -19.52 64.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.388 0.613 . . . . 0.0 110.788 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.78 -22.05 78.63 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.801 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.536 ' HB3' ' HB3' ' A' ' 26' ' ' ARG . 67.4 m -132.67 -16.88 2.58 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 117.584 0.692 . . . . 0.0 111.877 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.468 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 19.4 m -94.81 133.86 38.06 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.428 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 14.4 ptt180 -111.38 179.87 3.91 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 41.77 48.32 3.7 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 124.089 0.868 . . . . 0.0 111.984 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.883 HG22 HD13 ' A' ' 129' ' ' LEU . 7.4 mt -80.6 104.14 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 109.695 -0.484 . . . . 0.0 109.695 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.589 ' HA ' HD12 ' A' ' 129' ' ' LEU . 78.0 m -146.57 127.06 14.09 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.735 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -95.66 155.7 16.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.718 0.77 . . . . 0.0 113.068 -179.122 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.454 ' HB2' HH22 ' A' ' 22' ' ' ARG . 31.0 t70 -94.28 75.63 3.96 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.428 177.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.7 -53.82 4.74 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.747 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.605 ' CB ' ' HB3' ' A' ' 40' ' ' ASN . . . -149.62 -10.8 0.3 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 120.781 0.324 . . . . 0.0 110.455 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -92.55 96.27 10.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.138 0.494 . . . . 0.0 110.814 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.811 HD22 HD13 ' A' ' 153' ' ' LEU . 45.4 tp -59.65 129.01 39.8 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.329 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.614 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 26.7 ttm180 -133.34 120.02 20.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.195 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.615 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -142.15 149.43 39.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.648 0.737 . . . . 0.0 112.053 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.497 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 63.3 mm-40 -83.65 75.46 10.05 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.365 -1.288 . . . . 0.0 108.873 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.856 ' SG ' HD13 ' A' ' 164' ' ' LEU . 56.0 m -62.96 124.24 20.59 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.86 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.536 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 16.2 ttm180 -76.51 118.01 18.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.736 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.618 ' HG2' ' HA3' ' A' ' 162' ' ' GLY . 10.7 mtm180 -84.1 163.96 19.5 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.76 -16.22 11.33 Favored Glycine 0 C--N 1.338 0.648 0 O-C-N 124.374 1.046 . . . . 0.0 113.387 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -72.39 -10.34 59.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.346 0.593 . . . . 0.0 109.819 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.48 13.98 64.48 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -114.2 162.29 12.45 Favored Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.208 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.497 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 61.5 m-85 -100.99 138.78 37.58 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.959 0.409 . . . . 0.0 111.138 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.8 m -132.5 132.21 42.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.589 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 m -69.39 110.44 4.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.185 0.517 . . . . 0.0 111.635 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.436 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 40.4 t -114.51 142.31 46.57 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.784 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.614 ' HB ' ' HG3' ' A' ' 22' ' ' ARG . 1.9 p -139.52 135.44 40.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.098 0.475 . . . . 0.0 111.35 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.484 HG23 ' HB3' ' A' ' 21' ' ' LEU . 12.3 tt -134.42 150.5 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.087 -177.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.498 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 2.7 m-20 -84.87 97.98 10.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.564 HD23 ' HB3' ' A' ' 21' ' ' LEU . 3.9 mm? -79.58 -8.93 59.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.242 0.544 . . . . 0.0 110.545 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.605 ' HB3' ' CB ' ' A' ' 19' ' ' ALA . 12.9 p30 -65.22 -15.75 62.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.766 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.6 mtt85 -113.97 20.07 16.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.557 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -136.82 -31.7 0.84 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.346 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.857 HD22 HD13 ' A' ' 151' ' ' ILE . 48.3 mt -103.8 133.58 48.55 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.118 0.485 . . . . 0.0 110.044 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.715 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 6.1 m -122.31 146.78 46.98 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.306 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.444 ' HB3' HD22 ' A' ' 140' ' ' LEU . 8.1 p-10 -94.78 91.81 6.66 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.758 ' HB3' ' HD2' ' A' ' 51' ' ' ARG . 15.1 t70 -93.51 97.6 10.63 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.741 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.6 t30 53.2 46.96 25.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.396 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.562 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 75.44 29.37 60.04 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.957 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.571 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 70.5 m-70 -142.68 122.59 13.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.954 ' HB3' ' HB ' ' A' ' 151' ' ' ILE . 14.7 m-85 -62.5 126.12 26.27 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.758 ' HD2' ' HB3' ' A' ' 46' ' ' ASP . 54.3 mtt85 -143.98 137.71 27.92 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.344 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.523 ' CD1' HD11 ' A' ' 151' ' ' ILE . 86.6 m95 . . . . . 0 C--N 1.325 -0.474 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.6 m . . . . . 0 N--CA 1.45 -0.435 0 CA-C-O 121.151 0.501 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 106' ' ' GLN . . . -124.59 177.15 6.09 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.112 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.4 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 1.9 p -129.46 120.18 25.01 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.485 HG21 ' CE1' ' A' ' 80' ' ' PHE . 7.9 p -107.05 147.39 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.565 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 13.4 m -95.37 124.87 39.62 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.586 HG21 HD12 ' A' ' 99' ' ' ILE . 47.9 t -73.99 133.13 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.362 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -99.16 170.2 8.85 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 124.384 1.052 . . . . 0.0 111.17 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.853 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 41.5 tt0 -61.48 119.63 8.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.645 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.55 18.78 51.23 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.67 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -110.36 148.02 32.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.15 0.475 . . . . 0.0 111.014 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.647 ' HA ' HG12 ' A' ' 99' ' ' ILE . 74.3 p -126.57 173.17 9.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.367 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.61 HD22 HG23 ' A' ' 99' ' ' ILE . 1.5 mm? -52.75 -43.03 65.49 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.539 0.685 . . . . 0.0 109.701 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.458 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 65.1 mtp180 -61.8 -38.26 87.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.744 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -72.9 -41.01 65.07 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 72' ' ' THR . 42.8 mm -62.71 -47.98 90.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.735 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -55.49 -50.38 60.42 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.213 178.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.13 -36.74 84.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.754 0.312 . . . . 0.0 111.432 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -70.32 -42.82 71.45 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.485 ' CE1' HG21 ' A' ' 65' ' ' VAL . 97.5 m-85 -105.08 18.72 21.87 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.5 t70 52.94 39.08 28.65 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.681 0.753 . . . . 0.0 111.528 178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.735 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 3.4 p -116.86 170.88 8.28 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.218 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.66 ' O ' HG13 ' A' ' 87' ' ' ILE . 6.1 t70 -96.06 124.4 40.05 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.031 -0.667 . . . . 0.0 110.199 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.458 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 5.7 p90 -52.29 -29.49 23.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.512 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -68.86 -43.22 75.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.425 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.668 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 14.0 tp10 -65.31 -45.56 83.85 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.66 HG13 ' O ' ' A' ' 83' ' ' ASP . 4.8 mt -54.97 -46.42 76.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.18 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.596 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.01 -50.01 72.37 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.889 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.414 ' NE ' ' HA ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -55.61 -39.67 71.09 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.668 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 10.9 mmt180 -69.91 -30.98 68.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.688 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.74 HD22 HD13 ' A' ' 93' ' ' ILE . 66.1 t30 -95.39 -3.85 46.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.154 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 50.4 m-80 74.9 17.82 2.72 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.935 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.74 HD13 HD22 ' A' ' 91' ' ' ASN . 14.3 pt -105.55 -179.77 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.549 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 2.3 mp0 -104.69 161.52 14.07 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.505 ' O ' HD23 ' A' ' 73' ' ' LEU . 15.9 p-10 -60.33 -59.65 5.06 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 122.027 0.917 . . . . 0.0 109.284 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -75.78 12.28 1.12 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.602 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.549 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 3.8 t70 -63.62 -35.62 81.11 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 9.5 mp 72.17 117.16 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 O-C-N 124.193 0.933 . . . . 0.0 109.313 -176.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.647 HG12 ' HA ' ' A' ' 72' ' ' THR . 7.5 pt -95.72 178.97 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.918 -178.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.456 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 91.3 m-85 -124.35 157.6 64.16 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.751 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.853 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 53.6 Cg_endo -72.4 131.93 18.39 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 123.198 2.598 . . . . 0.0 113.044 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.42 18.96 24.54 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' A' ' 66' ' ' THR . 33.9 tt0 -105.79 158.71 16.54 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 83.0 t -119.21 118.75 58.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 109.722 -0.474 . . . . 0.0 109.722 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.596 HD11 HG21 ' A' ' 99' ' ' ILE . 94.9 mt -112.52 150.55 31.12 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.035 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.625 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 40.8 mt-30 -90.56 111.74 23.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.781 0.8 . . . . 0.0 110.964 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.0 m -119.55 151.23 51.41 Favored Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.608 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.45 -16.13 53.49 Favored 'Trans proline' 0 N--CA 1.475 0.389 0 C-N-CA 123.542 2.828 . . . . 0.0 114.975 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.6 t . . . . . 0 C--N 1.322 -0.611 0 CA-C-O 121.01 0.433 . . . . 0.0 111.39 179.842 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.715 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.446 -0.699 0 N-CA-C 113.18 0.032 . . . . 0.0 113.18 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 15.5 m120 75.25 24.39 1.44 Allowed 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.457 0.703 . . . . 0.0 112.099 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.602 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 23.8 p90 -59.62 -40.19 86.74 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.069 0.461 . . . . 0.0 110.019 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.51 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 66.0 t-105 -56.69 -34.58 67.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.386 -178.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -57.03 -25.81 59.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.86 0.362 . . . . 0.0 111.028 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.815 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 9.7 m -132.01 25.45 4.61 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.477 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.51 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -115.89 139.87 49.79 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 120.98 0.419 . . . . 0.0 110.816 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.462 ' HD3' ' HA ' ' A' ' 125' ' ' ARG . 17.8 mmt180 -128.98 146.72 50.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.486 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.7 t70 51.35 59.31 4.69 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 124.014 0.821 . . . . 0.0 110.745 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.534 HG12 HD11 ' A' ' 136' ' ' LEU . 35.1 t -82.78 124.65 39.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.598 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -145.66 144.01 30.16 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.07 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.883 HD13 HG22 ' A' ' 14' ' ' ILE . 21.3 mt -86.25 138.85 31.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.29 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.64 HG23 ' HB ' ' A' ' 135' ' ' VAL . 34.4 m -132.6 157.56 43.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.92 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.447 ' O ' ' HG2' ' A' ' 134' ' ' LYS . 0.7 OUTLIER 65.37 18.08 11.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.387 178.578 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.736 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 90.42 30.46 12.09 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.222 -0.99 . . . . 0.0 113.829 178.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.565 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 86.69 -9.87 69.73 Favored Glycine 0 C--O 1.261 1.832 0 CA-C-O 123.011 1.339 . . . . 0.0 113.213 176.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.728 ' HG3' HG23 ' A' ' 135' ' ' VAL . 8.4 ptpp? -74.18 -17.4 60.91 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.728 HG23 ' HG3' ' A' ' 134' ' ' LYS . 22.8 t -137.79 143.13 34.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.782 177.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.671 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 34.1 tp -126.24 119.15 26.7 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.5 ' OE2' ' HD3' ' A' ' 148' ' ' ARG . 16.2 tt0 -112.15 138.26 49.08 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.76 0.314 . . . . 0.0 111.357 -176.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . . . -162.86 167.04 23.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.988 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 124' ' ' ALA . 3.9 mm-40 -94.36 106.17 18.14 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.562 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 67.0 mt -96.96 130.5 44.26 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.268 0.556 . . . . 0.0 111.567 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.815 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 74.4 ttt180 -73.28 141.32 47.19 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.128 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.531 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 2.0 p90 -159.06 -169.94 2.84 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 121.081 -0.247 . . . . 0.0 111.352 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.7 m -56.01 -29.65 60.67 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -101.14 27.16 21.87 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.243 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 93.68 -111.1 4.07 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.363 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -128.88 133.32 47.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.717 0.258 . . . . 0.0 110.339 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.531 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 54.0 t30 -133.01 141.42 48.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.712 0.291 . . . . 0.0 110.497 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.5 ' HD3' ' OE2' ' A' ' 137' ' ' GLU . 24.9 ttm180 -79.6 114.73 18.75 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.921 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.571 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 36.2 t -125.78 168.26 14.05 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.698 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.671 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -146.73 163.05 37.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.082 0.468 . . . . 0.0 111.978 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.954 ' HB ' ' HB3' ' A' ' 50' ' ' PHE . 9.0 tt -145.47 152.9 14.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.302 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.675 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 15.1 m-85 -93.32 105.84 17.87 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.811 HD13 HD22 ' A' ' 21' ' ' LEU . 22.2 mt -67.25 -34.09 76.7 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.243 178.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.46 ' HA ' ' CD1' ' A' ' 7' ' ' PHE . 1.9 p-10 -57.41 -11.93 2.22 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.908 178.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.912 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 36.5 mt-10 -62.3 -55.27 29.84 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.106 0.479 . . . . 0.0 111.938 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -118.34 -12.13 9.94 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.959 -0.697 . . . . 0.0 111.828 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.438 ' CG2' ' HG ' ' A' ' 164' ' ' LEU . 49.6 mm -87.2 108.84 18.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.298 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -115.25 154.86 16.7 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.562 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.552 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.0 t30 -94.47 113.68 25.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.107 0.479 . . . . 0.0 109.891 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.459 HH11 ' HD2' ' A' ' 160' ' ' ARG . 15.2 tpt180 -110.97 86.72 2.37 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.92 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.0 t30 55.17 55.9 7.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.368 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.618 ' HA3' ' HG2' ' A' ' 27' ' ' ARG . . . 79.99 7.63 88.35 Favored Glycine 0 C--O 1.228 -0.231 0 CA-C-N 115.509 -0.769 . . . . 0.0 113.781 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -123.47 125.16 44.41 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.855 0.359 . . . . 0.0 111.397 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.856 HD13 ' SG ' ' A' ' 25' ' ' CYS . 0.2 OUTLIER -73.87 112.09 9.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.591 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 47.9 mm . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.166 -179.125 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.75 -26.66 12.18 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.22 -72.63 0.64 Allowed Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 119.66 -1.257 . . . . 0.0 112.61 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 64.53 14.43 8.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.615 0.245 . . . . 0.0 110.677 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.581 ' CE2' HD13 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -64.05 -32.5 74.07 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.994 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.5 t -70.7 -11.1 60.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.359 0.6 . . . . 0.0 109.728 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.58 -16.92 72.13 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.418 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.494 ' HB2' ' HB3' ' A' ' 26' ' ' ARG . 33.3 p -137.21 -11.27 1.68 Allowed 'General case' 0 C--O 1.221 -0.419 0 O-C-N 122.507 -0.408 . . . . 0.0 111.928 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 12.1 m -105.18 132.53 51.28 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.585 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 25.1 ptt180 -108.89 -176.77 3.13 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 44.28 42.3 5.08 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 123.913 0.758 . . . . 0.0 112.058 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.93 HG22 HD13 ' A' ' 129' ' ' LEU . 5.6 mt -80.2 100.97 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 121.108 0.48 . . . . 0.0 110.889 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.621 ' CA ' HD12 ' A' ' 129' ' ' LEU . 71.7 m -147.82 127.13 13.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.515 -0.766 . . . . 0.0 108.984 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.751 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -92.57 158.36 16.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.676 0.75 . . . . 0.0 112.782 -179.046 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -96.13 74.31 2.98 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.18 -55.41 5.03 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.226 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 40' ' ' ASN . . . -148.67 -12.42 0.34 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -85.89 92.37 8.63 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.78 HD22 HD23 ' A' ' 153' ' ' LEU . 43.2 tp -58.87 125.2 22.57 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.546 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 2.3 ttt180 -133.08 122.64 24.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.14 0.495 . . . . 0.0 110.703 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.621 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -138.83 176.24 8.86 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.243 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.585 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 6.2 mt-10 -115.61 80.07 1.38 Allowed 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.601 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 55.6 m -64.77 126.69 28.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.691 -178.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.494 ' HB3' ' HB2' ' A' ' 10' ' ' SER . 43.5 ttt-85 -74.73 114.68 13.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.676 178.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.6 ttm180 -82.57 154.9 24.76 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -48.75 -22.47 2.82 Favored Glycine 0 C--N 1.332 0.325 0 O-C-N 124.633 1.208 . . . . 0.0 115.115 -177.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -72.48 -14.41 61.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.509 0.671 . . . . 0.0 110.574 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.31 7.78 53.97 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -102.74 147.44 17.03 Favored Glycine 0 C--O 1.225 -0.445 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.511 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.438 ' HD1' ' O ' ' A' ' 24' ' ' GLU . 84.4 m-85 -96.57 124.63 40.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.02 0.41 . . . . 0.0 110.318 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.9 m -117.01 126.44 52.89 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.339 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.3 m -67.09 126.25 28.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.253 0.549 . . . . 0.0 110.245 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 46.8 t -129.86 152.69 49.06 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.763 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.667 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 5.3 p -144.12 133.77 19.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.044 0.45 . . . . 0.0 111.171 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.441 HG23 ' HB3' ' A' ' 21' ' ' LEU . 11.2 tt -135.07 153.53 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.226 -178.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -82.97 111.6 18.98 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 122.041 -0.412 . . . . 0.0 111.157 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.538 HD23 ' HB3' ' A' ' 21' ' ' LEU . 2.0 mm? -88.83 -2.0 58.37 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.456 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 66.9 t30 -74.78 -14.73 60.74 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -107.18 17.25 23.17 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.296 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.464 ' HB2' HD13 ' A' ' 39' ' ' LEU . 39.8 m-85 -134.01 -33.86 1.02 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.339 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.64 HD22 HD13 ' A' ' 151' ' ' ILE . 35.8 mt -105.73 137.18 44.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.926 0.394 . . . . 0.0 111.624 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.634 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 5.9 m -129.94 140.76 50.88 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.677 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.803 ' CB ' ' HG ' ' A' ' 140' ' ' LEU . 21.2 p-10 -80.71 93.79 6.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.36 0.6 . . . . 0.0 110.542 178.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -92.78 91.24 7.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.981 0.42 . . . . 0.0 111.065 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.9 t30 51.86 45.23 28.58 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.361 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.35 34.4 29.26 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.728 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.658 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 32.8 t60 -155.35 122.0 5.33 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.741 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 55.3 m-85 -58.44 143.98 43.65 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.93 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.648 ' NE ' ' HA ' ' A' ' 51' ' ' ARG . 4.4 mmp_? -146.14 134.26 21.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.449 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.772 ' HZ2' ' HA ' ' A' ' 153' ' ' LEU . 95.0 m95 . . . . . 0 C--N 1.322 -0.62 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.107 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.2 m . . . . . 0 N--CA 1.45 -0.462 0 CA-C-O 120.95 0.405 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.3 177.16 7.79 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.203 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.449 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 8.9 p -130.32 119.73 23.27 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.415 HG21 ' CE1' ' A' ' 80' ' ' PHE . 8.2 p -109.48 140.51 27.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.685 0.278 . . . . 0.0 110.623 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 7.1 m -88.27 131.1 34.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.246 0.546 . . . . 0.0 110.28 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.499 ' CG2' HD12 ' A' ' 99' ' ' ILE . 43.0 t -81.1 134.93 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.9 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.597 HE21 ' HA ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -108.8 170.61 7.93 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 124.1 0.875 . . . . 0.0 109.939 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.667 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 34.7 tt0 -65.12 120.13 12.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.834 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.67 -7.19 45.52 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.879 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -95.04 148.15 22.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.331 0.586 . . . . 0.0 112.029 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.609 ' HA ' HG12 ' A' ' 99' ' ' ILE . 74.5 p -133.38 170.75 15.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.695 HD22 HG23 ' A' ' 99' ' ' ILE . 1.1 mm? -52.18 -45.9 65.32 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.899 0.772 . . . . 0.0 109.453 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -57.49 -38.64 74.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.367 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.66 -43.74 46.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.594 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.557 HG12 ' O ' ' A' ' 72' ' ' THR . 43.5 mm -59.83 -46.55 93.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.885 0.374 . . . . 0.0 110.059 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.645 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.86 -51.73 56.39 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.555 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -66.85 -30.81 71.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.025 0.44 . . . . 0.0 111.43 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -70.12 -46.82 63.99 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.415 ' CE1' HG21 ' A' ' 65' ' ' VAL . 89.7 m-85 -103.59 12.62 34.72 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.0 t0 60.21 57.88 2.8 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.96 0.886 . . . . 0.0 110.812 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.645 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -140.02 164.88 28.85 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.065 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.686 ' O ' HG13 ' A' ' 87' ' ' ILE . 6.8 m-20 -83.05 114.95 21.64 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.643 ' HD1' ' HB2' ' A' ' 95' ' ' ASN . 10.6 p90 -54.57 -31.53 56.86 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.724 0.64 . . . . 0.0 111.142 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.528 ' HA ' ' HB3' ' A' ' 95' ' ' ASN . 51.0 t-80 -71.86 -36.03 70.01 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.719 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.595 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 9.9 tp10 -68.77 -47.0 67.3 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.686 HG13 ' O ' ' A' ' 83' ' ' ASP . 7.1 mt -51.91 -47.94 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.017 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.593 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.83 -50.92 69.05 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.345 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -56.8 -39.79 74.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.934 0.397 . . . . 0.0 111.418 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.595 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 21.7 mmt180 -70.17 -31.07 68.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.108 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 17.5 t-20 -90.74 -6.04 54.93 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.985 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 93.0 m-20 79.5 17.75 0.8 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.524 0.73 . . . . 0.0 111.089 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.593 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 14.5 pt -110.68 -173.17 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.585 178.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.539 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 52.5 mt-30 -115.1 154.42 28.94 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.643 ' HB2' ' HD1' ' A' ' 84' ' ' PHE . 6.9 p-10 -56.6 -55.1 38.25 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 122.199 1.0 . . . . 0.0 109.329 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -78.52 12.92 1.78 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.091 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.539 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 0.7 OUTLIER -70.96 -29.96 66.1 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.093 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 9.6 mp 69.88 114.61 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 O-C-N 124.266 0.979 . . . . 0.0 110.433 -177.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.695 HG23 HD22 ' A' ' 73' ' ' LEU . 9.5 pt -94.63 176.03 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 114.81 -1.087 . . . . 0.0 111.338 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.556 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 90.5 m-85 -130.71 160.03 68.28 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.941 -178.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.667 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 20.1 Cg_endo -66.05 135.28 40.03 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.299 2.666 . . . . 0.0 114.048 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.73 23.38 18.5 Favored Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.397 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.49 ' O ' ' HA ' ' A' ' 66' ' ' THR . 46.1 mt-30 -111.88 165.35 12.16 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 120.574 -0.45 . . . . 0.0 109.837 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.449 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 65.6 t -125.45 115.73 44.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.496 ' HB3' HG22 ' A' ' 87' ' ' ILE . 81.7 mt -108.19 150.87 26.69 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.711 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -90.62 115.41 27.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.394 0.616 . . . . 0.0 110.613 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.0 m -120.37 150.5 51.95 Favored Pre-proline 0 C--N 1.311 -1.08 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.388 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.93 -19.28 58.27 Favored 'Trans proline' 0 C--N 1.332 -0.304 0 C-N-CA 123.195 2.597 . . . . 0.0 113.96 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 C--N 1.32 -0.694 0 CA-C-O 121.356 0.598 . . . . 0.0 111.351 179.937 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.634 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.444 -0.809 0 N-CA-C 112.088 -0.405 . . . . 0.0 112.088 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 21.6 m120 75.24 27.16 1.12 Allowed 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.751 0.82 . . . . 0.0 112.476 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.593 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 18.8 p90 -63.46 -39.29 94.07 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.546 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 63.7 t-105 -61.94 -31.44 71.77 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.133 -178.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -58.75 -16.22 15.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 111.27 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.729 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 36.3 m -145.75 30.55 1.08 Allowed 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.164 177.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.546 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -110.38 136.47 49.49 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.595 177.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.4 tmm_? -125.03 137.04 54.23 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.61 57.99 3.52 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.625 0.578 . . . . 0.0 111.164 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.505 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 34.6 t -85.53 124.96 40.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.114 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.486 ' O ' HD12 ' A' ' 136' ' ' LEU . 38.7 ptt180 -148.98 142.97 25.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.956 0.408 . . . . 0.0 111.143 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.93 HD13 HG22 ' A' ' 14' ' ' ILE . 23.1 mt -85.09 131.97 34.38 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.74 HG23 ' HB ' ' A' ' 135' ' ' VAL . 28.9 m -125.28 158.98 33.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.712 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.68 ' HB3' ' CG ' ' A' ' 134' ' ' LYS . 0.2 OUTLIER 68.55 11.13 8.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.152 179.52 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.664 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 91.28 31.33 9.77 Favored Glycine 0 N--CA 1.437 -1.251 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.092 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.508 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 93.25 -14.91 64.17 Favored Glycine 0 C--O 1.265 2.062 0 CA-C-O 123.005 1.336 . . . . 0.0 113.627 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.68 ' CG ' ' HB3' ' A' ' 131' ' ' ASP . 7.8 ptpp? -72.99 -15.63 61.53 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 121.241 -1.153 . . . . 0.0 109.024 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.74 ' HB ' HG23 ' A' ' 130' ' ' VAL . 12.0 t -139.27 147.37 24.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.718 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.579 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 47.9 tp -128.95 123.14 31.73 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -112.46 130.94 55.82 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 123.273 0.358 . . . . 0.0 110.772 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.727 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.72 161.6 26.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.188 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.668 ' HG2' ' HG3' ' A' ' 148' ' ' ARG . 39.3 mt-10 -98.0 106.17 18.43 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.628 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.803 ' HG ' ' CB ' ' A' ' 45' ' ' ASN . 0.5 OUTLIER -89.71 126.03 35.5 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.852 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.729 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 52.3 ttt-85 -69.97 140.38 52.97 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.647 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.664 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 2.9 p90 -151.6 -164.94 2.11 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.148 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.3 t -59.78 -25.61 65.05 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -107.65 28.88 11.29 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.591 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 96.46 -114.45 4.94 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.485 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -125.27 129.38 49.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.78 0.29 . . . . 0.0 110.666 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.664 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 22.9 t-20 -123.56 132.87 54.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.711 0.291 . . . . 0.0 111.114 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.668 ' HG3' ' HG2' ' A' ' 139' ' ' GLU . 38.2 mtp85 -74.86 113.18 11.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.533 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.658 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 33.7 t -128.9 165.53 20.88 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.047 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.579 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 19.4 ptt180 -147.74 148.69 31.25 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.138 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.741 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 11.6 tt -130.68 161.67 40.15 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.428 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.531 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 14.6 m-85 -104.88 105.46 15.53 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 122.265 -0.272 . . . . 0.0 110.991 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.78 HD23 HD22 ' A' ' 21' ' ' LEU . 9.9 mp -69.27 -31.62 70.25 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.502 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.626 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 11.1 t70 -58.99 -7.84 1.21 Allowed 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.932 178.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.528 ' HG3' ' O ' ' A' ' 152' ' ' TYR . 37.0 mt-10 -72.73 -51.78 17.81 Favored 'General case' 0 CA--C 1.508 -0.635 0 O-C-N 121.862 -0.523 . . . . 0.0 112.31 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -122.55 2.22 9.57 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.126 -177.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.412 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 46.2 mm -106.26 110.44 31.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.431 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.449 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -113.43 168.77 12.68 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.28 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.601 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 1.6 t30 -100.83 119.8 39.19 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.666 ' HD3' HD12 ' A' ' 165' ' ' ILE . 58.5 ttt180 -115.12 88.68 2.92 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.807 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 17.8 m120 59.55 34.7 22.49 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.937 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.58 -4.55 43.34 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.023 -1.084 . . . . 0.0 114.243 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.603 ' HG2' ' O ' ' A' ' 160' ' ' ARG . 14.4 pt-20 -122.02 139.79 53.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.683 0.742 . . . . 0.0 110.9 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.404 ' CD2' ' HD2' ' A' ' 7' ' ' PHE . 76.0 mt -76.23 115.12 15.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.386 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.666 HD12 ' HD3' ' A' ' 160' ' ' ARG . 47.7 mt . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.953 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.634 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 33.9 m-85 . . . . . 0 N--CA 1.452 -0.37 0 CA-C-O 120.703 0.287 . . . . 0.0 111.488 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.39 -26.99 6.51 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -76.09 -67.85 1.63 Allowed Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 119.069 -1.539 . . . . 0.0 112.363 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 63.94 15.01 8.84 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 122.973 0.509 . . . . 0.0 110.71 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.685 ' CE2' HD13 ' A' ' 14' ' ' ILE . 2.1 p90 -56.4 -37.23 69.85 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.549 ' HA ' HD11 ' A' ' 14' ' ' ILE . 3.9 m -60.2 -23.05 63.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.841 0.353 . . . . 0.0 111.745 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.19 -21.66 77.2 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.974 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.517 ' HB2' ' HB3' ' A' ' 26' ' ' ARG . 33.2 p -125.19 -24.88 3.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.12 0.486 . . . . 0.0 111.321 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.2 m -94.64 131.63 40.22 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.815 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 12' ' ' ARG . 10.5 ptm180 -113.4 -179.54 3.67 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.426 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 9.0 m-20 47.53 44.65 17.12 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 123.832 0.708 . . . . 0.0 111.41 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.762 HG22 ' CD1' ' A' ' 129' ' ' LEU . 7.2 mt -80.22 103.25 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-O 121.039 0.447 . . . . 0.0 110.425 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.586 ' O ' ' HB3' ' A' ' 22' ' ' ARG . 72.0 m -146.95 127.5 14.15 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.85 HD21 HD12 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -91.91 157.99 16.53 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.086 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -97.24 76.08 2.6 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 113.958 -1.474 . . . . 0.0 107.815 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.44 -58.92 5.01 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.994 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -148.66 -6.45 0.4 Allowed 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -97.81 98.03 9.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.117 0.484 . . . . 0.0 110.382 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.901 ' HB2' HD22 ' A' ' 39' ' ' LEU . 42.9 tp -54.25 129.88 36.74 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 114.871 -1.058 . . . . 0.0 112.489 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.586 ' HB3' ' O ' ' A' ' 15' ' ' CYS . 16.2 ttp180 -132.62 124.1 27.67 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.601 -0.439 . . . . 0.0 110.089 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.639 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -147.23 144.43 28.89 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.663 0.744 . . . . 0.0 111.682 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.623 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 2.3 mm-40 -79.27 75.66 5.84 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.882 178.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.598 ' HB2' ' HA2' ' A' ' 162' ' ' GLY . 46.2 m -62.43 124.57 21.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.49 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.517 ' HB3' ' HB2' ' A' ' 10' ' ' SER . 58.6 ttp180 -68.92 119.92 14.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.336 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -90.27 153.5 20.42 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.93 -13.07 4.23 Favored Glycine 0 C--N 1.33 0.232 0 O-C-N 124.443 1.09 . . . . 0.0 115.005 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -83.52 -2.91 57.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.978 0.418 . . . . 0.0 110.554 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.59 10.99 66.79 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -112.4 145.29 18.02 Favored Glycine 0 C--O 1.226 -0.387 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.408 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.623 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 69.4 m-85 -89.35 133.36 34.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.878 0.339 . . . . 0.0 110.433 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.8 m -115.16 124.75 52.28 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.307 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.0 m -68.31 107.42 2.82 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.09 0.472 . . . . 0.0 109.938 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 48.0 t -113.18 152.58 29.53 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.062 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.664 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.2 p -145.13 130.61 13.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.097 0.475 . . . . 0.0 110.757 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.4 HG23 ' HB3' ' A' ' 21' ' ' LEU . 15.3 tt -130.11 143.23 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.676 -177.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.15 101.37 3.92 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.71 0.29 . . . . 0.0 111.572 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.901 HD22 ' HB2' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -82.44 -9.78 59.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.079 0.466 . . . . 0.0 110.301 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.528 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 2.1 p-10 -62.59 -18.13 61.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.215 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -112.63 20.7 16.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.303 0.573 . . . . 0.0 110.179 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 27.4 m-85 -131.34 -33.35 1.48 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.001 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.751 HD22 HD13 ' A' ' 151' ' ' ILE . 50.3 mt -106.25 135.01 48.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.689 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.632 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 3.3 m -126.34 138.15 53.54 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.033 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.901 ' CB ' ' HG ' ' A' ' 140' ' ' LEU . 16.1 p-10 -86.75 102.14 13.96 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.524 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.467 ' CB ' ' HD3' ' A' ' 51' ' ' ARG . 17.1 t70 -107.05 93.2 4.42 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.083 0.468 . . . . 0.0 110.507 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.7 t30 55.99 43.15 27.69 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.096 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 149' ' ' SER . . . 83.06 27.36 41.03 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.697 -0.764 . . . . 0.0 113.649 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.443 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 69.9 m-70 -144.47 139.06 28.06 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.974 ' HZ ' ' HB3' ' A' ' 138' ' ' ALA . 49.8 m-85 -80.88 144.25 32.11 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.206 0.527 . . . . 0.0 111.892 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.467 ' HD3' ' CB ' ' A' ' 46' ' ' ASP . 26.6 mtp180 -146.6 132.82 19.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.711 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.624 ' HZ2' ' HA ' ' A' ' 153' ' ' LEU . 97.2 m95 . . . . . 0 C--N 1.32 -0.708 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.315 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 55.3 m . . . . . 0 N--CA 1.453 -0.321 0 CA-C-O 121.077 0.465 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -133.89 176.59 8.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.642 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.512 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 20.7 p -129.62 122.58 29.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.885 0.374 . . . . 0.0 111.124 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.479 HG21 ' CE2' ' A' ' 80' ' ' PHE . 10.8 p -108.22 139.79 29.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.838 0.352 . . . . 0.0 111.46 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.0 m -91.62 125.64 36.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.242 0.544 . . . . 0.0 109.648 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.872 HG21 HD12 ' A' ' 99' ' ' ILE . 86.6 t -84.06 131.14 34.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.341 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -106.1 169.46 8.49 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 124.059 0.849 . . . . 0.0 110.688 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.686 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 33.0 tt0 -55.65 117.67 3.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.295 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.36 4.89 40.52 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.34 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.452 ' HB2' HG13 ' A' ' 67' ' ' VAL . 95.3 m-20 -109.75 138.44 46.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.065 0.46 . . . . 0.0 111.939 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.671 ' HA ' HG12 ' A' ' 99' ' ' ILE . 68.6 p -122.84 173.99 7.42 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.744 HD22 HG23 ' A' ' 99' ' ' ILE . 0.7 OUTLIER -51.34 -43.06 61.66 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.525 0.602 . . . . 0.0 110.372 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -62.07 -35.89 79.99 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.883 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -73.89 -40.63 63.06 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.441 HG12 ' O ' ' A' ' 72' ' ' THR . 46.1 mm -63.14 -49.25 84.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.692 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -59.31 -52.57 52.46 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.652 -0.704 . . . . 0.0 113.539 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -64.5 -25.59 68.06 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -81.57 -49.5 10.47 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.479 ' CE2' HG21 ' A' ' 65' ' ' VAL . 96.2 m-85 -94.13 12.95 24.7 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.8 t70 60.59 44.32 11.74 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.998 0.904 . . . . 0.0 110.797 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.692 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.8 p -126.19 162.4 25.5 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.865 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.471 ' O ' HG13 ' A' ' 87' ' ' ILE . 4.1 p-10 -92.91 119.09 31.85 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.558 0.694 . . . . 0.0 109.437 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.694 ' HD2' ' HB2' ' A' ' 95' ' ' ASN . 7.7 p90 -47.86 -32.57 6.34 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 114.431 -1.258 . . . . 0.0 111.895 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.412 ' HA ' ' HB3' ' A' ' 95' ' ' ASN . 40.7 t-80 -60.48 -47.85 84.33 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.951 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.604 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 6.2 tp10 -63.54 -47.04 83.24 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.928 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.493 HD12 ' HA ' ' A' ' 84' ' ' PHE . 5.1 mt -49.7 -47.06 21.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.413 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.612 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.84 -50.3 71.48 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.907 178.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 85' ' ' HIS . 48.6 mtm180 -58.9 -34.48 71.73 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.604 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 11.5 mmt180 -74.98 -28.22 60.47 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.914 0.388 . . . . 0.0 111.538 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.484 HD22 HG23 ' A' ' 93' ' ' ILE . 5.4 t30 -96.43 -5.1 40.48 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.622 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 89.6 m-20 78.2 15.66 1.36 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.313 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.612 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 17.0 pt -103.57 -169.22 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.388 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 41.6 mt-30 -120.42 153.35 36.69 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.694 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 4.4 p30 -56.94 -57.5 12.27 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 121.826 0.822 . . . . 0.0 109.6 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.68 11.93 2.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.495 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 0.7 OUTLIER -71.48 -35.08 70.69 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.369 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.487 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 9.7 mp 72.65 119.46 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.367 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.872 HD12 HG21 ' A' ' 67' ' ' VAL . 7.1 pt -94.55 176.68 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.328 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.507 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 92.7 m-85 -124.44 160.39 53.25 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.977 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.686 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 28.9 Cg_endo -70.66 132.04 21.13 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.958 2.439 . . . . 0.0 113.143 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.47 9.29 41.55 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -100.46 148.03 25.2 Favored 'General case' 0 C--O 1.215 -0.757 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.512 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 61.1 t -114.6 111.15 34.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.658 HD11 HG21 ' A' ' 99' ' ' ILE . 64.3 mt -101.08 151.66 21.54 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.086 -177.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.452 ' HG2' HG22 ' A' ' 64' ' ' THR . 17.8 mt-30 -90.29 113.72 25.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.702 0.763 . . . . 0.0 110.786 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.8 m -120.19 151.1 52.69 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.607 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.99 -16.35 54.42 Favored 'Trans proline' 0 C--N 1.333 -0.262 0 C-N-CA 123.392 2.728 . . . . 0.0 114.201 -177.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.2 t . . . . . 0 C--N 1.321 -0.654 0 CA-C-O 120.939 0.399 . . . . 0.0 111.088 -179.969 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.632 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.442 -0.957 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 19.7 m120 74.35 25.77 1.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.465 0.706 . . . . 0.0 112.241 178.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.613 ' CD2' ' HE1' ' A' ' 50' ' ' PHE . 12.4 p90 -64.14 -40.43 96.14 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.591 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 62.7 t-105 -59.17 -31.01 68.6 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.081 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -53.77 -28.02 32.32 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.739 0.304 . . . . 0.0 110.834 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.752 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 16.2 m -137.63 31.18 2.55 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.281 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.591 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -111.65 146.69 37.01 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.15 0.5 . . . . 0.0 111.318 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -132.34 148.02 52.41 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.558 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 50.66 50.82 18.18 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 124.053 0.846 . . . . 0.0 112.116 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.483 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 31.6 t -74.22 125.24 33.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -149.59 153.51 37.22 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.126 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.762 ' CD1' HG22 ' A' ' 14' ' ' ILE . 25.8 mt -97.5 139.71 33.01 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.807 0.337 . . . . 0.0 110.799 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.541 HG23 ' HB ' ' A' ' 135' ' ' VAL . 33.7 m -133.44 156.04 41.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.789 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.592 ' HB3' ' HD2' ' A' ' 134' ' ' LYS . 1.4 m-20 70.13 5.74 5.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.663 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.73 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 99.35 35.59 4.66 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.289 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.61 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 82.48 -9.58 58.08 Favored Glycine 0 C--O 1.256 1.523 0 CA-C-O 123.003 1.335 . . . . 0.0 113.198 176.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.648 ' O ' ' HA ' ' A' ' 152' ' ' TYR . 18.1 ptpt -74.47 -16.23 60.86 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.569 HG23 ' HG3' ' A' ' 134' ' ' LYS . 24.4 t -140.69 140.21 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.075 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.85 HD12 HD21 ' A' ' 16' ' ' LEU . 7.7 tt -119.01 125.15 48.7 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -110.35 124.45 51.71 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.974 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -157.46 155.67 30.82 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.939 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 31.1 mt-10 -95.0 108.33 20.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.272 0.558 . . . . 0.0 110.605 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.901 ' HG ' ' CB ' ' A' ' 45' ' ' ASN . 0.2 OUTLIER -90.24 128.7 36.46 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.752 -179.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.752 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 75.7 ttt180 -70.04 140.69 52.87 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.403 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.481 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.7 p90 -156.46 -171.95 3.89 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.383 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.8 m -55.87 -29.9 60.65 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.787 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -97.67 20.75 49.42 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.204 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 98.75 -110.12 3.94 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.251 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -129.44 133.1 47.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.636 0.255 . . . . 0.0 110.786 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.481 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 11.8 t30 -134.43 127.37 31.39 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.642 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 29.7 ttp180 -79.93 102.35 9.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.448 0.642 . . . . 0.0 110.759 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.443 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 11.4 t -105.27 174.62 5.8 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.124 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.662 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 34.7 ptt180 -147.43 148.24 31.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.918 0.389 . . . . 0.0 111.787 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.751 HD13 HD22 ' A' ' 43' ' ' LEU . 10.9 tt -131.6 159.59 42.96 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.512 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.689 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 44.0 m-85 -99.79 106.04 17.88 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.341 0.115 . . . . 0.0 110.775 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.71 HD11 HD21 ' A' ' 129' ' ' LEU . 16.5 mt -68.74 -35.86 77.66 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.312 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.431 ' HA ' ' HD1' ' A' ' 7' ' ' PHE . 8.3 p-10 -58.26 -8.05 1.02 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.976 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.689 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 41.8 mt-10 -69.41 -55.2 11.02 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.236 0.541 . . . . 0.0 111.912 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -122.23 6.02 9.7 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.306 -177.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.471 HG12 ' CH2' ' A' ' 52' ' ' TRP . 44.3 mm -107.15 113.2 42.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.88 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -112.71 173.04 14.95 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.965 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.535 ' CG ' ' HB3' ' A' ' 25' ' ' CYS . 0.9 OUTLIER -110.95 128.27 55.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.96 89.14 3.07 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.37 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 56.99 42.16 26.58 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.442 0.464 . . . . 0.0 111.794 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.598 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 92.51 7.93 62.93 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.928 -0.654 . . . . 0.0 113.406 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -123.59 127.01 47.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.147 0.473 . . . . 0.0 112.094 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.405 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 42.1 mt -70.82 110.39 5.56 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.481 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 63.3 mt . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.382 179.854 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.478 ' HD2' ' HG2' ' A' ' 155' ' ' GLU . 45.3 m-85 . . . . . 0 N--CA 1.456 -0.154 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -118.73 -27.75 5.78 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.54 -71.24 0.85 Allowed Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 119.988 -1.101 . . . . 0.0 112.784 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 65.78 10.47 6.85 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 122.455 0.302 . . . . 0.0 110.749 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.634 ' CE2' HD13 ' A' ' 14' ' ' ILE . 1.1 p90 -61.08 -34.08 74.36 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.404 ' HA ' HD11 ' A' ' 14' ' ' ILE . 23.3 t -68.02 -16.88 64.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.106 0.479 . . . . 0.0 110.279 -178.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.24 -21.16 79.94 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.746 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 11.1 m -130.45 -19.17 3.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.978 0.389 . . . . 0.0 111.622 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 m -94.41 135.09 36.23 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.561 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 11.7 ptm180 -112.72 -178.91 3.51 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.432 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 0.6 OUTLIER 40.75 47.98 2.57 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 123.909 0.755 . . . . 0.0 112.343 -179.648 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.825 HG22 HD13 ' A' ' 129' ' ' LEU . 7.9 mt -80.66 103.83 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.597 ' HA ' HD12 ' A' ' 129' ' ' LEU . 45.4 t -147.95 126.19 12.23 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.78 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -92.34 154.93 18.26 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.559 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -95.09 74.66 3.45 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.4 -57.87 4.88 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.925 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.453 ' HA ' ' HZ ' ' A' ' 120' ' ' PHE . . . -145.28 -9.31 0.58 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.816 0.341 . . . . 0.0 110.257 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -94.98 95.59 8.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.823 0.344 . . . . 0.0 110.089 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.857 ' HB2' HD22 ' A' ' 39' ' ' LEU . 42.8 tp -59.28 128.12 35.53 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.369 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.543 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 51.1 ttt180 -131.1 129.83 42.38 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.05 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.62 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -150.61 147.34 27.3 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.383 0.611 . . . . 0.0 111.19 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.571 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 1.3 mm-40 -84.49 81.31 8.9 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.842 178.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.553 ' HB2' ' HA2' ' A' ' 162' ' ' GLY . 58.6 m -67.6 128.08 35.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.494 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 10' ' ' SER . 51.1 ttt-85 -74.37 116.19 14.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.793 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -89.5 159.02 17.45 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.092 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.48 -18.23 3.52 Favored Glycine 0 C--N 1.337 0.592 0 O-C-N 124.861 1.351 . . . . 0.0 114.442 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -71.64 -12.37 61.31 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.03 9.62 60.58 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.39 163.69 12.12 Favored Glycine 0 C--O 1.228 -0.238 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.032 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.571 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 70.2 m-85 -100.02 134.03 43.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.63 0.252 . . . . 0.0 110.499 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.6 m -123.79 128.68 49.9 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.271 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.4 114.72 6.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.02 0.438 . . . . 0.0 110.771 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 29.7 t -119.89 149.56 41.89 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.777 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 2.8 p -142.04 136.48 29.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.002 0.43 . . . . 0.0 111.204 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.444 HG23 ' HB3' ' A' ' 21' ' ' LEU . 13.4 tt -134.06 144.38 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.73 -177.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -77.84 98.81 5.71 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.798 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.857 HD22 ' HB2' ' A' ' 21' ' ' LEU . 1.3 mp -76.25 -6.4 51.25 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.272 0.558 . . . . 0.0 110.153 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.619 HD21 ' HA ' ' A' ' 119' ' ' ASN . 4.8 t-20 -63.61 -21.65 66.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.65 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.8 ptt85 -111.32 19.35 18.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.039 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.553 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 38.6 m-85 -131.44 -32.66 1.52 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.638 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.739 HD22 HD13 ' A' ' 151' ' ' ILE . 51.7 mt -109.71 138.53 45.95 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.036 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 m -132.79 144.22 50.09 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.612 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.467 ' ND2' ' HB2' ' A' ' 123' ' ' SER . 21.6 p-10 -88.27 106.5 18.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.425 0.631 . . . . 0.0 110.205 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -103.24 92.43 4.51 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 122.133 -0.354 . . . . 0.0 110.906 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 49.51 44.29 24.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.78 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.595 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 85.82 30.0 24.8 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.486 178.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.675 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 21.9 t-160 -152.58 124.6 8.01 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.766 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 63.6 m-85 -62.26 143.3 57.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.791 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.4 mtm180 -144.8 134.32 23.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.409 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.553 ' HA ' ' O ' ' A' ' 42' ' ' TYR . 99.4 m95 . . . . . 0 C--N 1.323 -0.563 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.882 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.8 m . . . . . 0 N--CA 1.448 -0.554 0 CA-C-O 121.177 0.513 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 106' ' ' GLN . . . -106.43 176.55 5.13 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.68 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.55 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 10.0 p -126.85 115.89 20.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.957 0.408 . . . . 0.0 112.074 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.562 HG21 ' CE2' ' A' ' 80' ' ' PHE . 7.4 p -106.29 148.04 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.062 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 10.3 m -93.04 130.27 38.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.172 0.51 . . . . 0.0 110.454 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.553 HG21 HD12 ' A' ' 99' ' ' ILE . 58.2 t -83.26 138.39 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.185 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -108.4 171.2 7.55 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 124.373 1.045 . . . . 0.0 109.61 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.7 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 63.7 tt0 -68.95 126.05 28.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.395 -178.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.44 8.55 59.71 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.988 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -119.84 123.18 43.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.902 0.382 . . . . 0.0 110.962 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.557 ' HA ' HG12 ' A' ' 99' ' ' ILE . 69.3 p -104.76 -176.91 3.21 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.61 HD22 HG23 ' A' ' 99' ' ' ILE . 1.3 mm? -51.53 -40.79 60.34 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.392 0.615 . . . . 0.0 109.55 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.443 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 38.8 ttm180 -60.06 -42.47 94.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.253 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -70.66 -43.39 69.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.355 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 72' ' ' THR . 38.3 mm -62.96 -45.33 99.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.732 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.95 -56.22 26.36 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.654 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -64.72 -26.73 68.49 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 45.6 ttm-85 -72.98 -38.86 66.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.562 ' CE2' HG21 ' A' ' 65' ' ' VAL . 96.8 m-85 -111.02 19.64 18.26 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.9 t70 55.27 36.17 26.48 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.679 0.752 . . . . 0.0 111.776 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.732 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.5 p -113.72 171.19 7.73 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.672 ' O ' HG13 ' A' ' 87' ' ' ILE . 6.9 t70 -97.77 127.34 43.65 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.91 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.503 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 11.1 p90 -52.92 -30.12 32.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.287 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -73.33 -38.01 65.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.975 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -68.16 -45.91 72.21 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.672 HG13 ' O ' ' A' ' 83' ' ' ASP . 6.0 mt -54.67 -47.03 73.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.61 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.93 -47.89 81.28 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.679 177.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -56.75 -42.41 79.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.981 0.42 . . . . 0.0 111.369 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -69.79 -36.24 75.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.759 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.534 HD22 HG23 ' A' ' 93' ' ' ILE . 7.2 t30 -89.4 -5.33 57.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.387 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 94.0 m-20 74.8 21.05 2.17 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.587 0.755 . . . . 0.0 111.425 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.61 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 17.6 pt -108.89 -173.48 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.581 ' H ' ' HB2' ' A' ' 97' ' ' ASP . 88.7 mt-30 -110.62 158.15 18.9 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.535 ' O ' HD23 ' A' ' 73' ' ' LEU . 3.2 p-10 -58.98 -55.34 36.46 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-O 122.221 1.01 . . . . 0.0 108.43 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -79.68 12.06 2.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.666 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.581 ' HB2' ' H ' ' A' ' 94' ' ' GLN . 4.4 t70 -63.73 -32.57 74.1 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.1 mt 70.68 112.44 0.05 Allowed 'General case' 0 C--O 1.234 0.249 0 O-C-N 124.465 1.103 . . . . 0.0 110.123 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.835 HG21 HD11 ' A' ' 105' ' ' LEU . 14.4 pt -95.33 175.14 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.155 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.512 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 97.5 m-85 -128.96 158.8 71.52 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.969 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.7 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 20.8 Cg_endo -66.97 138.81 49.19 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.508 2.806 . . . . 0.0 114.307 -178.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.07 11.3 57.72 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.702 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 66' ' ' THR . 74.1 mt-30 -102.64 166.04 10.73 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.352 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.55 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 80.9 t -122.39 114.78 43.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-O 120.931 0.396 . . . . 0.0 110.198 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.835 HD11 HG21 ' A' ' 99' ' ' ILE . 79.0 mt -107.26 152.01 24.68 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.823 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 63' ' ' ALA . 72.9 mt-30 -89.9 116.22 27.81 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.795 0.807 . . . . 0.0 111.45 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.9 m -126.29 150.91 71.42 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 114.253 -1.339 . . . . 0.0 109.954 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.68 -17.41 59.82 Favored 'Trans proline' 0 N--CA 1.476 0.442 0 C-N-CA 123.735 2.957 . . . . 0.0 114.952 -177.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.6 t . . . . . 0 C--N 1.324 -0.542 0 CA-C-O 120.942 0.401 . . . . 0.0 111.268 -179.859 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.445 -0.718 0 N-CA-C 111.905 -0.478 . . . . 0.0 111.905 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.619 ' HA ' HD21 ' A' ' 40' ' ' ASN . 6.9 m-20 72.28 25.55 2.84 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 178.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.6 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 25.3 p90 -55.78 -39.14 70.84 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.627 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 62.2 t-105 -59.03 -32.96 70.21 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.67 -178.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -52.31 -38.6 58.91 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 121.7 0.762 . . . . 0.0 110.77 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.946 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 17.2 m -122.91 25.85 8.42 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.503 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.627 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -114.72 134.61 54.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.857 0.36 . . . . 0.0 111.05 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.602 ' HD2' ' O ' ' A' ' 124' ' ' ALA . 7.1 mpt_? -131.33 158.61 40.23 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.631 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.9 t70 53.94 46.1 26.32 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.761 0.791 . . . . 0.0 110.214 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.493 ' CG1' HD11 ' A' ' 136' ' ' LEU . 22.5 t -79.85 122.09 34.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.614 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 128' ' ' ARG . 1.3 ptp85 -146.55 147.8 31.5 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.286 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.825 HD13 HG22 ' A' ' 14' ' ' ILE . 19.4 mt -86.97 127.84 35.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.204 0.526 . . . . 0.0 110.072 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.853 HG23 ' HB ' ' A' ' 135' ' ' VAL . 27.6 m -116.79 157.17 17.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.909 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.501 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 0.9 OUTLIER 68.42 3.23 3.67 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.584 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.642 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 97.91 29.24 7.78 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.32 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 98.34 -22.05 42.89 Favored Glycine 0 C--O 1.261 1.828 0 CA-C-O 123.014 1.341 . . . . 0.0 113.098 177.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.66 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 40.5 pttt -67.97 -14.79 63.24 Favored 'General case' 0 C--N 1.317 -0.814 0 O-C-N 121.279 -1.13 . . . . 0.0 109.271 177.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.853 ' HB ' HG23 ' A' ' 130' ' ' VAL . 3.1 t -140.85 146.91 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.895 177.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 26.5 tp -129.33 122.62 29.91 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -117.49 137.62 52.41 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.884 0.373 . . . . 0.0 110.988 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.636 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -160.09 169.32 23.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.575 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 124' ' ' ALA . 8.5 mm-40 -95.33 106.45 18.5 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.595 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 58.8 mt -97.81 125.06 42.46 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.457 0.646 . . . . 0.0 111.468 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.946 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 65.4 ttt180 -70.28 141.34 52.41 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.933 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.42 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 4.8 p90 -152.35 -173.73 4.65 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.868 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.0 m -56.2 -24.66 43.3 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -108.56 27.98 12.5 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.502 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 102.43 -117.89 5.94 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.161 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.431 ' CH2' ' HD3' ' A' ' 125' ' ' ARG . 80.0 m95 -127.2 142.14 51.56 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.42 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 54.6 t30 -138.02 137.74 38.16 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.8 ttt85 -85.03 113.75 21.68 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.065 0.46 . . . . 0.0 110.72 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.675 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 47.5 t -122.75 166.61 14.67 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.943 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 10.2 ptt180 -147.37 145.25 29.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.205 0.526 . . . . 0.0 111.677 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.766 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 6.9 tt -124.79 150.56 29.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.676 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.326 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.584 ' CB ' ' HG3' ' A' ' 155' ' ' GLU . 18.1 m-85 -94.74 103.96 15.87 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 122.166 -0.334 . . . . 0.0 110.921 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.743 HD13 HD22 ' A' ' 21' ' ' LEU . 25.4 mt -65.07 -36.51 84.57 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.09 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.66 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 8.8 t70 -57.61 -7.97 0.77 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.943 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.584 ' HG3' ' CB ' ' A' ' 152' ' ' TYR . 42.0 mt-10 -70.63 -54.31 12.46 Favored 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 122.002 -0.436 . . . . 0.0 112.081 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -125.57 5.03 7.54 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.165 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.498 HG12 ' CH2' ' A' ' 52' ' ' TRP . 41.7 mm -101.87 106.47 19.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -110.89 161.88 12.68 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.978 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.506 ' HA ' ' O ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER -103.61 136.36 43.46 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -119.01 86.55 2.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.621 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 48.6 50.48 17.01 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.553 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 99.55 6.01 55.18 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.318 -0.944 . . . . 0.0 113.815 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 159' ' ' ASN . 37.8 mt-10 -123.25 153.81 39.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 117.121 0.461 . . . . 0.0 111.288 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.454 HD21 ' HD2' ' A' ' 7' ' ' PHE . 30.8 mt -103.58 121.61 43.26 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.581 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 13.8 tt . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.956 -179.416 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.525 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 58.0 m-85 . . . . . 0 C--O 1.233 0.198 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -96.2 -32.45 12.45 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.91 -74.94 0.37 Allowed Glycine 0 N--CA 1.436 -1.345 0 C-N-CA 119.994 -1.098 . . . . 0.0 113.275 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 66.46 15.72 10.19 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 122.332 0.253 . . . . 0.0 110.83 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.608 ' CE2' HD13 ' A' ' 14' ' ' ILE . 1.4 p90 -61.43 -35.11 76.64 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.509 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.572 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.9 OUTLIER -64.48 -21.43 66.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.246 0.546 . . . . 0.0 110.419 -179.001 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.47 -25.3 75.89 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.265 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 18.4 p -125.72 -10.93 6.72 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 117.135 0.467 . . . . 0.0 111.173 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 6.8 m -107.98 132.33 53.63 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -111.81 -179.46 3.7 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 45.37 46.3 10.36 Favored 'General case' 0 C--N 1.315 -0.933 0 O-C-N 123.859 0.724 . . . . 0.0 111.762 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.875 HG22 HD13 ' A' ' 129' ' ' LEU . 8.0 mt -80.92 106.82 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.6 ' HA ' HD12 ' A' ' 129' ' ' LEU . 73.5 m -147.78 126.98 12.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.064 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.787 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -102.47 158.89 15.9 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 121.431 0.634 . . . . 0.0 111.991 179.447 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -103.47 77.63 1.52 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.77 -54.71 4.98 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.589 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -149.53 -13.44 0.29 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.146 0.498 . . . . 0.0 110.291 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.57 ' HG3' ' CG2' ' A' ' 36' ' ' VAL . 21.0 tpt180 -83.25 85.75 7.16 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.316 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.787 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 54.0 tp -62.78 128.4 35.75 Favored 'General case' 0 C--O 1.213 -0.838 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -133.66 121.88 22.64 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.797 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.623 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -143.22 147.31 34.65 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.452 0.644 . . . . 0.0 111.54 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.514 ' O ' ' HD2' ' A' ' 32' ' ' TYR . 4.7 mm-40 -82.21 76.76 9.08 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.561 -1.199 . . . . 0.0 109.376 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.566 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 69.5 m -65.04 124.81 23.05 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.194 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 10' ' ' SER . 72.0 ttt180 -64.67 134.59 54.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.89 178.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -115.05 151.87 33.48 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.65 -10.62 6.4 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 114.495 -1.23 . . . . 0.0 113.737 -178.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -79.22 1.46 24.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.17 0.51 . . . . 0.0 110.155 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.95 12.15 74.93 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.963 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -130.21 160.56 23.01 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 119.984 -1.103 . . . . 0.0 112.953 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.514 ' HD2' ' O ' ' A' ' 24' ' ' GLU . 76.7 m-85 -95.85 125.15 40.21 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.9 m -108.4 137.34 46.52 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.733 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.1 m -71.93 112.74 8.28 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.151 0.5 . . . . 0.0 110.387 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.432 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 28.0 t -114.32 146.45 40.49 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.19 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.9 p -143.37 133.71 21.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.062 0.458 . . . . 0.0 110.981 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.451 HG23 ' HB3' ' A' ' 21' ' ' LEU . 9.3 tt -135.18 154.0 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.892 -177.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.547 ' OD1' ' HB3' ' A' ' 40' ' ' ASN . 35.2 t0 -89.46 112.4 23.54 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.079 -0.388 . . . . 0.0 110.664 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.521 HD23 ' CB ' ' A' ' 21' ' ' LEU . 3.6 mm? -86.46 -4.83 59.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.927 0.394 . . . . 0.0 110.149 178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.547 ' HB3' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -71.68 -15.45 62.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.805 0.812 . . . . 0.0 108.892 179.058 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.8 mtt180 -105.87 13.22 29.77 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.527 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.426 ' HB2' HD13 ' A' ' 39' ' ' LEU . 48.2 m-85 -133.96 -29.51 1.29 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.712 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.872 HD22 HD13 ' A' ' 151' ' ' ILE . 31.9 mt -109.2 140.62 42.57 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.107 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.487 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 3.1 m -128.56 145.36 51.15 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.842 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.639 HD22 ' HA ' ' A' ' 120' ' ' PHE . 8.1 p30 -89.93 104.43 16.99 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -106.67 94.26 5.03 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.373 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 50.08 42.93 25.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.225 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.659 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 86.2 29.7 24.54 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.241 -0.98 . . . . 0.0 113.125 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.628 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 16.9 t-80 -153.71 127.33 8.72 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.806 ' HZ ' ' HB3' ' A' ' 138' ' ' ALA . 81.4 m-85 -64.08 149.53 47.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.929 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -144.63 129.5 18.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.82 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.474 ' HZ2' ' O ' ' A' ' 152' ' ' TYR . 94.2 m95 . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.971 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 49.2 m . . . . . 0 N--CA 1.451 -0.416 0 CA-C-O 121.127 0.489 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -124.28 176.72 6.26 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.873 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.464 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 17.4 p -128.06 113.67 16.09 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.355 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.432 HG21 ' CE2' ' A' ' 80' ' ' PHE . 9.7 p -102.63 139.78 22.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.918 0.389 . . . . 0.0 110.957 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 8.2 m -88.47 126.16 35.1 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.546 ' CG2' HD12 ' A' ' 99' ' ' ILE . 43.9 t -75.33 130.23 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.132 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -103.6 169.43 8.53 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 124.258 0.974 . . . . 0.0 110.344 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.6 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 6.1 tp-100 -62.0 121.29 12.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.265 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.03 16.04 39.84 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.908 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -121.04 129.54 53.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.862 0.331 . . . . 0.0 111.075 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.655 ' HA ' HG12 ' A' ' 99' ' ' ILE . 74.4 p -115.02 178.05 4.42 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.587 HD22 HG23 ' A' ' 99' ' ' ILE . 1.3 mm? -52.24 -42.71 63.84 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.641 0.734 . . . . 0.0 109.31 178.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.698 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 65.8 mtt180 -59.74 -41.12 90.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.4 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -71.61 -44.48 64.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.278 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.555 HG12 ' O ' ' A' ' 72' ' ' THR . 37.8 mm -58.83 -45.28 91.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.628 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.44 -49.96 68.88 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.693 -0.685 . . . . 0.0 113.321 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.698 ' HD3' ' O ' ' A' ' 74' ' ' ARG . 1.0 OUTLIER -73.84 -27.04 60.89 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 122.434 -0.451 . . . . 0.0 111.632 -179.011 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -76.54 -38.48 54.97 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.432 ' CE2' HG21 ' A' ' 65' ' ' VAL . 95.6 m-85 -112.47 19.94 17.11 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.2 t70 53.55 55.0 9.17 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 122.072 0.939 . . . . 0.0 111.701 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.628 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -136.32 172.87 12.38 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.235 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.678 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.9 t70 -98.73 122.66 42.24 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.905 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.442 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 14.1 p90 -53.16 -27.56 21.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.091 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.78 -34.61 58.0 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.923 0.392 . . . . 0.0 109.954 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.506 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 39.7 tt0 -69.42 -48.56 60.6 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.678 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.4 mt -53.36 -43.89 52.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.973 178.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.601 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.44 -52.0 65.29 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.322 178.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -61.25 -32.41 72.21 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.846 ' HB3' ' HB2' ' A' ' 106' ' ' GLN . 1.9 mmp_? -65.34 -37.11 86.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.08 0.467 . . . . 0.0 110.491 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.703 HD22 HG23 ' A' ' 93' ' ' ILE . 9.9 t30 -93.62 -4.35 50.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.928 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 17.3 m120 78.34 16.82 1.21 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.491 0.716 . . . . 0.0 111.178 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.703 HG23 HD22 ' A' ' 91' ' ' ASN . 11.1 pt -102.57 -175.88 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.56 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 26.2 mt-30 -112.29 160.89 17.21 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.738 -0.385 . . . . 0.0 109.969 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.442 ' O ' HD23 ' A' ' 73' ' ' LEU . 11.2 p-10 -55.82 -58.26 8.6 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 122.36 1.076 . . . . 0.0 109.277 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -76.39 12.0 1.38 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.859 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.56 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 1.9 t70 -66.17 -35.92 81.75 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.9 mp 68.71 115.88 0.04 OUTLIER 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.097 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.741 HG21 HD11 ' A' ' 105' ' ' LEU . 10.1 pt -94.54 176.6 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.665 -178.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.458 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 15.3 m-85 -129.25 157.22 76.78 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.624 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.6 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 17.9 Cg_endo -64.93 135.82 45.97 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 122.889 2.393 . . . . 0.0 112.863 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.68 20.95 22.94 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' ' 66' ' ' THR . 92.6 mt-30 -109.77 165.81 11.4 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.464 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 88.5 t -125.52 115.21 42.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.741 HD11 HG21 ' A' ' 99' ' ' ILE . 87.1 mt -110.77 151.2 28.06 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.952 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.846 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 71.2 mt-30 -90.19 115.08 27.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.872 0.844 . . . . 0.0 110.581 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.1 151.25 68.92 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.36 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.22 -21.03 71.91 Favored 'Trans proline' 0 N--CA 1.474 0.346 0 C-N-CA 123.395 2.73 . . . . 0.0 114.673 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.9 t . . . . . 0 C--N 1.32 -0.688 0 CA-C-O 121.079 0.466 . . . . 0.0 111.184 179.735 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.444 -0.785 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 90.9 m-20 74.21 29.8 1.26 Allowed 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 122.94 0.496 . . . . 0.0 111.459 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.639 ' HA ' HD22 ' A' ' 45' ' ' ASN . 19.6 p90 -62.75 -39.36 93.89 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.076 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.639 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 42.8 t-105 -62.35 -32.39 73.16 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.848 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -52.58 -37.69 58.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.796 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.67 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 31.3 m -123.29 26.62 7.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.462 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.639 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -107.42 144.64 34.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.251 177.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.471 ' HB2' ' CZ3' ' A' ' 146' ' ' TRP . 1.8 tpt180 -129.75 137.85 50.77 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.7 t70 54.53 67.66 0.98 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.481 0.658 . . . . 0.0 110.659 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.501 HG12 HD11 ' A' ' 136' ' ' LEU . 39.2 t -91.79 124.51 44.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.866 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -148.0 148.11 30.36 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.972 0.415 . . . . 0.0 110.559 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.875 HD13 HG22 ' A' ' 14' ' ' ILE . 30.4 mt -86.68 134.83 33.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.674 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.599 HG23 ' HB ' ' A' ' 135' ' ' VAL . 35.6 m -127.82 157.31 39.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.18 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.49 ' HB3' ' HD3' ' A' ' 134' ' ' LYS . 6.4 m-20 72.38 1.88 4.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.931 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.628 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 99.09 28.03 7.93 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.628 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.522 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 98.07 -23.14 37.34 Favored Glycine 0 C--O 1.266 2.13 0 CA-C-O 123.282 1.49 . . . . 0.0 112.654 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.789 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 15.9 ptmt -64.72 -20.0 66.09 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 121.721 -0.87 . . . . 0.0 108.933 177.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.599 ' HB ' HG23 ' A' ' 130' ' ' VAL . 6.8 t -136.94 146.01 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.324 0.583 . . . . 0.0 110.378 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.561 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 30.5 tp -124.95 121.54 34.74 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.5 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 40.2 tt0 -112.02 134.46 53.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.951 0.405 . . . . 0.0 111.788 -177.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.806 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -163.29 161.85 24.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.749 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -96.06 110.29 22.56 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.659 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 50.8 mt -96.19 137.04 35.85 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.175 0.512 . . . . 0.0 111.115 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.67 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 56.4 ttt180 -72.59 140.74 48.23 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.942 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.498 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 3.3 p90 -159.42 -170.34 2.92 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.563 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.4 m -54.66 -32.46 59.24 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 123.349 0.406 . . . . 0.0 111.789 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -97.51 16.52 60.43 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.404 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 141' ' ' ARG . . . 101.58 -110.23 3.8 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.266 -0.968 . . . . 0.0 112.395 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.471 ' CZ3' ' HB2' ' A' ' 125' ' ' ARG . 70.7 m95 -132.93 129.39 38.24 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.498 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 65.7 t30 -130.35 145.02 51.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.721 0.295 . . . . 0.0 110.617 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -73.88 109.28 7.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.272 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.628 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 35.8 t -122.6 165.32 16.64 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.561 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 27.7 mtt85 -145.98 158.82 43.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.09 0.471 . . . . 0.0 111.026 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.872 HD13 HD22 ' A' ' 43' ' ' LEU . 10.2 tt -140.21 146.87 24.06 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.063 178.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.708 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 69.4 m-85 -90.71 102.76 15.51 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.301 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.733 HD13 HD22 ' A' ' 21' ' ' LEU . 20.6 mt -63.21 -34.16 77.05 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.813 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.789 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 6.1 t70 -58.52 -9.09 1.45 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.156 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.708 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 43.6 mt-10 -74.2 -50.69 18.11 Favored 'General case' 0 CA--C 1.508 -0.663 0 O-C-N 121.92 -0.488 . . . . 0.0 112.156 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -120.53 1.25 10.62 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.39 -177.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.419 HG12 ' HH2' ' A' ' 52' ' ' TRP . 47.5 mm -105.93 110.79 32.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.029 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -114.98 160.14 13.36 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.174 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.566 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.8 t30 -102.53 128.31 49.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.925 0.393 . . . . 0.0 109.972 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.416 ' HB2' HD11 ' A' ' 165' ' ' ILE . 58.6 ttt-85 -124.46 91.39 3.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.451 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 58.82 42.23 20.24 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.34 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.519 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 92.19 15.39 53.87 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.882 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 159' ' ' ASN . 10.5 tp10 -124.09 143.86 50.21 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.674 -0.309 . . . . 0.0 111.225 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.555 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 18.6 mt -103.31 110.49 22.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.927 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.504 HD13 ' H ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.818 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.4 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 22.7 m-85 . . . . . 0 CA--C 1.516 -0.345 0 CA-C-O 121.65 0.738 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.76 -25.92 2.04 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.642 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.06 -70.17 1.25 Allowed Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 119.576 -1.297 . . . . 0.0 112.718 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 66.08 10.85 7.37 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 122.535 0.334 . . . . 0.0 110.619 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.672 ' CE2' HD13 ' A' ' 14' ' ' ILE . 1.0 OUTLIER -58.5 -33.53 69.93 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.54 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.2 p -63.32 -22.35 66.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.507 0.594 . . . . 0.0 110.398 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.03 -21.73 79.02 Favored Glycine 0 CA--C 1.522 0.519 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.421 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 26' ' ' ARG . 59.4 m -127.84 -18.18 4.31 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 117.15 0.475 . . . . 0.0 111.485 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.8 m -101.42 129.98 47.55 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.973 0.416 . . . . 0.0 109.97 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.478 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 2.8 ptm180 -110.08 -178.47 3.53 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 42.89 47.72 4.9 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 123.748 0.655 . . . . 0.0 112.358 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.858 HG22 HD13 ' A' ' 129' ' ' LEU . 6.3 mt -81.76 103.39 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-O 121.253 0.549 . . . . 0.0 109.833 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.602 ' CA ' HD12 ' A' ' 129' ' ' LEU . 82.6 m -145.67 125.1 13.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.858 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.769 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -93.39 153.42 18.52 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 122.021 0.915 . . . . 0.0 113.1 -178.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -94.05 73.92 4.08 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.956 -1.474 . . . . 0.0 107.835 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.03 -55.2 4.78 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.946 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.526 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -146.33 -12.4 0.47 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.083 0.468 . . . . 0.0 110.102 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -88.89 94.49 9.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.898 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.911 ' HB2' HD22 ' A' ' 39' ' ' LEU . 46.7 tp -60.15 122.86 15.46 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.473 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 15' ' ' CYS . 51.4 ttp180 -126.25 125.58 42.61 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.581 -178.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.636 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -148.25 145.91 28.41 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.63 0.728 . . . . 0.0 111.323 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.591 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 2.3 mm-40 -81.17 76.04 8.13 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.386 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.658 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 54.9 m -64.99 130.44 43.37 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.306 0.574 . . . . 0.0 111.336 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.472 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 3.8 tmm_? -72.18 118.88 15.61 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.394 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 14.0 ptm180 -87.17 156.44 19.69 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -50.92 -20.44 4.32 Favored Glycine 0 C--N 1.339 0.702 0 O-C-N 124.672 1.232 . . . . 0.0 114.768 -177.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -72.22 -9.96 59.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.236 0.541 . . . . 0.0 110.057 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.13 6.43 63.15 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.429 ' O ' ' HG2' ' A' ' 27' ' ' ARG . . . -106.36 164.9 13.53 Favored Glycine 0 C--O 1.224 -0.506 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.524 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.591 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 71.0 m-85 -101.61 130.34 47.92 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.878 0.37 . . . . 0.0 110.912 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.4 m -119.1 133.46 55.78 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.873 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.8 m -71.48 110.4 6.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.279 0.561 . . . . 0.0 111.079 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.4 t -113.61 150.88 32.46 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.665 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 5.1 p -144.88 137.02 21.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.937 0.399 . . . . 0.0 110.676 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.474 HG23 ' HB3' ' A' ' 21' ' ' LEU . 10.6 tt -133.98 144.77 34.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.267 -177.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.0 92.71 3.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.025 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.911 HD22 ' HB2' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -71.87 -11.13 60.65 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.139 0.495 . . . . 0.0 110.669 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.526 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 26.5 p30 -67.25 -8.64 33.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.909 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.434 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 30.5 ttm180 -108.25 -0.91 20.58 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.729 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 91.4 m-85 -125.64 -23.03 4.12 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.634 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.645 HD22 HD13 ' A' ' 151' ' ' ILE . 48.7 mt -111.02 137.66 48.39 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.19 0.519 . . . . 0.0 111.207 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.428 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 5.2 m -130.61 146.16 52.06 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.051 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.664 HD22 ' HA ' ' A' ' 120' ' ' PHE . 7.2 p30 -94.91 106.05 18.01 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -102.42 90.03 3.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.976 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.477 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 66.9 t30 52.5 43.23 31.26 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.138 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.579 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 84.75 38.64 9.33 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.644 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -150.9 137.61 18.9 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.716 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 15.0 m-85 -80.51 141.76 34.84 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.298 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -141.03 131.55 25.39 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.489 ' CD1' HD11 ' A' ' 151' ' ' ILE . 86.1 m95 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.598 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 91.0 m . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 121.168 0.508 . . . . 0.0 110.467 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.89 177.9 7.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.743 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.459 HG22 ' HG2' ' A' ' 106' ' ' GLN . 11.5 p -128.8 115.78 18.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.72 0.295 . . . . 0.0 111.284 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.495 HG21 ' CE2' ' A' ' 80' ' ' PHE . 12.0 p -102.07 145.41 11.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.066 0.46 . . . . 0.0 111.447 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 3.8 m -92.96 131.33 38.06 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.938 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.535 ' CG2' HD12 ' A' ' 99' ' ' ILE . 49.2 t -83.31 135.62 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.808 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -102.63 169.42 8.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 124.349 1.03 . . . . 0.0 111.051 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.651 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 6.5 tp-100 -63.39 116.66 5.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.389 -178.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.68 -16.47 58.67 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.96 -0.564 . . . . 0.0 113.151 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -82.38 134.96 35.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.027 0.441 . . . . 0.0 110.979 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.59 ' HA ' HG12 ' A' ' 99' ' ' ILE . 68.6 p -113.37 178.64 4.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.692 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.683 HD22 HG23 ' A' ' 99' ' ' ILE . 1.7 mm? -52.96 -41.18 64.29 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.216 0.532 . . . . 0.0 110.198 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.518 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 43.1 ttm105 -65.65 -36.88 84.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.282 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -68.47 -39.4 81.42 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 72' ' ' THR . 42.2 mm -66.41 -49.55 74.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.504 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.767 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -58.07 -45.84 93.38 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.67 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 78' ' ' ARG . 24.8 ttm180 -64.68 -37.24 86.9 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.899 0.381 . . . . 0.0 111.815 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -77.92 -33.87 51.56 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.495 ' CE2' HG21 ' A' ' 65' ' ' VAL . 96.4 m-85 -110.3 20.46 17.79 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.5 t0 53.87 46.32 25.95 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.9 0.857 . . . . 0.0 111.135 178.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.767 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.8 p -130.09 170.77 13.59 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.425 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.619 ' O ' HG13 ' A' ' 87' ' ' ILE . 6.2 t70 -100.16 122.55 43.17 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.542 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 8.8 p90 -51.09 -30.19 15.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.512 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -63.67 -48.1 78.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.62 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.697 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 16.5 mm-40 -67.7 -43.39 80.2 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.337 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.619 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.3 mt -53.68 -48.36 60.38 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.773 0.797 . . . . 0.0 109.01 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.634 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.17 -48.43 78.42 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.827 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -37.85 78.19 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.697 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 68.7 mmt-85 -67.92 -33.6 75.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.822 0.344 . . . . 0.0 110.994 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.525 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 11.4 t-20 -92.8 -5.33 51.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.535 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 5.6 m-20 78.2 15.3 1.4 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.359 0.664 . . . . 0.0 111.031 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.634 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 15.4 pt -100.83 -177.78 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.621 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . 16.7 mm100 -110.83 152.51 26.59 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.022 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.566 ' O ' HD23 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -53.87 -68.71 0.16 Allowed 'General case' 0 C--O 1.243 0.711 0 CA-C-O 122.194 0.997 . . . . 0.0 110.252 179.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -73.75 13.4 0.5 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.547 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.621 ' HB2' ' HB2' ' A' ' 94' ' ' GLN . 7.3 t70 -66.84 -31.79 72.64 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 8.5 mp 73.97 114.17 0.06 Allowed 'General case' 0 N--CA 1.463 0.206 0 O-C-N 124.361 1.038 . . . . 0.0 109.829 -177.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.683 HG23 HD22 ' A' ' 73' ' ' LEU . 7.1 pt -94.61 176.36 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.651 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.506 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 92.3 m-85 -123.25 160.04 51.91 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.598 -178.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.651 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 42.1 Cg_endo -70.55 139.19 36.93 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 123.43 2.753 . . . . 0.0 113.716 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.6 9.56 61.28 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.463 ' O ' ' HA ' ' A' ' 66' ' ' THR . 27.1 tt0 -94.09 162.85 13.71 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 115.16 -0.52 . . . . 0.0 109.754 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 72.9 t -127.43 118.95 50.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.53 HD11 HG21 ' A' ' 99' ' ' ILE . 69.8 mt -115.38 151.66 34.26 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.124 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.459 ' HG2' HG22 ' A' ' 64' ' ' THR . 71.8 mt-30 -89.65 118.33 29.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.67 0.747 . . . . 0.0 110.987 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.408 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 29.6 m -125.19 151.88 70.08 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.43 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.408 ' HD2' ' HB ' ' A' ' 107' ' ' VAL . 29.9 Cg_endo -62.92 -16.89 56.96 Favored 'Trans proline' 0 N--CA 1.472 0.253 0 C-N-CA 123.196 2.597 . . . . 0.0 114.392 -177.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.4 t . . . . . 0 C--N 1.323 -0.568 0 CA-C-O 121.035 0.445 . . . . 0.0 111.056 179.829 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.441 -1.018 0 N-CA-C 111.396 -0.681 . . . . 0.0 111.396 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.6 m120 69.42 31.18 3.89 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 122.943 0.497 . . . . 0.0 111.96 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.664 ' HA ' HD22 ' A' ' 45' ' ' ASN . 24.0 p90 -59.38 -35.78 74.58 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.585 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 57.5 t-105 -64.97 -33.23 75.53 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.826 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.52 -22.69 45.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.293 0.568 . . . . 0.0 110.954 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.745 ' OG ' ' HB3' ' A' ' 141' ' ' ARG . 47.9 t -133.64 23.98 4.01 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.179 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.585 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -111.02 144.5 40.04 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.334 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.615 ' HB2' ' CZ3' ' A' ' 146' ' ' TRP . 0.1 OUTLIER -129.52 128.03 41.99 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.437 ' N ' ' HD3' ' A' ' 125' ' ' ARG . 24.6 t0 56.94 62.92 2.07 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 124.071 0.857 . . . . 0.0 111.626 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.57 ' CG1' HD11 ' A' ' 136' ' ' LEU . 60.5 t -76.06 131.05 35.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.525 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -140.88 138.42 33.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.449 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.858 HD13 HG22 ' A' ' 14' ' ' ILE . 13.7 mt -86.91 131.9 33.97 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 177.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.639 HG23 ' HB ' ' A' ' 135' ' ' VAL . 33.9 m -128.74 158.61 41.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.213 0.53 . . . . 0.0 111.189 -178.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 67.46 11.54 8.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.014 -0.993 . . . . 0.0 111.889 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.702 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 92.73 31.22 8.87 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.203 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.536 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 88.23 -16.62 51.7 Favored Glycine 0 C--O 1.263 1.944 0 CA-C-O 123.441 1.578 . . . . 0.0 112.687 177.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.913 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 14.8 ptpt -68.09 -16.42 64.01 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 121.381 -1.07 . . . . 0.0 109.1 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.639 ' HB ' HG23 ' A' ' 130' ' ' VAL . 14.3 t -140.55 141.76 31.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.981 177.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.57 HD11 ' CG1' ' A' ' 127' ' ' VAL . 42.6 tp -120.53 126.88 51.45 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -120.16 134.64 55.21 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.746 0.308 . . . . 0.0 110.455 -177.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . . . -160.63 158.98 29.85 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.675 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -95.05 108.68 20.77 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.579 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 56.0 mt -94.19 131.29 39.91 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.699 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.745 ' HB3' ' OG ' ' A' ' 123' ' ' SER . 65.2 ttt180 -73.46 141.23 46.85 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.443 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.637 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 0.8 OUTLIER -154.56 -170.68 3.6 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.583 -179.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.2 m -58.34 -26.55 63.24 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -95.0 6.25 69.19 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.389 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 141' ' ' ARG . . . 111.26 -112.49 3.19 Favored Glycine 0 C--O 1.224 -0.491 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.746 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.615 ' CZ3' ' HB2' ' A' ' 125' ' ' ARG . 93.4 m95 -124.85 126.04 44.94 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.637 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 60.6 t30 -118.27 140.27 50.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.445 -178.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -73.55 104.74 4.62 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.2 m -118.55 156.3 29.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.577 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 17.4 ptt180 -148.79 163.43 37.38 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.535 -0.466 . . . . 0.0 112.16 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.716 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 8.9 tt -148.42 144.77 18.71 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.612 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.608 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.631 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 38.0 m-85 -88.76 104.42 16.88 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 122.154 -0.341 . . . . 0.0 110.929 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.695 HD11 HD21 ' A' ' 129' ' ' LEU . 27.8 mt -66.69 -35.31 79.83 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.904 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.913 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 4.8 t0 -55.91 -10.24 0.74 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.947 178.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.631 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 45.4 mt-10 -71.74 -55.09 8.29 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -125.22 8.58 7.91 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.884 -0.726 . . . . 0.0 112.388 -176.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.454 HG12 ' CH2' ' A' ' 52' ' ' TRP . 41.1 mm -106.65 107.81 23.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -110.54 178.04 19.73 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.656 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.658 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -117.75 134.44 54.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.893 0.377 . . . . 0.0 110.808 179.364 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.482 ' HB2' HD13 ' A' ' 165' ' ' ILE . 43.9 ttm180 -125.2 92.68 3.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.363 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 66.9 t30 57.9 46.35 16.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.83 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.464 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 87.52 11.56 68.55 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.613 178.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -122.69 133.03 54.51 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 117.19 0.495 . . . . 0.0 110.956 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.478 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 29.7 mt -76.03 122.59 24.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.471 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.482 HD13 ' HB2' ' A' ' 160' ' ' ARG . 43.7 pt . . . . . 0 C--N 1.323 -0.565 0 CA-C-O 121.646 0.736 . . . . 0.0 111.765 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.559 ' CD1' ' HG2' ' A' ' 155' ' ' GLU . 64.7 m-85 . . . . . 0 N--CA 1.455 -0.221 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.72 -27.89 11.52 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -71.02 -73.87 0.76 Allowed Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 119.068 -1.539 . . . . 0.0 112.16 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 65.44 23.07 11.94 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 122.711 0.404 . . . . 0.0 110.145 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.793 ' HD2' HD11 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -64.62 -34.96 79.51 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.531 179.725 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.415 ' HA ' HD11 ' A' ' 14' ' ' ILE . 28.8 t -66.02 -15.47 63.06 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.487 0.66 . . . . 0.0 109.916 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.55 -28.42 72.34 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.113 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 28.6 m -136.33 -3.22 2.18 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 117.413 0.607 . . . . 0.0 111.494 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.407 ' OG ' ' HB1' ' A' ' 23' ' ' ALA . 6.0 t -105.92 133.72 50.19 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.486 ' CG ' ' HB2' ' A' ' 24' ' ' GLU . 14.9 ptm180 -112.02 -176.39 2.91 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.428 ' HB2' ' HG2' ' A' ' 24' ' ' GLU . 2.3 m-20 42.61 44.52 3.68 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 124.04 0.837 . . . . 0.0 112.177 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.885 HG22 HD13 ' A' ' 129' ' ' LEU . 6.4 mt -78.17 102.86 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-O 121.012 0.434 . . . . 0.0 109.886 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.599 ' HA ' HD12 ' A' ' 129' ' ' LEU . 80.0 m -147.35 126.1 12.63 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.702 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -89.12 153.57 20.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.007 0.908 . . . . 0.0 113.191 -178.322 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.668 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 21.3 t70 -92.96 72.07 4.72 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 113.726 -1.579 . . . . 0.0 107.166 177.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.56 -56.69 5.03 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.939 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.429 ' H ' ' H ' ' A' ' 20' ' ' ARG . . . -148.56 -12.1 0.34 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.668 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 56.3 mtp180 -84.4 89.51 7.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.017 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.88 HD22 HD13 ' A' ' 153' ' ' LEU . 42.6 tp -57.24 123.46 15.41 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.155 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.593 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 22.2 ttp180 -125.74 134.73 51.67 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.141 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.583 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -155.63 141.69 18.28 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.695 0.759 . . . . 0.0 111.363 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.486 ' HB2' ' CG ' ' A' ' 12' ' ' ARG . 78.2 mm-40 -78.93 79.58 5.32 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.367 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.754 ' SG ' HD13 ' A' ' 164' ' ' LEU . 25.6 m -67.09 122.49 17.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.183 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 10' ' ' SER . 58.1 ttt-85 -68.69 118.85 12.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.391 178.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.1 ttt180 -88.0 155.1 20.0 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -47.25 -25.05 2.59 Favored Glycine 0 N--CA 1.463 0.459 0 O-C-N 124.598 1.187 . . . . 0.0 115.533 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -75.24 -5.77 46.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.205 0.526 . . . . 0.0 110.89 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.85 5.98 65.86 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -101.63 135.22 12.08 Favored Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.585 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 94.8 m-85 -87.81 130.52 34.84 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.776 0.322 . . . . 0.0 110.366 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 41.7 m -118.08 137.05 53.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.525 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.5 m -71.18 111.25 6.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.286 0.565 . . . . 0.0 111.16 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 162' ' ' GLY . 32.3 t -117.46 149.75 40.06 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.474 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.7 p -144.77 137.02 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.969 0.414 . . . . 0.0 111.633 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.624 HG22 HD23 ' A' ' 164' ' ' LEU . 12.4 tt -135.36 148.14 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.32 -178.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.47 ' OD2' ' HB3' ' A' ' 40' ' ' ASN . 25.2 t70 -81.89 109.24 16.08 Favored 'General case' 0 CA--C 1.516 -0.363 0 O-C-N 121.938 -0.476 . . . . 0.0 111.3 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.629 HD23 ' HB3' ' A' ' 21' ' ' LEU . 3.4 mm? -88.3 0.93 55.59 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.119 0.485 . . . . 0.0 110.092 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.47 ' HB3' ' OD2' ' A' ' 38' ' ' ASP . 26.2 t-20 -73.86 -24.5 59.76 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.7 mtt85 -100.63 13.41 34.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.248 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -132.02 -31.24 1.5 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.295 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.872 HD22 HD13 ' A' ' 151' ' ' ILE . 49.3 mt -105.85 134.79 48.41 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.999 0.428 . . . . 0.0 110.8 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.558 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 1.9 m -126.79 146.36 50.28 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.288 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.75 HD22 ' HA ' ' A' ' 120' ' ' PHE . 8.0 p30 -91.98 100.93 13.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.743 0.782 . . . . 0.0 109.498 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -100.89 94.06 5.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.042 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.418 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 64.3 t30 52.18 43.87 30.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.486 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.741 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 80.29 41.09 12.19 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.644 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.461 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 34.3 t-80 -160.69 127.69 4.23 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.713 ' HB2' ' HB ' ' A' ' 151' ' ' ILE . 87.6 m-85 -67.52 151.44 47.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.892 0.377 . . . . 0.0 111.547 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -148.39 130.47 15.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.038 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.429 ' CD1' HD11 ' A' ' 151' ' ' ILE . 96.3 m95 . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.094 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.45 -0.443 0 CA-C-O 121.016 0.436 . . . . 0.0 110.005 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.35 176.14 6.04 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.966 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.4 p -130.93 125.49 33.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.599 0.238 . . . . 0.0 111.111 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.588 HG21 ' CE2' ' A' ' 80' ' ' PHE . 8.4 p -115.46 143.33 25.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.959 0.409 . . . . 0.0 111.285 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 16.3 m -88.53 127.11 35.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.087 0.47 . . . . 0.0 109.873 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.497 ' CG2' HD12 ' A' ' 99' ' ' ILE . 43.7 t -75.92 134.57 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.788 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -104.48 169.54 8.41 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 124.541 1.15 . . . . 0.0 111.451 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.635 ' OE1' ' HG3' ' A' ' 101' ' ' PRO . 51.0 tp60 -64.25 116.06 5.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.55 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.78 -4.56 57.85 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.291 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.39 122.4 43.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.764 0.316 . . . . 0.0 110.92 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.688 ' HA ' HG12 ' A' ' 99' ' ' ILE . 75.5 p -105.37 -177.83 3.48 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.659 HD22 HG23 ' A' ' 99' ' ' ILE . 1.4 mm? -52.58 -41.85 63.97 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 121.396 0.617 . . . . 0.0 109.384 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.422 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 39.4 ttm180 -64.34 -37.95 89.32 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.091 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -73.08 -38.59 66.35 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.102 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.558 HG12 ' O ' ' A' ' 72' ' ' THR . 46.0 mm -64.81 -48.21 85.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.649 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -54.65 -53.64 37.81 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.718 -0.674 . . . . 0.0 113.03 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -68.25 -25.23 65.08 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -78.35 -41.99 31.85 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.588 ' CE2' HG21 ' A' ' 65' ' ' VAL . 89.2 m-85 -107.6 12.71 27.39 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.4 t70 61.31 52.61 3.78 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.804 0.811 . . . . 0.0 111.046 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.649 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.0 p -134.72 169.66 17.0 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.403 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.656 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.6 t70 -95.94 121.08 37.3 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.708 -0.397 . . . . 0.0 109.992 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.613 ' HD2' ' HB2' ' A' ' 95' ' ' ASN . 17.7 p90 -50.63 -31.31 15.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.923 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.78 -42.87 76.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.309 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.694 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 11.6 mm-40 -68.22 -43.87 77.0 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.656 HG13 ' O ' ' A' ' 83' ' ' ASP . 6.5 mt -53.5 -47.82 59.06 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-O 121.435 0.636 . . . . 0.0 109.474 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.632 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.18 -50.88 70.06 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.529 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -59.98 -36.18 76.6 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.694 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 83.3 mmt-85 -68.08 -34.81 77.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.991 0.424 . . . . 0.0 110.622 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.456 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 4.5 t30 -91.3 -5.06 55.23 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.805 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 0.9 OUTLIER 78.55 13.48 1.42 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.451 179.385 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.632 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 19.0 pt -98.74 -171.36 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -117.84 151.17 37.89 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.253 -0.28 . . . . 0.0 110.548 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.613 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 21.1 p-10 -53.07 -56.97 12.13 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-O 122.088 0.947 . . . . 0.0 109.294 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -75.96 6.82 4.65 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.425 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -66.55 -35.8 81.11 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.4 mp 67.62 115.13 0.03 OUTLIER 'General case' 0 C--O 1.235 0.332 0 CA-C-O 122.138 0.971 . . . . 0.0 109.987 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.688 HG12 ' HA ' ' A' ' 72' ' ' THR . 7.8 pt -93.74 174.96 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.038 -177.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.553 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 64.4 m-85 -127.15 160.6 58.85 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.689 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.635 ' HG3' ' OE1' ' A' ' 69' ' ' GLN . 34.8 Cg_endo -67.22 137.6 44.31 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.063 2.509 . . . . 0.0 113.941 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.49 17.9 32.29 Favored Glycine 0 N--CA 1.44 -1.075 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.707 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.537 ' O ' ' HA ' ' A' ' 66' ' ' THR . 45.7 mt-30 -106.83 165.06 11.6 Favored 'General case' 0 C--O 1.216 -0.682 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.864 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.3 t -125.81 110.03 23.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.652 HD11 HG21 ' A' ' 99' ' ' ILE . 63.8 mt -105.25 152.01 23.41 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.21 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 38.5 mt-30 -89.84 114.6 26.37 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.747 0.784 . . . . 0.0 110.415 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.0 m -117.88 150.55 47.37 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.71 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.44 -16.34 43.05 Favored 'Trans proline' 0 C--N 1.331 -0.375 0 C-N-CA 123.004 2.469 . . . . 0.0 113.387 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.4 t . . . . . 0 C--N 1.318 -0.763 0 CA-C-O 121.001 0.429 . . . . 0.0 110.318 179.678 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.558 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.44 -1.049 0 N-CA-C 112.379 -0.289 . . . . 0.0 112.379 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 71.14 30.14 2.73 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 122.903 0.481 . . . . 0.0 111.215 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.75 ' HA ' HD22 ' A' ' 45' ' ' ASN . 25.6 p90 -57.44 -39.06 75.44 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.603 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 67.6 t-105 -62.33 -34.58 76.91 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.915 -1.038 . . . . 0.0 111.966 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.83 -25.69 20.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.986 0.422 . . . . 0.0 111.369 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.814 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 19.3 m -134.28 29.46 3.66 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.037 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.603 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -115.73 141.13 48.49 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.193 0.521 . . . . 0.0 111.48 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -129.77 149.32 51.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.07 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.06 50.58 16.33 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 123.614 0.571 . . . . 0.0 110.83 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.476 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 30.2 t -80.74 117.89 27.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.883 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 35.4 ptt85 -145.89 144.57 30.28 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.191 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.885 HD13 HG22 ' A' ' 14' ' ' ILE . 23.4 mt -84.61 131.12 34.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.291 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.472 HG23 ' HB ' ' A' ' 135' ' ' VAL . 34.4 m -126.54 167.57 20.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.403 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.573 ' HB3' ' CE ' ' A' ' 134' ' ' LYS . 1.2 m-20 64.45 10.18 5.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.612 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.651 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 93.82 24.34 20.66 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.848 -0.692 . . . . 0.0 113.481 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 94.64 -18.88 56.24 Favored Glycine 0 C--O 1.268 2.241 0 CA-C-O 123.803 1.779 . . . . 0.0 111.914 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.763 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 65.4 pttt -69.52 -14.21 62.74 Favored 'General case' 0 C--N 1.313 -1.018 0 O-C-N 121.598 -0.942 . . . . 0.0 108.769 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.647 HG23 ' HG3' ' A' ' 134' ' ' LYS . 23.5 t -139.47 137.18 40.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 121.355 0.597 . . . . 0.0 110.513 177.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 30.3 tp -117.31 121.97 42.62 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.541 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 35.8 tt0 -115.01 134.81 54.87 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.864 0.364 . . . . 0.0 111.46 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.685 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.42 163.11 27.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.569 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 41.7 mt-10 -94.53 108.43 20.38 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.741 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 59.7 mt -94.99 130.59 41.59 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.338 0.59 . . . . 0.0 110.753 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.814 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 73.5 ttt180 -70.73 140.66 51.46 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.88 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.501 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 5.6 p90 -158.3 -171.91 3.67 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 18.4 m -54.85 -30.52 57.8 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.3 18.51 56.39 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.369 -0.92 . . . . 0.0 113.723 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 103.9 -120.67 6.77 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.278 -0.963 . . . . 0.0 112.332 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -123.57 124.28 42.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.944 0.372 . . . . 0.0 110.601 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.501 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 27.3 t-20 -118.81 125.83 50.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.473 ' HD3' ' OE2' ' A' ' 137' ' ' GLU . 55.1 ttm-85 -74.74 99.24 3.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.245 0.545 . . . . 0.0 110.033 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.461 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 7.3 t -112.3 173.08 6.54 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.105 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.541 ' HG2' ' HG3' ' A' ' 137' ' ' GLU . 15.6 mtm180 -145.2 163.84 33.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.107 0.479 . . . . 0.0 111.398 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.872 HD13 HD22 ' A' ' 43' ' ' LEU . 9.1 tt -143.24 148.98 18.74 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.392 178.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.597 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 12.6 m-85 -92.06 103.93 16.38 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 122.028 -0.42 . . . . 0.0 110.964 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.88 HD13 HD22 ' A' ' 21' ' ' LEU . 22.5 mt -67.15 -34.14 76.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.111 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.763 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 7.7 t70 -58.32 -7.76 0.96 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.274 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.56 ' HG3' ' CB ' ' A' ' 152' ' ' TYR . 40.5 mt-10 -72.39 -51.03 22.25 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 121.91 -0.494 . . . . 0.0 111.976 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -119.26 -5.6 10.41 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 120.499 -0.481 . . . . 0.0 112.285 -177.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.463 ' CG2' ' HG ' ' A' ' 164' ' ' LEU . 48.9 mm -100.21 114.23 38.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.841 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -118.79 176.44 16.09 Favored Glycine 0 C--O 1.225 -0.422 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.289 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.586 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.0 t30 -112.1 123.81 51.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.943 0.401 . . . . 0.0 110.149 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -118.63 85.88 2.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.928 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 52.2 43.72 30.36 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.497 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 103.29 -4.82 48.41 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.294 -0.955 . . . . 0.0 114.085 178.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -121.92 129.43 52.53 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 117.223 0.512 . . . . 0.0 111.426 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.793 HD11 ' HD2' ' A' ' 7' ' ' PHE . 1.8 tp -71.12 113.32 8.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.553 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 11.0 tp . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.392 -179.027 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -111.8 -25.41 9.48 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -66.8 -72.75 0.72 Allowed Glycine 0 N--CA 1.433 -1.503 0 C-N-CA 119.366 -1.397 . . . . 0.0 112.405 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 60.69 17.16 7.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.74 0.305 . . . . 0.0 110.725 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.7 ' CE2' HD13 ' A' ' 14' ' ' ILE . 0.4 OUTLIER -60.92 -32.57 72.05 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.398 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.491 ' OG ' ' HG2' ' A' ' 134' ' ' LYS . 23.1 t -66.0 -19.84 65.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.037 0.446 . . . . 0.0 110.375 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.7 -20.6 78.69 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.079 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.515 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 51.2 p -129.4 -24.66 2.77 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 117.241 0.521 . . . . 0.0 111.375 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.422 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 5.9 m -96.71 130.88 43.86 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 12' ' ' ARG . 12.5 ptm180 -115.07 -174.18 2.45 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 47.69 40.77 12.65 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 123.513 0.508 . . . . 0.0 111.225 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.876 HG22 HD13 ' A' ' 129' ' ' LEU . 7.7 mt -80.71 103.31 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-O 120.832 0.348 . . . . 0.0 110.164 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.605 ' HA ' HD12 ' A' ' 129' ' ' LEU . 79.0 m -146.9 128.09 14.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.809 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.749 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -99.41 152.89 19.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.701 0.762 . . . . 0.0 112.956 -179.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -93.85 75.87 4.22 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.33 -55.08 4.82 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.542 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.577 ' HB1' ' HB2' ' A' ' 40' ' ' ASN . . . -148.69 -7.86 0.38 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.901 0.381 . . . . 0.0 110.507 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.4 mmm-85 -89.27 90.53 8.38 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.767 ' HB2' HD22 ' A' ' 39' ' ' LEU . 55.0 tp -62.67 127.79 32.92 Favored 'General case' 0 C--O 1.213 -0.839 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.566 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 42.9 ttt180 -133.34 131.75 40.48 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.441 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.631 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -150.84 145.93 26.01 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.744 0.783 . . . . 0.0 111.516 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 1.7 mm-40 -82.97 74.58 9.92 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.34 178.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.556 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 60.0 m -60.74 124.2 19.72 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.143 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.515 ' HB2' ' O ' ' A' ' 10' ' ' SER . 19.7 ttp180 -70.57 127.43 32.66 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.13 0.491 . . . . 0.0 110.749 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.484 ' HG3' ' CG ' ' A' ' 161' ' ' ASN . 37.2 ttp180 -97.29 151.9 19.42 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.32 -15.86 1.96 Allowed Glycine 0 N--CA 1.46 0.278 0 O-C-N 124.717 1.261 . . . . 0.0 115.006 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -75.96 -9.01 58.26 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.054 0.454 . . . . 0.0 110.432 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.66 6.86 60.59 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -112.27 161.69 12.64 Favored Glycine 0 C--O 1.224 -0.525 0 C-N-CA 120.455 -0.878 . . . . 0.0 112.202 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.513 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 86.2 m-85 -100.38 139.1 36.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.005 0.403 . . . . 0.0 110.856 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.1 t -122.89 120.64 34.05 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 m -63.73 115.53 4.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.157 0.503 . . . . 0.0 110.487 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.4 t -120.99 152.82 38.11 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.063 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.566 ' HB ' ' HG3' ' A' ' 22' ' ' ARG . 3.2 p -145.05 138.66 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 120.855 0.359 . . . . 0.0 111.433 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.5 tt -135.5 147.8 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.486 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -80.74 105.34 11.9 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.767 HD22 ' HB2' ' A' ' 21' ' ' LEU . 1.5 tp -84.71 -6.14 59.35 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.441 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.577 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 64.2 t30 -73.45 -14.31 61.22 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -105.88 15.37 26.74 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.427 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 66.3 m-85 -131.44 -32.67 1.52 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.635 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.773 HD22 HD13 ' A' ' 151' ' ' ILE . 33.2 mt -106.48 136.49 46.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.025 0.441 . . . . 0.0 111.423 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.637 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 9.0 m -125.74 146.81 49.6 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.701 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.608 ' ND2' ' HB2' ' A' ' 123' ' ' SER . 21.4 p-10 -95.13 93.7 7.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.669 0.747 . . . . 0.0 109.585 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -94.64 95.83 9.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.059 0.457 . . . . 0.0 111.758 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.465 ' HA ' ' HB2' ' A' ' 142' ' ' TYR . 62.5 t30 47.67 44.19 17.23 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.172 178.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.78 34.04 14.32 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.751 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -150.61 131.12 13.85 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.831 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 24.8 m-85 -75.34 138.3 41.68 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 51' ' ' ARG . 53.8 mtt-85 -140.7 136.38 32.55 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.518 ' CH2' HG12 ' A' ' 157' ' ' ILE . 98.2 m95 . . . . . 0 C--N 1.322 -0.616 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.353 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.0 m . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 120.92 0.391 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.89 177.37 4.99 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.164 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.544 HG22 ' HG2' ' A' ' 106' ' ' GLN . 10.6 p -127.7 117.08 21.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.856 0.36 . . . . 0.0 110.835 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.459 HG21 ' CE2' ' A' ' 80' ' ' PHE . 8.9 p -103.0 142.29 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.19 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 24.9 m -88.1 127.67 35.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.249 0.547 . . . . 0.0 110.095 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.511 HG21 HD12 ' A' ' 99' ' ' ILE . 48.7 t -79.16 134.67 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.364 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -107.4 171.08 7.58 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.307 1.004 . . . . 0.0 109.458 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.681 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 59.4 tt0 -65.85 123.18 19.1 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.794 -178.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.12 -4.23 58.71 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.348 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -105.77 122.68 46.57 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.89 0.376 . . . . 0.0 111.132 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.651 ' HA ' HG12 ' A' ' 99' ' ' ILE . 68.5 p -106.49 179.94 4.12 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.659 HD22 HG23 ' A' ' 99' ' ' ILE . 1.5 mm? -51.66 -43.4 62.65 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.461 0.648 . . . . 0.0 109.752 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 74' ' ' ARG . 42.8 ttt180 -60.65 -38.98 86.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.424 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -72.18 -45.67 59.43 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 72' ' ' THR . 45.0 mm -57.82 -47.66 85.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.003 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.672 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.19 -53.05 47.67 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.109 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -69.73 -26.43 64.32 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 122.469 -0.43 . . . . 0.0 111.786 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -75.87 -38.84 57.52 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.06 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.459 ' CE2' HG21 ' A' ' 65' ' ' VAL . 72.4 m-85 -111.16 19.62 18.2 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.7 t70 53.25 47.91 23.26 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.548 0.69 . . . . 0.0 111.783 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.672 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 3.3 p -127.88 171.05 12.14 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.651 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.1 t0 -96.75 117.89 32.03 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.707 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.432 ' HA ' HD12 ' A' ' 87' ' ' ILE . 3.3 p90 -50.49 -33.19 20.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.909 -1.042 . . . . 0.0 111.803 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.93 -41.44 91.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.17 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.654 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 33.0 tt0 -71.78 -46.64 57.7 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.695 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.651 HG13 ' O ' ' A' ' 83' ' ' ASP . 6.5 mt -49.7 -45.74 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.625 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.22 -51.1 69.13 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.416 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -63.67 -28.93 70.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.654 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 22.1 mmt180 -65.08 -39.79 93.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.288 0.566 . . . . 0.0 110.248 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 12.5 m120 -94.12 -3.6 50.76 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.677 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 93.7 m-20 79.08 11.01 1.51 Allowed 'General case' 0 N--CA 1.47 0.571 0 O-C-N 123.859 0.724 . . . . 0.0 111.455 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.625 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 18.9 pt -93.92 -173.48 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.509 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . 30.1 mm-40 -114.81 157.6 23.04 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 122.108 -0.37 . . . . 0.0 110.636 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.52 ' O ' HD23 ' A' ' 73' ' ' LEU . 3.4 p30 -55.62 -69.05 0.15 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.836 0.826 . . . . 0.0 109.728 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.59 13.43 0.62 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.335 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.509 ' HB2' ' HB2' ' A' ' 94' ' ' GLN . 5.6 t70 -64.3 -30.16 71.22 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.1 mp 68.55 113.5 0.04 OUTLIER 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.195 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.659 HG23 HD22 ' A' ' 73' ' ' LEU . 8.5 pt -93.85 175.83 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.227 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.501 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 85.7 m-85 -125.95 158.06 67.13 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.585 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.681 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 22.3 Cg_endo -67.28 139.16 49.08 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 123.135 2.557 . . . . 0.0 113.395 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.21 23.7 24.0 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.537 ' O ' ' HA ' ' A' ' 66' ' ' THR . 70.4 mt-30 -112.11 166.07 11.57 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.533 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 66.9 t -125.89 110.36 23.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.58 HD11 HG21 ' A' ' 99' ' ' ILE . 75.8 mt -103.95 151.04 23.65 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.4 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.637 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 62.7 mt-30 -90.74 117.58 29.49 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.832 0.825 . . . . 0.0 110.6 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.8 m -125.65 150.56 68.66 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.702 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.38 -19.34 67.91 Favored 'Trans proline' 0 C--N 1.332 -0.325 0 C-N-CA 123.262 2.641 . . . . 0.0 113.722 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.5 t . . . . . 0 C--N 1.324 -0.528 0 CA-C-O 121.059 0.457 . . . . 0.0 111.088 179.961 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.637 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.443 -0.871 0 N-CA-C 112.726 -0.15 . . . . 0.0 112.726 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 72.02 27.43 2.7 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.406 0.683 . . . . 0.0 111.011 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.63 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 22.6 p90 -60.36 -40.67 91.59 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.087 0.47 . . . . 0.0 109.798 178.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.616 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 43.1 t-105 -65.29 -28.87 69.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.913 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.17 -19.49 54.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.737 0.303 . . . . 0.0 111.013 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.608 ' HB2' ' ND2' ' A' ' 45' ' ' ASN . 22.9 m -139.15 27.62 2.34 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 120.899 0.381 . . . . 0.0 110.252 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.616 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -110.54 148.26 32.49 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.37 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 125' ' ' ARG . 11.6 ttm180 -133.14 140.28 47.53 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.952 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.433 ' HB3' ' NH2' ' A' ' 128' ' ' ARG . 69.7 m-20 58.04 58.76 3.4 Favored 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 123.787 0.68 . . . . 0.0 111.123 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.499 ' CG1' HD11 ' A' ' 136' ' ' LEU . 40.5 t -86.79 115.88 28.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.839 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.433 ' NH2' ' HB3' ' A' ' 126' ' ' ASP . 0.0 OUTLIER -138.13 145.41 41.57 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.344 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.876 HD13 HG22 ' A' ' 14' ' ' ILE . 16.1 mt -85.23 133.26 34.18 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.757 HG23 ' HB ' ' A' ' 135' ' ' VAL . 27.3 m -125.27 159.37 32.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.347 -179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.569 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 0.3 OUTLIER 69.99 1.74 3.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.89 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.697 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 94.74 33.37 6.74 Favored Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.097 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 94.65 -20.89 46.2 Favored Glycine 0 C--O 1.263 1.936 0 CA-C-O 122.997 1.332 . . . . 0.0 113.21 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.777 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 0.2 OUTLIER -66.77 -16.43 64.25 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 121.307 -1.114 . . . . 0.0 109.214 178.591 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.757 ' HB ' HG23 ' A' ' 130' ' ' VAL . 9.4 t -141.72 145.57 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.262 0.553 . . . . 0.0 109.824 177.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 30.1 tp -125.72 121.04 32.3 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.469 ' HG3' ' HE ' ' A' ' 150' ' ' ARG . 20.8 tt0 -110.28 135.39 51.09 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.818 0.342 . . . . 0.0 111.632 -177.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.638 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -163.66 157.14 18.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.541 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.442 ' HG2' ' HD2' ' A' ' 148' ' ' ARG . 18.1 mt-10 -95.81 108.12 20.43 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 45' ' ' ASN . 58.6 mt -92.57 131.45 37.68 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.415 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.547 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 64.3 ttt180 -70.41 139.63 51.88 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.295 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.598 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 4.9 p90 -154.71 -164.11 1.74 Allowed 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.005 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.2 m -62.76 -14.62 46.94 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -125.83 36.45 2.74 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.416 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.77 -122.81 7.32 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.761 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -122.7 125.85 46.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.755 0.312 . . . . 0.0 110.399 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.598 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 46.5 t-20 -111.32 133.84 53.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.616 -178.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.442 ' HD2' ' HG2' ' A' ' 139' ' ' GLU . 4.1 tpt180 -73.49 98.01 2.69 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -113.55 160.66 18.28 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.899 -177.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.572 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 34.0 mtt180 -146.48 158.02 43.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.732 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.831 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 9.2 tt -141.67 142.11 28.98 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.02 178.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.607 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 27.7 m-85 -87.53 102.54 14.68 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.817 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.786 HD11 HD21 ' A' ' 129' ' ' LEU . 22.1 mt -63.96 -34.8 78.8 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.59 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.777 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 5.6 t70 -56.41 -9.4 0.69 Allowed 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.265 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.607 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 40.4 mt-10 -72.27 -52.71 15.08 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 121.923 -0.486 . . . . 0.0 112.287 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -124.43 3.23 8.4 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.549 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.518 HG12 ' CH2' ' A' ' 52' ' ' TRP . 39.7 mm -103.59 108.6 24.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.484 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -116.33 166.44 12.35 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.239 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.556 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.3 t30 -102.22 130.8 48.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.782 0.325 . . . . 0.0 110.232 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 160' ' ' ARG . 25.7 ttp85 -118.19 85.9 2.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.878 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.484 ' CG ' ' HG3' ' A' ' 27' ' ' ARG . 21.7 t30 53.13 47.22 24.97 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.378 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 96.46 9.05 57.05 Favored Glycine 0 C--O 1.229 -0.185 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.611 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -122.79 142.37 50.81 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.691 HD11 ' CD2' ' A' ' 7' ' ' PHE . 11.8 tp -99.61 111.34 23.69 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.953 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.417 -179.798 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.759 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 37.0 m-85 . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 121.189 0.519 . . . . 0.0 109.718 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.53 -27.71 0.67 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.457 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -69.56 -68.74 1.55 Allowed Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 119.931 -1.128 . . . . 0.0 113.643 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 42.1 m-80 68.73 16.98 8.93 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 122.268 0.227 . . . . 0.0 110.497 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.746 ' CD2' HD11 ' A' ' 164' ' ' LEU . 1.2 p90 -64.22 -32.64 74.3 Favored 'General case' 0 C--O 1.218 -0.581 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.032 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.512 ' HA ' HD11 ' A' ' 14' ' ' ILE . 22.7 t -70.37 -16.29 62.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.73 0.776 . . . . 0.0 109.606 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.65 -20.67 73.7 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 115.129 -0.942 . . . . 0.0 113.241 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.553 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 75.5 p -127.49 -22.84 3.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.405 0.602 . . . . 0.0 111.365 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 9.2 m -98.15 133.98 41.84 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.945 0.402 . . . . 0.0 109.956 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.573 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 35.2 ptt180 -110.54 -177.37 3.22 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.459 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 12.7 m-20 43.85 44.54 5.83 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 123.714 0.634 . . . . 0.0 112.213 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.899 HG22 HD13 ' A' ' 129' ' ' LEU . 5.8 mt -78.95 104.86 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.607 ' CA ' HD12 ' A' ' 129' ' ' LEU . 72.7 m -146.4 126.38 13.66 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.298 0.639 . . . . 0.0 109.651 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.753 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -98.93 152.83 19.35 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.673 0.749 . . . . 0.0 112.773 -179.646 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -96.07 74.99 3.03 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.55 -54.44 4.95 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.43 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.515 ' HB1' ' HB2' ' A' ' 40' ' ' ASN . . . -148.58 -10.09 0.36 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 36.8 mtp-105 -83.13 86.17 7.06 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.618 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.793 HD22 HD13 ' A' ' 153' ' ' LEU . 51.1 tp -62.1 116.7 5.17 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-O 121.301 0.572 . . . . 0.0 111.578 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.506 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 33.9 ttp-105 -122.58 131.29 53.76 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.556 -177.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.587 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -152.34 146.89 25.72 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.452 0.644 . . . . 0.0 111.246 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.573 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 1.6 mm-40 -80.73 77.29 7.59 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.412 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.597 ' SG ' HD13 ' A' ' 164' ' ' LEU . 64.3 m -61.98 125.68 24.68 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.748 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.553 ' HB2' ' O ' ' A' ' 10' ' ' SER . 35.3 ttm180 -74.44 115.17 13.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.098 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.543 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 16.8 ptm180 -79.2 151.37 31.28 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -50.67 -18.97 2.9 Favored Glycine 0 C--N 1.339 0.697 0 O-C-N 124.338 1.024 . . . . 0.0 114.195 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.63 -12.89 61.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.15 0.5 . . . . 0.0 110.451 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.62 7.89 56.39 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.543 ' O ' ' HG2' ' A' ' 27' ' ' ARG . . . -104.48 157.49 16.87 Favored Glycine 0 C--O 1.223 -0.563 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.246 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.49 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 62.7 m-85 -100.85 129.81 46.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.901 0.381 . . . . 0.0 110.906 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.3 m -122.15 130.09 52.91 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.097 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -69.08 110.44 4.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.111 0.482 . . . . 0.0 111.449 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.2 t -114.79 151.53 33.65 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.931 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.9 p -145.7 135.51 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 120.879 0.371 . . . . 0.0 110.58 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.496 HG23 ' HB3' ' A' ' 21' ' ' LEU . 8.6 tt -134.92 144.34 34.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.734 -178.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.591 ' HB3' ' CD ' ' A' ' 41' ' ' ARG . 5.1 t70 -78.84 106.42 10.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.848 0.356 . . . . 0.0 110.605 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.569 HD23 ' HB3' ' A' ' 21' ' ' LEU . 2.1 mm? -85.97 -0.41 55.42 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.453 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.515 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 64.4 t30 -71.91 -22.35 61.5 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.591 ' CD ' ' HB3' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -103.87 16.5 26.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.406 0.622 . . . . 0.0 110.191 178.291 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.411 ' HB2' HD13 ' A' ' 39' ' ' LEU . 14.0 m-85 -125.89 -35.27 2.5 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.146 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.826 HD22 HD13 ' A' ' 151' ' ' ILE . 36.6 mt -106.54 142.27 36.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.377 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.458 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 0.7 OUTLIER -133.1 140.8 47.84 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.492 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.551 ' CG ' ' HB3' ' A' ' 140' ' ' LEU . 9.0 t30 -88.54 108.1 19.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.989 0.423 . . . . 0.0 109.925 177.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -109.33 91.04 3.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.344 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 54.46 47.49 22.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.195 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.727 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 78.56 33.32 38.95 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.746 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.485 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 68.6 m80 -147.59 127.64 13.7 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.731 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 50.4 m-85 -68.78 146.01 53.28 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.901 0.382 . . . . 0.0 110.963 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -145.49 130.7 18.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.838 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.527 ' CD1' HD11 ' A' ' 151' ' ' ILE . 97.0 m95 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.841 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.7 m . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 120.925 0.393 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -129.07 177.77 6.89 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.167 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.515 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 10.0 p -127.98 118.22 23.14 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.896 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.453 HG21 ' CE2' ' A' ' 80' ' ' PHE . 10.1 p -106.22 142.65 18.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.81 0.338 . . . . 0.0 111.004 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 9.1 m -88.6 125.08 34.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.272 0.558 . . . . 0.0 109.884 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.486 ' CG2' HD12 ' A' ' 99' ' ' ILE . 53.4 t -73.67 133.09 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.623 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -102.85 168.87 8.95 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 124.723 1.264 . . . . 0.0 110.845 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.592 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 25.3 tt0 -62.69 122.21 15.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.151 -178.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.39 -8.77 72.07 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.868 -0.605 . . . . 0.0 113.186 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.25 122.86 36.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.744 0.272 . . . . 0.0 111.453 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.588 ' HA ' HG12 ' A' ' 99' ' ' ILE . 81.2 p -105.67 -179.44 3.94 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.613 HD22 HG23 ' A' ' 99' ' ' ILE . 1.1 mm? -52.5 -41.39 63.37 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.299 0.571 . . . . 0.0 109.836 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.512 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 83.6 mtp180 -64.44 -36.99 85.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.335 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -72.14 -42.9 65.46 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.77 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 72' ' ' THR . 39.2 mm -61.03 -47.0 95.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.683 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.58 -50.56 64.19 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.85 -0.614 . . . . 0.0 113.07 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.459 ' HA ' ' NE ' ' A' ' 78' ' ' ARG . 3.5 tpm_? -71.1 -25.44 62.6 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 122.462 -0.434 . . . . 0.0 111.713 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -79.23 -42.39 26.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.193 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.453 ' CE2' HG21 ' A' ' 65' ' ' VAL . 99.2 m-85 -108.06 18.94 20.61 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.2 t70 55.75 51.13 12.89 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.735 0.778 . . . . 0.0 111.86 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.683 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.6 p -131.99 171.75 13.2 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.321 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.674 ' O ' HG13 ' A' ' 87' ' ' ILE . 14.9 t0 -97.63 120.4 37.94 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.747 -0.381 . . . . 0.0 109.99 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.512 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 17.8 p90 -51.51 -31.93 25.72 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.797 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.474 ' HB2' ' OD1' ' A' ' 83' ' ' ASP . 0.2 OUTLIER -68.29 -41.96 80.18 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.323 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.606 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 40.2 mt-10 -68.68 -47.05 67.46 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.9 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.674 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.9 mt -51.31 -46.02 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.555 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.36 -51.89 65.82 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.182 178.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 66.0 mtp180 -62.82 -30.46 71.5 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.606 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 8.2 mmp_? -73.07 -28.17 62.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.254 0.55 . . . . 0.0 110.327 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 6.7 t30 -96.14 -4.79 42.09 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.831 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 17.7 m120 80.24 13.44 0.91 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.69 0.796 . . . . 0.0 111.222 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.555 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 14.5 pt -105.58 -171.23 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.497 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.658 ' H ' ' HB2' ' A' ' 97' ' ' ASP . 3.8 mm-40 -118.72 163.63 16.56 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.501 ' O ' HD23 ' A' ' 73' ' ' LEU . 5.9 p30 -55.07 -55.15 34.3 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 122.535 1.16 . . . . 0.0 109.167 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -78.63 11.98 2.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.573 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.658 ' HB2' ' H ' ' A' ' 94' ' ' GLN . 4.9 t70 -63.29 -33.64 75.95 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.6 mt 68.75 112.38 0.04 OUTLIER 'General case' 0 C--O 1.232 0.163 0 O-C-N 124.382 1.051 . . . . 0.0 109.99 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.788 HG21 HD11 ' A' ' 105' ' ' LEU . 10.0 pt -95.31 175.3 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.458 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.494 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 67.9 m-85 -128.8 157.59 74.98 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.779 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.592 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 22.0 Cg_endo -66.71 133.08 30.58 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.957 2.438 . . . . 0.0 113.152 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.49 14.08 39.25 Favored Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 66' ' ' THR . 33.6 tt0 -103.35 162.93 12.59 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.515 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 91.9 t -122.17 118.25 54.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.788 HD11 HG21 ' A' ' 99' ' ' ILE . 96.9 mt -111.89 152.01 28.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.948 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -89.91 113.98 25.7 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.689 0.757 . . . . 0.0 110.975 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.4 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 24.9 m -123.35 152.07 63.75 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 114.178 -1.373 . . . . 0.0 109.983 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.4 ' HD2' ' HB ' ' A' ' 107' ' ' VAL . 34.1 Cg_endo -64.77 -15.59 51.0 Favored 'Trans proline' 0 N--CA 1.472 0.248 0 C-N-CA 123.633 2.889 . . . . 0.0 114.869 -177.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 C--N 1.322 -0.604 0 CA-C-O 120.931 0.396 . . . . 0.0 111.128 179.897 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.458 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.443 -0.877 0 N-CA-C 112.293 -0.323 . . . . 0.0 112.293 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 18.1 m120 74.81 34.7 0.69 Allowed 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 123.158 0.583 . . . . 0.0 111.536 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.635 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 19.3 p90 -64.31 -36.53 84.42 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.514 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 50.5 t-105 -64.6 -26.26 68.32 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.667 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.49 -13.56 52.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.131 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.5 p -142.87 22.37 1.94 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.462 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.551 ' O ' ' HD2' ' A' ' 125' ' ' ARG . . . -113.24 144.67 42.31 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.055 0.455 . . . . 0.0 111.753 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.551 ' HD2' ' O ' ' A' ' 124' ' ' ALA . 1.3 mpt_? -136.55 150.8 48.81 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.665 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 53.8 53.84 10.75 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.165 0.507 . . . . 0.0 111.609 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.517 ' CG1' HD11 ' A' ' 136' ' ' LEU . 41.8 t -80.19 128.31 38.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.264 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.414 ' O ' HD12 ' A' ' 136' ' ' LEU . 2.0 ptp180 -146.43 140.51 26.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.951 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.899 HD13 HG22 ' A' ' 14' ' ' ILE . 16.5 mt -86.6 126.96 34.85 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 177.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.749 HG23 ' HB ' ' A' ' 135' ' ' VAL . 27.6 m -118.33 165.46 13.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.817 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.575 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 0.2 OUTLIER 68.58 2.4 3.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.521 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.594 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 91.87 25.43 22.53 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.988 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 104.66 -21.33 36.92 Favored Glycine 0 C--O 1.267 2.182 0 CA-C-O 123.128 1.404 . . . . 0.0 112.721 178.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.734 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 0.0 OUTLIER -71.06 -10.37 59.63 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.177 -1.19 . . . . 0.0 109.775 179.083 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.749 ' HB ' HG23 ' A' ' 130' ' ' VAL . 20.4 t -143.08 146.94 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.601 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 35.1 tp -127.31 124.47 38.8 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -113.24 133.02 55.3 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 123.33 0.394 . . . . 0.0 110.478 -177.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.651 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -161.66 158.19 25.67 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.876 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -95.18 108.42 20.55 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.727 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 36.2 mt -97.06 133.14 42.12 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.389 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 145' ' ' GLY . 40.2 ttt180 -73.81 141.36 46.2 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.87 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.655 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 0.7 OUTLIER -158.67 -166.8 1.97 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 4.6 m -53.64 -30.86 44.97 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.43 0.456 . . . . 0.0 112.089 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -103.35 30.34 10.55 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.587 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 141' ' ' ARG . . . 89.91 -114.07 4.3 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.007 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -122.73 125.27 45.2 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.709 0.254 . . . . 0.0 110.563 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.655 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 27.7 t-20 -119.29 131.39 55.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.344 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -78.19 96.84 5.3 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.114 0.483 . . . . 0.0 110.041 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.485 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 23.5 t -103.36 170.18 8.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.342 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.601 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 36.5 ptt180 -148.95 154.94 40.11 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.752 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.826 HD13 HD22 ' A' ' 43' ' ' LEU . 10.7 tt -139.86 150.9 21.89 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.001 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.704 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 9.1 m-85 -92.33 104.88 17.18 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 122.003 -0.436 . . . . 0.0 110.56 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.793 HD13 HD22 ' A' ' 21' ' ' LEU . 21.2 mt -66.61 -35.46 80.25 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.929 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.734 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 10.5 t70 -57.61 -12.58 2.93 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.879 178.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.759 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 42.1 mt-10 -61.55 -56.08 23.83 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 121.121 0.486 . . . . 0.0 111.909 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -119.86 -4.6 10.16 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.59 -177.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.477 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 46.7 mm -94.44 112.32 26.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.33 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -117.78 166.84 12.71 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.383 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.565 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 1.5 t30 -107.24 132.21 53.33 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 122.403 0.281 . . . . 0.0 110.416 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -122.26 90.06 3.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.07 0.462 . . . . 0.0 110.123 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 47.0 m-80 54.9 40.42 31.98 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.22 2.16 44.74 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.824 177.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -119.69 140.23 50.99 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.933 0.396 . . . . 0.0 110.235 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.746 HD11 ' CD2' ' A' ' 7' ' ' PHE . 7.6 tp -96.78 111.23 23.49 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.304 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 34.2 pt . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.428 -179.905 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.02 -28.28 14.23 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.0 -75.55 0.38 Allowed Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 119.649 -1.262 . . . . 0.0 113.139 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 64.09 16.38 9.94 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 122.463 0.305 . . . . 0.0 110.893 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.697 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -62.2 -30.98 71.46 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 116.75 -0.204 . . . . 0.0 111.251 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.0 t -67.8 -16.37 64.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.4 0.619 . . . . 0.0 110.084 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.09 -22.94 67.29 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.744 -0.662 . . . . 0.0 113.319 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 16.8 p -126.29 -17.74 5.11 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 122.12 -0.635 . . . . 0.0 111.51 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.421 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 3.3 m -105.18 133.48 49.88 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.3 ptt85 -114.36 -175.7 2.74 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 46.3 45.06 13.08 Favored 'General case' 0 C--N 1.316 -0.891 0 O-C-N 123.858 0.724 . . . . 0.0 111.518 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.887 HG22 HD13 ' A' ' 129' ' ' LEU . 6.6 mt -81.14 100.7 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-O 120.938 0.399 . . . . 0.0 109.972 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.571 ' CA ' HD12 ' A' ' 129' ' ' LEU . 74.0 m -142.78 126.42 16.93 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.773 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -93.67 158.87 15.47 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.883 0.849 . . . . 0.0 113.037 -179.087 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -99.44 74.99 1.94 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 113.995 -1.457 . . . . 0.0 107.623 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.91 -57.68 4.56 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.947 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.735 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -143.47 -9.22 0.74 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 120.676 0.274 . . . . 0.0 110.898 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -96.59 97.74 9.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.276 0.56 . . . . 0.0 110.906 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.913 ' HB2' HD22 ' A' ' 39' ' ' LEU . 46.5 tp -61.75 121.68 13.47 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.966 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.529 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 53.5 ttt180 -126.61 127.87 45.9 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.506 -0.477 . . . . 0.0 110.813 -178.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.597 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -146.59 150.08 34.79 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.608 0.718 . . . . 0.0 111.069 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 3.0 mm-40 -83.94 71.34 10.5 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.122 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.572 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 34.7 m -60.01 125.75 24.88 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.741 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 10' ' ' SER . 27.7 ttp180 -66.77 126.59 29.5 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.151 178.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -102.37 155.11 18.46 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -52.52 -17.62 4.58 Favored Glycine 0 C--N 1.337 0.584 0 O-C-N 124.582 1.176 . . . . 0.0 114.747 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.21 -9.12 58.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.054 0.454 . . . . 0.0 110.216 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.47 11.44 62.45 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -119.87 165.56 13.5 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.558 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.513 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 88.4 m-85 -100.22 129.19 46.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.007 0.432 . . . . 0.0 110.847 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 75.1 m -113.68 126.03 54.79 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.959 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 m -67.27 114.65 6.16 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.217 0.532 . . . . 0.0 109.768 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 39.7 t -120.4 150.94 39.98 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.265 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.4 p -142.34 140.86 28.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.862 0.363 . . . . 0.0 110.86 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.431 HG22 HD23 ' A' ' 164' ' ' LEU . 15.8 tt -134.86 144.79 33.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.109 -178.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.4 94.02 2.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.385 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.913 HD22 ' HB2' ' A' ' 21' ' ' LEU . 0.9 OUTLIER -76.35 -14.91 60.07 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 120.915 0.388 . . . . 0.0 111.351 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.735 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 26.8 p-10 -67.75 -10.96 57.14 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.202 0.525 . . . . 0.0 109.939 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.411 ' HG3' ' OD1' ' A' ' 40' ' ' ASN . 37.4 mtt180 -106.58 11.3 30.69 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.482 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -135.8 -26.2 1.22 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.715 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.816 HD22 HD13 ' A' ' 151' ' ' ILE . 33.2 mt -109.83 134.46 52.02 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.962 0.41 . . . . 0.0 110.919 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.537 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 47.7 m -126.1 146.52 49.89 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.695 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.654 HD22 ' HA ' ' A' ' 120' ' ' PHE . 8.7 p30 -86.2 101.06 12.68 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -102.63 92.59 4.7 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.453 -178.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.0 t30 51.52 43.81 29.44 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.626 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.573 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 82.84 28.13 39.23 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.571 -0.824 . . . . 0.0 113.003 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.71 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 17.6 t-80 -149.88 126.43 10.91 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.705 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 72.6 m-85 -60.54 152.22 26.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.615 0.245 . . . . 0.0 111.026 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 11.4 ttm180 -141.68 132.18 25.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.087 0.47 . . . . 0.0 111.9 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.488 ' CZ2' ' HA ' ' A' ' 153' ' ' LEU . 57.4 m95 . . . . . 0 C--N 1.318 -0.783 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.729 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.446 -0.658 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.95 177.55 5.45 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.328 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.4 p -128.87 115.37 17.78 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.463 HG21 ' CE2' ' A' ' 80' ' ' PHE . 10.7 p -106.68 140.0 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.844 0.354 . . . . 0.0 111.105 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 14.0 m -88.55 130.31 35.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.047 0.451 . . . . 0.0 110.231 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.569 ' CG2' HD12 ' A' ' 99' ' ' ILE . 52.2 t -80.8 131.92 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.251 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -99.09 171.47 8.0 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 124.342 1.026 . . . . 0.0 109.705 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.728 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 35.0 tt0 -65.66 124.49 22.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.44 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.5 -1.21 66.28 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.531 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.426 ' CG ' HH22 ' A' ' 79' ' ' ARG . 85.7 m-20 -88.52 147.54 24.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.233 0.539 . . . . 0.0 111.531 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.687 ' HA ' HG12 ' A' ' 99' ' ' ILE . 38.1 p -133.06 168.21 18.9 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.618 HD22 HG23 ' A' ' 99' ' ' ILE . 1.8 mm? -49.76 -45.54 49.62 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.551 0.614 . . . . 0.0 110.307 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.598 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 65.8 mtt180 -63.58 -34.73 78.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.8 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.55 -37.24 65.62 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 72' ' ' THR . 47.8 mm -68.05 -48.76 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.587 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.729 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -59.34 -49.43 78.63 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.705 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.634 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -63.37 -33.02 74.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.081 0.467 . . . . 0.0 110.786 -179.428 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.426 HH22 ' CG ' ' A' ' 71' ' ' ASP . 32.9 ttm180 -74.31 -41.95 60.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.554 -178.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.463 ' CE2' HG21 ' A' ' 65' ' ' VAL . 98.8 m-85 -104.64 20.09 19.24 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 54.15 37.57 27.38 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.293 0.568 . . . . 0.0 112.349 178.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.729 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -119.17 167.16 12.1 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.599 ' O ' HG13 ' A' ' 87' ' ' ILE . 8.4 t0 -90.93 119.35 31.06 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.758 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.608 ' HD2' ' HB2' ' A' ' 95' ' ' ASN . 10.4 p90 -51.49 -32.63 28.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.191 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -62.91 -46.31 88.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.203 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.641 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 30.4 tt0 -66.87 -44.19 81.61 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.723 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.599 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.4 mt -52.12 -45.94 42.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.622 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.24 -50.12 71.46 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.987 177.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -58.45 -34.11 70.47 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.641 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 28.3 mmt180 -68.33 -38.52 81.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.101 0.477 . . . . 0.0 110.482 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 2.8 t-20 -91.53 -5.26 54.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.32 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 48.9 m-80 76.98 16.46 1.77 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.086 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.622 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 16.9 pt -101.25 -176.39 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.55 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 80.4 mm-40 -107.42 158.85 16.85 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.608 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 5.8 p30 -61.24 -55.4 32.41 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 122.137 0.97 . . . . 0.0 108.832 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -79.86 11.91 3.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.427 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.9 t70 -63.35 -35.44 80.39 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 7.6 mp 69.69 115.47 0.04 OUTLIER 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.74 -177.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.731 HG21 HD11 ' A' ' 105' ' ' LEU . 6.8 pt -94.64 175.74 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.472 -178.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.543 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 89.2 m-85 -124.35 160.29 53.48 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.957 -178.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.728 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 37.6 Cg_endo -69.74 133.06 24.7 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.082 2.521 . . . . 0.0 114.016 -178.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.76 14.63 33.91 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.583 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 66' ' ' THR . 44.0 mt-30 -102.41 164.19 11.81 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.83 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 67.1 t -123.56 116.31 47.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.731 HD11 HG21 ' A' ' 99' ' ' ILE . 89.4 mt -110.33 151.33 27.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.024 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.627 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 71.2 mt-30 -90.3 117.48 29.07 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.703 0.763 . . . . 0.0 110.872 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.31 150.42 60.32 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.467 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.43 -17.62 58.07 Favored 'Trans proline' 0 C--N 1.332 -0.318 0 C-N-CA 123.498 2.799 . . . . 0.0 114.017 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.4 t . . . . . 0 C--N 1.324 -0.519 0 CA-C-O 121.041 0.448 . . . . 0.0 111.131 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.537 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.446 -0.694 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 78.37 27.51 0.51 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.858 0.863 . . . . 0.0 112.461 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.654 ' HA ' HD22 ' A' ' 45' ' ' ASN . 26.5 p90 -63.87 -38.62 91.76 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.695 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.539 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 61.2 t-105 -63.02 -29.14 70.6 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.881 -178.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -57.11 -20.97 28.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.738 0.304 . . . . 0.0 111.112 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.678 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 57.6 m -141.9 30.82 1.63 Allowed 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.493 178.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.539 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -113.31 138.64 49.74 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.847 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 125' ' ' ARG . 11.4 mmt180 -126.95 146.05 50.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.262 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.5 t70 51.12 56.65 7.66 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 123.831 0.707 . . . . 0.0 110.659 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.53 ' CG1' HD11 ' A' ' 136' ' ' LEU . 45.0 t -79.66 120.32 30.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.44 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.85 141.34 34.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.177 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.887 HD13 HG22 ' A' ' 14' ' ' ILE . 17.8 mt -85.91 128.29 34.8 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.83 HG23 HG13 ' A' ' 135' ' ' VAL . 31.0 m -123.68 157.54 30.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.358 0.599 . . . . 0.0 111.224 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.925 ' HB3' ' HE3' ' A' ' 134' ' ' LYS . 5.9 m-20 65.67 16.98 10.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.897 178.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.694 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 91.8 25.3 23.08 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.942 178.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 91.16 -15.31 61.37 Favored Glycine 0 C--O 1.269 2.322 0 CA-C-O 123.638 1.688 . . . . 0.0 112.384 177.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.925 ' HE3' ' HB3' ' A' ' 131' ' ' ASP . 20.0 pttp -65.12 -15.71 62.69 Favored 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 121.463 -1.022 . . . . 0.0 108.929 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.83 HG13 HG23 ' A' ' 130' ' ' VAL . 2.2 p -149.03 135.58 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.547 0.689 . . . . 0.0 110.83 176.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 29.6 tp -110.3 125.08 52.77 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.073 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.406 ' CD ' ' HE ' ' A' ' 148' ' ' ARG . 31.9 tt0 -117.92 139.95 50.42 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.861 0.363 . . . . 0.0 111.52 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.663 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.96 168.8 20.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.17 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -95.25 107.55 19.66 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.573 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 57.1 mt -98.93 131.89 44.66 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.277 0.561 . . . . 0.0 111.168 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.678 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 33.7 ttt180 -72.28 142.01 48.89 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.071 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -153.89 -173.89 4.75 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.917 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 13.4 m -58.6 -22.71 57.03 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -105.39 20.02 38.38 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.233 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 106.73 -115.33 4.66 Favored Glycine 0 C--O 1.229 -0.212 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.298 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -130.31 138.07 50.27 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -132.18 141.44 49.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.924 0.392 . . . . 0.0 111.701 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.406 ' HE ' ' CD ' ' A' ' 137' ' ' GLU . 69.5 ttt180 -74.76 103.53 5.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.146 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.71 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 32.6 t -121.65 162.08 21.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.326 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 10.3 ptt180 -148.55 152.6 37.11 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 120.957 0.408 . . . . 0.0 111.474 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.816 HD13 HD22 ' A' ' 43' ' ' LEU . 8.7 tt -132.36 131.96 60.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.73 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 135' ' ' VAL . 89.8 m-85 -75.89 101.22 5.08 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.56 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.727 HD13 HD22 ' A' ' 21' ' ' LEU . 35.7 mt -64.45 -36.22 83.47 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.191 178.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.845 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 11.7 t70 -55.35 -11.49 0.81 Allowed 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.425 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.539 ' HG3' ' CB ' ' A' ' 152' ' ' TYR . 38.0 mt-10 -71.41 -49.39 42.38 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 121.93 -0.481 . . . . 0.0 112.224 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -127.02 5.68 6.51 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 119.963 -0.695 . . . . 0.0 112.611 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.403 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 46.9 mm -106.58 109.65 28.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.478 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -116.38 166.22 12.34 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.187 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.572 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.9 t30 -100.79 123.21 44.66 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.41 ' O ' ' HB3' ' A' ' 163' ' ' GLU . 14.2 ttt85 -119.17 86.52 2.56 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.155 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 59.61 49.12 8.72 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 79.92 13.14 82.61 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.489 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 160' ' ' ARG . 28.2 tt0 -122.67 120.24 33.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.026 0.441 . . . . 0.0 110.037 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.697 HD11 ' CD2' ' A' ' 7' ' ' PHE . 8.5 tp -77.25 120.73 22.71 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.072 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 12.6 tt . . . . . 0 C--N 1.323 -0.581 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.987 -179.096 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 . . . . . 0 N--CA 1.453 -0.319 0 CA-C-O 121.36 0.6 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -125.29 -25.58 3.77 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.642 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -84.09 -70.93 1.33 Allowed Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 118.771 -1.68 . . . . 0.0 113.488 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.628 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 63.0 t30 57.3 31.95 20.95 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.207 0.603 . . . . 0.0 110.283 -178.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.611 ' CE2' HD13 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -60.28 -32.91 71.64 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.028 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.458 ' HA ' HD11 ' A' ' 14' ' ' ILE . 34.0 t -59.17 -20.8 57.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.523 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.52 -42.17 93.76 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.836 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 26' ' ' ARG . 49.4 m -114.97 -18.05 11.35 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.9 m -92.38 134.86 34.53 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.471 ' CG ' ' HB2' ' A' ' 24' ' ' GLU . 16.7 ptt180 -113.27 -177.54 3.16 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.494 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 0.4 OUTLIER 42.61 44.63 3.72 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 123.873 0.733 . . . . 0.0 112.457 179.18 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.916 HG22 HD13 ' A' ' 129' ' ' LEU . 5.8 mt -78.98 105.14 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 CA-C-O 120.953 0.406 . . . . 0.0 110.292 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.607 ' HA ' HD12 ' A' ' 129' ' ' LEU . 80.4 m -146.82 127.62 14.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.37 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.749 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -96.97 155.86 16.6 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.621 0.724 . . . . 0.0 112.779 -179.279 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -96.22 75.1 2.97 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.433 -1.258 . . . . 0.0 107.958 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.51 -58.35 4.88 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.893 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -149.19 5.97 0.66 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.199 0.523 . . . . 0.0 110.21 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.575 ' HG2' ' CG2' ' A' ' 36' ' ' VAL . 32.3 ttt85 -108.32 93.99 4.82 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.825 ' HB2' HD22 ' A' ' 39' ' ' LEU . 55.0 tp -63.18 129.6 41.02 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -177.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.535 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 34.8 ttt180 -134.04 129.26 35.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.159 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.624 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -148.58 149.98 32.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.471 0.653 . . . . 0.0 110.983 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.55 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 3.3 mt-10 -87.64 80.67 7.91 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.773 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.587 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 58.7 m -63.47 127.86 33.23 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.408 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.5 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 36.8 ttm180 -71.13 114.93 9.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.364 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 9.0 ptp180 -79.6 152.6 29.97 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 179.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.36 -19.5 12.79 Favored Glycine 0 C--N 1.336 0.549 0 O-C-N 124.369 1.043 . . . . 0.0 114.03 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.58 -12.03 60.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.446 0.641 . . . . 0.0 109.821 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.29 5.22 56.05 Favored Glycine 0 CA--C 1.505 -0.589 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.526 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.454 ' O ' ' HG2' ' A' ' 27' ' ' ARG . . . -105.61 167.78 14.92 Favored Glycine 0 C--O 1.222 -0.649 0 C-N-CA 120.065 -1.064 . . . . 0.0 113.14 -178.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.55 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 57.9 m-85 -101.27 131.47 47.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.166 0.483 . . . . 0.0 110.907 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.9 m -118.49 123.35 44.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.191 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.5 m -69.1 112.31 5.63 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.9 t -118.25 155.41 30.61 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.028 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.575 ' CG2' ' HG2' ' A' ' 20' ' ' ARG . 2.6 p -145.43 139.08 21.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.878 0.371 . . . . 0.0 111.662 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.449 HG23 ' HB3' ' A' ' 21' ' ' LEU . 14.0 tt -135.13 148.06 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.471 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.439 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 17.7 m-20 -84.41 104.53 14.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.862 0.363 . . . . 0.0 111.475 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.825 HD22 ' HB2' ' A' ' 21' ' ' LEU . 3.0 mp -83.69 -12.15 56.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.428 0.632 . . . . 0.0 110.417 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.528 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 16.5 p30 -62.84 -19.09 63.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.021 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -112.92 19.9 16.88 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.968 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.644 ' HD2' ' CE3' ' A' ' 52' ' ' TRP . 0.1 OUTLIER -138.12 -27.6 0.89 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.366 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.863 HD22 HD13 ' A' ' 151' ' ' ILE . 62.5 mt -106.09 132.21 52.44 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.619 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 3.2 m -129.35 141.92 50.95 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.541 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.709 ' HB3' ' HG ' ' A' ' 140' ' ' LEU . 8.5 p30 -79.36 115.77 19.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.149 177.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -114.82 89.34 3.07 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.907 0.384 . . . . 0.0 110.248 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.3 t30 51.78 45.02 28.85 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.242 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.0 32.18 30.02 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.808 -0.711 . . . . 0.0 113.131 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.616 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 16.0 t-80 -150.85 125.19 9.45 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.78 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 45.3 m-85 -63.08 141.84 58.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.886 0.374 . . . . 0.0 111.672 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.647 ' NE ' ' HA ' ' A' ' 51' ' ' ARG . 3.4 mmp_? -146.26 135.82 23.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.841 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.644 ' CE3' ' HD2' ' A' ' 42' ' ' TYR . 95.0 m95 . . . . . 0 C--N 1.32 -0.682 0 CA-C-O 121.124 0.488 . . . . 0.0 109.743 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.45 -0.446 0 CA-C-O 120.861 0.362 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -127.8 176.11 7.81 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.75 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.529 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 6.8 p -127.93 116.11 19.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.543 HG21 ' CE2' ' A' ' 80' ' ' PHE . 7.9 p -103.61 142.41 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 120.887 0.375 . . . . 0.0 110.844 178.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 9.8 m -88.38 130.95 35.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.161 0.505 . . . . 0.0 109.929 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.458 ' CG2' HD12 ' A' ' 99' ' ' ILE . 56.6 t -82.33 133.58 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.854 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -103.86 171.34 7.41 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.985 0.803 . . . . 0.0 110.2 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.621 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 53.7 tt0 -61.27 119.39 8.35 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.122 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.17 -9.91 63.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.888 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.455 ' HB3' HD11 ' A' ' 76' ' ' ILE . 84.9 m-20 -75.44 146.65 40.54 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.147 0.499 . . . . 0.0 111.529 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.624 ' HA ' HG12 ' A' ' 99' ' ' ILE . 24.3 p -135.99 163.15 30.96 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.615 HD22 HG23 ' A' ' 99' ' ' ILE . 1.6 mm? -49.18 -44.22 42.84 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.363 0.529 . . . . 0.0 110.634 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.442 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 70.1 mtp180 -59.96 -43.39 95.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.276 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -72.94 -33.88 66.21 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.537 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 72' ' ' THR . 44.0 mm -66.6 -46.91 84.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.716 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.48 -49.08 76.15 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.91 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -65.41 -32.43 74.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.059 0.456 . . . . 0.0 111.151 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.429 HH22 ' CG ' ' A' ' 71' ' ' ASP . 34.5 ttm180 -70.65 -40.33 73.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.73 -178.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.543 ' CE2' HG21 ' A' ' 65' ' ' VAL . 94.6 m-85 -110.42 16.91 21.32 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 56.22 37.56 28.96 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.445 0.64 . . . . 0.0 111.411 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.716 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.9 p -116.28 166.1 12.42 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.373 -0.83 . . . . 0.0 108.901 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.65 ' O ' HG13 ' A' ' 87' ' ' ILE . 3.7 t70 -92.22 124.6 36.42 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.101 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.442 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 9.7 p90 -52.28 -31.35 32.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.753 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 23.0 t-80 -66.79 -43.26 84.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.949 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.77 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 10.1 mm-40 -63.2 -51.54 65.93 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.361 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.65 HG13 ' O ' ' A' ' 83' ' ' ASP . 3.5 mt -50.94 -48.12 29.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 O-C-N 124.139 0.899 . . . . 0.0 109.475 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.625 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.51 -49.5 75.09 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.268 178.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -61.79 -34.05 75.21 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.77 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 14.7 mmt85 -65.28 -38.19 89.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.08 0.467 . . . . 0.0 110.525 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.428 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 11.5 m120 -93.13 -3.36 54.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.61 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 76.5 m-20 73.72 19.67 3.17 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.247 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.625 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 16.9 pt -100.68 -177.29 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.688 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.506 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 35.6 mt-30 -108.17 155.57 20.28 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.55 ' O ' HD23 ' A' ' 73' ' ' LEU . 3.1 p30 -54.94 -62.6 1.55 Allowed 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 122.116 0.96 . . . . 0.0 108.937 178.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -76.4 12.23 1.3 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.385 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.506 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.4 t70 -63.63 -34.5 77.96 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 8.7 mp 73.03 116.63 0.05 Allowed 'General case' 0 N--CA 1.462 0.136 0 O-C-N 124.399 1.062 . . . . 0.0 109.598 -177.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.744 HG21 HD11 ' A' ' 105' ' ' LEU . 11.2 pt -93.83 177.68 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.208 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.509 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 40.5 m-85 -129.48 157.76 75.37 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-O 120.892 0.377 . . . . 0.0 111.413 -178.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.621 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 25.7 Cg_endo -65.72 137.75 51.0 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.229 2.619 . . . . 0.0 113.905 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.12 13.65 57.25 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.867 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.479 ' O ' ' HA ' ' A' ' 66' ' ' THR . 95.5 mt-30 -100.87 168.39 9.67 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.216 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.529 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 63.2 t -127.6 110.61 22.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-O 120.921 0.391 . . . . 0.0 109.974 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.744 HD11 HG21 ' A' ' 99' ' ' ILE . 89.0 mt -103.6 150.4 24.0 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.678 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 75.8 mt-30 -91.34 116.47 28.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.973 0.892 . . . . 0.0 111.38 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.1 m -124.12 151.5 65.71 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 114.207 -1.36 . . . . 0.0 109.691 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -65.07 -15.03 48.44 Favored 'Trans proline' 0 N--CA 1.476 0.445 0 C-N-CA 123.571 2.847 . . . . 0.0 114.855 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.0 t . . . . . 0 C--N 1.322 -0.61 0 CA-C-O 121.008 0.433 . . . . 0.0 111.197 179.624 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.619 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.441 -0.993 0 N-CA-C 112.618 -0.193 . . . . 0.0 112.618 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 73.41 23.45 2.51 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.437 0.695 . . . . 0.0 111.931 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.696 ' HA ' HD22 ' A' ' 45' ' ' ASN . 22.7 p90 -61.62 -38.51 87.92 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.549 -0.46 . . . . 0.0 109.854 178.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.553 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 63.5 t-105 -59.87 -33.86 72.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.474 -178.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -54.59 -25.95 29.51 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.101 0.476 . . . . 0.0 111.124 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.722 ' HB2' ' HB3' ' A' ' 141' ' ' ARG . 19.4 p -136.98 30.12 2.78 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.512 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.553 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -109.29 140.3 43.13 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.889 0.376 . . . . 0.0 110.835 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.412 ' HB3' ' HB2' ' A' ' 139' ' ' GLU . 61.0 ttp180 -127.51 138.91 53.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.932 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 55.36 54.47 8.58 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.244 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.501 ' CG1' HD11 ' A' ' 136' ' ' LEU . 29.7 t -76.67 121.43 28.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.643 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -144.94 146.01 31.8 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.65 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.916 HD13 HG22 ' A' ' 14' ' ' ILE . 18.4 mt -86.75 128.85 35.04 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 120.973 0.416 . . . . 0.0 110.157 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.597 HG23 ' HB ' ' A' ' 135' ' ' VAL . 35.1 m -125.75 160.18 32.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.646 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 69.04 5.77 5.26 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.389 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.665 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 97.32 29.06 8.12 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.439 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.536 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 91.8 -16.27 59.74 Favored Glycine 0 C--O 1.265 2.045 0 CA-C-O 123.689 1.716 . . . . 0.0 112.494 178.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.662 ' O ' ' HA ' ' A' ' 152' ' ' TYR . 5.8 ptpp? -70.87 -17.44 62.72 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 121.433 -1.039 . . . . 0.0 108.454 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.597 ' HB ' HG23 ' A' ' 130' ' ' VAL . 17.5 t -138.73 137.92 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.314 0.578 . . . . 0.0 110.736 178.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.693 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 29.6 tp -117.58 118.36 31.92 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -108.4 130.25 55.23 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.772 0.32 . . . . 0.0 111.276 -176.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.758 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.35 161.56 27.5 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.72 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.849 ' HG3' HH11 ' A' ' 148' ' ' ARG . 49.3 mt-10 -96.01 108.5 20.9 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.422 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.709 ' HG ' ' HB3' ' A' ' 45' ' ' ASN . 1.0 OUTLIER -90.96 126.78 36.17 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.959 178.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.722 ' HB3' ' HB2' ' A' ' 123' ' ' SER . 76.1 ttt180 -69.59 140.81 53.82 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.164 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.633 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 2.3 p90 -156.83 -165.98 1.99 Allowed 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.074 -179.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.2 t -58.42 -32.53 68.75 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.319 0.387 . . . . 0.0 111.121 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.19 28.88 13.26 Favored Glycine 0 C--N 1.329 0.182 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.478 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 89.52 -118.95 5.35 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.591 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -120.03 129.32 54.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.699 0.25 . . . . 0.0 110.73 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.633 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 53.7 t30 -121.34 134.18 55.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.74 0.305 . . . . 0.0 110.766 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.849 HH11 ' HG3' ' A' ' 139' ' ' GLU . 19.8 tpt180 -75.0 96.94 3.27 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.591 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.616 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 11.6 t -109.41 168.03 9.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.428 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.693 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 36.5 ptt180 -148.11 149.65 32.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.444 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.863 HD13 HD22 ' A' ' 43' ' ' LEU . 12.1 tt -132.98 140.72 46.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.581 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.662 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 26.6 m-85 -83.17 102.97 12.23 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.852 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.774 HD11 HD21 ' A' ' 129' ' ' LEU . 26.8 mt -65.25 -36.7 84.95 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.127 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.628 ' HB2' ' HA ' ' A' ' 6' ' ' ASN . 13.8 p-10 -61.69 2.83 0.16 Allowed 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.561 ' HG3' ' CB ' ' A' ' 152' ' ' TYR . 43.1 mt-10 -76.24 -52.43 10.03 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 121.729 -0.607 . . . . 0.0 110.758 178.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -118.02 -12.26 10.11 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.633 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.443 ' O ' ' HA3' ' A' ' 5' ' ' GLY . 50.8 mm -91.86 114.74 29.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 116.77 -0.196 . . . . 0.0 110.754 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -122.28 167.63 14.8 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.115 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.587 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 3.3 t30 -103.46 123.29 46.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.025 0.44 . . . . 0.0 109.959 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 29.5 ttt85 -124.68 93.08 3.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.341 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 60.61 45.04 10.84 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.215 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 84.81 10.75 78.43 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.684 -0.769 . . . . 0.0 113.197 178.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -122.74 152.82 40.23 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.511 HD21 ' HD2' ' A' ' 7' ' ' PHE . 24.4 mt -97.17 119.65 36.05 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.492 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 43.0 pt . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.148 -179.759 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.655 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 32.6 m-85 . . . . . 0 CA--C 1.516 -0.34 0 CA-C-O 120.801 0.334 . . . . 0.0 110.499 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -137.68 -25.93 0.99 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.569 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 6' ' ' ASN . . . -68.88 -72.63 0.81 Allowed Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 119.738 -1.22 . . . . 0.0 113.597 -178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 25.5 m-80 69.69 10.31 7.53 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 122.498 0.319 . . . . 0.0 110.219 -178.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.785 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.9 OUTLIER -61.59 -34.93 76.46 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.61 -178.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.45 ' HA ' HD11 ' A' ' 14' ' ' ILE . 35.0 t -67.81 -14.87 63.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.476 0.655 . . . . 0.0 109.877 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.68 -27.76 64.5 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.964 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 20.9 p -125.69 -19.57 4.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 117.225 0.512 . . . . 0.0 111.992 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 11.8 m -94.99 129.04 42.22 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.698 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 35.4 ptt180 -108.01 -178.36 3.59 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.481 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 1.6 m-20 41.11 47.58 2.8 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 124.068 0.855 . . . . 0.0 112.489 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.924 HG22 HD13 ' A' ' 129' ' ' LEU . 8.1 mt -80.65 107.44 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-O 120.877 0.37 . . . . 0.0 110.292 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.713 ' CA ' HD12 ' A' ' 129' ' ' LEU . 46.1 t -150.2 128.53 12.11 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.701 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -96.7 158.56 15.37 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 122.047 0.927 . . . . 0.0 113.012 -178.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -99.51 76.4 2.02 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.14 -53.57 4.77 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.879 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.46 ' CB ' ' HB3' ' A' ' 40' ' ' ASN . . . -149.55 -12.41 0.29 Allowed 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 120.746 0.308 . . . . 0.0 110.195 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -86.1 90.13 8.03 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.448 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.003 HD12 HD11 ' A' ' 129' ' ' LEU . 8.5 tp -61.64 112.97 2.46 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.671 -179.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.495 ' HE ' ' CG2' ' A' ' 34' ' ' THR . 18.8 ttt85 -118.28 130.59 56.13 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.277 -178.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.679 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -149.65 150.9 32.86 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.407 0.623 . . . . 0.0 110.997 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.698 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 1.6 mm-40 -83.39 73.83 10.13 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.145 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.651 ' SG ' HD13 ' A' ' 164' ' ' LEU . 67.8 m -61.22 117.06 5.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.595 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 10' ' ' SER . 44.5 ttt180 -64.59 116.75 6.5 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.804 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.7 ttt85 -90.86 152.49 20.73 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.044 0.45 . . . . 0.0 109.957 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.63 -13.83 4.56 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 114.353 -1.294 . . . . 0.0 114.037 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -73.85 -11.08 60.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.114 0.483 . . . . 0.0 110.321 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.5 8.49 57.36 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -123.78 154.39 17.54 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.099 -1.048 . . . . 0.0 112.837 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.475 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 88.0 m-85 -87.87 125.49 34.51 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.712 0.291 . . . . 0.0 110.446 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.7 m -109.19 131.94 54.59 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.495 ' CG2' ' HE ' ' A' ' 22' ' ' ARG . 2.5 m -73.72 110.71 8.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.229 0.538 . . . . 0.0 109.98 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 30.3 t -115.5 153.59 30.87 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.635 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.7 p -146.14 137.27 18.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.794 0.331 . . . . 0.0 110.869 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.514 HG23 ' HB3' ' A' ' 21' ' ' LEU . 8.7 tt -134.68 137.05 51.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.733 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.643 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 13.3 m-20 -75.22 103.1 5.24 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.826 0.345 . . . . 0.0 111.558 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.818 ' HG ' HD11 ' A' ' 153' ' ' LEU . 3.4 mm? -83.11 -5.37 59.08 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.926 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.643 ' OD1' ' HB3' ' A' ' 38' ' ' ASP . 34.5 p-10 -67.06 -14.07 62.54 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.574 ' HE ' ' HB2' ' A' ' 38' ' ' ASP . 27.8 mtm180 -106.65 7.75 30.76 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.962 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.703 ' HB2' HD13 ' A' ' 39' ' ' LEU . 88.5 m-85 -130.95 -29.34 1.89 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.862 HD22 HD13 ' A' ' 151' ' ' ILE . 60.9 mt -106.22 132.69 51.98 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.779 0.323 . . . . 0.0 110.405 -179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.734 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 1.0 OUTLIER -123.44 143.03 50.4 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.603 -179.496 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 7.0 p-10 -88.25 93.61 9.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.791 0.805 . . . . 0.0 109.176 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -93.27 93.63 8.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.297 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.487 ' HA ' ' HB2' ' A' ' 142' ' ' TYR . 8.6 t-20 51.25 48.49 22.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.092 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.611 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 76.64 32.42 50.66 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.049 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.639 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 59.9 t60 -152.12 124.69 8.35 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.796 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 48.5 m-85 -60.71 144.15 52.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.887 0.375 . . . . 0.0 111.483 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -143.03 131.74 22.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.475 -178.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.495 ' HZ2' ' O ' ' A' ' 152' ' ' TYR . 99.6 m95 . . . . . 0 C--N 1.322 -0.608 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 36.0 m . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 121.108 0.48 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -130.9 178.59 6.55 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.191 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.516 HG22 ' HG2' ' A' ' 106' ' ' GLN . 4.6 p -128.33 115.56 18.46 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.77 143.25 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 120.869 0.366 . . . . 0.0 111.086 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 3.5 m -87.98 129.25 35.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.481 ' CG2' HD12 ' A' ' 99' ' ' ILE . 57.4 t -79.66 132.25 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.647 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -101.03 168.61 9.49 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 124.254 0.971 . . . . 0.0 110.475 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.668 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 35.1 tt0 -66.03 120.21 12.74 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.87 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.85 -11.07 52.76 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.771 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.06 130.26 45.38 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.134 0.467 . . . . 0.0 111.402 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.618 ' HA ' HG12 ' A' ' 99' ' ' ILE . 82.6 p -107.41 179.76 4.15 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.668 HD22 HG23 ' A' ' 99' ' ' ILE . 1.4 mm? -53.64 -43.64 68.9 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.436 0.636 . . . . 0.0 109.511 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.523 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 7.0 ttp85 -63.31 -36.05 82.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.39 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 79' ' ' ARG . 50.2 m-20 -73.77 -41.83 61.9 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.568 HG12 ' O ' ' A' ' 72' ' ' THR . 45.3 mm -61.32 -47.68 92.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.605 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.723 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.19 -51.34 58.11 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.651 -0.704 . . . . 0.0 113.083 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.448 HH11 ' HD2' ' A' ' 78' ' ' ARG . 47.1 mtp85 -70.21 -23.71 62.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.796 0.331 . . . . 0.0 111.691 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 37.2 ttt180 -78.91 -39.37 35.02 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -110.97 19.45 18.48 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t70 55.22 59.24 4.09 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.693 0.759 . . . . 0.0 111.335 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.723 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.4 p -142.35 164.59 29.72 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.364 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.574 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.8 t0 -91.04 120.89 32.39 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.523 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 5.0 p90 -52.19 -30.47 27.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.429 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -66.66 -41.87 87.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.602 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.695 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 64.3 mm-40 -66.06 -49.62 67.0 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.485 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.574 HG13 ' O ' ' A' ' 83' ' ' ASP . 4.1 mt -51.93 -47.53 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.523 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.58 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.77 -50.4 71.2 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.112 178.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -60.3 -33.82 72.91 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.695 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 27.4 mmt180 -71.19 -31.83 68.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.914 0.388 . . . . 0.0 110.44 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 3.7 t-20 -91.73 -5.97 52.74 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.615 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 90.7 m-20 77.15 17.76 1.54 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.033 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.58 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 14.2 pt -105.69 -174.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.577 178.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.449 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 64.6 mt-30 -110.25 162.57 14.49 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.614 ' O ' HD23 ' A' ' 73' ' ' LEU . 4.2 p-10 -58.59 -68.67 0.24 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.317 1.055 . . . . 0.0 110.003 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -74.33 13.47 0.58 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.545 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.5 t70 -59.65 -29.39 68.0 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.407 HD22 HG21 ' A' ' 72' ' ' THR . 34.1 mt 72.4 110.6 0.06 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.816 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.668 HG23 HD22 ' A' ' 73' ' ' LEU . 10.2 pt -95.62 172.56 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.405 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.58 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 73.7 m-85 -126.74 161.45 53.12 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.31 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.668 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 24.8 Cg_endo -66.31 139.6 55.32 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.203 2.602 . . . . 0.0 113.843 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.07 16.72 43.23 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' A' ' 66' ' ' THR . 25.8 mt-30 -103.18 166.57 10.36 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.082 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.426 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 82.5 t -126.91 114.43 37.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.56 HD11 HG21 ' A' ' 99' ' ' ILE . 88.1 mt -112.2 151.65 29.31 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.801 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.516 ' HG2' HG22 ' A' ' 64' ' ' THR . 34.3 mt-30 -90.47 117.26 29.03 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.615 0.721 . . . . 0.0 110.923 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.423 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 35.2 m -126.27 152.59 73.92 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.634 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 107' ' ' VAL . 18.0 Cg_endo -57.52 -48.04 19.04 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.353 2.035 . . . . 0.0 113.578 -177.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 C--N 1.323 -0.564 0 CA-C-O 121.254 0.55 . . . . 0.0 111.635 -178.824 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.734 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.443 -0.878 0 N-CA-C 113.184 0.034 . . . . 0.0 113.184 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 19.5 m120 73.29 29.09 1.72 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.054 0.542 . . . . 0.0 111.418 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.592 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 21.8 p90 -60.59 -37.92 82.94 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.519 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 47.8 t-105 -60.57 -30.39 69.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.559 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.47 -33.02 58.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.939 0.399 . . . . 0.0 110.537 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.775 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 6.7 m -131.28 28.84 4.68 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.852 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.519 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -108.65 140.78 41.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.896 0.379 . . . . 0.0 110.889 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.565 ' HB3' ' HB2' ' A' ' 139' ' ' GLU . 11.3 tpp85 -124.09 135.2 53.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.462 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 54.85 55.46 7.78 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.765 0.666 . . . . 0.0 111.849 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.526 HG12 HD11 ' A' ' 136' ' ' LEU . 40.1 t -78.03 123.58 35.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.822 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.435 ' O ' HD12 ' A' ' 136' ' ' LEU . 8.9 ptp180 -149.49 149.0 30.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.827 0.346 . . . . 0.0 110.589 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 1.003 HD11 HD12 ' A' ' 21' ' ' LEU . 92.5 mt -86.6 134.85 33.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.056 0.455 . . . . 0.0 110.495 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.626 HG23 ' HB ' ' A' ' 135' ' ' VAL . 26.8 m -124.61 157.67 32.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.921 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.739 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 0.3 OUTLIER 72.99 -4.41 2.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.059 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.644 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 104.18 32.0 4.48 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.821 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.682 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 94.88 -22.72 36.51 Favored Glycine 0 C--O 1.262 1.869 0 CA-C-O 123.203 1.446 . . . . 0.0 112.588 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.739 ' HG3' ' HB3' ' A' ' 131' ' ' ASP . 13.4 ptmt -65.73 -17.66 64.77 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 121.872 -0.781 . . . . 0.0 109.086 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.626 ' HB ' HG23 ' A' ' 130' ' ' VAL . 8.4 t -140.82 146.53 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.831 177.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.615 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 41.1 tp -126.13 124.69 41.1 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.534 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 34.1 tt0 -114.43 137.83 51.34 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.85 0.357 . . . . 0.0 111.403 -177.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.556 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -163.21 164.69 25.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.177 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.565 ' HB2' ' HB3' ' A' ' 125' ' ' ARG . 17.5 mm-40 -94.9 106.41 18.4 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 177.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.611 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 59.0 mt -96.71 130.03 44.01 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.2 0.524 . . . . 0.0 111.197 -178.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.775 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 42.6 ttt180 -77.09 141.29 40.3 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.688 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.487 ' HB2' ' HA ' ' A' ' 47' ' ' ASN . 6.8 p90 -155.65 -169.21 3.04 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.976 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.9 p -58.22 -22.53 52.36 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -109.19 28.24 11.36 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.31 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.63 -123.19 7.45 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.858 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -123.19 135.55 54.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.56 0.219 . . . . 0.0 110.51 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.436 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 57.9 t30 -134.91 142.61 46.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.898 0.38 . . . . 0.0 110.828 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.9 tpp85 -76.61 110.47 11.2 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.066 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.639 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 9.2 t -124.9 165.53 17.91 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.615 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 35.2 mtt85 -146.37 152.37 38.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.712 0.292 . . . . 0.0 110.881 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.862 HD13 HD22 ' A' ' 43' ' ' LEU . 12.4 tt -135.77 142.76 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.022 178.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.589 ' CB ' ' HG3' ' A' ' 155' ' ' GLU . 8.5 m-85 -86.35 101.84 13.46 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 122.471 -0.143 . . . . 0.0 111.31 -178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.818 HD11 ' HG ' ' A' ' 39' ' ' LEU . 3.9 mm? -61.14 -37.53 83.17 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.079 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.654 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 13.1 t70 -55.2 -16.24 3.01 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.209 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.655 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 41.2 mt-10 -63.28 -54.01 43.93 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -124.48 2.92 8.37 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.786 -0.766 . . . . 0.0 112.404 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.617 HG13 HD12 ' A' ' 153' ' ' LEU . 43.5 mm -104.03 112.96 39.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.357 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.557 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -118.73 168.33 13.24 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.562 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.554 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.8 t30 -104.71 122.16 45.1 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 15.7 ttm-85 -123.85 93.68 4.0 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.29 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 59.23 41.54 19.94 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.478 -0.783 . . . . 0.0 113.063 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 90.45 10.05 64.17 Favored Glycine 0 C--O 1.229 -0.193 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.211 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -121.43 134.21 55.09 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.216 0.531 . . . . 0.0 110.211 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.785 HD11 ' CD2' ' A' ' 7' ' ' PHE . 8.1 tp -96.35 107.31 19.66 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.741 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.444 ' HA ' HD12 ' A' ' 37' ' ' ILE . 19.8 pt . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.003 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.514 ' CD1' ' HG2' ' A' ' 155' ' ' GLU . 13.6 m-85 . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 120.97 0.414 . . . . 0.0 111.684 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -109.18 -28.45 9.02 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -62.4 -70.98 0.89 Allowed Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 119.495 -1.336 . . . . 0.0 112.694 -178.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 65.08 18.93 11.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.803 0.335 . . . . 0.0 110.498 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.742 ' HD2' HD11 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -65.19 -30.69 71.62 Favored 'General case' 0 C--O 1.217 -0.647 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.73 179.815 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.9 t -71.53 -9.32 58.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.705 0.764 . . . . 0.0 109.512 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.49 -23.01 57.51 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 115.12 -0.945 . . . . 0.0 113.054 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.484 ' HB2' HD22 ' A' ' 159' ' ' ASN . 20.2 m -129.39 -22.0 3.12 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 117.287 0.544 . . . . 0.0 111.26 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.505 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 13.0 m -99.31 133.49 43.53 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 12' ' ' ARG . 4.3 ptp180 -113.45 -174.49 2.47 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 42.61 45.52 4.02 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 123.854 0.721 . . . . 0.0 111.489 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.867 HG22 HD13 ' A' ' 129' ' ' LEU . 6.7 mt -79.54 109.26 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.008 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.638 ' CA ' HD12 ' A' ' 129' ' ' LEU . 53.8 t -149.54 127.24 11.7 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.42 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.742 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -94.7 154.7 17.19 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.584 0.706 . . . . 0.0 111.832 -179.547 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -97.47 75.49 2.5 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 114.42 -1.264 . . . . 0.0 107.65 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.13 -55.51 5.04 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.431 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.495 ' HA ' ' HZ ' ' A' ' 120' ' ' PHE . . . -148.51 -12.89 0.34 Allowed 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -87.15 91.64 8.78 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.893 0.377 . . . . 0.0 110.792 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.847 HD22 HD13 ' A' ' 153' ' ' LEU . 42.7 tp -60.86 124.65 21.07 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.138 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 54.5 ttp180 -128.35 131.94 48.58 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.773 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.635 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -149.72 145.9 26.93 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.612 0.72 . . . . 0.0 111.431 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.549 ' O ' ' HD2' ' A' ' 32' ' ' TYR . 19.8 mm-40 -78.73 71.26 5.18 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.645 178.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.681 ' SG ' HD13 ' A' ' 164' ' ' LEU . 61.6 m -60.08 121.65 12.4 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.717 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 10' ' ' SER . 25.0 ttt85 -67.91 132.08 46.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.038 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.718 ' HG2' ' HA3' ' A' ' 162' ' ' GLY . 18.8 mtm180 -103.75 155.88 18.25 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.27 -11.48 3.49 Favored Glycine 0 C--N 1.336 0.548 0 O-C-N 124.383 1.052 . . . . 0.0 114.389 -178.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -80.25 -4.46 53.33 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.19 10.97 73.59 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -179.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.66 152.68 17.37 Favored Glycine 0 C--O 1.225 -0.456 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.97 -178.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.549 ' HD2' ' O ' ' A' ' 24' ' ' GLU . 70.9 m-85 -101.55 125.31 48.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.721 0.296 . . . . 0.0 110.247 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.7 p -117.8 141.13 48.76 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.046 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.8 m -72.66 111.99 8.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.262 0.553 . . . . 0.0 111.219 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.416 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 44.2 t -115.32 148.61 39.02 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.343 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.6 p -144.97 137.96 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.944 0.402 . . . . 0.0 111.561 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.595 HG22 HD23 ' A' ' 164' ' ' LEU . 14.0 tt -134.5 154.2 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.341 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -89.17 110.24 21.01 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 121.836 -0.54 . . . . 0.0 111.487 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.569 HD23 ' HB3' ' A' ' 21' ' ' LEU . 2.9 mm? -87.55 -6.81 58.17 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.512 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.59 -17.27 64.57 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.1 mtt-85 -95.08 2.7 55.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.992 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 96.1 m-85 -131.36 -23.23 2.41 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.689 HD22 HD13 ' A' ' 151' ' ' ILE . 63.2 mt -105.98 136.59 45.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.845 0.355 . . . . 0.0 111.576 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.469 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 15.8 m -134.79 136.35 42.49 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.15 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.829 HD22 ' HA ' ' A' ' 120' ' ' PHE . 8.3 p30 -80.2 107.77 13.27 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.418 177.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -113.87 94.96 5.07 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.503 ' HA ' ' HB2' ' A' ' 142' ' ' TYR . 7.7 t30 56.95 49.41 14.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.756 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.552 ' O ' ' HB2' ' A' ' 149' ' ' SER . . . 71.91 31.12 64.87 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.201 178.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.511 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 38.8 m80 -144.45 129.04 18.11 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.732 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 26.3 m-85 -68.4 136.96 54.13 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.589 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -144.0 132.49 22.19 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.069 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.618 ' CD1' HD11 ' A' ' 151' ' ' ILE . 99.8 m95 . . . . . 0 C--O 1.236 0.359 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.163 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 87.9 m . . . . . 0 N--CA 1.452 -0.329 0 CA-C-O 121.057 0.456 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.65 176.32 8.55 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.263 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.439 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 4.8 p -127.41 121.33 30.6 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.794 0.331 . . . . 0.0 111.602 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.5 HG21 ' CE2' ' A' ' 80' ' ' PHE . 9.8 p -109.73 144.47 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.75 0.31 . . . . 0.0 110.411 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 18.1 m -88.19 128.07 35.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.101 0.477 . . . . 0.0 110.395 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.492 ' CG2' HD12 ' A' ' 99' ' ' ILE . 57.1 t -73.16 128.11 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.743 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -100.83 169.2 9.16 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 124.577 1.173 . . . . 0.0 111.196 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.618 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 26.4 tp60 -68.19 112.17 4.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.75 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.38 18.55 16.37 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.71 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -125.38 117.57 24.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.619 0.247 . . . . 0.0 110.463 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.687 ' HA ' HG12 ' A' ' 99' ' ' ILE . 81.9 p -104.9 -179.03 3.82 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.665 HD22 HG23 ' A' ' 99' ' ' ILE . 0.9 OUTLIER -52.88 -41.01 63.94 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.419 178.826 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 46.5 mtm105 -63.51 -39.02 93.34 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.168 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 79' ' ' ARG . 19.6 m-20 -70.95 -41.18 71.46 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.338 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 72' ' ' THR . 35.8 mm -63.92 -46.99 92.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.656 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -56.66 -54.76 34.02 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.75 -0.659 . . . . 0.0 113.02 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -64.86 -27.41 68.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.977 0.417 . . . . 0.0 111.734 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 71.9 ttt180 -74.24 -42.21 60.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.172 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.5 ' CE2' HG21 ' A' ' 65' ' ' VAL . 68.2 m-85 -111.45 19.75 17.9 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.2 t70 54.26 36.54 25.35 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.966 0.889 . . . . 0.0 111.316 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.656 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 3.6 p -113.79 163.5 14.97 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.615 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.0 t70 -92.71 124.69 36.9 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.935 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.515 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 4.0 p90 -51.67 -30.34 21.47 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.255 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.407 ' HD2' HD22 ' A' ' 95' ' ' ASN . 6.5 t-80 -64.71 -44.36 90.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.029 178.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.702 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 28.0 mm-40 -67.02 -48.25 68.93 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.934 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.615 HG13 ' O ' ' A' ' 83' ' ' ASP . 3.4 mt -53.46 -46.19 58.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.592 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.1 -51.28 67.21 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.35 178.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -57.35 -39.56 76.21 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.618 0.246 . . . . 0.0 111.53 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.702 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 63.9 mmt-85 -63.06 -37.51 87.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.009 0.433 . . . . 0.0 110.778 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.728 HD22 HD13 ' A' ' 93' ' ' ILE . 64.0 t30 -89.38 -5.34 57.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.948 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 95.2 m-20 74.46 22.16 2.18 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.556 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.728 HD13 HD22 ' A' ' 91' ' ' ASN . 14.8 pt -108.18 -176.98 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.212 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.454 ' H ' ' HB2' ' A' ' 97' ' ' ASP . 85.1 mm-40 -108.98 155.96 20.27 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.493 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.7 p30 -55.12 -60.43 3.39 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-O 122.104 0.954 . . . . 0.0 109.119 178.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -74.09 11.5 0.9 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.036 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.454 ' HB2' ' H ' ' A' ' 94' ' ' GLN . 5.3 t70 -64.86 -33.15 75.32 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.425 HD22 HG21 ' A' ' 72' ' ' THR . 51.0 mt 70.05 111.84 0.05 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.11 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.687 HG12 ' HA ' ' A' ' 72' ' ' THR . 9.2 pt -94.7 172.54 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.158 -178.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.499 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 19.3 m-85 -125.43 157.97 66.01 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.86 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.618 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 23.2 Cg_endo -65.25 132.63 32.28 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.986 2.458 . . . . 0.0 113.492 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.78 21.05 10.67 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.843 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.531 ' O ' ' HA ' ' A' ' 66' ' ' THR . 51.2 mt-30 -110.46 167.72 10.0 Favored 'General case' 0 C--O 1.215 -0.712 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.044 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.439 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 81.5 t -125.84 111.0 25.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.543 HD11 HG21 ' A' ' 99' ' ' ILE . 90.7 mt -107.16 150.63 26.39 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.155 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.614 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 47.4 mt-30 -89.41 114.92 26.44 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.713 0.768 . . . . 0.0 110.927 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.6 m -121.06 150.86 54.32 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 114.358 -1.292 . . . . 0.0 109.794 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.66 -19.81 59.74 Favored 'Trans proline' 0 N--CA 1.472 0.211 0 C-N-CA 123.458 2.772 . . . . 0.0 114.351 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.5 t . . . . . 0 C--N 1.323 -0.581 0 CA-C-O 120.975 0.417 . . . . 0.0 110.382 179.693 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.469 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.441 -0.993 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 74.51 27.49 1.37 Allowed 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.607 0.763 . . . . 0.0 112.636 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.829 ' HA ' HD22 ' A' ' 45' ' ' ASN . 19.4 p90 -62.36 -38.32 89.07 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.006 178.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.484 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 58.2 t-105 -61.72 -29.78 70.33 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 123.63 0.581 . . . . 0.0 111.634 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.15 -34.64 45.61 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.355 0.597 . . . . 0.0 110.539 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.956 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 17.8 m -132.64 32.34 3.88 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.484 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -114.37 137.36 51.91 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.403 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -131.95 151.3 51.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.183 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.6 t70 55.79 49.09 16.86 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.845 0.831 . . . . 0.0 109.763 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.496 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 29.6 t -77.2 119.29 25.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.746 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -142.36 144.21 33.06 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.79 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.867 HD13 HG22 ' A' ' 14' ' ' ILE . 19.8 mt -87.76 125.46 34.44 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.613 HG23 ' HB ' ' A' ' 135' ' ' VAL . 30.4 m -118.11 158.2 19.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.809 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 69.06 4.78 4.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.157 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.634 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 97.37 30.69 7.19 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.81 -0.709 . . . . 0.0 113.384 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 93.66 -21.38 41.48 Favored Glycine 0 C--O 1.266 2.097 0 CA-C-O 123.043 1.357 . . . . 0.0 113.112 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.849 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 15.8 ptpt -65.81 -17.88 64.94 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 121.785 -0.832 . . . . 0.0 108.834 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.613 ' HB ' HG23 ' A' ' 130' ' ' VAL . 17.2 t -139.47 141.62 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.676 177.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.587 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 24.4 tp -121.12 123.15 41.6 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.567 ' OE2' ' HD2' ' A' ' 148' ' ' ARG . 23.1 tt0 -117.26 131.34 56.85 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.1 0.476 . . . . 0.0 111.182 -177.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . . . -159.98 160.3 33.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.433 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -94.67 109.14 21.1 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.819 ' HG ' ' CB ' ' A' ' 45' ' ' ASN . 0.8 OUTLIER -91.7 131.04 37.37 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.016 -179.528 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.956 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 36.5 ttt180 -75.98 140.56 42.09 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.6 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.503 ' HB2' ' HA ' ' A' ' 47' ' ' ASN . 3.5 p90 -154.46 -176.23 5.79 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.852 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 46.6 m -56.28 -27.96 57.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.859 0.361 . . . . 0.0 111.686 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -97.35 25.76 25.77 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.283 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.85 -120.08 6.33 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.756 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -126.72 137.26 53.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.575 0.226 . . . . 0.0 110.473 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -133.93 132.9 40.78 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.369 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.567 ' HD2' ' OE2' ' A' ' 137' ' ' GLU . 16.3 ttp180 -74.87 98.11 3.47 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.56 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.552 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 35.1 t -106.15 164.38 12.04 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.907 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 15.8 ptt180 -147.62 145.94 29.17 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.694 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.732 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 14.7 tt -129.85 150.62 34.8 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.576 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.827 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 80.7 m-85 -89.46 103.88 16.48 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 122.144 -0.347 . . . . 0.0 111.079 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.847 HD13 HD22 ' A' ' 21' ' ' LEU . 34.2 mt -66.68 -33.78 76.41 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.299 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.849 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 10.1 t70 -58.42 -8.18 1.11 Allowed 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.159 178.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.827 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 38.8 mt-10 -68.77 -51.88 36.41 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 121.117 0.484 . . . . 0.0 111.785 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -119.25 -15.03 9.2 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.156 -177.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.466 HG21 HD21 ' A' ' 21' ' ' LEU . 50.2 mm -88.21 112.95 24.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.153 -179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.499 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -119.49 173.71 15.18 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.715 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.566 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.7 t30 -113.3 127.71 56.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -122.26 93.15 3.89 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 66.6 t30 53.05 58.15 5.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.545 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.718 ' HA3' ' HG2' ' A' ' 27' ' ' ARG . . . 78.91 11.41 85.24 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.567 -0.742 . . . . 0.0 114.821 178.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -123.75 143.66 50.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 117.542 0.671 . . . . 0.0 110.958 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.742 HD11 ' HD2' ' A' ' 7' ' ' PHE . 5.5 tp -91.58 118.8 30.93 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.944 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.7 pp . . . . . 0 C--N 1.325 -0.461 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.807 -178.658 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.629 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 55.4 m-85 . . . . . 0 C--O 1.232 0.132 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -108.52 -30.74 8.1 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.96 -69.97 1.22 Allowed Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 119.825 -1.178 . . . . 0.0 112.448 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 62.18 21.15 12.24 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 122.606 0.362 . . . . 0.0 111.229 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.713 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -64.32 -33.34 75.61 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 121.12 -0.232 . . . . 0.0 110.873 179.368 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.409 ' HA ' HD11 ' A' ' 14' ' ' ILE . 42.6 t -61.95 -18.24 59.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.47 0.653 . . . . 0.0 110.188 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.17 -31.46 69.14 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.124 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.502 ' HB2' ' HB3' ' A' ' 26' ' ' ARG . 21.6 p -126.67 -8.22 6.2 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 117.399 0.6 . . . . 0.0 111.742 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.1 m -105.32 128.95 53.74 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.44 ' CG ' ' HB2' ' A' ' 24' ' ' GLU . 13.8 ptm180 -110.05 -176.71 3.07 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.452 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 21.7 m-20 43.27 44.47 4.61 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 124.036 0.835 . . . . 0.0 112.306 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.901 HG22 HD13 ' A' ' 129' ' ' LEU . 8.3 mt -79.6 103.2 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -178.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.57 ' CA ' HD12 ' A' ' 129' ' ' LEU . 57.7 m -147.1 127.2 13.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.707 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.743 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -96.98 151.29 19.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.711 0.767 . . . . 0.0 112.805 -179.604 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 21.7 t70 -93.82 74.74 4.24 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 177.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.42 -54.44 4.9 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.155 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.559 ' HB1' ' HB2' ' A' ' 40' ' ' ASN . . . -147.97 -12.83 0.37 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.264 -0.468 . . . . 0.0 109.742 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.482 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -82.55 86.74 6.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.545 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.743 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 35.9 tp -60.95 124.45 20.53 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.485 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.546 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 34.7 ttt180 -132.17 127.59 36.23 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.877 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.604 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -146.0 145.98 30.82 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.668 0.747 . . . . 0.0 111.421 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.452 ' HG3' ' HB2' ' A' ' 13' ' ' ASP . 2.1 mm-40 -83.68 76.4 9.98 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.411 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.601 ' SG ' HD13 ' A' ' 164' ' ' LEU . 35.8 m -66.54 125.57 26.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.393 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.502 ' HB3' ' HB2' ' A' ' 10' ' ' SER . 30.3 ttt180 -70.41 121.75 18.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.651 178.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 27' ' ' ARG . 10.7 ptp180 -100.05 163.84 12.25 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.755 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.4 -15.95 4.54 Favored Glycine 0 C--N 1.34 0.782 0 O-C-N 124.934 1.396 . . . . 0.0 114.114 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.6 -12.49 61.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.516 0.674 . . . . 0.0 109.417 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.57 9.52 62.86 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.654 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -119.93 162.26 14.11 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.08 -1.057 . . . . 0.0 113.286 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.473 ' CE2' ' HB2' ' A' ' 26' ' ' ARG . 84.2 m-85 -100.44 125.2 46.71 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.0 p -116.6 140.76 49.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.393 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -73.58 113.92 11.23 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.17 0.51 . . . . 0.0 111.43 -178.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 32.9 t -116.14 151.02 36.46 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.649 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.6 p -144.77 139.6 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.308 0.575 . . . . 0.0 112.091 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.408 HG23 ' HB3' ' A' ' 21' ' ' LEU . 13.7 tt -135.47 143.38 36.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.479 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -76.34 96.85 4.08 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.603 HD23 HD11 ' A' ' 43' ' ' LEU . 5.3 tp -73.5 -4.54 34.47 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.046 0.45 . . . . 0.0 110.408 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.559 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 64.3 t30 -73.83 -11.7 60.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 74.0 mtt180 -102.48 5.08 39.32 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.233 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 13.7 m-85 -127.57 -26.09 3.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.778 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.665 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 49.3 mt -105.02 138.76 40.73 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.8 0.333 . . . . 0.0 110.899 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.454 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 4.0 m -134.68 134.76 41.46 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.678 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.686 HD21 HD22 ' A' ' 140' ' ' LEU . 1.0 OUTLIER -73.33 110.37 7.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.685 177.221 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -111.9 86.95 2.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.245 0.545 . . . . 0.0 110.407 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.41 ' HA ' ' HB2' ' A' ' 142' ' ' TYR . 21.5 t-20 51.82 46.22 26.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.23 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.498 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 82.98 40.01 9.7 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.573 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.415 ' HA ' ' HB3' ' A' ' 149' ' ' SER . 16.5 t60 -162.2 128.63 3.64 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.886 ' HB2' ' HB ' ' A' ' 151' ' ' ILE . 96.2 m-85 -67.6 156.81 35.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.817 0.342 . . . . 0.0 111.146 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.433 ' HA ' ' HD3' ' A' ' 51' ' ' ARG . 16.7 mmt180 -148.91 126.89 11.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.169 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.976 ' HZ2' ' HA ' ' A' ' 153' ' ' LEU . 72.9 m95 . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.511 178.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 83.6 m . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.088 0.47 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.26 176.38 5.88 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.586 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.466 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 13.2 p -127.73 111.03 13.23 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.905 0.383 . . . . 0.0 111.176 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.568 HG21 ' CE2' ' A' ' 80' ' ' PHE . 9.1 p -97.54 144.37 11.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.042 0.448 . . . . 0.0 111.218 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 8.2 m -91.09 127.46 36.52 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.478 ' CG2' HD12 ' A' ' 99' ' ' ILE . 49.1 t -75.87 131.68 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.585 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -98.08 168.95 9.95 Favored 'General case' 0 N--CA 1.445 -0.679 0 O-C-N 124.657 1.223 . . . . 0.0 110.569 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.593 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 52.3 tt0 -69.65 119.75 14.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.781 -178.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.39 -1.67 50.1 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.475 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -110.12 131.71 54.82 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.084 0.469 . . . . 0.0 111.687 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.652 ' HA ' HG12 ' A' ' 99' ' ' ILE . 67.5 p -108.59 -177.62 3.37 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.651 HD22 HG23 ' A' ' 99' ' ' ILE . 1.4 mm? -52.85 -40.81 63.71 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.454 0.645 . . . . 0.0 109.889 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.0 ttm-85 -62.9 -37.16 85.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.211 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -74.15 -42.0 60.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.905 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 72' ' ' THR . 44.7 mm -62.0 -48.31 89.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.715 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -54.44 -52.87 41.87 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.688 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -64.5 -33.7 76.5 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 35.7 ttm-85 -68.69 -37.46 79.56 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.568 ' CE2' HG21 ' A' ' 65' ' ' VAL . 87.1 m-85 -111.72 18.37 19.03 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 55.02 34.07 21.67 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.236 0.541 . . . . 0.0 111.794 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.715 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 3.0 p -111.37 170.49 8.09 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.608 ' HB3' ' HG3' ' A' ' 86' ' ' GLU . 32.6 t0 -98.26 121.53 40.3 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.419 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.503 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 4.3 p90 -51.82 -29.72 20.42 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.586 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.461 ' HB2' ' OD2' ' A' ' 83' ' ' ASP . 69.2 m80 -63.8 -47.22 81.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.513 177.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.748 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 41.6 mt-10 -62.05 -53.49 54.75 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.942 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.587 HG13 ' O ' ' A' ' 83' ' ' ASP . 3.3 mt -48.0 -46.6 12.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.275 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.601 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.72 -51.06 68.64 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.211 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 89' ' ' ARG . 49.4 mtp85 -59.16 -36.77 75.85 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.748 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 12.3 mmt85 -69.43 -30.44 68.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.699 0.285 . . . . 0.0 110.98 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 2.6 t-20 -95.1 -4.72 45.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.825 0.345 . . . . 0.0 110.871 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 15.9 m120 78.25 13.81 1.52 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.769 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.601 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 19.6 pt -101.64 -173.55 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.288 179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.508 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . 64.4 mt-30 -113.88 157.64 22.1 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.126 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.574 ' O ' HD23 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -56.54 -69.73 0.14 Allowed 'General case' 0 C--O 1.244 0.778 0 CA-C-O 122.061 0.934 . . . . 0.0 110.101 179.663 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -73.28 13.91 0.38 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.716 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.508 ' HB2' ' HB2' ' A' ' 94' ' ' GLN . 1.9 t70 -65.99 -29.32 69.69 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.094 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 8.8 mp 71.33 112.3 0.06 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 122.033 0.921 . . . . 0.0 110.55 -178.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.652 HG12 ' HA ' ' A' ' 72' ' ' THR . 9.0 pt -94.59 177.22 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.155 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.519 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 79.2 m-85 -128.7 158.77 71.09 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.593 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 28.1 Cg_endo -67.0 138.96 49.56 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.949 2.433 . . . . 0.0 113.056 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.35 18.49 42.07 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.508 ' O ' ' HA ' ' A' ' 66' ' ' THR . 41.4 tt0 -103.89 164.28 11.8 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.466 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 69.7 t -125.58 118.2 51.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 120.938 0.399 . . . . 0.0 109.978 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.509 ' HB3' HG22 ' A' ' 87' ' ' ILE . 78.9 mt -114.44 151.07 33.77 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.147 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.534 ' HB2' ' CB ' ' A' ' 90' ' ' ARG . 75.8 mt-30 -90.91 115.2 27.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.668 0.747 . . . . 0.0 110.92 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.444 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 34.0 m -126.99 151.97 74.91 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.843 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.444 ' HD2' ' HB ' ' A' ' 107' ' ' VAL . 29.7 Cg_endo -63.8 -15.37 48.55 Favored 'Trans proline' 0 N--CA 1.474 0.352 0 C-N-CA 123.624 2.883 . . . . 0.0 115.207 -177.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 C--N 1.322 -0.616 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.225 179.813 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.444 -0.799 0 N-CA-C 112.257 -0.337 . . . . 0.0 112.257 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 71.89 29.4 2.45 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 123.055 0.542 . . . . 0.0 111.373 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.665 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 12.5 p90 -61.19 -37.98 84.88 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.107 0.48 . . . . 0.0 110.183 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.452 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 48.6 t-105 -64.85 -26.25 68.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.636 -178.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.46 -18.3 61.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.213 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.78 ' HB2' ' HB3' ' A' ' 141' ' ' ARG . 11.2 p -140.07 22.67 2.42 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.971 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.452 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -111.73 141.96 44.69 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.901 0.382 . . . . 0.0 111.091 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -133.74 151.2 51.54 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 58.83 34.81 23.94 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.363 0.414 . . . . 0.0 111.646 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.498 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 30.8 t -66.92 123.82 20.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.81 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.491 ' O ' HD12 ' A' ' 136' ' ' LEU . 39.1 ptt180 -148.12 142.71 26.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.088 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.901 HD13 HG22 ' A' ' 14' ' ' ILE . 22.3 mt -85.52 131.79 34.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.081 0.467 . . . . 0.0 110.044 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.617 HG23 ' HB ' ' A' ' 135' ' ' VAL . 27.5 m -126.92 162.36 31.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.825 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 67.16 7.26 5.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.785 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.686 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 95.39 31.35 7.58 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.914 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.777 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 90.03 -19.28 43.23 Favored Glycine 0 CA--C 1.541 1.671 0 CA-C-O 123.226 1.459 . . . . 0.0 112.824 177.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.773 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 0.7 OUTLIER -68.18 -14.92 63.34 Favored 'General case' 0 C--N 1.314 -0.952 0 O-C-N 121.121 -1.223 . . . . 0.0 109.564 178.071 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.617 ' HB ' HG23 ' A' ' 130' ' ' VAL . 14.6 t -140.49 149.06 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.783 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 39.0 tp -130.72 125.25 33.4 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.403 ' HG2' ' HD2' ' A' ' 148' ' ' ARG . 33.6 tt0 -114.65 136.25 53.25 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.622 0.249 . . . . 0.0 111.363 -177.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.802 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.73 163.51 26.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.105 0.479 . . . . 0.0 111.323 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -94.72 106.5 18.49 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.686 HD22 HD21 ' A' ' 45' ' ' ASN . 36.6 mt -96.25 132.23 41.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.104 0.478 . . . . 0.0 111.316 -178.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.78 ' HB3' ' HB2' ' A' ' 123' ' ' SER . 42.5 ttt180 -75.82 140.55 42.34 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.256 -0.883 . . . . 0.0 110.674 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.509 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.7 p90 -160.3 -170.3 2.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.429 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 6.1 p -56.12 -29.29 60.46 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -94.49 11.67 69.84 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.726 -0.749 . . . . 0.0 113.171 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 141' ' ' ARG . . . 101.08 -111.46 4.14 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.039 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -126.75 129.85 49.17 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.509 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 9.1 t30 -125.55 140.19 52.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.992 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.403 ' HD2' ' HG2' ' A' ' 137' ' ' GLU . 12.5 tpp85 -73.49 100.04 3.16 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.415 ' HB3' ' HA ' ' A' ' 49' ' ' HIS . 1.0 OUTLIER -111.62 155.43 23.38 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.425 -177.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 4.8 ptp180 -146.51 145.28 30.1 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.135 0.493 . . . . 0.0 111.274 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.886 ' HB ' ' HB2' ' A' ' 50' ' ' PHE . 15.4 tt -126.47 159.74 35.22 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.81 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.489 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.871 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 68.5 m-85 -103.94 107.15 17.9 Favored 'General case' 0 C--N 1.311 -1.106 0 O-C-N 122.361 -0.212 . . . . 0.0 110.655 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.976 ' HA ' ' HZ2' ' A' ' 52' ' ' TRP . 8.4 mp -68.9 -37.18 78.81 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.221 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.773 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 6.1 t70 -57.08 -8.41 0.66 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.869 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.871 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 61.0 mt-10 -73.78 -55.43 6.24 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 121.972 -0.455 . . . . 0.0 111.811 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -122.0 9.8 10.02 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.114 -0.634 . . . . 0.0 112.671 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.446 ' HB ' ' O ' ' A' ' 153' ' ' LEU . 45.1 mm -110.95 109.62 29.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.356 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.488 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -115.58 166.65 12.26 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.048 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.565 ' CG ' ' HB3' ' A' ' 25' ' ' CYS . 1.8 t30 -101.51 124.84 47.83 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.413 ' NH2' ' HG2' ' A' ' 163' ' ' GLU . 48.3 ttp180 -112.99 86.12 2.31 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.694 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 50.26 51.06 17.48 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 92.87 6.64 63.41 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.762 178.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.413 ' HG2' ' NH2' ' A' ' 160' ' ' ARG . 6.7 tp10 -122.16 149.75 43.17 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.713 HD11 ' CD2' ' A' ' 7' ' ' PHE . 5.3 tp -99.11 118.16 35.22 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 12.2 tt . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.673 -178.542 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.479 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 53.5 m-85 . . . . . 0 N--CA 1.457 -0.116 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.31 -29.39 10.8 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.66 -73.41 0.58 Allowed Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 119.772 -1.204 . . . . 0.0 113.154 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 65.26 15.61 10.1 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 122.46 0.304 . . . . 0.0 110.484 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.61 ' CE2' HD13 ' A' ' 14' ' ' ILE . 1.4 p90 -60.14 -37.26 79.53 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.562 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.588 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.7 OUTLIER -59.85 -24.05 63.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.268 0.556 . . . . 0.0 110.604 -179.427 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.87 -33.96 87.25 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.404 -0.816 . . . . 0.0 113.44 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 18.8 p -121.12 -3.74 9.55 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 117.188 0.494 . . . . 0.0 111.689 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.7 m -110.39 131.85 54.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.119 0.485 . . . . 0.0 109.997 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.597 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 18.8 ptt180 -107.95 179.94 4.08 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 42.52 47.79 4.48 Favored 'General case' 0 C--N 1.316 -0.867 0 O-C-N 123.883 0.739 . . . . 0.0 112.767 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.777 HG22 HD13 ' A' ' 129' ' ' LEU . 7.3 mt -81.49 102.44 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-O 121.043 0.449 . . . . 0.0 109.919 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.562 ' HA ' HD12 ' A' ' 129' ' ' LEU . 46.4 t -147.76 128.69 14.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.457 -0.792 . . . . 0.0 108.985 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.741 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -92.99 159.48 15.29 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.629 0.728 . . . . 0.0 112.007 -179.241 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -104.31 77.64 1.42 Allowed 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.22 -61.02 4.52 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.134 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' A' ' 40' ' ' ASN . . . -146.02 -13.36 0.48 Allowed 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.282 -0.459 . . . . 0.0 109.913 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -86.16 95.15 9.48 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.81 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.894 ' HB2' HD22 ' A' ' 39' ' ' LEU . 33.8 tp -59.75 128.27 36.11 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.758 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 35' ' ' SER . 34.8 ttp180 -133.17 128.03 35.13 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.939 -178.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.621 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -149.47 147.29 28.05 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.546 0.688 . . . . 0.0 111.144 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.597 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 2.1 mm-40 -82.96 79.62 9.26 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.464 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.574 ' HB3' ' CG ' ' A' ' 159' ' ' ASN . 61.4 m -67.34 129.43 39.89 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.762 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 10' ' ' SER . 43.1 ttp180 -72.35 120.8 18.46 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.251 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.7 ttt-85 -96.05 153.71 17.63 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.09 -16.37 4.33 Favored Glycine 0 C--N 1.335 0.493 0 O-C-N 124.611 1.194 . . . . 0.0 114.765 -177.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.87 -13.88 61.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.238 0.542 . . . . 0.0 110.001 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.38 10.13 56.09 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.59 160.64 13.9 Favored Glycine 0 C--O 1.225 -0.461 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.485 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.522 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 88.5 m-85 -97.98 130.59 44.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.955 0.407 . . . . 0.0 110.685 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.0 m -110.69 129.1 55.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.364 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.36 110.37 5.26 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 29.4 t -112.46 147.17 37.08 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.219 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.668 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.3 p -144.76 133.09 17.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.027 0.441 . . . . 0.0 110.686 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.407 HG23 ' HB3' ' A' ' 21' ' ' LEU . 11.0 tt -133.93 146.83 30.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.648 -177.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -78.96 103.74 9.11 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.924 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.894 HD22 ' HB2' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -78.96 -5.17 53.13 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 120.858 0.361 . . . . 0.0 110.245 178.601 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.651 HD22 ' HB3' ' A' ' 121' ' ' TRP . 25.1 t-20 -70.9 -17.88 62.69 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -106.07 17.49 23.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.382 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 41.3 m-85 -135.97 -34.7 0.8 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.314 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.856 HD22 HD13 ' A' ' 151' ' ' ILE . 38.6 mt -106.09 136.32 45.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.867 -179.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.681 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 3.0 m -126.6 143.59 51.17 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.78 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.629 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 6.8 p-10 -93.23 93.56 8.31 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 122.01 0.909 . . . . 0.0 108.568 178.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.422 ' HB3' ' HG3' ' A' ' 51' ' ' ARG . 31.9 t70 -94.3 95.74 9.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.16 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 54.68 45.65 26.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.525 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.703 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 77.87 29.94 53.23 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.467 178.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.556 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 23.7 t-160 -148.03 124.93 11.27 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.799 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 25.3 m-85 -62.54 136.42 57.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.248 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.422 ' HG3' ' HB3' ' A' ' 46' ' ' ASP . 17.1 mmm180 -145.01 133.12 21.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.701 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.469 ' CD1' HD11 ' A' ' 151' ' ' ILE . 98.6 m95 . . . . . 0 C--N 1.326 -0.433 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.6 m . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 121.067 0.46 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -126.46 176.76 6.92 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.665 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.1 p -128.37 118.01 22.42 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 t -107.06 137.2 39.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.802 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 18.9 m -87.78 124.82 34.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.081 0.467 . . . . 0.0 109.916 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.501 ' CG2' HD12 ' A' ' 99' ' ' ILE . 42.2 t -71.06 133.91 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.125 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.494 ' HB3' ' OD2' ' A' ' 71' ' ' ASP . 4.5 tt0 -104.16 171.33 7.4 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 124.464 1.103 . . . . 0.0 110.411 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.673 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 58.9 tp60 -60.22 119.68 8.35 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.374 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.94 6.53 79.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.996 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.494 ' OD2' ' HB3' ' A' ' 68' ' ' GLN . 27.6 m-20 -103.82 124.03 48.17 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 117.393 0.597 . . . . 0.0 110.581 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.625 ' HA ' HG12 ' A' ' 99' ' ' ILE . 80.3 p -105.18 179.44 4.27 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.571 ' CD2' HG23 ' A' ' 99' ' ' ILE . 2.2 mm? -51.6 -41.57 61.32 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.59 0.709 . . . . 0.0 109.403 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -59.61 -39.36 83.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.384 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 79' ' ' ARG . 13.4 m-20 -73.85 -46.65 43.68 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.119 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 72' ' ' THR . 42.4 mm -57.12 -48.05 82.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.709 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.736 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -59.78 -54.28 38.9 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.852 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -33.04 74.39 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.92 0.39 . . . . 0.0 111.524 -178.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 35.6 ttt180 -74.0 -39.82 63.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.031 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -105.78 19.33 20.73 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 59.26 26.82 15.71 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.736 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -110.12 168.64 9.29 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.503 ' O ' HG13 ' A' ' 87' ' ' ILE . 4.3 p-10 -96.65 122.17 39.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.71 0.767 . . . . 0.0 109.836 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.422 ' HA ' HD12 ' A' ' 87' ' ' ILE . 3.0 p90 -48.64 -32.16 7.83 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.036 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.41 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 10.9 m80 -60.36 -48.93 79.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.991 178.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.608 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 28.4 tt0 -63.18 -46.33 87.62 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.205 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.54 ' HB ' HD12 ' A' ' 73' ' ' LEU . 3.5 mt -52.51 -49.58 43.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.572 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.27 -49.21 74.97 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.408 178.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 85' ' ' HIS . 62.0 mtm180 -56.67 -38.13 71.77 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.608 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 13.0 mtt180 -70.02 -36.29 74.98 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.158 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.806 HD22 HD13 ' A' ' 93' ' ' ILE . 66.8 t30 -85.76 -5.51 59.24 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.964 0.411 . . . . 0.0 110.276 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 15.9 m120 75.5 18.92 2.2 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.611 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.806 HD13 HD22 ' A' ' 91' ' ' ASN . 14.3 pt -105.66 -170.38 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.204 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.556 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 28.5 mm-40 -117.97 158.72 24.41 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.506 ' O ' HD23 ' A' ' 73' ' ' LEU . 6.3 p30 -55.72 -57.62 11.26 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-O 121.877 0.846 . . . . 0.0 109.956 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.12 12.51 2.78 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 121.831 -0.543 . . . . 0.0 111.294 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.556 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 0.8 OUTLIER -62.69 -31.2 72.06 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.617 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 7.0 mp 71.38 111.18 0.06 Allowed 'General case' 0 C--N 1.338 0.108 0 O-C-N 124.358 1.037 . . . . 0.0 110.732 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.649 HG21 HD11 ' A' ' 105' ' ' LEU . 6.4 pt -94.43 176.0 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.977 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.476 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 92.7 m-85 -121.07 158.2 53.28 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.91 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.673 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 43.4 Cg_endo -72.3 133.36 20.88 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 123.042 2.495 . . . . 0.0 112.889 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 101.59 14.12 30.7 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' A' ' 66' ' ' THR . 40.0 mt-30 -102.92 168.44 9.2 Favored 'General case' 0 C--O 1.216 -0.699 0 C-N-CA 120.641 -0.424 . . . . 0.0 109.956 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 63.5 t -126.15 118.48 51.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.649 HD11 HG21 ' A' ' 99' ' ' ILE . 95.8 mt -113.93 150.07 34.28 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.188 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -89.58 110.72 21.55 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.986 0.898 . . . . 0.0 111.21 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.1 m -115.59 151.57 46.28 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.555 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.71 -18.06 53.02 Favored 'Trans proline' 0 C--N 1.331 -0.349 0 C-N-CA 123.069 2.513 . . . . 0.0 114.376 -178.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.0 t . . . . . 0 C--N 1.32 -0.681 0 CA-C-O 120.875 0.369 . . . . 0.0 111.225 -179.777 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.681 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.444 -0.778 0 N-CA-C 112.676 -0.169 . . . . 0.0 112.676 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 73.18 29.1 1.77 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.278 0.631 . . . . 0.0 111.554 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.585 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 20.0 p90 -59.87 -37.69 80.05 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-O 121.108 0.48 . . . . 0.0 110.06 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.651 ' HB3' HD22 ' A' ' 40' ' ' ASN . 4.1 t-105 -66.27 -26.55 67.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.195 -178.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.89 -25.49 66.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.139 0.495 . . . . 0.0 110.143 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.697 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 4.2 m -133.42 27.03 4.11 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.323 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.617 ' HB3' ' HE3' ' A' ' 121' ' ' TRP . . . -105.65 155.82 18.87 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.001 0.429 . . . . 0.0 110.898 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.0 mmm-85 -146.43 142.35 28.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.755 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 53.55 35.57 21.21 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.246 0.546 . . . . 0.0 111.371 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.585 ' HB ' ' CB ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -79.74 127.36 39.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.812 -179.848 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.45 ' O ' HD12 ' A' ' 136' ' ' LEU . 15.6 ptt180 -151.31 158.82 44.32 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.571 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.835 HD21 HD11 ' A' ' 153' ' ' LEU . 17.1 mt -86.1 136.59 33.16 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 120.996 0.427 . . . . 0.0 110.825 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.573 HG23 ' HB ' ' A' ' 135' ' ' VAL . 31.2 m -132.35 159.48 43.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.471 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.481 ' HB3' ' HD3' ' A' ' 134' ' ' LYS . 4.6 m-20 69.63 4.87 4.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.398 178.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.661 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 98.04 28.84 7.96 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.597 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.517 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 93.07 -18.85 55.26 Favored Glycine 0 C--O 1.269 2.283 0 CA-C-O 123.773 1.763 . . . . 0.0 112.623 177.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.695 ' HG3' HG23 ' A' ' 135' ' ' VAL . 20.9 ptmt -67.52 -19.97 65.37 Favored 'General case' 0 C--N 1.313 -0.986 0 O-C-N 121.452 -1.028 . . . . 0.0 108.82 178.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.695 HG23 ' HG3' ' A' ' 134' ' ' LYS . 4.2 t -138.15 146.67 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 121.279 0.561 . . . . 0.0 110.874 178.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.625 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 50.6 tp -126.46 116.31 20.93 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.484 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 32.5 tt0 -105.05 137.15 43.25 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.437 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.585 ' CB ' ' HB ' ' A' ' 127' ' ' VAL . . . -161.96 164.07 28.62 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.185 0.517 . . . . 0.0 112.283 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -95.9 106.25 18.37 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.703 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 50.2 mt -98.24 129.79 44.97 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.307 0.575 . . . . 0.0 111.244 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.697 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 62.4 ttt180 -71.32 141.18 50.47 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.5 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.437 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.6 p90 -159.09 -173.78 4.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.226 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 17.0 m -61.04 -26.21 67.47 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -94.83 16.12 61.93 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.875 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 102.1 -114.99 5.1 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.412 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -128.69 128.84 44.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.931 0.396 . . . . 0.0 110.371 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.437 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 47.0 t30 -124.25 130.86 53.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.218 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.474 ' HA ' ' O ' ' A' ' 138' ' ' ALA . 13.8 ttp180 -78.15 96.58 5.21 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.266 0.555 . . . . 0.0 110.617 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.556 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 20.0 t -104.13 170.43 7.92 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.172 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 8.7 mtp85 -146.22 147.73 31.75 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 121.155 -0.218 . . . . 0.0 110.615 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.856 HD13 HD22 ' A' ' 43' ' ' LEU . 9.9 tt -131.34 152.62 37.62 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.538 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.146 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.672 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 84.4 m-85 -96.65 105.02 17.06 Favored 'General case' 0 C--N 1.313 -1.012 0 O-C-N 122.286 -0.259 . . . . 0.0 111.024 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.835 HD11 HD21 ' A' ' 129' ' ' LEU . 16.9 mt -65.72 -37.24 85.86 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.11 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.663 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 9.4 t70 -53.59 -14.4 0.85 Allowed 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.144 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.672 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 41.1 mt-10 -66.51 -54.79 19.99 Favored 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 121.682 -0.636 . . . . 0.0 112.715 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -122.18 1.05 9.69 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.141 -0.624 . . . . 0.0 112.492 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 45.5 mm -104.09 110.78 31.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.484 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.597 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -118.69 166.41 12.97 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.232 -0.985 . . . . 0.0 113.105 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.574 ' CG ' ' HB3' ' A' ' 25' ' ' CYS . 2.6 t30 -98.25 122.26 41.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.415 -0.393 . . . . 0.0 110.077 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -117.81 86.77 2.58 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 58.86 47.37 12.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.184 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.549 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 87.67 7.55 75.0 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.485 178.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -124.09 132.74 53.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.04 0.447 . . . . 0.0 111.567 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.578 HD21 ' HD2' ' A' ' 7' ' ' PHE . 30.0 mt -84.63 114.31 21.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.642 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 46.0 pt . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.222 178.783 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.471 ' CD1' ' HG2' ' A' ' 155' ' ' GLU . 28.9 m-85 . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.54 -27.41 12.37 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.2 -76.39 0.27 Allowed Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.13 -1.033 . . . . 0.0 112.91 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 65.66 11.03 7.22 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.547 0.339 . . . . 0.0 111.138 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.644 ' CE2' HD13 ' A' ' 14' ' ' ILE . 1.6 p90 -61.33 -33.02 72.91 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 121.133 -0.227 . . . . 0.0 111.281 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.533 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.8 OUTLIER -62.58 -25.41 68.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.326 0.584 . . . . 0.0 110.562 -178.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.73 -22.99 77.0 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.183 -0.917 . . . . 0.0 113.596 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.516 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 22.9 p -125.73 -16.39 5.73 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 117.722 0.761 . . . . 0.0 111.72 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.6 m -99.72 131.71 45.53 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.427 ' CG ' ' HB2' ' A' ' 24' ' ' GLU . 15.2 ptm180 -109.18 178.82 4.34 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.412 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 7.8 m-20 44.67 47.57 8.71 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.454 0.701 . . . . 0.0 112.56 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.679 HG22 HD13 ' A' ' 129' ' ' LEU . 10.2 mt -80.77 106.18 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.758 ' HA ' HD12 ' A' ' 129' ' ' LEU . 72.2 m -147.8 128.04 13.85 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.733 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -94.04 154.62 17.54 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.22 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -96.21 73.93 2.93 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.002 -1.453 . . . . 0.0 107.694 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.17 -60.17 4.72 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.793 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.445 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -145.42 0.46 0.89 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.135 0.493 . . . . 0.0 110.47 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -104.48 93.82 4.99 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.005 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.815 HD23 HD11 ' A' ' 129' ' ' LEU . 2.8 tm? -60.06 132.45 53.97 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.671 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.618 ' H ' HD22 ' A' ' 21' ' ' LEU . 33.2 ttm105 -134.52 128.0 32.48 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.198 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.635 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -148.39 148.49 30.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.679 0.752 . . . . 0.0 111.141 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 2.6 mm-40 -82.85 76.95 9.66 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.196 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.517 ' SG ' HD13 ' A' ' 164' ' ' LEU . 84.8 m -63.36 126.74 28.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.717 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.516 ' HB2' ' O ' ' A' ' 10' ' ' SER . 37.2 ttt180 -69.54 122.57 19.3 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.353 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.567 ' HG3' ' OD1' ' A' ' 161' ' ' ASN . 20.4 ttt85 -99.3 152.06 20.36 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.891 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -52.19 -17.9 4.33 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 114.119 -1.4 . . . . 0.0 114.712 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.451 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 4.6 m-20 -74.94 -7.46 53.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.103 0.478 . . . . 0.0 110.696 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.51 8.13 62.75 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.64 154.95 16.38 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.368 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.477 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 80.8 m-85 -92.4 125.53 37.09 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.3 m -108.23 130.35 55.16 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.332 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.2 m -68.98 112.44 5.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.862 0.363 . . . . 0.0 110.588 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.472 ' HB3' HD22 ' A' ' 164' ' ' LEU . 32.2 t -116.44 151.24 36.43 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.265 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 1.4 p -144.38 130.93 15.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.964 0.411 . . . . 0.0 110.675 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.438 ' CG2' ' HB3' ' A' ' 21' ' ' LEU . 17.8 tt -122.95 149.23 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.98 -178.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.471 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 22.7 m-20 -82.78 93.57 7.46 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.563 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.67 HD13 HD11 ' A' ' 43' ' ' LEU . 39.2 mt -73.27 -13.38 61.12 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.019 0.438 . . . . 0.0 109.997 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.5 ' OD1' ' HG3' ' A' ' 41' ' ' ARG . 23.8 p30 -66.27 -16.22 63.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.432 0.634 . . . . 0.0 109.625 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.5 ' HG3' ' OD1' ' A' ' 40' ' ' ASN . 48.0 mtm180 -117.29 20.28 13.73 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.418 178.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.573 ' HB2' ' HA ' ' A' ' 39' ' ' LEU . 9.6 m-85 -133.4 -30.92 1.26 Allowed 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.295 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.965 HD22 HD13 ' A' ' 151' ' ' ILE . 42.2 mt -114.63 135.8 53.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.854 0.359 . . . . 0.0 110.781 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.66 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 1.9 m -124.21 147.66 47.87 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.038 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.571 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 7.5 p-10 -94.86 98.77 10.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.596 0.713 . . . . 0.0 110.478 178.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -99.99 94.41 6.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.191 0.519 . . . . 0.0 110.824 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.488 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 64.0 t30 52.68 45.37 28.8 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.213 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.711 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 79.96 32.57 35.81 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.608 178.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -149.14 131.34 15.47 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.808 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 58.7 m-85 -72.63 145.37 47.35 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.955 0.407 . . . . 0.0 111.427 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -143.5 133.62 24.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.063 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.559 ' HZ2' ' O ' ' A' ' 152' ' ' TYR . 97.9 m95 . . . . . 0 C--N 1.323 -0.582 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.451 -0.424 0 CA-C-O 120.944 0.402 . . . . 0.0 110.069 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -131.46 177.47 7.47 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.933 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.416 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 21.2 p -128.23 121.29 29.02 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.411 HG23 HG21 ' A' ' 107' ' ' VAL . 4.2 t -107.36 134.3 49.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.928 178.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 7.2 m -87.51 125.82 34.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.494 ' CG2' HD12 ' A' ' 99' ' ' ILE . 42.0 t -73.14 132.29 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.103 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -104.19 170.63 7.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 124.388 1.055 . . . . 0.0 109.47 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.594 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 58.8 tt0 -66.63 124.28 22.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.51 -178.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.05 3.22 73.45 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.978 -0.63 . . . . 0.0 113.592 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -109.59 121.4 45.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.035 0.418 . . . . 0.0 111.231 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.59 ' HA ' HG12 ' A' ' 99' ' ' ILE . 81.4 p -102.56 -178.11 3.59 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.647 HD22 HG23 ' A' ' 99' ' ' ILE . 1.1 mm? -51.99 -40.98 61.79 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.347 0.594 . . . . 0.0 109.834 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.43 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 48.7 ttm-85 -62.95 -39.65 95.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.164 -178.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -71.7 -42.93 66.8 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.959 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.556 HG12 ' O ' ' A' ' 72' ' ' THR . 45.6 mm -61.72 -48.79 87.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.796 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.674 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -58.33 -54.09 40.47 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.422 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -58.5 -41.17 84.76 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.761 0.315 . . . . 0.0 111.77 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -65.1 -43.98 90.31 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -98.43 11.79 37.05 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.9 t70 63.4 23.12 13.58 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.359 0.599 . . . . 0.0 112.106 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.674 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.3 p -104.37 171.67 7.21 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.577 ' O ' HG13 ' A' ' 87' ' ' ILE . 5.8 t70 -98.01 125.31 42.89 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.9 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.524 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 9.3 p90 -50.78 -29.68 12.19 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.366 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -65.12 -46.21 81.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.541 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.734 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 56.7 mm-40 -69.14 -41.44 77.31 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.314 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.577 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.8 mt -54.87 -47.5 75.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.657 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.53 -48.58 76.93 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.5 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -54.4 -43.01 71.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.351 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.734 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 24.7 mmm-85 -72.82 -27.4 61.94 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 3.3 t-20 -94.01 -4.79 48.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.892 0.377 . . . . 0.0 111.103 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 90.1 m-20 75.61 17.49 2.37 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.756 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.657 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 19.2 pt -105.67 -172.44 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.534 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 18.1 mm-40 -116.31 154.46 30.15 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.561 ' O ' HD23 ' A' ' 73' ' ' LEU . 1.2 p30 -52.25 -65.96 0.47 Allowed 'General case' 0 C--O 1.244 0.777 0 CA-C-O 122.225 1.012 . . . . 0.0 109.872 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -76.06 13.42 0.89 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.824 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 4.6 t0 -63.59 -31.48 72.66 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 7.9 mp 72.06 112.35 0.06 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.611 -178.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.647 HG23 HD22 ' A' ' 73' ' ' LEU . 9.8 pt -94.85 176.63 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.815 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.556 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 94.1 m-85 -131.16 158.01 76.45 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.743 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.594 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 18.4 Cg_endo -63.98 138.26 61.66 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 123.301 2.667 . . . . 0.0 113.823 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.41 20.8 31.23 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.79 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.542 ' O ' ' HA ' ' A' ' 66' ' ' THR . 77.2 mt-30 -110.4 166.07 11.28 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.178 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.416 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 95.6 t -125.09 118.51 53.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.566 HD11 HG21 ' A' ' 99' ' ' ILE . 76.9 mt -112.35 150.59 30.84 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.35 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -90.8 116.93 29.03 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.582 0.706 . . . . 0.0 110.656 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.411 HG21 HG23 ' A' ' 65' ' ' VAL . 33.6 m -119.83 151.27 52.12 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.454 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.06 -18.98 51.9 Favored 'Trans proline' 0 C--N 1.332 -0.33 0 C-N-CA 123.098 2.532 . . . . 0.0 114.332 -178.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.9 t . . . . . 0 C--N 1.326 -0.448 0 CA-C-O 121.032 0.444 . . . . 0.0 111.131 -179.806 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.66 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.445 -0.712 0 CA-C-O 120.19 -0.228 . . . . 0.0 113.155 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 14.0 m120 73.94 26.71 1.73 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.059 0.544 . . . . 0.0 112.111 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.551 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 20.7 p90 -60.65 -37.23 80.82 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.04 0.448 . . . . 0.0 110.348 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.571 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 71.0 t-105 -61.79 -34.43 75.88 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.404 -178.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -54.02 -27.42 31.88 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.143 0.277 . . . . 0.0 110.894 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.666 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 9.3 m -132.85 28.54 4.2 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.479 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.571 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -107.51 143.89 35.25 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.968 0.413 . . . . 0.0 111.387 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -126.69 143.05 51.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.817 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 49.12 57.47 6.43 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.668 0.605 . . . . 0.0 112.01 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.434 ' CG1' HD11 ' A' ' 136' ' ' LEU . 40.3 t -80.45 121.76 34.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.841 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.66 148.14 29.72 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.292 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.815 HD11 HD23 ' A' ' 21' ' ' LEU . 33.6 mt -85.54 145.23 27.48 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.137 0.494 . . . . 0.0 111.411 -179.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.944 HG23 ' HB ' ' A' ' 135' ' ' VAL . 29.0 m -132.31 157.1 43.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.64 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 71.83 1.12 3.77 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.772 0.829 . . . . 0.0 110.387 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.619 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 93.14 28.42 11.83 Favored Glycine 0 N--CA 1.433 -1.535 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.165 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.527 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 104.66 -18.19 44.56 Favored Glycine 0 C--O 1.271 2.44 0 CA-C-O 123.45 1.583 . . . . 0.0 113.165 178.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.758 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 1.6 mttp -72.16 -13.58 61.59 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 121.221 -1.164 . . . . 0.0 108.854 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.944 ' HB ' HG23 ' A' ' 130' ' ' VAL . 3.2 t -143.28 151.36 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.443 177.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.542 HD13 HD23 ' A' ' 129' ' ' LEU . 33.1 tp -131.26 125.77 33.7 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -116.07 131.62 56.89 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.175 0.512 . . . . 0.0 110.911 -177.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.779 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -159.64 155.15 25.66 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.38 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 15.3 mt-10 -94.64 106.33 18.31 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.711 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 47.0 mt -91.41 134.32 34.72 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.154 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.666 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 72.4 ttt180 -69.99 140.84 53.0 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.932 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.539 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.5 p90 -156.04 -169.75 3.17 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.458 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 23.0 t -57.58 -30.81 65.57 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.297 0.373 . . . . 0.0 111.545 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -98.24 23.5 35.89 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.171 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 98.77 -107.83 3.49 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.217 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -133.0 127.71 34.75 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.539 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 10.9 t30 -123.18 129.99 52.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.665 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 32.9 ttm180 -76.44 102.81 6.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.138 0.494 . . . . 0.0 109.807 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.473 ' HB3' ' O ' ' A' ' 48' ' ' GLY . 18.1 p -114.96 172.3 7.13 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.232 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 6.3 ptp180 -148.55 152.62 37.12 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.565 -0.454 . . . . 0.0 112.051 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.965 HD13 HD22 ' A' ' 43' ' ' LEU . 12.1 tt -130.64 160.97 41.38 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.824 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.948 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 79.8 m-85 -107.55 106.74 17.25 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 121.856 -0.527 . . . . 0.0 110.25 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.683 HD11 HD21 ' A' ' 129' ' ' LEU . 23.8 mt -62.89 -36.01 81.93 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.213 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.758 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 9.5 t70 -57.39 -8.58 0.81 Allowed 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.504 178.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.948 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 46.7 mt-10 -75.05 -50.83 15.19 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 121.831 -0.543 . . . . 0.0 111.962 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -125.94 7.38 7.34 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -177.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.516 HG12 ' CH2' ' A' ' 52' ' ' TRP . 43.5 mm -107.58 106.07 19.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.169 178.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -111.35 161.88 12.64 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.637 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.509 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 1.4 t30 -100.55 120.37 39.92 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 31.9 ttp-105 -112.38 87.24 2.53 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.535 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.567 ' OD1' ' HG3' ' A' ' 27' ' ' ARG . 3.0 t-20 59.26 35.79 23.5 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.437 178.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 35' ' ' SER . . . 105.29 -0.07 40.69 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.972 178.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -123.3 134.2 54.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.717 0.758 . . . . 0.0 111.768 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.596 HD11 ' CD2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -74.89 129.46 37.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.895 178.701 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 9.4 tp . . . . . 0 C--N 1.321 -0.633 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.205 -179.718 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.91 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 66.8 m-85 . . . . . 0 CA--C 1.516 -0.357 0 CA-C-O 120.925 0.393 . . . . 0.0 110.313 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -123.22 -30.02 3.77 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.762 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -77.91 -69.24 1.41 Allowed Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 119.56 -1.305 . . . . 0.0 112.689 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 68.16 14.81 9.33 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.889 0.476 . . . . 0.0 111.3 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.598 ' CE2' HD13 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -58.9 -33.91 71.08 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 -179.279 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.482 ' HA ' HD11 ' A' ' 14' ' ' ILE . 8.8 p -61.2 -27.62 68.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.135 0.493 . . . . 0.0 111.579 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.79 -20.64 79.77 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.574 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 5.1 m -120.67 -19.61 7.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.45 0.625 . . . . 0.0 111.455 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 m -104.33 135.6 45.48 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -112.47 177.58 4.59 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 43.43 50.47 6.15 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 124.037 0.836 . . . . 0.0 111.878 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.914 HG22 HD13 ' A' ' 129' ' ' LEU . 12.3 mt -82.05 104.82 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.593 ' CA ' HD12 ' A' ' 129' ' ' LEU . 71.0 m -146.23 128.67 15.94 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 122.823 0.449 . . . . 0.0 109.83 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.827 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -100.23 158.62 15.74 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 121.628 0.727 . . . . 0.0 112.717 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -100.57 76.57 1.84 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.328 -1.305 . . . . 0.0 107.551 176.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.28 -54.11 4.85 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.779 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.558 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -149.04 -13.16 0.31 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.892 0.377 . . . . 0.0 110.184 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.62 88.37 7.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.587 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.827 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 44.0 tp -61.79 121.02 11.84 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.868 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.529 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 39.9 ttt180 -128.49 130.27 47.27 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.432 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.657 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -148.89 150.59 33.22 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.673 0.749 . . . . 0.0 111.076 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.447 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 5.0 mm-40 -85.48 74.53 10.32 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.163 -1.38 . . . . 0.0 108.413 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.693 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 65.0 m -64.97 129.62 40.39 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.829 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 10' ' ' SER . 26.7 ttm180 -65.33 131.65 47.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.328 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 35.1 ttt85 -108.86 151.46 26.23 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -52.99 -16.74 4.44 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 114.319 -1.31 . . . . 0.0 114.519 -178.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -72.74 -6.15 42.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.112 0.482 . . . . 0.0 110.416 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.99 6.68 66.74 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -120.5 169.66 14.16 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.412 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.447 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 69.0 m-85 -96.93 140.05 32.04 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.869 0.366 . . . . 0.0 110.555 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.41 ' HB3' ' HA3' ' A' ' 162' ' ' GLY . 9.4 t -121.72 130.23 53.29 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.4 m -72.5 112.89 8.96 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.268 0.556 . . . . 0.0 110.969 -178.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 40.5 t -116.65 148.38 41.04 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.465 -179.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.657 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.4 p -144.32 136.44 22.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-O 120.775 0.321 . . . . 0.0 111.156 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.6 tt -136.19 146.44 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.516 -178.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.59 97.12 4.97 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.689 HD22 ' HB2' ' A' ' 21' ' ' LEU . 1.6 tp -79.96 -6.51 57.64 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.014 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.558 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 15.2 p30 -65.03 -20.24 66.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.167 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 41' ' ' ARG . 10.8 ptp180 -105.58 16.53 25.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.298 0.571 . . . . 0.0 110.857 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -127.46 -33.6 2.32 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.131 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.672 HD22 HD13 ' A' ' 151' ' ' ILE . 31.9 mt -106.07 144.11 33.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.358 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.54 147.63 52.55 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.849 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.45 ' ND2' ' HB2' ' A' ' 123' ' ' SER . 23.2 p-10 -98.38 94.12 6.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.504 0.668 . . . . 0.0 109.811 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -94.78 93.6 7.59 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.977 0.418 . . . . 0.0 111.49 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.4 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 66.5 t30 52.83 47.0 25.64 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.16 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.736 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 78.04 29.93 52.67 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.791 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.531 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 33.7 m80 -141.99 125.64 16.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.811 ' HB3' ' HB ' ' A' ' 151' ' ' ILE . 14.2 m-85 -68.3 136.55 53.64 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.802 0.334 . . . . 0.0 111.103 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.8 mtp180 -141.76 135.32 29.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.579 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.472 ' CD1' HD11 ' A' ' 151' ' ' ILE . 96.7 m95 . . . . . 0 C--N 1.323 -0.583 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.4 m . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 121.197 0.523 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -133.56 176.67 8.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.835 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.493 HG22 ' HG2' ' A' ' 106' ' ' GLN . 6.9 p -129.34 118.07 21.65 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 122.413 -0.18 . . . . 0.0 111.357 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.565 HG21 ' CE2' ' A' ' 80' ' ' PHE . 9.0 p -110.43 145.03 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.886 0.374 . . . . 0.0 111.386 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.2 m -91.22 123.51 34.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.716 HG21 HD12 ' A' ' 99' ' ' ILE . 63.7 t -76.69 130.26 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.244 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -101.72 169.99 8.46 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 124.455 1.097 . . . . 0.0 110.008 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.619 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 9.6 tt0 -63.22 114.46 3.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.251 -178.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.0 -5.83 27.26 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.878 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.46 124.44 49.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 117.284 0.542 . . . . 0.0 112.188 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.546 ' O ' HG12 ' A' ' 76' ' ' ILE . 81.0 p -101.24 -178.97 3.9 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.664 HD22 HG23 ' A' ' 99' ' ' ILE . 0.7 OUTLIER -53.59 -40.46 65.71 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.555 0.693 . . . . 0.0 109.809 179.179 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.64 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -69.81 -34.37 73.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.041 -178.204 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -72.71 -38.98 67.31 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 72' ' ' THR . 45.1 mm -62.4 -47.17 94.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 177.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.767 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -56.68 -48.37 77.95 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.401 178.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.2 mtm180 -66.99 -35.98 81.16 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 122.515 -0.403 . . . . 0.0 111.923 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -69.66 -38.73 77.19 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.565 ' CE2' HG21 ' A' ' 65' ' ' VAL . 89.0 m-85 -110.52 16.71 21.37 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -178.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.0 t70 53.42 47.75 23.41 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.751 0.786 . . . . 0.0 110.852 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.767 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.8 p -124.42 170.97 10.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.591 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.65 ' O ' HG13 ' A' ' 87' ' ' ILE . 8.9 t70 -96.85 120.1 36.55 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.467 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.64 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 14.3 p90 -51.13 -32.61 23.46 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.708 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.446 ' HB2' ' OD1' ' A' ' 83' ' ' ASP . 0.3 OUTLIER -67.7 -42.93 81.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.76 179.733 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.678 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 8.7 mm-40 -66.67 -43.75 83.68 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.974 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.65 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.8 mt -53.52 -47.04 60.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.609 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.93 -51.14 68.06 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.15 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -57.38 -43.07 83.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.678 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 78.1 mtt180 -68.18 -23.27 64.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.055 0.455 . . . . 0.0 110.987 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 21.8 t-20 -99.04 -5.72 29.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.853 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 5.2 m-20 77.91 15.96 1.45 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.783 0.833 . . . . 0.0 111.637 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.609 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 10.4 pt -106.24 -176.42 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 17.9 mm-40 -111.65 158.22 19.53 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.633 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 16.7 p-10 -55.87 -60.45 3.44 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 122.103 0.954 . . . . 0.0 109.47 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -76.6 12.53 1.25 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.116 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 3.9 t70 -65.17 -33.58 76.35 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 9.1 mp 72.43 112.42 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 124.301 1.001 . . . . 0.0 110.16 -177.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.716 HD12 HG21 ' A' ' 67' ' ' VAL . 10.6 pt -95.32 175.91 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.407 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.489 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 83.0 m-85 -128.68 158.59 71.61 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.583 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.619 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 19.9 Cg_endo -67.6 134.97 34.52 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.994 2.463 . . . . 0.0 112.997 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.84 17.54 25.33 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.384 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -110.66 157.5 19.64 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 120.619 -0.433 . . . . 0.0 109.948 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.405 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 61.3 t -116.73 116.6 52.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.587 HD11 HG21 ' A' ' 99' ' ' ILE . 69.3 mt -109.92 151.0 27.63 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.57 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.493 ' HG2' HG22 ' A' ' 64' ' ' THR . 66.3 mt-30 -89.88 107.42 19.1 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.894 0.854 . . . . 0.0 111.146 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.4 m -112.62 151.32 43.82 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-N 113.934 -1.484 . . . . 0.0 109.151 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.19 -18.88 65.03 Favored 'Trans proline' 0 C--N 1.332 -0.325 0 C-N-CA 123.146 2.564 . . . . 0.0 114.158 -177.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.6 t . . . . . 0 C--N 1.323 -0.551 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.3 -179.435 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 112.069 -0.412 . . . . 0.0 112.069 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 74.97 32.78 0.78 Allowed 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.268 0.627 . . . . 0.0 111.902 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.638 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 20.0 p90 -66.36 -35.96 81.67 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.301 0.572 . . . . 0.0 109.865 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.493 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 24.5 t-105 -66.39 -21.87 66.23 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.239 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.94 -24.97 60.21 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.828 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.646 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 50.5 m -143.76 33.59 1.27 Allowed 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.689 178.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.493 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -102.01 147.58 26.4 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 177.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.717 ' HD2' ' HB2' ' A' ' 126' ' ' ASP . 8.0 tmm_? -143.71 140.86 30.23 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.717 ' HB2' ' HD2' ' A' ' 125' ' ' ARG . 1.2 t70 58.3 25.65 12.99 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.789 0.681 . . . . 0.0 110.765 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.599 ' HB ' ' CB ' ' A' ' 138' ' ' ALA . 0.4 OUTLIER -67.06 119.75 13.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.926 -179.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.25 151.62 46.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.302 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.914 HD13 HG22 ' A' ' 14' ' ' ILE . 15.9 mt -85.44 131.21 34.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.261 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.605 HG23 ' HB ' ' A' ' 135' ' ' VAL . 26.9 m -126.55 163.9 27.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.234 -178.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.414 ' HB3' ' HD2' ' A' ' 134' ' ' LYS . 9.7 m-20 64.13 7.72 3.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.97 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.683 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 97.24 31.04 7.05 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.273 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 87.93 -13.74 60.45 Favored Glycine 0 C--O 1.259 1.69 0 CA-C-O 123.506 1.614 . . . . 0.0 112.474 177.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.653 ' O ' ' HA ' ' A' ' 152' ' ' TYR . 17.4 ptpt -72.33 -17.09 61.87 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.605 ' HB ' HG23 ' A' ' 130' ' ' VAL . 17.5 t -139.92 138.77 38.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.328 177.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.599 ' CD1' HD11 ' A' ' 16' ' ' LEU . 36.5 tp -119.91 115.21 23.33 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -107.57 126.26 52.33 Favored 'General case' 0 C--N 1.316 -0.884 0 O-C-N 123.28 0.362 . . . . 0.0 110.213 -177.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.599 ' CB ' ' HB ' ' A' ' 127' ' ' VAL . . . -150.07 160.25 43.79 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.277 0.56 . . . . 0.0 111.89 -178.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -96.29 106.8 19.06 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.736 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 50.0 mt -97.03 129.02 44.53 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.39 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.646 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 22.1 ttt180 -70.05 139.72 52.69 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.224 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.637 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.9 p90 -155.78 -167.94 2.64 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.163 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 4.3 m -56.32 -29.55 61.41 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -104.72 29.84 11.11 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.388 -0.91 . . . . 0.0 113.53 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.7 -112.52 4.38 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.631 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -125.6 126.46 44.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.741 0.305 . . . . 0.0 110.689 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.637 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 63.2 t30 -118.53 129.23 55.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.495 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -78.38 98.73 6.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.205 0.526 . . . . 0.0 109.956 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.531 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 21.7 t -109.45 168.21 9.56 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.178 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.581 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 16.5 ptt180 -149.1 152.76 36.72 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.468 -0.493 . . . . 0.0 112.12 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.811 ' HB ' ' HB3' ' A' ' 50' ' ' PHE . 6.1 tt -133.02 152.84 36.7 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.92 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.653 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 95.8 m-85 -95.44 103.4 15.27 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.771 -0.195 . . . . 0.0 110.666 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.764 HD11 HD21 ' A' ' 129' ' ' LEU . 19.9 mt -67.06 -35.83 80.71 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.169 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -52.91 -19.26 2.44 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.189 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.91 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 36.0 mt-10 -63.39 -55.86 20.98 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -121.88 5.7 9.91 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 119.655 -0.818 . . . . 0.0 112.705 -176.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.432 HG12 ' CH2' ' A' ' 52' ' ' TRP . 45.0 mm -107.25 111.68 36.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.689 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -113.55 -178.17 19.35 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.57 178.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.693 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -124.86 136.67 54.01 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.773 0.32 . . . . 0.0 110.548 179.753 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -124.82 86.78 2.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.047 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.533 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 90.3 m-20 54.39 50.96 15.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.37 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.578 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 89.8 7.82 68.15 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.496 178.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -123.65 117.12 24.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.984 0.392 . . . . 0.0 111.367 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.499 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 25.0 mt -67.23 123.15 19.49 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.518 178.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 13.4 tt . . . . . 0 C--N 1.323 -0.58 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.891 -179.537 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 1.015 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 21.9 m-85 . . . . . 0 C--O 1.234 0.247 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -102.07 -31.56 10.57 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -70.77 -65.71 2.4 Favored Glycine 0 N--CA 1.434 -1.437 0 C-N-CA 119.511 -1.328 . . . . 0.0 112.205 -178.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 64.37 19.66 11.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.631 -0.285 . . . . 0.0 110.895 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.712 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.7 OUTLIER -58.44 -42.62 87.76 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.542 -179.664 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.451 ' HA ' HD11 ' A' ' 14' ' ' ILE . 8.9 m -62.11 -13.31 25.59 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.03 0.443 . . . . 0.0 110.851 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -64.27 -30.51 78.01 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.18 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.653 ' HB3' ' HB3' ' A' ' 26' ' ' ARG . 49.7 m -131.76 -18.54 2.73 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.677 0.275 . . . . 0.0 111.282 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.471 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 18.7 m -89.8 129.92 36.12 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -112.43 -177.65 3.21 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 43.69 45.36 5.89 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 123.832 0.708 . . . . 0.0 111.728 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.909 HG22 HD13 ' A' ' 129' ' ' LEU . 5.3 mt -79.8 103.89 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 CA-C-O 120.921 0.391 . . . . 0.0 110.402 -178.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.593 ' CA ' HD12 ' A' ' 129' ' ' LEU . 73.4 m -143.76 126.79 16.42 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.749 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -92.47 153.77 18.9 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.839 0.828 . . . . 0.0 112.861 -178.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -94.38 74.27 3.88 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.228 -1.351 . . . . 0.0 107.756 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.21 -55.87 4.96 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.068 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.651 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -148.6 -7.12 0.39 Allowed 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.035 0.445 . . . . 0.0 109.913 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -94.6 95.46 8.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.453 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.872 HD22 HD13 ' A' ' 153' ' ' LEU . 41.8 tp -60.27 118.12 6.01 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.807 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.531 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 34.0 ttt180 -123.02 129.84 52.02 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.35 -178.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.676 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -148.39 149.28 31.48 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.573 0.701 . . . . 0.0 111.178 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 69.7 mm-40 -82.48 70.52 9.45 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.011 178.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.632 ' SG ' HD13 ' A' ' 164' ' ' LEU . 59.1 m -57.84 114.41 2.3 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.953 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.653 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 10.8 ttp180 -67.11 125.99 27.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.392 178.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.547 ' HG2' ' CA ' ' A' ' 162' ' ' GLY . 7.1 mtm180 -96.34 162.77 13.35 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.85 -10.09 6.17 Favored Glycine 0 C--N 1.339 0.705 0 O-C-N 124.37 1.044 . . . . 0.0 113.759 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -76.97 -8.31 57.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.442 0.639 . . . . 0.0 109.43 178.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.38 14.21 66.59 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.01 161.06 13.2 Favored Glycine 0 C--O 1.225 -0.42 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.177 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.534 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 75.8 m-85 -101.15 133.14 46.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.701 0.286 . . . . 0.0 110.565 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.436 ' OG ' ' HD3' ' A' ' 27' ' ' ARG . 74.0 m -126.22 133.3 51.55 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.099 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 m -70.28 116.17 10.32 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.33 0.586 . . . . 0.0 111.367 -178.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 46.6 t -122.59 152.27 40.6 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.458 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 5.8 p -145.21 140.33 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 120.933 0.397 . . . . 0.0 112.032 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.531 HG23 ' HB3' ' A' ' 21' ' ' LEU . 10.2 tt -135.65 145.69 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.983 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.13 99.25 7.65 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.59 HD23 ' HB3' ' A' ' 21' ' ' LEU . 3.5 mm? -81.18 -8.7 59.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.09 0.471 . . . . 0.0 110.808 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.651 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 7.1 p30 -67.58 -13.15 61.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.453 179.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 41' ' ' ARG . 19.2 mtp180 -114.32 22.43 13.74 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -136.18 -31.09 0.92 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.67 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.828 HD22 HD13 ' A' ' 151' ' ' ILE . 35.9 mt -110.15 133.38 53.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.728 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.715 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 1.4 m -123.65 138.3 54.56 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.211 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.84 ' CB ' ' HG ' ' A' ' 140' ' ' LEU . 6.7 p-10 -79.66 93.26 5.49 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.82 0.819 . . . . 0.0 110.329 177.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.406 ' HB2' ' HG3' ' A' ' 51' ' ' ARG . 21.8 t70 -96.2 92.79 6.56 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 121.916 -0.49 . . . . 0.0 111.326 -179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.494 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 64.8 t30 49.19 47.54 21.96 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.361 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.66 43.5 18.51 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.964 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -161.98 123.41 2.74 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.694 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 55.8 m-85 -65.4 151.28 46.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.726 0.298 . . . . 0.0 110.574 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.406 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 37.7 mmt180 -141.51 128.65 20.89 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.518 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.649 ' HZ2' ' HA ' ' A' ' 153' ' ' LEU . 44.6 m95 . . . . . 0 C--N 1.323 -0.558 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.847 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.4 m . . . . . 0 N--CA 1.45 -0.438 0 CA-C-O 121.168 0.508 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 106' ' ' GLN . . . -128.63 177.28 7.14 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.872 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.433 ' HB ' ' CG2' ' A' ' 104' ' ' VAL . 6.6 p -128.58 114.34 16.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.769 0.319 . . . . 0.0 111.626 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.463 HG21 ' CE1' ' A' ' 80' ' ' PHE . 11.8 p -101.67 143.38 14.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.937 0.399 . . . . 0.0 110.621 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 3.7 m -89.95 127.48 36.03 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.403 ' CG2' HD12 ' A' ' 99' ' ' ILE . 45.7 t -72.07 132.12 33.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.721 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.411 ' HG2' ' H ' ' A' ' 69' ' ' GLN . 3.4 tt0 -98.11 171.1 8.46 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 125.043 1.464 . . . . 0.0 109.813 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.595 ' CA ' ' HB3' ' A' ' 101' ' ' PRO . 24.6 tt0 -71.03 129.69 39.63 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.895 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.05 13.92 82.48 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.585 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -114.37 121.39 43.44 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.826 0.346 . . . . 0.0 110.248 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.58 ' HA ' HG12 ' A' ' 99' ' ' ILE . 80.0 p -103.38 -179.68 4.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.595 HD22 HG23 ' A' ' 99' ' ' ILE . 1.5 mm? -51.94 -42.03 62.51 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -60.01 -40.07 87.97 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 114.506 -1.224 . . . . 0.0 111.257 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -71.4 -40.37 70.55 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.671 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 72' ' ' THR . 32.5 mm -64.44 -48.38 85.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.669 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -58.8 -45.34 95.06 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.425 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -65.27 -37.08 86.09 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.866 0.365 . . . . 0.0 111.259 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -73.96 -40.24 63.16 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.463 ' CE1' HG21 ' A' ' 65' ' ' VAL . 95.4 m-85 -102.82 13.15 35.08 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.0 t70 58.07 27.57 15.09 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.558 0.694 . . . . 0.0 111.526 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.669 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 3.1 p -105.52 171.59 7.25 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.64 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.3 t0 -94.38 120.16 34.2 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.156 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.543 ' HD2' ' HB2' ' A' ' 95' ' ' ASN . 10.9 p90 -53.12 -30.3 35.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.588 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.429 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -68.57 -41.74 79.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.678 179.17 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -67.75 -48.33 66.71 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.664 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.64 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.4 mt -49.99 -43.79 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.577 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.59 -51.76 66.05 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.427 178.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 85' ' ' HIS . 61.4 mtp180 -64.23 -25.93 68.28 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.854 ' HB3' ' HB2' ' A' ' 106' ' ' GLN . 1.0 OUTLIER -72.66 -28.14 62.54 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.24 0.543 . . . . 0.0 110.161 179.183 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 18.0 t-20 -101.12 -5.33 25.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.319 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 23.4 m120 79.4 15.92 0.93 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.006 0.922 . . . . 0.0 111.148 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.577 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 15.1 pt -103.14 -169.79 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.597 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.534 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 55.1 mt-30 -116.66 161.21 19.56 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.559 ' O ' HD23 ' A' ' 73' ' ' LEU . 6.7 p30 -57.39 -58.74 6.95 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-O 122.245 1.021 . . . . 0.0 109.277 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -78.44 12.22 2.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.065 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 1.8 t70 -62.93 -31.57 72.68 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 6.8 mp 70.78 112.33 0.06 Allowed 'General case' 0 C--O 1.234 0.245 0 O-C-N 124.37 1.044 . . . . 0.0 110.503 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.595 HG23 HD22 ' A' ' 73' ' ' LEU . 9.4 pt -95.84 172.07 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 114.497 -1.228 . . . . 0.0 110.505 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.458 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 69.4 m-85 -125.52 156.36 70.67 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.305 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.595 ' HB3' ' CA ' ' A' ' 69' ' ' GLN . 39.2 Cg_endo -68.75 134.49 30.32 Favored 'Trans proline' 0 CA--C 1.517 -0.361 0 C-N-CA 123.042 2.494 . . . . 0.0 113.642 -177.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.85 13.4 37.38 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' A' ' 66' ' ' THR . 49.2 mt-30 -104.76 170.87 7.63 Favored 'General case' 0 C--O 1.216 -0.67 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.138 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.433 ' CG2' ' HB ' ' A' ' 64' ' ' THR . 9.9 p -126.49 131.03 71.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-O 121.441 0.639 . . . . 0.0 110.612 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.586 HD11 HG21 ' A' ' 99' ' ' ILE . 80.0 mt -125.09 151.32 45.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.759 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.854 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 38.7 mt-30 -89.75 113.4 24.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 122.031 0.92 . . . . 0.0 111.649 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.432 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 35.8 m -123.02 152.07 62.49 Favored Pre-proline 0 C--N 1.314 -0.976 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.013 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.432 ' HD2' ' HB ' ' A' ' 107' ' ' VAL . 32.0 Cg_endo -64.37 -17.61 60.26 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 123.425 2.75 . . . . 0.0 115.37 -176.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.7 t . . . . . 0 C--N 1.323 -0.584 0 CA-C-O 121.189 0.519 . . . . 0.0 112.112 -179.391 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.715 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.446 -0.686 0 CA-C-O 120.442 -0.088 . . . . 0.0 112.973 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 16.0 m120 75.34 24.92 1.34 Allowed 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 123.575 0.75 . . . . 0.0 112.261 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.565 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 25.0 p90 -58.44 -39.37 79.66 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.288 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.516 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 60.3 t-105 -58.71 -31.89 68.68 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.01 -178.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.68 -30.43 61.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.839 0.352 . . . . 0.0 110.672 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.571 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 11.0 m -132.79 30.46 4.04 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.581 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.516 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -118.09 138.51 52.2 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 120.784 0.326 . . . . 0.0 110.743 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.413 ' HG2' ' CZ3' ' A' ' 146' ' ' TRP . 2.3 mmp_? -128.55 147.51 50.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.134 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 56.43 45.06 23.34 Favored 'General case' 0 CA--C 1.518 -0.264 0 O-C-N 123.695 0.622 . . . . 0.0 112.007 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.513 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 39.5 t -69.98 116.24 10.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.658 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -138.5 143.45 39.56 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.639 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.909 HD13 HG22 ' A' ' 14' ' ' ILE . 29.5 mt -86.38 138.71 31.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.345 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.681 HG23 ' HB ' ' A' ' 135' ' ' VAL . 26.7 m -131.08 160.97 41.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.431 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.471 ' HB3' ' HG2' ' A' ' 134' ' ' LYS . 0.7 OUTLIER 65.16 13.43 8.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.015 179.133 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.676 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 91.9 26.46 19.41 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.507 -0.854 . . . . 0.0 113.265 178.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.555 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 92.45 -18.02 55.86 Favored Glycine 0 C--O 1.265 2.074 0 CA-C-O 123.9 1.833 . . . . 0.0 112.225 177.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.755 ' HG3' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -67.98 -17.6 64.48 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.255 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.755 HG23 ' HG3' ' A' ' 134' ' ' LYS . 15.0 t -135.94 144.6 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.388 176.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.619 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 26.0 tp -127.49 124.69 38.94 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -120.58 134.63 55.26 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.212 0.529 . . . . 0.0 110.979 -177.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.623 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -157.58 162.74 38.77 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.864 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.574 ' HG2' ' HG3' ' A' ' 148' ' ' ARG . 45.1 mt-10 -94.71 105.14 17.06 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.84 ' HG ' ' CB ' ' A' ' 45' ' ' ASN . 1.4 mp -90.4 128.97 36.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.485 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.571 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 67.1 ttt180 -69.77 140.86 53.44 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.037 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.494 ' HB2' ' OD1' ' A' ' 47' ' ' ASN . 1.2 p90 -156.08 -167.81 2.57 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.139 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.3 t -60.41 -27.49 67.5 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.971 0.415 . . . . 0.0 111.123 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -101.91 27.19 21.52 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.348 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 92.67 -119.94 6.01 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.751 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.413 ' CZ3' ' HG2' ' A' ' 125' ' ' ARG . 79.2 m95 -124.64 125.68 44.51 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.477 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 25.0 t-20 -129.01 142.39 50.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.817 0.342 . . . . 0.0 111.095 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.574 ' HG3' ' HG2' ' A' ' 139' ' ' GLU . 25.1 mtp180 -74.12 108.47 6.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.716 0.769 . . . . 0.0 110.481 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.487 ' HB2' HD22 ' A' ' 140' ' ' LEU . 1.1 m -113.03 157.6 21.35 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.078 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.619 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 9.1 ptt180 -145.95 147.49 31.77 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.381 0.61 . . . . 0.0 112.343 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.828 HD13 HD22 ' A' ' 43' ' ' LEU . 8.7 tt -132.37 151.88 35.53 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.99 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 9.0 m-85 -92.24 104.85 17.16 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.871 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.872 HD13 HD22 ' A' ' 21' ' ' LEU . 30.5 mt -68.5 -32.59 72.67 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.131 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.639 ' HB3' ' HA ' ' A' ' 134' ' ' LYS . 1.4 p30 -54.7 -18.44 4.63 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.853 177.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 1.015 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 37.2 mt-10 -64.63 -52.26 58.31 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -122.49 6.4 9.54 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.734 -0.786 . . . . 0.0 112.87 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.435 ' O ' ' HA3' ' A' ' 5' ' ' GLY . 47.8 mm -107.15 110.38 31.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.663 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -115.24 156.11 15.87 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.451 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.547 ' HA ' ' O ' ' A' ' 163' ' ' GLU . 1.7 t30 -97.13 127.91 43.55 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 122.518 0.327 . . . . 0.0 110.151 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 -115.68 87.43 2.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.257 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 65.4 t30 50.43 52.63 14.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.81 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.547 ' CA ' ' HG2' ' A' ' 27' ' ' ARG . . . 95.07 7.1 59.87 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.968 -0.634 . . . . 0.0 114.343 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 159' ' ' ASN . 44.6 mt-10 -122.55 154.77 37.46 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 117.415 0.608 . . . . 0.0 110.509 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.712 HD11 ' CD2' ' A' ' 7' ' ' PHE . 7.7 tp -111.3 110.16 20.5 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.89 0.376 . . . . 0.0 110.561 -178.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 38.9 pt . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.018 -179.515 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.948 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 30.7 m-85 . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.742 0.306 . . . . 0.0 111.459 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -110.44 -30.68 7.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.712 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -71.37 -63.45 3.09 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 119.732 -1.223 . . . . 0.0 112.39 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 66.03 15.66 10.16 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 122.526 0.33 . . . . 0.0 111.432 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.689 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.2 OUTLIER -60.51 -39.68 88.66 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.082 -179.323 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.78 -16.81 62.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.006 0.431 . . . . 0.0 111.554 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.55 -20.01 79.77 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.077 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 45.8 m -140.41 -13.03 1.02 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 117.33 0.565 . . . . 0.0 112.081 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.7 m -98.66 133.25 43.27 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.635 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 25.0 ptt180 -110.1 -172.13 1.98 Allowed 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.434 ' HB3' ' HG3' ' A' ' 24' ' ' GLU . 20.9 t70 42.05 40.31 1.61 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.829 0.852 . . . . 0.0 111.976 -179.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.877 HG22 HD13 ' A' ' 129' ' ' LEU . 6.4 mt -77.02 99.26 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 CA-C-O 121.104 0.478 . . . . 0.0 109.917 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.639 ' CA ' HD12 ' A' ' 129' ' ' LEU . 73.1 m -147.68 124.67 11.34 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.353 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.752 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -94.03 152.69 18.62 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.84 0.829 . . . . 0.0 112.985 -179.006 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -93.27 75.2 4.59 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.043 -1.435 . . . . 0.0 107.233 177.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.21 -53.31 4.63 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.735 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.497 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -149.07 -11.35 0.32 Allowed 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 120.94 0.4 . . . . 0.0 110.234 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.432 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 3.4 mpt_? -89.48 92.55 9.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.87 0.367 . . . . 0.0 110.389 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.819 HD22 HD23 ' A' ' 153' ' ' LEU . 46.8 tp -61.36 123.98 19.33 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.716 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.653 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 41.9 ttp180 -125.03 137.22 54.23 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.266 -0.573 . . . . 0.0 110.257 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.587 ' CB ' HG12 ' A' ' 14' ' ' ILE . . . -157.29 145.84 19.55 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.587 0.708 . . . . 0.0 111.084 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.635 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 3.5 mt-10 -84.52 77.03 10.1 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.504 -1.225 . . . . 0.0 108.706 178.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.621 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 55.9 m -62.78 120.67 11.72 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.899 -178.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 10' ' ' SER . 9.0 tmm_? -70.76 114.89 9.3 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.914 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 10.2 ptp180 -89.17 159.0 17.69 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.041 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.46 -15.95 6.41 Favored Glycine 0 C--N 1.339 0.732 0 O-C-N 124.713 1.258 . . . . 0.0 114.067 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -72.38 -12.5 61.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.618 0.723 . . . . 0.0 109.417 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.7 8.8 60.5 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.933 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' A' ' 27' ' ' ARG . . . -112.77 160.62 13.04 Favored Glycine 0 CA--C 1.512 -0.151 0 C-N-CA 120.199 -1.001 . . . . 0.0 113.657 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.449 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 89.3 m-85 -101.39 124.7 47.49 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.1 p -118.68 133.23 56.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.438 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.1 m -71.0 111.38 6.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.062 0.458 . . . . 0.0 110.843 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.2 t -117.4 152.1 35.67 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.481 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.56 ' HB ' ' HG3' ' A' ' 22' ' ' ARG . 3.9 p -145.04 136.38 20.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.788 0.328 . . . . 0.0 110.224 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.528 HG23 HD23 ' A' ' 39' ' ' LEU . 11.8 tt -135.29 151.65 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.075 -177.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.565 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 1.6 m-20 -79.61 105.88 11.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.684 0.278 . . . . 0.0 111.36 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.637 HD13 ' HB2' ' A' ' 42' ' ' TYR . 1.5 mm? -88.93 -1.64 58.2 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.198 0.523 . . . . 0.0 110.333 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.565 ' OD1' ' HB3' ' A' ' 38' ' ' ASP . 32.3 p-10 -69.55 -14.62 62.94 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 38' ' ' ASP . 6.1 ptp180 -109.9 11.87 24.04 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.609 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.637 ' HB2' HD13 ' A' ' 39' ' ' LEU . 41.4 m-85 -127.36 -31.63 2.52 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.868 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.631 HD22 HD13 ' A' ' 151' ' ' ILE . 39.8 mt -108.96 139.02 44.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.084 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.551 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 4.1 m -129.71 149.09 51.61 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.518 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.763 HD22 ' HA ' ' A' ' 120' ' ' PHE . 7.6 p30 -98.51 104.83 16.9 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -108.03 91.97 3.87 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 121.85 -0.531 . . . . 0.0 111.092 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.537 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 62.4 t30 57.08 45.04 21.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.015 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.816 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 78.67 31.68 44.03 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.795 178.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.586 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 22.4 t-80 -148.69 122.17 9.11 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.756 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 38.1 m-85 -64.04 138.61 58.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.617 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -144.97 139.15 27.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.687 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.718 ' CZ2' ' HA ' ' A' ' 153' ' ' LEU . 99.2 m95 . . . . . 0 C--N 1.321 -0.643 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 177.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 87.3 m . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 121.324 0.583 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -123.07 178.26 5.16 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.356 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.404 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 2.0 p -128.77 122.77 31.3 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.1 t -111.45 135.6 50.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.096 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.1 m -87.48 127.36 35.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.342 0.592 . . . . 0.0 110.034 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.549 ' CG2' HD12 ' A' ' 99' ' ' ILE . 44.5 t -74.64 131.78 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.538 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -101.19 172.03 7.25 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 124.854 1.346 . . . . 0.0 109.905 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.582 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 6.9 tt0 -59.04 125.86 25.33 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.144 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.88 2.74 88.39 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.091 -0.576 . . . . 0.0 114.092 177.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -92.34 138.04 31.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 117.246 0.523 . . . . 0.0 111.315 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.551 ' HA ' HG12 ' A' ' 99' ' ' ILE . 55.1 p -119.5 173.98 6.66 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.599 HD12 ' HB ' ' A' ' 87' ' ' ILE . 1.3 mm? -52.6 -40.5 62.75 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.182 0.515 . . . . 0.0 110.416 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.53 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 13.7 mtp180 -67.01 -35.47 80.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.787 -178.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -72.31 -38.22 68.75 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.521 HG12 ' O ' ' A' ' 72' ' ' THR . 42.0 mm -67.15 -45.83 85.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.715 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -55.14 -55.82 26.29 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.579 179.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -59.79 -42.94 94.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.91 0.386 . . . . 0.0 112.04 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -64.01 -36.27 83.45 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -110.35 19.99 18.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.8 t70 56.3 30.55 16.96 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.448 0.642 . . . . 0.0 111.717 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.715 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 3.6 p -112.85 171.31 7.61 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.59 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.9 t70 -99.24 127.18 45.19 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.53 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 4.8 p90 -51.43 -30.55 19.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.226 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -65.43 -44.79 86.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.719 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.721 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 24.2 mm-40 -63.22 -51.0 68.04 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.801 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.599 ' HB ' HD12 ' A' ' 73' ' ' LEU . 2.7 mt -52.76 -47.04 51.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.64 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.595 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.59 -50.74 70.07 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.617 178.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -56.47 -40.12 74.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.138 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.721 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 13.8 mmt85 -65.83 -33.48 75.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.102 0.477 . . . . 0.0 111.071 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.682 HD22 HD13 ' A' ' 93' ' ' ILE . 66.3 t30 -92.13 -4.76 53.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.792 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 92.3 m-20 75.94 19.14 1.94 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.487 0.715 . . . . 0.0 110.777 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.682 HD13 HD22 ' A' ' 91' ' ' ASN . 14.4 pt -106.18 -176.26 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.739 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.555 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 49.2 mt-30 -107.36 166.06 10.93 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.539 ' O ' HD23 ' A' ' 73' ' ' LEU . 6.1 p30 -63.83 -53.5 49.78 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-O 122.141 0.972 . . . . 0.0 108.407 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.4 ' OE1' ' HB3' ' A' ' 94' ' ' GLN . 0.8 OUTLIER -79.56 11.06 3.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.785 -179.67 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.555 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.8 t70 -61.54 -32.23 72.28 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.1 mt 68.84 114.07 0.04 OUTLIER 'General case' 0 C--O 1.233 0.21 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.061 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.734 HG21 HD11 ' A' ' 105' ' ' LEU . 9.2 pt -94.56 175.64 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.238 -178.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.474 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 41.3 m-85 -128.72 156.54 77.4 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.83 -178.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.582 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 32.0 Cg_endo -67.07 133.02 29.6 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 123.286 2.658 . . . . 0.0 113.241 -178.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.43 19.29 25.85 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -112.54 155.74 23.81 Favored 'General case' 0 C--O 1.212 -0.901 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.404 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 88.2 t -116.18 122.68 70.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 O-C-N 121.789 -0.569 . . . . 0.0 110.405 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.734 HD11 HG21 ' A' ' 99' ' ' ILE . 95.9 mt -113.42 151.25 31.59 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.92 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.569 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 78.2 mt-30 -90.22 116.27 28.08 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.642 0.734 . . . . 0.0 110.801 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.406 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 31.5 m -123.23 151.84 62.89 Favored Pre-proline 0 C--N 1.31 -1.119 0 CA-C-N 114.173 -1.376 . . . . 0.0 109.441 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' A' ' 107' ' ' VAL . 37.9 Cg_endo -65.07 -22.32 62.17 Favored 'Trans proline' 0 N--CA 1.473 0.282 0 C-N-CA 123.147 2.565 . . . . 0.0 114.952 -177.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.0 t . . . . . 0 C--N 1.322 -0.604 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.586 -179.42 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.551 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.444 -0.83 0 N-CA-C 112.221 -0.351 . . . . 0.0 112.221 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 15.2 m120 73.63 31.33 1.3 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.007 0.523 . . . . 0.0 112.122 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.763 ' HA ' HD22 ' A' ' 45' ' ' ASN . 27.5 p90 -59.6 -35.84 75.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.95 0.405 . . . . 0.0 110.141 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.56 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 61.8 t-105 -63.09 -31.71 72.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.068 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.88 -31.51 40.04 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.852 0.358 . . . . 0.0 110.99 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.85 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 18.5 m -131.19 28.26 4.75 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.691 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.56 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -110.48 142.95 41.53 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.395 178.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.45 ' HD2' ' OD2' ' A' ' 126' ' ' ASP . 6.6 tmm_? -137.15 139.24 41.02 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.45 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 3.6 m-20 63.08 54.54 2.1 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.261 0.553 . . . . 0.0 110.567 -178.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.466 ' CG1' HD11 ' A' ' 136' ' ' LEU . 38.3 t -85.69 122.83 38.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.402 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.424 ' O ' HD12 ' A' ' 136' ' ' LEU . 16.2 ptt180 -144.84 142.7 30.15 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.754 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.877 HD13 HG22 ' A' ' 14' ' ' ILE . 16.5 mt -85.42 130.38 34.6 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.532 HG23 ' HB ' ' A' ' 135' ' ' VAL . 27.8 m -124.49 163.47 24.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.512 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.473 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 5.3 m-20 68.08 6.0 4.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.203 178.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.635 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 93.66 28.25 11.59 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.181 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.495 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 96.89 -19.27 55.46 Favored Glycine 0 C--O 1.264 1.978 0 CA-C-O 123.08 1.378 . . . . 0.0 113.145 177.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.574 ' O ' ' HA ' ' A' ' 152' ' ' TYR . 10.5 pttp -72.75 -10.91 60.34 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 121.196 -1.179 . . . . 0.0 109.665 178.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.532 ' HB ' HG23 ' A' ' 130' ' ' VAL . 22.3 t -144.26 140.44 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 121.383 0.611 . . . . 0.0 110.444 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.624 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 44.1 tp -121.14 125.28 46.81 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -114.75 131.36 56.81 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.989 0.423 . . . . 0.0 110.893 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.627 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -161.44 157.8 25.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.675 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.522 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 36.9 mt-10 -95.56 109.95 22.11 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.816 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 46.3 mt -95.74 134.17 38.99 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.956 -178.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.85 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 36.1 ttt180 -70.76 141.09 51.47 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.701 179.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.601 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.7 p90 -161.83 -170.49 2.57 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.593 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 45.5 t -54.31 -28.68 43.95 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.41 0.444 . . . . 0.0 111.883 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -105.45 30.38 9.96 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.461 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 141' ' ' ARG . . . 91.55 -114.93 4.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.518 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -126.8 128.15 46.13 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.601 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 57.3 t30 -117.62 143.67 45.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.957 0.408 . . . . 0.0 111.988 -178.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -76.75 94.57 3.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.122 178.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.586 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 35.8 t -111.11 160.88 16.49 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.445 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.624 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 28.6 ptt180 -148.59 154.58 39.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.548 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.756 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 8.0 tt -136.96 151.95 27.89 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.565 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.078 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.621 ' HB3' ' OD1' ' A' ' 154' ' ' ASP . 26.3 m-85 -95.08 103.27 15.12 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.839 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.819 HD23 HD22 ' A' ' 21' ' ' LEU . 7.1 mp -70.64 -29.27 65.58 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.976 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.621 ' OD1' ' HB3' ' A' ' 152' ' ' TYR . 21.9 p-10 -56.27 -13.96 2.5 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.914 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.948 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 31.1 mt-10 -68.96 -54.11 17.1 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -123.11 3.73 9.29 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.719 -0.792 . . . . 0.0 112.576 -176.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.492 HG21 HD21 ' A' ' 21' ' ' LEU . 43.2 mm -105.32 112.85 40.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.127 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.448 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -118.47 178.53 16.79 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.878 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.621 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -109.6 125.71 52.85 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.86 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.91 85.06 2.04 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 65.0 t30 52.2 49.59 20.26 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.388 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 94.11 2.22 64.44 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.707 -0.758 . . . . 0.0 114.338 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -122.31 126.04 47.25 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.982 0.42 . . . . 0.0 109.894 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.689 HD11 ' CD2' ' A' ' 7' ' ' PHE . 7.6 tp -73.78 128.45 35.56 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.754 -178.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 10.8 tp . . . . . 0 C--O 1.223 -0.33 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -179.103 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.689 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 27.9 m-85 . . . . . 0 CA--C 1.517 -0.312 0 CA-C-O 121.187 0.518 . . . . 0.0 110.304 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.3 -26.69 0.9 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.525 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -72.7 -69.76 1.34 Allowed Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 119.541 -1.314 . . . . 0.0 113.376 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 68.39 16.73 9.23 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 122.624 0.37 . . . . 0.0 110.366 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.669 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -63.63 -30.54 71.64 Favored 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -178.801 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.402 ' HA ' HD11 ' A' ' 14' ' ' ILE . 97.2 p -70.37 -12.39 61.55 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.715 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.22 -26.03 60.5 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.283 -0.872 . . . . 0.0 112.782 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.444 ' HB2' ' HB3' ' A' ' 26' ' ' ARG . 35.0 p -126.49 -23.65 3.75 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.221 0.51 . . . . 0.0 112.069 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.0 m -90.09 135.28 33.75 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.532 ' HG2' ' N ' ' A' ' 13' ' ' ASP . 44.3 ttt-85 -110.86 171.08 7.68 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.539 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.532 ' N ' ' HG2' ' A' ' 12' ' ' ARG . 48.7 m-20 46.01 48.65 12.45 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.349 0.659 . . . . 0.0 111.999 178.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.877 HG22 HD13 ' A' ' 129' ' ' LEU . 9.4 mt -79.36 105.71 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.657 ' HA ' HD12 ' A' ' 129' ' ' LEU . 75.5 m -147.18 126.81 13.33 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.011 0.524 . . . . 0.0 109.977 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.768 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -97.79 156.61 16.49 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -179.07 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -96.88 74.4 2.64 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.063 -1.426 . . . . 0.0 107.669 177.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.12 -52.89 4.57 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.031 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.574 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -149.26 -13.36 0.3 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.183 0.516 . . . . 0.0 110.004 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 20' ' ' ARG . 23.4 ttm180 -90.89 92.63 8.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.331 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.812 HD13 HD11 ' A' ' 129' ' ' LEU . 37.3 tp -63.46 130.49 44.6 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.736 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -134.17 127.05 31.23 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.033 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.656 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -146.72 147.02 30.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.244 0.545 . . . . 0.0 111.501 -178.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.737 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 7.2 mm-40 -78.59 74.7 5.12 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.392 177.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.625 ' SG ' HD13 ' A' ' 164' ' ' LEU . 68.9 m -60.3 126.9 29.24 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 120.971 0.415 . . . . 0.0 111.029 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.444 ' HB3' ' HB2' ' A' ' 10' ' ' SER . 65.6 ttt180 -68.51 121.67 16.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.237 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.559 ' HD3' ' HB3' ' A' ' 29' ' ' ASP . 6.0 ptp180 -94.91 149.59 21.08 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 177.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.42 -11.33 3.58 Favored Glycine 0 C--N 1.34 0.775 0 O-C-N 124.35 1.031 . . . . 0.0 113.642 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.559 ' HB3' ' HD3' ' A' ' 27' ' ' ARG . 19.8 t70 -71.68 -15.64 62.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.441 0.639 . . . . 0.0 109.548 178.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.13 5.4 53.01 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.048 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.22 172.41 14.26 Favored Glycine 0 C--N 1.322 -0.197 0 C-N-CA 119.959 -1.115 . . . . 0.0 113.517 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.737 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 41.2 m-85 -101.87 128.92 48.03 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 178.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.6 m -114.45 130.81 56.75 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.267 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 m -67.47 110.01 3.45 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.092 0.473 . . . . 0.0 110.846 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.505 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 41.7 t -115.06 151.93 33.39 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.512 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -145.94 133.66 15.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.08 0.467 . . . . 0.0 111.824 -178.777 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.475 HG22 HD23 ' A' ' 164' ' ' LEU . 10.7 tt -135.4 141.23 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.869 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.02 108.84 15.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.07 0.462 . . . . 0.0 111.052 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.587 HD23 ' HB3' ' A' ' 21' ' ' LEU . 3.1 mm? -81.14 -7.33 59.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.621 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.574 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 26.9 p30 -68.62 -9.6 50.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.57 0.7 . . . . 0.0 109.364 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -104.94 0.15 27.53 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.617 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.545 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 75.8 m-85 -126.06 -28.09 3.2 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.842 HD22 HD13 ' A' ' 151' ' ' ILE . 36.5 mt -106.31 142.84 35.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.988 0.423 . . . . 0.0 112.023 -178.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.2 m -135.43 139.78 44.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.446 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.815 ' CB ' ' HG ' ' A' ' 140' ' ' LEU . 7.8 p-10 -83.48 93.93 7.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.522 0.677 . . . . 0.0 110.286 178.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.44 ' CB ' ' HD2' ' A' ' 51' ' ' ARG . 9.1 t0 -99.88 94.79 6.49 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 122.1 -0.375 . . . . 0.0 110.63 -179.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.519 ' HA ' ' HB2' ' A' ' 142' ' ' TYR . 10.2 t-20 52.47 49.28 20.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.52 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 149' ' ' SER . . . 72.0 38.98 59.63 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.696 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -157.29 123.02 4.69 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.756 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 65.4 m-85 -62.46 144.9 55.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.191 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.44 ' HD2' ' CB ' ' A' ' 46' ' ' ASP . 70.0 mtt180 -148.0 133.02 18.19 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.38 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.545 ' HA ' ' O ' ' A' ' 42' ' ' TYR . 97.3 m95 . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.273 178.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.5 m . . . . . 0 C--O 1.234 0.25 0 CA-C-O 120.951 0.405 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -133.53 176.55 8.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.545 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.427 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 2.4 p -128.8 117.97 21.98 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.218 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.514 HG21 ' CE2' ' A' ' 80' ' ' PHE . 14.2 p -104.68 141.17 20.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.003 0.43 . . . . 0.0 111.575 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 5.6 m -93.09 126.7 38.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.236 0.541 . . . . 0.0 109.691 178.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.593 ' CG2' HD12 ' A' ' 99' ' ' ILE . 53.9 t -79.59 135.22 26.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.092 -179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -100.83 169.84 8.72 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 124.355 1.034 . . . . 0.0 110.643 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.713 ' CA ' ' HB3' ' A' ' 101' ' ' PRO . 50.1 tt0 -66.15 116.71 7.52 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.978 -177.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.25 -3.29 47.36 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.321 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -100.29 139.32 36.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.999 0.428 . . . . 0.0 111.213 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.692 ' HA ' HG12 ' A' ' 99' ' ' ILE . 69.6 p -120.29 179.43 4.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.542 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.663 HD22 HG23 ' A' ' 99' ' ' ILE . 1.1 mm? -51.5 -40.61 59.9 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.19 0.519 . . . . 0.0 110.191 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -61.75 -38.47 88.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.354 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -72.3 -40.21 67.68 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.666 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 72' ' ' THR . 41.7 mm -64.96 -47.38 88.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.886 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.646 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -61.23 -44.29 98.3 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.92 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -65.54 -36.38 83.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.075 0.464 . . . . 0.0 111.251 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -75.27 -44.21 47.02 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.514 ' CE2' HG21 ' A' ' 65' ' ' VAL . 89.7 m-85 -101.91 17.32 23.42 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -176.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.4 t70 54.33 42.72 31.29 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.527 0.679 . . . . 0.0 111.521 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.646 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.1 p -123.07 166.2 15.53 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.672 ' O ' HG13 ' A' ' 87' ' ' ILE . 6.8 t70 -93.88 124.52 37.94 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.599 -0.841 . . . . 0.0 110.115 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.574 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 18.9 p90 -51.5 -31.78 25.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.19 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.494 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 3.7 t60 -66.58 -44.1 83.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.727 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.67 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 17.9 mm-40 -67.61 -47.35 69.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.254 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.672 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.8 mt -51.06 -45.34 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.435 0.636 . . . . 0.0 109.336 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.623 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.63 -50.77 69.93 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.935 178.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' A' ' 85' ' ' HIS . 74.6 mtp180 -57.32 -41.98 80.96 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.67 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 15.4 mtp180 -70.89 -21.78 62.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.852 0.358 . . . . 0.0 111.376 -178.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 17.4 t-20 -101.13 -5.23 25.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.951 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 16.0 m120 78.0 14.58 1.55 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.49 0.716 . . . . 0.0 111.494 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.623 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 16.7 pt -106.27 -174.64 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.576 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 78.6 mm-40 -113.48 155.37 25.44 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.555 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 4.5 p30 -54.07 -58.87 5.7 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-O 122.259 1.028 . . . . 0.0 109.058 178.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -75.33 12.26 1.0 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.747 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.576 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.1 t0 -69.49 -34.09 73.81 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 10.3 mp 70.22 116.62 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 O-C-N 124.21 0.944 . . . . 0.0 108.98 -176.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.696 HG21 HD11 ' A' ' 105' ' ' LEU . 7.5 pt -93.56 177.07 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.993 -177.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.405 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 2.3 m-85 -123.87 156.04 66.03 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.401 -177.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.713 ' HB3' ' CA ' ' A' ' 69' ' ' GLN . 32.6 Cg_endo -68.71 130.6 20.97 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.258 2.639 . . . . 0.0 113.062 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.05 12.54 49.14 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 66' ' ' THR . 63.4 tt0 -101.0 159.72 14.98 Favored 'General case' 0 C--O 1.214 -0.792 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.427 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 85.6 t -120.59 120.47 62.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.04 0.448 . . . . 0.0 110.203 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.696 HD11 HG21 ' A' ' 99' ' ' ILE . 68.4 mt -111.49 152.0 27.97 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.549 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -90.78 115.81 28.14 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.564 0.697 . . . . 0.0 111.208 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.2 m -124.57 151.26 67.03 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.407 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -63.32 -17.08 58.41 Favored 'Trans proline' 0 C--N 1.332 -0.302 0 C-N-CA 123.305 2.67 . . . . 0.0 114.92 -177.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.9 t . . . . . 0 C--N 1.32 -0.676 0 C-N-CA 120.551 -0.459 . . . . 0.0 111.462 -179.91 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.445 -0.724 0 N-CA-C 111.349 -0.701 . . . . 0.0 111.349 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.3 m120 73.74 27.22 1.75 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 177.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.662 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 22.5 p90 -58.39 -36.72 73.97 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.376 -0.53 . . . . 0.0 109.886 178.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.531 ' HB2' ' HB2' ' A' ' 19' ' ' ALA . 52.8 t-105 -63.79 -34.62 78.31 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.854 -178.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -56.86 -19.78 19.4 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.155 0.502 . . . . 0.0 110.788 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.813 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 13.0 m -138.75 29.12 2.35 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.444 178.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.529 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -116.22 145.83 42.81 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.2 0.524 . . . . 0.0 111.94 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.45 HH11 ' HD3' ' A' ' 125' ' ' ARG . 29.1 mtp-105 -133.69 153.88 51.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.378 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 52.03 39.91 27.3 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 123.713 0.633 . . . . 0.0 112.128 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.504 ' CG1' HD11 ' A' ' 136' ' ' LEU . 22.5 t -67.19 121.51 16.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.056 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -144.83 140.5 28.45 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.689 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.877 HD13 HG22 ' A' ' 14' ' ' ILE . 16.4 mt -86.36 122.39 30.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.147 0.498 . . . . 0.0 109.912 178.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.635 HG23 ' HB ' ' A' ' 135' ' ' VAL . 35.2 m -115.63 159.36 15.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.367 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.601 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 1.4 m-20 71.06 -0.7 2.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.212 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.562 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 98.6 28.18 8.09 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.033 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.506 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 100.24 -23.94 33.98 Favored Glycine 0 C--O 1.264 1.98 0 CA-C-O 123.192 1.44 . . . . 0.0 112.618 178.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.73 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 6.9 ptmm? -65.08 -18.85 65.65 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 121.803 -0.822 . . . . 0.0 109.601 178.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.635 ' HB ' HG23 ' A' ' 130' ' ' VAL . 15.1 t -139.08 141.19 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.289 0.566 . . . . 0.0 109.976 177.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 30.1 tp -121.66 121.16 36.73 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.507 ' OE2' ' HD3' ' A' ' 150' ' ' ARG . 36.7 tt0 -111.93 132.53 54.69 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.209 -177.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.748 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -163.22 161.89 25.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.594 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -94.65 105.85 17.82 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.815 ' HG ' ' CB ' ' A' ' 45' ' ' ASN . 1.9 mp -89.82 128.52 36.18 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.543 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.813 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 41.0 ttt180 -70.61 140.53 51.67 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.097 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.663 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.3 p90 -157.22 -171.81 3.76 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.951 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.1 p -56.44 -29.2 61.35 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.168 0.293 . . . . 0.0 111.601 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.03 26.12 25.52 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.142 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.87 -110.98 4.1 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.365 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -130.05 133.31 46.62 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.663 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 14.4 t-20 -123.93 136.92 54.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.764 0.316 . . . . 0.0 111.361 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -76.7 93.73 3.7 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.505 ' OG ' HD22 ' A' ' 140' ' ' LEU . 24.2 p -110.71 162.91 14.29 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.506 -178.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.597 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 14.0 mtm-85 -143.91 152.37 41.02 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.858 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.842 HD13 HD22 ' A' ' 43' ' ' LEU . 11.1 tt -137.95 143.2 33.97 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.467 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.735 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 35.7 m-85 -83.89 101.66 11.83 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 122.195 -0.316 . . . . 0.0 110.925 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.772 HD13 HD22 ' A' ' 21' ' ' LEU . 20.4 mt -62.92 -33.6 75.67 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.116 178.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.73 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 12.7 t70 -56.13 -14.11 2.48 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.805 178.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.735 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 38.9 mt-10 -64.3 -55.8 18.87 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 53.6 m-70 -121.54 2.35 10.15 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 119.851 -0.74 . . . . 0.0 112.111 -177.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' A' ' 153' ' ' LEU . 47.0 mm -103.95 112.76 38.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.605 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.58 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -121.52 164.76 14.61 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.36 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.574 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.9 t30 -99.63 130.64 45.87 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.665 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 28.8 ttm180 -122.78 87.02 2.68 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.205 0.526 . . . . 0.0 110.425 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 64.9 t30 53.93 44.05 29.99 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.654 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.95 -6.78 47.96 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.127 -1.035 . . . . 0.0 114.733 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.665 ' HG2' ' O ' ' A' ' 160' ' ' ARG . 12.9 pt-20 -118.99 138.4 52.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 117.81 0.805 . . . . 0.0 110.696 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.669 HD11 ' CD2' ' A' ' 7' ' ' PHE . 7.4 tp -91.7 118.63 30.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.075 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 12.0 tt . . . . . 0 C--N 1.323 -0.585 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.272 -179.06 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.747 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 56.3 m-85 . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 120.873 0.368 . . . . 0.0 111.731 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.84 -29.99 10.15 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.459 -179.392 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.21 -69.15 1.45 Allowed Glycine 0 N--CA 1.436 -1.324 0 C-N-CA 119.948 -1.12 . . . . 0.0 113.051 -178.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 69.55 11.81 8.05 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.564 0.345 . . . . 0.0 110.94 -179.475 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.593 ' CE2' HD13 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -59.64 -35.0 73.53 Favored 'General case' 0 C--O 1.214 -0.786 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.635 -179.004 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.3 p -64.87 -13.77 57.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.04 0.447 . . . . 0.0 111.502 -179.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.64 -12.42 62.63 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.98 179.37 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 14.8 m -126.67 -34.11 2.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.491 0.663 . . . . 0.0 110.732 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 9.0 m -92.77 133.59 35.89 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.685 -179.042 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.435 ' HG3' ' HB2' ' A' ' 24' ' ' GLU . 9.1 ptp180 -111.76 -173.65 2.29 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.455 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 2.3 m-20 44.76 39.65 3.64 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 123.607 0.567 . . . . 0.0 112.419 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.972 HG22 HD13 ' A' ' 129' ' ' LEU . 5.0 mt -78.74 103.86 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 CA-C-O 120.951 0.405 . . . . 0.0 110.503 -178.564 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.593 ' CA ' HD12 ' A' ' 129' ' ' LEU . 71.2 m -147.63 126.53 12.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.284 178.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.801 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -101.03 155.16 18.14 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.904 0.859 . . . . 0.0 112.951 -179.373 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -99.02 77.0 2.15 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.036 -1.438 . . . . 0.0 107.559 176.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.06 -56.76 5.0 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.856 179.177 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.524 ' HB1' ' HB2' ' A' ' 40' ' ' ASN . . . -148.66 -12.28 0.34 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.087 0.47 . . . . 0.0 109.918 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.454 HH11 ' HD3' ' A' ' 20' ' ' ARG . 44.0 mtp-105 -81.75 86.43 6.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.343 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.801 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 42.1 tp -62.0 116.07 4.6 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 122.825 0.45 . . . . 0.0 111.884 -179.497 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.547 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 39.1 ttt180 -122.99 127.89 49.45 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.226 -179.104 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.64 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -148.66 146.65 28.26 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.506 0.67 . . . . 0.0 111.107 -179.339 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 1.2 mm-40 -85.53 79.88 9.25 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.643 178.39 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.629 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 37.6 m -65.63 126.73 29.3 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.213 -178.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 10' ' ' SER . 30.8 ttm180 -65.47 124.07 21.31 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.311 178.535 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.555 ' HD3' ' O ' ' A' ' 161' ' ' ASN . 18.4 ttp180 -105.08 151.2 24.28 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.524 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.9 2.61 0.56 Allowed Glycine 0 C--N 1.334 0.432 0 CA-C-N 114.525 -1.216 . . . . 0.0 113.944 -178.314 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.42 ' H ' ' C ' ' A' ' 27' ' ' ARG . 33.1 t70 -84.73 -9.25 58.39 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.454 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.5 10.64 57.89 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -133.9 162.99 24.53 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.155 -1.021 . . . . 0.0 112.867 -179.666 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.469 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 71.2 m-85 -88.71 146.39 25.07 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.525 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.4 t -127.83 126.13 41.09 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.569 178.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.6 m -67.26 117.24 9.01 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 41.6 t -124.32 151.95 43.68 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.179 -179.403 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.689 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.4 p -144.31 134.92 20.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.904 0.383 . . . . 0.0 111.196 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.472 HG23 ' HB3' ' A' ' 21' ' ' LEU . 11.2 tt -135.62 152.94 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.878 -178.372 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.414 ' OD2' ' HB3' ' A' ' 40' ' ' ASN . 19.3 t70 -82.81 112.77 19.94 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.647 0.26 . . . . 0.0 110.451 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.492 HD23 ' HB3' ' A' ' 21' ' ' LEU . 2.7 mm? -92.81 0.89 57.49 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.356 0.598 . . . . 0.0 109.562 178.075 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.524 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 11.1 t30 -76.17 -19.57 58.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.202 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' A' ' 41' ' ' ARG . 4.7 ptp180 -97.89 6.14 48.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.329 178.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.55 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 33.3 m-85 -129.25 -27.7 2.42 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.554 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.82 HD22 HD13 ' A' ' 151' ' ' ILE . 53.3 mt -105.96 137.94 42.99 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.134 0.492 . . . . 0.0 110.807 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m -131.78 143.59 50.33 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.414 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.553 ' CG ' ' HB3' ' A' ' 140' ' ' LEU . 7.9 t30 -90.47 110.92 22.02 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.481 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.461 ' CB ' ' HD3' ' A' ' 51' ' ' ARG . 35.4 t70 -115.61 92.72 4.0 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.238 179.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 65.1 t30 57.99 45.23 18.37 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.099 179.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.765 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 73.6 38.25 51.46 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.304 -0.951 . . . . 0.0 112.009 179.107 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.625 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 23.8 t60 -151.12 121.43 7.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.768 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 38.1 m-85 -65.6 139.49 58.44 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.142 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.461 ' HD3' ' CB ' ' A' ' 46' ' ' ASP . 78.1 mtp180 -147.17 133.3 19.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.708 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.55 ' HA ' ' O ' ' A' ' 42' ' ' TYR . 98.3 m95 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.037 178.13 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 88.8 m . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 120.865 0.364 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.84 177.09 4.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.19 -179.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.536 HG22 ' HG2' ' A' ' 106' ' ' GLN . 12.3 p -128.58 119.47 24.84 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.678 0.275 . . . . 0.0 111.711 -179.354 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.468 HG21 ' CE2' ' A' ' 80' ' ' PHE . 8.3 p -105.89 141.52 21.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 120.793 0.33 . . . . 0.0 111.086 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.2 m -89.75 128.41 36.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.424 0.63 . . . . 0.0 109.996 179.109 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.597 ' CG2' HD12 ' A' ' 99' ' ' ILE . 48.8 t -79.71 138.22 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.072 -179.387 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -108.55 171.26 7.52 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 124.06 0.85 . . . . 0.0 111.09 -179.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.646 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 36.5 tt0 -54.28 114.31 1.59 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.539 -178.536 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.4 2.69 63.53 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 121.151 -0.547 . . . . 0.0 113.793 178.319 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -91.28 143.82 26.25 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 117.163 0.482 . . . . 0.0 111.537 -179.405 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.774 ' HA ' HG12 ' A' ' 99' ' ' ILE . 35.0 p -130.69 169.13 16.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.274 178.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.669 HD22 HG23 ' A' ' 99' ' ' ILE . 1.0 OUTLIER -49.77 -43.38 48.15 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.202 0.455 . . . . 0.0 111.512 -179.516 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -65.06 -35.88 82.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.542 -177.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -74.07 -37.71 64.14 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 72' ' ' THR . 45.0 mm -67.86 -47.9 77.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.367 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.719 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -58.13 -48.25 84.22 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.751 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -34.56 78.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.785 0.326 . . . . 0.0 111.341 -179.186 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -71.37 -47.54 55.7 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.604 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.468 ' CE2' HG21 ' A' ' 65' ' ' VAL . 86.2 m-85 -100.5 19.85 16.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -177.217 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 53.38 45.49 28.27 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.233 0.54 . . . . 0.0 112.012 178.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.719 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.2 p -126.14 168.0 14.63 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.315 179.497 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.65 ' O ' HG13 ' A' ' 87' ' ' ILE . 9.2 t70 -93.33 123.46 36.63 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 121.846 -0.534 . . . . 0.0 109.647 179.176 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.545 ' HD2' ' HB2' ' A' ' 95' ' ' ASN . 2.5 p90 -52.0 -27.07 12.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.011 179.735 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.93 -37.65 54.92 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.062 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.683 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 3.8 tp10 -64.86 -47.78 76.66 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.65 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.2 mt -53.86 -45.77 63.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.853 178.63 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.574 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.36 -52.07 65.07 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.91 178.511 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.1 mtt-85 -61.22 -30.18 70.27 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.683 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 32.8 mmt180 -72.73 -31.81 65.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.096 0.474 . . . . 0.0 110.395 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 21.1 t-20 -93.61 -6.02 47.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.754 179.349 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 92.0 m-20 79.04 17.12 0.93 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.092 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.574 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 16.1 pt -107.22 -173.03 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.843 178.509 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.536 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 3.5 mm100 -112.61 161.4 16.85 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.433 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.545 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 16.4 p-10 -62.36 -52.41 63.76 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.581 1.182 . . . . 0.0 108.394 179.473 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 96' ' ' GLU . 35.2 tt0 -73.64 4.74 4.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 113.867 -1.515 . . . . 0.0 110.822 179.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 0.9 OUTLIER -64.76 -37.45 87.64 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.625 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.41 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 7.9 mp 70.24 116.42 0.04 OUTLIER 'General case' 0 C--O 1.231 0.12 0 O-C-N 124.12 0.888 . . . . 0.0 109.716 -177.682 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.81 HG21 HD11 ' A' ' 105' ' ' LEU . 8.0 pt -93.95 175.72 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.881 -177.617 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.527 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 14.2 m-85 -126.04 158.85 64.69 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.921 -178.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.646 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 28.8 Cg_endo -64.98 136.07 46.86 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.298 2.665 . . . . 0.0 113.212 -179.747 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.7 15.58 56.38 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.467 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -103.8 153.68 20.45 Favored 'General case' 0 C--O 1.209 -1.036 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.386 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.502 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 62.0 t -116.12 119.55 62.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 O-C-N 121.75 -0.594 . . . . 0.0 110.567 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.81 HD11 HG21 ' A' ' 99' ' ' ILE . 77.5 mt -113.49 152.09 30.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.572 -179.229 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.656 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 71.2 mt-30 -90.78 122.4 33.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.546 0.688 . . . . 0.0 110.729 179.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.7 m -129.98 151.18 77.83 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.585 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.23 -20.45 70.74 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 123.734 2.956 . . . . 0.0 114.793 -177.21 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.7 t . . . . . 0 C--N 1.324 -0.525 0 CA-C-O 120.924 0.392 . . . . 0.0 110.725 179.817 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.445 -0.717 0 N-CA-C 111.619 -0.592 . . . . 0.0 111.619 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.448 ' HA ' ' OD1' ' A' ' 40' ' ' ASN . 17.9 m120 69.43 31.64 3.73 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 123.019 0.528 . . . . 0.0 112.176 178.156 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.637 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 24.5 p90 -60.07 -34.95 74.13 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.527 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.507 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 20.7 t-105 -63.44 -33.16 74.96 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.821 -178.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.27 -23.62 49.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.981 0.42 . . . . 0.0 110.929 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.0 p -133.19 24.35 4.17 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.052 179.812 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.507 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -108.99 146.43 33.9 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.02 0.438 . . . . 0.0 111.5 179.026 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -146.41 146.01 30.45 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 61.26 26.22 16.1 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.73 0.776 . . . . 0.0 110.53 -179.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.574 ' HB ' ' CB ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -75.81 125.48 35.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.833 -179.93 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -150.06 155.67 40.29 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.654 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.972 HD13 HG22 ' A' ' 14' ' ' ILE . 30.5 mt -86.54 131.41 34.18 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.966 0.412 . . . . 0.0 110.102 179.573 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.442 HG23 ' HB ' ' A' ' 135' ' ' VAL . 33.3 m -125.79 158.59 34.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.918 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.559 ' HB3' ' HD2' ' A' ' 134' ' ' LYS . 3.7 m-20 68.84 7.34 6.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.448 178.486 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.665 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 96.32 32.9 6.45 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.561 178.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 87.56 -15.81 52.77 Favored Glycine 0 C--O 1.266 2.151 0 CA-C-O 123.579 1.655 . . . . 0.0 112.833 177.361 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.84 ' HG3' HG23 ' A' ' 135' ' ' VAL . 18.2 ptpt -67.41 -24.23 65.63 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.233 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.84 HG23 ' HG3' ' A' ' 134' ' ' LYS . 26.1 t -136.36 137.13 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 121.43 0.633 . . . . 0.0 110.806 178.811 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.6 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 36.0 tp -112.26 114.83 27.82 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.366 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -104.47 125.99 51.16 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.357 -177.317 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.614 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . . . -154.38 161.75 41.55 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.158 0.504 . . . . 0.0 111.256 -179.264 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -103.28 106.37 16.87 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 177.448 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.765 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 38.6 mt -94.07 135.37 35.5 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.722 -178.146 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 145' ' ' GLY . 70.3 ttt180 -69.84 140.96 53.32 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.355 179.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.599 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.0 OUTLIER -157.92 -167.81 2.34 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.849 -0.341 . . . . 0.0 111.549 -179.165 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.7 m -56.02 -26.91 50.83 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.053 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -106.35 27.35 17.26 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.13 -1.033 . . . . 0.0 113.238 -178.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 141' ' ' ARG . . . 95.1 -106.35 3.39 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.101 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -127.81 129.95 47.84 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.599 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 56.4 t30 -123.6 137.29 54.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.047 0.451 . . . . 0.0 111.517 -179.114 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 39.8 ttt180 -76.31 105.88 7.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.925 178.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.625 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 10.2 t -121.47 165.44 15.62 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -146.4 158.12 43.85 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.125 -179.558 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.82 HD13 HD22 ' A' ' 43' ' ' LEU . 9.8 tt -141.89 145.55 24.02 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.37 179.193 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.66 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 23.3 m-85 -86.86 104.8 16.55 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 121.069 -0.253 . . . . 0.0 111.088 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.694 HD13 HD22 ' A' ' 21' ' ' LEU . 16.4 mt -67.68 -31.97 72.3 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.242 178.295 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.435 ' OD2' ' HB2' ' A' ' 134' ' ' LYS . 2.1 p30 -55.0 -17.33 3.64 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.129 177.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.747 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 35.1 mt-10 -63.18 -53.08 58.84 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.222 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -123.3 5.01 9.12 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.728 -177.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.431 HG21 HD21 ' A' ' 21' ' ' LEU . 48.3 mm -105.69 110.34 30.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.693 178.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -115.97 172.84 14.41 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.632 178.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.629 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.2 OUTLIER -112.26 130.03 56.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.984 0.421 . . . . 0.0 110.983 179.893 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -125.41 94.01 4.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.327 179.098 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.555 ' O ' ' HD3' ' A' ' 27' ' ' ARG . 2.3 m-20 62.88 39.68 10.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.678 178.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.525 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 88.36 13.45 63.57 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.902 179.196 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -122.97 135.85 54.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.759 0.314 . . . . 0.0 111.299 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.499 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 37.4 mt -82.16 121.39 26.55 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.107 178.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 12.6 tt . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.197 -179.463 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.986 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 38.0 m-85 . . . . . 0 CA--C 1.519 -0.224 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.63 -33.55 4.82 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.341 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -70.63 -62.47 3.62 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 119.763 -1.208 . . . . 0.0 112.694 -179.035 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 65.48 16.52 10.56 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 122.532 0.333 . . . . 0.0 111.041 -179.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.732 ' HD2' HD11 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -63.74 -34.95 79.02 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.732 -179.277 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.43 ' HA ' HD11 ' A' ' 14' ' ' ILE . 16.6 p -63.79 -18.83 64.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.139 0.495 . . . . 0.0 110.988 -179.494 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.92 -26.29 69.41 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 115.682 -0.69 . . . . 0.0 113.341 179.226 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.568 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 33.5 p -127.12 -20.33 4.17 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 117.583 0.691 . . . . 0.0 111.819 -179.224 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.6 t -96.62 131.3 43.41 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -112.54 -176.99 3.04 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.451 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 16.6 m-20 43.62 45.55 5.81 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 123.971 0.794 . . . . 0.0 111.874 -179.802 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 1.08 HG22 HD13 ' A' ' 129' ' ' LEU . 7.6 mt -78.32 102.66 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-O 120.904 0.383 . . . . 0.0 110.075 -178.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.647 ' CA ' HD12 ' A' ' 129' ' ' LEU . 56.9 m -144.73 128.43 17.21 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.168 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.767 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -97.44 157.81 15.8 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.941 0.877 . . . . 0.0 112.956 -179.24 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -99.45 74.87 1.93 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 113.994 -1.457 . . . . 0.0 107.779 177.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.52 -53.22 4.66 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.137 179.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.541 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -149.07 -13.57 0.31 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 120.951 0.405 . . . . 0.0 110.147 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -85.86 92.92 8.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.604 179.067 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.013 HD12 HD11 ' A' ' 129' ' ' LEU . 9.5 tp -62.91 114.81 3.88 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.713 -179.786 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' A' ' 35' ' ' SER . 43.7 ttp180 -119.62 133.94 55.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.612 -178.265 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.628 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -152.78 148.13 26.86 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.402 179.791 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.51 ' O ' ' HD1' ' A' ' 32' ' ' TYR . 1.8 mm-40 -83.82 79.73 9.38 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.814 179.148 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.668 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 67.2 m -61.45 121.68 13.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.013 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.568 ' HB2' ' O ' ' A' ' 10' ' ' SER . 36.4 ttt-85 -70.64 122.21 19.34 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.273 178.532 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.7 ttt-85 -93.53 154.59 17.8 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.272 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.03 -15.0 6.23 Favored Glycine 0 C--N 1.335 0.509 0 O-C-N 124.36 1.037 . . . . 0.0 114.164 -178.251 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -79.27 -3.48 46.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.198 0.523 . . . . 0.0 109.788 178.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.46 9.51 72.32 Favored Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.97 144.31 17.31 Favored Glycine 0 C--O 1.227 -0.343 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.998 -179.067 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.51 ' HD1' ' O ' ' A' ' 24' ' ' GLU . 74.3 m-85 -90.46 125.69 35.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.788 0.328 . . . . 0.0 110.277 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.7 m -115.75 130.5 56.87 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.638 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.7 m -65.63 124.32 22.06 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.8 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 42.5 t -129.31 147.07 51.11 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.139 179.331 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.59 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 7.7 p -144.66 137.8 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.705 0.288 . . . . 0.0 110.967 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.534 HG22 HD23 ' A' ' 164' ' ' LEU . 8.5 tt -135.32 147.42 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.605 -178.357 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -76.38 99.77 4.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.723 0.297 . . . . 0.0 111.338 179.277 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.822 HD12 ' HG ' ' A' ' 43' ' ' LEU . 1.2 mm? -82.83 -4.41 58.02 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.102 0.477 . . . . 0.0 111.089 179.887 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.541 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 7.0 p30 -69.87 -10.68 59.39 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.369 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.9 mtt85 -102.54 6.06 39.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.829 179.17 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.494 ' HB2' HD13 ' A' ' 39' ' ' LEU . 7.1 m-85 -134.18 -24.75 1.61 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.569 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.822 ' HG ' HD12 ' A' ' 39' ' ' LEU . 61.7 mt -105.83 128.74 53.93 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.752 0.31 . . . . 0.0 110.522 179.433 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.66 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 1.0 OUTLIER -125.1 135.95 53.18 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.487 -179.845 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.841 ' HB3' ' HG ' ' A' ' 140' ' ' LEU . 18.8 p-10 -79.26 92.45 5.12 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.359 0.6 . . . . 0.0 110.033 178.336 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -86.82 86.85 7.35 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.307 0.575 . . . . 0.0 110.333 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.486 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 64.5 t30 50.22 44.62 26.24 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.253 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.71 34.82 10.87 Favored Glycine 0 C--O 1.221 -0.657 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.725 178.368 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -150.68 131.56 14.19 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.429 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.724 ' HB3' ' HB ' ' A' ' 151' ' ' ILE . 21.3 m-85 -72.21 140.0 48.47 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.559 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.426 ' HD3' ' HA ' ' A' ' 51' ' ' ARG . 10.5 mmt180 -143.88 134.15 24.47 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.087 -179.448 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.626 ' HH2' HD13 ' A' ' 153' ' ' LEU . 96.5 m95 . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.258 177.53 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 37.7 m . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 121.193 0.521 . . . . 0.0 111.671 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.64 176.62 8.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.009 179.085 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.514 HG22 ' HG2' ' A' ' 106' ' ' GLN . 7.8 p -129.59 122.16 28.55 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.208 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.545 HG21 ' CE2' ' A' ' 80' ' ' PHE . 8.2 p -113.02 147.44 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 120.751 0.31 . . . . 0.0 111.072 179.26 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 4.9 m -90.52 129.95 36.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.099 0.476 . . . . 0.0 110.284 179.101 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.483 ' CG2' HD12 ' A' ' 99' ' ' ILE . 54.0 t -78.78 133.48 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.485 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -104.17 169.34 8.55 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.333 1.021 . . . . 0.0 110.486 -179.496 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.629 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 63.4 tt0 -68.13 120.16 13.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.292 -178.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.33 9.36 55.5 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.856 179.332 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -116.88 128.35 55.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.964 0.412 . . . . 0.0 111.494 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.584 ' HA ' HG12 ' A' ' 99' ' ' ILE . 67.8 p -106.68 -179.2 3.87 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.329 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.64 HD22 HG23 ' A' ' 99' ' ' ILE . 1.4 mm? -52.21 -43.1 64.07 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.406 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 3.4 tmt_? -59.38 -41.64 89.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.366 -179.292 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -73.12 -38.2 66.4 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.595 -178.345 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.532 HG12 ' O ' ' A' ' 72' ' ' THR . 45.8 mm -63.83 -48.89 84.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.542 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.741 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -59.23 -47.24 91.8 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.391 179.206 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -25.49 64.78 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.796 0.332 . . . . 0.0 111.838 -178.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 48.9 ttm-85 -82.51 -34.51 27.92 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.116 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.545 ' CE2' HG21 ' A' ' 65' ' ' VAL . 95.0 m-85 -110.83 20.26 17.74 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.321 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.9 t70 55.06 42.1 31.18 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.62 0.724 . . . . 0.0 111.711 178.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.741 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -125.26 170.98 10.75 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.348 179.255 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.574 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.4 t70 -98.39 123.15 42.35 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.87 179.366 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.52 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 5.9 p90 -50.97 -30.37 14.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.99 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -67.24 -43.73 81.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.229 179.525 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.688 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 26.3 mt-10 -64.9 -48.27 74.8 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.355 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.574 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.1 mt -49.59 -50.21 17.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.458 179.196 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.604 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.63 -50.74 68.15 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.295 178.681 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -56.56 -37.63 70.8 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.688 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 75.3 mtt180 -73.91 -29.48 62.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.841 0.353 . . . . 0.0 111.03 -179.407 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 15.1 t-20 -93.19 -5.16 50.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.031 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 93.4 m-20 79.23 12.46 1.27 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.586 0.754 . . . . 0.0 111.497 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.604 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 14.8 pt -102.8 179.43 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.445 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.565 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 2.6 mp0 -105.96 155.94 18.87 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.468 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.3 p-10 -56.82 -56.09 26.07 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.226 1.012 . . . . 0.0 108.82 179.21 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -77.95 12.03 1.96 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.438 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.565 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.9 t70 -65.34 -34.9 79.41 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.469 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.413 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 8.2 mp 70.78 115.3 0.05 OUTLIER 'General case' 0 C--O 1.233 0.215 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.107 -178.117 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.778 HG21 HD11 ' A' ' 105' ' ' LEU . 7.5 pt -95.29 178.66 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.538 -178.526 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.554 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 61.8 m-85 -130.53 158.34 74.89 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.478 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.629 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 22.9 Cg_endo -64.95 139.21 60.73 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 123.323 2.682 . . . . 0.0 114.402 -178.414 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.39 20.22 33.07 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.014 178.085 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.552 ' O ' ' HA ' ' A' ' 66' ' ' THR . 79.2 mt-30 -109.59 168.21 9.57 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.413 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 77.8 t -126.36 112.06 28.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.047 0.451 . . . . 0.0 110.042 179.1 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.778 HD11 HG21 ' A' ' 99' ' ' ILE . 87.2 mt -107.23 151.42 25.46 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.581 -179.645 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.514 ' HG2' HG22 ' A' ' 64' ' ' THR . 37.4 mt-30 -91.06 112.38 24.26 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.741 0.781 . . . . 0.0 111.387 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.7 m -115.78 152.0 46.92 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.459 179.701 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.37 -21.94 60.43 Favored 'Trans proline' 0 C--N 1.332 -0.315 0 C-N-CA 122.909 2.406 . . . . 0.0 114.409 -177.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.9 t . . . . . 0 C--N 1.323 -0.57 0 CA-C-O 120.86 0.362 . . . . 0.0 110.987 -179.755 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.66 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.441 -1.03 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 20.9 m120 70.7 27.03 3.75 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 122.998 0.519 . . . . 0.0 112.118 178.595 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.623 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 17.2 p90 -60.07 -39.47 86.17 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.658 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.55 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 38.9 t-105 -61.75 -29.88 70.42 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.208 -178.267 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -55.96 -28.31 56.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.665 0.269 . . . . 0.0 110.803 -179.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.7 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 3.9 m -135.25 28.74 3.39 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.855 0.36 . . . . 0.0 110.48 178.497 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.55 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -110.61 144.34 39.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.766 0.317 . . . . 0.0 110.706 178.873 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -136.64 149.72 48.13 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.137 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 59.34 45.23 14.2 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.693 0.62 . . . . 0.0 111.139 179.343 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.475 ' CG1' HD11 ' A' ' 136' ' ' LEU . 21.4 t -74.84 121.37 26.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.194 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -145.17 140.65 28.1 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.036 -179.375 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 1.08 HD13 HG22 ' A' ' 14' ' ' ILE . 54.1 mt -86.76 127.11 34.98 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.038 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.535 HG23 ' HB ' ' A' ' 135' ' ' VAL . 34.6 m -119.95 163.17 17.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.854 -178.701 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 66.27 9.23 6.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.474 178.654 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.687 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 94.69 31.83 7.59 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.116 179.487 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.706 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 86.8 -13.92 57.7 Favored Glycine 0 C--O 1.256 1.521 0 CA-C-O 123.274 1.485 . . . . 0.0 112.812 177.548 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.607 ' HG3' HG23 ' A' ' 135' ' ' VAL . 19.0 ptpt -72.86 -14.22 61.45 Favored 'General case' 0 C--N 1.311 -1.098 0 O-C-N 121.592 -0.946 . . . . 0.0 108.76 178.155 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.607 HG23 ' HG3' ' A' ' 134' ' ' LYS . 22.7 t -141.68 138.73 31.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.638 177.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.58 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 27.8 tp -119.99 125.39 48.26 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.527 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.527 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 28.3 tt0 -114.98 132.52 56.56 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 123.504 0.503 . . . . 0.0 110.948 -177.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . . . -161.39 158.52 26.96 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.247 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 30.5 mt-10 -94.88 106.82 18.83 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.841 ' HG ' ' HB3' ' A' ' 45' ' ' ASN . 0.4 OUTLIER -89.54 123.37 33.57 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.435 -179.877 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.7 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 36.6 ttt180 -69.29 140.81 54.42 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.606 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 2.5 p90 -155.53 -170.39 3.43 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.429 -179.008 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 3.1 m -56.96 -27.94 61.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.106 0.479 . . . . 0.0 112.0 -179.36 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.29 17.2 58.21 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.598 -0.811 . . . . 0.0 113.19 -179.312 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 103.41 -107.9 3.13 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.031 179.768 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -129.6 127.69 41.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.785 0.292 . . . . 0.0 110.639 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.606 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 52.0 t-20 -120.88 117.18 26.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.76 0.314 . . . . 0.0 110.534 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 31.6 ttm180 -74.99 94.74 2.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.886 178.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.3 m -111.54 174.02 6.07 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.403 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.58 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 44.6 mtt85 -142.37 165.68 26.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.058 0.456 . . . . 0.0 112.003 -177.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.724 ' HB ' ' HB3' ' A' ' 50' ' ' PHE . 14.3 tt -145.44 161.98 12.38 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.372 179.169 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.599 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 12.1 m-85 -104.43 104.27 14.12 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 122.144 -0.347 . . . . 0.0 111.72 -178.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.708 HD11 ' HG ' ' A' ' 39' ' ' LEU . 4.1 mm? -65.65 -36.43 83.67 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.328 179.071 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.472 ' HB3' ' HA ' ' A' ' 134' ' ' LYS . 6.0 p-10 -57.34 -11.96 2.17 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.18 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.986 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 36.1 mt-10 -67.76 -54.89 15.65 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -121.33 3.6 10.29 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.041 -0.664 . . . . 0.0 112.467 -177.37 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.639 HG13 HD12 ' A' ' 153' ' ' LEU . 45.9 mm -104.26 114.16 43.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 C-N-CA 120.181 -0.607 . . . . 0.0 110.585 179.023 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.407 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -115.14 175.79 16.21 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.928 -0.654 . . . . 0.0 113.159 179.52 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.668 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.0 t30 -117.4 129.05 55.6 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.5 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.671 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 40.8 ttm180 -124.67 88.32 2.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.712 179.674 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 51.95 46.15 27.07 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 178.636 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.9 -8.98 50.94 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.285 -0.96 . . . . 0.0 115.019 177.404 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.671 ' HG2' ' O ' ' A' ' 160' ' ' ARG . 12.9 pt-20 -114.18 146.6 40.13 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 117.901 0.851 . . . . 0.0 110.634 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.732 HD11 ' HD2' ' A' ' 7' ' ' PHE . 4.6 tp -91.15 106.92 18.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.675 -179.578 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.562 HD13 ' HB2' ' A' ' 160' ' ' ARG . 31.7 pt . . . . . 0 C--N 1.322 -0.6 0 CA-C-O 121.366 0.603 . . . . 0.0 112.149 -178.474 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 1.012 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 35.3 m-85 . . . . . 0 CA--C 1.52 -0.202 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -121.87 -31.32 3.96 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.021 178.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -78.55 -66.44 1.73 Allowed Glycine 0 N--CA 1.436 -1.352 0 C-N-CA 119.525 -1.322 . . . . 0.0 112.046 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 65.96 15.26 10.0 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.605 0.362 . . . . 0.0 111.018 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.741 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -58.31 -37.27 74.75 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -178.972 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.4 ' HA ' HD11 ' A' ' 14' ' ' ILE . 28.8 t -60.04 -18.25 45.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.379 0.609 . . . . 0.0 110.816 -179.649 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.52 -33.32 61.13 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.578 179.008 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.521 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 20.2 m -120.9 -17.98 7.72 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 117.683 0.741 . . . . 0.0 111.32 -179.461 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.415 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 15.6 m -97.99 131.46 44.4 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -114.19 -175.64 2.72 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.425 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 0.9 OUTLIER 46.03 42.37 9.43 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 123.76 0.663 . . . . 0.0 111.87 179.284 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.906 HG22 HD13 ' A' ' 129' ' ' LEU . 7.5 mt -78.82 105.48 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-O 121.18 0.514 . . . . 0.0 110.063 -178.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.57 ' CA ' HD12 ' A' ' 129' ' ' LEU . 65.3 m -147.72 128.6 14.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.887 179.433 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.761 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -97.97 159.87 14.66 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -178.711 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.431 ' HB2' ' HB2' ' A' ' 20' ' ' ARG . 24.1 m-20 -99.1 73.77 1.94 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.129 177.113 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.86 -59.46 4.72 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.742 179.645 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.649 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -147.8 10.96 0.95 Allowed 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.273 0.558 . . . . 0.0 110.274 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.431 ' HB2' ' HB2' ' A' ' 17' ' ' ASP . 72.1 mtm180 -110.05 91.24 3.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.86 179.428 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.97 ' HB2' HD22 ' A' ' 39' ' ' LEU . 44.3 tp -60.47 122.47 14.69 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.636 -178.646 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 48.7 ttp180 -127.51 132.17 49.98 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.345 -178.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.629 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -149.83 145.25 26.48 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.511 0.672 . . . . 0.0 110.74 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.528 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 3.8 mm-40 -80.54 68.51 6.77 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.671 178.283 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.7 ' SG ' HD13 ' A' ' 164' ' ' LEU . 57.5 m -57.28 124.47 18.95 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.018 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.521 ' HB2' ' O ' ' A' ' 10' ' ' SER . 42.6 ttt-85 -65.75 126.36 28.19 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.414 179.241 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 33.9 ptt180 -98.48 155.29 17.33 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.063 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.93 -11.95 4.89 Favored Glycine 0 C--N 1.338 0.689 0 O-C-N 124.513 1.133 . . . . 0.0 113.919 -179.024 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.01 -11.65 60.86 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.048 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.35 8.27 60.04 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.857 179.531 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.435 ' O ' ' HG2' ' A' ' 27' ' ' ARG . . . -123.7 178.07 16.5 Favored Glycine 0 C--O 1.225 -0.432 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.392 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.528 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 83.2 m-85 -101.58 140.99 35.11 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.912 0.387 . . . . 0.0 111.168 179.573 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 p -128.93 133.97 48.05 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.904 179.231 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 m -71.32 111.07 6.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.094 0.473 . . . . 0.0 111.608 -178.383 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 36.4 t -116.27 147.57 41.37 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.948 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 5.4 p -143.14 137.55 26.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 120.867 0.365 . . . . 0.0 111.152 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.6 tt -132.66 154.32 39.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.012 -177.511 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -81.15 95.12 6.79 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.97 HD22 ' HB2' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -76.1 -14.23 60.19 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.697 0.76 . . . . 0.0 109.461 178.355 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.649 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 5.2 p30 -66.62 -15.96 63.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.803 178.377 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -114.24 31.03 6.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.1 179.071 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.428 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 24.4 m-85 -150.45 -30.97 0.2 Allowed 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.208 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.902 HD22 HD13 ' A' ' 151' ' ' ILE . 41.7 mt -105.94 127.5 53.19 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.775 0.321 . . . . 0.0 110.495 179.273 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.657 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 1.0 OUTLIER -123.91 137.78 54.58 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.452 179.984 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.813 ' HB3' ' HG ' ' A' ' 140' ' ' LEU . 19.4 p-10 -78.34 92.21 4.52 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.484 0.659 . . . . 0.0 110.831 178.59 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -87.5 86.71 7.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.072 0.463 . . . . 0.0 110.725 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 52.03 43.66 30.19 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.312 179.24 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.55 40.04 9.27 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.995 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -157.81 118.98 3.54 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.746 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.804 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 29.7 m-85 -62.44 140.88 58.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.28 -179.358 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.425 ' HD2' ' O ' ' A' ' 50' ' ' PHE . 16.3 mmm180 -140.41 139.03 35.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.235 179.508 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.653 ' CZ2' ' HA ' ' A' ' 153' ' ' LEU . 86.2 m95 . . . . . 0 C--N 1.325 -0.471 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.449 -0.523 0 CA-C-O 121.176 0.512 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -121.98 176.58 5.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.431 179.525 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.2 p -126.81 120.8 30.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.028 0.442 . . . . 0.0 112.151 -179.093 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.9 p -110.18 144.85 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.006 178.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 5.7 m -89.19 127.27 35.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.079 179.044 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.548 ' CG2' HD12 ' A' ' 99' ' ' ILE . 60.5 t -73.38 131.66 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.55 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -101.0 170.08 8.52 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 124.485 1.115 . . . . 0.0 111.136 -178.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.71 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 57.7 tp60 -58.76 118.56 5.84 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.682 -178.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.81 -5.36 85.04 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 121.106 -0.568 . . . . 0.0 113.705 177.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -90.36 127.56 36.22 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 117.084 0.442 . . . . 0.0 111.056 -179.662 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.69 ' HA ' HG12 ' A' ' 99' ' ' ILE . 68.9 p -107.93 -179.33 3.87 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.728 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.68 HD22 HG23 ' A' ' 99' ' ' ILE . 1.2 mm? -53.02 -42.73 65.96 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.538 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 74' ' ' ARG . 42.2 ttm180 -62.43 -35.33 78.93 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.145 -178.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -74.06 -46.7 41.47 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.585 179.626 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.528 HG12 ' O ' ' A' ' 72' ' ' THR . 43.8 mm -58.31 -48.4 85.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.209 -179.649 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.692 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -58.64 -55.55 30.17 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.112 179.464 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -33.95 75.98 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.047 0.451 . . . . 0.0 111.114 -178.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -73.5 -40.41 64.09 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -106.57 15.17 26.14 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -178.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.0 t70 60.33 49.89 6.64 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.589 0.709 . . . . 0.0 111.826 178.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.692 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.5 p -134.55 165.59 24.85 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.786 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.512 ' O ' HG13 ' A' ' 87' ' ' ILE . 3.9 p-10 -95.24 121.43 36.87 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.775 0.797 . . . . 0.0 109.689 178.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.561 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 5.9 p90 -48.11 -31.36 5.48 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.174 -1.375 . . . . 0.0 112.115 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.44 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 22.4 t-80 -60.23 -50.28 74.27 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.963 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.497 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 7.9 tp10 -65.39 -45.65 83.18 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.107 179.712 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.567 ' HB ' HD12 ' A' ' 73' ' ' LEU . 4.3 mt -51.4 -46.16 34.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.725 0.774 . . . . 0.0 109.51 179.446 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.572 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.98 -50.75 69.54 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.719 178.611 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.421 HH21 ' CD ' ' A' ' 86' ' ' GLU . 52.2 ttp180 -59.2 -37.15 76.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.758 0.313 . . . . 0.0 111.794 -179.381 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.683 ' HB3' ' HB2' ' A' ' 106' ' ' GLN . 2.0 mmp_? -65.11 -32.32 73.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.928 0.394 . . . . 0.0 110.903 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.6 HD22 HG23 ' A' ' 93' ' ' ILE . 6.0 t30 -96.09 -5.03 41.8 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.959 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 17.3 m120 77.36 18.3 1.4 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.355 0.662 . . . . 0.0 111.029 -179.228 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.6 HG23 HD22 ' A' ' 91' ' ' ASN . 10.6 pt -105.84 179.53 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.827 178.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.552 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 12.0 mm100 -102.93 154.55 19.1 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.744 HD22 ' HG3' ' A' ' 96' ' ' GLU . 1.1 p-10 -55.7 -61.5 2.31 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-O 122.259 1.028 . . . . 0.0 109.696 179.036 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.744 ' HG3' HD22 ' A' ' 95' ' ' ASN . 43.6 mt-10 -78.49 12.48 1.98 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.582 -179.461 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.552 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 4.3 t0 -61.89 -32.43 72.8 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.127 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.491 HD22 HG21 ' A' ' 72' ' ' THR . 41.2 mt 71.78 114.38 0.05 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.176 -178.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.69 HG12 ' HA ' ' A' ' 72' ' ' THR . 8.2 pt -95.2 175.54 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.354 -179.152 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.497 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 40.4 m-85 -124.71 157.44 65.88 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.21 -178.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.71 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 40.7 Cg_endo -67.85 138.71 45.42 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 123.122 2.548 . . . . 0.0 113.456 -178.526 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.76 13.59 43.24 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.374 179.159 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.516 ' O ' ' HA ' ' A' ' 66' ' ' THR . 44.1 mt-30 -100.44 168.69 9.59 Favored 'General case' 0 C--O 1.217 -0.658 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.297 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 89.5 t -128.53 109.16 18.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.7 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.657 HD11 HG21 ' A' ' 99' ' ' ILE . 82.0 mt -107.15 151.56 25.23 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.019 -178.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.683 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 39.6 mt-30 -89.89 116.44 27.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.598 0.713 . . . . 0.0 110.859 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.0 m -121.98 150.74 56.88 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 114.37 -1.287 . . . . 0.0 109.544 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.99 -18.4 62.05 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 123.352 2.701 . . . . 0.0 114.29 -177.699 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 C--N 1.325 -0.48 0 CA-C-O 121.255 0.55 . . . . 0.0 111.139 -179.656 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.657 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.445 -0.711 0 N-CA-C 112.211 -0.355 . . . . 0.0 112.211 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.3 m120 70.9 21.13 5.16 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 178.741 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.626 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 21.6 p90 -58.02 -37.5 74.44 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.045 0.45 . . . . 0.0 109.941 178.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.511 ' HB2' ' HB2' ' A' ' 19' ' ' ALA . 58.3 t-105 -59.93 -32.21 70.57 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.144 -178.495 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.9 -28.31 56.14 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.946 0.403 . . . . 0.0 110.392 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.951 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 69.7 m -133.26 30.12 3.93 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.921 179.135 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.491 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -115.88 136.48 53.0 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.981 0.42 . . . . 0.0 111.731 178.845 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -129.32 151.35 50.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.963 178.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 40.8 t0 56.22 51.36 11.83 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.742 0.782 . . . . 0.0 110.575 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.483 HG22 ' HB1' ' A' ' 138' ' ' ALA . 21.9 t -83.98 127.15 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.588 -179.644 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 25.0 ptt-85 -154.38 146.88 24.04 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.95 0.405 . . . . 0.0 110.358 179.164 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.906 HD13 HG22 ' A' ' 14' ' ' ILE . 19.5 mt -86.17 130.67 34.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.83 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.717 HG23 ' HB ' ' A' ' 135' ' ' VAL . 28.0 m -123.88 156.95 30.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.003 -178.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.482 ' HB3' ' CG ' ' A' ' 134' ' ' LYS . 0.7 OUTLIER 65.65 16.87 10.7 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.043 179.145 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.698 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 88.31 30.79 15.43 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.625 178.119 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.521 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 89.75 -14.44 61.63 Favored Glycine 0 C--O 1.26 1.735 0 CA-C-O 123.442 1.579 . . . . 0.0 113.031 177.112 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.786 ' HG3' HG23 ' A' ' 135' ' ' VAL . 21.5 ptmt -69.85 -17.35 63.37 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 121.334 -1.098 . . . . 0.0 108.384 178.396 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.786 HG23 ' HG3' ' A' ' 134' ' ' LYS . 3.9 t -140.17 144.72 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.083 177.79 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 28.3 tp -126.14 121.91 34.2 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.497 ' HG3' ' HG3' ' A' ' 150' ' ' ARG . 30.9 tt0 -112.58 133.34 54.68 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.883 0.373 . . . . 0.0 111.285 -177.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.537 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -161.86 163.8 29.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.62 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 124' ' ' ALA . 46.7 mt-10 -96.33 105.79 17.92 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 178.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.813 ' HG ' ' HB3' ' A' ' 45' ' ' ASN . 1.6 mp -89.85 125.2 35.24 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.927 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.951 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 74.7 ttt180 -70.87 140.86 51.21 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.047 178.669 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -155.59 -175.84 5.64 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.186 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 6.0 m -56.89 -31.46 64.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.759 0.314 . . . . 0.0 111.485 -179.256 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -88.33 7.65 81.0 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.766 -179.032 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 109.7 -121.83 6.2 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.127 179.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -122.86 125.1 44.74 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.629 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -123.3 140.39 53.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.874 0.368 . . . . 0.0 111.549 -179.092 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -72.55 102.37 3.23 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.824 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.473 ' HB2' HD22 ' A' ' 140' ' ' LEU . 1.4 m -113.07 156.34 23.3 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.351 -178.052 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -145.53 153.85 41.55 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.961 0.41 . . . . 0.0 111.065 179.84 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.902 HD13 HD22 ' A' ' 43' ' ' LEU . 9.4 tt -136.24 152.06 29.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.971 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.606 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 92.4 m-85 -97.11 104.49 16.51 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.419 0.152 . . . . 0.0 110.701 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.762 HD11 HD21 ' A' ' 129' ' ' LEU . 22.5 mt -68.74 -33.46 73.95 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.331 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.534 ' HB3' ' HA ' ' A' ' 134' ' ' LYS . 10.2 p-10 -56.84 -13.19 2.38 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.713 178.119 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 1.012 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 37.8 mt-10 -70.0 -55.42 9.62 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -122.98 11.32 9.56 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.72 -0.792 . . . . 0.0 113.048 -176.232 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.54 HG12 ' CH2' ' A' ' 52' ' ' TRP . 38.0 mm -112.94 111.94 38.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.421 178.196 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.433 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -115.05 175.62 16.11 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.191 179.093 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.545 ' CG ' ' HB3' ' A' ' 25' ' ' CYS . 3.3 t30 -115.11 129.51 56.7 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 122.651 0.38 . . . . 0.0 110.278 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 41.0 ttt85 -125.94 97.75 5.24 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.258 179.434 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 61.83 32.39 18.09 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.149 179.24 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 93.68 12.31 57.03 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.495 -0.86 . . . . 0.0 113.093 179.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -122.48 134.21 54.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.069 0.462 . . . . 0.0 110.814 179.628 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.741 HD11 ' CD2' ' A' ' 7' ' ' PHE . 4.4 tp -78.24 118.73 20.74 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.983 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 10.3 tp . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.356 -178.988 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.466 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 34.0 m-85 . . . . . 0 N--CA 1.458 -0.053 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -96.07 -31.11 13.19 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.065 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.56 -74.62 0.48 Allowed Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 119.879 -1.153 . . . . 0.0 113.227 -179.071 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 64.69 16.67 10.51 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 122.488 0.315 . . . . 0.0 110.25 -179.286 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.904 ' HD2' HD11 ' A' ' 164' ' ' LEU . 0.2 OUTLIER -61.14 -34.79 75.57 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.679 -179.316 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.433 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.7 OUTLIER -64.76 -17.51 64.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.331 0.586 . . . . 0.0 110.246 -179.262 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.15 -37.18 92.78 Favored Glycine 0 CA--C 1.523 0.544 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.647 178.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.498 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 30.9 m -118.06 -27.64 6.07 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 120.985 0.421 . . . . 0.0 111.404 -179.419 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 5.8 t -88.94 128.9 35.7 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 12' ' ' ARG . 11.3 ptm85 -114.41 -177.05 3.04 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.74 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.425 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 3.8 m-20 46.09 43.18 10.56 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 123.759 0.662 . . . . 0.0 111.675 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.924 HG22 HD13 ' A' ' 129' ' ' LEU . 6.1 mt -78.44 103.61 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.261 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.576 ' CA ' HD12 ' A' ' 129' ' ' LEU . 58.4 m -143.34 127.77 17.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.612 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.804 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -101.14 156.61 17.32 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.892 0.853 . . . . 0.0 113.15 -179.725 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 22.3 t70 -98.71 74.58 2.09 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 113.914 -1.494 . . . . 0.0 107.468 177.236 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.5 -54.53 4.6 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.622 179.859 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.75 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -147.05 -13.04 0.42 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 120.954 0.406 . . . . 0.0 110.294 179.55 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.415 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 0.4 OUTLIER -82.99 86.81 6.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.444 179.14 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.804 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 45.2 tp -62.47 119.78 9.82 Favored 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 122.949 0.499 . . . . 0.0 112.158 -179.691 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 15.9 ttp180 -124.31 135.87 53.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.358 -178.585 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.657 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -155.42 140.36 17.27 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.498 0.666 . . . . 0.0 111.374 179.714 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.572 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 3.5 mm-40 -77.94 82.23 4.31 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.901 178.198 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.635 ' SG ' HD13 ' A' ' 164' ' ' LEU . 34.5 m -69.85 120.58 15.8 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.886 -178.04 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 10' ' ' SER . 50.6 ttp85 -72.42 114.9 11.04 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.76 178.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.405 ' HB3' ' C ' ' A' ' 161' ' ' ASN . 2.9 ptp180 -92.1 160.6 15.13 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.233 179.242 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.75 -14.0 4.87 Favored Glycine 0 C--N 1.335 0.485 0 O-C-N 124.806 1.316 . . . . 0.0 113.902 -178.21 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -71.82 -12.47 61.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.789 0.804 . . . . 0.0 109.646 178.519 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.79 10.36 58.97 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.005 179.591 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -122.37 167.05 14.85 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 119.872 -1.156 . . . . 0.0 113.762 -179.011 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.572 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 78.1 m-85 -99.4 126.82 45.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.686 0.279 . . . . 0.0 110.516 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.5 t -113.71 126.18 54.94 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.398 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.7 m -66.59 114.36 5.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.092 0.472 . . . . 0.0 110.746 -179.291 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 36.2 t -119.04 148.85 42.56 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.405 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.9 p -145.3 138.47 21.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.693 0.282 . . . . 0.0 110.601 179.395 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.2 tt -135.32 153.52 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.627 -178.197 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.74 92.56 6.06 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.392 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.738 HD21 HD22 ' A' ' 153' ' ' LEU . 6.8 tp -78.6 -9.59 59.42 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.686 -177.46 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.75 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 28.4 p-10 -70.64 -12.99 61.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.497 0.665 . . . . 0.0 109.73 179.373 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.457 HH11 ' HD3' ' A' ' 41' ' ' ARG . 40.3 mtt180 -100.09 7.49 44.61 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.192 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 52.3 m-85 -129.44 -27.17 2.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.16 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.731 HD22 HD13 ' A' ' 151' ' ' ILE . 35.3 mt -107.25 140.16 40.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.069 0.461 . . . . 0.0 110.899 179.556 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 50' ' ' PHE . 5.4 m -127.17 149.09 50.13 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.915 -179.869 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.584 HD22 ' C ' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -91.67 94.41 9.37 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.255 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -103.41 92.15 4.36 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.12 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.433 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 64.3 t30 46.95 44.61 14.88 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 114.749 -1.114 . . . . 0.0 112.324 178.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.24 42.74 7.82 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.957 178.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.431 ' HD2' ' O ' ' A' ' 50' ' ' PHE . 7.8 t60 -167.43 123.62 1.12 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.751 ' HZ ' ' HB3' ' A' ' 138' ' ' ALA . 62.0 m-85 -62.6 154.6 28.5 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.787 0.327 . . . . 0.0 110.602 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -148.11 133.79 18.86 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.974 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.473 ' CZ2' ' HA ' ' A' ' 153' ' ' LEU . 93.9 m95 . . . . . 0 C--N 1.315 -0.892 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.448 -0.533 0 CA-C-O 121.052 0.453 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -125.2 174.14 8.29 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.466 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 1.2 p -129.83 114.25 15.68 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.782 0.325 . . . . 0.0 111.567 -179.07 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.485 HG21 ' CE2' ' A' ' 80' ' ' PHE . 11.5 p -99.81 135.07 36.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.936 0.398 . . . . 0.0 110.988 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.5 m -88.7 121.84 31.5 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.623 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.607 HG21 HD12 ' A' ' 99' ' ' ILE . 46.2 t -72.6 130.54 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.373 -179.428 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -100.85 169.15 9.18 Favored 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 124.149 0.906 . . . . 0.0 110.661 179.362 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.728 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 29.9 tt0 -60.21 108.69 0.83 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.524 -179.038 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.83 -10.97 20.93 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.296 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.556 ' HB3' HD11 ' A' ' 76' ' ' ILE . 68.3 m-20 -85.66 148.5 25.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.176 0.512 . . . . 0.0 111.79 -179.146 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.543 ' O ' HG12 ' A' ' 76' ' ' ILE . 23.4 p -133.93 158.48 43.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.434 178.795 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.69 HD23 ' HA ' ' A' ' 95' ' ' ASN . 1.8 tp -48.56 -45.27 37.49 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.039 0.447 . . . . 0.0 111.289 -179.651 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.544 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 43.7 ttp180 -60.13 -40.82 91.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.308 -179.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -74.31 -40.63 62.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.367 -178.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.556 HD11 ' HB3' ' A' ' 71' ' ' ASP . 47.6 mm -60.21 -46.47 94.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.159 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.713 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -55.44 -58.83 12.03 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.421 178.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -59.9 -33.18 71.51 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.675 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -66.55 -48.85 68.36 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.559 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.485 ' CE2' HG21 ' A' ' 65' ' ' VAL . 96.2 m-85 -97.52 13.23 30.67 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.196 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.7 t70 60.33 36.69 20.52 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.132 0.968 . . . . 0.0 110.711 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.713 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.1 p -114.54 171.79 7.42 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.548 179.229 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.714 ' O ' HG13 ' A' ' 87' ' ' ILE . 5.9 t0 -99.66 125.33 45.48 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 121.78 -0.575 . . . . 0.0 109.888 -179.702 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.544 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 31.9 p90 -54.3 -29.52 47.84 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.663 0.744 . . . . 0.0 109.938 178.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.536 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 22.3 t-80 -69.77 -41.37 75.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.544 178.6 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.699 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 36.8 tt0 -69.16 -48.9 61.03 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.638 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.714 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.2 mt -51.87 -43.31 34.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.678 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.564 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.61 -51.58 66.74 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.452 178.556 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.536 ' HG3' ' O ' ' A' ' 85' ' ' HIS . 41.2 mtm180 -61.62 -33.4 73.85 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.883 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.699 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 47.0 mmm-85 -73.36 -35.09 65.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.922 0.392 . . . . 0.0 110.896 -179.497 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.517 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 3.0 t-20 -88.11 -5.15 58.61 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.812 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.517 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 91.0 m-20 79.43 10.68 1.44 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.53 0.732 . . . . 0.0 111.085 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.564 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 21.9 pt -100.84 -174.01 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.783 179.25 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.611 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 66.2 mm-40 -110.54 162.34 14.8 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.087 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.69 ' HA ' HD23 ' A' ' 73' ' ' LEU . 1.4 p30 -55.5 -69.9 0.12 Allowed 'General case' 0 C--O 1.244 0.804 0 CA-C-O 122.336 1.065 . . . . 0.0 109.977 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -72.86 12.8 0.46 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.656 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.611 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.8 t70 -57.36 -33.21 67.55 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.389 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 55.4 mt 71.8 115.14 0.05 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-N 114.286 -1.324 . . . . 0.0 109.89 -178.621 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.607 HD12 HG21 ' A' ' 67' ' ' VAL . 17.1 pt -94.07 174.35 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.043 -178.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.456 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 17.3 m-85 -129.08 158.58 72.39 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.696 -178.603 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.728 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 25.5 Cg_endo -67.11 131.41 25.17 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.839 2.359 . . . . 0.0 112.438 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.33 15.12 36.26 Favored Glycine 0 N--CA 1.438 -1.177 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 -179.59 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -103.08 155.63 18.26 Favored 'General case' 0 C--O 1.214 -0.799 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.306 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.466 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 59.4 t -117.89 120.83 65.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 O-C-N 121.993 -0.442 . . . . 0.0 109.815 179.368 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.429 ' HB3' ' CG2' ' A' ' 87' ' ' ILE . 77.9 mt -112.07 150.84 30.12 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.397 -178.827 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.423 ' HB2' ' CB ' ' A' ' 90' ' ' ARG . 74.1 mt-30 -90.9 112.84 24.86 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.729 0.776 . . . . 0.0 110.781 179.065 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.41 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 34.0 m -126.45 151.08 72.18 Favored Pre-proline 0 C--N 1.313 -0.998 0 CA-C-N 114.214 -1.357 . . . . 0.0 109.019 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 107' ' ' VAL . 32.2 Cg_endo -63.2 -18.56 65.51 Favored 'Trans proline' 0 N--CA 1.473 0.321 0 C-N-CA 123.561 2.841 . . . . 0.0 115.259 -176.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.9 t . . . . . 0 C--N 1.323 -0.579 0 C-N-CA 120.374 -0.531 . . . . 0.0 111.48 -179.547 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . . . . . . 0 N--CA 1.447 -0.573 0 N-CA-C 112.239 -0.345 . . . . 0.0 112.239 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 72.65 29.23 2.03 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.989 0.515 . . . . 0.0 111.327 178.337 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.655 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 22.7 p90 -59.48 -36.52 76.18 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 121.304 0.573 . . . . 0.0 109.963 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.443 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 24.0 t-105 -65.15 -24.6 67.45 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.113 -178.363 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.94 -14.06 60.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.856 0.36 . . . . 0.0 110.925 -179.746 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.428 ' HB2' ' HB3' ' A' ' 141' ' ' ARG . 9.7 p -144.65 22.32 1.63 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.926 179.011 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -104.48 151.53 23.45 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.782 0.325 . . . . 0.0 110.915 179.08 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 63.0 ttp180 -141.5 144.53 34.4 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.106 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 57.73 52.53 8.06 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.197 0.522 . . . . 0.0 111.123 179.578 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.504 ' CG1' HD11 ' A' ' 136' ' ' LEU . 21.3 t -81.65 119.12 30.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.526 -179.565 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -143.4 142.43 31.24 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.344 -179.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.924 HD13 HG22 ' A' ' 14' ' ' ILE . 27.3 mt -86.18 129.55 34.81 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.952 178.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.57 HG23 ' HB ' ' A' ' 135' ' ' VAL . 34.6 m -121.72 154.78 26.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.175 0.512 . . . . 0.0 111.046 -178.845 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.546 ' HB3' ' HD3' ' A' ' 134' ' ' LYS . 9.6 m-20 71.41 3.65 4.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.953 179.054 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.662 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 98.41 31.95 6.25 Favored Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.554 178.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.482 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 92.95 -19.73 50.14 Favored Glycine 0 C--O 1.263 1.91 0 CA-C-O 122.966 1.315 . . . . 0.0 113.272 177.545 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.756 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 18.6 ptmt -66.31 -18.97 65.67 Favored 'General case' 0 C--N 1.318 -0.795 0 O-C-N 121.634 -0.921 . . . . 0.0 108.991 178.104 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.57 ' HB ' HG23 ' A' ' 130' ' ' VAL . 11.7 t -140.24 141.58 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.688 177.667 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.635 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 22.7 tp -121.2 121.97 38.95 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.368 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.531 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 35.0 tt0 -111.02 132.97 53.77 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 120.858 0.361 . . . . 0.0 111.297 -177.336 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.751 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.55 155.24 19.44 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.678 179.153 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -94.05 106.84 18.8 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.549 HD13 ' HA ' ' A' ' 45' ' ' ASN . 59.8 mt -90.7 131.77 36.19 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.308 -178.864 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.428 ' HB3' ' HB2' ' A' ' 123' ' ' SER . 49.8 ttt85 -73.33 141.81 47.09 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.422 179.513 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.433 ' HB2' ' OD1' ' A' ' 47' ' ' ASN . 10.7 p90 -151.14 -165.08 2.16 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.72 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.4 m -70.52 2.44 3.99 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -135.88 31.73 2.6 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.675 -179.663 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 97.57 -134.62 11.81 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.766 179.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -117.03 124.95 50.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.569 0.223 . . . . 0.0 110.791 -179.655 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -115.0 131.55 56.89 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.106 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 31.2 ttm-85 -76.06 94.67 3.48 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.236 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.415 ' HB3' ' HA ' ' A' ' 49' ' ' HIS . 1.1 m -102.9 164.31 11.7 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.49 -178.725 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.635 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 39.1 mtt85 -145.5 149.42 34.62 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.008 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.731 HD13 HD22 ' A' ' 43' ' ' LEU . 9.3 tt -131.28 148.7 32.81 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.282 179.383 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.75 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 70.9 m-85 -92.54 102.53 14.98 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 122.277 -0.265 . . . . 0.0 111.293 -178.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.738 HD22 HD21 ' A' ' 39' ' ' LEU . 19.9 mt -67.49 -35.91 80.06 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.214 179.437 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.756 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 8.2 t70 -56.48 -10.1 0.87 Allowed 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.159 178.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.75 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 46.8 mt-10 -73.44 -48.67 31.84 Favored 'General case' 0 CA--C 1.509 -0.603 0 O-C-N 121.847 -0.533 . . . . 0.0 112.151 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -124.86 3.64 8.1 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.563 -177.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.4 HG12 ' CH2' ' A' ' 52' ' ' TRP . 45.6 mm -109.79 111.68 37.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.293 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.569 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -116.55 166.44 12.38 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.384 179.318 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.62 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -98.41 124.91 43.35 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.316 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 160' ' ' ARG . 22.0 ttt180 -112.69 86.63 2.4 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.029 -179.678 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.405 ' C ' ' HB3' ' A' ' 27' ' ' ARG . 56.9 t30 51.87 43.52 30.1 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.257 179.267 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.551 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 101.68 -3.79 53.34 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 119.985 -1.103 . . . . 0.0 114.063 178.659 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -122.38 128.67 51.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 117.062 0.431 . . . . 0.0 111.192 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.904 HD11 ' HD2' ' A' ' 7' ' ' PHE . 3.3 tp -70.6 129.23 38.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.158 -179.817 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 11.0 tp . . . . . 0 C--N 1.326 -0.431 0 CA-C-O 120.983 0.42 . . . . 0.0 111.297 -178.757 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.709 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 53.6 m-85 . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 120.695 0.283 . . . . 0.0 111.28 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.28 -34.83 10.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.321 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -69.55 -65.01 2.72 Favored Glycine 0 N--CA 1.435 -1.427 0 C-N-CA 119.594 -1.289 . . . . 0.0 112.907 -178.626 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 67.84 15.68 9.62 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 122.289 0.236 . . . . 0.0 110.906 -179.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.653 ' CE2' HD13 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -64.87 -33.4 75.93 Favored 'General case' 0 C--O 1.215 -0.717 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.189 -179.345 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.2 t -67.72 -7.73 29.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.104 0.478 . . . . 0.0 110.582 -179.7 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.1 -7.33 58.53 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.584 178.574 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.551 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 49.0 m -135.11 -28.18 1.19 Allowed 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 117.026 0.413 . . . . 0.0 111.387 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.471 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 33.5 m -84.51 145.7 27.97 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.375 0.607 . . . . 0.0 109.625 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -116.82 160.49 20.75 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.841 -179.06 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 45.73 55.24 7.01 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 123.245 0.618 . . . . 0.0 112.544 178.658 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.989 HG22 HD13 ' A' ' 129' ' ' LEU . 8.5 mt -80.22 103.62 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 120.8 0.333 . . . . 0.0 110.35 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.636 ' CA ' HD12 ' A' ' 129' ' ' LEU . 69.3 m -145.47 128.29 16.33 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.508 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.723 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -92.34 158.31 16.16 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.227 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -100.0 76.13 1.91 Allowed 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.248 -1.342 . . . . 0.0 107.626 177.338 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.98 -61.99 4.65 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 114.788 -1.097 . . . . 0.0 111.555 179.097 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.706 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -144.82 -2.64 0.82 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.367 -0.416 . . . . 0.0 110.221 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.481 ' HB3' ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -97.59 96.06 8.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.397 178.99 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.986 HD12 HD11 ' A' ' 129' ' ' LEU . 4.8 tp -60.33 117.12 4.83 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 123.39 0.676 . . . . 0.0 111.441 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.584 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 25.8 ttt180 -120.23 126.73 51.34 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.965 0.412 . . . . 0.0 110.845 -178.311 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.662 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -147.51 142.49 26.97 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.727 0.775 . . . . 0.0 111.32 -179.698 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.548 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 7.7 mm-40 -77.24 76.12 3.79 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.716 178.029 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.692 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 65.2 m -62.17 128.02 34.11 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.214 -178.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.551 ' HB2' ' O ' ' A' ' 10' ' ' SER . 17.1 ttp180 -73.54 116.45 14.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.421 179.634 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 27' ' ' ARG . 14.9 ptt180 -86.22 156.31 20.35 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.324 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.44 -14.96 3.73 Favored Glycine 0 C--N 1.338 0.68 0 O-C-N 124.631 1.207 . . . . 0.0 114.433 -177.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -73.15 -13.6 61.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.504 0.668 . . . . 0.0 109.617 178.16 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.92 6.65 59.12 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.569 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.42 164.78 12.4 Favored Glycine 0 C--O 1.225 -0.416 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.545 -179.156 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.548 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 84.3 m-85 -100.94 138.17 38.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.918 0.359 . . . . 0.0 110.83 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.1 m -126.89 126.91 44.08 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.102 179.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.9 m -65.26 116.12 6.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.065 0.46 . . . . 0.0 111.056 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 45.8 t -122.64 152.45 40.47 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.536 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.637 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 5.3 p -144.54 138.81 23.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.557 0.218 . . . . 0.0 111.04 -179.771 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.447 HG23 HD13 ' A' ' 39' ' ' LEU . 15.2 tt -133.12 148.58 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 120.929 0.395 . . . . 0.0 111.099 -178.725 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.71 95.43 5.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.969 -179.482 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.827 HD22 ' HB2' ' A' ' 21' ' ' LEU . 1.8 mp -75.48 -18.11 59.93 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 120.945 0.403 . . . . 0.0 111.023 178.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.706 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 27.8 p-10 -67.6 -7.4 26.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.423 179.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.1 mtt180 -114.22 14.66 18.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.146 179.445 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.632 ' HD1' ' HE3' ' A' ' 52' ' ' TRP . 0.2 OUTLIER -141.78 -23.31 0.71 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.097 -179.27 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.867 HD22 HD13 ' A' ' 151' ' ' ILE . 57.5 mt -110.07 131.55 54.96 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.474 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.529 ' HB3' ' HA2' ' A' ' 118' ' ' GLY . 0.5 OUTLIER -127.51 141.35 51.68 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.147 -179.12 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.605 ' ND2' HD22 ' A' ' 140' ' ' LEU . 12.3 m-20 -81.25 90.81 6.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.756 177.512 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -85.01 86.89 7.34 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.952 0.406 . . . . 0.0 110.389 177.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.55 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 16.6 t-20 50.85 45.8 26.92 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.272 179.25 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.646 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 83.02 40.13 9.57 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.183 179.012 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -155.13 121.32 5.22 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.723 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.739 ' HB3' ' HB ' ' A' ' 151' ' ' ILE . 25.8 m-85 -65.59 135.37 54.99 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.147 179.492 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 40.1 mmm-85 -136.64 141.32 43.19 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.856 0.36 . . . . 0.0 111.4 -179.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.717 ' HH2' HD13 ' A' ' 153' ' ' LEU . 92.6 m95 . . . . . 0 C--N 1.323 -0.566 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.919 178.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.449 -0.487 0 CA-C-O 120.947 0.403 . . . . 0.0 110.361 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.62 176.46 5.37 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.039 -179.699 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.454 ' HB ' ' CG2' ' A' ' 104' ' ' VAL . 4.5 p -129.18 116.43 19.18 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.74 0.305 . . . . 0.0 111.707 -178.831 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.449 HG21 ' CE1' ' A' ' 80' ' ' PHE . 14.5 p -104.57 139.53 25.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.922 0.392 . . . . 0.0 111.018 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 6.2 m -88.68 127.23 35.58 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.8 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.566 ' CG2' HD12 ' A' ' 99' ' ' ILE . 43.1 t -75.28 133.58 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.358 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -99.18 170.4 8.7 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 124.727 1.267 . . . . 0.0 110.32 -179.489 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.766 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 29.2 tp60 -61.05 110.4 1.35 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.227 -178.834 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.12 -12.27 58.79 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.493 178.384 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -81.77 129.49 34.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.93 0.395 . . . . 0.0 111.288 -179.435 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.57 ' HA ' HG12 ' A' ' 99' ' ' ILE . 67.4 p -109.2 178.11 4.55 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.774 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.604 HD22 HG23 ' A' ' 99' ' ' ILE . 1.6 mm? -53.25 -41.89 65.92 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.444 0.64 . . . . 0.0 109.599 178.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.414 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 28.6 ttm180 -61.67 -41.49 97.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.105 -179.599 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 79' ' ' ARG . 24.3 m-20 -67.31 -43.59 81.27 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.773 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.535 HG12 ' O ' ' A' ' 72' ' ' THR . 37.2 mm -61.67 -48.2 89.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.147 179.586 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.608 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.74 -47.58 87.66 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.893 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.481 ' HA ' ' NE ' ' A' ' 78' ' ' ARG . 5.4 tpm_? -71.48 -29.91 65.37 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 122.47 -0.429 . . . . 0.0 111.601 -179.27 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 40.8 ttt180 -75.04 -39.39 61.03 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.106 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.449 ' CE1' HG21 ' A' ' 65' ' ' VAL . 97.1 m-85 -110.45 15.17 22.33 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.515 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.4 t70 56.33 53.79 8.38 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 122.025 0.917 . . . . 0.0 111.969 179.028 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.608 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -134.24 170.97 14.91 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.61 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.635 ' O ' HG13 ' A' ' 87' ' ' ILE . 5.5 t70 -97.38 123.0 41.07 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.428 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.43 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 6.7 p90 -49.6 -31.12 9.97 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 124.579 1.174 . . . . 0.0 111.327 179.263 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -63.42 -48.85 76.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.856 179.281 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.721 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 19.2 mm-40 -67.65 -43.5 80.17 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.363 -178.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.635 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.1 mt -53.61 -46.91 61.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.703 0.763 . . . . 0.0 108.948 179.005 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.605 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.21 -51.49 66.08 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.344 178.598 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -61.55 -33.43 73.83 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -177.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.721 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 15.9 mmp_? -68.26 -32.06 71.96 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.289 0.566 . . . . 0.0 110.041 179.275 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.841 HD22 HD13 ' A' ' 93' ' ' ILE . 65.1 t30 -91.28 -4.88 55.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.479 179.474 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 51.5 m-80 77.57 15.96 1.59 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.534 0.733 . . . . 0.0 110.7 -179.432 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.841 HD13 HD22 ' A' ' 91' ' ' ASN . 15.6 pt -105.16 -173.32 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.781 178.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.407 ' HA ' ' OE1' ' A' ' 94' ' ' GLN . 16.5 mm-40 -115.49 154.46 29.28 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.235 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.552 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.5 p-10 -51.59 -63.3 1.18 Allowed 'General case' 0 C--O 1.244 0.77 0 CA-C-O 121.964 0.888 . . . . 0.0 110.176 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.18 13.5 0.9 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.143 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 8.4 t70 -66.16 -32.35 73.73 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.689 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 8.3 mp 70.46 113.97 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.956 -177.549 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.604 HG23 HD22 ' A' ' 73' ' ' LEU . 7.4 pt -94.17 175.92 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.671 -178.337 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.509 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 96.6 m-85 -120.5 159.25 48.86 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.088 -178.731 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.766 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 50.9 Cg_endo -72.57 135.73 24.62 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.177 2.585 . . . . 0.0 112.425 -179.827 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.99 17.87 36.22 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.659 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 66' ' ' THR . 96.5 mt-30 -110.17 159.49 17.31 Favored 'General case' 0 C--O 1.209 -1.038 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.848 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.454 ' CG2' ' HB ' ' A' ' 64' ' ' THR . 8.4 p -116.46 131.24 69.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.553 0.692 . . . . 0.0 110.695 178.621 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.45 HD11 HG21 ' A' ' 99' ' ' ILE . 90.8 mt -121.38 151.02 40.63 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.573 -179.569 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.562 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 41.4 mt-30 -90.74 112.23 23.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.79 0.805 . . . . 0.0 110.917 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.8 m -120.74 151.28 54.23 Favored Pre-proline 0 C--N 1.315 -0.911 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.674 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -65.02 -17.95 60.73 Favored 'Trans proline' 0 C--N 1.332 -0.315 0 C-N-CA 123.147 2.565 . . . . 0.0 114.645 -177.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 C--N 1.323 -0.565 0 CA-C-O 120.869 0.366 . . . . 0.0 111.066 179.964 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 44' ' ' SER . . . . . . . . 0 N--CA 1.443 -0.84 0 N-CA-C 112.751 -0.14 . . . . 0.0 112.751 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 70.7 26.92 3.77 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.854 0.462 . . . . 0.0 111.35 179.168 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.568 ' HB2' ' OD1' ' A' ' 45' ' ' ASN . 20.2 p90 -57.12 -35.86 69.98 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 121.078 0.466 . . . . 0.0 110.325 179.219 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -59.13 -35.98 74.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.069 -178.194 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -66.56 -13.47 61.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.082 0.467 . . . . 0.0 111.386 -179.005 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.481 ' OG ' ' HB3' ' A' ' 141' ' ' ARG . 29.9 t -129.7 8.14 5.31 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.386 -179.71 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -104.35 149.35 25.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.073 0.464 . . . . 0.0 111.573 -179.489 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.536 ' HB2' ' CZ3' ' A' ' 146' ' ' TRP . 1.3 tmm_? -135.76 132.79 37.23 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.178 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.456 ' HB2' ' CZ ' ' A' ' 125' ' ' ARG . 34.6 t70 54.95 67.64 0.99 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.775 0.798 . . . . 0.0 110.693 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.513 ' CG1' HD11 ' A' ' 136' ' ' LEU . 42.0 t -84.68 126.66 40.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.86 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -144.04 141.12 29.92 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.229 -179.052 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.989 HD13 HG22 ' A' ' 14' ' ' ILE . 30.9 mt -86.55 125.31 33.69 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.627 HG23 ' HB ' ' A' ' 135' ' ' VAL . 35.6 m -118.6 161.2 17.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.691 -179.228 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.777 ' HB3' ' HE2' ' A' ' 134' ' ' LYS . 6.1 m-20 66.17 12.51 8.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.597 178.682 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.679 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 90.75 28.43 16.14 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.395 178.413 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.641 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 93.13 -16.78 59.72 Favored Glycine 0 C--O 1.261 1.812 0 CA-C-O 123.378 1.543 . . . . 0.0 112.92 177.246 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.777 ' HE2' ' HB3' ' A' ' 131' ' ' ASP . 17.5 pttm -71.31 -12.57 61.51 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 121.348 -1.09 . . . . 0.0 109.283 177.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.627 ' HB ' HG23 ' A' ' 130' ' ' VAL . 18.3 t -142.31 139.34 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.27 177.433 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.522 HD13 HD21 ' A' ' 16' ' ' LEU . 48.9 tp -118.66 122.54 42.78 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.356 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.444 ' OE2' ' HD3' ' A' ' 148' ' ' ARG . 17.1 tt0 -118.51 130.59 56.01 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.986 0.422 . . . . 0.0 110.903 -176.539 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 127' ' ' VAL . . . -156.49 166.24 33.97 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.186 -179.645 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 44.4 mt-10 -94.44 111.33 23.08 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.718 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.646 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 19.8 mt -98.17 132.14 43.94 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.325 -178.333 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.481 ' HB3' ' OG ' ' A' ' 123' ' ' SER . 72.2 ttt180 -73.98 141.23 45.88 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.601 179.667 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.55 ' HB2' ' OD1' ' A' ' 47' ' ' ASN . 1.4 p90 -157.65 -172.94 4.15 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.804 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.2 m -55.21 -31.95 61.85 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.211 0.319 . . . . 0.0 111.728 -179.539 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -93.41 15.29 63.32 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.253 -178.604 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 103.22 -110.99 3.83 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.293 179.664 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.536 ' CZ3' ' HB2' ' A' ' 125' ' ' ARG . 80.0 m95 -131.56 128.32 39.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.785 0.293 . . . . 0.0 110.706 -179.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -128.38 135.11 49.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.173 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.444 ' HD3' ' OE2' ' A' ' 137' ' ' GLU . 36.4 ttm180 -74.13 106.42 5.79 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 8.2 m -116.18 165.81 12.74 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.702 -178.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 15.2 ptt180 -147.0 164.78 31.91 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -178.55 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.867 HD13 HD22 ' A' ' 43' ' ' LEU . 8.3 tt -141.27 161.52 22.15 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.335 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.58 ' O ' ' HZ2' ' A' ' 52' ' ' TRP . 20.3 m-85 -104.58 104.36 14.18 Favored 'General case' 0 C--N 1.316 -0.868 0 O-C-N 122.307 -0.246 . . . . 0.0 110.699 -179.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.839 HD12 HG13 ' A' ' 157' ' ' ILE . 4.4 mm? -66.19 -36.19 82.43 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.218 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.411 ' OD1' ' HB3' ' A' ' 152' ' ' TYR . 16.6 p-10 -57.42 -9.85 1.21 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 179.035 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.709 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 32.9 mt-10 -71.93 -50.74 26.48 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 179.801 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -121.52 0.03 9.85 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.333 -0.547 . . . . 0.0 112.371 -177.366 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.839 HG13 HD12 ' A' ' 153' ' ' LEU . 45.1 mm -106.97 117.17 52.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.517 179.1 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.595 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -123.29 173.8 16.4 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.93 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.692 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.4 OUTLIER -106.13 126.45 52.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.987 0.423 . . . . 0.0 110.258 179.229 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.543 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 8.7 tpt180 -117.44 86.93 2.61 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.801 179.612 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 65.9 t30 55.26 40.65 31.65 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.463 178.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 105.61 -7.45 42.5 Favored Glycine 0 C--O 1.228 -0.25 0 C-N-CA 120.138 -1.029 . . . . 0.0 114.978 177.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 160' ' ' ARG . 13.2 pt-20 -122.04 141.44 51.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 117.936 0.868 . . . . 0.0 111.2 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.585 HD13 HD23 ' A' ' 21' ' ' LEU . 30.8 mt -74.98 122.22 23.16 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.867 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 6.5 tp . . . . . 0 C--N 1.323 -0.557 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.902 -179.533 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.845 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.613 ' HB2' ' ND2' ' A' ' 6' ' ' ASN . 22.4 m120 -88.07 -175.38 5.06 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.912 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 27.7 m-85 -96.51 -89.43 0.26 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.104 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.15 -30.62 4.61 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.045 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -70.82 -66.77 2.08 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 119.796 -1.192 . . . . 0.0 113.383 -178.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.613 ' ND2' ' HB2' ' A' ' 2' ' ' ASN . 16.1 m120 68.37 11.99 8.56 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.515 0.326 . . . . 0.0 110.677 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.647 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.9 OUTLIER -58.47 -35.93 72.94 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 121.076 -0.25 . . . . 0.0 111.135 -179.221 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.6 p -62.81 -19.52 64.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.388 0.613 . . . . 0.0 110.788 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.78 -22.05 78.63 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.801 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.536 ' HB3' ' HB3' ' A' ' 26' ' ' ARG . 67.4 m -132.67 -16.88 2.58 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 117.584 0.692 . . . . 0.0 111.877 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.468 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 19.4 m -94.81 133.86 38.06 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.428 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 14.4 ptt180 -111.38 179.87 3.91 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 41.77 48.32 3.7 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 124.089 0.868 . . . . 0.0 111.984 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.883 HG22 HD13 ' A' ' 129' ' ' LEU . 7.4 mt -80.6 104.14 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 109.695 -0.484 . . . . 0.0 109.695 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.589 ' HA ' HD12 ' A' ' 129' ' ' LEU . 78.0 m -146.57 127.06 14.09 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.735 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -95.66 155.7 16.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.718 0.77 . . . . 0.0 113.068 -179.122 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.454 ' HB2' HH22 ' A' ' 22' ' ' ARG . 31.0 t70 -94.28 75.63 3.96 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.428 177.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.7 -53.82 4.74 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.747 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.605 ' CB ' ' HB3' ' A' ' 40' ' ' ASN . . . -149.62 -10.8 0.3 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 120.781 0.324 . . . . 0.0 110.455 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -92.55 96.27 10.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.138 0.494 . . . . 0.0 110.814 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.811 HD22 HD13 ' A' ' 153' ' ' LEU . 45.4 tp -59.65 129.01 39.8 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.329 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.614 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 26.7 ttm180 -133.34 120.02 20.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.195 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.615 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -142.15 149.43 39.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.648 0.737 . . . . 0.0 112.053 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.497 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 63.3 mm-40 -83.65 75.46 10.05 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.365 -1.288 . . . . 0.0 108.873 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.856 ' SG ' HD13 ' A' ' 164' ' ' LEU . 56.0 m -62.96 124.24 20.59 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.86 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.536 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 16.2 ttm180 -76.51 118.01 18.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.736 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.618 ' HG2' ' HA3' ' A' ' 162' ' ' GLY . 10.7 mtm180 -84.1 163.96 19.5 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.76 -16.22 11.33 Favored Glycine 0 C--N 1.338 0.648 0 O-C-N 124.374 1.046 . . . . 0.0 113.387 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -72.39 -10.34 59.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.346 0.593 . . . . 0.0 109.819 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.48 13.98 64.48 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -114.2 162.29 12.45 Favored Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.208 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.497 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 61.5 m-85 -100.99 138.78 37.58 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.959 0.409 . . . . 0.0 111.138 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.8 m -132.5 132.21 42.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.589 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 m -69.39 110.44 4.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.185 0.517 . . . . 0.0 111.635 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.436 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 40.4 t -114.51 142.31 46.57 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.784 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.614 ' HB ' ' HG3' ' A' ' 22' ' ' ARG . 1.9 p -139.52 135.44 40.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.098 0.475 . . . . 0.0 111.35 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.484 HG23 ' HB3' ' A' ' 21' ' ' LEU . 12.3 tt -134.42 150.5 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.087 -177.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.498 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 2.7 m-20 -84.87 97.98 10.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.564 HD23 ' HB3' ' A' ' 21' ' ' LEU . 3.9 mm? -79.58 -8.93 59.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.242 0.544 . . . . 0.0 110.545 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.605 ' HB3' ' CB ' ' A' ' 19' ' ' ALA . 12.9 p30 -65.22 -15.75 62.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.766 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.545 ' HD3' ' O ' ' A' ' 114' ' ' GLY . 58.6 mtt85 -113.97 20.07 16.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.557 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -136.82 -31.7 0.84 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.346 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.857 HD22 HD13 ' A' ' 151' ' ' ILE . 48.3 mt -103.8 133.58 48.55 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.118 0.485 . . . . 0.0 110.044 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.715 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 6.1 m -122.31 146.78 46.98 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.306 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.444 ' HB3' HD22 ' A' ' 140' ' ' LEU . 8.1 p-10 -94.78 91.81 6.66 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.758 ' HB3' ' HD2' ' A' ' 51' ' ' ARG . 15.1 t70 -93.51 97.6 10.63 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.741 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.6 t30 53.2 46.96 25.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.396 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.562 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 75.44 29.37 60.04 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.957 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.571 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 70.5 m-70 -142.68 122.59 13.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.954 ' HB3' ' HB ' ' A' ' 151' ' ' ILE . 14.7 m-85 -62.5 126.12 26.27 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.758 ' HD2' ' HB3' ' A' ' 46' ' ' ASP . 54.3 mtt85 -143.98 137.71 27.92 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.344 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.523 ' CD1' HD11 ' A' ' 151' ' ' ILE . 86.6 m95 -73.45 110.91 8.1 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.7 t 65.29 -76.25 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.258 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.4 t -156.44 26.86 0.34 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.47 0.652 . . . . 0.0 109.409 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.8 -73.17 1.19 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.992 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -117.51 -52.57 0.33 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.158 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -173.61 -129.9 1.21 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.139 -0.553 . . . . 0.0 111.769 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.43 161.69 22.43 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.182 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.933 ' HA3' ' HB ' ' A' ' 109' ' ' THR . . . -164.32 -156.54 8.94 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.342 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 164.0 118.15 0.43 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.789 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.64 -143.44 17.83 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.896 -0.668 . . . . 0.0 111.808 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.6 m -141.26 114.31 8.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.151 0.501 . . . . 0.0 111.033 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 106' ' ' GLN . . . -124.59 177.15 6.09 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.112 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.4 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 1.9 p -129.46 120.18 25.01 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.485 HG21 ' CE1' ' A' ' 80' ' ' PHE . 7.9 p -107.05 147.39 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.565 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 13.4 m -95.37 124.87 39.62 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.586 HG21 HD12 ' A' ' 99' ' ' ILE . 47.9 t -73.99 133.13 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.362 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -99.16 170.2 8.85 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 124.384 1.052 . . . . 0.0 111.17 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.853 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 41.5 tt0 -61.48 119.63 8.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.645 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.55 18.78 51.23 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.67 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -110.36 148.02 32.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.15 0.475 . . . . 0.0 111.014 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.647 ' HA ' HG12 ' A' ' 99' ' ' ILE . 74.3 p -126.57 173.17 9.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.367 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.61 HD22 HG23 ' A' ' 99' ' ' ILE . 1.5 mm? -52.75 -43.03 65.49 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.539 0.685 . . . . 0.0 109.701 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.458 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 65.1 mtp180 -61.8 -38.26 87.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.744 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -72.9 -41.01 65.07 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 72' ' ' THR . 42.8 mm -62.71 -47.98 90.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.735 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -55.49 -50.38 60.42 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.213 178.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.13 -36.74 84.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.754 0.312 . . . . 0.0 111.432 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -70.32 -42.82 71.45 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.485 ' CE1' HG21 ' A' ' 65' ' ' VAL . 97.5 m-85 -105.08 18.72 21.87 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.5 t70 52.94 39.08 28.65 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.681 0.753 . . . . 0.0 111.528 178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.735 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 3.4 p -116.86 170.88 8.28 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.218 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.66 ' O ' HG13 ' A' ' 87' ' ' ILE . 6.1 t70 -96.06 124.4 40.05 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.031 -0.667 . . . . 0.0 110.199 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.458 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 5.7 p90 -52.29 -29.49 23.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.512 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -68.86 -43.22 75.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.425 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.668 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 14.0 tp10 -65.31 -45.56 83.85 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.66 HG13 ' O ' ' A' ' 83' ' ' ASP . 4.8 mt -54.97 -46.42 76.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.18 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.596 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.01 -50.01 72.37 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.889 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.414 ' NE ' ' HA ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -55.61 -39.67 71.09 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.668 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 10.9 mmt180 -69.91 -30.98 68.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.688 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.74 HD22 HD13 ' A' ' 93' ' ' ILE . 66.1 t30 -95.39 -3.85 46.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.154 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 50.4 m-80 74.9 17.82 2.72 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.935 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.74 HD13 HD22 ' A' ' 91' ' ' ASN . 14.3 pt -105.55 -179.77 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.549 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 2.3 mp0 -104.69 161.52 14.07 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.505 ' O ' HD23 ' A' ' 73' ' ' LEU . 15.9 p-10 -60.33 -59.65 5.06 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 122.027 0.917 . . . . 0.0 109.284 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -75.78 12.28 1.12 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.602 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.549 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 3.8 t70 -63.62 -35.62 81.11 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 9.5 mp 72.17 117.16 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 O-C-N 124.193 0.933 . . . . 0.0 109.313 -176.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.647 HG12 ' HA ' ' A' ' 72' ' ' THR . 7.5 pt -95.72 178.97 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.918 -178.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.456 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 91.3 m-85 -124.35 157.6 64.16 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.751 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.853 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 53.6 Cg_endo -72.4 131.93 18.39 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 123.198 2.598 . . . . 0.0 113.044 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.42 18.96 24.54 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' A' ' 66' ' ' THR . 33.9 tt0 -105.79 158.71 16.54 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 83.0 t -119.21 118.75 58.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 109.722 -0.474 . . . . 0.0 109.722 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.596 HD11 HG21 ' A' ' 99' ' ' ILE . 94.9 mt -112.52 150.55 31.12 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.035 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.625 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 40.8 mt-30 -90.56 111.74 23.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.781 0.8 . . . . 0.0 110.964 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.0 m -119.55 151.23 51.41 Favored Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.608 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.45 -16.13 53.49 Favored 'Trans proline' 0 N--CA 1.475 0.389 0 C-N-CA 123.542 2.828 . . . . 0.0 114.975 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.933 ' HB ' ' HA3' ' A' ' 59' ' ' GLY . 6.6 t -153.15 152.68 31.54 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.01 0.433 . . . . 0.0 111.39 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -97.55 -176.57 3.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.0 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -86.08 -45.09 5.76 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.352 -0.928 . . . . 0.0 111.45 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.06 179.16 35.88 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.986 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 51.0 m -152.36 -47.2 0.1 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.909 0.385 . . . . 0.0 110.291 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.545 ' O ' ' HD3' ' A' ' 41' ' ' ARG . . . 166.1 49.7 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.239 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -143.16 91.39 0.17 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.799 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.45 60.22 2.88 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 41' ' ' ARG . . . -123.36 -28.62 3.93 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.38 -0.41 . . . . 0.0 111.735 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.715 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -109.0 -84.61 1.61 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.121 -1.038 . . . . 0.0 113.18 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 15.5 m120 75.25 24.39 1.44 Allowed 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.457 0.703 . . . . 0.0 112.099 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.602 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 23.8 p90 -59.62 -40.19 86.74 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.069 0.461 . . . . 0.0 110.019 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.51 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 66.0 t-105 -56.69 -34.58 67.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.386 -178.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -57.03 -25.81 59.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.86 0.362 . . . . 0.0 111.028 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.815 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 9.7 m -132.01 25.45 4.61 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.477 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.51 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -115.89 139.87 49.79 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 120.98 0.419 . . . . 0.0 110.816 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.462 ' HD3' ' HA ' ' A' ' 125' ' ' ARG . 17.8 mmt180 -128.98 146.72 50.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.486 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.7 t70 51.35 59.31 4.69 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 124.014 0.821 . . . . 0.0 110.745 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.534 HG12 HD11 ' A' ' 136' ' ' LEU . 35.1 t -82.78 124.65 39.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.598 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -145.66 144.01 30.16 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.07 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.883 HD13 HG22 ' A' ' 14' ' ' ILE . 21.3 mt -86.25 138.85 31.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.29 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.64 HG23 ' HB ' ' A' ' 135' ' ' VAL . 34.4 m -132.6 157.56 43.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.92 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.447 ' O ' ' HG2' ' A' ' 134' ' ' LYS . 0.7 OUTLIER 65.37 18.08 11.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.387 178.578 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.736 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 90.42 30.46 12.09 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.222 -0.99 . . . . 0.0 113.829 178.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.565 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 86.69 -9.87 69.73 Favored Glycine 0 C--O 1.261 1.832 0 CA-C-O 123.011 1.339 . . . . 0.0 113.213 176.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.728 ' HG3' HG23 ' A' ' 135' ' ' VAL . 8.4 ptpp? -74.18 -17.4 60.91 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.728 HG23 ' HG3' ' A' ' 134' ' ' LYS . 22.8 t -137.79 143.13 34.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.782 177.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.671 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 34.1 tp -126.24 119.15 26.7 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.5 ' OE2' ' HD3' ' A' ' 148' ' ' ARG . 16.2 tt0 -112.15 138.26 49.08 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.76 0.314 . . . . 0.0 111.357 -176.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . . . -162.86 167.04 23.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.988 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 124' ' ' ALA . 3.9 mm-40 -94.36 106.17 18.14 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.562 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 67.0 mt -96.96 130.5 44.26 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.268 0.556 . . . . 0.0 111.567 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.815 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 74.4 ttt180 -73.28 141.32 47.19 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.128 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.531 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 2.0 p90 -159.06 -169.94 2.84 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 121.081 -0.247 . . . . 0.0 111.352 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.7 m -56.01 -29.65 60.67 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -101.14 27.16 21.87 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.243 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 93.68 -111.1 4.07 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.363 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -128.88 133.32 47.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.717 0.258 . . . . 0.0 110.339 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.531 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 54.0 t30 -133.01 141.42 48.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.712 0.291 . . . . 0.0 110.497 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.5 ' HD3' ' OE2' ' A' ' 137' ' ' GLU . 24.9 ttm180 -79.6 114.73 18.75 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.921 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.571 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 36.2 t -125.78 168.26 14.05 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.698 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.671 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -146.73 163.05 37.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.082 0.468 . . . . 0.0 111.978 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.954 ' HB ' ' HB3' ' A' ' 50' ' ' PHE . 9.0 tt -145.47 152.9 14.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.302 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.675 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 15.1 m-85 -93.32 105.84 17.87 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.811 HD13 HD22 ' A' ' 21' ' ' LEU . 22.2 mt -67.25 -34.09 76.7 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.243 178.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.46 ' HA ' ' CD1' ' A' ' 7' ' ' PHE . 1.9 p-10 -57.41 -11.93 2.22 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.908 178.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.912 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 36.5 mt-10 -62.3 -55.27 29.84 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.106 0.479 . . . . 0.0 111.938 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -118.34 -12.13 9.94 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.959 -0.697 . . . . 0.0 111.828 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.438 ' CG2' ' HG ' ' A' ' 164' ' ' LEU . 49.6 mm -87.2 108.84 18.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.298 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -115.25 154.86 16.7 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.562 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.552 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.0 t30 -94.47 113.68 25.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.107 0.479 . . . . 0.0 109.891 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.459 HH11 ' HD2' ' A' ' 160' ' ' ARG . 15.2 tpt180 -110.97 86.72 2.37 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.92 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.0 t30 55.17 55.9 7.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.368 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.618 ' HA3' ' HG2' ' A' ' 27' ' ' ARG . . . 79.99 7.63 88.35 Favored Glycine 0 C--O 1.228 -0.231 0 CA-C-N 115.509 -0.769 . . . . 0.0 113.781 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -123.47 125.16 44.41 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.855 0.359 . . . . 0.0 111.397 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.856 HD13 ' SG ' ' A' ' 25' ' ' CYS . 0.2 OUTLIER -73.87 112.09 9.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.591 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 47.9 mm -118.95 140.08 44.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.166 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -91.18 134.48 34.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.29 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 4.6 p . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.12 178.923 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.628 ' HA3' ' OD1' ' A' ' 6' ' ' ASN . . . . . . . . 0 N--CA 1.482 1.735 0 N-CA-C 111.699 -0.56 . . . . 0.0 111.699 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.878 HD22 ' HG2' ' A' ' 155' ' ' GLU . 5.5 t30 -86.82 -69.93 0.64 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.766 0.317 . . . . 0.0 111.296 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -126.74 -94.05 0.47 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.75 -26.66 12.18 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.22 -72.63 0.64 Allowed Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 119.66 -1.257 . . . . 0.0 112.61 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.628 ' OD1' ' HA3' ' A' ' 1' ' ' GLY . 39.1 m-80 64.53 14.43 8.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.615 0.245 . . . . 0.0 110.677 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.581 ' CE2' HD13 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -64.05 -32.5 74.07 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.994 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.5 t -70.7 -11.1 60.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.359 0.6 . . . . 0.0 109.728 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.58 -16.92 72.13 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.418 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.494 ' HB2' ' HB3' ' A' ' 26' ' ' ARG . 33.3 p -137.21 -11.27 1.68 Allowed 'General case' 0 C--O 1.221 -0.419 0 O-C-N 122.507 -0.408 . . . . 0.0 111.928 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 12.1 m -105.18 132.53 51.28 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.585 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 25.1 ptt180 -108.89 -176.77 3.13 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 44.28 42.3 5.08 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 123.913 0.758 . . . . 0.0 112.058 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.93 HG22 HD13 ' A' ' 129' ' ' LEU . 5.6 mt -80.2 100.97 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 121.108 0.48 . . . . 0.0 110.889 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.621 ' CA ' HD12 ' A' ' 129' ' ' LEU . 71.7 m -147.82 127.13 13.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.515 -0.766 . . . . 0.0 108.984 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.751 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -92.57 158.36 16.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.676 0.75 . . . . 0.0 112.782 -179.046 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -96.13 74.31 2.98 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.18 -55.41 5.03 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.226 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 40' ' ' ASN . . . -148.67 -12.42 0.34 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -85.89 92.37 8.63 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.78 HD22 HD23 ' A' ' 153' ' ' LEU . 43.2 tp -58.87 125.2 22.57 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.546 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 2.3 ttt180 -133.08 122.64 24.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.14 0.495 . . . . 0.0 110.703 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.621 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -138.83 176.24 8.86 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.243 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.585 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 6.2 mt-10 -115.61 80.07 1.38 Allowed 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.601 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 55.6 m -64.77 126.69 28.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.691 -178.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.494 ' HB3' ' HB2' ' A' ' 10' ' ' SER . 43.5 ttt-85 -74.73 114.68 13.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.676 178.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.6 ttm180 -82.57 154.9 24.76 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -48.75 -22.47 2.82 Favored Glycine 0 C--N 1.332 0.325 0 O-C-N 124.633 1.208 . . . . 0.0 115.115 -177.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -72.48 -14.41 61.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.509 0.671 . . . . 0.0 110.574 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.31 7.78 53.97 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -102.74 147.44 17.03 Favored Glycine 0 C--O 1.225 -0.445 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.511 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.438 ' HD1' ' O ' ' A' ' 24' ' ' GLU . 84.4 m-85 -96.57 124.63 40.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.02 0.41 . . . . 0.0 110.318 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.9 m -117.01 126.44 52.89 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.339 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.3 m -67.09 126.25 28.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.253 0.549 . . . . 0.0 110.245 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 46.8 t -129.86 152.69 49.06 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.763 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.667 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 5.3 p -144.12 133.77 19.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.044 0.45 . . . . 0.0 111.171 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.441 HG23 ' HB3' ' A' ' 21' ' ' LEU . 11.2 tt -135.07 153.53 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.226 -178.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -82.97 111.6 18.98 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 122.041 -0.412 . . . . 0.0 111.157 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.538 HD23 ' HB3' ' A' ' 21' ' ' LEU . 2.0 mm? -88.83 -2.0 58.37 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.456 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 66.9 t30 -74.78 -14.73 60.74 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.767 ' HD3' ' HA2' ' A' ' 115' ' ' GLY . 50.9 mtm180 -107.18 17.25 23.17 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.296 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.464 ' HB2' HD13 ' A' ' 39' ' ' LEU . 39.8 m-85 -134.01 -33.86 1.02 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.339 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.64 HD22 HD13 ' A' ' 151' ' ' ILE . 35.8 mt -105.73 137.18 44.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.926 0.394 . . . . 0.0 111.624 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.634 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 5.9 m -129.94 140.76 50.88 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.677 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.803 ' CB ' ' HG ' ' A' ' 140' ' ' LEU . 21.2 p-10 -80.71 93.79 6.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.36 0.6 . . . . 0.0 110.542 178.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -92.78 91.24 7.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.981 0.42 . . . . 0.0 111.065 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.9 t30 51.86 45.23 28.58 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.361 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.35 34.4 29.26 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.728 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.658 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 32.8 t60 -155.35 122.0 5.33 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.741 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 55.3 m-85 -58.44 143.98 43.65 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.93 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.648 ' NE ' ' HA ' ' A' ' 51' ' ' ARG . 4.4 mmp_? -146.14 134.26 21.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.449 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.772 ' HZ2' ' HA ' ' A' ' 153' ' ' LEU . 95.0 m95 -77.38 114.24 16.01 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.107 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.5 t -129.58 85.06 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.8 m -81.61 60.79 4.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.983 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.57 38.22 94.46 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.959 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.53 142.39 48.26 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.442 -0.408 . . . . 0.0 112.3 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.901 ' HA3' ' HB2' ' A' ' 63' ' ' ALA . . . 77.4 62.26 2.46 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.767 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -127.1 90.37 0.35 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.732 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.8 10.81 66.5 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.437 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.5 169.65 20.78 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.424 -0.893 . . . . 0.0 112.75 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.33 -143.56 16.6 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.069 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.2 m -134.17 126.65 30.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.95 0.405 . . . . 0.0 110.081 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.901 ' HB2' ' HA3' ' A' ' 57' ' ' GLY . . . -132.3 177.16 7.79 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.203 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.449 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 8.9 p -130.32 119.73 23.27 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.415 HG21 ' CE1' ' A' ' 80' ' ' PHE . 8.2 p -109.48 140.51 27.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.685 0.278 . . . . 0.0 110.623 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 7.1 m -88.27 131.1 34.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.246 0.546 . . . . 0.0 110.28 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.499 ' CG2' HD12 ' A' ' 99' ' ' ILE . 43.0 t -81.1 134.93 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.9 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.597 HE21 ' HA ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -108.8 170.61 7.93 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 124.1 0.875 . . . . 0.0 109.939 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.667 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 34.7 tt0 -65.12 120.13 12.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.834 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.67 -7.19 45.52 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.879 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -95.04 148.15 22.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.331 0.586 . . . . 0.0 112.029 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.609 ' HA ' HG12 ' A' ' 99' ' ' ILE . 74.5 p -133.38 170.75 15.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.695 HD22 HG23 ' A' ' 99' ' ' ILE . 1.1 mm? -52.18 -45.9 65.32 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.899 0.772 . . . . 0.0 109.453 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -57.49 -38.64 74.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.367 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.66 -43.74 46.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.594 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.557 HG12 ' O ' ' A' ' 72' ' ' THR . 43.5 mm -59.83 -46.55 93.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.885 0.374 . . . . 0.0 110.059 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.645 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.86 -51.73 56.39 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.555 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -66.85 -30.81 71.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.025 0.44 . . . . 0.0 111.43 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -70.12 -46.82 63.99 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.415 ' CE1' HG21 ' A' ' 65' ' ' VAL . 89.7 m-85 -103.59 12.62 34.72 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.0 t0 60.21 57.88 2.8 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.96 0.886 . . . . 0.0 110.812 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.645 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -140.02 164.88 28.85 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.065 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.686 ' O ' HG13 ' A' ' 87' ' ' ILE . 6.8 m-20 -83.05 114.95 21.64 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.643 ' HD1' ' HB2' ' A' ' 95' ' ' ASN . 10.6 p90 -54.57 -31.53 56.86 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.724 0.64 . . . . 0.0 111.142 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.528 ' HA ' ' HB3' ' A' ' 95' ' ' ASN . 51.0 t-80 -71.86 -36.03 70.01 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.719 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.595 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 9.9 tp10 -68.77 -47.0 67.3 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.686 HG13 ' O ' ' A' ' 83' ' ' ASP . 7.1 mt -51.91 -47.94 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.017 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.593 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.83 -50.92 69.05 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.345 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -56.8 -39.79 74.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.934 0.397 . . . . 0.0 111.418 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.595 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 21.7 mmt180 -70.17 -31.07 68.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.108 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 17.5 t-20 -90.74 -6.04 54.93 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.985 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 93.0 m-20 79.5 17.75 0.8 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.524 0.73 . . . . 0.0 111.089 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.593 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 14.5 pt -110.68 -173.17 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.585 178.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.539 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 52.5 mt-30 -115.1 154.42 28.94 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.643 ' HB2' ' HD1' ' A' ' 84' ' ' PHE . 6.9 p-10 -56.6 -55.1 38.25 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 122.199 1.0 . . . . 0.0 109.329 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -78.52 12.92 1.78 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.091 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.539 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 0.7 OUTLIER -70.96 -29.96 66.1 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.093 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 9.6 mp 69.88 114.61 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 O-C-N 124.266 0.979 . . . . 0.0 110.433 -177.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.695 HG23 HD22 ' A' ' 73' ' ' LEU . 9.5 pt -94.63 176.03 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 114.81 -1.087 . . . . 0.0 111.338 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.556 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 90.5 m-85 -130.71 160.03 68.28 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.941 -178.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.667 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 20.1 Cg_endo -66.05 135.28 40.03 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.299 2.666 . . . . 0.0 114.048 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.73 23.38 18.5 Favored Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.397 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.49 ' O ' ' HA ' ' A' ' 66' ' ' THR . 46.1 mt-30 -111.88 165.35 12.16 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 120.574 -0.45 . . . . 0.0 109.837 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.449 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 65.6 t -125.45 115.73 44.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.496 ' HB3' HG22 ' A' ' 87' ' ' ILE . 81.7 mt -108.19 150.87 26.69 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.711 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -90.62 115.41 27.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.394 0.616 . . . . 0.0 110.613 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.0 m -120.37 150.5 51.95 Favored Pre-proline 0 C--N 1.311 -1.08 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.388 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.93 -19.28 58.27 Favored 'Trans proline' 0 C--N 1.332 -0.304 0 C-N-CA 123.195 2.597 . . . . 0.0 113.96 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.7 t -152.53 147.61 26.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.356 0.598 . . . . 0.0 111.351 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.5 ' HG2' ' HB1' ' A' ' 63' ' ' ALA . 13.8 mmmm -99.34 -169.84 1.82 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.965 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.91 -48.57 74.94 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 65.42 35.57 91.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.378 -0.439 . . . . 0.0 113.467 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.9 m -73.1 -37.12 66.84 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.955 0.407 . . . . 0.0 110.184 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 127.14 -67.96 0.54 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.732 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.767 ' HA2' ' HD3' ' A' ' 41' ' ' ARG . . . -78.72 68.49 3.01 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.62 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 159.27 71.51 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.924 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -114.74 -34.28 5.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.288 0.566 . . . . 0.0 109.605 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.634 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -103.36 -76.09 1.11 Allowed Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.088 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 21.6 m120 75.24 27.16 1.12 Allowed 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.751 0.82 . . . . 0.0 112.476 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.593 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 18.8 p90 -63.46 -39.29 94.07 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.546 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 63.7 t-105 -61.94 -31.44 71.77 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.133 -178.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -58.75 -16.22 15.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 111.27 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.729 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 36.3 m -145.75 30.55 1.08 Allowed 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.164 177.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.546 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -110.38 136.47 49.49 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.595 177.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.4 tmm_? -125.03 137.04 54.23 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.61 57.99 3.52 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.625 0.578 . . . . 0.0 111.164 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.505 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 34.6 t -85.53 124.96 40.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.114 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.486 ' O ' HD12 ' A' ' 136' ' ' LEU . 38.7 ptt180 -148.98 142.97 25.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.956 0.408 . . . . 0.0 111.143 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.93 HD13 HG22 ' A' ' 14' ' ' ILE . 23.1 mt -85.09 131.97 34.38 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.74 HG23 ' HB ' ' A' ' 135' ' ' VAL . 28.9 m -125.28 158.98 33.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.712 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.68 ' HB3' ' CG ' ' A' ' 134' ' ' LYS . 0.2 OUTLIER 68.55 11.13 8.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.152 179.52 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.664 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 91.28 31.33 9.77 Favored Glycine 0 N--CA 1.437 -1.251 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.092 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.508 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 93.25 -14.91 64.17 Favored Glycine 0 C--O 1.265 2.062 0 CA-C-O 123.005 1.336 . . . . 0.0 113.627 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.68 ' CG ' ' HB3' ' A' ' 131' ' ' ASP . 7.8 ptpp? -72.99 -15.63 61.53 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 121.241 -1.153 . . . . 0.0 109.024 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.74 ' HB ' HG23 ' A' ' 130' ' ' VAL . 12.0 t -139.27 147.37 24.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.718 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.579 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 47.9 tp -128.95 123.14 31.73 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -112.46 130.94 55.82 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 123.273 0.358 . . . . 0.0 110.772 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.727 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.72 161.6 26.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.188 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.668 ' HG2' ' HG3' ' A' ' 148' ' ' ARG . 39.3 mt-10 -98.0 106.17 18.43 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.628 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.803 ' HG ' ' CB ' ' A' ' 45' ' ' ASN . 0.5 OUTLIER -89.71 126.03 35.5 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.852 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.729 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 52.3 ttt-85 -69.97 140.38 52.97 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.647 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.664 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 2.9 p90 -151.6 -164.94 2.11 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.148 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.3 t -59.78 -25.61 65.05 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -107.65 28.88 11.29 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.591 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 96.46 -114.45 4.94 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.485 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -125.27 129.38 49.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.78 0.29 . . . . 0.0 110.666 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.664 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 22.9 t-20 -123.56 132.87 54.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.711 0.291 . . . . 0.0 111.114 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.668 ' HG3' ' HG2' ' A' ' 139' ' ' GLU . 38.2 mtp85 -74.86 113.18 11.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.533 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.658 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 33.7 t -128.9 165.53 20.88 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.047 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.579 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 19.4 ptt180 -147.74 148.69 31.25 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.138 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.741 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 11.6 tt -130.68 161.67 40.15 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.428 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.531 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 14.6 m-85 -104.88 105.46 15.53 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 122.265 -0.272 . . . . 0.0 110.991 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.78 HD23 HD22 ' A' ' 21' ' ' LEU . 9.9 mp -69.27 -31.62 70.25 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.502 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.626 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 11.1 t70 -58.99 -7.84 1.21 Allowed 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.932 178.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.878 ' HG2' HD22 ' A' ' 2' ' ' ASN . 37.0 mt-10 -72.73 -51.78 17.81 Favored 'General case' 0 CA--C 1.508 -0.635 0 O-C-N 121.862 -0.523 . . . . 0.0 112.31 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.537 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 53.8 m-70 -122.55 2.22 9.57 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.126 -177.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.412 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 46.2 mm -106.26 110.44 31.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.431 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.469 ' HA3' ' OXT' ' A' ' 167' ' ' CYS . . . -113.43 168.77 12.68 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.28 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.601 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 1.6 t30 -100.83 119.8 39.19 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.666 ' HD3' HD12 ' A' ' 165' ' ' ILE . 58.5 ttt180 -115.12 88.68 2.92 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.807 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 17.8 m120 59.55 34.7 22.49 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.937 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.58 -4.55 43.34 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.023 -1.084 . . . . 0.0 114.243 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.603 ' HG2' ' O ' ' A' ' 160' ' ' ARG . 14.4 pt-20 -122.02 139.79 53.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.683 0.742 . . . . 0.0 110.9 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.404 ' CD2' ' HD2' ' A' ' 7' ' ' PHE . 76.0 mt -76.23 115.12 15.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.386 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.666 HD12 ' HD3' ' A' ' 160' ' ' ARG . 47.7 mt -141.08 146.71 23.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.953 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.537 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 14.0 p80 -56.66 124.32 17.95 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.469 ' OXT' ' HA3' ' A' ' 158' ' ' GLY . 42.6 t . . . . . 0 C--O 1.254 1.294 0 O-C-N 123.958 0.786 . . . . 0.0 110.987 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -89.78 179.54 5.98 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.634 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 33.9 m-85 -121.94 -89.12 0.61 Allowed 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.488 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.39 -26.99 6.51 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -76.09 -67.85 1.63 Allowed Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 119.069 -1.539 . . . . 0.0 112.363 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 63.94 15.01 8.84 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 122.973 0.509 . . . . 0.0 110.71 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.685 ' CE2' HD13 ' A' ' 14' ' ' ILE . 2.1 p90 -56.4 -37.23 69.85 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.549 ' HA ' HD11 ' A' ' 14' ' ' ILE . 3.9 m -60.2 -23.05 63.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.841 0.353 . . . . 0.0 111.745 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.19 -21.66 77.2 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.974 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.517 ' HB2' ' HB3' ' A' ' 26' ' ' ARG . 33.2 p -125.19 -24.88 3.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.12 0.486 . . . . 0.0 111.321 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.2 m -94.64 131.63 40.22 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.815 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 12' ' ' ARG . 10.5 ptm180 -113.4 -179.54 3.67 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.426 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 9.0 m-20 47.53 44.65 17.12 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 123.832 0.708 . . . . 0.0 111.41 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.762 HG22 ' CD1' ' A' ' 129' ' ' LEU . 7.2 mt -80.22 103.25 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-O 121.039 0.447 . . . . 0.0 110.425 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.586 ' O ' ' HB3' ' A' ' 22' ' ' ARG . 72.0 m -146.95 127.5 14.15 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.85 HD21 HD12 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -91.91 157.99 16.53 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.086 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -97.24 76.08 2.6 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 113.958 -1.474 . . . . 0.0 107.815 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.44 -58.92 5.01 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.994 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -148.66 -6.45 0.4 Allowed 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -97.81 98.03 9.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.117 0.484 . . . . 0.0 110.382 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.901 ' HB2' HD22 ' A' ' 39' ' ' LEU . 42.9 tp -54.25 129.88 36.74 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 114.871 -1.058 . . . . 0.0 112.489 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.586 ' HB3' ' O ' ' A' ' 15' ' ' CYS . 16.2 ttp180 -132.62 124.1 27.67 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.601 -0.439 . . . . 0.0 110.089 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.639 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -147.23 144.43 28.89 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.663 0.744 . . . . 0.0 111.682 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.623 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 2.3 mm-40 -79.27 75.66 5.84 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.882 178.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.598 ' HB2' ' HA2' ' A' ' 162' ' ' GLY . 46.2 m -62.43 124.57 21.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.49 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.517 ' HB3' ' HB2' ' A' ' 10' ' ' SER . 58.6 ttp180 -68.92 119.92 14.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.336 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -90.27 153.5 20.42 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.93 -13.07 4.23 Favored Glycine 0 C--N 1.33 0.232 0 O-C-N 124.443 1.09 . . . . 0.0 115.005 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -83.52 -2.91 57.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.978 0.418 . . . . 0.0 110.554 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.59 10.99 66.79 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -112.4 145.29 18.02 Favored Glycine 0 C--O 1.226 -0.387 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.408 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.623 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 69.4 m-85 -89.35 133.36 34.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.878 0.339 . . . . 0.0 110.433 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.8 m -115.16 124.75 52.28 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.307 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.0 m -68.31 107.42 2.82 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.09 0.472 . . . . 0.0 109.938 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 48.0 t -113.18 152.58 29.53 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.062 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.664 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.2 p -145.13 130.61 13.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.097 0.475 . . . . 0.0 110.757 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.4 HG23 ' HB3' ' A' ' 21' ' ' LEU . 15.3 tt -130.11 143.23 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.676 -177.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.15 101.37 3.92 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.71 0.29 . . . . 0.0 111.572 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.901 HD22 ' HB2' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -82.44 -9.78 59.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.079 0.466 . . . . 0.0 110.301 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.528 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 2.1 p-10 -62.59 -18.13 61.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.215 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.579 ' O ' ' HB3' ' A' ' 117' ' ' ALA . 18.1 ptt180 -112.63 20.7 16.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.303 0.573 . . . . 0.0 110.179 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 27.4 m-85 -131.34 -33.35 1.48 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.001 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.751 HD22 HD13 ' A' ' 151' ' ' ILE . 50.3 mt -106.25 135.01 48.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.689 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.632 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 3.3 m -126.34 138.15 53.54 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.033 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.901 ' CB ' ' HG ' ' A' ' 140' ' ' LEU . 16.1 p-10 -86.75 102.14 13.96 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.524 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.467 ' CB ' ' HD3' ' A' ' 51' ' ' ARG . 17.1 t70 -107.05 93.2 4.42 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.083 0.468 . . . . 0.0 110.507 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.7 t30 55.99 43.15 27.69 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.096 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 149' ' ' SER . . . 83.06 27.36 41.03 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.697 -0.764 . . . . 0.0 113.649 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.443 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 69.9 m-70 -144.47 139.06 28.06 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.974 ' HZ ' ' HB3' ' A' ' 138' ' ' ALA . 49.8 m-85 -80.88 144.25 32.11 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.206 0.527 . . . . 0.0 111.892 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.467 ' HD3' ' CB ' ' A' ' 46' ' ' ASP . 26.6 mtp180 -146.6 132.82 19.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.711 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.624 ' HZ2' ' HA ' ' A' ' 153' ' ' LEU . 97.2 m95 -73.83 133.1 43.15 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.315 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.493 HG23 ' HD3' ' A' ' 79' ' ' ARG . 14.8 m 30.45 62.09 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.871 1.269 . . . . 0.0 113.603 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.8 m -106.84 20.85 18.43 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.084 0.469 . . . . 0.0 110.818 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.15 -36.22 60.37 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.467 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.66 175.65 14.27 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.506 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.423 ' H ' ' HB2' ' A' ' 81' ' ' ASP . . . -136.43 -98.92 0.54 Allowed Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.419 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . 98.46 131.2 7.12 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.521 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.779 ' HA3' ' HB ' ' A' ' 109' ' ' THR . . . -169.86 -171.2 35.17 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.798 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -158.83 52.68 0.39 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.253 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.95 -137.17 2.3 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.383 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 55.3 m -140.92 117.35 10.78 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.077 0.465 . . . . 0.0 110.732 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.507 ' HB1' ' HG2' ' A' ' 110' ' ' LYS . . . -133.89 176.59 8.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.642 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.512 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 20.7 p -129.62 122.58 29.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.885 0.374 . . . . 0.0 111.124 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.479 HG21 ' CE2' ' A' ' 80' ' ' PHE . 10.8 p -108.22 139.79 29.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.838 0.352 . . . . 0.0 111.46 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.0 m -91.62 125.64 36.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.242 0.544 . . . . 0.0 109.648 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.872 HG21 HD12 ' A' ' 99' ' ' ILE . 86.6 t -84.06 131.14 34.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.341 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -106.1 169.46 8.49 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 124.059 0.849 . . . . 0.0 110.688 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.686 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 33.0 tt0 -55.65 117.67 3.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.295 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.36 4.89 40.52 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.34 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.452 ' HB2' HG13 ' A' ' 67' ' ' VAL . 95.3 m-20 -109.75 138.44 46.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.065 0.46 . . . . 0.0 111.939 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.671 ' HA ' HG12 ' A' ' 99' ' ' ILE . 68.6 p -122.84 173.99 7.42 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.744 HD22 HG23 ' A' ' 99' ' ' ILE . 0.7 OUTLIER -51.34 -43.06 61.66 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.525 0.602 . . . . 0.0 110.372 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -62.07 -35.89 79.99 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.883 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -73.89 -40.63 63.06 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.441 HG12 ' O ' ' A' ' 72' ' ' THR . 46.1 mm -63.14 -49.25 84.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.692 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -59.31 -52.57 52.46 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.652 -0.704 . . . . 0.0 113.539 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -64.5 -25.59 68.06 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.493 ' HD3' HG23 ' A' ' 53' ' ' VAL . 40.2 ttm180 -81.57 -49.5 10.47 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.479 ' CE2' HG21 ' A' ' 65' ' ' VAL . 96.2 m-85 -94.13 12.95 24.7 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.423 ' HB2' ' H ' ' A' ' 57' ' ' GLY . 15.8 t70 60.59 44.32 11.74 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.998 0.904 . . . . 0.0 110.797 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.692 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.8 p -126.19 162.4 25.5 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.865 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.471 ' O ' HG13 ' A' ' 87' ' ' ILE . 4.1 p-10 -92.91 119.09 31.85 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.558 0.694 . . . . 0.0 109.437 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.694 ' HD2' ' HB2' ' A' ' 95' ' ' ASN . 7.7 p90 -47.86 -32.57 6.34 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 114.431 -1.258 . . . . 0.0 111.895 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.412 ' HA ' ' HB3' ' A' ' 95' ' ' ASN . 40.7 t-80 -60.48 -47.85 84.33 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.951 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.604 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 6.2 tp10 -63.54 -47.04 83.24 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.928 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.493 HD12 ' HA ' ' A' ' 84' ' ' PHE . 5.1 mt -49.7 -47.06 21.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.413 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.612 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.84 -50.3 71.48 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.907 178.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 85' ' ' HIS . 48.6 mtm180 -58.9 -34.48 71.73 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.604 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 11.5 mmt180 -74.98 -28.22 60.47 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.914 0.388 . . . . 0.0 111.538 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.484 HD22 HG23 ' A' ' 93' ' ' ILE . 5.4 t30 -96.43 -5.1 40.48 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.622 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 89.6 m-20 78.2 15.66 1.36 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.313 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.612 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 17.0 pt -103.57 -169.22 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.388 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 41.6 mt-30 -120.42 153.35 36.69 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.694 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 4.4 p30 -56.94 -57.5 12.27 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 121.826 0.822 . . . . 0.0 109.6 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.68 11.93 2.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.495 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 0.7 OUTLIER -71.48 -35.08 70.69 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.369 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.487 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 9.7 mp 72.65 119.46 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.367 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.872 HD12 HG21 ' A' ' 67' ' ' VAL . 7.1 pt -94.55 176.68 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.328 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.507 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 92.7 m-85 -124.44 160.39 53.25 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.977 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.686 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 28.9 Cg_endo -70.66 132.04 21.13 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.958 2.439 . . . . 0.0 113.143 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.47 9.29 41.55 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -100.46 148.03 25.2 Favored 'General case' 0 C--O 1.215 -0.757 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.512 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 61.1 t -114.6 111.15 34.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.658 HD11 HG21 ' A' ' 99' ' ' ILE . 64.3 mt -101.08 151.66 21.54 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.086 -177.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.452 ' HG2' HG22 ' A' ' 64' ' ' THR . 17.8 mt-30 -90.29 113.72 25.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.702 0.763 . . . . 0.0 110.786 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.8 m -120.19 151.1 52.69 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.607 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.99 -16.35 54.42 Favored 'Trans proline' 0 C--N 1.333 -0.262 0 C-N-CA 123.392 2.728 . . . . 0.0 114.201 -177.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.779 ' HB ' ' HA3' ' A' ' 59' ' ' GLY . 14.2 t -157.26 157.58 34.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.939 0.399 . . . . 0.0 111.088 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.507 ' HG2' ' HB1' ' A' ' 63' ' ' ALA . 12.6 mmmm -99.63 -170.38 1.89 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.469 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -102.39 -151.72 23.88 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.75 77.7 0.61 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.739 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.5 p -86.38 -27.74 24.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.919 0.39 . . . . 0.0 110.391 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 124.26 -66.07 0.53 Allowed Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.808 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -152.58 31.39 0.84 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.017 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -145.75 52.65 0.57 Allowed Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.724 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 41' ' ' ARG . . . -109.81 -17.95 13.54 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.504 0.669 . . . . 0.0 109.745 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.632 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -118.59 -82.9 0.85 Allowed Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.891 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 19.7 m120 74.35 25.77 1.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.465 0.706 . . . . 0.0 112.241 178.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.613 ' CD2' ' HE1' ' A' ' 50' ' ' PHE . 12.4 p90 -64.14 -40.43 96.14 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.591 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 62.7 t-105 -59.17 -31.01 68.6 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.081 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -53.77 -28.02 32.32 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.739 0.304 . . . . 0.0 110.834 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.752 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 16.2 m -137.63 31.18 2.55 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.281 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.591 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -111.65 146.69 37.01 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.15 0.5 . . . . 0.0 111.318 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -132.34 148.02 52.41 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.558 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 50.66 50.82 18.18 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 124.053 0.846 . . . . 0.0 112.116 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.483 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 31.6 t -74.22 125.24 33.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -149.59 153.51 37.22 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.126 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.762 ' CD1' HG22 ' A' ' 14' ' ' ILE . 25.8 mt -97.5 139.71 33.01 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.807 0.337 . . . . 0.0 110.799 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.541 HG23 ' HB ' ' A' ' 135' ' ' VAL . 33.7 m -133.44 156.04 41.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.789 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.592 ' HB3' ' HD2' ' A' ' 134' ' ' LYS . 1.4 m-20 70.13 5.74 5.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.663 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.73 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 99.35 35.59 4.66 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.289 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.61 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 82.48 -9.58 58.08 Favored Glycine 0 C--O 1.256 1.523 0 CA-C-O 123.003 1.335 . . . . 0.0 113.198 176.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.648 ' O ' ' HA ' ' A' ' 152' ' ' TYR . 18.1 ptpt -74.47 -16.23 60.86 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.569 HG23 ' HG3' ' A' ' 134' ' ' LYS . 24.4 t -140.69 140.21 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.075 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.85 HD12 HD21 ' A' ' 16' ' ' LEU . 7.7 tt -119.01 125.15 48.7 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -110.35 124.45 51.71 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.974 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -157.46 155.67 30.82 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.939 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 31.1 mt-10 -95.0 108.33 20.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.272 0.558 . . . . 0.0 110.605 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.901 ' HG ' ' CB ' ' A' ' 45' ' ' ASN . 0.2 OUTLIER -90.24 128.7 36.46 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.752 -179.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.752 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 75.7 ttt180 -70.04 140.69 52.87 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.403 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.481 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.7 p90 -156.46 -171.95 3.89 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.383 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.8 m -55.87 -29.9 60.65 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.787 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -97.67 20.75 49.42 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.204 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 98.75 -110.12 3.94 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.251 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -129.44 133.1 47.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.636 0.255 . . . . 0.0 110.786 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.481 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 11.8 t30 -134.43 127.37 31.39 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.642 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 29.7 ttp180 -79.93 102.35 9.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.448 0.642 . . . . 0.0 110.759 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.443 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 11.4 t -105.27 174.62 5.8 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.124 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.662 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 34.7 ptt180 -147.43 148.24 31.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.918 0.389 . . . . 0.0 111.787 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.751 HD13 HD22 ' A' ' 43' ' ' LEU . 10.9 tt -131.6 159.59 42.96 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.512 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.689 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 44.0 m-85 -99.79 106.04 17.88 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.341 0.115 . . . . 0.0 110.775 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.71 HD11 HD21 ' A' ' 129' ' ' LEU . 16.5 mt -68.74 -35.86 77.66 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.312 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.431 ' HA ' ' HD1' ' A' ' 7' ' ' PHE . 8.3 p-10 -58.26 -8.05 1.02 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.976 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.689 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 41.8 mt-10 -69.41 -55.2 11.02 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.236 0.541 . . . . 0.0 111.912 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.473 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 77.5 m-70 -122.23 6.02 9.7 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.306 -177.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.471 HG12 ' CH2' ' A' ' 52' ' ' TRP . 44.3 mm -107.15 113.2 42.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.88 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 167' ' ' CYS . . . -112.71 173.04 14.95 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.965 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.535 ' CG ' ' HB3' ' A' ' 25' ' ' CYS . 0.9 OUTLIER -110.95 128.27 55.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.96 89.14 3.07 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.37 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 56.99 42.16 26.58 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.442 0.464 . . . . 0.0 111.794 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.598 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 92.51 7.93 62.93 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.928 -0.654 . . . . 0.0 113.406 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -123.59 127.01 47.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.147 0.473 . . . . 0.0 112.094 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.405 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 42.1 mt -70.82 110.39 5.56 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.481 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 63.3 mt -135.15 141.31 43.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.382 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.473 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 9.7 p-80 -54.73 123.83 14.54 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.452 ' O ' ' HA3' ' A' ' 158' ' ' GLY . 43.3 t . . . . . 0 C--O 1.249 1.058 0 O-C-N 123.714 0.634 . . . . 0.0 111.217 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.618 ' HA2' ' OD1' ' A' ' 6' ' ' ASN . . . . . . . . 0 N--CA 1.483 1.822 0 N-CA-C 112.34 -0.304 . . . . 0.0 112.34 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 154' ' ' ASP . 1.0 OUTLIER -90.05 -59.96 2.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.742 0.306 . . . . 0.0 110.571 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.478 ' HD2' ' HG2' ' A' ' 155' ' ' GLU . 45.3 m-85 -139.75 -83.59 0.25 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.854 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.616 ' HB1' ' SG ' ' A' ' 167' ' ' CYS . . . -118.73 -27.75 5.78 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.54 -71.24 0.85 Allowed Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 119.988 -1.101 . . . . 0.0 112.784 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.618 ' OD1' ' HA2' ' A' ' 1' ' ' GLY . 74.1 m-20 65.78 10.47 6.85 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 122.455 0.302 . . . . 0.0 110.749 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.634 ' CE2' HD13 ' A' ' 14' ' ' ILE . 1.1 p90 -61.08 -34.08 74.36 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.404 ' HA ' HD11 ' A' ' 14' ' ' ILE . 23.3 t -68.02 -16.88 64.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.106 0.479 . . . . 0.0 110.279 -178.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.24 -21.16 79.94 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.746 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 11.1 m -130.45 -19.17 3.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.978 0.389 . . . . 0.0 111.622 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 m -94.41 135.09 36.23 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.561 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 11.7 ptm180 -112.72 -178.91 3.51 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.432 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 0.6 OUTLIER 40.75 47.98 2.57 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 123.909 0.755 . . . . 0.0 112.343 -179.648 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.825 HG22 HD13 ' A' ' 129' ' ' LEU . 7.9 mt -80.66 103.83 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.597 ' HA ' HD12 ' A' ' 129' ' ' LEU . 45.4 t -147.95 126.19 12.23 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.78 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -92.34 154.93 18.26 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.559 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -95.09 74.66 3.45 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.4 -57.87 4.88 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.925 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.453 ' HA ' ' HZ ' ' A' ' 120' ' ' PHE . . . -145.28 -9.31 0.58 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.816 0.341 . . . . 0.0 110.257 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -94.98 95.59 8.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.823 0.344 . . . . 0.0 110.089 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.857 ' HB2' HD22 ' A' ' 39' ' ' LEU . 42.8 tp -59.28 128.12 35.53 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.369 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.543 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 51.1 ttt180 -131.1 129.83 42.38 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.05 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.62 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -150.61 147.34 27.3 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.383 0.611 . . . . 0.0 111.19 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.571 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 1.3 mm-40 -84.49 81.31 8.9 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.842 178.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.553 ' HB2' ' HA2' ' A' ' 162' ' ' GLY . 58.6 m -67.6 128.08 35.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.494 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 10' ' ' SER . 51.1 ttt-85 -74.37 116.19 14.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.793 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -89.5 159.02 17.45 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.092 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.48 -18.23 3.52 Favored Glycine 0 C--N 1.337 0.592 0 O-C-N 124.861 1.351 . . . . 0.0 114.442 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -71.64 -12.37 61.31 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.03 9.62 60.58 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.39 163.69 12.12 Favored Glycine 0 C--O 1.228 -0.238 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.032 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.571 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 70.2 m-85 -100.02 134.03 43.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.63 0.252 . . . . 0.0 110.499 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.6 m -123.79 128.68 49.9 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.271 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.4 114.72 6.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.02 0.438 . . . . 0.0 110.771 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 29.7 t -119.89 149.56 41.89 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.777 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 2.8 p -142.04 136.48 29.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.002 0.43 . . . . 0.0 111.204 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.444 HG23 ' HB3' ' A' ' 21' ' ' LEU . 13.4 tt -134.06 144.38 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.73 -177.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -77.84 98.81 5.71 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.798 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.857 HD22 ' HB2' ' A' ' 21' ' ' LEU . 1.3 mp -76.25 -6.4 51.25 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.272 0.558 . . . . 0.0 110.153 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.619 HD21 ' HA ' ' A' ' 119' ' ' ASN . 4.8 t-20 -63.61 -21.65 66.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.65 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.708 ' HD3' ' HA2' ' A' ' 115' ' ' GLY . 16.8 ptt85 -111.32 19.35 18.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.039 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.553 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 38.6 m-85 -131.44 -32.66 1.52 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.638 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.739 HD22 HD13 ' A' ' 151' ' ' ILE . 51.7 mt -109.71 138.53 45.95 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.036 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 m -132.79 144.22 50.09 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.612 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.467 ' ND2' ' HB2' ' A' ' 123' ' ' SER . 21.6 p-10 -88.27 106.5 18.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.425 0.631 . . . . 0.0 110.205 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -103.24 92.43 4.51 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 122.133 -0.354 . . . . 0.0 110.906 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 49.51 44.29 24.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.78 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.595 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 85.82 30.0 24.8 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.486 178.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.675 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 21.9 t-160 -152.58 124.6 8.01 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.766 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 63.6 m-85 -62.26 143.3 57.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.791 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.4 mtm180 -144.8 134.32 23.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.409 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.553 ' HA ' ' O ' ' A' ' 42' ' ' TYR . 99.4 m95 -75.58 141.76 42.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.882 177.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.533 HG22 ' HA ' ' A' ' 42' ' ' TYR . 17.5 m -64.28 115.93 3.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.329 0.585 . . . . 0.0 110.747 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.8 t -95.7 -10.35 29.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.497 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -105.08 -4.61 41.46 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.455 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.6 -136.92 15.12 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.981 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -88.7 -141.15 7.73 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.33 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -142.61 -164.69 10.25 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.029 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -102.18 -14.5 28.34 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.142 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 114.06 -110.58 2.43 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.339 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.31 -111.48 4.18 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.285 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.8 m -119.4 114.45 22.35 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.177 0.513 . . . . 0.0 110.539 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.523 ' HB1' ' HG2' ' A' ' 110' ' ' LYS . . . -106.43 176.55 5.13 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.68 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.55 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 10.0 p -126.85 115.89 20.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.957 0.408 . . . . 0.0 112.074 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.562 HG21 ' CE2' ' A' ' 80' ' ' PHE . 7.4 p -106.29 148.04 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.062 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 10.3 m -93.04 130.27 38.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.172 0.51 . . . . 0.0 110.454 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.553 HG21 HD12 ' A' ' 99' ' ' ILE . 58.2 t -83.26 138.39 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.185 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -108.4 171.2 7.55 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 124.373 1.045 . . . . 0.0 109.61 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.7 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 63.7 tt0 -68.95 126.05 28.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.395 -178.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.44 8.55 59.71 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.988 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -119.84 123.18 43.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.902 0.382 . . . . 0.0 110.962 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.557 ' HA ' HG12 ' A' ' 99' ' ' ILE . 69.3 p -104.76 -176.91 3.21 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.61 HD22 HG23 ' A' ' 99' ' ' ILE . 1.3 mm? -51.53 -40.79 60.34 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.392 0.615 . . . . 0.0 109.55 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.443 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 38.8 ttm180 -60.06 -42.47 94.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.253 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -70.66 -43.39 69.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.355 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 72' ' ' THR . 38.3 mm -62.96 -45.33 99.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.732 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.95 -56.22 26.36 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.654 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -64.72 -26.73 68.49 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 45.6 ttm-85 -72.98 -38.86 66.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.562 ' CE2' HG21 ' A' ' 65' ' ' VAL . 96.8 m-85 -111.02 19.64 18.26 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.9 t70 55.27 36.17 26.48 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.679 0.752 . . . . 0.0 111.776 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.732 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.5 p -113.72 171.19 7.73 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.672 ' O ' HG13 ' A' ' 87' ' ' ILE . 6.9 t70 -97.77 127.34 43.65 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.91 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.503 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 11.1 p90 -52.92 -30.12 32.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.287 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -73.33 -38.01 65.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.975 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -68.16 -45.91 72.21 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.672 HG13 ' O ' ' A' ' 83' ' ' ASP . 6.0 mt -54.67 -47.03 73.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.61 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.93 -47.89 81.28 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.679 177.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -56.75 -42.41 79.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.981 0.42 . . . . 0.0 111.369 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -69.79 -36.24 75.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.759 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.534 HD22 HG23 ' A' ' 93' ' ' ILE . 7.2 t30 -89.4 -5.33 57.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.387 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 94.0 m-20 74.8 21.05 2.17 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.587 0.755 . . . . 0.0 111.425 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.61 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 17.6 pt -108.89 -173.48 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.581 ' H ' ' HB2' ' A' ' 97' ' ' ASP . 88.7 mt-30 -110.62 158.15 18.9 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.535 ' O ' HD23 ' A' ' 73' ' ' LEU . 3.2 p-10 -58.98 -55.34 36.46 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-O 122.221 1.01 . . . . 0.0 108.43 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -79.68 12.06 2.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.666 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.581 ' HB2' ' H ' ' A' ' 94' ' ' GLN . 4.4 t70 -63.73 -32.57 74.1 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.1 mt 70.68 112.44 0.05 Allowed 'General case' 0 C--O 1.234 0.249 0 O-C-N 124.465 1.103 . . . . 0.0 110.123 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.835 HG21 HD11 ' A' ' 105' ' ' LEU . 14.4 pt -95.33 175.14 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.155 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.512 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 97.5 m-85 -128.96 158.8 71.52 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.969 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.7 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 20.8 Cg_endo -66.97 138.81 49.19 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.508 2.806 . . . . 0.0 114.307 -178.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.07 11.3 57.72 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.702 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 66' ' ' THR . 74.1 mt-30 -102.64 166.04 10.73 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.352 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.55 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 80.9 t -122.39 114.78 43.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-O 120.931 0.396 . . . . 0.0 110.198 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.835 HD11 HG21 ' A' ' 99' ' ' ILE . 79.0 mt -107.26 152.01 24.68 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.823 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 63' ' ' ALA . 72.9 mt-30 -89.9 116.22 27.81 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.795 0.807 . . . . 0.0 111.45 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.9 m -126.29 150.91 71.42 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 114.253 -1.339 . . . . 0.0 109.954 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.68 -17.41 59.82 Favored 'Trans proline' 0 N--CA 1.476 0.442 0 C-N-CA 123.735 2.957 . . . . 0.0 114.952 -177.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.6 t -148.54 153.01 37.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.942 0.401 . . . . 0.0 111.268 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.523 ' HG2' ' HB1' ' A' ' 63' ' ' ALA . 11.1 mmmm -101.63 -170.05 1.77 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.265 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.74 118.61 14.67 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.975 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 81.62 -80.85 1.7 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.849 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.6 t -142.93 -87.98 0.14 Allowed 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.18 48.14 1.0 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.388 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.708 ' HA2' ' HD3' ' A' ' 41' ' ' ARG . . . -77.68 61.23 3.66 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.616 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 174.76 56.95 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.499 ' H ' ' HA ' ' A' ' 41' ' ' ARG . . . -99.23 -39.0 8.66 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.097 -0.552 . . . . 0.0 110.353 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . -85.77 -60.92 1.73 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.905 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.619 ' HA ' HD21 ' A' ' 40' ' ' ASN . 6.9 m-20 72.28 25.55 2.84 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 178.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.6 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 25.3 p90 -55.78 -39.14 70.84 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.627 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 62.2 t-105 -59.03 -32.96 70.21 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.67 -178.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -52.31 -38.6 58.91 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 121.7 0.762 . . . . 0.0 110.77 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.946 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 17.2 m -122.91 25.85 8.42 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.503 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.627 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -114.72 134.61 54.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.857 0.36 . . . . 0.0 111.05 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.602 ' HD2' ' O ' ' A' ' 124' ' ' ALA . 7.1 mpt_? -131.33 158.61 40.23 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.631 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.9 t70 53.94 46.1 26.32 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.761 0.791 . . . . 0.0 110.214 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.493 ' CG1' HD11 ' A' ' 136' ' ' LEU . 22.5 t -79.85 122.09 34.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.614 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 128' ' ' ARG . 1.3 ptp85 -146.55 147.8 31.5 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.286 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.825 HD13 HG22 ' A' ' 14' ' ' ILE . 19.4 mt -86.97 127.84 35.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.204 0.526 . . . . 0.0 110.072 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.853 HG23 ' HB ' ' A' ' 135' ' ' VAL . 27.6 m -116.79 157.17 17.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.909 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.501 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 0.9 OUTLIER 68.42 3.23 3.67 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.584 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.642 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 97.91 29.24 7.78 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.32 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 98.34 -22.05 42.89 Favored Glycine 0 C--O 1.261 1.828 0 CA-C-O 123.014 1.341 . . . . 0.0 113.098 177.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.66 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 40.5 pttt -67.97 -14.79 63.24 Favored 'General case' 0 C--N 1.317 -0.814 0 O-C-N 121.279 -1.13 . . . . 0.0 109.271 177.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.853 ' HB ' HG23 ' A' ' 130' ' ' VAL . 3.1 t -140.85 146.91 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.895 177.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 26.5 tp -129.33 122.62 29.91 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -117.49 137.62 52.41 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.884 0.373 . . . . 0.0 110.988 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.636 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -160.09 169.32 23.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.575 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 124' ' ' ALA . 8.5 mm-40 -95.33 106.45 18.5 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.595 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 58.8 mt -97.81 125.06 42.46 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.457 0.646 . . . . 0.0 111.468 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.946 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 65.4 ttt180 -70.28 141.34 52.41 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.933 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.42 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 4.8 p90 -152.35 -173.73 4.65 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.868 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.0 m -56.2 -24.66 43.3 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -108.56 27.98 12.5 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.502 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 102.43 -117.89 5.94 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.161 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.431 ' CH2' ' HD3' ' A' ' 125' ' ' ARG . 80.0 m95 -127.2 142.14 51.56 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.42 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 54.6 t30 -138.02 137.74 38.16 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.8 ttt85 -85.03 113.75 21.68 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.065 0.46 . . . . 0.0 110.72 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.675 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 47.5 t -122.75 166.61 14.67 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.943 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 10.2 ptt180 -147.37 145.25 29.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.205 0.526 . . . . 0.0 111.677 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.766 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 6.9 tt -124.79 150.56 29.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.676 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.326 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.584 ' CB ' ' HG3' ' A' ' 155' ' ' GLU . 18.1 m-85 -94.74 103.96 15.87 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 122.166 -0.334 . . . . 0.0 110.921 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.743 HD13 HD22 ' A' ' 21' ' ' LEU . 25.4 mt -65.07 -36.51 84.57 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.09 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.66 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 8.8 t70 -57.61 -7.97 0.77 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.943 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.584 ' HG3' ' CB ' ' A' ' 152' ' ' TYR . 42.0 mt-10 -70.63 -54.31 12.46 Favored 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 122.002 -0.436 . . . . 0.0 112.081 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.506 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 80.7 m-70 -125.57 5.03 7.54 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.165 -177.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.498 HG12 ' CH2' ' A' ' 52' ' ' TRP . 41.7 mm -101.87 106.47 19.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.506 ' HA3' ' OXT' ' A' ' 167' ' ' CYS . . . -110.89 161.88 12.68 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.978 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.506 ' HA ' ' O ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER -103.61 136.36 43.46 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -119.01 86.55 2.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.621 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 48.6 50.48 17.01 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.553 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 99.55 6.01 55.18 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.318 -0.944 . . . . 0.0 113.815 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 159' ' ' ASN . 37.8 mt-10 -123.25 153.81 39.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 117.121 0.461 . . . . 0.0 111.288 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.454 HD21 ' HD2' ' A' ' 7' ' ' PHE . 30.8 mt -103.58 121.61 43.26 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.581 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.73 HG12 ' H ' ' A' ' 166' ' ' HIS . 13.8 tt -148.04 -179.47 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.956 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.73 ' H ' HG12 ' A' ' 165' ' ' ILE . 4.9 t60 -78.16 107.56 10.83 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.616 ' SG ' ' HB1' ' A' ' 4' ' ' ALA . 47.3 t . . . . . 0 C--O 1.251 1.156 0 O-C-N 123.788 0.68 . . . . 0.0 111.778 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.654 ' HA2' ' OD1' ' A' ' 6' ' ' ASN . . . . . . . . 0 N--CA 1.484 1.834 0 N-CA-C 112.371 -0.292 . . . . 0.0 112.371 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 154' ' ' ASP . 0.9 OUTLIER -91.85 -69.41 0.74 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 122.792 -0.24 . . . . 0.0 111.546 -179.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.525 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 58.0 m-85 -132.55 -100.46 0.28 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.567 ' HB1' ' SG ' ' A' ' 167' ' ' CYS . . . -96.2 -32.45 12.45 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -177.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.91 -74.94 0.37 Allowed Glycine 0 N--CA 1.436 -1.345 0 C-N-CA 119.994 -1.098 . . . . 0.0 113.275 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.654 ' OD1' ' HA2' ' A' ' 1' ' ' GLY . 39.0 m-80 66.46 15.72 10.19 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 122.332 0.253 . . . . 0.0 110.83 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.608 ' CE2' HD13 ' A' ' 14' ' ' ILE . 1.4 p90 -61.43 -35.11 76.64 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.509 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.572 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.9 OUTLIER -64.48 -21.43 66.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.246 0.546 . . . . 0.0 110.419 -179.001 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.47 -25.3 75.89 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.265 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 18.4 p -125.72 -10.93 6.72 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 117.135 0.467 . . . . 0.0 111.173 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 6.8 m -107.98 132.33 53.63 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -111.81 -179.46 3.7 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 45.37 46.3 10.36 Favored 'General case' 0 C--N 1.315 -0.933 0 O-C-N 123.859 0.724 . . . . 0.0 111.762 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.875 HG22 HD13 ' A' ' 129' ' ' LEU . 8.0 mt -80.92 106.82 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.6 ' HA ' HD12 ' A' ' 129' ' ' LEU . 73.5 m -147.78 126.98 12.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.064 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.787 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -102.47 158.89 15.9 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 121.431 0.634 . . . . 0.0 111.991 179.447 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -103.47 77.63 1.52 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.77 -54.71 4.98 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.589 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -149.53 -13.44 0.29 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.146 0.498 . . . . 0.0 110.291 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.57 ' HG3' ' CG2' ' A' ' 36' ' ' VAL . 21.0 tpt180 -83.25 85.75 7.16 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.316 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.787 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 54.0 tp -62.78 128.4 35.75 Favored 'General case' 0 C--O 1.213 -0.838 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -133.66 121.88 22.64 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.797 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.623 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -143.22 147.31 34.65 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.452 0.644 . . . . 0.0 111.54 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.514 ' O ' ' HD2' ' A' ' 32' ' ' TYR . 4.7 mm-40 -82.21 76.76 9.08 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.561 -1.199 . . . . 0.0 109.376 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.566 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 69.5 m -65.04 124.81 23.05 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.194 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 10' ' ' SER . 72.0 ttt180 -64.67 134.59 54.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.89 178.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -115.05 151.87 33.48 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.65 -10.62 6.4 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 114.495 -1.23 . . . . 0.0 113.737 -178.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -79.22 1.46 24.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.17 0.51 . . . . 0.0 110.155 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.95 12.15 74.93 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.963 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -130.21 160.56 23.01 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 119.984 -1.103 . . . . 0.0 112.953 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.514 ' HD2' ' O ' ' A' ' 24' ' ' GLU . 76.7 m-85 -95.85 125.15 40.21 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.9 m -108.4 137.34 46.52 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.733 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.1 m -71.93 112.74 8.28 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.151 0.5 . . . . 0.0 110.387 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.432 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 28.0 t -114.32 146.45 40.49 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.19 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.9 p -143.37 133.71 21.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.062 0.458 . . . . 0.0 110.981 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.451 HG23 ' HB3' ' A' ' 21' ' ' LEU . 9.3 tt -135.18 154.0 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.892 -177.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.547 ' OD1' ' HB3' ' A' ' 40' ' ' ASN . 35.2 t0 -89.46 112.4 23.54 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.079 -0.388 . . . . 0.0 110.664 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.521 HD23 ' CB ' ' A' ' 21' ' ' LEU . 3.6 mm? -86.46 -4.83 59.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.927 0.394 . . . . 0.0 110.149 178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.547 ' HB3' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -71.68 -15.45 62.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.805 0.812 . . . . 0.0 108.892 179.058 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.54 ' HD3' ' O ' ' A' ' 114' ' ' GLY . 30.8 mtt180 -105.87 13.22 29.77 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.527 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.426 ' HB2' HD13 ' A' ' 39' ' ' LEU . 48.2 m-85 -133.96 -29.51 1.29 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.712 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.872 HD22 HD13 ' A' ' 151' ' ' ILE . 31.9 mt -109.2 140.62 42.57 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.107 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.487 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 3.1 m -128.56 145.36 51.15 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.842 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.639 HD22 ' HA ' ' A' ' 120' ' ' PHE . 8.1 p30 -89.93 104.43 16.99 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -106.67 94.26 5.03 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.373 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 50.08 42.93 25.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.225 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.659 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 86.2 29.7 24.54 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.241 -0.98 . . . . 0.0 113.125 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.628 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 16.9 t-80 -153.71 127.33 8.72 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.806 ' HZ ' ' HB3' ' A' ' 138' ' ' ALA . 81.4 m-85 -64.08 149.53 47.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.929 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -144.63 129.5 18.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.82 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.474 ' HZ2' ' O ' ' A' ' 152' ' ' TYR . 94.2 m95 -76.07 133.57 40.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.971 177.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.4 m -122.67 54.06 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.316 0.579 . . . . 0.0 110.205 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.9 m -75.8 7.37 3.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.378 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -130.36 26.0 4.21 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.947 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.12 56.75 5.04 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.354 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.575 ' HA3' ' HA3' ' A' ' 112' ' ' GLY . . . 128.66 -119.18 2.96 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.883 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.4 -178.23 40.52 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -149.83 49.1 0.57 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.287 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.96 167.4 31.87 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.076 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 108' ' ' PRO . . . 101.68 -140.34 14.82 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.011 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 49.2 m -126.14 119.65 28.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.127 0.489 . . . . 0.0 110.555 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -124.28 176.72 6.26 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.873 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.464 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 17.4 p -128.06 113.67 16.09 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.355 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.443 ' HA ' ' HE3' ' A' ' 110' ' ' LYS . 9.7 p -102.63 139.78 22.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.918 0.389 . . . . 0.0 110.957 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 8.2 m -88.47 126.16 35.1 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.546 ' CG2' HD12 ' A' ' 99' ' ' ILE . 43.9 t -75.33 130.23 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.132 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -103.6 169.43 8.53 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 124.258 0.974 . . . . 0.0 110.344 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.6 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 6.1 tp-100 -62.0 121.29 12.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.265 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.03 16.04 39.84 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.908 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -121.04 129.54 53.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.862 0.331 . . . . 0.0 111.075 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.655 ' HA ' HG12 ' A' ' 99' ' ' ILE . 74.4 p -115.02 178.05 4.42 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.587 HD22 HG23 ' A' ' 99' ' ' ILE . 1.3 mm? -52.24 -42.71 63.84 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.641 0.734 . . . . 0.0 109.31 178.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.698 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 65.8 mtt180 -59.74 -41.12 90.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.4 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -71.61 -44.48 64.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.278 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.555 HG12 ' O ' ' A' ' 72' ' ' THR . 37.8 mm -58.83 -45.28 91.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.628 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.44 -49.96 68.88 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.693 -0.685 . . . . 0.0 113.321 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.698 ' HD3' ' O ' ' A' ' 74' ' ' ARG . 1.0 OUTLIER -73.84 -27.04 60.89 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 122.434 -0.451 . . . . 0.0 111.632 -179.011 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -76.54 -38.48 54.97 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.432 ' CE2' HG21 ' A' ' 65' ' ' VAL . 95.6 m-85 -112.47 19.94 17.11 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.2 t70 53.55 55.0 9.17 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 122.072 0.939 . . . . 0.0 111.701 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.628 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -136.32 172.87 12.38 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.235 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.678 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.9 t70 -98.73 122.66 42.24 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.905 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.442 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 14.1 p90 -53.16 -27.56 21.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.091 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.78 -34.61 58.0 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.923 0.392 . . . . 0.0 109.954 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.506 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 39.7 tt0 -69.42 -48.56 60.6 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.678 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.4 mt -53.36 -43.89 52.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.973 178.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.601 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.44 -52.0 65.29 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.322 178.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -61.25 -32.41 72.21 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.846 ' HB3' ' HB2' ' A' ' 106' ' ' GLN . 1.9 mmp_? -65.34 -37.11 86.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.08 0.467 . . . . 0.0 110.491 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.703 HD22 HG23 ' A' ' 93' ' ' ILE . 9.9 t30 -93.62 -4.35 50.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.928 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 17.3 m120 78.34 16.82 1.21 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.491 0.716 . . . . 0.0 111.178 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.703 HG23 HD22 ' A' ' 91' ' ' ASN . 11.1 pt -102.57 -175.88 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.56 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 26.2 mt-30 -112.29 160.89 17.21 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.738 -0.385 . . . . 0.0 109.969 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.442 ' O ' HD23 ' A' ' 73' ' ' LEU . 11.2 p-10 -55.82 -58.26 8.6 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 122.36 1.076 . . . . 0.0 109.277 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -76.39 12.0 1.38 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.859 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.56 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 1.9 t70 -66.17 -35.92 81.75 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.9 mp 68.71 115.88 0.04 OUTLIER 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.097 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.741 HG21 HD11 ' A' ' 105' ' ' LEU . 10.1 pt -94.54 176.6 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.665 -178.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.458 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 15.3 m-85 -129.25 157.22 76.78 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.624 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.6 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 17.9 Cg_endo -64.93 135.82 45.97 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 122.889 2.393 . . . . 0.0 112.863 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.68 20.95 22.94 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' ' 66' ' ' THR . 92.6 mt-30 -109.77 165.81 11.4 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.464 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 88.5 t -125.52 115.21 42.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.741 HD11 HG21 ' A' ' 99' ' ' ILE . 87.1 mt -110.77 151.2 28.06 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.952 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.846 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 71.2 mt-30 -90.19 115.08 27.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.872 0.844 . . . . 0.0 110.581 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.1 151.25 68.92 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.36 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 32.2 Cg_endo -62.22 -21.03 71.91 Favored 'Trans proline' 0 N--CA 1.474 0.346 0 C-N-CA 123.395 2.73 . . . . 0.0 114.673 -177.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.9 t -153.89 156.56 37.78 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.079 0.466 . . . . 0.0 111.184 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.443 ' HE3' ' HA ' ' A' ' 65' ' ' VAL . 13.3 mmmm -96.25 -165.98 1.36 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.444 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -76.3 63.51 2.93 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.68 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.575 ' HA3' ' HA3' ' A' ' 57' ' ' GLY . . . -152.83 134.93 4.67 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.5 m -133.8 12.48 4.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.045 0.45 . . . . 0.0 110.616 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.54 ' O ' ' HD3' ' A' ' 41' ' ' ARG . . . 68.03 41.71 86.66 Favored Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.545 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -124.91 93.9 0.45 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.676 -0.774 . . . . 0.0 111.885 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.33 53.3 13.88 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -79.58 -29.97 41.44 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.97 -0.615 . . . . 0.0 110.171 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . -106.91 -68.46 0.68 Allowed Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.483 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 90.9 m-20 74.21 29.8 1.26 Allowed 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 122.94 0.496 . . . . 0.0 111.459 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.639 ' HA ' HD22 ' A' ' 45' ' ' ASN . 19.6 p90 -62.75 -39.36 93.89 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.076 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.639 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 42.8 t-105 -62.35 -32.39 73.16 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.848 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -52.58 -37.69 58.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.796 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.67 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 31.3 m -123.29 26.62 7.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.462 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.639 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -107.42 144.64 34.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.251 177.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.471 ' HB2' ' CZ3' ' A' ' 146' ' ' TRP . 1.8 tpt180 -129.75 137.85 50.77 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.7 t70 54.53 67.66 0.98 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.481 0.658 . . . . 0.0 110.659 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.501 HG12 HD11 ' A' ' 136' ' ' LEU . 39.2 t -91.79 124.51 44.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.866 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -148.0 148.11 30.36 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.972 0.415 . . . . 0.0 110.559 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.875 HD13 HG22 ' A' ' 14' ' ' ILE . 30.4 mt -86.68 134.83 33.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.674 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.599 HG23 ' HB ' ' A' ' 135' ' ' VAL . 35.6 m -127.82 157.31 39.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.18 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.49 ' HB3' ' HD3' ' A' ' 134' ' ' LYS . 6.4 m-20 72.38 1.88 4.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.931 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.628 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 99.09 28.03 7.93 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.628 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.522 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 98.07 -23.14 37.34 Favored Glycine 0 C--O 1.266 2.13 0 CA-C-O 123.282 1.49 . . . . 0.0 112.654 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.789 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 15.9 ptmt -64.72 -20.0 66.09 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 121.721 -0.87 . . . . 0.0 108.933 177.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.599 ' HB ' HG23 ' A' ' 130' ' ' VAL . 6.8 t -136.94 146.01 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.324 0.583 . . . . 0.0 110.378 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.561 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 30.5 tp -124.95 121.54 34.74 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.5 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 40.2 tt0 -112.02 134.46 53.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.951 0.405 . . . . 0.0 111.788 -177.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.806 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -163.29 161.85 24.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.749 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -96.06 110.29 22.56 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.659 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 50.8 mt -96.19 137.04 35.85 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.175 0.512 . . . . 0.0 111.115 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.67 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 56.4 ttt180 -72.59 140.74 48.23 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.942 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.498 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 3.3 p90 -159.42 -170.34 2.92 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.563 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.4 m -54.66 -32.46 59.24 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 123.349 0.406 . . . . 0.0 111.789 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -97.51 16.52 60.43 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.404 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 141' ' ' ARG . . . 101.58 -110.23 3.8 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.266 -0.968 . . . . 0.0 112.395 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.471 ' CZ3' ' HB2' ' A' ' 125' ' ' ARG . 70.7 m95 -132.93 129.39 38.24 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.498 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 65.7 t30 -130.35 145.02 51.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.721 0.295 . . . . 0.0 110.617 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -73.88 109.28 7.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.272 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.628 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 35.8 t -122.6 165.32 16.64 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.561 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 27.7 mtt85 -145.98 158.82 43.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.09 0.471 . . . . 0.0 111.026 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.872 HD13 HD22 ' A' ' 43' ' ' LEU . 10.2 tt -140.21 146.87 24.06 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.063 178.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.708 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 69.4 m-85 -90.71 102.76 15.51 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.301 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.733 HD13 HD22 ' A' ' 21' ' ' LEU . 20.6 mt -63.21 -34.16 77.05 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.813 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.789 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 6.1 t70 -58.52 -9.09 1.45 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.156 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.708 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 43.6 mt-10 -74.2 -50.69 18.11 Favored 'General case' 0 CA--C 1.508 -0.663 0 O-C-N 121.92 -0.488 . . . . 0.0 112.156 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.518 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 13.1 m170 -120.53 1.25 10.62 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.39 -177.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.419 HG12 ' HH2' ' A' ' 52' ' ' TRP . 47.5 mm -105.93 110.79 32.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.029 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.459 ' HA3' ' OXT' ' A' ' 167' ' ' CYS . . . -114.98 160.14 13.36 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.174 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.566 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.8 t30 -102.53 128.31 49.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.925 0.393 . . . . 0.0 109.972 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.416 ' HB2' HD11 ' A' ' 165' ' ' ILE . 58.6 ttt-85 -124.46 91.39 3.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.451 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 58.82 42.23 20.24 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.34 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.519 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 92.19 15.39 53.87 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.882 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 159' ' ' ASN . 10.5 tp10 -124.09 143.86 50.21 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.674 -0.309 . . . . 0.0 111.225 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.555 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 18.6 mt -103.31 110.49 22.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.927 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.504 HD13 ' H ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -138.28 178.31 4.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.818 179.751 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.518 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 9.1 p80 -72.9 113.78 10.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.822 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.567 ' SG ' ' HB1' ' A' ' 4' ' ' ALA . 46.9 t . . . . . 0 C--O 1.252 1.197 0 O-C-N 123.871 0.732 . . . . 0.0 111.63 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.812 0 N-CA-C 112.09 -0.404 . . . . 0.0 112.09 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.572 ' HB3' ' OD2' ' A' ' 154' ' ' ASP . 19.6 p-10 -88.12 151.74 22.5 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.457 0.646 . . . . 0.0 111.297 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.4 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 22.7 m-85 -133.16 -61.34 0.83 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.554 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.579 ' HB1' ' SG ' ' A' ' 167' ' ' CYS . . . -131.76 -25.92 2.04 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.642 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.06 -70.17 1.25 Allowed Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 119.576 -1.297 . . . . 0.0 112.718 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.459 ' ND2' HD22 ' A' ' 2' ' ' ASN . 2.4 m-20 66.08 10.85 7.37 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 122.535 0.334 . . . . 0.0 110.619 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.672 ' CE2' HD13 ' A' ' 14' ' ' ILE . 1.0 OUTLIER -58.5 -33.53 69.93 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.54 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.2 p -63.32 -22.35 66.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.507 0.594 . . . . 0.0 110.398 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.03 -21.73 79.02 Favored Glycine 0 CA--C 1.522 0.519 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.421 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 26' ' ' ARG . 59.4 m -127.84 -18.18 4.31 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 117.15 0.475 . . . . 0.0 111.485 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.8 m -101.42 129.98 47.55 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.973 0.416 . . . . 0.0 109.97 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.478 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 2.8 ptm180 -110.08 -178.47 3.53 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 42.89 47.72 4.9 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 123.748 0.655 . . . . 0.0 112.358 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.858 HG22 HD13 ' A' ' 129' ' ' LEU . 6.3 mt -81.76 103.39 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-O 121.253 0.549 . . . . 0.0 109.833 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.602 ' CA ' HD12 ' A' ' 129' ' ' LEU . 82.6 m -145.67 125.1 13.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.858 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.769 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -93.39 153.42 18.52 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 122.021 0.915 . . . . 0.0 113.1 -178.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -94.05 73.92 4.08 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.956 -1.474 . . . . 0.0 107.835 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.03 -55.2 4.78 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.946 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.526 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -146.33 -12.4 0.47 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.083 0.468 . . . . 0.0 110.102 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -88.89 94.49 9.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.898 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.911 ' HB2' HD22 ' A' ' 39' ' ' LEU . 46.7 tp -60.15 122.86 15.46 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.473 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 15' ' ' CYS . 51.4 ttp180 -126.25 125.58 42.61 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.581 -178.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.636 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -148.25 145.91 28.41 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.63 0.728 . . . . 0.0 111.323 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.591 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 2.3 mm-40 -81.17 76.04 8.13 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.386 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.658 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 54.9 m -64.99 130.44 43.37 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.306 0.574 . . . . 0.0 111.336 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.472 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 3.8 tmm_? -72.18 118.88 15.61 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.394 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 14.0 ptm180 -87.17 156.44 19.69 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -50.92 -20.44 4.32 Favored Glycine 0 C--N 1.339 0.702 0 O-C-N 124.672 1.232 . . . . 0.0 114.768 -177.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -72.22 -9.96 59.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.236 0.541 . . . . 0.0 110.057 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.13 6.43 63.15 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.429 ' O ' ' HG2' ' A' ' 27' ' ' ARG . . . -106.36 164.9 13.53 Favored Glycine 0 C--O 1.224 -0.506 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.524 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.591 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 71.0 m-85 -101.61 130.34 47.92 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.878 0.37 . . . . 0.0 110.912 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.4 m -119.1 133.46 55.78 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.873 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.8 m -71.48 110.4 6.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.279 0.561 . . . . 0.0 111.079 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.4 t -113.61 150.88 32.46 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.665 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 5.1 p -144.88 137.02 21.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.937 0.399 . . . . 0.0 110.676 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.474 HG23 ' HB3' ' A' ' 21' ' ' LEU . 10.6 tt -133.98 144.77 34.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.267 -177.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.0 92.71 3.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.025 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.911 HD22 ' HB2' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -71.87 -11.13 60.65 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.139 0.495 . . . . 0.0 110.669 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.526 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 26.5 p30 -67.25 -8.64 33.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.909 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.434 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 30.5 ttm180 -108.25 -0.91 20.58 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.729 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 91.4 m-85 -125.64 -23.03 4.12 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.634 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.645 HD22 HD13 ' A' ' 151' ' ' ILE . 48.7 mt -111.02 137.66 48.39 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.19 0.519 . . . . 0.0 111.207 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.428 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 5.2 m -130.61 146.16 52.06 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.051 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.664 HD22 ' HA ' ' A' ' 120' ' ' PHE . 7.2 p30 -94.91 106.05 18.01 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -102.42 90.03 3.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.976 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.477 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 66.9 t30 52.5 43.23 31.26 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.138 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.579 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 84.75 38.64 9.33 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.644 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -150.9 137.61 18.9 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.716 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 15.0 m-85 -80.51 141.76 34.84 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.298 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -141.03 131.55 25.39 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.489 ' CD1' HD11 ' A' ' 151' ' ' ILE . 86.1 m95 -76.04 136.81 39.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.598 177.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.68 88.01 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.9 m -115.09 30.53 7.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.6 0.714 . . . . 0.0 110.268 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -153.87 47.69 0.53 Allowed Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.182 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -129.2 144.67 15.63 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.795 -0.716 . . . . 0.0 111.992 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -120.21 -156.96 10.06 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.486 -0.645 . . . . 0.0 111.486 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.21 -118.02 1.4 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.031 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.01 -142.03 6.28 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.12 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -130.0 84.27 0.32 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.279 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 108' ' ' PRO . . . -145.59 -125.97 1.79 Allowed Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 91.0 m -140.81 118.0 11.3 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.168 0.508 . . . . 0.0 110.467 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.463 ' HB1' ' HG2' ' A' ' 110' ' ' LYS . . . -132.89 177.9 7.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.743 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.459 HG22 ' HG2' ' A' ' 106' ' ' GLN . 11.5 p -128.8 115.78 18.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.72 0.295 . . . . 0.0 111.284 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.495 HG21 ' CE2' ' A' ' 80' ' ' PHE . 12.0 p -102.07 145.41 11.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.066 0.46 . . . . 0.0 111.447 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 3.8 m -92.96 131.33 38.06 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.938 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.535 ' CG2' HD12 ' A' ' 99' ' ' ILE . 49.2 t -83.31 135.62 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.808 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -102.63 169.42 8.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 124.349 1.03 . . . . 0.0 111.051 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.651 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 6.5 tp-100 -63.39 116.66 5.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.389 -178.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.68 -16.47 58.67 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.96 -0.564 . . . . 0.0 113.151 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -82.38 134.96 35.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.027 0.441 . . . . 0.0 110.979 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.59 ' HA ' HG12 ' A' ' 99' ' ' ILE . 68.6 p -113.37 178.64 4.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.692 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.683 HD22 HG23 ' A' ' 99' ' ' ILE . 1.7 mm? -52.96 -41.18 64.29 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.216 0.532 . . . . 0.0 110.198 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.518 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 43.1 ttm105 -65.65 -36.88 84.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.282 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -68.47 -39.4 81.42 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 72' ' ' THR . 42.2 mm -66.41 -49.55 74.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.504 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.767 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -58.07 -45.84 93.38 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.67 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 78' ' ' ARG . 24.8 ttm180 -64.68 -37.24 86.9 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.899 0.381 . . . . 0.0 111.815 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -77.92 -33.87 51.56 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.495 ' CE2' HG21 ' A' ' 65' ' ' VAL . 96.4 m-85 -110.3 20.46 17.79 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.5 t0 53.87 46.32 25.95 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.9 0.857 . . . . 0.0 111.135 178.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.767 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.8 p -130.09 170.77 13.59 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.425 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.619 ' O ' HG13 ' A' ' 87' ' ' ILE . 6.2 t70 -100.16 122.55 43.17 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.542 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 8.8 p90 -51.09 -30.19 15.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.512 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -63.67 -48.1 78.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.62 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.697 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 16.5 mm-40 -67.7 -43.39 80.2 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.337 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.619 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.3 mt -53.68 -48.36 60.38 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.773 0.797 . . . . 0.0 109.01 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.634 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.17 -48.43 78.42 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.827 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -37.85 78.19 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.697 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 68.7 mmt-85 -67.92 -33.6 75.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.822 0.344 . . . . 0.0 110.994 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.525 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 11.4 t-20 -92.8 -5.33 51.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.535 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 5.6 m-20 78.2 15.3 1.4 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.359 0.664 . . . . 0.0 111.031 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.634 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 15.4 pt -100.83 -177.78 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.621 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . 16.7 mm100 -110.83 152.51 26.59 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.022 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.566 ' O ' HD23 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -53.87 -68.71 0.16 Allowed 'General case' 0 C--O 1.243 0.711 0 CA-C-O 122.194 0.997 . . . . 0.0 110.252 179.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -73.75 13.4 0.5 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.547 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.621 ' HB2' ' HB2' ' A' ' 94' ' ' GLN . 7.3 t70 -66.84 -31.79 72.64 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 8.5 mp 73.97 114.17 0.06 Allowed 'General case' 0 N--CA 1.463 0.206 0 O-C-N 124.361 1.038 . . . . 0.0 109.829 -177.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.683 HG23 HD22 ' A' ' 73' ' ' LEU . 7.1 pt -94.61 176.36 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.651 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.506 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 92.3 m-85 -123.25 160.04 51.91 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.598 -178.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.651 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 42.1 Cg_endo -70.55 139.19 36.93 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 123.43 2.753 . . . . 0.0 113.716 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.6 9.56 61.28 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.463 ' O ' ' HA ' ' A' ' 66' ' ' THR . 27.1 tt0 -94.09 162.85 13.71 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 115.16 -0.52 . . . . 0.0 109.754 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 72.9 t -127.43 118.95 50.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.53 HD11 HG21 ' A' ' 99' ' ' ILE . 69.8 mt -115.38 151.66 34.26 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.124 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.459 ' HG2' HG22 ' A' ' 64' ' ' THR . 71.8 mt-30 -89.65 118.33 29.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.67 0.747 . . . . 0.0 110.987 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.408 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 29.6 m -125.19 151.88 70.08 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.43 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 29.9 Cg_endo -62.92 -16.89 56.96 Favored 'Trans proline' 0 N--CA 1.472 0.253 0 C-N-CA 123.196 2.597 . . . . 0.0 114.392 -177.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.4 t -160.81 150.88 17.64 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.035 0.445 . . . . 0.0 111.056 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.463 ' HG2' ' HB1' ' A' ' 63' ' ' ALA . 11.9 mmmm -93.32 -171.97 2.8 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.6 -43.65 94.1 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.09 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -116.72 -155.65 10.41 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.1 p -66.89 -47.55 71.45 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.325 0.583 . . . . 0.0 110.892 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.56 -60.12 0.34 Allowed Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.799 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -164.17 129.93 2.1 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.223 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.27 60.64 2.34 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.502 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.429 ' H ' ' HA ' ' A' ' 41' ' ' ARG . . . -98.77 -29.68 12.86 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.197 0.522 . . . . 0.0 110.281 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . -106.63 -56.3 0.64 Allowed Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.396 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.6 m120 69.42 31.18 3.89 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 122.943 0.497 . . . . 0.0 111.96 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.664 ' HA ' HD22 ' A' ' 45' ' ' ASN . 24.0 p90 -59.38 -35.78 74.58 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.585 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 57.5 t-105 -64.97 -33.23 75.53 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.826 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.52 -22.69 45.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.293 0.568 . . . . 0.0 110.954 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.745 ' OG ' ' HB3' ' A' ' 141' ' ' ARG . 47.9 t -133.64 23.98 4.01 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.179 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.585 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -111.02 144.5 40.04 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.334 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.615 ' HB2' ' CZ3' ' A' ' 146' ' ' TRP . 0.1 OUTLIER -129.52 128.03 41.99 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.437 ' N ' ' HD3' ' A' ' 125' ' ' ARG . 24.6 t0 56.94 62.92 2.07 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 124.071 0.857 . . . . 0.0 111.626 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.57 ' CG1' HD11 ' A' ' 136' ' ' LEU . 60.5 t -76.06 131.05 35.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.525 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -140.88 138.42 33.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.449 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.858 HD13 HG22 ' A' ' 14' ' ' ILE . 13.7 mt -86.91 131.9 33.97 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 177.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.639 HG23 ' HB ' ' A' ' 135' ' ' VAL . 33.9 m -128.74 158.61 41.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.213 0.53 . . . . 0.0 111.189 -178.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 67.46 11.54 8.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.014 -0.993 . . . . 0.0 111.889 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.702 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 92.73 31.22 8.87 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.203 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.536 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 88.23 -16.62 51.7 Favored Glycine 0 C--O 1.263 1.944 0 CA-C-O 123.441 1.578 . . . . 0.0 112.687 177.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.913 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 14.8 ptpt -68.09 -16.42 64.01 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 121.381 -1.07 . . . . 0.0 109.1 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.639 ' HB ' HG23 ' A' ' 130' ' ' VAL . 14.3 t -140.55 141.76 31.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.981 177.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.57 HD11 ' CG1' ' A' ' 127' ' ' VAL . 42.6 tp -120.53 126.88 51.45 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -120.16 134.64 55.21 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.746 0.308 . . . . 0.0 110.455 -177.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . . . -160.63 158.98 29.85 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.675 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -95.05 108.68 20.77 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.579 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 56.0 mt -94.19 131.29 39.91 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.699 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.745 ' HB3' ' OG ' ' A' ' 123' ' ' SER . 65.2 ttt180 -73.46 141.23 46.85 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.443 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.637 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 0.8 OUTLIER -154.56 -170.68 3.6 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.583 -179.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.2 m -58.34 -26.55 63.24 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -95.0 6.25 69.19 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.389 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 141' ' ' ARG . . . 111.26 -112.49 3.19 Favored Glycine 0 C--O 1.224 -0.491 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.746 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.615 ' CZ3' ' HB2' ' A' ' 125' ' ' ARG . 93.4 m95 -124.85 126.04 44.94 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.637 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 60.6 t30 -118.27 140.27 50.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.445 -178.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -73.55 104.74 4.62 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.2 m -118.55 156.3 29.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.577 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 17.4 ptt180 -148.79 163.43 37.38 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.535 -0.466 . . . . 0.0 112.16 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.716 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 8.9 tt -148.42 144.77 18.71 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.612 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.608 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.631 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 38.0 m-85 -88.76 104.42 16.88 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 122.154 -0.341 . . . . 0.0 110.929 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.695 HD11 HD21 ' A' ' 129' ' ' LEU . 27.8 mt -66.69 -35.31 79.83 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.904 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.913 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 4.8 t0 -55.91 -10.24 0.74 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.947 178.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.631 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 45.4 mt-10 -71.74 -55.09 8.29 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.4 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 30.2 m80 -125.22 8.58 7.91 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.884 -0.726 . . . . 0.0 112.388 -176.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.454 HG12 ' CH2' ' A' ' 52' ' ' TRP . 41.1 mm -106.65 107.81 23.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 167' ' ' CYS . . . -110.54 178.04 19.73 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.656 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.658 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -117.75 134.44 54.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.893 0.377 . . . . 0.0 110.808 179.364 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.482 ' HB2' HD13 ' A' ' 165' ' ' ILE . 43.9 ttm180 -125.2 92.68 3.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.363 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 66.9 t30 57.9 46.35 16.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.83 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.464 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 87.52 11.56 68.55 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.613 178.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -122.69 133.03 54.51 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 117.19 0.495 . . . . 0.0 110.956 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.478 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 29.7 mt -76.03 122.59 24.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.471 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.482 HD13 ' HB2' ' A' ' 160' ' ' ARG . 43.7 pt -138.96 -174.55 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.646 0.736 . . . . 0.0 111.765 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.4 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 42.7 t-80 -95.08 110.98 22.84 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.133 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.579 ' SG ' ' HB1' ' A' ' 4' ' ' ALA . 53.6 t . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.501 -0.761 . . . . 0.0 111.034 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.665 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.42 ' HB3' ' HD1' ' A' ' 3' ' ' TYR . 21.6 m-80 -138.25 -75.64 0.39 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.559 ' CD1' ' HG2' ' A' ' 155' ' ' GLU . 64.7 m-85 -128.7 -97.0 0.39 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.878 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.72 -27.89 11.52 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -71.02 -73.87 0.76 Allowed Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 119.068 -1.539 . . . . 0.0 112.16 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 65.44 23.07 11.94 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 122.711 0.404 . . . . 0.0 110.145 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.793 ' HD2' HD11 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -64.62 -34.96 79.51 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.531 179.725 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.415 ' HA ' HD11 ' A' ' 14' ' ' ILE . 28.8 t -66.02 -15.47 63.06 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.487 0.66 . . . . 0.0 109.916 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.55 -28.42 72.34 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.113 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 28.6 m -136.33 -3.22 2.18 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 117.413 0.607 . . . . 0.0 111.494 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.407 ' OG ' ' HB1' ' A' ' 23' ' ' ALA . 6.0 t -105.92 133.72 50.19 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.486 ' CG ' ' HB2' ' A' ' 24' ' ' GLU . 14.9 ptm180 -112.02 -176.39 2.91 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.428 ' HB2' ' HG2' ' A' ' 24' ' ' GLU . 2.3 m-20 42.61 44.52 3.68 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 124.04 0.837 . . . . 0.0 112.177 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.885 HG22 HD13 ' A' ' 129' ' ' LEU . 6.4 mt -78.17 102.86 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-O 121.012 0.434 . . . . 0.0 109.886 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.599 ' HA ' HD12 ' A' ' 129' ' ' LEU . 80.0 m -147.35 126.1 12.63 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.702 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -89.12 153.57 20.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.007 0.908 . . . . 0.0 113.191 -178.322 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.668 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 21.3 t70 -92.96 72.07 4.72 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 113.726 -1.579 . . . . 0.0 107.166 177.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.56 -56.69 5.03 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.939 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.429 ' H ' ' H ' ' A' ' 20' ' ' ARG . . . -148.56 -12.1 0.34 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.668 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 56.3 mtp180 -84.4 89.51 7.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.017 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.88 HD22 HD13 ' A' ' 153' ' ' LEU . 42.6 tp -57.24 123.46 15.41 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.155 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.593 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 22.2 ttp180 -125.74 134.73 51.67 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.141 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.583 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -155.63 141.69 18.28 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.695 0.759 . . . . 0.0 111.363 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.486 ' HB2' ' CG ' ' A' ' 12' ' ' ARG . 78.2 mm-40 -78.93 79.58 5.32 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.367 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.754 ' SG ' HD13 ' A' ' 164' ' ' LEU . 25.6 m -67.09 122.49 17.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.183 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 10' ' ' SER . 58.1 ttt-85 -68.69 118.85 12.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.391 178.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.1 ttt180 -88.0 155.1 20.0 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -47.25 -25.05 2.59 Favored Glycine 0 N--CA 1.463 0.459 0 O-C-N 124.598 1.187 . . . . 0.0 115.533 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -75.24 -5.77 46.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.205 0.526 . . . . 0.0 110.89 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.85 5.98 65.86 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -101.63 135.22 12.08 Favored Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.585 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 94.8 m-85 -87.81 130.52 34.84 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.776 0.322 . . . . 0.0 110.366 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 41.7 m -118.08 137.05 53.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.525 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.5 m -71.18 111.25 6.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.286 0.565 . . . . 0.0 111.16 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 162' ' ' GLY . 32.3 t -117.46 149.75 40.06 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.474 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.7 p -144.77 137.02 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.969 0.414 . . . . 0.0 111.633 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.624 HG22 HD23 ' A' ' 164' ' ' LEU . 12.4 tt -135.36 148.14 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.32 -178.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.47 ' OD2' ' HB3' ' A' ' 40' ' ' ASN . 25.2 t70 -81.89 109.24 16.08 Favored 'General case' 0 CA--C 1.516 -0.363 0 O-C-N 121.938 -0.476 . . . . 0.0 111.3 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.629 HD23 ' HB3' ' A' ' 21' ' ' LEU . 3.4 mm? -88.3 0.93 55.59 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.119 0.485 . . . . 0.0 110.092 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.47 ' HB3' ' OD2' ' A' ' 38' ' ' ASP . 26.2 t-20 -73.86 -24.5 59.76 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.765 ' HG2' ' H ' ' A' ' 116' ' ' GLY . 60.7 mtt85 -100.63 13.41 34.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.248 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -132.02 -31.24 1.5 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.295 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.872 HD22 HD13 ' A' ' 151' ' ' ILE . 49.3 mt -105.85 134.79 48.41 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.999 0.428 . . . . 0.0 110.8 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.558 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 1.9 m -126.79 146.36 50.28 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.288 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.75 HD22 ' HA ' ' A' ' 120' ' ' PHE . 8.0 p30 -91.98 100.93 13.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.743 0.782 . . . . 0.0 109.498 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -100.89 94.06 5.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.042 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.418 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 64.3 t30 52.18 43.87 30.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.486 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.741 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 80.29 41.09 12.19 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.644 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.461 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 34.3 t-80 -160.69 127.69 4.23 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.713 ' HB2' ' HB ' ' A' ' 151' ' ' ILE . 87.6 m-85 -67.52 151.44 47.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.892 0.377 . . . . 0.0 111.547 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -148.39 130.47 15.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.038 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.429 ' CD1' HD11 ' A' ' 151' ' ' ILE . 96.3 m95 -76.1 120.4 21.36 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.094 177.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.0 m -107.68 113.39 43.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.244 0.545 . . . . 0.0 110.847 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.4 m -82.93 60.21 5.29 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.828 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.21 64.51 1.46 Allowed Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.224 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.98 58.36 4.93 Favored Glycine 0 CA--C 1.518 0.225 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.408 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.9 -156.85 29.05 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.728 ' HA2' ' HB3' ' A' ' 113' ' ' SER . . . 124.52 174.59 14.09 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.477 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.43 154.96 12.8 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.811 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.48 -168.01 16.07 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.797 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 108' ' ' PRO . . . 84.51 -100.54 2.38 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.652 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.9 m -122.1 114.48 20.97 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.016 0.436 . . . . 0.0 110.005 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.35 176.14 6.04 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.966 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.4 p -130.93 125.49 33.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.599 0.238 . . . . 0.0 111.111 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.588 HG21 ' CE2' ' A' ' 80' ' ' PHE . 8.4 p -115.46 143.33 25.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.959 0.409 . . . . 0.0 111.285 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 16.3 m -88.53 127.11 35.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.087 0.47 . . . . 0.0 109.873 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.497 ' CG2' HD12 ' A' ' 99' ' ' ILE . 43.7 t -75.92 134.57 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.788 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -104.48 169.54 8.41 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 124.541 1.15 . . . . 0.0 111.451 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.635 ' OE1' ' HG3' ' A' ' 101' ' ' PRO . 51.0 tp60 -64.25 116.06 5.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.55 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.78 -4.56 57.85 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.291 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.39 122.4 43.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.764 0.316 . . . . 0.0 110.92 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.688 ' HA ' HG12 ' A' ' 99' ' ' ILE . 75.5 p -105.37 -177.83 3.48 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.659 HD22 HG23 ' A' ' 99' ' ' ILE . 1.4 mm? -52.58 -41.85 63.97 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 121.396 0.617 . . . . 0.0 109.384 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.422 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 39.4 ttm180 -64.34 -37.95 89.32 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.091 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -73.08 -38.59 66.35 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.102 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.558 HG12 ' O ' ' A' ' 72' ' ' THR . 46.0 mm -64.81 -48.21 85.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.649 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -54.65 -53.64 37.81 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.718 -0.674 . . . . 0.0 113.03 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -68.25 -25.23 65.08 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -78.35 -41.99 31.85 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.588 ' CE2' HG21 ' A' ' 65' ' ' VAL . 89.2 m-85 -107.6 12.71 27.39 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.4 t70 61.31 52.61 3.78 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.804 0.811 . . . . 0.0 111.046 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.649 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.0 p -134.72 169.66 17.0 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.403 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.656 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.6 t70 -95.94 121.08 37.3 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.708 -0.397 . . . . 0.0 109.992 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.613 ' HD2' ' HB2' ' A' ' 95' ' ' ASN . 17.7 p90 -50.63 -31.31 15.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.923 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.78 -42.87 76.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.309 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.694 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 11.6 mm-40 -68.22 -43.87 77.0 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.656 HG13 ' O ' ' A' ' 83' ' ' ASP . 6.5 mt -53.5 -47.82 59.06 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-O 121.435 0.636 . . . . 0.0 109.474 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.632 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.18 -50.88 70.06 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.529 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -59.98 -36.18 76.6 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.694 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 83.3 mmt-85 -68.08 -34.81 77.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.991 0.424 . . . . 0.0 110.622 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.456 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 4.5 t30 -91.3 -5.06 55.23 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.805 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 0.9 OUTLIER 78.55 13.48 1.42 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.451 179.385 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.632 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 19.0 pt -98.74 -171.36 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -117.84 151.17 37.89 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.253 -0.28 . . . . 0.0 110.548 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.613 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 21.1 p-10 -53.07 -56.97 12.13 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-O 122.088 0.947 . . . . 0.0 109.294 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -75.96 6.82 4.65 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.425 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -66.55 -35.8 81.11 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.4 mp 67.62 115.13 0.03 OUTLIER 'General case' 0 C--O 1.235 0.332 0 CA-C-O 122.138 0.971 . . . . 0.0 109.987 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.688 HG12 ' HA ' ' A' ' 72' ' ' THR . 7.8 pt -93.74 174.96 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.038 -177.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.553 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 64.4 m-85 -127.15 160.6 58.85 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.689 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.635 ' HG3' ' OE1' ' A' ' 69' ' ' GLN . 34.8 Cg_endo -67.22 137.6 44.31 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.063 2.509 . . . . 0.0 113.941 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.49 17.9 32.29 Favored Glycine 0 N--CA 1.44 -1.075 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.707 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.537 ' O ' ' HA ' ' A' ' 66' ' ' THR . 45.7 mt-30 -106.83 165.06 11.6 Favored 'General case' 0 C--O 1.216 -0.682 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.864 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.3 t -125.81 110.03 23.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.652 HD11 HG21 ' A' ' 99' ' ' ILE . 63.8 mt -105.25 152.01 23.41 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.21 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 38.5 mt-30 -89.84 114.6 26.37 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.747 0.784 . . . . 0.0 110.415 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.0 m -117.88 150.55 47.37 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.71 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 41.8 Cg_endo -68.44 -16.34 43.05 Favored 'Trans proline' 0 C--N 1.331 -0.375 0 C-N-CA 123.004 2.469 . . . . 0.0 113.387 -178.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.4 t -156.78 148.7 22.82 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.001 0.429 . . . . 0.0 110.318 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -92.19 -172.81 3.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.484 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -80.22 -78.21 0.92 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.466 -0.874 . . . . 0.0 111.721 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -102.97 103.48 2.4 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.965 -0.635 . . . . 0.0 111.568 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.728 ' HB3' ' HA2' ' A' ' 58' ' ' GLY . 24.5 m -61.56 -40.84 96.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.792 0.33 . . . . 0.0 110.818 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -82.27 40.76 2.73 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.293 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -72.59 98.43 0.84 Allowed Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.765 ' H ' ' HG2' ' A' ' 41' ' ' ARG . . . 81.06 53.3 3.97 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -80.05 -29.07 39.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.013 -0.594 . . . . 0.0 110.61 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.558 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -105.75 -68.51 0.71 Allowed Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.379 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 71.14 30.14 2.73 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 122.903 0.481 . . . . 0.0 111.215 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.75 ' HA ' HD22 ' A' ' 45' ' ' ASN . 25.6 p90 -57.44 -39.06 75.44 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.603 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 67.6 t-105 -62.33 -34.58 76.91 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.915 -1.038 . . . . 0.0 111.966 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.83 -25.69 20.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.986 0.422 . . . . 0.0 111.369 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.814 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 19.3 m -134.28 29.46 3.66 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.037 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.603 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -115.73 141.13 48.49 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.193 0.521 . . . . 0.0 111.48 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -129.77 149.32 51.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.07 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.06 50.58 16.33 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 123.614 0.571 . . . . 0.0 110.83 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.476 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 30.2 t -80.74 117.89 27.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.883 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 35.4 ptt85 -145.89 144.57 30.28 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.191 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.885 HD13 HG22 ' A' ' 14' ' ' ILE . 23.4 mt -84.61 131.12 34.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.291 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.472 HG23 ' HB ' ' A' ' 135' ' ' VAL . 34.4 m -126.54 167.57 20.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.403 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.573 ' HB3' ' CE ' ' A' ' 134' ' ' LYS . 1.2 m-20 64.45 10.18 5.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.612 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.651 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 93.82 24.34 20.66 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.848 -0.692 . . . . 0.0 113.481 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 94.64 -18.88 56.24 Favored Glycine 0 C--O 1.268 2.241 0 CA-C-O 123.803 1.779 . . . . 0.0 111.914 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.763 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 65.4 pttt -69.52 -14.21 62.74 Favored 'General case' 0 C--N 1.313 -1.018 0 O-C-N 121.598 -0.942 . . . . 0.0 108.769 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.647 HG23 ' HG3' ' A' ' 134' ' ' LYS . 23.5 t -139.47 137.18 40.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 121.355 0.597 . . . . 0.0 110.513 177.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 30.3 tp -117.31 121.97 42.62 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.541 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 35.8 tt0 -115.01 134.81 54.87 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.864 0.364 . . . . 0.0 111.46 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.685 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.42 163.11 27.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.569 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 41.7 mt-10 -94.53 108.43 20.38 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.741 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 59.7 mt -94.99 130.59 41.59 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.338 0.59 . . . . 0.0 110.753 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.814 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 73.5 ttt180 -70.73 140.66 51.46 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.88 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.501 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 5.6 p90 -158.3 -171.91 3.67 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 18.4 m -54.85 -30.52 57.8 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.3 18.51 56.39 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.369 -0.92 . . . . 0.0 113.723 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 103.9 -120.67 6.77 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.278 -0.963 . . . . 0.0 112.332 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -123.57 124.28 42.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.944 0.372 . . . . 0.0 110.601 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.501 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 27.3 t-20 -118.81 125.83 50.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.473 ' HD3' ' OE2' ' A' ' 137' ' ' GLU . 55.1 ttm-85 -74.74 99.24 3.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.245 0.545 . . . . 0.0 110.033 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.461 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 7.3 t -112.3 173.08 6.54 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.105 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.541 ' HG2' ' HG3' ' A' ' 137' ' ' GLU . 15.6 mtm180 -145.2 163.84 33.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.107 0.479 . . . . 0.0 111.398 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.872 HD13 HD22 ' A' ' 43' ' ' LEU . 9.1 tt -143.24 148.98 18.74 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.392 178.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.597 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 12.6 m-85 -92.06 103.93 16.38 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 122.028 -0.42 . . . . 0.0 110.964 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.88 HD13 HD22 ' A' ' 21' ' ' LEU . 22.5 mt -67.15 -34.14 76.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.111 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.763 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 7.7 t70 -58.32 -7.76 0.96 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.274 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.56 ' HG3' ' CB ' ' A' ' 152' ' ' TYR . 40.5 mt-10 -72.39 -51.03 22.25 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 121.91 -0.494 . . . . 0.0 111.976 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -119.26 -5.6 10.41 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 120.499 -0.481 . . . . 0.0 112.285 -177.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.463 ' CG2' ' HG ' ' A' ' 164' ' ' LEU . 48.9 mm -100.21 114.23 38.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.841 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -118.79 176.44 16.09 Favored Glycine 0 C--O 1.225 -0.422 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.289 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.586 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.0 t30 -112.1 123.81 51.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.943 0.401 . . . . 0.0 110.149 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -118.63 85.88 2.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.928 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 52.2 43.72 30.36 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.497 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 103.29 -4.82 48.41 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.294 -0.955 . . . . 0.0 114.085 178.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -121.92 129.43 52.53 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 117.223 0.512 . . . . 0.0 111.426 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.793 HD11 ' HD2' ' A' ' 7' ' ' PHE . 1.8 tp -71.12 113.32 8.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.553 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.423 HG13 ' N ' ' A' ' 166' ' ' HIS . 11.0 tp -102.78 164.55 3.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.392 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.423 ' N ' HG13 ' A' ' 165' ' ' ILE . 39.4 p-80 -125.72 130.32 51.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.736 0.303 . . . . 0.0 110.386 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 40.6 t . . . . . 0 C--O 1.251 1.181 0 CA-C-O 118.905 -0.569 . . . . 0.0 109.798 179.791 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.738 0 N-CA-C 111.884 -0.487 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.413 HD21 ' HD2' ' A' ' 152' ' ' TYR . 1.0 OUTLIER -82.81 -73.6 0.39 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.739 0.304 . . . . 0.0 111.741 -179.803 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -130.12 -88.02 0.5 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.413 ' HB1' ' SG ' ' A' ' 167' ' ' CYS . . . -111.8 -25.41 9.48 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -66.8 -72.75 0.72 Allowed Glycine 0 N--CA 1.433 -1.503 0 C-N-CA 119.366 -1.397 . . . . 0.0 112.405 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 60.69 17.16 7.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.74 0.305 . . . . 0.0 110.725 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.7 ' CE2' HD13 ' A' ' 14' ' ' ILE . 0.4 OUTLIER -60.92 -32.57 72.05 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.398 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.491 ' OG ' ' HG2' ' A' ' 134' ' ' LYS . 23.1 t -66.0 -19.84 65.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.037 0.446 . . . . 0.0 110.375 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.7 -20.6 78.69 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.079 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.515 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 51.2 p -129.4 -24.66 2.77 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 117.241 0.521 . . . . 0.0 111.375 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.422 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 5.9 m -96.71 130.88 43.86 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 12' ' ' ARG . 12.5 ptm180 -115.07 -174.18 2.45 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 47.69 40.77 12.65 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 123.513 0.508 . . . . 0.0 111.225 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.876 HG22 HD13 ' A' ' 129' ' ' LEU . 7.7 mt -80.71 103.31 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-O 120.832 0.348 . . . . 0.0 110.164 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.605 ' HA ' HD12 ' A' ' 129' ' ' LEU . 79.0 m -146.9 128.09 14.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.809 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.749 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -99.41 152.89 19.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.701 0.762 . . . . 0.0 112.956 -179.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -93.85 75.87 4.22 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.33 -55.08 4.82 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.542 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.577 ' HB1' ' HB2' ' A' ' 40' ' ' ASN . . . -148.69 -7.86 0.38 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.901 0.381 . . . . 0.0 110.507 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.4 mmm-85 -89.27 90.53 8.38 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.767 ' HB2' HD22 ' A' ' 39' ' ' LEU . 55.0 tp -62.67 127.79 32.92 Favored 'General case' 0 C--O 1.213 -0.839 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.566 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 42.9 ttt180 -133.34 131.75 40.48 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.441 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.631 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -150.84 145.93 26.01 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.744 0.783 . . . . 0.0 111.516 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 1.7 mm-40 -82.97 74.58 9.92 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.34 178.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.556 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 60.0 m -60.74 124.2 19.72 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.143 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.515 ' HB2' ' O ' ' A' ' 10' ' ' SER . 19.7 ttp180 -70.57 127.43 32.66 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.13 0.491 . . . . 0.0 110.749 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.484 ' HG3' ' CG ' ' A' ' 161' ' ' ASN . 37.2 ttp180 -97.29 151.9 19.42 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.32 -15.86 1.96 Allowed Glycine 0 N--CA 1.46 0.278 0 O-C-N 124.717 1.261 . . . . 0.0 115.006 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -75.96 -9.01 58.26 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.054 0.454 . . . . 0.0 110.432 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.66 6.86 60.59 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -112.27 161.69 12.64 Favored Glycine 0 C--O 1.224 -0.525 0 C-N-CA 120.455 -0.878 . . . . 0.0 112.202 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.513 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 86.2 m-85 -100.38 139.1 36.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.005 0.403 . . . . 0.0 110.856 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.1 t -122.89 120.64 34.05 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 m -63.73 115.53 4.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.157 0.503 . . . . 0.0 110.487 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.4 t -120.99 152.82 38.11 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.063 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.566 ' HB ' ' HG3' ' A' ' 22' ' ' ARG . 3.2 p -145.05 138.66 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 120.855 0.359 . . . . 0.0 111.433 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.5 tt -135.5 147.8 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.486 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -80.74 105.34 11.9 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.767 HD22 ' HB2' ' A' ' 21' ' ' LEU . 1.5 tp -84.71 -6.14 59.35 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.441 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.577 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 64.2 t30 -73.45 -14.31 61.22 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.895 ' HG2' ' HA3' ' A' ' 116' ' ' GLY . 98.1 mtt180 -105.88 15.37 26.74 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.427 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 66.3 m-85 -131.44 -32.67 1.52 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.635 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.773 HD22 HD13 ' A' ' 151' ' ' ILE . 33.2 mt -106.48 136.49 46.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.025 0.441 . . . . 0.0 111.423 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.637 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 9.0 m -125.74 146.81 49.6 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.701 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.608 ' ND2' ' HB2' ' A' ' 123' ' ' SER . 21.4 p-10 -95.13 93.7 7.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.669 0.747 . . . . 0.0 109.585 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -94.64 95.83 9.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.059 0.457 . . . . 0.0 111.758 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.465 ' HA ' ' HB2' ' A' ' 142' ' ' TYR . 62.5 t30 47.67 44.19 17.23 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.172 178.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.78 34.04 14.32 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.751 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -150.61 131.12 13.85 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.831 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 24.8 m-85 -75.34 138.3 41.68 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 51' ' ' ARG . 53.8 mtt-85 -140.7 136.38 32.55 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.518 ' CH2' HG12 ' A' ' 157' ' ' ILE . 98.2 m95 -76.01 107.23 8.07 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.353 177.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.44 ' HB ' ' OG ' ' A' ' 44' ' ' SER . 92.5 t -133.52 129.1 55.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.861 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.7 m -122.25 12.42 10.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.111 0.482 . . . . 0.0 110.605 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.32 -76.71 1.0 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.173 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.743 ' HA2' ' HA ' ' A' ' 117' ' ' ALA . . . 172.95 177.82 42.51 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.522 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.04 -170.01 43.04 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -126.41 153.34 18.63 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.299 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -148.28 -140.63 3.36 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.24 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.2 35.84 0.32 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.981 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.93 -105.24 1.33 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.492 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.0 m -138.28 114.11 9.9 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.92 0.391 . . . . 0.0 110.281 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.89 177.37 4.99 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.164 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.544 HG22 ' HG2' ' A' ' 106' ' ' GLN . 10.6 p -127.7 117.08 21.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.856 0.36 . . . . 0.0 110.835 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.459 HG21 ' CE2' ' A' ' 80' ' ' PHE . 8.9 p -103.0 142.29 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.19 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 24.9 m -88.1 127.67 35.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.249 0.547 . . . . 0.0 110.095 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.511 HG21 HD12 ' A' ' 99' ' ' ILE . 48.7 t -79.16 134.67 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.364 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -107.4 171.08 7.58 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.307 1.004 . . . . 0.0 109.458 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.681 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 59.4 tt0 -65.85 123.18 19.1 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.794 -178.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.12 -4.23 58.71 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.348 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -105.77 122.68 46.57 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.89 0.376 . . . . 0.0 111.132 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.651 ' HA ' HG12 ' A' ' 99' ' ' ILE . 68.5 p -106.49 179.94 4.12 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.659 HD22 HG23 ' A' ' 99' ' ' ILE . 1.5 mm? -51.66 -43.4 62.65 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.461 0.648 . . . . 0.0 109.752 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 74' ' ' ARG . 42.8 ttt180 -60.65 -38.98 86.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.424 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -72.18 -45.67 59.43 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 72' ' ' THR . 45.0 mm -57.82 -47.66 85.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.003 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.672 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.19 -53.05 47.67 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.109 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -69.73 -26.43 64.32 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 122.469 -0.43 . . . . 0.0 111.786 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -75.87 -38.84 57.52 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.06 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.459 ' CE2' HG21 ' A' ' 65' ' ' VAL . 72.4 m-85 -111.16 19.62 18.2 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.7 t70 53.25 47.91 23.26 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.548 0.69 . . . . 0.0 111.783 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.672 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 3.3 p -127.88 171.05 12.14 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.651 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.1 t0 -96.75 117.89 32.03 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.707 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.432 ' HA ' HD12 ' A' ' 87' ' ' ILE . 3.3 p90 -50.49 -33.19 20.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.909 -1.042 . . . . 0.0 111.803 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.93 -41.44 91.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.17 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.654 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 33.0 tt0 -71.78 -46.64 57.7 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.695 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.651 HG13 ' O ' ' A' ' 83' ' ' ASP . 6.5 mt -49.7 -45.74 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.625 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.22 -51.1 69.13 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.416 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -63.67 -28.93 70.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.654 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 22.1 mmt180 -65.08 -39.79 93.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.288 0.566 . . . . 0.0 110.248 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 12.5 m120 -94.12 -3.6 50.76 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.677 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 93.7 m-20 79.08 11.01 1.51 Allowed 'General case' 0 N--CA 1.47 0.571 0 O-C-N 123.859 0.724 . . . . 0.0 111.455 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.625 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 18.9 pt -93.92 -173.48 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.509 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . 30.1 mm-40 -114.81 157.6 23.04 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 122.108 -0.37 . . . . 0.0 110.636 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.52 ' O ' HD23 ' A' ' 73' ' ' LEU . 3.4 p30 -55.62 -69.05 0.15 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.836 0.826 . . . . 0.0 109.728 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.59 13.43 0.62 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.335 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.509 ' HB2' ' HB2' ' A' ' 94' ' ' GLN . 5.6 t70 -64.3 -30.16 71.22 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.1 mp 68.55 113.5 0.04 OUTLIER 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.195 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.659 HG23 HD22 ' A' ' 73' ' ' LEU . 8.5 pt -93.85 175.83 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.227 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.501 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 85.7 m-85 -125.95 158.06 67.13 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.585 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.681 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 22.3 Cg_endo -67.28 139.16 49.08 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 123.135 2.557 . . . . 0.0 113.395 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.21 23.7 24.0 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.537 ' O ' ' HA ' ' A' ' 66' ' ' THR . 70.4 mt-30 -112.11 166.07 11.57 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.533 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 66.9 t -125.89 110.36 23.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.58 HD11 HG21 ' A' ' 99' ' ' ILE . 75.8 mt -103.95 151.04 23.65 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.4 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.637 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 62.7 mt-30 -90.74 117.58 29.49 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.832 0.825 . . . . 0.0 110.6 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.8 m -125.65 150.56 68.66 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.702 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.38 -19.34 67.91 Favored 'Trans proline' 0 C--N 1.332 -0.325 0 C-N-CA 123.262 2.641 . . . . 0.0 113.722 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.5 t -155.96 149.11 24.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.059 0.457 . . . . 0.0 111.088 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.716 ' HB2' ' HA2' ' A' ' 114' ' ' GLY . 12.4 mmmm -85.73 174.19 9.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.513 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -89.36 69.62 2.53 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 104.14 92.76 2.26 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 43.5 m 75.89 83.23 0.09 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.32 0.581 . . . . 0.0 110.562 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.716 ' HA2' ' HB2' ' A' ' 110' ' ' LYS . . . -60.12 -55.46 30.11 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.092 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.89 -121.94 2.24 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.895 ' HA3' ' HG2' ' A' ' 41' ' ' ARG . . . 174.93 -82.38 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.066 -1.064 . . . . 0.0 113.172 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.743 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . . . -131.49 -35.69 1.3 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.637 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -91.76 -66.42 1.14 Allowed Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.726 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 72.02 27.43 2.7 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.406 0.683 . . . . 0.0 111.011 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.63 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 22.6 p90 -60.36 -40.67 91.59 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.087 0.47 . . . . 0.0 109.798 178.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.616 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 43.1 t-105 -65.29 -28.87 69.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.913 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.17 -19.49 54.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.737 0.303 . . . . 0.0 111.013 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.608 ' HB2' ' ND2' ' A' ' 45' ' ' ASN . 22.9 m -139.15 27.62 2.34 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 120.899 0.381 . . . . 0.0 110.252 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.616 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -110.54 148.26 32.49 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.37 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 125' ' ' ARG . 11.6 ttm180 -133.14 140.28 47.53 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.952 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.433 ' HB3' ' NH2' ' A' ' 128' ' ' ARG . 69.7 m-20 58.04 58.76 3.4 Favored 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 123.787 0.68 . . . . 0.0 111.123 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.499 ' CG1' HD11 ' A' ' 136' ' ' LEU . 40.5 t -86.79 115.88 28.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.839 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.433 ' NH2' ' HB3' ' A' ' 126' ' ' ASP . 0.0 OUTLIER -138.13 145.41 41.57 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.344 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.876 HD13 HG22 ' A' ' 14' ' ' ILE . 16.1 mt -85.23 133.26 34.18 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.757 HG23 ' HB ' ' A' ' 135' ' ' VAL . 27.3 m -125.27 159.37 32.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.347 -179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.569 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 0.3 OUTLIER 69.99 1.74 3.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.89 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.697 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 94.74 33.37 6.74 Favored Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.097 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 94.65 -20.89 46.2 Favored Glycine 0 C--O 1.263 1.936 0 CA-C-O 122.997 1.332 . . . . 0.0 113.21 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.777 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 0.2 OUTLIER -66.77 -16.43 64.25 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 121.307 -1.114 . . . . 0.0 109.214 178.591 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.757 ' HB ' HG23 ' A' ' 130' ' ' VAL . 9.4 t -141.72 145.57 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.262 0.553 . . . . 0.0 109.824 177.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 30.1 tp -125.72 121.04 32.3 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.469 ' HG3' ' HE ' ' A' ' 150' ' ' ARG . 20.8 tt0 -110.28 135.39 51.09 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.818 0.342 . . . . 0.0 111.632 -177.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.638 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -163.66 157.14 18.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.541 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.442 ' HG2' ' HD2' ' A' ' 148' ' ' ARG . 18.1 mt-10 -95.81 108.12 20.43 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 45' ' ' ASN . 58.6 mt -92.57 131.45 37.68 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.415 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.547 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 64.3 ttt180 -70.41 139.63 51.88 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.295 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.598 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 4.9 p90 -154.71 -164.11 1.74 Allowed 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.005 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.2 m -62.76 -14.62 46.94 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -125.83 36.45 2.74 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.416 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.77 -122.81 7.32 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.761 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -122.7 125.85 46.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.755 0.312 . . . . 0.0 110.399 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.598 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 46.5 t-20 -111.32 133.84 53.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.616 -178.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.442 ' HD2' ' HG2' ' A' ' 139' ' ' GLU . 4.1 tpt180 -73.49 98.01 2.69 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -113.55 160.66 18.28 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.899 -177.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.572 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 34.0 mtt180 -146.48 158.02 43.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.732 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.831 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 9.2 tt -141.67 142.11 28.98 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.02 178.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.607 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 27.7 m-85 -87.53 102.54 14.68 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.817 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.786 HD11 HD21 ' A' ' 129' ' ' LEU . 22.1 mt -63.96 -34.8 78.8 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.59 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.777 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 5.6 t70 -56.41 -9.4 0.69 Allowed 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.265 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.607 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 40.4 mt-10 -72.27 -52.71 15.08 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 121.923 -0.486 . . . . 0.0 112.287 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.528 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 43.6 m80 -124.43 3.23 8.4 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.549 -177.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.518 HG12 ' CH2' ' A' ' 52' ' ' TRP . 39.7 mm -103.59 108.6 24.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.62 ' HA3' ' OXT' ' A' ' 167' ' ' CYS . . . -116.33 166.44 12.35 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.239 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.556 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.3 t30 -102.22 130.8 48.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.782 0.325 . . . . 0.0 110.232 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 160' ' ' ARG . 25.7 ttp85 -118.19 85.9 2.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.878 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.484 ' CG ' ' HG3' ' A' ' 27' ' ' ARG . 21.7 t30 53.13 47.22 24.97 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.378 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 96.46 9.05 57.05 Favored Glycine 0 C--O 1.229 -0.185 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.611 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -122.79 142.37 50.81 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.691 HD11 ' CD2' ' A' ' 7' ' ' PHE . 11.8 tp -99.61 111.34 23.69 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.953 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.0 pp -141.27 -170.02 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.417 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.528 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 6.7 p80 -86.66 123.52 31.92 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.256 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.62 ' OXT' ' HA3' ' A' ' 158' ' ' GLY . 51.0 t . . . . . 0 C--O 1.249 1.031 0 O-C-N 123.896 0.748 . . . . 0.0 111.55 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.748 0 N-CA-C 111.546 -0.621 . . . . 0.0 111.546 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -109.72 171.65 7.32 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.759 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 37.0 m-85 -132.88 -65.44 0.71 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.718 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.53 -27.71 0.67 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.457 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -69.56 -68.74 1.55 Allowed Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 119.931 -1.128 . . . . 0.0 113.643 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 42.1 m-80 68.73 16.98 8.93 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 122.268 0.227 . . . . 0.0 110.497 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.746 ' CD2' HD11 ' A' ' 164' ' ' LEU . 1.2 p90 -64.22 -32.64 74.3 Favored 'General case' 0 C--O 1.218 -0.581 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.032 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.512 ' HA ' HD11 ' A' ' 14' ' ' ILE . 22.7 t -70.37 -16.29 62.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.73 0.776 . . . . 0.0 109.606 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.65 -20.67 73.7 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 115.129 -0.942 . . . . 0.0 113.241 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.553 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 75.5 p -127.49 -22.84 3.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.405 0.602 . . . . 0.0 111.365 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 9.2 m -98.15 133.98 41.84 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.945 0.402 . . . . 0.0 109.956 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.573 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 35.2 ptt180 -110.54 -177.37 3.22 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.459 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 12.7 m-20 43.85 44.54 5.83 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 123.714 0.634 . . . . 0.0 112.213 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.899 HG22 HD13 ' A' ' 129' ' ' LEU . 5.8 mt -78.95 104.86 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.607 ' CA ' HD12 ' A' ' 129' ' ' LEU . 72.7 m -146.4 126.38 13.66 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.298 0.639 . . . . 0.0 109.651 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.753 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -98.93 152.83 19.35 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.673 0.749 . . . . 0.0 112.773 -179.646 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -96.07 74.99 3.03 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.55 -54.44 4.95 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.43 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.515 ' HB1' ' HB2' ' A' ' 40' ' ' ASN . . . -148.58 -10.09 0.36 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 36.8 mtp-105 -83.13 86.17 7.06 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.618 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.793 HD22 HD13 ' A' ' 153' ' ' LEU . 51.1 tp -62.1 116.7 5.17 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-O 121.301 0.572 . . . . 0.0 111.578 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.506 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 33.9 ttp-105 -122.58 131.29 53.76 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.556 -177.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.587 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -152.34 146.89 25.72 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.452 0.644 . . . . 0.0 111.246 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.573 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 1.6 mm-40 -80.73 77.29 7.59 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.412 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.597 ' SG ' HD13 ' A' ' 164' ' ' LEU . 64.3 m -61.98 125.68 24.68 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.748 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.553 ' HB2' ' O ' ' A' ' 10' ' ' SER . 35.3 ttm180 -74.44 115.17 13.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.098 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.543 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 16.8 ptm180 -79.2 151.37 31.28 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -50.67 -18.97 2.9 Favored Glycine 0 C--N 1.339 0.697 0 O-C-N 124.338 1.024 . . . . 0.0 114.195 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.63 -12.89 61.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.15 0.5 . . . . 0.0 110.451 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.62 7.89 56.39 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.543 ' O ' ' HG2' ' A' ' 27' ' ' ARG . . . -104.48 157.49 16.87 Favored Glycine 0 C--O 1.223 -0.563 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.246 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.49 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 62.7 m-85 -100.85 129.81 46.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.901 0.381 . . . . 0.0 110.906 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.3 m -122.15 130.09 52.91 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.097 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -69.08 110.44 4.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.111 0.482 . . . . 0.0 111.449 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.2 t -114.79 151.53 33.65 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.931 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.9 p -145.7 135.51 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 120.879 0.371 . . . . 0.0 110.58 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.496 HG23 ' HB3' ' A' ' 21' ' ' LEU . 8.6 tt -134.92 144.34 34.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.734 -178.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.591 ' HB3' ' CD ' ' A' ' 41' ' ' ARG . 5.1 t70 -78.84 106.42 10.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.848 0.356 . . . . 0.0 110.605 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.569 HD23 ' HB3' ' A' ' 21' ' ' LEU . 2.1 mm? -85.97 -0.41 55.42 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.453 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.515 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 64.4 t30 -71.91 -22.35 61.5 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.591 ' CD ' ' HB3' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -103.87 16.5 26.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.406 0.622 . . . . 0.0 110.191 178.291 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.411 ' HB2' HD13 ' A' ' 39' ' ' LEU . 14.0 m-85 -125.89 -35.27 2.5 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.146 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.826 HD22 HD13 ' A' ' 151' ' ' ILE . 36.6 mt -106.54 142.27 36.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.377 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.458 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 0.7 OUTLIER -133.1 140.8 47.84 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.492 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.551 ' CG ' ' HB3' ' A' ' 140' ' ' LEU . 9.0 t30 -88.54 108.1 19.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.989 0.423 . . . . 0.0 109.925 177.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -109.33 91.04 3.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.344 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 54.46 47.49 22.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.195 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.727 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 78.56 33.32 38.95 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.746 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.485 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 68.6 m80 -147.59 127.64 13.7 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.731 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 50.4 m-85 -68.78 146.01 53.28 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.901 0.382 . . . . 0.0 110.963 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.436 ' HB3' ' OG ' ' A' ' 54' ' ' SER . 16.6 mmt180 -145.49 130.7 18.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.838 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.527 ' CD1' HD11 ' A' ' 151' ' ' ILE . 97.0 m95 -75.72 110.82 10.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.841 177.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.4 m 32.78 47.35 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.582 1.153 . . . . 0.0 113.744 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.436 ' OG ' ' HB3' ' A' ' 51' ' ' ARG . 26.1 m -83.33 69.13 9.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.477 0.656 . . . . 0.0 110.389 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.21 -60.05 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.27 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.63 128.21 4.51 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.491 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -175.4 73.52 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.147 -0.549 . . . . 0.0 111.877 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.03 169.58 30.1 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.928 -0.654 . . . . 0.0 111.845 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -86.08 69.77 3.12 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.328 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.82 -162.58 12.83 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.123 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.42 -136.91 14.03 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.36 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.7 m -135.03 128.43 32.32 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.925 0.393 . . . . 0.0 110.278 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.496 ' HB1' ' HG2' ' A' ' 110' ' ' LYS . . . -129.07 177.77 6.89 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.167 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.515 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 10.0 p -127.98 118.22 23.14 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.896 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.457 ' HA ' ' HE3' ' A' ' 110' ' ' LYS . 10.1 p -106.22 142.65 18.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.81 0.338 . . . . 0.0 111.004 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 9.1 m -88.6 125.08 34.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.272 0.558 . . . . 0.0 109.884 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.486 ' CG2' HD12 ' A' ' 99' ' ' ILE . 53.4 t -73.67 133.09 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.623 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -102.85 168.87 8.95 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 124.723 1.264 . . . . 0.0 110.845 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.592 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 25.3 tt0 -62.69 122.21 15.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.151 -178.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.39 -8.77 72.07 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.868 -0.605 . . . . 0.0 113.186 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.25 122.86 36.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.744 0.272 . . . . 0.0 111.453 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.588 ' HA ' HG12 ' A' ' 99' ' ' ILE . 81.2 p -105.67 -179.44 3.94 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.613 HD22 HG23 ' A' ' 99' ' ' ILE . 1.1 mm? -52.5 -41.39 63.37 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.299 0.571 . . . . 0.0 109.836 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.512 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 83.6 mtp180 -64.44 -36.99 85.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.335 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -72.14 -42.9 65.46 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.77 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 72' ' ' THR . 39.2 mm -61.03 -47.0 95.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.683 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.58 -50.56 64.19 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.85 -0.614 . . . . 0.0 113.07 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.459 ' HA ' ' NE ' ' A' ' 78' ' ' ARG . 3.5 tpm_? -71.1 -25.44 62.6 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 122.462 -0.434 . . . . 0.0 111.713 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -79.23 -42.39 26.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.193 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.453 ' CE2' HG21 ' A' ' 65' ' ' VAL . 99.2 m-85 -108.06 18.94 20.61 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.2 t70 55.75 51.13 12.89 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.735 0.778 . . . . 0.0 111.86 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.683 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.6 p -131.99 171.75 13.2 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.321 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.674 ' O ' HG13 ' A' ' 87' ' ' ILE . 14.9 t0 -97.63 120.4 37.94 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.747 -0.381 . . . . 0.0 109.99 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.512 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 17.8 p90 -51.51 -31.93 25.72 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.797 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.474 ' HB2' ' OD1' ' A' ' 83' ' ' ASP . 0.2 OUTLIER -68.29 -41.96 80.18 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.323 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.606 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 40.2 mt-10 -68.68 -47.05 67.46 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.9 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.674 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.9 mt -51.31 -46.02 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.555 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.36 -51.89 65.82 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.182 178.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 66.0 mtp180 -62.82 -30.46 71.5 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.606 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 8.2 mmp_? -73.07 -28.17 62.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.254 0.55 . . . . 0.0 110.327 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 6.7 t30 -96.14 -4.79 42.09 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.831 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 17.7 m120 80.24 13.44 0.91 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.69 0.796 . . . . 0.0 111.222 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.555 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 14.5 pt -105.58 -171.23 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.497 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.658 ' H ' ' HB2' ' A' ' 97' ' ' ASP . 3.8 mm-40 -118.72 163.63 16.56 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.501 ' O ' HD23 ' A' ' 73' ' ' LEU . 5.9 p30 -55.07 -55.15 34.3 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 122.535 1.16 . . . . 0.0 109.167 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -78.63 11.98 2.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.573 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.658 ' HB2' ' H ' ' A' ' 94' ' ' GLN . 4.9 t70 -63.29 -33.64 75.95 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.6 mt 68.75 112.38 0.04 OUTLIER 'General case' 0 C--O 1.232 0.163 0 O-C-N 124.382 1.051 . . . . 0.0 109.99 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.788 HG21 HD11 ' A' ' 105' ' ' LEU . 10.0 pt -95.31 175.3 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.458 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.494 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 67.9 m-85 -128.8 157.59 74.98 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.779 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.592 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 22.0 Cg_endo -66.71 133.08 30.58 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.957 2.438 . . . . 0.0 113.152 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.49 14.08 39.25 Favored Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 66' ' ' THR . 33.6 tt0 -103.35 162.93 12.59 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.515 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 91.9 t -122.17 118.25 54.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.788 HD11 HG21 ' A' ' 99' ' ' ILE . 96.9 mt -111.89 152.01 28.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.948 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -89.91 113.98 25.7 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.689 0.757 . . . . 0.0 110.975 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.4 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 24.9 m -123.35 152.07 63.75 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 114.178 -1.373 . . . . 0.0 109.983 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.4 ' HD2' ' HB ' ' A' ' 107' ' ' VAL . 34.1 Cg_endo -64.77 -15.59 51.0 Favored 'Trans proline' 0 N--CA 1.472 0.248 0 C-N-CA 123.633 2.889 . . . . 0.0 114.869 -177.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.2 t -155.74 156.89 35.64 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.931 0.396 . . . . 0.0 111.128 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.496 ' HG2' ' HB1' ' A' ' 63' ' ' ALA . 13.0 mmmm -105.83 170.39 7.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.376 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -81.58 -81.82 0.85 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.039 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -112.15 156.8 15.35 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 34.8 m -129.83 -23.11 2.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 117.176 0.488 . . . . 0.0 111.534 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.55 -45.48 1.62 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.124 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -152.48 -71.96 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -125.38 -108.63 1.7 Allowed Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 41' ' ' ARG . . . -125.7 -22.7 4.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.869 0.366 . . . . 0.0 110.422 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.458 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -123.72 -71.9 0.24 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.293 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 18.1 m120 74.81 34.7 0.69 Allowed 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 123.158 0.583 . . . . 0.0 111.536 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.635 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 19.3 p90 -64.31 -36.53 84.42 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.514 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 50.5 t-105 -64.6 -26.26 68.32 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.667 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.49 -13.56 52.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.131 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.5 p -142.87 22.37 1.94 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.462 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.551 ' O ' ' HD2' ' A' ' 125' ' ' ARG . . . -113.24 144.67 42.31 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.055 0.455 . . . . 0.0 111.753 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.551 ' HD2' ' O ' ' A' ' 124' ' ' ALA . 1.3 mpt_? -136.55 150.8 48.81 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.665 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 53.8 53.84 10.75 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.165 0.507 . . . . 0.0 111.609 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.517 ' CG1' HD11 ' A' ' 136' ' ' LEU . 41.8 t -80.19 128.31 38.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.264 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.414 ' O ' HD12 ' A' ' 136' ' ' LEU . 2.0 ptp180 -146.43 140.51 26.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.951 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.899 HD13 HG22 ' A' ' 14' ' ' ILE . 16.5 mt -86.6 126.96 34.85 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 177.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.749 HG23 ' HB ' ' A' ' 135' ' ' VAL . 27.6 m -118.33 165.46 13.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.817 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.575 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 0.2 OUTLIER 68.58 2.4 3.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.521 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.594 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 91.87 25.43 22.53 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.988 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 104.66 -21.33 36.92 Favored Glycine 0 C--O 1.267 2.182 0 CA-C-O 123.128 1.404 . . . . 0.0 112.721 178.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.734 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 0.0 OUTLIER -71.06 -10.37 59.63 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.177 -1.19 . . . . 0.0 109.775 179.083 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.749 ' HB ' HG23 ' A' ' 130' ' ' VAL . 20.4 t -143.08 146.94 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.601 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 35.1 tp -127.31 124.47 38.8 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -113.24 133.02 55.3 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 123.33 0.394 . . . . 0.0 110.478 -177.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.651 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -161.66 158.19 25.67 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.876 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -95.18 108.42 20.55 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.727 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 36.2 mt -97.06 133.14 42.12 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.389 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 145' ' ' GLY . 40.2 ttt180 -73.81 141.36 46.2 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.87 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.655 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 0.7 OUTLIER -158.67 -166.8 1.97 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 4.6 m -53.64 -30.86 44.97 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.43 0.456 . . . . 0.0 112.089 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -103.35 30.34 10.55 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.587 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 141' ' ' ARG . . . 89.91 -114.07 4.3 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.007 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -122.73 125.27 45.2 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.709 0.254 . . . . 0.0 110.563 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.655 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 27.7 t-20 -119.29 131.39 55.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.344 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -78.19 96.84 5.3 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.114 0.483 . . . . 0.0 110.041 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.485 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 23.5 t -103.36 170.18 8.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.342 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.601 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 36.5 ptt180 -148.95 154.94 40.11 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.752 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.826 HD13 HD22 ' A' ' 43' ' ' LEU . 10.7 tt -139.86 150.9 21.89 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.001 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.704 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 9.1 m-85 -92.33 104.88 17.18 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 122.003 -0.436 . . . . 0.0 110.56 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.793 HD13 HD22 ' A' ' 21' ' ' LEU . 21.2 mt -66.61 -35.46 80.25 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.929 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.734 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 10.5 t70 -57.61 -12.58 2.93 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.879 178.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.759 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 42.1 mt-10 -61.55 -56.08 23.83 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 121.121 0.486 . . . . 0.0 111.909 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.583 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 51.7 m-70 -119.86 -4.6 10.16 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.59 -177.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.477 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 46.7 mm -94.44 112.32 26.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.33 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.651 ' HA3' ' OXT' ' A' ' 167' ' ' CYS . . . -117.78 166.84 12.71 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.383 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.565 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 1.5 t30 -107.24 132.21 53.33 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 122.403 0.281 . . . . 0.0 110.416 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -122.26 90.06 3.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.07 0.462 . . . . 0.0 110.123 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 47.0 m-80 54.9 40.42 31.98 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.22 2.16 44.74 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.824 177.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -119.69 140.23 50.99 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.933 0.396 . . . . 0.0 110.235 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.746 HD11 ' CD2' ' A' ' 7' ' ' PHE . 7.6 tp -96.78 111.23 23.49 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.304 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 34.2 pt -138.73 -166.92 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.428 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.583 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 3.5 p80 -88.85 129.37 35.6 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.604 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.651 ' OXT' ' HA3' ' A' ' 158' ' ' GLY . 49.1 t . . . . . 0 C--O 1.25 1.089 0 O-C-N 123.895 0.747 . . . . 0.0 111.861 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.544 ' HA2' ' OD1' ' A' ' 6' ' ' ASN . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 112.0 -0.44 . . . . 0.0 112.0 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -83.91 -69.11 0.66 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.7 0.286 . . . . 0.0 111.109 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -138.39 -99.73 0.18 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.452 ' HB1' ' SG ' ' A' ' 167' ' ' CYS . . . -97.02 -28.28 14.23 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.0 -75.55 0.38 Allowed Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 119.649 -1.262 . . . . 0.0 113.139 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.544 ' OD1' ' HA2' ' A' ' 1' ' ' GLY . 37.2 m-80 64.09 16.38 9.94 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 122.463 0.305 . . . . 0.0 110.893 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.697 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -62.2 -30.98 71.46 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 116.75 -0.204 . . . . 0.0 111.251 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.0 t -67.8 -16.37 64.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.4 0.619 . . . . 0.0 110.084 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.09 -22.94 67.29 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.744 -0.662 . . . . 0.0 113.319 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 16.8 p -126.29 -17.74 5.11 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 122.12 -0.635 . . . . 0.0 111.51 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.421 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 3.3 m -105.18 133.48 49.88 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.3 ptt85 -114.36 -175.7 2.74 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 46.3 45.06 13.08 Favored 'General case' 0 C--N 1.316 -0.891 0 O-C-N 123.858 0.724 . . . . 0.0 111.518 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.887 HG22 HD13 ' A' ' 129' ' ' LEU . 6.6 mt -81.14 100.7 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-O 120.938 0.399 . . . . 0.0 109.972 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.571 ' CA ' HD12 ' A' ' 129' ' ' LEU . 74.0 m -142.78 126.42 16.93 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.773 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -93.67 158.87 15.47 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.883 0.849 . . . . 0.0 113.037 -179.087 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -99.44 74.99 1.94 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 113.995 -1.457 . . . . 0.0 107.623 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.91 -57.68 4.56 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.947 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.735 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -143.47 -9.22 0.74 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 120.676 0.274 . . . . 0.0 110.898 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -96.59 97.74 9.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.276 0.56 . . . . 0.0 110.906 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.913 ' HB2' HD22 ' A' ' 39' ' ' LEU . 46.5 tp -61.75 121.68 13.47 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.966 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.529 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 53.5 ttt180 -126.61 127.87 45.9 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.506 -0.477 . . . . 0.0 110.813 -178.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.597 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -146.59 150.08 34.79 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.608 0.718 . . . . 0.0 111.069 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 3.0 mm-40 -83.94 71.34 10.5 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.122 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.572 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 34.7 m -60.01 125.75 24.88 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.741 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 10' ' ' SER . 27.7 ttp180 -66.77 126.59 29.5 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.151 178.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -102.37 155.11 18.46 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -52.52 -17.62 4.58 Favored Glycine 0 C--N 1.337 0.584 0 O-C-N 124.582 1.176 . . . . 0.0 114.747 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.21 -9.12 58.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.054 0.454 . . . . 0.0 110.216 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.47 11.44 62.45 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -119.87 165.56 13.5 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.558 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.513 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 88.4 m-85 -100.22 129.19 46.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.007 0.432 . . . . 0.0 110.847 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 75.1 m -113.68 126.03 54.79 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.959 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 m -67.27 114.65 6.16 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.217 0.532 . . . . 0.0 109.768 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 39.7 t -120.4 150.94 39.98 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.265 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.4 p -142.34 140.86 28.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.862 0.363 . . . . 0.0 110.86 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.431 HG22 HD23 ' A' ' 164' ' ' LEU . 15.8 tt -134.86 144.79 33.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.109 -178.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.4 94.02 2.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.385 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.913 HD22 ' HB2' ' A' ' 21' ' ' LEU . 0.9 OUTLIER -76.35 -14.91 60.07 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 120.915 0.388 . . . . 0.0 111.351 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.735 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 26.8 p-10 -67.75 -10.96 57.14 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.202 0.525 . . . . 0.0 109.939 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.42 ' O ' ' HB3' ' A' ' 117' ' ' ALA . 37.4 mtt180 -106.58 11.3 30.69 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.482 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -135.8 -26.2 1.22 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.715 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.816 HD22 HD13 ' A' ' 151' ' ' ILE . 33.2 mt -109.83 134.46 52.02 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.962 0.41 . . . . 0.0 110.919 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.537 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 47.7 m -126.1 146.52 49.89 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.695 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.654 HD22 ' HA ' ' A' ' 120' ' ' PHE . 8.7 p30 -86.2 101.06 12.68 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -102.63 92.59 4.7 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.453 -178.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.0 t30 51.52 43.81 29.44 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.626 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.573 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 82.84 28.13 39.23 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.571 -0.824 . . . . 0.0 113.003 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.71 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 17.6 t-80 -149.88 126.43 10.91 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.705 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 72.6 m-85 -60.54 152.22 26.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.615 0.245 . . . . 0.0 111.026 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 11.4 ttm180 -141.68 132.18 25.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.087 0.47 . . . . 0.0 111.9 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.488 ' CZ2' ' HA ' ' A' ' 153' ' ' LEU . 57.4 m95 -79.23 114.61 18.3 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.729 177.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.6 t -93.55 -44.95 13.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.8 m 55.32 84.83 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.114 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.18 -72.41 0.28 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.776 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.66 135.85 9.03 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.954 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.92 51.18 0.9 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.637 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 160.77 -156.4 27.73 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.837 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.38 -15.02 80.43 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.584 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.54 139.45 10.73 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.283 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.39 -44.04 3.25 Favored Glycine 0 CA--C 1.504 -0.637 0 CA-C-O 122.016 0.786 . . . . 0.0 111.866 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.0 m -138.04 130.06 28.66 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 113.97 -1.115 . . . . 0.0 109.364 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.473 ' HB1' ' HG2' ' A' ' 110' ' ' LYS . . . -122.95 177.55 5.45 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.328 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.4 p -128.87 115.37 17.78 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.463 HG21 ' CE2' ' A' ' 80' ' ' PHE . 10.7 p -106.68 140.0 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.844 0.354 . . . . 0.0 111.105 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 14.0 m -88.55 130.31 35.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.047 0.451 . . . . 0.0 110.231 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.569 ' CG2' HD12 ' A' ' 99' ' ' ILE . 52.2 t -80.8 131.92 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.251 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -99.09 171.47 8.0 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 124.342 1.026 . . . . 0.0 109.705 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.728 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 35.0 tt0 -65.66 124.49 22.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.44 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.5 -1.21 66.28 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.531 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.426 ' CG ' HH22 ' A' ' 79' ' ' ARG . 85.7 m-20 -88.52 147.54 24.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.233 0.539 . . . . 0.0 111.531 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.687 ' HA ' HG12 ' A' ' 99' ' ' ILE . 38.1 p -133.06 168.21 18.9 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.618 HD22 HG23 ' A' ' 99' ' ' ILE . 1.8 mm? -49.76 -45.54 49.62 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.551 0.614 . . . . 0.0 110.307 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.598 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 65.8 mtt180 -63.58 -34.73 78.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.8 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.55 -37.24 65.62 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 72' ' ' THR . 47.8 mm -68.05 -48.76 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.587 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.729 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -59.34 -49.43 78.63 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.705 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.634 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -63.37 -33.02 74.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.081 0.467 . . . . 0.0 110.786 -179.428 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.426 HH22 ' CG ' ' A' ' 71' ' ' ASP . 32.9 ttm180 -74.31 -41.95 60.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.554 -178.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.463 ' CE2' HG21 ' A' ' 65' ' ' VAL . 98.8 m-85 -104.64 20.09 19.24 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 54.15 37.57 27.38 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.293 0.568 . . . . 0.0 112.349 178.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.729 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -119.17 167.16 12.1 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.599 ' O ' HG13 ' A' ' 87' ' ' ILE . 8.4 t0 -90.93 119.35 31.06 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.758 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.608 ' HD2' ' HB2' ' A' ' 95' ' ' ASN . 10.4 p90 -51.49 -32.63 28.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.191 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -62.91 -46.31 88.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.203 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.641 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 30.4 tt0 -66.87 -44.19 81.61 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.723 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.599 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.4 mt -52.12 -45.94 42.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.622 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.24 -50.12 71.46 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.987 177.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -58.45 -34.11 70.47 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.641 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 28.3 mmt180 -68.33 -38.52 81.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.101 0.477 . . . . 0.0 110.482 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 2.8 t-20 -91.53 -5.26 54.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.32 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 48.9 m-80 76.98 16.46 1.77 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.086 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.622 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 16.9 pt -101.25 -176.39 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.55 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 80.4 mm-40 -107.42 158.85 16.85 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.608 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 5.8 p30 -61.24 -55.4 32.41 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 122.137 0.97 . . . . 0.0 108.832 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -79.86 11.91 3.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.427 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.9 t70 -63.35 -35.44 80.39 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 7.6 mp 69.69 115.47 0.04 OUTLIER 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.74 -177.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.731 HG21 HD11 ' A' ' 105' ' ' LEU . 6.8 pt -94.64 175.74 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.472 -178.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.543 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 89.2 m-85 -124.35 160.29 53.48 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.957 -178.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.728 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 37.6 Cg_endo -69.74 133.06 24.7 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.082 2.521 . . . . 0.0 114.016 -178.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.76 14.63 33.91 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.583 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 66' ' ' THR . 44.0 mt-30 -102.41 164.19 11.81 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.83 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 67.1 t -123.56 116.31 47.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.731 HD11 HG21 ' A' ' 99' ' ' ILE . 89.4 mt -110.33 151.33 27.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.024 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.627 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 71.2 mt-30 -90.3 117.48 29.07 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.703 0.763 . . . . 0.0 110.872 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.31 150.42 60.32 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.467 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.43 -17.62 58.07 Favored 'Trans proline' 0 C--N 1.332 -0.318 0 C-N-CA 123.498 2.799 . . . . 0.0 114.017 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.4 t -152.7 152.59 31.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.041 0.448 . . . . 0.0 111.131 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.473 ' HG2' ' HB1' ' A' ' 63' ' ' ALA . 13.2 mmmm -100.62 -178.33 3.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.602 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -88.03 110.79 3.66 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.017 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -71.3 118.1 7.11 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.35 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.6 m -74.57 -34.7 62.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.811 0.339 . . . . 0.0 111.078 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.96 -50.79 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.59 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 132.03 144.21 5.29 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.507 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 122.73 61.7 0.21 Allowed Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 41' ' ' ARG . . . -91.27 -30.4 16.63 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.801 0.334 . . . . 0.0 111.53 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.537 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -94.71 -74.18 1.23 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.49 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 78.37 27.51 0.51 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.858 0.863 . . . . 0.0 112.461 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.654 ' HA ' HD22 ' A' ' 45' ' ' ASN . 26.5 p90 -63.87 -38.62 91.76 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.695 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.539 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 61.2 t-105 -63.02 -29.14 70.6 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.881 -178.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -57.11 -20.97 28.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.738 0.304 . . . . 0.0 111.112 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.678 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 57.6 m -141.9 30.82 1.63 Allowed 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.493 178.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.539 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -113.31 138.64 49.74 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.847 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 125' ' ' ARG . 11.4 mmt180 -126.95 146.05 50.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.262 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.5 t70 51.12 56.65 7.66 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 123.831 0.707 . . . . 0.0 110.659 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.53 ' CG1' HD11 ' A' ' 136' ' ' LEU . 45.0 t -79.66 120.32 30.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.44 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.85 141.34 34.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.177 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.887 HD13 HG22 ' A' ' 14' ' ' ILE . 17.8 mt -85.91 128.29 34.8 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.83 HG23 HG13 ' A' ' 135' ' ' VAL . 31.0 m -123.68 157.54 30.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.358 0.599 . . . . 0.0 111.224 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.925 ' HB3' ' HE3' ' A' ' 134' ' ' LYS . 5.9 m-20 65.67 16.98 10.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.897 178.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.694 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 91.8 25.3 23.08 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.942 178.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 91.16 -15.31 61.37 Favored Glycine 0 C--O 1.269 2.322 0 CA-C-O 123.638 1.688 . . . . 0.0 112.384 177.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.925 ' HE3' ' HB3' ' A' ' 131' ' ' ASP . 20.0 pttp -65.12 -15.71 62.69 Favored 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 121.463 -1.022 . . . . 0.0 108.929 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.83 HG13 HG23 ' A' ' 130' ' ' VAL . 2.2 p -149.03 135.58 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.547 0.689 . . . . 0.0 110.83 176.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 29.6 tp -110.3 125.08 52.77 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.073 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.406 ' CD ' ' HE ' ' A' ' 148' ' ' ARG . 31.9 tt0 -117.92 139.95 50.42 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.861 0.363 . . . . 0.0 111.52 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.663 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.96 168.8 20.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.17 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -95.25 107.55 19.66 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.573 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 57.1 mt -98.93 131.89 44.66 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.277 0.561 . . . . 0.0 111.168 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.678 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 33.7 ttt180 -72.28 142.01 48.89 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.071 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -153.89 -173.89 4.75 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.917 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 13.4 m -58.6 -22.71 57.03 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -105.39 20.02 38.38 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.233 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 106.73 -115.33 4.66 Favored Glycine 0 C--O 1.229 -0.212 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.298 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -130.31 138.07 50.27 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -132.18 141.44 49.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.924 0.392 . . . . 0.0 111.701 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.406 ' HE ' ' CD ' ' A' ' 137' ' ' GLU . 69.5 ttt180 -74.76 103.53 5.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.146 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.71 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 32.6 t -121.65 162.08 21.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.326 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 10.3 ptt180 -148.55 152.6 37.11 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 120.957 0.408 . . . . 0.0 111.474 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.816 HD13 HD22 ' A' ' 43' ' ' LEU . 8.7 tt -132.36 131.96 60.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.73 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 135' ' ' VAL . 89.8 m-85 -75.89 101.22 5.08 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.56 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.727 HD13 HD22 ' A' ' 21' ' ' LEU . 35.7 mt -64.45 -36.22 83.47 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.191 178.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.845 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 11.7 t70 -55.35 -11.49 0.81 Allowed 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.425 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.539 ' HG3' ' CB ' ' A' ' 152' ' ' TYR . 38.0 mt-10 -71.41 -49.39 42.38 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 121.93 -0.481 . . . . 0.0 112.224 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.567 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 50.6 m80 -127.02 5.68 6.51 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 119.963 -0.695 . . . . 0.0 112.611 -177.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.403 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 46.9 mm -106.58 109.65 28.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.631 ' HA3' ' O ' ' A' ' 167' ' ' CYS . . . -116.38 166.22 12.34 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.187 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.572 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.9 t30 -100.79 123.21 44.66 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.41 ' O ' ' HB3' ' A' ' 163' ' ' GLU . 14.2 ttt85 -119.17 86.52 2.56 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.155 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 59.61 49.12 8.72 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 79.92 13.14 82.61 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.489 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 160' ' ' ARG . 28.2 tt0 -122.67 120.24 33.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.026 0.441 . . . . 0.0 110.037 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.697 HD11 ' CD2' ' A' ' 7' ' ' PHE . 8.5 tp -77.25 120.73 22.71 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.072 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.843 HG12 ' H ' ' A' ' 166' ' ' HIS . 12.6 tt -150.46 -172.21 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.987 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.843 ' H ' HG12 ' A' ' 165' ' ' ILE . 3.4 m-70 -85.84 124.0 31.83 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.214 -0.304 . . . . 0.0 110.426 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.631 ' O ' ' HA3' ' A' ' 158' ' ' GLY . 53.3 t . . . . . 0 C--O 1.245 0.857 0 O-C-N 124.079 0.862 . . . . 0.0 111.26 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.464 ' HA2' ' CD2' ' A' ' 152' ' ' TYR . . . . . . . . 0 N--CA 1.482 1.732 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -66.35 136.9 56.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.441 0.638 . . . . 0.0 111.109 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -120.38 -64.71 1.22 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.101 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -125.29 -25.58 3.77 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.642 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -84.09 -70.93 1.33 Allowed Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 118.771 -1.68 . . . . 0.0 113.488 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.628 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 63.0 t30 57.3 31.95 20.95 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.207 0.603 . . . . 0.0 110.283 -178.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.611 ' CE2' HD13 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -60.28 -32.91 71.64 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.028 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.458 ' HA ' HD11 ' A' ' 14' ' ' ILE . 34.0 t -59.17 -20.8 57.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.523 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.52 -42.17 93.76 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.836 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 26' ' ' ARG . 49.4 m -114.97 -18.05 11.35 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.9 m -92.38 134.86 34.53 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.471 ' CG ' ' HB2' ' A' ' 24' ' ' GLU . 16.7 ptt180 -113.27 -177.54 3.16 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.494 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 0.4 OUTLIER 42.61 44.63 3.72 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 123.873 0.733 . . . . 0.0 112.457 179.18 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.916 HG22 HD13 ' A' ' 129' ' ' LEU . 5.8 mt -78.98 105.14 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 CA-C-O 120.953 0.406 . . . . 0.0 110.292 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.607 ' HA ' HD12 ' A' ' 129' ' ' LEU . 80.4 m -146.82 127.62 14.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.37 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.749 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -96.97 155.86 16.6 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.621 0.724 . . . . 0.0 112.779 -179.279 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -96.22 75.1 2.97 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.433 -1.258 . . . . 0.0 107.958 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.51 -58.35 4.88 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.893 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -149.19 5.97 0.66 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.199 0.523 . . . . 0.0 110.21 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.575 ' HG2' ' CG2' ' A' ' 36' ' ' VAL . 32.3 ttt85 -108.32 93.99 4.82 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.825 ' HB2' HD22 ' A' ' 39' ' ' LEU . 55.0 tp -63.18 129.6 41.02 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -177.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.535 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 34.8 ttt180 -134.04 129.26 35.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.159 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.624 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -148.58 149.98 32.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.471 0.653 . . . . 0.0 110.983 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.55 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 3.3 mt-10 -87.64 80.67 7.91 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.773 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.587 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 58.7 m -63.47 127.86 33.23 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.408 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.5 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 36.8 ttm180 -71.13 114.93 9.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.364 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 9.0 ptp180 -79.6 152.6 29.97 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 179.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.36 -19.5 12.79 Favored Glycine 0 C--N 1.336 0.549 0 O-C-N 124.369 1.043 . . . . 0.0 114.03 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.58 -12.03 60.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.446 0.641 . . . . 0.0 109.821 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.29 5.22 56.05 Favored Glycine 0 CA--C 1.505 -0.589 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.526 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.454 ' O ' ' HG2' ' A' ' 27' ' ' ARG . . . -105.61 167.78 14.92 Favored Glycine 0 C--O 1.222 -0.649 0 C-N-CA 120.065 -1.064 . . . . 0.0 113.14 -178.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.55 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 57.9 m-85 -101.27 131.47 47.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.166 0.483 . . . . 0.0 110.907 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.9 m -118.49 123.35 44.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.191 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.5 m -69.1 112.31 5.63 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.9 t -118.25 155.41 30.61 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.028 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.575 ' CG2' ' HG2' ' A' ' 20' ' ' ARG . 2.6 p -145.43 139.08 21.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.878 0.371 . . . . 0.0 111.662 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.449 HG23 ' HB3' ' A' ' 21' ' ' LEU . 14.0 tt -135.13 148.06 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.471 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.439 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 17.7 m-20 -84.41 104.53 14.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.862 0.363 . . . . 0.0 111.475 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.825 HD22 ' HB2' ' A' ' 21' ' ' LEU . 3.0 mp -83.69 -12.15 56.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.428 0.632 . . . . 0.0 110.417 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.528 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 16.5 p30 -62.84 -19.09 63.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.021 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.452 ' O ' ' HB3' ' A' ' 117' ' ' ALA . 13.2 ptm180 -112.92 19.9 16.88 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.968 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.644 ' HD2' ' CE3' ' A' ' 52' ' ' TRP . 0.1 OUTLIER -138.12 -27.6 0.89 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.366 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.863 HD22 HD13 ' A' ' 151' ' ' ILE . 62.5 mt -106.09 132.21 52.44 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.619 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 3.2 m -129.35 141.92 50.95 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.541 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.709 ' HB3' ' HG ' ' A' ' 140' ' ' LEU . 8.5 p30 -79.36 115.77 19.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.149 177.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -114.82 89.34 3.07 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.907 0.384 . . . . 0.0 110.248 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.3 t30 51.78 45.02 28.85 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.242 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.0 32.18 30.02 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.808 -0.711 . . . . 0.0 113.131 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.616 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 16.0 t-80 -150.85 125.19 9.45 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.78 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 45.3 m-85 -63.08 141.84 58.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.886 0.374 . . . . 0.0 111.672 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.647 ' NE ' ' HA ' ' A' ' 51' ' ' ARG . 3.4 mmp_? -146.26 135.82 23.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.841 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.644 ' CE3' ' HD2' ' A' ' 42' ' ' TYR . 95.0 m95 -74.36 105.95 5.75 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.124 0.488 . . . . 0.0 109.743 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.604 HG13 ' HB1' ' A' ' 117' ' ' ALA . 11.0 t 56.31 54.56 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.377 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.6 p 60.29 -59.9 0.07 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.39 1.476 . . . . 0.0 113.165 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -166.18 36.65 0.25 Allowed Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.81 41.53 14.79 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -79.34 152.86 36.56 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.273 -0.489 . . . . 0.0 112.755 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.86 144.53 18.46 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.152 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.19 146.39 22.83 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.045 -0.597 . . . . 0.0 112.403 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 163.92 -176.98 39.88 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.376 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.35 -127.47 8.8 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 121.075 -0.583 . . . . 0.0 111.829 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.3 m -134.25 130.52 37.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.861 0.362 . . . . 0.0 110.252 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.444 ' HB1' ' HG2' ' A' ' 110' ' ' LYS . . . -127.8 176.11 7.81 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.75 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.529 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 6.8 p -127.93 116.11 19.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.543 HG21 ' CE2' ' A' ' 80' ' ' PHE . 7.9 p -103.61 142.41 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 120.887 0.375 . . . . 0.0 110.844 178.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 9.8 m -88.38 130.95 35.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.161 0.505 . . . . 0.0 109.929 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.458 ' CG2' HD12 ' A' ' 99' ' ' ILE . 56.6 t -82.33 133.58 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.854 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -103.86 171.34 7.41 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.985 0.803 . . . . 0.0 110.2 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.621 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 53.7 tt0 -61.27 119.39 8.35 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.122 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.17 -9.91 63.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.888 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.455 ' HB3' HD11 ' A' ' 76' ' ' ILE . 84.9 m-20 -75.44 146.65 40.54 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.147 0.499 . . . . 0.0 111.529 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.624 ' HA ' HG12 ' A' ' 99' ' ' ILE . 24.3 p -135.99 163.15 30.96 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.615 HD22 HG23 ' A' ' 99' ' ' ILE . 1.6 mm? -49.18 -44.22 42.84 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.363 0.529 . . . . 0.0 110.634 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.442 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 70.1 mtp180 -59.96 -43.39 95.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.276 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -72.94 -33.88 66.21 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.537 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 72' ' ' THR . 44.0 mm -66.6 -46.91 84.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.716 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.48 -49.08 76.15 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.91 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -65.41 -32.43 74.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.059 0.456 . . . . 0.0 111.151 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.429 HH22 ' CG ' ' A' ' 71' ' ' ASP . 34.5 ttm180 -70.65 -40.33 73.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.73 -178.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.543 ' CE2' HG21 ' A' ' 65' ' ' VAL . 94.6 m-85 -110.42 16.91 21.32 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 56.22 37.56 28.96 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.445 0.64 . . . . 0.0 111.411 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.716 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.9 p -116.28 166.1 12.42 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.373 -0.83 . . . . 0.0 108.901 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.65 ' O ' HG13 ' A' ' 87' ' ' ILE . 3.7 t70 -92.22 124.6 36.42 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.101 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.442 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 9.7 p90 -52.28 -31.35 32.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.753 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 23.0 t-80 -66.79 -43.26 84.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.949 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.77 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 10.1 mm-40 -63.2 -51.54 65.93 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.361 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.65 HG13 ' O ' ' A' ' 83' ' ' ASP . 3.5 mt -50.94 -48.12 29.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 O-C-N 124.139 0.899 . . . . 0.0 109.475 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.625 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.51 -49.5 75.09 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.268 178.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -61.79 -34.05 75.21 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.77 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 14.7 mmt85 -65.28 -38.19 89.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.08 0.467 . . . . 0.0 110.525 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.428 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 11.5 m120 -93.13 -3.36 54.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.61 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 76.5 m-20 73.72 19.67 3.17 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.247 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.625 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 16.9 pt -100.68 -177.29 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.688 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.506 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 35.6 mt-30 -108.17 155.57 20.28 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.55 ' O ' HD23 ' A' ' 73' ' ' LEU . 3.1 p30 -54.94 -62.6 1.55 Allowed 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 122.116 0.96 . . . . 0.0 108.937 178.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -76.4 12.23 1.3 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.385 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.506 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.4 t70 -63.63 -34.5 77.96 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 8.7 mp 73.03 116.63 0.05 Allowed 'General case' 0 N--CA 1.462 0.136 0 O-C-N 124.399 1.062 . . . . 0.0 109.598 -177.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.744 HG21 HD11 ' A' ' 105' ' ' LEU . 11.2 pt -93.83 177.68 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.208 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.509 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 40.5 m-85 -129.48 157.76 75.37 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-O 120.892 0.377 . . . . 0.0 111.413 -178.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.621 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 25.7 Cg_endo -65.72 137.75 51.0 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.229 2.619 . . . . 0.0 113.905 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.12 13.65 57.25 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.867 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.479 ' O ' ' HA ' ' A' ' 66' ' ' THR . 95.5 mt-30 -100.87 168.39 9.67 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.216 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.529 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 63.2 t -127.6 110.61 22.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-O 120.921 0.391 . . . . 0.0 109.974 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.744 HD11 HG21 ' A' ' 99' ' ' ILE . 89.0 mt -103.6 150.4 24.0 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.678 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 75.8 mt-30 -91.34 116.47 28.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.973 0.892 . . . . 0.0 111.38 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.1 m -124.12 151.5 65.71 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 114.207 -1.36 . . . . 0.0 109.691 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -65.07 -15.03 48.44 Favored 'Trans proline' 0 N--CA 1.476 0.445 0 C-N-CA 123.571 2.847 . . . . 0.0 114.855 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.0 t -152.9 155.71 37.55 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.008 0.433 . . . . 0.0 111.197 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 110' ' ' LYS . 12.9 mmmm -100.31 -180.0 4.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.816 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -161.94 90.39 0.11 Allowed Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.531 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -107.6 129.01 9.44 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.176 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.0 m -84.67 28.78 0.65 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.173 0.511 . . . . 0.0 110.756 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -170.64 42.89 0.19 Allowed Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.625 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 141.01 -161.5 26.78 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 127.44 -67.08 0.55 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.8 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.604 ' HB1' HG13 ' A' ' 53' ' ' VAL . . . -100.57 -22.58 14.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.983 0.42 . . . . 0.0 111.715 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.619 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -102.51 -82.31 1.63 Allowed Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.26 -0.971 . . . . 0.0 112.618 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 73.41 23.45 2.51 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.437 0.695 . . . . 0.0 111.931 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.696 ' HA ' HD22 ' A' ' 45' ' ' ASN . 22.7 p90 -61.62 -38.51 87.92 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.549 -0.46 . . . . 0.0 109.854 178.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.553 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 63.5 t-105 -59.87 -33.86 72.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.474 -178.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -54.59 -25.95 29.51 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.101 0.476 . . . . 0.0 111.124 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.722 ' HB2' ' HB3' ' A' ' 141' ' ' ARG . 19.4 p -136.98 30.12 2.78 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.512 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.553 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -109.29 140.3 43.13 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.889 0.376 . . . . 0.0 110.835 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.412 ' HB3' ' HB2' ' A' ' 139' ' ' GLU . 61.0 ttp180 -127.51 138.91 53.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.932 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 55.36 54.47 8.58 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.244 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.501 ' CG1' HD11 ' A' ' 136' ' ' LEU . 29.7 t -76.67 121.43 28.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.643 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -144.94 146.01 31.8 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.65 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.916 HD13 HG22 ' A' ' 14' ' ' ILE . 18.4 mt -86.75 128.85 35.04 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 120.973 0.416 . . . . 0.0 110.157 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.597 HG23 ' HB ' ' A' ' 135' ' ' VAL . 35.1 m -125.75 160.18 32.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.646 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 69.04 5.77 5.26 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.389 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.665 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 97.32 29.06 8.12 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.439 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.536 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 91.8 -16.27 59.74 Favored Glycine 0 C--O 1.265 2.045 0 CA-C-O 123.689 1.716 . . . . 0.0 112.494 178.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.662 ' O ' ' HA ' ' A' ' 152' ' ' TYR . 5.8 ptpp? -70.87 -17.44 62.72 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 121.433 -1.039 . . . . 0.0 108.454 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.597 ' HB ' HG23 ' A' ' 130' ' ' VAL . 17.5 t -138.73 137.92 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.314 0.578 . . . . 0.0 110.736 178.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.693 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 29.6 tp -117.58 118.36 31.92 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -108.4 130.25 55.23 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.772 0.32 . . . . 0.0 111.276 -176.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.758 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.35 161.56 27.5 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.72 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.849 ' HG3' HH11 ' A' ' 148' ' ' ARG . 49.3 mt-10 -96.01 108.5 20.9 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.422 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.709 ' HG ' ' HB3' ' A' ' 45' ' ' ASN . 1.0 OUTLIER -90.96 126.78 36.17 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.959 178.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.722 ' HB3' ' HB2' ' A' ' 123' ' ' SER . 76.1 ttt180 -69.59 140.81 53.82 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.164 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.633 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 2.3 p90 -156.83 -165.98 1.99 Allowed 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.074 -179.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.2 t -58.42 -32.53 68.75 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.319 0.387 . . . . 0.0 111.121 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.19 28.88 13.26 Favored Glycine 0 C--N 1.329 0.182 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.478 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 89.52 -118.95 5.35 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.591 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -120.03 129.32 54.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.699 0.25 . . . . 0.0 110.73 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.633 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 53.7 t30 -121.34 134.18 55.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.74 0.305 . . . . 0.0 110.766 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.849 HH11 ' HG3' ' A' ' 139' ' ' GLU . 19.8 tpt180 -75.0 96.94 3.27 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.591 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.616 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 11.6 t -109.41 168.03 9.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.428 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.693 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 36.5 ptt180 -148.11 149.65 32.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.444 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.863 HD13 HD22 ' A' ' 43' ' ' LEU . 12.1 tt -132.98 140.72 46.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.581 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.662 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 26.6 m-85 -83.17 102.97 12.23 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.852 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.774 HD11 HD21 ' A' ' 129' ' ' LEU . 26.8 mt -65.25 -36.7 84.95 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.127 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.628 ' HB2' ' HA ' ' A' ' 6' ' ' ASN . 13.8 p-10 -61.69 2.83 0.16 Allowed 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.561 ' HG3' ' CB ' ' A' ' 152' ' ' TYR . 43.1 mt-10 -76.24 -52.43 10.03 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 121.729 -0.607 . . . . 0.0 110.758 178.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -118.02 -12.26 10.11 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.633 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.443 ' O ' ' HA3' ' A' ' 5' ' ' GLY . 50.8 mm -91.86 114.74 29.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 116.77 -0.196 . . . . 0.0 110.754 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -122.28 167.63 14.8 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.115 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.587 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 3.3 t30 -103.46 123.29 46.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.025 0.44 . . . . 0.0 109.959 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 29.5 ttt85 -124.68 93.08 3.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.341 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 60.61 45.04 10.84 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.215 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 84.81 10.75 78.43 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.684 -0.769 . . . . 0.0 113.197 178.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -122.74 152.82 40.23 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.511 HD21 ' HD2' ' A' ' 7' ' ' PHE . 24.4 mt -97.17 119.65 36.05 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.492 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 43.0 pt -114.31 170.29 4.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.148 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -130.09 116.86 19.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.035 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 41.6 t . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.706 -0.664 . . . . 0.0 110.178 -179.668 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.669 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -92.92 168.77 10.93 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.655 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 32.6 m-85 -103.16 -76.75 0.58 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.499 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -137.68 -25.93 0.99 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.569 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 6' ' ' ASN . . . -68.88 -72.63 0.81 Allowed Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 119.738 -1.22 . . . . 0.0 113.597 -178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 25.5 m-80 69.69 10.31 7.53 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 122.498 0.319 . . . . 0.0 110.219 -178.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.785 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.9 OUTLIER -61.59 -34.93 76.46 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.61 -178.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.45 ' HA ' HD11 ' A' ' 14' ' ' ILE . 35.0 t -67.81 -14.87 63.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.476 0.655 . . . . 0.0 109.877 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.68 -27.76 64.5 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.964 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 20.9 p -125.69 -19.57 4.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 117.225 0.512 . . . . 0.0 111.992 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 11.8 m -94.99 129.04 42.22 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.698 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 35.4 ptt180 -108.01 -178.36 3.59 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.481 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 1.6 m-20 41.11 47.58 2.8 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 124.068 0.855 . . . . 0.0 112.489 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.924 HG22 HD13 ' A' ' 129' ' ' LEU . 8.1 mt -80.65 107.44 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-O 120.877 0.37 . . . . 0.0 110.292 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.713 ' CA ' HD12 ' A' ' 129' ' ' LEU . 46.1 t -150.2 128.53 12.11 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.701 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -96.7 158.56 15.37 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 122.047 0.927 . . . . 0.0 113.012 -178.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -99.51 76.4 2.02 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.14 -53.57 4.77 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.879 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.46 ' CB ' ' HB3' ' A' ' 40' ' ' ASN . . . -149.55 -12.41 0.29 Allowed 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 120.746 0.308 . . . . 0.0 110.195 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -86.1 90.13 8.03 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.448 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.003 HD12 HD11 ' A' ' 129' ' ' LEU . 8.5 tp -61.64 112.97 2.46 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.671 -179.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.495 ' HE ' ' CG2' ' A' ' 34' ' ' THR . 18.8 ttt85 -118.28 130.59 56.13 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.277 -178.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.679 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -149.65 150.9 32.86 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.407 0.623 . . . . 0.0 110.997 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.698 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 1.6 mm-40 -83.39 73.83 10.13 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.145 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.651 ' SG ' HD13 ' A' ' 164' ' ' LEU . 67.8 m -61.22 117.06 5.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.595 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 10' ' ' SER . 44.5 ttt180 -64.59 116.75 6.5 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.804 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.7 ttt85 -90.86 152.49 20.73 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.044 0.45 . . . . 0.0 109.957 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.63 -13.83 4.56 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 114.353 -1.294 . . . . 0.0 114.037 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -73.85 -11.08 60.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.114 0.483 . . . . 0.0 110.321 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.5 8.49 57.36 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -123.78 154.39 17.54 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.099 -1.048 . . . . 0.0 112.837 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.475 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 88.0 m-85 -87.87 125.49 34.51 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.712 0.291 . . . . 0.0 110.446 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.7 m -109.19 131.94 54.59 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.495 ' CG2' ' HE ' ' A' ' 22' ' ' ARG . 2.5 m -73.72 110.71 8.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.229 0.538 . . . . 0.0 109.98 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 30.3 t -115.5 153.59 30.87 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.635 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.7 p -146.14 137.27 18.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.794 0.331 . . . . 0.0 110.869 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.514 HG23 ' HB3' ' A' ' 21' ' ' LEU . 8.7 tt -134.68 137.05 51.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.733 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.643 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 13.3 m-20 -75.22 103.1 5.24 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.826 0.345 . . . . 0.0 111.558 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.818 ' HG ' HD11 ' A' ' 153' ' ' LEU . 3.4 mm? -83.11 -5.37 59.08 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.926 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.643 ' OD1' ' HB3' ' A' ' 38' ' ' ASP . 34.5 p-10 -67.06 -14.07 62.54 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.574 ' HE ' ' HB2' ' A' ' 38' ' ' ASP . 27.8 mtm180 -106.65 7.75 30.76 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.962 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.703 ' HB2' HD13 ' A' ' 39' ' ' LEU . 88.5 m-85 -130.95 -29.34 1.89 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.862 HD22 HD13 ' A' ' 151' ' ' ILE . 60.9 mt -106.22 132.69 51.98 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.779 0.323 . . . . 0.0 110.405 -179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.734 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 1.0 OUTLIER -123.44 143.03 50.4 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.603 -179.496 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 7.0 p-10 -88.25 93.61 9.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.791 0.805 . . . . 0.0 109.176 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -93.27 93.63 8.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.297 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.487 ' HA ' ' HB2' ' A' ' 142' ' ' TYR . 8.6 t-20 51.25 48.49 22.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.092 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.611 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 76.64 32.42 50.66 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.049 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.639 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 59.9 t60 -152.12 124.69 8.35 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.796 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 48.5 m-85 -60.71 144.15 52.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.887 0.375 . . . . 0.0 111.483 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.715 ' HG3' ' HA3' ' A' ' 55' ' ' GLY . 0.2 OUTLIER -143.03 131.74 22.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.475 -178.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.495 ' HZ2' ' O ' ' A' ' 152' ' ' TYR . 99.6 m95 -75.59 111.41 10.87 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 176.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.3 t 66.48 -80.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 123.704 0.802 . . . . 0.0 111.532 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.6 p -127.2 -22.63 3.7 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.98 0.419 . . . . 0.0 111.368 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.715 ' HA3' ' HG3' ' A' ' 51' ' ' ARG . . . 71.52 22.57 78.61 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.018 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.54 118.48 9.2 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.427 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -83.87 157.96 34.55 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.591 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.32 9.24 48.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.022 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.51 175.61 47.5 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.366 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.64 20.2 32.72 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.35 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 112.38 124.49 4.35 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.161 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 36.0 m -141.3 114.85 8.91 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.108 0.48 . . . . 0.0 110.323 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.467 ' HB1' ' HG2' ' A' ' 110' ' ' LYS . . . -130.9 178.59 6.55 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.191 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.516 HG22 ' HG2' ' A' ' 106' ' ' GLN . 4.6 p -128.33 115.56 18.46 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.499 ' HA ' ' HE3' ' A' ' 110' ' ' LYS . 7.3 p -102.77 143.25 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 120.869 0.366 . . . . 0.0 111.086 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 3.5 m -87.98 129.25 35.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.481 ' CG2' HD12 ' A' ' 99' ' ' ILE . 57.4 t -79.66 132.25 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.647 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -101.03 168.61 9.49 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 124.254 0.971 . . . . 0.0 110.475 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.668 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 35.1 tt0 -66.03 120.21 12.74 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.87 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.85 -11.07 52.76 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.771 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.06 130.26 45.38 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.134 0.467 . . . . 0.0 111.402 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.618 ' HA ' HG12 ' A' ' 99' ' ' ILE . 82.6 p -107.41 179.76 4.15 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.668 HD22 HG23 ' A' ' 99' ' ' ILE . 1.4 mm? -53.64 -43.64 68.9 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.436 0.636 . . . . 0.0 109.511 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.523 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 7.0 ttp85 -63.31 -36.05 82.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.39 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 79' ' ' ARG . 50.2 m-20 -73.77 -41.83 61.9 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.568 HG12 ' O ' ' A' ' 72' ' ' THR . 45.3 mm -61.32 -47.68 92.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.605 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.723 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.19 -51.34 58.11 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.651 -0.704 . . . . 0.0 113.083 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.448 HH11 ' HD2' ' A' ' 78' ' ' ARG . 47.1 mtp85 -70.21 -23.71 62.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.796 0.331 . . . . 0.0 111.691 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 37.2 ttt180 -78.91 -39.37 35.02 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -110.97 19.45 18.48 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t70 55.22 59.24 4.09 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.693 0.759 . . . . 0.0 111.335 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.723 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.4 p -142.35 164.59 29.72 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.364 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.574 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.8 t0 -91.04 120.89 32.39 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.523 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 5.0 p90 -52.19 -30.47 27.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.429 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -66.66 -41.87 87.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.602 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.695 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 64.3 mm-40 -66.06 -49.62 67.0 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.485 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.574 HG13 ' O ' ' A' ' 83' ' ' ASP . 4.1 mt -51.93 -47.53 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.523 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.58 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.77 -50.4 71.2 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.112 178.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -60.3 -33.82 72.91 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.695 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 27.4 mmt180 -71.19 -31.83 68.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.914 0.388 . . . . 0.0 110.44 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 3.7 t-20 -91.73 -5.97 52.74 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.615 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 90.7 m-20 77.15 17.76 1.54 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.033 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.58 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 14.2 pt -105.69 -174.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.577 178.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.449 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 64.6 mt-30 -110.25 162.57 14.49 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.614 ' O ' HD23 ' A' ' 73' ' ' LEU . 4.2 p-10 -58.59 -68.67 0.24 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.317 1.055 . . . . 0.0 110.003 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -74.33 13.47 0.58 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.545 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.5 t70 -59.65 -29.39 68.0 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.407 HD22 HG21 ' A' ' 72' ' ' THR . 34.1 mt 72.4 110.6 0.06 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.816 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.668 HG23 HD22 ' A' ' 73' ' ' LEU . 10.2 pt -95.62 172.56 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.405 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.58 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 73.7 m-85 -126.74 161.45 53.12 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.31 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.668 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 24.8 Cg_endo -66.31 139.6 55.32 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.203 2.602 . . . . 0.0 113.843 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.07 16.72 43.23 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' A' ' 66' ' ' THR . 25.8 mt-30 -103.18 166.57 10.36 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.082 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.426 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 82.5 t -126.91 114.43 37.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.56 HD11 HG21 ' A' ' 99' ' ' ILE . 88.1 mt -112.2 151.65 29.31 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.801 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.516 ' HG2' HG22 ' A' ' 64' ' ' THR . 34.3 mt-30 -90.47 117.26 29.03 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.615 0.721 . . . . 0.0 110.923 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.423 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 35.2 m -126.27 152.59 73.92 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.634 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 107' ' ' VAL . 18.0 Cg_endo -57.52 -48.04 19.04 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.353 2.035 . . . . 0.0 113.578 -177.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.1 t -123.72 155.22 38.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.254 0.55 . . . . 0.0 111.635 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.499 ' HE3' ' HA ' ' A' ' 65' ' ' VAL . 11.3 mmmm -99.38 -170.23 1.88 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.697 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -175.32 -45.36 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 63.65 -113.71 6.15 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.282 -0.485 . . . . 0.0 112.8 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 19.5 m -119.08 12.38 12.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.936 0.398 . . . . 0.0 110.771 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.439 ' O ' ' HD2' ' A' ' 41' ' ' ARG . . . 166.4 -42.26 0.26 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.211 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.25 -117.88 0.67 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.65 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.42 47.04 60.01 Favored Glycine 0 CA--C 1.502 -0.778 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 41' ' ' ARG . . . -111.18 -52.74 2.77 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.825 -0.687 . . . . 0.0 110.732 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.734 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -83.01 -77.87 1.08 Allowed Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.523 -0.762 . . . . 0.0 113.184 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 19.5 m120 73.29 29.09 1.72 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.054 0.542 . . . . 0.0 111.418 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.592 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 21.8 p90 -60.59 -37.92 82.94 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.519 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 47.8 t-105 -60.57 -30.39 69.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.559 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.47 -33.02 58.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.939 0.399 . . . . 0.0 110.537 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.775 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 6.7 m -131.28 28.84 4.68 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.852 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.519 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -108.65 140.78 41.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.896 0.379 . . . . 0.0 110.889 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.565 ' HB3' ' HB2' ' A' ' 139' ' ' GLU . 11.3 tpp85 -124.09 135.2 53.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.462 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 54.85 55.46 7.78 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.765 0.666 . . . . 0.0 111.849 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.526 HG12 HD11 ' A' ' 136' ' ' LEU . 40.1 t -78.03 123.58 35.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.822 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.435 ' O ' HD12 ' A' ' 136' ' ' LEU . 8.9 ptp180 -149.49 149.0 30.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.827 0.346 . . . . 0.0 110.589 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 1.003 HD11 HD12 ' A' ' 21' ' ' LEU . 92.5 mt -86.6 134.85 33.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.056 0.455 . . . . 0.0 110.495 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.626 HG23 ' HB ' ' A' ' 135' ' ' VAL . 26.8 m -124.61 157.67 32.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.921 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.739 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 0.3 OUTLIER 72.99 -4.41 2.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.059 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.644 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 104.18 32.0 4.48 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.821 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.682 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 94.88 -22.72 36.51 Favored Glycine 0 C--O 1.262 1.869 0 CA-C-O 123.203 1.446 . . . . 0.0 112.588 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.739 ' HG3' ' HB3' ' A' ' 131' ' ' ASP . 13.4 ptmt -65.73 -17.66 64.77 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 121.872 -0.781 . . . . 0.0 109.086 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.626 ' HB ' HG23 ' A' ' 130' ' ' VAL . 8.4 t -140.82 146.53 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.831 177.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.615 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 41.1 tp -126.13 124.69 41.1 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.534 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 34.1 tt0 -114.43 137.83 51.34 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.85 0.357 . . . . 0.0 111.403 -177.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.556 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -163.21 164.69 25.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.177 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.565 ' HB2' ' HB3' ' A' ' 125' ' ' ARG . 17.5 mm-40 -94.9 106.41 18.4 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 177.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.611 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 59.0 mt -96.71 130.03 44.01 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.2 0.524 . . . . 0.0 111.197 -178.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.775 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 42.6 ttt180 -77.09 141.29 40.3 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.688 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.487 ' HB2' ' HA ' ' A' ' 47' ' ' ASN . 6.8 p90 -155.65 -169.21 3.04 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.976 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.9 p -58.22 -22.53 52.36 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -109.19 28.24 11.36 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.31 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.63 -123.19 7.45 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.858 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -123.19 135.55 54.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.56 0.219 . . . . 0.0 110.51 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.436 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 57.9 t30 -134.91 142.61 46.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.898 0.38 . . . . 0.0 110.828 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.9 tpp85 -76.61 110.47 11.2 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.066 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.639 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 9.2 t -124.9 165.53 17.91 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.615 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 35.2 mtt85 -146.37 152.37 38.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.712 0.292 . . . . 0.0 110.881 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.862 HD13 HD22 ' A' ' 43' ' ' LEU . 12.4 tt -135.77 142.76 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.022 178.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.589 ' CB ' ' HG3' ' A' ' 155' ' ' GLU . 8.5 m-85 -86.35 101.84 13.46 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 122.471 -0.143 . . . . 0.0 111.31 -178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.818 HD11 ' HG ' ' A' ' 39' ' ' LEU . 3.9 mm? -61.14 -37.53 83.17 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.079 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.654 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 13.1 t70 -55.2 -16.24 3.01 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.209 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.655 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 41.2 mt-10 -63.28 -54.01 43.93 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.521 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 48.4 m80 -124.48 2.92 8.37 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.786 -0.766 . . . . 0.0 112.404 -177.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.617 HG13 HD12 ' A' ' 153' ' ' LEU . 43.5 mm -104.03 112.96 39.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.357 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.638 ' HA3' ' OXT' ' A' ' 167' ' ' CYS . . . -118.73 168.33 13.24 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.562 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.554 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.8 t30 -104.71 122.16 45.1 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 15.7 ttm-85 -123.85 93.68 4.0 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.29 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 59.23 41.54 19.94 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.478 -0.783 . . . . 0.0 113.063 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 90.45 10.05 64.17 Favored Glycine 0 C--O 1.229 -0.193 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.211 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -121.43 134.21 55.09 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.216 0.531 . . . . 0.0 110.211 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.785 HD11 ' CD2' ' A' ' 7' ' ' PHE . 8.1 tp -96.35 107.31 19.66 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.741 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.444 ' HA ' HD12 ' A' ' 37' ' ' ILE . 19.8 pt -140.9 -176.59 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.003 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.521 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 7.9 p80 -71.49 124.65 25.12 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.638 ' OXT' ' HA3' ' A' ' 158' ' ' GLY . 42.6 t . . . . . 0 C--O 1.247 0.965 0 O-C-N 123.804 0.69 . . . . 0.0 111.553 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.717 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.511 ' HB3' ' HD1' ' A' ' 3' ' ' TYR . 19.0 m-80 -90.55 -80.47 0.33 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.514 ' CD1' ' HG2' ' A' ' 155' ' ' GLU . 13.6 m-85 -118.24 -94.48 0.5 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.97 0.414 . . . . 0.0 111.684 -178.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -109.18 -28.45 9.02 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -62.4 -70.98 0.89 Allowed Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 119.495 -1.336 . . . . 0.0 112.694 -178.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 65.08 18.93 11.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.803 0.335 . . . . 0.0 110.498 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.742 ' HD2' HD11 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -65.19 -30.69 71.62 Favored 'General case' 0 C--O 1.217 -0.647 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.73 179.815 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.9 t -71.53 -9.32 58.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.705 0.764 . . . . 0.0 109.512 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.49 -23.01 57.51 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 115.12 -0.945 . . . . 0.0 113.054 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.484 ' HB2' HD22 ' A' ' 159' ' ' ASN . 20.2 m -129.39 -22.0 3.12 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 117.287 0.544 . . . . 0.0 111.26 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.505 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 13.0 m -99.31 133.49 43.53 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 12' ' ' ARG . 4.3 ptp180 -113.45 -174.49 2.47 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 42.61 45.52 4.02 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 123.854 0.721 . . . . 0.0 111.489 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.867 HG22 HD13 ' A' ' 129' ' ' LEU . 6.7 mt -79.54 109.26 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.008 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.638 ' CA ' HD12 ' A' ' 129' ' ' LEU . 53.8 t -149.54 127.24 11.7 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.42 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.742 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -94.7 154.7 17.19 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.584 0.706 . . . . 0.0 111.832 -179.547 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -97.47 75.49 2.5 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 114.42 -1.264 . . . . 0.0 107.65 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.13 -55.51 5.04 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.431 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.495 ' HA ' ' HZ ' ' A' ' 120' ' ' PHE . . . -148.51 -12.89 0.34 Allowed 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -87.15 91.64 8.78 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.893 0.377 . . . . 0.0 110.792 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.847 HD22 HD13 ' A' ' 153' ' ' LEU . 42.7 tp -60.86 124.65 21.07 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.138 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 54.5 ttp180 -128.35 131.94 48.58 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.773 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.635 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -149.72 145.9 26.93 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.612 0.72 . . . . 0.0 111.431 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.549 ' O ' ' HD2' ' A' ' 32' ' ' TYR . 19.8 mm-40 -78.73 71.26 5.18 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.645 178.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.681 ' SG ' HD13 ' A' ' 164' ' ' LEU . 61.6 m -60.08 121.65 12.4 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.717 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 10' ' ' SER . 25.0 ttt85 -67.91 132.08 46.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.038 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.718 ' HG2' ' HA3' ' A' ' 162' ' ' GLY . 18.8 mtm180 -103.75 155.88 18.25 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.27 -11.48 3.49 Favored Glycine 0 C--N 1.336 0.548 0 O-C-N 124.383 1.052 . . . . 0.0 114.389 -178.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -80.25 -4.46 53.33 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.19 10.97 73.59 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -179.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.66 152.68 17.37 Favored Glycine 0 C--O 1.225 -0.456 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.97 -178.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.549 ' HD2' ' O ' ' A' ' 24' ' ' GLU . 70.9 m-85 -101.55 125.31 48.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.721 0.296 . . . . 0.0 110.247 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.7 p -117.8 141.13 48.76 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.046 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.8 m -72.66 111.99 8.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.262 0.553 . . . . 0.0 111.219 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.416 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 44.2 t -115.32 148.61 39.02 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.343 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.6 p -144.97 137.96 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.944 0.402 . . . . 0.0 111.561 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.595 HG22 HD23 ' A' ' 164' ' ' LEU . 14.0 tt -134.5 154.2 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.341 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -89.17 110.24 21.01 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 121.836 -0.54 . . . . 0.0 111.487 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.569 HD23 ' HB3' ' A' ' 21' ' ' LEU . 2.9 mm? -87.55 -6.81 58.17 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.512 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.59 -17.27 64.57 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.1 mtt-85 -95.08 2.7 55.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.992 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 96.1 m-85 -131.36 -23.23 2.41 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.689 HD22 HD13 ' A' ' 151' ' ' ILE . 63.2 mt -105.98 136.59 45.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.845 0.355 . . . . 0.0 111.576 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.469 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 15.8 m -134.79 136.35 42.49 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.15 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.829 HD22 ' HA ' ' A' ' 120' ' ' PHE . 8.3 p30 -80.2 107.77 13.27 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.418 177.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -113.87 94.96 5.07 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.503 ' HA ' ' HB2' ' A' ' 142' ' ' TYR . 7.7 t30 56.95 49.41 14.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.756 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.552 ' O ' ' HB2' ' A' ' 149' ' ' SER . . . 71.91 31.12 64.87 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.201 178.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.511 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 38.8 m80 -144.45 129.04 18.11 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.732 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 26.3 m-85 -68.4 136.96 54.13 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.589 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -144.0 132.49 22.19 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.069 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.618 ' CD1' HD11 ' A' ' 151' ' ' ILE . 99.8 m95 -75.11 134.41 41.32 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.163 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.2 m -111.24 154.22 12.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.985 0.421 . . . . 0.0 109.91 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.0 t -97.36 1.19 49.1 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.7 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 167.41 -31.22 0.19 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.263 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.29 -173.31 28.66 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.091 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -164.42 96.27 0.13 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.881 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.98 49.89 0.27 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.276 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -118.98 -40.5 0.64 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.155 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.27 64.73 0.61 Allowed Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.615 -0.803 . . . . 0.0 112.486 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -178.14 -121.3 0.69 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.858 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 87.9 m -131.13 126.43 35.69 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.057 0.456 . . . . 0.0 110.581 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.465 ' HB1' ' HG2' ' A' ' 110' ' ' LYS . . . -132.65 176.32 8.55 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.263 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.439 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 4.8 p -127.41 121.33 30.6 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.794 0.331 . . . . 0.0 111.602 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.5 HG21 ' CE2' ' A' ' 80' ' ' PHE . 9.8 p -109.73 144.47 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.75 0.31 . . . . 0.0 110.411 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 18.1 m -88.19 128.07 35.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.101 0.477 . . . . 0.0 110.395 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.492 ' CG2' HD12 ' A' ' 99' ' ' ILE . 57.1 t -73.16 128.11 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.743 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -100.83 169.2 9.16 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 124.577 1.173 . . . . 0.0 111.196 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.618 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 26.4 tp60 -68.19 112.17 4.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.75 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.38 18.55 16.37 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.71 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -125.38 117.57 24.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.619 0.247 . . . . 0.0 110.463 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.687 ' HA ' HG12 ' A' ' 99' ' ' ILE . 81.9 p -104.9 -179.03 3.82 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.665 HD22 HG23 ' A' ' 99' ' ' ILE . 0.9 OUTLIER -52.88 -41.01 63.94 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.419 178.826 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 46.5 mtm105 -63.51 -39.02 93.34 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.168 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 79' ' ' ARG . 19.6 m-20 -70.95 -41.18 71.46 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.338 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 72' ' ' THR . 35.8 mm -63.92 -46.99 92.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.656 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -56.66 -54.76 34.02 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.75 -0.659 . . . . 0.0 113.02 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -64.86 -27.41 68.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.977 0.417 . . . . 0.0 111.734 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 71.9 ttt180 -74.24 -42.21 60.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.172 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.5 ' CE2' HG21 ' A' ' 65' ' ' VAL . 68.2 m-85 -111.45 19.75 17.9 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.2 t70 54.26 36.54 25.35 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.966 0.889 . . . . 0.0 111.316 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.656 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 3.6 p -113.79 163.5 14.97 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.615 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.0 t70 -92.71 124.69 36.9 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.935 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.515 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 4.0 p90 -51.67 -30.34 21.47 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.255 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.407 ' HD2' HD22 ' A' ' 95' ' ' ASN . 6.5 t-80 -64.71 -44.36 90.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.029 178.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.702 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 28.0 mm-40 -67.02 -48.25 68.93 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.934 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.615 HG13 ' O ' ' A' ' 83' ' ' ASP . 3.4 mt -53.46 -46.19 58.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.592 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.1 -51.28 67.21 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.35 178.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -57.35 -39.56 76.21 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.618 0.246 . . . . 0.0 111.53 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.702 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 63.9 mmt-85 -63.06 -37.51 87.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.009 0.433 . . . . 0.0 110.778 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.728 HD22 HD13 ' A' ' 93' ' ' ILE . 64.0 t30 -89.38 -5.34 57.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.948 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 95.2 m-20 74.46 22.16 2.18 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.556 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.728 HD13 HD22 ' A' ' 91' ' ' ASN . 14.8 pt -108.18 -176.98 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.212 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.454 ' H ' ' HB2' ' A' ' 97' ' ' ASP . 85.1 mm-40 -108.98 155.96 20.27 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.493 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.7 p30 -55.12 -60.43 3.39 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-O 122.104 0.954 . . . . 0.0 109.119 178.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -74.09 11.5 0.9 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.036 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.454 ' HB2' ' H ' ' A' ' 94' ' ' GLN . 5.3 t70 -64.86 -33.15 75.32 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.425 HD22 HG21 ' A' ' 72' ' ' THR . 51.0 mt 70.05 111.84 0.05 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.11 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.687 HG12 ' HA ' ' A' ' 72' ' ' THR . 9.2 pt -94.7 172.54 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.158 -178.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.499 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 19.3 m-85 -125.43 157.97 66.01 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.86 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.618 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 23.2 Cg_endo -65.25 132.63 32.28 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.986 2.458 . . . . 0.0 113.492 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.78 21.05 10.67 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.843 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.531 ' O ' ' HA ' ' A' ' 66' ' ' THR . 51.2 mt-30 -110.46 167.72 10.0 Favored 'General case' 0 C--O 1.215 -0.712 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.044 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.439 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 81.5 t -125.84 111.0 25.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.543 HD11 HG21 ' A' ' 99' ' ' ILE . 90.7 mt -107.16 150.63 26.39 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.155 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.614 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 47.4 mt-30 -89.41 114.92 26.44 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.713 0.768 . . . . 0.0 110.927 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.6 m -121.06 150.86 54.32 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 114.358 -1.292 . . . . 0.0 109.794 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.66 -19.81 59.74 Favored 'Trans proline' 0 N--CA 1.472 0.211 0 C-N-CA 123.458 2.772 . . . . 0.0 114.351 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.5 t -151.54 145.85 25.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.975 0.417 . . . . 0.0 110.382 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.485 ' HE2' ' OD1' ' A' ' 119' ' ' ASN . 19.9 mmmt -88.6 177.01 6.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.309 0.576 . . . . 0.0 111.566 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.59 153.23 10.45 Favored Glycine 0 N--CA 1.439 -1.106 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -177.08 -170.7 39.84 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.222 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.1 p -80.87 -18.35 47.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.998 0.427 . . . . 0.0 111.298 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -129.31 46.09 1.1 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.027 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.66 -70.7 1.67 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.439 -0.41 . . . . 0.0 112.865 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.49 61.33 1.18 Allowed Glycine 0 N--CA 1.442 -0.923 0 N-CA-C 111.746 -0.541 . . . . 0.0 111.746 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -93.05 -38.09 11.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.405 0.621 . . . . 0.0 109.533 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.469 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -93.56 -59.74 1.19 Allowed Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.485 ' OD1' ' HE2' ' A' ' 110' ' ' LYS . 40.1 m-80 74.51 27.49 1.37 Allowed 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.607 0.763 . . . . 0.0 112.636 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.829 ' HA ' HD22 ' A' ' 45' ' ' ASN . 19.4 p90 -62.36 -38.32 89.07 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.006 178.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.484 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 58.2 t-105 -61.72 -29.78 70.33 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 123.63 0.581 . . . . 0.0 111.634 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.15 -34.64 45.61 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.355 0.597 . . . . 0.0 110.539 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.956 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 17.8 m -132.64 32.34 3.88 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.484 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -114.37 137.36 51.91 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.403 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -131.95 151.3 51.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.183 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.6 t70 55.79 49.09 16.86 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.845 0.831 . . . . 0.0 109.763 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.496 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 29.6 t -77.2 119.29 25.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.746 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -142.36 144.21 33.06 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.79 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.867 HD13 HG22 ' A' ' 14' ' ' ILE . 19.8 mt -87.76 125.46 34.44 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.613 HG23 ' HB ' ' A' ' 135' ' ' VAL . 30.4 m -118.11 158.2 19.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.809 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 69.06 4.78 4.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.157 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.634 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 97.37 30.69 7.19 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.81 -0.709 . . . . 0.0 113.384 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 93.66 -21.38 41.48 Favored Glycine 0 C--O 1.266 2.097 0 CA-C-O 123.043 1.357 . . . . 0.0 113.112 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.849 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 15.8 ptpt -65.81 -17.88 64.94 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 121.785 -0.832 . . . . 0.0 108.834 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.613 ' HB ' HG23 ' A' ' 130' ' ' VAL . 17.2 t -139.47 141.62 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.676 177.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.587 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 24.4 tp -121.12 123.15 41.6 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.567 ' OE2' ' HD2' ' A' ' 148' ' ' ARG . 23.1 tt0 -117.26 131.34 56.85 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.1 0.476 . . . . 0.0 111.182 -177.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . . . -159.98 160.3 33.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.433 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -94.67 109.14 21.1 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.819 ' HG ' ' CB ' ' A' ' 45' ' ' ASN . 0.8 OUTLIER -91.7 131.04 37.37 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.016 -179.528 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.956 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 36.5 ttt180 -75.98 140.56 42.09 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.6 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.503 ' HB2' ' HA ' ' A' ' 47' ' ' ASN . 3.5 p90 -154.46 -176.23 5.79 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.852 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 46.6 m -56.28 -27.96 57.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.859 0.361 . . . . 0.0 111.686 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -97.35 25.76 25.77 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.283 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.85 -120.08 6.33 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.756 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -126.72 137.26 53.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.575 0.226 . . . . 0.0 110.473 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -133.93 132.9 40.78 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.369 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.567 ' HD2' ' OE2' ' A' ' 137' ' ' GLU . 16.3 ttp180 -74.87 98.11 3.47 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.56 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.552 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 35.1 t -106.15 164.38 12.04 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.907 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 15.8 ptt180 -147.62 145.94 29.17 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.694 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.732 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 14.7 tt -129.85 150.62 34.8 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.576 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.827 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 80.7 m-85 -89.46 103.88 16.48 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 122.144 -0.347 . . . . 0.0 111.079 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.847 HD13 HD22 ' A' ' 21' ' ' LEU . 34.2 mt -66.68 -33.78 76.41 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.299 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.849 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 10.1 t70 -58.42 -8.18 1.11 Allowed 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.159 178.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.827 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 38.8 mt-10 -68.77 -51.88 36.41 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 121.117 0.484 . . . . 0.0 111.785 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.433 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 88.6 m-70 -119.25 -15.03 9.2 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.156 -177.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.466 HG21 HD21 ' A' ' 21' ' ' LEU . 50.2 mm -88.21 112.95 24.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.153 -179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.499 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -119.49 173.71 15.18 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.715 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.566 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.7 t30 -113.3 127.71 56.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -122.26 93.15 3.89 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 66.6 t30 53.05 58.15 5.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.545 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.718 ' HA3' ' HG2' ' A' ' 27' ' ' ARG . . . 78.91 11.41 85.24 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.567 -0.742 . . . . 0.0 114.821 178.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -123.75 143.66 50.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 117.542 0.671 . . . . 0.0 110.958 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.742 HD11 ' HD2' ' A' ' 7' ' ' PHE . 5.5 tp -91.58 118.8 30.93 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.944 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.7 pp -129.3 175.36 10.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.807 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.433 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 25.9 p80 -118.22 138.03 52.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.546 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 6.2 p . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.563 -0.732 . . . . 0.0 110.722 -178.83 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.663 0 N-CA-C 111.454 -0.658 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.507 ' HB2' ' HB3' ' A' ' 154' ' ' ASP . 4.0 m120 -78.11 -72.82 0.35 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.86 0.33 . . . . 0.0 111.366 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.629 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 55.4 m-85 -134.9 -92.3 0.3 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.502 ' HB1' ' SG ' ' A' ' 167' ' ' CYS . . . -108.52 -30.74 8.1 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -178.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.96 -69.97 1.22 Allowed Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 119.825 -1.178 . . . . 0.0 112.448 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 62.18 21.15 12.24 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 122.606 0.362 . . . . 0.0 111.229 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.713 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -64.32 -33.34 75.61 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 121.12 -0.232 . . . . 0.0 110.873 179.368 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.409 ' HA ' HD11 ' A' ' 14' ' ' ILE . 42.6 t -61.95 -18.24 59.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.47 0.653 . . . . 0.0 110.188 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.17 -31.46 69.14 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.124 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.502 ' HB2' ' HB3' ' A' ' 26' ' ' ARG . 21.6 p -126.67 -8.22 6.2 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 117.399 0.6 . . . . 0.0 111.742 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.1 m -105.32 128.95 53.74 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.44 ' CG ' ' HB2' ' A' ' 24' ' ' GLU . 13.8 ptm180 -110.05 -176.71 3.07 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.452 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 21.7 m-20 43.27 44.47 4.61 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 124.036 0.835 . . . . 0.0 112.306 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.901 HG22 HD13 ' A' ' 129' ' ' LEU . 8.3 mt -79.6 103.2 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -178.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.57 ' CA ' HD12 ' A' ' 129' ' ' LEU . 57.7 m -147.1 127.2 13.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.707 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.743 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -96.98 151.29 19.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.711 0.767 . . . . 0.0 112.805 -179.604 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 21.7 t70 -93.82 74.74 4.24 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 177.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.42 -54.44 4.9 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.155 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.559 ' HB1' ' HB2' ' A' ' 40' ' ' ASN . . . -147.97 -12.83 0.37 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.264 -0.468 . . . . 0.0 109.742 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.482 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -82.55 86.74 6.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.545 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.743 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 35.9 tp -60.95 124.45 20.53 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.485 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.546 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 34.7 ttt180 -132.17 127.59 36.23 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.877 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.604 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -146.0 145.98 30.82 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.668 0.747 . . . . 0.0 111.421 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.452 ' HG3' ' HB2' ' A' ' 13' ' ' ASP . 2.1 mm-40 -83.68 76.4 9.98 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.411 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.601 ' SG ' HD13 ' A' ' 164' ' ' LEU . 35.8 m -66.54 125.57 26.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.393 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.502 ' HB3' ' HB2' ' A' ' 10' ' ' SER . 30.3 ttt180 -70.41 121.75 18.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.651 178.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 27' ' ' ARG . 10.7 ptp180 -100.05 163.84 12.25 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.755 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.4 -15.95 4.54 Favored Glycine 0 C--N 1.34 0.782 0 O-C-N 124.934 1.396 . . . . 0.0 114.114 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.6 -12.49 61.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.516 0.674 . . . . 0.0 109.417 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.57 9.52 62.86 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.654 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -119.93 162.26 14.11 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.08 -1.057 . . . . 0.0 113.286 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.473 ' CE2' ' HB2' ' A' ' 26' ' ' ARG . 84.2 m-85 -100.44 125.2 46.71 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.0 p -116.6 140.76 49.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.393 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -73.58 113.92 11.23 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.17 0.51 . . . . 0.0 111.43 -178.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 32.9 t -116.14 151.02 36.46 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.649 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.6 p -144.77 139.6 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.308 0.575 . . . . 0.0 112.091 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.408 HG23 ' HB3' ' A' ' 21' ' ' LEU . 13.7 tt -135.47 143.38 36.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.479 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -76.34 96.85 4.08 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.603 HD23 HD11 ' A' ' 43' ' ' LEU . 5.3 tp -73.5 -4.54 34.47 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.046 0.45 . . . . 0.0 110.408 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.559 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 64.3 t30 -73.83 -11.7 60.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.511 ' HG2' ' HA3' ' A' ' 116' ' ' GLY . 74.0 mtt180 -102.48 5.08 39.32 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.233 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 13.7 m-85 -127.57 -26.09 3.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.778 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.665 ' HB2' ' CD1' ' A' ' 120' ' ' PHE . 49.3 mt -105.02 138.76 40.73 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.8 0.333 . . . . 0.0 110.899 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.454 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 4.0 m -134.68 134.76 41.46 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.678 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.686 HD21 HD22 ' A' ' 140' ' ' LEU . 1.0 OUTLIER -73.33 110.37 7.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.685 177.221 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -111.9 86.95 2.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.245 0.545 . . . . 0.0 110.407 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.41 ' HA ' ' HB2' ' A' ' 142' ' ' TYR . 21.5 t-20 51.82 46.22 26.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.23 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.498 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 82.98 40.01 9.7 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.573 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.415 ' HA ' ' HB3' ' A' ' 149' ' ' SER . 16.5 t60 -162.2 128.63 3.64 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.886 ' HB2' ' HB ' ' A' ' 151' ' ' ILE . 96.2 m-85 -67.6 156.81 35.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.817 0.342 . . . . 0.0 111.146 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.433 ' HA ' ' HD3' ' A' ' 51' ' ' ARG . 16.7 mmt180 -148.91 126.89 11.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.169 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.976 ' HZ2' ' HA ' ' A' ' 153' ' ' LEU . 72.9 m95 -75.94 125.15 28.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.511 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.6 m -119.92 113.18 39.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.409 0.623 . . . . 0.0 110.096 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.1 m -92.74 48.93 1.4 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.26 0.552 . . . . 0.0 110.271 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.97 1.76 88.68 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.279 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.44 71.28 2.52 Favored Glycine 0 C--O 1.237 0.32 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.455 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -91.7 -31.88 9.05 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.476 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -79.32 79.24 1.65 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.234 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.15 75.86 2.13 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.356 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.03 -145.63 17.81 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.334 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.03 -124.01 6.3 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.113 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 83.6 m -130.11 120.08 24.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.088 0.47 . . . . 0.0 110.595 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.486 ' HB1' ' HG2' ' A' ' 110' ' ' LYS . . . -122.26 176.38 5.88 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.586 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.466 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 13.2 p -127.73 111.03 13.23 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.905 0.383 . . . . 0.0 111.176 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.568 HG21 ' CE2' ' A' ' 80' ' ' PHE . 9.1 p -97.54 144.37 11.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.042 0.448 . . . . 0.0 111.218 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 8.2 m -91.09 127.46 36.52 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.478 ' CG2' HD12 ' A' ' 99' ' ' ILE . 49.1 t -75.87 131.68 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.585 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -98.08 168.95 9.95 Favored 'General case' 0 N--CA 1.445 -0.679 0 O-C-N 124.657 1.223 . . . . 0.0 110.569 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.593 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 52.3 tt0 -69.65 119.75 14.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.781 -178.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.39 -1.67 50.1 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.475 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -110.12 131.71 54.82 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.084 0.469 . . . . 0.0 111.687 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.652 ' HA ' HG12 ' A' ' 99' ' ' ILE . 67.5 p -108.59 -177.62 3.37 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.651 HD22 HG23 ' A' ' 99' ' ' ILE . 1.4 mm? -52.85 -40.81 63.71 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.454 0.645 . . . . 0.0 109.889 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.0 ttm-85 -62.9 -37.16 85.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.211 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -74.15 -42.0 60.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.905 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 72' ' ' THR . 44.7 mm -62.0 -48.31 89.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.715 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -54.44 -52.87 41.87 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.688 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -64.5 -33.7 76.5 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 35.7 ttm-85 -68.69 -37.46 79.56 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.609 ' HE1' ' HA3' ' A' ' 111' ' ' GLY . 87.1 m-85 -111.72 18.37 19.03 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 55.02 34.07 21.67 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.236 0.541 . . . . 0.0 111.794 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.715 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 3.0 p -111.37 170.49 8.09 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.608 ' HB3' ' HG3' ' A' ' 86' ' ' GLU . 32.6 t0 -98.26 121.53 40.3 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.419 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.503 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 4.3 p90 -51.82 -29.72 20.42 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.586 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.461 ' HB2' ' OD2' ' A' ' 83' ' ' ASP . 69.2 m80 -63.8 -47.22 81.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.513 177.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.748 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 41.6 mt-10 -62.05 -53.49 54.75 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.942 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.587 HG13 ' O ' ' A' ' 83' ' ' ASP . 3.3 mt -48.0 -46.6 12.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.275 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.601 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.72 -51.06 68.64 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.211 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 89' ' ' ARG . 49.4 mtp85 -59.16 -36.77 75.85 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.748 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 12.3 mmt85 -69.43 -30.44 68.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.699 0.285 . . . . 0.0 110.98 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 2.6 t-20 -95.1 -4.72 45.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.825 0.345 . . . . 0.0 110.871 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 15.9 m120 78.25 13.81 1.52 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.769 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.601 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 19.6 pt -101.64 -173.55 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.288 179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.508 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . 64.4 mt-30 -113.88 157.64 22.1 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.126 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.574 ' O ' HD23 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -56.54 -69.73 0.14 Allowed 'General case' 0 C--O 1.244 0.778 0 CA-C-O 122.061 0.934 . . . . 0.0 110.101 179.663 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -73.28 13.91 0.38 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.716 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.508 ' HB2' ' HB2' ' A' ' 94' ' ' GLN . 1.9 t70 -65.99 -29.32 69.69 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.094 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 8.8 mp 71.33 112.3 0.06 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 122.033 0.921 . . . . 0.0 110.55 -178.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.652 HG12 ' HA ' ' A' ' 72' ' ' THR . 9.0 pt -94.59 177.22 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.155 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.519 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 79.2 m-85 -128.7 158.77 71.09 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.593 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 28.1 Cg_endo -67.0 138.96 49.56 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.949 2.433 . . . . 0.0 113.056 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.35 18.49 42.07 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.508 ' O ' ' HA ' ' A' ' 66' ' ' THR . 41.4 tt0 -103.89 164.28 11.8 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.466 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 69.7 t -125.58 118.2 51.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 120.938 0.399 . . . . 0.0 109.978 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.509 ' HB3' HG22 ' A' ' 87' ' ' ILE . 78.9 mt -114.44 151.07 33.77 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.147 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.534 ' HB2' ' CB ' ' A' ' 90' ' ' ARG . 75.8 mt-30 -90.91 115.2 27.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.668 0.747 . . . . 0.0 110.92 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.444 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 34.0 m -126.99 151.97 74.91 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.843 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.444 ' HD2' ' HB ' ' A' ' 107' ' ' VAL . 29.7 Cg_endo -63.8 -15.37 48.55 Favored 'Trans proline' 0 N--CA 1.474 0.352 0 C-N-CA 123.624 2.883 . . . . 0.0 115.207 -177.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.6 t -153.2 150.75 29.34 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.225 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.539 ' HE3' ' HA ' ' A' ' 65' ' ' VAL . 12.6 mmmm -98.46 170.32 8.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.069 0.461 . . . . 0.0 110.942 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.609 ' HA3' ' HE1' ' A' ' 80' ' ' PHE . . . -132.34 144.84 16.71 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -74.66 -82.43 0.42 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.586 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 19.5 m 55.25 47.01 22.51 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.25 0.548 . . . . 0.0 110.636 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 122.28 47.48 0.28 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.387 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 117.17 156.64 10.54 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.001 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.511 ' HA3' ' HG2' ' A' ' 41' ' ' ARG . . . -152.07 -71.14 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.459 -0.657 . . . . 0.0 111.459 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 41' ' ' ARG . . . -140.62 -44.44 0.4 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.064 0.459 . . . . 0.0 110.853 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . -87.76 -57.63 1.92 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.257 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 71.89 29.4 2.45 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 123.055 0.542 . . . . 0.0 111.373 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.665 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 12.5 p90 -61.19 -37.98 84.88 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.107 0.48 . . . . 0.0 110.183 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.452 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 48.6 t-105 -64.85 -26.25 68.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.636 -178.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.46 -18.3 61.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.213 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.78 ' HB2' ' HB3' ' A' ' 141' ' ' ARG . 11.2 p -140.07 22.67 2.42 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.971 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.452 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -111.73 141.96 44.69 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.901 0.382 . . . . 0.0 111.091 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -133.74 151.2 51.54 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 58.83 34.81 23.94 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.363 0.414 . . . . 0.0 111.646 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.498 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 30.8 t -66.92 123.82 20.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.81 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.491 ' O ' HD12 ' A' ' 136' ' ' LEU . 39.1 ptt180 -148.12 142.71 26.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.088 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.901 HD13 HG22 ' A' ' 14' ' ' ILE . 22.3 mt -85.52 131.79 34.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.081 0.467 . . . . 0.0 110.044 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.617 HG23 ' HB ' ' A' ' 135' ' ' VAL . 27.5 m -126.92 162.36 31.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.825 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 67.16 7.26 5.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.785 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.686 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 95.39 31.35 7.58 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.914 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.777 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 90.03 -19.28 43.23 Favored Glycine 0 CA--C 1.541 1.671 0 CA-C-O 123.226 1.459 . . . . 0.0 112.824 177.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.773 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 0.7 OUTLIER -68.18 -14.92 63.34 Favored 'General case' 0 C--N 1.314 -0.952 0 O-C-N 121.121 -1.223 . . . . 0.0 109.564 178.071 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.617 ' HB ' HG23 ' A' ' 130' ' ' VAL . 14.6 t -140.49 149.06 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.783 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 39.0 tp -130.72 125.25 33.4 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.403 ' HG2' ' HD2' ' A' ' 148' ' ' ARG . 33.6 tt0 -114.65 136.25 53.25 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.622 0.249 . . . . 0.0 111.363 -177.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.802 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.73 163.51 26.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.105 0.479 . . . . 0.0 111.323 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -94.72 106.5 18.49 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.686 HD22 HD21 ' A' ' 45' ' ' ASN . 36.6 mt -96.25 132.23 41.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.104 0.478 . . . . 0.0 111.316 -178.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.78 ' HB3' ' HB2' ' A' ' 123' ' ' SER . 42.5 ttt180 -75.82 140.55 42.34 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.256 -0.883 . . . . 0.0 110.674 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.509 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.7 p90 -160.3 -170.3 2.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.429 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 6.1 p -56.12 -29.29 60.46 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -94.49 11.67 69.84 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.726 -0.749 . . . . 0.0 113.171 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 141' ' ' ARG . . . 101.08 -111.46 4.14 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.039 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -126.75 129.85 49.17 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.509 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 9.1 t30 -125.55 140.19 52.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.992 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.403 ' HD2' ' HG2' ' A' ' 137' ' ' GLU . 12.5 tpp85 -73.49 100.04 3.16 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.415 ' HB3' ' HA ' ' A' ' 49' ' ' HIS . 1.0 OUTLIER -111.62 155.43 23.38 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.425 -177.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 4.8 ptp180 -146.51 145.28 30.1 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.135 0.493 . . . . 0.0 111.274 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.886 ' HB ' ' HB2' ' A' ' 50' ' ' PHE . 15.4 tt -126.47 159.74 35.22 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.81 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.489 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.871 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 68.5 m-85 -103.94 107.15 17.9 Favored 'General case' 0 C--N 1.311 -1.106 0 O-C-N 122.361 -0.212 . . . . 0.0 110.655 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.976 ' HA ' ' HZ2' ' A' ' 52' ' ' TRP . 8.4 mp -68.9 -37.18 78.81 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.221 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.773 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 6.1 t70 -57.08 -8.41 0.66 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.869 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.871 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 61.0 mt-10 -73.78 -55.43 6.24 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 121.972 -0.455 . . . . 0.0 111.811 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.534 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 88.7 m-70 -122.0 9.8 10.02 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.114 -0.634 . . . . 0.0 112.671 -177.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.446 ' HB ' ' O ' ' A' ' 153' ' ' LEU . 45.1 mm -110.95 109.62 29.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.356 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 167' ' ' CYS . . . -115.58 166.65 12.26 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.048 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.565 ' CG ' ' HB3' ' A' ' 25' ' ' CYS . 1.8 t30 -101.51 124.84 47.83 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.413 ' NH2' ' HG2' ' A' ' 163' ' ' GLU . 48.3 ttp180 -112.99 86.12 2.31 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.694 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 50.26 51.06 17.48 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 92.87 6.64 63.41 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.762 178.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.413 ' HG2' ' NH2' ' A' ' 160' ' ' ARG . 6.7 tp10 -122.16 149.75 43.17 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.713 HD11 ' CD2' ' A' ' 7' ' ' PHE . 5.3 tp -99.11 118.16 35.22 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.503 HG12 ' H ' ' A' ' 166' ' ' HIS . 12.2 tt -145.16 170.21 6.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.673 -178.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.534 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 19.3 p80 -70.87 123.18 21.38 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.565 ' O ' ' HA3' ' A' ' 158' ' ' GLY . 53.3 t . . . . . 0 C--O 1.247 0.941 0 O-C-N 123.852 0.72 . . . . 0.0 111.576 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.645 ' HA3' ' OD1' ' A' ' 6' ' ' ASN . . . . . . . . 0 N--CA 1.483 1.811 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -100.72 -68.51 0.81 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.479 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 53.5 m-85 -128.97 -94.6 0.42 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.31 -29.39 10.8 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.66 -73.41 0.58 Allowed Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 119.772 -1.204 . . . . 0.0 113.154 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.645 ' OD1' ' HA3' ' A' ' 1' ' ' GLY . 36.5 m-80 65.26 15.61 10.1 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 122.46 0.304 . . . . 0.0 110.484 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.61 ' CE2' HD13 ' A' ' 14' ' ' ILE . 1.4 p90 -60.14 -37.26 79.53 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.562 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.588 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.7 OUTLIER -59.85 -24.05 63.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.268 0.556 . . . . 0.0 110.604 -179.427 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.87 -33.96 87.25 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.404 -0.816 . . . . 0.0 113.44 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 18.8 p -121.12 -3.74 9.55 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 117.188 0.494 . . . . 0.0 111.689 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.7 m -110.39 131.85 54.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.119 0.485 . . . . 0.0 109.997 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.597 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 18.8 ptt180 -107.95 179.94 4.08 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 42.52 47.79 4.48 Favored 'General case' 0 C--N 1.316 -0.867 0 O-C-N 123.883 0.739 . . . . 0.0 112.767 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.777 HG22 HD13 ' A' ' 129' ' ' LEU . 7.3 mt -81.49 102.44 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-O 121.043 0.449 . . . . 0.0 109.919 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.562 ' HA ' HD12 ' A' ' 129' ' ' LEU . 46.4 t -147.76 128.69 14.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.457 -0.792 . . . . 0.0 108.985 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.741 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -92.99 159.48 15.29 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.629 0.728 . . . . 0.0 112.007 -179.241 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -104.31 77.64 1.42 Allowed 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.22 -61.02 4.52 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.134 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' A' ' 40' ' ' ASN . . . -146.02 -13.36 0.48 Allowed 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.282 -0.459 . . . . 0.0 109.913 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -86.16 95.15 9.48 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.81 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.894 ' HB2' HD22 ' A' ' 39' ' ' LEU . 33.8 tp -59.75 128.27 36.11 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.758 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 35' ' ' SER . 34.8 ttp180 -133.17 128.03 35.13 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.939 -178.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.621 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -149.47 147.29 28.05 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.546 0.688 . . . . 0.0 111.144 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.597 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 2.1 mm-40 -82.96 79.62 9.26 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.464 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.574 ' HB3' ' CG ' ' A' ' 159' ' ' ASN . 61.4 m -67.34 129.43 39.89 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.762 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 10' ' ' SER . 43.1 ttp180 -72.35 120.8 18.46 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.251 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.7 ttt-85 -96.05 153.71 17.63 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.09 -16.37 4.33 Favored Glycine 0 C--N 1.335 0.493 0 O-C-N 124.611 1.194 . . . . 0.0 114.765 -177.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.87 -13.88 61.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.238 0.542 . . . . 0.0 110.001 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.38 10.13 56.09 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.59 160.64 13.9 Favored Glycine 0 C--O 1.225 -0.461 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.485 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.522 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 88.5 m-85 -97.98 130.59 44.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.955 0.407 . . . . 0.0 110.685 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.0 m -110.69 129.1 55.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.364 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.36 110.37 5.26 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 29.4 t -112.46 147.17 37.08 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.219 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.668 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.3 p -144.76 133.09 17.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.027 0.441 . . . . 0.0 110.686 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.407 HG23 ' HB3' ' A' ' 21' ' ' LEU . 11.0 tt -133.93 146.83 30.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.648 -177.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -78.96 103.74 9.11 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.924 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.894 HD22 ' HB2' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -78.96 -5.17 53.13 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 120.858 0.361 . . . . 0.0 110.245 178.601 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.651 HD22 ' HB3' ' A' ' 121' ' ' TRP . 25.1 t-20 -70.9 -17.88 62.69 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -106.07 17.49 23.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.382 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 41.3 m-85 -135.97 -34.7 0.8 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.314 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.856 HD22 HD13 ' A' ' 151' ' ' ILE . 38.6 mt -106.09 136.32 45.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.867 -179.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.681 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 3.0 m -126.6 143.59 51.17 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.78 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.629 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 6.8 p-10 -93.23 93.56 8.31 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 122.01 0.909 . . . . 0.0 108.568 178.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.422 ' HB3' ' HG3' ' A' ' 51' ' ' ARG . 31.9 t70 -94.3 95.74 9.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.16 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 54.68 45.65 26.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.525 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.703 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 77.87 29.94 53.23 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.467 178.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.556 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 23.7 t-160 -148.03 124.93 11.27 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.799 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 25.3 m-85 -62.54 136.42 57.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.248 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.422 ' HG3' ' HB3' ' A' ' 46' ' ' ASP . 17.1 mmm180 -145.01 133.12 21.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.701 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.469 ' CD1' HD11 ' A' ' 151' ' ' ILE . 98.6 m95 -73.47 109.64 7.15 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.8 t 64.76 -78.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 O-C-N 123.865 0.728 . . . . 0.0 110.986 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.0 t -138.91 12.76 2.67 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.442 0.639 . . . . 0.0 109.495 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.417 ' HA3' ' CZ ' ' A' ' 51' ' ' ARG . . . 81.67 100.25 0.4 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.668 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.9 167.76 20.95 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.984 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.52 -156.62 7.61 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.94 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.07 155.52 53.56 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.537 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.54 -88.97 0.9 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.575 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 152.63 -132.76 3.81 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.821 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -169.43 169.69 42.15 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.168 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.6 m -129.05 124.75 35.67 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.067 0.46 . . . . 0.0 110.472 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -126.46 176.76 6.92 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.665 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.1 p -128.37 118.01 22.42 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 t -107.06 137.2 39.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.802 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 18.9 m -87.78 124.82 34.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.081 0.467 . . . . 0.0 109.916 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.501 ' CG2' HD12 ' A' ' 99' ' ' ILE . 42.2 t -71.06 133.91 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.125 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.494 ' HB3' ' OD2' ' A' ' 71' ' ' ASP . 4.5 tt0 -104.16 171.33 7.4 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 124.464 1.103 . . . . 0.0 110.411 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.673 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 58.9 tp60 -60.22 119.68 8.35 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.374 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.94 6.53 79.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.996 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.494 ' OD2' ' HB3' ' A' ' 68' ' ' GLN . 27.6 m-20 -103.82 124.03 48.17 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 117.393 0.597 . . . . 0.0 110.581 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.625 ' HA ' HG12 ' A' ' 99' ' ' ILE . 80.3 p -105.18 179.44 4.27 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.571 ' CD2' HG23 ' A' ' 99' ' ' ILE . 2.2 mm? -51.6 -41.57 61.32 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.59 0.709 . . . . 0.0 109.403 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -59.61 -39.36 83.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.384 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 79' ' ' ARG . 13.4 m-20 -73.85 -46.65 43.68 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.119 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 72' ' ' THR . 42.4 mm -57.12 -48.05 82.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.709 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.736 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -59.78 -54.28 38.9 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.852 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -33.04 74.39 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.92 0.39 . . . . 0.0 111.524 -178.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 35.6 ttt180 -74.0 -39.82 63.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.031 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -105.78 19.33 20.73 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 59.26 26.82 15.71 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.736 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -110.12 168.64 9.29 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.503 ' O ' HG13 ' A' ' 87' ' ' ILE . 4.3 p-10 -96.65 122.17 39.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.71 0.767 . . . . 0.0 109.836 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.422 ' HA ' HD12 ' A' ' 87' ' ' ILE . 3.0 p90 -48.64 -32.16 7.83 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.036 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.41 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 10.9 m80 -60.36 -48.93 79.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.991 178.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.608 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 28.4 tt0 -63.18 -46.33 87.62 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.205 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.54 ' HB ' HD12 ' A' ' 73' ' ' LEU . 3.5 mt -52.51 -49.58 43.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.572 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.27 -49.21 74.97 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.408 178.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 85' ' ' HIS . 62.0 mtm180 -56.67 -38.13 71.77 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.608 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 13.0 mtt180 -70.02 -36.29 74.98 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.158 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.806 HD22 HD13 ' A' ' 93' ' ' ILE . 66.8 t30 -85.76 -5.51 59.24 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.964 0.411 . . . . 0.0 110.276 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 15.9 m120 75.5 18.92 2.2 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.611 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.806 HD13 HD22 ' A' ' 91' ' ' ASN . 14.3 pt -105.66 -170.38 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.204 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.556 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 28.5 mm-40 -117.97 158.72 24.41 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.506 ' O ' HD23 ' A' ' 73' ' ' LEU . 6.3 p30 -55.72 -57.62 11.26 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-O 121.877 0.846 . . . . 0.0 109.956 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.12 12.51 2.78 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 121.831 -0.543 . . . . 0.0 111.294 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.556 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 0.8 OUTLIER -62.69 -31.2 72.06 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.617 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 7.0 mp 71.38 111.18 0.06 Allowed 'General case' 0 C--N 1.338 0.108 0 O-C-N 124.358 1.037 . . . . 0.0 110.732 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.649 HG21 HD11 ' A' ' 105' ' ' LEU . 6.4 pt -94.43 176.0 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.977 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.476 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 92.7 m-85 -121.07 158.2 53.28 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.91 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.673 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 43.4 Cg_endo -72.3 133.36 20.88 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 123.042 2.495 . . . . 0.0 112.889 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 101.59 14.12 30.7 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' A' ' 66' ' ' THR . 40.0 mt-30 -102.92 168.44 9.2 Favored 'General case' 0 C--O 1.216 -0.699 0 C-N-CA 120.641 -0.424 . . . . 0.0 109.956 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 63.5 t -126.15 118.48 51.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.649 HD11 HG21 ' A' ' 99' ' ' ILE . 95.8 mt -113.93 150.07 34.28 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.188 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -89.58 110.72 21.55 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.986 0.898 . . . . 0.0 111.21 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.1 m -115.59 151.57 46.28 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.555 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.71 -18.06 53.02 Favored 'Trans proline' 0 C--N 1.331 -0.349 0 C-N-CA 123.069 2.513 . . . . 0.0 114.376 -178.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.0 t -154.13 148.02 25.53 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.875 0.369 . . . . 0.0 111.225 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -90.26 -172.23 3.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.09 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.55 -51.99 5.32 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.805 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 167.04 173.22 35.11 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.952 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 26.0 t -110.08 -29.83 8.04 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.066 0.46 . . . . 0.0 109.857 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.8 -52.14 4.16 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.126 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -159.86 151.22 21.89 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.6 56.85 3.04 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.045 -0.597 . . . . 0.0 111.632 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -118.49 -28.78 5.62 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.791 0.329 . . . . 0.0 110.868 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.681 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -120.47 -75.97 0.44 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.321 -0.942 . . . . 0.0 112.676 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 73.18 29.1 1.77 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.278 0.631 . . . . 0.0 111.554 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.585 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 20.0 p90 -59.87 -37.69 80.05 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-O 121.108 0.48 . . . . 0.0 110.06 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.651 ' HB3' HD22 ' A' ' 40' ' ' ASN . 4.1 t-105 -66.27 -26.55 67.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.195 -178.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.89 -25.49 66.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.139 0.495 . . . . 0.0 110.143 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.697 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 4.2 m -133.42 27.03 4.11 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.323 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.617 ' HB3' ' HE3' ' A' ' 121' ' ' TRP . . . -105.65 155.82 18.87 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.001 0.429 . . . . 0.0 110.898 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.0 mmm-85 -146.43 142.35 28.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.755 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 53.55 35.57 21.21 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.246 0.546 . . . . 0.0 111.371 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.585 ' HB ' ' CB ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -79.74 127.36 39.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.812 -179.848 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.45 ' O ' HD12 ' A' ' 136' ' ' LEU . 15.6 ptt180 -151.31 158.82 44.32 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.571 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.835 HD21 HD11 ' A' ' 153' ' ' LEU . 17.1 mt -86.1 136.59 33.16 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 120.996 0.427 . . . . 0.0 110.825 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.573 HG23 ' HB ' ' A' ' 135' ' ' VAL . 31.2 m -132.35 159.48 43.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.471 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.481 ' HB3' ' HD3' ' A' ' 134' ' ' LYS . 4.6 m-20 69.63 4.87 4.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.398 178.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.661 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 98.04 28.84 7.96 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.597 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.517 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 93.07 -18.85 55.26 Favored Glycine 0 C--O 1.269 2.283 0 CA-C-O 123.773 1.763 . . . . 0.0 112.623 177.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.695 ' HG3' HG23 ' A' ' 135' ' ' VAL . 20.9 ptmt -67.52 -19.97 65.37 Favored 'General case' 0 C--N 1.313 -0.986 0 O-C-N 121.452 -1.028 . . . . 0.0 108.82 178.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.695 HG23 ' HG3' ' A' ' 134' ' ' LYS . 4.2 t -138.15 146.67 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 121.279 0.561 . . . . 0.0 110.874 178.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.625 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 50.6 tp -126.46 116.31 20.93 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.484 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 32.5 tt0 -105.05 137.15 43.25 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.437 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.585 ' CB ' ' HB ' ' A' ' 127' ' ' VAL . . . -161.96 164.07 28.62 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.185 0.517 . . . . 0.0 112.283 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -95.9 106.25 18.37 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.703 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 50.2 mt -98.24 129.79 44.97 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.307 0.575 . . . . 0.0 111.244 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.697 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 62.4 ttt180 -71.32 141.18 50.47 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.5 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.437 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.6 p90 -159.09 -173.78 4.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.226 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 17.0 m -61.04 -26.21 67.47 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -94.83 16.12 61.93 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.875 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 102.1 -114.99 5.1 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.412 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -128.69 128.84 44.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.931 0.396 . . . . 0.0 110.371 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.437 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 47.0 t30 -124.25 130.86 53.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.218 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.474 ' HA ' ' O ' ' A' ' 138' ' ' ALA . 13.8 ttp180 -78.15 96.58 5.21 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.266 0.555 . . . . 0.0 110.617 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.556 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 20.0 t -104.13 170.43 7.92 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.172 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 8.7 mtp85 -146.22 147.73 31.75 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 121.155 -0.218 . . . . 0.0 110.615 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.856 HD13 HD22 ' A' ' 43' ' ' LEU . 9.9 tt -131.34 152.62 37.62 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.538 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.146 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.672 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 84.4 m-85 -96.65 105.02 17.06 Favored 'General case' 0 C--N 1.313 -1.012 0 O-C-N 122.286 -0.259 . . . . 0.0 111.024 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.835 HD11 HD21 ' A' ' 129' ' ' LEU . 16.9 mt -65.72 -37.24 85.86 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.11 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.663 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 9.4 t70 -53.59 -14.4 0.85 Allowed 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.144 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.672 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 41.1 mt-10 -66.51 -54.79 19.99 Favored 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 121.682 -0.636 . . . . 0.0 112.715 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.509 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 77.3 m-70 -122.18 1.05 9.69 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.141 -0.624 . . . . 0.0 112.492 -176.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 45.5 mm -104.09 110.78 31.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.484 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.73 ' HA3' ' O ' ' A' ' 167' ' ' CYS . . . -118.69 166.41 12.97 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.232 -0.985 . . . . 0.0 113.105 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.574 ' CG ' ' HB3' ' A' ' 25' ' ' CYS . 2.6 t30 -98.25 122.26 41.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.415 -0.393 . . . . 0.0 110.077 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -117.81 86.77 2.58 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 58.86 47.37 12.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.184 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.549 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 87.67 7.55 75.0 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.485 178.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -124.09 132.74 53.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.04 0.447 . . . . 0.0 111.567 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.578 HD21 ' HD2' ' A' ' 7' ' ' PHE . 30.0 mt -84.63 114.31 21.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.642 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 46.0 pt -142.24 176.66 3.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.222 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.509 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 3.6 p80 -66.68 118.6 10.47 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.44 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.73 ' O ' ' HA3' ' A' ' 158' ' ' GLY . 39.5 t . . . . . 0 C--O 1.242 0.678 0 CA-C-O 118.521 -0.752 . . . . 0.0 112.166 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.455 ' HA3' ' OD1' ' A' ' 6' ' ' ASN . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 111.659 -0.577 . . . . 0.0 111.659 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.522 ' HB3' ' HD1' ' A' ' 3' ' ' TYR . 19.0 m-80 -77.27 -76.68 0.17 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.746 0.273 . . . . 0.0 111.664 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.522 ' HD1' ' HB3' ' A' ' 2' ' ' ASN . 28.9 m-85 -129.75 -97.55 0.36 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.54 -27.41 12.37 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.2 -76.39 0.27 Allowed Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.13 -1.033 . . . . 0.0 112.91 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.455 ' OD1' ' HA3' ' A' ' 1' ' ' GLY . 30.0 m-80 65.66 11.03 7.22 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.547 0.339 . . . . 0.0 111.138 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.644 ' CE2' HD13 ' A' ' 14' ' ' ILE . 1.6 p90 -61.33 -33.02 72.91 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 121.133 -0.227 . . . . 0.0 111.281 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.533 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.8 OUTLIER -62.58 -25.41 68.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.326 0.584 . . . . 0.0 110.562 -178.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.73 -22.99 77.0 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.183 -0.917 . . . . 0.0 113.596 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.516 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 22.9 p -125.73 -16.39 5.73 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 117.722 0.761 . . . . 0.0 111.72 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.6 m -99.72 131.71 45.53 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.427 ' CG ' ' HB2' ' A' ' 24' ' ' GLU . 15.2 ptm180 -109.18 178.82 4.34 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.412 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 7.8 m-20 44.67 47.57 8.71 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.454 0.701 . . . . 0.0 112.56 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.679 HG22 HD13 ' A' ' 129' ' ' LEU . 10.2 mt -80.77 106.18 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.758 ' HA ' HD12 ' A' ' 129' ' ' LEU . 72.2 m -147.8 128.04 13.85 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.733 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -94.04 154.62 17.54 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.22 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -96.21 73.93 2.93 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.002 -1.453 . . . . 0.0 107.694 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.17 -60.17 4.72 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.793 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.445 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -145.42 0.46 0.89 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.135 0.493 . . . . 0.0 110.47 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -104.48 93.82 4.99 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.005 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.815 HD23 HD11 ' A' ' 129' ' ' LEU . 2.8 tm? -60.06 132.45 53.97 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.671 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.618 ' H ' HD22 ' A' ' 21' ' ' LEU . 33.2 ttm105 -134.52 128.0 32.48 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.198 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.635 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -148.39 148.49 30.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.679 0.752 . . . . 0.0 111.141 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 2.6 mm-40 -82.85 76.95 9.66 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.196 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.517 ' SG ' HD13 ' A' ' 164' ' ' LEU . 84.8 m -63.36 126.74 28.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.717 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.516 ' HB2' ' O ' ' A' ' 10' ' ' SER . 37.2 ttt180 -69.54 122.57 19.3 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.353 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.567 ' HG3' ' OD1' ' A' ' 161' ' ' ASN . 20.4 ttt85 -99.3 152.06 20.36 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.891 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -52.19 -17.9 4.33 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 114.119 -1.4 . . . . 0.0 114.712 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.451 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 4.6 m-20 -74.94 -7.46 53.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.103 0.478 . . . . 0.0 110.696 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.51 8.13 62.75 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.64 154.95 16.38 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.368 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.477 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 80.8 m-85 -92.4 125.53 37.09 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.3 m -108.23 130.35 55.16 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.332 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.2 m -68.98 112.44 5.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.862 0.363 . . . . 0.0 110.588 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.472 ' HB3' HD22 ' A' ' 164' ' ' LEU . 32.2 t -116.44 151.24 36.43 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.265 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 1.4 p -144.38 130.93 15.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.964 0.411 . . . . 0.0 110.675 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.438 ' CG2' ' HB3' ' A' ' 21' ' ' LEU . 17.8 tt -122.95 149.23 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.98 -178.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.471 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 22.7 m-20 -82.78 93.57 7.46 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.563 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.67 HD13 HD11 ' A' ' 43' ' ' LEU . 39.2 mt -73.27 -13.38 61.12 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.019 0.438 . . . . 0.0 109.997 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.5 ' OD1' ' HG3' ' A' ' 41' ' ' ARG . 23.8 p30 -66.27 -16.22 63.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.432 0.634 . . . . 0.0 109.625 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.684 ' HG2' ' HA3' ' A' ' 116' ' ' GLY . 48.0 mtm180 -117.29 20.28 13.73 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.418 178.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.573 ' HB2' ' HA ' ' A' ' 39' ' ' LEU . 9.6 m-85 -133.4 -30.92 1.26 Allowed 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.295 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.965 HD22 HD13 ' A' ' 151' ' ' ILE . 42.2 mt -114.63 135.8 53.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.854 0.359 . . . . 0.0 110.781 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.66 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 1.9 m -124.21 147.66 47.87 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.038 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.571 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 7.5 p-10 -94.86 98.77 10.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.596 0.713 . . . . 0.0 110.478 178.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -99.99 94.41 6.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.191 0.519 . . . . 0.0 110.824 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.488 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 64.0 t30 52.68 45.37 28.8 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.213 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.711 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 79.96 32.57 35.81 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.608 178.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -149.14 131.34 15.47 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.808 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 58.7 m-85 -72.63 145.37 47.35 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.955 0.407 . . . . 0.0 111.427 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -143.5 133.62 24.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.063 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.559 ' HZ2' ' O ' ' A' ' 152' ' ' TYR . 97.9 m95 -75.27 126.43 31.0 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.2 t 65.72 -68.12 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.931 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.621 ' O ' ' HE2' ' A' ' 110' ' ' LYS . 49.1 m 65.29 -56.95 0.3 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -117.85 -12.97 7.48 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.319 -0.943 . . . . 0.0 114.555 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.04 128.08 36.5 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.371 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.75 86.15 1.39 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.096 -0.574 . . . . 0.0 112.332 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -148.46 178.25 26.16 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.57 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.41 -79.66 0.58 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.646 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -144.4 119.34 1.26 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.237 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.13 -141.71 10.14 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.786 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.1 m -133.59 129.77 37.44 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.944 0.402 . . . . 0.0 110.069 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.49 ' HB1' ' HG2' ' A' ' 110' ' ' LYS . . . -131.46 177.47 7.47 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.933 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.416 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 21.2 p -128.23 121.29 29.02 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.441 HG22 ' HE3' ' A' ' 110' ' ' LYS . 4.2 t -107.36 134.3 49.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.928 178.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 7.2 m -87.51 125.82 34.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.494 ' CG2' HD12 ' A' ' 99' ' ' ILE . 42.0 t -73.14 132.29 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.103 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -104.19 170.63 7.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 124.388 1.055 . . . . 0.0 109.47 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.594 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 58.8 tt0 -66.63 124.28 22.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.51 -178.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.05 3.22 73.45 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.978 -0.63 . . . . 0.0 113.592 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -109.59 121.4 45.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.035 0.418 . . . . 0.0 111.231 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.59 ' HA ' HG12 ' A' ' 99' ' ' ILE . 81.4 p -102.56 -178.11 3.59 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.647 HD22 HG23 ' A' ' 99' ' ' ILE . 1.1 mm? -51.99 -40.98 61.79 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.347 0.594 . . . . 0.0 109.834 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.43 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 48.7 ttm-85 -62.95 -39.65 95.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.164 -178.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -71.7 -42.93 66.8 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.959 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.556 HG12 ' O ' ' A' ' 72' ' ' THR . 45.6 mm -61.72 -48.79 87.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.796 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.674 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -58.33 -54.09 40.47 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.422 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -58.5 -41.17 84.76 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.761 0.315 . . . . 0.0 111.77 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -65.1 -43.98 90.31 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -98.43 11.79 37.05 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.9 t70 63.4 23.12 13.58 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.359 0.599 . . . . 0.0 112.106 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.674 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.3 p -104.37 171.67 7.21 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.577 ' O ' HG13 ' A' ' 87' ' ' ILE . 5.8 t70 -98.01 125.31 42.89 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.9 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.524 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 9.3 p90 -50.78 -29.68 12.19 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.366 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -65.12 -46.21 81.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.541 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.734 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 56.7 mm-40 -69.14 -41.44 77.31 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.314 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.577 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.8 mt -54.87 -47.5 75.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.657 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.53 -48.58 76.93 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.5 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -54.4 -43.01 71.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.351 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.734 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 24.7 mmm-85 -72.82 -27.4 61.94 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 3.3 t-20 -94.01 -4.79 48.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.892 0.377 . . . . 0.0 111.103 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 90.1 m-20 75.61 17.49 2.37 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.756 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.657 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 19.2 pt -105.67 -172.44 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.534 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 18.1 mm-40 -116.31 154.46 30.15 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.561 ' O ' HD23 ' A' ' 73' ' ' LEU . 1.2 p30 -52.25 -65.96 0.47 Allowed 'General case' 0 C--O 1.244 0.777 0 CA-C-O 122.225 1.012 . . . . 0.0 109.872 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -76.06 13.42 0.89 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.824 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 4.6 t0 -63.59 -31.48 72.66 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 7.9 mp 72.06 112.35 0.06 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.611 -178.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.647 HG23 HD22 ' A' ' 73' ' ' LEU . 9.8 pt -94.85 176.63 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.815 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.556 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 94.1 m-85 -131.16 158.01 76.45 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.743 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.594 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 18.4 Cg_endo -63.98 138.26 61.66 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 123.301 2.667 . . . . 0.0 113.823 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.41 20.8 31.23 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.79 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.542 ' O ' ' HA ' ' A' ' 66' ' ' THR . 77.2 mt-30 -110.4 166.07 11.28 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.178 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.416 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 95.6 t -125.09 118.51 53.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.566 HD11 HG21 ' A' ' 99' ' ' ILE . 76.9 mt -112.35 150.59 30.84 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.35 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -90.8 116.93 29.03 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.582 0.706 . . . . 0.0 110.656 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.411 HG21 HG23 ' A' ' 65' ' ' VAL . 33.6 m -119.83 151.27 52.12 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.454 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.06 -18.98 51.9 Favored 'Trans proline' 0 C--N 1.332 -0.33 0 C-N-CA 123.098 2.532 . . . . 0.0 114.332 -178.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.9 t -154.5 147.53 24.63 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.032 0.444 . . . . 0.0 111.131 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.621 ' HE2' ' O ' ' A' ' 54' ' ' SER . 12.2 mmmm -93.42 -176.23 4.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.026 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -131.6 99.07 0.4 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.077 -178.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 156.82 109.52 0.3 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.05 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 19.6 m -136.96 55.62 1.82 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.872 0.368 . . . . 0.0 111.109 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -82.31 -93.48 0.56 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.043 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.41 ' HA3' HD21 ' A' ' 119' ' ' ASN . . . -96.9 -67.98 0.96 Allowed Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.684 ' HA3' ' HG2' ' A' ' 41' ' ' ARG . . . -112.19 -75.12 0.73 Allowed Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -148.55 -51.63 0.17 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.024 0.44 . . . . 0.0 110.265 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.66 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -85.87 -72.18 1.3 Allowed Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.155 -179.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 14.0 m120 73.94 26.71 1.73 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.059 0.544 . . . . 0.0 112.111 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.551 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 20.7 p90 -60.65 -37.23 80.82 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.04 0.448 . . . . 0.0 110.348 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.571 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 71.0 t-105 -61.79 -34.43 75.88 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.404 -178.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -54.02 -27.42 31.88 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.143 0.277 . . . . 0.0 110.894 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.666 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 9.3 m -132.85 28.54 4.2 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.479 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.571 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -107.51 143.89 35.25 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.968 0.413 . . . . 0.0 111.387 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -126.69 143.05 51.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.817 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 49.12 57.47 6.43 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.668 0.605 . . . . 0.0 112.01 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.434 ' CG1' HD11 ' A' ' 136' ' ' LEU . 40.3 t -80.45 121.76 34.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.841 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.66 148.14 29.72 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.292 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.815 HD11 HD23 ' A' ' 21' ' ' LEU . 33.6 mt -85.54 145.23 27.48 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.137 0.494 . . . . 0.0 111.411 -179.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.944 HG23 ' HB ' ' A' ' 135' ' ' VAL . 29.0 m -132.31 157.1 43.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.64 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 71.83 1.12 3.77 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.772 0.829 . . . . 0.0 110.387 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.619 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 93.14 28.42 11.83 Favored Glycine 0 N--CA 1.433 -1.535 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.165 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.527 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 104.66 -18.19 44.56 Favored Glycine 0 C--O 1.271 2.44 0 CA-C-O 123.45 1.583 . . . . 0.0 113.165 178.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.758 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 1.6 mttp -72.16 -13.58 61.59 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 121.221 -1.164 . . . . 0.0 108.854 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.944 ' HB ' HG23 ' A' ' 130' ' ' VAL . 3.2 t -143.28 151.36 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.443 177.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.542 HD13 HD23 ' A' ' 129' ' ' LEU . 33.1 tp -131.26 125.77 33.7 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -116.07 131.62 56.89 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.175 0.512 . . . . 0.0 110.911 -177.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.779 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -159.64 155.15 25.66 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.38 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 15.3 mt-10 -94.64 106.33 18.31 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.711 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 47.0 mt -91.41 134.32 34.72 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.154 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.666 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 72.4 ttt180 -69.99 140.84 53.0 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.932 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.539 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.5 p90 -156.04 -169.75 3.17 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.458 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 23.0 t -57.58 -30.81 65.57 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.297 0.373 . . . . 0.0 111.545 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -98.24 23.5 35.89 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.171 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 98.77 -107.83 3.49 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.217 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -133.0 127.71 34.75 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.539 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 10.9 t30 -123.18 129.99 52.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.665 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 32.9 ttm180 -76.44 102.81 6.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.138 0.494 . . . . 0.0 109.807 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.473 ' HB3' ' O ' ' A' ' 48' ' ' GLY . 18.1 p -114.96 172.3 7.13 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.232 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 6.3 ptp180 -148.55 152.62 37.12 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.565 -0.454 . . . . 0.0 112.051 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.965 HD13 HD22 ' A' ' 43' ' ' LEU . 12.1 tt -130.64 160.97 41.38 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.824 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.948 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 79.8 m-85 -107.55 106.74 17.25 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 121.856 -0.527 . . . . 0.0 110.25 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.683 HD11 HD21 ' A' ' 129' ' ' LEU . 23.8 mt -62.89 -36.01 81.93 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.213 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.758 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 9.5 t70 -57.39 -8.58 0.81 Allowed 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.504 178.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.948 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 46.7 mt-10 -75.05 -50.83 15.19 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 121.831 -0.543 . . . . 0.0 111.962 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.6 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 91.3 m-70 -125.94 7.38 7.34 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -177.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.516 HG12 ' CH2' ' A' ' 52' ' ' TRP . 43.5 mm -107.58 106.07 19.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.169 178.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' A' ' 167' ' ' CYS . . . -111.35 161.88 12.64 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.637 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.509 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 1.4 t30 -100.55 120.37 39.92 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 31.9 ttp-105 -112.38 87.24 2.53 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.535 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.567 ' OD1' ' HG3' ' A' ' 27' ' ' ARG . 3.0 t-20 59.26 35.79 23.5 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.437 178.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 35' ' ' SER . . . 105.29 -0.07 40.69 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.972 178.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -123.3 134.2 54.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.717 0.758 . . . . 0.0 111.768 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.596 HD11 ' CD2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -74.89 129.46 37.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.895 178.701 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.408 HG13 ' N ' ' A' ' 166' ' ' HIS . 9.4 tp -154.7 157.68 4.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.205 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.6 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 4.1 p-80 -61.19 111.42 1.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.582 ' O ' ' HA3' ' A' ' 158' ' ' GLY . 43.1 t . . . . . 0 C--O 1.247 0.958 0 O-C-N 123.852 0.72 . . . . 0.0 111.024 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.543 0 N-CA-C 112.336 -0.305 . . . . 0.0 112.336 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.628 ' HB3' ' OD1' ' A' ' 154' ' ' ASP . 17.8 m120 -93.3 -95.61 0.15 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 122.298 0.239 . . . . 0.0 110.409 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.91 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 66.8 m-85 -125.22 -90.56 0.55 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.925 0.393 . . . . 0.0 110.313 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -123.22 -30.02 3.77 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.762 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -77.91 -69.24 1.41 Allowed Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 119.56 -1.305 . . . . 0.0 112.689 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 68.16 14.81 9.33 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.889 0.476 . . . . 0.0 111.3 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.598 ' CE2' HD13 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -58.9 -33.91 71.08 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 -179.279 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.482 ' HA ' HD11 ' A' ' 14' ' ' ILE . 8.8 p -61.2 -27.62 68.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.135 0.493 . . . . 0.0 111.579 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.79 -20.64 79.77 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.574 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 5.1 m -120.67 -19.61 7.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.45 0.625 . . . . 0.0 111.455 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 m -104.33 135.6 45.48 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -112.47 177.58 4.59 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 43.43 50.47 6.15 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 124.037 0.836 . . . . 0.0 111.878 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.914 HG22 HD13 ' A' ' 129' ' ' LEU . 12.3 mt -82.05 104.82 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.593 ' CA ' HD12 ' A' ' 129' ' ' LEU . 71.0 m -146.23 128.67 15.94 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 122.823 0.449 . . . . 0.0 109.83 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.827 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -100.23 158.62 15.74 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 121.628 0.727 . . . . 0.0 112.717 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -100.57 76.57 1.84 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.328 -1.305 . . . . 0.0 107.551 176.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.28 -54.11 4.85 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.779 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.558 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -149.04 -13.16 0.31 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.892 0.377 . . . . 0.0 110.184 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.62 88.37 7.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.587 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.827 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 44.0 tp -61.79 121.02 11.84 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.868 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.529 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 39.9 ttt180 -128.49 130.27 47.27 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.432 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.657 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -148.89 150.59 33.22 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.673 0.749 . . . . 0.0 111.076 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.447 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 5.0 mm-40 -85.48 74.53 10.32 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.163 -1.38 . . . . 0.0 108.413 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.693 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 65.0 m -64.97 129.62 40.39 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.829 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 10' ' ' SER . 26.7 ttm180 -65.33 131.65 47.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.328 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 161' ' ' ASN . 35.1 ttt85 -108.86 151.46 26.23 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -52.99 -16.74 4.44 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 114.319 -1.31 . . . . 0.0 114.519 -178.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -72.74 -6.15 42.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.112 0.482 . . . . 0.0 110.416 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.99 6.68 66.74 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -120.5 169.66 14.16 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.412 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.447 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 69.0 m-85 -96.93 140.05 32.04 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.869 0.366 . . . . 0.0 110.555 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.41 ' HB3' ' HA3' ' A' ' 162' ' ' GLY . 9.4 t -121.72 130.23 53.29 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.4 m -72.5 112.89 8.96 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.268 0.556 . . . . 0.0 110.969 -178.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 40.5 t -116.65 148.38 41.04 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.465 -179.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.657 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.4 p -144.32 136.44 22.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-O 120.775 0.321 . . . . 0.0 111.156 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.6 tt -136.19 146.44 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.516 -178.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.59 97.12 4.97 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.689 HD22 ' HB2' ' A' ' 21' ' ' LEU . 1.6 tp -79.96 -6.51 57.64 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.014 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.558 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 15.2 p30 -65.03 -20.24 66.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.167 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.542 ' O ' ' HB3' ' A' ' 117' ' ' ALA . 10.8 ptp180 -105.58 16.53 25.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.298 0.571 . . . . 0.0 110.857 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -127.46 -33.6 2.32 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.131 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.672 HD22 HD13 ' A' ' 151' ' ' ILE . 31.9 mt -106.07 144.11 33.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.358 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.54 147.63 52.55 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.849 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.45 ' ND2' ' HB2' ' A' ' 123' ' ' SER . 23.2 p-10 -98.38 94.12 6.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.504 0.668 . . . . 0.0 109.811 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -94.78 93.6 7.59 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.977 0.418 . . . . 0.0 111.49 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.4 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 66.5 t30 52.83 47.0 25.64 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.16 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.736 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 78.04 29.93 52.67 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.791 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.531 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 33.7 m80 -141.99 125.64 16.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.811 ' HB3' ' HB ' ' A' ' 151' ' ' ILE . 14.2 m-85 -68.3 136.55 53.64 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.802 0.334 . . . . 0.0 111.103 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.8 mtp180 -141.76 135.32 29.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.579 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.472 ' CD1' HD11 ' A' ' 151' ' ' ILE . 96.7 m95 -74.68 136.62 41.87 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 176.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.601 HG21 ' HB1' ' A' ' 117' ' ' ALA . 4.6 p -54.65 116.28 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.638 0.732 . . . . 0.0 111.008 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.5 m -117.44 31.2 6.86 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.745 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 145.11 -33.76 1.59 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.973 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.23 -54.52 3.56 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.226 -0.512 . . . . 0.0 112.707 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -164.02 -41.65 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.23 -141.95 18.62 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.223 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.84 -154.31 25.29 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.189 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.3 149.82 15.68 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.198 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 108' ' ' PRO . . . 124.19 -142.47 14.16 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.788 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.4 m -139.17 113.79 9.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.197 0.523 . . . . 0.0 110.824 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.518 ' HB1' ' HG2' ' A' ' 110' ' ' LYS . . . -133.56 176.67 8.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.835 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.493 HG22 ' HG2' ' A' ' 106' ' ' GLN . 6.9 p -129.34 118.07 21.65 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 122.413 -0.18 . . . . 0.0 111.357 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.565 HG21 ' CE2' ' A' ' 80' ' ' PHE . 9.0 p -110.43 145.03 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.886 0.374 . . . . 0.0 111.386 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.2 m -91.22 123.51 34.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.716 HG21 HD12 ' A' ' 99' ' ' ILE . 63.7 t -76.69 130.26 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.244 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -101.72 169.99 8.46 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 124.455 1.097 . . . . 0.0 110.008 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.619 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 9.6 tt0 -63.22 114.46 3.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.251 -178.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.0 -5.83 27.26 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.878 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.46 124.44 49.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 117.284 0.542 . . . . 0.0 112.188 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.546 ' O ' HG12 ' A' ' 76' ' ' ILE . 81.0 p -101.24 -178.97 3.9 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.664 HD22 HG23 ' A' ' 99' ' ' ILE . 0.7 OUTLIER -53.59 -40.46 65.71 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.555 0.693 . . . . 0.0 109.809 179.179 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.64 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -69.81 -34.37 73.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.041 -178.204 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -72.71 -38.98 67.31 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 72' ' ' THR . 45.1 mm -62.4 -47.17 94.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 177.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.767 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -56.68 -48.37 77.95 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.401 178.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.2 mtm180 -66.99 -35.98 81.16 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 122.515 -0.403 . . . . 0.0 111.923 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -69.66 -38.73 77.19 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.565 ' CE2' HG21 ' A' ' 65' ' ' VAL . 89.0 m-85 -110.52 16.71 21.37 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -178.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.0 t70 53.42 47.75 23.41 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.751 0.786 . . . . 0.0 110.852 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.767 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.8 p -124.42 170.97 10.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.591 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.65 ' O ' HG13 ' A' ' 87' ' ' ILE . 8.9 t70 -96.85 120.1 36.55 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.467 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.64 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 14.3 p90 -51.13 -32.61 23.46 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.708 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.446 ' HB2' ' OD1' ' A' ' 83' ' ' ASP . 0.3 OUTLIER -67.7 -42.93 81.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.76 179.733 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.678 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 8.7 mm-40 -66.67 -43.75 83.68 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.974 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.65 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.8 mt -53.52 -47.04 60.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.609 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.93 -51.14 68.06 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.15 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -57.38 -43.07 83.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.678 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 78.1 mtt180 -68.18 -23.27 64.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.055 0.455 . . . . 0.0 110.987 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 21.8 t-20 -99.04 -5.72 29.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.853 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 5.2 m-20 77.91 15.96 1.45 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.783 0.833 . . . . 0.0 111.637 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.609 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 10.4 pt -106.24 -176.42 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 17.9 mm-40 -111.65 158.22 19.53 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.633 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 16.7 p-10 -55.87 -60.45 3.44 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 122.103 0.954 . . . . 0.0 109.47 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -76.6 12.53 1.25 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.116 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 3.9 t70 -65.17 -33.58 76.35 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 9.1 mp 72.43 112.42 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 124.301 1.001 . . . . 0.0 110.16 -177.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.716 HD12 HG21 ' A' ' 67' ' ' VAL . 10.6 pt -95.32 175.91 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.407 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.489 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 83.0 m-85 -128.68 158.59 71.61 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.583 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.619 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 19.9 Cg_endo -67.6 134.97 34.52 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.994 2.463 . . . . 0.0 112.997 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.84 17.54 25.33 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.384 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -110.66 157.5 19.64 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 120.619 -0.433 . . . . 0.0 109.948 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.405 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 61.3 t -116.73 116.6 52.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.587 HD11 HG21 ' A' ' 99' ' ' ILE . 69.3 mt -109.92 151.0 27.63 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.57 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.493 ' HG2' HG22 ' A' ' 64' ' ' THR . 66.3 mt-30 -89.88 107.42 19.1 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.894 0.854 . . . . 0.0 111.146 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.4 m -112.62 151.32 43.82 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-N 113.934 -1.484 . . . . 0.0 109.151 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 32.5 Cg_endo -64.19 -18.88 65.03 Favored 'Trans proline' 0 C--N 1.332 -0.325 0 C-N-CA 123.146 2.564 . . . . 0.0 114.158 -177.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.6 t -150.42 155.22 39.16 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.3 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.518 ' HG2' ' HB1' ' A' ' 63' ' ' ALA . 12.9 mmmm -103.38 168.99 8.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.129 0.49 . . . . 0.0 111.29 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -88.48 127.65 8.71 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.699 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 129.52 121.43 2.34 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.09 -0.576 . . . . 0.0 111.679 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 51.1 m -136.01 -33.12 0.85 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.799 0.333 . . . . 0.0 111.138 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.29 -68.65 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.53 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -93.32 -115.78 2.46 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -105.59 -109.93 3.45 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.444 -0.884 . . . . 0.0 110.988 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.601 ' HB1' HG21 ' A' ' 53' ' ' VAL . . . -141.24 -26.52 0.7 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.643 0.259 . . . . 0.0 111.408 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . -106.45 -62.95 0.6 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.069 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 74.97 32.78 0.78 Allowed 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.268 0.627 . . . . 0.0 111.902 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.638 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 20.0 p90 -66.36 -35.96 81.67 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.301 0.572 . . . . 0.0 109.865 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.493 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 24.5 t-105 -66.39 -21.87 66.23 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.239 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.94 -24.97 60.21 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.828 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.646 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 50.5 m -143.76 33.59 1.27 Allowed 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.689 178.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.493 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -102.01 147.58 26.4 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 177.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.717 ' HD2' ' HB2' ' A' ' 126' ' ' ASP . 8.0 tmm_? -143.71 140.86 30.23 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.717 ' HB2' ' HD2' ' A' ' 125' ' ' ARG . 1.2 t70 58.3 25.65 12.99 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.789 0.681 . . . . 0.0 110.765 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.599 ' HB ' ' CB ' ' A' ' 138' ' ' ALA . 0.4 OUTLIER -67.06 119.75 13.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.926 -179.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.25 151.62 46.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.302 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.914 HD13 HG22 ' A' ' 14' ' ' ILE . 15.9 mt -85.44 131.21 34.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.261 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.605 HG23 ' HB ' ' A' ' 135' ' ' VAL . 26.9 m -126.55 163.9 27.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.234 -178.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.414 ' HB3' ' HD2' ' A' ' 134' ' ' LYS . 9.7 m-20 64.13 7.72 3.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.97 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.683 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 97.24 31.04 7.05 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.273 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 87.93 -13.74 60.45 Favored Glycine 0 C--O 1.259 1.69 0 CA-C-O 123.506 1.614 . . . . 0.0 112.474 177.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.653 ' O ' ' HA ' ' A' ' 152' ' ' TYR . 17.4 ptpt -72.33 -17.09 61.87 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.605 ' HB ' HG23 ' A' ' 130' ' ' VAL . 17.5 t -139.92 138.77 38.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.328 177.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.599 ' CD1' HD11 ' A' ' 16' ' ' LEU . 36.5 tp -119.91 115.21 23.33 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -107.57 126.26 52.33 Favored 'General case' 0 C--N 1.316 -0.884 0 O-C-N 123.28 0.362 . . . . 0.0 110.213 -177.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.599 ' CB ' ' HB ' ' A' ' 127' ' ' VAL . . . -150.07 160.25 43.79 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.277 0.56 . . . . 0.0 111.89 -178.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -96.29 106.8 19.06 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.736 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 50.0 mt -97.03 129.02 44.53 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.39 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.646 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 22.1 ttt180 -70.05 139.72 52.69 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.224 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.637 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.9 p90 -155.78 -167.94 2.64 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.163 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 4.3 m -56.32 -29.55 61.41 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -104.72 29.84 11.11 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.388 -0.91 . . . . 0.0 113.53 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.7 -112.52 4.38 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.631 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -125.6 126.46 44.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.741 0.305 . . . . 0.0 110.689 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.637 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 63.2 t30 -118.53 129.23 55.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.495 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -78.38 98.73 6.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.205 0.526 . . . . 0.0 109.956 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.531 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 21.7 t -109.45 168.21 9.56 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.178 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.581 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 16.5 ptt180 -149.1 152.76 36.72 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.468 -0.493 . . . . 0.0 112.12 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.811 ' HB ' ' HB3' ' A' ' 50' ' ' PHE . 6.1 tt -133.02 152.84 36.7 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.92 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.653 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 95.8 m-85 -95.44 103.4 15.27 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.771 -0.195 . . . . 0.0 110.666 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.764 HD11 HD21 ' A' ' 129' ' ' LEU . 19.9 mt -67.06 -35.83 80.71 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.169 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.628 ' OD1' ' HB3' ' A' ' 2' ' ' ASN . 2.8 p30 -52.91 -19.26 2.44 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.189 178.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.91 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 36.0 mt-10 -63.39 -55.86 20.98 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.504 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 76.4 m-70 -121.88 5.7 9.91 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 119.655 -0.818 . . . . 0.0 112.705 -176.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.432 HG12 ' CH2' ' A' ' 52' ' ' TRP . 45.0 mm -107.25 111.68 36.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.689 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.643 ' HA3' ' O ' ' A' ' 167' ' ' CYS . . . -113.55 -178.17 19.35 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.57 178.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.693 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -124.86 136.67 54.01 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.773 0.32 . . . . 0.0 110.548 179.753 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -124.82 86.78 2.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.047 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.533 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 90.3 m-20 54.39 50.96 15.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.37 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.578 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 89.8 7.82 68.15 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.496 178.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -123.65 117.12 24.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.984 0.392 . . . . 0.0 111.367 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.499 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 25.0 mt -67.23 123.15 19.49 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.518 178.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 13.4 tt -151.06 147.42 15.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.891 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.504 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 44.9 p-80 -55.68 126.86 27.26 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.643 ' O ' ' HA3' ' A' ' 158' ' ' GLY . 42.4 t . . . . . 0 C--O 1.247 0.934 0 O-C-N 123.839 0.712 . . . . 0.0 111.238 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.599 0 N-CA-C 111.839 -0.504 . . . . 0.0 111.839 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.633 ' HB2' ' OD1' ' A' ' 6' ' ' ASN . 36.1 m-20 -111.56 177.99 4.47 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 1.015 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 21.9 m-85 -108.42 -98.96 0.37 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.511 -0.476 . . . . 0.0 112.022 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.499 ' HB1' ' SG ' ' A' ' 167' ' ' CYS . . . -102.07 -31.56 10.57 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -70.77 -65.71 2.4 Favored Glycine 0 N--CA 1.434 -1.437 0 C-N-CA 119.511 -1.328 . . . . 0.0 112.205 -178.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.633 ' OD1' ' HB2' ' A' ' 2' ' ' ASN . 37.2 m-80 64.37 19.66 11.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.631 -0.285 . . . . 0.0 110.895 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.712 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.7 OUTLIER -58.44 -42.62 87.76 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.542 -179.664 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.451 ' HA ' HD11 ' A' ' 14' ' ' ILE . 8.9 m -62.11 -13.31 25.59 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.03 0.443 . . . . 0.0 110.851 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -64.27 -30.51 78.01 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.18 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.653 ' HB3' ' HB3' ' A' ' 26' ' ' ARG . 49.7 m -131.76 -18.54 2.73 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.677 0.275 . . . . 0.0 111.282 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.471 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 18.7 m -89.8 129.92 36.12 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -112.43 -177.65 3.21 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 43.69 45.36 5.89 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 123.832 0.708 . . . . 0.0 111.728 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.909 HG22 HD13 ' A' ' 129' ' ' LEU . 5.3 mt -79.8 103.89 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 CA-C-O 120.921 0.391 . . . . 0.0 110.402 -178.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.593 ' CA ' HD12 ' A' ' 129' ' ' LEU . 73.4 m -143.76 126.79 16.42 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.749 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -92.47 153.77 18.9 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.839 0.828 . . . . 0.0 112.861 -178.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -94.38 74.27 3.88 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.228 -1.351 . . . . 0.0 107.756 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.21 -55.87 4.96 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.068 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.651 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -148.6 -7.12 0.39 Allowed 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.035 0.445 . . . . 0.0 109.913 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -94.6 95.46 8.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.453 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.872 HD22 HD13 ' A' ' 153' ' ' LEU . 41.8 tp -60.27 118.12 6.01 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.807 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.531 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 34.0 ttt180 -123.02 129.84 52.02 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.35 -178.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.676 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -148.39 149.28 31.48 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.573 0.701 . . . . 0.0 111.178 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 69.7 mm-40 -82.48 70.52 9.45 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.011 178.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.632 ' SG ' HD13 ' A' ' 164' ' ' LEU . 59.1 m -57.84 114.41 2.3 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.953 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.653 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 10.8 ttp180 -67.11 125.99 27.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.392 178.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.547 ' HG2' ' CA ' ' A' ' 162' ' ' GLY . 7.1 mtm180 -96.34 162.77 13.35 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.85 -10.09 6.17 Favored Glycine 0 C--N 1.339 0.705 0 O-C-N 124.37 1.044 . . . . 0.0 113.759 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -76.97 -8.31 57.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.442 0.639 . . . . 0.0 109.43 178.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.38 14.21 66.59 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.01 161.06 13.2 Favored Glycine 0 C--O 1.225 -0.42 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.177 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.534 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 75.8 m-85 -101.15 133.14 46.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.701 0.286 . . . . 0.0 110.565 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.436 ' OG ' ' HD3' ' A' ' 27' ' ' ARG . 74.0 m -126.22 133.3 51.55 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.099 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 m -70.28 116.17 10.32 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.33 0.586 . . . . 0.0 111.367 -178.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 46.6 t -122.59 152.27 40.6 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.458 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 5.8 p -145.21 140.33 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 120.933 0.397 . . . . 0.0 112.032 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.531 HG23 ' HB3' ' A' ' 21' ' ' LEU . 10.2 tt -135.65 145.69 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.983 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.13 99.25 7.65 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.59 HD23 ' HB3' ' A' ' 21' ' ' LEU . 3.5 mm? -81.18 -8.7 59.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.09 0.471 . . . . 0.0 110.808 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.651 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 7.1 p30 -67.58 -13.15 61.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.453 179.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.424 ' O ' ' HB3' ' A' ' 117' ' ' ALA . 19.2 mtp180 -114.32 22.43 13.74 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -136.18 -31.09 0.92 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.67 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.828 HD22 HD13 ' A' ' 151' ' ' ILE . 35.9 mt -110.15 133.38 53.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.728 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.715 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 1.4 m -123.65 138.3 54.56 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.211 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.84 ' CB ' ' HG ' ' A' ' 140' ' ' LEU . 6.7 p-10 -79.66 93.26 5.49 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.82 0.819 . . . . 0.0 110.329 177.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.406 ' HB2' ' HG3' ' A' ' 51' ' ' ARG . 21.8 t70 -96.2 92.79 6.56 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 121.916 -0.49 . . . . 0.0 111.326 -179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.494 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 64.8 t30 49.19 47.54 21.96 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.361 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.66 43.5 18.51 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.964 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -161.98 123.41 2.74 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.694 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 55.8 m-85 -65.4 151.28 46.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.726 0.298 . . . . 0.0 110.574 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.406 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 37.7 mmt180 -141.51 128.65 20.89 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.518 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.649 ' HZ2' ' HA ' ' A' ' 153' ' ' LEU . 44.6 m95 -76.69 118.34 19.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.847 177.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.0 m -125.39 56.43 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.342 0.591 . . . . 0.0 110.475 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.0 p -75.91 36.86 0.14 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.138 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.566 ' HA3' ' HB2' ' A' ' 63' ' ' ALA . . . -151.65 27.99 0.94 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -130.85 168.98 21.68 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.997 -0.62 . . . . 0.0 111.697 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.36 -50.28 2.12 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.034 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 168.89 144.9 4.38 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.172 -0.537 . . . . 0.0 111.916 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.29 96.43 2.26 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.73 -0.747 . . . . 0.0 111.924 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.94 138.62 37.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.604 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 108' ' ' PRO . . . -170.13 -123.39 0.68 Allowed Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.4 m -124.89 116.54 22.38 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.168 0.508 . . . . 0.0 110.417 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.595 ' HB1' ' HG2' ' A' ' 110' ' ' LYS . . . -128.63 177.28 7.14 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.872 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.433 ' HB ' ' CG2' ' A' ' 104' ' ' VAL . 6.6 p -128.58 114.34 16.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.769 0.319 . . . . 0.0 111.626 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.463 HG21 ' CE1' ' A' ' 80' ' ' PHE . 11.8 p -101.67 143.38 14.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.937 0.399 . . . . 0.0 110.621 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 3.7 m -89.95 127.48 36.03 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.403 ' CG2' HD12 ' A' ' 99' ' ' ILE . 45.7 t -72.07 132.12 33.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.721 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.411 ' HG2' ' H ' ' A' ' 69' ' ' GLN . 3.4 tt0 -98.11 171.1 8.46 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 125.043 1.464 . . . . 0.0 109.813 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.595 ' CA ' ' HB3' ' A' ' 101' ' ' PRO . 24.6 tt0 -71.03 129.69 39.63 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.895 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.05 13.92 82.48 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.585 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -114.37 121.39 43.44 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.826 0.346 . . . . 0.0 110.248 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.58 ' HA ' HG12 ' A' ' 99' ' ' ILE . 80.0 p -103.38 -179.68 4.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.595 HD22 HG23 ' A' ' 99' ' ' ILE . 1.5 mm? -51.94 -42.03 62.51 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -60.01 -40.07 87.97 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 114.506 -1.224 . . . . 0.0 111.257 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -71.4 -40.37 70.55 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.671 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 72' ' ' THR . 32.5 mm -64.44 -48.38 85.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.669 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -58.8 -45.34 95.06 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.425 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -65.27 -37.08 86.09 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.866 0.365 . . . . 0.0 111.259 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -73.96 -40.24 63.16 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.463 ' CE1' HG21 ' A' ' 65' ' ' VAL . 95.4 m-85 -102.82 13.15 35.08 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.0 t70 58.07 27.57 15.09 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.558 0.694 . . . . 0.0 111.526 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.669 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 3.1 p -105.52 171.59 7.25 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.64 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.3 t0 -94.38 120.16 34.2 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.156 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.543 ' HD2' ' HB2' ' A' ' 95' ' ' ASN . 10.9 p90 -53.12 -30.3 35.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.588 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.429 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -68.57 -41.74 79.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.678 179.17 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -67.75 -48.33 66.71 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.664 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.64 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.4 mt -49.99 -43.79 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.577 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.59 -51.76 66.05 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.427 178.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 85' ' ' HIS . 61.4 mtp180 -64.23 -25.93 68.28 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.854 ' HB3' ' HB2' ' A' ' 106' ' ' GLN . 1.0 OUTLIER -72.66 -28.14 62.54 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.24 0.543 . . . . 0.0 110.161 179.183 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 18.0 t-20 -101.12 -5.33 25.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.319 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 23.4 m120 79.4 15.92 0.93 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.006 0.922 . . . . 0.0 111.148 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.577 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 15.1 pt -103.14 -169.79 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.597 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.534 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 55.1 mt-30 -116.66 161.21 19.56 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.559 ' O ' HD23 ' A' ' 73' ' ' LEU . 6.7 p30 -57.39 -58.74 6.95 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-O 122.245 1.021 . . . . 0.0 109.277 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -78.44 12.22 2.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.065 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 1.8 t70 -62.93 -31.57 72.68 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 6.8 mp 70.78 112.33 0.06 Allowed 'General case' 0 C--O 1.234 0.245 0 O-C-N 124.37 1.044 . . . . 0.0 110.503 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.595 HG23 HD22 ' A' ' 73' ' ' LEU . 9.4 pt -95.84 172.07 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 114.497 -1.228 . . . . 0.0 110.505 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.458 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 69.4 m-85 -125.52 156.36 70.67 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.305 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.595 ' HB3' ' CA ' ' A' ' 69' ' ' GLN . 39.2 Cg_endo -68.75 134.49 30.32 Favored 'Trans proline' 0 CA--C 1.517 -0.361 0 C-N-CA 123.042 2.494 . . . . 0.0 113.642 -177.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.85 13.4 37.38 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' A' ' 66' ' ' THR . 49.2 mt-30 -104.76 170.87 7.63 Favored 'General case' 0 C--O 1.216 -0.67 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.138 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.433 ' CG2' ' HB ' ' A' ' 64' ' ' THR . 9.9 p -126.49 131.03 71.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-O 121.441 0.639 . . . . 0.0 110.612 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.586 HD11 HG21 ' A' ' 99' ' ' ILE . 80.0 mt -125.09 151.32 45.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.759 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.854 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 38.7 mt-30 -89.75 113.4 24.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 122.031 0.92 . . . . 0.0 111.649 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.432 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 35.8 m -123.02 152.07 62.49 Favored Pre-proline 0 C--N 1.314 -0.976 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.013 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 32.0 Cg_endo -64.37 -17.61 60.26 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 123.425 2.75 . . . . 0.0 115.37 -176.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.7 t -149.56 152.72 35.99 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.189 0.519 . . . . 0.0 112.112 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.595 ' HG2' ' HB1' ' A' ' 63' ' ' ALA . 11.6 mmmm -107.11 175.23 5.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.969 178.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -119.47 107.95 1.44 Allowed Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -97.45 95.72 1.73 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.749 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 18.2 m -80.08 -22.02 42.69 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.652 0.263 . . . . 0.0 111.396 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.02 -48.72 38.54 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.621 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 176.23 -60.84 0.1 Allowed Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -104.39 -81.45 1.5 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 41' ' ' ARG . . . -143.42 -49.82 0.32 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.178 0.513 . . . . 0.0 109.899 178.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.715 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -89.62 -81.27 1.33 Allowed Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.973 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 16.0 m120 75.34 24.92 1.34 Allowed 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 123.575 0.75 . . . . 0.0 112.261 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.565 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 25.0 p90 -58.44 -39.37 79.66 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.288 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.516 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 60.3 t-105 -58.71 -31.89 68.68 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.01 -178.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.68 -30.43 61.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.839 0.352 . . . . 0.0 110.672 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.571 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 11.0 m -132.79 30.46 4.04 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.581 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.516 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -118.09 138.51 52.2 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 120.784 0.326 . . . . 0.0 110.743 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.413 ' HG2' ' CZ3' ' A' ' 146' ' ' TRP . 2.3 mmp_? -128.55 147.51 50.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.134 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 56.43 45.06 23.34 Favored 'General case' 0 CA--C 1.518 -0.264 0 O-C-N 123.695 0.622 . . . . 0.0 112.007 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.513 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 39.5 t -69.98 116.24 10.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.658 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -138.5 143.45 39.56 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.639 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.909 HD13 HG22 ' A' ' 14' ' ' ILE . 29.5 mt -86.38 138.71 31.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.345 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.681 HG23 ' HB ' ' A' ' 135' ' ' VAL . 26.7 m -131.08 160.97 41.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.431 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.471 ' HB3' ' HG2' ' A' ' 134' ' ' LYS . 0.7 OUTLIER 65.16 13.43 8.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.015 179.133 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.676 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 91.9 26.46 19.41 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.507 -0.854 . . . . 0.0 113.265 178.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.555 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 92.45 -18.02 55.86 Favored Glycine 0 C--O 1.265 2.074 0 CA-C-O 123.9 1.833 . . . . 0.0 112.225 177.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.755 ' HG3' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -67.98 -17.6 64.48 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.255 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.755 HG23 ' HG3' ' A' ' 134' ' ' LYS . 15.0 t -135.94 144.6 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.388 176.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.619 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 26.0 tp -127.49 124.69 38.94 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -120.58 134.63 55.26 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.212 0.529 . . . . 0.0 110.979 -177.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.623 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -157.58 162.74 38.77 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.864 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.574 ' HG2' ' HG3' ' A' ' 148' ' ' ARG . 45.1 mt-10 -94.71 105.14 17.06 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.84 ' HG ' ' CB ' ' A' ' 45' ' ' ASN . 1.4 mp -90.4 128.97 36.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.485 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.571 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 67.1 ttt180 -69.77 140.86 53.44 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.037 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.494 ' HB2' ' OD1' ' A' ' 47' ' ' ASN . 1.2 p90 -156.08 -167.81 2.57 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.139 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.3 t -60.41 -27.49 67.5 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.971 0.415 . . . . 0.0 111.123 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -101.91 27.19 21.52 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.348 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 92.67 -119.94 6.01 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.751 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.413 ' CZ3' ' HG2' ' A' ' 125' ' ' ARG . 79.2 m95 -124.64 125.68 44.51 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.477 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 25.0 t-20 -129.01 142.39 50.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.817 0.342 . . . . 0.0 111.095 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.574 ' HG3' ' HG2' ' A' ' 139' ' ' GLU . 25.1 mtp180 -74.12 108.47 6.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.716 0.769 . . . . 0.0 110.481 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.487 ' HB2' HD22 ' A' ' 140' ' ' LEU . 1.1 m -113.03 157.6 21.35 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.078 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.619 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 9.1 ptt180 -145.95 147.49 31.77 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.381 0.61 . . . . 0.0 112.343 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.828 HD13 HD22 ' A' ' 43' ' ' LEU . 8.7 tt -132.37 151.88 35.53 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.99 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 9.0 m-85 -92.24 104.85 17.16 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.871 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.872 HD13 HD22 ' A' ' 21' ' ' LEU . 30.5 mt -68.5 -32.59 72.67 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.131 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.639 ' HB3' ' HA ' ' A' ' 134' ' ' LYS . 1.4 p30 -54.7 -18.44 4.63 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.853 177.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 1.015 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 37.2 mt-10 -64.63 -52.26 58.31 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.523 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 65.5 m-70 -122.49 6.4 9.54 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.734 -0.786 . . . . 0.0 112.87 -178.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.435 ' O ' ' HA3' ' A' ' 5' ' ' GLY . 47.8 mm -107.15 110.38 31.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.663 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.54 ' HA3' ' OXT' ' A' ' 167' ' ' CYS . . . -115.24 156.11 15.87 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.451 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.547 ' HA ' ' O ' ' A' ' 163' ' ' GLU . 1.7 t30 -97.13 127.91 43.55 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 122.518 0.327 . . . . 0.0 110.151 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 -115.68 87.43 2.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.257 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 65.4 t30 50.43 52.63 14.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.81 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.547 ' CA ' ' HG2' ' A' ' 27' ' ' ARG . . . 95.07 7.1 59.87 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.968 -0.634 . . . . 0.0 114.343 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 159' ' ' ASN . 44.6 mt-10 -122.55 154.77 37.46 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 117.415 0.608 . . . . 0.0 110.509 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.712 HD11 ' CD2' ' A' ' 7' ' ' PHE . 7.7 tp -111.3 110.16 20.5 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.89 0.376 . . . . 0.0 110.561 -178.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 38.9 pt -134.6 -173.73 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.018 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.523 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 1.9 p-80 -83.43 122.03 27.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.671 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.54 ' OXT' ' HA3' ' A' ' 158' ' ' GLY . 46.2 t . . . . . 0 C--O 1.251 1.148 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.805 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.484 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.623 ' HB3' ' HA ' ' A' ' 6' ' ' ASN . 1.7 m-80 -61.51 152.36 30.37 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.047 0.451 . . . . 0.0 110.543 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.948 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 30.7 m-85 -101.74 -84.98 0.44 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.459 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -110.44 -30.68 7.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.712 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 167' ' ' CYS . . . -71.37 -63.45 3.09 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 119.732 -1.223 . . . . 0.0 112.39 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.623 ' HA ' ' HB3' ' A' ' 2' ' ' ASN . 2.4 m-20 66.03 15.66 10.16 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 122.526 0.33 . . . . 0.0 111.432 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.689 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.2 OUTLIER -60.51 -39.68 88.66 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.082 -179.323 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.78 -16.81 62.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.006 0.431 . . . . 0.0 111.554 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.55 -20.01 79.77 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.077 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 45.8 m -140.41 -13.03 1.02 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 117.33 0.565 . . . . 0.0 112.081 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.7 m -98.66 133.25 43.27 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.635 ' HG2' ' HB2' ' A' ' 24' ' ' GLU . 25.0 ptt180 -110.1 -172.13 1.98 Allowed 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.434 ' HB3' ' HG3' ' A' ' 24' ' ' GLU . 20.9 t70 42.05 40.31 1.61 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.829 0.852 . . . . 0.0 111.976 -179.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.877 HG22 HD13 ' A' ' 129' ' ' LEU . 6.4 mt -77.02 99.26 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 CA-C-O 121.104 0.478 . . . . 0.0 109.917 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.639 ' CA ' HD12 ' A' ' 129' ' ' LEU . 73.1 m -147.68 124.67 11.34 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.353 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.752 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -94.03 152.69 18.62 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.84 0.829 . . . . 0.0 112.985 -179.006 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -93.27 75.2 4.59 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.043 -1.435 . . . . 0.0 107.233 177.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.21 -53.31 4.63 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.735 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.497 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -149.07 -11.35 0.32 Allowed 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 120.94 0.4 . . . . 0.0 110.234 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.432 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 3.4 mpt_? -89.48 92.55 9.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.87 0.367 . . . . 0.0 110.389 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.819 HD22 HD23 ' A' ' 153' ' ' LEU . 46.8 tp -61.36 123.98 19.33 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.716 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.653 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 41.9 ttp180 -125.03 137.22 54.23 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.266 -0.573 . . . . 0.0 110.257 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.587 ' CB ' HG12 ' A' ' 14' ' ' ILE . . . -157.29 145.84 19.55 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.587 0.708 . . . . 0.0 111.084 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.635 ' HB2' ' HG2' ' A' ' 12' ' ' ARG . 3.5 mt-10 -84.52 77.03 10.1 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.504 -1.225 . . . . 0.0 108.706 178.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.621 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 55.9 m -62.78 120.67 11.72 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.899 -178.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 10' ' ' SER . 9.0 tmm_? -70.76 114.89 9.3 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.914 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 10.2 ptp180 -89.17 159.0 17.69 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.041 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.46 -15.95 6.41 Favored Glycine 0 C--N 1.339 0.732 0 O-C-N 124.713 1.258 . . . . 0.0 114.067 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -72.38 -12.5 61.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.618 0.723 . . . . 0.0 109.417 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.7 8.8 60.5 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.933 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' A' ' 27' ' ' ARG . . . -112.77 160.62 13.04 Favored Glycine 0 CA--C 1.512 -0.151 0 C-N-CA 120.199 -1.001 . . . . 0.0 113.657 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.449 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 89.3 m-85 -101.39 124.7 47.49 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.1 p -118.68 133.23 56.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.438 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.1 m -71.0 111.38 6.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.062 0.458 . . . . 0.0 110.843 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.2 t -117.4 152.1 35.67 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.481 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.56 ' HB ' ' HG3' ' A' ' 22' ' ' ARG . 3.9 p -145.04 136.38 20.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.788 0.328 . . . . 0.0 110.224 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.528 HG23 HD23 ' A' ' 39' ' ' LEU . 11.8 tt -135.29 151.65 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.075 -177.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.565 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . 1.6 m-20 -79.61 105.88 11.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.684 0.278 . . . . 0.0 111.36 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.637 HD13 ' HB2' ' A' ' 42' ' ' TYR . 1.5 mm? -88.93 -1.64 58.2 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.198 0.523 . . . . 0.0 110.333 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.565 ' OD1' ' HB3' ' A' ' 38' ' ' ASP . 32.3 p-10 -69.55 -14.62 62.94 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 38' ' ' ASP . 6.1 ptp180 -109.9 11.87 24.04 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.609 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.637 ' HB2' HD13 ' A' ' 39' ' ' LEU . 41.4 m-85 -127.36 -31.63 2.52 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.868 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.631 HD22 HD13 ' A' ' 151' ' ' ILE . 39.8 mt -108.96 139.02 44.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.084 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.551 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 4.1 m -129.71 149.09 51.61 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.518 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.763 HD22 ' HA ' ' A' ' 120' ' ' PHE . 7.6 p30 -98.51 104.83 16.9 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -108.03 91.97 3.87 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 121.85 -0.531 . . . . 0.0 111.092 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.537 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 62.4 t30 57.08 45.04 21.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.015 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.816 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 78.67 31.68 44.03 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.795 178.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.586 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 22.4 t-80 -148.69 122.17 9.11 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.756 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 38.1 m-85 -64.04 138.61 58.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.617 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -144.97 139.15 27.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.687 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.718 ' CZ2' ' HA ' ' A' ' 153' ' ' LEU . 99.2 m95 -75.08 128.93 36.66 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.578 HG23 ' H ' ' A' ' 55' ' ' GLY . 15.9 m 41.77 -128.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 O-C-N 124.414 1.071 . . . . 0.0 111.999 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.6 m -120.28 8.59 10.88 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.939 0.4 . . . . 0.0 110.456 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.578 ' H ' HG23 ' A' ' 53' ' ' VAL . . . 79.18 -43.84 2.55 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.305 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 142.56 91.33 0.16 Allowed Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.812 -0.515 . . . . 0.0 111.812 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -139.65 157.68 25.29 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.95 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.96 162.34 34.05 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.32 -170.73 39.33 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.074 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.18 34.72 1.09 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.355 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 108' ' ' PRO . . . -89.38 -115.8 1.5 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.897 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 87.3 m -128.37 113.57 15.74 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.324 0.583 . . . . 0.0 110.428 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.527 ' HB1' ' HG2' ' A' ' 110' ' ' LYS . . . -123.07 178.26 5.16 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.356 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.404 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 2.0 p -128.77 122.77 31.3 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.1 t -111.45 135.6 50.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.096 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.1 m -87.48 127.36 35.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.342 0.592 . . . . 0.0 110.034 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.549 ' CG2' HD12 ' A' ' 99' ' ' ILE . 44.5 t -74.64 131.78 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.538 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -101.19 172.03 7.25 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 124.854 1.346 . . . . 0.0 109.905 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.582 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 6.9 tt0 -59.04 125.86 25.33 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.144 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.88 2.74 88.39 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.091 -0.576 . . . . 0.0 114.092 177.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -92.34 138.04 31.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 117.246 0.523 . . . . 0.0 111.315 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.551 ' HA ' HG12 ' A' ' 99' ' ' ILE . 55.1 p -119.5 173.98 6.66 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.599 HD12 ' HB ' ' A' ' 87' ' ' ILE . 1.3 mm? -52.6 -40.5 62.75 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.182 0.515 . . . . 0.0 110.416 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.53 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 13.7 mtp180 -67.01 -35.47 80.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.787 -178.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -72.31 -38.22 68.75 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.521 HG12 ' O ' ' A' ' 72' ' ' THR . 42.0 mm -67.15 -45.83 85.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.715 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -55.14 -55.82 26.29 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.579 179.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -59.79 -42.94 94.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.91 0.386 . . . . 0.0 112.04 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.543 ' HD3' ' HB3' ' A' ' 113' ' ' SER . 40.2 ttm180 -64.01 -36.27 83.45 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -110.35 19.99 18.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.8 t70 56.3 30.55 16.96 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.448 0.642 . . . . 0.0 111.717 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.715 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 3.6 p -112.85 171.31 7.61 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.59 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.9 t70 -99.24 127.18 45.19 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.53 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 4.8 p90 -51.43 -30.55 19.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.226 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -65.43 -44.79 86.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.719 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.721 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 24.2 mm-40 -63.22 -51.0 68.04 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.801 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.599 ' HB ' HD12 ' A' ' 73' ' ' LEU . 2.7 mt -52.76 -47.04 51.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.64 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.595 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.59 -50.74 70.07 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.617 178.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -56.47 -40.12 74.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.138 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.721 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 13.8 mmt85 -65.83 -33.48 75.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.102 0.477 . . . . 0.0 111.071 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.682 HD22 HD13 ' A' ' 93' ' ' ILE . 66.3 t30 -92.13 -4.76 53.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.792 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 92.3 m-20 75.94 19.14 1.94 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.487 0.715 . . . . 0.0 110.777 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.682 HD13 HD22 ' A' ' 91' ' ' ASN . 14.4 pt -106.18 -176.26 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.739 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.555 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 49.2 mt-30 -107.36 166.06 10.93 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.539 ' O ' HD23 ' A' ' 73' ' ' LEU . 6.1 p30 -63.83 -53.5 49.78 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-O 122.141 0.972 . . . . 0.0 108.407 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.4 ' OE1' ' HB3' ' A' ' 94' ' ' GLN . 0.8 OUTLIER -79.56 11.06 3.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.785 -179.67 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.555 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.8 t70 -61.54 -32.23 72.28 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.1 mt 68.84 114.07 0.04 OUTLIER 'General case' 0 C--O 1.233 0.21 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.061 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.734 HG21 HD11 ' A' ' 105' ' ' LEU . 9.2 pt -94.56 175.64 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.238 -178.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.474 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 41.3 m-85 -128.72 156.54 77.4 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.83 -178.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.582 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 32.0 Cg_endo -67.07 133.02 29.6 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 123.286 2.658 . . . . 0.0 113.241 -178.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.43 19.29 25.85 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -112.54 155.74 23.81 Favored 'General case' 0 C--O 1.212 -0.901 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.404 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 88.2 t -116.18 122.68 70.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 O-C-N 121.789 -0.569 . . . . 0.0 110.405 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.734 HD11 HG21 ' A' ' 99' ' ' ILE . 95.9 mt -113.42 151.25 31.59 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.92 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.569 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 78.2 mt-30 -90.22 116.27 28.08 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.642 0.734 . . . . 0.0 110.801 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.406 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 31.5 m -123.23 151.84 62.89 Favored Pre-proline 0 C--N 1.31 -1.119 0 CA-C-N 114.173 -1.376 . . . . 0.0 109.441 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 37.9 Cg_endo -65.07 -22.32 62.17 Favored 'Trans proline' 0 N--CA 1.473 0.282 0 C-N-CA 123.147 2.565 . . . . 0.0 114.952 -177.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.0 t -147.11 155.1 41.89 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.586 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.527 ' HG2' ' HB1' ' A' ' 63' ' ' ALA . 12.3 mmmm -104.06 174.0 6.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.429 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.3 145.33 5.97 Favored Glycine 0 N--CA 1.439 -1.165 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.528 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -74.45 90.29 0.73 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.082 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.543 ' HB3' ' HD3' ' A' ' 79' ' ' ARG . 29.8 m -119.13 49.47 1.33 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.171 0.51 . . . . 0.0 110.689 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 149.31 -65.21 0.39 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.06 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -178.4 -170.35 40.38 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 121.02 -0.61 . . . . 0.0 111.842 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.35 54.15 6.35 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.95 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -102.95 -33.34 9.34 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.345 -0.428 . . . . 0.0 110.803 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.551 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -104.18 -70.14 0.8 Allowed Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.221 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 15.2 m120 73.63 31.33 1.3 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.007 0.523 . . . . 0.0 112.122 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.763 ' HA ' HD22 ' A' ' 45' ' ' ASN . 27.5 p90 -59.6 -35.84 75.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.95 0.405 . . . . 0.0 110.141 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.56 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 61.8 t-105 -63.09 -31.71 72.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.068 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.88 -31.51 40.04 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.852 0.358 . . . . 0.0 110.99 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.85 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 18.5 m -131.19 28.26 4.75 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.691 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.56 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -110.48 142.95 41.53 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.395 178.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.45 ' HD2' ' OD2' ' A' ' 126' ' ' ASP . 6.6 tmm_? -137.15 139.24 41.02 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.45 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 3.6 m-20 63.08 54.54 2.1 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.261 0.553 . . . . 0.0 110.567 -178.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.466 ' CG1' HD11 ' A' ' 136' ' ' LEU . 38.3 t -85.69 122.83 38.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.402 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.424 ' O ' HD12 ' A' ' 136' ' ' LEU . 16.2 ptt180 -144.84 142.7 30.15 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.754 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.877 HD13 HG22 ' A' ' 14' ' ' ILE . 16.5 mt -85.42 130.38 34.6 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.532 HG23 ' HB ' ' A' ' 135' ' ' VAL . 27.8 m -124.49 163.47 24.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.512 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.473 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 5.3 m-20 68.08 6.0 4.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.203 178.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.635 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 93.66 28.25 11.59 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.181 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.495 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 96.89 -19.27 55.46 Favored Glycine 0 C--O 1.264 1.978 0 CA-C-O 123.08 1.378 . . . . 0.0 113.145 177.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.574 ' O ' ' HA ' ' A' ' 152' ' ' TYR . 10.5 pttp -72.75 -10.91 60.34 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 121.196 -1.179 . . . . 0.0 109.665 178.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.532 ' HB ' HG23 ' A' ' 130' ' ' VAL . 22.3 t -144.26 140.44 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 121.383 0.611 . . . . 0.0 110.444 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.624 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 44.1 tp -121.14 125.28 46.81 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -114.75 131.36 56.81 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.989 0.423 . . . . 0.0 110.893 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.627 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -161.44 157.8 25.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.675 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.522 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 36.9 mt-10 -95.56 109.95 22.11 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.816 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 46.3 mt -95.74 134.17 38.99 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.956 -178.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.85 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 36.1 ttt180 -70.76 141.09 51.47 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.701 179.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.601 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.7 p90 -161.83 -170.49 2.57 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.593 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 45.5 t -54.31 -28.68 43.95 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.41 0.444 . . . . 0.0 111.883 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -105.45 30.38 9.96 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.461 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 141' ' ' ARG . . . 91.55 -114.93 4.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.518 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -126.8 128.15 46.13 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.601 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 57.3 t30 -117.62 143.67 45.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.957 0.408 . . . . 0.0 111.988 -178.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -76.75 94.57 3.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.122 178.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.586 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 35.8 t -111.11 160.88 16.49 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.445 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.624 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 28.6 ptt180 -148.59 154.58 39.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.548 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.756 ' HB ' ' CB ' ' A' ' 50' ' ' PHE . 8.0 tt -136.96 151.95 27.89 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.565 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.078 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.621 ' HB3' ' OD1' ' A' ' 154' ' ' ASP . 26.3 m-85 -95.08 103.27 15.12 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.839 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.819 HD23 HD22 ' A' ' 21' ' ' LEU . 7.1 mp -70.64 -29.27 65.58 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.976 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.621 ' OD1' ' HB3' ' A' ' 152' ' ' TYR . 21.9 p-10 -56.27 -13.96 2.5 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.914 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.948 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 31.1 mt-10 -68.96 -54.11 17.1 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.505 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 76.2 m-70 -123.11 3.73 9.29 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.719 -0.792 . . . . 0.0 112.576 -176.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.492 HG21 HD21 ' A' ' 21' ' ' LEU . 43.2 mm -105.32 112.85 40.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.127 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.541 ' HA3' ' OXT' ' A' ' 167' ' ' CYS . . . -118.47 178.53 16.79 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.878 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.621 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -109.6 125.71 52.85 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.86 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.91 85.06 2.04 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 65.0 t30 52.2 49.59 20.26 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.388 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 94.11 2.22 64.44 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.707 -0.758 . . . . 0.0 114.338 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -122.31 126.04 47.25 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.982 0.42 . . . . 0.0 109.894 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.689 HD11 ' CD2' ' A' ' 7' ' ' PHE . 7.6 tp -73.78 128.45 35.56 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.754 -178.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.817 HG13 ' H ' ' A' ' 166' ' ' HIS . 10.8 tp -159.36 -173.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -179.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.817 ' H ' HG13 ' A' ' 165' ' ' ILE . 19.1 p80 -82.49 125.45 31.11 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.131 -0.356 . . . . 0.0 110.163 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.541 ' OXT' ' HA3' ' A' ' 158' ' ' GLY . 53.1 t . . . . . 0 C--O 1.254 1.329 0 O-C-N 123.907 0.754 . . . . 0.0 112.121 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.69 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.4 167.5 11.48 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.04 0.448 . . . . 0.0 109.959 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.689 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 27.9 m-85 -128.84 -68.34 0.75 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.304 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.3 -26.69 0.9 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.525 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -72.7 -69.76 1.34 Allowed Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 119.541 -1.314 . . . . 0.0 113.376 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 68.39 16.73 9.23 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 122.624 0.37 . . . . 0.0 110.366 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.669 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -63.63 -30.54 71.64 Favored 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -178.801 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.402 ' HA ' HD11 ' A' ' 14' ' ' ILE . 97.2 p -70.37 -12.39 61.55 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.715 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.22 -26.03 60.5 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.283 -0.872 . . . . 0.0 112.782 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.444 ' HB2' ' HB3' ' A' ' 26' ' ' ARG . 35.0 p -126.49 -23.65 3.75 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.221 0.51 . . . . 0.0 112.069 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.0 m -90.09 135.28 33.75 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.532 ' HG2' ' N ' ' A' ' 13' ' ' ASP . 44.3 ttt-85 -110.86 171.08 7.68 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.539 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.532 ' N ' ' HG2' ' A' ' 12' ' ' ARG . 48.7 m-20 46.01 48.65 12.45 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.349 0.659 . . . . 0.0 111.999 178.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.877 HG22 HD13 ' A' ' 129' ' ' LEU . 9.4 mt -79.36 105.71 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.657 ' HA ' HD12 ' A' ' 129' ' ' LEU . 75.5 m -147.18 126.81 13.33 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.011 0.524 . . . . 0.0 109.977 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.768 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -97.79 156.61 16.49 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -179.07 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -96.88 74.4 2.64 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.063 -1.426 . . . . 0.0 107.669 177.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.12 -52.89 4.57 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.031 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.574 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -149.26 -13.36 0.3 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.183 0.516 . . . . 0.0 110.004 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 20' ' ' ARG . 23.4 ttm180 -90.89 92.63 8.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.331 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.812 HD13 HD11 ' A' ' 129' ' ' LEU . 37.3 tp -63.46 130.49 44.6 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.736 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -134.17 127.05 31.23 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.033 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.656 ' HB1' HG12 ' A' ' 14' ' ' ILE . . . -146.72 147.02 30.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.244 0.545 . . . . 0.0 111.501 -178.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.737 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 7.2 mm-40 -78.59 74.7 5.12 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.392 177.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.625 ' SG ' HD13 ' A' ' 164' ' ' LEU . 68.9 m -60.3 126.9 29.24 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 120.971 0.415 . . . . 0.0 111.029 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.444 ' HB3' ' HB2' ' A' ' 10' ' ' SER . 65.6 ttt180 -68.51 121.67 16.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.237 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.559 ' HD3' ' HB3' ' A' ' 29' ' ' ASP . 6.0 ptp180 -94.91 149.59 21.08 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 177.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.42 -11.33 3.58 Favored Glycine 0 C--N 1.34 0.775 0 O-C-N 124.35 1.031 . . . . 0.0 113.642 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.559 ' HB3' ' HD3' ' A' ' 27' ' ' ARG . 19.8 t70 -71.68 -15.64 62.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.441 0.639 . . . . 0.0 109.548 178.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.13 5.4 53.01 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.048 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.22 172.41 14.26 Favored Glycine 0 C--N 1.322 -0.197 0 C-N-CA 119.959 -1.115 . . . . 0.0 113.517 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.737 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 41.2 m-85 -101.87 128.92 48.03 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 178.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.6 m -114.45 130.81 56.75 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.267 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 m -67.47 110.01 3.45 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.092 0.473 . . . . 0.0 110.846 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.505 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 41.7 t -115.06 151.93 33.39 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.512 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -145.94 133.66 15.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.08 0.467 . . . . 0.0 111.824 -178.777 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.475 HG22 HD23 ' A' ' 164' ' ' LEU . 10.7 tt -135.4 141.23 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.869 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.02 108.84 15.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.07 0.462 . . . . 0.0 111.052 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.587 HD23 ' HB3' ' A' ' 21' ' ' LEU . 3.1 mm? -81.14 -7.33 59.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.621 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.574 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 26.9 p30 -68.62 -9.6 50.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.57 0.7 . . . . 0.0 109.364 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.484 ' HA ' ' H ' ' A' ' 117' ' ' ALA . 15.4 ttm180 -104.94 0.15 27.53 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.617 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.548 ' HA ' HG22 ' A' ' 53' ' ' VAL . 75.8 m-85 -126.06 -28.09 3.2 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.842 HD22 HD13 ' A' ' 151' ' ' ILE . 36.5 mt -106.31 142.84 35.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.988 0.423 . . . . 0.0 112.023 -178.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.2 m -135.43 139.78 44.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.446 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.815 ' CB ' ' HG ' ' A' ' 140' ' ' LEU . 7.8 p-10 -83.48 93.93 7.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.522 0.677 . . . . 0.0 110.286 178.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.44 ' CB ' ' HD2' ' A' ' 51' ' ' ARG . 9.1 t0 -99.88 94.79 6.49 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 122.1 -0.375 . . . . 0.0 110.63 -179.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.519 ' HA ' ' HB2' ' A' ' 142' ' ' TYR . 10.2 t-20 52.47 49.28 20.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.52 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 149' ' ' SER . . . 72.0 38.98 59.63 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.696 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -157.29 123.02 4.69 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.756 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 65.4 m-85 -62.46 144.9 55.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.191 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.44 ' HD2' ' CB ' ' A' ' 46' ' ' ASP . 70.0 mtt180 -148.0 133.02 18.19 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.38 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.545 ' HA ' ' O ' ' A' ' 42' ' ' TYR . 97.3 m95 -74.44 135.36 42.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.273 178.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.548 HG22 ' HA ' ' A' ' 42' ' ' TYR . 13.7 m -58.81 105.93 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.531 0.682 . . . . 0.0 110.946 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.6 m -89.69 -14.24 35.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.651 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -96.16 -60.28 1.02 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.177 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.48 -147.45 19.02 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.262 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.68 -135.48 2.01 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.012 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.72 42.17 62.49 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.425 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.09 121.47 11.71 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.204 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.08 -177.74 19.56 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.361 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.29 -66.84 0.46 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.862 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.5 m -139.64 113.85 8.96 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.805 -0.697 . . . . 0.0 110.639 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.597 ' HB1' ' HG2' ' A' ' 110' ' ' LYS . . . -133.53 176.55 8.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.545 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.427 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 2.4 p -128.8 117.97 21.98 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.218 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.514 HG21 ' CE2' ' A' ' 80' ' ' PHE . 14.2 p -104.68 141.17 20.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.003 0.43 . . . . 0.0 111.575 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 5.6 m -93.09 126.7 38.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.236 0.541 . . . . 0.0 109.691 178.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.593 ' CG2' HD12 ' A' ' 99' ' ' ILE . 53.9 t -79.59 135.22 26.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.092 -179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -100.83 169.84 8.72 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 124.355 1.034 . . . . 0.0 110.643 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.713 ' CA ' ' HB3' ' A' ' 101' ' ' PRO . 50.1 tt0 -66.15 116.71 7.52 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.978 -177.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.25 -3.29 47.36 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.321 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -100.29 139.32 36.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.999 0.428 . . . . 0.0 111.213 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.692 ' HA ' HG12 ' A' ' 99' ' ' ILE . 69.6 p -120.29 179.43 4.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.542 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.663 HD22 HG23 ' A' ' 99' ' ' ILE . 1.1 mm? -51.5 -40.61 59.9 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.19 0.519 . . . . 0.0 110.191 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -61.75 -38.47 88.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.354 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -72.3 -40.21 67.68 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.666 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 72' ' ' THR . 41.7 mm -64.96 -47.38 88.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.886 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.646 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -61.23 -44.29 98.3 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.92 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -65.54 -36.38 83.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.075 0.464 . . . . 0.0 111.251 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -75.27 -44.21 47.02 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.514 ' CE2' HG21 ' A' ' 65' ' ' VAL . 89.7 m-85 -101.91 17.32 23.42 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -176.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.4 t70 54.33 42.72 31.29 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.527 0.679 . . . . 0.0 111.521 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.646 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.1 p -123.07 166.2 15.53 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.672 ' O ' HG13 ' A' ' 87' ' ' ILE . 6.8 t70 -93.88 124.52 37.94 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.599 -0.841 . . . . 0.0 110.115 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.574 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 18.9 p90 -51.5 -31.78 25.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.19 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.494 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 3.7 t60 -66.58 -44.1 83.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.727 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.67 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 17.9 mm-40 -67.61 -47.35 69.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.254 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.672 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.8 mt -51.06 -45.34 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.435 0.636 . . . . 0.0 109.336 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.623 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.63 -50.77 69.93 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.935 178.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' A' ' 85' ' ' HIS . 74.6 mtp180 -57.32 -41.98 80.96 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.67 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 15.4 mtp180 -70.89 -21.78 62.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.852 0.358 . . . . 0.0 111.376 -178.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 17.4 t-20 -101.13 -5.23 25.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.951 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 16.0 m120 78.0 14.58 1.55 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.49 0.716 . . . . 0.0 111.494 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.623 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 16.7 pt -106.27 -174.64 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.576 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 78.6 mm-40 -113.48 155.37 25.44 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.555 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 4.5 p30 -54.07 -58.87 5.7 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-O 122.259 1.028 . . . . 0.0 109.058 178.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -75.33 12.26 1.0 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.747 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.576 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.1 t0 -69.49 -34.09 73.81 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 10.3 mp 70.22 116.62 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 O-C-N 124.21 0.944 . . . . 0.0 108.98 -176.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.696 HG21 HD11 ' A' ' 105' ' ' LEU . 7.5 pt -93.56 177.07 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.993 -177.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.405 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 2.3 m-85 -123.87 156.04 66.03 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.401 -177.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.713 ' HB3' ' CA ' ' A' ' 69' ' ' GLN . 32.6 Cg_endo -68.71 130.6 20.97 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.258 2.639 . . . . 0.0 113.062 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.05 12.54 49.14 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 66' ' ' THR . 63.4 tt0 -101.0 159.72 14.98 Favored 'General case' 0 C--O 1.214 -0.792 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.427 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 85.6 t -120.59 120.47 62.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.04 0.448 . . . . 0.0 110.203 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.696 HD11 HG21 ' A' ' 99' ' ' ILE . 68.4 mt -111.49 152.0 27.97 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.549 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -90.78 115.81 28.14 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.564 0.697 . . . . 0.0 111.208 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.2 m -124.57 151.26 67.03 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.407 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -63.32 -17.08 58.41 Favored 'Trans proline' 0 C--N 1.332 -0.302 0 C-N-CA 123.305 2.67 . . . . 0.0 114.92 -177.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.9 t -157.69 154.32 28.11 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.551 -0.459 . . . . 0.0 111.462 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.597 ' HG2' ' HB1' ' A' ' 63' ' ' ALA . 12.8 mmmm -101.28 174.82 5.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.741 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -175.62 93.58 0.09 OUTLIER Glycine 0 N--CA 1.443 -0.833 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.154 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 83.4 68.2 1.43 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.178 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.9 m -151.51 47.34 0.81 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.988 0.423 . . . . 0.0 110.366 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.05 -50.43 4.29 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.023 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 137.97 -97.39 0.25 Allowed Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.294 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.35 69.72 1.02 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.504 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.484 ' H ' ' HA ' ' A' ' 41' ' ' ARG . . . -119.66 -39.67 2.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.951 0.405 . . . . 0.0 110.707 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . -90.42 -53.54 2.28 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.59 -0.815 . . . . 0.0 111.349 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.3 m120 73.74 27.22 1.75 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 177.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.662 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 22.5 p90 -58.39 -36.72 73.97 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.376 -0.53 . . . . 0.0 109.886 178.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.531 ' HB2' ' HB2' ' A' ' 19' ' ' ALA . 52.8 t-105 -63.79 -34.62 78.31 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.854 -178.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -56.86 -19.78 19.4 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.155 0.502 . . . . 0.0 110.788 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.813 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 13.0 m -138.75 29.12 2.35 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.444 178.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.529 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -116.22 145.83 42.81 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.2 0.524 . . . . 0.0 111.94 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.45 HH11 ' HD3' ' A' ' 125' ' ' ARG . 29.1 mtp-105 -133.69 153.88 51.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.378 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 52.03 39.91 27.3 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 123.713 0.633 . . . . 0.0 112.128 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.504 ' CG1' HD11 ' A' ' 136' ' ' LEU . 22.5 t -67.19 121.51 16.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.056 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -144.83 140.5 28.45 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.689 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.877 HD13 HG22 ' A' ' 14' ' ' ILE . 16.4 mt -86.36 122.39 30.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.147 0.498 . . . . 0.0 109.912 178.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.635 HG23 ' HB ' ' A' ' 135' ' ' VAL . 35.2 m -115.63 159.36 15.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.367 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.601 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 1.4 m-20 71.06 -0.7 2.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.212 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.562 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 98.6 28.18 8.09 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.033 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.506 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 100.24 -23.94 33.98 Favored Glycine 0 C--O 1.264 1.98 0 CA-C-O 123.192 1.44 . . . . 0.0 112.618 178.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.73 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 6.9 ptmm? -65.08 -18.85 65.65 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 121.803 -0.822 . . . . 0.0 109.601 178.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.635 ' HB ' HG23 ' A' ' 130' ' ' VAL . 15.1 t -139.08 141.19 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.289 0.566 . . . . 0.0 109.976 177.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 30.1 tp -121.66 121.16 36.73 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.507 ' OE2' ' HD3' ' A' ' 150' ' ' ARG . 36.7 tt0 -111.93 132.53 54.69 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.209 -177.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.748 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -163.22 161.89 25.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.594 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -94.65 105.85 17.82 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.815 ' HG ' ' CB ' ' A' ' 45' ' ' ASN . 1.9 mp -89.82 128.52 36.18 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.543 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.813 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 41.0 ttt180 -70.61 140.53 51.67 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.097 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.663 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.3 p90 -157.22 -171.81 3.76 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.951 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.1 p -56.44 -29.2 61.35 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.168 0.293 . . . . 0.0 111.601 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.03 26.12 25.52 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.142 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 94.87 -110.98 4.1 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.365 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -130.05 133.31 46.62 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.663 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 14.4 t-20 -123.93 136.92 54.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.764 0.316 . . . . 0.0 111.361 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -76.7 93.73 3.7 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.505 ' OG ' HD22 ' A' ' 140' ' ' LEU . 24.2 p -110.71 162.91 14.29 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.506 -178.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.597 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 14.0 mtm-85 -143.91 152.37 41.02 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.858 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.842 HD13 HD22 ' A' ' 43' ' ' LEU . 11.1 tt -137.95 143.2 33.97 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.467 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.735 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 35.7 m-85 -83.89 101.66 11.83 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 122.195 -0.316 . . . . 0.0 110.925 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.772 HD13 HD22 ' A' ' 21' ' ' LEU . 20.4 mt -62.92 -33.6 75.67 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.116 178.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.73 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 12.7 t70 -56.13 -14.11 2.48 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.805 178.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.735 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 38.9 mt-10 -64.3 -55.8 18.87 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.617 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 53.6 m-70 -121.54 2.35 10.15 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 119.851 -0.74 . . . . 0.0 112.111 -177.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' A' ' 153' ' ' LEU . 47.0 mm -103.95 112.76 38.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.605 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.58 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -121.52 164.76 14.61 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.36 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.574 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.9 t30 -99.63 130.64 45.87 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.665 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 28.8 ttm180 -122.78 87.02 2.68 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.205 0.526 . . . . 0.0 110.425 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 64.9 t30 53.93 44.05 29.99 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.654 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.95 -6.78 47.96 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.127 -1.035 . . . . 0.0 114.733 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.665 ' HG2' ' O ' ' A' ' 160' ' ' ARG . 12.9 pt-20 -118.99 138.4 52.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 117.81 0.805 . . . . 0.0 110.696 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.669 HD11 ' CD2' ' A' ' 7' ' ' PHE . 7.4 tp -91.7 118.63 30.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.075 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.511 HG12 ' N ' ' A' ' 166' ' ' HIS . 12.0 tt -149.04 167.31 3.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.272 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.617 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 10.9 p-80 -61.9 123.19 17.37 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.523 ' OXT' ' HA3' ' A' ' 158' ' ' GLY . 50.8 t . . . . . 0 C--O 1.252 1.235 0 O-C-N 123.799 0.687 . . . . 0.0 111.348 -179.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.785 ' HA ' ' OD1' ' A' ' 154' ' ' ASP . 1.2 m-80 -75.96 137.86 40.59 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.602 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.747 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 56.3 m-85 -91.62 -90.32 0.17 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.731 -178.741 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.84 -29.99 10.15 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.459 -179.392 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.21 -69.15 1.45 Allowed Glycine 0 N--CA 1.436 -1.324 0 C-N-CA 119.948 -1.12 . . . . 0.0 113.051 -178.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.489 ' OD1' ' HB2' ' A' ' 2' ' ' ASN . 37.1 m-80 69.55 11.81 8.05 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.564 0.345 . . . . 0.0 110.94 -179.475 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.593 ' CE2' HD13 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -59.64 -35.0 73.53 Favored 'General case' 0 C--O 1.214 -0.786 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.635 -179.004 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.3 p -64.87 -13.77 57.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.04 0.447 . . . . 0.0 111.502 -179.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.64 -12.42 62.63 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.98 179.37 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 14.8 m -126.67 -34.11 2.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.491 0.663 . . . . 0.0 110.732 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 9.0 m -92.77 133.59 35.89 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.685 -179.042 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.435 ' HG3' ' HB2' ' A' ' 24' ' ' GLU . 9.1 ptp180 -111.76 -173.65 2.29 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.455 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 2.3 m-20 44.76 39.65 3.64 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 123.607 0.567 . . . . 0.0 112.419 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.972 HG22 HD13 ' A' ' 129' ' ' LEU . 5.0 mt -78.74 103.86 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 CA-C-O 120.951 0.405 . . . . 0.0 110.503 -178.564 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.593 ' CA ' HD12 ' A' ' 129' ' ' LEU . 71.2 m -147.63 126.53 12.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.284 178.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.801 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -101.03 155.16 18.14 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.904 0.859 . . . . 0.0 112.951 -179.373 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -99.02 77.0 2.15 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.036 -1.438 . . . . 0.0 107.559 176.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.06 -56.76 5.0 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.856 179.177 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.524 ' HB1' ' HB2' ' A' ' 40' ' ' ASN . . . -148.66 -12.28 0.34 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.087 0.47 . . . . 0.0 109.918 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.454 HH11 ' HD3' ' A' ' 20' ' ' ARG . 44.0 mtp-105 -81.75 86.43 6.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.343 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.801 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 42.1 tp -62.0 116.07 4.6 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 122.825 0.45 . . . . 0.0 111.884 -179.497 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.547 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 39.1 ttt180 -122.99 127.89 49.45 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.226 -179.104 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.64 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -148.66 146.65 28.26 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.506 0.67 . . . . 0.0 111.107 -179.339 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 1.2 mm-40 -85.53 79.88 9.25 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.643 178.39 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.629 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 37.6 m -65.63 126.73 29.3 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.213 -178.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 10' ' ' SER . 30.8 ttm180 -65.47 124.07 21.31 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.311 178.535 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.555 ' HD3' ' O ' ' A' ' 161' ' ' ASN . 18.4 ttp180 -105.08 151.2 24.28 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.524 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.9 2.61 0.56 Allowed Glycine 0 C--N 1.334 0.432 0 CA-C-N 114.525 -1.216 . . . . 0.0 113.944 -178.314 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.42 ' H ' ' C ' ' A' ' 27' ' ' ARG . 33.1 t70 -84.73 -9.25 58.39 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.454 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.5 10.64 57.89 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -133.9 162.99 24.53 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.155 -1.021 . . . . 0.0 112.867 -179.666 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.469 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 71.2 m-85 -88.71 146.39 25.07 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.525 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.4 t -127.83 126.13 41.09 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.569 178.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.6 m -67.26 117.24 9.01 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 41.6 t -124.32 151.95 43.68 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.179 -179.403 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.689 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.4 p -144.31 134.92 20.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.904 0.383 . . . . 0.0 111.196 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.472 HG23 ' HB3' ' A' ' 21' ' ' LEU . 11.2 tt -135.62 152.94 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.878 -178.372 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.414 ' OD2' ' HB3' ' A' ' 40' ' ' ASN . 19.3 t70 -82.81 112.77 19.94 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.647 0.26 . . . . 0.0 110.451 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.492 HD23 ' HB3' ' A' ' 21' ' ' LEU . 2.7 mm? -92.81 0.89 57.49 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.356 0.598 . . . . 0.0 109.562 178.075 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.524 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 11.1 t30 -76.17 -19.57 58.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.202 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' A' ' 41' ' ' ARG . 4.7 ptp180 -97.89 6.14 48.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.329 178.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.55 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 33.3 m-85 -129.25 -27.7 2.42 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.554 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.82 HD22 HD13 ' A' ' 151' ' ' ILE . 53.3 mt -105.96 137.94 42.99 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.134 0.492 . . . . 0.0 110.807 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m -131.78 143.59 50.33 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.414 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.553 ' CG ' ' HB3' ' A' ' 140' ' ' LEU . 7.9 t30 -90.47 110.92 22.02 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.481 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.461 ' CB ' ' HD3' ' A' ' 51' ' ' ARG . 35.4 t70 -115.61 92.72 4.0 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.238 179.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 65.1 t30 57.99 45.23 18.37 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.099 179.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.765 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 73.6 38.25 51.46 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.304 -0.951 . . . . 0.0 112.009 179.107 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.625 ' HA ' ' OG ' ' A' ' 149' ' ' SER . 23.8 t60 -151.12 121.43 7.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.768 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 38.1 m-85 -65.6 139.49 58.44 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.142 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.461 ' HD3' ' CB ' ' A' ' 46' ' ' ASP . 78.1 mtp180 -147.17 133.3 19.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.708 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.55 ' HA ' ' O ' ' A' ' 42' ' ' TYR . 98.3 m95 -75.22 133.04 41.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.037 178.13 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.484 HG22 ' H ' ' A' ' 55' ' ' GLY . 7.5 p -98.84 129.14 49.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.057 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.4 p -81.32 -18.5 45.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.414 -178.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.484 ' H ' HG22 ' A' ' 53' ' ' VAL . . . -137.08 -80.08 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.725 -179.418 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.471 ' HA2' ' HB1' ' A' ' 117' ' ' ALA . . . 171.46 169.66 34.61 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.9 -179.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.1 -149.15 14.82 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.449 -0.661 . . . . 0.0 111.449 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.66 -85.71 0.61 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.02 179.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.43 -71.19 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.058 -0.592 . . . . 0.0 111.967 179.438 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.3 -73.99 0.31 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.14 -117.72 4.75 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.005 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 88.8 m -135.54 114.58 12.2 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.865 0.364 . . . . 0.0 110.085 179.416 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.477 ' HB1' ' HG2' ' A' ' 110' ' ' LYS . . . -117.84 177.09 4.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.19 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.536 HG22 ' HG2' ' A' ' 106' ' ' GLN . 12.3 p -128.58 119.47 24.84 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.678 0.275 . . . . 0.0 111.711 -179.354 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.468 HG21 ' CE2' ' A' ' 80' ' ' PHE . 8.3 p -105.89 141.52 21.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 120.793 0.33 . . . . 0.0 111.086 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.2 m -89.75 128.41 36.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.424 0.63 . . . . 0.0 109.996 179.109 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.597 ' CG2' HD12 ' A' ' 99' ' ' ILE . 48.8 t -79.71 138.22 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.072 -179.387 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -108.55 171.26 7.52 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 124.06 0.85 . . . . 0.0 111.09 -179.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.646 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 36.5 tt0 -54.28 114.31 1.59 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.539 -178.536 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.4 2.69 63.53 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 121.151 -0.547 . . . . 0.0 113.793 178.319 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -91.28 143.82 26.25 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 117.163 0.482 . . . . 0.0 111.537 -179.405 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.774 ' HA ' HG12 ' A' ' 99' ' ' ILE . 35.0 p -130.69 169.13 16.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.274 178.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.669 HD22 HG23 ' A' ' 99' ' ' ILE . 1.0 OUTLIER -49.77 -43.38 48.15 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.202 0.455 . . . . 0.0 111.512 -179.516 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -65.06 -35.88 82.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.542 -177.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -74.07 -37.71 64.14 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 72' ' ' THR . 45.0 mm -67.86 -47.9 77.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.367 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.719 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -58.13 -48.25 84.22 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.751 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -34.56 78.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.785 0.326 . . . . 0.0 111.341 -179.186 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -71.37 -47.54 55.7 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.604 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.468 ' CE2' HG21 ' A' ' 65' ' ' VAL . 86.2 m-85 -100.5 19.85 16.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -177.217 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 53.38 45.49 28.27 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.233 0.54 . . . . 0.0 112.012 178.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.719 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.2 p -126.14 168.0 14.63 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.315 179.497 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.65 ' O ' HG13 ' A' ' 87' ' ' ILE . 9.2 t70 -93.33 123.46 36.63 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 121.846 -0.534 . . . . 0.0 109.647 179.176 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.545 ' HD2' ' HB2' ' A' ' 95' ' ' ASN . 2.5 p90 -52.0 -27.07 12.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.011 179.735 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.93 -37.65 54.92 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.062 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.683 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 3.8 tp10 -64.86 -47.78 76.66 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.65 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.2 mt -53.86 -45.77 63.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.853 178.63 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.574 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.36 -52.07 65.07 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.91 178.511 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.1 mtt-85 -61.22 -30.18 70.27 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.683 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 32.8 mmt180 -72.73 -31.81 65.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.096 0.474 . . . . 0.0 110.395 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 21.1 t-20 -93.61 -6.02 47.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.754 179.349 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 92.0 m-20 79.04 17.12 0.93 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.092 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.574 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 16.1 pt -107.22 -173.03 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.843 178.509 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.536 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 3.5 mm100 -112.61 161.4 16.85 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.433 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.545 ' HB2' ' HD2' ' A' ' 84' ' ' PHE . 16.4 p-10 -62.36 -52.41 63.76 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.581 1.182 . . . . 0.0 108.394 179.473 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 96' ' ' GLU . 35.2 tt0 -73.64 4.74 4.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 113.867 -1.515 . . . . 0.0 110.822 179.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 0.9 OUTLIER -64.76 -37.45 87.64 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.625 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.41 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 7.9 mp 70.24 116.42 0.04 OUTLIER 'General case' 0 C--O 1.231 0.12 0 O-C-N 124.12 0.888 . . . . 0.0 109.716 -177.682 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.81 HG21 HD11 ' A' ' 105' ' ' LEU . 8.0 pt -93.95 175.72 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.881 -177.617 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.527 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 14.2 m-85 -126.04 158.85 64.69 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.921 -178.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.646 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 28.8 Cg_endo -64.98 136.07 46.86 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.298 2.665 . . . . 0.0 113.212 -179.747 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.7 15.58 56.38 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.467 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -103.8 153.68 20.45 Favored 'General case' 0 C--O 1.209 -1.036 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.386 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.502 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 62.0 t -116.12 119.55 62.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 O-C-N 121.75 -0.594 . . . . 0.0 110.567 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.81 HD11 HG21 ' A' ' 99' ' ' ILE . 77.5 mt -113.49 152.09 30.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.572 -179.229 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.656 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 71.2 mt-30 -90.78 122.4 33.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.546 0.688 . . . . 0.0 110.729 179.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.7 m -129.98 151.18 77.83 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.585 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.23 -20.45 70.74 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 123.734 2.956 . . . . 0.0 114.793 -177.21 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.7 t -147.79 152.56 37.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.924 0.392 . . . . 0.0 110.725 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.864 ' HB3' ' HA3' ' A' ' 114' ' ' GLY . 11.3 mmmm -98.56 164.64 12.18 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.194 0.521 . . . . 0.0 111.131 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -151.02 152.46 24.27 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.272 179.564 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.82 -101.5 0.72 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.088 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 21.8 m -77.69 1.93 18.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.902 0.382 . . . . 0.0 110.843 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.864 ' HA3' ' HB3' ' A' ' 110' ' ' LYS . . . -97.42 -88.35 1.86 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.844 179.448 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 109.78 -153.27 17.01 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.097 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 111.43 59.68 0.47 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.722 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.471 ' HB1' ' HA2' ' A' ' 56' ' ' GLY . . . -117.32 -41.38 2.98 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.02 0.438 . . . . 0.0 110.539 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . -99.7 -58.24 0.9 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.619 179.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.448 ' HA ' ' OD1' ' A' ' 40' ' ' ASN . 17.9 m120 69.43 31.64 3.73 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 123.019 0.528 . . . . 0.0 112.176 178.156 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.637 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 24.5 p90 -60.07 -34.95 74.13 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.527 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.507 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 20.7 t-105 -63.44 -33.16 74.96 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.821 -178.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.27 -23.62 49.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.981 0.42 . . . . 0.0 110.929 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.0 p -133.19 24.35 4.17 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.052 179.812 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.507 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -108.99 146.43 33.9 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.02 0.438 . . . . 0.0 111.5 179.026 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -146.41 146.01 30.45 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 61.26 26.22 16.1 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.73 0.776 . . . . 0.0 110.53 -179.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.574 ' HB ' ' CB ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -75.81 125.48 35.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.833 -179.93 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -150.06 155.67 40.29 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.654 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.972 HD13 HG22 ' A' ' 14' ' ' ILE . 30.5 mt -86.54 131.41 34.18 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.966 0.412 . . . . 0.0 110.102 179.573 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.442 HG23 ' HB ' ' A' ' 135' ' ' VAL . 33.3 m -125.79 158.59 34.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.918 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.559 ' HB3' ' HD2' ' A' ' 134' ' ' LYS . 3.7 m-20 68.84 7.34 6.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.448 178.486 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.665 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 96.32 32.9 6.45 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.561 178.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 87.56 -15.81 52.77 Favored Glycine 0 C--O 1.266 2.151 0 CA-C-O 123.579 1.655 . . . . 0.0 112.833 177.361 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.84 ' HG3' HG23 ' A' ' 135' ' ' VAL . 18.2 ptpt -67.41 -24.23 65.63 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.233 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.84 HG23 ' HG3' ' A' ' 134' ' ' LYS . 26.1 t -136.36 137.13 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 121.43 0.633 . . . . 0.0 110.806 178.811 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.6 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 36.0 tp -112.26 114.83 27.82 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.366 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -104.47 125.99 51.16 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.357 -177.317 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.614 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . . . -154.38 161.75 41.55 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.158 0.504 . . . . 0.0 111.256 -179.264 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -103.28 106.37 16.87 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 177.448 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.765 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 38.6 mt -94.07 135.37 35.5 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.722 -178.146 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 145' ' ' GLY . 70.3 ttt180 -69.84 140.96 53.32 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.355 179.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.599 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 1.0 OUTLIER -157.92 -167.81 2.34 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.849 -0.341 . . . . 0.0 111.549 -179.165 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.7 m -56.02 -26.91 50.83 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.053 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -106.35 27.35 17.26 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.13 -1.033 . . . . 0.0 113.238 -178.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 141' ' ' ARG . . . 95.1 -106.35 3.39 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.101 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -127.81 129.95 47.84 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.599 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 56.4 t30 -123.6 137.29 54.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.047 0.451 . . . . 0.0 111.517 -179.114 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 39.8 ttt180 -76.31 105.88 7.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.925 178.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.625 ' OG ' ' HA ' ' A' ' 49' ' ' HIS . 10.2 t -121.47 165.44 15.62 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -146.4 158.12 43.85 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.125 -179.558 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.82 HD13 HD22 ' A' ' 43' ' ' LEU . 9.8 tt -141.89 145.55 24.02 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.37 179.193 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.66 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 23.3 m-85 -86.86 104.8 16.55 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 121.069 -0.253 . . . . 0.0 111.088 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.694 HD13 HD22 ' A' ' 21' ' ' LEU . 16.4 mt -67.68 -31.97 72.3 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.242 178.295 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.785 ' OD1' ' HA ' ' A' ' 2' ' ' ASN . 2.1 p30 -55.0 -17.33 3.64 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.129 177.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.747 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 35.1 mt-10 -63.18 -53.08 58.84 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.222 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.586 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 58.1 m80 -123.3 5.01 9.12 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.728 -177.567 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.431 HG21 HD21 ' A' ' 21' ' ' LEU . 48.3 mm -105.69 110.34 30.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.693 178.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.569 ' HA3' ' O ' ' A' ' 167' ' ' CYS . . . -115.97 172.84 14.41 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.632 178.445 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.629 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.2 OUTLIER -112.26 130.03 56.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.984 0.421 . . . . 0.0 110.983 179.893 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -125.41 94.01 4.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.327 179.098 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.555 ' O ' ' HD3' ' A' ' 27' ' ' ARG . 2.3 m-20 62.88 39.68 10.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.678 178.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.525 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 88.36 13.45 63.57 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.902 179.196 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -122.97 135.85 54.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.759 0.314 . . . . 0.0 111.299 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.499 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 37.4 mt -82.16 121.39 26.55 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.107 178.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 12.6 tt -149.89 155.58 7.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.197 -179.463 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.586 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 1.5 p-80 -56.85 117.15 3.66 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.522 0.201 . . . . 0.0 110.519 179.503 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.569 ' O ' ' HA3' ' A' ' 158' ' ' GLY . 41.5 t . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.609 -0.71 . . . . 0.0 111.635 -179.672 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.593 0 N-CA-C 111.731 -0.547 . . . . 0.0 111.731 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.446 ' HB2' ' HA ' ' A' ' 6' ' ' ASN . 20.1 m120 -125.41 -153.29 0.55 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.986 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 38.0 m-85 -91.61 -89.37 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.193 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.63 -33.55 4.82 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.341 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -70.63 -62.47 3.62 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 119.763 -1.208 . . . . 0.0 112.694 -179.035 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.446 ' HA ' ' HB2' ' A' ' 2' ' ' ASN . 37.7 m-80 65.48 16.52 10.56 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 122.532 0.333 . . . . 0.0 111.041 -179.498 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.732 ' HD2' HD11 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -63.74 -34.95 79.02 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.732 -179.277 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.43 ' HA ' HD11 ' A' ' 14' ' ' ILE . 16.6 p -63.79 -18.83 64.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.139 0.495 . . . . 0.0 110.988 -179.494 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.92 -26.29 69.41 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 115.682 -0.69 . . . . 0.0 113.341 179.226 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.568 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 33.5 p -127.12 -20.33 4.17 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 117.583 0.691 . . . . 0.0 111.819 -179.224 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.6 t -96.62 131.3 43.41 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -112.54 -176.99 3.04 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.451 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 16.6 m-20 43.62 45.55 5.81 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 123.971 0.794 . . . . 0.0 111.874 -179.802 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 1.08 HG22 HD13 ' A' ' 129' ' ' LEU . 7.6 mt -78.32 102.66 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-O 120.904 0.383 . . . . 0.0 110.075 -178.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.647 ' CA ' HD12 ' A' ' 129' ' ' LEU . 56.9 m -144.73 128.43 17.21 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.168 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.767 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -97.44 157.81 15.8 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.941 0.877 . . . . 0.0 112.956 -179.24 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -99.45 74.87 1.93 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 113.994 -1.457 . . . . 0.0 107.779 177.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.52 -53.22 4.66 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.137 179.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.541 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -149.07 -13.57 0.31 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 120.951 0.405 . . . . 0.0 110.147 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -85.86 92.92 8.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.604 179.067 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.013 HD12 HD11 ' A' ' 129' ' ' LEU . 9.5 tp -62.91 114.81 3.88 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.713 -179.786 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' A' ' 35' ' ' SER . 43.7 ttp180 -119.62 133.94 55.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.612 -178.265 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.628 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -152.78 148.13 26.86 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.402 179.791 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.51 ' O ' ' HD1' ' A' ' 32' ' ' TYR . 1.8 mm-40 -83.82 79.73 9.38 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.814 179.148 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.668 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 67.2 m -61.45 121.68 13.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.013 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.568 ' HB2' ' O ' ' A' ' 10' ' ' SER . 36.4 ttt-85 -70.64 122.21 19.34 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.273 178.532 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.7 ttt-85 -93.53 154.59 17.8 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.272 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.03 -15.0 6.23 Favored Glycine 0 C--N 1.335 0.509 0 O-C-N 124.36 1.037 . . . . 0.0 114.164 -178.251 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -79.27 -3.48 46.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.198 0.523 . . . . 0.0 109.788 178.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.46 9.51 72.32 Favored Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.97 144.31 17.31 Favored Glycine 0 C--O 1.227 -0.343 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.998 -179.067 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.51 ' HD1' ' O ' ' A' ' 24' ' ' GLU . 74.3 m-85 -90.46 125.69 35.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.788 0.328 . . . . 0.0 110.277 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.7 m -115.75 130.5 56.87 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.638 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.7 m -65.63 124.32 22.06 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.8 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 42.5 t -129.31 147.07 51.11 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.139 179.331 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.59 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 7.7 p -144.66 137.8 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.705 0.288 . . . . 0.0 110.967 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.534 HG22 HD23 ' A' ' 164' ' ' LEU . 8.5 tt -135.32 147.42 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.605 -178.357 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -76.38 99.77 4.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.723 0.297 . . . . 0.0 111.338 179.277 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.822 HD12 ' HG ' ' A' ' 43' ' ' LEU . 1.2 mm? -82.83 -4.41 58.02 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.102 0.477 . . . . 0.0 111.089 179.887 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.541 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 7.0 p30 -69.87 -10.68 59.39 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.369 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.479 ' O ' ' HB3' ' A' ' 117' ' ' ALA . 57.9 mtt85 -102.54 6.06 39.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.829 179.17 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.494 ' HB2' HD13 ' A' ' 39' ' ' LEU . 7.1 m-85 -134.18 -24.75 1.61 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.569 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.822 ' HG ' HD12 ' A' ' 39' ' ' LEU . 61.7 mt -105.83 128.74 53.93 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.752 0.31 . . . . 0.0 110.522 179.433 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.66 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 1.0 OUTLIER -125.1 135.95 53.18 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.487 -179.845 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.841 ' HB3' ' HG ' ' A' ' 140' ' ' LEU . 18.8 p-10 -79.26 92.45 5.12 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.359 0.6 . . . . 0.0 110.033 178.336 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -86.82 86.85 7.35 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.307 0.575 . . . . 0.0 110.333 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.486 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 64.5 t30 50.22 44.62 26.24 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.253 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.71 34.82 10.87 Favored Glycine 0 C--O 1.221 -0.657 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.725 178.368 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -150.68 131.56 14.19 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.429 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.724 ' HB3' ' HB ' ' A' ' 151' ' ' ILE . 21.3 m-85 -72.21 140.0 48.47 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.559 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.426 ' HD3' ' HA ' ' A' ' 51' ' ' ARG . 10.5 mmt180 -143.88 134.15 24.47 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.087 -179.448 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.626 ' HH2' HD13 ' A' ' 153' ' ' LEU . 96.5 m95 -75.33 104.61 5.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.258 177.53 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.3 t 68.01 -61.78 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.042 0.839 . . . . 0.0 112.42 179.053 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.401 ' HB3' ' HB3' ' A' ' 51' ' ' ARG . 66.8 p 49.06 62.07 2.8 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.899 0.857 . . . . 0.0 110.402 -178.627 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.538 ' O ' ' HA3' ' A' ' 59' ' ' GLY . . . 91.29 -48.34 2.91 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.702 -178.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.28 26.66 11.87 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.399 179.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.42 56.2 3.47 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.161 179.544 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.77 17.96 19.61 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.524 179.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 55' ' ' GLY . . . -83.35 125.52 7.06 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.099 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.63 165.61 14.17 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -179.354 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 108' ' ' PRO . . . 118.96 -122.2 5.26 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.046 -179.475 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 37.7 m -134.94 117.53 15.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.193 0.521 . . . . 0.0 111.671 -179.595 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.64 176.62 8.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.009 179.085 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.514 HG22 ' HG2' ' A' ' 106' ' ' GLN . 7.8 p -129.59 122.16 28.55 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.208 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.545 HG21 ' CE2' ' A' ' 80' ' ' PHE . 8.2 p -113.02 147.44 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 120.751 0.31 . . . . 0.0 111.072 179.26 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 4.9 m -90.52 129.95 36.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.099 0.476 . . . . 0.0 110.284 179.101 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.483 ' CG2' HD12 ' A' ' 99' ' ' ILE . 54.0 t -78.78 133.48 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.485 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -104.17 169.34 8.55 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.333 1.021 . . . . 0.0 110.486 -179.496 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.629 ' N ' ' HB3' ' A' ' 101' ' ' PRO . 63.4 tt0 -68.13 120.16 13.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.292 -178.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.33 9.36 55.5 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.856 179.332 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -116.88 128.35 55.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.964 0.412 . . . . 0.0 111.494 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.584 ' HA ' HG12 ' A' ' 99' ' ' ILE . 67.8 p -106.68 -179.2 3.87 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.329 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.64 HD22 HG23 ' A' ' 99' ' ' ILE . 1.4 mm? -52.21 -43.1 64.07 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.406 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 3.4 tmt_? -59.38 -41.64 89.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.366 -179.292 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -73.12 -38.2 66.4 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.595 -178.345 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.532 HG12 ' O ' ' A' ' 72' ' ' THR . 45.8 mm -63.83 -48.89 84.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.542 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.741 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -59.23 -47.24 91.8 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.391 179.206 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -25.49 64.78 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.796 0.332 . . . . 0.0 111.838 -178.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 48.9 ttm-85 -82.51 -34.51 27.92 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.116 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.545 ' CE2' HG21 ' A' ' 65' ' ' VAL . 95.0 m-85 -110.83 20.26 17.74 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.321 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.9 t70 55.06 42.1 31.18 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.62 0.724 . . . . 0.0 111.711 178.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.741 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -125.26 170.98 10.75 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.348 179.255 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.574 ' O ' HG13 ' A' ' 87' ' ' ILE . 7.4 t70 -98.39 123.15 42.35 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.87 179.366 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.52 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 5.9 p90 -50.97 -30.37 14.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.99 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -67.24 -43.73 81.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.229 179.525 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.688 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 26.3 mt-10 -64.9 -48.27 74.8 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.355 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.574 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.1 mt -49.59 -50.21 17.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.458 179.196 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.604 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.63 -50.74 68.15 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.295 178.681 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -56.56 -37.63 70.8 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.688 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 75.3 mtt180 -73.91 -29.48 62.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.841 0.353 . . . . 0.0 111.03 -179.407 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 15.1 t-20 -93.19 -5.16 50.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.031 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 93.4 m-20 79.23 12.46 1.27 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.586 0.754 . . . . 0.0 111.497 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.604 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 14.8 pt -102.8 179.43 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.445 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.565 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 2.6 mp0 -105.96 155.94 18.87 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.468 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.3 p-10 -56.82 -56.09 26.07 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.226 1.012 . . . . 0.0 108.82 179.21 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -77.95 12.03 1.96 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.438 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.565 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.9 t70 -65.34 -34.9 79.41 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.469 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.413 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 8.2 mp 70.78 115.3 0.05 OUTLIER 'General case' 0 C--O 1.233 0.215 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.107 -178.117 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.778 HG21 HD11 ' A' ' 105' ' ' LEU . 7.5 pt -95.29 178.66 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.538 -178.526 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.554 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 61.8 m-85 -130.53 158.34 74.89 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.478 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.629 ' HB3' ' N ' ' A' ' 69' ' ' GLN . 22.9 Cg_endo -64.95 139.21 60.73 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 123.323 2.682 . . . . 0.0 114.402 -178.414 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.39 20.22 33.07 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.014 178.085 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.552 ' O ' ' HA ' ' A' ' 66' ' ' THR . 79.2 mt-30 -109.59 168.21 9.57 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.413 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 77.8 t -126.36 112.06 28.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.047 0.451 . . . . 0.0 110.042 179.1 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.778 HD11 HG21 ' A' ' 99' ' ' ILE . 87.2 mt -107.23 151.42 25.46 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.581 -179.645 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.514 ' HG2' HG22 ' A' ' 64' ' ' THR . 37.4 mt-30 -91.06 112.38 24.26 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.741 0.781 . . . . 0.0 111.387 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.7 m -115.78 152.0 46.92 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.459 179.701 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 37.8 Cg_endo -65.37 -21.94 60.43 Favored 'Trans proline' 0 C--N 1.332 -0.315 0 C-N-CA 122.909 2.406 . . . . 0.0 114.409 -177.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.9 t -148.66 151.25 34.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.86 0.362 . . . . 0.0 110.987 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.431 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 12.0 mmmm -95.57 169.08 10.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.053 178.692 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -101.96 64.94 0.46 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.76 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 166.34 139.98 2.78 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.935 179.669 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.6 p -139.89 -72.64 0.37 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.718 0.294 . . . . 0.0 110.633 -179.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 149.61 -73.07 0.29 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.067 179.69 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.36 142.74 9.92 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.128 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.95 62.11 2.16 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.54 179.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 41' ' ' ARG . . . -109.06 -30.64 7.96 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.234 0.54 . . . . 0.0 109.841 179.326 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.66 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -110.22 -69.64 0.61 Allowed Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.723 179.622 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 20.9 m120 70.7 27.03 3.75 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 122.998 0.519 . . . . 0.0 112.118 178.595 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.623 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 17.2 p90 -60.07 -39.47 86.17 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.658 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.55 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 38.9 t-105 -61.75 -29.88 70.42 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.208 -178.267 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -55.96 -28.31 56.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.665 0.269 . . . . 0.0 110.803 -179.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.7 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 3.9 m -135.25 28.74 3.39 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.855 0.36 . . . . 0.0 110.48 178.497 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.55 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -110.61 144.34 39.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.766 0.317 . . . . 0.0 110.706 178.873 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -136.64 149.72 48.13 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.137 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 59.34 45.23 14.2 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.693 0.62 . . . . 0.0 111.139 179.343 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.475 ' CG1' HD11 ' A' ' 136' ' ' LEU . 21.4 t -74.84 121.37 26.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.194 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -145.17 140.65 28.1 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.036 -179.375 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 1.08 HD13 HG22 ' A' ' 14' ' ' ILE . 54.1 mt -86.76 127.11 34.98 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.038 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.535 HG23 ' HB ' ' A' ' 135' ' ' VAL . 34.6 m -119.95 163.17 17.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.854 -178.701 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 66.27 9.23 6.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.474 178.654 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.687 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 94.69 31.83 7.59 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.116 179.487 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.706 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 86.8 -13.92 57.7 Favored Glycine 0 C--O 1.256 1.521 0 CA-C-O 123.274 1.485 . . . . 0.0 112.812 177.548 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.607 ' HG3' HG23 ' A' ' 135' ' ' VAL . 19.0 ptpt -72.86 -14.22 61.45 Favored 'General case' 0 C--N 1.311 -1.098 0 O-C-N 121.592 -0.946 . . . . 0.0 108.76 178.155 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.607 HG23 ' HG3' ' A' ' 134' ' ' LYS . 22.7 t -141.68 138.73 31.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.638 177.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.58 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 27.8 tp -119.99 125.39 48.26 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.527 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.527 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 28.3 tt0 -114.98 132.52 56.56 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 123.504 0.503 . . . . 0.0 110.948 -177.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . . . -161.39 158.52 26.96 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.247 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 30.5 mt-10 -94.88 106.82 18.83 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.841 ' HG ' ' HB3' ' A' ' 45' ' ' ASN . 0.4 OUTLIER -89.54 123.37 33.57 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.435 -179.877 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.7 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 36.6 ttt180 -69.29 140.81 54.42 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.606 ' CE1' ' HB2' ' A' ' 147' ' ' ASN . 2.5 p90 -155.53 -170.39 3.43 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.429 -179.008 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 3.1 m -56.96 -27.94 61.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.106 0.479 . . . . 0.0 112.0 -179.36 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.29 17.2 58.21 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.598 -0.811 . . . . 0.0 113.19 -179.312 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 103.41 -107.9 3.13 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.031 179.768 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -129.6 127.69 41.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.785 0.292 . . . . 0.0 110.639 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.606 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . 52.0 t-20 -120.88 117.18 26.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.76 0.314 . . . . 0.0 110.534 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 31.6 ttm180 -74.99 94.74 2.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.886 178.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.3 m -111.54 174.02 6.07 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.403 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.58 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 44.6 mtt85 -142.37 165.68 26.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.058 0.456 . . . . 0.0 112.003 -177.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.724 ' HB ' ' HB3' ' A' ' 50' ' ' PHE . 14.3 tt -145.44 161.98 12.38 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.372 179.169 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.599 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 12.1 m-85 -104.43 104.27 14.12 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 122.144 -0.347 . . . . 0.0 111.72 -178.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.708 HD11 ' HG ' ' A' ' 39' ' ' LEU . 4.1 mm? -65.65 -36.43 83.67 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.328 179.071 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.472 ' HB3' ' HA ' ' A' ' 134' ' ' LYS . 6.0 p-10 -57.34 -11.96 2.17 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.18 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.986 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 36.1 mt-10 -67.76 -54.89 15.65 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.416 ' HA ' ' OXT' ' A' ' 167' ' ' CYS . 90.4 m-70 -121.33 3.6 10.29 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.041 -0.664 . . . . 0.0 112.467 -177.37 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.639 HG13 HD12 ' A' ' 153' ' ' LEU . 45.9 mm -104.26 114.16 43.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 C-N-CA 120.181 -0.607 . . . . 0.0 110.585 179.023 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.407 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -115.14 175.79 16.21 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.928 -0.654 . . . . 0.0 113.159 179.52 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.668 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 2.0 t30 -117.4 129.05 55.6 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.5 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.671 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 40.8 ttm180 -124.67 88.32 2.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.712 179.674 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 51.95 46.15 27.07 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 178.636 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.9 -8.98 50.94 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.285 -0.96 . . . . 0.0 115.019 177.404 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.671 ' HG2' ' O ' ' A' ' 160' ' ' ARG . 12.9 pt-20 -114.18 146.6 40.13 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 117.901 0.851 . . . . 0.0 110.634 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.732 HD11 ' HD2' ' A' ' 7' ' ' PHE . 4.6 tp -91.15 106.92 18.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.675 -179.578 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.562 HD13 ' HB2' ' A' ' 160' ' ' ARG . 31.7 pt -100.84 173.43 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.366 0.603 . . . . 0.0 112.149 -178.474 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.414 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 36.8 p-80 -126.75 129.8 49.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.991 -179.706 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.416 ' OXT' ' HA ' ' A' ' 156' ' ' HIS . 22.7 p . . . . . 0 C--O 1.247 0.923 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -94.1 -95.78 0.16 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.771 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 1.012 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 35.3 m-85 -139.21 -90.62 0.19 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -121.87 -31.32 3.96 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.021 178.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -78.55 -66.44 1.73 Allowed Glycine 0 N--CA 1.436 -1.352 0 C-N-CA 119.525 -1.322 . . . . 0.0 112.046 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 65.96 15.26 10.0 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.605 0.362 . . . . 0.0 111.018 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.741 ' CD2' HD11 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -58.31 -37.27 74.75 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -178.972 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.4 ' HA ' HD11 ' A' ' 14' ' ' ILE . 28.8 t -60.04 -18.25 45.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.379 0.609 . . . . 0.0 110.816 -179.649 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.52 -33.32 61.13 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.578 179.008 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.521 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 20.2 m -120.9 -17.98 7.72 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 117.683 0.741 . . . . 0.0 111.32 -179.461 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.415 ' OG ' ' HA ' ' A' ' 25' ' ' CYS . 15.6 m -97.99 131.46 44.4 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -114.19 -175.64 2.72 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.425 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 0.9 OUTLIER 46.03 42.37 9.43 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 123.76 0.663 . . . . 0.0 111.87 179.284 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.906 HG22 HD13 ' A' ' 129' ' ' LEU . 7.5 mt -78.82 105.48 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-O 121.18 0.514 . . . . 0.0 110.063 -178.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.57 ' CA ' HD12 ' A' ' 129' ' ' LEU . 65.3 m -147.72 128.6 14.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.887 179.433 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.761 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -97.97 159.87 14.66 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -178.711 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.431 ' HB2' ' HB2' ' A' ' 20' ' ' ARG . 24.1 m-20 -99.1 73.77 1.94 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.129 177.113 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.86 -59.46 4.72 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.742 179.645 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.649 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -147.8 10.96 0.95 Allowed 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.273 0.558 . . . . 0.0 110.274 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.431 ' HB2' ' HB2' ' A' ' 17' ' ' ASP . 72.1 mtm180 -110.05 91.24 3.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.86 179.428 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.97 ' HB2' HD22 ' A' ' 39' ' ' LEU . 44.3 tp -60.47 122.47 14.69 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.636 -178.646 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 48.7 ttp180 -127.51 132.17 49.98 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.345 -178.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.629 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -149.83 145.25 26.48 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.511 0.672 . . . . 0.0 110.74 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.528 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 3.8 mm-40 -80.54 68.51 6.77 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.671 178.283 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.7 ' SG ' HD13 ' A' ' 164' ' ' LEU . 57.5 m -57.28 124.47 18.95 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.018 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.521 ' HB2' ' O ' ' A' ' 10' ' ' SER . 42.6 ttt-85 -65.75 126.36 28.19 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.414 179.241 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 33.9 ptt180 -98.48 155.29 17.33 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.063 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.93 -11.95 4.89 Favored Glycine 0 C--N 1.338 0.689 0 O-C-N 124.513 1.133 . . . . 0.0 113.919 -179.024 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.01 -11.65 60.86 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.048 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.35 8.27 60.04 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.857 179.531 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.435 ' O ' ' HG2' ' A' ' 27' ' ' ARG . . . -123.7 178.07 16.5 Favored Glycine 0 C--O 1.225 -0.432 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.392 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.528 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 83.2 m-85 -101.58 140.99 35.11 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.912 0.387 . . . . 0.0 111.168 179.573 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 p -128.93 133.97 48.05 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.904 179.231 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 m -71.32 111.07 6.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.094 0.473 . . . . 0.0 111.608 -178.383 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 36.4 t -116.27 147.57 41.37 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.948 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 5.4 p -143.14 137.55 26.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 120.867 0.365 . . . . 0.0 111.152 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.6 tt -132.66 154.32 39.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.012 -177.511 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -81.15 95.12 6.79 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.97 HD22 ' HB2' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -76.1 -14.23 60.19 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.697 0.76 . . . . 0.0 109.461 178.355 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.649 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 5.2 p30 -66.62 -15.96 63.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.803 178.377 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.456 ' HD2' ' O ' ' A' ' 114' ' ' GLY . 56.6 mtm180 -114.24 31.03 6.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.1 179.071 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.428 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 24.4 m-85 -150.45 -30.97 0.2 Allowed 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.208 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.902 HD22 HD13 ' A' ' 151' ' ' ILE . 41.7 mt -105.94 127.5 53.19 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.775 0.321 . . . . 0.0 110.495 179.273 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.657 ' OG ' ' HA2' ' A' ' 118' ' ' GLY . 1.0 OUTLIER -123.91 137.78 54.58 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.452 179.984 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.813 ' HB3' ' HG ' ' A' ' 140' ' ' LEU . 19.4 p-10 -78.34 92.21 4.52 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.484 0.659 . . . . 0.0 110.831 178.59 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -87.5 86.71 7.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.072 0.463 . . . . 0.0 110.725 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 52.03 43.66 30.19 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.312 179.24 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.55 40.04 9.27 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.995 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -157.81 118.98 3.54 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.746 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.804 ' CB ' ' HB ' ' A' ' 151' ' ' ILE . 29.7 m-85 -62.44 140.88 58.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.28 -179.358 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.588 ' HB3' ' HA2' ' A' ' 55' ' ' GLY . 16.3 mmm180 -140.41 139.03 35.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.235 179.508 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.653 ' CZ2' ' HA ' ' A' ' 153' ' ' LEU . 86.2 m95 -76.86 153.1 35.12 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 t 64.64 -92.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 113.763 -1.562 . . . . 0.0 112.841 177.243 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.4 m -129.26 34.76 4.35 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.029 0.443 . . . . 0.0 110.362 -178.272 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.588 ' HA2' ' HB3' ' A' ' 51' ' ' ARG . . . 72.14 32.0 63.44 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.84 -179.695 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.28 128.73 44.62 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.899 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.32 28.36 15.11 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.795 -0.716 . . . . 0.0 111.917 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.51 -126.03 3.32 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -139.49 -60.25 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.137 179.545 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.54 176.38 16.11 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.898 -0.667 . . . . 0.0 111.77 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 108' ' ' PRO . . . -176.25 -115.63 0.43 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.067 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.3 m -129.59 116.78 19.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.176 0.512 . . . . 0.0 110.549 179.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -121.98 176.58 5.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.431 179.525 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.2 p -126.81 120.8 30.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.028 0.442 . . . . 0.0 112.151 -179.093 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.9 p -110.18 144.85 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.006 178.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 5.7 m -89.19 127.27 35.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.079 179.044 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.548 ' CG2' HD12 ' A' ' 99' ' ' ILE . 60.5 t -73.38 131.66 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.55 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -101.0 170.08 8.52 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 124.485 1.115 . . . . 0.0 111.136 -178.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.71 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 57.7 tp60 -58.76 118.56 5.84 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.682 -178.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.81 -5.36 85.04 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 121.106 -0.568 . . . . 0.0 113.705 177.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -90.36 127.56 36.22 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 117.084 0.442 . . . . 0.0 111.056 -179.662 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.69 ' HA ' HG12 ' A' ' 99' ' ' ILE . 68.9 p -107.93 -179.33 3.87 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.728 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.68 HD22 HG23 ' A' ' 99' ' ' ILE . 1.2 mm? -53.02 -42.73 65.96 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.538 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 74' ' ' ARG . 42.2 ttm180 -62.43 -35.33 78.93 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.145 -178.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -74.06 -46.7 41.47 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.585 179.626 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.528 HG12 ' O ' ' A' ' 72' ' ' THR . 43.8 mm -58.31 -48.4 85.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.209 -179.649 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.692 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -58.64 -55.55 30.17 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.112 179.464 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -33.95 75.98 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.047 0.451 . . . . 0.0 111.114 -178.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -73.5 -40.41 64.09 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -106.57 15.17 26.14 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -178.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.0 t70 60.33 49.89 6.64 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.589 0.709 . . . . 0.0 111.826 178.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.692 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.5 p -134.55 165.59 24.85 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.786 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.512 ' O ' HG13 ' A' ' 87' ' ' ILE . 3.9 p-10 -95.24 121.43 36.87 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.775 0.797 . . . . 0.0 109.689 178.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.561 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 5.9 p90 -48.11 -31.36 5.48 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.174 -1.375 . . . . 0.0 112.115 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.44 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 22.4 t-80 -60.23 -50.28 74.27 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.963 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.497 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 7.9 tp10 -65.39 -45.65 83.18 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.107 179.712 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.567 ' HB ' HD12 ' A' ' 73' ' ' LEU . 4.3 mt -51.4 -46.16 34.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.725 0.774 . . . . 0.0 109.51 179.446 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.572 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.98 -50.75 69.54 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.719 178.611 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.421 HH21 ' CD ' ' A' ' 86' ' ' GLU . 52.2 ttp180 -59.2 -37.15 76.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.758 0.313 . . . . 0.0 111.794 -179.381 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.683 ' HB3' ' HB2' ' A' ' 106' ' ' GLN . 2.0 mmp_? -65.11 -32.32 73.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.928 0.394 . . . . 0.0 110.903 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.6 HD22 HG23 ' A' ' 93' ' ' ILE . 6.0 t30 -96.09 -5.03 41.8 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.959 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 17.3 m120 77.36 18.3 1.4 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.355 0.662 . . . . 0.0 111.029 -179.228 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.6 HG23 HD22 ' A' ' 91' ' ' ASN . 10.6 pt -105.84 179.53 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.827 178.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.552 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 12.0 mm100 -102.93 154.55 19.1 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.744 HD22 ' HG3' ' A' ' 96' ' ' GLU . 1.1 p-10 -55.7 -61.5 2.31 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-O 122.259 1.028 . . . . 0.0 109.696 179.036 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.744 ' HG3' HD22 ' A' ' 95' ' ' ASN . 43.6 mt-10 -78.49 12.48 1.98 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.582 -179.461 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.552 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 4.3 t0 -61.89 -32.43 72.8 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.127 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.491 HD22 HG21 ' A' ' 72' ' ' THR . 41.2 mt 71.78 114.38 0.05 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.176 -178.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.69 HG12 ' HA ' ' A' ' 72' ' ' THR . 8.2 pt -95.2 175.54 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.354 -179.152 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.497 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 40.4 m-85 -124.71 157.44 65.88 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.21 -178.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.71 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 40.7 Cg_endo -67.85 138.71 45.42 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 123.122 2.548 . . . . 0.0 113.456 -178.526 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.76 13.59 43.24 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.374 179.159 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.516 ' O ' ' HA ' ' A' ' 66' ' ' THR . 44.1 mt-30 -100.44 168.69 9.59 Favored 'General case' 0 C--O 1.217 -0.658 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.297 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 89.5 t -128.53 109.16 18.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.7 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.657 HD11 HG21 ' A' ' 99' ' ' ILE . 82.0 mt -107.15 151.56 25.23 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.019 -178.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.683 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 39.6 mt-30 -89.89 116.44 27.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.598 0.713 . . . . 0.0 110.859 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.0 m -121.98 150.74 56.88 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 114.37 -1.287 . . . . 0.0 109.544 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 34.8 Cg_endo -64.99 -18.4 62.05 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 123.352 2.701 . . . . 0.0 114.29 -177.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.2 t -148.18 152.55 37.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.255 0.55 . . . . 0.0 111.139 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.586 ' HB3' ' O ' ' A' ' 116' ' ' GLY . 0.1 OUTLIER -94.02 -166.16 1.45 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.339 179.682 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -103.79 -115.6 4.1 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.532 -178.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.864 ' HA2' ' HB2' ' A' ' 117' ' ' ALA . . . 147.39 -17.89 1.5 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.349 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.4 m -67.44 -24.64 65.65 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.444 -0.378 . . . . 0.0 111.504 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.456 ' O ' ' HD2' ' A' ' 41' ' ' ARG . . . -145.45 -83.62 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.293 179.765 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -122.25 150.42 16.97 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.137 -0.554 . . . . 0.0 111.823 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.586 ' O ' ' HB3' ' A' ' 110' ' ' LYS . . . 78.49 67.5 1.61 Allowed Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.864 ' HB2' ' HA2' ' A' ' 112' ' ' GLY . . . -122.15 -47.57 2.14 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.125 0.488 . . . . 0.0 110.364 -179.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.657 ' HA2' ' OG ' ' A' ' 44' ' ' SER . . . -96.96 -74.36 1.19 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.211 -179.566 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.3 m120 70.9 21.13 5.16 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 178.741 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.626 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 21.6 p90 -58.02 -37.5 74.44 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.045 0.45 . . . . 0.0 109.941 178.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.511 ' HB2' ' HB2' ' A' ' 19' ' ' ALA . 58.3 t-105 -59.93 -32.21 70.57 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.144 -178.495 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.9 -28.31 56.14 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.946 0.403 . . . . 0.0 110.392 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.951 ' HB3' ' HB3' ' A' ' 141' ' ' ARG . 69.7 m -133.26 30.12 3.93 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.921 179.135 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.491 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -115.88 136.48 53.0 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.981 0.42 . . . . 0.0 111.731 178.845 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -129.32 151.35 50.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.963 178.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 40.8 t0 56.22 51.36 11.83 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.742 0.782 . . . . 0.0 110.575 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.483 HG22 ' HB1' ' A' ' 138' ' ' ALA . 21.9 t -83.98 127.15 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.588 -179.644 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 25.0 ptt-85 -154.38 146.88 24.04 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.95 0.405 . . . . 0.0 110.358 179.164 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.906 HD13 HG22 ' A' ' 14' ' ' ILE . 19.5 mt -86.17 130.67 34.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.83 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.717 HG23 ' HB ' ' A' ' 135' ' ' VAL . 28.0 m -123.88 156.95 30.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.003 -178.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.482 ' HB3' ' CG ' ' A' ' 134' ' ' LYS . 0.7 OUTLIER 65.65 16.87 10.7 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.043 179.145 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.698 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 88.31 30.79 15.43 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.625 178.119 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.521 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 89.75 -14.44 61.63 Favored Glycine 0 C--O 1.26 1.735 0 CA-C-O 123.442 1.579 . . . . 0.0 113.031 177.112 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.786 ' HG3' HG23 ' A' ' 135' ' ' VAL . 21.5 ptmt -69.85 -17.35 63.37 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 121.334 -1.098 . . . . 0.0 108.384 178.396 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.786 HG23 ' HG3' ' A' ' 134' ' ' LYS . 3.9 t -140.17 144.72 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.083 177.79 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 28.3 tp -126.14 121.91 34.2 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.497 ' HG3' ' HG3' ' A' ' 150' ' ' ARG . 30.9 tt0 -112.58 133.34 54.68 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.883 0.373 . . . . 0.0 111.285 -177.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.537 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -161.86 163.8 29.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.62 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 124' ' ' ALA . 46.7 mt-10 -96.33 105.79 17.92 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 178.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.813 ' HG ' ' HB3' ' A' ' 45' ' ' ASN . 1.6 mp -89.85 125.2 35.24 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.927 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.951 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 74.7 ttt180 -70.87 140.86 51.21 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.047 178.669 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -155.59 -175.84 5.64 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.186 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 6.0 m -56.89 -31.46 64.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.759 0.314 . . . . 0.0 111.485 -179.256 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -88.33 7.65 81.0 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.766 -179.032 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 109.7 -121.83 6.2 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.127 179.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -122.86 125.1 44.74 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.629 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -123.3 140.39 53.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.874 0.368 . . . . 0.0 111.549 -179.092 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -72.55 102.37 3.23 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.824 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.473 ' HB2' HD22 ' A' ' 140' ' ' LEU . 1.4 m -113.07 156.34 23.3 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.351 -178.052 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -145.53 153.85 41.55 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.961 0.41 . . . . 0.0 111.065 179.84 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.902 HD13 HD22 ' A' ' 43' ' ' LEU . 9.4 tt -136.24 152.06 29.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.971 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.606 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 92.4 m-85 -97.11 104.49 16.51 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.419 0.152 . . . . 0.0 110.701 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.762 HD11 HD21 ' A' ' 129' ' ' LEU . 22.5 mt -68.74 -33.46 73.95 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.331 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.534 ' HB3' ' HA ' ' A' ' 134' ' ' LYS . 10.2 p-10 -56.84 -13.19 2.38 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.713 178.119 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 1.012 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 37.8 mt-10 -70.0 -55.42 9.62 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.431 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 88.0 m-70 -122.98 11.32 9.56 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.72 -0.792 . . . . 0.0 113.048 -176.232 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.54 HG12 ' CH2' ' A' ' 52' ' ' TRP . 38.0 mm -112.94 111.94 38.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.421 178.196 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.614 ' HA3' ' OXT' ' A' ' 167' ' ' CYS . . . -115.05 175.62 16.11 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.191 179.093 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.545 ' CG ' ' HB3' ' A' ' 25' ' ' CYS . 3.3 t30 -115.11 129.51 56.7 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 122.651 0.38 . . . . 0.0 110.278 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 41.0 ttt85 -125.94 97.75 5.24 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.258 179.434 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 61.83 32.39 18.09 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.149 179.24 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 93.68 12.31 57.03 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.495 -0.86 . . . . 0.0 113.093 179.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -122.48 134.21 54.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.069 0.462 . . . . 0.0 110.814 179.628 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.741 HD11 ' CD2' ' A' ' 7' ' ' PHE . 4.4 tp -78.24 118.73 20.74 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.983 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 10.3 tp -144.78 151.92 15.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.356 -178.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.431 ' HA ' ' O ' ' A' ' 156' ' ' HIS . 29.7 p-80 -59.81 125.6 24.28 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.521 -0.177 . . . . 0.0 110.521 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.614 ' OXT' ' HA3' ' A' ' 158' ' ' GLY . 44.7 t . . . . . 0 C--O 1.253 1.256 0 O-C-N 123.922 0.764 . . . . 0.0 111.273 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.508 ' HA3' ' OD1' ' A' ' 6' ' ' ASN . . . . . . . . 0 N--CA 1.48 1.612 0 N-CA-C 112.08 -0.408 . . . . 0.0 112.08 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.719 HD22 ' HB3' ' A' ' 152' ' ' TYR . 6.2 m-20 -88.43 -71.06 0.6 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 122.155 0.182 . . . . 0.0 111.472 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.466 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 34.0 m-85 -139.14 -98.25 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.145 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.415 ' HB1' ' SG ' ' A' ' 167' ' ' CYS . . . -96.07 -31.11 13.19 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.065 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.56 -74.62 0.48 Allowed Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 119.879 -1.153 . . . . 0.0 113.227 -179.071 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.508 ' OD1' ' HA3' ' A' ' 1' ' ' GLY . 35.3 m-80 64.69 16.67 10.51 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 122.488 0.315 . . . . 0.0 110.25 -179.286 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.904 ' HD2' HD11 ' A' ' 164' ' ' LEU . 0.2 OUTLIER -61.14 -34.79 75.57 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.679 -179.316 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.433 ' HA ' HD11 ' A' ' 14' ' ' ILE . 0.7 OUTLIER -64.76 -17.51 64.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.331 0.586 . . . . 0.0 110.246 -179.262 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.15 -37.18 92.78 Favored Glycine 0 CA--C 1.523 0.544 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.647 178.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.498 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 30.9 m -118.06 -27.64 6.07 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 120.985 0.421 . . . . 0.0 111.404 -179.419 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 5.8 t -88.94 128.9 35.7 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 12' ' ' ARG . 11.3 ptm85 -114.41 -177.05 3.04 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.74 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.425 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 3.8 m-20 46.09 43.18 10.56 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 123.759 0.662 . . . . 0.0 111.675 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.924 HG22 HD13 ' A' ' 129' ' ' LEU . 6.1 mt -78.44 103.61 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.261 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.576 ' CA ' HD12 ' A' ' 129' ' ' LEU . 58.4 m -143.34 127.77 17.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.612 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.804 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -101.14 156.61 17.32 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.892 0.853 . . . . 0.0 113.15 -179.725 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 22.3 t70 -98.71 74.58 2.09 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 113.914 -1.494 . . . . 0.0 107.468 177.236 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.5 -54.53 4.6 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.622 179.859 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.75 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -147.05 -13.04 0.42 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 120.954 0.406 . . . . 0.0 110.294 179.55 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.415 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 0.4 OUTLIER -82.99 86.81 6.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.444 179.14 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.804 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 45.2 tp -62.47 119.78 9.82 Favored 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 122.949 0.499 . . . . 0.0 112.158 -179.691 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 14' ' ' ILE . 15.9 ttp180 -124.31 135.87 53.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.358 -178.585 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.657 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -155.42 140.36 17.27 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.498 0.666 . . . . 0.0 111.374 179.714 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.572 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 3.5 mm-40 -77.94 82.23 4.31 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.901 178.198 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.635 ' SG ' HD13 ' A' ' 164' ' ' LEU . 34.5 m -69.85 120.58 15.8 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.886 -178.04 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 10' ' ' SER . 50.6 ttp85 -72.42 114.9 11.04 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.76 178.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.405 ' HB3' ' C ' ' A' ' 161' ' ' ASN . 2.9 ptp180 -92.1 160.6 15.13 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.233 179.242 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.75 -14.0 4.87 Favored Glycine 0 C--N 1.335 0.485 0 O-C-N 124.806 1.316 . . . . 0.0 113.902 -178.21 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -71.82 -12.47 61.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.789 0.804 . . . . 0.0 109.646 178.519 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.79 10.36 58.97 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.005 179.591 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -122.37 167.05 14.85 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 119.872 -1.156 . . . . 0.0 113.762 -179.011 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.572 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 78.1 m-85 -99.4 126.82 45.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.686 0.279 . . . . 0.0 110.516 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.5 t -113.71 126.18 54.94 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.398 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.7 m -66.59 114.36 5.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.092 0.472 . . . . 0.0 110.746 -179.291 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 36.2 t -119.04 148.85 42.56 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.405 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.9 p -145.3 138.47 21.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.693 0.282 . . . . 0.0 110.601 179.395 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.2 tt -135.32 153.52 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.627 -178.197 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.74 92.56 6.06 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.392 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.738 HD21 HD22 ' A' ' 153' ' ' LEU . 6.8 tp -78.6 -9.59 59.42 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.686 -177.46 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.75 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 28.4 p-10 -70.64 -12.99 61.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.497 0.665 . . . . 0.0 109.73 179.373 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.779 ' HG2' ' HA3' ' A' ' 116' ' ' GLY . 40.3 mtt180 -100.09 7.49 44.61 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.192 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 52' ' ' TRP . 52.3 m-85 -129.44 -27.17 2.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.16 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.731 HD22 HD13 ' A' ' 151' ' ' ILE . 35.3 mt -107.25 140.16 40.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.069 0.461 . . . . 0.0 110.899 179.556 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 50' ' ' PHE . 5.4 m -127.17 149.09 50.13 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.915 -179.869 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.584 HD22 ' C ' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -91.67 94.41 9.37 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.255 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -103.41 92.15 4.36 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.12 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.433 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 64.3 t30 46.95 44.61 14.88 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 114.749 -1.114 . . . . 0.0 112.324 178.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.24 42.74 7.82 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.957 178.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.431 ' HD2' ' O ' ' A' ' 50' ' ' PHE . 7.8 t60 -167.43 123.62 1.12 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.751 ' HZ ' ' HB3' ' A' ' 138' ' ' ALA . 62.0 m-85 -62.6 154.6 28.5 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.787 0.327 . . . . 0.0 110.602 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -148.11 133.79 18.86 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.974 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.473 ' CZ2' ' HA ' ' A' ' 153' ' ' LEU . 93.9 m95 -75.48 110.42 9.85 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.664 HG23 ' H ' ' A' ' 54' ' ' SER . 4.6 m 40.91 -99.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 O-C-N 124.402 1.064 . . . . 0.0 112.368 -178.543 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.664 ' H ' HG23 ' A' ' 53' ' ' VAL . 24.5 t -140.75 21.72 2.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.172 0.51 . . . . 0.0 109.962 179.511 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.9 -27.45 11.11 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.018 -179.368 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -146.72 -155.96 6.74 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.222 -0.513 . . . . 0.0 111.834 179.705 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.42 169.78 36.35 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.205 -179.661 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -118.3 128.11 7.59 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.131 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -104.81 -122.73 5.12 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.06 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -176.65 142.35 5.86 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -159.29 -105.67 0.21 Allowed Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.534 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 16.5 m -115.06 126.2 54.43 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.052 0.453 . . . . 0.0 110.819 179.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -125.2 174.14 8.29 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.466 ' HB ' ' CG1' ' A' ' 104' ' ' VAL . 1.2 p -129.83 114.25 15.68 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.782 0.325 . . . . 0.0 111.567 -179.07 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.485 HG21 ' CE2' ' A' ' 80' ' ' PHE . 11.5 p -99.81 135.07 36.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.936 0.398 . . . . 0.0 110.988 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.5 m -88.7 121.84 31.5 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.623 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.607 HG21 HD12 ' A' ' 99' ' ' ILE . 46.2 t -72.6 130.54 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.373 -179.428 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -100.85 169.15 9.18 Favored 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 124.149 0.906 . . . . 0.0 110.661 179.362 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.728 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 29.9 tt0 -60.21 108.69 0.83 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.524 -179.038 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.83 -10.97 20.93 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.296 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.556 ' HB3' HD11 ' A' ' 76' ' ' ILE . 68.3 m-20 -85.66 148.5 25.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.176 0.512 . . . . 0.0 111.79 -179.146 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.543 ' O ' HG12 ' A' ' 76' ' ' ILE . 23.4 p -133.93 158.48 43.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.434 178.795 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.69 HD23 ' HA ' ' A' ' 95' ' ' ASN . 1.8 tp -48.56 -45.27 37.49 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.039 0.447 . . . . 0.0 111.289 -179.651 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.544 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 43.7 ttp180 -60.13 -40.82 91.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.308 -179.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -74.31 -40.63 62.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.367 -178.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.556 HD11 ' HB3' ' A' ' 71' ' ' ASP . 47.6 mm -60.21 -46.47 94.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.159 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.713 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -55.44 -58.83 12.03 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.421 178.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -59.9 -33.18 71.51 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.675 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -66.55 -48.85 68.36 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.559 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.485 ' CE2' HG21 ' A' ' 65' ' ' VAL . 96.2 m-85 -97.52 13.23 30.67 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.196 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.7 t70 60.33 36.69 20.52 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.132 0.968 . . . . 0.0 110.711 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.713 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 2.1 p -114.54 171.79 7.42 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.548 179.229 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.714 ' O ' HG13 ' A' ' 87' ' ' ILE . 5.9 t0 -99.66 125.33 45.48 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 121.78 -0.575 . . . . 0.0 109.888 -179.702 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.544 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 31.9 p90 -54.3 -29.52 47.84 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.663 0.744 . . . . 0.0 109.938 178.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.536 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 22.3 t-80 -69.77 -41.37 75.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.544 178.6 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.699 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 36.8 tt0 -69.16 -48.9 61.03 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.638 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.714 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.2 mt -51.87 -43.31 34.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.678 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.564 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -62.61 -51.58 66.74 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.452 178.556 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.536 ' HG3' ' O ' ' A' ' 85' ' ' HIS . 41.2 mtm180 -61.62 -33.4 73.85 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.883 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.699 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 47.0 mmm-85 -73.36 -35.09 65.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.922 0.392 . . . . 0.0 110.896 -179.497 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.517 ' O ' ' HB2' ' A' ' 92' ' ' ASN . 3.0 t-20 -88.11 -5.15 58.61 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.812 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.517 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 91.0 m-20 79.43 10.68 1.44 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.53 0.732 . . . . 0.0 111.085 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.564 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 21.9 pt -100.84 -174.01 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.783 179.25 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.611 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 66.2 mm-40 -110.54 162.34 14.8 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.087 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.69 ' HA ' HD23 ' A' ' 73' ' ' LEU . 1.4 p30 -55.5 -69.9 0.12 Allowed 'General case' 0 C--O 1.244 0.804 0 CA-C-O 122.336 1.065 . . . . 0.0 109.977 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -72.86 12.8 0.46 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.656 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.611 ' HB2' ' O ' ' A' ' 94' ' ' GLN . 2.8 t70 -57.36 -33.21 67.55 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.389 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 55.4 mt 71.8 115.14 0.05 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-N 114.286 -1.324 . . . . 0.0 109.89 -178.621 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.607 HD12 HG21 ' A' ' 67' ' ' VAL . 17.1 pt -94.07 174.35 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.043 -178.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.456 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 17.3 m-85 -129.08 158.58 72.39 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.696 -178.603 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.728 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 25.5 Cg_endo -67.11 131.41 25.17 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.839 2.359 . . . . 0.0 112.438 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.33 15.12 36.26 Favored Glycine 0 N--CA 1.438 -1.177 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 -179.59 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -103.08 155.63 18.26 Favored 'General case' 0 C--O 1.214 -0.799 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.306 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.466 ' CG1' ' HB ' ' A' ' 64' ' ' THR . 59.4 t -117.89 120.83 65.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 O-C-N 121.993 -0.442 . . . . 0.0 109.815 179.368 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.429 ' HB3' ' CG2' ' A' ' 87' ' ' ILE . 77.9 mt -112.07 150.84 30.12 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.397 -178.827 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.423 ' HB2' ' CB ' ' A' ' 90' ' ' ARG . 74.1 mt-30 -90.9 112.84 24.86 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.729 0.776 . . . . 0.0 110.781 179.065 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.41 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 34.0 m -126.45 151.08 72.18 Favored Pre-proline 0 C--N 1.313 -0.998 0 CA-C-N 114.214 -1.357 . . . . 0.0 109.019 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 107' ' ' VAL . 32.2 Cg_endo -63.2 -18.56 65.51 Favored 'Trans proline' 0 N--CA 1.473 0.321 0 C-N-CA 123.561 2.841 . . . . 0.0 115.259 -176.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.9 t -154.22 155.54 35.43 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.374 -0.531 . . . . 0.0 111.48 -179.547 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -98.9 -174.59 2.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.152 179.344 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -90.16 -52.31 2.58 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.356 179.425 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 178.88 169.69 39.85 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 179.661 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.9 p -100.18 -56.65 2.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.945 0.403 . . . . 0.0 110.689 179.525 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -162.26 -83.83 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.803 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -99.31 -50.97 1.38 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.18 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.779 ' HA3' ' HG2' ' A' ' 41' ' ' ARG . . . -149.77 -85.88 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.389 179.861 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.469 ' H ' ' HA ' ' A' ' 41' ' ' ARG . . . -130.02 -50.73 1.12 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.833 0.349 . . . . 0.0 111.105 -179.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 43' ' ' LEU . . . -79.88 -60.37 2.45 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.239 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 72.65 29.23 2.03 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.989 0.515 . . . . 0.0 111.327 178.337 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.655 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 22.7 p90 -59.48 -36.52 76.18 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 121.304 0.573 . . . . 0.0 109.963 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.443 ' HA ' ' HB3' ' A' ' 124' ' ' ALA . 24.0 t-105 -65.15 -24.6 67.45 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.113 -178.363 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.94 -14.06 60.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.856 0.36 . . . . 0.0 110.925 -179.746 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.428 ' HB2' ' HB3' ' A' ' 141' ' ' ARG . 9.7 p -144.65 22.32 1.63 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.926 179.011 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' A' ' 121' ' ' TRP . . . -104.48 151.53 23.45 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.782 0.325 . . . . 0.0 110.915 179.08 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 63.0 ttp180 -141.5 144.53 34.4 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.106 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 57.73 52.53 8.06 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.197 0.522 . . . . 0.0 111.123 179.578 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.504 ' CG1' HD11 ' A' ' 136' ' ' LEU . 21.3 t -81.65 119.12 30.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.526 -179.565 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -143.4 142.43 31.24 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.344 -179.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.924 HD13 HG22 ' A' ' 14' ' ' ILE . 27.3 mt -86.18 129.55 34.81 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.952 178.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.57 HG23 ' HB ' ' A' ' 135' ' ' VAL . 34.6 m -121.72 154.78 26.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.175 0.512 . . . . 0.0 111.046 -178.845 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.546 ' HB3' ' HD3' ' A' ' 134' ' ' LYS . 9.6 m-20 71.41 3.65 4.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.953 179.054 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.662 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 98.41 31.95 6.25 Favored Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.554 178.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.482 ' HA3' HG21 ' A' ' 14' ' ' ILE . . . 92.95 -19.73 50.14 Favored Glycine 0 C--O 1.263 1.91 0 CA-C-O 122.966 1.315 . . . . 0.0 113.272 177.545 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.756 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 18.6 ptmt -66.31 -18.97 65.67 Favored 'General case' 0 C--N 1.318 -0.795 0 O-C-N 121.634 -0.921 . . . . 0.0 108.991 178.104 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.57 ' HB ' HG23 ' A' ' 130' ' ' VAL . 11.7 t -140.24 141.58 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.688 177.667 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.635 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 22.7 tp -121.2 121.97 38.95 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.368 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.531 ' HG3' ' HG2' ' A' ' 150' ' ' ARG . 35.0 tt0 -111.02 132.97 53.77 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 120.858 0.361 . . . . 0.0 111.297 -177.336 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.751 ' HB3' ' HZ ' ' A' ' 50' ' ' PHE . . . -162.55 155.24 19.44 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.678 179.153 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -94.05 106.84 18.8 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.549 HD13 ' HA ' ' A' ' 45' ' ' ASN . 59.8 mt -90.7 131.77 36.19 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.308 -178.864 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.428 ' HB3' ' HB2' ' A' ' 123' ' ' SER . 49.8 ttt85 -73.33 141.81 47.09 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.422 179.513 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.433 ' HB2' ' OD1' ' A' ' 47' ' ' ASN . 10.7 p90 -151.14 -165.08 2.16 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.72 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.4 m -70.52 2.44 3.99 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -135.88 31.73 2.6 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.675 -179.663 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 97.57 -134.62 11.81 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.766 179.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -117.03 124.95 50.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.569 0.223 . . . . 0.0 110.791 -179.655 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -115.0 131.55 56.89 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.106 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 31.2 ttm-85 -76.06 94.67 3.48 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.236 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.415 ' HB3' ' HA ' ' A' ' 49' ' ' HIS . 1.1 m -102.9 164.31 11.7 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.49 -178.725 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.635 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 39.1 mtt85 -145.5 149.42 34.62 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.008 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.731 HD13 HD22 ' A' ' 43' ' ' LEU . 9.3 tt -131.28 148.7 32.81 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.282 179.383 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.75 ' HB2' ' HG3' ' A' ' 155' ' ' GLU . 70.9 m-85 -92.54 102.53 14.98 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 122.277 -0.265 . . . . 0.0 111.293 -178.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.738 HD22 HD21 ' A' ' 39' ' ' LEU . 19.9 mt -67.49 -35.91 80.06 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.214 179.437 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.756 ' HB2' ' HA ' ' A' ' 134' ' ' LYS . 8.2 t70 -56.48 -10.1 0.87 Allowed 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.159 178.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.75 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 46.8 mt-10 -73.44 -48.67 31.84 Favored 'General case' 0 CA--C 1.509 -0.603 0 O-C-N 121.847 -0.533 . . . . 0.0 112.151 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.407 ' O ' ' HA ' ' A' ' 166' ' ' HIS . 58.3 m80 -124.86 3.64 8.1 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.563 -177.6 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.4 HG12 ' CH2' ' A' ' 52' ' ' TRP . 45.6 mm -109.79 111.68 37.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.293 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.569 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -116.55 166.44 12.38 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.384 179.318 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.62 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -98.41 124.91 43.35 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.316 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 160' ' ' ARG . 22.0 ttt180 -112.69 86.63 2.4 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.029 -179.678 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.405 ' C ' ' HB3' ' A' ' 27' ' ' ARG . 56.9 t30 51.87 43.52 30.1 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.257 179.267 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.551 ' HA2' ' HB2' ' A' ' 25' ' ' CYS . . . 101.68 -3.79 53.34 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 119.985 -1.103 . . . . 0.0 114.063 178.659 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -122.38 128.67 51.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 117.062 0.431 . . . . 0.0 111.192 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.904 HD11 ' HD2' ' A' ' 7' ' ' PHE . 3.3 tp -70.6 129.23 38.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.158 -179.817 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.509 HG13 ' N ' ' A' ' 166' ' ' HIS . 11.0 tp -152.93 170.39 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.983 0.42 . . . . 0.0 111.297 -178.757 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.509 ' N ' HG13 ' A' ' 165' ' ' ILE . 19.7 t-80 -69.45 110.45 4.74 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.364 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.557 ' O ' ' HA3' ' A' ' 158' ' ' GLY . 51.9 t . . . . . 0 C--O 1.246 0.884 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.531 -178.465 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.747 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.551 ' HA ' ' OD2' ' A' ' 154' ' ' ASP . 1.8 m120 -71.52 155.84 40.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.94 0.4 . . . . 0.0 110.348 -178.614 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.709 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 53.6 m-85 -105.19 -90.93 0.4 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.28 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.28 -34.83 10.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.321 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 157' ' ' ILE . . . -69.55 -65.01 2.72 Favored Glycine 0 N--CA 1.435 -1.427 0 C-N-CA 119.594 -1.289 . . . . 0.0 112.907 -178.626 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.527 ' HA ' ' CB ' ' A' ' 2' ' ' ASN . 37.9 m-80 67.84 15.68 9.62 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 122.289 0.236 . . . . 0.0 110.906 -179.663 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.653 ' CE2' HD13 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -64.87 -33.4 75.93 Favored 'General case' 0 C--O 1.215 -0.717 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.189 -179.345 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.2 t -67.72 -7.73 29.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.104 0.478 . . . . 0.0 110.582 -179.7 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.1 -7.33 58.53 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.584 178.574 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.551 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 49.0 m -135.11 -28.18 1.19 Allowed 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 117.026 0.413 . . . . 0.0 111.387 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.471 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 33.5 m -84.51 145.7 27.97 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.375 0.607 . . . . 0.0 109.625 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -116.82 160.49 20.75 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.841 -179.06 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 45.73 55.24 7.01 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 123.245 0.618 . . . . 0.0 112.544 178.658 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.989 HG22 HD13 ' A' ' 129' ' ' LEU . 8.5 mt -80.22 103.62 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 120.8 0.333 . . . . 0.0 110.35 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.636 ' CA ' HD12 ' A' ' 129' ' ' LEU . 69.3 m -145.47 128.29 16.33 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.508 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.723 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -92.34 158.31 16.16 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.227 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -100.0 76.13 1.91 Allowed 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.248 -1.342 . . . . 0.0 107.626 177.338 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.98 -61.99 4.65 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 114.788 -1.097 . . . . 0.0 111.555 179.097 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.706 ' HB1' ' HB3' ' A' ' 40' ' ' ASN . . . -144.82 -2.64 0.82 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.367 -0.416 . . . . 0.0 110.221 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.481 ' HB3' ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -97.59 96.06 8.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.397 178.99 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.986 HD12 HD11 ' A' ' 129' ' ' LEU . 4.8 tp -60.33 117.12 4.83 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 123.39 0.676 . . . . 0.0 111.441 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.584 ' HG3' ' HB ' ' A' ' 36' ' ' VAL . 25.8 ttt180 -120.23 126.73 51.34 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.965 0.412 . . . . 0.0 110.845 -178.311 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.662 ' HB2' HG23 ' A' ' 14' ' ' ILE . . . -147.51 142.49 26.97 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.727 0.775 . . . . 0.0 111.32 -179.698 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.548 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . 7.7 mm-40 -77.24 76.12 3.79 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.716 178.029 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.692 ' HB3' ' OD1' ' A' ' 159' ' ' ASN . 65.2 m -62.17 128.02 34.11 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.214 -178.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.551 ' HB2' ' O ' ' A' ' 10' ' ' SER . 17.1 ttp180 -73.54 116.45 14.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.421 179.634 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 27' ' ' ARG . 14.9 ptt180 -86.22 156.31 20.35 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.324 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.44 -14.96 3.73 Favored Glycine 0 C--N 1.338 0.68 0 O-C-N 124.631 1.207 . . . . 0.0 114.433 -177.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -73.15 -13.6 61.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.504 0.668 . . . . 0.0 109.617 178.16 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.92 6.65 59.12 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.569 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.42 164.78 12.4 Favored Glycine 0 C--O 1.225 -0.416 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.545 -179.156 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.548 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 84.3 m-85 -100.94 138.17 38.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.918 0.359 . . . . 0.0 110.83 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.1 m -126.89 126.91 44.08 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.102 179.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.9 m -65.26 116.12 6.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.065 0.46 . . . . 0.0 111.056 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 45.8 t -122.64 152.45 40.47 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.536 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.637 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 5.3 p -144.54 138.81 23.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.557 0.218 . . . . 0.0 111.04 -179.771 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.447 HG23 HD13 ' A' ' 39' ' ' LEU . 15.2 tt -133.12 148.58 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 120.929 0.395 . . . . 0.0 111.099 -178.725 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.71 95.43 5.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.969 -179.482 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.827 HD22 ' HB2' ' A' ' 21' ' ' LEU . 1.8 mp -75.48 -18.11 59.93 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 120.945 0.403 . . . . 0.0 111.023 178.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.706 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 27.8 p-10 -67.6 -7.4 26.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.423 179.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.528 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 33.1 mtt180 -114.22 14.66 18.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.146 179.445 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.632 ' HD1' ' HE3' ' A' ' 52' ' ' TRP . 0.2 OUTLIER -141.78 -23.31 0.71 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.097 -179.27 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.867 HD22 HD13 ' A' ' 151' ' ' ILE . 57.5 mt -110.07 131.55 54.96 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.474 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.529 ' HB3' ' HA2' ' A' ' 118' ' ' GLY . 0.5 OUTLIER -127.51 141.35 51.68 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.147 -179.12 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.605 ' ND2' HD22 ' A' ' 140' ' ' LEU . 12.3 m-20 -81.25 90.81 6.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.756 177.512 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -85.01 86.89 7.34 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.952 0.406 . . . . 0.0 110.389 177.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.55 ' OD1' ' HB2' ' A' ' 142' ' ' TYR . 16.6 t-20 50.85 45.8 26.92 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.272 179.25 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.646 ' HA2' ' HB2' ' A' ' 140' ' ' LEU . . . 83.02 40.13 9.57 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.183 179.012 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -155.13 121.32 5.22 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.723 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.739 ' HB3' ' HB ' ' A' ' 151' ' ' ILE . 25.8 m-85 -65.59 135.37 54.99 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.147 179.492 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 40.1 mmm-85 -136.64 141.32 43.19 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.856 0.36 . . . . 0.0 111.4 -179.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.717 ' HH2' HD13 ' A' ' 153' ' ' LEU . 92.6 m95 -75.82 143.12 42.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.919 178.544 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.6 t 64.08 -87.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 123.978 0.911 . . . . 0.0 110.824 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 62.2 m -158.03 22.64 0.26 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.63 -56.07 4.69 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.642 -178.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.44 149.72 19.23 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.215 -0.517 . . . . 0.0 111.858 179.555 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.469 ' H ' ' HB3' ' A' ' 81' ' ' ASP . . . -87.8 -31.76 14.57 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.16 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.98 -102.15 2.46 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.317 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.33 -145.29 4.88 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 143.78 -33.8 1.73 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.927 179.639 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -175.6 -132.18 1.56 Allowed Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.692 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.1 m -130.08 113.81 14.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.947 0.403 . . . . 0.0 110.361 -179.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.62 176.46 5.37 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.039 -179.699 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.454 ' HB ' ' CG2' ' A' ' 104' ' ' VAL . 4.5 p -129.18 116.43 19.18 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.74 0.305 . . . . 0.0 111.707 -178.831 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.449 HG21 ' CE1' ' A' ' 80' ' ' PHE . 14.5 p -104.57 139.53 25.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.922 0.392 . . . . 0.0 111.018 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 6.2 m -88.68 127.23 35.58 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.8 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.566 ' CG2' HD12 ' A' ' 99' ' ' ILE . 43.1 t -75.28 133.58 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.358 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -99.18 170.4 8.7 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 124.727 1.267 . . . . 0.0 110.32 -179.489 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.766 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 29.2 tp60 -61.05 110.4 1.35 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.227 -178.834 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.12 -12.27 58.79 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.493 178.384 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -81.77 129.49 34.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.93 0.395 . . . . 0.0 111.288 -179.435 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.57 ' HA ' HG12 ' A' ' 99' ' ' ILE . 67.4 p -109.2 178.11 4.55 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.774 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.604 HD22 HG23 ' A' ' 99' ' ' ILE . 1.6 mm? -53.25 -41.89 65.92 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.444 0.64 . . . . 0.0 109.599 178.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.414 ' HA ' ' HB3' ' A' ' 84' ' ' PHE . 28.6 ttm180 -61.67 -41.49 97.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.105 -179.599 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 79' ' ' ARG . 24.3 m-20 -67.31 -43.59 81.27 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.773 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.535 HG12 ' O ' ' A' ' 72' ' ' THR . 37.2 mm -61.67 -48.2 89.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.147 179.586 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.608 ' HA2' ' SG ' ' A' ' 82' ' ' CYS . . . -57.74 -47.58 87.66 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.893 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.481 ' HA ' ' NE ' ' A' ' 78' ' ' ARG . 5.4 tpm_? -71.48 -29.91 65.37 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 122.47 -0.429 . . . . 0.0 111.601 -179.27 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 40.8 ttt180 -75.04 -39.39 61.03 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.106 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.449 ' CE1' HG21 ' A' ' 65' ' ' VAL . 97.1 m-85 -110.45 15.17 22.33 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.515 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.469 ' HB3' ' H ' ' A' ' 57' ' ' GLY . 37.4 t70 56.33 53.79 8.38 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 122.025 0.917 . . . . 0.0 111.969 179.028 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.608 ' SG ' ' HA2' ' A' ' 77' ' ' GLY . 1.7 p -134.24 170.97 14.91 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.61 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.635 ' O ' HG13 ' A' ' 87' ' ' ILE . 5.5 t70 -97.38 123.0 41.07 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.428 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.43 ' HB2' ' HB3' ' A' ' 73' ' ' LEU . 6.7 p90 -49.6 -31.12 9.97 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 124.579 1.174 . . . . 0.0 111.327 179.263 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -63.42 -48.85 76.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.856 179.281 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.721 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 19.2 mm-40 -67.65 -43.5 80.17 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.363 -178.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.635 HG13 ' O ' ' A' ' 83' ' ' ASP . 5.1 mt -53.61 -46.91 61.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.703 0.763 . . . . 0.0 108.948 179.005 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.605 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . . . -63.21 -51.49 66.08 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.344 178.598 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -61.55 -33.43 73.83 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -177.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.721 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 15.9 mmp_? -68.26 -32.06 71.96 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.289 0.566 . . . . 0.0 110.041 179.275 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.841 HD22 HD13 ' A' ' 93' ' ' ILE . 65.1 t30 -91.28 -4.88 55.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.479 179.474 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 51.5 m-80 77.57 15.96 1.59 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.534 0.733 . . . . 0.0 110.7 -179.432 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.841 HD13 HD22 ' A' ' 91' ' ' ASN . 15.6 pt -105.16 -173.32 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.781 178.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.407 ' HA ' ' OE1' ' A' ' 94' ' ' GLN . 16.5 mm-40 -115.49 154.46 29.28 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.235 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.552 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.5 p-10 -51.59 -63.3 1.18 Allowed 'General case' 0 C--O 1.244 0.77 0 CA-C-O 121.964 0.888 . . . . 0.0 110.176 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.18 13.5 0.9 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.143 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 8.4 t70 -66.16 -32.35 73.73 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.689 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 8.3 mp 70.46 113.97 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.956 -177.549 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.604 HG23 HD22 ' A' ' 73' ' ' LEU . 7.4 pt -94.17 175.92 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.671 -178.337 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.509 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 96.6 m-85 -120.5 159.25 48.86 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.088 -178.731 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.766 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 50.9 Cg_endo -72.57 135.73 24.62 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.177 2.585 . . . . 0.0 112.425 -179.827 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.99 17.87 36.22 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.659 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 66' ' ' THR . 96.5 mt-30 -110.17 159.49 17.31 Favored 'General case' 0 C--O 1.209 -1.038 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.848 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.454 ' CG2' ' HB ' ' A' ' 64' ' ' THR . 8.4 p -116.46 131.24 69.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.553 0.692 . . . . 0.0 110.695 178.621 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.45 HD11 HG21 ' A' ' 99' ' ' ILE . 90.8 mt -121.38 151.02 40.63 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.573 -179.569 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.562 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 41.4 mt-30 -90.74 112.23 23.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.79 0.805 . . . . 0.0 110.917 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.8 m -120.74 151.28 54.23 Favored Pre-proline 0 C--N 1.315 -0.911 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.674 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -65.02 -17.95 60.73 Favored 'Trans proline' 0 C--N 1.332 -0.315 0 C-N-CA 123.147 2.565 . . . . 0.0 114.645 -177.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.1 t -153.83 152.52 30.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.869 0.366 . . . . 0.0 111.066 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -96.75 -165.14 1.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.276 179.387 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.93 -47.14 20.32 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.214 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 127.09 -152.22 18.59 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 -179.768 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.5 t -112.78 -38.87 4.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.948 0.374 . . . . 0.0 110.152 179.597 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.528 ' O ' ' HB3' ' A' ' 41' ' ' ARG . . . 111.48 -47.49 1.04 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.824 179.408 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -58.0 104.75 0.5 Allowed Glycine 0 CA--C 1.516 0.123 0 C-N-CA 121.271 -0.49 . . . . 0.0 112.931 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.66 49.92 6.88 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -179.652 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -103.5 -52.71 2.94 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.311 -0.444 . . . . 0.0 110.596 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 44' ' ' SER . . . -82.85 -74.64 1.19 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.751 -179.095 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 70.7 26.92 3.77 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.854 0.462 . . . . 0.0 111.35 179.168 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.568 ' HB2' ' OD1' ' A' ' 45' ' ' ASN . 20.2 p90 -57.12 -35.86 69.98 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 121.078 0.466 . . . . 0.0 110.325 179.219 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -59.13 -35.98 74.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.069 -178.194 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -66.56 -13.47 61.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.082 0.467 . . . . 0.0 111.386 -179.005 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.481 ' OG ' ' HB3' ' A' ' 141' ' ' ARG . 29.9 t -129.7 8.14 5.31 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.386 -179.71 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -104.35 149.35 25.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.073 0.464 . . . . 0.0 111.573 -179.489 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.536 ' HB2' ' CZ3' ' A' ' 146' ' ' TRP . 1.3 tmm_? -135.76 132.79 37.23 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.178 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.456 ' HB2' ' CZ ' ' A' ' 125' ' ' ARG . 34.6 t70 54.95 67.64 0.99 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.775 0.798 . . . . 0.0 110.693 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.513 ' CG1' HD11 ' A' ' 136' ' ' LEU . 42.0 t -84.68 126.66 40.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.86 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -144.04 141.12 29.92 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.229 -179.052 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.989 HD13 HG22 ' A' ' 14' ' ' ILE . 30.9 mt -86.55 125.31 33.69 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.627 HG23 ' HB ' ' A' ' 135' ' ' VAL . 35.6 m -118.6 161.2 17.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.691 -179.228 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.777 ' HB3' ' HE2' ' A' ' 134' ' ' LYS . 6.1 m-20 66.17 12.51 8.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.597 178.682 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.679 ' O ' HD12 ' A' ' 14' ' ' ILE . . . 90.75 28.43 16.14 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.395 178.413 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.641 ' O ' ' HB2' ' A' ' 153' ' ' LEU . . . 93.13 -16.78 59.72 Favored Glycine 0 C--O 1.261 1.812 0 CA-C-O 123.378 1.543 . . . . 0.0 112.92 177.246 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.777 ' HE2' ' HB3' ' A' ' 131' ' ' ASP . 17.5 pttm -71.31 -12.57 61.51 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 121.348 -1.09 . . . . 0.0 109.283 177.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.627 ' HB ' HG23 ' A' ' 130' ' ' VAL . 18.3 t -142.31 139.34 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.27 177.433 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.522 HD13 HD21 ' A' ' 16' ' ' LEU . 48.9 tp -118.66 122.54 42.78 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.356 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.444 ' OE2' ' HD3' ' A' ' 148' ' ' ARG . 17.1 tt0 -118.51 130.59 56.01 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.986 0.422 . . . . 0.0 110.903 -176.539 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 127' ' ' VAL . . . -156.49 166.24 33.97 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.186 -179.645 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 44.4 mt-10 -94.44 111.33 23.08 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.718 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.646 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 19.8 mt -98.17 132.14 43.94 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.325 -178.333 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.481 ' HB3' ' OG ' ' A' ' 123' ' ' SER . 72.2 ttt180 -73.98 141.23 45.88 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.601 179.667 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.55 ' HB2' ' OD1' ' A' ' 47' ' ' ASN . 1.4 p90 -157.65 -172.94 4.15 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.804 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.2 m -55.21 -31.95 61.85 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.211 0.319 . . . . 0.0 111.728 -179.539 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -93.41 15.29 63.32 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.253 -178.604 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 103.22 -110.99 3.83 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.293 179.664 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.536 ' CZ3' ' HB2' ' A' ' 125' ' ' ARG . 80.0 m95 -131.56 128.32 39.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.785 0.293 . . . . 0.0 110.706 -179.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -128.38 135.11 49.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.173 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.444 ' HD3' ' OE2' ' A' ' 137' ' ' GLU . 36.4 ttm180 -74.13 106.42 5.79 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 8.2 m -116.18 165.81 12.74 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.702 -178.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 15.2 ptt180 -147.0 164.78 31.91 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -178.55 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.867 HD13 HD22 ' A' ' 43' ' ' LEU . 8.3 tt -141.27 161.52 22.15 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.335 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.58 ' O ' ' HZ2' ' A' ' 52' ' ' TRP . 20.3 m-85 -104.58 104.36 14.18 Favored 'General case' 0 C--N 1.316 -0.868 0 O-C-N 122.307 -0.246 . . . . 0.0 110.699 -179.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.839 HD12 HG13 ' A' ' 157' ' ' ILE . 4.4 mm? -66.19 -36.19 82.43 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.218 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.551 ' OD2' ' HA ' ' A' ' 2' ' ' ASN . 16.6 p-10 -57.42 -9.85 1.21 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 179.035 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.709 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . 32.9 mt-10 -71.93 -50.74 26.48 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 179.801 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -121.52 0.03 9.85 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.333 -0.547 . . . . 0.0 112.371 -177.366 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.839 HG13 HD12 ' A' ' 153' ' ' LEU . 45.1 mm -106.97 117.17 52.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.517 179.1 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.595 ' HA2' ' HB3' ' A' ' 7' ' ' PHE . . . -123.29 173.8 16.4 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.93 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.692 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 0.4 OUTLIER -106.13 126.45 52.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.987 0.423 . . . . 0.0 110.258 179.229 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.543 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 8.7 tpt180 -117.44 86.93 2.61 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.801 179.612 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 65.9 t30 55.26 40.65 31.65 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.463 178.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 105.61 -7.45 42.5 Favored Glycine 0 C--O 1.228 -0.25 0 C-N-CA 120.138 -1.029 . . . . 0.0 114.978 177.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 160' ' ' ARG . 13.2 pt-20 -122.04 141.44 51.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 117.936 0.868 . . . . 0.0 111.2 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.585 HD13 HD23 ' A' ' 21' ' ' LEU . 30.8 mt -74.98 122.22 23.16 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.867 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 6.5 tp -122.48 141.06 44.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.902 -179.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 37.8 p-80 -97.02 128.5 44.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.837 179.289 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 20.6 p . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.741 -0.647 . . . . 0.0 110.213 -179.551 . . . . . . . . 0 0 . 1 stop_ save_